PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hosseini, P; Sokolow, SH; Vandegrift, KJ; Kilpatrick, AM; Daszak, P				Hosseini, Parviez; Sokolow, Susanne H.; Vandegrift, Kurt J.; Kilpatrick, A. Marm; Daszak, Peter			Predictive Power of Air Travel and Socio-Economic Data for Early Pandemic Spread	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; INFLUENZA; DETERMINANTS; GENOMICS; VIRUS	Background: Controlling the pandemic spread of newly emerging diseases requires rapid, targeted allocation of limited resources among nations. Critical, early control steps would be greatly enhanced if the key risk factors can be identified that accurately predict early disease spread immediately after emergence. Methodology/Principal Findings: Here, we examine the role of travel, trade, and national healthcare resources in predicting the emergence and initial spread of 2009 A/H1N1 influenza. We find that incorporating national healthcare resource data into our analyses allowed a much greater capacity to predict the international spread of this virus. In countries with lower healthcare resources, the reporting of 2009 A/H1N1 cases was significantly delayed, likely reflecting a lower capacity for testing and reporting, as well as other socio-political issues. We also report substantial international trade in live swine and poultry in the decade preceding the pandemic which may have contributed to the emergence and mixed genotype of this pandemic strain. However, the lack of knowledge of recent evolution of each H1N1 viral gene segment precludes the use of this approach to determine viral origins. Conclusions/Significance: We conclude that strategies to prevent pandemic influenza virus emergence and spread in the future should include: 1) enhanced surveillance for strains resulting from reassortment in traded livestock; 2) rapid deployment of control measures in the initial spreading phase to countries where travel data predict the pathogen will reach and to countries where lower healthcare resources will likely cause delays in reporting. Our results highlight the benefits, for all parties, when higher income countries provide additional healthcare resources for lower income countries, particularly those that have high air traffic volumes. In particular, international authorities should prioritize aid to those poorest countries where both the risk of emerging infectious diseases and air traffic volume is highest. This strategy will result in earlier detection of pathogens and a reduction in the impact of future pandemics.	[Hosseini, Parviez; Vandegrift, Kurt J.; Daszak, Peter] EcoHlth Alliance, New York, NY USA; [Sokolow, Susanne H.; Kilpatrick, A. Marm] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA	EcoHealth Alliance; University of California System; University of California Santa Cruz	Hosseini, P (corresponding author), EcoHlth Alliance, New York, NY USA.	hosseini@ecohealthalliance.org; daszak@ecohealthalliance.org	daszak, peter/U-4588-2017; Hosseini, Parviez/F-8439-2010	daszak, peter/0000-0002-2046-5695; Sokolow, Susanne/0000-0002-5111-9322	John E. Fogarty International Center [3R01-TW005869-05S1]; NSF [EF-0622391/EF-0914866, HSD-0525216]; National Institute of Allergy and Infectious Diseases-National Institutes of Health (NIAID-NIH) [NO1-AI-25490, BCS-0826779]; Eppley Foundation; New York Community Trust; FOGARTY INTERNATIONAL CENTER [R01TW005869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025490] Funding Source: NIH RePORTER	John E. Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NSF(National Science Foundation (NSF)); National Institute of Allergy and Infectious Diseases-National Institutes of Health (NIAID-NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eppley Foundation; New York Community Trust; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the following: National Institutes of Health/National Science Foundation (NIH/NSF) "Ecology of Infectious Diseases'' award from the John E. Fogarty International Center (3R01-TW005869-05S1); NSF "Predicting Spatial Variation in West Nile Virus Transmission'' (EF-0622391/EF-0914866); NSF "Socio-economic and environmental drivers of emerging infectious diseases'' (HSD-0525216); National Institute of Allergy and Infectious Diseases-National Institutes of Health (NIAID-NIH) contract # NO1-AI-25490; NSF "Human and Social Dynamics: Collaborative Research: Human-Related Factors Affecting Emerging Infectious Diseases'' (BCS-0826779); the Eppley Foundation; and the New York Community Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; DIIO LLC, 2009, APGDAT DIIO; Farmer P, 1997, SOC SCI MED, V44, P347, DOI 10.1016/S0277-9536(96)00143-8; Farmer P, 1996, EMERG INFECT DIS, V2, P259, DOI 10.3201/eid0204.960402; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gerrits RJ, 2005, THERIOGENOLOGY, V63, P283, DOI 10.1016/j.theriogenology.2004.09.013; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Huang YX, 2005, ACTA TROP, V96, P223, DOI 10.1016/j.actatropica.2005.07.015; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; R Core Team, 2020, R LANG ENV STAT COMP; Rios J, 2006, J AM MOSQUITO CONTR, V22, P254, DOI 10.2987/8756-971X(2006)22[254:DASAOW]2.0.CO;2; RODGERS GB, 1979, POP STUD-J DEMOG, V33, P343, DOI 10.2307/2173539; SABIROVIV M, 2009, H1N1 INFLUENZA PRELI; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Smolinsky M.S., 2003, MICROBIAL THREATS HL; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; *UN STAT DIV, 2009, UN COMM TRAD STAT DA; VANDEGRIFT KJ, 2010, SCIENCES, V1195, P113; World Bank, 2009, WORLD DEV IND ONL; World Health Organization, 2009, GLOB AL RESP	31	49	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12763	10.1371/journal.pone.0012763	http://dx.doi.org/10.1371/journal.pone.0012763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856678	gold, Green Published, Green Submitted			2022-12-27	WOS:000281815800025
J	Esposito, E; Mazzon, E; Paterniti, I; Impellizzeri, D; Bramanti, P; Cuzzocrea, S				Esposito, Emanuela; Mazzon, Emanuela; Paterniti, Irene; Impellizzeri, Daniela; Bramanti, Placido; Cuzzocrea, Salvatore			Olprinone Attenuates the Acute Inflammatory Response and Apoptosis after Spinal Cord Trauma in Mice	PLOS ONE			English	Article							PHOSPHODIESTERASE-III INHIBITOR; FAS-MEDIATED APOPTOSIS; VASCULAR SMOOTH-MUSCLE; NITRIC-OXIDE SYNTHASE; KAPPA-B ACTIVATION; THERAPEUTIC TARGETS; RECEPTOR ACTIVATION; NEURON DEGENERATION; ADENOSINE RECEPTOR; SIGNALING PATHWAYS	Background: Olprinone hydrochloride is a newly developed compound that selectively inhibits PDE type III and is characterized by several properties, including positive inotropic effects, peripheral vasodilatory effects, and a bronchodilator effect. In clinical settings, olprinone is commonly used to treat congestive cardiac failure, due to its inotropic and vasodilating effects. The mechanism of these cardiac effects is attributed to increased cellular concentrations of cAMP. The aim of the present study was to evaluate the pharmacological action of olprinone on the secondary damage in experimental spinal cord injury (SCI) in mice. Methodology/Principal Findings: Traumatic SCI is characterized by an immediate, irreversible loss of tissue at the lesion site, as well as a secondary expansion of tissue damage over time. Although secondary injury should be preventable, no effective treatment options currently exist for patients with SCI. Spinal cord trauma was induced in mice by the application of vascular clips (force of 24 g) to the dura via a four-level T5-T8 laminectomy. SCI in mice resulted in severe trauma characterized by edema, neutrophil infiltration, and production of inflammatory mediators, tissue damage, apoptosis, and locomotor disturbance. Olprinone treatment (0.2 mg/kg, i.p.) 1 and 6 h after the SCI significantly reduced: (1) the degree of spinal cord inflammation and tissue injury (histological score), (2) neutrophil infiltration (myeloperoxidase activity), (3) nitrotyrosine formation, (4) pro-inflammatory cytokines, (5) NF-kappa B expression, (6) p-ERK1/2 and p38 expression and (7) apoptosis (TUNEL staining, FAS ligand, Bax and Bcl-2 expression). Moreover, olprinone significantly ameliorated the recovery of hind-limb function (evaluated by motor recovery score). Conclusions/Significance: Taken together, our results clearly demonstrate that olprinone treatment reduces the development of inflammation and tissue injury associated with spinal cord trauma.	[Esposito, Emanuela; Paterniti, Irene; Impellizzeri, Daniela; Cuzzocrea, Salvatore] Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, Messina, Italy; [Esposito, Emanuela; Mazzon, Emanuela; Bramanti, Placido; Cuzzocrea, Salvatore] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy	University of Messina; IRCCS Bonino Pulejo	Esposito, E (corresponding author), Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, Messina, Italy.	salvator@unime.it	Bramanti, Placido/K-5117-2016; Mazzon, Emanuela/AAL-4334-2020	Impellizzeri, Daniela/0000-0001-9492-3161; Esposito, Emanuela/0000-0002-2663-6387; mazzon, emanuela/0000-0002-5073-717X	Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)	Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)	This study was supported by a grant from Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) "Bonino Pulejo''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackery A, 2006, J NEUROTRAUM, V23, P604, DOI 10.1089/neu.2006.23.604; Aggarwal S, 1999, CLIN EXP IMMUNOL, V117, P285; Aizawa T, 2003, CIRC RES, V93, P406, DOI 10.1161/01.RES.0000091074.33584.F0; Anas C, 2007, INT J UROL, V14, P219, DOI 10.1111/j.1442-2042.2007.01689.x; ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; Ankeny DP, 2009, NEUROSCIENCE, V158, P1112, DOI 10.1016/j.neuroscience.2008.07.001; Asano T, 2005, CNS NEUROL DISORD-DR, V4, P127, DOI 10.2174/1568007053544084; Bao F, 2003, J NEUROSCI RES, V71, P220, DOI 10.1002/jnr.10481; Bar-Peled O, 1999, J NEUROSCI RES, V55, P542, DOI 10.1002/(SICI)1097-4547(19990301)55:5<542::AID-JNR2>3.0.CO;2-7; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Bethea JR, 1998, J NEUROSCI, V18, P3251; Bhat NR, 1998, J NEUROSCI, V18, P1633; Brook GA, 1998, J NEUROSCI RES, V53, P51, DOI 10.1002/(SICI)1097-4547(19980701)53:1<51::AID-JNR6>3.0.CO;2-I; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Ceruti S, 2009, BRAIN, V132, P2206, DOI 10.1093/brain/awp147; Chen XL, 1996, AM J PHYSIOL-HEART C, V271, pH962, DOI 10.1152/ajpheart.1996.271.3.H962; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Choi SH, 2003, J NEUROSCI, V23, P5877; CRISAFULLI C, 2010, INTENSIVE CARE MED; Cuzzocrea S, 2006, J PHARMACOL EXP THER, V319, P127, DOI 10.1124/jpet.106.108076; Eigler A, 1998, J LEUKOCYTE BIOL, V63, P101, DOI 10.1002/jlb.63.1.101; Fitch MT, 1999, J NEUROSCI, V19, P8182; Genovese T, 2008, CURR MED CHEM, V15, P477; Genovese T, 2006, J PHARMACOL EXP THER, V316, P1006, DOI 10.1124/jpet.105.097188; Genovese T, 2006, J NEUROSURG-SPINE, V4, P145, DOI 10.3171/spi.2006.4.2.145; Genovese T, 2005, J PHARMACOL EXP THER, V312, P449, DOI 10.1124/jpet.104.076711; Genovese T, 2010, J BIOL REG HOMEOS AG, V24, P73; Glaser J, 2006, J NEUROSCI RES, V84, P724, DOI 10.1002/jnr.20982; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; Hirota K, 2001, ACTA ANAESTH SCAND, V45, P510, DOI 10.1034/j.1399-6576.2001.045004510.x; Hu JG, 1996, J BIOL CHEM, V271, P2543, DOI 10.1074/jbc.271.5.2543; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Joshi M, 2002, J NEUROTRAUM, V19, P175, DOI 10.1089/08977150252806947; Lee HT, 2001, AM J KIDNEY DIS, V38, P610, DOI 10.1053/ajkd.2001.26888; Maegele M, 2005, SHOCK, V23, P476, DOI 10.1097/01.shk.0000159929.87737.5c; MALEFYT RD, 1991, J EXP MED, V174, P1209; Matsui T, 2002, J CEREBR BLOOD F MET, V22, P711, DOI 10.1097/00004647-200206000-00010; Miyakawa H, 2008, J ANESTH, V22, P27, DOI 10.1007/s00540-007-0572-4; Miyamoto N, 2010, J CEREBR BLOOD F MET, V30, P299, DOI 10.1038/jcbfm.2009.210; Mizushige K, 2002, CARDIOVASC DRUG REV, V20, P163; Mizutani A, 2005, SHOCK, V24, P281, DOI 10.1097/01.shk.0000175555.95676.34; Mullane K, 1989, Prog Clin Biol Res, V301, P39; Nesic-Taylor O, 2005, J NEUROSCI RES, V79, P628, DOI 10.1002/jnr.20400; OHHARA H, 1989, ARZNEIMITTELFORSCH, V39-1, P38; Okayama N, 2010, ANESTH ANALG, V110, P888, DOI 10.1213/ANE.0b013e3181cb5cdd; Okuda K, 1997, Masui, V46, P1580; Okusa MD, 2001, KIDNEY INT, V59, P2114, DOI 10.1046/j.1523-1755.2001.0590062114.x; Okusa MD, 2002, AM J PHYSIOL-RENAL, V282, pF10, DOI 10.1152/ajprenal.2002.282.1.F10; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Rahman A, 2004, AM J PHYSIOL-LUNG C, V287, pL1017, DOI 10.1152/ajplung.00072.2004; Rivlin A S, 1978, Surg Neurol, V10, P38; Sadiq A, 2003, THROMB RES, V111, P357, DOI 10.1016/j.thromres.2003.09.024; Sanada S, 2001, CIRCULATION, V104, P705, DOI 10.1161/hc3201.092216; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Sirin BH, 2002, ACTA CARDIOL, V57, P279, DOI 10.2143/AC.57.4.2005427; Streit WJ, 1998, EXP NEUROL, V152, P74, DOI 10.1006/exnr.1998.6835; TAJIMI M, 1991, N-S ARCH PHARMACOL, V344, P602; TATOR CH, 1991, NEUROCHIRURGIE, V37, P291; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Trivedi A, 2006, CLIN NEUROSCI RES, V6, P283, DOI 10.1016/j.cnr.2006.09.007; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X; Verma IM, 2004, ANN RHEUM DIS, V63, P57, DOI 10.1136/ard.2004.028266; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Xu Z, 2006, LIFE SCI, V79, P1895, DOI 10.1016/j.lfs.2006.06.023; YAMAGUCHI K, 2009, SHOCK; Yamaguchi K, 2010, SHOCK, V33, P436, DOI 10.1097/SHK.0b013e3181be3d7a; Yoshino O, 2004, SPINE, V29, P1394, DOI 10.1097/01.BRS.0000129894.34550.48; Yu WR, 2009, EUR J NEUROSCI, V29, P114, DOI 10.1111/j.1460-9568.2008.06555.x; Zager RA, 2005, AM J PHYSIOL-RENAL, V289, pF289, DOI 10.1152/ajprenal.00023.2005	73	23	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12170	10.1371/journal.pone.0012170	http://dx.doi.org/10.1371/journal.pone.0012170			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830289	Green Published, gold, Green Submitted			2022-12-27	WOS:000281631300001
J	Goletti, D; Raja, A; Kabeer, BSA; Rodrigues, C; Sodha, A; Carrara, S; Vernet, G; Longuet, C; Ippolito, G; Thangaraj, S; Leportier, M; Girardi, E; Lagrange, PH				Goletti, Delia; Raja, Alamelu; Kabeer, Basirudeen Syed Ahamed; Rodrigues, Camilla; Sodha, Archana; Carrara, Stefania; Vernet, Guy; Longuet, Christophe; Ippolito, Giuseppe; Thangaraj, Satheesh; Leportier, Marc; Girardi, Enrico; Lagrange, Philippe Henri			Is IP-10 an Accurate Marker for Detecting M. tuberculosis-Specific Response in HIV-Infected Persons?	PLOS ONE			English	Article							GAMMA-INDUCIBLE PROTEIN-10; T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; ACTIVE TUBERCULOSIS; LATENT TUBERCULOSIS; IFN-GAMMA; DIAGNOSIS; ASSAY; BIOMARKERS	The suboptimal sensitivity of Interferon (IFN)-gamma-based in-vitro assays, especially in immunocompromised individuals, emphasizes the need for alternative markers for diagnosing tuberculosis (TB). The objective of this study was to evaluate whether interferon-inducible protein (IP)-10, monocyte chemotactic protein (MCP)-2 and interleukin (IL)-2 can be useful biomarkers for evaluating a specific response to RD1 antigens associated to active TB disease in HIV-infected individuals. Methodology/Principal Findings: The study was carried out in India, the country with the highest TB burden in the world. Sixty-six HIV-infected individuals were prospectively enrolled, 28 with active-pulmonary-TB and 38 without. The whole blood assay based on RD1-selected peptides (experimental test) and QuantiFERON-TB Gold In tube (QFT-IT) was performed. Plasma was harvested at day-1-post-culture and soluble factors were evaluated by ELISA. The results indicate that by detecting IP-10, the sensitivity of the experimental test and QFT-antigen (75% and 85.7% respectively) for active TB was higher compared to the same assays based on IFN-gamma (42.9% and 60.7% respectively) and was not influenced by the ability to respond to the mitogen. By detecting IP-10, the specificity of the experimental test and QFT-antigen (57.9% and 13.2% respectively) for active TB was lower than what was reported for the same assays using IFN-gamma-detection (78.9% and 68.4% respectively). On the other side, in vitro IL-2 and MCP-2 responses were not significantly associated with active TB. Conclusions: HIV infection does not impair RD1-specific response detected by IP-10, while it significantly decreases IFN-gamma-mediated responses. At the moment it is unclear whether higher detection is related to higher sensitivity or lower specificity of the assay. Further studies in high and low TB endemic countries are needed to elucidate this.	[Goletti, Delia; Carrara, Stefania] Lazzaro Spallanzani Natl Inst Infect Dis INMI, Dept Epidemiol & Preclin Res, Translat Res Unit, Rome, Italy; [Raja, Alamelu; Kabeer, Basirudeen Syed Ahamed] TB Res Ctr ICMR, Dept Immunol, Madras, Tamil Nadu, India; [Rodrigues, Camilla; Sodha, Archana] PD Hinduja Natl Hosp & Res Ctr, Dept Microbiol, Bombay, Maharashtra, India; [Vernet, Guy; Longuet, Christophe] Fdn Merieux, Sci Direct, Lyon, France; [Ippolito, Giuseppe] INMI, Sci Direct, Rome, Italy; [Thangaraj, Satheesh; Leportier, Marc] BioMerieux, Res & Dev Immunoassays, Marcy Letoile, France; [Girardi, Enrico] INMI, Dept Epidemiol & Preclin Res, Rome, Italy; [Lagrange, Philippe Henri] St Louis Hosp, Microbiol Serv, Paris, France	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); IRCCS Lazzaro Spallanzani; bioMerieux; IRCCS Lazzaro Spallanzani; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Goletti, D (corresponding author), Lazzaro Spallanzani Natl Inst Infect Dis INMI, Dept Epidemiol & Preclin Res, Translat Res Unit, Rome, Italy.	delia.goletti@inmi.it	Ippolito, Giuseppe/J-7207-2017; Kabeer, Basirudeen Syed Ahamed/AAQ-7599-2020; goletti, delia/AAM-6577-2020	Kabeer, Basirudeen Syed Ahamed/0000-0002-7287-1636; Goletti, Delia/0000-0001-8360-4376; Girardi, Enrico/0000-0001-8182-5896; Ippolito, Giuseppe/0000-0002-1076-2979	Fondation Merieux; Italian Ministry of Health and Ricerca Finalizzata [06.76.1, 07.103]	Fondation Merieux; Italian Ministry of Health and Ricerca Finalizzata(Ministry of Health, Italy)	The study was supported by grants from Fondation Merieux and from the Italian Ministry of Health and Ricerca Finalizzata 06.76.1 and 07.103. ML and ST are employees of Biomerieux. Biomeriueux through their employees' involvement established the scientific, laboratory and medical network that allowed the accomplishment of a main project on "tool box for tuberculosis diagnosis'' and consequently of the satellite studies. The study described in this manuscript was a satellite study of the main project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Berktas M, 2004, J INT MED RES, V32, P324, DOI 10.1177/147323000403200313; BISELLI R, 2010, CLIN MICROB IN PRESS; Butera O, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-182; Carrara S, 2004, CLIN INFECT DIS, V38, P754, DOI 10.1086/381754; Chadha VK, 2003, INT J TUBERC LUNG D, V7, P172; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Goletti D, 2005, CLIN DIAGN LAB IMMUN, V12, P1311, DOI 10.1128/CDLI.12.11.1311-1316.2005; Goletti D, 2010, EUR RESPIR J, V36, P135, DOI 10.1183/09031936.00140009; Goletti D, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-11; Goletti D, 2007, CLIN INFECT DIS, V45, P1652, DOI 10.1086/523012; Goletti D, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-5; Goletti D, 2006, J INFECT DIS, V194, P984, DOI 10.1086/507427; Goletti D, 2010, J INFECTION, V61, P133, DOI 10.1016/j.jinf.2010.05.002; Goletti D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003417; Harada Nobuyuki, 2004, Kekkaku, V79, P725; Hoffmann M, 2010, EUR INFECT DIS, V4, P23; Kabeer BSA, 2010, AIDS, V24, P323, DOI 10.1097/QAD.0b013e328334895e; Kabeer BSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009051; Kabeer BSA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005718; Lange C, 2010, RESPIROLOGY, V15, P220, DOI 10.1111/j.1440-1843.2009.01692.x; Lawn SD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-99; Leidl L, 2010, EUR RESPIR J, V35, P619, DOI 10.1183/09031936.00045509; Leyten EMS, 2007, CLIN VACCINE IMMUNOL, V14, P880, DOI 10.1128/CVI.00132-07; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Ministry of Health & Family Welfare, 2009, REV NAT TUB CONTR PR; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Ruhwald M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002858; Sargentini V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-99; Vincenti D, 2007, CLIN EXP IMMUNOL, V150, P91, DOI 10.1111/j.1365-2249.2007.03462.x; Vincenti D, 2003, MOL MED, V9, P105, DOI 10.1007/BF03402042; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901	38	74	75	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12577	10.1371/journal.pone.0012577	http://dx.doi.org/10.1371/journal.pone.0012577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830287	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000281631300010
J	Dunachie, SJ; Berthoud, T; Keating, SM; Hill, AVS; Fletcher, HA				Dunachie, Susanna J.; Berthoud, Tamara; Keating, Sheila M.; Hill, Adrian V. S.; Fletcher, Helen A.			MIG and the Regulatory Cytokines IL-10 and TGF-beta 1 Correlate with Malaria Vaccine Immunogenicity and Efficacy	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CIRCUMSPOROZOITE PROTEIN VACCINE; PLASMODIUM-FALCIPARUM INFECTION; PRODUCTION IN-VITRO; IFN-GAMMA; T-CELLS; TGF-BETA; PROTECTIVE IMMUNITY; AFRICAN CHILDREN; INTERFERON-GAMMA	Malaria remains one of the world's greatest killers and a vaccine is urgently required. There are no established correlates of protection against malaria either for natural immunity to the disease or for immunity conferred by candidate malaria vaccines. The RTS,S/AS02A vaccine offers significant partial efficacy against malaria. mRNA expression of five key cytokines interferon-gamma (IFN-gamma), monokine induced by gamma (MIG), interleukin-10 (IL-10), transforming growth factor-beta (TGF-beta) and forkhead box P3 (FoxP3) in peripheral blood mononuclear cells were measured by real-time RT-PCR before and after vaccination with RTS, S/AS02A and Modified Vaccinia virus Ankara encoding the circumsporozoite protein (MVA-CS) in healthy malaria-naive adult volunteers. The only significant change was in IFN-gamma mRNA expression, which was increased seven days after vaccination (P = 0.04). Expression of MIG mRNA seven days after vaccination correlated inversely with time to detection of parasites by blood film in an experimental sporozoite challenge (r = 0.94 P = 0.005). An inverse relationship was seen between both TGF-beta 1 and IL-10 mRNA at baseline and the anti-circumsporozoite IgG antibody response (r = -0.644 P = 0.022 and r = -0.554 P = 0.031 respectively). This study demonstrates the potential for MIG expression as a correlate of protection against malaria. Baseline levels of the regulatory cytokines TGF-beta and IL-10 inversely correlated with antibody levels post vaccination and warrant further studies to improve understanding of individual differences in response to vaccination.	[Dunachie, Susanna J.; Berthoud, Tamara; Keating, Sheila M.; Hill, Adrian V. S.; Fletcher, Helen A.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Jenner Inst, Oxford, England	University of Oxford; Jenner Institute	Dunachie, SJ (corresponding author), Univ Oxford, Ctr Clin Vaccinol & Trop Med, Jenner Inst, Oxford, England.	susie.dunachie@ndm.ox.ac.uk	Fletcher, Helen/D-1470-2011; Keating, Sheila/B-1652-2013	Keating, Sheila/0000-0002-8324-3694; Fletcher, Helen/0000-0002-0435-1006; Dunachie, Susanna/0000-0001-5665-6293	Wellcome Trust; UK Medical Research Council; PATH Malaria Vaccine Initiative; NIHR; MRC [G84/6323] Funding Source: UKRI; Medical Research Council [G84/6323] Funding Source: researchfish; National Institute for Health Research [CL-2008-13-010] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); PATH Malaria Vaccine Initiative; NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by funding from the Wellcome Trust, the UK Medical Research Council, the PATH Malaria Vaccine Initiative and an NIHR award to the Oxford Biomedical Research Centre. AVSH is a Wellcome Trust Principal Research Fellow and SJD was an MRC Clinical Fellow when most of this work was performed. SJD is now an Academic Clinical Lecturer at Oxford University Clinical Academic Graduate School (OUCAGS@medsci.ox.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramo C, 2006, MICROBES INFECT, V8, P45, DOI 10.1016/j.micinf.2005.05.019; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; BAKE AWLV, 1992, CELL IMMUNOL, V144, P417, DOI 10.1016/0008-8749(92)90256-O; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bejon P, 2007, J IMMUNOL, V179, P4193, DOI 10.4049/jimmunol.179.6.4193; Beniguel L, 2003, PARASITE IMMUNOL, V25, P39, DOI 10.1046/j.1365-3024.2003.00603.x; Berthoud TK, 2009, J IMMUNOL METHODS, V340, P33, DOI 10.1016/j.jim.2008.09.021; BERTHOUD TK, 2008, J IMMUNOL METHODS; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Brice GT, 2001, J IMMUNOL METHODS, V257, P55, DOI 10.1016/S0022-1759(01)00446-X; Campbell DI, 2003, PEDIATR RES, V54, P306, DOI 10.1203/01.PDR.0000076666.16021.5E; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Dodoo D, 2002, J INFECT DIS, V185, P971, DOI 10.1086/339408; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; Dunachie SJ, 2006, VACCINE, V24, P2850, DOI 10.1016/j.vaccine.2005.12.041; Fletcher HA, 2008, VACCINE, V26, P5269, DOI 10.1016/j.vaccine.2008.07.040; Fowkes FJ, PLOS MED, V7; Grainger DJ, 1999, HUM MOL GENET, V8, P93, DOI 10.1093/hmg/8.1.93; Hardison JL, 2006, INFECT IMMUN, V74, P125, DOI 10.1128/IAI.74.1.125-134.2006; Hasan Z, 2009, SCAND J IMMUNOL, V69, P259, DOI 10.1111/j.1365-3083.2008.02217.x; HOFFMAN SL, 1987, EXP PARASITOL, V64, P64, DOI 10.1016/0014-4894(87)90009-9; Hoffman SL, 1996, MALARIA VACCINE DEV; Hviid L, 1998, Expert Rev Mol Med, V1998, P1, DOI 10.1017/S1462399498000179; KEHRL JH, 1986, J IMMUNOL, V137, P3855; Kempf K, 2006, HORM METAB RES, V38, P346, DOI 10.1055/s-2006-925403; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Lalvani A, 1999, J INFECT DIS, V180, P1656, DOI 10.1086/315074; LALVANI A, 1994, RES IMMUNOL, V145, P461, DOI 10.1016/S0923-2494(94)80177-0; LEE G, 1987, J EXP MED, V166, P1290, DOI 10.1084/jem.166.5.1290; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; MWACHARO J, PLOS ONE IN PRESS; Omer FM, 2003, J IMMUNOL, V171, P5430, DOI 10.4049/jimmunol.171.10.5430; Othoro C, 1999, J INFECT DIS, V179, P279, DOI 10.1086/314548; Perez-Machado MA, 2003, EUR J IMMUNOL, V33, P2307, DOI 10.1002/eji.200323308; Petritus PM, 2008, J IMMUNOL, V180, P444, DOI 10.4049/jimmunol.180.1.444; Richie T, 2006, PARASITOLOGY, V133, pS113, DOI 10.1017/S0031182006001843; Sacarlal J, 2009, J INFECT DIS, V200, P329, DOI 10.1086/600119; Sarkar SA, 2007, DIABETES, V56, P72, DOI 10.2337/db06-0617; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Su Z, 2006, INFECT IMMUN, V74, P2138, DOI 10.1128/IAI.74.4.2138-2144.2006; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490	48	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12557	10.1371/journal.pone.0012557	http://dx.doi.org/10.1371/journal.pone.0012557			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838432	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000281627700010
J	Fischer, T; Langner, R; Diers, K; Brocke, B; Birbaumer, N				Fischer, Thomas; Langner, Robert; Diers, Kersten; Brocke, Burkhard; Birbaumer, Niels			Temporo-Spatial Dynamics of Event-Related EEG Beta Activity during the Initial Contingent Negative Variation	PLOS ONE			English	Article							ELECTROMAGNETIC TOMOGRAPHY; RESPONSE ANTICIPATION; MOTOR PREPARATION; BRAIN NETWORKS; CORTEX; SYNCHRONIZATION; HUMANS; TASK; POTENTIALS; ATTENTION	In the electroencephalogram (EEG), early anticipatory processes are accompanied by a slow negative potential, the initial contingent negative variation (iCNV), occurring between 500 and 1500 ms after cue onset over prefrontal cortical regions in tasks with cue-target intervals of about 3 s or longer. However, the temporal sequence of the distributed cortical activity contributing to iCNV generation remains unclear. During iCNV generation, selectively enhanced low-beta activity has been reported. Here we studied the temporal order of activation foci in cortical regions assumed to underlie iCNV generation using source reconstruction of low-beta (13-18 Hz) activity. During the iCNV, elicited by a cued simple reaction-time task, low-beta power peaked first (750 ms after cue onset) in anterior frontal and limbic regions and last (140 ms later) in posterior areas. This activity occurred 3300 ms before target onset and provides evidence for the temporally ordered involvement of both cognitive-control and motor-preparation processes already at early stages during the preparation for speeded action.	[Fischer, Thomas; Diers, Kersten; Brocke, Burkhard] Tech Univ Dresden, Dept Psychol, Chair Differential & Personal Psychol, Dresden, Germany; [Langner, Robert] Rhein Westfal TH Aachen, Dept Psychiat & Psychotherapy, Aachen, Germany; [Fischer, Thomas; Langner, Robert] Rhein Westfal TH Aachen, Dept Neurol, Neuropsychol Sect, Aachen, Germany; [Langner, Robert] Res Ctr Juelich, Inst Neurosci & Med INM 2, Julich, Germany; [Birbaumer, Niels] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Birbaumer, Niels] Osped San Camillo, Ist Ricovero & Cura Carattere Sci, Venice, Italy	Technische Universitat Dresden; RWTH Aachen University; RWTH Aachen University; Helmholtz Association; Research Center Julich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Fischer, T (corresponding author), Tech Univ Dresden, Dept Psychol, Chair Differential & Personal Psychol, Dresden, Germany.	thomas.fischer@tu-dresden.de		Birbaumer, Niels/0000-0002-6786-5127; Langner, Robert/0000-0002-3237-001X	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre M, 2006, CLIN NEUROPHYSIOL, V117, P16, DOI 10.1016/j.clinph.2005.08.030; Bender S, 2005, NEUROIMAGE, V27, P737, DOI 10.1016/j.neuroimage.2005.05.020; BIRBAUMER N, 1990, PHYSIOL REV, V70, P1, DOI 10.1152/physrev.1990.70.1.1; BIRBAUMER N, 1981, BIOL PSYCHOL, V13, P251, DOI 10.1016/0301-0511(81)90040-5; BRUNIA CHM, 1993, PSYCHOPHYSIOLOGY, V30, P327, DOI 10.1111/j.1469-8986.1993.tb02054.x; Coull JT, 2000, NEUROPSYCHOLOGIA, V38, P808, DOI 10.1016/S0028-3932(99)00132-3; Critchley HD, 2005, NEUROIMAGE, V27, P885, DOI 10.1016/j.neuroimage.2005.05.047; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Fan J, 2007, J NEUROSCI, V27, P2272, DOI 10.1523/JNEUROSCI.3470-06.2007; Flores AB, 2009, BRAIN COGNITION, V71, P129, DOI 10.1016/j.bandc.2009.04.011; Gomez CA, 2007, BRAIN RES BULL, V73, P40, DOI 10.1016/j.brainresbull.2007.01.015; Gomez CM, 2003, NEUROIMAGE, V20, P216, DOI 10.1016/S1053-8119(03)00295-7; Hamano T, 1997, EVOKED POTENTIAL, V104, P257, DOI 10.1016/S0168-5597(97)96107-4; Heyder K, 2004, ACTA PSYCHOL, V115, P271, DOI 10.1016/j.actpsy.2003.12.010; KAMP A, 1972, ELECTROEN CLIN NEURO, V33, P257, DOI 10.1016/0013-4694(72)90152-6; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Loveless N E, 1974, Biol Psychol, V1, P303, DOI 10.1016/0301-0511(74)90005-2; Lutcke H, 2009, J COGNITIVE NEUROSCI, V21, P2172, DOI 10.1162/jocn.2008.21165; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Mantanus H, 1984, Rev Electroencephalogr Neurophysiol Clin, V14, P97, DOI 10.1016/S0370-4475(84)80013-1; Molnar M, 2008, PSYCHOPHYSIOLOGY, V45, P412, DOI 10.1111/j.1469-8986.2008.00648.x; MONTARON MF, 1988, EXP BRAIN RES, V69, P559; Nagai Y, 2004, NEUROIMAGE, V21, P1232, DOI 10.1016/j.neuroimage.2003.10.036; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pascual-Marqui Roberto D., 2009, P121; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Swick D, 2002, NEUROPSYCHOLOGIA, V40, P1240, DOI 10.1016/S0028-3932(01)00226-3; Tallon-Baudry C, 1999, VISUAL NEUROSCI, V16, P449, DOI 10.1017/S0952523899163065; Tang AC, 2005, NEUROIMAGE, V25, P539, DOI 10.1016/j.neuroimage.2004.11.027; von Stein A, 1999, CEREB CORTEX, V9, P137, DOI 10.1093/cercor/9.2.137; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0	32	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12514	10.1371/journal.pone.0012514	http://dx.doi.org/10.1371/journal.pone.0012514			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824080	Green Published, Green Submitted, gold			2022-12-27	WOS:000281480900007
J	Kuenne, C; Voget, S; Pischimarov, J; Oehm, S; Goesmann, A; Daniel, R; Hain, T; Chakraborty, T				Kuenne, Carsten; Voget, Sonja; Pischimarov, Jordan; Oehm, Sebastian; Goesmann, Alexander; Daniel, Rolf; Hain, Torsten; Chakraborty, Trinad			Comparative Analysis of Plasmids in the Genus Listeria	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; CONJUGATIVE PLASMID; MODIFICATION SYSTEM; BACILLUS-ANTHRACIS; DNA-POLYMERASES; GENOME SEQUENCE; MONOCYTOGENES; REPLICATION; VIRULENCE; CADMIUM	Background: We sequenced four plasmids of the genus Listeria, including two novel plasmids from L. monocytogenes serotype 1/2c and 7 strains as well as one from the species L. grayi. A comparative analysis in conjunction with 10 published Listeria plasmids revealed a common evolutionary background. Principal Findings: All analysed plasmids share a common replicon-type related to theta-replicating plasmid pAMbeta1. Nonetheless plasmids could be broadly divided into two distinct groups based on replicon diversity and the genetic content of the respective plasmid groups. Listeria plasmids are characterized by the presence of a large number of diverse mobile genetic elements and a commonly occurring translesion DNA polymerase both of which have probably contributed to the evolution of these plasmids. We detected small non-coding RNAs on some plasmids that were homologous to those present on the chromosome of L. monocytogenes EGD-e. Multiple genes involved in heavy metal resistance (cadmium, copper, arsenite) as well as multidrug efflux (MDR, SMR, MATE) were detected on all listerial plasmids. These factors promote bacterial growth and survival in the environment and may have been acquired as a result of selective pressure due to the use of disinfectants in food processing environments. MDR efflux pumps have also recently been shown to promote transport of cyclic diadenosine monophosphate (c-di-AMP) as a secreted molecule able to trigger a cytosolic host immune response following infection. Conclusions: The comparative analysis of 14 plasmids of genus Listeria implied the existence of a common ancestor. Ubiquitously-occurring MDR genes on plasmids and their role in listerial infection now deserve further attention.	[Kuenne, Carsten; Pischimarov, Jordan; Hain, Torsten; Chakraborty, Trinad] Univ Giessen, Inst Med Microbiol, Giessen, Germany; [Voget, Sonja; Daniel, Rolf] Univ Gottingen, Goettingen Genom Lab, Inst Genet & Microbiol, D-3400 Gottingen, Germany; [Oehm, Sebastian; Goesmann, Alexander] Univ Bielefeld, Ctr Biotechnol, Bioinformat Resource Facil, Bielefeld, Germany	Justus Liebig University Giessen; University of Gottingen; University of Bielefeld	Kuenne, C (corresponding author), Univ Giessen, Inst Med Microbiol, Giessen, Germany.	Torsten.Hain@mikrobio.med.uni-giessen.de; Trinad.Chakraborty@mikrobio.med.uni-giessen.de	Daniel, Rolf/AAQ-5933-2021	Daniel, Rolf/0000-0002-8646-7925; Goesmann, Alexander/0000-0002-7086-2568; Kuenne, Carsten/0000-0001-8013-5906	German Ministry of Education and Research; sncRNAomics; SPATELIS	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); sncRNAomics; SPATELIS	The project was funded by the German Ministry of Education and Research through the ERANET program grants sncRNAomics and SPATELIS to T. H. and T. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizoglu RO, 2009, APPL ENVIRON MICROB, V75, P5315, DOI 10.1128/AEM.00458-09; Ballal A, 2007, J BIOSCIENCES, V32, P559, DOI 10.1007/s12038-007-0055-7; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Boylan JA, 2006, MOL MICROBIOL, V59, P475, DOI 10.1111/j.1365-2958.2005.04963.x; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Brondsted L, 2003, FEMS MICROBIOL LETT, V219, P233, DOI 10.1016/S0378-1097(03)00052-1; Bruand C, 1998, MOL MICROBIOL, V30, P135, DOI 10.1046/j.1365-2958.1998.01044.x; CANCHAYA C, 2010, APPL ENV MICROBIOL; Ceragioli M, 2010, APPL ENVIRON MICROB, V76, P3352, DOI 10.1128/AEM.03003-09; Chakraborty T, 2000, INT J MED MICROBIOL, V290, P167; Chopin MC, 2005, CURR OPIN MICROBIOL, V8, P473, DOI 10.1016/j.mib.2005.06.006; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Fang F, 2008, APPL ENVIRON MICROB, V74, P3216, DOI 10.1128/AEM.02631-07; FISTROVICI E, 1990, INT J FOOD MICROBIOL, V10, P43, DOI 10.1016/0168-1605(90)90006-Q; FLAMM RK, 1984, INFECT IMMUN, V44, P157, DOI 10.1128/IAI.44.1.157-161.1984; Francia MV, 2004, J BACTERIOL, V186, P5003, DOI 10.1128/jb.186.15.5003-5016.2004; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Gibson CM, 2000, J BACTERIOL, V182, P448, DOI 10.1128/JB.182.2.448-455.2000; Gilmour MW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-120; Glaser P, 2001, SCIENCE, V294, P849; Graves LM, 2010, INT J SYST EVOL MICR, V60, P1280, DOI 10.1099/ijs.0.014118-0; Guillet C, 2010, EMERG INFECT DIS, V16, P136, DOI 10.3201/eid1601.091155; HADORN K, 1993, EUR J CLIN MICROBIOL, V12, P928, DOI 10.1007/BF01992167; Hain T, 2006, J BACTERIOL, V188, P7405, DOI 10.1128/JB.00758-06; Harvey J, 2001, APPL ENVIRON MICROB, V67, P840, DOI 10.1128/AEM.67.2.840-847.2001; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Kim MH, 2008, J BIOL CHEM, V283, P31981, DOI 10.1074/jbc.M804092200; KOLSTAD J, 1992, INT J FOOD MICROBIOL, V16, P247, DOI 10.1016/0168-1605(92)90085-H; Koskiniemi S, 2009, P NATL ACAD SCI USA, V106, P10248, DOI 10.1073/pnas.0904389106; Kosman DJ, 2010, J BIOL INORG CHEM, V15, P15, DOI 10.1007/s00775-009-0590-9; Kuenne CT, 2007, BIOINFORMATICS, V23, P125, DOI 10.1093/bioinformatics/btl556; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; LA CS, 2007, MOL MICROBIOL, V66, P1148; LEBRUN M, 1992, APPL ENVIRON MICROB, V58, P3183, DOI 10.1128/AEM.58.9.3183-3186.1992; LEBRUN M, 1994, J BACTERIOL, V176, P3040, DOI 10.1128/JB.176.10.3040-3048.1994; LECLERCQ A, 2009, INT J SYST EVOL MICR; Madsen A, 2001, FEMS MICROBIOL LETT, V200, P91, DOI 10.1111/j.1574-6968.2001.tb10698.x; Masaoka Y, 2000, J BACTERIOL, V182, P2307, DOI 10.1128/JB.182.8.2307-2310.2000; McLauchlin J, 1997, J APPL MICROBIOL, V83, P381, DOI 10.1046/j.1365-2672.1997.00238.x; McLauchlin J, 2004, INT J FOOD MICROBIOL, V92, P15, DOI 10.1016/S0168-1605(03)00326-X; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Nelson KE, 2004, NUCLEIC ACIDS RES, V32, P2386, DOI 10.1093/nar/gkh562; Orsi RH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-539; PEREZDIAZ JC, 1982, PLASMID, V8, P112, DOI 10.1016/0147-619X(82)90049-X; PETERKIN PI, 1992, CAN J MICROBIOL, V38, P161, DOI 10.1139/m92-027; POYARTSALMERON C, 1990, LANCET, V335, P1422, DOI 10.1016/0140-6736(90)91447-I; Roy CR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.262pe14; Steinweg C, 2010, J BACTERIOL, V192, P1473, DOI 10.1128/JB.01415-09; Su P, 1999, APPL ENVIRON MICROB, V65, P686; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tinsley E, 2004, J BACTERIOL, V186, P2717, DOI 10.1128/JB.186.9.2717-2723.2004; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Van der Auwera GA, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-103; Francia MV, 2007, J BACTERIOL, V189, P8546, DOI 10.1128/JB.00719-07; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; WEAVER KE, 1993, J BACTERIOL, V175, P1900, DOI 10.1128/JB.175.7.1900-1909.1993; Wilcks A, 1999, J BACTERIOL, V181, P3193, DOI 10.1128/JB.181.10.3193-3200.1999; WOODWARD JJ, 2010, SCIENCE; Zhang ZG, 2007, BIOCHEMISTRY-US, V46, P5218, DOI 10.1021/bi7001604	60	80	81	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12511	10.1371/journal.pone.0012511	http://dx.doi.org/10.1371/journal.pone.0012511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824078	Green Published, Green Submitted, gold			2022-12-27	WOS:000281480900005
J	Chen, MI; Barr, IG; Koh, GCH; Lee, VJ; Lee, CPS; Shaw, R; Lin, C; Yap, J; Cook, AR; Tan, BH; Loh, JP; Barkham, T; Chow, VTK; Lin, RTP; Leo, YS				Chen, Mark I.; Barr, Ian G.; Koh, Gerald C. H.; Lee, Vernon J.; Lee, Caroline P. S.; Shaw, Robert; Lin, Cui; Yap, Jonathan; Cook, Alex R.; Tan, Boon Huan; Loh, Jin Phang; Barkham, Timothy; Chow, Vincent T. K.; Lin, Raymond T. P.; Leo, Yee-Sin			Serological Response in RT-PCR Confirmed H1N1-2009 Influenza A by Hemagglutination Inhibition and Virus Neutralization Assays: An Observational Study	PLOS ONE			English	Article							H1N1; INFECTION	Background: We describe the serological response following H1N1-2009 influenza A infections confirmed by reverse-transcriptase polymerase chain reaction (RT-PCR). Methodology and Principal Findings: The study included patients admitted to hospital, subjects of a seroepidemiologic cohort study, and participants identified from outbreak studies in Singapore. Baseline (first available blood sample) and follow-up blood samples were analyzed for antibody titers to H1N1-2009 and recently circulating seasonal influenza A virus strains by hemagglutination inhibition (HI) and virus micro-neutralization (VM) assays. 267 samples from 118 cases of H1N1-2009 were analyzed. Geometric mean titers by HI peaked at 123 (95% confidence interval, CI 43-356) between days 30 to 39. The chance of observing seroconversion (four-fold or greater increase of antibodies) was maximized when restricting analysis to 45 participants with baseline sera collected within 5 days of onset and follow-up sera collected 15 or more days after onset; for these participants, 82% and 89% seroconverted to A/California/7/2009 H1N1 by HI and VM respectively. A four-fold or greater increase in cross-reactive antibody titers to seasonal A/Brisbane/59/2007 H1N1, A/Brisbane/10/2007 H3N2 and A/Wisconsin/15/2009 H3N2 occurred in 20%, 18% and 16% of participants respectively. Conclusions and Significance: Appropriately timed paired serology detects 80-90% RT-PCR confirmed H1N1-2009; Antibodies from infection with H1N1-2009 cross-reacted with seasonal influenza viruses.	[Chen, Mark I.; Lee, Caroline P. S.; Leo, Yee-Sin] Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore; [Koh, Gerald C. H.; Lee, Vernon J.] Natl Univ Singapore, Ctr Hlth Serv Res, Singapore 117548, Singapore; [Chen, Mark I.] Duke NUS Grad Med Sch, Singapore, Singapore; [Barr, Ian G.; Shaw, Robert] World Hlth Org Collaborating Ctr Reference & Res, Melbourne, Vic, Australia; [Lee, Vernon J.; Yap, Jonathan] Minist Def, Biodefence Ctr, Singapore, Singapore; [Lee, Vernon J.] Australian Natl Univ, Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Lin, Cui; Lin, Raymond T. P.] Minist Hlth, Natl Publ Hlth Lab, Singapore, Singapore; [Cook, Alex R.] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Tan, Boon Huan; Loh, Jin Phang] DSO Natl Labs, Detect & Diagnost Lab, Singapore, Singapore; [Barkham, Timothy] Tan Tock Seng Hosp, Dept Lab Med, Singapore, Singapore; [Chow, Vincent T. K.] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore	Tan Tock Seng Hospital; National University of Singapore; National University of Singapore; World Health Organization; Australian National University; Ministry of Health-Singapore; National University of Singapore; Tan Tock Seng Hospital; National University of Singapore	Chen, MI (corresponding author), Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore.	Mark_IC_Chen@ttsh.com.sg	Yap, Jonathan/AAJ-7266-2020; Chen, Mark/AGC-5338-2022; Cook, Alex/S-3576-2019; Cook, Alex/B-5941-2011; Chen, Mark/CAG-2949-2022; Tan, Boon Huan/ABB-8381-2021	Yap, Jonathan/0000-0002-5227-8536; Chen, Mark/0000-0001-9369-5830; Cook, Alex/0000-0002-6271-5832; Chen, Mark/0000-0001-9369-5830; Tan, Boon Huan/0000-0002-4976-7988; Barr, Ian/0000-0002-7351-418X; Chow, Vincent/0000-0003-2634-6213; Koh, Choon Huat Gerald/0000-0002-6453-6897	National Medical Research Council of Singapore [NMRC/H1N1O/002/2009]; Australian Government Department of Health and Ageing	National Medical Research Council of Singapore(National Medical Research Council, Singapore); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	The project was funded as part of the grant NMRC/H1N1O/002/2009 awarded by the National Medical Research Council of Singapore (www.nmrc.gov.sg/corp/index.aspx). The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health and Ageing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P81; Beyer WEP, 2004, VIRUS RES, V103, P125, DOI 10.1016/j.virusres.2004.02.024; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; CHEN MI, 2009, EMERG INFEC IN PRESS; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; FLAHAULT A, 2009, PLOS CURR INFLUENZA, DOI DOI 10.1371/CURRENTS.RRN1140; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; LEE VJ, J INFECT DI IN PRESS; LEO YS, 2009, EMERG INFECT DIS; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Ong JBS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010036; ROSS T, 2010, PLOS CURR INFLUENZA; Tay J, 2010, ANN ACAD MED SINGAP, V39, P313; WHO, 2009, WHO PAND H1N1 2009 U, P112; WHO, 2010, WKLY EPIDEMIOL REC, V85, P229; *WHO, 1982, CONC PROC LAB BAS IN; World Health Organization, 2009, WHO CDC PROT REALT R; Yin-Murphy M, 1970, Singapore Med J, V11, P33; Zambon M, 2001, ARCH INTERN MED, V161, P2116, DOI 10.1001/archinte.161.17.2116	24	42	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12474	10.1371/journal.pone.0012474	http://dx.doi.org/10.1371/journal.pone.0012474			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20814575	gold, Green Published			2022-12-27	WOS:000281375500008
J	Harewood, L; Liu, M; Keeling, J; Howatson, A; Whiteford, M; Branney, P; Evans, M; Fantes, J; FitzPatrick, DR				Harewood, Louise; Liu, Monica; Keeling, Jean; Howatson, Alan; Whiteford, Margo; Branney, Peter; Evans, Margaret; Fantes, Judy; FitzPatrick, David R.			Bilateral Renal Agenesis/Hypoplasia/Dysplasia (BRAHD): Postmortem Analysis of 45 Cases with Breakpoint Mapping of Two De Novo Translocations	PLOS ONE			English	Article							VACTERL-ASSOCIATION; NERVOUS-SYSTEM; MULLERIAN-DUCT; MICE LACKING; MUTATIONS; AGENESIS; DISEASE; KIDNEY; GENE; RET	Background: Bilateral renal agenesis/hypoplasia/dysplasia (BRAHD) is a relatively common, lethal malformation in humans. Established clinical risk factors include maternal insulin dependent diabetes mellitus and male sex of the fetus. In the majority of cases, no specific etiology can be established, although teratogenic, syndromal and single gene causes can be assigned to some cases. Methodology/Principal Findings: 45 unrelated fetuses, stillbirths or infants with lethal BRAHD were ascertained through a single regional paediatric pathology service (male:female 34:11 or 3.1:1). The previously reported phenotypic overlaps with VACTERL, caudal dysgenesis, hemifacial microsomia and Mullerian defects were confirmed. A new finding is that 16/45 (35.6%; m:f 13:3 or 4.3:1) BRAHD cases had one or more extrarenal malformations indicative of a disoder of laterality determination including; incomplete lobulation of right lung (seven cases), malrotation of the gut (seven cases) and persistence of the left superior vena cava (five cases). One such case with multiple laterality defects and sirelomelia was found to have a de novo apparently balanced reciprocal translocation 46, XY, t(2;6)(p22.3;q12). Translocation breakpoint mapping was performed by interphase fluorescent in-situ hybridization (FISH) using nuclei extracted from archival tissue sections in both this case and an isolated bilateral renal agenesis case associated with a de novo 46, XY, t(1;2)(q41;p25.3). Both t(2; 6) breakpoints mapped to gene-free regions with no strong evidence of cis-regulatory potential. Ten genes localized within 500 kb of the t(1;2) breakpoints. Wholemount in-situ expression analyses of the mouse orthologs of these genes in embryonic mouse kidneys showed strong expression of Esrrg, encoding a nuclear steroid hormone receptor. Immunohistochemical analysis showed that Esrrg was restricted to proximal ductal tissue within the embryonic kidney. Conclusions/Significance: The previously unreported association of BRAHD with laterality defects suggests that renal agenesis may share a common etiology with heterotaxy in some cases. Translocation breakpoint mapping identified ESRRG as a plausible candidate gene for BRAHD.	[Harewood, Louise; Branney, Peter; Fantes, Judy; FitzPatrick, David R.] Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Liu, Monica] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; [Keeling, Jean; Evans, Margaret] New Royal Infirm, Dept Paediat Pathol, Edinburgh, Midlothian, Scotland; [Howatson, Alan] Royal Hosp Sick Children, Dept Paediat Pathol, Glasgow G3 8SJ, Lanark, Scotland; [Whiteford, Margo] Royal Hosp Sick Children, Dept Clin Genet, Glasgow G3 8SJ, Lanark, Scotland; [FitzPatrick, David R.] Western Gen Hosp, SE Scotland Reg Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Glasgow; University of Glasgow; University of Edinburgh	Harewood, L (corresponding author), Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland.	david.fitzpatrick@hgu.mrc.ac.uk	FitzPatrick, David R/C-7301-2013	Harewood, Louise/0000-0002-6398-6714; FitzPatrick, David R./0000-0003-4861-969X	National Institutes of Health (NIH) [P50 DE16215]; Medical Research Council [MC_U127561093] Funding Source: researchfish; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016215] Funding Source: NIH RePORTER; MRC [MC_U127561093] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was funded by an intramural program grant in the name of David FitzPatrick and by a grant from the National Institutes of Health (NIH) P50 DE16215. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Alazami AM, 2009, AM J HUM GENET, V85, P414, DOI 10.1016/j.ajhg.2009.08.010; Avni FE, 2010, PEDIATR RADIOL, V40, P939, DOI 10.1007/s00247-010-1599-5; BANKIER A, 1985, J MED GENET, V22, P104, DOI 10.1136/jmg.22.2.104; Biason-Lauber A, 2004, NEW ENGL J MED, V351, P792, DOI 10.1056/NEJMoa040533; Bruce JH, 2009, FETAL PEDIATR PATHOL, V28, P109, DOI 10.1080/15513810902772383; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; CARTER CO, 1981, J MED GENET, V18, P158, DOI 10.1136/jmg.18.2.158; CHEN A, 1995, AM J MED GENET, V58, P365, DOI 10.1002/ajmg.1320580413; Chong SS, 1997, HUM MOL GENET, V6, P147, DOI 10.1093/hmg/6.2.147; CORSELLO G, 1992, AM J MED GENET, V44, P813, DOI 10.1002/ajmg.1320440619; Costantini F, 2006, DIFFERENTIATION, V74, P402, DOI 10.1111/j.1432-0436.2006.00106.x; CURRY CJR, 1984, AM J MED GENET, V19, P679, DOI 10.1002/ajmg.1320190408; Davies JA, 2004, HUM MOL GENET, V13, P235, DOI 10.1093/hmg/ddh015; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Fantes JA, 2008, AM J HUM GENET, V82, P916, DOI 10.1016/j.ajhg.2008.02.007; FITCH N, 1977, CAN MED ASSOC J, V116, P381; Gebbia M, 1997, NAT GENET, V17, P305, DOI 10.1038/ng1197-305; Gell JS, 2003, SEMIN REPROD MED, V21, P375; Goldmuntz E, 2002, AM J HUM GENET, V70, P776, DOI 10.1086/339079; Gotoh I, 2007, GENES CELLS, V12, P105, DOI 10.1111/j.1365-2443.2006.01035.x; Guan XY, 1996, NAT GENET, V12, P10, DOI 10.1038/ng0196-10; HACK M, 1974, CLIN GENET, V5, P173; Harewood L, 2010, CLIN DYSMORPHOL, V19, P5, DOI 10.1097/MCD.0b013e328331ddbe; Hiruma T, 2003, J ANAT, V203, P539, DOI 10.1046/j.1469-7580.2003.00245.x; Jacob M, 1999, CELLS TISSUES ORGANS, V164, P63, DOI 10.1159/000016644; Joss S, 2003, CLIN GENET, V63, P239; Kanwar YS, 2005, PEDIATR NEPHROL, V20, P858, DOI 10.1007/s00467-005-1888-7; Katoh M, 2002, INT J MOL MED, V10, P11; KHOURY MJ, 1983, PEDIATRICS, V71, P815; Kibar Z, 2007, NEW ENGL J MED, V356, P1432, DOI 10.1056/NEJMoa060651; Kosaki R, 1999, AM J MED GENET, V82, P70, DOI 10.1002/(SICI)1096-8628(19990101)82:1<70::AID-AJMG14>3.0.CO;2-Y; KOVACS T, 1991, Acta Paediatrica Hungarica, V31, P13; Ludwig KS, 1998, ARCH GYNECOL OBSTET, V262, P27, DOI 10.1007/s004040050225; MCPHERSON E, 1987, AM J MED GENET, V26, P863, DOI 10.1002/ajmg.1320260413; Nielsen GL, 2005, DIABETIC MED, V22, P693, DOI 10.1111/j.1464-5491.2005.01477.x; O'Rahilly R., 1987, DEV STAGES HUMAN EMB; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Oram SW, 2007, NEOPLASIA, V9, P643, DOI 10.1593/neo.07415; POTTER EL, 1946, J PEDIATR, V29, P68, DOI 10.1016/S0022-3476(46)80241-5; POTTER EL, 1946, AM J OBSTET GYNECOL, V51, P885, DOI 10.1016/S0002-9378(16)39968-9; PRAMANIK AK, 1977, AM J DIS CHILD, V131, P672, DOI 10.1001/archpedi.1977.02120190066013; RITCHEY ML, 1994, UROLOGY, V43, P88, DOI 10.1016/S0090-4295(94)80273-4; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; ROODHOOFT M, 1984, NEW ENGL J MED, V310, P1341, DOI 10.1056/NEJM198405243102101; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Sellick GS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh163; Shaul D B, 1997, Semin Pediatr Surg, V6, P187; Skinner MA, 2008, AM J HUM GENET, V82, P344, DOI 10.1016/j.ajhg.2007.10.008; Slavotinek AM, 2002, J MED GENET, V39, P623, DOI 10.1136/jmg.39.9.623; Tasse C, 2007, CLIN DYSMORPHOL, V16, P1, DOI 10.1097/MCD.0b013e328010d313; Wheeler PG, 2001, AM J MED GENET, V103, P99, DOI 10.1002/ajmg.1510; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178; ZELOP CM, 1993, OBSTET GYNECOL, V81, P412	56	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12375	10.1371/journal.pone.0012375	http://dx.doi.org/10.1371/journal.pone.0012375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811621	Green Submitted, Green Published, gold			2022-12-27	WOS:000281234700011
J	Garcia-Arriaza, J; Najera, JL; Gomez, CE; Sorzano, COS; Esteban, M				Garcia-Arriaza, Juan; Luis Najera, Jose; Gomez, Carmen E.; Sorzano, Carlos Oscar S.; Esteban, Mariano			Immunogenic Profiling in Mice of a HIV/AIDS Vaccine Candidate (MVA-B) Expressing Four HIV-1 Antigens and Potentiation by Specific Gene Deletions	PLOS ONE			English	Article							T-CELL RESPONSES; POXVIRUS VECTORS MVA; VIRUS ANKARA MVA; IMMUNE-RESPONSES; CLADE-C; PRECLINICAL EVALUATION; DNA PRIME; NYVAC; MEMORY; VIREMIA	Background: The immune parameters of HIV/AIDS vaccine candidates that might be relevant in protection against HIV-1 infection are still undefined. The highly attenuated poxvirus strain MVA is one of the most promising vectors to be use as HIV-1 vaccine. We have previously described a recombinant MVA expressing HIV-1 Env, Gag, Pol and Nef antigens from clade B (referred as MVA-B), that induced HIV-1-specific immune responses in different animal models and gene signatures in human dendritic cells (DCs) with immunoregulatory function. Methodology/Principal Findings: In an effort to characterize in more detail the immunogenic profile of MVA-B and to improve its immunogenicity we have generated a new vector lacking two genes (A41L and B16R), known to counteract host immune responses by blocking the action of CC-chemokines and of interleukin 1 beta, respectively (referred as MVA-B Delta A41L/Delta B16R). A DNA prime/MVA boost immunization protocol was used to compare the adaptive and memory HIV-1 specific immune responses induced in mice by the parental MVA-B and by the double deletion mutant MVA-B Delta A41L/Delta B16R. Flow cytometry analysis revealed that both vectors triggered HIV-1-specific CD4(+) and CD8(+) T cells, with the CD8(+) T-cell compartment responsible for >91.9% of the total HIV-1 responses in both immunization groups. However, MVA-B Delta A41L/Delta B16R enhanced the magnitude and polyfunctionality of the HIV-1-specific CD4(+) and CD8(+) T-cell immune responses. HIV-1specific CD4(+) T-cell responses were polyfunctional and preferentially Env-specific in both immunization groups. Significantly, while MVA-B induced preferentially Env-specific CD8(+) T-cell responses, MVA-B Delta A41L/Delta B16R induced more GPN-specific CD8(+) T-cell responses, with an enhanced polyfunctional pattern. Both vectors were capable of producing similar levels of antibodies against Env. Conclusions/Significance: These findings revealed that MVA-B and MVA-B Delta A41L/Delta B16R induced in mice robust, polyfunctional and durable T-cell responses to HIV-1 antigens, but the double deletion mutant showed enhanced magnitude and quality of HIV-1 adaptive and memory responses. Our observations are relevant in the immune evaluation of MVA-B and on improvements of MVA vectors as HIV-1 vaccines.	[Garcia-Arriaza, Juan; Luis Najera, Jose; Gomez, Carmen E.; Esteban, Mariano] CSIC, Dept Mol & Cellular Biol, Ctr Nacl Biotecnol, Madrid, Spain; [Sorzano, Carlos Oscar S.] CSIC, Biocomp Unit, Ctr Nacl Biotecnol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Garcia-Arriaza, J (corresponding author), CSIC, Dept Mol & Cellular Biol, Ctr Nacl Biotecnol, Madrid, Spain.	mesteban@cnb.csic.es	Sorzano, Carlos Oscar S S./F-2639-2016; GARCIA-ARRIAZA, JUAN/Q-6243-2017; Esteban, Mariano/ABG-5375-2020; S. Sorzano, Carlos Oscar/ABE-4884-2021; NAJERA, Jose Luis/W-8177-2019; Gomez, Carmen Elena/K-1940-2014	Sorzano, Carlos Oscar S S./0000-0002-9473-283X; GARCIA-ARRIAZA, JUAN/0000-0002-5167-5724; Esteban, Mariano/0000-0003-0846-2827; S. Sorzano, Carlos Oscar/0000-0002-9473-283X; Gomez, Carmen Elena/0000-0002-5414-7935; Najera, jose Luis/0000-0001-7798-3330	FIPSE (Fundacion para la Investigacion y la Prevencion del Sida en Espana) [36551/06, 360731/09]; Ministry of Science and Innovation [SAF2008-02036]; Foundation Botin of Spain	FIPSE (Fundacion para la Investigacion y la Prevencion del Sida en Espana); Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Foundation Botin of Spain	This investigation was supported by grants from FIPSE (Fundacion para la Investigacion y la Prevencion del Sida en Espana)-36551/06 and 360731/09, the Ministry of Science and Innovation (SAF2008-02036) and Foundation Botin of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; Amara RR, 2005, VIROLOGY, V343, P246, DOI 10.1016/j.virol.2005.08.027; Amara RR, 2002, J VIROL, V76, P7625, DOI 10.1128/JVI.76.15.7625-7631.2002; Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Bahar MW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040005; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Blanchard TJ, 1998, J GEN VIROL, V79, P1159, DOI 10.1099/0022-1317-79-5-1159; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Clark RH, 2006, J GEN VIROL, V87, P29, DOI 10.1099/vir.0.81417-0; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; Esteban M, 2009, HUM VACCINES, V5, P867, DOI 10.4161/hv.9693; FALKNER FG, 1990, J VIROL, V64, P3108, DOI 10.1128/JVI.64.6.3108-3111.1990; FENNER F, 1948, LANCET, V252, P915, DOI 10.1016/S0140-6736(48)91599-2; Flanagan K, 2004, CELL IMMUNOL, V231, P75, DOI 10.1016/j.cellimm.2004.12.006; Genesca Meritxell, 2010, Curr HIV/AIDS Rep, V7, P19, DOI 10.1007/s11904-009-0035-7; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; Gomez CE, 2009, VACCINE, V27, P3165, DOI 10.1016/j.vaccine.2009.03.049; Gomez CE, 2007, VACCINE, V25, P2863, DOI 10.1016/j.vaccine.2006.09.090; GUERRA S, 2010, J VIROL; Guerra S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000096; Guo ZH, 2003, BLOOD, V102, P4441, DOI 10.1182/blood-2002-11-3420; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Im EJ, 2007, AIDS RES HUM RETROV, V23, P857, DOI 10.1089/aid.2007.0009; Khayyamian S, 2002, P NATL ACAD SCI USA, V99, P6198, DOI 10.1073/pnas.092576699; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; McCormack S, 2008, VACCINE, V26, P3162, DOI 10.1016/j.vaccine.2008.02.072; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; MIYAHIRA Y, 1995, J IMMUNOL METHODS, V181, P45, DOI 10.1016/0022-1759(94)00327-S; Mooij P, 2008, J VIROL, V82, P2975, DOI 10.1128/JVI.02216-07; Mooij P, 2009, J VIROL, V83, P5881, DOI 10.1128/JVI.02345-08; NAJERA JL, PLOS ONE, V5; Najera JL, 2006, J VIROL, V80, P6033, DOI 10.1128/JVI.02108-05; Ng A, 2001, J GEN VIROL, V82, P2095, DOI 10.1099/0022-1317-82-9-2095; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robinson HL, 2007, AIDS RES HUM RETROV, V23, P1555, DOI 10.1089/aid.2007.0165; Rouder JN, 2005, PSYCHON B REV, V12, P573, DOI 10.3758/BF03196750; Ruiz-Arguello MB, 2008, J VIROL, V82, P917, DOI 10.1128/JVI.02111-07; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Soldevila G, 2004, IMMUNOLOGY, V112, P191, DOI 10.1111/j.1365-2567.2004.01863.x; SPRIGGS MK, 1992, CELL, V71, P145, DOI 10.1016/0092-8674(92)90273-F; Staib C, 2005, J GEN VIROL, V86, P1997, DOI 10.1099/vir.0.80646-0; Wang W, 2000, J BIOL CHEM, V275, P22313, DOI 10.1074/jbc.M001461200; Wild J, 2009, VIRAL IMMUNOL, V22, P309, DOI 10.1089/vim.2009.0038; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	57	65	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12395	10.1371/journal.pone.0012395	http://dx.doi.org/10.1371/journal.pone.0012395			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20811493	Green Published, gold			2022-12-27	WOS:000281154300018
J	Vinuela, A; Snoek, LB; Riksen, JAG; Kammenga, JE				Vinuela, Ana; Snoek, L. Basten; Riksen, Joost A. G.; Kammenga, Jan E.			Genome-Wide Gene Expression Analysis in Response to Organophosphorus Pesticide Chlorpyrifos and Diazinon in C. elegans	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; BINARY-MIXTURE; MODEL; MECHANISM; BIOCONDUCTOR; TOXICITY; PATHWAYS	Organophosphorus pesticides (OPs) were originally designed to affect the nervous system by inhibiting the enzyme acetylcholinesterase, an important regulator of the neurotransmitter acetylcholine. Over the past years evidence is mounting that these compounds affect many other processes. Little is known, however, about gene expression responses against OPs in the nematode Caenorhabditis elegans. This is surprising because C. elegans is extensively used as a model species in toxicity studies. To address this question we performed a microarray study in C. elegans which was exposed for 72 hrs to two widely used Ops, chlorpyrifos and diazinon, and a low dose mixture of these two compounds. Our analysis revealed transcriptional responses related to detoxification, stress, innate immunity, and transport and metabolism of lipids in all treatments. We found that for both compounds as well as in the mixture, these processes were regulated by different gene transcripts. Our results illustrate intense, and unexpected crosstalk between gene pathways in response to chlorpyrifos and diazinon in C. elegans.	[Vinuela, Ana; Snoek, L. Basten; Riksen, Joost A. G.; Kammenga, Jan E.] Wageningen Univ, Nematol Lab, Wageningen, Netherlands	Wageningen University & Research	Vinuela, A (corresponding author), Wageningen Univ, Nematol Lab, Wageningen, Netherlands.	jan.kammenga@wur.nl	Viñuela, Ana/L-5015-2019; Snoek, Basten L/E-4713-2014	Viñuela, Ana/0000-0003-3771-8537; Snoek, Basten L/0000-0001-5321-2996	EU; Ecogenomics Consortium of the Netherlands Genomics Initiative	EU(European Commission); Ecogenomics Consortium of the Netherlands Genomics Initiative	This work was supported by the EU FP6 framework programme NoMiracle (http://nomiracle.jrc.ec.europa.eu/default.aspx) and Ecogenomics Consortium of the Netherlands Genomics Initiative (NGI)(http://www.ecogenomics.nl/) to AV and LBS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2005, P NATL ACAD SCI USA, V102, P16275, DOI 10.1073/pnas.0508105102; Boyd WA, 2010, NEUROTOXICOL TERATOL, V32, P68, DOI 10.1016/j.ntt.2008.12.004; Cole RD, 2004, TOXICOL APPL PHARM, V194, P248, DOI 10.1016/j.taap.2003.09.013; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; Dong J, 2005, BBA-GENE STRUCT EXPR, V1727, P16, DOI 10.1016/j.bbaexp.2004.11.007; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Duysen EG, 2001, J PHARMACOL EXP THER, V299, P528; Evans EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000175; Ewbank JJ, 2006, SIGNALING IMMUNE RES; Hong FX, 2008, BIOINFORMATICS, V24, P374, DOI 10.1093/bioinformatics/btm620; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Lewis JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-202; Li Qing, 2007, Journal of Nippon Medical School, V74, P92, DOI 10.1272/jnms.74.92; Liang J, 2007, DEV BIOL, V305, P714, DOI 10.1016/j.ydbio.2007.02.038; Martin HL, 2009, ENVIRON TOXICOL CHEM, V28, P97, DOI 10.1897/07-215.1; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Menzel R, 2005, ARCH BIOCHEM BIOPHYS, V438, P93, DOI 10.1016/j.abb.2005.03.020; Moser VC, 2006, TOXICOL SCI, V92, P235, DOI 10.1093/toxsci/kfj189; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Oostingh GJ, 2009, J IMMUNOTOXICOL, V6, P136, DOI 10.1080/15476910902977407; Poet TS, 2004, NEUROTOXICOLOGY, V25, P1013, DOI 10.1016/j.neuro.2004.03.002; Poet TS, 2003, TOXICOL SCI, V72, P193, DOI 10.1093/toxsci/kfg035; Pope C, 2005, ENVIRON TOXICOL PHAR, V19, P433, DOI 10.1016/j.etap.2004.12.048; Pope CN, 1999, J TOXICOL ENV HEAL B, V2, P161, DOI 10.1080/109374099281205; Roh JY, 2008, ECOTOX ENVIRON SAFE, V71, P483, DOI 10.1016/j.ecoenv.2007.11.007; Roh JY, 2006, ENVIRON TOXICOL CHEM, V25, P2946, DOI 10.1897/05-676R.1; Ruan QL, 2009, J TOXICOL ENV HEAL A, V72, P746, DOI 10.1080/15287390902841532; Savage-Dunn C., 2005, TGF BETA SIGNALING; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Slotkin TA, 2008, BRAIN RES BULL, V76, P424, DOI 10.1016/j.brainresbull.2008.01.001; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Svendsen C, 2010, ENVIRON TOXICOL CHEM, V29, P1182, DOI 10.1002/etc.140; Taubert S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000021; TIM H, 2006, J EXPT ZOOLOGY A, V305, P720; Timchalk C, 2008, NEUROTOXICOLOGY, V29, P428, DOI 10.1016/j.neuro.2008.02.004; Timchalk C, 2005, TOXICOL APPL PHARM, V205, P31, DOI 10.1016/j.taap.2004.09.004; Timchalk C, 2002, TOXICOL SCI, V66, P34, DOI 10.1093/toxsci/66.1.34; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Yang YH, 2003, INST MATH S, V40, P403	41	36	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12145	10.1371/journal.pone.0012145	http://dx.doi.org/10.1371/journal.pone.0012145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808445	gold, Green Published, Green Submitted			2022-12-27	WOS:000280968000004
J	Wu, SP; Liu, J; Reedy, MC; Tregear, RT; Winkler, H; Franzini-Armstrong, C; Sasaki, H; Lucaveche, C; Goldman, YE; Reedy, MK; Taylor, KA				Wu, Shenping; Liu, Jun; Reedy, Mary C.; Tregear, Richard T.; Winkler, Hanspeter; Franzini-Armstrong, Clara; Sasaki, Hiroyuki; Lucaveche, Carmen; Goldman, Yale E.; Reedy, Michael K.; Taylor, Kenneth A.			Electron Tomography of Cryofixed, Isometrically Contracting Insect Flight Muscle Reveals Novel Actin-Myosin Interactions	PLOS ONE			English	Article							X-RAY-DIFFRACTION; CROSS-BRIDGES; FORCE GENERATION; STRUCTURAL-CHANGES; SKELETAL-MUSCLE; POWER STROKE; 3-DIMENSIONAL RECONSTRUCTION; STRETCH-ACTIVATION; STRONG BINDING; THIN FILAMENT	Background: Isometric muscle contraction, where force is generated without muscle shortening, is a molecular traffic jam in which the number of actin-attached motors is maximized and all states of motor action are trapped with consequently high heterogeneity. This heterogeneity is a major limitation to deciphering myosin conformational changes in situ. Methodology: We used multivariate data analysis to group repeat segments in electron tomograms of isometrically contracting insect flight muscle, mechanically monitored, rapidly frozen, freeze substituted, and thin sectioned. Improved resolution reveals the helical arrangement of F-actin subunits in the thin filament enabling an atomic model to be built into the thin filament density independent of the myosin. Actin-myosin attachments can now be assigned as weak or strong by their motor domain orientation relative to actin. Myosin attachments were quantified everywhere along the thin filament including troponin. Strong binding myosin attachments are found on only four F-actin subunits, the "target zone'', situated exactly midway between successive troponin complexes. They show an axial lever arm range of 77 degrees/12.9 nm. The lever arm azimuthal range of strong binding attachments has a highly skewed, 127 degrees range compared with X-ray crystallographic structures. Two types of weak actin attachments are described. One type, found exclusively in the target zone, appears to represent pre-working-stroke intermediates. The other, which contacts tropomyosin rather than actin, is positioned M-ward of the target zone, i.e. the position toward which thin filaments slide during shortening. Conclusion: We present a model for the weak to strong transition in the myosin ATPase cycle that incorporates azimuthal movements of the motor domain on actin. Stress/strain in the S2 domain may explain azimuthal lever arm changes in the strong binding attachments. The results support previous conclusions that the weak attachments preceding force generation are very different from strong binding attachments.	[Wu, Shenping; Liu, Jun; Winkler, Hanspeter; Taylor, Kenneth A.] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Tregear, Richard T.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Reedy, Mary C.; Lucaveche, Carmen; Reedy, Michael K.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Franzini-Armstrong, Clara; Goldman, Yale E.] Univ Penn, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Sasaki, Hiroyuki] Jikei Univ, Sch Med, Core Res Facil, Div Fine Morphol, Tokyo, Japan	State University System of Florida; Florida State University; MRC Laboratory Molecular Biology; Duke University; University of Pennsylvania; Jikei University	Wu, SP (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	taylor@bio.fsu.edu		Sasaki, Hiroyuki/0000-0002-5358-5853	National Institute of General Medical Sciences (NIGMS) [GM30598]; National Heart, Lung and Blood Institute (NHLBI) [HL15835]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) [AR14317]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL015835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR014317, R01AR014317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030598, R01GM082948] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (NIGMS) grant GM30598 to KAT, the National Heart, Lung and Blood Institute (NHLBI) grant HL15835 to YEG and CF-A and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) grant AR14317 to MKR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AL-Khayat HA, 2003, BIOPHYS J, V85, P1063, DOI 10.1016/S0006-3495(03)74545-7; Baker TS, 1996, CURR OPIN STRUC BIOL, V6, P585, DOI 10.1016/S0959-440X(96)80023-6; Beausang JF, 2008, BIOPHYS J, V95, P5820, DOI 10.1529/biophysj.108.140319; Bershitsky SY, 1997, NATURE, V388, P186, DOI 10.1038/40651; BRENNER B, 1993, P NATL ACAD SCI USA, V90, P5252, DOI 10.1073/pnas.90.11.5252; Brunello E, 2007, P NATL ACAD SCI USA, V104, P20114, DOI 10.1073/pnas.0707626104; BULLARD B, 1985, J MOL BIOL, V182, P443, DOI 10.1016/0022-2836(85)90203-7; Burgess S, 2004, J MOL BIOL, V341, P1161, DOI 10.1016/j.jmb.2004.06.077; Conibear PB, 1998, BIOPHYS J, V75, P926, DOI 10.1016/S0006-3495(98)77581-2; Cooke R, 1997, PHYSIOL REV, V77, P671, DOI 10.1152/physrev.1997.77.3.671; COOKE R, 1982, NATURE, V300, P776, DOI 10.1038/300776a0; COOKE R, 1986, CRIT REV BIOCHEM MOL, V21, P53, DOI 10.3109/10409238609113609; Corrie JET, 1999, NATURE, V400, P425, DOI 10.1038/22704; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; Dobbie I, 1998, NATURE, V396, P383, DOI 10.1038/24647; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Esaki S, 2007, BIOSYSTEMS, V88, P293, DOI 10.1016/j.biosystems.2006.03.013; Farman GP, 2009, J STRUCT BIOL, V168, P240, DOI 10.1016/j.jsb.2009.07.020; Ferenczi MA, 2005, STRUCTURE, V13, P131, DOI 10.1016/j.str.2004.11.007; FRADO LL, 1992, J MOL BIOL, V223, P391, DOI 10.1016/0022-2836(92)90659-8; Frank J, 2006, 3 DIMENSIONAL ELECT; Galkin VE, 2003, J MOL BIOL, V325, P623, DOI 10.1016/S0022-2836(02)01309-8; Geeves M. A., 1995, Biophysical Journal, V68, P194; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Gu J, 2002, BIOPHYS J, V82, P2123, DOI 10.1016/S0006-3495(02)75559-8; HASELGROVE JC, 1984, J MUSCLE RES CELL M, V5, P3, DOI 10.1007/BF00713149; HASELGROVE JC, 1973, J MOL BIOL, V77, P549, DOI 10.1016/0022-2836(73)90222-2; Heinrich B., 1996, THERMAL WARRIORS STR; HIROSE K, 1994, J CELL BIOL, V127, P763, DOI 10.1083/jcb.127.3.763; HIROSE K, 1993, BIOPHYS J, V65, P397, DOI 10.1016/S0006-3495(93)81061-0; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Holmes KC, 2000, PHILOS T R SOC B, V355, P419, DOI 10.1098/rstb.2000.0583; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; HOLMES KC, 1980, PROC R SOC SER B-BIO, V207, P13, DOI 10.1098/rspb.1980.0012; Houdusse A, 2000, P NATL ACAD SCI USA, V97, P11238, DOI 10.1073/pnas.200376897; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; HUXLEY HE, 1968, J MOL BIOL, V37, P507, DOI 10.1016/0022-2836(68)90118-6; HUXLEY HE, 1994, BIOPHYS J, V67, P2411, DOI 10.1016/S0006-3495(94)80728-3; Irving M, 2000, NAT STRUCT BIOL, V7, P482, DOI 10.1038/75890; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Juanhuix J, 2001, BIOPHYS J, V80, P1429, DOI 10.1016/S0006-3495(01)76115-2; Katayama E, 1998, ADV EXP MED BIOL, V453, P37; KOSTER AJ, 1992, ULTRAMICROSCOPY, V46, P207, DOI 10.1016/0304-3991(92)90016-D; Lenart TD, 1996, BIOPHYS J, V71, P2289, DOI 10.1016/S0006-3495(96)79464-X; Leonard KR, 2006, MOL B INT U, P141, DOI 10.1007/0-387-31213-7_11; Linari M, 2004, BIOPHYS J, V87, P1101, DOI 10.1529/biophysj.103.037374; Linari M, 1998, BIOPHYS J, V74, P2459, DOI 10.1016/S0006-3495(98)77954-8; Linari M, 2007, BIOPHYS J, V92, P2476, DOI 10.1529/biophysj.106.099549; Littlefield KP, 2008, J MOL BIOL, V381, P519, DOI 10.1016/j.jmb.2008.06.029; Liu J, 2004, J STRUCT BIOL, V147, P268, DOI 10.1016/j.jsb.2004.03.008; Liu J, 2006, J MOL BIOL, V362, P844, DOI 10.1016/j.jmb.2006.07.084; LOMBARDI V, 1992, NATURE, V355, P638, DOI 10.1038/355638a0; MARSTON EV, 1984, J MUSCLE RES CELL M, V5, P363; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; MOLLOY JE, 1995, BIOPHYS J, V68, pS298; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Narita A, 2001, J MOL BIOL, V308, P241, DOI 10.1006/jmbi.2001.4598; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; OSTAP EM, 1995, BIOPHYS J, V69, P177, DOI 10.1016/S0006-3495(95)79888-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pirani A, 2006, J MOL BIOL, V357, P707, DOI 10.1016/j.jmb.2005.12.050; Poole KJV, 2006, J STRUCT BIOL, V155, P273, DOI 10.1016/j.jsb.2006.02.020; PRINGLE JWS, 1978, PROC R SOC SER B-BIO, V201, P107, DOI 10.1098/rspb.1978.0035; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Reedy M, 1998, PFLUG ARCH EUR J PHY, V436, pR20; REEDY MC, 1987, J MUSCLE RES CELL M, V8, P473, DOI 10.1007/BF01567908; REEDY MC, 1988, J MOL BIOL, V204, P357, DOI 10.1016/0022-2836(88)90582-7; REEDY MK, 1985, J MOL BIOL, V185, P145, DOI 10.1016/0022-2836(85)90188-3; REEDY MK, 1983, J MUSCLE RES CELL M, V4, P25, DOI 10.1007/BF00711957; REEDY MK, 1968, J MOL BIOL, V31, P155, DOI 10.1016/0022-2836(68)90437-3; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; SAXTON WO, 1984, ULTRAMICROSCOPY, V13, P57, DOI 10.1016/0304-3991(84)90057-3; Schmitz H, 1996, J MOL BIOL, V264, P279, DOI 10.1006/jmbi.1996.0641; Schmitz H, 1997, J CELL BIOL, V139, P695, DOI 10.1083/jcb.139.3.695; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; SQUIRE JM, 1988, J MUSCLE RES CELL M, V9, P344, DOI 10.1007/BF01773878; Steffen W, 2001, P NATL ACAD SCI USA, V98, P14949, DOI 10.1073/pnas.261560698; Taylor KA, 1999, CELL, V99, P421, DOI 10.1016/S0092-8674(00)81528-7; Taylor KA, 2007, METHOD CELL BIOL, V79, P321, DOI 10.1016/S0091-679X(06)79013-6; Tregear RT, 2004, BIOPHYS J, V86, P3009, DOI 10.1016/S0006-3495(04)74350-7; Tsaturyan AK, 2005, BIOPHYS J, V88, P1902, DOI 10.1529/biophysj.104.050047; Tsaturyan AK, 1999, BIOPHYS J, V77, P354, DOI 10.1016/S0006-3495(99)76895-5; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Vilfan A, 2009, BIOPHYS J, V97, P1130, DOI 10.1016/j.bpj.2009.06.008; Volkmann N, 2005, MOL CELL, V19, P595, DOI 10.1016/j.molcel.2005.07.015; WAKABAYASHI K, 1994, BIOPHYS J, V67, P2422, DOI 10.1016/S0006-3495(94)80729-5; Walker M, 1999, P NATL ACAD SCI USA, V96, P465, DOI 10.1073/pnas.96.2.465; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; Winkler H, 1996, J MOL BIOL, V264, P302, DOI 10.1006/jmbi.1996.0642; Winkler H, 2006, ULTRAMICROSCOPY, V106, P240, DOI 10.1016/j.ultramic.2005.07.007; Wong WNW, 1999, BIOCHEMISTRY-US, V38, P1365, DOI 10.1021/bi982467g; Wu SP, 2009, J STRUCT BIOL, V168, P485, DOI 10.1016/j.jsb.2009.08.007; Yanagida T, 2000, CURR OPIN CELL BIOL, V12, P20, DOI 10.1016/S0955-0674(99)00052-6; Yanagida T, 2000, PHILOS T ROY SOC B, V355, P441, DOI 10.1098/rstb.2000.0585	98	38	39	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12643	10.1371/journal.pone.0012643	http://dx.doi.org/10.1371/journal.pone.0012643			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844746	Green Published, gold, Green Submitted			2022-12-27	WOS:000281687200010
J	Steer, CD; Golding, J; Bolton, PF				Steer, Colin D.; Golding, Jean; Bolton, Patrick F.			Traits Contributing to the Autistic Spectrum	PLOS ONE			English	Article							DISORDERS; COMMUNICATION; POPULATION; CHILDREN; ALSPAC; TWIN; ASSOCIATION; PREVALENCE; DIAGNOSIS; QUOTIENT	Background: It is increasingly recognised that traits associated with autism reflect a spectrum with no clear boundary between typical and atypical behaviour. Dimensional traits are needed to investigate the broader autism phenotype. Methods and Principal Findings: Ninety-three individual measures reflecting components of social, communication and repetitive behaviours characterising autistic spectrum disorder (ASD) were identified between the ages of 6 months and 9 years from the ALSPAC database. Using missing value imputation, data for 13,138 children were analysed. Factor analysis suggested the existence of 7 factors explaining 85% of the variance. The factors were labelled: verbal ability, language acquisition, social understanding, semantic-pragmatic skills, repetitive-stereotyped behaviour, articulation and social inhibition. Four factors (1, 3, 5 and 7) were specific to ASD being more strongly associated with this phenotype than other co-morbid conditions while other factors were more associated with learning difficulties and specific language impairment. Nevertheless, all 7 factors contributed independently to the explanation of ASD (p<0.001). Exploration of putative genetic causal factors such as variants in the CNTNAP2 gene showed a varying pattern of associations with these traits. An alternative predictive model of ASD was derived using four individual measures: the coherence subscale of the Children's Communication Checklist (9y), the Social and Communication Disorders Checklist (91 m), repetitive behaviour (69 m) and the sociability subscale of the Emotionality Activity and Sociability measure (38 m). Although univarably these traits performed better than some factors, their combined explanations of ASD were similar (R(2) = 0.48). Conclusions and Significance: These results support the fractional nature of ASD with different aetiological origins for these components despite pleiotropic genetic effects being observed. These traits are likely to be useful in the exploration of ASD.	[Steer, Colin D.; Golding, Jean] Univ Bristol, Bristol, Avon, England; [Bolton, Patrick F.] Kings Coll London, Inst Psychiat, London WC2R 2LS, England	University of Bristol; University of London; King's College London	Steer, CD (corresponding author), Univ Bristol, Bristol, Avon, England.	Colin.Steer@bristol.ac.uk		Golding, Jean/0000-0003-2826-3307	UK Medical Research Council [RD1589]; UK NIHR Biomedical Research Centre for Mental Health at the Institute of Psychiatry; Kings College London; South London and Maudsley NHS Foundation Trust; UK Medical Research Council; Wellcome Trust; University of Bristol; Medical Research Council [G9817803B, G0400085, G9815508, G0500870] Funding Source: researchfish; MRC [G0400085, G0500870] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK NIHR Biomedical Research Centre for Mental Health at the Institute of Psychiatry; Kings College London(General Electric); South London and Maudsley NHS Foundation Trust; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was funded by the UK Medical Research Council grant RD1589. Patrick Bolton is supported by the UK NIHR Biomedical Research Centre for Mental Health at the Institute of Psychiatry, Kings College London and The South London and Maudsley NHS Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are extremely grateful to all the families who took part in this study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. The UK Medical Research Council, the Wellcome Trust and the University of Bristol currently provide core support for ALSPAC. This publication is the work of the authors and Jean Golding and Colin Steer will serve as guarantors for the contents of this paper.	Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Auyeung B, 2008, J AUTISM DEV DISORD, V38, P1230, DOI 10.1007/s10803-007-0504-z; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bandalos DL, 2009, STATISTICAL AND METHODOLOGICAL MYTHS AND URBAN LEGENDS: DOCTRINE, VERITY AND FABLE IN THE ORGANIZATIONAL AND SOCIAL SCIENCES, P61; Barbeau EB, 2009, BRIT J PSYCHOL, V100, P23, DOI 10.1348/000712608X337788; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Bishop DVM, 1998, J CHILD PSYCHOL PSYC, V39, P879, DOI 10.1111/1469-7610.00388; BOLTON P, 1994, J CHILD PSYCHOL PSYC, V35, P877, DOI 10.1111/j.1469-7610.1994.tb02300.x; Boomsma A, 2008, J CHILD PSYCHOL PSYC, V49, P809, DOI 10.1111/j.1469-7610.2008.01897.x; Buss A., 1984, TEMPERAMENT EARLY DE; CASPI A, 1995, CHILD DEV, V66, P55, DOI 10.1111/j.1467-8624.1995.tb00855.x; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Constantino JN, 2004, J CHILD PSYCHOL PSYC, V45, P719, DOI 10.1111/j.1469-7610.2004.00266.x; Constantino JN, 2000, J DEV BEHAV PEDIATR, V21, P2, DOI 10.1097/00004703-200002000-00002; Dworzynski K, 2009, J AUTISM DEV DISORD, V39, P1197, DOI 10.1007/s10803-009-0736-1; Elander J, 1996, INT J METHOD PSYCH, V6, P63, DOI 10.1002/(SICI)1234-988X(199607)6:2<63::AID-MPR151>3.3.CO;2-M; Fenson L, 2000, APPL PSYCHOLINGUIST, V21, P95, DOI 10.1017/S0142716400001053; Fenson L., 1993, MACARTHUR COMMUNICAT; Filipek PA, 2000, NEUROLOGY, V55, P468, DOI 10.1212/WNL.55.4.468; FRANKENBURG WK, 1967, J PEDIATR-US, V71, P181, DOI 10.1016/S0022-3476(67)80070-2; Frazier TW, 2008, J AUTISM DEV DISORD, V38, P474, DOI 10.1007/s10803-007-0415-z; Gathercole S E, 1994, Memory, V2, P103, DOI 10.1080/09658219408258940; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Grice JW, 2001, PSYCHOL METHODS, V6, P430, DOI 10.1037//1082-989X.6.4.430; Happe F, 2008, NEUROPSYCHOL REV, V18, P287, DOI 10.1007/s11065-008-9076-8; Harman H. H., 1976, MODERN FACTOR ANAL; Hoekstra RA, 2008, J AUTISM DEV DISORD, V38, P1555, DOI 10.1007/s10803-008-0538-x; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; HU LT, 1999, STRUCTURAL EQUATION, V1, P55; Jones RW, 2000, EUR J HUM GENET, V8, P653, DOI 10.1038/sj.ejhg.5200502; London E, 2007, BRAIN PATHOL, V17, P408, DOI 10.1111/j.1750-3639.2007.00103.x; Mandy WPL, 2008, J CHILD PSYCHOL PSYC, V49, P795, DOI 10.1111/j.1469-7610.2008.01911.x; NOWICKI S, 1994, J NONVERBAL BEHAV, V18, P9, DOI 10.1007/BF02169077; Ronald A, 2006, J AM ACAD CHILD PSY, V45, P691, DOI 10.1097/01.chi.0000215325.13058.9d; Rust J., 1996, MANUAL WECHSLER OBJE; Skuse DH, 2009, J AM ACAD CHILD PSY, V48, P128, DOI 10.1097/CHI.0b013e31819176b8; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; Snow AV, 2009, J CHILD PSYCHOL PSYC, V50, P734, DOI 10.1111/j.1469-7610.2008.02018.x; STPOURCAIN B, AM J PSYCHI IN PRESS; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wechsler D., 1992, WECHSLER INTELLIGENC; WIDAMAN KF, 1993, MULTIVAR BEHAV RES, V28, P263, DOI 10.1207/s15327906mbr2803_1; Williams E, 2008, DEV MED CHILD NEUROL, V50, P672, DOI 10.1111/j.1469-8749.2008.03042.x; Wing L., 1988, DIAGNOSIS ASSESSMENT, P91, DOI 10.1007/978-1-4899-0792-9_7; World Health Organization, 1992, INT CLASS DIS REL HL	52	60	62	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12633	10.1371/journal.pone.0012633	http://dx.doi.org/10.1371/journal.pone.0012633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	648IV	20838614	Green Published, Green Submitted, gold			2022-12-27	WOS:000281687100012
J	Carpaneto, A; Koepsell, H; Bamberg, E; Hedrich, R; Geiger, D				Carpaneto, Armando; Koepsell, Hermann; Bamberg, Ernst; Hedrich, Rainer; Geiger, Dietmar			Sucrose- and H+-Dependent Charge Movements Associated with the Gating of Sucrose Transporter ZmSUT1	PLOS ONE			English	Article							NA+ GLUCOSE COTRANSPORTER; ALTERNATING ACCESS MODEL; NA+/GLUCOSE COTRANSPORTER; XENOPUS-OOCYTES; CONFORMATIONAL-CHANGES; ELECTROGENIC PROPERTIES; ARABIDOPSIS-THALIANA; VOLTAGE-DEPENDENCE; ION CHANNELS; KINETICS	Background: In contrast to man the majority of higher plants use sucrose as mobile carbohydrate. Accordingly proton-driven sucrose transporters are crucial for cell-to-cell and long-distance distribution within the plant body. Generally very negative plant membrane potentials and the ability to accumulate sucrose quantities of more than 1 M document that plants must have evolved transporters with unique structural and functional features. Methodology/Principal Findings: To unravel the functional properties of one specific high capacity plasma membrane sucrose transporter in detail, we expressed the sucrose/H+ co-transporter from maize ZmSUT1 in Xenopus oocytes. Application of sucrose in an acidic pH environment elicited inward proton currents. Interestingly the sucrose-dependent H+ transport was associated with a decrease in membrane capacitance (C-m). In addition to sucrose C-m was modulated by the membrane potential and external protons. In order to explore the molecular mechanism underlying these C-m changes, presteady-state currents (I-pre) of ZmSUT1 transport were analyzed. Decay of I-pre could be best fitted by double exponentials. When plotted against the voltage the charge Q, associated to I-pre, was dependent on sucrose and protons. The mathematical derivative of the charge Q versus voltage was well in line with the observed C-m changes. Based on these parameters a turnover rate of 500 molecules sucrose/s was calculated. In contrast to gating currents of voltage dependent-potassium channels the analysis of ZmSUT1-derived presteady-state currents in the absence of sucrose (I = Q/iota) was sufficient to predict ZmSUT1 transport-associated currents. Conclusions: Taken together our results indicate that in the absence of sucrose, 'trapped' protons move back and forth between an outer and an inner site within the transmembrane domains of ZmSUT1. This movement of protons in the electric field of the membrane gives rise to the presteady-state currents and in turn to C-m changes. Upon application of external sucrose, protons can pass the membrane turning presteady-state into transport currents.	[Carpaneto, Armando] CNR, Ist Biofis, Genoa, Italy; [Koepsell, Hermann] Univ Wurzburg, Inst Anat & Zellbiol, Wurzburg, Germany; [Bamberg, Ernst] Max Planck Inst Biophys, D-6000 Frankfurt, Germany; [Hedrich, Rainer; Geiger, Dietmar] Univ Wurzburg, Julis von Sachs Inst, Wurzburg, Germany	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Wurzburg; Max Planck Society; University of Wurzburg	Carpaneto, A (corresponding author), CNR, Ist Biofis, Genoa, Italy.	geiger@botanik.uni-wuerzburg.de	Hedrich, Rainer/G-8771-2011; Carpaneto, Armando/F-7754-2013; Geiger, Dietmar/D-6914-2014; Geiger, Dietmar/AAH-8140-2019	Hedrich, Rainer/0000-0003-3224-1362; Geiger, Dietmar/0000-0003-0715-5710; Geiger, Dietmar/0000-0003-0715-5710; Carpaneto, Armando/0000-0002-5060-3657	Deutsche Forschungsgemeinschaft (DFG) [SFB487, GE2195/1-1]; Italian Consiglio Nazionale delle Ricerche (CNR)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Italian Consiglio Nazionale delle Ricerche (CNR)(Consiglio Nazionale delle Ricerche (CNR))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de/index.jsp) grants within SFB487 to RH and HK. DG was supported by DFG grant GE2195/1-1. AC was supported by Italian Consiglio Nazionale delle Ricerche (CNR, Short-term Mobility program 2007 and 2009, http://www.cnr.it/sitocnr/Englishversion/CNR/Dataandstatistics/International-activities/Shorttermmobilityprogram.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN RH, 1976, J PHYSIOL-LONDON, V254, P317, DOI 10.1113/jphysiol.1976.sp011234; Aoki N, 1999, PLANT CELL PHYSIOL, V40, P1072, DOI 10.1093/oxfordjournals.pcp.a029489; ARMSTRONG CM, 1975, BIOPHYS J, V15, P932, DOI 10.1016/S0006-3495(75)85868-1; Becker D, 1996, P NATL ACAD SCI USA, V93, P8123, DOI 10.1073/pnas.93.15.8123; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BIRNIR B, 1991, PFLUG ARCH EUR J PHY, V418, P79, DOI 10.1007/BF00370455; Boorer KJ, 1996, J BIOL CHEM, V271, P25139, DOI 10.1074/jbc.271.41.25139; BOORER KJ, 1994, J BIOL CHEM, V269, P20417; Bossi E, 1999, J PHYSIOL-LONDON, V515, P729, DOI 10.1111/j.1469-7793.1999.729ab.x; Carpaneto A, 2005, J BIOL CHEM, V280, P21437, DOI 10.1074/jbc.M501785200; Cherubino F, 2010, J MOL NEUROSCI, V41, P243, DOI 10.1007/s12031-009-9281-9; Fesce R, 2002, J PHYSIOL-LONDON, V545, P739, DOI 10.1113/jphysiol.2002.026823; Forster I, 1998, J GEN PHYSIOL, V112, P1, DOI 10.1085/jgp.112.1.1; Hilgemann DW, 1999, J GEN PHYSIOL, V114, P459, DOI 10.1085/jgp.114.3.459; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; KEYNES RD, 1994, Q REV BIOPHYS, V27, P339, DOI 10.1017/S0033583500003097; Klamo EM, 1996, J BIOL CHEM, V271, P14937, DOI 10.1074/jbc.271.25.14937; Loo DDF, 1998, P NATL ACAD SCI USA, V95, P7789, DOI 10.1073/pnas.95.13.7789; Loo DDF, 2005, J GEN PHYSIOL, V125, P13, DOI 10.1085/jgp.200409150; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Loo DDF, 2006, J GEN PHYSIOL, V128, P701, DOI 10.1085/jgp.200609643; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Majumdar DS, 2007, P NATL ACAD SCI USA, V104, P12640, DOI 10.1073/pnas.0700969104; Meinild AK, 2002, BIOCHEMISTRY-US, V41, P1250, DOI 10.1021/bi011661r; Nussberger S, 1997, J BIOL CHEM, V272, P7777, DOI 10.1074/jbc.272.12.7777; PARENT L, 1992, J MEMBRANE BIOL, V125, P63; PARENT L, 1992, J MEMBRANE BIOL, V125, P49; Peres A, 2004, NEWS PHYSIOL SCI, V19, P80, DOI 10.1152/nips.01504.2003; RIESMEIER JW, 1993, PLANT CELL, V5, P1591, DOI 10.1105/tpc.5.11.1591; Sauer N, 2007, FEBS LETT, V581, P2309, DOI 10.1016/j.febslet.2007.03.048; Sauer Norbert, 1994, Plant Journal, V6, P67, DOI 10.1046/j.1365-313X.1994.6010067.x; Schmitt BM, 2002, BIOPHYS J, V82, P1345, DOI 10.1016/S0006-3495(02)75490-8; Slewinski TL, 2009, J EXP BOT, V60, P881, DOI 10.1093/jxb/ern335; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Su A, 1996, BIOPHYS J, V70, P762, DOI 10.1016/S0006-3495(96)79616-9; Van Bel AJE, 2003, PLANT CELL ENVIRON, V26, P125, DOI 10.1046/j.1365-3040.2003.00963.x; Zhou JJ, 1997, J MEMBRANE BIOL, V159, P113, DOI 10.1007/s002329900275	37	28	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12605	10.1371/journal.pone.0012605	http://dx.doi.org/10.1371/journal.pone.0012605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20838661	Green Published, gold, Green Submitted			2022-12-27	WOS:000281631300028
J	Mohr, W; Grosskopf, T; Wallace, DWR; LaRoche, J				Mohr, Wiebke; Grosskopf, Tobias; Wallace, Douglas W. R.; LaRoche, Julie			Methodological Underestimation of Oceanic Nitrogen Fixation Rates	PLOS ONE			English	Article							DISSOLVED ORGANIC NITROGEN; N-2 FIXATION; FIXED-NITROGEN; TRICHODESMIUM SPP.; DINITROGEN FIXATION; CIRCADIAN-RHYTHM; RELEASE; IMS101; WATER; DENITRIFICATION	The two commonly applied methods to assess dinitrogen (N(2)) fixation rates are the (15)N(2)-tracer addition and the acetylene reduction assay (ARA). Discrepancies between the two methods as well as inconsistencies between N(2) fixation rates and biomass/ growth rates in culture experiments have been attributed to variable excretion of recently fixed N(2). Here we demonstrate that the (15)N(2)-tracer addition method underestimates N(2) fixation rates significantly when the (15)N(2) tracer is introduced as a gas bubble. The injected (15)N(2) gas bubble does not attain equilibrium with the surrounding water leading to a (15)N(2) concentration lower than assumed by the method used to calculate (15)N(2)-fixation rates. The resulting magnitude of underestimation varies with the incubation time, to a lesser extent on the amount of injected gas and is sensitive to the timing of the bubble injection relative to diel N(2) fixation patterns. Here, we propose and test a modified (15)N(2) tracer method based on the addition of (15)N(2)-enriched seawater that provides an instantaneous, constant enrichment and allows more accurate calculation of N(2) fixation rates for both field and laboratory studies. We hypothesise that application of N(2) fixation measurements using this modified method will significantly reduce the apparent imbalances in the oceanic fixed-nitrogen budget.	[Mohr, Wiebke; Grosskopf, Tobias; Wallace, Douglas W. R.; LaRoche, Julie] Leibniz Inst Meereswissensch IFM GEOMAR, Kiel, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Mohr, W (corresponding author), Leibniz Inst Meereswissensch IFM GEOMAR, Kiel, Germany.	wmohr@ifm-geomar.de	LaRoche, Julie/A-1109-2010	LaRoche, Julie/0000-0003-4809-6411; Mohr, Wiebke/0000-0002-1126-1455	German Research Association [754]	German Research Association(German Research Foundation (DFG))	This work is a contribution of the Collaborative Research Centre 754 "Climate-Biogeochemistry Interactions in the Tropical Ocean" (www.sfb754.de), which is supported by the German Research Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altabet MA, 2007, BIOGEOSCIENCES, V4, P75, DOI 10.5194/bg-4-75-2007; ASHER WE, 1991, ENVIRON SCI TECHNOL, V25, P1294, DOI 10.1021/es00019a011; Brandes JA, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001856; Burns JA, 2006, J PHYCOL, V42, P900, DOI 10.1111/j.1529-8817.2006.00239.x; Capone D.G., 1993, HDB METHODS AQUATIC, P621, DOI 10.1201/9780203752746-74; Capone DG, 2001, METHOD MICROBIOL, V30, P501, DOI 10.1016/S0580-9517(01)30060-0; Chen YB, 1996, J PHYCOL, V32, P916, DOI 10.1111/j.0022-3646.1996.00916.x; Chen YB, 1998, J BACTERIOL, V180, P3598, DOI 10.1128/JB.180.14.3598-3605.1998; Codispoti LA, 2007, BIOGEOSCIENCES, V4, P233, DOI 10.5194/bg-4-233-2007; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; ColonLopez M, 1997, J BACTERIOL, V179, P4319, DOI 10.1128/jb.179.13.4319-4327.1997; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Frew NM, 1997, SEA SURFACE GLOBAL C, P121, DOI DOI 10.1017/CBO9780511525025.006; Gallon JR, 2002, LIMNOL OCEANOGR, V47, P1514, DOI 10.4319/lo.2002.47.5.1514; GLIBERT PM, 1994, APPL ENVIRON MICROB, V60, P3996, DOI 10.1128/AEM.60.11.3996-4000.1994; Goebel NL, 2007, ISME J, V1, P606, DOI 10.1038/ismej.2007.80; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Gruber N, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1, DOI 10.1016/B978-0-12-372522-6.00001-3; Hamme RC, 2004, DEEP-SEA RES PT I, V51, P1517, DOI 10.1016/j.dsr.2004.06.009; KANA TM, 1990, MAR ECOL PROG SER, V64, P293, DOI 10.3354/meps064293; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Mahaffey C, 2005, AM J SCI, V305, P546, DOI 10.2475/ajs.305.6-8.546; Mohr W, 2010, ENVIRON MICROBIOL, V12, P412, DOI 10.1111/j.1462-2920.2009.02078.x; Montoya JP, 2002, LIMNOL OCEANOGR, V47, P1617, DOI 10.4319/lo.2002.47.6.1617; Montoya JP, 1996, APPL ENVIRON MICROB, V62, P986, DOI 10.1128/AEM.62.3.986-993.1996; Mulholland MR, 2007, BIOGEOSCIENCES, V4, P37, DOI 10.5194/bg-4-37-2007; Mulholland MR, 2006, LIMNOL OCEANOGR, V51, P1762, DOI 10.4319/lo.2006.51.4.1762; Mulholland MR, 2005, LIMNOL OCEANOGR, V50, P839, DOI 10.4319/lo.2005.50.3.0839; Mulholland MR, 2004, AQUAT MICROB ECOL, V37, P85, DOI 10.3354/ame037085; Orcutt KM, 2001, DEEP-SEA RES PT II, V48, P1583, DOI 10.1016/S0967-0645(00)00157-0; WEISS RF, 1970, DEEP-SEA RES, V17, P721, DOI 10.1016/0011-7471(70)90037-9; Zehr JP, 2007, BIOLOGY OF THE NITROGEN CYCLE, P193, DOI 10.1016/B978-044452857-5.50014-X	32	289	295	8	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12583	10.1371/journal.pone.0012583	http://dx.doi.org/10.1371/journal.pone.0012583			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838446	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000281627700023
J	Weldon, WC; Wang, BZ; Martin, MP; Koutsonanos, DG; Skountzou, I; Compans, RW				Weldon, William C.; Wang, Bao-Zhong; Martin, Maria P.; Koutsonanos, Dimitrios G.; Skountzou, Ioanna; Compans, Richard W.			Enhanced Immunogenicity of Stabilized Trimeric Soluble Influenza Hemagglutinin	PLOS ONE			English	Article							A VIRUS HEMAGGLUTININ; MEMBRANE-FUSION; RECEPTOR-BINDING; LEUCINE-ZIPPER; VACCINE; BACULOVIRUS; ANTIBODIES; GLYCOPROTEIN; IMMUNIZATION; PROTEIN	Background: The recent swine-origin H1N1 pandemic illustrates the need to develop improved procedures for rapid production of influenza vaccines. One alternative to the current egg-based manufacture of influenza vaccine is to produce a hemagglutinin (HA) subunit vaccine using a recombinant expression system with the potential for high protein yields, ease of cloning new antigenic variants, and an established safety record in humans. Methodology/Principal Findings: We generated a soluble HA (sHA), derived from the H3N2 virus A/Aichi/2/68, modified at the C-terminus with a GCN4pII trimerization repeat to stabilize the native trimeric structure of HA. When expressed in the baculovirus system, the modified sHA formed native trimers. In contrast, the unmodified sHA was found to present epitopes recognized by a low-pH conformation specific monoclonal antibody. We found that mice primed and boosted with 3 mu g of trimeric sHA in the absence of adjuvants had significantly higher IgG and HAI titers than mice that received the unmodified sHA. This correlated with an increased survival and reduced body weight loss following lethal challenge with mouse-adapted A/Aichi/2/68 virus. In addition, mice receiving a single vaccination of the trimeric sHA in the absence of adjuvants had improved survival and body weight loss compared to mice vaccinated with the unmodified sHA. Conclusions/Significance: Our data indicate that the recombinant trimeric sHA presents native trimeric epitopes while the unmodified sHA presents epitopes not exposed in the native HA molecule. The epitopes presented in the unmodified sHA constitute a "silent face'' which may skew the antibody response to epitopes not accessible in live virus at neutral pH. The results demonstrate that the trimeric sHA is a more effective influenza vaccine candidate and emphasize the importance of structure-based antigen design in improving recombinant HA vaccines.	[Weldon, William C.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Emory University; Emory University	Weldon, WC (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	rcompan@emory.edu	Compans, Richard W/I-4087-2013; Skountzou, Ioanna/A-4454-2010	Compans, Richard W/0000-0003-2360-335X; Skountzou, Ioanna/0000-0002-6429-244X; Wang, Bao-Zhong/0000-0002-1561-4318; Tripp, Ralph/0000-0002-2924-9956	National Institutes of Health [AI074579, EB006369]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006369] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported by National Institutes of Health grants AI074579 and EB006369. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brett IC, 2005, VIROLOGY, V339, P273, DOI 10.1016/j.virol.2005.06.006; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; CDC, 2010, 2009 2010 INFL SEAS; Cornelissen LAHM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010645; Crawford J, 1999, VACCINE, V17, P2265, DOI 10.1016/S0264-410X(98)00494-0; DAVIES GE, 1970, P NATL ACAD SCI USA, V66, P651, DOI 10.1073/pnas.66.3.651; De Filette M, 2008, J BIOL CHEM, V283, P11382, DOI 10.1074/jbc.M800650200; de Vries RP, 2010, VIROLOGY, V403, P17, DOI 10.1016/j.virol.2010.03.047; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Heyman B, 2000, ANNU REV IMMUNOL, V18, P709, DOI 10.1146/annurev.immunol.18.1.709; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; HOCART MJ, 1989, J GEN VIROL, V70, P809, DOI 10.1099/0022-1317-70-4-809; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Johansson BE, 1999, VACCINE, V17, P2073, DOI 10.1016/S0264-410X(98)00413-7; Johansson BE, 2007, VACCINE, V25, P3062, DOI 10.1016/j.vaccine.2007.01.030; King JC, 2009, VACCINE, V27, P6589, DOI 10.1016/j.vaccine.2009.08.032; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; NESTOROWICZ AN, 1985, VACCINE, V3, P175, DOI 10.1016/0264-410X(85)90099-4; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; Pancera M, 2005, J VIROL, V79, P9954, DOI 10.1128/JVI.79.15.9954-9969.2005; Ronnelid J, 2008, ADV EXP MED BIOL, V632, P187, DOI 10.1007/978-0-387-78952-1_14; RUIGROK RWH, 1988, J GEN VIROL, V69, P2785, DOI 10.1099/0022-1317-69-11-2785; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SKEHEL JJ, 1982, P NATL ACAD SCI-BIOL, V79, P968, DOI 10.1073/pnas.79.4.968; SMITH CA, 1991, J EXP MED, V173, P953, DOI 10.1084/jem.173.4.953; Treanor JJ, 2006, J INFECT DIS, V193, P1223, DOI 10.1086/503050; Treanor JJ, 2001, VACCINE, V19, P1732, DOI 10.1016/S0264-410X(00)00395-9; Treanor JJ, 2007, JAMA-J AM MED ASSOC, V297, P1577, DOI 10.1001/jama.297.14.1577; Vanlandschoot P, 1996, ARCH VIROL, V141, P1715, DOI 10.1007/BF01718294; Vanlandschoot P, 1998, ARCH VIROL, V143, P227, DOI 10.1007/s007050050282; Wang BZ, 2007, J VIROL, V81, P10869, DOI 10.1128/JVI.00542-07; Wang K, 2006, VACCINE, V24, P2176, DOI 10.1016/j.vaccine.2005.11.005; Webby RJ, 2007, CURR TOP MICROBIOL, V315, P67; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; World Health Organization, 2002, WHO MAN AN INFL DIAG; Yang XZ, 2000, J VIROL, V74, P4746, DOI 10.1128/JVI.74.10.4746-4754.2000; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322	43	87	105	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12466	10.1371/journal.pone.0012466	http://dx.doi.org/10.1371/journal.pone.0012466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824188	gold, Green Submitted, Green Published			2022-12-27	WOS:000281456100004
J	Buxton, ILO; Singer, CA; Tichenor, JN				Buxton, Iain L. O.; Singer, Cherie A.; Tichenor, Jennifer N.			Expression of Stretch-Activated Two-Pore Potassium Channels in Human Myometrium in Pregnancy and Labor	PLOS ONE			English	Article							DOMAIN K+-CHANNELS; PRETERM BIRTH; FUNCTIONAL-PROPERTIES; ARACHIDONIC-ACID; SPLICE VARIANTS; PROTEIN-KINASE; NITRIC-OXIDE; CYCLIC-GMP; TREK-1; PROGESTERONE	Background: We tested the hypothesis that the stretch-activated, four-transmembrane domain, two pore potassium channels (K2P), TREK-1 and TRAAK are gestationally-regulated in human myometrium and contribute to uterine relaxation during pregnancy until labor. Methodology: We determined the gene and protein expression of K2P channels in non-pregnant, pregnant term and preterm laboring myometrium. We employed both molecular biological and functional studies of K2P channels in myometrial samples taken from women undergoing cesarean delivery of a fetus. Principal Findings: TREK-1, but not TREK-2, channels are expressed in human myometrium and significantly up-regulated during pregnancy. Down-regulation of TREK-1 message was seen by Q-PCR in laboring tissues consistent with a role for TREK-1 in maintaining uterine quiescence prior to labor. The TRAAK channel was unregulated in the same women. Blockade of stretch-activated channels with a channel non-specific tarantula toxin (GsMTx-4) or the more specific TREK-1 antagonist L-methionine ethyl ester altered contractile frequency in a dose-dependent manner in pregnant myometrium. Arachidonic acid treatment lowered contractile tension an effect blocked by fluphenazine. Functional studies are consistent with a role for TREK-1 in uterine quiescence. Conclusions: We provide evidence supporting a role for TREK-1 in contributing to uterine quiescence during gestation and hypothesize that dysregulation of this mechanism may underlie certain cases of spontaneous pre-term birth.	[Buxton, Iain L. O.] Univ Nevada, Sch Med, Dept Pharmacol, Reno, NV 89557 USA; Univ Nevada, Sch Med, Dept Obstet & Gynecol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno	Buxton, ILO (corresponding author), Univ Nevada, Sch Med, Dept Pharmacol, Reno, NV 89557 USA.	ibuxton@medicine.nevada.edu			National Institutes of Health Child Health and Human Development [HD053028]; March of Dimes National Prematurity Initiative [21-FY06-576]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053028] Funding Source: NIH RePORTER	National Institutes of Health Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); March of Dimes National Prematurity Initiative(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health Child Health and Human Development grant HD053028 and March of Dimes National Prematurity Initiative Grant 21-FY06-576 to Dr. Buxton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Practice Bulletins--Obstetrics, 2003, Int J Gynaecol Obstet, V82, P127; Bai XL, 2005, REPRODUCTION, V129, P525, DOI 10.1530/rep.1.00442; Baker SA, 2008, BRIT J PHARMACOL, V153, P1259, DOI 10.1038/sj.bjp.0707690; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Behrman R.E, 2006, PRETERM BIRTH CAUSES; Benkusky NA, 2000, J BIOL CHEM, V275, P27712; Bowman CL, 2007, TOXICON, V49, P249, DOI 10.1016/j.toxicon.2006.09.030; Brainard AM, 2007, SEMIN CELL DEV BIOL, V18, P332, DOI 10.1016/j.semcdb.2007.05.008; Brainard AM, 2005, AM J PHYSIOL-CELL PH, V289, pC49, DOI 10.1152/ajpcell.00399.2004; Briery CM, 2009, SOUTH MED J, V102, P900, DOI 10.1097/SMJ.0b013e3181afee12; Buxton I L, 2000, AACN Clin Issues, V11, P271, DOI 10.1097/00044067-200005000-00010; Buxton ILO, 2001, BRIT J PHARMACOL, V134, P206, DOI 10.1038/sj.bjp.0704226; Cheng Longxian, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P31; Curley M, 2002, MOL HUM REPROD, V8, P941, DOI 10.1093/molehr/8.10.941; Curley Michael, 2004, Reprod Biol Endocrinol, V2, P67, DOI 10.1186/1477-7827-2-67; Dodd JM, 2008, OBSTET GYNECOL, V112, P127, DOI 10.1097/AOG.0b013e31817d0262; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gu WL, 2002, J PHYSIOL-LONDON, V539, P657, DOI 10.1113/jphysiol.2001.013432; Han J, 2003, AM J PHYSIOL-CELL PH, V285, pC529, DOI 10.1152/ajpcell.00601.2002; Helliwell RJA, 2006, J CLIN ENDOCR METAB, V91, P597, DOI 10.1210/jc.2005-1982; Higby K, 1999, DRUG SAFETY, V21, P35, DOI 10.2165/00002018-199921010-00004; Hogue CJR, 2005, AM J OBSTET GYNECOL, V192, pS47, DOI 10.1016/j.ajog.2005.01.073; Hu KL, 2003, NEURON, V38, P417, DOI 10.1016/S0896-6273(03)00256-3; HWANG SJ, 2008, JPHYSIOL; Jindal HK, 2008, AM J PHYSIOL-HEART C, V294, pH2012, DOI 10.1152/ajpheart.01374.2007; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; Kim D, 2003, TRENDS PHARMACOL SCI, V24, P648, DOI 10.1016/j.tips.2003.10.008; Koh SD, 2001, J BIOL CHEM, V276, P44338, DOI 10.1074/jbc.M108125200; Kuenzli KA, 1996, BRIT J PHARMACOL, V119, P737, DOI 10.1111/j.1476-5381.1996.tb15734.x; Li ZB, 2005, BIOCHEM BIOPH RES CO, V327, P1163, DOI 10.1016/j.bbrc.2004.12.124; Liu W, 2004, CLIN EXP PHARMACOL P, V31, P174, DOI 10.1111/j.1440-1681.2004.03964.x; MACDORMAN MF, 2008, RECENT TRENDS INFANT, P1; Mazzone J, 2003, P W PHARMACOL SOC, V46, P74; Mazzone JN, 2002, P W PHARMACOL SOC, V45, P184; Meadows HJ, 2000, PFLUG ARCH EUR J PHY, V439, P714, DOI 10.1007/s004240050997; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; Park KJ, 2005, BRIT J PHARMACOL, V144, P1126, DOI 10.1038/sj.bjp.0706154; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Patel AJ, 2001, ANESTHESIOLOGY, V95, P1013, DOI 10.1097/00000542-200110000-00034; Rittenberg C, 2009, J REPROD MED, V54, P47; Sakura H, 1999, J PHYSIOL-LONDON, V521, P337, DOI 10.1111/j.1469-7793.1999.00337.x; Sanders KM, 2006, J PHYSIOL-LONDON, V570, P37, DOI 10.1113/jphysiol.2005.098897; Smith V, 2009, EUR J OBSTET GYN R B, V142, P3, DOI 10.1016/j.ejogrb.2008.09.008; Steele DF, 2007, BIOCHEM SOC T, V35, P1069, DOI 10.1042/BST0351069; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Tan JHC, 2004, EXP PHYSIOL, V89, P237, DOI 10.1113/expphysiol.2003.027052; Thummler S, 2007, BIOCHEM BIOPH RES CO, V354, P284, DOI 10.1016/j.bbrc.2006.12.199; Tichenor JN, 2005, P W PHARMACOL SOC, V48, P44; *WHO, 2001, WHO REP; XIAN TL, 2006, CARDIOVASC RES, V69, P86, DOI DOI 10.1016/J.CARDIORES.2005.08.018	53	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12372	10.1371/journal.pone.0012372	http://dx.doi.org/10.1371/journal.pone.0012372			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811500	Green Published, Green Submitted, gold			2022-12-27	WOS:000281234700009
J	Prasov, L; Brown, NL; Glaser, T				Prasov, Lev; Brown, Nadean L.; Glaser, Tom			A Critical Analysis of Atoh7 (Math5) mRNA Splicing in the Developing Mouse Retina	PLOS ONE			English	Article							PROGENITOR-CELL COMPETENCE; POLYMERASE CHAIN-REACTION; GANGLION-CELL; REVERSE-TRANSCRIPTASE; INTRONLESS GENES; PCR; SITE; AMPLIFICATION; EXPRESSION; ANTIBODIES	The Math5 (Atoh7) gene is transiently expressed during retinogenesis by progenitors exiting mitosis, and is essential for ganglion cell (RGC) development. Math5 contains a single exon, and its 1.7 kb mRNA encodes a 149-aa polypeptide. Mouse Math5 mutants have essentially no RGCs or optic nerves. Given the importance of this gene in retinal development, we thoroughly investigated the possibility of Math5 mRNA splicing by Northern blot, 3'RACE, RNase protection assays, and RT-PCR, using RNAs extracted from embryonic eyes and adult cerebellum, or transcribed in vitro from cDNA clones. Because Math5 mRNA contains an elevated G+C content, we used graded concentrations of betaine, an isostabilizing agent that disrupts secondary structure. Although similar to 10% of cerebellar Math5 RNAs are spliced, truncating the polypeptide, our results show few, if any, spliced Math5 transcripts exist in the developing retina (<1%). Rare deleted cDNAs do arise via RT-mediated RNA template switching in vitro, and are selectively amplified during PCR. These data differ starkly from a recent study (Kanadia and Cepko 2010), which concluded that the vast majority of Math5 and other bHLH transcripts are spliced to generate noncoding RNAs. Our findings clarify the architecture of the Math5 gene and its mechanism of action. These results have implications for all members of the bHLH gene family, for any gene that is alternatively spliced, and for the interpretation of all RT-PCR experiments.	[Prasov, Lev; Glaser, Tom] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Prasov, Lev; Glaser, Tom] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Brown, Nadean L.] Univ Cincinnati, Sch Med, Div Dev Biol, Dept Pediat & Ophthalmol,Cincinnati Childrens Res, Cincinnati, OH USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Prasov, L (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.	tglaser@umich.edu	Prasov, Lev/AAX-1642-2020; , Nadean/HCH-9314-2022	Prasov, Lev/0000-0002-6635-1116; 	National Institutes of Health (NIH) [EY14259, EY13612, GM07863, EY13934]; Glaucoma Foundation; NATIONAL EYE INSTITUTE [R01EY013612, T32EY013934, R01EY014259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glaucoma Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was funded by National Institutes of Health (NIH) R01 grants to TG (EY14259) and NLB (EY13612) and The Glaucoma Foundation (TG). LP was supported by NIH T32 grants to the University of Michigan Medical Scientist (GM07863) and Vision Research (EY13934) Training Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO S, 1986, J MOL EVOL, V23, P11, DOI 10.1007/BF02100994; ALTSHULER DM, 1991, P RET RES F, V3, P37; BAIM SB, 1985, MOL CELL BIOL, V5, P1839, DOI 10.1128/MCB.5.8.1839; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; BERGET SM, 1977, COLD SPRING HARB SYM, V42, P523; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; BERK AJ, 1977, CELL, V12, P721, DOI 10.1016/0092-8674(77)90272-0; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Blackburn DC, 2008, DEV DYNAM, V237, P2209, DOI 10.1002/dvdy.21634; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Brincat JL, 2002, J VIROL, V76, P88, DOI 10.1128/JVI.76.1.88-95.2002; Brown NL, 2002, MAMM GENOME, V13, P95, DOI 10.1007/s00335-001-2101-3; Brown NL, 1998, DEVELOPMENT, V125, P4821; Brown NL, 2001, DEVELOPMENT, V128, P2497; Brzezinski JA, 2005, INVEST OPHTH VIS SCI, V46, P2540, DOI 10.1167/iovs.04-1123; Brzezinski JA, 2003, DEV BIOL, V259, P553; BRZEZINSKI JA, 2004, INVEST OPHTH VIS SCI, V45, P3422; CECH TR, 1986, CELL, V44, P207, DOI 10.1016/0092-8674(86)90751-8; Cho EA, 1998, MECH DEVELOP, V77, P9; Chooniedass-Kothari S, 2004, FEBS LETT, V566, P43, DOI 10.1016/j.febslet.2004.03.104; Cocquet J, 2006, GENOMICS, V88, P127, DOI 10.1016/j.ygeno.2005.12.013; DERJAGUIN BV, 1973, NATURE, V244, P430, DOI 10.1038/244430a0; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; Eisenstein M, 2005, NAT METHODS, V2, P396, DOI 10.1038/nmeth0505-396; ENGELBRECHT J, 1992, J MOL BIOL, V227, P108, DOI 10.1016/0022-2836(92)90685-D; Fedorov A, 2001, NUCLEIC ACIDS RES, V29, P1464, DOI 10.1093/nar/29.7.1464; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Fox-Walsh KL, 2005, P NATL ACAD SCI USA, V102, P16176, DOI 10.1073/pnas.0508489102; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; Gentles AJ, 1999, TRENDS GENET, V15, P47, DOI 10.1016/S0168-9525(98)01648-5; GRAY NK, 1994, MOL BIOL REP, V19, P195, DOI 10.1007/BF00986961; Harlow E., 1988, ANTIBODIES LAB MANUA; Harrington ED, 2004, NAT GENET, V36, P916, DOI 10.1038/ng0904-916; Henke W, 1997, NUCLEIC ACIDS RES, V25, P3957, DOI 10.1093/nar/25.19.3957; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HUFNAGEL RB, 2010, DEV BIOL; Irimia M, 2008, TRENDS GENET, V24, P378, DOI 10.1016/j.tig.2008.05.007; Jaillon O, 2008, NATURE, V451, P359, DOI 10.1038/nature06495; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; Jeffares DC, 2008, TRENDS GENET, V24, P375, DOI 10.1016/j.tig.2008.05.006; Kanadia RN, 2010, GENE DEV, V24, P229, DOI 10.1101/gad.1847110; Kanekar S, 1997, NEURON, V19, P981, DOI 10.1016/S0896-6273(00)80391-8; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; Kenneson A, 2001, HUM MOL GENET, V10, P1449, DOI 10.1093/hmg/10.14.1449; Kitabayashi M, 2003, BIOSCI BIOTECH BIOCH, V67, P2474, DOI 10.1271/bbb.67.2474; Leygue E, 1996, AM J PATHOL, V148, P1097; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219; Mader RM, 2001, J LAB CLIN MED, V137, P422, DOI 10.1067/mlc.2001.115452; Maquat LE, 2001, RNA, V7, P445, DOI 10.1017/S1355838201002229; Margulies EH, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e60; Mastick GS, 2001, MOL CELL NEUROSCI, V17, P190, DOI 10.1006/mcne.2000.0924; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; McCullough AJ, 2000, MOL CELL BIOL, V20, P9225, DOI 10.1128/MCB.20.24.9225-9235.2000; MELCHIOR WB, 1973, P NATL ACAD SCI USA, V70, P298, DOI 10.1073/pnas.70.2.298; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mitrovich QM, 2000, GENE DEV, V14, P2173, DOI 10.1101/gad.819900; Mu XQ, 2005, DEV BIOL, V280, P467, DOI 10.1016/j.ydbio.2005.01.028; Mytelka DS, 1996, NUCLEIC ACIDS RES, V24, P2774, DOI 10.1093/nar/24.14.2774; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Pfeiffer JK, 2001, J VIROL, V75, P11263, DOI 10.1128/JVI.75.23.11263-11274.2001; REES WA, 1993, BIOCHEMISTRY-US, V32, P137, DOI 10.1021/bi00052a019; Rhodes KJ, 2006, J NEUROSCI, V26, P8017, DOI 10.1523/JNEUROSCI.2728-06.2006; Roy SW, 2008, BIOESSAYS, V30, P601, DOI 10.1002/bies.20749; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Sakharkar MK, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-67; Saper CB, 2003, J COMP NEUROL, V465, P161, DOI 10.1002/cne.10858; Saul SM, 2008, MOL CELL NEUROSCI, V37, P153, DOI 10.1016/j.mcn.2007.09.006; Schonbrunner NJ, 2006, BIOCHEMISTRY-US, V45, P12786, DOI 10.1021/bi0609117; Stolting KN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-565; Tabaska JE, 1999, GENE, V231, P77, DOI 10.1016/S0378-1119(99)00104-3; Telesnitsky A., 1997, P121; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800; Wallace VA, 1999, DEVELOPMENT, V126, P2901; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Weissensteiner T, 1996, BIOTECHNIQUES, V21, P1102; Wong LL, 2009, DEVELOPMENT, V136, P1707, DOI 10.1242/dev.027607; WU WM, 1995, J BIOL CHEM, V270, P325, DOI 10.1074/jbc.270.1.263; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; Zaphiropoulos PG, 2002, FEBS LETT, V527, P326, DOI 10.1016/S0014-5793(02)03239-8; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	87	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12315	10.1371/journal.pone.0012315	http://dx.doi.org/10.1371/journal.pone.0012315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808762	Green Published, Green Submitted, gold			2022-12-27	WOS:000281154300001
J	Thors, L; Bergh, A; Persson, E; Hammarsten, P; Stattin, P; Egevad, L; Granfors, T; Fowler, CJ				Thors, Lina; Bergh, Anders; Persson, Emma; Hammarsten, Peter; Stattin, Par; Egevad, Lars; Granfors, Torvald; Fowler, Christopher J.			Fatty Acid Amide Hydrolase in Prostate Cancer: Association with Disease Severity and Outcome, CB1 Receptor Expression and Regulation by IL-4	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CENTRAL-NERVOUS-SYSTEM; CANNABINOID RECEPTORS; TUMOR-GROWTH; TRANSCRIPTIONAL REGULATION; ANANDAMIDE HYDROLASE; CELL-PROLIFERATION; PANCREATIC-CANCER; INDUCED APOPTOSIS; T-LYMPHOCYTES	Background: Recent data have indicated that there may be a dysregulation of endocannabinoid metabolism in cancer. Here we have investigated the expression of the endocannabinoid metabolising enzyme fatty acid amide hydrolase (FAAH) in a well characterised tissue microarray from patients diagnosed with prostate cancer at transurethral resection for voiding problems. Methodology/Principal Findings: FAAH immunoreactivity (FAAH-IR) was assessed in formalin-fixed paraffin-embedded non-malignant and tumour cores from 412 patients with prostate cancer. CB1 receptor immunoreactivity (CB1IR) scores were available for this dataset. FAAH-IR was seen in epithelial cells and blood vessel walls but not in the stroma. Tumour epithelial FAAH-IR was positively correlated with the disease severity at diagnosis (Gleason score, tumour stage, % of the specimen that contained tumour) for cases with mid-range CB1IR scores, but not for those with high CB1IR scores. For the 281 cases who only received palliative therapy at the end stages of the disease, a high tumour epithelial FAAH-IR was associated with a poor disease-specific survival. Multivariate Cox proportional-hazards regression analyses indicated that FAAH-IR gave additional prognostic information to that provided by CB1IR when a midrange, but not a high CB1IR cutoff value was used. Interleukin-4 (IL-4) receptor IR was found on tumour epithelial cells and incubation of prostate cancer PC-3 and R3327 AT1 cells with IL-4 increased their FAAH activity. Conclusions/Significance: Tumour epithelial FAAH-IR is associated with prostate cancer severity and outcome at mid-range, but not high, CB1IR scores. The correlation with CB1IR in the tumour tissue may be related to a common local dysregulation by a component of the tumour microenvironment.	[Thors, Lina; Fowler, Christopher J.] Umea Univ, Pharmacol Unit, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Bergh, Anders; Hammarsten, Peter] Umea Univ, Pathol Unit, Dept Med Biosci, Umea, Sweden; [Persson, Emma] Umea Univ, Dept Oncol, Umea, Sweden; [Persson, Emma] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Stattin, Par] Umea Univ, Urol & Androl Unit, Dept Surg & Perioperat Sci, Umea, Sweden; [Egevad, Lars] Karolinska Univ Hosp, Dept Pathol & Cytol, Stockholm, Sweden; [Granfors, Torvald] Cent Hosp Vasteras, Dept Urol, Vasteras, Sweden	Umea University; Umea University; Umea University; Umea University; Umea University; Karolinska Institutet; Karolinska University Hospital; Vasteras Central Hospital	Thors, L (corresponding author), Umea Univ, Pharmacol Unit, Dept Pharmacol & Clin Neurosci, Umea, Sweden.	cf@pharm.umu.se	Fowler, Christopher J./M-6313-2019	Fowler, Christopher J./0000-0002-6658-7874; Thors, Lina/0000-0002-4948-6676; Egevad, Lars/0000-0001-8531-222X	Swedish Science Council [12158]; Swedish Cancer Society [CAN 2007/712]; Umea University/Cancer Research Fund Norrland; Medical Faculty, Umea University; NIH [DA11322]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011322] Funding Source: NIH RePORTER	Swedish Science Council; Swedish Cancer Society(Swedish Cancer Society); Umea University/Cancer Research Fund Norrland; Medical Faculty, Umea University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank the Swedish Science Council (Grant no. 12158, medicine, C.J. Fowler); the Swedish Cancer Society (Grant no. CAN 2007/712, Anders Bergh); the Lions Cancer Research Fund at Umea University/Cancer Research Fund Norrland and the Research Funds of the Medical Faculty, Umea University (C.J. Fowler) for financial support. The funding source for the antibody (to Dr. Mackie) was grant NIH DA11322. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Bifulco M, 2004, FASEB J, V18, P1606, DOI 10.1096/fj.04-1754fje; Borner C, 2008, MOL PHARMACOL, V73, P1013, DOI 10.1124/mol.107.042945; Borner C, 2007, J LEUKOCYTE BIOL, V81, P336, DOI 10.1189/jlb.0306224; Boldrup L, 2004, J BIOCHEM BIOPH METH, V60, P171, DOI 10.1016/j.jbbm.2004.04.020; Chung LWK, 2005, J UROLOGY, V173, P10, DOI 10.1097/01.ju.0000141582.15218.10; Chung SC, 2009, EUR J CANCER, V45, P174, DOI 10.1016/j.ejca.2008.10.010; Conticello C, 2004, J IMMUNOL, V172, P5467, DOI 10.4049/jimmunol.172.9.5467; COX DR, 1972, J R STAT SOC B, V34, P187; Cudaback E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008702; Czifra G, 2009, J CANCER RES CLIN, V135, P507, DOI 10.1007/s00432-008-0482-3; Egertova M, 1998, P ROY SOC B-BIOL SCI, V265, P2081, DOI 10.1098/rspb.1998.0543; Egevad L, 2002, BJU INT, V89, P538, DOI 10.1046/j.1464-410X.2002.02669.x; Endsley MP, 2008, INT J CANCER, V123, P1318, DOI 10.1002/ijc.23674; Endsley MP, 2007, INT J CANCER, V121, P984, DOI 10.1002/ijc.22761; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Fowler CJ, 2008, PHARMACOL RES, V58, P72, DOI 10.1016/j.phrs.2008.07.002; Fowler CJ, 2010, CURR TOP MED CHEM, V10, P814; Freimuth N, 2010, J PHARMACOL EXP THER, V332, P336, DOI 10.1124/jpet.109.157735; Galve-Roperh I, 2000, NAT MED, V6, P313, DOI 10.1038/73171; Gifford AN, 1999, J PHARMACOL EXP THER, V288, P478; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; Goparaju SK, 1998, FEBS LETT, V422, P69, DOI 10.1016/S0014-5793(97)01603-7; Hammarsten P, 2010, CLIN CANCER RES, V16, P1245, DOI 10.1158/1078-0432.CCR-09-0103; Harkany T, 2003, EUR J NEUROSCI, V18, P1979, DOI 10.1046/j.1460-9568.2003.02898.x; HARRINGTON CR, 1990, ANAL BIOCHEM, V186, P285, DOI 10.1016/0003-2697(90)90081-J; Hart S, 2004, CANCER RES, V64, P1943, DOI 10.1158/0008-5472.CAN-03-3720; HOEHE MR, 1991, NEW BIOL, V3, P880; Husain SR, 2003, MOL CANCER THER, V2, P245; Jhaveri MD, 2006, J NEUROSCI, V26, P13318, DOI 10.1523/JNEUROSCI.3326-06.2006; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Lee SO, 2008, PROSTATE, V68, P85, DOI 10.1002/pros.20691; Li ZG, 2008, CANCER RES, V68, P8687, DOI 10.1158/0008-5472.CAN-08-0449; Ligresti A, 2003, GASTROENTEROLOGY, V125, P677, DOI 10.1016/S0016-5085(03)00881-3; Lorente M, 2009, GLIA, V57, P1374, DOI 10.1002/glia.20856; Maccarrone M, 2001, J IMMUNOL, V166, P7183, DOI 10.4049/jimmunol.166.12.7183; Maccarrone M, 2000, J BIOL CHEM, V275, P31938, DOI 10.1074/jbc.M005722200; Maccarrone M, 2003, J BIOL CHEM, V278, P13318, DOI 10.1074/jbc.M211248200; McPartland JM, 2007, GENE, V397, P126, DOI 10.1016/j.gene.2007.04.017; Melck D, 2000, ENDOCRINOLOGY, V141, P118, DOI 10.1210/en.141.1.118; Michalski CW, 2008, INT J CANCER, V122, P742, DOI 10.1002/ijc.23114; Mimeault M, 2006, CARCINOGENESIS, V27, P1, DOI 10.1093/carcin/bgi229; Mimeault M, 2003, PROSTATE, V56, P1, DOI 10.1002/pros.10190; Nithipatikom K, 2004, CANCER RES, V64, P8826, DOI 10.1158/0008-5472.CAN-04-3136; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; OKADA H, 1992, VIRCHOWS ARCH A, V421, P157, DOI 10.1007/BF01607049; Olea-Herrero N, 2009, BRIT J CANCER, V101, P940, DOI 10.1038/sj.bjc.6605248; Olver S, 2007, TISSUE ANTIGENS, V69, P293, DOI 10.1111/j.1399-0039.2007.00831.x; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Pisanti S, 2009, PHARMACOL RES, V60, P107, DOI 10.1016/j.phrs.2009.03.011; Prokopchuk O, 2005, BRIT J CANCER, V92, P921, DOI 10.1038/sj.bjc.6602416; Rossi G, 2007, ENDOCRINOLOGY, V148, P1431, DOI 10.1210/en.2006-0969; Ruiz L, 1999, FEBS LETT, V458, P400, DOI 10.1016/S0014-5793(99)01073-X; SANCHEZ L, 2005, COMPREHENSIVE MOL IN, V1, P1; Sarfaraz S, 2005, CANCER RES, V65, P1635, DOI 10.1158/0008-5472.CAN-04-3410; Sarfaraz S, 2006, J BIOL CHEM, V281, P39480, DOI 10.1074/jbc.M603495200; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Tsou K, 1998, NEUROSCI LETT, V254, P137, DOI 10.1016/S0304-3940(98)00700-9; Waleh NS, 2002, GENE, V291, P203, DOI 10.1016/S0378-1119(02)00598-X; Wan MH, 1998, GENOMICS, V54, P408, DOI 10.1006/geno.1998.5597; Wang DZ, 2008, CANCER RES, V68, P6468, DOI 10.1158/0008-5472.CAN-08-0896; Wikstrom P, 2009, PROSTATE, V69, P799, DOI 10.1002/pros.20927; Wise GJ, 2000, J UROLOGY, V164, P722, DOI 10.1016/S0022-5347(05)67289-8; Xu XD, 2006, CANCER GENET CYTOGEN, V171, P31, DOI 10.1016/j.cancergencyto.2006.06.014; ZWEIG MH, 1993, CLIN CHEM, V39, P561	65	56	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12275	10.1371/journal.pone.0012275	http://dx.doi.org/10.1371/journal.pone.0012275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808855	Green Published, gold, Green Submitted			2022-12-27	WOS:000281075500010
J	Ryckman, KK; Fielding, K; Hill, AV; Mendy, M; Rayco-Solon, P; Sirugo, G; van der Sande, MA; Waight, P; Whittle, HC; Hall, AJ; Williams, SM; Hennig, BJ				Ryckman, Kelli K.; Fielding, Katherine; Hill, Adrian V.; Mendy, Maimuna; Rayco-Solon, Pura; Sirugo, Giorgio; van der Sande, Marianne A.; Waight, Pauline; Whittle, Hilton C.; Hall, Andrew J.; Williams, Scott M.; Hennig, Branwen J.			Host Genetic Factors and Vaccine-Induced Immunity to HBV Infection: Haplotype Analysis	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; DISEASE SUSCEPTIBILITY; SURFACE-ANTIGEN; IMMUNOGENETICS; RESPONSES; TWINS	Hepatitis B virus (HBV) infection remains a significant health burden world-wide, although vaccines help decrease this problem. We previously identified associations of single nucleotide polymorphisms in several candidate genes with vaccine-induced peak antibody level (anti-HBs), which is predictive of long-term vaccine efficacy and protection against infection and persistent carriage; here we report on a haplotype-based analysis. A total of 688 SNPs from 117 genes were examined for a two, three and four sliding window haplotype analysis in a Gambian cohort. Analysis was performed on 197 unrelated individuals, 454 individuals from 174 families, and the combined sample (N = 651). Global and individual haplotype association tests were carried out (adjusted for covariates), employing peak anti-HBs level as outcome. Five genes (CD44, CD58, CDC42, IL19 and IL1R1) had at least one significant haplotype in the unrelated or family analysis as well as the combined analysis. Previous single locus results were confirmed for CD44 (combined global p = 9.1 x 10(-5) for rs353644-rs353630-rs7937602) and CD58 (combined global p = 0.008 for rs1414275-rs11588376-rs1016140). Haplotypes in CDC42, IL19 and IL1R1 also associated with peak anti-HBs level. We have identified strong haplotype effects on HBV vaccine-induced antibody level in five genes, three of which, CDC42, IL19 and IL1R1, did not show evidence of association in a single SNP analyses and corroborated the majority of these effects in two datasets. The haplotype analysis identified associations with HBV vaccine-induced immunity in several new genes.	[Ryckman, Kelli K.; Williams, Scott M.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37203 USA; [Ryckman, Kelli K.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Rayco-Solon, Pura; Hennig, Branwen J.] London Sch Hyg & Trop Med, Med Res Council Int Nutr Grp, London WC1, England; [Hill, Adrian V.] Univ Oxford, Welcome Trust Ctr Human Genet, Oxford, England; [Hill, Adrian V.] Univ Oxford, Jenner Inst, Oxford, England; [Mendy, Maimuna; van der Sande, Marianne A.; Waight, Pauline; Whittle, Hilton C.] MRC Labs, Banjul, Gambia; [Rayco-Solon, Pura; Hennig, Branwen J.] MRC, Keneba, Gambia; [van der Sande, Marianne A.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Sirugo, Giorgio] Osped S Pietro FBF, Unita Genet Med, Rome, Italy	Vanderbilt University; University of Iowa; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Jenner Institute; MRC Laboratory Molecular Biology; University of London; London School of Hygiene & Tropical Medicine; Netherlands National Institute for Public Health & the Environment	Ryckman, KK (corresponding author), Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37203 USA.	smwilliams@chgr.mc.vanderbilt.edu	Sirugo, Giorgio/L-1628-2016; Williams, Scott/Q-4812-2019; Mendy, Maimuna/ABD-5038-2021; Hennig, Branwen/M-6444-2014; Sirugo, Giorgio/N-9056-2019; Williams, Scott/B-9491-2012	Williams, Scott/0000-0002-4835-9544; Fielding, Katherine/0000-0002-6524-3754; Ryckman, Kelli/0000-0002-9496-4147; Hennig, Branwen J./0000-0003-4127-8386; van der Sande, Marianne AB/0000-0002-4778-6739	Wellcome Trust [GR069267AIA]; MRC [MC_U123292699, MC_U123292700, MC_U190071516] Funding Source: UKRI; Medical Research Council [MC_U190071516, MC_U123292700, MC_U123292699] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by a Wellcome Trust Advanced Fellowship grant to BJH (grant number GR069267AIA, http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPER CA, 1995, EXP CLIN IMMUNOGENET, V12, P171; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brazzoli M, 2008, J VIROL, V82, P8316, DOI 10.1128/JVI.00665-08; Clark AG, 2004, GENET EPIDEMIOL, V27, P321, DOI 10.1002/gepi.20025; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; Davila S, 2010, GENES IMMUN, V11, P232, DOI 10.1038/gene.2010.1; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hennig BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001898; Hodge JW, 2005, J IMMUNOL, V174, P5994, DOI 10.4049/jimmunol.174.10.5994; Hohler T, 2002, J HEPATOL, V37, P387, DOI 10.1016/S0168-8278(02)00205-2; Kimman TG, 2007, COMMUNITY GENET, V10, P201, DOI 10.1159/000106559; Kimura K, 2009, J GASTROENTEROL, V44, P218, DOI 10.1007/s00535-008-2300-8; Kruger A, 2005, CLIN EXP IMMUNOL, V140, P325, DOI 10.1111/j.1365-2249.2005.02765.x; LIN TM, 1989, ANTICANCER RES, V9, P737; Milich DR, 2003, AUTOIMMUN REV, V2, P248, DOI 10.1016/S1568-9972(03)00031-4; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Newport MJ, 2004, GENES IMMUN, V5, P122, DOI 10.1038/sj.gene.6364051; Sirugo G, 2008, HUM GENET, V123, P557, DOI 10.1007/s00439-008-0511-y; Stanley SL, 2007, J INFECT DIS, V196, P212, DOI 10.1086/518794; Tan TL, 2008, BBA-MOL CELL RES, V1783, P360, DOI 10.1016/j.bbamcr.2007.10.024; Thursz M, 2001, QJM-MON J ASSOC PHYS, V94, P287, DOI 10.1093/qjmed/94.6.287; van der Sande MAB, 2006, J INFECT DIS, V193, P1528, DOI 10.1086/503433; Van LH, 2001, ENV HLTH PERSPECT, V109, P757; Wang CB, 2004, HEPATOLOGY, V39, P978, DOI 10.1002/hep.20142; Zuckerman JN, 2006, J MED VIROL, V78, P169, DOI 10.1002/jmv.20524; 2009, HEPATITIS B FACT SHE	29	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12273	10.1371/journal.pone.0012273	http://dx.doi.org/10.1371/journal.pone.0012273			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20806065	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000281011600031
J	Voigt, A; Herholz, D; Fiesel, FC; Kaur, K; Muller, D; Karsten, P; Weber, SS; Kahle, PJ; Marquardt, T; Schulz, JB				Voigt, Aaron; Herholz, David; Fiesel, Fabienne C.; Kaur, Kavita; Mueller, Daniel; Karsten, Peter; Weber, Stephanie S.; Kahle, Philipp J.; Marquardt, Till; Schulz, Joerg B.			TDP-43-Mediated Neuron Loss In Vivo Requires RNA-Binding Activity	PLOS ONE			English	Article							NUCLEAR FACTOR TDP-43; MUTATIONS; DROSOPHILA; ALS; TOL2; GENE; ELEMENT; EXON-9	Alteration and/or mutations of the ribonucleoprotein TDP-43 have been firmly linked to human neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). The relative impacts of TDP-43 alteration, mutation, or inherent protein function on neural integrity, however, remain less clear-a situation confounded by conflicting reports based on transient and/or random-insertion transgenic expression. We therefore performed a stringent comparative investigation of impacts of these TDP-43 modifications on neural integrity in vivo. To achieve this, we systematically screened ALS/FTLD-associated and synthetic TDP-43 isoforms via same-site gene insertion and neural expression in Drosophila; followed by transposon-based motor neuron-specific transgenesis in a chick vertebrate system. Using this bi-systemic approach we uncovered a requirement of inherent TDP-43 RNA-binding function-but not ALS/FTLD-linked mutation, mislocalization, or truncation-for TDP-43-mediated neurotoxicity in vivo.	[Voigt, Aaron; Kaur, Kavita; Karsten, Peter; Schulz, Joerg B.] Rhein Westfal TH Aachen, Dept Neurol, Univ Med Ctr, D-5100 Aachen, Germany; [Herholz, David; Mueller, Daniel; Marquardt, Till] European Neurosci Inst Gottingen, Dev Neurobiol Lab, Gottingen, Germany; [Fiesel, Fabienne C.; Weber, Stephanie S.; Kahle, Philipp J.] Hertie Inst Clin Brain Res, Dept Neurodegenerat, Lab Funct Neurogenet, Tubingen, Germany; [Fiesel, Fabienne C.; Weber, Stephanie S.; Kahle, Philipp J.] German Ctr Neurodegenerat Dis, Tubingen, Germany; [Schulz, Joerg B.] JARA Brain Julich Aachen Res Alliance, Julich, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Voigt, A (corresponding author), Rhein Westfal TH Aachen, Dept Neurol, Univ Med Ctr, D-5100 Aachen, Germany.	T.Marquardt@eni-g.de; jschulz@ukaachen.de	Schulz, Jörg B/D-9786-2012	Schulz, Jörg B/0000-0002-8903-0593; Fiesel, Fabienne/0000-0002-1919-9676	START; German Competence Net Degenerative Dementias [01GI0703]; Gattingen graduate school for neurobiology fellowship	START(Austrian Science Fund (FWF)); German Competence Net Degenerative Dementias; Gattingen graduate school for neurobiology fellowship	This research project is supported by the START-Program of the Faculty of Medicine, RWTH Aachen and by the German Competence Net Degenerative Dementias, grant number 01GI0703, as well as an Emmy Noether Grant of the Deutsche Forschungsgemeinschaft. D.M. is supported by a Gattingen graduate school for neurobiology fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2009, ADV GENET, V66, P1, DOI 10.1016/S0065-2660(09)66001-6; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Gendron TF, 2010, NEUROPATH APPL NEURO, V36, P97, DOI [10.1111/j.1365-2990.2009.01060.x, 10.1111/j.1365-2990.2010.01060.x]; Giordana MT, 2010, BRAIN PATHOL, V20, P351, DOI 10.1111/j.1750-3639.2009.00284.x; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kawakami K, 2004, GENETICS, V166, P895, DOI 10.1534/genetics.166.2.895; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; LAGIERTOURENNE C, 2010, HUM MOL GENET; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Zhou HX, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000887	30	147	152	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12247	10.1371/journal.pone.0012247	http://dx.doi.org/10.1371/journal.pone.0012247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20806063	Green Published, gold, Green Submitted			2022-12-27	WOS:000281011600019
J	Vilceanu, D; Stucky, CL				Vilceanu, Daniel; Stucky, Cheryl L.			TRPA1 Mediates Mechanical Currents in the Plasma Membrane of Mouse Sensory Neurons	PLOS ONE			English	Article							CHANNEL; MECHANOTRANSDUCTION; TRANSDUCTION; EXPRESSION; ANKYRIN; COLD; A1	Mechanosensitive channels serve as essential sensors for cells to interact with their environment. The identity of mechanosensitive channels that underlie somatosensory touch transduction is still a mystery. One promising mechanotransduction candidate is the Transient Receptor Potential Ankyrin 1 (TRPA1) ion channel. To determine the role of TRPA1 in the generation of mechanically-sensitive currents, we used dorsal root ganglion (DRG) neuron cultures from adult mice and applied rapid focal mechanical stimulation (indentation) to the soma membrane. Small neurons (diameter, 27 mu m) were studied because TRPA1 is functionally present in these neurons which largely give rise to C-fiber afferents in vivo. Small neurons were classified by isolectin B4 binding. Mechanically-activated inward currents were classified into two subtypes: Slowly Adapting and Transient. First, significantly more IB4 negative neurons (84%) responded to mechanical stimulation than IB4 positive neurons (54%). Second, 89% of Slowly Adapting currents were present in IB4 negative neurons whereas only 11% were found in IB4 positive neurons. Third, Slowly Adapting currents were completely absent in IB4 negative neurons from TRPA1-/- mice. Consistent with this, Slowly Adapting currents were abolished in wild type IB4 negative neurons stimulated in the presence of a TRPA1 antagonist, HC-030031. In addition, the amplitude of Transient mechanically-activated currents in IB4 positive neurons from TRPA1-/- mice was reduced by over 60% compared to TRPA1+/+ controls; however, a similar reduction did not occur in wild-type neurons treated with HC-030031. Transfection of TRPA1 in HEK293 cells did not significantly alter the proportion or magnitude of mechanically-activated currents in HEK293 cells, indicating that TRPA1 alone is not sufficient to confer mechanical sensitivity. These parallel genetic and pharmacological data demonstrate that TRPA1 mediates the Slowly Adapting mechanically-activated currents in small-diameter IB4 negative neurons from adult mice. The TRPA1 protein may also contribute to a complex that mediates Transient mechanically-activated currents in small IB4 positive C fiber type neurons.	[Vilceanu, Daniel; Stucky, Cheryl L.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Vilceanu, D (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	cstucky@mcw.edu			National Institutes of Health [NS40538, NS070711]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040538, R01NS070711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health grant NS40538 and NS070711 to C.L.S.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Anand U, 2008, NEUROSCI LETT, V438, P221, DOI 10.1016/j.neulet.2008.04.007; Anishkin A, 2005, CURR OPIN NEUROBIOL, V15, P397, DOI 10.1016/j.conb.2005.06.002; Atoyan R, 2009, J INVEST DERMATOL, V129, P2312, DOI 10.1038/jid.2009.58; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Dirajlal S, 2003, J NEUROPHYSIOL, V89, P513, DOI 10.1152/jn.00371.2002; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Drew LJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-12-j0001.2002; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Inoue R, 2009, PHARMACOL THERAPEUT, V123, P371, DOI 10.1016/j.pharmthera.2009.05.009; Jaquemar D, 1999, J BIOL CHEM, V274, P7325, DOI 10.1074/jbc.274.11.7325; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kerstein PC, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-19; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lechner SG, 2009, EMBO J, V28, P1479, DOI 10.1038/emboj.2009.73; Martinac B, 2008, PHYSIOL REV, V88, P1449, DOI 10.1152/physrev.00005.2008; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; McCarter GC, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-28; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Rugiero F, 2009, NEUROPHARMACOLOGY, V56, P1138, DOI 10.1016/j.neuropharm.2009.03.012; Salas MM, 2009, EUR J NEUROSCI, V29, P1568, DOI 10.1111/j.1460-9568.2009.06702.x; Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001; Stokes NR, 2003, P NATL ACAD SCI USA, V100, P15959, DOI 10.1073/pnas.2536607100; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Stucky CL, 1999, J NEUROSCI, V19, P6497; Tsunozaki M, 2009, CURR OPIN NEUROBIOL, V19, P362, DOI 10.1016/j.conb.2009.07.008; Vilceanu D, 2010, J PAIN, V11, P588, DOI 10.1016/j.jpain.2009.09.018; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	31	105	107	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12177	10.1371/journal.pone.0012177	http://dx.doi.org/10.1371/journal.pone.0012177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808441	Green Published, Green Submitted, gold			2022-12-27	WOS:000280968000008
J	Thompson, PD; Tipney, H; Brass, A; Noyes, H; Kemp, S; Naessens, J; Tassabehji, M				Thompson, Pamela D.; Tipney, Hannah; Brass, Andy; Noyes, Harry; Kemp, Steve; Naessens, Jan; Tassabehji, May			Claudin 13, a Member of the Claudin Family Regulated in Mouse Stress Induced Erythropoiesis	PLOS ONE			English	Article							CHROMOSOMAL PASSENGER COMPLEX; TIGHT JUNCTION; TRYPANOSOMA-CONGOLENSE; TERMINAL DIFFERENTIATION; TRANSCRIPTION FACTORS; C-KIT; GENE-EXPRESSION; PROTEIN; CELLS; SURVIVIN	Mammals are able to rapidly produce red blood cells in response to stress. The molecular pathways used in this process are important in understanding responses to anaemia in multiple biological settings. Here we characterise the novel gene Claudin 13 (Cldn13), a member of the Claudin family of tight junction proteins using RNA expression, microarray and phylogenetic analysis. We present evidence that Cldn13 appears to be co-ordinately regulated as part of a stress induced erythropoiesis pathway and is a mouse-specific gene mainly expressed in tissues associated with haematopoietic function. CLDN13 phylogenetically groups with its genomic neighbour CLDN4, a conserved tight junction protein with a putative role in epithelial to mesenchymal transition, suggesting a recent duplication event. Mechanisms of mammalian stress erythropoiesis are of importance in anaemic responses and expression microarray analyses demonstrate that Cldn13 is the most abundant Claudin in spleen from mice infected with Trypanosoma congolense. In mice prone to anaemia (C57BL/6), its expression is reduced compared to strains which display a less severe anaemic response (A/J and BALB/c) and is differentially regulated in spleen during disease progression. Genes clustering with Cldn13 on microarrays are key regulators of erythropoiesis (Tal1, Trim10, E2f2), erythrocyte membrane proteins (Rhd and Gypa), associated with red cell volume (Tmcc2) and indirectly associated with erythropoietic pathways (Cdca8, Cdkn2d, Cenpk). Relationships between genes appearing co-ordinately regulated with Cldn13 post-infection suggest new insights into the molecular regulation and pathways involved in stress induced erythropoiesis and suggest a novel, previously unreported role for claudins in correct cell polarisation and protein partitioning prior to erythroblast enucleation.	[Thompson, Pamela D.; Tassabehji, May] Univ Manchester, St Marys Hosp, Manchester M13 0JH, Lancs, England; [Tipney, Hannah] Univ Colorado Denver, Ctr Computat Pharmacol, Aurora, CO USA; [Brass, Andy] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England; [Brass, Andy] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Noyes, Harry; Kemp, Steve] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England; [Kemp, Steve; Naessens, Jan] Int Livestock Res Inst, Nairobi, Kenya	University of Manchester; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Manchester; University of Manchester; University of Liverpool; CGIAR; International Livestock Research Institute (ILRI)	Thompson, PD (corresponding author), Univ Manchester, St Marys Hosp, Manchester M13 0JH, Lancs, England.	m.tassabehji@manchester.ac.uk	Noyes, Harry A/B-1151-2010	Noyes, Harry A/0000-0002-0656-200X; Thompson, Pamela/0000-0002-2660-6348; Brass, Andrew/0000-0002-0389-7058	Wellcome Trust [GR1061183, WT066764MF, GR066764MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was supported by the Wellcome Trust (grant nos. GR1061183, WT066764MF, GR066764MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuazza G, 2006, AM J PHYSIOL-RENAL, V291, pF1132, DOI 10.1152/ajprenal.00063.2006; Acharya P, 2004, AM J PHYSIOL-RENAL, V287, pF305, DOI 10.1152/ajprenal.00341.2003; Adelman CA, 2002, DEVELOPMENT, V129, P539; ANDRIANARIVO AG, 1995, EXP PARASITOL, V80, P407, DOI 10.1006/expr.1995.1053; Blaybel R, 2008, CELL RES, V18, P834, DOI 10.1038/cr.2008.68; BRODSKY I, 1966, CANCER RES, V26, P198; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Burgess A, 2006, J BIOL CHEM, V281, P9987, DOI 10.1074/jbc.M512714200; Chagraoui J, 2003, BLOOD, V101, P2973, DOI 10.1182/blood-2002-05-1341; Chasis JA, 2006, CURR OPIN HEMATOL, V13, P137, DOI 10.1097/01.moh.0000219657.57915.30; Chen HQ, 2007, J BIOL CHEM, V282, P4124, DOI 10.1074/jbc.M610231200; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Cramer EM, 1999, BLOOD, V94, P3683, DOI 10.1182/blood.V94.11.3683.423a23_3683_3693; D'Souza T, 2007, EXP CELL RES, V313, P3364, DOI 10.1016/j.yexcr.2007.06.026; de la Grange PB, 2006, BLOOD, V108, P2998, DOI 10.1182/blood-2006-05-022988; Delhommeau F, 2002, BLOOD, V100, P2629, DOI 10.1182/blood.V100.7.2629; DOMINIQUE G, BRIT J HAEMATOLOGY, V148, P161; Dumitriu B, 2006, BLOOD, V108, P1198, DOI 10.1182/blood-2006-02-004184; Fan JJ, 2009, J BIOL CHEM, V284, P30484, DOI 10.1074/jbc.M109.029876; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fujita H, 2006, J HISTOCHEM CYTOCHEM, V54, P933, DOI 10.1369/jhc.6A6944.2006; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Hall MA, 2003, P NATL ACAD SCI USA, V100, P992, DOI 10.1073/pnas.0237324100; HAMAZAKI Y, 2007, NAT IMMUNOL ADV ONLI; Hancock D, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-264; Harada H, 1999, MOL CELL BIOL, V19, P3808; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Holmes JL, 2006, GENE EXPR PATTERNS, V6, P581, DOI 10.1016/j.modgep.2005.12.001; Hua VB, 2003, J MEMBRANE BIOL, V194, P59, DOI 10.1007/s00232-003-2026-8; Ihanus E, 2007, BLOOD, V109, P802, DOI 10.1182/blood-2006-04-014878; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ito S, 2007, BLOOD, V109, P1923, DOI 10.1182/blood-2006-06-030841; JIANG J, BLOOD; Kadri Z, 2005, MOL CELL BIOL, V25, P7412, DOI 10.1128/MCB.25.17.7412-7422.2005; Kadri Z, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000123; Kierstein S, 2006, GENES IMMUN, V7, P667, DOI 10.1038/sj.gene.6364345; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Kollmar R, 2001, P NATL ACAD SCI USA, V98, P10196, DOI 10.1073/pnas.171325898; Kumada M, 2002, GENE, V299, P165, DOI 10.1016/S0378-1119(02)01054-5; Lahlil R, 2004, MOL CELL BIOL, V24, P1439, DOI 10.1128/MCB.24.4.1439-1452.2004; Lanaspa MA, 2008, P NATL ACAD SCI USA, V105, P15797, DOI 10.1073/pnas.0805761105; Langbein L, 2003, EUR J CELL BIOL, V82, P385, DOI 10.1078/0171-9335-00330; LANHAM SM, 1968, NATURE, V218, P1273, DOI 10.1038/2181273a0; LATASHA C, 2008, DEV DYNAM, V237, P436; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Le Van Kim C, 2006, BLOOD REV, V20, P93, DOI 10.1016/j.blre.2005.04.002; Lee JCM, 2004, BLOOD, V103, P1912, DOI 10.1182/blood-2003-03-0928; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Leung CG, 2007, J EXP MED, V204, P1603, DOI 10.1084/jem.20062395; Loh YH, 2004, GENOME RES, V14, P1248, DOI 10.1101/gr.2400004; Lu SJ, 2008, BLOOD, V112, P4475, DOI 10.1182/blood-2008-05-157198; Mancini A, 2000, FEBS LETT, V482, P54, DOI 10.1016/S0014-5793(00)02036-6; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Matsuoka M, 1998, ONCOGENE, V16, P2075, DOI 10.1038/sj.onc.1201745; Mattagajasingh SN, 2000, J BIOL CHEM, V275, P30573, DOI 10.1074/jbc.M004578200; Matter K, 2005, CURR OPIN CELL BIOL, V17, P453, DOI 10.1016/j.ceb.2005.08.003; Matushansky I, 2000, P NATL ACAD SCI USA, V97, P14317, DOI 10.1073/pnas.250488697; MCMILLAN BJ, 2007, J BIOL CHEM; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Michl P, 2003, CANCER RES, V63, P6265; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Moriwaki K, 2007, DEV BIOL, V312, P509, DOI 10.1016/j.ydbio.2007.09.049; Naessens J, 2006, INT J PARASITOL, V36, P521, DOI 10.1016/j.ijpara.2006.02.012; Naessens J, 2005, CLIN EXP IMMUNOL, V139, P405, DOI 10.1111/j.1365-2249.2004.02717.x; Nakamura Y, 2003, PARASITOL RES, V90, P171, DOI 10.1007/s00436-003-0844-3; Noyes HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005170; O'Donovan KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010045; Ojok L, 2001, J COMP PATHOL, V124, P149, DOI 10.1053/jcpa.2000.0445; Oliveira SS, 2007, CELL MOL LIFE SCI, V64, P17, DOI 10.1007/s00018-006-6314-1; PASTERNACK GR, 1985, J BIOL CHEM, V260, P3676; Paw BH, 2003, NAT GENET, V34, P59, DOI 10.1038/ng1137; Perry JM, 2007, BLOOD, V109, P4494, DOI 10.1182/blood-2006-04-016154; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P840, DOI 10.1073/pnas.0607196104; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; Qian F, 2005, DEV DYNAM, V233, P1163, DOI 10.1002/dvdy.20444; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; SIMPSON CF, 1967, J CELL BIOL, V35, P237, DOI 10.1083/jcb.35.1.237; Song JX, 2005, IMMUNITY, V22, P621, DOI 10.1016/j.immuni.2005.03.012; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Uehara K, 2008, HISTOCHEM CELL BIOL, V129, P95, DOI 10.1007/s00418-007-0343-1; Umehara D, 2010, J VIROL, V84, P7675, DOI 10.1128/JVI.00488-10; Vader G, 2006, EMBO REP, V7, P85, DOI 10.1038/sj.embor.7400562; Valero MC, 2000, GENOMICS, V69, P1, DOI 10.1006/geno.2000.6312; Van Itallie Christina M, 2004, Proc Am Thorac Soc, V1, P38, DOI 10.1513/pats.2306013; von Lindern M, 2001, ONCOGENE, V20, P3651, DOI 10.1038/sj.onc.1204494; XIANG Z, 2009, AM J HEMATOL, V84, P492; Yamashita A, 2000, FEBS LETT, V481, P147, DOI 10.1016/S0014-5793(00)01987-6; Yi ZH, 2006, PLOS GENET, V2, P129, DOI 10.1371/journal.pgen.0020014	96	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12667	10.1371/journal.pone.0012667	http://dx.doi.org/10.1371/journal.pone.0012667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844758	gold, Green Published			2022-12-27	WOS:000281687300011
J	Cai, QL; Robertson, ES				Cai, Qiliang; Robertson, Erle S.			Ubiquitin/SUMO Modification Regulates VHL Protein Stability and Nucleocytoplasmic Localization	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; HIPPEL-LINDAU-DISEASE; CYTOPLASMIC LOCALIZATION; FIBRONECTIN MATRIX; GERMLINE MUTATIONS; RENAL-CARCINOMA; PVHL; CELL; NUCLEAR; GROWTH	Functional inactivation of the von Hippel-Lindau (VHL) tumor suppressor protein is linked to the development of several forms of cancer as well as oncogenic progression like sporadic renal clear-cell carcinomas (RCC). Despite the critical role played by VHL in destruction of hypoxia-inducible factor alpha (HIF alpha) via ubiquitin-mediated proteolysis, very little is known about the post-translational modification which regulates VHL activity. Our previous study showed that the SUMO E3 ligase PIASy interacts with VHL and induces VHL SUMOylation on lysine residue 171 (Cai et al, PLoS ONE, 2010, 5(3):e9720). Here we further report that VHL also undergoes ubiquitylation on both lysine residues 171 and 196, which is blocked by PIASy. Moreover, using a VHL-SUMO1 or ubiquitin fusion protein, we found that ubiquitylated VHL is localized predominantly in the cytoplasm, while SUMOylated VHL results in increased VHL protein stability and nuclear redistribution. Interestingly, substitution of lysine 171 and 196 to arginine of VHL abrogates its inhibitory function on the transcriptional activity of HIF alpha, and tube formation in vitro. This demonstrates that post-translational modifications like ubiquitylation and SUMOylation contributes to VHL protein stability and nucleocytoplasmic shuttling, and that the overall function of VHL in tumor suppression may require a precise and dynamically regulated process which involves protein modification.	[Cai, Qiliang] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Abramson Comprehens Canc Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Cai, QL (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	erle@upenn.edu			National Cancer Institute [5R01CA091792-08, 5R01CA108461-05, 1R01CA137894-01, 1R01CA138434-01A209]; National Institute of Allergy and Infectious Diseases [5R01AI067037-04]; National Institute of Dental and Craniofacial Research [5R01DE017338-03]; NATIONAL CANCER INSTITUTE [R01CA108461, R01CA138434, R01CA091792, R01CA137894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017338] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	National Cancer Institute 5R01CA091792-08, 5R01CA108461-05, 1R01CA137894-01 and 1R01CA138434-01A209; National Institute of Allergy and Infectious Diseases 5R01AI067037-04 and National Institute of Dental and Craniofacial Research 5R01DE017338-03 (to ESR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cai QL, 2006, PLOS PATHOG, V2, P1002, DOI 10.1371/journal.ppat.0020116; Cai Q, 2007, J VIROL, V81, P10413, DOI 10.1128/JVI.00611-07; Cai QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009720; CHEN F, 1995, CANCER RES, V55, P4804; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Davidowitz EJ, 2001, MOL CELL BIOL, V21, P865, DOI 10.1128/MCB.21.3.865-874.2001; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Jung CR, 2006, NAT MED, V12, P809, DOI 10.1038/nm1440; Kaelin WG, 1998, TRENDS GENET, V14, P423, DOI 10.1016/S0168-9525(98)01558-3; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Knauth K, 2006, ONCOGENE, V25, P370, DOI 10.1038/sj.onc.1209062; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Lee S, 1996, P NATL ACAD SCI USA, V93, P1770, DOI 10.1073/pnas.93.5.1770; Lee S, 1999, MOL CELL BIOL, V19, P1486; Lewis MD, 2003, ONCOGENE, V22, P3992, DOI 10.1038/sj.onc.1206683; LINEHAN WM, 1995, JAMA-J AM MED ASSOC, V273, P564; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mekhail K, 2005, J CELL BIOL, V170, P733, DOI 10.1083/jcb.200506030; Mekhail K, 2004, NAT CELL BIOL, V6, P642, DOI 10.1038/ncb1144; Mikhaylova O, 2008, MOL CELL BIOL, V28, P2701, DOI 10.1128/MCB.01231-07; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Pause A, 1998, P NATL ACAD SCI USA, V95, P993, DOI 10.1073/pnas.95.3.993; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Russell RC, 2008, EMBO REP, V9, P486, DOI 10.1038/embor.2008.19; Scheffner M, 1999, NATURE, V398, P103, DOI 10.1038/18105; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Stickle NH, 2004, MOL CELL BIOL, V24, P3251, DOI 10.1128/MCB.24.8.3251-3261.2004; van der Harst E, 1998, INT J CANCER, V77, P337, DOI 10.1002/(SICI)1097-0215(19980729)77:3<337::AID-IJC5>3.3.CO;2-C; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699; Zbar B, 1996, HUM MUTAT, V8, P348, DOI 10.1002/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3	43	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12636	10.1371/journal.pone.0012636	http://dx.doi.org/10.1371/journal.pone.0012636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844582	Green Submitted, gold, Green Published			2022-12-27	WOS:000281687200006
J	Pulit, SL; Voight, BF; de Bakker, PIW				Pulit, Sara L.; Voight, Benjamin F.; de Bakker, Paul I. W.			Multiethnic Genetic Association Studies Improve Power for Locus Discovery	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; RISK LOCI; FLIP-FLOP; SUSCEPTIBILITY; POPULATIONS; VARIANTS; KCNQ1	To date, genome-wide association studies have focused almost exclusively on populations of European ancestry. These studies continue with the advent of next-generation sequencing, designed to systematically catalog and test low-frequency variation for a role in disease. A complementary approach would be to focus further efforts on cohorts of multiple ethnicities. This leverages the idea that population genetic drift may have elevated some variants to higher allele frequency in different populations, boosting statistical power to detect an association. Based on empirical allele frequency distributions from eleven populations represented in HapMap Phase 3 and the 1000 Genomes Project, we simulate a range of genetic models to quantify the power of association studies in multiple ethnicities relative to studies that exclusively focus on samples of European ancestry. In each of these simulations, a first phase of GWAS in exclusively European samples is followed by a second GWAS phase in any of the other populations (including a multiethnic design). We find that nontrivial power gains can be achieved by conducting future whole-genome studies in worldwide populations, where, in particular, African populations contribute the largest relative power gains for low-frequency alleles (<5%) of moderate effect that suffer from low power in samples of European descent. Our results emphasize the importance of broadening genetic studies to worldwide populations to ensure efficient discovery of genetic loci contributing to phenotypic trait variability, especially for those traits for which large numbers of samples of European ancestry have already been collected and tested.	[Pulit, Sara L.; de Bakker, Paul I. W.] Harvard Univ, Brigham & Womens Hosp, Div Genet, Sch Med,Dept Med, Boston, MA 02115 USA; [Pulit, Sara L.; Voight, Benjamin F.; de Bakker, Paul I. W.] Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Pulit, Sara L.; Voight, Benjamin F.; de Bakker, Paul I. W.] MIT, Cambridge, MA 02139 USA; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Pulit, SL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Genet, Sch Med,Dept Med, Boston, MA 02115 USA.	pdebakker@rics.bwh.harvard.edu	Voight, Benjamin/F-1775-2011; de Bakker, Paul IW/B-8730-2009	de Bakker, Paul IW/0000-0001-7735-7858; Pulit, Sara/0000-0002-2502-3669; Voight, Benjamin/0000-0002-6205-9994	National Institutes of Health/National Institute of Mental Health [R01MH084676]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084676] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors gratefully acknowledge support from the National Institutes of Health/National Institute of Mental Health (R01MH084676). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; *INT HAPMAP 3 CONS, 2010, NATURE IN PRESS; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarthy MI, 2008, NAT GENET, V40, P1039, DOI 10.1038/ng0908-1039; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; ROSENBERG NA, NAT REV GENET, V11, P356; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Skoll AD, 2007, GENET EPIDEMIOL, V31, P776, DOI 10.1002/gepi.20240; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Teo YY, 2009, GENET EPIDEMIOL, V33, P128, DOI 10.1002/gepi.20366; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zaitlen N, 2010, AM J HUM GENET, V86, P23, DOI 10.1016/j.ajhg.2009.11.016; Zaykin DV, 2008, AM J HUM GENET, V82, P794, DOI 10.1016/j.ajhg.2008.02.001; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; GENOMES DEEP CATALOG	22	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12600	10.1371/journal.pone.0012600	http://dx.doi.org/10.1371/journal.pone.0012600			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IV	20838612	Green Published, Green Submitted, gold			2022-12-27	WOS:000281687100005
J	Gullick, NJ; Evans, HG; Church, LD; Jayaraj, DM; Filer, A; Kirkham, BW; Taams, LS				Gullick, Nicola J.; Evans, Hayley G.; Church, Leigh D.; Jayaraj, David M.; Filer, Andrew; Kirkham, Bruce W.; Taams, Leonie S.			Linking Power Doppler Ultrasound to the Presence of Th17 Cells in the Rheumatoid Arthritis Joint	PLOS ONE			English	Article							RECEIVING CONCOMITANT METHOTREXATE; NECROSIS-FACTOR-ALPHA; MONOCLONAL-ANTIBODY; TNF-ALPHA; DESTRUCTIVE ARTHRITIS; ACTIVATED MONOCYTES; INHIBITORY FACTOR; DISEASE-ACTIVITY; SYNOVIAL TISSUE; T-CELLS	Background: Power Doppler ultrasound (PDUS) is increasingly used to assess synovitis in Rheumatoid Arthritis (RA). Prior studies have shown correlations between PDUS scores and vessel counts, but relationships with T cell immunopathology have not been described. Methodology/Principal Findings: PBMC were isolated from healthy controls (HC) or RA patients and stimulated ex vivo with PMA and ionomycin for 3 hours in the presence of Golgistop. Paired synovial fluid (SF) or synovial tissue (ST) were analysed where available. Intracellular expression of IL-17, IFN gamma, and TNF alpha by CD4+ T cells was determined by flow cytometry. Synovial blood flow was evaluated by PDUS signal at the knees, wrists and metacarpophalangeal joints of RA patients. Serum, SF and fibroblast culture supernatant levels of vascular endothelial growth factor-A (VEGF-A) were measured by ELISA. The frequency of IL17+IFN gamma-CD4+ T cells (Th17 cells) was significantly elevated in peripheral blood (PB) from RA patients vs. HC (median (IQR) 0.5 (0.28-1.59)% vs. 0.32 (0.21-0.54)%, p = 0.005). Th17 cells were further enriched (mean 6.6-fold increase) in RA SF relative to RA PB. Patients with active disease had a higher percentage of IL-17+ T cells in ST than patients in remission, suggesting a possible role for Th17 cells in active synovitis in RA. Indeed, the percentage of Th17 cells, but not Th1, in SF positively correlated with CRP (r = 0.51, p = 0.04) and local PDUS-defined synovitis (r = 0.61, p = 0.002). Furthermore, patients with high levels of IL-17+ CD4+ T cells in SF had increased levels of the angiogenic factor VEGF-A in SF. Finally, IL-17, but not IFN gamma, increased VEGF-A production by RA synovial fibroblasts in vitro. Conclusions/Significance: Our data demonstrate a link between the presence of pro-inflammatory Th17 cells in SF and local PDUS scores, and offer a novel immunological explanation for the observation that rapid joint damage progression occurs in patients with persistent positive PDUS signal.	[Gullick, Nicola J.; Evans, Hayley G.; Jayaraj, David M.; Taams, Leonie S.] Kings Coll London, Ctr Mol & Cellular Biol Inflammat, London WC2R 2LS, England; [Gullick, Nicola J.; Evans, Hayley G.; Jayaraj, David M.; Kirkham, Bruce W.; Taams, Leonie S.] Guys & St Thomas Hosp, Natl Inst Hlth Res Comprehens Biomed Res Ctr, London SE1 9RT, England; [Gullick, Nicola J.; Kirkham, Bruce W.] Guys & St Thomas NHS Fdn Trust, Dept Rheumatol, London, England; [Church, Leigh D.; Filer, Andrew] Univ Birmingham, Rheumatol Res Grp, Div Immun & Infect, Birmingham, W Midlands, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of Birmingham	Gullick, NJ (corresponding author), Kings Coll London, Ctr Mol & Cellular Biol Inflammat, London WC2R 2LS, England.	leonie.taams@kcl.ac.uk	Filer, Andrew/AAP-9179-2021; Gullick, Nicola J/GWZ-1369-2022	Filer, Andrew/0000-0001-8164-6249; Church, Leigh/0000-0001-9081-1445; Gullick, Nicola/0000-0001-8970-4116; Taams, Leonie/0000-0002-9337-7194	Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre; King's College Hospital NHS Foundation Trust [R050719]; Versus Arthritis [18547] Funding Source: researchfish	Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College Hospital NHS Foundation Trust; Versus Arthritis(Versus Arthritis)	The authors acknowledge financial support from the Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust (to NG, HE, DJ, BK and LT), and from the Guy's and St Thomas' Charity (R050719 to NG and BK). AF is funded by Arthritis Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson T, 2002, Eur J Echocardiogr, V3, P240; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Brown AK, 2006, ARTHRITIS RHEUM, V54, P3761, DOI 10.1002/art.22190; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chabaud M, 1998, J IMMUNOL, V161, P409; Chabaud M, 2000, CYTOKINE, V12, P1092, DOI 10.1006/cyto.2000.0681; Chen Z, 2007, ARTHRITIS RHEUM-US, V56, P2936, DOI 10.1002/art.22866; CHU CQ, 1991, ARTHRITIS RHEUM, V34, P1125, DOI 10.1002/art.1780340908; Cope AP, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2412; Doodes PD, 2008, J IMMUNOL, V181, P329, DOI 10.4049/jimmunol.181.1.329; Evans HG, 2007, P NATL ACAD SCI USA, V104, P17034, DOI 10.1073/pnas.0708426104; Evans HG, 2009, P NATL ACAD SCI USA, V106, P6232, DOI 10.1073/pnas.0808144106; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Genovese MC, 2002, ARTHRITIS RHEUM, V46, P1443, DOI 10.1002/art.10308; GotisGraham I, 1997, ARTHRITIS RHEUM, V40, P479, DOI 10.1002/art.1780400314; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Jandus C, 2008, ARTHRITIS RHEUM, V58, P2307, DOI 10.1002/art.23655; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Kirkham BW, 2006, ARTHRITIS RHEUM, V54, P1122, DOI 10.1002/art.21749; Koenders MI, 2006, J IMMUNOL, V176, P6262, DOI 10.4049/jimmunol.176.10.6262; Leipe J., 2010, ARTHRITIS RHEUM; Lubberts E, 2005, ARTHRITIS RES THER, V7, P29, DOI 10.1186/ar1478; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Morand EF, 2002, RHEUMATOLOGY, V41, P558, DOI 10.1093/rheumatology/41.5.558; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; Naredo E, 2008, ARTHRITIS RHEUM, V58, P2248, DOI 10.1002/art.23682; Naredo E, 2007, ARTHRIT RHEUM-ARTHR, V57, P116, DOI 10.1002/art.22461; Nishimoto N, 2006, CURR OPIN RHEUMATOL, V18, P277, DOI 10.1097/01.bor.0000218949.19860.d1; Paleolog EM, 2002, ARTHRITIS RES THER, V4, pS81, DOI 10.1186/ar575; Pickens SR, 2010, J IMMUNOL, V184, P3233, DOI 10.4049/jimmunol.0903271; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; Ruddy MJ, 2004, J LEUKOCYTE BIOL, V76, P135, DOI 10.1189/jlb.0204065; Ryu S, 2006, CLIN RHEUMATOL, V25, P16, DOI 10.1007/s10067-005-1081-1; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Sato Kojiro, 2008, Allergol Int, V57, P109, DOI 10.2332/allergolint.R-07-158; Shahrara S, 2009, J IMMUNOL, V182, P3884, DOI 10.4049/jimmunol.0802246; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Skapenko A, 2009, NAT REV RHEUMATOL, V5, P491, DOI 10.1038/nrrheum.2009.157; Stamp LK, 2009, J RHEUMATOL, V36, P2403, DOI 10.3899/jrheum.081304; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; Taylor PC, 2006, ARTHRITIS RHEUM-US, V54, P47, DOI 10.1002/art.21544; VANROON JAG, 1995, ANN RHEUM DIS, V54, P836, DOI 10.1136/ard.54.10.836; VERWILGHEN J, 1993, IMMUNOLOGY, V80, P96; Walther M, 2001, ARTHRITIS RHEUM, V44, P331, DOI 10.1002/1529-0131(200102)44:2<331::AID-ANR50>3.0.CO;2-0; WILBRINK B, 1991, BRIT J RHEUMATOL, V30, P265; Yamada H, 2008, ANN RHEUM DIS, V67, P1299, DOI 10.1136/ard.2007.080341	50	66	69	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12516	10.1371/journal.pone.0012516	http://dx.doi.org/10.1371/journal.pone.0012516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824142	Green Published, gold, Green Submitted			2022-12-27	WOS:000281456100017
J	Ioannidis, JPA; Belbasis, L; Evangelou, E				Ioannidis, John P. A.; Belbasis, Lazaros; Evangelou, Evangelos			Fifty-Year Fate and Impact of General Medical Journals	PLOS ONE			English	Article							SLEEPING BEAUTIES; SCIENCE; DISEASE; CITATIONS	Background: Influential medical journals shape medical science and practice and their prestige is usually appraised by citation impact metrics, such as the journal impact factor. However, how permanent are medical journals and how stable is their impact over time? Methods and Results: We evaluated what happened to general medical journals that were publishing papers half a century ago, in 1959. Data were retrieved from ISI Web of Science for citations and PubMed (Journals function) for journal history. Of 27 eligible journals publishing in 1959, 4 have stopped circulation (including two of the most prestigious journals in 1959) and another 7 changed name between 1959 and 2009. Only 6 of these 27 journals have been published continuously with their initial name since they started circulation. The citation impact of papers published in 1959 gives a very different picture from the current journal impact factor; the correlation between the two is non-significant and very close to zero. Only 13 of the 5,223 papers published in 1959 received at least 5 citations in 2009. Conclusions: Journals are more permanent entities than single papers, but they are also subject to major change and their relative prominence can change markedly over time.	[Ioannidis, John P. A.; Belbasis, Lazaros; Evangelou, Evangelos] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Ioannidis, John P. A.] Fdn Res & Technol Hellas, Biomed Res Inst, Ioannina, Greece; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Dept Med, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Inst Clin Res & Hlth Policy Studies, Tufts Med Ctr, Boston, MA 02111 USA; [Ioannidis, John P. A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	University of Ioannina; Foundation for Research & Technology - Hellas (FORTH); Tufts University; Tufts Medical Center; Tufts University; Harvard University; Harvard T.H. Chan School of Public Health	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Belbasis, Lazaros/F-9889-2013; Ioannidis, John P. A./G-9836-2011; Evangelou, Evangelos/C-3033-2013	Evangelou, Evangelos/0000-0002-5488-2999; Belbasis, Lazaros/0000-0002-2334-6974				[Anonymous], 2006, PLOS MED, V3, P707, DOI 10.1371/journal.pmed.0030291; Bollen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006022; Burrell QL, 2005, SCIENTOMETRICS, V65, P381, DOI 10.1007/s11192-005-0280-5; Chalmers I, 2000, ANN INTERN MED, V133, P238, DOI 10.7326/0003-4819-133-3-200008010-00024; Chew M, 2007, J ROY SOC MED, V100, P142, DOI 10.1258/jrsm.100.3.142; COBB LA, 1959, NEW ENGL J MED, V260, P1115, DOI 10.1056/NEJM195905282602204; Colman E, 1999, LANCET, V354, P324, DOI 10.1016/S0140-6736(98)11102-9; Evans JA, 2008, SCIENCE, V321, P395, DOI 10.1126/science.1150473; FLETCHER CM, 1959, BMJ-BRIT MED J, V2, P257, DOI 10.1136/bmj.2.5147.257; FORD CE, 1959, LANCET, V1, P711; FRIEDMAN M, 1959, JAMA-J AM MED ASSOC, V169, P1286, DOI 10.1001/jama.1959.03000290012005; GAJDUSEK DC, 1959, AM J MED, V26, P442, DOI 10.1016/0002-9343(59)90251-7; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; GARFIELD E, 1972, SCIENCE, V178, P471, DOI 10.1126/science.178.4060.471; Glanzel W, 2004, SCIENTIST, V18, P8; Ioannidis JPA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000005; JACOBS PA, 1959, LANCET, V1, P710; KUPPERMAN HS, 1959, JAMA-J AM MED ASSOC, V171, P1627, DOI 10.1001/jama.1959.03010300001001; Lariviere V, 2009, J AM SOC INF SCI TEC, V60, P858, DOI 10.1002/asi.21011; MARTIN RL, 1959, ANAL CHEM, V31, P1957; Michon F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006544; Perneger TV, 2010, J CLIN EPIDEMIOL, V63, P660, DOI 10.1016/j.jclinepi.2009.09.012; PRINZMETAL M, 1959, AM J MED, V27, P375, DOI 10.1016/0002-9343(59)90003-8; Rosvall M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008694; RUNYON EH, 1959, MED CLIN N AM, V43, P273, DOI 10.1016/S0025-7125(16)34193-1; Smith R, 2006, J ROY SOC MED, V99, P115, DOI 10.1258/jrsm.99.3.115; STUNKARD A, 1959, ARCH INTERN MED, V103, P79, DOI 10.1001/archinte.1959.00270010085011; *THOMS REUT, ISI WEB SCI; van Raan AFJ, 2004, SCIENTOMETRICS, V59, P467, DOI 10.1023/B:SCIE.0000018543.82441.f1; WEST ED, 1959, BRIT MED J, V1, P191; WROBLEWSKI F, 1959, AM J MED, V27, P911, DOI 10.1016/0002-9343(59)90175-5; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201	32	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12531	10.1371/journal.pone.0012531	http://dx.doi.org/10.1371/journal.pone.0012531			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824146	Green Published, gold, Green Submitted			2022-12-27	WOS:000281456100023
J	Negishi, M; Saraya, A; Mochizuki, S; Helin, K; Koseki, H; Iwama, A				Negishi, Masamitsu; Saraya, Atsunori; Mochizuki, Shinobu; Helin, Kristian; Koseki, Haruhiko; Iwama, Atsushi			A Novel Zinc Finger Protein Zfp277 Mediates Transcriptional Repression of the Ink4a/Arf Locus through Polycomb Repressive Complex 1	PLOS ONE			English	Article							DEMETHYLASE JMJD3 CONTRIBUTES; HEMATOPOIETIC STEM-CELLS; ENHANCED SELF-RENEWAL; REPLICATIVE LIFE-SPAN; CELLULAR SENESCENCE; HISTONE H2A; INK4A-ARF LOCUS; BMI-1; MOUSE; CANCER	Background: Polycomb group (PcG) proteins play a crucial role in cellular senescence as key transcriptional regulators of the Ink4a/Arf tumor suppressor gene locus. However, how PcG complexes target and contribute to stable gene silencing of the Ink4a/Arf locus remains little understood. Methodology/Principal Findings: We examined the function of Zinc finger domain-containing protein 277 (Zfp277), a novel zinc finger protein that interacts with the PcG protein Bmi1. Zfp277 binds to the Ink4a/Arf locus in a Bmi1-independent manner and interacts with polycomb repressor complex (PRC) 1 through direct interaction with Bmi1. Loss of Zfp277 in mouse embryonic fibroblasts (MEFs) caused dissociation of PcG proteins from the Ink4a/Arf locus, resulting in premature senescence associated with derepressed p16(Ink4a) and p19(Arf) expression. Levels of both Zfp277 and PcG proteins inversely correlated with those of reactive oxygen species (ROS) in senescing MEFs, but the treatment of Zfp277(-/-) MEFs with an antioxidant restored the binding of PRC2 but not PRC1 to the Ink4a/Arf locus. Notably, forced expression of Bmi1 in Zfp277(-/-) MEFs did not restore the binding of Bmi1 to the Ink4a/Arf locus and failed to bypass cellular senescence. A Zfp277 mutant that could not bind Bmi1 did not rescue Zfp277(-/-) MEFs from premature senescence. Conclusions/Significance: Our findings implicate Zfp277 in the transcriptional regulation of the Ink4a/Arf locus and suggest that the interaction of Zfp277 with Bmi1 is essential for the recruitment of PRC1 to the Ink4a/Arf locus. Our findings also highlight dynamic regulation of both Zfp277 and PcG proteins by the oxidative stress pathways.	[Negishi, Masamitsu; Saraya, Atsunori; Iwama, Atsushi] Chiba Univ, Dept Cellular & Mol Med, Grad Sch Med, Chiba, Japan; [Mochizuki, Shinobu; Koseki, Haruhiko] RIKEN Res Ctr Allergy & Immunol, Lab Dev Genet, Yokohama, Kanagawa, Japan; [Helin, Kristian] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Helin, Kristian] Univ Copenhagen, Ctr Epigenet, Copenhagen, Denmark; [Negishi, Masamitsu; Saraya, Atsunori; Koseki, Haruhiko; Iwama, Atsushi] JST, CREST, Tokyo, Japan	Chiba University; RIKEN; University of Copenhagen; University of Copenhagen; Japan Science & Technology Agency (JST)	Negishi, M (corresponding author), Chiba Univ, Dept Cellular & Mol Med, Grad Sch Med, Chiba, Japan.	aiwama@faculty.chiba-u.jp	Koseki, Haruhiko/I-3825-2014; Helin, Kristian/K-2526-2019; Helin, Kristian/HDM-8306-2022	Koseki, Haruhiko/0000-0001-8424-5854; Helin, Kristian/0000-0003-1975-6097	MEXT, Japan [21390289]; Japan Science and Technology Corporation (JST); Takeda Science Foundation	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Grants-in-Aid for Scientific Research (#21390289) and for the Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan, a Grant-in-Aid for the Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Corporation (JST), and a grant from the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Akasaka T, 2001, DEVELOPMENT, V128, P1587; Atsuta T, 2001, HYBRIDOMA, V20, P43, DOI 10.1089/027245701300060427; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Chiba T, 2007, GASTROENTEROLOGY, V133, P937, DOI 10.1053/j.gastro.2007.06.016; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Fukamachi H, 2001, BIOCHEM BIOPH RES CO, V280, P1069, DOI 10.1006/bbrc.2001.4247; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Herz HM, 2010, GENE DEV, V24, P857, DOI 10.1101/gad.1921610; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kranc KR, 2003, MOL CELL BIOL, V23, P7658, DOI 10.1128/MCB.23.21.7658-7666.2003; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Lee N, 2005, NATURE, V438, P234, DOI 10.1038/nature04120; Lennon PA, 2007, AM J MED GENET A, V143A, P791, DOI 10.1002/ajmg.a.31632; Liang H, 2000, GENOMICS, V66, P226, DOI 10.1006/geno.2000.6198; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; Miki J, 2007, GENES CELLS, V12, P1371, DOI 10.1111/j.1365-2443.2007.01135.x; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Negishi M, 2007, BIOCHEM BIOPH RES CO, V353, P992, DOI 10.1016/j.bbrc.2006.12.166; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Ren XJ, 2008, MOL CELL BIOL, V28, P2884, DOI 10.1128/MCB.00949-07; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Tzatsos A, 2009, P NATL ACAD SCI USA, V106, P2641, DOI 10.1073/pnas.0813139106; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022	60	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12373	10.1371/journal.pone.0012373	http://dx.doi.org/10.1371/journal.pone.0012373			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808772	Green Published, gold, Green Submitted			2022-12-27	WOS:000281154300011
J	Gulliksson, M; Carvalho, RFS; Ulleras, E; Nilsson, G				Gulliksson, Magdalena; Carvalho, Ricardo F. S.; Ulleras, Erik; Nilsson, Gunnar			Mast Cell Survival and Mediator Secretion in Response to Hypoxia	PLOS ONE			English	Article							CD30 LIGAND; EXPRESSION; IL-6; HIF-1-ALPHA; CYTOKINES; EFFECTOR	Tissue hypoxia is a consequence of decreased oxygen levels in different inflammatory conditions, many associated with mast cell activation. However, the effect of hypoxia on mast cell functions is not well established. Here, we have investigated the effect of hypoxia per se on human mast cell survival, mediator secretion, and reactivity. Human cord blood derived mast cells were subjected to three different culturing conditions: culture and stimulation in normoxia (21% O-2); culture and stimulation in hypoxia (1% O-2); or 24 hour culture in hypoxia followed by stimulation in normoxia. Hypoxia, per se, did not induce mast cell degranulation, but we observed an increased secretion of IL-6, where autocrine produced IL-6 promoted mast cell survival. Hypoxia did not have any effect on A23187 induced degranulation or secretion of cytokines. In contrast, cytokine secretion after LPS or CD30 treatment was attenuated, but not inhibited, in hypoxia compared to normoxia. Our data suggests that mast cell survival, degranulation and cytokine release are sustained under hypoxia. This may be of importance for host defence where mast cells in a hypoxic tissue can react to intruders, but also in chronic inflammations where mast cell reactivity is not inhibited by the inflammatory associated hypoxia.	[Gulliksson, Magdalena; Carvalho, Ricardo F. S.; Nilsson, Gunnar] Karolinska Inst, Clin Immunol & Allergy Unit, Dept Med, Stockholm, Sweden; [Ulleras, Erik] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden	Karolinska Institutet; Swedish University of Agricultural Sciences	Gulliksson, M (corresponding author), Karolinska Inst, Clin Immunol & Allergy Unit, Dept Med, Stockholm, Sweden.	Gunnar.P.Nilsson@ki.se		Nilsson, Gunnar/0000-0001-6795-5512	Swedish Research Council-Medicine; Swedish Cancer Foundation; Swedish Cancer and Allergy Fund; Consul Th C Berghs Foundation; Hans von Kantzows Foundation; Ollie and Elof Ericssons Foundation; King Gustav Vs 80-years Foundation; Ellen, Walter and Lennart Hesselmans foundation; Karolinska Institutet; European Union [504926]	Swedish Research Council-Medicine(Swedish Research Council); Swedish Cancer Foundation; Swedish Cancer and Allergy Fund; Consul Th C Berghs Foundation; Hans von Kantzows Foundation; Ollie and Elof Ericssons Foundation; King Gustav Vs 80-years Foundation; Ellen, Walter and Lennart Hesselmans foundation; Karolinska Institutet(Karolinska Institutet); European Union(European Commission)	This study was supported by grants to Gunnar Nilsson awarded by the following: The Swedish Research Council-Medicine, The Swedish Cancer Foundation, The Swedish Cancer and Allergy Fund, Consul Th C Berghs Foundation, Hans von Kantzows Foundation, Ollie and Elof Ericssons Foundation, King Gustav Vs 80-years Foundation, Ellen, Walter and Lennart Hesselmans foundation, and The Karolinska Institutet. Ricardo F. S. Carvalho was supported by a Marie Curie Early Stage Research Training Fellowship of the European Unions Sixth Framework Programme under contract number 504926. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Chan RK, 2003, BRIT J SURG, V90, P1470, DOI 10.1002/bjs.4408; Cruse G, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-2; Demasi M, 2003, J BIOL CHEM, V278, P38607, DOI 10.1074/jbc.M305944200; Endoh I, 2007, CLIN EXP IMMUNOL, V148, P161, DOI 10.1111/j.1365-2249.2007.03332.x; Fei PW, 2004, CANCER CELL, V6, P597, DOI 10.1016/j.ccr.2004.10.012; Fischer M, 2006, J CLIN INVEST, V116, P2748, DOI 10.1172/JCI24274; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Gulliksson M, 2006, ALLERGY, V61, P1473, DOI 10.1111/j.1398-9995.2006.01213.x; Gulliksson M, 2007, BBA-MOL CELL BIOL L, V1771, P1156, DOI 10.1016/j.bbalip.2007.06.001; Jeong HJ, 2003, BIOCHEM BIOPH RES CO, V306, P805, DOI 10.1016/S0006-291X(03)01073-8; Lee K, 2007, PHARMACOL THERAPEUT, V113, P229, DOI 10.1016/j.pharmthera.2006.08.001; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Matsui H, 1999, CARDIOVASC RES, V42, P104, DOI 10.1016/S0008-6363(98)00285-5; Metz M, 2007, TRENDS IMMUNOL, V28, P234, DOI 10.1016/j.it.2007.03.003; Molin D, 2001, BRIT J HAEMATOL, V114, P616, DOI 10.1046/j.1365-2141.2001.02977.x; Murdoch C, 2005, J IMMUNOL, V175, P6257, DOI 10.4049/jimmunol.175.10.6257; NILSSON G, 1999, INFLAMMATION BASIC P, P97; Norrby K, 2002, APMIS, V110, P355, DOI 10.1034/j.1600-0463.2002.100501.x; Oskeritzian CA, 2004, J IMMUNOL, V172, P593, DOI 10.4049/jimmunol.172.1.593; Ribatti D, 2004, CLIN EXP ALLERGY, V34, P1660, DOI 10.1111/j.1365-2222.2004.02104.x; Saito H, 1996, J IMMUNOL, V157, P343; Singh Manjeet, 2003, Journal of Cardiovascular Pharmacology and Therapeutics, V8, P135, DOI 10.1177/107424840300800207; Soule BP, 2007, J IMMUNOL, V179, P3276, DOI 10.4049/jimmunol.179.5.3276; Steiner DRS, 2003, J APPL PHYSIOL, V94, P325, DOI 10.1152/japplphysiol.00637.2002; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Sundstrom M, 2003, IMMUNOLOGY, V108, P89, DOI 10.1046/j.1365-2567.2003.01559.x; Suzuki-Nishimura T, 1998, GEN PHARMACOL-VASC S, V31, P617, DOI 10.1016/S0306-3623(98)00066-4; Theoharides TC, 2004, TRENDS IMMUNOL, V25, P235, DOI 10.1016/j.it.2004.02.013; Walczak-Drzewiecka A, 2008, J IMMUNOL, V181, P1665, DOI 10.4049/jimmunol.181.3.1665; WASSERMAN SI, 1984, ARTHRITIS RHEUM, V27, P841, DOI 10.1002/art.1780270801; YANAGIDA M, 1995, BLOOD, V86, P3705, DOI 10.1182/blood.V86.10.3705.bloodjournal86103705; Zhang QZ, 2005, EXP CELL RES, V312, P145, DOI 10.1016/j.yexcr.2005.10.006	33	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12360	10.1371/journal.pone.0012360	http://dx.doi.org/10.1371/journal.pone.0012360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808808	Green Published, Green Submitted, gold			2022-12-27	WOS:000281153500032
J	Kimpel, J; Braun, SE; Qiu, G; Wong, FE; Conolle, M; Schmitz, JE; Brendel, C; Humeau, LM; Dropulic, B; Rossi, JJ; Berger, A; von Laer, D; Johnson, RP				Kimpel, Janine; Braun, Stephen E.; Qiu, Gang; Wong, Fay Eng; Conolle, Michelle; Schmitz, Joern E.; Brendel, Christian; Humeau, Laurent M.; Dropulic, Boro; Rossi, John J.; Berger, Annemarie; von Laer, Dorothee; Johnson, R. Paul			Survival of the Fittest: Positive Selection of CD4+T Cells Expressing a Membrane-Bound Fusion Inhibitor Following HIV-1 Infection	PLOS ONE			English	Article							MODIFIED T-CELLS; IMMUNODEFICIENCY-VIRUS; LENTIVIRAL VECTOR; GP41-DERIVED PEPTIDES; ANTIRETROVIRAL THERAPY; HEMATOPOIETIC-CELLS; GENE-EXPRESSION; LYMPHOCYTES; DELIVERY; CCR5	Although a variety of genetic strategies have been developed to inhibit HIV replication, few direct comparisons of the efficacy of these inhibitors have been carried out. Moreover, most studies have not examined whether genetic inhibitors are able to induce a survival advantage that results in an expansion of genetically-modified cells following HIV infection. We evaluated the efficacy of three leading genetic strategies to inhibit HIV replication: 1) an HIV-1 tat/rev-specific small hairpin (sh) RNA; 2) an RNA antisense gene specific for the HIV-1 envelope; and 3) a viral entry inhibitor, maC46. In stably transduced cell lines selected such that >95% of cells expressed the genetic inhibitor, the RNA antisense envelope and viral entry inhibitor maC46 provided the strongest inhibition of HIV-1 replication. However, when mixed populations of transduced and untransduced cells were challenged with HIV-1, the maC46 fusion inhibitor resulted in highly efficient positive selection of transduced cells, an effect that was evident even in mixed populations containing as few as 1% maC46-expressing cells. The selective advantage of the maC46 fusion inhibitor was also observed in HIV-1-infected cultures of primary T lymphocytes as well as in HIV-1-infected humanized mice. These results demonstrate robust inhibition of HIV replication with the fusion inhibitor maC46 and the antisense Env inhibitor, and importantly, a survival advantage of cells expressing the maC46 fusion inhibitor both in vitro and in vivo. Evaluation of the ability of genetic inhibitors of HIV-1 replication to confer a survival advantage on genetically-modified cells provides unique information not provided by standard techniques that may be important in the in vivo efficacy of these genes.	[Kimpel, Janine; Brendel, Christian; von Laer, Dorothee] Chemotherapeut Forschungsinst Georg Speyer Haus, Frankfurt, Germany; [Braun, Stephen E.; Qiu, Gang; Wong, Fay Eng; Conolle, Michelle; Johnson, R. Paul] Harvard Univ, Sch Med, Div Immunol, New England Primate Res Ctr, Southborough, MA 01772 USA; [Schmitz, Joern E.] Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Dept Med, Boston, MA 02215 USA; [Humeau, Laurent M.; Dropulic, Boro] VIRxSYS Corp, Gaithersburg, MD USA; [Rossi, John J.] Beckman Res Inst City Hope, Div Mol Biol, Duarte, CA USA; [Berger, Annemarie] JW Goethe Univ Hosp, Inst Med Virol, Frankfurt, Germany; [von Laer, Dorothee] Med Univ Innsbruck, Sekt Virol, Innsbruck, Austria; [Johnson, R. Paul] Massachusetts Gen Hosp, Ragon Inst MGH, Massachusetts Inst Technol & Harvard, Charlestown, MA USA; [Johnson, R. Paul] Massachusetts Gen Hosp, Infect Dis Unit, Charlestown, MA USA	Harvard University; Harvard University; Beth Israel Deaconess Medical Center; City of Hope; Beckman Research Institute of City of Hope; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Medical University of Innsbruck; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts General Hospital	Kimpel, J (corresponding author), Chemotherapeut Forschungsinst Georg Speyer Haus, Frankfurt, Germany.	paul_johnson@hms.harvard.edu	Brendel, Christian/HDN-6077-2022; Schmitz, Joern/A-4929-2018	Schmitz, Joern/0000-0001-8803-0922; Brendel, Christian/0000-0003-4081-4351; Kimpel, Janine/0000-0002-5210-7905; von Laer, Dorothee/0000-0001-5825-7237	National Institute of Health (NIH) [R01 CA73473, RR00168]; Partners/Fenway/Shattuck Center for AIDS Research (CFAR); NIH [AI 42851]; Deutsche Forschungsgemeinschaft, DFG [GRK1172]; NATIONAL CANCER INSTITUTE [R01CA073473] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR000168, P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI029329, P30AI042851] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Partners/Fenway/Shattuck Center for AIDS Research (CFAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft, DFG(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by the National Institute of Health (NIH) Grants R01 CA73473, RR00168 and by a developmental award from the Partners/Fenway/Shattuck Center for AIDS Research (CFAR), an NIH-funded program (AI 42851). JK and CB were supported by a scholarship from the Deutsche Forschungsgemeinschaft, DFG, GRK1172. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2004, HUM GENE THER, V15, P251, DOI 10.1089/104303404322886101; An DS, 2007, P NATL ACAD SCI USA, V104, P13110, DOI 10.1073/pnas.0705474104; Beyer WR, 2002, J VIROL, V76, P1488, DOI 10.1128/JVI.76.3.1488-1495.2002; Braun SE, 2005, MOL THER, V12, P1157, DOI 10.1016/j.ymthe.2005.07.698; Braun SE, 2006, FRONT BIOSCI-LANDMRK, V11, P838, DOI 10.2741/1841; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; DiGiusto DL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000931; Dropulic B, 2006, HUM GENE THER, V17, P577, DOI 10.1089/hum.2006.17.577; Egelhofer M, 2004, J VIROL, V78, P568, DOI 10.1128/JVI.78.2.568-575.2004; Estes JD, 2008, SEMIN IMMUNOL, V20, P181, DOI 10.1016/j.smim.2008.04.002; Hermann FG, 2009, HUM GENE THER, V20, P325, DOI 10.1089/hum.2006.158; HIGGINS JR, 1992, J MED PRIMATOL, V21, P265; Hildinger M, 2001, J VIROL, V75, P3038, DOI 10.1128/JVI.75.6.3038-3042.2001; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Humeau LM, 2004, MOL THER, V9, P902, DOI 10.1016/j.ymthe.2004.03.005; John V.B, 1990, THERMALLY ACTIVATED, P92, DOI [10.1007/978-1-349-10185-65, DOI 10.1007/978-1-349-10185-65]; Kozal MJ, 2009, CLIN MICROBIOL INFEC, V15, P69, DOI 10.1111/j.1469-0691.2008.02687.x; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Levine BL, 2006, P NATL ACAD SCI USA, V103, P17372, DOI 10.1073/pnas.0608138103; Li MJ, 2005, MOL THER, V12, P900, DOI 10.1016/j.ymthe.2005.07.524; Lohrengel S, 2005, J VIROL, V79, P10237, DOI 10.1128/JVI.79.16.10237-10246.2005; Lu XB, 2004, J GENE MED, V6, P963, DOI 10.1002/jgm.593; Lu XB, 2004, J VIROL, V78, P7079, DOI 10.1128/JVI.78.13.7079-7088.2004; Macpherson JL, 2005, J GENE MED, V7, P552, DOI 10.1002/jgm.705; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; Montessori V, 2004, CAN MED ASSOC J, V170, P229; Morgan RA, 2005, HUM GENE THER, V16, P1065, DOI 10.1089/hum.2005.16.1065; Mukherjee R, 2010, MOL THER, V18, P803, DOI 10.1038/mt.2009.316; Patel AK, 2006, J POSTGRAD MED, V52, P197; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Podsakoff GM, 2005, MOL THER, V12, P77, DOI 10.1016/j.ymthe.2005.02.024; Rossi JJ, 2007, NAT BIOTECHNOL, V25, P1444, DOI 10.1038/nbt1367; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Swan CH, 2006, GENE THER, V13, P1480, DOI 10.1038/sj.gt.3302801; van Lunzen J, 2007, MOL THER, V15, P1024, DOI 10.1038/mt.sj.6300124; von Laer D, 2006, J THEOR BIOL, V238, P60, DOI 10.1016/j.jtbi.2005.05.005; Woffendin C, 1996, P NATL ACAD SCI USA, V93, P2889, DOI 10.1073/pnas.93.7.2889; Zahn RC, 2008, GENE THER, V15, P1210, DOI 10.1038/gt.2008.73; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	39	42	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12357	10.1371/journal.pone.0012357	http://dx.doi.org/10.1371/journal.pone.0012357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808813	gold, Green Published, Green Submitted			2022-12-27	WOS:000281153500030
J	Lee, HJ; Kim, SA; Lee, HJ; Jeong, SJ; Han, I; Jung, JH; Lee, EO; Zhu, SD; Chen, CY; Kim, SH				Lee, Hyo-Jeong; Kim, Seung-Ae; Lee, Hyo-Jung; Jeong, Soo-Jin; Han, Ihn; Jung, Ji Hoon; Lee, Eun-Ok; Zhu, Shudong; Chen, Chang-Yan; Kim, Sung-Hoon			Paeonol Oxime Inhibits bFGF-Induced Angiogenesis and Reduces VEGF Levels in Fibrosarcoma Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SOFT-TISSUE SARCOMAS; MATRIX METALLOPROTEINASES; MELANOMA-CELLS; CANCER-THERAPY; ACTIVATION; EXPRESSION; APOPTOSIS; PATHWAYS; INACTIVATION	Background: We previously reported the anti-angiogenic activity of paeonol isolated from Moutan Cortex. In the present study, we investigated the negative effect of paeonol oxime (PO, a paeonol derivative) on basic fibroblast growth factor (bFGF)-mediated angiogenesis in human umbilical vein endothelial cells (HUVECs) (including tumor angiogenesis) and pro-survival activity in HT-1080 fibrosarcoma cell line. Methodology/Principal Findings: We showed that PO (IC50 = 17.3 mu g/ml) significantly inhibited bFGF-induced cell proliferation, which was achieved with higher concentrations of paeonol (IC50 over 200 mu g). The treatment with PO blocked bFGF-stimulated migration and in vitro capillary differentiation (tube formation) in a dose-dependent manner. Furthermore, PO was able to disrupt neovascularization in vivo. Interestingly, PO (25 mu g/ml) decreased the cell viability of HT-1080 fibrosarcoma cells but not that of HUVECs. The treatment with PO at 12.5 mu g/ml reduced the levels of phosphorylated AKT and VEGF expression (intracellular and extracelluar) in HT-1080 cells. Consistently, immunefluorescence imaging analysis revealed that PO treatment attenuated AKT phosphorylation in HT-1080 cells. Conclusions/Significance: Taken together, these results suggest that PO inhibits bFGF-induced angiogenesis in HUVECs and decreased the levels of PI3K, phospho-AKT and VEGF in HT-1080 cells.	[Lee, Hyo-Jeong; Kim, Seung-Ae; Lee, Hyo-Jung; Jeong, Soo-Jin; Han, Ihn; Jung, Ji Hoon; Lee, Eun-Ok; Kim, Sung-Hoon] Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea; [Zhu, Shudong; Chen, Chang-Yan] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	Kyung Hee University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Lee, HJ (corresponding author), Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea.	sungkim7@khu.ac.kr	Lee, Eun-Ok/AAH-9116-2020; Han, Ihn/ABH-6275-2020	Han, Ihn/0000-0002-1372-7319; kim, sunghoon/0000-0002-1570-3230	Korea government (MEST) [2009-0063466]	Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MEST) (No. 2009-0063466). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelmann I, 2010, RECENT RESULTS CANC, V180, P51, DOI 10.1007/978-3-540-78281-0_5; Arbiser JL, 2007, BLOOD, V109, P560, DOI 10.1182/blood-2006-06-029934; BICKNELL R, 1994, ANN ONCOL, V5, pS45, DOI 10.1093/annonc/5.suppl_4.S45; Borthwick GM, 2006, FASEB J, V20, P2009, DOI 10.1096/fj.06-5987com; Cezar-de-Mello PFT, 2006, ONCOGENE, V25, P122, DOI 10.1038/sj.onc.1209002; Chao C, 2001, ANN SURG ONCOL, V8, P260, DOI 10.1007/s10434-001-0260-9; Chen PN, 2005, CHEM-BIOL INTERACT, V156, P141, DOI 10.1016/j.cbi.2005.08.005; Chou TC, 2003, BRIT J PHARMACOL, V139, P1146, DOI 10.1038/sj.bjp.0705360; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264; GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8; Hsieh CL, 2006, J ETHNOPHARMACOL, V106, P208, DOI 10.1016/j.jep.2005.12.027; Huang H, 2008, INFLAMM RES, V57, P189, DOI 10.1007/s00011-007-7190-3; Huh JE, 2005, CARCINOGENESIS, V26, P1436, DOI 10.1093/carcin/bgi097; Ito Y, 1996, INT J CANCER, V67, P148, DOI 10.1002/(SICI)1097-0215(19960703)67:1<148::AID-IJC24>3.3.CO;2-6; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Kim SA, 2009, BIOL PHARM BULL, V32, P1142, DOI 10.1248/bpb.32.1142; Kim SH, 2004, INT IMMUNOPHARMACOL, V4, P279, DOI 10.1016/j.intimp.2003.12.013; Lee HJ, 2005, BIOL PHARM BULL, V28, P27, DOI 10.1248/bpb.28.27; Lee HJ, 2007, INT J CANCER, V120, P2481, DOI 10.1002/ijc.22486; Lee HJ, 2006, CARCINOGENESIS, V27, P2455, DOI 10.1093/carcin/bgl104; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakashio A, 2002, INT J CANCER, V98, P36, DOI 10.1002/ijc.10166; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Shankar Sharmila, 2008, J Mol Signal, V3, P7, DOI 10.1186/1750-2187-3-7; Shi YH, 2005, J PATHOL, V205, P530, DOI 10.1002/path.1734; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Trisciuoglio D, 2005, MOL BIOL CELL, V16, P4153, DOI 10.1091/mbc.E04-12-1087; Yudoh K, 2001, BRIT J CANCER, V84, P1610, DOI 10.1054/bjoc.2001.1837; Zhang CH, 2008, ANTI-CANCER DRUG, V19, P401, DOI 10.1097/CAD.0b013e3282f7f4eb; Zhang G, 1997, Zhong Yao Cai, V20, P626	32	28	34	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12358	10.1371/journal.pone.0012358	http://dx.doi.org/10.1371/journal.pone.0012358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808805	Green Published, Green Submitted, gold			2022-12-27	WOS:000281153500031
J	Lee, JM; Sathish, P; Donaghy, DJ; Roche, JR				Lee, Julia M.; Sathish, Puthigae; Donaghy, Daniel J.; Roche, John R.			Plants Modify Biological Processes to Ensure Survival following Carbon Depletion: A Lolium perenne Model	PLOS ONE			English	Article							WATER-SOLUBLE CARBOHYDRATE; DACTYLIS-GLOMERATA L.; GENE-EXPRESSION; DEFOLIATION MANAGEMENT; ENERGY RESERVES; HERBAGE QUALITY; LEAF SHEATHS; ROOT-GROWTH; RYEGRASS; REGROWTH	Background: Plants, due to their immobility, have evolved mechanisms allowing them to adapt to multiple environmental and management conditions. Short-term undesirable conditions (e. g. moisture deficit, cold temperatures) generally reduce photosynthetic carbon supply while increasing soluble carbohydrate accumulation. It is not known, however, what strategies plants may use in the long-term to adapt to situations resulting in net carbon depletion (i.e. reduced photosynthetic carbon supply and carbohydrate accumulation). In addition, many transcriptomic experiments have typically been undertaken under laboratory conditions; therefore, long-term acclimation strategies that plants use in natural environments are not well understood. Methodology/Principal Findings: Perennial ryegrass (Lolium perenne L.) was used as a model plant to define whether plants adapt to repetitive carbon depletion and to further elucidate their long-term acclimation mechanisms. Transcriptome changes in both lamina and stubble tissues of field-grown plants with depleted carbon reserves were characterised using reverse transcription-quantitative polymerase chain reaction (RT-qPCR). The RT-qPCR data for select key genes indicated that plants reduced fructan degradation, and increased photosynthesis and fructan synthesis capacities following carbon depletion. This acclimatory response was not sufficient to prevent a reduction (P<0.001) in net biomass accumulation, but ensured that the plant survived. Conclusions: Adaptations of plants with depleted carbon reserves resulted in reduced post-defoliation carbon mobilization and earlier replenishment of carbon reserves, thereby ensuring survival and continued growth. These findings will help pave the way to improve plant biomass production, for either grazing livestock or biofuel purposes.	[Lee, Julia M.; Roche, John R.] DairyNZ Ltd, Hamilton, New Zealand; [Sathish, Puthigae] ViaLactia Biosci NZ Ltd, Pastoral Genom, Auckland, New Zealand; [Donaghy, Daniel J.] Univ Tasmania, Burnie, Tas 7320, Australia	DairyNZ; University of Tasmania	Lee, JM (corresponding author), DairyNZ Ltd, Hamilton, New Zealand.	julia.lee@dairynz.co.nz	Roche, John/ABG-1722-2020	Roche, John/0000-0002-4165-9253; Puthigae, Sathish/0000-0001-8704-437X	DairyNZ; Pastoral Genomics; Foundation for Research, Science and Technology; T.R. Ellett Agricultural Research Trust; University of Tasmania	DairyNZ; Pastoral Genomics; Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); T.R. Ellett Agricultural Research Trust; University of Tasmania	This study was funded by DairyNZ, Pastoral Genomics, the Foundation for Research, Science and Technology, the T.R. Ellett Agricultural Research Trust and a Tasmanian Graduate Research Scholarship from the University of Tasmania. None of the authors were involved in the decision by the funding companies to fund the project, nor did those involved in the decision to fund the study have any role in study design, data collection and analysis, decision to publish or preparation of the manuscript. JML and JRR (DairyNZ) had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Amiard V, 2003, J EXP BOT, V54, P1231, DOI 10.1093/jxb/erg125; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Berthier A, 2009, PLANT CELL PHYSIOL, V50, P1329, DOI 10.1093/pcp/pcp081; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Braun DM, 2009, PLANT PHYSIOL, V149, P71, DOI 10.1104/pp.108.129049; Callow MN, 2005, GRASS FORAGE SCI, V60, P59, DOI 10.1111/j.1365-2494.2005.00451.x; Chalmers J, 2003, J PLANT PHYSIOL, V160, P1385, DOI 10.1078/0176-1617-01107; Chalmers J, 2005, PLANT BIOTECHNOL J, V3, P459, DOI 10.1111/j.1467-7652.2005.00148.x; deVisser R, 1997, PLANT CELL ENVIRON, V20, P37, DOI 10.1046/j.1365-3040.1997.d01-9.x; Donaghy DJ, 2008, AGRON J, V100, P122, DOI 10.2134/agronj2007.0016; Donaghy DJ, 1997, GRASS FORAGE SCI, V52, P401, DOI 10.1111/j.1365-2494.1997.tb02372.x; Donaghy DJ, 1998, GRASS FORAGE SCI, V53, P211, DOI 10.1046/j.1365-2494.1998.00129.x; FULKERSON WJ, 1995, GRASS FORAGE SCI, V50, P16, DOI 10.1111/j.1365-2494.1995.tb02289.x; Fulkerson WJ, 2001, AUST J EXP AGR, V41, P261, DOI 10.1071/EA00062; Graham Ian A., 2000, VVolume 9, P233; Hisano H, 2008, NEW PHYTOL, V178, P766, DOI 10.1111/j.1469-8137.2008.02409.x; KRAPP A, 1993, PLANT J, V3, P817, DOI 10.1111/j.1365-313X.1993.00817.x; LAMP CA, 1990, SPECIES DESCRIPTIONS, P57; Lasseur B, 2007, FUNCT PLANT BIOL, V34, P418, DOI 10.1071/FP06286; Lee JM, 2009, GRASS FORAGE SCI, V64, P266, DOI 10.1111/j.1365-2494.2009.00692.x; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Lytovchenko A, 2007, CURR OPIN PLANT BIOL, V10, P227, DOI 10.1016/j.pbi.2007.04.002; Morvan-Bertrand A, 1999, PLANT CELL ENVIRON, V22, P1097, DOI 10.1046/j.1365-3040.1999.00485.x; Morvan-Bertrand A, 1999, J EXP BOT, V50, P1817, DOI 10.1093/jexbot/50.341.1817; Morvan-Bertrand A, 2001, PLANTA, V213, P109, DOI 10.1007/s004250000478; Paul MJ, 2003, J EXP BOT, V54, P539, DOI 10.1093/jxb/erg052; PRUDHOMME MP, 1992, J PLANT PHYSIOL, V140, P282, DOI 10.1016/S0176-1617(11)81080-1; Rasmussen S., 2009, Proceedings of the New Zealand Grassland Association, V71, P167; Rensink WA, 2004, PLANT PHYSIOL, V135, P622, DOI 10.1104/pp.104.040170; Roche JR, 2009, ANIM PROD SCI, V49, P200, DOI 10.1071/EA07308; Rozen S, 2000, Methods Mol Biol, V132, P365; Sathish P, 2007, PLANT BIOTECHNOL J, V5, P146, DOI 10.1111/j.1467-7652.2006.00228.x; Sawbridge T, 2003, PLANT SCI, V165, P1089, DOI 10.1016/S0168-9452(03)00304-2; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; SMITH D, 1969, REMOVING ANAL TOTAL, P1; Strand A, 1997, PLANT J, V12, P605, DOI 10.1046/j.1365-313X.1997.00605.x; Turner LR, 2006, GRASS FORAGE SCI, V61, P164, DOI 10.1111/j.1365-2494.2006.00523.x; Turner LR, 2006, AUST J AGR RES, V57, P243, DOI 10.1071/AR05130; VSN International Ltd, 2008, GENSTAT REL 11 REF 3; Wissel K, 2003, PLANT PHYSIOL, V133, P1190, DOI 10.1104/pp.103.028191; Xu ZZ, 2006, PLANTA, V224, P1080, DOI 10.1007/s00425-006-0281-5; Xue GP, 2008, PLANT MOL BIOL, V67, P197, DOI 10.1007/s11103-008-9311-y	44	18	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12306	10.1371/journal.pone.0012306	http://dx.doi.org/10.1371/journal.pone.0012306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808836	Green Submitted, gold, Green Published			2022-12-27	WOS:000281077000012
J	Dumas, F; Byrne, RD; Vincent, B; Hobday, TMC; Poccia, DL; Larijani, B				Dumas, Fabrice; Byrne, Richard D.; Vincent, Ben; Hobday, Tina M. C.; Poccia, Dominic L.; Larijani, Banafshe			Spatial Regulation of Membrane Fusion Controlled by Modification of Phosphoinositides	PLOS ONE			English	Article							PHOSPHOLIPASE-C; PHOSPHATIDYLINOSITOL; BINDING; VESICLES	Membrane fusion plays a central role in many cell processes from vesicular transport to nuclear envelope reconstitution at mitosis but the mechanisms that underlie fusion of natural membranes are not well understood. Studies with synthetic membranes and theoretical considerations indicate that accumulation of lipids characterised by negative curvature such as diacylglycerol (DAG) facilitate fusion. However, the specific role of lipids in membrane fusion of natural membranes is not well established. Nuclear envelope (NE) assembly was used as a model for membrane fusion. A natural membrane population highly enriched in the enzyme and substrate needed to produce DAG has been isolated and is required for fusions leading to nuclear envelope formation, although it contributes only a small amount of the membrane eventually incorporated into the NE. It was postulated to initiate and regulate membrane fusion. Here we use a multidisciplinary approach including subcellular membrane purification, fluorescence spectroscopy and Forster resonance energy transfer (FRET)/two-photon fluorescence lifetime imaging microscopy (FLIM) to demonstrate that initiation of vesicle fusion arises from two unique sites where these vesicles bind to chromatin. Fusion is subsequently propagated to the endoplasmic reticulum-derived membranes that make up the bulk of the NE to ultimately enclose the chromatin. We show how initiation of multiple vesicle fusions can be controlled by localised production of DAG and propagated bidirectionally. Phospholipase C (PLC gamma), GTP hydrolysis and (phosphatidylinsositol-(4,5)-bisphosphate (PtdIns(4,5)P-2) are required for the latter process. We discuss the general implications of membrane fusion regulation and spatial control utilising such a mechanism.	[Dumas, Fabrice; Byrne, Richard D.; Hobday, Tina M. C.; Larijani, Banafshe] Canc Res UK, Cell Biophys Lab, Lincolns Inn Fields Labs, London, England; [Dumas, Fabrice] CNRS, IPBS, Toulouse, France; [Dumas, Fabrice] Univ Toulouse, UPS, IPBS, Toulouse, France; [Vincent, Ben; Poccia, Dominic L.] Amherst Coll, Dept Biol, Amherst, MA 01002 USA	Cancer Research UK; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Amherst College	Dumas, F (corresponding author), Canc Res UK, Cell Biophys Lab, Lincolns Inn Fields Labs, London, England.	dlpoccia@amherst.edu; banafshe.larijani@cancer.org.uk	Larijani, Banafshe/H-3909-2015	Larijani, Banafshe/0000-0003-4735-1169; Dumas, Fabrice/0000-0002-9164-4527	Cancer Research UK; Amherst College	Cancer Research UK(Cancer Research UK); Amherst College	This work was funded by the core funding of Cancer Research UK and Amherst College FRAP award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott B, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.181103; Barona T, 2005, J BIOL CHEM, V280, P41171, DOI 10.1074/jbc.M412863200; Byrne RD, 2005, BIOCHEM J, V387, P393, DOI 10.1042/BJ20040947; Byrne RD, 2007, CELL SIGNAL, V19, P913, DOI 10.1016/j.cellsig.2006.10.011; Byrne RD, 2009, CLIN LIPIDOL, V4, P103, DOI 10.2217/17584299.4.1.103; Byrne RD, 2009, ADV ENZYME REGUL, V49, P148, DOI 10.1016/j.advenzreg.2008.12.010; Byrne Richard D., 2008, V464, P207; CAMERON LA, 1994, DEV BIOL, V162, P568, DOI 10.1006/dbio.1994.1110; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; COLLAS P, 1995, DEV BIOL, V169, P123, DOI 10.1006/dbio.1995.1132; Collas P, 1998, METHOD CELL BIOL, V53, P417; Collas P, 1996, J CELL SCI, V109, P1275; Collas P, 1996, EUR J CELL BIOL, V71, P22; COTHREN CC, 1993, EXP CELL RES, V205, P126, DOI 10.1006/excr.1993.1066; Garnier-Lhomme M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004255; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Larijani B, 2001, BIOCHEM J, V356, P495, DOI 10.1042/0264-6021:3560495; Larijani B., 2007, SIGNAL TRANSDUCT, V7, P142, DOI [10.1002/sita.200600128, DOI 10.1002/SITA.200600128]; Larijani B, 2009, ANNU REV BIOPHYS, V38, P107, DOI 10.1146/annurev.biophys.050708.133625; Poccia D, 2009, BIOCHEM J, V418, P233, DOI 10.1042/BJ20082105; Schmid AC, 2004, FEBS LETT, V576, P9, DOI 10.1016/j.febslet.2004.08.052; TERASAKI M, 1991, J CELL BIOL, V114, P929, DOI 10.1083/jcb.114.5.929; Villar AV, 2000, BIOCHEMISTRY-US, V39, P14012, DOI 10.1021/bi992515c	24	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12208	10.1371/journal.pone.0012208	http://dx.doi.org/10.1371/journal.pone.0012208			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808914	Green Published, gold, Green Submitted			2022-12-27	WOS:000280968100012
J	Schaller, MA; Logue, H; Mukherjee, S; Lindell, DM; Coelho, AL; Lincoln, P; Carson, WF; Ito, T; Cavassani, KA; Chensue, SW; Hogaboam, CM; Lukacs, NW; Kunkel, SL				Schaller, Matthew A.; Logue, Hannah; Mukherjee, Sumanta; Lindell, Dennis M.; Coelho, Ana Lucia; Lincoln, Pamela; Carson, William F.; Ito, Toshihiro; Cavassani, Karen A.; Chensue, Stephen W.; Hogaboam, Cory M.; Lukacs, Nicholas W.; Kunkel, Steven L.			Delta-Like 4 Differentially Regulates Murine CD4(+) T Cell Expansion via BMI1	PLOS ONE			English	Article							IN-VIVO; GATA3 EXPRESSION; DENDRITIC CELLS; NOTCH LIGANDS; MEMORY; ACTIVATION; ANTIGEN; RESPONSES; SUBSETS; GENE	Background: Studies have shown that Notch is essential for the maintenance of a T cell Th2 phenotype in vivo. It has also been shown that Notch ligands have diverse functions during T cell activation. We chose to investigate the role of Notch ligands during the Th2 response. Principal Findings: We studied the relationship of two Notch ligands, delta-like 4 and jagged-1, to T cell proliferation in C57 Bl/6 mice. Our findings indicate that jagged-1 does not affect the rate of T cell proliferation in any subset examined. However, delta-like 4 causes an increase in the expansion of Th2 memory cells and a decrease in effector cell proliferation. Our in vivo studies indicate that the Notch system is dynamically regulated, and that blocking one Notch ligand increases the effective concentration of other Notch ligands, thus altering the response. Examination of genes related to the Notch pathway revealed that the Notch receptors were increased in memory T cells. Expression of BMI1, a gene involved in T cell proliferation, was also higher in memory T cells. Further experiments demonstrated that Notch directly regulates the expression of the BMI1 gene in T cells and may govern T cell proliferation through this pathway. Conclusions: From these experiments we can make several novel conclusions about the role of Notch ligands in T cell biology. The first is that delta-like 4 suppresses effector cell proliferation and enhances Th2 memory cell proliferation. The second is that blocking one Notch ligand in vivo effectively increases the concentration of other Notch ligands, which can then alter the response.	[Schaller, Matthew A.; Logue, Hannah; Mukherjee, Sumanta; Coelho, Ana Lucia; Lincoln, Pamela; Carson, William F.; Ito, Toshihiro; Cavassani, Karen A.; Chensue, Stephen W.; Hogaboam, Cory M.; Lukacs, Nicholas W.; Kunkel, Steven L.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Lindell, Dennis M.] Seattle Childrens Hosp, Ctr Immun & Immunotherapies, Seattle, WA USA	University of Michigan System; University of Michigan; Seattle Children's Hospital	Schaller, MA (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	mschalle@umich.edu	hogaboam, cory/M-3578-2014; Hogaboam, Cory M./AAI-1433-2021; Lukacs, Nicholas W/ABH-5583-2020; Schaller, Matthew/AAL-7640-2020	Hogaboam, Cory M./0000-0003-3366-4850; Carson, William F/0000-0001-9459-3924	National Institutes of Health [HL092853, HL089210, HL031963, HL031237]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031237, R01HL089216, R33HL092853, P01HL031963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI077712, R01AI043460, R01AI073876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by National Institutes of Health grants HL092853, HL089210, HL031963, and HL031237. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Carter LL, 1998, J IMMUNOTHER, V21, P181, DOI 10.1097/00002371-199805000-00003; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; GOH F, 2008, IMMUNOLOGY; Hosokawa H, 2006, J IMMUNOL, V177, P7656, DOI 10.4049/jimmunol.177.11.7656; Ito T, 2009, J CLIN INVEST, V119, P33, DOI 10.1172/JCI35647; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; JOSHI I, 2008, BLOOD; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Matsukawa A, 2000, J IMMUNOL, V164, P1699, DOI 10.4049/jimmunol.164.4.1699; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; McKinstry KK, 2007, J EXP MED, V204, P2199, DOI 10.1084/jem.20070041; Miyazaki M, 2008, IMMUNITY, V28, P231, DOI 10.1016/j.immuni.2007.12.013; Mukherjee S, 2009, J IMMUNOL, V182, P7381, DOI 10.4049/jimmunol.0804322; Nakayama T, 2009, SEMIN IMMUNOL, V21, P78, DOI 10.1016/j.smim.2009.02.001; Okamoto M, 2009, J IMMUNOL, V183, P2995, DOI 10.4049/jimmunol.0900692; Page K, 2008, J IMMUNOL, V180, P6317, DOI 10.4049/jimmunol.180.9.6317; Raaphorst FM, 2001, J IMMUNOL, V166, P5925, DOI 10.4049/jimmunol.166.10.5925; Rudd BD, 2007, J IMMUNOL, V178, P5820, DOI 10.4049/jimmunol.178.9.5820; Rutz S, 2005, EUR J IMMUNOL, V35, P2443, DOI 10.1002/eji.200526294; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schaller MA, 2007, J EXP MED, V204, P2925, DOI 10.1084/jem.20070661; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Tan AM, 2010, J IMMUNOL, V184, P3535, DOI 10.4049/jimmunol.0900340; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; Wen HT, 2008, BLOOD, V111, P1797, DOI 10.1182/blood-2007-08-106443; Yamashita M, 2008, J EXP MED, V205, P1109, DOI 10.1084/jem.20072000; Zhou L, 2008, BLOOD, V112, P308, DOI 10.1182/blood-2007-11-115204	35	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12172	10.1371/journal.pone.0012172	http://dx.doi.org/10.1371/journal.pone.0012172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808960	Green Submitted, gold, Green Published			2022-12-27	WOS:000280968100007
J	Kular, RK; Gogliotti, RG; Opal, P				Kular, Rupinder K.; Gogliotti, Rocky G.; Opal, Puneet			Cpd-1 Null Mice Display a Subtle Neurological Phenotype	PLOS ONE			English	Article							ACIDIC NUCLEAR-PROTEIN; MICROTUBULE-ASSOCIATED PROTEINS; LEUCINE-RICH REPEATS; PP32 EXPRESSION; PROSTATE-CANCER; MAPMODULIN; INHIBITOR; ATAXIN-1; BINDS; GENE	Background: CPD1 (also known as ANP32-E) belongs to a family of evolutionarily conserved acidic proteins with leucine rich repeats implicated in a variety of cellular processes regulating gene expression, vesicular trafficking, intracellular signaling and apoptosis. Because of its spatiotemporal expression pattern, CPD1 has been proposed to play an important role in brain morphogenesis and synaptic development. Methodology/Principal Findings: We have generated CPD1 knock-out mice that we have subsequently characterized. These mice are viable and fertile. However, they display a subtle neurological clasping phenotype and mild motor deficits. Conclusions/Significance: CPD1 is not essential for normal development; however, it appears to play a role in the regulation of fine motor functions. The minimal phenotype suggests compensatory biological mechanisms.	[Kular, Rupinder K.; Opal, Puneet] NW Univ Feinberg, Sch Med, Davee Dept Neurol, Chicago, IL USA; [Kular, Rupinder K.; Opal, Puneet] NW Univ Feinberg, Sch Med, Dept Cell & Mol Biol, Chicago, IL USA; [Gogliotti, Rocky G.] NW Univ Feinberg, Sch Med, Integrated Grad Program, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Kular, RK (corresponding author), NW Univ Feinberg, Sch Med, Davee Dept Neurol, Chicago, IL USA.	p-opal@northwestern.edu			NIH [K02 NS051340, R03HD054612-01A2, R21 NS060080-01A1, R01 NS062051, 5T32 NS41234-01]; National Ataxia Foundation; Brain Research Foundation; National Organization for Rare Disorders (NORD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD054612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082351, T32NS041234, R21NS060080, R01NS062051, K02NS051340] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Ataxia Foundation; Brain Research Foundation; National Organization for Rare Disorders (NORD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded in part by NIH (grants K02 NS051340, R03HD054612-01A2, R21 NS060080-01A1, R01 NS062051), the National Ataxia Foundation, the Brain Research Foundation and the National Organization for Rare Disorders (NORD). An NIH training grant: 5T32 NS41234-01 sponsored the work of R.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JN, 2001, ONCOGENE, V20, P2153, DOI 10.1038/sj.onc.1204294; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Brody JR, 2007, MODERN PATHOL, V20, P1238, DOI 10.1038/modpathol.3800974; Chen TH, 1996, MOL BIOL CELL, V7, P2045, DOI 10.1091/mbc.7.12.2045; Costes E., 2006, Horticultural Reviews, V32, P1; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Cvetanovic M, 2007, EMBO REP, V8, P671, DOI 10.1038/sj.embor.7400983; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Heng MY, 2007, J NEUROSCI, V27, P8989, DOI 10.1523/JNEUROSCI.1830-07.2007; Itin C, 1999, MOL BIOL CELL, V10, P2191, DOI 10.1091/mbc.10.7.2191; Jiang XJ, 2003, SCIENCE, V299, P223, DOI 10.1126/science.1076807; Kadkol SS, 1999, NAT MED, V5, P275, DOI 10.1038/6488; Kadkol SS, 1998, PROSTATE, V34, P231, DOI 10.1002/(SICI)1097-0045(19980215)34:3<231::AID-PROS11>3.0.CO;2-F; Kular RK, 2009, J BIOL CHEM, V284, P7783, DOI 10.1074/jbc.M806150200; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; Matilla A, 2005, CEREBELLUM, V4, P7, DOI 10.1080/14734220410019020; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; MATSUOKA K, 1994, P NATL ACAD SCI USA, V91, P9670, DOI 10.1073/pnas.91.21.9670; Mencinger M, 1998, BBA-GENE STRUCT EXPR, V1395, P176, DOI 10.1016/S0167-4781(97)00165-6; Mutai H, 2000, BIOCHEM BIOPH RES CO, V274, P427, DOI 10.1006/bbrc.2000.3133; Opal P, 2003, J BIOL CHEM, V278, P34691, DOI 10.1074/jbc.M302785200; Opal P, 2004, MOL CELL BIOL, V24, P3140, DOI 10.1128/MCB.24.8.3140-3149.2004; Radrizzani M, 2001, BRAIN RES, V907, P162, DOI 10.1016/S0006-8993(01)02351-4; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Ulitzur N, 1997, J BIOL CHEM, V272, P30577, DOI 10.1074/jbc.272.48.30577; Ulitzur N, 1997, P NATL ACAD SCI USA, V94, P5084, DOI 10.1073/pnas.94.10.5084; VAESEN M, 1994, BIOL CHEM H-S, V375, P113, DOI 10.1515/bchm3.1994.375.2.113; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003	28	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12649	10.1371/journal.pone.0012649	http://dx.doi.org/10.1371/journal.pone.0012649			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844742	Green Published, Green Submitted, gold			2022-12-27	WOS:000281687200014
J	Francis, CM; Borisenko, AV; Ivanova, NV; Eger, JL; Lim, BK; Guillen-Servent, A; Kruskop, SV; Mackie, I; Hebert, PDN				Francis, Charles M.; Borisenko, Alex V.; Ivanova, Natalia V.; Eger, Judith L.; Lim, Burton K.; Guillen-Servent, Antonio; Kruskop, Sergei V.; Mackie, Iain; Hebert, Paul D. N.			The Role of DNA Barcodes in Understanding and Conservation of Mammal Diversity in Southeast Asia	PLOS ONE			English	Article							ANCIENT DNA; VESPERTILIONIDAE; CHIROPTERA; BATS	Background: Southeast Asia is recognized as a region of very high biodiversity, much of which is currently at risk due to habitat loss and other threats. However, many aspects of this diversity, even for relatively well-known groups such as mammals, are poorly known, limiting ability to develop conservation plans. This study examines the value of DNA barcodes, sequences of the mitochondrial COI gene, to enhance understanding of mammalian diversity in the region and hence to aid conservation planning. Methodology and Principal Findings: DNA barcodes were obtained from nearly 1900 specimens representing 165 recognized species of bats. All morphologically or acoustically distinct species, based on classical taxonomy, could be discriminated with DNA barcodes except four closely allied species pairs. Many currently recognized species contained multiple barcode lineages, often with deep divergence suggesting unrecognized species. In addition, most widespread species showed substantial genetic differentiation across their distributions. Our results suggest that mammal species richness within the region may be underestimated by at least 50%, and there are higher levels of endemism and greater intra-specific population structure than previously recognized. Conclusions: DNA barcodes can aid conservation and research by assisting field workers in identifying species, by helping taxonomists determine species groups needing more detailed analysis, and by facilitating the recognition of the appropriate units and scales for conservation planning.	[Francis, Charles M.] Environm Canada, Canadian Wildlife Serv, Ottawa, ON K1A 0H3, Canada; [Borisenko, Alex V.; Ivanova, Natalia V.; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Eger, Judith L.; Lim, Burton K.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Guillen-Servent, Antonio] Inst Ecol AC, Xalapa, Veracruz, Mexico; [Kruskop, Sergei V.] Moscow MV Lomonosov State Univ, Zool Museum, Moscow, Russia; [Mackie, Iain] Univ Aberdeen, Aberdeen Ctr Environm Sustainabil, Aberdeen, Scotland	Environment & Climate Change Canada; Canadian Wildlife Service; University of Guelph; Royal Ontario Museum; Instituto de Ecologia - Mexico; Lomonosov Moscow State University; University of Aberdeen	Francis, CM (corresponding author), Environm Canada, Canadian Wildlife Serv, Ottawa, ON K1A 0H3, Canada.	charles.francis@ec.gc.ca	Borisenko, Alex/G-9107-2014; Hebert, Paul DN/C-4161-2013; Borisenko, Alex/GQZ-9054-2022; Guillén Servent, Antonio/R-2167-2018; Lim, Burton K/A-1148-2011	Borisenko, Alex/0000-0002-3061-3057; Hebert, Paul DN/0000-0002-3081-6700; Guillén Servent, Antonio/0000-0001-6273-485X; Lim, Burton K/0000-0002-0884-0421; Kruskop, Sergei/0000-0002-9846-0317	Canada Foundation for Innovation; Ontario Innovation Trust; Natural Sciences and Engineering Research Council of Canada; Gordon and Betty Moore Foundation; Wildlife Conservation Society; Royal Ontario Museum (ROM); Vietnamese-Russian Tropical Centre; Harrison Museum; U.S. National Science Foundation [DEB-0244430]; Darwin Initiative [14-036]; Carnegie Trust for the Universities of Scotland; University of Missouri	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Innovation Trust; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Wildlife Conservation Society; Royal Ontario Museum (ROM); Vietnamese-Russian Tropical Centre; Harrison Museum; U.S. National Science Foundation(National Science Foundation (NSF)); Darwin Initiative; Carnegie Trust for the Universities of Scotland; University of Missouri	DNA analyses were supported by grants to PDNH from the Canada Foundation for Innovation, the Ontario Innovation Trust, the Natural Sciences and Engineering Research Council of Canada, and the Gordon and Betty Moore Foundation. Field work was supported by the Wildlife Conservation Society, Royal Ontario Museum (ROM) and ROM Governors, Vietnamese-Russian Tropical Centre, the Harrison Museum, the U.S. National Science Foundation (DEB-0244430), the Darwin Initiative (Grant 14-036), the Carnegie Trust for the Universities of Scotland, the University of Missouri Research Board grants to Dr. Robert E. Ricklefs, as well as in-kind and financial support from various host institutions in local countries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise John C., 2004, P1; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Bates P. J. J., 1997, BATS INDIAN SUBCONTI; Bates PJJ, 2007, ACTA CHIROPTEROL, V9, P323, DOI 10.3161/1733-5329(2007)9[323:ANSOKC]2.0.CO;2; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; BORISENKO AV, 1999, PLECOTUS ET AL, P10; BORISSENKO AV, 2003, BATS VIETNAM ADJACEN; Campbell P, 2004, MOL PHYLOGENET EVOL, V33, P764, DOI 10.1016/j.ympev.2004.06.019; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Cooper A, 2000, SCIENCE, V289, P1139; Corbet G.B., 1992, P1; CSORBA G, 2003, ALANA BOOKS, V30, P160; FRANCIS CM, 1989, J MAMMAL, V70, P865, DOI 10.2307/1381730; FRANCIS CM, 2008, FIELD GUIDE MAMMALS; Grubb P, 2005, MAMMAL SPECIES WORLD, P637; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; INSKIPP T, CHECKLIST BIRDS ORIE; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; Kitchener AC, 2006, CURR BIOL, V16, P2377, DOI 10.1016/j.cub.2006.10.066; Kruskop SV, 2008, ACTA CHIROPTEROL, V10, P213, DOI 10.3161/150811008X414809; Kruskop SV, 2001, MAMMALIA, V65, P63, DOI 10.1515/mamm.2001.65.1.63; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; PAYNE J, 1985, FIELD GUIDE MAMMALS; Pfunder M, 2004, MOL ECOL, V13, P1277, DOI 10.1111/j.1365-294X.2004.02126.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reeder DeeAnn M., 2007, Occasional Papers Museum of Texas Tech University, V269, P1; Robson C., 2000, FIELD GUIDE BIRDS S; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Smith Andrew T., 2008, P1; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Wilmer Jessica Worthington, 1996, Bat Research News, V37, P1; Wilson D.E., 2005, MAMMAL SPECIES WORLD; Xu XF, 1996, J MOL EVOL, V43, P431, DOI 10.1007/PL00006103	46	168	183	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12575	10.1371/journal.pone.0012575	http://dx.doi.org/10.1371/journal.pone.0012575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838635	gold, Green Published, Green Submitted			2022-12-27	WOS:000281627700022
J	Fedrigo, O; Warner, LR; Pfefferle, AD; Babbitt, CC; Cruz-Gordillo, P; Wray, GA				Fedrigo, Olivier; Warner, Lisa R.; Pfefferle, Adam D.; Babbitt, Courtney C.; Cruz-Gordillo, Peter; Wray, Gregory A.			A Pipeline to Determine RT-QPCR Control Genes for Evolutionary Studies: Application to Primate Gene Expression across Multiple Tissues	PLOS ONE			English	Article							REAL-TIME PCR; HOUSEKEEPING GENES; HUMAN BRAIN; CHIMPANZEE GENOME; RNA QUANTITATION; SELECTION; NORMALIZATION; PATTERNS; HUMANS; IDENTIFICATION	Because many species-specific phenotypic differences are assumed to be caused by differential regulation of gene expression, many recent investigations have focused on measuring transcript abundance. Despite the availability of high-throughput platforms, quantitative real-time polymerase chain reaction (RT-QPCR) is often the method of choice because of its low cost and wider dynamic range. However, the accuracy of this technique heavily relies on the use of multiple valid control genes for normalization. We created a pipeline for choosing genes potentially useful as RT-QPCR control genes for measuring expression between human and chimpanzee samples across multiple tissues, using published microarrays and a measure of tissue-specificity. We identified 13 genes from the pipeline and from commonly used control genes: ACTB, USP49, ARGHGEF2, GSK3A, TBP, SDHA, EIF2B2, GPDH, YWHAZ, HPTR1, RPL13A, HMBS, and EEF2. We then tested these candidate genes and validated their expression stability across species. We established the rank order of the most preferable set of genes for single and combined tissues. Our results suggest that for at least three tissues (cerebral cortex, liver, and skeletal muscle), EIF2B2, EEF2, HMBS, and SDHA are useful genes for normalizing human and chimpanzee expression using RT-QPCR. Interestingly, other commonly used control genes, including TBP, GAPDH, and, especially ACTB do not perform as well. This pipeline could be easily adapted to other species for which expression data exist, providing taxonomically appropriate control genes for comparisons of gene expression among species.	[Fedrigo, Olivier; Warner, Lisa R.; Pfefferle, Adam D.; Babbitt, Courtney C.; Cruz-Gordillo, Peter; Wray, Gregory A.] Duke Univ, Dept Biol, Durham, NC 27710 USA; [Fedrigo, Olivier; Warner, Lisa R.; Babbitt, Courtney C.; Cruz-Gordillo, Peter; Wray, Gregory A.] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Wray, Gregory A.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA	Duke University; Duke University; Duke University	Fedrigo, O (corresponding author), Duke Univ, Dept Biol, Durham, NC 27710 USA.	ofedrigo@duke.edu		Cruz-Gordillo, Peter/0000-0002-0264-7348	National Science Foundation [NSF-BCS-08-27552]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant NSF-BCS-08-27552 (HOMINID) awarded to GAW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABBITT CC, 2010, GENOME BIOL EVOL, V67, P79; Blekhman R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000271; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Coulson DTR, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-46; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Fraser HB, 2005, PLOS BIOL, V3, P1653, DOI 10.1371/journal.pbio.0030274; Gilad Y, 2005, GENOME RES, V15, P674, DOI 10.1101/gr.3335705; Gilad Y, 2006, TRENDS GENET, V22, P456, DOI 10.1016/j.tig.2006.06.002; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Gu JY, 2003, TRENDS GENET, V19, P63, DOI 10.1016/S0168-9525(02)00040-9; Haygood R, 2010, P NATL ACAD SCI USA, V107, P7853, DOI 10.1073/pnas.0911249107; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Infante C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-28; Jeong AR, 2008, J MED PRIMATOL, V37, P290, DOI 10.1111/j.1600-0684.2008.00289.x; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Khaitovich P, 2004, GENOME RES, V14, P1462, DOI 10.1101/gr.2538704; Khaitovich P, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r124; Khaitovich P, 2006, PLOS GENET, V2, P1590, DOI 10.1371/journal.pgen.0020171; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nailis H, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-25; Olson MV, 2003, NAT REV GENET, V4, P20, DOI 10.1038/nrg981; Pilbrow AP, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-64; Popovici V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-42; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rozen S, 2000, Methods Mol Biol, V132, P365; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varki A, 2000, GENOME RES, V10, P1065, DOI 10.1101/gr.10.8.1065; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01	37	18	18	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12545	10.1371/journal.pone.0012545	http://dx.doi.org/10.1371/journal.pone.0012545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824057	Green Published, gold			2022-12-27	WOS:000281480900026
J	Grabarczyk, P; Nahse, V; Delin, M; Przybylski, G; Depke, M; Hildebrandt, P; Volker, U; Schmidt, CA				Grabarczyk, Piotr; Naehse, Viola; Delin, Martin; Przybylski, Grzegorz; Depke, Maren; Hildebrandt, Petra; Voelker, Uwe; Schmidt, Christian A.			Increased Expression of Bcl11b Leads to Chemoresistance Accompanied by G1 Accumulation	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITOR; ZINC-FINGER PROTEINS; T-LYMPHOCYTES; TRANSCRIPTIONAL REPRESSION; GENE-EXPRESSION; UP-REGULATION; NURD COMPLEX; PROMOTER; CTIP2; CELLS	Background: The expression of BCL11B was reported in T-cells, neurons and keratinocytes. Aberrations of BCL11B locus leading to abnormal gene transcription were identified in human hematological disorders and corresponding animal models. Recently, the elevated levels of Bcl11b protein have been described in a subset of squameous cell carcinoma cases. Despite the rapidly accumulating knowledge concerning Bcl11b biology, the contribution of this protein to normal or transformed cell homeostasis remains open. Methodology/Principal Findings: Here, by employing an overexpression strategy we revealed formerly unidentified features of Bcl11b. Two different T-cell lines were forced to express BCL11B at levels similar to those observed in primary Tcell leukemias. This resulted in markedly increased resistance to radiomimetic drugs while no influence on death-receptor apoptotic pathway was observed. Apoptosis resistance triggered by BCL11B overexpression was accompanied by a cell cycle delay caused by accumulation of cells at G1. This cell cycle restriction was associated with upregulation of CDKN1C (p57) and CDKN2C (p18) cyclin dependent kinase inhibitors. Moreover, p27 and p130 proteins accumulated and the SKP2 gene encoding a protein of the ubiquitin-binding complex responsible for their degradation was repressed. Furthermore, the expression of the MYCN oncogene was silenced which resulted in significant depletion of the protein in cells expressing high BCL11B levels. Both cell cycle restriction and resistance to DNA-damage-induced apoptosis coincided and required the histone deacetylase binding N-terminal domain of Bcl11b. The sensitivity to genotoxic stress could be restored by the histone deacetylase inhibitor trichostatine A. Conclusions: The data presented here suggest a potential role of BCL11B in tumor survival and encourage developing Bcl11b-inhibitory approaches as a potential tool to specifically target chemoresistant tumor cells.	[Grabarczyk, Piotr; Naehse, Viola; Delin, Martin; Przybylski, Grzegorz; Schmidt, Christian A.] Ernst Moritz Arndt Univ Greifswald, Dept Hematol & Oncol, Greifswald, Germany; [Depke, Maren; Hildebrandt, Petra; Voelker, Uwe] Interfac Inst Genet & Funct Gen, Dept Funct Gen, Greifswald, Germany; [Przybylski, Grzegorz] Polish Acad Sci, Inst Human Genet, PL-60479 Poznan, Poland	Ernst Moritz Arndt Universitat Greifswald; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences	Grabarczyk, P (corresponding author), Ernst Moritz Arndt Univ Greifswald, Dept Hematol & Oncol, Greifswald, Germany.	christian.schmidt@uni-greifswald.de		Volker, Uwe/0000-0002-5689-3448; Przybylski, Grzegorz/0000-0001-5783-1567	Deutsche Jose Carreras Leukemia Stiftung e.V [DJCLS R 09/31f]; Interfaculty Institute for Genetics and Functional Genomics; Bundesministerium fur Bildung und Forschung; Zentrum fur Innovationskompetenz Funktionelle Genomforschung [03ZIK331]	Deutsche Jose Carreras Leukemia Stiftung e.V; Interfaculty Institute for Genetics and Functional Genomics; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Zentrum fur Innovationskompetenz Funktionelle Genomforschung	The studies performed in the Department of Molecular Hematology were supported by Deutsche Jose Carreras Leukemia Stiftung e.V (Grant No. DJCLS R 09/31f). Work in the Interfaculty Institute for Genetics and Functional Genomics (U. V.) was supported by the Bundesministerium fur Bildung und Forschung, Zentrum fur Innovationskompetenz Funktionelle Genomforschung (ZIK FunGene 03ZIK331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Avram D, 2002, BIOCHEM J, V368, P555, DOI 10.1042/BJ20020496; Bhattacharya S, 2003, ONCOGENE, V22, P2443, DOI 10.1038/sj.onc.1206339; Cherrier T, 2009, ONCOGENE, V28, P3380, DOI 10.1038/onc.2009.193; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Cismasiu VB, 2006, BLOOD, V108, P2695, DOI 10.1182/blood-2006-05-021790; Cismasiu VB, 2009, BIOCHEM J, V417, P457, DOI 10.1042/BJ20080925; Cismasiu VB, 2005, ONCOGENE, V24, P6753, DOI 10.1038/sj.onc.1208904; CISMASIU VB, 2005, ONCOGENE; Ganguli-Indra G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005367; GOLONZHKA O, 2009, J INVESTIGATIVE DERM; Golonzhka O, 2007, GENE EXPR PATTERNS, V7, P754, DOI 10.1016/j.modgep.2007.06.002; Golonzhka O, 2009, P NATL ACAD SCI USA, V106, P4278, DOI 10.1073/pnas.0900568106; GORCZYCA W, 1993, CANCER RES, V53, P3186; Grabarczyk P, 2007, ONCOGENE, V26, P3797, DOI 10.1038/sj.onc.1210152; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; KAMIMURA K, 2007, ONCOGENE        0319; KAMIMURA K, 2007, BIOCH BIOPHYSICAL RE; KARLSSON A, 2007, BIOMEDCENTRAL CANC, V7; Ky N, 2009, APOPTOSIS, V14, P1095, DOI 10.1007/s10495-009-0368-0; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; Leid M, 2004, GENE EXPR PATTERNS, V4, P733, DOI 10.1016/j.modgep.2004.03.009; Liu DX, 2005, GENE DEV, V19, P719, DOI 10.1101/gad.1296405; Ma Y, 2007, ONCOGENE, V26, P3532, DOI 10.1038/sj.onc.1210143; Marban C, 2005, NUCLEIC ACIDS RES, V33, P2318, DOI 10.1093/nar/gki529; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; NAGAMACHI A, 2009, CANCER SCI, P1; Nagel S, 2003, CANCER RES, V63, P5329; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; OHI H, 2007, ONCOGENE; OSHIRO A, 2006, BLOOD; Oshiro A, 2006, BLOOD, V107, P4500, DOI 10.1182/blood-2005-09-3801; Przybylski GK, 2005, LEUKEMIA, V19, P201, DOI 10.1038/sj.leu.2403619; Senawong T, 2003, J BIOL CHEM, V278, P43041, DOI 10.1074/jbc.M307477200; Shinbo T, 1999, ONCOGENE, V18, P4131, DOI 10.1038/sj.onc.1202767; Tevosian SG, 1997, GENE DEV, V11, P383, DOI 10.1101/gad.11.3.383; Topark-Ngarm A, 2006, J BIOL CHEM, V281, P32272, DOI 10.1074/jbc.M602776200; TOPARKNGARM A, 2006, J BIOL CHEM; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wakabayashi Y, 2003, BIOCHEM BIOPH RES CO, V301, P598, DOI 10.1016/S0006-291X(02)03069-3; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Zindy F, 2006, P NATL ACAD SCI USA, V103, P11579, DOI 10.1073/pnas.0604727103	44	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12532	10.1371/journal.pone.0012532	http://dx.doi.org/10.1371/journal.pone.0012532			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824091	Green Submitted, gold, Green Published			2022-12-27	WOS:000281480900015
J	Uchida, K; Aramaki, M; Nakazawa, M; Yamagishi, C; Makino, S; Fukuda, K; Nakamura, T; Takahashi, T; Mikoshiba, K; Yamagishi, H				Uchida, Keiko; Aramaki, Megumi; Nakazawa, Maki; Yamagishi, Chihiro; Makino, Shinji; Fukuda, Keiichi; Nakamura, Takeshi; Takahashi, Takao; Mikoshiba, Katsuhiko; Yamagishi, Hiroyuki			Gene Knock-Outs of Inositol 1,4,5-Trisphosphate Receptors Types 1 and 2 Result in Perturbation of Cardiogenesis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; 2-AMINOETHOXYDIPHENYL BORATE; NF-ATC; EXPRESSION; CA2+; CELL; CALCINEURIN; INDUCTION; PULMONARY; PROMOTER	Background: Inositol 1,4,5-trisphosphate receptors (IP(3)R1, 2, and 3) are intracellular Ca2+ release channels that regulate various vital processes. Although the ryanodine receptor type 2, another type of intracellular Ca2+ release channel, has been shown to play a role in embryonic cardiomyocytes, the functions of the IP(3)Rs in cardiogenesis remain unclear. Methodology/Principal Findings: We found that IP(3)R1(-/-)-IP(3)R2(-/-) double-mutant mice died in utero with developmental defects of the ventricular myocardium and atrioventricular (AV) canal of the heart by embryonic day (E) 11.5, even though no cardiac defect was detectable in IP(3)R1(-/-) or IP(3)R2(-/-) single-mutant mice at this developmental stage. The double-mutant phenotype resembled that of mice deficient for calcineurin/NFATc signaling, and NFATc was inactive in embryonic hearts from the double knockout-mutant mice. The double mutation of IP(3)R1/R2 and pharmacologic inhibition of IP(3)Rs mimicked the phenotype of the AV valve defect that result from the inhibition of calcineurin, and it could be rescued by constitutively active calcineurin. Conclusions/Significance: Our results suggest an essential role for IP(3)Rs in cardiogenesis in part through the regulation of calcineurin-NFAT signaling.	[Uchida, Keiko; Aramaki, Megumi; Nakazawa, Maki; Yamagishi, Chihiro; Takahashi, Takao; Yamagishi, Hiroyuki] Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Makino, Shinji; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Regenerat Med & Adv Cardiac Therapeut, Tokyo, Japan; [Nakamura, Takeshi; Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, ICORP SORST, Calcium Oscillat Project, Saitama, Japan; [Mikoshiba, Katsuhiko] RIKEN, Dev Neurobiol Lab, Brain Sci Inst, Saitama, Japan	Keio University; Keio University; Japan Science & Technology Agency (JST); RIKEN	Uchida, K (corresponding author), Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan.	mikosiba@brain.riken.jp; hyamag@sc.itc.keio.ac.jp	Mikoshiba, Katsuhiko/N-7943-2015; Fukuda, Keiichi/L-3777-2013; Yamagishi, Hiroyuki/A-6345-2017		Ministry of Education, Culture, Sports, Science and Technology, Japan; Pfizer; Japan Automobile Association	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Pfizer(Pfizer); Japan Automobile Association	This work was supported by a Grant-in-Aid for Scientific Research (H.Y.) and a Grant-in-Aid for Young Scientists (K. U.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, the Pfizer Fund for Development Research (H.Y.), and a Research Fund from the Japan Automobile Association (H.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; BROCK TA, 1991, AM J PATHOL, V138, P213; Bushdid PB, 2003, CIRC RES, V92, P1305, DOI 10.1161/01.RES.0000077045.84609.9F; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; HOGAN PG, ANN REV IMMUNOL, V28, P491; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Jayaraman T, 2000, J BIOL CHEM, V275, P6417, DOI 10.1074/jbc.275.9.6417; Johnson EN, 2003, J BIOL CHEM, V278, P1686, DOI 10.1074/jbc.M210250200; Kockskamper J, 2008, J MOL CELL CARDIOL, V45, P128, DOI 10.1016/j.yjmcc.2008.05.014; KUBALAK SW, 1994, J BIOL CHEM, V269, P16961; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; MAEDA N, 1988, J NEUROCHEM, V51, P1724, DOI 10.1111/j.1471-4159.1988.tb01151.x; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; MJAATVEDT CH, 1989, DEV BIOL, V136, P118, DOI 10.1016/0012-1606(89)90135-8; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nakamura Y, 2005, MOL CELL BIOL, V25, P10979, DOI 10.1128/MCB.25.24.10979-10988.2005; Oka T, 2005, MOL CELL BIOL, V25, P6649, DOI 10.1128/MCB.25.15.6649-6659.2005; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rosemblit N, 1999, DEV BIOL, V206, P163, DOI 10.1006/dbio.1998.9120; Saneyoshi T, 2002, NATURE, V417, P295, DOI 10.1038/417295a; SUGIYAMA T, 1994, FEBS LETT, V354, P149, DOI 10.1016/0014-5793(94)01099-4; Takeshima H, 1998, EMBO J, V17, P3309, DOI 10.1093/emboj/17.12.3309; Thomas T, 1998, DEV BIOL, V196, P228, DOI 10.1006/dbio.1998.8849; Yamagishi H, 2000, J CLIN INVEST, V105, P261, DOI 10.1172/JCI8856; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093; Zhou B, 2002, J BIOL CHEM, V277, P10704, DOI 10.1074/jbc.M107068200	37	43	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12500	10.1371/journal.pone.0012500	http://dx.doi.org/10.1371/journal.pone.0012500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824138	Green Submitted, Green Published, gold			2022-12-27	WOS:000281456100012
J	Baki, SGA; Schwab, B; Haber, M; Fenton, AA; Bergold, PJ				Baki, Samah G. Abdel; Schwab, Ben; Haber, Margalit; Fenton, Andre A.; Bergold, Peter J.			Minocycline Synergizes with N-Acetylcysteine and Improves Cognition and Memory Following Traumatic Brain Injury in Rats	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; PLACE AVOIDANCE; SPATIAL INFORMATION; BEHAVIORAL EVIDENCE; MICE; NEURODEGENERATION; SEGREGATION	Background: There are no drugs presently available to treat traumatic brain injury (TBI). A variety of single drugs have failed clinical trials suggesting a role for drug combinations. Drug combinations acting synergistically often provide the greatest combination of potency and safety. The drugs examined (minocycline (MINO), N-acetylcysteine (NAC), simvastatin, cyclosporine A, and progesterone) had FDA-approval for uses other than TBI and limited brain injury in experimental TBI models. Methodology/Principal Findings: Drugs were dosed one hour after injury using the controlled cortical impact (CCI) TBI model in adult rats. One week later, drugs were tested for efficacy and drug combinations tested for synergy on a hierarchy of behavioral tests that included active place avoidance testing. As monotherapy, only MINO improved acquisition of the massed version of active place avoidance that required memory lasting less than two hours. MINO-treated animals, however, were impaired during the spaced version of the same avoidance task that required 24-hour memory retention. Co-administration of NAC with MINO synergistically improved spaced learning. Examination of brain histology 2 weeks after injury suggested that MINO plus NAC preserved white, but not grey matter, since lesion volume was unaffected, yet myelin loss was attenuated. When dosed 3 hours before injury, MINO plus NAC as single drugs had no effect on interleukin-1 formation; together they synergistically lowered interleukin-1 levels. This effect on interleukin-1 was not observed when the drugs were dosed one hour after injury. Conclusions/Significance: These observations suggest a potentially valuable role for MINO plus NAC to treat TBI.	[Baki, Samah G. Abdel] Suny Downstate Med Ctr, Dept Physiol, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Dept Pharmacol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Baki, SGA (corresponding author), Suny Downstate Med Ctr, Dept Physiol, Brooklyn, NY 11203 USA.	pbergold@downstate.edu		Bergold, Peter/0000-0002-6335-1380; Fenton, Andre/0000-0002-5063-1156	Traumatic Brain Injury/Post-Traumatic Stress Disorder [W81XWH-08-1-0293]	Traumatic Brain Injury/Post-Traumatic Stress Disorder	This work was supported by a Traumatic Brain Injury/Post-Traumatic Stress Disorder Congressionally Directed Medical Research Programs award W81XWH-08-1-0293 (http://cdmrp.army.mil) to P.J.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; Cimadevilla JM, 2001, BRAIN RES BULL, V54, P559, DOI 10.1016/S0361-9230(01)00448-8; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Dodd S, 2008, EXPERT OPIN BIOL TH, V8, P1955, DOI 10.1517/14728220802517901 ; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P11493, DOI 10.1073/pnas.95.19.11493; Frei E., 2003, CANC MED; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Kubik S, 2005, J NEUROSCI, V25, P9205, DOI 10.1523/JNEUROSCI.1707-05.2005; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI 10.1089/neu.2008-0794; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Moreno S, 2010, J ANTIMICROB CHEMOTH, V65, P827, DOI 10.1093/jac/dkq061; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; Paintlia MK, 2004, J NEUROSCI RES, V78, P347, DOI 10.1002/jnr.20261; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Raghupathi R, 2007, J NEUROTRAUM, V24, P1596, DOI 10.1089/neu.2007.3790; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Simi A, 2007, BIOCHEM SOC T, V35, P1122, DOI 10.1042/BST0351122; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Thomale UW, 2006, INTENS CARE MED, V32, P149, DOI 10.1007/s00134-005-2845-4; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Vafaei AA, 2007, NEUROBIOL LEARN MEM, V88, P87, DOI 10.1016/j.nlm.2007.02.004; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wang S, 2009, AM J NEURORADIOL, V30, P1907, DOI 10.3174/ajnr.A1697; Wesierska M, 2005, J NEUROSCI, V25, P2413, DOI 10.1523/JNEUROSCI.3962-04.2005; Wesierska M, 2009, NEUROBIOL LEARN MEM, V91, P41, DOI 10.1016/j.nlm.2008.09.005; White WB, 2010, NAT REV CARDIOL, V7, P303, DOI 10.1038/nrcardio.2010.55; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8	42	52	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12490	10.1371/journal.pone.0012490	http://dx.doi.org/10.1371/journal.pone.0012490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824218	Green Published, Green Submitted, gold			2022-12-27	WOS:000281405300016
J	Noel, JT; Arrach, N; Alagely, A; McClelland, M; Teplitski, M				Noel, Jason T.; Arrach, Nabil; Alagely, Ali; McClelland, Michael; Teplitski, Max			Specific Responses of Salmonella enterica to Tomato Varieties and Fruit Ripeness Identified by In Vivo Expression Technology	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; BIOFILM FORMATION; SEROVAR TYPHIMURIUM; GENES; COLONIZATION; VIRULENCE; CURLI; INFECTION; CELLULOSE; GROWTH	Background: Recent outbreaks of vegetable-associated gastroenteritis suggest that enteric pathogens colonize, multiply and persist in plants for extended periods of time, eventually infecting people. Genetic and physiological pathways, by which enterics colonize plants, are still poorly understood. Methodology/Principal Findings: To better understand interactions between Salmonella enterica sv. Typhimurium and tomatoes, a gfp-tagged Salmonella promoter library was screened inside red ripe fruits. Fifty-one unique constructs that were potentially differentially regulated in tomato relative to in vitro growth were identified. The expression of a subset of these promoters was tested in planta using recombinase-based in vivo expression technology ( RIVET) and fitness of the corresponding mutants was tested. Gene expression in Salmonella was affected by fruit maturity and tomato cultivar. A putative fadH promoter was upregulated most strongly in immature tomatoes. Expression of the fadH construct depended on the presence of linoleic acid, which is consistent with the reduced accumulation of this compound in mature tomato fruits. The cysB construct was activated in the fruit of cv. Hawaii 7997 ( resistant to a race of Ralstonia solanacearum) more strongly than in the universally susceptible tomato cv. Bonny Best. Known Salmonella motility and animal virulence genes ( hilA, flhDC, fliF and those encoded on the pSLT virulence plasmid) did not contribute significantly to fitness of the bacteria inside tomatoes, even though deletions of sirA and motA modestly increased fitness of Salmonella inside tomatoes. Conclusions/Significance: This study reveals the genetic basis of the interactions of Salmonella with plant hosts. Salmonella relies on a distinct set of metabolic and regulatory genes, which are differentially regulated in planta in response to host genotype and fruit maturity. This enteric pathogen colonizes tissues of tomatoes differently than plant pathogens, and relies little on its animal virulence genes for persistence within the fruit.	[Noel, Jason T.; Alagely, Ali; Teplitski, Max] Univ Florida, Genet Inst, Dept Soil & Water Sci, Gainesville, FL 32611 USA; [Arrach, Nabil; McClelland, Michael] Vaccine Res Inst San Diego, La Jolla, CA USA; [Arrach, Nabil] Sanford Burnham Med Res Inst, La Jolla, CA USA; [McClelland, Michael] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA	State University System of Florida; University of Florida; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Irvine	Noel, JT (corresponding author), Univ Florida, Genet Inst, Dept Soil & Water Sci, Gainesville, FL 32611 USA.	maxtep@ufl.edu	Arrach, Nabil/AAE-6806-2020; McClelland, Michael/A-8583-2011	McClelland, Michael/0000-0003-1788-9347	Florida Tomato Council; Center for Produce Safety, University of California, Davis; California Department of Food and Agriculture under Florida Agricultural Experiment Station [SCB09052, 0208876]; BARD [IS-4267-09]; National Institutes of Health [R01AI075093-01]; Tobacco [16KT-0045]; University of Florida; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075093] Funding Source: NIH RePORTER	Florida Tomato Council; Center for Produce Safety, University of California, Davis(University of California System); California Department of Food and Agriculture under Florida Agricultural Experiment Station; BARD(US-Israel Binational Science Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco; University of Florida(University of Florida); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by Florida Tomato Council and by the Center for Produce Safety, University of California, Davis and the California Department of Food and Agriculture through Specialty Crop Block Grant Program grant # SCB09052 under CRIS project # 0208876 of Florida Agricultural Experiment Station (MT, JTN). MM was supported, in part, by BARD IS-4267-09 and National Institutes of Health grant R01AI075093-01. NA was supported by Tobacco-Related Disease Research Program grant 16KT-0045. AA acknowledges support from the University of Florida Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2007, J MOL BIOL, V368, P1215, DOI 10.1016/j.jmb.2007.02.083; AbuOun M, 2009, J BIOL CHEM, V284, P29480, DOI 10.1074/jbc.M109.005868; Ahmer BMM, 1999, J BACTERIOL, V181, P1364, DOI 10.1128/JB.181.4.1364-1368.1999; Ahmer BMM, 1999, MOL MICROBIOL, V31, P971, DOI 10.1046/j.1365-2958.1999.01244.x; Andrews-Polymenis HL, 2009, CURR OPIN BIOTECH, V20, P149, DOI 10.1016/j.copbio.2009.02.002; Arrach N, 2008, CANCER RES, V68, P4827, DOI 10.1158/0008-5472.CAN-08-0552; Barak JD, 2005, APPL ENVIRON MICROB, V71, P5685, DOI 10.1128/AEM.71.10.5685-5691.2005; Barak JD, 2008, APPL ENVIRON MICROB, V74, P5568, DOI 10.1128/AEM.01077-08; Barak JD, 2007, MOL PLANT MICROBE IN, V20, P1083, DOI 10.1094/MPMI-20-9-1083; Bidol S. A., 2007, Morbidity and Mortality Weekly Report, V56, P909; Boch J, 2002, MOL MICROBIOL, V44, P73, DOI 10.1046/j.1365-2958.2002.02877.x; Boyer RR, 2007, J FOOD PROTECT, V70, P1339, DOI 10.4315/0362-028X-70.6.1339; Brandl MT, 2006, ANNU REV PHYTOPATHOL, V44, P367, DOI 10.1146/annurev.phyto.44.070505.143359; Brown DG, 2004, MOL MICROBIOL, V53, P1641, DOI 10.1111/j.1365-2958.2004.04237.x; Carrari F, 2006, PLANT PHYSIOL, V142, P1380, DOI 10.1104/pp.106.088534; CHELLEMI DO, 1994, J AM SOC HORTIC SCI, V119, P325, DOI 10.21273/JASHS.119.2.325; Cooley MB, 2003, APPL ENVIRON MICROB, V69, P4915, DOI 10.1128/AEM.69.8.4915-4926.2003; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dong YM, 2003, APPL ENVIRON MICROB, V69, P1783, DOI 10.1128/AEM.69.3.1783-1790.2003; Fortune DR, 2006, INFECT IMMUN, V74, P331, DOI 10.1128/IAI.74.1.331-339.2006; Gallegos-Robles MA, 2008, J FOOD PROTECT, V71, P2217, DOI 10.4315/0362-028X-71.11.2217; Hubbard PA, 2003, J BIOL CHEM, V278, P37553, DOI 10.1074/jbc.M304642200; Iniguez AL, 2005, MOL PLANT MICROBE IN, V18, P169, DOI 10.1094/MPMI-18-0169; Jeter C, 2005, MOL PLANT MICROBE IN, V18, P1235, DOI 10.1094/MPMI-18-1235; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; Klerks MM, 2007, APPL ENVIRON MICROB, V73, P4905, DOI 10.1128/AEM.02522-06; Klerks MM, 2007, ISME J, V1, P620, DOI 10.1038/ismej.2007.82; Kyle JL, 2010, APPL ENVIRON MICROB, V76, P1375, DOI 10.1128/AEM.02461-09; Lapidot A, 2009, J FOOD PROTECT, V72, P618, DOI 10.4315/0362-028X-72.3.618; Lynch MF, 2009, EPIDEMIOL INFECT, V137, P307, DOI 10.1017/S0950268808001969; Marco ML, 2005, ENVIRON MICROBIOL, V7, P1379, DOI 10.1111/j.1462-2920.2005.00825.x; Mathieu S, 2009, J EXP BOT, V60, P325, DOI 10.1093/jxb/ern294; Merighi M, 2005, J BACTERIOL, V187, P7407, DOI 10.1128/JB.187.21.7407-7416.2005; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Noel JT, 2010, MOL PLANT MICROBE IN, V23, P273, DOI 10.1094/MPMI-23-3-0273; Osorio CG, 2005, INFECT IMMUN, V73, P972, DOI 10.1128/IAI.73.2.972-980.2005; OSTROWSKI J, 1991, J BACTERIOL, V173, P2212, DOI 10.1128/JB.173.7.2212-2218.1991; Prouty AM, 2002, INFECT IMMUN, V70, P2640, DOI 10.1128/IAI.70.5.2640-2649.2002; Rodionov DA, 2004, MICROBIOL-SGM, V150, P3571, DOI 10.1099/mic.0.27041-0; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Shi X, 2007, J FOOD PROTECT, V70, P2725, DOI 10.4315/0362-028X-70.12.2725; Silby MW, 2004, J BACTERIOL, V186, P7411, DOI 10.1128/JB.186.21.7411-7419.2004; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; Solomon EB, 2005, J FOOD PROTECT, V68, P906, DOI 10.4315/0362-028X-68.5.906; Tamir-Ariel D, 2007, J BACTERIOL, V189, P6359, DOI 10.1128/JB.00320-07; Teplitski M, 2003, J BACTERIOL, V185, P7257, DOI 10.1128/JB.185.24.7257-7265.2003; TEPLITSKI M, 2004, GLOBAL REGULATORY NE; Teplitski M, 2006, MICROBIOL-SGM, V152, P3411, DOI 10.1099/mic.0.29118-0; Teplitski M, 2009, CURR OPIN BIOTECH, V20, P166, DOI 10.1016/j.copbio.2009.03.002; Turnbull AL, 2008, MICROBIOL-SGM, V154, P3410, DOI 10.1099/mic.0.2008/020347-0; Wang QF, 2009, MOL MICROBIOL, V74, P71, DOI 10.1111/j.1365-2958.2009.06851.x; Zhao YF, 2005, J BACTERIOL, V187, P8088, DOI 10.1128/JB.187.23.8088-8103.2005	53	55	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12406	10.1371/journal.pone.0012406	http://dx.doi.org/10.1371/journal.pone.0012406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824208	Green Published, gold			2022-12-27	WOS:000281405300007
J	Vebo, HC; Solheim, M; Snipen, L; Nes, IF; Brede, DA				Vebo, Heidi C.; Solheim, Margrete; Snipen, Lars; Nes, Ingolf F.; Brede, Dag A.			Comparative Genomic Analysis of Pathogenic and Probiotic Enterococcus faecalis Isolates, and Their Transcriptional Responses to Growth in Human Urine	PLOS ONE			English	Article							OXIDATIVE-STRESS-RESPONSE; UROPATHOGENIC ESCHERICHIA-COLI; INTESTINAL EPITHELIAL-CELLS; BIOFILM FORMATION; VIRULENCE FACTORS; TRACT-INFECTION; STREPTOCOCCUS-FAECALIS; ANTIBIOTIC-RESISTANCE; SURFACE PROTEIN; GENE-CLUSTER	Urinary tract infection (UTI) is the most common infection caused by enterococci, and Enterococcus faecalis accounts for the majority of enterococcal infections. Although a number of virulence related traits have been established, no comprehensive genomic or transcriptomic studies have been conducted to investigate how to distinguish pathogenic from non-pathogenic E. faecalis in their ability to cause UTI. In order to identify potential genetic traits or gene regulatory features that distinguish pathogenic from non-pathogenic E. faecalis with respect to UTI, we have performed comparative genomic analysis, and investigated growth capacity and transcriptome profiling in human urine in vitro. Six strains of different origins were cultivated and all grew readily in human urine. The three strains chosen for transcriptional analysis showed an overall similar response with respect to energy and nitrogen metabolism, stress mechanism, cell envelope modifications, and trace metal acquisition. Our results suggest that citrate and aspartate are significant for growth of E. faecalis in human urine, and manganese appear to be a limiting factor. The majority of virulence factors were either not differentially regulated or down-regulated. Notably, a significant up-regulation of genes involved in biofilm formation was observed. Strains from different origins have similar capacity to grow in human urine. The overall similar transcriptional responses between the two pathogenic and the probiotic strain suggest that the pathogenic potential of a certain E. faecalis strain may to a great extent be determined by presence of fitness and virulence factors, rather than the level of expression of such traits.	[Vebo, Heidi C.; Solheim, Margrete; Nes, Ingolf F.; Brede, Dag A.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, Lab Microbial Gene Technol & Food Microbiol, As, Norway; [Snipen, Lars] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, Biostat Sect, As, Norway	Norwegian University of Life Sciences; Norwegian University of Life Sciences	Vebo, HC (corresponding author), Biopk AS Bioinkubator, Genet Anal AS, As, Norway.	dag.anders.brede@umb.no			Research Council of Norway [142656, 441392]; European Union [LSHE-CT-2007-037410]	Research Council of Norway(Research Council of Norway); European Union(European Commission)	HCV and DAB were financially supported by grants 142656 and 441392, respectively, from The Research Council of Norway, and MS by a grant from the European Union Sixth Framework Program under contract LSHE-CT-2007-037410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakra A, 2007, APPL ENVIRON MICROB, V73, P2207, DOI 10.1128/AEM.01599-06; Alteri CJ, 2007, INFECT IMMUN, V75, P2679, DOI 10.1128/IAI.00076-06; BJORK S, 1987, J BIOL CHEM, V262, P6758; Blancato VS, 2008, J BACTERIOL, V190, P7419, DOI 10.1128/JB.01704-07; Bourgogne A, 2006, J BACTERIOL, V188, P2875, DOI 10.1128/JB.188.8.2875-2884.2006; Bourgogne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r110; Brinster S, 2009, NATURE, V458, P83, DOI 10.1038/nature07772; Carlos AR, 2009, INT J FOOD MICROBIOL, V129, P194, DOI 10.1016/j.ijfoodmicro.2008.11.003; CARLOS AR, 2009, J APPL MICROBIOL; CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; Coburn PS, 2008, INFECT IMMUN, V76, P5668, DOI 10.1128/IAI.00930-08; Creti R, 2004, J MED MICROBIOL, V53, P13, DOI 10.1099/jmm.0.05353-0; Creti R, 2009, INT J ARTIF ORGANS, V32, P611, DOI 10.1177/039139880903200910; DEIBEL RH, 1964, J BACTERIOL, V87, P988, DOI 10.1128/JB.87.5.988-992.1964; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Domann E, 2007, INT J MED MICROBIOL, V297, P533, DOI 10.1016/j.ijmm.2007.02.008; Eaton TJ, 2001, APPL ENVIRON MICROB, V67, P1628, DOI 10.1128/AEM.67.4.1628-1635.2001; Elgavish A, 1996, J CELL PHYSIOL, V169, P42, DOI 10.1002/(SICI)1097-4652(199610)169:1<42::AID-JCP5>3.0.CO;2-E; Elgavish A, 2000, J CELL PHYSIOL, V182, P232, DOI 10.1002/(SICI)1097-4652(200002)182:2<232::AID-JCP12>3.3.CO;2-X; FINNE J, 1989, J BIOL CHEM, V264, P5720; Flahaut S, 1996, FEMS MICROBIOL LETT, V138, P49, DOI 10.1016/0378-1097(96)00080-8; Franz CMAP, 2001, APPL ENVIRON MICROB, V67, P4385, DOI 10.1128/AEM.67.9.4385-4389.2001; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Giard JC, 2006, FEMS IMMUNOL MED MIC, V46, P410, DOI 10.1111/j.1574-695X.2005.00049.x; Giard JC, 2002, FEMS MICROBIOL LETT, V206, P235, DOI 10.1111/j.1574-6968.2002.tb11015.x; Giard JC, 2001, ELECTROPHORESIS, V22, P2947, DOI 10.1002/1522-2683(200108)22:14&lt;2947::AID-ELPS2947&gt;3.0.CO;2-K; Giard JC, 2000, J BACTERIOL, V182, P4512, DOI 10.1128/JB.182.16.4512-4520.2000; Giard JC, 1997, RES MICROBIOL, V148, P27, DOI 10.1016/S0923-2508(97)81897-9; GROSS PA, 1976, AM J MED SCI, V272, P75, DOI 10.1097/00000441-197607000-00009; Guiton PS, 2009, INFECT IMMUN, V77, P3626, DOI 10.1128/IAI.00219-09; Guo K, 2009, ANAL CHEM, V81, P3919, DOI 10.1021/ac900166a; Hallin PF, 2008, MOL BIOSYST, V4, P363, DOI 10.1039/b717118h; Hancock L. E., 2006, Gram-positive pathogens, P299; Hancock LE, 2002, P NATL ACAD SCI USA, V99, P1574, DOI 10.1073/pnas.032448299; Hechard Y, 2001, MICROBIOL-SGM, V147, P1575, DOI 10.1099/00221287-147-6-1575; Hufnagel M, 2004, J INFECT DIS, V189, P420, DOI 10.1086/381150; HUYCKE MM, 1991, ANTIMICROB AGENTS CH, V35, P1626, DOI 10.1128/AAC.35.8.1626; IKE Y, 1984, INFECT IMMUN, V45, P528, DOI 10.1128/IAI.45.2.528-530.1984; JARVISALO J, 1992, INT ARCH OCC ENV HEA, V63, P495, DOI 10.1007/BF00572116; JETT BD, 1992, INFECT IMMUN, V60, P2445, DOI 10.1128/IAI.60.6.2445-2452.1992; Jordan S, 2008, FEMS MICROBIOL REV, V32, P107, DOI 10.1111/j.1574-6976.2007.00091.x; Jude BA, 2009, J BACTERIOL, V191, P6911, DOI 10.1128/JB.00747-09; Kau AL, 2005, INFECT IMMUN, V73, P2461, DOI 10.1128/IAI.73.4.2461-2468.2005; Kemp KD, 2007, INFECT IMMUN, V75, P5399, DOI 10.1128/IAI.00663-07; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; KREFT B, 1992, INFECT IMMUN, V60, P25, DOI 10.1128/IAI.60.1.25-30.1992; Kristich CJ, 2008, APPL ENVIRON MICROB, V74, P3377, DOI 10.1128/AEM.02665-07; La Carbona S, 2007, MOL MICROBIOL, V66, P1148, DOI 10.1111/j.1365-2958.2007.05987.x; Laplace JM, 2000, APPL MICROBIOL BIOT, V53, P685, DOI 10.1007/s002530000350; Laport MS, 2004, RES MICROBIOL, V155, P252, DOI 10.1016/j.resmic.2004.02.002; Larsen TS, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-21; Le Breton Y, 2005, J APPL MICROBIOL, V98, P806, DOI 10.1111/j.1365-2672.2004.02468.x; Le Breton Y, 2007, APPL ENVIRON MICROB, V73, P3738, DOI 10.1128/AEM.00390-07; Lempiainen H, 2005, LETT APPL MICROBIOL, V41, P341, DOI 10.1111/j.1472-765X.2005.01769.x; Lloyd AL, 2007, J BACTERIOL, V189, P3532, DOI 10.1128/JB.01744-06; Low YL, 2003, J MED MICROBIOL, V52, P113, DOI 10.1099/jmm.0.05039-0; Maadani A, 2007, INFECT IMMUN, V75, P2634, DOI 10.1128/IAI.01372-06; MACLEOD RA, 1947, J BIOL CHEM, V170, P351; MACLEOD RA, 1951, J BACTERIOL, V62, P337, DOI 10.1128/JB.62.3.337-345.1951; Mannu L, 2003, INT J FOOD MICROBIOL, V88, P291, DOI 10.1016/S0168-1605(03)00191-0; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; McBride SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000582; McBride SM, 2009, J BACTERIOL, V191, P3392, DOI 10.1128/JB.00031-09; Mesnage S, 2008, J BIOL CHEM, V283, P19845, DOI 10.1074/jbc.M802323200; Mohamed JA, 2006, J INFECT DIS, V193, P231, DOI 10.1086/498871; Mohamed JA, 2004, INFECT IMMUN, V72, P3658, DOI 10.1128/IAI.72.6.3658-3663.2004; Mohamed JA, 2007, J MED MICROBIOL, V56, P1581, DOI 10.1099/jmm.0.47331-0; MURRAY BE, 1993, J BACTERIOL, V175, P5216, DOI 10.1128/JB.175.16.5216-5223.1993; Nallapareddy SR, 2005, J BACTERIOL, V187, P5709, DOI 10.1128/JB.187.16.5709-5718.2005; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Nannini EC, 2005, INFECT IMMUN, V73, P7772, DOI 10.1128/IAI.73.11.7772-7774.2005; OLMSTED SB, 1994, J INFECT DIS, V170, P1549, DOI 10.1093/infdis/170.6.1549; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin X, 2000, INFECT IMMUN, V68, P2579, DOI 10.1128/IAI.68.5.2579-2586.2000; Riboulet E, 2007, J MOL MICROB BIOTECH, V13, P140, DOI 10.1159/000103605; Riboulet-Bisson E, 2008, INFECT IMMUN, V76, P3064, DOI 10.1128/IAI.00161-08; Riboulet-Bisson E, 2009, CURR MICROBIOL, V58, P201, DOI 10.1007/s00284-008-9308-4; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Rince A, 2001, J BACTERIOL, V183, P1482, DOI 10.1128/JB.183.4.1482-1488.2001; Rince A, 2000, INT J FOOD MICROBIOL, V55, P87, DOI 10.1016/S0168-1605(00)00180-X; ROON RJ, 1972, J BACTERIOL, V109, P44, DOI 10.1128/JB.109.1.44-50.1972; Roos V, 2006, INFECT IMMUN, V74, P3565, DOI 10.1128/IAI.01959-05; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Russo TA, 1999, INFECT IMMUN, V67, P5306, DOI 10.1128/IAI.67.10.5306-5314.1999; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Schlievert PM, 1998, INFECT IMMUN, V66, P218, DOI 10.1128/IAI.66.1.218-223.1998; Semedo T, 2003, SYST APPL MICROBIOL, V26, P13, DOI 10.1078/0723202022528942; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Shankar N, 2001, INFECT IMMUN, V69, P4366, DOI 10.1128/IAI.69.7.4366-4372.2001; Shaykhutdinov RA, 2009, METABOLOMICS, V5, P307, DOI 10.1007/s11306-009-0155-5; Shepard BD, 2002, INFECT IMMUN, V70, P4344, DOI 10.1128/IAI.70.8.4344-4352.2002; Sifri CD, 2002, INFECT IMMUN, V70, P5647, DOI 10.1128/IAI.70.10.5647-5650.2002; Sillanpaa J, 2004, MICROBIOL-SGM, V150, P2069, DOI 10.1099/mic.0.27074-0; Singh KV, 2007, J INFECT DIS, V195, P1671, DOI 10.1086/517524; Singh KV, 2009, J INFECT DIS, V200, P417, DOI 10.1086/600124; Singh KV, 1998, FEMS IMMUNOL MED MIC, V21, P323, DOI 10.1016/S0928-8244(98)00087-X; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Snipen L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-91; Solheim M, 2007, APPL ENVIRON MICROB, V73, P5767, DOI 10.1128/AEM.00651-07; Solheim M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-194; STAMEY TA, 1980, J UROLOGY, V124, P461, DOI 10.1016/S0022-5347(17)55496-8; Tasevska N, 2005, CANCER EPIDEM BIOMAR, V14, P1287, DOI 10.1158/1055-9965.EPI-04-0827; Teng F, 2005, J INFECT DIS, V191, P472, DOI 10.1086/427191; Teng F, 2002, INFECT IMMUN, V70, P2010, DOI 10.1128/IAI.70.4.2010-2015.2002; Teng F, 2002, INFECT IMMUN, V70, P1991, DOI 10.1128/IAI.70.4.1991-1996.2002; Teng F, 2009, INFECT IMMUN, V77, P3759, DOI 10.1128/IAI.00149-09; Theilacker C, 2006, INFECT IMMUN, V74, P5703, DOI 10.1128/IAI.00570-06; Theilacker C, 2009, MOL MICROBIOL, V71, P1055, DOI [10.1111/j.1365-2958.2008.06587.x, 10.1111/j.1365-2958.2009.06587.x]; Thomas VC, 2009, MOL MICROBIOL, V72, P1022, DOI 10.1111/j.1365-2958.2009.06703.x; Thurlow LR, 2009, INFECT IMMUN, V77, P5551, DOI 10.1128/IAI.00576-09; Vebo HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007660; Verneuil N, 2005, MICROBIOL-SGM, V151, P3997, DOI 10.1099/mic.0.28325-0; Verneuil N, 2005, FEMS MICROBIOL LETT, V252, P137, DOI 10.1016/j.femsle.2005.08.043; Verneuil N, 2004, INFECT IMMUN, V72, P4424, DOI 10.1128/IAI.72.8.4424-4431.2004; Verneuil N, 2006, MICROBIOL-SGM, V152, P2579, DOI 10.1099/mic.0.28922-0; Walecka E, 2009, LETT APPL MICROBIOL, V49, P79, DOI 10.1111/j.1472-765X.2009.02629.x; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Xu Y, 1998, INFECT IMMUN, V66, P4313; Xu Y, 2000, INFECT IMMUN, V68, P815, DOI 10.1128/IAI.68.2.815-823.2000	123	68	68	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12489	10.1371/journal.pone.0012489	http://dx.doi.org/10.1371/journal.pone.0012489			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824220	gold, Green Submitted, Green Published			2022-12-27	WOS:000281405300015
J	Rincon, MT; Dassa, B; Flint, HJ; Travis, AJ; Jindou, S; Borovok, I; Lamed, R; Bayer, EA; Henrissat, B; Coutinho, PM; Antonopoulos, DA; Miller, MEB; White, BA				Rincon, Marco T.; Dassa, Bareket; Flint, Harry J.; Travis, Anthony J.; Jindou, Sadanari; Borovok, Ilya; Lamed, Raphael; Bayer, Edward A.; Henrissat, Bernard; Coutinho, Pedro M.; Antonopoulos, Dion A.; Miller, Margret E. Berg; White, Bryan A.			Abundance and Diversity of Dockerin-Containing Proteins in the Fiber-Degrading Rumen Bacterium, Ruminococcus flavefaciens FD-1	PLOS ONE			English	Article							GENE-CLUSTER; CELLULOSOME; COHESIN; RUMINOCOCCUS-FLAVEFACIENS-17; ORGANIZATION; DEGRADATION; SPECIFICITY; CELLULASE; XYLANASE; DOMAINS	Background: The cellulosome is a multi-enzyme machine, which plays a key role in the breakdown of plant cell walls in many anaerobic cellulose-degrading microorganisms. Ruminococcus flavefaciens FD-1, a major fiber-degrading bacterium present in the gut of herbivores, has the most intricate cellulosomal organization thus far described. Cellulosome complexes are assembled through high-affinity cohesin-dockerin interactions. More than two-hundred dockerin-containing proteins have been identified in the R. flavefaciens genome, yet the reason for the expansion of these crucial cellulosomal components is yet unknown. Methodology/Principal Findings: We have explored the full spectrum of 222 dockerin-containing proteins potentially involved in the assembly of cellulosome-like complexes of R. flavefaciens. Bioinformatic analysis of the various dockerin modules showed distinctive conservation patterns within their two Ca2+-binding repeats and their flanking regions. Thus, we established the conceptual framework for six major groups of dockerin types, according to their unique sequence features. Within this framework, the modular architecture of the parent proteins, some of which are multi-functional proteins, was evaluated together with their gene expression levels. Specific dockerin types were found to be associated with selected groups of functional components, such as carbohydrate-binding modules, numerous peptidases, and/or carbohydrate-active enzymes. In addition, members of other dockerin groups were linked to structural proteins, e. g., cohesin-containing proteins, belonging to the scaffoldins. Conclusions/Significance: This report profiles the abundance and sequence diversity of the R. flavefaciens FD-1 dockerins, and provides the molecular basis for future understanding of the potential for a wide array of cohesin-dockerin specificities. Conserved differences between dockerins may be reflected in their stability, function or expression within the context of the parent protein, in response to their role in the rumen environment.	[Rincon, Marco T.; Flint, Harry J.; Travis, Anthony J.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Microbial Ecol Grp, Aberdeen, Scotland; [Dassa, Bareket; Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Jindou, Sadanari; Borovok, Ilya; Lamed, Raphael] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, Ramat Aviv, Israel; [Henrissat, Bernard; Coutinho, Pedro M.] CNRS, Marseille, France; [Henrissat, Bernard; Coutinho, Pedro M.] Univ Aix Marseille 1, Marseille, France; [Henrissat, Bernard; Coutinho, Pedro M.] Univ Aix Marseille 2, F-13284 Marseille 07, France; [Antonopoulos, Dion A.; Miller, Margret E. Berg; White, Bryan A.] Univ Illinois, Dept Anim Sci, N Amer Consortium Genom Fibrolyt Ruminal Bacteria, Div Nutr Sci, Urbana, IL 61801 USA	University of Aberdeen; Weizmann Institute of Science; Tel Aviv University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Illinois System; University of Illinois Urbana-Champaign	Rincon, MT (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Microbial Ecol Grp, Aberdeen, Scotland.	h.flint@abdn.ac.uk	Henrissat, Bernard/J-2475-2012; Antonopoulos, Dionysios/ABE-6212-2020; BOROVOK, ILYA/ABB-7370-2022; Rincon, Marco T/T-4798-2019	Henrissat, Bernard/0000-0002-3434-8588; Antonopoulos, Dionysios/0000-0002-2238-5031; Berg, Margret/0000-0002-0411-1619; Travis, Anthony/0000-0001-9895-8310; BOROVOK, ILYA/0000-0003-1602-4499	Scottish Government Rural and Environment Research and Analysis Directorate; United States Department of Agriculture [2002-35206-11634]; United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel; Israel Science Foundation [966/09, 159/07]	Scottish Government Rural and Environment Research and Analysis Directorate; United States Department of Agriculture(United States Department of Agriculture (USDA)); United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation)	The Rowett Institute receives support from the Scottish Government Rural and Environment Research and Analysis Directorate. This work was supported by a United States Department of Agriculture grant for Functional Genomics of Ruminococcus flavefaciens FD-1 (Grant No. 2002-35206-11634). Additional support from the United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel, and the Israel Science Foundation (Grant Nos. 966/09 and 159/07) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aurilia V, 2000, MICROBIOL-SGM, V146, P1391, DOI 10.1099/00221287-146-6-1391; Aurilia V, 2000, ANAEROBE, V6, P333, DOI 10.1006/anae.2000.0358; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Bayer EA, 2008, CHEM REC, V8, P364, DOI 10.1002/tcr.20160; BRYANT MP, 1958, J BACTERIOL, V76, P529, DOI 10.1128/JB.76.5.529-537.1958; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; DEHORITY BA, 1967, J DAIRY SCI, V50, P1136, DOI 10.3168/jds.S0022-0302(67)87579-9; Ding SY, 2001, J BACTERIOL, V183, P1945, DOI 10.1128/JB.183.6.1945-1953.2001; DOERNER KC, 1990, APPL ENVIRON MICROB, V56, P1844, DOI 10.1128/AEM.56.6.1844-1850.1990; Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925; Flint HJ, 2008, ANN NY ACAD SCI, V1125, P280, DOI 10.1196/annals.1419.022; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; FLINT HJ, 1989, APPL ENVIRON MICROB, V55, P1230, DOI 10.1128/AEM.55.5.1230-1233.1989; FLINT HJ, 1993, J BACTERIOL, V175, P2943, DOI 10.1128/JB.175.10.2943-2951.1993; GARDNER RM, 1987, J BACTERIOL, V169, P4581, DOI 10.1128/jb.169.10.4581-4588.1987; Jindou S, 2008, FEMS MICROBIOL LETT, V285, P188, DOI 10.1111/j.1574-6968.2008.01234.x; Jindou S, 2006, J BACTERIOL, V188, P7971, DOI 10.1128/JB.00973-06; Kirby J, 1997, FEMS MICROBIOL LETT, V149, P213, DOI 10.1111/j.1574-6968.1997.tb10331.x; LAMED R, 1987, J BACTERIOL, V169, P3792, DOI 10.1128/jb.169.8.3792-3800.1987; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Pages S, 1997, PROTEINS, V29, P517, DOI 10.1002/(SICI)1097-0134(199712)29:4<517::AID-PROT11>3.3.CO;2-I; Peer A, 2009, FEMS MICROBIOL LETT, V291, P1, DOI 10.1111/j.1574-6968.2008.01420.x; PETTIPHER GL, 1979, J GEN MICROBIOL, V110, P21, DOI 10.1099/00221287-110-1-21; RASMUSSEN MA, 1988, APPL ENVIRON MICROB, V54, P890, DOI 10.1128/AEM.54.4.890-897.1988; Rincon MT, 2007, J BACTERIOL, V189, P4774, DOI 10.1128/JB.00143-07; Rincon MT, 2005, J BACTERIOL, V187, P7569, DOI 10.1128/JB.187.22.7569-7578.2005; Rincon MT, 2004, J BACTERIOL, V186, P2576, DOI 10.1128/JB.186.9.2576-2585.2004; Rincon MT, 2003, J BACTERIOL, V185, P703, DOI 10.1128/JB.185.3.703-713.2003; Rincon MT, 2001, APPL ENVIRON MICROB, V67, P4426, DOI 10.1128/AEM.67.10.4426-4431.2001; SIJPESTEIJN AK, 1951, J GEN MICROBIOL, V5, P869, DOI 10.1099/00221287-5-5-869; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WOOD TM, 1982, BIOCHEM J, V205, P129, DOI 10.1042/bj2050129	34	55	55	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12476	10.1371/journal.pone.0012476	http://dx.doi.org/10.1371/journal.pone.0012476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20814577	Green Published, Green Submitted, gold			2022-12-27	WOS:000281375500009
J	Close, DM; Patterson, SS; Ripp, S; Baek, SJ; Sanseverino, J; Sayler, GS				Close, Dan M.; Patterson, Stacey S.; Ripp, Steven; Baek, Seung J.; Sanseverino, John; Sayler, Gary S.			Autonomous Bioluminescent Expression of the Bacterial Luciferase Gene Cassette (lux) in a Mammalian Cell Line	PLOS ONE			English	Article							IN-VIVO; CODON OPTIMIZATION; SACCHAROMYCES-CEREVISIAE; FIREFLY LUCIFERASES; FUSION; ALDEHYDE; LUMINESCENCE; EFFICIENCY; YEAST	Background: The bacterial luciferase (lux) gene cassette consists of five genes (luxCDABE) whose protein products synergistically generate bioluminescent light signals exclusive of supplementary substrate additions or exogenous manipulations. Historically expressible only in prokaryotes, the lux operon was re-synthesized through a process of multi-bicistronic, codon-optimization to demonstrate for the first time self-directed bioluminescence emission in a mammalian HEK293 cell line in vitro and in vivo. Methodology/Principal Findings: Autonomous in vitro light production was shown to be 12-fold greater than the observable background associated with untransfected control cells. The availability of reduced riboflavin phosphate (FMNH2) was identified as the limiting bioluminescence substrate in the mammalian cell environment even after the addition of a constitutively expressed flavin reductase gene (frp) from Vibrio harveyi. FMNH2 supplementation led to a 151-fold increase in bioluminescence in cells expressing mammalian codon-optimized luxCDE and frp genes. When injected subcutaneously into nude mice, in vivo optical imaging permitted near instantaneous light detection that persisted independently for the 60 min length of the assay with negligible background. Conclusions/Significance: The speed, longevity, and self-sufficiency of lux expression in the mammalian cellular environment provides a viable and powerful alternative for real-time target visualization not currently offered by existing bioluminescent and fluorescent imaging technologies.	[Close, Dan M.; Patterson, Stacey S.; Ripp, Steven; Sanseverino, John; Sayler, Gary S.] Univ Tennessee, Ctr Environm Biotechnol, Knoxville, TN 37932 USA; [Baek, Seung J.] Univ Tennessee, Coll Vet Med, Dept Pathobiol, Knoxville, TN 37932 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Close, DM (corresponding author), Univ Tennessee, Ctr Environm Biotechnol, Knoxville, TN 37932 USA.	sayler@utk.edu	Close, Dan/A-4417-2012; Ripp, Steven/B-2305-2008; Ripp, Steven/AAU-1225-2021	Ripp, Steven/0000-0002-6836-1764; Ripp, Steven/0000-0002-6836-1764; Sanseverino, John/0000-0002-2693-9521; Close, Dan/0000-0003-4790-4448	National Institutes of Health, National Cancer Institute [CA127745-01]; National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET) [CBET-0853780]; Army Defense University; NATIONAL CANCER INSTITUTE [R21CA127745] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET)(National Science Foundation (NSF)); Army Defense University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health, National Cancer Institute, Cancer Imaging Program, award number CA127745-01, the National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET) under award number CBET-0853780, and the Army Defense University Research Instrumentation Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMASHANU S, 1990, J BIOLUM CHEMILUM, V5, P89, DOI 10.1002/bio.1170050204; Baggett B, 2004, MOL IMAGING, V3, P324, DOI 10.1162/1535350042973553; Barrett JW, 2006, VIRUS GENES, V33, P15, DOI 10.1007/s11262-005-0035-7; Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; Bloch S, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2070148; COLEPICOLO P, 1989, APPL ENVIRON MICROB, V55, P2601, DOI 10.1128/AEM.55.10.2601-2606.1989; Contag CH, 1995, MOL MICROBIOL, V18, P593, DOI 10.1111/j.1365-2958.1995.mmi_18040593.x; Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336; DUNN DK, 1973, BIOCHEMISTRY-US, V12, P4911, DOI 10.1021/bi00748a016; ESCHER A, 1989, P NATL ACAD SCI USA, V86, P6528, DOI 10.1073/pnas.86.17.6528; Gupta RK, 2003, FEMS YEAST RES, V4, P305, DOI 10.1016/S1567-1356(03)00174-0; Hollis RP, 2001, FEBS LETT, V506, P140, DOI 10.1016/S0014-5793(01)02905-2; Inoue Y, 2009, EUR J NUCL MED MOL I, V36, P771, DOI 10.1007/s00259-008-1022-8; Kalchenko V, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2364903; Kim CH, 1997, GENE, V199, P293, DOI 10.1016/S0378-1119(97)00384-3; Kim JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009364; KIRCHNER G, 1989, GENE, V81, P349, DOI 10.1016/0378-1119(89)90195-9; KONCZ C, 1987, P NATL ACAD SCI USA, V84, P131, DOI 10.1073/pnas.84.1.131; Mechold U, 2005, J BIOTECHNOL, V116, P245, DOI 10.1016/j.jbiotec.2004.12.003; MEIGHEN EA, 1991, MICROBIOL REV, V55, P123, DOI 10.1128/MMBR.55.1.123-142.1991; MEIGHEN EA, 1976, BIOCHEM BIOPH RES CO, V69, P423, DOI 10.1016/0006-291X(76)90539-8; OLSSON O, 1989, GENE, V81, P335, DOI 10.1016/0378-1119(89)90194-7; Oshiro M, 1998, METHOD CELL BIOL, V56, P45, DOI 10.1016/S0091-679X(08)60420-3; Patterson SS, 2005, J IND MICROBIOL BIOT, V32, P115, DOI 10.1007/s10295-005-0211-8; PAZZAGLI M, 1992, ANAL BIOCHEM, V204, P315, DOI 10.1016/0003-2697(92)90245-3; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Slimko EM, 2003, J NEUROSCI METH, V124, P75, DOI 10.1016/S0165-0270(02)00362-X; Szittner R, 2003, BIOCHEM BIOPH RES CO, V309, P66, DOI 10.1016/S0006-291X(03)01530-4; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vo-Dinh T, 2014, BIOMED PHOTONICS, DOI 10.1201/9780203008997-38; Welham PA, 2009, MOL BIOSYST, V5, P68, DOI 10.1039/b812094c; Westerlund-Karlsson A, 2002, BIOCHEM BIOPH RES CO, V296, P1072, DOI 10.1016/S0006-291X(02)02052-1; Zhao H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032388	33	95	98	6	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12441	10.1371/journal.pone.0012441	http://dx.doi.org/10.1371/journal.pone.0012441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805991	Green Published, gold			2022-12-27	WOS:000281301500010
J	Egger, JR; Konty, KJ; Borrelli, JM; Cummiskey, J; Blank, S				Egger, Joseph R.; Konty, Kevin J.; Borrelli, Jessica M.; Cummiskey, Julia; Blank, Susan			Monitoring Temporal Changes in the Specificity of an Oral HIV Test: A Novel Application for Use in Postmarketing Surveillance	PLOS ONE			English	Article							NEW-YORK-CITY	Background: Postmarketing surveillance is routinely conducted to monitor performance of pharmaceuticals and testing devices in the marketplace. However, these surveillance methods are often done retrospectively and, as a result, are not designed to detect issues with performance in real-time. Methods and Findings: Using HIV antibody screening test data from New York City STD clinics, we developed a formal, statistical method of prospectively detecting temporal clusters of poor performance of a screening test. From 2005 to 2008, New York City, as well as other states, observed unexpectedly high false-positive (FP) rates in an oral fluid-based rapid test used for screening HIV. We attempted to formally assess whether the performance of this HIV screening test statistically deviated from both local expectation and the manufacturer's claim for the test. Results indicate that there were two significant temporal clusters in the FP rate of the oral HIV test, both of which exceeded the manufacturer's upper limit of the 95% CI for the product. Furthermore, the FP rate of the test varied significantly by both STD clinic and test lot, though not by test operator. Conclusions: Continuous monitoring of surveillance data has the benefit of providing information regarding test performance, and if conducted in real-time, it can enable programs to examine reasons for poor test performance in close proximity to the occurrence. Techniques used in this study could be a valuable addition for postmarketing surveillance of test performance and may become particularly important with the increase in rapid testing methods.	[Egger, Joseph R.; Konty, Kevin J.] New York City Dept Hlth & Mental Hyg, Bur Epidemiol Serv, New York, NY USA; [Borrelli, Jessica M.; Cummiskey, Julia; Blank, Susan] New York City Dept Hlth & Mental Hyg, Bur STD Prevent & Control, New York, NY USA; [Blank, Susan] US Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA USA	New York City Department of Health & Mental Hygiene; New York City Department of Health & Mental Hygiene; Centers for Disease Control & Prevention - USA	Egger, JR (corresponding author), New York City Dept Hlth & Mental Hyg, Bur Epidemiol Serv, New York, NY USA.	jegger@health.nyc.gov						[Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P826; *CDCP, 2007, QUAL ASS GUID TEST U; ELMORE JG, 1994, NEW ENGL J MED, V331, P1493, DOI 10.1056/NEJM199412013312206; Gottlieb S, 2005, HEALTH AFFAIR, V24, P938, DOI 10.1377/hlthaff.24.4.938; Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646; Henning Kelly J, 2004, MMWR Suppl, V53, P5; Jafa K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000185; Jelinek T, 1999, J CLIN MICROBIOL, V37, P721, DOI 10.1128/JCM.37.3.721-723.1999; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; *ORASURE TECHN 1, 2009, ORAQUICK ADV RAP HIV; U.S. Food and Drug Administration, 2009, POSTM SURV PROGR; Wesolowski LG, 2006, AIDS, V20, P1661, DOI 10.1097/01.aids.0000238413.13442.ed; 2008, MMWR MORB MORTAL WKL, V57, P660	13	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12231	10.1371/journal.pone.0012231	http://dx.doi.org/10.1371/journal.pone.0012231			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811502	Green Published, Green Submitted, gold			2022-12-27	WOS:000281234700003
J	Pairet, B; Jaenicke, E				Pairet, Bruno; Jaenicke, Elmar			Structure of the Altitude Adapted Hemoglobin of Guinea Pig in the R2-State	PLOS ONE			English	Article							HIGH OXYGEN-AFFINITY; QUATERNARY STRUCTURE; DEOXY HUMAN; DEER MOUSE; ADAPTATION; BINDING; 2,3-DIPHOSPHOGLYCERATE; OXYHEMOGLOBIN; RESPIRATION; MECHANISM	Background: Guinea pigs are considered to be genetically adapted to a high altitude environment based on the consistent finding of a high oxygen affinity of their blood. Methodology/Principal Findings: The crystal structure of guinea pig hemoglobin at 1.8 angstrom resolution suggests that the increased oxygen affinity of guinea pig hemoglobin can be explained by two factors, namely a decreased stability of the T-state and an increased stability of the R2-state. The destabilization of the T-state can be related to the substitution of a highly conserved proline (P44) to histidine (H44) in the alpha-subunit, which causes a steric hindrance with H97 of the beta-subunit in the switch region. The stabilization of the R2-state is caused by two additional salt bridges at the beta 1/beta 2 interface. Conclusions/Significance: Both factors together are supposed to serve to shift the equilibrium between the conformational states towards the high affinity relaxed states resulting in an increased oxygen affinity.	[Pairet, Bruno; Jaenicke, Elmar] Johannes Gutenberg Univ Mainz, Inst Mol Biophys, Mainz, Germany	Johannes Gutenberg University of Mainz	Pairet, B (corresponding author), Johannes Gutenberg Univ Mainz, Inst Mol Biophys, Mainz, Germany.	elmar.jaenicke@uni-mainz.de	Jaenicke, Elmar/A-5317-2010	Jaenicke, Elmar/0000-0002-5157-7219	International Graduate School of Immunotherapy (DFG) [1043]; Computational Science Mainz (CSM)	International Graduate School of Immunotherapy (DFG)(German Research Foundation (DFG)); Computational Science Mainz (CSM)	B.P. thanks the International Graduate School of Immunotherapy (Graduiertenkolleg 1043, DFG) and the Computational Science Mainz (CSM) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1968, J CRYST GROWTH, DOI [rg/10.1016/00220248(68)900717, DOI 10.1016/0022-0248(68)90071-7]; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALDWIN J, 1979, J MOL BIOL, V129, P175, DOI 10.1016/0022-2836(79)90277-8; BARD H, 1979, PEDIATR RES, V13, P167, DOI 10.1203/00006450-197903000-00006; BARTELS H, 1969, RESP PHYSIOL, V7, P278, DOI 10.1016/0034-5687(69)90011-5; BAUER C, 1980, J COMP PHYSIOL, V136, P67, DOI 10.1007/BF00688624; BRAUNITZER G, 1979, H-S Z PHYSIOL CHEM, V360, P1941; BUNN HF, 1971, SCIENCE, V172, P1049, DOI 10.1126/science.172.3987.1049; Dickerson R.E., 1983, HEMOGLOBIN STRUCTURE; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HARANO T, 1982, HEMOGLOBIN, V6, P43, DOI 10.3109/03630268208996932; HONIG GR, 1980, BIOCHIM BIOPHYS ACTA, V626, P424, DOI 10.1016/0005-2795(80)90138-5; Jaenicke E, 2009, PROTEIN PEPTIDE LETT, V16, P444, DOI 10.2174/092986609787847983; JESSEN TH, 1991, P NATL ACAD SCI USA, V88, P6519, DOI 10.1073/pnas.88.15.6519; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KLEINSCHMIDT T, 1986, BIOL CHEM H-S, V367, P153, DOI 10.1515/bchm3.1986.367.1.153; Lukin JA, 2003, P NATL ACAD SCI USA, V100, P517, DOI 10.1073/pnas.232715799; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Ostojic H, 2002, BIOL RES, V35, P27, DOI 10.4067/S0716-97602002000100005; Paoli M, 2004, HDB METALLOPROTEINS, P1; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; PERUTZ MF, 1968, NATURE, V219, P131, DOI 10.1038/219131a0; PICCININI M, 1990, BIOL CHEM H-S, V371, P641, DOI 10.1515/bchm3.1990.371.2.641; Rivera M, 1995, COMP BIOCHEM PHYS A, V112, P411, DOI 10.1016/0300-9629(95)02008-X; Schumacher MA, 1997, P NATL ACAD SCI USA, V94, P7841, DOI 10.1073/pnas.94.15.7841; SHAANAN B, 1983, J MOL BIOL, V171, P31, DOI 10.1016/S0022-2836(83)80313-1; SILVA MM, 1992, J BIOL CHEM, V267, P17248; SNYDER LRG, 1988, EVOLUTION, V42, P689, DOI 10.1111/j.1558-5646.1988.tb02487.x; SRINIVASAN R, 1994, P NATL ACAD SCI USA, V91, P11113, DOI 10.1073/pnas.91.23.11113; Storz JF, 2008, HIGH ALT MED BIOL, V9, P148, DOI 10.1089/ham.2007.1079; Storz JF, 2009, P NATL ACAD SCI USA, V106, P14450, DOI 10.1073/pnas.0905224106; Tame JRH, 2000, ACTA CRYSTALLOGR D, V56, P805, DOI 10.1107/S0907444900006387; TUREK Z, 1978, PFLUG ARCH EUR J PHY, V376, P7, DOI 10.1007/BF00585241; TUREK Z, 1980, PFLUG ARCH EUR J PHY, V384, P109, DOI 10.1007/BF00584425; Weber RE, 2007, RESP PHYSIOL NEUROBI, V158, P132, DOI 10.1016/j.resp.2007.05.001; Winslow RM, 2007, RESP PHYSIOL NEUROBI, V158, P121, DOI 10.1016/j.resp.2007.03.011; Yokoyama T, 2006, J MOL BIOL, V356, P790, DOI 10.1016/j.jmb.2005.12.018	37	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12389	10.1371/journal.pone.0012389	http://dx.doi.org/10.1371/journal.pone.0012389			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20811494	gold, Green Submitted, Green Published			2022-12-27	WOS:000281154300017
J	Dhami, P; Saffrey, P; Bruce, AW; Dillon, SC; Chiang, K; Bonhoure, N; Koch, CM; Bye, J; James, K; Foad, NS; Ellis, P; Watkins, NA; Ouwehand, WH; Langford, C; Andrews, RM; Dunham, I; Vetrie, D				Dhami, Pawandeep; Saffrey, Peter; Bruce, Alexander W.; Dillon, Shane C.; Chiang, Kelly; Bonhoure, Nicolas; Koch, Christoph M.; Bye, Jackie; James, Keith; Foad, Nicola S.; Ellis, Peter; Watkins, Nicholas A.; Ouwehand, Willem H.; Langford, Cordelia; Andrews, Robert M.; Dunham, Ian; Vetrie, David			Complex Exon-Intron Marking by Histone Modifications Is Not Determined Solely by Nucleosome Distribution	PLOS ONE			English	Article							HUMAN GENOME; TRANSCRIPTION ELONGATION; CHROMATIN SIGNATURES; CELL-LINE; IN-VITRO; ELEMENTS; REGIONS; GENES; POLYADENYLATION; METHYLATIONS	It has recently been shown that nucleosome distribution, histone modifications and RNA polymerase II (Pol II) occupancy show preferential association with exons ("exon-intron marking"), linking chromatin structure and function to co-transcriptional splicing in a variety of eukaryotes. Previous ChIP-sequencing studies suggested that these marking patterns reflect the nucleosomal landscape. By analyzing ChIP-chip datasets across the human genome in three cell types, we have found that this marking system is far more complex than previously observed. We show here that a range of histone modifications and Pol II are preferentially associated with exons. However, there is noticeable cell-type specificity in the degree of exon marking by histone modifications and, surprisingly, this is also reflected in some histone modifications patterns showing biases towards introns. Exon-intron marking is laid down in the absence of transcription on silent genes, with some marking biases changing or becoming reversed for genes expressed at different levels. Furthermore, the relationship of this marking system with splicing is not simple, with only some histone modifications reflecting exon usage/inclusion, while others mirror patterns of exon exclusion. By examining nucleosomal distributions in all three cell types, we demonstrate that these histone modification patterns cannot solely be accounted for by differences in nucleosome levels between exons and introns. In addition, because of inherent differences between ChIP-chip array and ChIP-sequencing approaches, these platforms report different nucleosome distribution patterns across the human genome. Our findings confound existing views and point to active cellular mechanisms which dynamically regulate histone modification levels and account for exon-intron marking. We believe that these histone modification patterns provide links between chromatin accessibility, Pol II movement and co-transcriptional splicing.	[Dhami, Pawandeep; Bruce, Alexander W.; Dillon, Shane C.; Koch, Christoph M.; Bye, Jackie; James, Keith; Ellis, Peter; Ouwehand, Willem H.; Langford, Cordelia; Andrews, Robert M.; Dunham, Ian; Vetrie, David] Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Hinxton, England; [Saffrey, Peter; Chiang, Kelly; Bonhoure, Nicolas; Vetrie, David] Univ Glasgow, Inst Canc Sci, Glasgow G12 8QQ, Lanark, Scotland; [Foad, Nicola S.; Watkins, Nicholas A.; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge, England	Wellcome Trust Sanger Institute; University of Glasgow; University of Cambridge	Dhami, P (corresponding author), UCL, Inst Canc, London, England.	dlv1q@clinmed.gla.ac.uk	Bruce, Alexander W/H-4235-2014; Dillon, Shane/A-2280-2011	Bruce, Alexander W/0000-0003-4297-4412; Vetrie, David/0000-0003-2075-4662; Andrews, Robert/0000-0002-3491-2361; Koch, Christof/0000-0001-6482-8067; Dunham, Ian/0000-0003-2525-5598; Ouwehand, Willem/0000-0002-7744-1790	Wellcome Trust; National Institute for Health Research in England; National Human Genome Research Institute [U01HG003168]; Ministry of Education, Czech Republic [6007665801]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG003168] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research in England; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Ministry of Education, Czech Republic(Ministry of Education, Youth & Sports - Czech RepublicCzech Republic Government); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The Wellcome Trust (http://www.wellcome.ac.uk/); The National Institute for Health Research in England (http://www.nihr.ac.uk/Pages/default.aspx); The National Human Genome Research Institute (http://www.genome.gov/) Grant No: U01HG003168; Ministry of Education, Czech Republic Grant No. 6007665801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand E, 2008, CURR OPIN GENET DEV, V18, P145, DOI 10.1016/j.gde.2008.01.006; Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Auerbach RK, 2009, P NATL ACAD SCI USA, V106, P14926, DOI 10.1073/pnas.0905443106; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bruce AW, 2006, J NEUROCHEM, V98, P1828, DOI 10.1111/j.1471-4159.2006.04010.x; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; DHAMI P, PLOS ONE, V5, pE9059; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Forsberg EC, 2000, P NATL ACAD SCI USA, V97, P14494, DOI 10.1073/pnas.97.26.14494; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Howe KJ, 2003, RNA, V9, P993, DOI 10.1261/rna.5390803; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LARRICK JW, 1980, J IMMUNOL, V125, P6; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; LOZZIO BB, 1979, LEUKEMIA RES, V3, P363, DOI 10.1016/0145-2126(79)90033-X; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Nagy PL, 2003, P NATL ACAD SCI USA, V100, P6364, DOI 10.1073/pnas.1131966100; Nahkuri S, 2009, CELL CYCLE, V8, P3420, DOI 10.4161/cc.8.20.9916; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; Park NJ, 2004, MOL CELL BIOL, V24, P4092, DOI 10.1128/MCB.24.10.4092-4103.2004; Robson-Dixon ND, 2004, J BIOL CHEM, V279, P29075, DOI 10.1074/jbc.M312747200; Schor IE, 2009, P NATL ACAD SCI USA, V106, P4325, DOI 10.1073/pnas.0810666106; Schwartz S, 2010, EMBO J, V29, P1629, DOI 10.1038/emboj.2010.71; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Tyagi A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000470; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Yonaha M, 1999, MOL CELL, V3, P593, DOI 10.1016/S1097-2765(00)80352-4	49	48	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12339	10.1371/journal.pone.0012339	http://dx.doi.org/10.1371/journal.pone.0012339			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808788	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000281153500019
J	Lawson, VA; Lumicisi, B; Welton, J; Machalek, D; Gouramanis, K; Klemm, HM; Stewart, JD; Masters, CL; Hoke, DE; Collins, SJ; Hill, AF				Lawson, Victoria A.; Lumicisi, Brooke; Welton, Jeremy; Machalek, Dorothy; Gouramanis, Katrina; Klemm, Helen M.; Stewart, James D.; Masters, Colin L.; Hoke, David E.; Collins, Steven J.; Hill, Andrew F.			Glycosaminoglycan Sulphation Affects the Seeded Misfolding of a Mutant Prion Protein	PLOS ONE			English	Article							UNIFYING ELECTROSTATIC MECHANISM; CREUTZFELDT-JAKOB-DISEASE; INTRAVENTRICULAR PENTOSAN POLYSULFATE; SPONGIFORM ENCEPHALOPATHY AGENT; CELL-FREE FORMATION; HEPARAN-SULFATE; LIPID-MEMBRANES; IN-VITRO; NUCLEOCAPSID PROTEIN; AMYLOID PLAQUES	Background: The accumulation of protease resistant conformers of the prion protein (PrP(res)) is a key pathological feature of prion diseases. Polyanions, including RNA and glycosaminoglycans have been identified as factors that contribute to the propagation, transmission and pathogenesis of prion disease. Recent studies have suggested that the contribution of these cofactors to prion propagation may be species specific. Methodology/Principal Finding: In this study a cell-free assay was used to investigate the molecular basis of polyanion stimulated PrP(res) formation using brain tissue or cell line derived murine PrP. Enzymatic depletion of endogenous nucleic acids or heparan sulphate (HS) from the PrP(C) substrate was found to specifically prevent PrP(res) formation seeded by mouse derived PrP(Sc). Modification of the negative charge afforded by the sulphation of glycosaminoglycans increased the ability of a familial PrP mutant to act as a substrate for PrP(res) formation, while having no effect on PrP(res) formed by wildtype PrP. This difference may be due to the observed differences in the binding of wild type and mutant PrP for glycosaminoglycans. Conclusions/Significance: Cofactor requirements for PrP(res) formation are host species and prion strain specific and affected by disease associated mutations of the prion protein. This may explain both species and strain dependent propagation characteristics and provide insights into the underlying mechanisms of familial prion disease. It further highlights the challenge of designing effective therapeutics against a disease which effects a range of mammalian species, caused by range of aetiologies and prion strains.	[Lawson, Victoria A.; Lumicisi, Brooke; Welton, Jeremy; Machalek, Dorothy; Gouramanis, Katrina; Klemm, Helen M.; Stewart, James D.; Collins, Steven J.; Hill, Andrew F.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Hill, Andrew F.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Hill, Andrew F.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Lawson, Victoria A.; Masters, Colin L.; Collins, Steven J.; Hill, Andrew F.] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3052, Australia; [Hoke, David E.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	University of Melbourne; University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Monash University	Lawson, VA (corresponding author), Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia.	vlawson@unimelb.edu.au; afhill@unimelb.edu.au	Hill, Andrew F/B-4527-2009; Hill, Andrew F./GZL-4124-2022; Lawson, Victoria/AAJ-7392-2021; Hill, Andrew F./AAH-2854-2020; Welton, Jeremy/AAH-4120-2019	Hill, Andrew F/0000-0001-5581-2354; Hill, Andrew F./0000-0001-5581-2354; Welton, Jeremy/0000-0002-9446-9162; Stewart, James/0000-0002-1774-8619; Lawson, Victoria/0000-0002-7362-7176; Machalek, Dorothy/0000-0002-4101-8085	National Health and Medical Research Council (NHMRC) [400229, 400183]; University of Melbourne Research Grant Scheme; University of Melbourne; Faculty of Medicine, University of Melbourne	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne Research Grant Scheme(University of Melbourne); University of Melbourne(University of Melbourne); Faculty of Medicine, University of Melbourne(University of Melbourne)	This work was supported by National Health and Medical Research Council (NHMRC) Project Grant #400229 and The University of Melbourne Research Grant Scheme. VAL is the recipient of an NHMRC Howard Florey Fellowship and University of Melbourne CR Roper Fellowship. AFH is the recipient of an NHMRC RD Wright Career Development Award, and SJC is a recipient of an NHMRC Practitioner Fellowship #400183. JW is the recipient of the Mary Stewart Bursary from the Faculty of Medicine, University of Melbourne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjou KT, 2003, J GEN VIROL, V84, P2595, DOI 10.1099/vir.0.19073-0; Adler V, 2003, J MOL BIOL, V332, P47, DOI 10.1016/S0022-2836(03)00919-7; BAEUERLE PA, 1986, BIOCHEM BIOPH RES CO, V141, P870, DOI 10.1016/S0006-291X(86)80253-4; Ben-Zaken O, 2003, J BIOL CHEM, V278, P40041, DOI 10.1074/jbc.M301152200; Bone I, 2008, EUR J NEUROL, V15, P458, DOI 10.1111/j.1468-1331.2008.02108.x; Brazier MW, 2006, BRAIN RES BULL, V68, P346, DOI 10.1016/j.brainresbull.2005.09.010; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Cappai R, 1999, BIOCHEMISTRY-US, V38, P3280, DOI 10.1021/bi982328z; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; CHRISTOFINIS GJ, 1968, J PATHOL BACTERIOL, V95, P377, DOI 10.1002/path.1700950204; Collins SJ, 2004, LANCET, V363, P51, DOI 10.1016/S0140-6736(03)15171-9; Courageot MP, 2008, J GEN VIROL, V89, P341, DOI 10.1099/vir.0.83344-0; Critchley P, 2004, BIOCHEM BIOPH RES CO, V313, P559, DOI 10.1016/j.bbrc.2003.12.004; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; DELEAULT NR, BIOCHEMISTRY, V49, P3928; Derrington E, 2002, CR BIOL, V325, P17, DOI 10.1016/S1631-0691(02)01388-4; Doh-Ura K, 2004, J VIROL, V78, P4999, DOI 10.1128/JVI.78.10.4999-5006.2004; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; GABIZON R, 1993, J CELL PHYSIOL, V157, P319, DOI 10.1002/jcp.1041570215; Gabus C, 2001, J BIOL CHEM, V276, P19301, DOI 10.1074/jbc.M009754200; Gabus C, 2001, J MOL BIOL, V307, P1011, DOI 10.1006/jmbi.2001.4544; Gonzalez-Iglesias R, 2002, J MOL BIOL, V319, P527, DOI 10.1016/S0022-2836(02)00341-8; Hijazi N, 2005, J BIOL CHEM, V280, P17057, DOI 10.1074/jbc.M411314200; Horonchik L, 2005, J BIOL CHEM, V280, P17062, DOI 10.1074/jbc.M500122200; Kazlauskaite J, 2005, BIOCHEM SOC SYMP, V72, P211, DOI 10.1042/bss0720211; Kazlauskaite J, 2003, BIOCHEMISTRY-US, V42, P3295, DOI 10.1021/bi026872q; KIM JI, J BIOL CHEM, V285, P14087; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Kovacic P, 2008, J RECEPT SIG TRANSD, V28, P153, DOI [10.1080/10799890802084234, 10.1080/10799890802084234 ]; Kovacic P, 2007, J RECEPT SIG TRANSD, V27, P411, DOI 10.1080/10799890701699686; Kovacic P, 2007, J RECEPT SIG TRANSD, V27, P433, DOI 10.1080/10799890701699702; Lawson VA, 2008, INT J BIOCHEM CELL B, V40, P2793, DOI 10.1016/j.biocel.2008.05.024; Lawson VA, 2007, J GEN VIROL, V88, P2905, DOI 10.1099/vir.0.82961-0; Lee KS, 2007, P NATL ACAD SCI USA, V104, P9551, DOI 10.1073/pnas.0703910104; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lehmann S, 1996, J BIOL CHEM, V271, P1633, DOI 10.1074/jbc.271.3.1633; Lucassen R, 2003, BIOCHEMISTRY-US, V42, P4127, DOI 10.1021/bi027218d; Manson JC, 2000, ARCH VIROL, P95; Moore RA, 2006, PROTEIN SCI, V15, P609, DOI 10.1110/ps.051822606; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; Nandi PK, 2004, J MOL BIOL, V344, P827, DOI 10.1016/j.jmb.2004.09.080; Nandi PK, 2002, J MOL BIOL, V322, P153, DOI 10.1016/S0022-2836(02)00750-7; Nishina K, 2004, J BIOL CHEM, V279, P40788, DOI 10.1074/jbc.M406548200; Papakonstantinou E, 1999, ARCH BIOCHEM BIOPHYS, V370, P250, DOI 10.1006/abbi.1999.1405; Paquet S, 2007, J VIROL, V81, P10786, DOI 10.1128/JVI.01137-07; Parry A, 2007, J NEUROL NEUROSUR PS, V78, P733, DOI 10.1136/jnnp.2006.104505; Proske D, 2002, CHEMBIOCHEM, V3, P717, DOI 10.1002/1439-7633(20020802)3:8<717::AID-CBIC717>3.0.CO;2-C; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Safaiyan F, 1999, J BIOL CHEM, V274, P36267, DOI 10.1074/jbc.274.51.36267; Sanghera N, 2002, J MOL BIOL, V315, P1241, DOI 10.1006/jmbi.2001.5322; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; SNOW AD, 1989, ACTA NEUROPATHOL, V77, P337, DOI 10.1007/BF00687367; SNOW AD, 1990, LAB INVEST, V63, P601; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; Tateishi J, 1996, SEMIN VIROL, V7, P175, DOI 10.1006/smvy.1996.0022; TATEISHI J, 1979, ANN NEUROL, V5, P581, DOI 10.1002/ana.410050616; TAUBNER LM, 2009, J MOL BIOL; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; WANG F, SCIENCE; WANG F, SCIENCE, V327, P1132; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Yin SM, 2007, P NATL ACAD SCI USA, V104, P7546, DOI 10.1073/pnas.0610827104	69	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12351	10.1371/journal.pone.0012351	http://dx.doi.org/10.1371/journal.pone.0012351			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808809	Green Published, gold			2022-12-27	WOS:000281153500027
J	Zhang, F; Hu, YH; Xu, QB; Ye, S				Zhang, Feng; Hu, Yanhua; Xu, Qingbo; Ye, Shu			Different Effects of Angiotensin II and Angiotensin-(1-7) on Vascular Smooth Muscle Cell Proliferation and Migration	PLOS ONE			English	Article							FOCAL ADHESION KINASE; EPIDERMAL-GROWTH-FACTOR; STIMULATED MIGRATION; NEOINTIMAL FORMATION; STENT IMPLANTATION; NITRIC-OXIDE; VEIN GRAFTS; IN-VITRO; RECEPTOR; INHIBITION	Background: Angiotensin (Ang) II and Ang-(1-7) are two of the bioactive peptides of the rennin-angiotensin system. Ang II is involved in the development of cardiovascular disease, such as hypertension and atherosclerosis, while Ang-(1-7) shows cardiovascular protection in contrast to Ang II. Methodology/Principal Findings: In this study, we investigated effects of Ang II and Ang-(1-7) on vascular smooth muscle cell (SMC) proliferation and migration, which are critical in the formation of atherosclerotic lesions. Treatment with Ang II resulted in an increase of SMC proliferation, whereas Ang-(1-7) alone had no effects. However, preincubation with Ang-(1-7) inhibited Ang II-induced SMC proliferation. Ang II promoted SMC migration, and this effect was abolished by pretreatment with Ang-(1-7). The stimulatory effects of Ang II on SMC proliferation and migration were blocked by the Ang II receptor antagonist lorsartan, while the inhibitory effects of Ang-(1-7) were abolished by the Ang-(1-7) receptor antagonist A-799. Ang II treatment caused activation of ERK1/2 mediated signaling, and this was inhibited by preincubation of SMCs with Ang-(1-7). Conclusion: These results suggest that Ang-(1-7) inhibits Ang II-induced SMC proliferation and migration, at least in part, through negative modulation of Ang II induced ERK1/2 activity.	[Zhang, Feng; Ye, Shu] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Zhang, Feng] Peking Univ, Dept Physiol & Pathophysiol, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Hu, Yanhua; Xu, Qingbo] Kings Coll London, Div Cardiovasc, Kings BHF Ctr, London WC2R 2LS, England	University of London; Queen Mary University London; Peking University; University of London; King's College London	Zhang, F (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England.	s.ye@qmul.ac.uk	Ye, Shu/R-6384-2017; Ye, Shu/C-4067-2009	Ye, Shu/0000-0002-4126-4278; 	British Heart Foundation [PG/08/051/25141]; Chinese scholarship; National Institute of Health Research	British Heart Foundation(British Heart Foundation); Chinese scholarship; National Institute of Health Research(National Institute for Health Research (NIHR))	This work was supported by grants from the British Heart Foundation (PG/08/051/25141) and a Chinese scholarship. The work forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit, which is supported and funded by the National Institute of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOVY PR, 1989, J MED CHEM, V32, P520, DOI 10.1021/jm00123a002; Brosnihan KB, 1996, HYPERTENSION, V27, P523, DOI 10.1161/01.HYP.27.3.523; BURSON JM, 1994, AM J PHYSIOL, V267, pE260, DOI 10.1152/ajpendo.1994.267.2.E260; Cho A, 2000, ARTERIOSCL THROM VAS, V20, P2527, DOI 10.1161/01.ATV.20.12.2527; Clark MA, 2001, HYPERTENSION, V37, P1141, DOI 10.1161/01.HYP.37.4.1141; DAEMEN MJAP, 1991, CIRC RES, V68, P450, DOI 10.1161/01.RES.68.2.450; dos Santos RAS, 2001, HYPERTENSION, V38, P660, DOI 10.1161/01.HYP.38.3.660; DUBEY RK, 1995, J CLIN INVEST, V96, P141, DOI 10.1172/JCI118014; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Freeman EJ, 1996, HYPERTENSION, V28, P104, DOI 10.1161/01.HYP.28.1.104; Galis ZS, 2002, CIRC RES, V91, P852, DOI 10.1161/01.RES.0000041036.86977.14; Gallagher PE, 2004, CARCINOGENESIS, V25, P2045, DOI 10.1093/carcin/bgh236; Grobe JL, 2007, AM J PHYSIOL-HEART C, V292, pH736, DOI 10.1152/ajpheart.00937.2006; Heitsch H, 2001, HYPERTENSION, V37, P72, DOI 10.1161/01.HYP.37.1.72; Heringer-Walther S, 2009, HAEMATOL-HEMATOL J, V94, P857, DOI 10.3324/haematol.2008.000034; Hu YH, 1999, CIRCULATION, V100, P861, DOI 10.1161/01.CIR.100.8.861; Hu YH, 1997, ARTERIOSCL THROM VAS, V17, P2808, DOI 10.1161/01.ATV.17.11.2808; Hunger-Glaser I, 2003, J BIOL CHEM, V278, P22631, DOI 10.1074/jbc.M210876200; Izumi Y, 2001, CIRC RES, V88, P1120, DOI 10.1161/hh1101.091267; Keidar S, 2007, CARDIOVASC RES, V73, P463, DOI 10.1016/j.cardiores.2006.09.006; Kyaw M, 2004, MOL PHARMACOL, V65, P832, DOI 10.1124/mol.65.4.832; Langeveld B, 2005, HYPERTENSION, V45, P138, DOI 10.1161/01.HYP.0000149382.83973.c2; Lee HM, 2007, J PHARMACOL SCI, V105, P74, DOI 10.1254/jphs.FP0070770; Li CH, 2003, FASEB J, V17, P2106, DOI 10.1096/fj.03-0150fje; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu ZX, 2002, J BIOL CHEM, V277, P10452, DOI 10.1074/jbc.M107551200; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mercure C, 2008, CIRC RES, V103, P1319, DOI 10.1161/CIRCRESAHA.108.184911; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mugabe BE, 2010, J PHARMACOL EXP THER, V332, P116, DOI 10.1124/jpet.109.157552; Ohtsu H, 2005, ARTERIOSCL THROM VAS, V25, P1831, DOI 10.1161/01.ATV.0000175749.41799.9b; Pan CH, 2008, EXP PHYSIOL, V93, P599, DOI 10.1113/expphysiol.2007.041830; Roks AJM, 1999, HYPERTENSION, V34, P296, DOI 10.1161/01.HYP.34.2.296; Sampaio WO, 2007, HYPERTENSION, V50, P1093, DOI 10.1161/HYPERTENSIONAHA.106.084848; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Sharony R, 2006, AM J PHYSIOL-HEART C, V290, pH1651, DOI 10.1152/ajpheart.00530.2005; Strawn WB, 1999, HYPERTENSION, V33, P207, DOI 10.1161/01.HYP.33.1.207; Su Z, 2006, KIDNEY INT, V69, P2212, DOI 10.1038/sj.ki.5001509; Tallant EA, 1999, HYPERTENSION, V34, P950, DOI 10.1161/01.HYP.34.4.950; Tallant EA, 2005, AM J PHYSIOL-HEART C, V289, pH1560, DOI 10.1152/ajpheart.00941.2004; Tallant EA, 2003, HYPERTENSION, V42, P574, DOI 10.1161/01.HYP.0000090322.55782.30; Touyz RM, 1999, J HYPERTENS, V17, P907, DOI 10.1097/00004872-199917070-00006; Touyz RM, 2000, PHARMACOL REV, V52, P639; Ueda S, 2000, HYPERTENSION, V35, P998, DOI 10.1161/01.HYP.35.4.998; Ueda S, 2001, J HYPERTENS, V19, P2001, DOI 10.1097/00004872-200111000-00010; WANG Y, CIRC HEART FAIL; Weiss D, 2001, AM J CARDIOL, V87, p25C; Xi XP, 1999, ARTERIOSCL THROM VAS, V19, P73, DOI 10.1161/01.ATV.19.1.73; Yang XP, 2005, MOL CELLS, V20, P263; Yoshida O, 2005, AM HEART J, V149, DOI 10.1016/j.ahj.2004.08.006; Zeng WT, 2009, BIOCHEM BIOPH RES CO, V389, P138, DOI 10.1016/j.bbrc.2009.08.112; ZHANG J, 1979, AM J PHYSIOL-RENAL, V298, pF579	52	62	72	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12323	10.1371/journal.pone.0012323	http://dx.doi.org/10.1371/journal.pone.0012323			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808802	Green Published, gold, Green Submitted			2022-12-27	WOS:000281153500009
J	Cox, CL; Gotimer, K; Roy, AK; Castellanos, FX; Milham, MP; Kelly, C				Cox, Christine L.; Gotimer, Kristin; Roy, Amy K.; Castellanos, F. Xavier; Milham, Michael P.; Kelly, Clare			Your Resting Brain CAREs about Your Risky Behavior	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; ANTERIOR CINGULATE CORTEX; STATE FUNCTIONAL CONNECTIVITY; DECISION-MAKING; PREFRONTAL CORTEX; OUTCOME EXPECTANCIES; TAKING BEHAVIOR; YOUNG-ADULTS; REWARD ANTICIPATION; NEURAL MECHANISMS	Background: Research on the neural correlates of risk-related behaviors and personality traits has provided insight into mechanisms underlying both normal and pathological decision-making. Task-based neuroimaging studies implicate a distributed network of brain regions in risky decision-making. What remains to be understood are the interactions between these regions and their relation to individual differences in personality variables associated with real-world risk-taking. Methodology/Principal Findings: We employed resting state functional magnetic resonance imaging (R-fMRI) and resting state functional connectivity (RSFC) methods to investigate differences in the brain's intrinsic functional architecture associated with beliefs about the consequences of risky behavior. We obtained an individual measure of expected benefit from engaging in risky behavior, indicating a risk seeking or risk-averse personality, for each of 21 participants from whom we also collected a series of R-fMRI scans. The expected benefit scores were entered in statistical models assessing the RSFC of brain regions consistently implicated in both the evaluation of risk and reward, and cognitive control (i.e., orbitofrontal cortex, nucleus accumbens, lateral prefrontal cortex, dorsal anterior cingulate). We specifically focused on significant brain-behavior relationships that were stable across R-fMRI scans collected one year apart. Two stable expected benefit-RSFC relationships were observed: decreased expected benefit (increased risk-aversion) was associated with 1) stronger positive functional connectivity between right inferior frontal gyrus (IFG) and right insula, and 2) weaker negative functional connectivity between left nucleus accumbens and right parieto-occipital cortex. Conclusions/Significance: Task-based activation in the IFG and insula has been associated with risk-aversion, while activation in the nucleus accumbens and parietal cortex has been associated with both risk seeking and risk-averse tendencies. Our results suggest that individual differences in attitudes toward risk-taking are reflected in the brain's functional architecture and may have implications for engaging in real-world risky behaviors.	[Cox, Christine L.; Gotimer, Kristin; Roy, Amy K.; Castellanos, F. Xavier; Milham, Michael P.; Kelly, Clare] NYU, Phyllis Green & Randolph Cowen Inst Pediat Neuros, Ctr Child Study, Langone Med Ctr, New York, NY 10016 USA; [Castellanos, F. Xavier; Milham, Michael P.] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA	New York University; NYU Langone Medical Center; Nathan Kline Institute for Psychiatric Research	Cox, CL (corresponding author), NYU, Phyllis Green & Randolph Cowen Inst Pediat Neuros, Ctr Child Study, Langone Med Ctr, New York, NY 10016 USA.	Clare.Kelly@nyumc.org	Milham, Michael P./Y-3160-2019; Roy, Amy K/J-7613-2013; Castellanos, Francisco Xavier/K-1892-2014; Milham, Michael P/K-9501-2014; Kelly, Clare/H-4629-2016	Castellanos, Francisco Xavier/0000-0001-9192-9437; Kelly, Clare/0000-0001-8253-357X	National Institute on Drug Abuse [2T32DA007254-16A2, R03DA024775, R01DA016979]; National Institute of Mental Health [R01MH083246, R01MH081218, K23MH074821]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081218, R01MH083246, K23MH074821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016979, T32DA007254, R03DA024775] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Financial support for this project was provided by grants from the National Institute on Drug Abuse (2T32DA007254-16A2, postdoctoral training support for CLC; R03DA024775, to CK; R01DA016979, to FXC), the National Institute of Mental Health (R01MH083246 and R01MH081218, to FXC and MPM; K23MH074821, to AKR), as well as gifts to the NYU Child Study Center from the Stavros Niarchos Foundation, Leon Levy Foundation, and an endowment provided by Phyllis Green and Randolph Cowen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L., 2007, FMRIB ANAL GROUP TEC; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Aron JL, 2007, ADDICTION, V102, P33, DOI 10.1111/j.1360-0443.2006.01778.x; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Castilla J, 1999, DRUG ALCOHOL DEPEN, V56, P47, DOI 10.1016/S0376-8716(99)00008-3; Chambers CD, 2006, J COGNITIVE NEUROSCI, V18, P444, DOI 10.1162/jocn.2006.18.3.444; Christopoulos GI, 2009, J NEUROSCI, V29, P12574, DOI 10.1523/JNEUROSCI.2614-09.2009; Clark L, 2008, BRAIN, V131, P1311, DOI 10.1093/brain/awn066; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Combs-Lane AM, 2002, J INTERPERS VIOLENCE, V17, P165, DOI 10.1177/0886260502017002004; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craddock RC, 2009, MAGN RESON MED, V62, P1619, DOI 10.1002/mrm.22159; d'Acremont M, 2009, NEUROIMAGE, V47, P1929, DOI 10.1016/j.neuroimage.2009.04.096; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Di Martino A, 2009, AM J PSYCHIAT, V166, P891, DOI 10.1176/appi.ajp.2009.08121894; Engelmann JB, 2009, BRAIN RES, V1290, P28, DOI 10.1016/j.brainres.2009.06.078; Ernst M, 2005, NEUROIMAGE, V25, P1279, DOI 10.1016/j.neuroimage.2004.12.038; Ernst M, 2005, BIOL PSYCHIAT, V58, P597, DOI 10.1016/j.biopsych.2005.06.004; Fecteau S, 2007, J NEUROSCI, V27, P6212, DOI 10.1523/JNEUROSCI.0314-07.2007; Floden D, 2008, NEUROPSYCHOLOGIA, V46, P213, DOI 10.1016/j.neuropsychologia.2007.07.020; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fromme K, 1997, COGNITIVE THER RES, V21, P421, DOI 10.1023/A:1021932326716; Galvan A, 2007, DEVELOPMENTAL SCI, V10, pF8, DOI 10.1111/j.1467-7687.2006.00579.x; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Garavan H, 2008, PHILOS T R SOC B, V363, P3267, DOI 10.1098/rstb.2008.0106; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; James GA, 2009, NEUROIMAGE, V45, P778, DOI 10.1016/j.neuroimage.2008.12.049; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kashdan TB, 2006, COGNITIVE THER RES, V30, P749, DOI 10.1007/s10608-006-9017-x; Katz EC, 2000, COGNITIVE THER RES, V24, P1, DOI 10.1023/A:1005460107337; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kelly C, 2009, J NEUROSCI, V29, P7364, DOI 10.1523/JNEUROSCI.0810-09.2009; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Krain AL, 2006, NEUROIMAGE, V32, P477, DOI 10.1016/j.neuroimage.2006.02.047; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Lawrence AJ, 2009, ADDICTION, V104, P1006, DOI 10.1111/j.1360-0443.2009.02533.x; Lee TMC, 2008, NEUROSCI LETT, V438, P138, DOI 10.1016/j.neulet.2008.04.061; Leigh BC, 1999, ADDICTION, V94, P371, DOI 10.1046/j.1360-0443.1999.9433717.x; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Maner JK, 2007, PERS INDIV DIFFER, V42, P665, DOI 10.1016/j.paid.2006.08.016; Mantyla T, 2012, J ATTEN DISORD, V16, P164, DOI 10.1177/1087054709360494; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Milham MP, 2005, HUM BRAIN MAPP, V25, P328, DOI 10.1002/hbm.20110; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Mohr PNC, 2010, J NEUROSCI, V30, P6613, DOI 10.1523/JNEUROSCI.0003-10.2010; Mohr PNC, 2010, NEUROIMAGE, V49, P2556, DOI 10.1016/j.neuroimage.2009.10.060; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; O'Doherty J, 2003, J NEUROSCI, V23, P7931; Paulus MP, 2007, SCIENCE, V318, P602, DOI 10.1126/science.1142997; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Peters J, 2010, BEHAV BRAIN RES, V213, P135, DOI 10.1016/j.bbr.2010.04.031; Plichta MM, 2009, BIOL PSYCHIAT, V65, P7, DOI 10.1016/j.biopsych.2008.07.008; Rauch SL, 1997, BIOL PSYCHIAT, V42, P446, DOI 10.1016/S0006-3223(97)00145-5; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Samanez-Larkin GR, 2008, PSYCHOL SCI, V19, P320, DOI 10.1111/j.1467-9280.2008.02087.x; Scheres A, 2007, BIOL PSYCHIAT, V61, P720, DOI 10.1016/j.biopsych.2006.04.042; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stark DE, 2008, J NEUROSCI, V28, P13754, DOI 10.1523/JNEUROSCI.4544-08.2008; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Strohle A, 2008, NEUROIMAGE, V39, P966, DOI 10.1016/j.neuroimage.2007.09.044; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tobler PN, 2007, J NEUROPHYSIOL, V97, P1621, DOI 10.1152/jn.00745.2006; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; Van Leijenhorst L, 2010, NEUROIMAGE, V51, P345, DOI 10.1016/j.neuroimage.2010.02.038; Venkatraman V, 2007, SLEEP, V30, P603, DOI 10.1093/sleep/30.5.603; Venkatraman V, 2009, NEURON, V62, P593, DOI 10.1016/j.neuron.2009.04.007; Weller JA, 2009, SOC NEUROSCI-UK, V4, P347, DOI 10.1080/17470910902934400; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037; [No title captured]	85	40	43	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12296	10.1371/journal.pone.0012296	http://dx.doi.org/10.1371/journal.pone.0012296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808870	Green Published			2022-12-27	WOS:000281075500023
J	Swoboda, KJ; Scott, CB; Crawford, TO; Simard, LR; Reyna, SP; Krosschell, KJ; Acsadi, G; Elsheik, B; Schroth, MK; D'Anjou, G; LaSalle, B; Prior, TW; Sorenson, SL; Maczulski, JA; Bromberg, MB; Chan, GM; Kissel, JT				Swoboda, Kathryn J.; Scott, Charles B.; Crawford, Thomas O.; Simard, Louise R.; Reyna, Sandra P.; Krosschell, Kristin J.; Acsadi, Gyula; Elsheik, Bakri; Schroth, Mary K.; D'Anjou, Guy; LaSalle, Bernard; Prior, Thomas W.; Sorenson, Susan L.; Maczulski, Jo Anne; Bromberg, Mark B.; Chan, Gary M.; Kissel, John T.		Project Cure Spinal Muscular Atrop	SMA CARNI-VAL Trial Part I: Double-Blind, Randomized, Placebo-Controlled Trial of L-Carnitine and Valproic Acid in Spinal Muscular Atrophy	PLOS ONE			English	Article							FUNCTIONAL MOTOR SCALE; HAND-HELD DYNAMOMETRY; SMN2 COPY NUMBER; PROTEIN-LEVEL; MODEL MICE; CHILDREN; GENE; RELIABILITY; INCREASES; PHENOTYPE	Background: Valproic acid (VPA) has demonstrated potential as a therapeutic candidate for spinal muscular atrophy (SMA) in vitro and in vivo. Methods: Two cohorts of subjects were enrolled in the SMA CARNIVAL TRIAL, a non-ambulatory group of "sitters" (cohort 1) and an ambulatory group of "walkers" (cohort 2). Here, we present results for cohort 1: a multicenter phase II randomized double-blind intention-to-treat protocol in non-ambulatory SMA subjects 2-8 years of age. Sixty-one subjects were randomized 1: 1 to placebo or treatment for the first six months; all received active treatment the subsequent six months. The primary outcome was change in the modified Hammersmith Functional Motor Scale (MHFMS) score following six months of treatment. Secondary outcomes included safety and adverse event data, and change in MHFMS score for twelve versus six months of active treatment, body composition, quantitative SMN mRNA levels, maximum ulnar CMAP amplitudes, myometry and PFT measures. Results: At 6 months, there was no difference in change from the baseline MHFMS score between treatment and placebo groups (difference = 0.643, 95% CI = 21.22-2.51). Adverse events occurred in >80% of subjects and were more common in the treatment group. Excessive weight gain was the most frequent drug-related adverse event, and increased fat mass was negatively related to change in MHFMS values (p = 0.0409). Post-hoc analysis found that children ages two to three years that received 12 months treatment, when adjusted for baseline weight, had significantly improved MHFMS scores (p = 0.03) compared to those who received placebo the first six months. A linear regression analysis limited to the influence of age demonstrates young age as a significant factor in improved MHFMS scores (p = 0.007). Conclusions: This study demonstrated no benefit from six months treatment with VPA and L-carnitine in a young non-ambulatory cohort of subjects with SMA. Weight gain, age and treatment duration were significant confounding variables that should be considered in the design of future trials.	[Swoboda, Kathryn J.; Reyna, Sandra P.; Bromberg, Mark B.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT 84112 USA; [Scott, Charles B.] CBS Squared Inc, Ft Washington, PA USA; [Simard, Louise R.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Crawford, Thomas O.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Crawford, Thomas O.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [LaSalle, Bernard] Univ Utah, Sch Med, Gen Clin Res Ctr, Salt Lake City, UT USA; [Prior, Thomas W.] Ohio State Univ, Dept Mol Pathol, Columbus, OH 43210 USA; [Sorenson, Susan L.] Primary Childrens Med Ctr, Salt Lake City, UT 84103 USA; [Maczulski, Jo Anne] Pediat Occupat Therapy Serv, Chicago, IL USA; [Acsadi, Gyula] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Acsadi, Gyula] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; [Krosschell, Kristin J.] Northwestern Univ, Dept Phys Therapy & Human Movement Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [D'Anjou, Guy] Ste Justine Hosp, Div Pediat Neurol, Montreal, PQ, Canada; [Schroth, Mary K.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI USA; [Chan, Gary M.] Univ Utah, Dept Pediat Neonatol, Salt Lake City, UT USA; [Elsheik, Bakri; Kissel, John T.] Ohio State Univ, Dept Neurol, Med Ctr, Columbus, OH 43210 USA	Utah System of Higher Education; University of Utah; University of Manitoba; Johns Hopkins University; Johns Hopkins University; Utah System of Higher Education; University of Utah; University System of Ohio; Ohio State University; Wayne State University; Wayne State University; Northwestern University; Feinberg School of Medicine; Universite de Montreal; University of Wisconsin System; University of Wisconsin Madison; Utah System of Higher Education; University of Utah; University System of Ohio; Ohio State University	Swoboda, KJ (corresponding author), Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT 84112 USA.	Swoboda@genetics.utah.edu	Crawford, Thomas/E-6307-2012	Krosschell, Kristin/0000-0003-2879-5055; Simard, Louise/0000-0003-0391-8821; Swoboda, Kathryn/0000-0002-4593-6342	Families of Spinal Muscular Atrophy; University of Utah, Center for Clinical and Translational Sciences [UL1RR025764]; Johns Hopkins University, General Clinical Research Center [UL1RR025005]; University of Wisconsin, Clinical and Translational Research Core [UL1RR025011]; Ohio State University, General Clinical Research Center [M01-RR00034]; National Center for Research Resources, National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000034, UL1RR025011, UL1RR025005, UL1RR025764] Funding Source: NIH RePORTER	Families of Spinal Muscular Atrophy; University of Utah, Center for Clinical and Translational Sciences; Johns Hopkins University, General Clinical Research Center(Johns Hopkins UniversityUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Wisconsin, Clinical and Translational Research Core; Ohio State University, General Clinical Research Center(Ohio State UniversityUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded by Families of Spinal Muscular Atrophy. The investigation was also supported by grants UL1RR025764 (University of Utah, Center for Clinical and Translational Sciences), UL1RR025005 (Johns Hopkins University, General Clinical Research Center), UL1RR025011 (University of Wisconsin, Clinical and Translational Research Core) M01-RR00034 (Ohio State University, General Clinical Research Center) and the Clinical Research Center, Children's Hospital of Michigan, given by the National Center for Research Resources, National Institutes of Health. The funding sources had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beenakker EAC, 2001, NEUROMUSCULAR DISORD, V11, P441, DOI 10.1016/S0960-8966(01)00193-6; Brahe C, 1996, J MOL MED-JMM, V74, P555, DOI 10.1007/s001090050059; Brichta L, 2003, HUM MOL GENET, V12, P2481, DOI 10.1093/hmg/ddg256; Brichta L, 2006, ANN NEUROL, V59, P970, DOI 10.1002/ana.20836; CZEIZEL A, 1989, J MED GENET, V26, P761, DOI 10.1136/jmg.26.12.761; Dawson C, 1992, PEDIATR EXERC SCI, V4, P340; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Guo X, 2005, STAT MED, V24, P3479, DOI 10.1002/sim.2161; Kernochan LE, 2005, HUM MOL GENET, V14, P1171, DOI 10.1093/hmg/ddi130; Krosschell KJ, 2006, NEUROMUSCULAR DISORD, V16, P417, DOI 10.1016/j.nmd.2006.03.015; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Leng Y, 2006, J NEUROSCI, V26, P7502, DOI 10.1523/JNEUROSCI.0096-06.2006; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Mailman MD, 2002, GENET MED, V4, P20, DOI 10.1097/00125817-200201000-00004; Main M, 2003, EUR J PAEDIATR NEURO, V7, P155, DOI 10.1016/S1090-3798(03)00060-6; Merlini L, 2002, MUSCLE NERVE, V26, P64, DOI 10.1002/mus.10166; MERLINI L, 1992, NEUROMUSCULAR DISORD, V2, P197, DOI 10.1016/0960-8966(92)90006-R; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; Prior TW, 2004, AM J MED GENET A, V130A, P307, DOI 10.1002/ajmg.a.30251; ROBERTS DF, 1970, ARCH DIS CHILD, V45, P33, DOI 10.1136/adc.45.239.33; Simard LR, 2007, NEUROLOGY, V68, P451, DOI 10.1212/01.wnl.0000252934.70676.ab; Sloan Colleen, 2002, Physical and Occupational Therapy in Pediatrics, V22, P79, DOI 10.1300/J006v22n02_05; STUBERG WA, 1988, PHYS THER, V68, P977, DOI 10.1093/ptj/68.6.977; Sugai F, 2004, EUR J NEUROSCI, V20, P3179, DOI 10.1111/j.1460-9568.2004.03765.x; Sumner CJ, 2003, ANN NEUROL, V54, P647, DOI 10.1002/ana.10743; Swoboda KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005268; Swoboda KJ, 2005, ANN NEUROL, V57, P704, DOI 10.1002/ana.20473; Tsai LK, 2007, EUR J NEUROL, V14, pE8, DOI 10.1111/j.1468-1331.2007.01992.x; Tsai LK, 2008, J MOL MED, V86, P1243, DOI 10.1007/s00109-008-0388-1; Tsai LK, 2006, NEUROBIOL DIS, V24, P286, DOI 10.1016/j.nbd.2006.07.004; van Bergeijk J, 2006, CHEM BIOL DRUG DES, V67, P244, DOI 10.1111/j.1747-0285.2006.00369.x; Varni JW, 2007, J PEDIATR PSYCHOL, V32, P1151, DOI 10.1093/jpepsy/jsm008; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Weihl CC, 2006, NEUROLOGY, V67, P500, DOI 10.1212/01.wnl.0000231139.26253.d0; Wirth B, 2006, HUM GENET, V119, P422, DOI 10.1007/s00439-006-0156-7	37	120	127	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12140	10.1371/journal.pone.0012140	http://dx.doi.org/10.1371/journal.pone.0012140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808854	Green Published, gold, Green Submitted			2022-12-27	WOS:000281075500003
J	Benfield, CTO; Lyall, JW; Tiley, LS				Benfield, Camilla T. O.; Lyall, Jon W.; Tiley, Laurence S.			The Cytoplasmic Location of Chicken Mx Is Not the Determining Factor for Its Lack of Antiviral Activity	PLOS ONE			English	Article							INFLUENZA-VIRUS REPLICATION; THOGOTO-VIRUS; INTERFERON-ANTAGONIST; GENE-EXPRESSION; TRANSGENIC MICE; PROTEIN MX; V-PROTEIN; IN-VITRO; A VIRUS; RESISTANCE	Background: Chicken Mx belongs to the Mx family of interferon-induced dynamin-like GTPases, which in some species possess potent antiviral properties. Conflicting data exist for the antiviral capability of chicken Mx. Reports of anti-influenza activity of alleles encoding an Asn631 polymorphism have not been supported by subsequent studies. The normal cytoplasmic localisation of chicken Mx may influence its antiviral capacity. Here we report further studies to determine the antiviral potential of chicken Mx against Newcastle disease virus (NDV), an economically important cytoplasmic RNA virus of chickens, and Thogoto virus, an orthomyxovirus known to be exquisitely sensitive to the cytoplasmic MxA protein from humans. We also report the consequences of re-locating chicken Mx to the nucleus. Methodology/Principal Findings: Chicken Mx was tested in virus infection assays using NDV. Neither the Asn631 nor Ser631 Mx alleles (when transfected into 293T cells) showed inhibition of virus-directed gene expression when the cells were subsequently infected with NDV. Human MxA however did show significant inhibition of NDV-directed gene expression. Chicken Mx failed to inhibit a Thogoto virus (THOV) minireplicon system in which the cytoplasmic human MxA protein showed potent and specific inhibition. Relocalisation of chicken Mx to the nucleus was achieved by inserting the Simian Virus 40 large T antigen nuclear localisation sequence (SV40 NLS) at the N-terminus of chicken Mx. Nuclear re-localised chicken Mx did not inhibit influenza (A/PR/8/34) gene expression during virus infection in cell culture or influenza polymerase activity in A/PR/8/34 or A/Turkey/50-92/91 minireplicon systems. Conclusions/Significance: The chicken Mx protein (Asn631) lacks inhibitory effects against THOV and NDV, and is unable to suppress influenza replication when artificially re-localised to the cell nucleus. Thus, the natural cytoplasmic localisation of the chicken Mx protein does not account for its lack of antiviral activity.	[Benfield, Camilla T. O.; Lyall, Jon W.; Tiley, Laurence S.] Univ Cambridge, Dept Vet Med, Cambridge, England	University of Cambridge	Benfield, CTO (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Med, Sect Virol,Div Infect Dis, London, England.	c.benfield@imperial.ac.uk		Benfield, Camilla/0000-0001-7851-4181	Department for Environment, Food and Rural Affairs (DEFRA); Higher Education Funding Council for England (HEFCE); Veterinary Training Research Initiative (VTRI); Royal College of Veterinary Surgeons Trust [911]; Biotechnology and Biological Sciences Research Council (BBSRC) [BBS/B/00239]; BBSRC [BB/G00479X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/00239, BB/G00479X/1] Funding Source: researchfish	Department for Environment, Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA)); Higher Education Funding Council for England (HEFCE)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Veterinary Training Research Initiative (VTRI); Royal College of Veterinary Surgeons Trust; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Cambridge Infectious Diseases Consortium (CIDC), which is funded jointly by the Department for Environment, Food and Rural Affairs (DEFRA) and the Higher Education Funding Council for England (HEFCE) as part of the Veterinary Training Research Initiative (VTRI), a grant awarded to CB from the Royal College of Veterinary Surgeons Trust (Grant No. 911), and Biotechnology and Biological Sciences Research Council (BBSRC) Grant Nos. BBS/B/00239 and BB/G00479X/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNHEITER H, 1990, CELL, V62, P51, DOI 10.1016/0092-8674(90)90239-B; BAZZIGHER L, 1993, VIROLOGY, V195, P100, DOI 10.1006/viro.1993.1350; Benfield CTO, 2008, J VIROL, V82, P7533, DOI 10.1128/JVI.00185-08; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Berlin S, 2008, IMMUNOGENETICS, V60, P689, DOI 10.1007/s00251-008-0324-0; BERNASCONI D, 1995, J INTERF CYTOK RES, V15, P47, DOI 10.1089/jir.1995.15.47; Carlos TS, 2007, VIROLOGY, V363, P166, DOI 10.1016/j.virol.2007.01.014; Carrasco M, 2004, TRAFFIC, V5, P979, DOI 10.1111/j.1600-0854.2004.00237.x; Choudhary S, 2001, J VIROL, V75, P4823, DOI 10.1128/JVI.75.10.4823-4831.2001; DITTMANN J, 2008, J VIROL; DREIDING P, 1985, VIROLOGY, V140, P192, DOI 10.1016/0042-6822(85)90460-X; Engel-Herbert I, 2003, J VIROL METHODS, V108, P19, DOI 10.1016/S0166-0934(02)00247-1; Flohr F, 1999, FEBS LETT, V463, P24, DOI 10.1016/S0014-5793(99)01598-7; FRESE M, 1995, J VIROL, V69, P3904, DOI 10.1128/JVI.69.6.3904-3909.1995; Grimm D, 2007, P NATL ACAD SCI USA, V104, P6806, DOI 10.1073/pnas.0701849104; Holler O, 2009, REV SCI TECH OIE, V28, P219, DOI 10.20506/rst.28.1.1867; HORISBERGER MA, 1983, P NATL ACAD SCI-BIOL, V80, P1910, DOI 10.1073/pnas.80.7.1910; Howard W, 2007, AVIAN DIS, V51, P393, DOI 10.1637/7645-050906R1.1; Huang ZH, 2003, J VIROL, V77, P8676, DOI 10.1128/JVI.77.16.8676-8685.2003; Jatiani SS, 2004, BIOCHEM BIOPH RES CO, V323, P541, DOI 10.1016/j.bbrc.2004.08.134; JOHANNES L, 1993, J VIROL, V67, P1653, DOI 10.1128/JVI.67.3.1653-1657.1993; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; King MC, 2004, P NATL ACAD SCI USA, V101, P8957, DOI 10.1073/pnas.0403167101; Ko JH, 2004, ANIM GENET, V35, P119, DOI 10.1111/j.1365-2052.2004.01096.x; Ko JH, 2002, GENOME RES, V12, P595, DOI 10.1101/gr.210702. Article published online before print in March ; KRUG RM, 1985, J VIROL, V56, P201, DOI 10.1128/JVI.56.1.201-206.1985; Leroy MPP, 2007, AM J VET RES, V68, P988, DOI 10.2460/ajvr.68.9.988; LINDENMANN J, 1964, P SOC EXP BIOL MED, V116, P506, DOI 10.3181/00379727-116-29292; LINDENMANN J, 1962, VIROLOGY, V16, P203, DOI 10.1016/0042-6822(62)90297-0; Lussier MP, 2005, J BIOL CHEM, V280, P19393, DOI 10.1074/jbc.M500391200; MAHY BWJ, 1977, VIROLOGY, V83, P150, DOI 10.1016/0042-6822(77)90218-5; MEIER E, 1990, J VIROL, V64, P6263, DOI 10.1128/JVI.64.12.6263-6269.1990; Mibayashi M, 2002, MICROBIOL IMMUNOL, V46, P29, DOI 10.1111/j.1348-0421.2002.tb02673.x; Mullin AE, 2004, J GEN VIROL, V85, P3689, DOI 10.1099/vir.0.80518-0; Mundt E, 2007, J GEN VIROL, V88, P1319, DOI 10.1099/vir.0.82526-0; Mushinski JF, 2009, J BIOL CHEM, V284, P15206, DOI 10.1074/jbc.M806324200; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; PAVLOVIC J, 1995, J VIROL, V69, P4506, DOI 10.1128/JVI.69.7.4506-4510.1995; PAVLOVIC J, 1990, J VIROL, V64, P3370, DOI 10.1128/JVI.64.7.3370-3375.1990; PAVLOVIC J, 1992, J VIROL, V66, P2564, DOI 10.1128/JVI.66.4.2564-2569.1992; PITOSSI F, 1993, J VIROL, V67, P6726, DOI 10.1128/JVI.67.11.6726-6732.1993; Ponten A, 1997, J VIROL, V71, P2591, DOI 10.1128/JVI.71.4.2591-2599.1997; SCHNEIDERSCHAULIES S, 1994, J VIROL, V68, P6910, DOI 10.1128/JVI.68.11.6910-6917.1994; SCHNORR JJ, 1993, J VIROL, V67, P4760, DOI 10.1128/JVI.67.8.4760-4768.1993; Sironi L, 2008, VIROLOGY, V380, P152, DOI 10.1016/j.virol.2008.07.022; STAEHELI P, 1985, MOL CELL BIOL, V5, P2150, DOI 10.1128/MCB.5.8.2150; STAEHELI P, 1986, CELL, V44, P147, DOI 10.1016/0092-8674(86)90493-9; Stertz S, 2007, J INTERF CYTOK RES, V27, P847, DOI 10.1089/jir.2006.0176; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; Tumpey TM, 2007, J VIROL, V81, P10818, DOI 10.1128/JVI.01116-07; Turan K, 2004, NUCLEIC ACIDS RES, V32, P643, DOI 10.1093/nar/gkh192; Wagner E, 2001, J VIROL, V75, P9282, DOI 10.1128/JVI.75.19.9282-9286.2001; Weber F, 2000, J VIROL, V74, P560, DOI 10.1128/JVI.74.1.560-563.2000; Zhao H, 1996, VIROLOGY, V220, P330, DOI 10.1006/viro.1996.0321; ZURCHER T, 1992, EMBO J, V11, P1657, DOI 10.1002/j.1460-2075.1992.tb05212.x	56	20	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12151	10.1371/journal.pone.0012151	http://dx.doi.org/10.1371/journal.pone.0012151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808435	Green Published, Green Submitted, gold			2022-12-27	WOS:000280968000006
J	Kirmse, R; Qin, ZA; Weinert, CM; Hoenger, A; Buehler, MJ; Kreplak, L				Kirmse, Robert; Qin, Zhao; Weinert, Carl M.; Hoenger, Andrea; Buehler, Markus J.; Kreplak, Laurent			Plasticity of Intermediate Filament Subunits	PLOS ONE			English	Article							MOLECULAR ARCHITECTURE; TETRAMERIC VIMENTIN; COILED-COIL; DYNAMICS; PROTEIN; IDENTIFICATION; MICROSCOPY; KERATIN; UNITS; HEAD	Intermediate filaments (IFs) assembled in vitro from recombinantly expressed proteins have a diameter of 8-12 nm and can reach several micrometers in length. IFs assemble from a soluble pool of subunits, tetramers in the case of vimentin. Upon salt addition, the subunits form first unit length filaments (ULFs) within seconds and then assembly proceeds further by end-to-end fusion of ULFs and short filaments. So far, IF subunits have mainly been observed by electron microscopy of glycerol sprayed and rotary metal shadowed specimens. Due to the shear forces during spraying the IF subunits appear generally as straight thin rods. In this study, we used atomic force microscopy (AFM), cryo-electron microscopy (cryo-EM) combined with molecular modeling to investigate the conformation of the subunits of vimentin, desmin and keratin K5/K14 IFs in various conditions. Due to their anisotropic shape the subunits are difficult to image at high resolution by cryo-EM. In order to enhance contrast we used a cryo-negative staining approach. The subunits were clearly identified as thin, slightly curved rods. However the staining agent also forced the subunits to aggregate into two-dimensional networks of dot-like structures. To test this conformational change further, we imaged dried unfixed subunits on mica by AFM revealing a mixture of extended and dot-like conformations. The use of divalent ions such as calcium and magnesium, as well as glutaraldehyde exposure favored compact conformations over elongated ones. These experimental results as well as coarse-grained molecular dynamics simulations of a vimentin tetramer highlight the plasticity of IF subunits.	[Kirmse, Robert; Hoenger, Andrea] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Qin, Zhao; Buehler, Markus J.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Weinert, Carl M.; Kreplak, Laurent] Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS, Canada	University of Colorado System; University of Colorado Boulder; Massachusetts Institute of Technology (MIT); Dalhousie University	Kirmse, R (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	kreplak@dal.ca	Buehler, Markus J./C-4580-2008; Qin, Zhao/B-4667-2010	Buehler, Markus J./0000-0002-4173-9659; Qin, Zhao/0000-0001-5696-8553; kreplak, laurent/0000-0001-9370-9809; Hoenger, Andreas/0000-0001-9176-6658	Natural Sciences and Engineering Research Council of Canada; Air Force Office of Scientific Research [FA9550081-0321]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	Natural Sciences and Engineering Research Council of Canada discovery grant awarded to Laurent Kreplak and Air Force Office of Scientific Research Grant No. FA9550081-0321 awarded to Markus J. Buehler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian M, 1998, MICRON, V29, P145, DOI 10.1016/S0968-4328(97)00068-1; AEBI U, 1983, J CELL BIOL, V97, P1131, DOI 10.1083/jcb.97.4.1131; Ando S, 2004, BBA-PROTEINS PROTEOM, V1702, P53, DOI 10.1016/j.bbapap.2004.07.008; Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799; BREMER A, 1992, ULTRAMICROSCOPY, V46, P85, DOI 10.1016/0304-3991(92)90008-8; Colakoglu G, 2009, J CELL BIOL, V185, P769, DOI 10.1083/jcb.200809166; De Carlo S, 2002, J STRUCT BIOL, V138, P216, DOI 10.1016/S1047-8477(02)00035-7; De Carlo S, 2008, MICRON, V39, P934, DOI 10.1016/j.micron.2007.11.003; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Geisler N, 1998, J MOL BIOL, V282, P601, DOI 10.1006/jmbi.1998.1995; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466; HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; HISANAGA S, 1989, J NEUROSCI, V9, P959; Kirmse R, 2007, J BIOL CHEM, V282, P18563, DOI 10.1074/jbc.M701063200; Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092; Kreplak L, 2004, EXP CELL RES, V301, P77, DOI 10.1016/j.yexcr.2004.08.021; LEE SH, 1994, J CHEM PHYS, V100, P3334, DOI 10.1063/1.466425; Mucke N, 2005, J STRUCT BIOL, V150, P268, DOI 10.1016/j.jsb.2005.02.012; Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039; NORTH ACT, 1994, PROTEINS, V20, P174, DOI 10.1002/prot.340200207; Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009; Qin Z, 2010, J BIOMECH, V43, P15, DOI 10.1016/j.jbiomech.2009.09.004; Qin Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007294; Schwaiger I, 2002, NAT MATER, V1, P232, DOI 10.1038/nmat776; SOELLNER P, 1985, P NATL ACAD SCI USA, V82, P7929, DOI 10.1073/pnas.82.23.7929; Sokolova AV, 2006, P NATL ACAD SCI USA, V103, P16206, DOI 10.1073/pnas.0603629103; Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246; VIKSTROM KL, 1992, J CELL BIOL, V118, P121, DOI 10.1083/jcb.118.1.121	31	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12115	10.1371/journal.pone.0012115	http://dx.doi.org/10.1371/journal.pone.0012115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20814582	Green Submitted, gold, Green Published			2022-12-27	WOS:000280859700010
J	Pointon, AV; Walker, TM; Phillips, KM; Luo, JL; Riley, J; Zhang, SD; Parry, JD; Lyon, JJ; Marczylo, EL; Gant, TW				Pointon, Amy V.; Walker, Tracy M.; Phillips, Kate M.; Luo, Jinli; Riley, Joan; Zhang, Shu-Dong; Parry, Joel D.; Lyon, Jonathan J.; Marczylo, Emma L.; Gant, Timothy W.			Doxorubicin In Vivo Rapidly Alters Expression and Translation of Myocardial Electron Transport Chain Genes, Leads to ATP Loss and Caspase 3 Activation	PLOS ONE			English	Article							IRON REGULATORY PROTEIN-1; ANTHRACYCLINE CARDIOTOXICITY; CARDIAC MITOCHONDRIA; CYTOCHROME-C; HEART; CELLS; REDUCTION; STRESS; OVEREXPRESSION; ADRIAMYCIN	Background: Doxorubicin is one of the most effective anti-cancer drugs but its use is limited by cumulative cardiotoxicity that restricts lifetime dose. Redox damage is one of the most accepted mechanisms of toxicity, but not fully substantiated. Moreover doxorubicin is not an efficient redox cycling compound due to its low redox potential. Here we used genomic and chemical systems approaches in vivo to investigate the mechanisms of doxorubicin cardiotoxicity, and specifically test the hypothesis of redox cycling mediated cardiotoxicity. Methodology/Principal Findings: Mice were treated with an acute dose of either doxorubicin (DOX) (15 mg/kg) or 2,3-dimethoxy-1,4-naphthoquinone (DMNQ) (25 mg/kg). DMNQ is a more efficient redox cycling agent than DOX but unlike DOX has limited ability to inhibit gene transcription and DNA replication. This allowed specific testing of the redox hypothesis for cardiotoxicity. An acute dose was used to avoid pathophysiological effects in the genomic analysis. However similar data were obtained with a chronic model, but are not specifically presented. All data are deposited in the Gene Expression Omnibus (GEO). Pathway and biochemical analysis of cardiac global gene transcription and mRNA translation data derived at time points from 5 min after an acute exposure in vivo showed a pronounced effect on electron transport chain activity. This led to loss of ATP, increased AMPK expression, mitochondrial genome amplification and activation of caspase 3. No data gathered with either compound indicated general redox damage, though site specific redox damage in mitochondria cannot be entirely discounted. Conclusions/Significance: These data indicate the major mechanism of doxorubicin cardiotoxicity is via damage or inhibition of the electron transport chain and not general redox stress. There is a rapid response at transcriptional and translational level of many of the genes coding for proteins of the electron transport chain complexes. Still though ATP loss occurs with activation caspase 3 and these events probably account for the heart damage.	[Pointon, Amy V.; Phillips, Kate M.; Luo, Jinli; Riley, Joan; Zhang, Shu-Dong; Marczylo, Emma L.; Gant, Timothy W.] Syst Toxicol Grp, Med Res Council Toxicol Unit, Leicester, Leics, England; [Walker, Tracy M.; Parry, Joel D.; Lyon, Jonathan J.] GlaxoSmithKline PLC, Ware, Herts, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Leicester; GlaxoSmithKline	Pointon, AV (corresponding author), AstraZeneca, Dept Mol Toxicol, Macclesfield, Cheshire, England.	twg1@le.ac.uk	Zhang, Shu-Dong/G-1269-2010	Zhang, Shu-Dong/0000-0002-7721-0167; Gant, Timothy/0000-0001-9057-4937; Luo, Jinli/0000-0002-9241-5283	Medical Reseach Council; Biotechnology and Biological Sciences Research Council; GSK PLC	Medical Reseach Council; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GSK PLC	Funding for this study was received from the Medical Reseach Council (TWG, JL, JR, KMP, SDZ, ELM and TWG) the Biotechnology and Biological Sciences Research Council (AVP) and GSK PLC (AVP, TMW, JDP and JJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; TMW, JDP and JJL are all employees of GSK while AVP received a stipend from the company while undertaking this work. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ANDERS JC, 1984, J ANAL TOXICOL, V8, P260, DOI 10.1093/jat/8.6.260; Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Basova LV, 2007, BIOCHEMISTRY-US, V46, P3423, DOI 10.1021/bi061854k; Berthiaume JM, 2007, CARDIOVASC TOXICOL, V7, P178, DOI 10.1007/s12012-007-0026-0; Bird BRJH, 2008, CLIN CANCER RES, V14, P14, DOI 10.1158/1078-0432.CCR-07-1033; BIRONAITE DA, 1991, BIOCHIM BIOPHYS ACTA, V1060, P203, DOI 10.1016/S0005-2728(09)91008-8; Bratton SB, 2000, EXP CELL RES, V256, P27, DOI 10.1006/excr.2000.4835; Childs AC, 2002, CANCER RES, V62, P4592; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; DAVIES KJA, 1986, J BIOL CHEM, V261, P3060; Davies R, 2005, AM J PATHOL, V166, P1041, DOI 10.1016/S0002-9440(10)62325-5; DOROSHOW JH, 1986, J BIOL CHEM, V261, P3068; Forrest GL, 2000, CANCER RES, V60, P5158; GANT TW, 1988, CHEM-BIOL INTERACT, V65, P157, DOI 10.1016/0009-2797(88)90052-X; Gellerich FN, 2004, MITOCHONDRION, V4, P427, DOI 10.1016/j.mito.2004.07.007; GOORMAGHTIGH E, 1987, BIOCHEMISTRY-US, V26, P1789, DOI 10.1021/bi00380a043; HIRABAYSHI N, 1987, JAPENSE J SURG, V17, P406; HUANG C, CIRCULATION, V121, P675; Huo L, 2001, MOL CELL BIOL, V21, P644, DOI 10.1128/MCB.21.2.644-654.2001; JOHANSEN PB, 1981, CANCER CHEMOTH PHARM, V5, P267, DOI 10.1007/BF00434396; Kang YJ, 1996, J BIOL CHEM, V271, P12610, DOI 10.1074/jbc.271.21.12610; Kogan NM, 2007, J PHARMACOL EXP THER, V322, P646, DOI 10.1124/jpet.107.120865; Ladas EJ, 2004, J CLIN ONCOL, V22, P517, DOI 10.1200/JCO.2004.03.086; LAND EJ, 1983, ARCH BIOCHEM BIOPHYS, V225, P116, DOI 10.1016/0003-9861(83)90013-9; LEBRECHT D, 2009, CARDIOVAS P IN PRESS; MARCILLAT O, 1989, BIOCHEM J, V259, P181, DOI 10.1042/bj2590181; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Melamed D, 2009, METHODS, V48, P301, DOI 10.1016/j.ymeth.2009.04.020; Mik EG, 2009, J MOL CELL CARDIOL, V46, P943, DOI 10.1016/j.yjmcc.2009.02.002; Minotti G, 1998, FASEB J, V12, P541, DOI 10.1096/fasebj.12.7.541; Minotti G, 2001, CANCER RES, V61, P8422; Minotti G, 1999, FASEB J, V13, P199, DOI 10.1096/fasebj.13.2.199; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; NICOLAY K, 1987, BIOCHIM BIOPHYS ACTA, V892, P320, DOI 10.1016/0005-2728(87)90236-2; Oliveira PJ, 2006, TOXICOLOGY, V220, P160, DOI 10.1016/j.tox.2005.12.009; OLSON RD, 1988, P NATL ACAD SCI USA, V85, P3585, DOI 10.1073/pnas.85.10.3585; Parry JD, 2009, CHEM RES TOXICOL, V22, P717, DOI 10.1021/tx800472z; Pouillart P, 2004, CANCER TREAT REV, V30, P643, DOI 10.1016/j.ctrv.2004.06.002; POWIS G, 1980, BIOCHEM PHARMACOL, V29, P2567, DOI 10.1016/0006-2952(80)90068-4; Quinones A, 2001, MUTAT RES-GEN TOX EN, V494, P73, DOI 10.1016/S1383-5718(01)00179-6; Robert J, 2007, CARDIOVASC TOXICOL, V7, P135, DOI 10.1007/s12012-007-0022-4; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scatena R, 2007, AM J PHYSIOL-CELL PH, V293, pC12, DOI 10.1152/ajpcell.00314.2006; SELLEVOLD OFM, 1986, J MOL CELL CARDIOL, V18, P517, DOI 10.1016/S0022-2828(86)80917-8; Shell SA, 2008, CELL CYCLE, V7, P1769, DOI 10.4161/cc.7.12.6016; Simunek T, 2009, PHARMACOL REP, V61, P154; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Sullivan M, 2006, MOL HUM REPROD, V12, P653, DOI 10.1093/molehr/gal081; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; TEICHERT F, 2008, RAP COMMUNICATIONS M, V23, P151; Turton NJ, 2001, ONCOGENE, V20, P1300, DOI 10.1038/sj.onc.1204235; Wallace KB, 2003, PHARMACOL TOXICOL, V93, P105, DOI 10.1034/j.1600-0773.2003.930301.x; Wallace KB, 2000, ANNU REV PHARMACOL, V40, P353, DOI 10.1146/annurev.pharmtox.40.1.353; XIAOMING Y, 2006, AM J PATHOL, V290, pH1098; Zhang J, 2004, CURR PHARM BIOTECHNO, V5, P1; Zhu WQ, 2009, CIRCULATION, V119, P99, DOI 10.1161/CIRCULATIONAHA.108.799700	58	86	88	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12733	10.1371/journal.pone.0012733	http://dx.doi.org/10.1371/journal.pone.0012733			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856801	gold, Green Published, Green Submitted			2022-12-27	WOS:000281815800014
J	Berniker, M; Voss, M; Kording, K				Berniker, Max; Voss, Martin; Kording, Konrad			Learning Priors for Bayesian Computations in the Nervous System	PLOS ONE			English	Article							REACHING MOVEMENTS; PARIETAL CORTEX; ADAPTATION; UNCERTAINTY; REPRESENTATION; INTEGRATION; INFORMATION; PERCEPTION; DYNAMICS; DECISION	Our nervous system continuously combines new information from our senses with information it has acquired throughout life. Numerous studies have found that human subjects manage this by integrating their observations with their previous experience (priors) in a way that is close to the statistical optimum. However, little is known about the way the nervous system acquires or learns priors. Here we present results from experiments where the underlying distribution of target locations in an estimation task was switched, manipulating the prior subjects should use. Our experimental design allowed us to measure a subject's evolving prior while they learned. We confirm that through extensive practice subjects learn the correct prior for the task. We found that subjects can rapidly learn the mean of a new prior while the variance is learned more slowly and with a variable learning rate. In addition, we found that a Bayesian inference model could predict the time course of the observed learning while offering an intuitive explanation for the findings. The evidence suggests the nervous system continuously updates its priors to enable efficient behavior.	[Berniker, Max; Kording, Konrad] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Berniker, Max; Kording, Konrad] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Voss, Martin] Charite, Dept Psychiat & Psychotherapy, Berlin, Germany; [Voss, Martin] St Hedwig Hosp, Berlin, Germany	Northwestern University; Shirley Ryan AbilityLab; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Berniker, M (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.	mbernike@northwestern.edu	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499; Voss, Martin/0000-0002-5221-4647	NIH [1R01NS063399, 5P01NS0044393]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044393, R01NS063399] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH grant nrs. 1R01NS063399 and 5P01NS0044393. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WJ, 2004, NAT NEUROSCI, V7, P1057, DOI 10.1038/nn1312; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Burge J, 2008, J VISION, V8, DOI 10.1167/8.4.20; Chen HY, 2006, CEREB CORTEX, V16, P1462, DOI 10.1093/bhj087; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; DeWeese M, 1998, NEURAL COMPUT, V10, P1179, DOI 10.1162/089976698300017403; DIMA D, 2009, NEUROIMAGE; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; Hudson TE, 2007, J NEUROPHYSIOL, V98, P3034, DOI 10.1152/jn.00858.2007; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Lewis RF, 2001, EXP BRAIN RES, V138, P263, DOI 10.1007/s002210100719; Miyazaki M, 2005, J NEUROPHYSIOL, V94, P395, DOI 10.1152/jn.01168.2004; Nezafat R, 2001, EXP BRAIN RES, V140, P66, DOI 10.1007/s002210100787; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Schultz W, 2008, PHILOS T R SOC B, V363, P3801, DOI 10.1098/rstb.2008.0152; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; Tenenbaum JB, 2006, TRENDS COGN SCI, V10, P309, DOI 10.1016/j.tics.2006.05.009; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	29	88	88	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12686	10.1371/journal.pone.0012686	http://dx.doi.org/10.1371/journal.pone.0012686			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844766	Green Submitted, gold, Green Published			2022-12-27	WOS:000281687300020
J	Mueller, UG; Scott, JJ; Ishak, HD; Cooper, M; Rodrigues, A				Mueller, Ulrich G.; Scott, Jarrod J.; Ishak, Heather D.; Cooper, Michael; Rodrigues, Andre			Monoculture of Leafcutter Ant Gardens	PLOS ONE			English	Article							FUNGUS-GROWING ANTS; ATTINE ANT; SYMBIONT CHOICE; EVOLUTION; ATTA; CONFLICT; COEVOLUTION; MICROSATELLITES; PSEUDONOCARDIA; AGRICULTURE	Background: Leafcutter ants depend on the cultivation of symbiotic Attamyces fungi for food, which are thought to be grown by the ants in single-strain, clonal monoculture throughout the hundreds to thousands of gardens within a leafcutter nest. Monoculture eliminates cultivar-cultivar competition that would select for competitive fungal traits that are detrimental to the ants, whereas polyculture of several fungi could increase nutritional diversity and disease resistance of genetically variable gardens. Methodology/Principal Findings: Using three experimental approaches, we assessed cultivar diversity within nests of Atta leafcutter ants, which are most likely among all fungus-growing ants to cultivate distinct cultivar genotypes per nest because of the nests' enormous sizes (up to 5000 gardens) and extended lifespans (10-20 years). In Atta texana and in A. cephalotes, we resampled nests over a 5-year period to test for persistence of resident cultivar genotypes within each nest, and we tested for genetic differences between fungi from different nest sectors accessed through excavation. In A. texana, we also determined the number of Attamyces cells carried as a starter inoculum by a dispersing queens (minimally several thousand Attamyces cells), and we tested for genetic differences between Attamyces carried by sister queens dispersing from the same nest. Except for mutational variation arising during clonal Attamyces propagation, DNA fingerprinting revealed no evidence for fungal polyculture and no genotype turnover during the 5-year surveys. Conclusions/Significance: Atta leafcutter ants can achieve stable, fungal monoculture over many years. Mutational variation emerging within an Attamyces monoculture could provide genetic diversity for symbiont choice (gardening biases of the ants favoring specific mutational variants), an analog of artificial selection.	[Mueller, Ulrich G.; Scott, Jarrod J.; Ishak, Heather D.; Cooper, Michael; Rodrigues, Andre] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Mueller, Ulrich G.; Scott, Jarrod J.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Scott, Jarrod J.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Rodrigues, Andre] State Univ Sao Paulo UNESP, Ctr Study Social Insects, Sao Paulo, Brazil; [Rodrigues, Andre] Santa Cruz State Univ UESC, Dept Biol Sci, Ilheus, BA, Brazil	University of Texas System; University of Texas Austin; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Wisconsin System; University of Wisconsin Madison; Universidade Estadual Paulista; Universidade Estadual de Santa Cruz	Mueller, UG (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	umueller@mail.utexas.edu	Rodrigues, Andre/B-8148-2012	Rodrigues, Andre/0000-0002-4164-9362; Scott, Jarrod/0000-0001-9863-1318	National Science Foundation [DEB-0920138, DEB-0639879, DEB-0110073, DEB-0949689]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [02/05]; Division Of Environmental Biology [0919519] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The research was supported by National Science Foundation awards DEB-0920138, DEB-0639879, and DEB-0110073 to UGM; DEB-0949689 to T. R. Schultz, N. Mehdiabadi, and UGM; and a Fellowship (02/05) from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico to AR. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanen DK, 2009, SCIENCE, V326, P1103, DOI 10.1126/science.1173462; Advani NK, 2006, INSECT SOC, V53, P446, DOI 10.1007/s00040-005-0892-7; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Boomsma JJ, 2009, P NATL ACAD SCI USA, V106, P17611, DOI 10.1073/pnas.0910004106; BRUCH C, 1919, REV SOC ARGENT CIENC, V4, P579; Cahan S, 1999, BEHAV ECOL, V10, P585, DOI 10.1093/beheco/10.5.585; Caldera EJ, 2009, ENVIRON ENTOMOL, V38, P78, DOI 10.1603/022.038.0110; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; Currie CR, 1999, P NATL ACAD SCI USA, V96, P7998, DOI 10.1073/pnas.96.14.7998; Dutech C, 2007, FUNGAL GENET BIOL, V44, P933, DOI 10.1016/j.fgb.2007.05.003; Fernandez-Marin H, 2006, P ROY SOC B-BIOL SCI, V273, P1689, DOI 10.1098/rspb.2006.3492; Fernandez-Marin H, 2009, P ROY SOC B-BIOL SCI, V276, P2263, DOI 10.1098/rspb.2009.0184; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Frank SA, 1996, P ROY SOC B-BIOL SCI, V263, P339, DOI 10.1098/rspb.1996.0052; Gerardo NM, 2006, PLOS BIOL, V4, P1358, DOI 10.1371/journal.pbio.0040235; Gerardo NM, 2004, P ROY SOC B-BIOL SCI, V271, P1791, DOI 10.1098/rspb.2004.2792; Goncalves C. R., 1961, Studia Entomologica Petropolis (NS), V4, P113; Grosberg RK, 1998, TRENDS ECOL EVOL, V13, P112, DOI 10.1016/S0169-5347(97)01313-X; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; HERVEY A, 1977, BRITTONIA, V29, P226, DOI 10.2307/2805856; Huber J, 1905, BIOL CENTRALBLATT, V25, P606; Huber J., 1905, BIOL CENTRALBLATT, V25, P606; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Licht HHD, 2010, EVOLUTION, V64, P2055, DOI 10.1111/j.1558-5646.2010.00948.x; Lim S, 2004, FUNGAL GENET BIOL, V41, P1025, DOI 10.1016/j.fgb.2004.08.004; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Mehdiabadi NJ, 2006, BEHAV ECOL, V17, P291, DOI 10.1093/beheco/arj028; Mikheyev AS, 2007, MOL ECOL, V16, P209, DOI 10.1111/j.1365-294X.2006.03134.x; Mikheyev AS, 2006, P NATL ACAD SCI USA, V103, P10702, DOI 10.1073/pnas.0601441103; Mikheyev AS, 2010, AM NAT, V175, pE126, DOI 10.1086/652472; MINTZER A C, 1991, Psyche (Cambridge), V98, P1, DOI 10.1155/1991/71624; MINTZER AC, 1987, INSECT SOC, V34, P108, DOI 10.1007/BF02223829; Mohali Sari, 1998, Revista de Ecologia LatinoAmericana, V5, P1; Moller A., 1893, BOT MITT TROP, V6, P1; Moreira AA, 2004, STUD NEOTROP FAUNA E, V39, P109, DOI 10.1080/01650520412331333756; Moser JC, 2006, ANN ENTOMOL SOC AM, V99, P891, DOI 10.1603/0013-8746(2006)99[891:CEAMOA]2.0.CO;2; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Mueller UG, 2002, P NATL ACAD SCI USA, V99, P15247, DOI 10.1073/pnas.242594799; Mueller UG, 2002, AM NAT, V160, pS67, DOI 10.1086/342084; Mueller UG, 2004, BEHAV ECOL, V15, P357, DOI 10.1093/beheco/arh020; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; Mueller UG, 2008, EVOLUTION, V62, P2894, DOI 10.1111/j.1558-5646.2008.00501.x; Mueller UG, 2008, P NATL ACAD SCI USA, V105, P5287, DOI 10.1073/pnas.0801464105; Mueller UG, 2010, ANTON LEEUW INT J G, V98, P195, DOI 10.1007/s10482-010-9427-3; Mundt CC, 2002, ANNU REV PHYTOPATHOL, V40, P381, DOI 10.1146/annurev.phyto.40.011402.113723; Pagnocca FC, 2001, MYCOL RES, V105, P173, DOI 10.1017/S0953756200003191; Pinto-Tomas AA, 2009, SCIENCE, V326, P1120, DOI 10.1126/science.1173036; Poulsen M, 2005, SCIENCE, V307, P741, DOI 10.1126/science.1106688; Rodrigues A, 2008, MICROB ECOL, V56, P604, DOI 10.1007/s00248-008-9380-0; Rodrigues A, 2009, ANTON LEEUW INT J G, V96, P331, DOI 10.1007/s10482-009-9350-7; Roze D, 2001, AM NAT, V158, P638, DOI 10.1086/323590; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Santos AV, 2004, FEMS MICROBIOL LETT, V239, P319, DOI 10.1016/j.femsle.2004.09.005; Scott JJ, 2009, MOL ECOL RESOUR, V9, P1391, DOI 10.1111/j.1755-0998.2009.02684.x; Sen R, 2010, BEHAV ECOL SOCIOBIOL, V64, P1125, DOI 10.1007/s00265-010-0928-x; Sen R, 2009, P NATL ACAD SCI USA, V106, P17805, DOI 10.1073/pnas.0904827106; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Solomon SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002738; STAHEL G, 1939, REV ENTOMOL, V102, P27; STAHEL GEROLD, 1941, REV ENT [RIO DE JANEIRO], V12, P243; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Vellinga EC, 2004, NOVA HEDWIGIA, V78, P273, DOI 10.1127/0029-5035/2004/0078-0273; Vo TL, 2009, MYCOLOGIA, V101, P206, DOI 10.3852/07-055; Wang Y, 1999, J CHEM ECOL, V25, P935, DOI 10.1023/A:1020861221126; Weber N. A., 1937, Tropical Agriculture Trinidad, V14, P223; Weber N. A., 1972, GARDENING ANTS ATTIN; Wheeler WM, 1907, B AM MUS NAT HIST, V23, P669; WILSON EO, 1980, BEHAV ECOL SOCIOBIOL, V7, P143, DOI 10.1007/BF00299520; Wirth R., 2003, HERBIVORY LEAFCUTTIN; YEK SH, 2010, BIOL REV IN PRESS	71	53	53	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12668	10.1371/journal.pone.0012668	http://dx.doi.org/10.1371/journal.pone.0012668			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844760	Green Submitted, Green Published, gold			2022-12-27	WOS:000281687300012
J	Philip, SS; Yu, XS; Donnell, D; Vittinghoff, E; Buchbinder, S				Philip, Susan S.; Yu, Xuesong; Donnell, Deborah; Vittinghoff, Eric; Buchbinder, Susan			Serosorting Is Associated with a Decreased Risk of HIV Seroconversion in the EXPLORE Study Cohort	PLOS ONE			English	Article							SEXUAL PARTNERS; HOMOSEXUAL-MEN; GAY MEN; REDUCTION; INFECTION; BEHAVIORS; PERCEPTIONS; INCREASE; MSM	Background: Seroadaptation strategies such as serosorting and seropositioning originated within communities of men who have sex with men (MSM), but there are limited data about their effectiveness in preventing HIV transmission when utilized by HIV-negative men. Methodology/Principal Findings: Data from the EXPLORE cohort of HIV-negative MSM who reported both seroconcordant and serodiscordant partners were used to evaluate serosorting and seropositioning. The association of serosorting and seropositioning with HIV seroconversion was evaluated in this cohort of high risk MSM from six U.S. cities. Serosorting was independently associated with a small decrease in risk of HIV seroconversion (OR = 0.88; 95% CI, 0.81-0.95), even among participants reporting >= 10 partners. Those who more consistently practiced serosorting were more likely to be white (p = 0.01), have completed college (p = <0.0002) and to have had 10 or more partners in the six months before the baseline visit (p = 0.01) but did not differ in age, reporting HIV-infected partners, or drug use. There was no evidence of a seroconversion effect with seropositioning (OR 1.02, 95% CI, 0.92-1.14). Significance: In high risk HIV uninfected MSM who report unprotected anal intercourse with both seroconcordant and serodiscordant partners, serosorting was associated with a modest decreased risk of HIV infection. To maximize any potential benefit, it will be important to increase accurate knowledge of HIV status, through increased testing frequency, improved test technology, and continued development of strategies to increase disclosure.	[Philip, Susan S.; Buchbinder, Susan] San Francisco Dept Publ Hlth, San Francisco, CA USA; [Yu, Xuesong; Donnell, Deborah] Stat Ctr HIV AIDS Res & Prevent, Seattle, WA USA; [Philip, Susan S.; Vittinghoff, Eric; Buchbinder, Susan] Univ Calif San Francisco, San Francisco, CA 94143 USA	San Francisco Department of Public Health; Fred Hutchinson Cancer Center; University of California System; University of California San Francisco	Philip, SS (corresponding author), San Francisco Dept Publ Hlth, San Francisco, CA USA.	Susan.Philip@sfdph.org		Donnell, Deborah/0000-0002-0587-7480	National Institute of Allergy and Infectious Diseases; National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute of Mental Health; Office of AIDS Research, of the National Institutes of Health, United States Department of Health and Human Services [5 U01 AI46749]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI047981, U01AI047995, U01AI046749] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of AIDS Research, of the National Institutes of Health, United States Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the HIV Prevention Trials Network and sponsored by the National Institute of Allergy and Infectious Diseases, the National Institute of Child Health and Human Development, the National Institute on Drug Abuse, the National Institute of Mental Health, and the Office of AIDS Research, of the National Institutes of Health, United States Department of Health and Human Services, through a cooperative agreement with Family Health International (cooperative agreement 5 U01 AI46749) with a subsequent subcontract to Abt Associates Inc., with cooperative agreement U01 AI47981 to the University of Washington; and cooperative agreement U01 AI47995 to the University of California San Francisco. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Sifakis F., 2005, Morbidity and Mortality Weekly Report, V54, P597; Buchbinder SP, 2005, JAIDS-J ACQ IMM DEF, V39, P82, DOI 10.1097/01.qai.0000134740.41585.f4; Butler DM, 2007, AIDS, V21, P1218, DOI 10.1097/QAD.0b013e32814db7bf; Cox J, 2004, SEX TRANSM INFECT, V80, P518, DOI 10.1136/sti.2004.011288; Eaton LA, 2007, AM J PREV MED, V33, P479, DOI 10.1016/j.amepre.2007.08.004; Elford J, 2007, AIDS, V21, P243, DOI 10.1097/QAD.0b013e3280118fdb; Fenton KA, 2005, INFECT DIS CLIN N AM, V19, P311, DOI 10.1016/j.idc.2005.04.004; Golden MR, 2008, JAIDS-J ACQ IMM DEF, V49, P212, DOI 10.1097/QAI.0b013e31818455e8; Grov C, 2007, AIDS BEHAV, V11, P527, DOI 10.1007/s10461-007-9234-7; Jin FY, 2007, JAIDS-J ACQ IMM DEF, V46, P245, DOI 10.1097/QAI.0b013e3181565db5; Jin FY, 2009, AIDS, V23, P243, DOI 10.1097/QAD.0b013e32831fb51a; Klitzman R, 2007, AIDS CARE, V19, P749, DOI 10.1080/09540120600983971; Koblin B, 2004, LANCET, V364, P41, DOI 10.1016/S0140-6736(04)16588-4; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Koblin BA, 2003, AM J PUBLIC HEALTH, V93, P926, DOI 10.2105/AJPH.93.6.926; MacKellar DA, 2005, JAIDS-J ACQ IMM DEF, V38, P603, DOI 10.1097/01.qai.0000141481.48348.7e; Parsons JT, 2005, AIDS, V19, pS13, DOI 10.1097/01.aids.0000167348.15750.9a; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; THIEDE H, 2008, AM J PUBLIC HLTH; TRUONG HM, 2004, INCREASES SEROSORTIN; Van de Ven P, 2002, AIDS CARE, V14, P471, DOI 10.1080/09540120208629666; Xia Q, 2006, AIDS, V20, P2081, DOI 10.1097/01.aids.0000247566.57762.b2	22	62	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12662	10.1371/journal.pone.0012662	http://dx.doi.org/10.1371/journal.pone.0012662			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	648IW	20844744	gold, Green Published, Green Submitted			2022-12-27	WOS:000281687200020
J	Lee, Y; Bang, WY; Kim, S; Lazar, P; Kim, CW; Bahk, JD; Lee, KW				Lee, Yuno; Bang, Woo Young; Kim, Songmi; Lazar, Prettina; Kim, Chul Wook; Bahk, Jeong Dong; Lee, Keun Woo			Molecular Modeling Study for Interaction between Bacillus subtilis Obg and Nucleotides	PLOS ONE			English	Article							GTP-BINDING PROTEIN; 50S RIBOSOMAL-SUBUNIT; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; MUTATION; GTPASES; DOMAIN; GENE; OVEREXPRESSION; SPORULATION	The bacterial Obg proteins (Spo0B-associated GTP-binding protein) belong to the subfamily of P-loop GTPase proteins that contain two equally and highly conserved domains, a C-terminal GTP binding domain and an N-terminal glycine-rich domain which is referred as the "Obg fold'' and now it is considered as one of the new targets for antibacterial drug. When the Obg protein is associated with GTP, it becomes activated, because conformation of Obg fold changes due to the structural changes of GTPase switch elements in GTP binding site. In order to investigate the effects and structural changes in GTP bound to Obg and GTPase switch elements for activation, four different molecular dynamics (MD) simulations were performed with/without the three different nucleotides (GTP, GDP, and GDP + Pi) using the Bacillus subtilis Obg (BsObg) structure. The protein structures generated from the four different systems were compared using their representative structures. The pattern of C(alpha)-C(alpha) distance plot and angle between the two Obg fold domains of simulated apo form and each system (GTP, GDP, and GDP+Pi) were significantly different in the GTP-bound system from the others. The switch 2 element was significantly changed in GTP-bound system. Also root-mean-square fluctuation (RMSF) analysis revealed that the flexibility of the switch 2 element region was much higher than the others. This was caused by the characteristic binding mode of the nucleotides. When GTP was bound to Obg, its gamma-phosphate oxygen was found to interact with the key residue (D212) of the switch 2 element, on the contrary there was no such interaction found in other systems. Based on the results, we were able to predict the possible binding conformation of the activated form of Obg with L13, which is essential for the assembly with ribosome.	[Lee, Yuno; Bang, Woo Young; Kim, Songmi; Lazar, Prettina; Bahk, Jeong Dong; Lee, Keun Woo] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Environm Biotechnol Natl Core Res Ctr, Div Appl Life Sci, Jinju, Gyeongsangnam D, South Korea; [Bang, Woo Young; Kim, Chul Wook] Jinju Natl Univ, Swine Sci & Technol Ctr, Jinju, Gyeongsangnam D, South Korea	Gyeongsang National University	Lee, Y (corresponding author), Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Environm Biotechnol Natl Core Res Ctr, Div Appl Life Sci, Jinju, Gyeongsangnam D, South Korea.	kwlee@gnu.ac.kr			Ministry of Education, Science and Technology (MEST) [2009-0073267, 2009-0081539, 2009-0093813, 20090091489]	Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program (2009-0073267), Pioneer Research Center Program (2009-0081539), Priority Research Centers Program (2009-0093813), and Environmental Biotechnology National Core Research Center program (20090091489) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST). All students were recipients of fellowship from the BK21 Program of MEST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Brigo A, 2005, BIOPHYS J, V88, P3072, DOI 10.1529/biophysj.104.050286; Buglino J, 2002, STRUCTURE, V10, P1581, DOI 10.1016/S0969-2126(02)00882-1; Caldon CE, 2003, CURR OPIN MICROBIOL, V6, P135, DOI 10.1016/S1369-5274(03)00037-7; Comartin DJ, 2006, CURR OPIN PHARMACOL, V6, P453, DOI 10.1016/j.coph.2006.05.005; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Datta K, 2004, MOL MICROBIOL, V54, P1379, DOI 10.1111/j.1365-2958.2004.04354.x; Dutkiewicz R, 2002, CURR MICROBIOL, V45, P440, DOI 10.1007/s00284-002-3713-x; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Jiang MX, 2006, J BACTERIOL, V188, P6757, DOI 10.1128/JB.00444-06; Kobayashi G, 2001, MOL MICROBIOL, V41, P1037, DOI 10.1046/j.1365-2958.2001.02574.x; KOK J, 1994, J BACTERIOL, V176, P7155, DOI 10.1128/JB.176.23.7155-7160.1994; Kukimoto-Niino M, 2004, J MOL BIOL, V337, P761, DOI 10.1016/j.jmb.2004.01.047; Kuo S, 2008, J BACTERIOL, V190, P6625, DOI 10.1128/JB.00799-08; LEE Y, 2009, INTERDISCIPLINARY BI, V1, P1; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lin B, 2004, J BACTERIOL, V186, P481, DOI 10.1128/JB.186.2.481-489.2004; Lin B, 2001, MOL MICROBIOL, V39, P924, DOI 10.1046/j.1365-2958.2001.02285.x; Maddock J, 1997, J BACTERIOL, V179, P6426, DOI 10.1128/jb.179.20.6426-6431.1997; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Okamoto S, 1998, MOL MICROBIOL, V30, P107, DOI 10.1046/j.1365-2958.1998.01042.x; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Sato A, 2005, GENES CELLS, V10, P393, DOI 10.1111/j.1365-2443.2005.00851.x; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott JM, 2000, J BACTERIOL, V182, P2771, DOI 10.1128/JB.182.10.2771-2777.2000; Scott JM, 1999, J BACTERIOL, V181, P4653, DOI 10.1128/JB.181.15.4653-4660.1999; Sikora AE, 2006, J BACTERIOL, V188, P1205, DOI 10.1128/JB.188.3.1205-1210.2006; Slominska M, 2002, BIOCHEM J, V362, P579, DOI 10.1042/0264-6021:3620579; Tan J, 2002, J BACTERIOL, V184, P2692, DOI 10.1128/JB.184.10.2692-2698.2002; TRACH K, 1989, J BACTERIOL, V171, P1362, DOI 10.1128/jb.171.3.1362-1371.1989; van der Spoel D., 2005, GROMACS USER MANUAL; VIDWANS SJ, 1995, J BACTERIOL, V177, P3308, DOI 10.1128/jb.177.11.3308-3311.1995; Wittinghofer A, 2002, STRUCTURE, V10, P1471, DOI 10.1016/S0969-2126(02)00892-4; Wout P, 2004, J BACTERIOL, V186, P5249, DOI 10.1128/JB.186.16.5249-5257.2004	36	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12597	10.1371/journal.pone.0012597	http://dx.doi.org/10.1371/journal.pone.0012597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830302	gold, Green Published, Green Submitted			2022-12-27	WOS:000281631300024
J	Acevedo, JM; Centanin, L; Dekanty, A; Wappner, P				Acevedo, Julieta M.; Centanin, Lazaro; Dekanty, Andres; Wappner, Pablo			Oxygen Sensing in Drosophila: Multiple Isoforms of the Prolyl Hydroxylase Fatiga Have Different Capacity to Regulate HIF alpha/Sima	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; TRANSCRIPTIONAL RESPONSE; DOMAIN PROTEINS; HIF-1-ALPHA; CELLS; PHD2; O-2; FACTOR-1-ALPHA; LOCALIZATION; INHIBITION	Background: The Hypoxia Inducible Factor (HIF) mediates cellular adaptations to low oxygen. Prolyl-4-hydroxylases are oxygen sensors that hydroxylate the HIF alpha-subunit, promoting its proteasomal degradation in normoxia. Three HIFprolyl hydroxylases, encoded by independent genes, PHD1, PHD2, and PHD3, occur in mammals. PHD2, the longest PHD isoform includes a MYND domain, whose biochemical function is unclear. PHD2 and PHD3 genes are induced in hypoxia to shut down HIF dependent transcription upon reoxygenation, while expression of PHD1 is oxygen-independent. The physiologic significance of the diversity of the PHD oxygen sensors is intriguing. Methodology and Principal Findings: We have analyzed the Drosophila PHD locus, fatiga, which encodes 3 isoforms, FgaA, FgaB and FgaC that are originated through a combination of alternative initiation of transcription and alternative splicing. FgaA includes a MYND domain and is homologous to PHD2, while FgaB and FgaC are shorter isoforms most similar to PHD3. Through a combination of genetic experiments in vivo and molecular analyses in cell culture, we show that fgaB but not fgaA is induced in hypoxia, in a Sima-dependent manner, through a HIF-Responsive Element localized in the first intron of fgaA. The regulatory capacity of FgaB is stronger than that of FgaA, as complete reversion of fga loss-of-function phenotypes is observed upon transgenic expression of the former, and only partial rescue occurs after expression of the latter. Conclusions and Significance: Diversity of PHD isoforms is a conserved feature in evolution. As in mammals, there are hypoxia-inducible and non-inducible Drosophila PHDs, and a fly isoform including a MYND domain co-exists with isoforms lacking this domain. Our results suggest that the isoform devoid of a MYND domain has stronger regulatory capacity than that including this domain.	[Acevedo, Julieta M.; Centanin, Lazaro; Dekanty, Andres; Wappner, Pablo] Inst Leloir, Buenos Aires, DF, Argentina; [Wappner, Pablo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Acevedo, Julieta M.; Wappner, Pablo] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina	Leloir Institute; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Acevedo, JM (corresponding author), Inst Leloir, Buenos Aires, DF, Argentina.	pwappner@leloir.org.ar	Dekanty, Andres/C-3925-2018	Dekanty, Andres/0000-0002-0587-0449; Centanin, Lazaro/0000-0003-3889-4524; Wappner, Pablo/0000-0003-1517-0742; Acevedo, Julieta/0000-0003-2572-6222	Agencia de Promocion Cientifica y Tecnologica [PICT 0665]; Howard Hughes Medical Institute [55005973]; Wellcome Trust [WT087675MA]	Agencia de Promocion Cientifica y Tecnologica(ANPCyT); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Agencia de Promocion Cientifica y Tecnologica grant PICT 0665, the Howard Hughes Medical Institute grant Nu 55005973 and the Wellcome Trust grant WT087675MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansieau S, 2002, J BIOL CHEM, V277, P4906, DOI 10.1074/jbc.M110078200; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Barth S, 2009, J BIOL CHEM, V284, P23046, DOI 10.1074/jbc.M109.032631; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bruick RK, 2003, GENE DEV, V17, P2614, DOI 10.1101/gad.1145503; Centanin L, 2005, EMBO REP, V6, P1070, DOI 10.1038/sj.embor.7400528; Centanin L, 2008, DEV CELL, V14, P547, DOI 10.1016/j.devcel.2008.01.020; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Choi KO, 2005, MOL PHARMACOL, V68, P1803, DOI 10.1124/mol.105.015271; Dekanty A, 2005, J CELL SCI, V118, P5431, DOI 10.1242/jcs.02648; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Frei C, 2004, DEV CELL, V6, P241, DOI 10.1016/S1534-5807(03)00409-X; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Lavista-Llanos S, 2002, MOL CELL BIOL, V22, P6842, DOI 10.1128/MCB.22.19.6842-6853.2002; MAXWELL PH, 1993, P NATL ACAD SCI USA, V90, P2423, DOI 10.1073/pnas.90.6.2423; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Ozer A, 2005, P NATL ACAD SCI USA, V102, P7481, DOI 10.1073/pnas.0502716102; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; To KKW, 2005, J BIOL CHEM, V280, P38102, DOI 10.1074/jbc.M504342200; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12	31	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12390	10.1371/journal.pone.0012390	http://dx.doi.org/10.1371/journal.pone.0012390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811646	Green Published, gold, Green Submitted			2022-12-27	WOS:000281234700015
J	Zavadil, J; Ye, HH; Liu, ZJ; Wu, JJ; Lee, P; Hernando, E; Soteropoulos, P; Toruner, GA; Wei, JJ				Zavadil, Jiri; Ye, Huihui; Liu, Zhaojian; Wu, JingJing; Lee, Peng; Hernando, Eva; Soteropoulos, Patricia; Toruner, Gokce A.; Wei, Jian-Jun			Profiling and Functional Analyses of MicroRNAs and Their Target Gene Products in Human Uterine Leiomyomas	PLOS ONE			English	Article							EXPRESSION PROFILE; TUMORIGENIC FACTORS; TUMOR SIZE; TUBERIN; CANCER; LET-7; DIFFERENTIATION; PATHOGENESIS; SIGNATURES; FIBROIDS	Background: Human uterine leiomyomas (ULM) are characterized by dysregulation of a large number of genes and non-coding regulatory microRNAs. In order to identify microRNA:: mRNA associations relevant to ULM pathogenesis, we examined global correlation patterns between the altered microRNA expression and the predicted target genes in ULMs and matched myometria. Methodology/Principal Findings: Patterns of inverse association of microRNA with mRNA expression in ULMs revealed an involvement of multiple candidate pathways, including extensive transcriptional reprogramming, cell proliferation control, MAP kinase, TGF-beta, WNT, JAK/STAT signaling, remodeling of cell adhesion, and cell-cell and cell-matrix contacts. We further examined the correlation between the expression of the selected target gene protein products and microRNAs in thirty-six paired sets of leiomyomas and matched myometria. We found that a number of dysregulated microRNAs were inversely correlated with their targets at the protein level. The comparative genomic hybridization (CGH) in eight ULM patients revealed that partially shared deletions of two distinct chromosomal regions might be responsible for loss of cancer-associated microRNA expression and could thus contribute to the ULM pathogenesis via deregulation of target mRNAs. Last, we functionally tested the repressor effects of selected cancer-related microRNAs on their predicted target genes in vitro. Conclusions/Significance: We found that some but not all of the predicted and inversely correlated target genes in ULMs can be directly regulated by microRNAs in vitro. Our findings provide a broad overview of molecular events underlying the tumorigenesis of uterine ULMs and identify select genetic and regulatory events that alter microRNA expression and may play important roles in ULM pathobiology by positively regulating tumor growth while maintaining the non-invasive character of ULMs.	[Zavadil, Jiri; Ye, Huihui; Lee, Peng; Hernando, Eva] NYU, Sch Med, Dept Pathol, New York, NY 10012 USA; [Zavadil, Jiri] NYU, Inst Canc, New York, NY USA; [Zavadil, Jiri] NYU, Ctr Hlth Informat & Bioinformat, New York, NY USA; [Liu, Zhaojian; Wu, JingJing; Wei, Jian-Jun] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Soteropoulos, Patricia] Univ Med & Dent New Jersey, Dept Microbiol & Mol Genet, Publ Hlth Res Inst, Newark, NJ 07103 USA; [Toruner, Gokce A.] Univ Med & Dent New Jersey, Dept Pediat, Inst Genom Med, Newark, NJ 07103 USA	New York University; New York University; New York University; Northwestern University; Feinberg School of Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Zavadil, J (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10012 USA.	jianjun-wei@northwestern.edu	WEI, JJ/AAN-2638-2020; Toruner, Gokce A/J-5665-2015; Zavadil, Jiri/ABG-1780-2020; Toruner, Gokce/AAD-8412-2019	Zavadil, Jiri/0000-0003-0640-5562; Toruner, Gokce/0000-0002-5305-6337; Hernando, Eva/0000-0003-1023-0312	Department of Defence [W81XWH-09-1-0166]; National Institutes of Health [R03HD057380]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD057380] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER	Department of Defence; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded by Department of Defence Tuberous Sclerosis Complex Research Program (TSCRP) award W81XWH-09-1-0166 and National Institutes of Health Small Grant Program (NIH RO3) grant R03HD057380. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Arslan AA, 2005, HUM REPROD, V20, P852, DOI 10.1093/humrep/deh698; Bendoraite A, 2010, GYNECOL ONCOL, V116, P117, DOI 10.1016/j.ygyno.2009.08.009; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Carney SA, 2002, LAB INVEST, V82, P719, DOI 10.1097/01.LAB.0000017499.51216.3E; Catherino WH, 2004, GENE CHROMOSOME CANC, V40, P204, DOI 10.1002/gcc.20035; Chegini N, 2003, J SOC GYNECOL INVEST, V10, P161, DOI 10.1016/S1071-5576(03)00004-2; Cochrane DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/821717; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Flake GP, 2003, ENVIRON HEALTH PERSP, V111, P1037, DOI 10.1289/ehp.5787; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hoffman PJ, 2004, FERTIL STERIL, V82, P639, DOI 10.1016/j.fertnstert.2004.01.047; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kim VN, 2005, MOL CELLS, V19, P1; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Liu TL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000804; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo XP, 2005, ENDOCRINOLOGY, V146, P1097, DOI 10.1210/en.2004-1377; Marsh EE, 2008, FERTIL STERIL, V89, P1771, DOI 10.1016/j.fertnstert.2007.05.074; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Mizuguchi M, 1996, ANN NEUROL, V40, P941, DOI 10.1002/ana.410400621; Mizuguchi M, 1997, ACTA NEUROPATHOL, V94, P525, DOI 10.1007/s004010050746; Pan Q, 2008, J CELL MOL MED, V12, P227, DOI 10.1111/j.1582-4934.2007.00207.x; Peng Y, 2008, MOL CANCER RES, V6, P663, DOI 10.1158/1541-7786.MCR-07-0370; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Wang TS, 2007, GENE CHROMOSOME CANC, V46, P336, DOI 10.1002/gcc.20415; Wei JJ, 2005, FERTIL STERIL, V84, P474, DOI 10.1016/j.fertnstert.2005.01.142; Wei JJ, 2006, HUM REPROD, V21, P57, DOI 10.1093/humrep/dei309; Wei JJ, 2005, MODERN PATHOL, V18, P179, DOI 10.1038/modpathol.3800283; Weston G, 2003, MOL HUM REPROD, V9, P541, DOI 10.1093/molehr/gag066; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P152, DOI 10.1093/nar/gkl1032; Zavadil J, 2007, CELLS TISSUES ORGANS, V185, P157, DOI 10.1159/000101316; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036	45	55	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12362	10.1371/journal.pone.0012362	http://dx.doi.org/10.1371/journal.pone.0012362			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808773	Green Published, Green Submitted, gold			2022-12-27	WOS:000281154300005
J	Qian, J; Gao, HJ				Qian, Jin; Gao, Huajian			Soft Matrices Suppress Cooperative Behaviors among Receptor-Ligand Bonds in Cell Adhesion	PLOS ONE			English	Article							MEMBRANE ADHESION; PATTERN-FORMATION; MOLECULAR-BOND; FORCE; MECHANICS; DYNAMICS; LIFETIME; ELASTICITY; STRENGTH; CLUSTERS	The fact that biological tissues are stable over prolonged periods of time while individual receptor-ligand bonds only have limited lifetime underscores the critical importance of cooperative behaviors of multiple molecular bonds, in particular the competition between the rate of rupture of closed bonds (death rate) and the rate of rebinding of open bonds (birth rate) in a bond cluster. We have recently shown that soft matrices can greatly increase the death rate in a bond cluster by inducing severe stress concentration near the adhesion edges. In the present paper, we report a more striking effect that, irrespective of stress concentration, soft matrices also suppress the birth rate in a bond cluster by increasing the local separation distance between open bonds. This is shown by theoretical analysis as well as Monte Carlo simulations based on a stochastic-elasticity model in which stochastic descriptions of molecular bonds and elastic descriptions of interfacial force/separation are unified in a single modeling framework. Our findings not only are important for understanding the role of elastic matrices in cell adhesion, but also have general implications on adhesion between soft materials.	[Qian, Jin; Gao, Huajian] Brown Univ, Sch Engn, Providence, RI 02912 USA	Brown University	Qian, J (corresponding author), Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	huajian_gao@brown.edu	Qian, Jin/C-6115-2008; Gao, Huajian/F-9360-2010	Gao, Huajian/0000-0002-8656-846X	National Science Foundation (NSF) [CMMI-1028530]	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea)	Financial support from the National Science Foundation (NSF: CMMI-1028530) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALON R, 1995, NATURE, V374, P539, DOI 10.1038/374539a0; Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Buehler MJ, 2006, MODEL SIMUL MATER SC, V14, P799, DOI 10.1088/0965-0393/14/5/001; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Chang KC, 2000, P NATL ACAD SCI USA, V97, P11262, DOI 10.1073/pnas.200240897; Chen X, 2006, CURR OPIN CELL BIOL, V18, P572, DOI 10.1016/j.ceb.2006.07.002; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Erdmann T, 2007, EUR PHYS J E, V22, P123, DOI 10.1140/epje/e2007-00019-8; Erdmann T, 2004, J CHEM PHYS, V121, P8997, DOI 10.1063/1.1805496; Erdmann T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.108102; Erdmann T, 2006, BIOPHYS J, V91, pL60, DOI 10.1529/biophysj.106.090209; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; EVANS EA, 1985, BIOPHYS J, V48, P175, DOI 10.1016/S0006-3495(85)83770-X; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Freund LB, 2009, P NATL ACAD SCI USA, V106, P8818, DOI 10.1073/pnas.0903003106; Freund LB, 2004, J MECH PHYS SOLIDS, V52, P2455, DOI 10.1016/j.jmps.2004.05.004; Gao HJ, 2005, P NATL ACAD SCI USA, V102, P9469, DOI 10.1073/pnas.0503879102; Gao HJ, 2005, MECH MATER, V37, P275, DOI 10.1016/j.mechmat.2004.03.008; Gao HJ, 2004, P NATL ACAD SCI USA, V101, P7851, DOI 10.1073/pnas.0400757101; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goel N., 1974, STOCHASTIC MODELS BI; Johnson K. L., 1985, CONTACT MECH, DOI 10.1201/b17110-2; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; Lin Y, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.021909; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Qian J, 2008, LANGMUIR, V24, P1262, DOI 10.1021/la702401b; Qian J, 2009, BIOPHYS J, V97, P2438, DOI 10.1016/j.bpj.2009.08.027; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Schwarz US, 2004, P NATL ACAD SCI USA, V101, P6940, DOI 10.1073/pnas.0305822101; Seifert U, 2000, PHYS REV LETT, V84, P2750, DOI 10.1103/PhysRevLett.84.2750; Shenoy VB, 2005, P NATL ACAD SCI USA, V102, P3213, DOI 10.1073/pnas.0500368102; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Tada H., 2000, STRESS ANAL CRACKS H; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Walcott S, 2010, P NATL ACAD SCI USA, V107, P7757, DOI 10.1073/pnas.0912739107; Weikl TR, 2004, BIOPHYS J, V87, P3665, DOI 10.1529/biophysj.104.045609; Zamir E, 2001, J CELL SCI, V114, P3583; Zhu C, 2000, ANNU REV BIOMED ENG, V2, P189, DOI 10.1146/annurev.bioeng.2.1.189	56	35	35	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12342	10.1371/journal.pone.0012342	http://dx.doi.org/10.1371/journal.pone.0012342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808789	Green Published, gold, Green Submitted			2022-12-27	WOS:000281153500022
J	Chen, XF; Li, XL; Wang, P; Liu, Y; Zhang, ZG; Zhao, GP; Xu, HM; Zhu, J; Qin, XY; Chen, SC; Hu, LD; Kong, XY				Chen, Xianfeng; Li, Xinlei; Wang, Ping; Liu, Yang; Zhang, Zhenguo; Zhao, Guoping; Xu, Haiming; Zhu, Jun; Qin, Xueying; Chen, Suchao; Hu, Landian; Kong, Xiangyin			Novel Association Strategy with Copy Number Variation for Identifying New Risk Loci of Human Diseases	PLOS ONE			English	Article							BIPOLAR-DISORDER; ENHANCER DETECTION; BREAST-CANCER; HUMAN GENOME; SCHIZOPHRENIA; NUCLEOTIDE; EXPRESSION; CHANNELS; MATTERS; CYP2D6	Background: Copy number variations (CNV) are important causal genetic variations for human disease; however, the lack of a statistical model has impeded the systematic testing of CNVs associated with disease in large-scale cohort. Methodology/Principal Findings: Here, we developed a novel integrated strategy to test CNV-association in genome-wide case-control studies. We converted the single-nucleotide polymorphism (SNP) signal to copy number states using a well-trained hidden Markov model. We mapped the susceptible CNV-loci through SNP site-specific testing to cope with the physiological complexity of CNVs. We also ensured the credibility of the associated CNVs through further window-based CNV-pattern clustering. Genome-wide data with seven diseases were used to test our strategy and, in total, we identified 36 new susceptible loci that are associated with CNVs for the seven diseases: 5 with bipolar disorder, 4 with coronary artery disease, 1 with Crohn's disease, 7 with hypertension, 9 with rheumatoid arthritis, 7 with type 1 diabetes and 3 with type 2 diabetes. Fifteen of these identified loci were validated through genotype-association and physiological function from previous studies, which provide further confidence for our results. Notably, the genes associated with bipolar disorder converged in the phosphoinositide/calcium signaling, a well-known affected pathway in bipolar disorder, which further supports that CNVs have impact on bipolar disorder. Conclusions/Significance: Our results demonstrated the effectiveness and robustness of our CNV-association analysis and provided an alternative avenue for discovering new associated loci of human diseases.	[Chen, Xianfeng; Li, Xinlei; Wang, Ping; Liu, Yang; Zhang, Zhenguo; Hu, Landian; Kong, Xiangyin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Chen, Xianfeng; Li, Xinlei; Wang, Ping; Liu, Yang; Zhang, Zhenguo; Hu, Landian; Kong, Xiangyin] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Zhao, Guoping] Chinese Natl Human Genome Ctr Shanghai, Shanghai, Peoples R China; [Xu, Haiming; Zhu, Jun] Zhejiang Univ, Coll Agr & Biotechnol, Inst Bioinformat, Hangzhou 310003, Zhejiang, Peoples R China; [Qin, Xueying; Chen, Suchao] Zhejiang Univ, State Key Lab Comp Aided Design & Comp Graph, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Landian; Kong, Xiangyin] Shanghai Jiao Tong Univ, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Zhejiang University; Zhejiang University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Chen, XF (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China.	xykong@sibs.ac.cn	Zhang, Zhenguo/C-9960-2016; Xu, Haiming/AAF-8067-2019	Zhang, Zhenguo/0000-0002-9444-9604; Zhao, Guo-Ping/0000-0002-7621-6620	National High Technology Research and Development Program of China [2006AA02Z330]; National Basic Research Program of China [2007CB512202, 2007CB512100, 2004CB518603]; National Natural Science Foundation of China [30530450]; Chinese Academy of Sciences [KSCX1-YW-R-74]; Wellcome Trust [076113]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000073] Funding Source: NIH RePORTER	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National High Technology Research and Development Program of China (No. 2006AA02Z330), the National Basic Research Program of China (Nos. 2007CB512202, 2007CB512100 and 2004CB518603), the National Natural Science Foundation of China, Key Program (No. 30530450) and the Knowledge Innovation Program of the Chinese Academy of Sciences (No. KSCX1-YW-R-74). This study uses data generated by the Wellcome Trust Case-Control Consortium; funding for the project was provided by the Wellcome Trust (Award 076113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; [Anonymous], 2007, NATURE, V447, P661; Barnes C, 2008, NAT GENET, V40, P1245, DOI 10.1038/ng.206; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Borsotto M, 2007, PHARMACOGENOMICS J, V7, P123, DOI 10.1038/sj.tpj.6500400; Carter CJ, 2007, NEUROCHEM INT, V50, P461, DOI 10.1016/j.neuint.2006.11.009; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de Witte MA, 2008, J IMMUNOL, V180, P6365, DOI 10.4049/jimmunol.180.9.6365; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Ellingsen S, 2005, DEVELOPMENT, V132, P3799, DOI 10.1242/dev.01951; Fedorenko O, 2008, PSYCHOPHARMACOLOGY, V199, P47, DOI 10.1007/s00213-008-1095-x; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Graves TD, 2005, POSTGRAD MED J, V81, P20, DOI 10.1136/pgmj.2004.022012; Hahn CG, 2005, AM J PSYCHIAT, V162, P616, DOI 10.1176/appi.ajp.162.3.616; Hauck CR, 2006, EUR J CELL BIOL, V85, P235, DOI 10.1016/j.ejcb.2005.08.002; Hoskins JM, 2009, NAT REV CANCER, V9, P576, DOI 10.1038/nrc2683; Ilia M, 2004, INT REV NEUROBIOL, V59, P471; Kikuta H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S4; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; LEWANDOWSKI ED, 1995, CIRCULATION, V91, P2071, DOI 10.1161/01.CIR.91.7.2071; Lui WWY, 2003, MOL BIOL CELL, V14, P2385, DOI 10.1091/mbc.e02-11-0735; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Moberg PJ, 1999, NEUROPSYCHOPHARMACOL, V21, P325, DOI 10.1016/S0893-133X(99)00019-6; Mudge J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003625; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rodovicius Hiliaras, 2003, Medicina (Kaunas), V39, P62; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Servin AL, 2005, CLIN MICROBIOL REV, V18, P264, DOI 10.1128/CMR.18.2.264-292.2005; Stopkova P, 2004, BIOL PSYCHIAT, V55, P981, DOI 10.1016/j.biopsych.2004.01.014; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Umbach JA, 2004, CLIN NEUROSCI RES, V4, P253, DOI 10.1016/j.cnr.2004.09.002; Vergani L, 2007, MOL CELL ENDOCRINOL, V263, P29, DOI 10.1016/j.mce.2006.08.010; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Yu KD, 2009, NAT REV CANCER, V9, P842, DOI 10.1038/nrc2683-c1	36	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12185	10.1371/journal.pone.0012185	http://dx.doi.org/10.1371/journal.pone.0012185			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808825	Green Published, gold, Green Submitted			2022-12-27	WOS:000281077000001
J	Smits, SHJ; Meyer, T; Mueller, A; van Os, N; Stoldt, M; Willbold, D; Schmitt, L; Grieshaber, MK				Smits, Sander H. J.; Meyer, Tatu; Mueller, Andre; van Os, Nadine; Stoldt, Matthias; Willbold, Dieter; Schmitt, Lutz; Grieshaber, Manfred K.			Insights into the Mechanism of Ligand Binding to Octopine Dehydrogenase from Pecten maximus by NMR and Crystallography	PLOS ONE			English	Article							KINETIC MECHANISM; SCALLOP; ENZYME	Octopine dehydrogenase (OcDH) from the adductor muscle of the great scallop, Pecten maximus, catalyzes the NADH dependent, reductive condensation of L-arginine and pyruvate to octopine, NAD(+), and water during escape swimming and/or subsequent recovery. The structure of OcDH was recently solved and a reaction mechanism was proposed which implied an ordered binding of NADH, L-arginine and finally pyruvate. Here, the order of substrate binding as well as the underlying conformational changes were investigated by NMR confirming the model derived from the crystal structures. Furthermore, the crystal structure of the OcDH/NADH/agmatine complex was determined which suggests a key role of the side chain of L-arginine in protein cataylsis. Thus, the order of substrate binding to OcDH as well as the molecular signals involved in octopine formation can now be described in molecular detail.	[Smits, Sander H. J.; Meyer, Tatu; Schmitt, Lutz; Grieshaber, Manfred K.] Univ Dusseldorf, Inst Biochem, D-4000 Dusseldorf, Germany; [Mueller, Andre; van Os, Nadine; Grieshaber, Manfred K.] Univ Dusseldorf, Inst Zoophysiol, D-4000 Dusseldorf, Germany; [Stoldt, Matthias; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, D-4000 Dusseldorf, Germany; [Stoldt, Matthias; Willbold, Dieter] Res Ctr Julich, Inst Struct Biol & Biophys ISB 3, Julich, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich	Smits, SHJ (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, D-4000 Dusseldorf, Germany.	sander.smits@uni-duesseldorf.de	Willbold, Dieter/A-6280-2013; Stoldt, Matthias/G-5738-2013	Willbold, Dieter/0000-0002-0065-7366; Stoldt, Matthias/0000-0002-5060-4844; Mueller, Andre/0000-0001-7271-9303	Deutsche Forschungs Gemeinschaft [GR456/20-4]; North Rhein Westphalia graduate school Biostruct	Deutsche Forschungs Gemeinschaft(German Research Foundation (DFG)); North Rhein Westphalia graduate school Biostruct	This work was supported by the Deutsche Forschungs Gemeinschaft (grant GR456/20-4 to M.K.G.) and a stipendium of the North Rhein Westphalia graduate school Biostruct to T.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAICI A, 1974, EUR J BIOCHEM, V46, P59, DOI 10.1111/j.1432-1033.1974.tb03596.x; Baker PJ, 1998, NAT STRUCT BIOL, V5, P561, DOI 10.1038/817; Burk DL, 2007, J MOL BIOL, V373, P745, DOI 10.1016/j.jmb.2007.08.044; DOUBLET MO, 1975, EUR J BIOCHEM, V59, P185, DOI 10.1111/j.1432-1033.1975.tb02440.x; DOUBLET MO, 1975, EUR J BIOCHEM, V59, P175, DOI 10.1111/j.1432-1033.1975.tb02439.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GADE G, 1978, J COMP PHYSIOL, V124, P121; GORLACH M, 1992, EMBO J, V11, P3289, DOI 10.1002/j.1460-2075.1992.tb05407.x; GRIESHABER M, 1977, COMP BIOCHEM PHYS B, V58, P249, DOI 10.1016/0305-0491(77)90198-5; Grieshaber M K, 1994, Rev Physiol Biochem Pharmacol, V125, P43, DOI 10.1007/BFb0030909; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Keller R., 2004, THESIS SWISS FEDERAL; KREUTZER U, 1985, MOL PHYSIOL, V8, P371; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Muller A, 2007, FEBS J, V274, P6329, DOI 10.1111/j.1742-4658.2007.06151.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OLOMUCKI A, 1981, Biochemical Society Transactions, V9, P278; ORIOL C, 1972, EUR J BIOCHEM, V29, P288, DOI 10.1111/j.1432-1033.1972.tb01987.x; Peterson, 1998, ICRS NEWSLETTER, V1, P5; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; SCHRIMSHER JL, 1984, BIOCHEMISTRY-US, V23, P1348, DOI 10.1021/bi00302a002; Smits SHJ, 2008, ACTA CRYSTALLOGR F, V64, P836, DOI 10.1107/S1744309108025487; Smitst SHJ, 2008, J MOL BIOL, V381, P200, DOI 10.1016/j.jmb.2008.06.003; Stangler T, 2006, Z PHYS CHEM, V220, P567, DOI 10.1524/zpch.2006.220.5.567; SUBRAMANIAN S, 1979, TRENDS BIOCHEM SCI, V4, P102, DOI 10.1016/0968-0004(79)90392-X; THOAI NV, 1959, B SOC CHIM BIOL, V41, P735; THOAI NV, 1969, BIOCHIM BIOPHYS ACTA, V191, P46, DOI 10.1016/0005-2744(69)90313-1; THOMAS GE, 1971, MAR BIOL, V10, P87, DOI 10.1007/BF02026771	28	8	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12312	10.1371/journal.pone.0012312	http://dx.doi.org/10.1371/journal.pone.0012312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808820	Green Published, gold, Green Submitted			2022-12-27	WOS:000281075500029
J	Salazar, DL; Uchida, N; Hamers, FPT; Cummings, BJ; Anderson, AJ				Salazar, Desiree L.; Uchida, Nobuko; Hamers, Frank P. T.; Cummings, Brian J.; Anderson, Aileen J.			Human Neural Stem Cells Differentiate and Promote Locomotor Recovery in an Early Chronic Spinal coRd Injury NOD-scid Mouse Model	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; OLFACTORY ENSHEATHING CELLS; RESTRICTED PRECURSOR CELLS; TRAUMATIC BRAIN-INJURY; DELAYED TRANSPLANTATION; STEM/PROGENITOR CELLS; AXONAL REGENERATION; FUNCTIONAL RECOVERY; WHITE-MATTER; IN-VITRO	Background: Traumatic spinal cord injury (SCI) results in partial or complete paralysis and is characterized by a loss of neurons and oligodendrocytes, axonal injury, and demyelination/dysmyelination of spared axons. Approximately 1,250,000 individuals have chronic SCI in the U. S.; therefore treatment in the chronic stages is highly clinically relevant. Human neural stem cells (hCNS-SCns) were prospectively isolated based on fluorescence-activated cell sorting for a CD133(+) and CD24(-/lo) population from fetal brain, grown as neurospheres, and lineage restricted to generate neurons, oligodendrocytes and astrocytes. hCNS-SCns have recently been transplanted sub-acutely following spinal cord injury and found to promote improved locomotor recovery. We tested the ability of hCNS-SCns transplanted 30 days post SCI to survive, differentiate, migrate, and promote improved locomotor recovery. Methods and Findings: hCNS-SCns were transplanted into immunodeficient NOD-scid mice 30 days post spinal cord contusion injury. hCNS-SCns transplanted mice demonstrated significantly improved locomotor recovery compared to vehicle controls using open field locomotor testing and CatWalk gait analysis. Transplanted hCNS-SCns exhibited long-term engraftment, migration, limited proliferation, and differentiation predominantly to oligodendrocytes and neurons. Astrocytic differentiation was rare and mice did not exhibit mechanical allodynia. Furthermore, differentiated hCNS-SCns integrated with the host as demonstrated by co-localization of human cytoplasm with discrete staining for the paranodal marker contactin-associated protein. Conclusions: The results suggest that hCNS-SCns are capable of surviving, differentiating, and promoting improved locomotor recovery when transplanted into an early chronic injury microenvironment. These data suggest that hCNS-SCns transplantation has efficacy in an early chronic SCI setting and thus expands the "window of opportunity" for intervention.	[Salazar, Desiree L.; Anderson, Aileen J.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Salazar, Desiree L.; Cummings, Brian J.; Anderson, Aileen J.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA USA; [Salazar, Desiree L.; Cummings, Brian J.; Anderson, Aileen J.] Univ Calif Irvine, Reeve Irvine Res Ctr, Irvine, CA USA; [Uchida, Nobuko] StemCells Inc, Palo Alto, CA USA; [Hamers, Frank P. T.] Rehabil Hosp Tolbrug, sHertogenbosch, Netherlands; [Cummings, Brian J.; Anderson, Aileen J.] Univ Calif Irvine, Dept Phys Med & Rehabil, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Salazar, DL (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	aja@uci.edu	Anderson, Aileen J/H-5926-2012; Cummings, Brian J/C-9180-2012	Cummings, Brian J/0000-0003-3628-5290; Salazar, Desiree L./0000-0003-2912-6611	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) [R43 NS046975, R01 NS049885]; CRF [AAC-2005]; CIRM [T1-00008]; NSF [HRD0450366]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049885, R43NS046975] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CRF; CIRM(California Institute for Regenerative Medicine); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) R43 NS046975, NIH/NINDS R01 NS049885, and CRF AAC-2005 to A.J. Anderson. D.L. Salazar was supported by CIRM stem cell training grant T1-00008 and UC AGEP fellowship NSF HRD0450366. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bambakidis Nicholas C, 2004, Spine J, V4, P16, DOI 10.1016/j.spinee.2003.07.004; Barakat DJ, 2005, CELL TRANSPLANT, V14, P225, DOI 10.3727/000000005783983106; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Blakemore WF, 2000, BRAIN, V123, P1543, DOI 10.1093/brain/123.8.1543; BLIGHT AR, 1989, BRAIN RES BULL, V22, P47, DOI 10.1016/0361-9230(89)90126-3; Boockvar JA, 2005, NEUROSURGERY, V56, P163, DOI 10.1227/01.NEU.0000145866.25433.FF; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Cao QL, 2002, EXP NEUROL, V177, P349, DOI 10.1006/exnr.2002.7981; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chow SY, 2000, BRAIN RES, V874, P87, DOI 10.1016/S0006-8993(00)02443-4; Coumans JV, 2001, J NEUROSCI, V21, P9334, DOI 10.1523/JNEUROSCI.21-23-09334.2001; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Cummings BJ, 2006, NEUROL RES, V28, P474, DOI 10.1179/016164106X115116; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Engesser-Cesar C, 2005, J NEUROTRAUM, V22, P157, DOI 10.1089/neu.2005.22.157; Engesser-Cesar C, 2007, EUR J NEUROSCI, V25, P1931, DOI 10.1111/j.1460-9568.2007.05469.x; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fitch MT, 1999, J NEUROSCI, V19, P8182; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Fraidakis MJ, 2004, EXP NEUROL, V188, P33, DOI 10.1016/j.expneurol.2004.01.032; Galvan MD, 2008, J NEUROSCI, V28, P13876, DOI 10.1523/JNEUROSCI.2823-08.2008; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Greiner DL, 1998, STEM CELLS, V16, P166, DOI 10.1002/stem.160166; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Heine W, 2004, EXP NEUROL, V189, P231, DOI 10.1016/j.expneurol.2004.06.014; Hill CE, 2004, EXP NEUROL, V190, P289, DOI 10.1016/j.expneurol.2004.05.043; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Hooshmand MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005871; Houle JD, 2003, EXP NEUROL, V182, P247, DOI 10.1016/S0014-4886(03)00029-3; Ishii K, 2006, J NEUROSCI RES, V84, P1669, DOI 10.1002/jnr.21079; Jakovcevski I, 2005, J NEUROSCI, V25, P10064, DOI 10.1523/JNEUROSCI.2324-05.2005; Kakulas B A, 1999, J Spinal Cord Med, V22, P119; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Karimi-Abdolrezaee S, 2004, EUR J NEUROSCI, V19, P577, DOI 10.1111/j.0953-816X.2004.03164.x; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Keyvan-Fouladi N, 2003, J NEUROSCI, V23, P9428; Lasiene J, 2008, J NEUROSCI, V28, P3887, DOI 10.1523/JNEUROSCI.4756-07.2008; Liu Y, 1999, J NEUROSCI, V19, P4370; Liu Y, 2002, EXP NEUROL, V178, P150, DOI 10.1006/exnr.2002.7977; Llado J, 2004, MOL CELL NEUROSCI, V27, P322, DOI 10.1016/j.mcn.2004.07.010; Lu J, 2002, BRAIN, V125, P14, DOI 10.1093/brain/awf014; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Luchetti S, 2010, J NEUROTRAUM, V27, P411, DOI 10.1089/neu.2009.0930; Macias MY, 2006, EXP NEUROL, V201, P335, DOI 10.1016/j.expneurol.2006.04.035; Marsala M, 2004, EUR J NEUROSCI, V20, P2401, DOI 10.1111/j.1460-9568.2004.03702.x; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Mothe AJ, 2008, CELL TRANSPLANT, V17, P735, DOI 10.3727/096368908786516756; Nishi RA, 2007, J NEUROTRAUM, V24, P674, DOI 10.1089/neu.2006.0204; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Ogawa D, 2009, J NEUROSCI RES, V87, P307, DOI 10.1002/jnr.21843; Okano H, 2003, SEMIN CELL DEV BIOL, V14, P191, DOI 10.1016/S1084-9521(03)00011-9; Okano H, 2007, NEUROCHEM INT, V51, P68, DOI 10.1016/j.neuint.2007.04.013; Pallini R, 2005, NEUROSURGERY, V57, P1014, DOI 10.1227/01.NEU.0000180058.58372.4c; Parr AM, 2007, J NEUROTRAUM, V24, P835, DOI 10.1089/neu.2006.3771; Piao JH, 2006, J NEUROSCI RES, V84, P471, DOI 10.1002/jnr.20955; Plant GW, 2003, J NEUROTRAUM, V20, P1, DOI 10.1089/08977150360517146; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; PROCHAZKA M, 1992, DIABETES, V41, P98, DOI 10.2337/diabetes.41.1.98; Salazar DL, 2008, DEV DEGENERATION REG, P297; SERREZE DV, 1995, DIABETES, V44, P1392, DOI 10.2337/diabetes.44.12.1392; Shi R, 1997, NEUROSCIENCE, V77, P553, DOI 10.1016/S0306-4522(96)00477-0; Shi RY, 1997, EXP NEUROL, V148, P495, DOI 10.1006/exnr.1997.6706; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Smith PM, 2006, BRAIN PATHOL, V16, P99, DOI 10.1111/j.1750-3639.2006.00001.x; Su HX, 2007, EXP NEUROL, V206, P296, DOI 10.1016/j.expneurol.2007.05.018; Tan AM, 2007, EXP NEUROL, V206, P257, DOI 10.1016/j.expneurol.2007.05.013; Tarasenko YI, 2007, J NEUROSCI RES, V85, P47, DOI 10.1002/jnr.21098; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Tobias CA, 2003, EXP NEUROL, V184, P97, DOI 10.1016/S0014-4886(03)00394-7; Tripathi R, 2007, GLIA, V55, P698, DOI 10.1002/glia.20491; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vroemen M, 2003, EUR J NEUROSCI, V18, P743, DOI 10.1046/j.1460-9568.2003.02804.x; Wu P, 2002, GENE THER, V9, P245, DOI 10.1038/sj.gt.3301646; Yan J, 2007, PLOS MED, V4, P318, DOI 10.1371/journal.pmed.0040039; Zurita M, 2001, SURG NEUROL, V55, P249, DOI 10.1016/S0090-3019(01)00442-6	80	160	167	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12272	10.1371/journal.pone.0012272	http://dx.doi.org/10.1371/journal.pone.0012272			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20806064	Green Published, gold			2022-12-27	WOS:000281011600030
J	Wang, Z; Liu, TA; Lin, ZW; Hegarty, J; Koltun, WA; Wu, RL				Wang, Zhong; Liu, Tian; Lin, Zhenwu; Hegarty, John; Koltun, Walter A.; Wu, Rongling			A General Model for Multilocus Epistatic Interactions in Case-Control Studies	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; HIGH-ORDER INTERACTIONS; BREAST-CANCER; METABOLISM; HAPLOTYPE; INFERENCE; PATHWAYS; SYSTEMS; POWER	Background: Epistasis, i.e., the interaction of alleles at different loci, is thought to play a central role in the formation and progression of complex diseases. The complexity of disease expression should arise from a complex network of epistatic interactions involving multiple genes. Methodology: We develop a general model for testing high-order epistatic interactions for a complex disease in a case-control study. We incorporate the quantitative genetic theory of high-order epistasis into the setting of cases and controls sampled from a natural population. The new model allows the identification and testing of epistasis and its various genetic components. Conclusions: Simulation studies were used to examine the power and false positive rates of the model under different sampling strategies. The model was used to detect epistasis in a case-control study of inflammatory bowel disease, in which five SNPs at a candidate gene were typed, leading to the identification of a significant three-locus epistasis.	[Wang, Zhong; Wu, Rongling] Penn State Univ, Ctr Stat Genet, Hershey, PA 17033 USA; [Wang, Zhong; Wu, Rongling] Penn State Univ, Penn State Canc Inst, Hershey, PA USA; [Liu, Tian] Genome Inst Singapore, Human Genet Grp, Singapore, Singapore; [Lin, Zhenwu; Hegarty, John; Koltun, Walter A.] Penn State Univ, Dept Surg, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Wang, Z (corresponding author), Penn State Univ, Ctr Stat Genet, Hershey, PA 17033 USA.	rwu@hes.hmc.psu.edu	Wang, Zhong/C-3737-2014	Hegarty, John/0000-0003-3401-848X	National Science Foundation (NSF) [DMS/NIGMS-0540745]; Changjiang Scholars Award	National Science Foundation (NSF)(National Science Foundation (NSF)); Changjiang Scholars Award	This work is supported by National Science Foundation (NSF) grant DMS/NIGMS-0540745 and the Changjiang Scholars Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALISON M, 2009, BMC RES NOTES, V1; Bader JS, 2001, PHARMACOGENOMICS, V2, P11, DOI 10.1517/14622416.2.1.11; BARTUAL R, 1993, EUPHYTICA, V72, P149; BATESON W, 1910, MOL GEN GENETICS MGG, V3, P108; Beerenwinkel N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-60; Carlborg O, 2002, GENET RES, V79, P175, DOI 10.1017/S001667230200558X; EDWARDS T, 2010, GEN FRAMEWORK FORMAL; Gabutero E, 2007, AIDS, V21, P65, DOI 10.1097/QAD.0b013e3280117f49; Gayan J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-360; Hansen TF, 2001, GENETICS, V158, P477; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; HLAVACEK W, 2009, SCI STKE, V2; Huang LS, 1995, METHOD CELL BIOL, V48, P97; Imielinski M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-40; Jiang R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S65; Judson R, 2000, Pharmacogenomics, V1, P15, DOI 10.1517/14622416.1.1.15; Kayano M, 2009, BIOINFORMATICS, V25, P2735, DOI 10.1093/bioinformatics/btp531; Liang YL, 2008, STAT SURV, V2, P43, DOI 10.1214/07-SS026; Lin Z, 2009, DIS MARKERS, V27, P193, DOI [10.1155/2009/167534, 10.3233/DMA-2009-0662]; LIU T, 2010, BIOSTATISTI IN PRESS; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; McMullen MD, 1998, P NATL ACAD SCI USA, V95, P1996, DOI 10.1073/pnas.95.5.1996; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Nunkesser R, 2007, BIOINFORMATICS, V23, P3280, DOI 10.1093/bioinformatics/btm522; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RA F, 1968, AM J HUM GENET, V20, P402; Rha SY, 2007, ONCOLOGIST, V12, P622, DOI 10.1634/theoncologist.12-6-622; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Stich B, 2007, GENETICS, V176, P563, DOI 10.1534/genetics.106.067033; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Tian L, 2004, GENETICS, V168, P503, DOI 10.1534/genetics.104.029603; Wan X, 2010, BIOINFORMATICS, V26, P30, DOI 10.1093/bioinformatics/btp622; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; WORKMAN P, 1973, AM J HUM GENET, V25, P461; Wu RL, 1996, THEOR APPL GENET, V93, P102, DOI 10.1007/BF00225734; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110	39	32	33	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e11384	10.1371/journal.pone.0011384	http://dx.doi.org/10.1371/journal.pone.0011384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20814428	Green Published, Green Submitted, gold			2022-12-27	WOS:000281011600001
J	Gelin, A; Redrejo-Rodriguez, M; Laval, J; Fedorova, OS; Saparbaev, M; Ishchenko, AA				Gelin, Aurore; Redrejo-Rodriguez, Modesto; Laval, Jacques; Fedorova, Olga S.; Saparbaev, Murat; Ishchenko, Alexander A.			Genetic and Biochemical Characterization of Human AP Endonuclease 1 Mutants Deficient in Nucleotide Incision Repair Activity	PLOS ONE			English	Article							HUMAN APURINIC ENDONUCLEASE; HUMAN APURINIC/APYRIMIDINIC ENDONUCLEASE; BASE EXCISION-REPAIR; DNA-POLYMERASE-BETA; ESCHERICHIA-COLI; IONIZING-RADIATION; EXONUCLEASE-III; APYRIMIDINIC ENDONUCLEASE; ABASIC ENDONUCLEASE; ENZYME HAP1	Background: Human apurinic/apyrimidinic endonuclease 1 (APE1) is a key DNA repair enzyme involved in both base excision repair (BER) and nucleotide incision repair (NIR) pathways. In the BER pathway, APE1 cleaves DNA at AP sites and 3'-blocking moieties generated by DNA glycosylases. In the NIR pathway, APE1 incises DNA 59 to a number of oxidatively damaged bases. At present, physiological relevance of the NIR pathway is fairly well established in E. coli, but has yet to be elucidated in human cells. Methodology/Principal Finding: We identified amino acid residues in the APE1 protein that affect its function in either the BER or NIR pathway. Biochemical characterization of APE1 carrying single K98A, R185A, D308A and double K98A/R185A amino acid substitutions revealed that all mutants exhibited greatly reduced NIR and 3'-> 5' exonuclease activities, but were capable of performing BER functions to some extent. Expression of the APE1 mutants deficient in the NIR and exonuclease activities reduced the sensitivity of AP endonuclease-deficient E. coli xth nfo strain to an alkylating agent, methylmethanesulfonate, suggesting that our APE1 mutants are able to repair AP sites. Finally, the human NIR pathway was fully reconstituted in vitro using the purified APE1, human flap endonuclease 1, DNA polymerase beta and DNA ligase I proteins, thus establishing the minimal set of proteins required for a functional NIR pathway in human cells. Conclusion/Significance: Taken together, these data further substantiate the role of NIR as a distinct and separable function of APE1 that is essential for processing of potentially lethal oxidative DNA lesions.	[Gelin, Aurore] Univ Paris Sud, CNRS, UMR8126, Inst Cancerol Gustave Roussy, Villejuif, France; [Redrejo-Rodriguez, Modesto; Laval, Jacques; Saparbaev, Murat; Ishchenko, Alexander A.] Univ Paris Sud, CNRS, UMR8200, Inst Cancerol Gustave Roussy,Grp Reparat ADN, Villejuif, France; [Fedorova, Olga S.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk, Russia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Gelin, A (corresponding author), Univ Paris Sud, CNRS, UMR8126, Inst Cancerol Gustave Roussy, Villejuif, France.	ichtchen@igr.fr	Saparbaev, Murat K/N-3225-2015; Redrejo Rodríguez, Modesto/D-7247-2012; Fedorova, Olga S./E-1291-2013; Saparbaev, Murat/AAC-5478-2020; Fedorova, Olga/ABE-6637-2020; Ishchenko, Alexander/D-4133-2013	Saparbaev, Murat K/0000-0002-4630-1074; Redrejo Rodríguez, Modesto/0000-0003-0014-4162; Fedorova, Olga S./0000-0002-4001-7187; Saparbaev, Murat/0000-0002-4630-1074; Fedorova, Olga/0000-0002-4001-7187; Ishchenko, Alexander/0000-0002-0488-8858	Fondation pour la Recherche Medicale; Centre National de la Recherche Scientifique [PICS 5479-Russie]; Electricite de France [RB 2010]; Russian Foundation for Basic Research [10-04-00070]; Russian Ministry of Education and Science [02.740.11.0079, 02.740.11.5012]; Association pour la Recherche sur le Cancer; Fondation de France	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Electricite de France; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation de France(Fondation de France)	This work was supported by grants from Fondation pour la Recherche Medicale (http://www.frm.org) [EQUIPES FRM 2007 to MS]; Centre National de la Recherche Scientifique (http://www.cnrs.fr) [PICS 5479-Russie to MS]; Electricite de France (http://www.edf.fr) Contrat Radioprotection [RB 2010 to MS]; Russian Foundation for Basic Research (http://www.rfbr.ru) [10-04-00070 to OSF]; and Russian Ministry of Education and Science (http://mon.gov.ru) [02.740.11.0079 to OSF, 02.740.11.5012 to OSF and AAI]; Association pour la Recherche sur le Cancer (http://www.arc-cancer.net) [postdoctoral fellowships to MR-R]; Fondation de France (http://www.fondationdefrance.org) [to AAI]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN SA, 1994, MUTAT RES, V306, P35, DOI 10.1016/0027-5107(94)90165-1; Asagoshi K, 2010, DNA REPAIR, V9, P109, DOI 10.1016/j.dnarep.2009.11.002; Barnes T, 2009, NUCLEIC ACIDS RES, V37, P3946, DOI 10.1093/nar/gkp275; BARZILAY G, 1995, NUCLEIC ACIDS RES, V23, P1544, DOI 10.1093/nar/23.9.1544; Beernink PT, 2001, J MOL BIOL, V307, P1023, DOI 10.1006/jmbi.2001.4529; Bergeron F, 2010, P NATL ACAD SCI USA, V107, P5528, DOI 10.1073/pnas.1000193107; Berquist BR, 2008, J MOL BIOL, V379, P17, DOI 10.1016/j.jmb.2008.03.053; CHEN DS, 1994, ANN NY ACAD SCI, V726, P306, DOI 10.1111/j.1749-6632.1994.tb52834.x; Chou KM, 2003, J BIOL CHEM, V278, P18289, DOI 10.1074/jbc.M212143200; Chou KM, 2002, NATURE, V415, P655, DOI 10.1038/415655a; COUVEPRIVAT S, 2007, MOL B INT U, P54; CUNNINGHAM RP, 1986, J BACTERIOL, V168, P1120, DOI 10.1128/jb.168.3.1120-1127.1986; Daviet S, 2007, DNA REPAIR, V6, P8, DOI 10.1016/j.dnarep.2006.08.001; Demple B, 2005, DNA REPAIR, V4, P1442, DOI 10.1016/j.dnarep.2005.09.004; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450; Fromme JC, 2004, CURR OPIN STRUC BIOL, V14, P43, DOI 10.1016/j.sbi.2004.01.003; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Golan G, 2010, MUTAT RES-FUND MOL M, V685, P70, DOI 10.1016/j.mrfmmm.2009.08.017; Gorman MA, 1997, EMBO J, V16, P6548, DOI 10.1093/emboj/16.21.6548; Gros L, 2004, NUCLEIC ACIDS RES, V32, P73, DOI 10.1093/nar/gkh165; Gros L, 2002, ONCOGENE, V21, P8905, DOI 10.1038/sj.onc.1206005; Guliaev AB, 2004, NUCLEIC ACIDS RES, V32, P2844, DOI 10.1093/nar/gkh594; Hang B, 1996, P NATL ACAD SCI USA, V93, P13737, DOI 10.1073/pnas.93.24.13737; Hang B, 1998, CARCINOGENESIS, V19, P1339, DOI 10.1093/carcin/19.8.1339; Harrison L, 1999, J MOL BIOL, V290, P667, DOI 10.1006/jmbi.1999.2892; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; IDE H, 1994, BIOCHEMISTRY-US, V33, P7842, DOI 10.1021/bi00191a011; Ischenko AA, 2002, NATURE, V415, P183, DOI 10.1038/415183a; Ishchenko AA, 2006, P NATL ACAD SCI USA, V103, P2564, DOI 10.1073/pnas.0508582103; Ishchenko AA, 2004, BIOCHEMISTRY-US, V43, P15210, DOI 10.1021/bi049214+; Ishchenko AA, 2003, NUCLEIC ACIDS RES, V31, P6344, DOI 10.1093/nar/gkg812; Izumi T, 1998, CARCINOGENESIS, V19, P525, DOI 10.1093/carcin/19.3.525; Izumi T, 1999, J MOL BIOL, V287, P47, DOI 10.1006/jmbi.1999.2573; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Jiang L, 2001, SPECTROCHIM ACTA A, V57, P1711, DOI 10.1016/S1386-1425(01)00442-5; KANE CM, 1981, J BIOL CHEM, V256, P3405; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Lomax ME, 2004, BIOCHEMISTRY-US, V43, P11017, DOI 10.1021/bi049560r; Lowry DF, 2003, J MOL BIOL, V329, P311, DOI 10.1016/S0022-2836(03)00382-6; Lucas JA, 1999, BIOCHEMISTRY-US, V38, P4958, DOI 10.1021/bi982052v; Ludwig DL, 1998, MUTAT RES-DNA REPAIR, V409, P17, DOI 10.1016/S0921-8777(98)00039-1; Masuda Y, 1998, J BIOL CHEM, V273, P30360, DOI 10.1074/jbc.273.46.30360; Masuda Y, 1998, J BIOL CHEM, V273, P30352, DOI 10.1074/jbc.273.46.30352; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Muller E, 2003, NUCLEOS NUCLEOT NUCL, V22, P1563, DOI 10.1081/NCN-120023034; Nguyen LH, 2000, J MOL BIOL, V298, P447, DOI 10.1006/jmbi.2000.3653; Oezguen N, 2007, PROTEINS, V68, P313, DOI 10.1002/prot.21397; Podlutsky AJ, 2001, EMBO J, V20, P1477, DOI 10.1093/emboj/20.6.1477; ROBSON CN, 1991, NUCLEIC ACIDS RES, V19, P5519, DOI 10.1093/nar/19.20.5519; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Tell G, 2010, MOL CELL BIOL, V30, P366, DOI 10.1128/MCB.01174-09; Vascotto C, 2009, MOL CELL BIOL, V29, P1834, DOI 10.1128/MCB.01337-08; WALKER LJ, 1994, NUCLEIC ACIDS RES, V22, P4884, DOI 10.1093/nar/22.23.4884; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Wong D, 2003, J BIOL CHEM, V278, P36242, DOI 10.1074/jbc.M306065200; Wyatt MD, 1999, BIOESSAYS, V21, P668, DOI 10.1002/(SICI)1521-1878(199908)21:8<668::AID-BIES6>3.3.CO;2-4; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Yu E, 2010, BIOCHEMISTRY-US, V49, P3786, DOI 10.1021/bi901828t; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	62	37	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12241	10.1371/journal.pone.0012241	http://dx.doi.org/10.1371/journal.pone.0012241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808930	Green Published, Green Submitted, gold			2022-12-27	WOS:000280968100031
J	Novack, V; Pencina, M; Zahger, D; Fuchs, L; Nevzorov, R; Jotkowitz, A; Porath, A				Novack, Victor; Pencina, Michael; Zahger, Doron; Fuchs, Lior; Nevzorov, Roman; Jotkowitz, Allan; Porath, Avi			Routine Laboratory Results and Thirty Day and One-Year Mortality Risk Following Hospitalization with Acute Decompensated Heart Failure	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; MYOCARDIAL-INFARCTION; NATRIURETIC PEPTIDE; PREDICT SURVIVAL; VALIDATION; OUTCOMES; GLUCOSE; DEATH; MODEL	Introduction: Several blood tests are performed uniformly in patients hospitalized with acute decompensated heart failure and are predictive of the outcomes: complete blood count, electrolytes, renal function, glucose, albumin and uric acid. We sought to evaluate the relationship between routine admission laboratory tests results, patient characteristics and 30-day and one-year mortality of patients admitted for decompensated heart failure and to construct a simple mortality prediction tool. Methods: A retrospective population based study. Data from seven tertiary hospitals on all admissions with a principal diagnosis of heart failure during the years 2002-2005 throughout Israel were captured. Results: 8,246 patients were included in the study cohort. Thirty day mortality rate was 8.5% (701 patients) and one-year mortality rate was 28.7% (2,365 patients). Addition of five routine laboratory tests results (albumin, sodium, blood urea, uric acid and WBC) to a set of clinical and demographic characteristics improved c-statistics from 0.76 to 0.81 for 30-days and from 0.72 to 0.76 for one-year mortality prediction (both p-values <0.0001). Three dichotomized abnormal laboratory results with highest odds ratio for one-year mortality (hypoalbuminaemia, hyponatremia and elevated blood urea) were used to construct a simple prediction score, capable of discriminating from 1.1% to 21.4% in 30-day and from 11.6% to 55.6% in one-year mortality rates between patients with a score of 0 (1,477 patients) vs. score of 3 (544 patients). Discussion: A small set of abnormal routine laboratory results upon admission can risk-stratify and independently predict 30-day and one-year mortality in patients hospitalized with acute decompensated heart failure.	[Novack, Victor; Fuchs, Lior; Nevzorov, Roman; Jotkowitz, Allan; Porath, Avi] Soroka Univ, Med Ctr, Clin Res Ctr, Beer Sheva, Israel; [Novack, Victor; Pencina, Michael] Harvard Clin Res Inst, Boston, MA USA	Ben Gurion University; Soroka Medical Center; Harvard University; Harvard Medical School	Novack, V (corresponding author), Soroka Univ, Med Ctr, Clin Res Ctr, Beer Sheva, Israel.	VictorNo@clalit.org.il		Pencina, Michael/0000-0001-5798-8855				Aaronson KD, 1997, CIRCULATION, V95, P2660, DOI 10.1161/01.CIR.95.12.2660; Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; Anker SD, 2003, CIRCULATION, V107, P1991, DOI 10.1161/01.CIR.0000065637.10517.A0; Anker SD, 2002, INT J CARDIOL, V85, P51, DOI 10.1016/S0167-5273(02)00233-4; Battaglia M, 2006, ARCH INTERN MED, V166, P1073, DOI 10.1001/archinte.166.10.1073; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cooper HA, 1999, AM J CARDIOL, V84, P252, DOI 10.1016/S0002-9149(99)00272-6; De Denus S, 2006, J CARD FAIL, V12, P353, DOI 10.1016/j.cardfail.2006.02.014; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Gegenhuber A, 2007, J CARD FAIL, V13, P42, DOI 10.1016/j.cardfail.2006.09.004; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Horwich TB, 2008, AM HEART J, V155, P883, DOI 10.1016/j.ahj.2007.11.043; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Jotkowitz AB, 2006, ISRAEL MED ASSOC J, V8, P875; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Klein L, 2005, CIRCULATION, V111, P2454, DOI 10.1161/01.CIR.0000165065.82609.3D; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; MAISEL A, 2008, BIOMARKERS ASSESSMEN; METRA M, 2007, EUR J HEART FAIL; Mitchell JE, 2007, AM J CARDIOL, V99, p15D, DOI 10.1016/j.amjcard.2006.12.015; Oren RM, 2005, AM J CARDIOL, V95, p2B; Pascual-Figal DA, 2007, EUR J HEART FAIL, V9, P518, DOI 10.1016/j.ejheart.2006.09.001; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; SEWDARSEN M, 1989, Q J MED, V71, P461; Smith GL, 2006, ARCH INTERN MED, V166, P1134, DOI 10.1001/archinte.166.10.1134; Smith GL, 2006, J AM COLL CARDIOL, V47, P1987, DOI 10.1016/j.jacc.2005.11.084; Stranders I, 2004, ARCH INTERN MED, V164, P982, DOI 10.1001/archinte.164.9.982; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373	30	60	60	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12184	10.1371/journal.pone.0012184	http://dx.doi.org/10.1371/journal.pone.0012184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808904	Green Published, gold, Green Submitted			2022-12-27	WOS:000280968100010
J	Pullen, M; Clark, N; Zarinkamar, F; Topping, J; Lindsey, K				Pullen, Margaret; Clark, Nick; Zarinkamar, Fatemeh; Topping, Jennifer; Lindsey, Keith			Analysis of Vascular Development in the hydra Sterol Biosynthetic Mutants of Arabidopsis	PLOS ONE			English	Article							AUXIN BIOSYNTHESIS; CELL-DIVISION; TRANSCRIPTION FACTOR; GENE MONOPTEROS; ROOT-GROWTH; ETHYLENE; TRANSPORT; POLARITY; DIFFERENTIATION; ENDOCYTOSIS	Background: The control of vascular tissue development in plants is influenced by diverse hormonal signals, but their interactions during this process are not well understood. Wild-type sterol profiles are essential for growth, tissue patterning and signalling processes in plant development, and are required for regulated vascular patterning. Methodology/Principal Findings: Here we investigate the roles of sterols in vascular tissue development, through an analysis of the Arabidopsis mutants hydra1 and fackel/hydra2, which are defective in the enzymes sterol isomerase and sterol C-14 reductase respectively. We show that defective vascular patterning in the shoot is associated with ectopic cell divisions. Expression of the auxin-regulated AtHB8 homeobox gene is disrupted in mutant embryos and seedlings, associated with variably incomplete vascular strand formation and duplication of the longitudinal axis. Misexpression of the auxin reporter proIAA2:GUS and mislocalization of PIN proteins occurs in the mutants. Introduction of the ethylene-insensitive ein2 mutation partially rescues defective cell division, localization of PIN proteins, and vascular strand development. Conclusions: The results support a model in which sterols are required for correct auxin and ethylene crosstalk to regulate PIN localization, auxin distribution and AtHB8 expression, necessary for correct vascular development.	[Pullen, Margaret; Clark, Nick; Zarinkamar, Fatemeh; Topping, Jennifer; Lindsey, Keith] Univ Durham, Integrat Cell Biol Lab, Sch Biol & Biomed Sci, Durham, England	Durham University	Pullen, M (corresponding author), Univ Durham, Integrat Cell Biol Lab, Sch Biol & Biomed Sci, Durham, England.	keith.lindsey@durham.ac.uk	Lindsey, Keith/AAG-5228-2019	Lindsey, Keith/0000-0002-7992-6804; zarinkamar, fatemeh/0000-0002-2497-5131	Biotechnology and Biological Sciences Research Council [BBS/B/08418]; Durham University; BBSRC [BB/E006531/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E006531/1, BB/C512210/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Durham University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors gratefully acknowledge funding from the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk; BBS/B/08418) and Durham University (www.dur.ac.uk; studentship to MP) in support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1995, J MOL BIOL, V251, P533, DOI 10.1006/jmbi.1995.0454; Abel S, 1996, BIOESSAYS, V18, P647, DOI 10.1002/bies.950180808; Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Aloni R, 2001, J PLANT GROWTH REGUL, V20, P22, DOI 10.1007/s003440010001; Baima S, 1995, DEVELOPMENT, V121, P4171; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; BERLETH T, 1993, DEVELOPMENT, V118, P575; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Carland FM, 1999, PLANT CELL, V11, P2123, DOI 10.1105/tpc.11.11.2123; Carland FM, 2002, PLANT CELL, V14, P2045, DOI 10.1105/tpc.003939; Carland F, 2010, PLANT PHYSIOL, V153, P741, DOI 10.1104/pp.109.152587; Chilley PM, 2006, PLANT CELL, V18, P3058, DOI 10.1105/tpc.106.040790; Clouse SD, 2000, CURR BIOL, V10, pR601, DOI 10.1016/S0960-9822(00)00639-4; De Smet I, 2007, CURR OPIN GENET DEV, V17, P337, DOI 10.1016/j.gde.2007.04.012; Dengler NG, 2001, J PLANT GROWTH REGUL, V20, P1, DOI 10.1007/s003440010008; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Donner TJ, 2009, DEVELOPMENT, V136, P3235, DOI 10.1242/dev.037028; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Grebe M, 2003, CURR BIOL, V13, P1378, DOI 10.1016/S0960-9822(03)00538-4; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Hardtke CS, 2004, DEVELOPMENT, V131, P1089, DOI 10.1242/dev.00925; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Hauser MT, 2000, PLANT SOIL, V226, P1, DOI 10.1023/A:1026421417979; Ikeda Y, 2009, NAT CELL BIOL, V11, P731, DOI 10.1038/ncb1879; Jang JC, 2000, GENE DEV, V14, P1485; Kazama H, 2004, PLANT PHYSIOL, V134, P1614, DOI 10.1104/pp.103.031088; Kehr J, 2008, J EXP BOT, V59, P85, DOI 10.1093/jxb/erm176; KENDE H, 1993, ANNU REV PLANT PHYS, V44, P283, DOI 10.1146/annurev.pp.44.060193.001435; Koizumi K, 2000, DEVELOPMENT, V127, P3197; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Lindsey K, 2003, TRENDS PLANT SCI, V8, P521, DOI 10.1016/j.tplants.2003.09.012; Liu JL, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.26; Mattsson J, 1999, DEVELOPMENT, V126, P2979; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; McHale NA, 2004, PLANT CELL, V16, P1730, DOI 10.1105/tpc.021816; Men SZ, 2008, NAT CELL BIOL, V10, P237, DOI 10.1038/ncb1686; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Ortega-Martinez O, 2007, SCIENCE, V317, P507, DOI 10.1126/science.1143409; Pan JW, 2009, PLANT CELL, V21, P568, DOI 10.1105/tpc.108.061465; Paponov IA, 2005, TRENDS PLANT SCI, V10, P170, DOI 10.1016/j.tplants.2005.02.009; Peng LC, 2002, SCIENCE, V295, P147, DOI 10.1126/science.1064281; Petricka JJ, 2008, PLANT J, V56, P251, DOI 10.1111/j.1365-313X.2008.03595.x; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Przemeck GKH, 1996, PLANTA, V200, P229, DOI 10.1007/BF00208313; Ruzicka K, 2007, PLANT CELL, V19, P2197, DOI 10.1105/tpc.107.052126; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sachs T, 2000, PLANT CELL PHYSIOL, V41, P649, DOI 10.1093/pcp/41.6.649; Sauer M, 2006, GENE DEV, V20, P2902, DOI 10.1101/gad.390806; Scarpella E, 2004, DEVELOPMENT, V131, P3445, DOI 10.1242/dev.01182; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; Schrick K, 2000, GENE DEV, V14, P1471; Schrick K, 2004, PLANT J, V38, P227, DOI 10.1111/j.1365-313X.2004.02039.x; Schrick K, 2002, PLANT J, V31, P61, DOI 10.1046/j.1365-313X.2002.01333.x; Souter M, 2002, PLANT CELL, V14, P1017, DOI 10.1105/tpc.001248; Souter MA, 2004, PLANTA, V219, P773, DOI 10.1007/s00425-004-1280-z; Spencer MWB, 2007, PLANT PHYSIOL, V143, P924, DOI 10.1104/pp.106.087668; Stepanova AN, 2007, PLANT CELL, V19, P2169, DOI 10.1105/tpc.107.052068; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Swarup R, 2007, PLANT CELL, V19, P2186, DOI 10.1105/tpc.107.052100; Topping JF, 1997, DEVELOPMENT, V124, P4415; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Willemsen V, 2003, PLANT CELL, V15, P612, DOI 10.1105/tpc.008433	63	20	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12227	10.1371/journal.pone.0012227	http://dx.doi.org/10.1371/journal.pone.0012227			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808926	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000280968100024
J	Araujo, NAM; Andrade, JS; Herrmann, HJ				Araujo, Nuno A. M.; Andrade, Jose S., Jr.; Herrmann, Hans J.			Tactical Voting in Plurality Elections	PLOS ONE			English	Article							DYNAMICS; SCIENCE; COMMUNITY; DEMOCRACY; MODEL	How often will elections end in landslides? What is the probability for a head-to-head race? Analyzing ballot results from several large countries rather anomalous and yet unexplained distributions have been observed. We identify tactical voting as the driving ingredient for the anomalies and introduce a model to study its effect on plurality elections, characterized by the relative strength of the feedback from polls and the pairwise interaction between individuals in the society. With this model it becomes possible to explain the polarization of votes between two candidates, understand the small margin of victories frequently observed for different elections, and analyze the polls' impact in American, Canadian, and Brazilian ballots. Moreover, the model reproduces, quantitatively, the distribution of votes obtained in the Brazilian mayor elections with two, three, and four candidates.	[Araujo, Nuno A. M.; Herrmann, Hans J.] ETH, Inst Bldg Mat, Zurich, Switzerland; [Andrade, Jose S., Jr.; Herrmann, Hans J.] Univ Fed Ceara, Dept Fis, Fortaleza, Ceara, Brazil	Swiss Federal Institutes of Technology Domain; ETH Zurich; Universidade Federal do Ceara	Araujo, NAM (corresponding author), ETH, Inst Bldg Mat, Zurich, Switzerland.	nuno@ethz.ch	Araujo, Nuno A M/B-6313-2008; Andrade, José S/C-5451-2013	Araujo, Nuno A M/0000-0002-1677-6060; Andrade, José S/0000-0002-5571-7610	Competence Center for Coping with Crises in Complex Socio-Economic Systems, ETH (Swiss Federal Institute of Technology) [01-08-2]; Swiss National Science Foundation [200021_126853]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FUNCAP (Fundacao Cearense de Apoio ao Desenvolvimento Cientifico); National Institute of Science and Technology for Complex Systems	Competence Center for Coping with Crises in Complex Socio-Economic Systems, ETH (Swiss Federal Institute of Technology)(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FUNCAP (Fundacao Cearense de Apoio ao Desenvolvimento Cientifico); National Institute of Science and Technology for Complex Systems	Funding was received from Competence Center for Coping with Crises in Complex Socio-Economic Systems, ETH (Swiss Federal Institute of Technology) Grant 01-08-2, and Swiss National Science Foundation Grant 200021_126853. Additional funding was provided by Brazilian agencies CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) and FUNCAP (Fundacao Cearense de Apoio ao Desenvolvimento Cientifico), and the National Institute of Science and Technology for Complex Systems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade JS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018702; Andrade RFS, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036105; Andrade RFS, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056131; Antonakis J, 2009, SCIENCE, V323, P1183, DOI 10.1126/science.1167748; Araripe LE, 2006, INT J MOD PHYS C, V17, P1809, DOI 10.1142/S0129183106010200; Bernardes AT, 2002, EUR PHYS J B, V25, P123, DOI 10.1140/e10051-002-0013-y; Brams SJ, 2001, SCIENCE, V292, P1449, DOI 10.1126/science.292.5521.1449; Buchanan M, 2004, SCIENCE, V306, P799, DOI 10.1126/science.306.5697.799; Castellano C, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041129; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; CIPRA B, 2009, SCIENCE, V323, P874; Costa RN, 2003, PHYSICA A, V322, P698, DOI 10.1016/S0378-4371(02)01823-X; Costa RN, 1999, PHYS REV E, V60, P1067, DOI 10.1103/PhysRevE.60.1067; Fortunato S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138701; Galam S, 2004, PHYSICA A, V333, P453, DOI 10.1016/j.physa.2003.10.041; Geys B, 2006, ELECT STUD, V25, P637, DOI 10.1016/j.electstud.2005.09.002; Gonzalez MC, 2007, PHYSICA A, V379, P307, DOI 10.1016/j.physa.2007.01.002; Mobilia M, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.028701; Pattie C, 2000, ANN ASSOC AM GEOGR, V90, P41, DOI 10.1111/0004-5608.00183; Restrepo JM, 2009, PUBLIC CHOICE, V140, P395, DOI 10.1007/s11127-009-9427-x; RIKER WH, 1982, AM POLIT SCI REV, V76, P753, DOI 10.2307/1962968; Sanchez AD, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.048701; Sznajd-Weron K, 2000, INT J MOD PHYS C, V11, P1157, DOI 10.1142/S0129183100000936; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; WU FY, 1982, REV MOD PHYS, V54, P235, DOI 10.1103/RevModPhys.54.235	25	38	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12446	10.1371/journal.pone.0012446	http://dx.doi.org/10.1371/journal.pone.0012446			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	649ZP	20856800	gold, Green Submitted, Green Published			2022-12-27	WOS:000281815800001
J	Diallo, TO; Remoue, F; Gaayeb, L; Schacht, AM; Charrier, N; De Clerck, D; Dompnier, JP; Pillet, S; Garraud, O; N'Diaye, AA; Riveau, G				Diallo, Tamsir O.; Remoue, Franck; Gaayeb, Lobna; Schacht, Anne-Marie; Charrier, Nicole; De Clerck, Dick; Dompnier, Jean-Pierre; Pillet, Sophie; Garraud, Olivier; N'Diaye, Abdoulaye A.; Riveau, Gilles			Schistosomiasis Coinfection in Children Influences Acquired Immune Response against Plasmodium falciparum Malaria Antigens	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; C-TERMINAL FRAGMENT; IMMUNOGLOBULIN-G; INFLAMMATORY MARKERS; ANTIBODY-RESPONSES; INDIVIDUALS; SUBCLASSES; SENEGAL; MECHANISMS; INFECTION	Background: Malaria and schistosomiasis coinfection frequently occurs in tropical countries. This study evaluates the influence of Schistosoma haematobium infection on specific antibody responses and cytokine production to recombinant merozoite surface protein-1-19 (MSP1-(19)) and schizont extract of Plasmodium falciparum in malaria-infected children. Methodology: Specific IgG1 to MSP1-(19), as well as IgG1 and IgG3 to schizont extract were significantly increased in coinfected children compared to P. falciparum mono-infected children. Stimulation with MSP1-(19) lead to a specific production of both interleukin-10 (IL-10) and interferon-gamma (IFN-gamma), whereas the stimulation with schizont extract produced an IL-10 response only in the coinfected group. Conclusions: Our study suggests that schistosomiasis coinfection favours anti-malarial protective antibody responses, which could be associated with the regulation of IL-10 and IFN-gamma production and seems to be antigen-dependent. This study demonstrates the importance of infectious status of the population in the evaluation of acquired immunity against malaria and highlights the consequences of a multiple infection environment during clinical trials of anti-malaria vaccine candidates.	[Diallo, Tamsir O.; Gaayeb, Lobna; Schacht, Anne-Marie; Riveau, Gilles] Inst Pasteur, INSERM, U547, F-59019 Lille, France; [Diallo, Tamsir O.; Remoue, Franck; Gaayeb, Lobna; Schacht, Anne-Marie; Charrier, Nicole; De Clerck, Dick; Dompnier, Jean-Pierre; Pillet, Sophie; N'Diaye, Abdoulaye A.; Riveau, Gilles] ONG ESPOIR Sante, Lab Rech Med, St Louis, Senegal; [Remoue, Franck] IRD, UR Caracterisat & Controle Populat Vecteurs 016, F-34394 Montpellier, France; [Garraud, Olivier] Univ St Etienne, GIMAP, EA3064, St Etienne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut de Recherche pour le Developpement (IRD); Universite Jean Monnet	Diallo, TO (corresponding author), Inst Pasteur, INSERM, U547, F-59019 Lille, France.	tamsird@yahoo.fr			French Ministry of Education and Scientific Research [02MENRT00123]; Conseil Regional Nord-Pas de Calais (France) [04170049]	French Ministry of Education and Scientific Research; Conseil Regional Nord-Pas de Calais (France)(Region Hauts-de-France)	This work was supported by VIHPAL Program (French Ministry of Education and Scientific Research) - Grant number 02MENRT00123 - 2002-2005. Malaria in schistosomiasis infected populations. Immunological studies in humans and rats. The Conseil Regional Nord-Pas de Calais (France) - Grant number 04170049 - 2004-2007. Epidemiological studies for schistosomiasis control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aribot G, 1996, AM J TROP MED HYG, V54, P449, DOI 10.4269/ajtmh.1996.54.449; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Briand V, 2005, AM J TROP MED HYG, V72, P702, DOI 10.4269/ajtmh.2005.72.702; Cavanagh DR, 2001, INFECT IMMUN, V69, P1207, DOI 10.1128/IAI.69.2.1207-1211.2001; Conway DJ, 2000, NAT MED, V6, P689, DOI 10.1038/76272; Diallo TO, 2004, PARASITE IMMUNOL, V26, P365, DOI 10.1111/j.0141-9838.2004.00719.x; Diallo TO, 2002, AM J TROP MED HYG, V66, P137, DOI 10.4269/ajtmh.2002.66.137; Druilhe P, 2005, TRENDS PARASITOL, V21, P359, DOI 10.1016/j.pt.2005.06.011; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Egan AF, 1999, PARASITE IMMUNOL, V21, P133, DOI 10.1046/j.1365-3024.1999.00209.x; Garraud O, 2003, TRENDS IMMUNOL, V24, P30, DOI 10.1016/S1471-4906(02)00012-1; Garraud O, 2002, INFECT IMMUN, V70, P2820, DOI 10.1128/IAI.70.6.2820-2827.2002; Garraud O, 1999, IMMUNOLOGY, V97, P204, DOI 10.1046/j.1365-2567.1999.00763.x; Hartgers FC, 2008, PARASITOLOGY, V135, P855, DOI 10.1017/S0031182008000401; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; Joseph S, 2004, INFECT IMMUN, V72, P728, DOI 10.1128/IAI.72.2.728-734.2004; Keitel WA, 1999, VACCINE, V18, P531, DOI 10.1016/S0264-410X(99)00221-2; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lee EAM, 2002, INFECT IMMUN, V70, P1417, DOI 10.1128/IAI.70.3.1417-1421.2002; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Morgan WD, 1999, J MOL BIOL, V289, P113, DOI 10.1006/jmbi.1999.2753; Mutapi F, 2000, PARASITE IMMUNOL, V22, P207, DOI 10.1046/j.1365-3024.2000.00288.x; Nacher M, 2001, TRENDS PARASITOL, V17, P563, DOI 10.1016/S1471-4922(01)02117-1; Parija SC, 2009, INDIAN J PATHOL MICR, V52, P200, DOI 10.4103/0377-4929.48917; Picquet M, 1996, T ROY SOC TROP MED H, V90, P340, DOI 10.1016/S0035-9203(96)90501-5; Remoue F, 2003, T ROY SOC TROP MED H, V97, P361, DOI 10.1016/S0035-9203(03)90170-2; Sokhna C, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-43; Su Z, 2005, INFECT IMMUN, V73, P3531, DOI 10.1128/IAI.73.6.3531-3539.2005; Taylor-Robinson AW, 1998, INT J PARASITOL, V28, P135, DOI 10.1016/S0020-7519(97)00173-2; Tebo AE, 2001, EXP PARASITOL, V98, P20, DOI 10.1006/expr.2001.4619; Tongren JE, 2006, INFECT IMMUN, V74, P257, DOI 10.1128/IAI.74.1.257-264.2006; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van den Biggelaar AHJ, 2000, LANCET, V356, P1723, DOI 10.1016/S0140-6736(00)03206-2; Van Geertruyden JP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-258; *WHO, 2009, GLOB MAL EL REP TECH; Widhe M, 1998, SCAND J IMMUNOL, V47, P575; Winkler S, 1998, INFECT IMMUN, V66, P6040, DOI 10.1128/IAI.66.12.6040-6044.1998; Yazdani SS, 2006, CURR MOL MED, V6, P187, DOI 10.2174/156652406776055212	38	45	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12764	10.1371/journal.pone.0012764	http://dx.doi.org/10.1371/journal.pone.0012764			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856680	Green Submitted, Green Published, gold			2022-12-27	WOS:000281815800026
J	Lin, YC; Liu, YC; Huang, YY; Lien, CC				Lin, Yen-Chu; Liu, Yu-Chao; Huang, Yu-Yin; Lien, Cheng-Chang			High-Density Expression of Ca2+-Permeable ASIC1a Channels in NG2 Glia of Rat Hippocampus	PLOS ONE			English	Article							SENSING ION CHANNELS; CHONDROITIN-SULFATE PROTEOGLYCAN; OLIGODENDROCYTE PRECURSOR CELLS; CENTRAL-NERVOUS-SYSTEM; PROGENITOR CELLS; CEREBRAL-CORTEX; NA+ CHANNELS; WHITE-MATTER; NEURONS; BRAIN	NG2 cells, a fourth type of glial cell in the mammalian CNS, undergo reactive changes in response to a wide variety of brain insults. Recent studies have demonstrated that neuronally expressed acid-sensing ion channels (ASICs) are implicated in various neurological disorders including brain ischemia and seizures. Acidosis is a common feature of acute neurological conditions. It is postulated that a drop in pH may be the link between the pathological process and activation of NG2 cells. Such postulate immediately prompts the following questions: Do NG2 cells express ASICs? If so, what are their functional properties and subunit composition? Here, using a combination of electrophysiology, Ca2+ imaging and immunocytochemistry, we present evidence to demonstrate that NG2 cells of the rat hippocampus express high density of Ca2+-permeable ASIC1a channels compared with several types of hippocampal neurons. First, nucleated patch recordings from NG2 cells revealed high density of proton-activated currents. The magnitude of proton-activated current was pH dependent, with a pH for half-maximal activation of 6.3. Second, the current-voltage relationship showed a reversal close to the equilibrium potential for Na+. Third, psalmotoxin 1, a blocker specific for the ASIC1a channel, largely inhibited proton-activated currents. Fourth, Ca2+ imaging showed that activation of proton-activated channels led to an increase of [Ca2+](i). Finally, immunocytochemistry showed co-localization of ASIC1a and NG2 proteins in the hippocampus. Thus the acid chemosensor, the ASIC1a channel, may serve for inducing membrane depolarization and Ca2+ influx, thereby playing a crucial role in the NG2 cell response to injury following ischemia.	[Lin, Yen-Chu; Liu, Yu-Chao; Lien, Cheng-Chang] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Lin, Yen-Chu; Liu, Yu-Chao; Lien, Cheng-Chang] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Huang, Yu-Yin] Cheng Hsin Gen Hosp, Dept Anesthesiol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Cheng Hsin General Hospital	Lin, YC (corresponding author), Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan.	cclien@ym.edu.tw	Lien, Cheng-Chang/AAO-6249-2020	Lien, Cheng-Chang/0000-0002-6692-9942; Liu, Yu-Chao/0000-0001-8285-6328	Ministry of Education, Taiwan; National Health Research Institutes [NHRI-EX99-9720NC]; NHRI-EX99-9720NC), Taiwan National Science Council [NSC98-2321-B-010-001]; Cheng Hsin General Hospital [98-59]	Ministry of Education, Taiwan(Ministry of Education, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); NHRI-EX99-9720NC), Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Cheng Hsin General Hospital	Ministry of Education, Taiwan (Aim for The Top University Plan), National Health Research Institutes (NHRI-EX99-9720NC), Taiwan National Science Council (NSC98-2321-B-010-001) and Cheng Hsin General Hospital (98-59 to Y.Y.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bolshakov KV, 2002, NEUROSCIENCE, V110, P723, DOI 10.1016/S0306-4522(01)00582-6; Bordey A, 1997, J NEUROPHYSIOL, V78, P461, DOI 10.1152/jn.1997.78.1.461; Brilli E, 2009, J NEUROSCI RES, V87, P636, DOI 10.1002/jnr.21879; Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; CHU KC, 2010, EUR J NEURO IN PRESS; De Biase LM, 2010, J NEUROSCI, V30, P3600, DOI 10.1523/JNEUROSCI.6000-09.2010; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Ge WP, 2006, SCIENCE, V312, P1533, DOI 10.1126/science.1124669; Ge WP, 2009, P NATL ACAD SCI USA, V106, P328, DOI 10.1073/pnas.0811353106; Hamilton N, 2010, GLIA, V58, P66, DOI 10.1002/glia.20902; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Kafitz KW, 2008, J NEUROSCI METH, V169, P84, DOI 10.1016/j.jneumeth.2007.11.022; Karadottir R, 2008, NAT NEUROSCI, V11, P450, DOI 10.1038/nn2060; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Liao CW, 2009, NEUROSCIENCE, V164, P1701, DOI 10.1016/j.neuroscience.2009.09.052; Lin SC, 2004, GLIA, V47, P290, DOI 10.1002/glia.20060; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; Matsumoto K, 1996, J CEREBR BLOOD F MET, V16, P114, DOI 10.1097/00004647-199601000-00014; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Ong WY, 1999, NEUROSCIENCE, V92, P83, DOI 10.1016/S0306-4522(98)00751-9; PHILLIS JW, 1994, BRAIN RES BULL, V34, P457, DOI 10.1016/0361-9230(94)90019-1; Polito A, 2005, J ANAT, V207, P707, DOI 10.1111/j.1469-7580.2005.00454.x; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Tanaka Y, 2009, CEREB CORTEX, V19, P2181, DOI 10.1093/cercor/bhn238; Tong XP, 2009, J CELL BIOL, V186, P113, DOI 10.1083/jcb.200811071; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Weng JY, 2010, J NEUROSCI, V30, P6548, DOI 10.1523/JNEUROSCI.0582-10.2010; Wennstrom M, 2003, BIOL PSYCHIAT, V54, P1015, DOI 10.1016/S0006-3223(03)00693-0; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xiong ZG, 2008, CURR OPIN PHARMACOL, V8, P25, DOI 10.1016/j.coph.2007.09.001; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; Zalc B, 2000, NEUROSCIENTIST, V6, P5, DOI 10.1177/107385840000600109; Zhang M, 2008, NEUROSCIENCE, V154, P461, DOI 10.1016/j.neuroscience.2008.03.040; Zhou M, 2006, J NEUROPHYSIOL, V95, P134, DOI 10.1152/jn.00570.2005; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132	48	27	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12665	10.1371/journal.pone.0012665	http://dx.doi.org/10.1371/journal.pone.0012665			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844750	Green Published, Green Submitted, gold			2022-12-27	WOS:000281687300010
J	Inoue, K; Li, WJ; Kurata, H				Inoue, Kentaro; Li, Weijiang; Kurata, Hiroyuki			Diffusion Model Based Spectral Clustering for Protein-Protein Interaction Networks	PLOS ONE			English	Article							FUNCTIONAL MODULES; ORGANIZATION; MODULARITY; COMPLEXES; ALGORITHM	Background: A goal of systems biology is to analyze large-scale molecular networks including gene expressions and protein-protein interactions, revealing the relationships between network structures and their biological functions. Dividing a protein-protein interaction (PPI) network into naturally grouped parts is an essential way to investigate the relationship between topology of networks and their functions. However, clear modular decomposition is often hard due to the heterogeneous or scale-free properties of PPI networks. Methodology/Principal Findings: To address this problem, we propose a diffusion model-based spectral clustering algorithm, which analytically solves the cluster structure of PPI networks as a problem of random walks in the diffusion process in them. To cope with the heterogeneity of the networks, the power factor is introduced to adjust the diffusion matrix by weighting the transition (adjacency) matrix according to a node degree matrix. This algorithm is named adjustable diffusion matrix-based spectral clustering (ADMSC). To demonstrate the feasibility of ADMSC, we apply it to decomposition of a yeast PPI network, identifying biologically significant clusters with approximately equal size. Compared with other established algorithms, ADMSC facilitates clear and fast decomposition of PPI networks. Conclusions/Significance: ADMSC is proposed by introducing the power factor that adjusts the diffusion matrix to the heterogeneity of the PPI networks. ADMSC effectively partitions PPI networks into biologically significant clusters with almost equal sizes, while being very fast, robust and appealing simple.	[Inoue, Kentaro; Kurata, Hiroyuki] Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan; [Li, Weijiang] So Yangtze Univ, Key Lab Ind Biotechnol, Wuxi, Peoples R China	Kyushu Institute of Technology; Jiangnan University	Inoue, K (corresponding author), Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan.	kurata@bio.kyutech.ac.jp	Inoue, Kentaro/P-4920-2016	Inoue, Kentaro/0000-0002-7447-5856	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study is supported by a Grant-in-Aid for Scientific Research on Priority Areas, Systems Genomics, from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Andreopoulos B, 2007, BIOINFORMATICS, V23, P1124, DOI 10.1093/bioinformatics/btm064; Arnau V, 2005, BIOINFORMATICS, V21, P364, DOI 10.1093/bioinformatics/bti021; Asur S, 2007, BIOINFORMATICS, V23, pI29, DOI 10.1093/bioinformatics/btm212; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; Blatt M, 1996, PHYS REV LETT, V76, P3251, DOI 10.1103/PhysRevLett.76.3251; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Bu DB, 2003, NUCLEIC ACIDS RES, V31, P2443, DOI 10.1093/nar/gkg340; Donetti L, 2004, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2004/10/P10012; Dunn R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-39; Eriksen KA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.148701; Fischer I., 2004, IDSIA1204; Friedel CC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-519; Gagneur J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r57; Jiang JQ, 2009, APPL MATH LETT, V22, P1479, DOI 10.1016/j.aml.2009.02.005; King AD, 2004, BIOINFORMATICS, V20, P3013, DOI 10.1093/bioinformatics/bth351; Koren Y, 2003, LECT NOTES COMPUT SC, V2697, P496; Kozma B, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.018701; Kurata H, 2003, NUCLEIC ACIDS RES, V31, P4071, DOI 10.1093/nar/gkg461; Li WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002541; Li WJ, 2005, BIOINFORMATICS, V21, P2036, DOI 10.1093/bioinformatics/bti290; Luo F, 2007, BIOINFORMATICS, V23, P207, DOI 10.1093/bioinformatics/btl562; Meila M, 2001, ADV NEUR IN, V13, P873; Morrison JL, 2006, BIOINFORMATICS, V22, P2012, DOI 10.1093/bioinformatics/btl338; NADLER B, 2005, ARXIVMATH0506090V1NA; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Ng AY, 2002, ADV NEUR IN, V14, P849; Pereira-Leal JB, 2004, PROTEINS, V54, P49, DOI 10.1002/prot.10505; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Royer L, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000108; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sen TZ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-355; Song JM, 2009, BIOINFORMATICS, V25, P3143, DOI 10.1093/bioinformatics/btp551; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; van Dongen S, 2000, THESIS U UTRECHT; YEN L, 2005, CLUSTERING USING RAN, P317; Yoon J, 2006, BIOINFORMATICS, V22, P3106, DOI 10.1093/bioinformatics/btl533	40	22	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12623	10.1371/journal.pone.0012623	http://dx.doi.org/10.1371/journal.pone.0012623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830307	Green Submitted, Green Published, gold			2022-12-27	WOS:000281631300043
J	Loebig, M; Klement, J; Schmoller, A; Betz, S; Heuck, N; Schweiger, U; Peters, A; Schultes, B; Oltmanns, KM				Loebig, Michaela; Klement, Johanna; Schmoller, Andre; Betz, Simone; Heuck, Nicole; Schweiger, Ulrich; Peters, Achim; Schultes, Bernd; Oltmanns, Kerstin M.			Evidence for a Relationship between VEGF and BMI Independent of Insulin Sensitivity by Glucose Clamp Procedure in a Homogenous Group Healthy Young Men	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EXPRESSION; ANGIOGENESIS; RESISTANCE; HYPOGLYCEMIA; INDIVIDUALS; TURNOVER; CELLS	Background: This is the first study to experimentally explore the direct relationship between circulating VEGF levels and body mass index (BMI) as well as to unravel the role of insulin sensitivity in this context under standardized glucose clamp conditions as the methodical gold-standard. In order to control for known influencing factors such as gender, medication, and arterial hypertension, we examined a highly homogeneous group of young male subjects. Moreover, to encompass also subjects beyond the normal BMI range, low weight and obese participants were additionally included and stress hormones as a main regulator of VEGF were assessed. Methodology/Principal Findings: Under euglycemic clamp conditions, VEGF was measured in 15 normal weight (BMI 20-25 kg/m(2)), 15 low weight (BMI<20 kg/m(2)), and 15 obese (BMI>30 kg/m(2)) male subjects aged 18-30 years and the insulin sensitivity index (ISI) was calculated. Since stress axis activation promotes VEGF secretion, concentrations of ACTH, cortisol, and catecholamines were monitored. Despite of comparable ACTH (P = 0.145), cortisol (P = 0.840), and norepinephrine (P = 0.065) levels, VEGF concentrations differed significantly between BMI-groups (P = 0.008) with higher concentrations in obese subjects as compared to normal weight (P = 0.061) and low weight subjects (P = 0.002). Pearson's correlation analysis revealed a positive relationship between BMI and VEGF levels (r = 0.407; P = 0.010) but no correlation of VEGF with ISI (r = 0.224; P = 0.175). Conclusions/Significance: Our data demonstrate a positive correlation between concentrations of circulating VEGF levels and BMI in healthy male subjects under highly controlled conditions. This relationship which is apparently disconnected from insulin sensitivity may be part of some pathogenetic mechanisms underlying obesity and type 2 diabetes.	[Loebig, Michaela; Schmoller, Andre; Betz, Simone; Heuck, Nicole; Schweiger, Ulrich; Oltmanns, Kerstin M.] Univ Lubeck, Dept Psychiat & Psychotherapy, Lubeck, Germany; [Klement, Johanna; Peters, Achim] Univ Lubeck, Dept Internal Med 1, Lubeck, Germany; [Schultes, Bernd] Kantonsspital St Gallen, Dept Interdisciplinary, Obes Ctr, Rorschach, Switzerland	University of Lubeck; University of Lubeck; Kantonsspital St. Gallen	Loebig, M (corresponding author), Univ Lubeck, Dept Psychiat & Psychotherapy, Lubeck, Germany.	michaela.voss@psychiatrie.uk-sh.de			German research Foundation (DFG)	German research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants of the German research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderwald C, 2008, EUR J CLIN INVEST, V38, P227, DOI 10.1111/j.1365-2362.2008.01932.x; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Asano A, 1997, BIOCHEM J, V328, P179, DOI 10.1042/bj3280179; Bates DO, 2002, J ANAT, V200, P581, DOI 10.1046/j.1469-7580.2002.00066.x; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Dandona P, 2003, DIABETES CARE, V26, P3310, DOI 10.2337/diacare.26.12.3310; Dantz D, 2002, J CLIN ENDOCR METAB, V87, P835, DOI 10.1210/jc.87.2.835; DeFronzo RA, 1979, AM J PHYSIOL, V233, P214; DELATORRE NG, 2008, J CLIN ENDOCRINOL ME; Eriksson JW, 1999, DIABETES, V48, P1572, DOI 10.2337/diabetes.48.8.1572; Esteghamati A, 2008, ARCH MED RES, V39, P803, DOI 10.1016/j.arcmed.2008.08.004; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Fredriksson JM, 2000, J BIOL CHEM, V275, P13802, DOI 10.1074/jbc.275.18.13802; Gagne D, 2003, FERTIL STERIL, V80, P43, DOI 10.1016/S0015-0282(03)00552-1; Gaillard I, 2000, J CELL PHYSIOL, V185, P226, DOI 10.1002/1097-4652(200011)185:2<226::AID-JCP7>3.3.CO;2-5; Gunsilius E, 2002, BLOOD, V99, P393, DOI 10.1182/blood.V99.1.393; Kakizawa H, 2004, METABOLISM, V53, P550, DOI 10.1016/j.metabol.2003.12.002; Kimura K, 2007, ATHEROSCLEROSIS, V194, P182, DOI 10.1016/j.atherosclerosis.2006.07.025; Lutgendorf SK, 2003, CLIN CANCER RES, V9, P4514; Merl V, 2005, DIABETIC MED, V22, P1278, DOI 10.1111/j.1464-5491.2005.01590.x; Mick GJ, 2002, ENDOCRINOLOGY, V143, P948, DOI 10.1210/en.143.3.948; Miyazawa-Hoshimoto S, 2003, DIABETOLOGIA, V46, P1483, DOI 10.1007/s00125-003-1221-6; Nammi S, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-3; Natarajan R, 1997, AM J PHYSIOL-HEART C, V273, pH2224, DOI 10.1152/ajpheart.1997.273.5.H2224; Oltmanns KM, 2006, AM J PHYSIOL-ENDOC M, V290, pE434, DOI 10.1152/ajpendo.00508.2004; Randeva HS, 2004, CIRCULATION, V109, P2405, DOI 10.1161/01.CIR.0000129763.51060.77; SANDHOFER A, 2009, ATHEROSCLEROSIS; Silha JV, 2005, INT J OBESITY, V29, P1308, DOI 10.1038/sj.ijo.0802987; Sone H, 1996, BIOCHEM BIOPH RES CO, V221, P193, DOI 10.1006/bbrc.1996.0568; Toft I, 1998, HYPERTENSION, V32, P115, DOI 10.1161/01.HYP.32.1.115; WADA H, 2009, ATHEROSCLEROSIS; Yang EV, 2006, CANCER RES, V66, P10357, DOI 10.1158/0008-5472.CAN-06-2496	32	59	61	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12610	10.1371/journal.pone.0012610	http://dx.doi.org/10.1371/journal.pone.0012610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830305	gold, Green Published, Green Submitted			2022-12-27	WOS:000281631300031
J	Fernandez, P; Petres, S; Mecheri, S; Gysin, J; Scherf, A				Fernandez, Pablo; Petres, Stephane; Mecheri, Salaheddine; Gysin, Juerg; Scherf, Artur			Strain-Transcendent Immune Response to Recombinant Var2CSA DBL5-epsilon Domain Block P. falciparum Adhesion to Placenta-Derived BeWo Cells under Flow Conditions	PLOS ONE			English	Article							CHONDROITIN SULFATE-A; MICROVASCULAR ENDOTHELIAL-CELLS; CROSS-REACTIVE ANTIBODIES; PLASMODIUM-FALCIPARUM; INFECTED ERYTHROCYTES; PARASITE ADHESION; PREGNANCY; MALARIA; CYTOADHESION; SURFACE	Background: Pregnancy-associated malaria (PAM) is a serious consequence of the adhesion to the placental receptor chondroitin sulfate A (CSA) of Plasmodium falciparum-infected erythrocytes (PE) expressing the large cysteine-rich multidomain protein var2CSA. Women become resistant to PAM, and develop strain-transcending immunity against CSA-binding parasites. The identification of var2CSA regions that could elicit broadly neutralizing and adhesion-blocking antibodies is a key step for the design of prophylactic vaccine strategies. Methodology: Escherichia coli expressed var2CSA DBL domains were refolded and purified prior to immunization of mice and a goat. Protein-G-purified antibodies were tested for their ability to block FCR3(CSA)-infected erythrocytes binding to placental (BeWo) and monkey brain endothelial (ScC2) cell lines using a flow cytoadhesion inhibition assay mimicking closely the physiological conditions present in the placenta at shear stress of 0.05 Pa. DBL5-epsilon, DBL6-epsilon and DBL5-6-epsilon induced cross-reactive antibodies using Alum and Freund as adjuvants, which blocked cytoadhesion at values ranging between 40 to 96% at 0.5 mg IgG per ml. Importantly, antibodies raised against recombinant DBL5-epsilon from 3 distinct parasites genotypes (HB3, Dd2 and 7G8) showed strain-transcending inhibition ranging from 38 to 64% for the heterologuous FCR3(CSA). Conclusions: Using single and double DBL domains from var2CSA and Alum as adjuvant, we identified recombinant subunits inducing an immune response in experimental animals which is able to block efficiently parasite adhesion in a flow cytoadhesion assay that mimics closely the erythrocyte flow in the placenta. These subunits show promising features for inclusion into a vaccine aiming to protect against PAM.	[Fernandez, Pablo; Mecheri, Salaheddine; Scherf, Artur] Inst Pasteur, Unite Biol Interact Hote Parasite, Paris, France; [Fernandez, Pablo; Mecheri, Salaheddine; Scherf, Artur] CNRS, URA2581, Paris, France; [Petres, Stephane; Gysin, Juerg] Inst Pasteur, Host Pathogen Interact Unit, Abymes, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Fernandez, P (corresponding author), Inst Pasteur, Unite Biol Interact Hote Parasite, Paris, France.	artur.scherf@pasteur.fr	Scherf, Artur/A-9674-2014; Mecheri, Salah/M-8315-2013	Scherf, Artur/0000-0003-2411-3328; petres, stephane/0000-0002-4716-565X	PMI; Bill and Melinda Gates Foundation; Fondation pour la Recherche Medicale [DMI20091117309]	PMI(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	PMI Gates Malaria Programme grant, Bill and Melinda Gates Foundation. Fondation pour la Recherche Medicale (DMI20091117309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avril M, 2004, MICROBES INFECT, V6, P249, DOI 10.1016/j.micinf.2003.12.007; Avril M, 2008, INFECT IMMUN, V76, P1791, DOI 10.1128/IAI.01470-07; Avril M, 2006, MICROBES INFECT, V8, P2863, DOI 10.1016/j.micinf.2006.09.005; Avril M, 2010, INFECT IMMUN, V78, P2248, DOI 10.1128/IAI.00410-09; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Fernandez P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-170; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Fusai T, 2000, MOL BIOCHEM PARASIT, V108, P25, DOI 10.1016/S0166-6851(00)00199-7; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; GAY F, 1995, J IMMUNOL METHODS, V184, P15, DOI 10.1016/0022-1759(95)00070-Q; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Magistrado P, 2008, J INFECT DIS, V198, P1071, DOI 10.1086/591502; Ndam NGT, 2005, J INFECT DIS, V192, P331, DOI 10.1086/430933; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Oleinikov AV, 2008, J INFECT DIS, V197, P1119, DOI 10.1086/529526; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salanti A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-11; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Viebig NK, 2006, EXP PARASITOL, V112, P121, DOI 10.1016/j.exppara.2005.09.007; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466	25	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12558	10.1371/journal.pone.0012558	http://dx.doi.org/10.1371/journal.pone.0012558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838433	gold, Green Submitted, Green Published			2022-12-27	WOS:000281627700011
J	Zheng, ZQ; de Iongh, RU; Rathjen, PD; Rathjen, J				Zheng, Zhiqiang; de Iongh, Robb U.; Rathjen, Peter D.; Rathjen, Joy			A Requirement for FGF Signalling in the Formation of Primitive Streak-Like Intermediates from Primitive Ectoderm in Culture	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; EMBRYONIC STEM-CELLS; BONE MORPHOGENETIC PROTEIN-4; MOUSE ES CELLS; MESODERM INDUCTION; MAINTAIN PLURIPOTENCY; FACTOR RECEPTOR-1; BASIC FGF; DIFFERENTIATION; ENDODERM	Background: Embryonic stem (ES) cells hold considerable promise as a source of cells with therapeutic potential, including cells that can be used for drug screening and in cell replacement therapies. Differentiation of ES cells into the somatic lineages is a regulated process; before the promise of these cells can be realised robust and rational methods for directing differentiation into normal, functional and safe cells need to be developed. Previous in vivo studies have implicated fibroblast growth factor (FGF) signalling in lineage specification from pluripotent cells. Although FGF signalling has been suggested as essential for specification of mesoderm and endoderm in vivo and in culture, the exact role of this pathway remains unclear. Methodology/Principal Findings: Using a culture model based on early primitive ectoderm-like (EPL) cells we have investigated the role of FGF signalling in the specification of mesoderm. We were unable to demonstrate any mesoderm inductive capability associated with FGF1, 4 or 8 signalling, even when the factors were present at high concentrations, nor any enhancement in mesoderm formation induced by exogenous BMP4. Furthermore, there was no evidence of alteration of mesoderm sub-type formed with addition of FGF1, 4 or 8. Inhibition of endogenous FGF signalling, however, prevented mesoderm and favoured neural differentiation, suggesting FGF signalling was required but not sufficient for the differentiation of primitive ectoderm into primitive streak-like intermediates. The maintenance of ES cell/early epiblast pluripotent marker expression was also observed in cultures when FGF signalling was inhibited. Conclusions/Significance: FGF signalling has been shown to be required for the differentiation of primitive ectoderm to neurectoderm. This, coupled with our observations, suggest FGF signalling is required for differentiation of the primitive ectoderm into the germ lineages at gastrulation.	[Zheng, Zhiqiang; Rathjen, Peter D.; Rathjen, Joy] Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia; [de Iongh, Robb U.] Univ Melbourne, Dept Anat & Cell Biol, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne	Zheng, ZQ (corresponding author), Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia.	jrathjen@unimelb.edu.au	De Iongh, Robb U/H-9646-2019	De Iongh, Robb U/0000-0001-7013-1610; Zheng, Zhiqiang/0000-0003-1028-3246	University of Melbourne; Australian Stem Cell Centre (Monash University, Clayton, Victoria, Australia)	University of Melbourne(University of Melbourne); Australian Stem Cell Centre (Monash University, Clayton, Victoria, Australia)(Monash University)	This work was supported by the University of Melbourne and an equipment loan from the Australian Stem Cell Centre (Monash University, Clayton, Victoria, Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Beiman M, 1996, GENE DEV, V10, P2993, DOI 10.1101/gad.10.23.2993; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Chen Y, 2000, ONCOGENE, V19, P3750, DOI 10.1038/sj.onc.1203726; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Ciruna BG, 1997, DEVELOPMENT, V124, P2829; CORNELL RA, 1994, DEVELOPMENT, V120, P453; DELLERA P, 2003, CIRC RES, P414; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Era T, 2008, STEM CELLS, V26, P401, DOI 10.1634/stemcells.2006-0809; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ezzat S, 2005, CLIN CANCER RES, V11, P1336; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; Fisher LJ, 1997, NEUROBIOL DIS, V4, P1, DOI 10.1006/nbdi.1997.0137; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; GRIFFIN K, 1995, DEVELOPMENT, V121, P2983; HAUB O, 1991, DEVELOPMENT, V112, P397; Hughes JN, 2009, STEM CELLS, V27, P2941, DOI 10.1002/stem.218; Hughes JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005579; Isaacs HV, 1997, CELL MOL LIFE SCI, V53, P350, DOI 10.1007/PL00000611; JOHANSSON BM, 1995, MOL CELL BIOL, V15, P141, DOI 10.1128/MCB.15.1.141; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Kunii K, 2008, CANCER RES, V68, P2340, DOI 10.1158/0008-5472.CAN-07-5229; LABONNE C, 1994, DEVELOPMENT, V120, P463; LABONNE C, 1995, DEVELOPMENT, V121, P1475; Lake JA, 2000, J CELL SCI, V113, P555; Lin HY, 1998, MOL CELL BIOL, V18, P3762, DOI 10.1128/MCB.18.7.3762; Maher P, 1999, J BIOL CHEM, V274, P17491, DOI 10.1074/jbc.274.25.17491; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Maye P, 2000, MECH DEVELOP, V94, P117, DOI 10.1016/S0925-4773(00)00304-X; MCAVOY JW, 1989, DEVELOPMENT, V107, P221; MITRANI E, 1990, DEVELOPMENT, V109, P387; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; MONTELL DJ, 1994, TRENDS GENET, V10, P59, DOI 10.1016/0168-9525(94)90150-3; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; NISWANDER L, 1992, DEVELOPMENT, V114, P755; OHUCHI H, 1994, BIOCHEM BIOPH RES CO, V204, P882, DOI 10.1006/bbrc.1994.2542; Ornitz DM, 2001, GENOME BIOL, V2; ORRURTREGER A, 1991, DEVELOPMENT, V113, P1419; OSHEA K, 2004, BIOL REPROD SOC STUD, P1755; Pelton TA, 2002, J CELL SCI, V115, P329; Pick M, 2007, STEM CELLS, V25, P2206, DOI 10.1634/stemcells.2006-0713; Pollard SM, 2008, MOL CELL NEUROSCI, V38, P393, DOI 10.1016/j.mcn.2008.03.012; Rathjen J, 1999, J CELL SCI, V112, P601; Rathjen J, 2003, METHOD ENZYMOL, V365, P3; Rathjen J, 2002, DEVELOPMENT, V129, P2649; Rathjen J, 2001, CURR OPIN GENET DEV, V11, P587, DOI 10.1016/S0959-437X(00)00237-9; Sadlon TJ, 2004, STEM CELLS, V22, P457, DOI 10.1634/stemcells.22-4-457; SCHULTEMERKER S, 1995, CURR BIOL, V5, P62, DOI 10.1016/S0960-9822(95)00017-0; SCHULZ MW, 1993, DEVELOPMENT, V118, P117; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; Trudel S, 2004, BLOOD, V103, P3521, DOI 10.1182/blood-2003-10-3650; UMBHAUER M, 1995, NATURE, V376, P58, DOI 10.1038/376058a0; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Wang JK, 1997, ONCOGENE, V14, P1767, DOI 10.1038/sj.onc.1201021; WANG JK, 1994, MOL CELL BIOL, V14, P181, DOI 10.1128/MCB.14.1.181; Wang LS, 2005, BLOOD, V105, P4598, DOI 10.1182/blood-2004-10-4065; Willems E, 2008, DIFFERENTIATION, V76, P745, DOI 10.1111/j.1432-0436.2007.00257.x; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; YAMAGUCHI TP, 1995, CURR OPIN GENET DEV, V5, P485, DOI 10.1016/0959-437X(95)90053-J; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032; Yamanaka Y, 2010, DEVELOPMENT, V137, P715, DOI 10.1242/dev.043471; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; ZHAN X, 1994, J BIOL CHEM, V269, P20221	72	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12555	10.1371/journal.pone.0012555	http://dx.doi.org/10.1371/journal.pone.0012555			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838439	Green Published, gold			2022-12-27	WOS:000281627700008
J	Rolland, M; Carlson, JM; Manocheewa, S; Swain, JV; Lanxon-Cookson, E; Deng, WJ; Rousseau, CM; Raugi, DN; Learn, GH; Maust, BS; Coovadia, H; Ndung'u, T; Goulder, PJR; Walker, BD; Brander, C; Heckerman, DE; Mullins, JI				Rolland, Morgane; Carlson, Jonathan M.; Manocheewa, Siriphan; Swain, J. Victor; Lanxon-Cookson, Erinn; Deng, Wenjie; Rousseau, Christine M.; Raugi, Dana N.; Learn, Gerald H.; Maust, Brandon S.; Coovadia, Hoosen; Ndung'u, Thumbi; Goulder, Philip J. R.; Walker, Bruce D.; Brander, Christian; Heckerman, David E.; Mullins, James I.			Amino-Acid Co-Variation in HIV-1 Gag Subtype C: HLA-Mediated Selection Pressure and Compensatory Dynamics	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-LYMPHOCYTE ESCAPE; PROTEASE INHIBITORS; ELITE CONTROLLERS; VIRAL LOAD; ASSOCIATIONS; MUTATIONS; POLYMORPHISMS; TRANSMISSION; INFECTION	Background: Despite high potential for HIV-1 genetic variation, the emergence of some mutations is constrained by fitness costs, and may be associated with compensatory amino acid (AA) co-variation. To characterize the interplay between Cytotoxic T Lymphocyte (CTL)-mediated pressure and HIV-1 evolutionary pathways, we investigated AA co-variation in Gag sequences obtained from 449 South African individuals chronically infected with HIV-1 subtype C. Methodology/Principal Findings: Individuals with CTL responses biased toward Gag presented lower viral loads than individuals with under-represented Gag-specific CTL responses. Using methods that account for founder effects and HLA linkage disequilibrium, we identified 35 AA sites under Human Leukocyte Antigen (HLA)-restricted CTL selection pressure and 534 AA-to-AA interactions. Analysis of two-dimensional distances between co-varying residues revealed local stabilization mechanisms since 40% of associations involved neighboring residues. Key features of our co-variation analysis included sites with a high number of co-varying partners, such as HLA-associated sites, which had on average 55% more connections than other co-varying sites. Conclusions/Significance: Clusters of co-varying AA around HLA-associated sites (especially at typically conserved sites) suggested that cooperative interactions act to preserve the local structural stability and protein function when CTL escape mutations occur. These results expose HLA-imprinted HIV-1 polymorphisms and their interlinked mutational paths in Gag that are likely due to opposite selective pressures from host CTL-mediated responses and viral fitness constraints.	[Rolland, Morgane; Manocheewa, Siriphan; Swain, J. Victor; Lanxon-Cookson, Erinn; Deng, Wenjie; Rousseau, Christine M.; Raugi, Dana N.; Learn, Gerald H.; Maust, Brandon S.; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Mullins, James I.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Carlson, Jonathan M.; Heckerman, David E.] Microsoft Res, Redmond, WA USA; [Coovadia, Hoosen; Ndung'u, Thumbi; Goulder, Philip J. R.] Univ KwaZulu Natal, HIV Pathogenesis Program, Nelson Mandela Sch Med, Durban, South Africa; [Goulder, Philip J. R.] Univ Oxford, Dept Pediat, Nuffield Dept Med, Oxford, England; [Goulder, Philip J. R.; Walker, Bruce D.; Brander, Christian] Massachusetts Gen Hosp, Ragon Inst MGH MIT & Harvard, Boston, MA 02114 USA; [Goulder, Philip J. R.; Walker, Bruce D.; Brander, Christian] Harvard Univ, Sch Med, Boston, MA USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Microsoft; University of Kwazulu Natal; University of Oxford; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Rolland, M (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	mrolland@u.washington.edu	Learn, Jerry/E-3356-2012; Learn, Gerald H/B-6934-2011	Learn, Gerald H/0000-0003-0434-7733; Brander, Christian/0000-0002-0548-5778; Ndung'u, Thumbi/0000-0003-2962-3992	Bill and Melinda Gates Foundation [43437]; amfAR Mathilde Krim Fellowship [107005-43-RFNT]; US Public Health Services [AI057005]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, P01AI057005] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); amfAR Mathilde Krim Fellowship; US Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Bill and Melinda Gates Foundation to JM [# 43437], an amfAR Mathilde Krim Fellowship to MR [# 107005-43-RFNT] and the US Public Health Services [AI057005], including to M. R. and the Computational Biology Core of the University of Washington Center for AIDS Research and STDs [AI27757]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batada NN, 2006, PLOS COMPUT BIOL, V2, P748, DOI 10.1371/journal.pcbi.0020088; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Brockman MA, 2007, J VIROL, V81, P12608, DOI 10.1128/JVI.01369-07; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Carlson J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000591; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; FITCH WM, 1970, BIOCHEM GENET, V4, P579, DOI 10.1007/BF00486096; Gonzales MJ, 2003, AIDS, V17, P791, DOI 10.1097/00002030-200304110-00003; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hoffman NG, 2003, VIROLOGY, V314, P536, DOI 10.1016/S0042-6822(03)00484-7; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; MADDISON W.P., 2001, MACCLADE ANAL PHYLOG; Matthews PC, 2008, J VIROL, V82, P8548, DOI 10.1128/JVI.00580-08; Menendez-Arias Luis, 2003, Current Drug Targets - Infectious Disorders, V3, P355, DOI 10.2174/1568005033481033; Milicic A, 2005, J VIROL, V79, P13953, DOI 10.1128/JVI.79.22.13953-13962.2005; Miura T, 2008, J VIROL, V82, P8422, DOI 10.1128/JVI.00535-08; Miura T, 2009, J VIROL, V83, P140, DOI 10.1128/JVI.01471-08; Perno CF, 2006, ANTIVIR RES, V71, P293, DOI 10.1016/j.antiviral.2006.05.015; Plana M, 2002, J ACQ IMMUN DEF SYND, V29, P429, DOI 10.1097/00126334-200204150-00001; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Poon AFY, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030045; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rousseau CM, 2008, J VIROL, V82, P6434, DOI 10.1128/JVI.02455-07; Rousseau CM, 2007, J VIROL, V81, P4492, DOI 10.1128/JVI.02050-06; Rousseau CM, 2006, J VIROL METHODS, V136, P118, DOI 10.1016/j.jviromet.2006.04.009; Schneidewind A, 2007, J VIROL; Schneidewind A, 2008, J VIROL, V82, P5594, DOI 10.1128/JVI.02356-07; Storey John D, 2003, Methods Mol Biol, V224, P149; Svicher V, 2005, ANTIMICROB AGENTS CH, V49, P2015, DOI 10.1128/AAC.49.5.2015-2025.2005; Swofford D. L., 1999, PAUP 4 0 PHYLOGENETI; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Wu HL, 2006, J VIROL, V80, P2380, DOI 10.1128/JVI.80.5.2380-2389.2006; Wu TD, 2003, J VIROL, V77, P4836, DOI 10.1128/JVI.77.8.4836-4847.2003; YANOFSKY C, 1964, SCIENCE, V146, P1593, DOI 10.1126/science.146.3651.1593	42	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12463	10.1371/journal.pone.0012463	http://dx.doi.org/10.1371/journal.pone.0012463			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824187	Green Published, Green Submitted, gold			2022-12-27	WOS:000281456100003
J	Hoffmann, C; Galle, M; Dilling, S; Kappeli, R; Muller, AJ; Songhet, P; Beyaert, R; Hardt, WD				Hoffmann, Claudia; Galle, Marlies; Dilling, Sabrina; Kaeppeli, Rina; Mueller, Andreas J.; Songhet, Pascal; Beyaert, Rudi; Hardt, Wolf-Dietrich			In Macrophages, Caspase-1 Activation by SopE and the Type III Secretion System-1 of S. Typhimurium Can Proceed in the Absence of Flagellin	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; STREPTOMYCIN-PRETREATED MICE; SALMONELLA-TYPHIMURIUM; HOST-CELL; BACTERIAL INTERNALIZATION; PROTEIN SECRETION; INFLAMMASOME; IDENTIFICATION; RECOGNITION; INVASION	The innate immune system is of vital importance for protection against infectious pathogens. Inflammasome mediated caspase-1 activation and subsequent release of pro-inflammatory cytokines like IL-1 beta and IL-18 is an important arm of the innate immune system. Salmonella enterica subspecies 1 serovar Typhimurium (S. Typhimurium, SL1344) is an enteropathogenic bacterium causing diarrheal diseases. Different reports have shown that in macrophages, S. Typhimurium may activate caspase-1 by at least three different types of stimuli: flagellin, the type III secretion system 1 (T1) and the T1 effector protein SopE. However, the relative importance and interdependence of the different factors in caspase-1 activation is still a matter of debate. Here, we have analyzed their relative contributions to caspase-1 activation in LPS-pretreated RAW264.7 macrophages. Using flagellar mutants (fliGHI, flgK) and centrifugation to mediate pathogen-host cell contact, we show that flagellins account for a small part of the caspase-1 activation in RAW264.7 cells. In addition, functional flagella are of key importance for motility and host cell attachment which is a prerequisite for mediating caspase-1 activation via these three stimuli. Using site directed mutants lacking several T1 effector proteins and flagellin expression, we found that SopE elicits caspase-1 activation even when flagellins are absent. In contrast, disruption of essential genes of the T1 protein injection system (invG, sip beta) completely abolished caspase-1 activation. However, a robust level of caspase-1 activation is retained by the T1 system (or unidentified T1 effectors) in the absence of flagellin and SopE. T1-mediated inflammasome activation is in line with recent work by others and suggests that the T1 system itself may represent the basic caspase-1 activating stimulus in RAW264.7 macrophages which is further enhanced independently by SopE and/or flagellin.	[Hoffmann, Claudia; Dilling, Sabrina; Kaeppeli, Rina; Mueller, Andreas J.; Songhet, Pascal; Hardt, Wolf-Dietrich] Swiss Fed Inst Technol, D BIOL, Inst Microbiol, Zurich, Switzerland; [Galle, Marlies; Beyaert, Rudi] Univ Ghent VIB, Dept Mol Biomed Res, Unit Mol Signal Transduct Inflammat, B-9052 Ghent, Belgium; [Galle, Marlies; Beyaert, Rudi] Univ Ghent, Dept Mol Biol, B-9000 Ghent, Belgium	Swiss Federal Institutes of Technology Domain; ETH Zurich; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Hoffmann, C (corresponding author), Swiss Fed Inst Technol, D BIOL, Inst Microbiol, Zurich, Switzerland.	hardt@micro.biol.ethz.ch	Beyaert, Rudi/B-2589-2009	Muller, Andreas/0000-0002-0281-6383; Beyaert, Rudi/0000-0002-5704-582X; Hardt, Wolf-Dietrich/0000-0002-9892-6420	Swiss National Science Foundation [310000-113623/1]; ETH Zurich Research foundation [ETH-08 08-3]; Interuniversitaire Attractiepolen [IAP6/18]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO); University of Ghent [01G06B6]; Swiss SystemsX.ch initiative	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich Research foundation(ETH Zurich); Interuniversitaire Attractiepolen; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO)(FWO); University of Ghent(Ghent University); Swiss SystemsX.ch initiative	This work was supported in part by grants to WDH from the Swiss National Science Foundation (310000-113623/1), a grant (InfectX) from the Swiss SystemsX.ch initiative, evaluated by the Swiss National Science Foundation and the ETH Zurich Research foundation (ETH-08 08-3; WDH), as well as grants to RB from the Interuniversitaire Attractiepolen (IAP6/18), the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO), and the University of Ghent (GOA grant 01G06B6 and BOF predoctoral fellowship to M. Galle). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ehrbar K, 2004, J BACTERIOL, V186, P1215, DOI 10.1128/JB.186.4.1215-1219.2004; Ehrbar K, 2003, J BACTERIOL, V185, P6950, DOI 10.1128/JB.185.23.6950-6967.2003; Eichelberg K, 2000, INFECT IMMUN, V68, P2735, DOI 10.1128/IAI.68.5.2735-2743.2000; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Franchi L, 2010, EUR J IMMUNOL, V40, P611, DOI 10.1002/eji.200940180; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Friebel A, 2001, J BIOL CHEM, V276, P34035, DOI 10.1074/jbc.M100609200; Galle M, 2008, J CELL MOL MED, V12, P1767, DOI 10.1111/j.1582-4934.2007.00190.x; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; Hardt WD, 1997, P NATL ACAD SCI USA, V94, P9887, DOI 10.1073/pnas.94.18.9887; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Johnston JB, 2007, SEMIN IMMUNOPATHOL, V29, P261, DOI 10.1007/s00281-007-0080-5; JONES GW, 1981, J GEN MICROBIOL, V127, P351; KANIGA K, 1995, J BACTERIOL, V177, P3965, DOI 10.1128/jb.177.14.3965-3971.1995; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; KANIGA K, 1995, J BACTERIOL, V177, P7078, DOI 10.1128/jb.177.24.7078-7085.1995; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI 10.1146/annurev.immunol.021908.132715; Medina E, 1999, INFECT IMMUN, V67, P1093, DOI 10.1128/IAI.67.3.1093-1099.1999; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Mirold S, 1999, P NATL ACAD SCI USA, V96, P9845, DOI 10.1073/pnas.96.17.9845; Mirold S, 2001, J BACTERIOL, V183, P2348, DOI 10.1128/JB.183.7.2348-2358.2001; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Monack DM, 2001, MICROBES INFECT, V3, P1201, DOI 10.1016/S1286-4579(01)01480-0; Muller AJ, 2009, CELL HOST MICROBE, V6, P125, DOI 10.1016/j.chom.2009.07.007; OBERT S, 1994, MOL CELL BIOL, V14, P1333, DOI 10.1128/MCB.14.2.1333; Schlumberger MC, 2007, MOL MICROBIOL, V65, P741, DOI 10.1111/j.1365-2958.2007.05823.x; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shin H, 2007, CELL MICROBIOL, V9, P2893, DOI 10.1111/j.1462-5822.2007.01004.x; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Stender S, 2000, MOL MICROBIOL, V36, P1206, DOI 10.1046/j.1365-2958.2000.01933.x; Sun YH, 2007, J BIOL CHEM, V282, P33897, DOI 10.1074/jbc.C700181200; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; van der Velden AWM, 2003, J IMMUNOL, V171, P6742, DOI 10.4049/jimmunol.171.12.6742; VANDENABEELE P, 1990, J IMMUNOL METHODS, V135, P25, DOI 10.1016/0022-1759(90)90252-Q; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	48	34	36	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12477	10.1371/journal.pone.0012477	http://dx.doi.org/10.1371/journal.pone.0012477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20814576	Green Published, Green Submitted, gold			2022-12-27	WOS:000281375500010
J	Nyirenda, M; Zaba, B; Barnighausen, T; Hosegood, V; Newell, ML				Nyirenda, Makandwe; Zaba, Basia; Baernighausen, Till; Hosegood, Victoria; Newell, Marie-Louise			Adjusting HIV Prevalence for Survey Non-Response Using Mortality Rates: An Application of the Method Using Surveillance Data from Rural South Africa	PLOS ONE			English	Article							HIGH-RISK GROUPS; POPULATION; PREVENTION; BEHAVIORS; BIAS	Background: The main source of HIV prevalence estimates are household and population-based surveys; however, high refusal rates may hinder the interpretation of such estimates. The study objective was to evaluate whether population HIV prevalence estimates can be adjusted for survey non-response using mortality rates. Methodology/Principal Findings: Data come from the longitudinal Africa Centre Demographic Information System (ACDIS), in rural South Africa. Mortality rates for persons tested and not tested in the 2005 HIV surveillance were available from routine household surveillance. Assuming HIV status among individuals contacted but who refused to test (non-response) is missing at random and mortality among non-testers can be related to mortality of those tested a mathematical model was developed. Non-parametric bootstrapping was used to estimate the 95% confidence intervals around the estimates. Mortality rates were higher among untested (16.9 per thousand person-years) than tested population (11.6 per thousand person-years), suggesting higher HIV prevalence in the former. Adjusted HIV prevalence for females (15-49 years) was 31.6% (95% CI 26.1-37.1) compared to observed 25.2% (95% CI 24.0-26.4). For males (15-49 years) adjusted HIV prevalence was 19.8% (95% CI 14.8-24.8), compared to observed 13.2% (95% CI 12.1-14.3). For both sexes (15-49 years) combined, adjusted prevalence was 27.5% (95% CI 23.6-31.3), and observed prevalence was 19.7% (95% CI 19.6-21.3). Overall, observed prevalence underestimates the adjusted prevalence by around 7 percentage points (37% relative difference). Conclusions/Significance: We developed a simple approach to adjust HIV prevalence estimates for survey non-response. The approach has three features that make it easy to implement and effective in adjusting for selection bias than other approaches. Further research is needed to assess this approach in populations with widely available HIV treatment (ART).	[Nyirenda, Makandwe; Baernighausen, Till; Hosegood, Victoria; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Kwa Zulu, South Africa; [Baernighausen, Till] Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA; [Zaba, Basia; Hosegood, Victoria] London Sch Hyg & Trop Med, Ctr Populat Studies, London WC1, England; [Newell, Marie-Louise] UCL Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England	University of Kwazulu Natal; Harvard University; Harvard T.H. Chan School of Public Health; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Nyirenda, M (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Kwa Zulu, South Africa.	mnyirenda@africacentre.ac.za	Newell, Marie-Louise/AAE-8222-2019; Nyirenda, Makandwe/B-2963-2015; Nyirenda, Makandwe/R-4080-2018; Bärnighausen, Till/Y-2388-2019	Newell, Marie-Louise/0000-0002-1074-7699; Nyirenda, Makandwe/0000-0002-1839-877X; Hosegood, Victoria/0000-0002-2244-2518	Wellcome Trust, UK [GR082384/Z/07/Z, WT082599MA, WT075886]; National Institute of Child Health and Human Development (NICHD) [1R01-HD058482-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058482] Funding Source: NIH RePORTER	Wellcome Trust, UK(Wellcome Trust); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The Wellcome Trust, UK, provided funding support through grants to the Africa Centre Demographic and HIV surveillance (#GR082384/Z/07/Z), Victoria Hosegood (#WT082599MA) and the ALPHA-Network (#WT075886). Till Barnighausen was supported by grant 1R01-HD058482-01 from the National Institute of Child Health and Human Development (NICHD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnighausen T, 2008, J HUM HYPERTENS, V22, P236, DOI 10.1038/sj.jhh.1002308; Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Barnighausen T, 2010, AIDS RES HUM RETROV, V26, P401, DOI 10.1089/aid.2009.0236; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Boerma JT, 2003, LANCET, V362, P1929, DOI 10.1016/S0140-6736(03)14967-7; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Garcia-Calleja JM, 2006, SEX TRANSM INFECT, V82, pIII64, DOI 10.1136/sti.2006.019901; Gregson S, 2002, AIDS, V16, P643, DOI 10.1097/00002030-200203080-00017; HOULIHAN CF, 2010, INT J EPIDEMIOLOGY; Islam MM, 2008, INT J INFECT DIS, V12, P363, DOI 10.1016/j.ijid.2007.12.002; Joint United Nations Program on AIDS/ World Health Organization (UNAIDS/WHO), 2003, GUID COND HIV SENT S; MARSTON M, 2008, SEX TRANSM INFECT S1, V84, P71; Mishra V, 2008, SEX TRANSM INFECT, V84, pI63, DOI 10.1136/sti.2008.030411; Nardone A, 1999, J PUBLIC HEALTH MED, V21, P208, DOI 10.1093/pubmed/21.2.208; Nyirenda M, 2007, AIDS, V21, pS73, DOI 10.1097/01.aids.0000299413.82893.2b; Reniers G, 2009, AIDS, V23, P621, DOI 10.1097/QAD.0b013e3283269e13; Shisana O, 2009, S AFRICAN NATL HIV P; UNAIDS, 2008, REP GLOB AIDS EP; Walker N, 2003, AIDS, V17, P2215, DOI 10.1097/00002030-200310170-00010; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; World Health Organization, 2007, WORLD HLTH STAT 2007	21	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12370	10.1371/journal.pone.0012370	http://dx.doi.org/10.1371/journal.pone.0012370			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811499	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000281234700007
J	Sutherland, JS; de Jong, BC; Jeffries, DJ; Adetifa, IM; Ota, MOC				Sutherland, Jayne S.; de Jong, Bouke C.; Jeffries, David J.; Adetifa, Ifedayo M.; Ota, Martin O. C.			Production of TNF-alpha, IL-12(p40) and IL-17 Can Discriminate between Active TB Disease and Latent Infection in a West African Cohort	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; IFN-GAMMA; CELLS; ANTIGENS; INDUCTION; CYTOKINES; RESPONSES; DISTINCT; SUBSETS	Background: Mycobacterium tuberculosis (MTb) infects approximately 2 billion people world-wide resulting in almost 2 million deaths per year. Determining biomarkers that distinguish different stages of tuberculosis (TB) infection and disease will provide tools for more effective diagnosis and ultimately aid in the development of new vaccine candidates. The current diagnostic kits utilising production of IFN-gamma in response to TB antigens can detect MTb infection but are unable to distinguish between infection and disease. The aim of this study was to assess if the use of a longer term assay and the analysis of multiple cytokines would enhance diagnosis of active TB in a TB-endemic population. Methods: We compared production of multiple cytokines (TNF-alpha, IFN-gamma, IL-10, IL-12(p40), IL-13, IL-17 and IL-18) following long-term (7 days) stimulation of whole-blood with TB antigens (ESAT-6/CFP-10 (EC), PPD or TB10.4) from TB cases (n=36) and their Mycobacterium-infected (TST+; n=20) or uninfected (TST-; n=19) household contacts (HHC). Results and Conclusions: We found that TNF-alpha production following EC stimulation and TNF-alpha and IL-12(p40) following TB10.4 stimulation were significantly higher from TB cases compared to TST+ HHC, while production of IFN-gamma and IL-13 were significantly higher from TST+ compared to TST- HHC following PPD or EC stimulation. Combined analysis of TNF-alpha, IL12( p40) and IL-17 following TB10.4 stimulation resulted in 85% correct classification into TB cases or TST+ HHC. 74% correct classification into TST+ or TST- HHC was achieved with IFN-gamma alone following TB10.4 stimulation (69% following EC) and little enhancement was seen with additional cytokines. We also saw a tendency for TB cases infected with M. africanum to have increased TNF-alpha and IL-10 production compared to those infected with M. tuberculosis. Our results provide further insight into the pathogenesis of tuberculosis and may enhance the specificity of the currently available diagnostic tests, particularly for diagnosis of active TB.	[Sutherland, Jayne S.; de Jong, Bouke C.; Jeffries, David J.; Adetifa, Ifedayo M.; Ota, Martin O. C.] MRC Labs, Bacterial Dis Programme, Banjul, Gambia	MRC Laboratory Molecular Biology	Sutherland, JS (corresponding author), MRC Labs, Bacterial Dis Programme, Banjul, Gambia.	jsutherland@mrc.gm	de Jong, Bouke/A-3636-2013	de Jong, Bouke/0000-0002-1017-4675; Sutherland, Jayne/0000-0002-7083-4997	Bill & Melinda Gates Foundation; Medical Research Council (UK); Medical Research Council [MC_U190071468, MC_U190081982] Funding Source: researchfish; MRC [MC_U190071468, MC_U190081982] Funding Source: UKRI	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was jointly supported by the Bill & Melinda Gates Foundation (Grand Challenges for Global Health 6) (www.gatesfoundation.org) and the Medical Research Council (UK), The Gambia (www.mrc.gm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgun M, 2005, RESPIROLOGY, V10, P295, DOI 10.1111/j.1440-1843.2005.00710.x; Ashley D L, 2008, World Health Organ Tech Rep Ser, P1; Billeskov R, 2007, J IMMUNOL, V179, P3973, DOI 10.4049/jimmunol.179.6.3973; Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09; Butera O, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-182; Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21; Cristianini N, 2000, INTRO SUPPORT VECTOR; Cruz A, 2006, J IMMUNOL, V177, P1416, DOI 10.4049/jimmunol.177.3.1416; de Jong BC, 2006, J INFECT DIS, V193, P1279, DOI 10.1086/502977; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; de Jong BC, 2009, J CLIN MICROBIOL, V47, P994, DOI 10.1128/JCM.01216-08; Demissie A, 2006, CLIN VACCINE IMMUNOL, V13, P179, DOI 10.1128/CVI.13.2.179-186.2006; Djoba Siawaya JF, 2009, CLIN EXP IMMUNOL, V156, P69, DOI 10.1111/j.1365-2249.2009.03875.x; Dlugovitzky D, 1997, FEMS IMMUNOL MED MIC, V18, P203, DOI 10.1016/S0928-8244(97)00040-0; DOCKRELL H, 2007, MICROBIOL TODAY  NOV; Goldsack L, 2007, TUBERCULOSIS, V87, P465, DOI 10.1016/j.tube.2007.07.001; Goletti D, 2010, EUR RESPIR J, V36, P135, DOI 10.1183/09031936.00140009; JORGENSEN B, 1987, J ROY STAT SOC B MET, V49, P127; Kabeer BSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009051; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Lalvani A, 2008, J INFECT DIS, V197, P941, DOI 10.1086/529049; Martinez V, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-83; Morosini M, 2005, INT J TUBERC LUNG D, V9, P753; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Parida SK, 2010, DRUG DISCOV TODAY, V15, P148, DOI 10.1016/j.drudis.2009.10.005; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; van Pinxteren LAH, 2000, CLIN DIAGN LAB IMMUN, V7, P155, DOI 10.1128/CDLI.7.2.155-160.2000; Verreck FAW, 2002, CLIN INFECT DIS, V35, P210, DOI 10.1086/341314; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8	32	83	88	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12365	10.1371/journal.pone.0012365	http://dx.doi.org/10.1371/journal.pone.0012365			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20811496	Green Submitted, Green Published, gold			2022-12-27	WOS:000281154300008
J	Wengenroth, M; Blatow, M; Bendszus, M; Schneider, P				Wengenroth, Martina; Blatow, Maria; Bendszus, Martin; Schneider, Peter			Leftward Lateralization of Auditory Cortex Underlies Holistic Sound Perception in Williams Syndrome	PLOS ONE			English	Article							HESCHLS GYRUS; PLANUM TEMPORALE; HEARING-LOSS; NEURAL BASIS; INDIVIDUALS; ABNORMALITIES; ASYMMETRY; PHENOTYPE; CHILDREN; PITCH	Background: Individuals with the rare genetic disorder Williams-Beuren syndrome (WS) are known for their characteristic auditory phenotype including strong affinity to music and sounds. In this work we attempted to pinpoint a neural substrate for the characteristic musicality in WS individuals by studying the structure-function relationship of their auditory cortex. Since WS subjects had only minor musical training due to psychomotor constraints we hypothesized that any changes compared to the control group would reflect the contribution of genetic factors to auditory processing and musicality. Methodology/Principal Findings: Using psychoacoustics, magnetoencephalography and magnetic resonance imaging, we show that WS individuals exhibit extreme and almost exclusive holistic sound perception, which stands in marked contrast to the even distribution of this trait in the general population. Functionally, this was reflected by increased amplitudes of left auditory evoked fields. On the structural level, volume of the left auditory cortex was 2.2-fold increased in WS subjects as compared to control subjects. Equivalent volumes of the auditory cortex have been previously reported for professional musicians. Conclusions/Significance: There has been an ongoing debate in the neuroscience community as to whether increased gray matter of the auditory cortex in musicians is attributable to the amount of training or innate disposition. In this study musical education of WS subjects was negligible and control subjects were carefully matched for this parameter. Therefore our results not only unravel the neural substrate for this particular auditory phenotype, but in addition propose WS as a unique genetic model for training-independent auditory system properties.	[Wengenroth, Martina; Blatow, Maria; Bendszus, Martin; Schneider, Peter] Univ Heidelberg, Dept Neuroradiol, Sch Med, Heidelberg, Germany; [Schneider, Peter] Univ Heidelberg, Dept Neurol, Sch Med, Sect Biomagnetism, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Wengenroth, M (corresponding author), Univ Heidelberg, Dept Neuroradiol, Sch Med, Heidelberg, Germany.	martina.wengenroth@med.uni-heidelberg.de		Blatow, Maria/0000-0003-3371-5697; Schneider, Peter/0000-0002-1920-0438	University of Heidelberg Medical Faculty	University of Heidelberg Medical Faculty	M. Blatow was supported by the Olympia-Morata-Program of the University of Heidelberg Medical Faculty. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonell A, 2010, J MED GENET, V47, P312, DOI 10.1136/jmg.2009.071712; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Campbell LE, 2009, BRAIN RES, V1258, P96, DOI 10.1016/j.brainres.2008.11.101; Chiang MC, 2007, NEUROIMAGE, V36, P1096, DOI 10.1016/j.neuroimage.2007.04.024; Dykens EM, 2005, AM J MENT RETARD, V110, P346, DOI 10.1352/0895-8017(2005)110[346:MAAIWS]2.0.CO;2; Eckert MA, 2006, NEUROIMAGE, V33, P39, DOI 10.1016/j.neuroimage.2006.05.062; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; Galaburda AM, 2000, J COGNITIVE NEUROSCI, V12, P74, DOI 10.1162/089892900561995; Gao MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010292; Gaser C, 2003, ANN NY ACAD SCI, V999, P514, DOI 10.1196/annals.1284.062; Gaser C, 2006, NEUROIMAGE, V33, P46, DOI 10.1016/j.neuroimage.2006.06.018; GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; Gothelf D, 2006, NEUROLOGY, V66, P390, DOI 10.1212/01.wnl.0000196643.35395.5f; Holinger DP, 2005, BRAIN RES, V1037, P35, DOI 10.1016/j.brainres.2004.11.038; Hyde KL, 2008, NEUROPSYCHOLOGIA, V46, P632, DOI 10.1016/j.neuropsychologia.2007.09.004; Jarvinen-Pasley A, 2010, NEUROPSYCHOLOGIA, V48, P1047, DOI 10.1016/j.neuropsychologia.2009.12.002; Leonard CM, 2006, GENES BRAIN BEHAV, V5, P64, DOI 10.1111/j.1601-183X.2006.00196.x; LEONARD CM, 1993, ARCH NEUROL-CHICAGO, V50, P461, DOI 10.1001/archneur.1993.00540050013008; Levitin DJ, 1998, MUSIC PERCEPT, V15, P357; Levitin DJ, 2004, CHILD NEUROPSYCHOL, V10, P223, DOI 10.1080/09297040490909288; Levitin DJ, 2003, NEUROIMAGE, V18, P74, DOI 10.1006/nimg.2002.1297; LIEGEOISCHAUVEL C, 1991, BRAIN, V114, P139; Marler JA, 2005, AM J MED GENET A, V138A, P318, DOI 10.1002/ajmg.a.30970; Marler JA, 2010, AM J MED GENET C, V154C, P249, DOI 10.1002/ajmg.c.30262; Martens MA, 2008, J CHILD PSYCHOL PSYC, V49, P576, DOI 10.1111/j.1469-7610.2008.01887.x; Martens MA, 2010, NEUROPSYCHOLOGIA, V48, P2602, DOI 10.1016/j.neuropsychologia.2010.05.007; Meyer-Lindenberg A, 2004, NEURON, V43, P623, DOI 10.1016/j.neuron.2004.08.014; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Pantev C, 2000, J CLIN NEUROPHYSIOL, V17, P130, DOI 10.1097/00004691-200003000-00003; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Peoples R, 2000, AM J HUM GENET, V66, P47, DOI 10.1086/302722; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; Reiss AL, 2000, J COGNITIVE NEUROSCI, V12, P65, DOI 10.1162/089892900561986; Reiss AL, 2004, J NEUROSCI, V24, P5009, DOI 10.1523/JNEUROSCI.5272-03.2004; SCHEUERMAN GL, 1993, FUEL PROCESS TECHNOL, V35, P39, DOI 10.1016/0378-3820(93)90084-H; Schmitt JE, 2002, DEV MED CHILD NEUROL, V44, P292; Schmitt JE, 2001, ARCH NEUROL-CHICAGO, V58, P283, DOI 10.1001/archneur.58.2.283; Schneider P, 2005, NAT NEUROSCI, V8, P1241, DOI 10.1038/nn1530; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Schneider P, 2009, CONTEMP MUSIC REV, V28, P315, DOI 10.1080/07494460903404402; Seifritz E, 2002, SCIENCE, V297, P1706, DOI 10.1126/science.1074355; Steinmetz H, 1996, NEUROSCI BIOBEHAV R, V20, P587, DOI 10.1016/0149-7634(95)00071-2; Thompson PM, 2005, J NEUROSCI, V25, P4146, DOI 10.1523/JNEUROSCI.0165-05.2005; THORTONWELLS TA, 2010, J INTELLECT DEV DIS, V115, P172; Van Essen DC, 2006, J NEUROSCI, V26, P5470, DOI 10.1523/JNEUROSCI.4154-05.2006; Warrier C, 2009, J NEUROSCI, V29, P61, DOI 10.1523/JNEUROSCI.3489-08.2009; Westbury CF, 1999, CEREB CORTEX, V9, P392, DOI 10.1093/cercor/9.4.392; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	48	32	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12326	10.1371/journal.pone.0012326	http://dx.doi.org/10.1371/journal.pone.0012326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808792	Green Published, gold, Green Submitted			2022-12-27	WOS:000281153500011
J	Wilbe, M; Ziener, ML; Aronsson, A; Harlos, C; Sundberg, K; Norberg, E; Andersson, L; Lindblad-Toh, K; Hedhammar, A; Andersson, G; Lingaas, F				Wilbe, Maria; Ziener, Martine Lund; Aronsson, Anita; Harlos, Charlotte; Sundberg, Katarina; Norberg, Elin; Andersson, Lisa; Lindblad-Toh, Kerstin; Hedhammar, Ake; Andersson, Goran; Lingaas, Frode			DLA Class II Alleles Are Associated with Risk for Canine Symmetrical Lupoid Onychodystropy (SLO)	PLOS ONE			English	Article							IMMUNE PRIVILEGE; NAIL APPARATUS; DOGS; COMPLEX; SUSCEPTIBILITY; ONYCHOMADESIS; IMMUNOLOGY; DISORDERS; HAPLOTYPE; SEQUENCE	Symmetrical lupoid onychodystrophy (SLO) is an immune-mediated disease in dogs affecting the claws with a suggested autoimmune aethiology. Sequence-based genotyping of the polymorphic exon 2 from DLA-DRB1, -DQA1, and -DQB1 class II loci were performed in a total of 98 SLO Gordon setter cases and 98 healthy controls. A risk haplotype (DRB1*01801/DQA1*00101/DQB1*00802) was present in 53% of cases and 34% of controls and conferred an elevated risk of developing SLO with an odds ratio (OR) of 2.1. When dogs homozygous for the risk haplotype were compared to all dogs not carrying the haplotype the OR was 5.4. However, a stronger protective haplotype (DRB1*02001/DQA1*00401/DQB1*01303, OR = 0.03, 1/OR = 33) was present in 16.8% of controls, but only in a single case (0.5%). The effect of the protective haplotype was clearly stronger than the risk haplotype, since 11.2% of the controls were heterozygous for the risk and protective haplotypes, whereas this combination was absent from cases. When the dogs with the protective haplotype were excluded, an OR of 2.5 was obtained when dogs homozygous for the risk haplotype were compared to those heterozygous for the risk haplotype, suggesting a co-dominant effect of the risk haplotype. In smaller sample sizes of the bearded collie and giant schnauzer breeds we found the same or similar haplotypes, sharing the same DQA1 allele, over-represented among the cases suggesting that the risk is associated primarily with DLA-DQ. We obtained conclusive results that DLA class II is significantly associated with risk of developing SLO in Gordon setters, thus supporting that SLO is an immune-mediated disease. Further studies of SLO in dogs may provide important insight into immune privilege of the nail apparatus and also knowledge about a number of inflammatory disorders of the nail apparatus like lichen planus, psoriasis, alopecia areata and onycholysis.	[Wilbe, Maria; Harlos, Charlotte; Sundberg, Katarina; Andersson, Lisa; Andersson, Goran] Swedish Univ Agr Sci SLU, Biomed Ctr, Dept Anim Breeding & Genet, Uppsala, Sweden; [Ziener, Martine Lund] Fredrikstad Dyrehosp, Gamle Fredrikstad, Norway; [Aronsson, Anita] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden; [Norberg, Elin; Hedhammar, Ake] Swedish Univ Agr Sci SLU, Dept Clin Sci, Uppsala, Sweden; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Lindblad-Toh, Kerstin] Broad Inst, Cambridge, MA USA; [Lingaas, Frode] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway	Swedish University of Agricultural Sciences; Karolinska Institutet; Swedish University of Agricultural Sciences; Uppsala University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Norwegian University of Life Sciences	Wilbe, M (corresponding author), Swedish Univ Agr Sci SLU, Biomed Ctr, Dept Anim Breeding & Genet, Uppsala, Sweden.	Maria.Wilbe@hgen.slu.se; Frode.Lingaas@nvh.no	Andersson, Goran/AAK-6564-2020	Andersson, Goran/0000-0001-5131-3144; Hedhammar, Ake/0000-0001-7048-3851	European Commission [GA-201370]; FORMAS; Norwegian Gordon Setter Breed Club; Legacy of Veterinary Edvard Smidt; EURYI award	European Commission(European CommissionEuropean Commission Joint Research Centre); FORMAS(Swedish Research Council Formas); Norwegian Gordon Setter Breed Club; Legacy of Veterinary Edvard Smidt; EURYI award(European Science Foundation (ESF))	This work was supported by LUPA (part of the 7th Research Framework Programme of the European Commission), GA-201370, FORMAS and the Norwegian Gordon Setter Breed Club and the Legacy of Veterinary Edvard Smidt. KLT is a EURYI award recipient. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arin MJ, 2009, HUM GENET, V125, P355, DOI 10.1007/s00439-009-0646-5; Bergvall K, 1998, VET DERMATOL, V9, P263, DOI 10.1046/j.1365-3164.1998.00094.x; Bohnhorst JO, 2001, ACTA VET SCAND, V42, P323, DOI 10.1186/1751-0147-42-323; Debenham SL, 2005, GENOMICS, V85, P48, DOI 10.1016/j.ygeno.2004.09.009; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Greer KA, 2010, TISSUE ANTIGENS, V76, P110, DOI 10.1111/j.1399-0039.2010.01484.x; Haneke E, 2009, J DTSCH DERMATOL GES, V7, P787, DOI 10.1111/j.1610-0387.2009.07037.x; HEAD JR, 1985, PERSPECT BIOL MED, V29, P115; Ito T, 2005, J INVEST DERMATOL, V125, P1139, DOI 10.1111/j.0022-202X.2005.23927.x; Ito Taisuke, 2008, V10, P27, DOI 10.1159/000131412; Kennedy LJ, 2007, TISSUE ANTIGENS, V69, P269, DOI 10.1111/j.1399-0039.2006.00778.x; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P502, DOI 10.1111/j.1399-0039.2006.00715.x; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P467, DOI 10.1111/j.1399-0039.2006.00716.x; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P82, DOI 10.1111/j.1399-0039.2006.00614.x; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Mariani Sara M, 2004, MedGenMed, V6, P18; Mueller RS, 1999, VET DERMATOL, V10, P55, DOI 10.1046/j.1365-3164.1999.00120.x; Mueller RS, 2003, J AM ANIM HOSP ASSOC, V39, P139, DOI 10.5326/0390139; Mueller RS, 2000, VET DERMATOL, V11, P133, DOI 10.1046/j.1365-3164.2000.00174.x; Ollier WER, 2001, IMMUNOGENETICS, V53, P669, DOI 10.1007/s002510100372; SCOTT DW, 1995, J AM ANIM HOSP ASSOC, V31, P194, DOI 10.5326/15473317-31-3-194; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; Wilbe M, 2010, TISSUE ANTIGENS, V75, P712, DOI 10.1111/j.1399-0039.2010.01449.x; Wilbe M, 2010, NAT GENET, V42, P250, DOI 10.1038/ng.525; Wilbe M, 2009, IMMUNOGENETICS, V61, P557, DOI 10.1007/s00251-009-0387-6; Ziener ML, 2008, VET DERMATOL, V19, P88, DOI 10.1111/j.1365-3164.2008.00650.x	26	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12332	10.1371/journal.pone.0012332	http://dx.doi.org/10.1371/journal.pone.0012332			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808798	Green Published, Green Submitted, gold			2022-12-27	WOS:000281153500014
J	Fischer, W; Ganusov, VV; Giorgi, EE; Hraber, PT; Keele, BF; Leitner, T; Han, CS; Gleasner, CD; Green, L; Lo, CC; Nag, A; Wallstrom, TC; Wang, SY; McMichael, AJ; Haynes, BF; Hahn, BH; Perelson, AS; Borrow, P; Shaw, GM; Bhattacharya, T; Korber, BT				Fischer, Will; Ganusov, Vitaly V.; Giorgi, Elena E.; Hraber, Peter T.; Keele, Brandon F.; Leitner, Thomas; Han, Cliff S.; Gleasner, Cheryl D.; Green, Lance; Lo, Chien-Chi; Nag, Ambarish; Wallstrom, Timothy C.; Wang, Shuyi; McMichael, Andrew J.; Haynes, Barton F.; Hahn, Beatrice H.; Perelson, Alan S.; Borrow, Persephone; Shaw, George M.; Bhattacharya, Tanmoy; Korber, Bette T.			Transmission of Single HIV-1 Genomes and Dynamics of Early Immune Escape Revealed by Ultra-Deep Sequencing	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; IN-VIVO; RHESUS-MONKEYS; INFECTION; EVOLUTION; RESPONSES; VARIANTS; VACCINES; MUTATIONS; PHENOTYPE	We used ultra-deep sequencing to obtain tens of thousands of HIV-1 sequences from regions targeted by CD8+ T lymphocytes from longitudinal samples from three acutely infected subjects, and modeled viral evolution during the critical first weeks of infection. Previous studies suggested that a single virus established productive infection, but these conclusions were tempered because of limited sampling; now, we have greatly increased our confidence in this observation through modeling the observed earliest sample diversity based on vastly more extensive sampling. Conventional sequencing of HIV-1 from acute/early infection has shown different patterns of escape at different epitopes; we investigated the earliest escapes in exquisite detail. Over 3-6 weeks, ultradeep sequencing revealed that the virus explored an extraordinary array of potential escape routes in the process of evading the earliest CD8 T-lymphocyte responses - using 454 sequencing, we identified over 50 variant forms of each targeted epitope during early immune escape, while only 2-7 variants were detected in the same samples via conventional sequencing. In contrast to the diversity seen within epitopes, non-epitope regions, including the Envelope V3 region, which was sequenced as a control in each subject, displayed very low levels of variation. In early infection, in the regions sequenced, the consensus forms did not have a fitness advantage large enough to trigger reversion to consensus amino acids in the absence of immune pressure. In one subject, a genetic bottleneck was observed, with extensive diversity at the second time point narrowing to two dominant escape forms by the third time point, all within two months of infection. Traces of immune escape were observed in the earliest samples, suggesting that immune pressure is present and effective earlier than previously reported; quantifying the loss rate of the founder virus suggests a direct role for CD8 T-lymphocyte responses in viral containment after peak viremia. Dramatic shifts in the frequencies of epitope variants during the first weeks of infection revealed a complex interplay between viral fitness and immune escape.	[Fischer, Will; Ganusov, Vitaly V.; Giorgi, Elena E.; Hraber, Peter T.; Leitner, Thomas; Han, Cliff S.; Gleasner, Cheryl D.; Green, Lance; Lo, Chien-Chi; Nag, Ambarish; Wallstrom, Timothy C.; Perelson, Alan S.; Bhattacharya, Tanmoy; Korber, Bette T.] Los Alamos Natl Lab, Los Alamos, NM USA; [Ganusov, Vitaly V.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Giorgi, Elena E.] Univ Massachusetts, Dept Math & Stat, Amherst, MA 01003 USA; [Keele, Brandon F.] NCI, SAIC Frederick, Frederick, MD 21701 USA; [Wang, Shuyi; Hahn, Beatrice H.; Shaw, George M.] Univ Alabama, Dept Med, Birmingham, AL 35294 USA; [McMichael, Andrew J.] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Haynes, Barton F.] Duke Univ, Med Ctr, Durham, NC USA; [Borrow, Persephone] Univ Oxford, Jenner Inst, Compton, England; [Bhattacharya, Tanmoy; Korber, Bette T.] Santa Fe Inst, Santa Fe, NM 87501 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Massachusetts System; University of Massachusetts Amherst; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Alabama System; University of Alabama Birmingham; University of Oxford; Duke University; University of Oxford; Jenner Institute; The Santa Fe Institute	Fischer, W (corresponding author), Los Alamos Natl Lab, Los Alamos, NM USA.	btk@lanl.gov	Wallstrom, Timothy/J-9234-2017; Bhattacharya, Tanmoy/J-8956-2013; Fischer, Will/AAD-2807-2019; Fischer, Will/B-1323-2013; Perelson, Alan S/Z-1959-2019	Wallstrom, Timothy/0000-0002-9295-2441; Bhattacharya, Tanmoy/0000-0002-1060-652X; Fischer, Will/0000-0003-4579-4062; Fischer, Will/0000-0003-4579-4062; Perelson, Alan S/0000-0002-2455-0002; Korber, Bette/0000-0002-2026-5757; Borrow, Persephone/0000-0002-3877-9780; Han, Cliff/0000-0003-1972-0692; Ganusov, Vitaly/0000-0001-6572-1691; Hraber, Peter/0000-0002-2920-4897; Lo, Chien-Chi/0000-0003-3470-1078; Nag, Ambarish/0000-0001-5174-4673; Hahn, Beatrice/0000-0002-9400-9887	Los Alamos National Laboratory; National Institutes of Health (NIH) [AI-0678501]; Bill and Melinda Gates Foundation [37874]; Medical Research Council [MC_U137884177, G1000800a] Funding Source: researchfish; MRC [MC_U137884177] Funding Source: UKRI	Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this work was supplied by a Los Alamos National Laboratory Directed Research grant, National Institutes of Health (NIH) grant AI-0678501 (CHAVI), and the Bill and Melinda Gates Foundation (#37874). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Asquith B, 2006, PLOS BIOL, V4, P583, DOI 10.1371/journal.pbio.0040090; Bar KJ, 2010, J VIROL, V84, P6241, DOI 10.1128/JVI.00077-10; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Bimber BN, 2009, J VIROL, V83, P8247, DOI 10.1128/JVI.00897-09; Borroto R J, 1997, Rev Panam Salud Publica, V1, P3; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Crawford H, 2009, J EXP MED, V206, P909, DOI 10.1084/jem.20081984; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Ganusov VV, 2006, PLOS COMPUT BIOL, V2, P182, DOI 10.1371/journal.pcbi.0020024; Gasper-Smith N, 2008, J VIROL, V82, P7700, DOI 10.1128/JVI.00605-08; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Jones NA, 2004, J EXP MED, V200, P1243, DOI 10.1084/jem.20040511; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KORBER BTM, 1994, J VIROL, V68, P7467, DOI 10.1128/JVI.68.11.7467-7481.1994; Lavreys L, 2006, CLIN INFECT DIS, V42, P1333, DOI 10.1086/503258; Lee HY, 2009, J THEOR BIOL, V261, P341, DOI 10.1016/j.jtbi.2009.07.038; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Love TMT, 2010, J VIROL, V84, P5802, DOI 10.1128/JVI.00117-10; Luria SE, 1943, GENETICS, V28, P491; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Navarro G, 2001, ACM COMPUT SURV, V33, P31, DOI 10.1145/375360.375365; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Peut V, 2006, CURR HIV RES, V4, P191, DOI 10.2174/157016206776055110; Pillai S, 2003, AIDS RES HUM RETROV, V19, P145, DOI 10.1089/088922203762688658; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; R Core Team, 2020, R LANG ENV STAT COMP; Rousseau CM, 2009, AIDS RES HUM RETROV, V25, P297, DOI 10.1089/aid.2008.0208; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Schneidewind A, 2009, J VIROL, V83, P3993, DOI 10.1128/JVI.01108-08; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; Turnbull EL, 2006, J IMMUNOL, V176, P6130, DOI 10.4049/jimmunol.176.10.6130; Wang GP, 2010, J VIROL, V84, P6218, DOI 10.1128/JVI.02271-09; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; Wood N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000414	45	200	201	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12303	10.1371/journal.pone.0012303	http://dx.doi.org/10.1371/journal.pone.0012303			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808830	Green Published, Green Submitted, gold			2022-12-27	WOS:000281077000010
J	Chittenden, CM; Biagi, CA; Davidsen, JG; Davidsen, AG; Kondo, H; McKnight, A; Pedersen, OP; Raven, PA; Rikardsen, AH; Shrimpton, JM; Zuehlke, B; McKinley, RS; Devlin, RH				Chittenden, Cedar M.; Biagi, Carlo A.; Davidsen, Jan Grimsrud; Davidsen, Anette Grimsrud; Kondo, Hidehiro; McKnight, Allison; Pedersen, Ole-Petter; Raven, Peter A.; Rikardsen, Audun H.; Shrimpton, J. Mark; Zuehlke, Brett; McKinley, R. Scott; Devlin, Robert H.			Genetic versus Rearing-Environment Effects on Phenotype: Hatchery and Natural Rearing Effects on Hatchery-and Wild-Born Coho Salmon	PLOS ONE			English	Article							ONCORHYNCHUS-KISUTCH; AGONISTIC BEHAVIOR; GROWTH; FITNESS; TROUT; POPULATIONS; SURVIVAL; DENSITY; RIVER; PRODUCTIVITY	With the current trends in climate and fisheries, well-designed mitigative strategies for conserving fish stocks may become increasingly necessary. The poor post-release survival of hatchery-reared Pacific salmon indicates that salmon enhancement programs require assessment. The objective of this study was to determine the relative roles that genotype and rearing environment play in the phenotypic expression of young salmon, including their survival, growth, physiology, swimming endurance, predator avoidance and migratory behaviour. Wild-and hatchery-born coho salmon adults (Oncorhynchus kisutch) returning to the Chehalis River in British Columbia, Canada, were crossed to create pure hatchery, pure wild, and hybrid offspring. A proportion of the progeny from each cross was reared in a traditional hatchery environment, whereas the remaining fry were reared naturally in a contained side channel. The resulting phenotypic differences between replicates, between rearing environments, and between cross types were compared. While there were few phenotypic differences noted between genetic groups reared in the same habitat, rearing environment played a significant role in smolt size, survival, swimming endurance, predator avoidance and migratory behaviour. The lack of any observed genetic differences between wild-and hatchery-born salmon may be due to the long-term mixing of these genotypes from hatchery introgression into wild populations, or conversely, due to strong selection in nature-capable of maintaining highly fit genotypes whether or not fish have experienced part of their life history under cultured conditions.	[Chittenden, Cedar M.; Biagi, Carlo A.; McKnight, Allison; Raven, Peter A.; Zuehlke, Brett; McKinley, R. Scott; Devlin, Robert H.] Univ British Columbia, Ctr Aquaculture & Environm Res, W Vancouver, BC, Canada; [Chittenden, Cedar M.; Biagi, Carlo A.; McKnight, Allison; Raven, Peter A.; Zuehlke, Brett; McKinley, R. Scott; Devlin, Robert H.] Fisheries & Oceans Canada, W Vancouver, BC, Canada; [Chittenden, Cedar M.; Davidsen, Jan Grimsrud; Davidsen, Anette Grimsrud; Pedersen, Ole-Petter; Rikardsen, Audun H.] Univ Tromso, Dept Arct & Marine Biol, Tromso, Norway; [Kondo, Hidehiro] Tokyo Univ Marine Sci & Technol, Lab Genome Sci, Tokyo, Japan; [Shrimpton, J. Mark] Univ No British Columbia, Prince George, BC V2L 5P2, Canada	University of British Columbia; Fisheries & Oceans Canada; UiT The Arctic University of Tromso; Tokyo University of Marine Science & Technology; University of Northern British Columbia	Chittenden, CM (corresponding author), Univ British Columbia, Ctr Aquaculture & Environm Res, W Vancouver, BC, Canada.	Cedar.M.Chittenden@uit.no	Biagi, Carlo/AAN-2030-2020; Kondo, Hidehiro/O-1954-2014; Davidsen, Jan Grimsrud/AAN-5974-2020	Biagi, Carlo/0000-0002-6345-9674; Kondo, Hidehiro/0000-0001-5102-6831; Davidsen, Jan Grimsrud/0000-0002-7253-2327	Census of Marine Life; Gordon and Betty Moore Foundation; Pacific Salmon Foundation; NSERC	Census of Marine Life; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Pacific Salmon Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this work was provided by Census of Marine Life, the Gordon and Betty Moore Foundation, the Pacific Salmon Foundation and a grant from NSERC to RSM. The Pacific Ocean Shelf Tracking project (POST) acoustic receiver arrays were designed and deployed by Kintama Research Corp. None of these organizations were directly involved in the study design, analysis, or writing of the paper, nor the decision to submit the manuscript for publication. This work is a contribution to the Census of Marine Life.	Araki H, 2008, EVOL APPL, V1, P342, DOI 10.1111/j.1752-4571.2008.00026.x; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Araki H, 2009, BIOL LETTERS, V5, P621, DOI 10.1098/rsbl.2009.0315; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; ARGUE AW, 1983, CANADIAN B FISHERIES, P211; BANKS JL, 1992, PROG FISH CULT, V54, P137, DOI 10.1577/1548-8640(1992)054<0137:EODALO>2.3.CO;2; BANKS JL, 1994, AQUACULTURE, V119, P201, DOI 10.1016/0044-8486(94)90176-7; Beamish RJ, 2008, T AM FISH SOC, V137, P503, DOI 10.1577/T07-080.1; Berejikian BA, 1996, CAN J FISH AQUAT SCI, V53, P2004, DOI 10.1139/cjfas-53-9-2004; Bradford MJ, 2000, CAN J FISH AQUAT SCI, V57, P13, DOI 10.1139/cjfas-57-1-13; BRAUNER CJ, 1994, CAN J FISH AQUAT SCI, V51, P2188, DOI 10.1139/f94-220; Brown C, 2002, FISH FISH, V3, P79, DOI 10.1046/j.1467-2979.2002.00077.x; Bryden CA, 2004, AQUACULTURE, V235, P249, DOI 10.1016/j.aquaculture.2004.01.027; BURROWS RE, 1969, T AM FISH SOC, V98, P777, DOI 10.1577/1548-8659(1969)98[777:TIOFQO]2.0.CO;2; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Campbell B, 2006, T AM FISH SOC, V135, P164, DOI 10.1577/T05-115.1; Chittenden CM, 2008, J FISH BIOL, V72, P614, DOI 10.1111/j.1095-8649.2007.01729.x; Chittenden C, 2009, ENVIRON BIOL FISH, V84, P129, DOI 10.1007/s10641-008-9396-9; Coronado C, 1998, CAN J FISH AQUAT SCI, V55, P2067, DOI 10.1139/cjfas-55-9-2067; CRESSWELL RC, 1981, J FISH BIOL, V18, P429, DOI 10.1111/j.1095-8649.1981.tb03784.x; CROSS CL, 1991, CAN TECH REP FISH AQ, V1816, P48; Dannewitz J, 2004, J APPL ECOL, V41, P355, DOI 10.1111/j.0021-8901.2004.00895.x; Flagg TA, 1999, NMFSNWFSC38 US DEP C; Ford MJ, 2004, CONSERV GENET, V5, P797, DOI 10.1007/s10592-004-1983-5; GOEDE RW, 1990, AM FISHERIES SOC S, V8, P93; Goodman D, 2005, CAN J FISH AQUAT SCI, V62, P374, DOI 10.1139/F04-187; Greene C.W, 1952, T AM FISH SOC, V81, P43; Hanson RW, 2003, BIOCHIMIE, V85, P1199, DOI 10.1016/j.biochi.2003.10.022; Hendry AP, 2000, SCIENCE, V290, P516, DOI 10.1126/science.290.5491.516; HILBORN R, 1992, FISHERIES, V17, P5, DOI 10.1577/1548-8446(1992)017<0005:HATFOS>2.0.CO;2; LEON KA, 1986, PROG FISH CULT, V48, P43, DOI 10.1577/1548-8640(1986)48&lt;43:EOEOFC&gt;2.0.CO;2; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lynch M, 2001, CONSERV GENET, V2, P363, DOI 10.1023/A:1012550620717; MASON JW, 1967, T AM FISH SOC, V96, P313, DOI 10.1577/1548-8659(1967)96[313:CSOWAD]2.0.CO;2; Maynard DJ, 1996, PROG FISH CULT, V58, P187, DOI 10.1577/1548-8640(1996)058&lt;0187:EODSWL&gt;2.3.CO;2; MAYNARD DJ, 1998, P 48 ANN PAC NW FISH, P81; MCCORMICK SD, 1993, CAN J FISH AQUAT SCI, V50, P656, DOI 10.1139/f93-075; Miller R.B., 1952, T AM FISH SOC, V81, P35; Morita K, 2006, ICES J MAR SCI, V63, P1353, DOI 10.1016/j.icesjms.2006.03.024; MUNDIE JH, 1990, N AM J FISH MANAGE, V21, P327; Nickelson T, 2003, CAN J FISH AQUAT SCI, V60, P1050, DOI 10.1139/F03-091; Raven PA, 2008, GEN COMP ENDOCR, V159, P26, DOI 10.1016/j.ygcen.2008.07.011; REFSTIE T, 1977, AQUACULTURE, V11, P329, DOI 10.1016/0044-8486(77)90082-5; Reimers N., 1963, T AM FISH SOC, V92, P39, DOI [10.1577/1548-8659(1963)92[39:BCWTAO]2.0.CO;2., DOI 10.1577/1548-8659(1963)92[39:BCWTAO]2.0.CO;2]; Reisenbichler RR, 1999, ICES J MAR SCI, V56, P459, DOI 10.1006/jmsc.1999.0455; RIDDELL BE, 1991, AQUACULTURE, V98, P161, DOI 10.1016/0044-8486(91)90381-G; Rise ML, 2006, J MOL ENDOCRINOL, V37, P259, DOI 10.1677/jme.1.02031; SHRIMPTON JM, 1994, CAN J FISH AQUAT SCI, V51, P2179, DOI 10.1139/f94-219; Singer TD, 2003, AQUACULTURE, V222, P15, DOI 10.1016/S0044-8486(03)00099-1; SOSIAK AJ, 1978, THESIS U NEW BRUNSWI; Sundstrom LF, 2004, P ROY SOC B-BIOL SCI, V271, pS350, DOI 10.1098/rsbl.2004.0189; SWAIN DP, 1990, CAN J FISH AQUAT SCI, V47, P566, DOI 10.1139/f90-065; SWAIN DP, 1991, CAN J FISH AQUAT SCI, V48, P1783, DOI 10.1139/f91-210; Sweeting RM, 2004, REV FISH BIOL FISHER, V14, P361, DOI 10.1007/s11160-005-3793-3; Sweeting RM, 2003, N AM J FISH MANAGE, V23, P492, DOI 10.1577/1548-8675(2003)023<0492:ROWCSB>2.0.CO;2; Thompson RB., 1966, THESIS U WASHINGTON; TYMCHUK WE, 2006, ROLE GENOTYPE ENV PH, V4; Tymchuk WE, 2006, T AM FISH SOC, V135, P442, DOI 10.1577/T05-181.1; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Ward BR, 2000, CAN J FISH AQUAT SCI, V57, P298, DOI 10.1139/cjfas-57-2-298; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; *WORLD ORG AN HLTH, 2006, MAN DIAGN TESTS AQ A; ZHANG Z, 1995, CAN J FISH AQUAT SCI, V52, P344, DOI 10.1139/f95-035; [No title captured]	64	46	47	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12261	10.1371/journal.pone.0012261	http://dx.doi.org/10.1371/journal.pone.0012261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808853	Green Published, gold, Green Submitted			2022-12-27	WOS:000281075500006
J	Dumas, G; Nadel, J; Soussignan, R; Martinerie, J; Garnero, L				Dumas, Guillaume; Nadel, Jacqueline; Soussignan, Robert; Martinerie, Jacques; Garnero, Line			Inter-Brain Synchronization during Social Interaction	PLOS ONE			English	Article							PHASE SYNCHRONIZATION; BROCAS AREA; OSCILLATIONS; MOVEMENT; MEG; MECHANISMS; EEG; CONTINGENCY; IMITATION; AWARENESS	During social interaction, both participants are continuously active, each modifying their own actions in response to the continuously changing actions of the partner. This continuous mutual adaptation results in interactional synchrony to which both members contribute. Freely exchanging the role of imitator and model is a well-framed example of interactional synchrony resulting from a mutual behavioral negotiation. How the participants' brain activity underlies this process is currently a question that hyperscanning recordings allow us to explore. In particular, it remains largely unknown to what extent oscillatory synchronization could emerge between two brains during social interaction. To explore this issue, 18 participants paired as 9 dyads were recorded with dual-video and dual-EEG setups while they were engaged in spontaneous imitation of hand movements. We measured interactional synchrony and the turn-taking between model and imitator. We discovered by the use of nonlinear techniques that states of interactional synchrony correlate with the emergence of an interbrain synchronizing network in the alpha-mu band between the right centroparietal regions. These regions have been suggested to play a pivotal role in social interaction. Here, they acted symmetrically as key functional hubs in the interindividual brainweb. Additionally, neural synchronization became asymmetrical in the higher frequency bands possibly reflecting a top-down modulation of the roles of model and imitator in the ongoing interaction.	[Dumas, Guillaume; Martinerie, Jacques; Garnero, Line] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France; [Dumas, Guillaume; Martinerie, Jacques; Garnero, Line] INSERM, U975, Paris, France; [Dumas, Guillaume; Martinerie, Jacques; Garnero, Line] CNRS, UMR 7225, Paris, France; [Nadel, Jacqueline] Hop La Pitie Salpetriere, CNRS, USR 3246, Ctr Emot, Paris, France; [Soussignan, Robert] U B, Ctr Sci Gout Alimentat, UMR 6265, CNRS,INRA 1324, Dijon, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Dumas, G (corresponding author), Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France.	guillaume.dumas@upmc.fr	Dumas, Guillaume/E-3756-2012	Dumas, Guillaume/0000-0002-2253-1844; Lauwereyns, Jan/0000-0003-0551-2550	French National Center for Scientific Research; Direction generale de l'armement (DGA); Computer Neuroscience Program [070005IPAM]	French National Center for Scientific Research(Centre National de la Recherche Scientifique (CNRS)); Direction generale de l'armement (DGA); Computer Neuroscience Program	This work was supported in part by funds from the French National Center for Scientific Research (http://www.cnrs.fr/). This work was also supported by a PhD fellowship of the Direction generale de l'armement (DGA) (http://www.defense.gouv.fr/dga/) and the Computer Neuroscience Program no070005IPAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERS S, 2010, NEUROIMAGE IN PRESS; ASTOLFI L, 2010, BRAIN TOPOGRAPHY, P1; Babiloni C, 2002, NEUROIMAGE, V17, P559, DOI 10.1006/nimg.2002.1192; BABILONI F, 2006, ANN INT C IEEE ENG M, P3666; Battelli L, 2007, TRENDS COGN SCI, V11, P204, DOI 10.1016/j.tics.2007.03.001; Battellil L, 2008, CURR OPIN NEUROBIOL, V18, P120, DOI 10.1016/j.conb.2008.08.004; Betti V, 2009, J NEUROSCI, V29, P12384, DOI 10.1523/JNEUROSCI.2759-09.2009; Bickford A., 2005, USING ELAN GETTING S; Blakemore SJ, 2003, CURR OPIN NEUROBIOL, V13, P219, DOI 10.1016/S0959-4388(03)00043-6; Bradberry TJ, 2010, J NEUROSCI, V30, P3432, DOI 10.1523/JNEUROSCI.6107-09.2010; Chavez M, 2006, J NEUROSCI METH, V154, P149, DOI 10.1016/j.jneumeth.2005.12.009; Decety J, 2002, NEUROIMAGE, V15, P265, DOI 10.1006/nimg.2001.0938; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Desmurget M, 2009, SCIENCE, V324, P811, DOI 10.1126/science.1169896; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fogel A., 1993, DEV RELATIONSHIPS OR; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; GALLESE V, 2007, J AM PSYCHOANAL ASS, V131, P176; GRYNSZPAN O, 2006, IST027574; Hamzei F, 2003, NEUROIMAGE, V19, P637, DOI 10.1016/S1053-8119(03)00087-9; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Harrington DL, 1998, J NEUROSCI, V18, P1085; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iizuka H, 2004, ARTIF LIFE, V10, P361, DOI 10.1162/1064546041766442; Ikegami T, 2007, INFANT BEHAV DEV, V30, P278, DOI 10.1016/j.infbeh.2007.02.002; Jackson PL, 2004, CURR OPIN NEUROBIOL, V14, P259, DOI 10.1016/j.conb.2004.01.020; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jerbi K, 2007, P NATL ACAD SCI USA, V104, P7676, DOI 10.1073/pnas.0609632104; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lindenberger U, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-22; Makuuchi M, 2005, CEREB CORTEX, V15, P563, DOI 10.1093/cercor/bhh157; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Maris E, 2007, J NEUROSCI METH, V163, P161, DOI 10.1016/j.jneumeth.2007.02.011; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Meltzoff A. N, 2002, THE IMITATIVE MIND D, V6; Molenberghs P, 2009, NEUROSCI BIOBEHAV R, V33, P975, DOI 10.1016/j.neubiorev.2009.03.010; Montague PR, 2002, NEUROIMAGE, V16, P1159, DOI 10.1006/nimg.2002.1150; Nadel J., 1999, IMITATION INFANCY; NADEL J, 1993, NEW PERSPECTIVES EAR; Nadel J, 1999, DEVELOPMENTAL SCI, V2, P164, DOI 10.1111/1467-7687.00065; NADELBRULFERT J, 1982, INT J BEHAV DEV, V5, P95, DOI 10.1177/016502548200500105; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Pantazis D, 2005, NEUROIMAGE, V25, P383, DOI 10.1016/j.neuroimage.2004.09.040; Pfurtscheller G, 2003, NEUROSCI LETT, V339, P111, DOI 10.1016/S0304-3940(02)01479-9; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; Pistohl T, 2008, J NEUROSCI METH, V167, P105, DOI 10.1016/j.jneumeth.2007.10.001; Prepin K, 2007, ADV ROBOTICS, V21, P1709, DOI 10.1163/156855307782506192; Redcay E, 2010, NEUROIMAGE, V50, P1639, DOI 10.1016/j.neuroimage.2010.01.052; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Schippers MB, 2010, P NATL ACAD SCI USA, V107, P9388, DOI 10.1073/pnas.1001791107; Shannon C.E., 1963, MATH THEORY COMMUNIC; Soussignan R, 2006, INFANCY, V10, P123, DOI 10.1207/s15327078in1002_2; Tallon-Baudry C, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0008.2001; Thompson E, 2001, TRENDS COGN SCI, V5, P418, DOI 10.1016/S1364-6613(00)01750-2; Tognoli E, 2007, P NATL ACAD SCI USA, V104, P8190, DOI 10.1073/pnas.0611453104; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Waldert S, 2008, J NEUROSCI, V28, P1000, DOI 10.1523/JNEUROSCI.5171-07.2008; Wallstrom GL, 2004, INT J PSYCHOPHYSIOL, V53, P105, DOI 10.1016/j.ijpsycho.2004.03.007; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Wilson M, 2005, PSYCHON B REV, V12, P957, DOI 10.3758/BF03206432; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Wyart V, 2008, J NEUROSCI, V28, P2667, DOI 10.1523/JNEUROSCI.4748-07.2008	66	448	459	6	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12166	10.1371/journal.pone.0012166	http://dx.doi.org/10.1371/journal.pone.0012166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808907	Green Published, Green Submitted, gold			2022-12-27	WOS:000280968100006
J	Cleveland, ZI; Cofer, GP; Metz, G; Beaver, D; Nouls, J; Kaushik, SS; Kraft, M; Wolber, J; Kelly, KT; McAdams, HP; Driehuys, B				Cleveland, Zackary I.; Cofer, Gary P.; Metz, Gregory; Beaver, Denise; Nouls, John; Kaushik, S. Sivaram; Kraft, Monica; Wolber, Jan; Kelly, Kevin T.; McAdams, H. Page; Driehuys, Bastiaan			Hyperpolarized Xe-129 MR Imaging of Alveolar Gas Uptake in Humans	PLOS ONE			English	Article							LASER-POLARIZED XE-129; NUCLEAR-MAGNETIC-RESONANCE; REGIONAL LUNG DENSITY; SINGLE BREATH-HOLD; DIFFUSING-CAPACITY; BLOOD-FLOW; HE-3 MRI; MORPHOMETRIC TECHNIQUES; PULMONARY PERFUSION; NOBLE-GASES	Background: One of the central physiological functions of the lungs is to transfer inhaled gases from the alveoli to pulmonary capillary blood. However, current measures of alveolar gas uptake provide only global information and thus lack the sensitivity and specificity needed to account for regional variations in gas exchange. Methods and Principal Findings: Here we exploit the solubility, high magnetic resonance (MR) signal intensity, and large chemical shift of hyperpolarized (HP) Xe-129 to probe the regional uptake of alveolar gases by directly imaging HP Xe-129 dissolved in the gas exchange tissues and pulmonary capillary blood of human subjects. The resulting single breath-hold, three-dimensional MR images are optimized using millisecond repetition times and high flip angle radio-frequency pulses, because the dissolved HP Xe-129 magnetization is rapidly replenished by diffusive exchange with alveolar Xe-129. The dissolved HP Xe-129 MR images display significant, directional heterogeneity, with increased signal intensity observed from the gravity-dependent portions of the lungs. Conclusions: The features observed in dissolved-phase Xe-129 MR images are consistent with gravity-dependent lung deformation, which produces increased ventilation, reduced alveolar size (i.e., higher surface-to-volume ratios), higher tissue densities, and increased perfusion in the dependent portions of the lungs. Thus, these results suggest that dissolved HP Xe-129 imaging reports on pulmonary function at a fundamental level.	[Cleveland, Zackary I.; Cofer, Gary P.; Nouls, John; Kaushik, S. Sivaram; Driehuys, Bastiaan] Duke Univ, Med Ctr, Ctr Vivo Microscopy, Durham, NC 27710 USA; [Cleveland, Zackary I.; Cofer, Gary P.; Nouls, John; Kaushik, S. Sivaram; McAdams, H. Page; Driehuys, Bastiaan] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; [Metz, Gregory; Beaver, Denise; Kraft, Monica] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Kelly, Kevin T.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Cleveland, ZI (corresponding author), Duke Univ, Med Ctr, Ctr Vivo Microscopy, Durham, NC 27710 USA.	bastiaan.driehuys@duke.edu	McAdams, Holman P/N-8218-2015	McAdams, Holman P/0000-0002-7044-3320; Driehuys, Bastiaan/0000-0002-1236-4210	GE Healthcare; Duke Center for In Vivo Microscopy; National Institutes of Health/National Center for Research Resources National Biomedical Technology Research Center [P41 RR005959]; National Heart Lung and Blood Institute (NHLBI) [R21 HL087094]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005959] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL087094] Funding Source: NIH RePORTER	GE Healthcare(General ElectricGE Healthcare); Duke Center for In Vivo Microscopy; National Institutes of Health/National Center for Research Resources National Biomedical Technology Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Heart Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by GE Healthcare (http://www.gehealthcare.com) with additional support from the Duke Center for In Vivo Microscopy (http://www.civm.duhs.duke.edu), a National Institutes of Health/National Center for Research Resources National Biomedical Technology Research Center (P41 RR005959, http://www.ncrr.nih.gov) and then the National Heart Lung and Blood Institute (NHLBI R21 HL087094, http://www.nhlbi.nih.gov). The funders contributed to the study design and preparation of the manuscript but had no role in the data collection and analysis or in the decision to publish.	Abdeen N, 2006, MAGN RESON MED, V56, P255, DOI 10.1002/mrm.20943; Baumgartner WA, 2004, J APPL PHYSIOL, V97, P522, DOI 10.1152/japplphysiol.00068.2003; BRUDIN LH, 1987, J APPL PHYSIOL, V63, P1324, DOI 10.1152/jappl.1987.63.4.1324; BRUDIN LH, 1986, J APPL PHYSIOL, V60, P1155, DOI 10.1152/jappl.1986.60.4.1155; Bucholz E, 2008, MAGN RESON MED, V60, P111, DOI 10.1002/mrm.21618; CHEN RYZ, 1980, J APPL PHYSIOL, V49, P178, DOI 10.1152/jappl.1980.49.2.178; Conhaim RL, 1996, AM J PHYSIOL-HEART C, V271, pH996, DOI 10.1152/ajpheart.1996.271.3.H996; CRAPO JD, 1983, RESP PHYSIOL, V51, P183, DOI 10.1016/0034-5687(83)90039-7; CRAPO JD, 1988, J APPL PHYSIOL, V64, P2083, DOI 10.1152/jappl.1988.64.5.2083; de Lange EE, 2006, CHEST, V130, P1055, DOI 10.1378/chest.130.4.1055; Deninger AJ, 2002, MAGN RESON MED, V48, P223, DOI 10.1002/mrm.10206; Driehuys B, 1996, APPL PHYS LETT, V69, P1668, DOI 10.1063/1.117022; Driehuys B, 2006, P NATL ACAD SCI USA, V103, P18278, DOI 10.1073/pnas.0608458103; Fichele S, 2004, J MAGN RESON IMAGING, V20, P331, DOI 10.1002/jmri.20104; Fischbach F., 2008, MANUAL LAB DIAGNOSTI; Freeman LM, 2008, SEMIN NUCL MED, V38, P432, DOI 10.1053/j.semnuclmed.2008.07.001; Gierada DS, 2000, NMR BIOMED, V13, P176, DOI 10.1002/1099-1492(200006)13:4<176::AID-NBM640>3.0.CO;2-I; GLAZIER JB, 1967, J APPL PHYSIOL, V23, P694, DOI 10.1152/jappl.1967.23.5.694; Goodson BM, 2002, J MAGN RESON, V155, P157, DOI 10.1006/jmre.2001.2341; Guenther D, 2000, NMR BIOMED, V13, P182, DOI 10.1002/1099-1492(200006)13:4<182::AID-NBM642>3.0.CO;2-N; Hegewald MJ, 2009, CLIN REV ALLERG IMMU, V37, P159, DOI 10.1007/s12016-009-8125-2; Hopkins SR, 2007, J APPL PHYSIOL, V103, P240, DOI 10.1152/japplphysiol.01289.2006; Hughes JMB, 2003, RESP PHYSIOL NEUROBI, V138, P115, DOI 10.1016/j.resp.2003.08.004; Hughes M, 2008, J APPL PHYSIOL, V104, P1531, DOI 10.1152/japplphysiol.01092.2007; JAMESON CJ, 1988, J CHEM PHYS, V89, P4074, DOI 10.1063/1.454842; KANEKO K, 1966, J APPL PHYSIOL, V21, P767, DOI 10.1152/jappl.1966.21.3.767; LACHMANN B, 1990, LANCET, V335, P1413; Mansson S, 2003, MAGNET RESON MED, V50, P1170, DOI 10.1002/mrm.10649; Miller GW, 2004, MAGN RESON MATER PHY, V16, P218, DOI 10.1007/s10334-003-0028-2; Moller HE, 1998, J MAGN RESON, V135, P133, DOI 10.1006/jmre.1998.1563; Mugler JP, 1997, MAGN RESON MED, V37, P809, DOI 10.1002/mrm.1910370602; MUGLER JP, P ISMRM 18 ANN M 201; Musch G, 2002, J APPL PHYSIOL, V93, P1841, DOI 10.1152/japplphysiol.00223.2002; OKADA O, 1992, J APPL PHYSIOL, V72, P1838, DOI 10.1152/jappl.1992.72.5.1838; Parraga G, 2007, INVEST RADIOL, V42, P384, DOI 10.1097/01.rli.0000262571.81771.66; Patz S, 2008, ACAD RADIOL, V15, P713, DOI 10.1016/j.acra.2008.01.008; Patz S, 2007, EUR J RADIOL, V64, P335, DOI 10.1016/j.ejrad.2007.08.008; Peters DC, 2000, MAGNET RESON MED, V43, P91, DOI 10.1002/(SICI)1522-2594(200001)43:1<91::AID-MRM11>3.0.CO;2-4; Prisk GK, 2007, J APPL PHYSIOL, V103, P883, DOI 10.1152/japplphysiol.00292.2007; ROUGHTON FJW, 1957, J APPL PHYSIOL, V11, P290, DOI 10.1152/jappl.1957.11.2.290; Ruppert K, 2000, NMR BIOMED, V13, P220, DOI 10.1002/1099-1492(200006)13:4<220::AID-NBM638>3.0.CO;2-F; Ruppert K, 2004, MAGNET RESON MED, V51, P676, DOI 10.1002/mrm.10736; Ruppert K, 2000, MAGNET RESON MED, V44, P349, DOI 10.1002/1522-2594(200009)44:3<349::AID-MRM2>3.0.CO;2-J; Ruppert K, 2007, MAGN RESON MED, V57, P1099, DOI 10.1002/mrm.21241; Ruset IC, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.053002; Song JY, 2009, IEEE T BIO-MED ENG, V56, P1134, DOI 10.1109/TBME.2009.2012721; Swanson SD, 1999, MAGNET RESON MED, V42, P1137, DOI 10.1002/(SICI)1522-2594(199912)42:6<1137::AID-MRM19>3.0.CO;2-4; Swanson SD, 1997, MAGNET RESON MED, V38, P695, DOI 10.1002/mrm.1910380503; Theilmann RJ, 2009, J MAGN RESON IMAGING, V30, P527, DOI 10.1002/jmri.21866; WEATHERSBY PK, 1980, UNDERSEA BIOMED RES, V7, P277; Weibel ER, 2007, J APPL PHYSIOL, V102, P459, DOI 10.1152/japplphysiol.00808.2006; Weibel ER, 2009, SWISS MED WKLY, V139, P375, DOI smw-12270; WEST JB, 1960, J APPL PHYSIOL, V15, P405, DOI 10.1152/jappl.1960.15.3.405; Wolber J, 2000, MAGNET RESON MED, V43, P491, DOI 10.1002/(SICI)1522-2594(200004)43:4<491::AID-MRM1>3.0.CO;2-6; Wolber J, 1999, P NATL ACAD SCI USA, V96, P3664, DOI 10.1073/pnas.96.7.3664	55	124	128	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12192	10.1371/journal.pone.0012192	http://dx.doi.org/10.1371/journal.pone.0012192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808950	gold, Green Published, Green Submitted			2022-12-27	WOS:000280968000018
J	Deb, C; LaFrance-Corey, RG; Schmalstieg, WF; Sauer, BM; Wang, HA; German, CL; Windebank, AJ; Rodriguez, M; Howe, CL				Deb, Chandra; LaFrance-Corey, Reghann G.; Schmalstieg, William F.; Sauer, Brian M.; Wang, Huan; German, Christopher L.; Windebank, Anthony J.; Rodriguez, Moses; Howe, Charles L.			CD8(+) T Cells Cause Disability and Axon Loss in a Mouse Model of Multiple Sclerosis	PLOS ONE			English	Article							NERVOUS-SYSTEM REMYELINATION; CEREBROSPINAL-FLUID; CLONAL EXPANSIONS; MOTOR FUNCTION; VIRAL MODEL; NATALIZUMAB; EXPRESSION; PERFORIN; INFILTRATE; ABSENCE	Background: The objective of this study was to test the hypothesis that CD8(+) T cells directly mediate motor disability and axon injury in the demyelinated central nervous system. We have previously observed that genetic deletion of the CD8(+) T cell effector molecule perforin leads to preservation of motor function and preservation of spinal axons in chronically demyelinated mice. Methodology/Principal Findings: To determine if CD8(+) T cells are necessary and sufficient to directly injure demyelinated axons, we adoptively transferred purified perforin-competent CD8(+) spinal cord-infiltrating T cells into profoundly demyelinated but functionally preserved perforin-deficient host mice. Transfer of CD8(+) spinal cord-infiltrating T cells rapidly and irreversibly impaired motor function, disrupted spinal cord motor conduction, and reduced the number of medium and large-caliber spinal axons. Likewise, immunodepletion of CD8(+) T cells from chronically demyelinated wildtype mice preserved motor function and limited axon loss without altering other disease parameters. Conclusions/Significance: In multiple sclerosis patients, CD8(+) T cells outnumber CD4(+) T cells in active lesions and the number of CD8(+) T cells correlates with the extent of ongoing axon injury and functional disability. Our findings suggest that CD8(+) T cells may directly injure demyelinated axons and are therefore a viable therapeutic target to protect axons and motor function in patients with multiple sclerosis.	[Deb, Chandra; LaFrance-Corey, Reghann G.; Schmalstieg, William F.; Windebank, Anthony J.; Rodriguez, Moses; Howe, Charles L.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA; [Sauer, Brian M.; German, Christopher L.; Howe, Charles L.] Mayo Clin, Coll Med, Neurobiol Dis PhD Program, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Deb, C (corresponding author), Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA.	howe@mayo.edu	Sauer, Brian/AAI-1407-2021	Rodriguez, Moses/0000-0001-6328-6497; Howe, Charles/0000-0002-3889-8739	Mayo early career development award; National MS Society [RG3636]; NIH [NS32129]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032129] Funding Source: NIH RePORTER	Mayo early career development award; National MS Society(National Multiple Sclerosis Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by a generous gift from Donald and Frances Herdrich to CLH, by a Mayo early career development award to CLH, by grant RG3636 from the National MS Society to CLH (www.nmss.org), and by grant NS32129 from the NIH to MR (www.ninds.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; Begolka WS, 2001, J NEUROVIROL, V7, P409; Bieber AJ, 2003, ANN NEUROL, V53, P680, DOI 10.1002/ana.10578; CHEN ML, 2009, EUR J IMMUNOL; Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670; Deb C, 2009, J NEUROIMMUNOL, V214, P33, DOI 10.1016/j.jneuroim.2009.06.013; Deb C, 2009, J NEUROPATH EXP NEUR, V68, P1037, DOI 10.1097/NEN.0b013e3181b5417e; Friese MA, 2005, BRAIN, V128, P1747, DOI 10.1093/brain/awh578; Friese MA, 2009, ANN NEUROL, V66, P132, DOI 10.1002/ana.21744; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Govermant Joan, 2005, Current Drug Targets - Inflammation and Allergy, V4, P239, DOI 10.2174/1568010053586264; HAUSER SL, 1986, ANN NEUROL, V19, P578, DOI 10.1002/ana.410190610; Havrdova E, 2009, LANCET NEUROL, V8, P254, DOI 10.1016/S1474-4422(09)70021-3; Hoftberger R, 2004, BRAIN PATHOL, V14, P43; Howe CL, 2008, CURR TOP MICROBIOL, V318, P93; Howe CL, 2007, J NEUROIMMUNOL, V188, P13, DOI 10.1016/j.jneuroim.2007.04.005; Howe CL, 2007, NEUROBIOL DIS, V25, P354, DOI 10.1016/j.nbd.2006.10.001; Jacobsen M, 2002, BRAIN, V125, P538, DOI 10.1093/brain/awf059; Junker A, 2007, BRAIN, V130, P2789, DOI 10.1093/brain/awm214; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; Linda H, 2009, NEW ENGL J MED, V361, P1081, DOI 10.1056/NEJMoa0810316; Malmestrom C, 2008, J NEUROIMMUNOL, V196, P159, DOI 10.1016/j.jneuroim.2008.03.001; Murray PD, 1998, J NEUROSCI, V18, P7306; Okuda DT, 2009, NAT REV NEUROL, V5, P591, DOI 10.1038/nrneurol.2009.157; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Rivera-Quinones C, 1998, NAT MED, V4, P187, DOI 10.1038/nm0298-187; RODRIGUEZ M, 1991, LAB INVEST, V64, P358; Skulina C, 2004, P NATL ACAD SCI USA, V101, P2428, DOI 10.1073/pnas.0308689100; Sobottka B, 2009, AM J PATHOL, V175, P1160, DOI 10.2353/ajpath.2009.090340; vanOosten BW, 1997, NEUROLOGY, V49, P351, DOI 10.1212/WNL.49.2.351; Weiner HL, 2009, ANN NEUROL, V65, P239, DOI 10.1002/ana.21640	31	32	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12478	10.1371/journal.pone.0012478	http://dx.doi.org/10.1371/journal.pone.0012478			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20814579	Green Submitted, gold, Green Published			2022-12-27	WOS:000281375500011
J	Tyssen, D; Henderson, SA; Johnson, A; Sterjovski, J; Moore, K; La, J; Zanin, M; Sonza, S; Karellas, P; Giannis, MP; Krippner, G; Wesselingh, S; McCarthy, T; Gorry, PR; Ramsland, PA; Cone, R; Paull, JRA; Lewis, GR; Tachedjian, G				Tyssen, David; Henderson, Scott A.; Johnson, Adam; Sterjovski, Jasminka; Moore, Katie; La, Jennifer; Zanin, Mark; Sonza, Secondo; Karellas, Peter; Giannis, Michael P.; Krippner, Guy; Wesselingh, Steve; McCarthy, Tom; Gorry, Paul R.; Ramsland, Paul A.; Cone, Richard; Paull, Jeremy R. A.; Lewis, Gareth R.; Tachedjian, Gilda			Structure Activity Relationship of Dendrimer Microbicides with Dual Action Antiviral Activity	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HERPES-SIMPLEX-VIRUS; CANDIDATE TOPICAL MICROBICIDES; RANDOMIZED CONTROLLED-TRIAL; HIV-INFECTION; SPL7013 GEL; VAGINAL MICROBICIDES; MACROPHAGE TROPISM; TYPE-1 REPLICATION; IN-VITRO	Background: Topical microbicides, used by women to prevent the transmission of HIV and other sexually transmitted infections are urgently required. Dendrimers are highly branched nanoparticles being developed as microbicides. However, the anti-HIV and HSV structure-activity relationship of dendrimers comprising benzyhydryl amide cores and lysine branches, and a comprehensive analysis of their broad-spectrum anti-HIV activity and mechanism of action have not been published. Methods and Findings: Dendrimers with optimized activity against HIV-1 and HSV-2 were identified with respect to the number of lysine branches (generations) and surface groups. Antiviral activity was determined in cell culture assays. Time-of-addition assays were performed to determine dendrimer mechanism of action. In vivo toxicity and HSV-2 inhibitory activity were evaluated in the mouse HSV-2 susceptibility model. Surface groups imparting the most potent inhibitory activity against HIV-1 and HSV-2 were naphthalene disulfonic acid (DNAA) and 3,5-disulfobenzoic acid exhibiting the greatest anionic charge and hydrophobicity of the seven surface groups tested. Their anti-HIV-1 activity did not appreciably increase beyond a second-generation dendrimer while dendrimers larger than two generations were required for potent anti-HSV-2 activity. Second (SPL7115) and fourth generation (SPL7013) DNAA dendrimers demonstrated broad-spectrum anti-HIV activity. However, SPL7013 was more active against HSV and blocking HIV-1 envelope mediated cell-to-cell fusion. SPL7013 and SPL7115 inhibited viral entry with similar potency against CXCR4-(X4) and CCR5-using (R5) HIV-1 strains. SPL7013 was not toxic and provided at least 12 h protection against HSV-2 in the mouse vagina. Conclusions: Dendrimers can be engineered with optimized potency against HIV and HSV representing a unique platform for the controlled synthesis of chemically defined multivalent agents as viral entry inhibitors. SPL7013 is formulated as VivaGel (R) and is currently in clinical development to provide protection against HIV and HSV. SPL7013 could also be combined with other microbicides.	[Tyssen, David; Johnson, Adam; Sterjovski, Jasminka; Moore, Katie; La, Jennifer; Zanin, Mark; Sonza, Secondo; Wesselingh, Steve; Gorry, Paul R.; Ramsland, Paul A.; Tachedjian, Gilda] Burnet Inst, Ctr Virol, Melbourne, Vic, Australia; [Tyssen, David; Johnson, Adam; Sterjovski, Jasminka; Moore, Katie; La, Jennifer; Zanin, Mark; Sonza, Secondo; Wesselingh, Steve; Gorry, Paul R.; Ramsland, Paul A.; Tachedjian, Gilda] Burnet Inst, Ctr Immunol, Melbourne, Vic, Australia; [Henderson, Scott A.; Karellas, Peter; Giannis, Michael P.; Krippner, Guy; McCarthy, Tom; Paull, Jeremy R. A.; Lewis, Gareth R.] Starpharma Pty Ltd, Melbourne, Vic, Australia; [Wesselingh, Steve] Monash Univ, Fac Nursing & Hlth Sci, Clayton, Vic, Australia; [La, Jennifer] Monash Univ, Fac Pharm & Pharmaceut Sci, Parkville, Vic, Australia; [Sonza, Secondo; Tachedjian, Gilda] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Gorry, Paul R.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Gorry, Paul R.; Tachedjian, Gilda] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Ramsland, Paul A.] Univ Melbourne, Dept Surg Austin Hlth, Heidelberg, Vic, Australia; [Ramsland, Paul A.] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Cone, Richard] Johns Hopkins Univ, Dept Biophys, Baltimore, MD USA	Burnet Institute; Burnet Institute; Monash University; Monash University; Monash University; University of Melbourne; Monash University; Austin Research Institute; University of Melbourne; Monash University; Johns Hopkins University	Tyssen, D (corresponding author), Burnet Inst, Ctr Virol, Melbourne, Vic, Australia.	gildat@burnet.edu.au	Tachedjian, Gilda/AAF-1327-2020	Tachedjian, Gilda/0000-0002-7733-7037; Zanin, Mark/0000-0003-3158-1744; Paull, Jeremy/0000-0002-9981-421X; Sterjovski, Jasminka/0000-0002-2471-3000; Ramsland, Paul/0000-0002-2107-2738	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN266200500042C, U19 AI060598]; NIAD, NIH [N01-AI-05420, N01-AI-25478]; National Health and Medical Research Council of Australia (NHMRC) [543105, 365209]; Australian Centre for HIV and Hepatitis Virology Research [ACH2]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI060598, N01AI005420] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAD, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Centre for HIV and Hepatitis Virology Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by US Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under Contract No. HHSN266200500042C and Grant No. U19 AI060598 awarded to Starpharma Pty Ltd. Southern Research Institute evaluation of dendrimer activity was supported by US funds NIAD, NIH contracts N01-AI-05420 (Principal Investigator: Dr Luke Pallansch) and N01-AI-25478 (Principal Investigator: Mr Roger Ptak), under the direction of Dr Steven Turk, Project Officer, NIAID, Division of AIDS. G. T. was supported by the National Health and Medical Research Council of Australia (NHMRC) Senior Research Fellowship 543105 and funding from the Australian Centre for HIV and Hepatitis Virology Research (ACH2). P. A. R. was supported by the NHMRC R. Douglas Wright Career Development Award 365209. The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The results and conclusions of this report are those of the authors and do not necessarily represent the views of NIH.	Abner SR, 2005, J INFECT DIS, V192, P1545, DOI 10.1086/462424; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Balzarini J, 2007, LANCET, V369, P787, DOI 10.1016/S0140-6736(07)60202-5; Bernstein DI, 2003, ANTIMICROB AGENTS CH, V47, P3784, DOI 10.1128/AAC.47.12.3784-3788.2003; BINDER D, 1987, J MED CHEM, V30, P678, DOI 10.1021/jm00387a017; BIRCH CJ, 1992, J INFECT DIS, V166, P108, DOI 10.1093/infdis/166.1.108; Bourne N, 2000, ANTIMICROB AGENTS CH, V44, P2471, DOI 10.1128/AAC.44.9.2471-2474.2000; Boyd BJ, 2006, MOL PHARMACEUT, V3, P614, DOI 10.1021/mp060032e; Brown JM, 2007, AIDS, V21, P1515, DOI 10.1097/QAD.0b013e3282004929; Butler DM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000447; Chen MY, 2009, JAIDS-J ACQ IMM DEF, V50, P375, DOI 10.1097/QAI.0b013e318198a7e6; CHISEMBELE M, 2010, 17 C RET OPP INF SAN; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; Cummins JE, 2007, ANTIMICROB AGENTS CH, V51, P1770, DOI 10.1128/AAC.01129-06; Dezzutti CS, 2004, ANTIMICROB AGENTS CH, V48, P3834, DOI 10.1128/AAC.48.10.3834-3844.2004; Etemad-Moghadam B, 2000, J VIROL, V74, P4433, DOI 10.1128/JVI.74.9.4433-4440.2000; Feldblum PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001474; Fletcher PS, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-46; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gajbhiye V, 2009, J PHARM PHARMACOL, V61, P989, DOI 10.1211/jpp/61.08.0002; Galen BT, 2007, J INFECT DIS, V195, P1332, DOI 10.1086/513279; Gao F, 1996, J VIROL, V70, P1651, DOI 10.1128/JVI.70.3.1651-1667.1996; Gong E, 2005, ANTIVIR RES, V68, P139, DOI 10.1016/j.antiviral.2005.08.004; Gorry PR, 2001, J VIROL, V75, P10073, DOI 10.1128/JVI.75.21.10073-10089.2001; Gray L, 2005, VIROLOGY, V337, P384, DOI 10.1016/j.virol.2005.04.034; Hantson Anke, 2005, Antiviral Chemistry & Chemotherapy, V16, P253; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huskens D, 2009, ANTIVIR RES, V84, P38, DOI 10.1016/j.antiviral.2009.07.013; Jiang YH, 2005, AIDS RES HUM RETROV, V21, P207, DOI 10.1089/aid.2005.21.207; *JOINT UN PROGR HI, 2003, STIGMA DISCRIMINATIO; Kaminskas LM, 2007, MOL PHARMACEUT, V4, P949, DOI 10.1021/mp070047s; KARIM QA, 2010, SCIENCE         0719; Karim SA, 2009, 16 C RETR OPP INF MO; Ketas TJ, 2007, VIROLOGY, V364, P281, DOI 10.1016/j.virol.2007.02.022; Lacey CJN, 2006, AIDS, V20, P1027, DOI 10.1097/01.aids.0000222075.83490.ca; Lackman-Smith C, 2008, ANTIMICROB AGENTS CH, V52, P1768, DOI 10.1128/AAC.01328-07; LEVY JA, 1988, JAMA-J AM MED ASSOC, V259, P3037, DOI 10.1001/jama.259.20.3037; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; MATTHEWS BR, 2002, Patent No. 02079299; McCarthy TD, 2005, MOL PHARMACEUT, V2, P312, DOI 10.1021/mp050023q; McElrath MJ, 2010, ANTIMICROB AGENTS CH, V54, P763, DOI 10.1128/AAC.00891-09; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Moore JP, 2003, P NATL ACAD SCI USA, V100, P10598, DOI 10.1073/pnas.1932511100; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; Nanjwade BK, 2009, EUR J PHARM SCI, V38, P185, DOI 10.1016/j.ejps.2009.07.008; O'Loughlin J, 2010, SEX TRANSM DIS, V37, P100, DOI 10.1097/OLQ.0b013e3181bc0aac; PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6; PRICE CF, 2010, SPL7013 GEL VIVAGEL; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Roberts BP, 2009, MACROMOLECULES, V42, P2775, DOI 10.1021/ma802154e; Rusconi S, 1996, ANTIMICROB AGENTS CH, V40, P234, DOI 10.1128/AAC.40.1.234; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Scordi-Bello IA, 2005, ANTIMICROB AGENTS CH, V49, P3607, DOI 10.1128/AAC.49.9.3607-3615.2005; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Sonza S, 1996, J VIROL, V70, P3863, DOI 10.1128/JVI.70.6.3863-3869.1996; Sonza S, 2009, ANTIMICROB AGENTS CH, V53, P3565, DOI 10.1128/AAC.00102-09; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Springer CJ, 1995, J MED CHEM, V38, P5051, DOI 10.1021/jm00026a013; Sterjovski J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-89; Tao W, 2008, AIDS RES HUM RETROV, V24, P925, DOI 10.1089/aid.2008.0043; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Witvrouw M, 2000, MOL PHARMACOL, V58, P1100, DOI 10.1124/mol.58.5.1100; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995; Yap SH, 2007, PLOS MED, V4, P1887, DOI 10.1371/journal.pmed.0040335; Zhang YJ, 2002, J VIROL, V76, P6332, DOI 10.1128/JVI.76.12.6332-6343.2002	70	134	137	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12309	10.1371/journal.pone.0012309	http://dx.doi.org/10.1371/journal.pone.0012309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808791	gold, Green Published			2022-12-27	WOS:000281153500004
J	Wolford, JL; Chishti, Y; Jin, QL; Ward, J; Chen, LH; Vogt, S; Finney, L				Wolford, Janet L.; Chishti, Yasmin; Jin, Qiaoling; Ward, Jesse; Chen, Liaohai; Vogt, Stefan; Finney, Lydia			Loss of Pluripotency in Human Embryonic Stem Cells Directly Correlates with an Increase in Nuclear Zinc	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; FLUORESCENT SENSORS; DIFFERENTIATION; METALLOTHIONEIN; CHROMATIN; BIOLOGY; ACTIVATION; COPPER	The pluripotency of human embryonic stem cells (hESCs) is important to investigations of early development and to cell replacement therapy, but the mechanism behind pluripotency is incompletely understood. Zinc has been shown to play a key role in differentiation of non-pluripotent cell types, but here its role in hESCs is directly examined. By mapping the distribution of metals in hESCs at high resolution by x-ray fluorescence microprobe (XFM) and by analyzing subcellular metal content, we have found evidence that loss of pluripotency is directly correlated with an increase in nuclear zinc. Zinc elevation not only redefines our understanding of the mechanisms that support pluripotency, but also may act as a biomarker and an intervention point for stem cell differentiation.	[Wolford, Janet L.; Chishti, Yasmin; Jin, Qiaoling; Chen, Liaohai; Finney, Lydia] Argonne Natl Lab, Adv Photon Source, Biosci Div, Argonne, IL 60439 USA; [Ward, Jesse; Vogt, Stefan; Finney, Lydia] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Wolford, JL (corresponding author), Argonne Natl Lab, Adv Photon Source, Biosci Div, Argonne, IL 60439 USA.	lfinney@anl.gov	Jin, Qiaoling/D-2303-2016; Vogt, Stefan/B-9547-2009; Vogt, Stefan/J-7937-2013	Vogt, Stefan/0000-0002-8034-5513; Vogt, Stefan/0000-0002-8034-5513	Department of Energy Office of Science [DE-AC02-06CH11357]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	Department of Energy Office of Science(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work, including use of the Advanced Photon Source at Argonne National Laboratory, was supported by the Department of Energy Office of Science under contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Siva S. K. Dasa for support in the maintenance of our cell cultures. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357.	Adamczyk M, 2007, FEBS LETT, V581, P1409, DOI 10.1016/j.febslet.2007.02.063; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Bell SG, 2009, CHEMBIOCHEM, V10, P55, DOI 10.1002/cbic.200800511; Beyersmann D, 2001, BIOMETALS, V14, P331, DOI 10.1023/A:1012905406548; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Burdette SC, 2001, J AM CHEM SOC, V123, P7831, DOI 10.1021/ja010059l; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Chen LY, 2008, HUM MOL GENET, V17, pR23, DOI 10.1093/hmg/ddn050; CHERIAN MG, 1994, ENVIRON HEALTH PERSP, V102, P131, DOI 10.2307/3431776; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Domaille DW, 2008, NAT CHEM BIOL, V4, P168, DOI 10.1038/nchembio.69; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Finney L, 2007, P NATL ACAD SCI USA, V104, P2247, DOI 10.1073/pnas.0607238104; Finney L, 2010, ACS CHEM BIOL, V5, P577, DOI 10.1021/cb1000263; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; Gee KR, 2002, CELL CALCIUM, V31, P245, DOI 10.1016/S0143-4160(02)00053-2; Gee KR, 2002, J AM CHEM SOC, V124, P776, DOI 10.1021/ja011774y; Glesne D, 2006, J STRUCT BIOL, V155, P2, DOI 10.1016/j.jsb.2005.09.012; GRUMMT F, 1986, EXP CELL RES, V163, P191, DOI 10.1016/0014-4827(86)90572-0; Hirano T, 2000, J AM CHEM SOC, V122, P12399, DOI 10.1021/ja002467f; Huang HR, 2006, BIOCHEM BIOPH RES CO, V351, P321, DOI 10.1016/j.bbrc.2006.09.171; IDO A, 1994, DEV BIOL, V163, P184, DOI 10.1006/dbio.1994.1134; Keenen B, 2009, J CELL PHYSIOL, V219, P1, DOI 10.1002/jcp.21654; Kelleher SL, 2009, GENES NUTR, V4, P83, DOI 10.1007/s12263-009-0119-4; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kobrossy L, 2006, J BIOL CHEM, V281, P25926, DOI 10.1074/jbc.M602555200; Lee SJ, 2009, GLIA, V57, P1351, DOI 10.1002/glia.20854; Maret W, 2000, J NUTR, V130, p1455S, DOI 10.1093/jn/130.5.1455S; NAGEL WW, 1995, P NATL ACAD SCI USA, V92, P579, DOI 10.1073/pnas.92.2.579; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Park SW, 2005, J NEUROSCI, V25, P3350, DOI 10.1523/JNEUROSCI.0186-05.2005; Paunesku T, 2006, J CELL BIOCHEM, V99, P1489, DOI 10.1002/jcb.21047; PETRIE L, 1991, BIOCHEM J, V276, P109, DOI 10.1042/bj2760109; SAAVEDRA RA, 1986, SCIENCE, V234, P1589, DOI 10.1126/science.3787266; Schmidt C, 1999, ARCH BIOCHEM BIOPHYS, V364, P91, DOI 10.1006/abbi.1999.1107; Suhy DA, 1999, J BIOL CHEM, V274, P9183, DOI 10.1074/jbc.274.14.9183; Takahashi Y, 2005, J CELL PHYSIOL, V202, P563, DOI 10.1002/jcp.20158; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Vogt S, 2003, J PHYS IV, V104, P635, DOI 10.1051/jp4:20030160; Wang ZX, 2007, STEM CELLS, V25, P2173, DOI 10.1634/stemcells.2007-0085; Wang ZX, 2008, STEM CELLS, V26, P2791, DOI 10.1634/stemcells.2008-0443; Yang LC, 2005, P NATL ACAD SCI USA, V102, P11179, DOI 10.1073/pnas.0406547102; ZALEWSKI PD, 1994, J HISTOCHEM CYTOCHEM, V42, P877, DOI 10.1177/42.7.8014471; [No title captured]	45	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12308	10.1371/journal.pone.0012308	http://dx.doi.org/10.1371/journal.pone.0012308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808840	Green Published, Green Submitted, gold			2022-12-27	WOS:000281077000013
J	Alger, SE; Lau, HY; Fishbein, W				Alger, Sara E.; Lau, Hiuyan; Fishbein, William			Delayed Onset of a Daytime Nap Facilitates Retention of Declarative Memory	PLOS ONE			English	Article							SLOW-WAVE SLEEP; EYE-MOVEMENT SLEEP; SYNAPTIC HOMEOSTASIS; PARADOXICAL SLEEP; PROCEDURAL MEMORY; EMOTIONAL MEMORY; REM-SLEEP; CONSOLIDATION; HIPPOCAMPUS; INCREASES	Background: Learning followed by a period of sleep, even as little as a nap, promotes memory consolidation. It is now generally recognized that sleep facilitates the stabilization of information acquired prior to sleep. However, the temporal nature of the effect of sleep on retention of declarative memory is yet to be understood. We examined the impact of a delayed nap onset on the recognition of neutral pictorial stimuli with an added spatial component. Methodology/Principal Findings: Participants completed an initial study session involving 150 neutral pictures of people, places, and objects. Immediately following the picture presentation, participants were asked to make recognition judgments on a subset of "old'', previously seen, pictures versus intermixed "new'' pictures. Participants were then divided into one of four groups who either took a 90-minute nap immediately, 2 hours, or 4 hours after learning, or remained awake for the duration of the experiment. 6 hours after initial learning, participants were again tested on the remaining "old'' pictures, with "new'' pictures intermixed. Conclusions/Significance: Interestingly, we found a stabilizing benefit of sleep on the memory trace reflected as a significant negative correlation between the average time elapsed before napping and decline in performance from test to retest (p = .001). We found a significant interaction between the groups and their performance from test to retest (p = .010), with the 4-hour delay group performing significantly better than both those who slept immediately and those who remained awake (p = .044, p = .010, respectively). Analysis of sleep data revealed a significant positive correlation between amount of slow wave sleep (SWS) achieved and length of the delay before sleep onset (p = .048). The findings add to the understanding of memory processing in humans, suggesting that factors such as waking processing and homeostatic increases in need for sleep over time modulate the importance of sleep to consolidation of neutral declarative memories.	[Alger, Sara E.; Lau, Hiuyan; Fishbein, William] CUNY City Coll, Dept Psychol, Cognit Neurosci Subprogram, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Alger, SE (corresponding author), CUNY City Coll, Dept Psychol, Cognit Neurosci Subprogram, New York, NY 10031 USA.	sealger78@gmail.com		Alger, Sara/0000-0002-5078-6510	CUNY Research Foundation (PSC-CUNY) [PSCREG -38-661]	CUNY Research Foundation (PSC-CUNY)	This work was supported by the CUNY Research Foundation (PSC-CUNY) Grant #: PSCREG -38-661 to WF. http://www.rfcuny.org/rfwebsite/research/content.aspx?catID=1190. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhaus J, 2008, NEUROBIOL LEARN MEM, V89, P76, DOI 10.1016/j.nlm.2007.08.010; Backhaus J, 2006, SLEEP MED, V7, P508, DOI 10.1016/j.sleep.2006.04.002; Baran B, 2010, EXP BRAIN RES, V203, P471, DOI 10.1007/s00221-010-2242-2; Battaglia FP, 2004, LEARN MEMORY, V11, P697, DOI 10.1101/lm.73504; Behrens CJ, 2005, NAT NEUROSCI, V8, P1560, DOI 10.1038/nn1571; BENINGTON JH, 1995, BRAIN RES, V692, P79, DOI 10.1016/0006-8993(95)00590-M; Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cohen DA, 2005, P NATL ACAD SCI USA, V102, P18237, DOI 10.1073/pnas.0506072102; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; EKSTRAND BR, 1967, J EXP PSYCHOL, V75, P64, DOI 10.1037/h0024907; Ellenbogen JM, 2006, CURR BIOL, V16, P1290, DOI 10.1016/j.cub.2006.05.024; Ellenbogen JM, 2006, CURR OPIN NEUROBIOL, V16, P716, DOI 10.1016/j.conb.2006.10.006; Fenn KM, 2003, NATURE, V425, P614, DOI 10.1038/nature01951; FISHBEIN W, 1977, BEHAV BIOL, V19, P425, DOI 10.1016/S0091-6773(77)91903-4; FISHBEIN W, 1971, SCIENCE, V172, P80, DOI 10.1126/science.172.3978.80; Gais S, 2004, LEARN MEMORY, V11, P679, DOI 10.1101/lm.80504; Gais S, 2002, J NEUROSCI, V22, P6830; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; Hu P, 2006, PSYCHOL SCI, V17, P891, DOI 10.1111/j.1467-9280.2006.01799.x; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kali S, 2004, NAT NEUROSCI, V7, P286, DOI 10.1038/nn1202; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Mednick S, 2003, NAT NEUROSCI, V6, P697, DOI 10.1038/nn1078; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; Nishida M, 2009, CEREB CORTEX, V19, P1158, DOI 10.1093/cercor/bhn155; Payne JD, 2008, PSYCHOL SCI, V19, P781, DOI 10.1111/j.1467-9280.2008.02157.x; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Racsmany M, 2010, PSYCHOL SCI, V21, P80, DOI 10.1177/0956797609354074; RADULOVACKI M, 1982, BRAIN RES, V246, P178, DOI 10.1016/0006-8993(82)90161-5; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Retey JV, 2005, P NATL ACAD SCI USA, V102, P15676, DOI 10.1073/pnas.0505414102; Ritchey M, 2008, CEREB CORTEX, V18, P2494, DOI 10.1093/cercor/bhm262; Schabus M, 2005, SOMNOLOGIE, V9, P148, DOI [DOI 10.1111/J.1439-054X.2005.00054.X, 10.1111/j.1439-054X.2005.00054, DOI 10.1111/J.1439-054X.2005.00054]; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Smith C, 2001, SLEEP MED REV, V5, P491, DOI 10.1053/smrv.2001.0164; Smith C, 1996, BEHAV BRAIN RES, V78, P49, DOI 10.1016/0166-4328(95)00218-9; SMITH C, 1991, CAN J PSYCHOL, V45, P115, DOI 10.1037/h0084279; Sterpenich V, 2009, J NEUROSCI, V29, P5143, DOI 10.1523/JNEUROSCI.0561-09.2009; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Tucker MA, 2006, NEUROBIOL LEARN MEM, V86, P241, DOI 10.1016/j.nlm.2006.03.005; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	52	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12131	10.1371/journal.pone.0012131	http://dx.doi.org/10.1371/journal.pone.0012131			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	637ZU	20808821	Green Published, gold			2022-12-27	WOS:000280859700020
J	Lukov, GL; Goodell, MA				Lukov, Georgi L.; Goodell, Margaret A.			LYL1 Degradation by the Proteasome Is Directed by a N-Terminal PEST Rich Site in a Phosphorylation-Independent Manner	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; TRANSCRIPTION FACTOR LYL1; ADULT HEMATOPOIETIC STEM; T-CELL; CHROMOSOMAL TRANSLOCATION; PROTEIN-DEGRADATION; GENE; SCL; MOTIF; PROTEOLYSIS	Background: The Lymphoblastic leukemia 1 (LYL1) gene is a proto-oncogenic transcription factor found upregulated in patients with T-cell acute lymphoblastic leukemia (T-cell ALL). Initially, the upregulation was described to be as a result of a translocation. However, further studies revealed that transcriptional upregulation of LYL1could also occur without translocations. In addition, post-translational mechanisms, such as protein degradation could influence LYL1 expression as well. Methodology/Principal Findings: In this study, we considered possible post-translational regulation of Lyl1, and investigated fundamental mechanisms governing LYL1 degradation in cell-based culture assays. We identify a PEST sequence motif located in the N-terminus of LYL1, which determines the efficiency of LYL1 degradation by the proteasome. The absence of the PEST degradation site leads to accumulation or upregulation of LYL1. We also show that LYL1 is phosphorylated by MAPK at S-36, and determined that proteasomal degradation of LYL1 occurs in a phosphorylation-independent manner. Conclusions/Significance: Understanding LYL1 degradation is a step forward not only towards deciphering the normal function and regulation of LYL1, but could suggest post-translational mechanisms for upregulation of LYL1 that may contribute to its oncogenic role.	[Lukov, Georgi L.; Goodell, Margaret A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lukov, Georgi L.; Goodell, Margaret A.] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Lukov, GL (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.	goodell@bcm.edu	Lukov, Georgi/AAI-8544-2021	Goodell, Margaret A./0000-0003-1111-2932	National Institutes of Health [DK58192, HL081007, P50CA126752]; NATIONAL CANCER INSTITUTE [P50CA126752] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL081007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The financial support for this work was provided by National Institutes of Health grants DK58192, HL081007, and P50CA126752. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belizario JE, 2008, CURR PROTEIN PEPT SC, V9, P210, DOI 10.2174/138920308784534023; Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; Bruckner R, 2000, CANCER GENET CYTOGEN, V119, P77, DOI 10.1016/S0165-4608(99)00214-9; Capron C, 2006, BLOOD, V107, P4678, DOI 10.1182/blood-2005-08-3145; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chan WYI, 2007, BLOOD, V109, P1908, DOI 10.1182/blood-2006-05-023226; Clarke DJ, 2002, CELL CYCLE, V1, P231, DOI 10.4161/cc.1.4.129; CLEARY ML, 1988, J EXP MED, V167, P682, DOI 10.1084/jem.167.2.682; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DIMAURO I, 2009, BRIT J HAEMATOL, V146, P689; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Garay-Malpartida HM, 2005, BIOINFORMATICS, V21, pI169, DOI 10.1093/bioinformatics/bti1034; GARRELL J, 1991, BIOESSAYS, V13, P493, DOI 10.1002/bies.950131002; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hann SR, 2006, SEMIN CANCER BIOL, V16, P288, DOI 10.1016/j.semcancer.2006.08.004; Hirai I, 2004, ONCOGENE, V23, P5124, DOI 10.1038/sj.onc.1207658; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lee SY, 2005, LEUKEMIA, V19, P1841, DOI 10.1038/sj.leu.2403896; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; MELLENTIN JD, 1989, CELL, V58, P77, DOI 10.1016/0092-8674(89)90404-2; Meng YS, 2005, LEUKEMIA, V19, P1941, DOI 10.1038/sj.leu.2403836; Miyamoto A, 1996, MOL CELL BIOL, V16, P2394; NAGEL S, 2009, LEUK RES; Orr SJ, 2007, J BIOL CHEM, V282, P3418, DOI 10.1074/jbc.C600216200; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Sorokin AV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1411, DOI 10.1134/S000629790913001X; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Terme JM, 2009, BLOOD, V113, P6695, DOI 10.1182/blood-2008-07-166835; VISVADER J, 1991, ONCOGENE, V6, P187; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Zhong Y, 2007, ONCOGENE, V26, P6937, DOI 10.1038/sj.onc.1210494	33	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12692	10.1371/journal.pone.0012692	http://dx.doi.org/10.1371/journal.pone.0012692			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844761	Green Published, Green Submitted, gold			2022-12-27	WOS:000281687300023
J	Corbo, V; Ritelli, R; Barbi, S; Funel, N; Campani, D; Bardelli, A; Scarpa, A				Corbo, Vincenzo; Ritelli, Rossana; Barbi, Stefano; Funel, Niccola; Campani, Daniela; Bardelli, Alberto; Scarpa, Aldo			Mutational Profiling of Kinases in Human Tumours of Pancreatic Origin Identifies Candidate Cancer Genes in Ductal and Ampulla of Vater Carcinomas	PLOS ONE			English	Article							GASTROINTESTINAL STROMAL TUMORS; FACTOR RECEPTOR EGFR; COLORECTAL CANCERS; SOMATIC MUTATIONS; HUMAN BREAST; GERMLINE MUTATIONS; SOLID TUMORS; PIK3CA GENE; K-RAS; GROWTH	Background: Protein kinases are key regulators of cellular processes (such as proliferation, apoptosis and invasion) that are often deregulated in human cancers. Accordingly, kinase genes have been the first to be systematically analyzed in human tumors leading to the discovery that many oncogenes correspond to mutated kinases. In most cases the genetic alterations translate in constitutively active kinase proteins, which are amenable of therapeutic targeting. Tumours of the pancreas are aggressive neoplasms for which no effective therapeutic strategy is currently available. Methodology/Principal Findings: We conducted a DNA-sequence analysis of a selected set of 35 kinase genes in a panel of 52 pancreatic exocrine neoplasms, including 36 pancreatic ductal adenocarcinoma, and 16 ampulla of Vater cancer. Among other changes we found somatic mutations in ATM, EGFR, EPHA3, EPHB2, and KIT, none of which was previously described in cancers. Conclusions/Significance: Although the alterations identified require further experimental evaluation, the localization within defined protein domains indicates functional relevance for most of them. Some of the mutated genes, including the tyrosine kinases EPHA3 and EPHB2, are clearly amenable to pharmacological intervention and could represent novel therapeutic targets for these incurable cancers.	[Corbo, Vincenzo; Ritelli, Rossana; Scarpa, Aldo] Univ Verona, ARC NET Res Ctr, Policlin GB Rossi, I-37100 Verona, Italy; [Barbi, Stefano; Scarpa, Aldo] Univ Verona, Dept Pathol, Policlin GB Rossi, I-37100 Verona, Italy; [Funel, Niccola; Campani, Daniela] Univ Pisa, Dept Pathol, Pisa, Italy; [Bardelli, Alberto] Univ Torino, Sch Med, Mol Genet Lab, Inst Canc Res & Treatment, Candiolo, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin	Corbo, V (corresponding author), Univ Verona, ARC NET Res Ctr, Policlin GB Rossi, I-37100 Verona, Italy.	aldo.scarpa@univr.it	scarpa, aldo/K-6832-2016; Corbo, Vincenzo/J-7754-2016; BARDELLI, Alberto/J-9721-2018	scarpa, aldo/0000-0003-1678-739X; Corbo, Vincenzo/0000-0002-6340-8009; Funel, Niccola/0000-0002-5028-2363; CAMPANI, DANIELA/0000-0001-5987-734X; BARDELLI, Alberto/0000-0003-1647-5070	Associazione Italiana Ricerca Cancro (AIRC); Fondazione CariParo; Fondazione Monte dei Paschi di Siena; Italian Ministry of Health, Rome, Italy; European Community [PL018771]	Associazione Italiana Ricerca Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione CariParo(Fondazione Cariparo); Fondazione Monte dei Paschi di Siena; Italian Ministry of Health, Rome, Italy(Ministry of Health, Italy); European Community(European Commission)	This work was supported by grants from Associazione Italiana Ricerca Cancro (AIRC, http://www.airc.it/), Fondazione CariParo (www.fondazionecariparo.it), Fondazione Monte dei Paschi di Siena (http://www.fondazionemps.it/); Italian Ministry of Health, Rome, Italy (http://www.salute.gov.it/); European Community FP VI Program Grant PL018771 (MolDiagPaca, http://www.moldiagpaca.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alazzouzi H, 2005, CANCER RES, V65, P10170, DOI 10.1158/0008-5472.CAN-05-2580; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Balakrishnan A, 2007, CANCER RES, V67, P3545, DOI 10.1158/0008-5472.CAN-07-0065; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Bateman AC, 2008, PANCREAS, V36, P76, DOI 10.1097/mpa.0b013e3181469881; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boultwood J, 2001, J CLIN PATHOL, V54, P512, DOI 10.1136/jcp.54.7.512; Buttitta F, 2006, INT J CANCER, V119, P2586, DOI 10.1002/ijc.22143; Campbell TN, 2008, CURR ISSUES MOL BIOL, V10, P61; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Fabbro D, 2002, PHARMACOL THERAPEUT, V93, P79, DOI 10.1016/S0163-7258(02)00179-1; Furuse J, 2008, J HEPATO-BILIARY-PAN, V15, P55, DOI 10.1007/s00534-007-1280-z; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Ikenoue T, 2005, CANCER RES, V65, P4562, DOI 10.1158/0008-5472.CAN-04-4114; Immervoll H, 2006, VIRCHOWS ARCH, V448, P788, DOI 10.1007/s00428-006-0191-8; Ishimura N, 2003, CANCER LETT, V199, P169, DOI 10.1016/S0304-3835(03)00384-7; Jang JH, 2001, CANCER RES, V61, P3541; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Leary A, 2007, CANCER INVEST, V25, P347, DOI 10.1080/07357900701259694; Lee J, 2007, CANCER-AM CANCER SOC, V109, P1561, DOI 10.1002/cncr.22559; Lee JW, 2006, CLIN CANCER RES, V12, P57, DOI 10.1158/1078-0432.CCR-05-0976; Li Junsheng, 2003, Mol Cancer, V2, P32, DOI 10.1186/1476-4598-2-32; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Menoyo A, 2001, CANCER RES, V61, P7727; Merlos-Suarez A, 2008, CURR OPIN CELL BIOL, V20, P194, DOI 10.1016/j.ceb.2008.01.011; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sorio C, 2001, VIRCHOWS ARCH, V438, P154, DOI 10.1007/s004280000343; Steeghs N, 2007, ANN SURG ONCOL, V14, P942, DOI 10.1245/s10434-006-9227-1; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tzeng CWD, 2007, SURGERY, V141, P464, DOI 10.1016/j.surg.2006.09.009; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yasuda A, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-46; Zamo A, 2007, J MOL DIAGN, V9, P151, DOI 10.2353/jmoldx.2007.060041	51	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12653	10.1371/journal.pone.0012653	http://dx.doi.org/10.1371/journal.pone.0012653			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IV	20838624	Green Submitted, Green Published, gold			2022-12-27	WOS:000281687100014
J	Azuma, M; Sawahata, R; Akao, Y; Ebihara, T; Yamazaki, S; Matsumoto, M; Hashimoto, M; Fukase, K; Fujimoto, Y; Seya, T				Azuma, Masahiro; Sawahata, Ryoko; Akao, Yuusuke; Ebihara, Takashi; Yamazaki, Sayuri; Matsumoto, Misako; Hashimoto, Masahito; Fukase, Koichi; Fujimoto, Yukari; Seya, Tsukasa			The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; NATURAL-KILLER-CELLS; STAPHYLOCOCCUS-AUREUS; CUTTING EDGE; BACTERIAL LIPOPROTEINS; MYCOBACTERIUM-BOVIS; ADAPTER MOLECULE; RECOGNITION; TLR2; ENHANCEMENT	Natural killer (NK) cells are lymphocyte effectors that are activated to control certain microbial infections and tumors. Many NK-activating and regulating receptors are involved in regulating NK cell function. In addition, activation of naive NK cells is fundamentally triggered by cytokines or myeloid dendritic cells (mDC) in various modes. In this study, we synthesized 16 S[ 2,3-bis(palmitoyl) propyl] cysteine (Pam2Cys) lipopeptides with sequences designed from lipoproteins of Staphylococcus aureus, and assessed their functional properties using mouse (C57BL/6) bone marrow-derived DC (BMDC) and NK cells. NK cell activation was evaluated by three criteria: IFN-gamma production, up-regulation of NK activation markers and cytokines, and NK target (B16D8 cell) cytotoxicity. The diacylated lipopeptides acted as TLR2 ligands, inducing up-regulation of CD25/CD69/CD86, IL-6, and IL-12p40, which represent maturation of BMDC. Strikingly, the Pam2Cys lipopeptides induced mouse NK cell activation based on these criteria. Cell-cell contact by Pam2Cys peptide-stimulated BMDC and NK cells rather than soluble mediators released by stimulated BMDC induced activation of NK cells. For most lipopeptides, the BMDC TLR2/MyD88 pathway was responsible for driving NK activation, while some slightly induced direct activation of NK cells via the TLR2/MyD88 pathway in NK cells. The potential for NK activation was critically regulated by the peptide primary sequence. Hydrophobic or proline-containing sequences proximal to the N-terminal lipid moiety interfered with the ability of lipopeptides to induce BMDC-mediated NK activation. This mode of NK activation is distinctly different from that induced by polyI:C, which is closely associated with type I IFN-inducing pathways of BMDC. These results imply that the MyD88 pathway of BMDC governs an alternative NK-activating pathway in which the peptide sequence of TLR2-agonistic lipopeptides critically affects the potential for NK activation.	[Azuma, Masahiro; Sawahata, Ryoko; Akao, Yuusuke; Ebihara, Takashi; Yamazaki, Sayuri; Matsumoto, Misako; Seya, Tsukasa] Hokkaido Univ, Dept Microbiol & Immunol, Grad Sch Med, Sapporo, Hokkaido, Japan; [Hashimoto, Masahito] Kagoshima Univ, Dept Nanostruct & Adv Mat, Kagoshima 890, Japan; [Fukase, Koichi; Fujimoto, Yukari] Osaka Univ, Dept Chem, Grad Sch Sci, Toyonaka, Osaka 560, Japan	Hokkaido University; Kagoshima University; Osaka University	Azuma, M (corresponding author), Hokkaido Univ, Dept Microbiol & Immunol, Grad Sch Med, Sapporo, Hokkaido, Japan.	seya-tu@pop.med.hokudai.ac.jp	美佐子, 松本/A-4497-2012; Seya, Tsukasa/A-4336-2012; Fujimoto, Yukari/M-7282-2014	Ebihara, Takashi/0000-0002-6056-3230; Fujimoto, Yukari/0000-0001-5320-3192	Ministry of Education, Science, and Culture; Ministry of Health, Labor, and Welfare of Japan; Yakult Foundation; Waxmann Foundation; MEXT	Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Yakult Foundation; Waxmann Foundation; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid from the Ministry of Education, Science, and Culture (Specified Project for Advanced Research) and the Ministry of Health, Labor, and Welfare of Japan, and by the Yakult and Waxmann Foundations. Financial support by the Sapporo Biocluster "Bio-S" the Knowledge Cluster Initiative of the MEXT, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2009, CANCER SCI, V100, P1494, DOI 10.1111/j.1349-7006.2009.01188.x; Akazawa T, 2007, P NATL ACAD SCI USA, V104, P252, DOI 10.1073/pnas.0605978104; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Chavakis T, 2007, TRENDS IMMUNOL, V28, P408, DOI 10.1016/j.it.2007.07.002; Ebihara Takashi, 2009, Current Immunology Reviews, V5, P200; Fujimoto Y, 2009, CHEMBIOCHEM, V10, P2311, DOI 10.1002/cbic.200900242; Fujita M, 2003, J IMMUNOL, V171, P3675, DOI 10.4049/jimmunol.171.7.3675; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Granucci F, 2008, CELL MOL LIFE SCI, V65, P1683, DOI 10.1007/s00018-008-8009-2; Haller D, 2002, CLIN DIAGN LAB IMMUN, V9, P649, DOI 10.1128/CDLI.9.3.649-657.2002; Hamerman JA, 2004, J IMMUNOL, V172, P2001, DOI 10.4049/jimmunol.172.4.2001; Hashimoto M, 2006, INT IMMUNOL, V18, P355, DOI 10.1093/intimm/dxh374; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; KANG JY, 2009, IMMUNITY        1118; LINDGREN A, 2010, INNATE IMMUN    0203; Marcenaro E, 2008, INT IMMUNOL, V20, P1155, DOI 10.1093/intimm/dxn073; Martinez J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000811; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; McCartney S, 2009, J EXP MED, V206, P2967, DOI 10.1084/jem.20091181; METZGER J, 1991, J MED CHEM, V34, P1969, DOI 10.1021/jm00111a008; MIAN MF, 2010, MOL THER        0504; Miyake T, 2009, J IMMUNOL, V183, P2522, DOI 10.4049/jimmunol.0901500; Nakao Y, 2005, J IMMUNOL, V174, P1566, DOI 10.4049/jimmunol.174.3.1566; Nishiguchi M, 2001, J IMMUNOL, V166, P2610, DOI 10.4049/jimmunol.166.4.2610; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Seya T, 2010, CANCER SCI, V101, P313, DOI 10.1111/j.1349-7006.2009.01442.x; Seya T, 2009, CANCER IMMUNOL IMMUN, V58, P1175, DOI 10.1007/s00262-008-0652-9; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; TANAKA H, 1988, CANCER RES, V48, P1456; Tawaratsumida K, 2009, J BIOL CHEM, V284, P9147, DOI 10.1074/jbc.M900429200; Tsuji S, 2000, INFECT IMMUN, V68, P6883, DOI 10.1128/IAI.68.12.6883-6890.2000; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182	40	40	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12550	10.1371/journal.pone.0012550	http://dx.doi.org/10.1371/journal.pone.0012550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824059	Green Published, gold			2022-12-27	WOS:000281480900028
J	Jud, C; Hayoz, A; Albrecht, U				Jud, Corinne; Hayoz, Antoinette; Albrecht, Urs			High Amplitude Phase Resetting in Rev-Erb alpha/Per1 Double Mutant Mice	PLOS ONE			English	Article							MAMMALIAN CIRCADIAN CLOCK; MPER2; LIGHT; RHYTHMS; TRANSCRIPTION; GENE; CRYPTOCHROME; OSCILLATORS; EXPRESSION; INDUCTION	Over time, organisms developed various strategies to adapt to their environment. Circadian clocks are thought to have evolved to adjust to the predictable rhythms of the light-dark cycle caused by the rotation of the Earth around its own axis. The rhythms these clocks generate persist even in the absence of environmental cues with a period of about 24 hours. To tick in time, they continuously synchronize themselves to the prevailing photoperiod by appropriate phase shifts. In this study, we disrupted two molecular components of the mammalian circadian oscillator, Rev-Erba and Period1 (Per1). We found that mice lacking these genes displayed robust circadian rhythms with significantly shorter periods under constant darkness conditions. Strikingly, they showed high amplitude resetting in response to a brief light pulse at the end of their subjective night phase, which is rare in mammals. Surprisingly, Cry1, a clock component not inducible by light in mammals, became slightly inducible in these mice. Taken together, Rev-Erba and Per1 may be part of a mechanism preventing drastic phase shifts in mammals.	[Jud, Corinne; Hayoz, Antoinette; Albrecht, Urs] Univ Fribourg, Biochem Unit, Dept Med, CH-1700 Fribourg, Switzerland	University of Fribourg	Jud, C (corresponding author), Univ Fribourg, Adolphe Merkle Inst, Marly, Switzerland.	urs.albrecht@unifr.ch	Albrecht, Urs/A-9831-2011	Albrecht, Urs/0000-0002-0663-8676	Swiss National Science Foundation; European Union; state of Fribourg (Switzerland)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); state of Fribourg (Switzerland)	This work has been supported by the Swiss National Science Foundation, the European Union FP6 Integrated Project EUCLOCK and the state of Fribourg (Switzerland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Aschoff, 1965, CIRCADIAN CLOCKS, P95; ASCHOFF J, 1969, AEROSPACE MED, V40, P844; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Johnson Carl Hirschie, 1992, P209; Jud C, 2005, BIOL PROCED ONLINE, V7, P101, DOI 10.1251/bpo109; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Lin FJ, 2001, MOL CELL BIOL, V21, P7287, DOI 10.1128/MCB.21.21.7287-7294.2001; MOORE RY, 1972, J COMP NEUROL, V146, P1, DOI 10.1002/cne.901460102; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Oster H, 2003, GENE DEV, V17, P1366, DOI 10.1101/gad.256103; Oster H, 2002, GENE DEV, V16, P2633, DOI 10.1101/gad.233702; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; RAMIREZSOLIS R, 1993, CELL, V73, P279, DOI 10.1016/0092-8674(93)90229-J; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tamai TK, 2007, P NATL ACAD SCI USA, V104, P14712, DOI 10.1073/pnas.0704588104; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Vallone D, 2004, P NATL ACAD SCI USA, V101, P4106, DOI 10.1073/pnas.0305436101; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Winfree A., 1980, BIOMATHEMATICS; WINFREE AT, 1970, J THEOR BIOL, V28, P327, DOI 10.1016/0022-5193(70)90075-5; Yan L, 2002, EUR J NEUROSCI, V16, P1531, DOI 10.1046/j.1460-9568.2002.02224.x; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	38	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12540	10.1371/journal.pone.0012540	http://dx.doi.org/10.1371/journal.pone.0012540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824053	Green Published, gold, Green Submitted			2022-12-27	WOS:000281480900022
J	Ward, C; Kuehn, D; Burden, RE; Gormley, JA; Jaquin, TJ; Gazdoiu, M; Small, D; Bicknell, R; Johnston, JA; Scott, CJ; Olwill, SA				Ward, Claire; Kuehn, Diana; Burden, Roberta E.; Gormley, Julie A.; Jaquin, Thomas J.; Gazdoiu, Mihaela; Small, Donna; Bicknell, Roy; Johnston, James A.; Scott, Christopher J.; Olwill, Shane A.			Antibody Targeting of Cathepsin S Inhibits Angiogenesis and Synergistically Enhances Anti-VEGF	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR EXPRESSION; TUMOR-GROWTH; BEVACIZUMAB; INVASION; MODEL; IRINOTECAN	Background: Angiogenesis is a key hallmark of tumourigenesis and its inhibition is a proven strategy for the development of novel anti-cancer therapeutics. An important aspect of early angiogenesis is the co-ordinated migration and invasion of endothelial cells through the hypoxic tumour tissue. Cathepsin S has been shown to play an important role in angiogenesis as has vascular endothelial growth factor (VEGF). We sought to assess the anti-angiogenic effect of Fsn0503, a novel cathepsin S inhibitory antibody, when combined with anti-VEGF on vascular development. Methodology/Principal Findings: Cathepsin S expression and secretion from endothelial cells was characterised using RTPCR and western blotting. We further show that cathepsin S promotes pericellular hydrolysis of extracellular matrix components in the tumour microenvironment and facilitates endothelial invasion. The cathepsin S inhibitory antibody, Fsn0503, blocks extracellular proteolysis, inhibiting endothelial invasion and tube formation in cell-based assays. The antiangiogenic effects of Fsn0503 were also shown in vivo where it significantly retarded the development of vasculature in human xenograft models. Furthermore, when Fsn0503 was combined with an anti-VEGF antibody, a synergistic inhibition of microvascular development was observed. Conclusions/Significance: Taken together, this data demonstrates that the antibody-mediated targeting of cathepsin S represents a novel method of inhibiting angiogenesis. Furthermore, when used in combination with anti-VEGF therapies, Fsn0503 has the potential to significantly enhance current treatments of tumour neovascularisation and may also be of use in the treatment of other conditions associated with inappropriate angiogenesis.	[Ward, Claire; Kuehn, Diana; Burden, Roberta E.; Gormley, Julie A.; Jaquin, Thomas J.; Gazdoiu, Mihaela; Small, Donna; Olwill, Shane A.] Fus Antibodies Ltd, Drug Discovery, Belfast, Antrim, North Ireland; [Burden, Roberta E.; Small, Donna; Scott, Christopher J.] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [Bicknell, Roy] Univ Birmingham, Coll Med & Dent, Sch Immun & Infect, Birmingham, W Midlands, England; [Johnston, James A.] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [Bicknell, Roy] Univ Birmingham, Coll Med & Dent, Sch Canc Studies, Birmingham, W Midlands, England	Queens University Belfast; University of Birmingham; Queens University Belfast; University of Birmingham	Ward, C (corresponding author), Fus Antibodies Ltd, Drug Discovery, Belfast, Antrim, North Ireland.	c.scott@qub.ac.uk; shane.olwill@fusionantibodies.com	Jaquin, Thomas/AAF-8142-2020	Bicknell, Roy/0000-0002-0941-8919; Small, Donna/0000-0001-8995-2590	Fusion Antibodies Ltd. Scientists at Fusion Antibodies	Fusion Antibodies Ltd. Scientists at Fusion Antibodies	This work was funded by Fusion Antibodies Ltd. Scientists at Fusion Antibodies in conjunction with academic collaborators designed the study, collected and analysed data and prepared the manuscript for publication.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Amaya H, 1997, CANCER LETT, V119, P227, DOI 10.1016/S0304-3835(97)00280-2; Bell-McGuinn KM, 2007, CANCER RES, V67, P7378, DOI 10.1158/0008-5472.CAN-07-0602; Bergsland E, 2004, ONCOLOGIST, V9, P36, DOI 10.1634/theoncologist.9-suppl_1-36; Brown NS, 2005, BRIT J CANCER, V92, P1696, DOI 10.1038/sj.bjc.6602522; Burden RE, 2008, MOL CANCER THER, V7, P538, DOI 10.1158/1535-7163.MCT-07-0528; Burden RE, 2009, CLIN CANCER RES, V15, P6042, DOI 10.1158/1078-0432.CCR-09-1262; Chen HX, 2009, NAT REV CLIN ONCOL, V6, P465, DOI 10.1038/nrclinonc.2009.94; Drevs J, 2002, CANCER RES, V62, P4015; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heath VL, 2009, NAT REV CLIN ONCOL, V6, P395, DOI 10.1038/nrclinonc.2009.52; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; JORDANS S, 2009, BMC BIOCH, V22, P10; Lee CG, 2000, CANCER RES, V60, P5565; Loges S, 2009, CANCER CELL, V15, P167, DOI 10.1016/j.ccr.2009.02.007; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Ryschich E, 2006, CANCER RES, V66, P198, DOI 10.1158/0008-5472.CAN-05-1636; Shi GP, 2003, CIRC RES, V92, P493, DOI 10.1161/01.RES.0000060485.20318.96; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; SHOJAEI F, CANC RES, V68, P5501; Vredenburgh JJ, 2007, CLIN CANCER RES, V13, P1253, DOI 10.1158/1078-0432.CCR-06-2309; Wang B, 2006, J BIOL CHEM, V281, P6020, DOI 10.1074/jbc.M509134200	26	48	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12543	10.1371/journal.pone.0012543	http://dx.doi.org/10.1371/journal.pone.0012543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824056	Green Published, Green Submitted, gold			2022-12-27	WOS:000281480900024
J	Schaller, F; Fernandes, AM; Hodler, C; Munch, C; Pasantes, JJ; Rietschel, W; Schempp, W				Schaller, Felix; Fernandes, Antonio M.; Hodler, Christine; Muench, Claudia; Pasantes, Juan J.; Rietschel, Wolfram; Schempp, Werner			Y Chromosomal Variation Tracks the Evolution of Mating Systems in Chimpanzee and Bonobo	PLOS ONE			English	Article							PAN-PANISCUS; CAPTIVE BONOBOS; MALE-DOMINANCE; GENE; SEX; TROGLODYTES; HOMINOIDS; TSPY; SIZE; APES	The male-specific regions of the Y chromosome (MSY) of the human and the chimpanzee (Pan troglodytes) are fully sequenced. The most striking difference is the dramatic rearrangement of large parts of their respective MSYs. These non-recombining regions include ampliconic gene families that are known to be important for male reproduction, and are consequently under significant selective pressure. However, whether the published Y-chromosomal pattern of ampliconic fertility genes is invariable within P. troglodytes is an open but fundamental question pertinent to discussions of the evolutionary fate of the Y chromosome in different primate mating systems. To solve this question we applied fluorescence in situ hybridisation (FISH) of testis-specific expressed ampliconic fertility genes to metaphase Y chromosomes of 17 chimpanzees derived from 11 wild-born males and 16 bonobos representing seven wild-born males. We show that of eleven P. troglodytes Y-chromosomal lines, ten Y-chromosomal variants were detected based on the number and arrangement of the ampliconic fertility genes DAZ (deleted in azoospermia) and CDY (chromodomain protein Y)-a so-far never-described variation of a species' Y chromosome. In marked contrast, no variation was evident among seven Y-chromosomal lines of the bonobo, P. paniscus, the chimpanzee's closest living relative. Although, loss of variation of the Y chromosome in the bonobo by a founder effect or genetic drift cannot be excluded, these contrasting patterns might be explained in the context of the species' markedly different social and mating behaviour. In chimpanzees, multiple males copulate with a receptive female during a short period of visible anogenital swelling, and this may place significant selection on fertility genes. In bonobos, however, female mate choice may make sperm competition redundant (leading to monomorphism of fertility genes), since ovulation in this species is concealed by the prolonged anogenital swelling, and because female bonobos can occupy high-ranking positions in the group and are thus able to determine mate choice more freely.	[Schaller, Felix; Fernandes, Antonio M.; Hodler, Christine; Muench, Claudia; Pasantes, Juan J.; Schempp, Werner] Univ Freiburg, Inst Human Genet, Freiburg, Germany; [Pasantes, Juan J.] Univ Vigo, Dept Biochem Genet & Immunol, Vigo 36310, Spain; [Rietschel, Wolfram] Wilhelma Zool Bot Garten, Stuttgart, Germany	University of Freiburg; Universidade de Vigo	Schaller, F (corresponding author), Univ Freiburg, Inst Human Genet, Freiburg, Germany.	werner.schempp@uniklinik-freiburg.de		Pasantes, Juan J/0000-0001-6515-3946	Deutsche Forschungsgemeinschaft [SCHE 214/8-1/8-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SCHE 214/8-1/8-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begun DR, 2005, AM J PHYS ANTHROPOL, P72; BOESCH C, 1996, SOCIAL GROUPING TAI; Brown GM, 1998, HUM MOL GENET, V7, P97, DOI 10.1093/hmg/7.1.97; Constable JL, 2001, MOL ECOL, V10, P1279, DOI 10.1046/j.1365-294X.2001.01262.x; Delgado RA, 2000, EVOL ANTHROPOL, V9, P201; Deschner T, 2003, ANIM BEHAV, V66, P551, DOI 10.1006/anbe.2003.2210; Dixson A.F., 1998, PRIMATE SEXUALITY CO; Dixson AF, 2004, PHYSIOL BEHAV, V83, P361, DOI 10.1016/j.physbeh.2004.08.022; Eriksson J, 2006, MOL ECOL, V15, P939, DOI 10.1111/j.1365-294X.2006.02845.x; Furuichi T, 2009, PRIMATES, V50, P197, DOI 10.1007/s10329-009-0141-6; Glaser B, 1998, MAMM GENOME, V9, P226, DOI 10.1007/s003359900730; Glaser B, 1997, CHROMOSOME RES, V5, P167, DOI 10.1023/A:1018490713273; Gonder MK, 1997, NATURE, V388, P337, DOI 10.1038/41005; Goodall J., 1986, CHIMPANZEES GOMBE PA; Goto H, 2009, J MOL EVOL, V68, P134, DOI 10.1007/s00239-008-9189-y; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; HASEGAWA T, 1990, SPERM COMPETITION MA; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Hughes JF, 2005, NATURE, V437, P101, DOI 10.1038/nature04101; KANO T, 1982, Primates, V23, P171, DOI 10.1007/BF02381159; Kano T., 1992, LAST APE PYGMY CHIMP; Kirsch S, 2008, GENOME RES, V18, P1030, DOI 10.1101/gr.076711.108; Kuroki Y, 2006, NAT GENET, V38, P158, DOI 10.1038/ng1729; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Marvan R, 2006, FOLIA PRIMATOL, V77, P364, DOI 10.1159/000093702; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Nishida T., 1968, Primates, V9, P167, DOI 10.1007/BF01730971; Nishida T., 1979, GREAT APES, P73; PARISH AR, 1994, ETHOL SOCIOBIOL, V15, P157, DOI 10.1016/0162-3095(94)90038-8; PEREBOOM JJM, 2008, INT STUDBOOK BONOBO; Perry GH, 2007, MOL BIOL EVOL, V24, P853, DOI 10.1093/molbev/msm002; Reinartz GE, 2000, MOL ECOL, V9, P315, DOI 10.1046/j.1365-294x.2000.00852.x; RIED T, 1992, P NATL ACAD SCI USA, V89, P1388, DOI 10.1073/pnas.89.4.1388; Sannen A, 2003, BEHAVIOUR, V140, P683, DOI 10.1163/156853903322149504; SCHEMPP W, 1983, HUM GENET, V63, P171, DOI 10.1007/BF00291539; SCHEMPP W, 1995, CHROMOSOME RES, V3, P227, DOI 10.1007/BF00713047; Schmidt J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005288; Shaffer LG, 2009, INT SYST HUM CYT NOM; Skaletsky H, 2003, NATURE, V423, P855; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; Thompson JAM, 2003, PRIMATES, V44, P191, DOI 10.1007/s10329-002-0029-1; Tutin C E, 1980, J Reprod Fertil Suppl, VSuppl 28, P43; Tyler-Smith C, 2006, NAT GENET, V38, P141, DOI 10.1038/ng0206-141; Van Coillie S, 2008, ANIM CONSERV, V11, P306, DOI 10.1111/j.1469-1795.2008.00186.x; WEBER B, 1986, CYTOGENET CELL GENET, V43, P72, DOI 10.1159/000132300; Yu N, 2003, GENETICS, V164, P1511; Yu YH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-96; ZIHLMAN AL, 1978, NATURE, V275, P744, DOI 10.1038/275744a0; ZIHLMAN AL, 1978, FOLIA PRIMATOL, V29, P86, DOI 10.1159/000155830	49	10	10	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12482	10.1371/journal.pone.0012482	http://dx.doi.org/10.1371/journal.pone.0012482			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824190	Green Published, Green Submitted, gold			2022-12-27	WOS:000281456100007
J	Yi, XF; Cai, YD; He, ZS; Cui, WR; Kong, XY				Yi, Xianfu; Cai, Yu-Dong; He, Zhisong; Cui, WeiRen; Kong, Xiangyin			Prediction of Nucleosome Positioning Based on Transcription Factor Binding Sites	PLOS ONE			English	Article							CHROMATIN-STRUCTURE; DNA; YEAST; SEQUENCE; GENE; ORGANIZATION; ELONGATION; OCCUPANCY; REGIONS; BARRIER	Background: The DNA of all eukaryotic organisms is packaged into nucleosomes, the basic repeating units of chromatin. The nucleosome consists of a histone octamer around which a DNA core is wrapped and the linker histone H1, which is associated with linker DNA. By altering the accessibility of DNA sequences, the nucleosome has profound effects on all DNA-dependent processes. Understanding the factors that influence nucleosome positioning is of great importance for the study of genomic control mechanisms. Transcription factors (TFs) have been suggested to play a role in nucleosome positioning in vivo. Principal Findings: Here, the minimum redundancy maximum relevance (mRMR) feature selection algorithm, the nearest neighbor algorithm (NNA), and the incremental feature selection (IFS) method were used to identify the most important TFs that either favor or inhibit nucleosome positioning by analyzing the numbers of transcription factor binding sites (TFBSs) in 53,021 nucleosomal DNA sequences and 50,299 linker DNA sequences. A total of nine important families of TFs were extracted from 35 families, and the overall prediction accuracy was 87.4% as evaluated by the jackknife cross-validation test. Conclusions: Our results are consistent with the notion that TFs are more likely to bind linker DNA sequences than the sequences in the nucleosomes. In addition, our results imply that there may be some TFs that are important for nucleosome positioning but that play an insignificant role in discriminating nucleosome-forming DNA sequences from nucleosome-inhibiting DNA sequences. The hypothesis that TFs play a role in nucleosome positioning is, thus, confirmed by the results of this study.	[Yi, Xianfu; Kong, Xiangyin] Chinese Acad Sci, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Yi, Xianfu; Kong, Xiangyin] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [He, Zhisong; Cui, WeiRen] Zhejiang Univ, Coll Life Sci, Dept Bioinformat, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai University; Fudan University; Zhejiang University	Yi, XF (corresponding author), Chinese Acad Sci, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn; xykong@sibs.ac.cn	Xianfu, Yi/H-4768-2012	Yi, Xianfu/0000-0002-8094-2676; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2004CB518603]; 11th Five-Year Plan [2008ZX10001-001]; Chinese Academy of Sciences [KSCX1-YW-22]	National Basic Research Program of China(National Basic Research Program of China); 11th Five-Year Plan(National Key Technology R&D Program); Chinese Academy of Sciences(Chinese Academy of Sciences)	The study was supported by National Basic Research Program of China (2004CB518603), the 11th Five-Year Plan (2008ZX10001-001) and the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX1-YW-22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; [Anonymous], 1908, BIOMETRIKA, V6, P1; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Bishop C.M., 1995, NEURAL NETWORKS PATT; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cai YD, 2009, J PROTEOME RES, V8, P999, DOI 10.1021/pr800717y; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen KF, 2008, NUCLEIC ACIDS RES, V36, P6228, DOI 10.1093/nar/gkn626; CHODAVARAPU RK, 2010, NATURE; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHUNG HR, 2008, J MOL BIOL; Collings CK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010933; Cristianini N, 2000, INTRO SUPPORT VECTOR; Edwards A.L., 1976, INTRO LINEAR REGRESS; Ercan S, 2004, MOL CELL BIOL, V24, P10026, DOI 10.1128/MCB.24.22.10026-10035.2004; Fernandez AG, 2007, J MOL BIOL, V371, P649, DOI 10.1016/j.jmb.2007.05.090; Fitzgerald DJ, 1999, J MOL BIOL, V293, P477, DOI 10.1006/jmbi.1999.3171; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; He CS, 2005, LECT NOTES ARTIF INT, V3801, P927; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; KAPLAN N, 2008, NATURE, V17, P17; Kohonen T, 1998, NEUROCOMPUTING, V21, P19, DOI 10.1016/S0925-2312(98)00031-9; KOHONEN T, 1988, NEURAL NETWORKS, V1, P3, DOI 10.1016/0893-6080(88)90020-2; Kohonen T, 1997, NEURAL COMPUT, V9, P1321, DOI 10.1162/neco.1997.9.6.1321; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Lewin B., 2004, GENE, VVIII; Li SJ, 2007, J BIOMOL STRUCT DYN, V25, P49, DOI 10.1080/07391102.2007.10507154; Liu HD, 2008, BIOPHYS J, V94, P4597, DOI 10.1529/biophysj.107.117028; Loden M, 2005, CHROMOSOME RES, V13, P289, DOI 10.1007/s10577-005-2166-z; Luger K., 2000, NUCLEOSOMES STRUCTUR; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Narlikar L, 2007, PLOS COMPUT BIOL, V3, P2199, DOI 10.1371/journal.pcbi.0030215; Niu B, 2009, J COMPUT CHEM, V30, P33, DOI 10.1002/jcc.21024; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pusarla RH, 2007, FEBS J, V274, P2396, DOI 10.1111/j.1742-4658.2007.05775.x; Qian ZL, 2007, BIOINFORMATICS, V23, P2449, DOI 10.1093/bioinformatics/btm348; Qian ZL, 2006, BIOCHEM BIOPH RES CO, V348, P1034, DOI 10.1016/j.bbrc.2006.07.149; Rando OJ, 2007, CURR OPIN CELL BIOL, V19, P250, DOI 10.1016/j.ceb.2007.04.006; Scholkopf B., 2002, LEARNING KERNELS; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal MR, 2008, STAT APPL GENET MOL, V7; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Shen CH, 2001, J BIOL CHEM, V276, P35209, DOI 10.1074/jbc.M104733200; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; STRAKA C, 1991, EMBO J, V10, P361, DOI 10.1002/j.1460-2075.1991.tb07957.x; Stunkel W, 1997, MOL CELL BIOL, V17, P4397; Tanaka Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-309; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Tolstorukov MY, 2008, BIOINFORMATICS, V24, P1456, DOI 10.1093/bioinformatics/btn212; Vapnik V., 2013, NATURE STAT LAERNING; Vapnik V., 1998, STAT LEARNING THEORY; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; WATSON JD, 2003, MOL BIOL GENE B CUMM; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Yin SY, 2009, BIOCHEM BIOPH RES CO, V385, P363, DOI 10.1016/j.bbrc.2009.05.072; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Yuan GC, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040013, 10.1371/journal.pcbi.0040013.eor]	67	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12495	10.1371/journal.pone.0012495	http://dx.doi.org/10.1371/journal.pone.0012495			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824131	gold, Green Published, Green Submitted			2022-12-27	WOS:000281456100009
J	Brothers, N; Duckworth, AR; Safina, C; Gilman, EL				Brothers, Nigel; Duckworth, Alan R.; Safina, Carl; Gilman, Eric L.			Seabird Bycatch in Pelagic Longline Fisheries Is Grossly Underestimated when Using Only Haul Data	PLOS ONE			English	Article							MORTALITY; ALBATROSS; AUSTRALIA; IMPACTS; TARGET	Hundreds of thousands of seabirds are killed each year as bycatch in longline fisheries. Seabirds are predominantly caught during line setting but bycatch is generally recorded during line hauling, many hours after birds are caught. Bird loss during this interval may lead to inaccurate bycatch information. In this 15 year study, seabird bycatch was recorded during both line setting and line hauling from four fishing regions: Indian Ocean, Southern Ocean, Coral Sea and central Pacific Ocean. Over 43,000 albatrosses, petrels and skuas representing over 25 species were counted during line setting of which almost 6,000 seabirds attempted to take the bait. Bait-taking interactions were placed into one of four categories. (i) The majority (57%) of bait-taking attempts were "unsuccessful'' involving seabirds that did not take the bait nor get caught or hooked. (ii) One-third of attempts were "successful'' with seabirds removing the bait while not getting caught. (iii) One-hundred and seventy-six seabirds (3% of attempts) were observed being "caught'' during line setting, with three albatross species - Laysan (Phoebastria immutabilis), black-footed (P. nigripes) and black-browed (Thalassarche melanophrys)-dominating this category. However, of these, only 85 (48%) seabird carcasses were retrieved during line hauling. Most caught seabirds were hooked through the bill. (iv) The remainder of seabird-bait interactions (7%) was not clearly observed, but likely involved more "caught'' seabirds. Bait taking attempts and percentage outcome (e. g. successful, caught) varied between seabird species and was not always related to species abundance around fishing vessels. Using only haul data to calculate seabird bycatch grossly underestimates actual bycatch levels, with the level of seabird bycatch from pelagic longline fishing possibly double what was previously thought.	[Duckworth, Alan R.; Safina, Carl; Gilman, Eric L.] Blue Ocean Inst, Cold Spring Harbor, NY USA; [Gilman, Eric L.] Tetra Tech Inc, Honolulu, HI USA; [Gilman, Eric L.] Hawaii Pacific Univ, Coll Nat & Computat Sci, Honolulu, HI USA			EricLGilman@gmail.com	Duckworth, Alan/F-3290-2017; Gilman, Eric/AAF-2147-2019	Duckworth, Alan/0000-0002-5451-7633; Gilman, Eric/0000-0002-4216-2513	Gordon and Betty Moore Foundation	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	Financial support was provided by the Gordon and Betty Moore Foundation to the Blue Ocean Institute for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CATCHING FISH NOT BI; Baker GB, 2007, BIOL CONSERV, V137, P319, DOI 10.1016/j.biocon.2007.02.012; Brander K, 2008, MAR POLLUT BULL, V56, P1957, DOI 10.1016/j.marpolbul.2008.08.024; BROTHERS N, 1991, BIOL CONSERV, V55, P255, DOI 10.1016/0006-3207(91)90031-4; BROTHERS N, 2000, AFMA RES FUND FINAL; BROTHERS N, 1999, 937 UNFAO; *CCAMLR, 2002, 21 M SCI COMM COMM C, P288; Gales R, 1998, BIOL CONSERV, V86, P37, DOI 10.1016/S0006-3207(98)00011-1; Gilman E, 2005, FISH FISH, V6, P35, DOI 10.1111/j.1467-2679.2005.00175.x; Gilman E, 2003, OCEAN COAST MANAGE, V46, P985, DOI 10.1016/j.ocecoaman.2003.12.001; GILMAN E, 2007, 1025 UNFAO; Gilman E., 2006, INCIDENTAL CAPTURE S; Gilman Eric, 2008, Endangered Species Research, V5, P309, DOI 10.3354/esr00133; Gilman E, 2008, MAR POLICY, V32, P1, DOI 10.1016/j.marpol.2007.05.001; Gilman E, 2007, FISHERIES SCI, V73, P208, DOI 10.1111/j.1444-2906.2007.01321.x; Gilman E, 2010, FISH FISH, V11, P57, DOI 10.1111/j.1467-2979.2009.00342.x; IUCN, 2014, IUCN RED LIST THREAT; Lundin, 2009, HDB MARINE FISHERIES, P150; Melvin EF, 2001, UASGCP REP, V2001, P161; Moore JE, 2008, ANIM CONSERV, V11, P257, DOI 10.1111/j.1469-1795.2008.00197.x; Niel C, 2005, CONSERV BIOL, V19, P826, DOI 10.1111/j.1523-1739.2005.00310.x; *NMFS, 2009, 2008 ANN REP SEAB IN; Pauly D, 2005, MILLENNIUM ECOSYSTEM, V1, P477; Tasker Mark L., 1992, Netherlands Journal of Aquatic Ecology, V26, P59, DOI 10.1007/BF02298028; Tasker ML, 2000, ICES J MAR SCI, V57, P531, DOI 10.1006/jmsc.2000.0714; *UNFAO, 2005, 470 UNFAO; *UNFAO, 1999, INT PLAN ACT CONS MA; *UNFAO, 1999, INT PLAN ACT RED INC; *UNFAO, 2009, GUID RED SEA TURTL M; Vega R, 2009, FISH RES, V98, P22, DOI 10.1016/j.fishres.2009.03.010; Ward P, 2009, FISH RES, V97, P253, DOI 10.1016/j.fishres.2009.02.009; Watkins BP, 2008, ANIM CONSERV, V11, P247, DOI 10.1111/j.1469-1795.2008.00192.x; WEIMERSKIRCH H, 1987, OIKOS, V49, P315, DOI 10.2307/3565767	33	53	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12491	10.1371/journal.pone.0012491	http://dx.doi.org/10.1371/journal.pone.0012491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824163	gold, Green Submitted, Green Published			2022-12-27	WOS:000281405300017
J	Setiadi, AF; Ray, NC; Kohrt, HE; Kapelner, A; Carcamo-Cavazos, V; Levic, EB; Yadegarynia, S; van der Loos, CM; Schwartz, EJ; Holmes, S; Lee, PP				Setiadi, A. Francesca; Ray, Nelson C.; Kohrt, Holbrook E.; Kapelner, Adam; Carcamo-Cavazos, Valeria; Levic, Edina B.; Yadegarynia, Sina; van der Loos, Chris M.; Schwartz, Erich J.; Holmes, Susan; Lee, Peter P.			Quantitative, Architectural Analysis of Immune Cell Subsets in Tumor-Draining Lymph Nodes from Breast Cancer Patients and Healthy Lymph Nodes	PLOS ONE			English	Article								Background: To date, pathological examination of specimens remains largely qualitative. Quantitative measures of tissue spatial features are generally not captured. To gain additional mechanistic and prognostic insights, a need for quantitative architectural analysis arises in studying immune cell-cancer interactions within the tumor microenvironment and tumor-draining lymph nodes (TDLNs). Methodology/Principal Findings: We present a novel, quantitative image analysis approach incorporating 1) multi-color tissue staining, 2) high-resolution, automated whole-section imaging, 3) custom image analysis software that identifies cell types and locations, and 4) spatial statistical analysis. As a proof of concept, we applied this approach to study the architectural patterns of T and B cells within tumor-draining lymph nodes from breast cancer patients versus healthy lymph nodes. We found that the spatial grouping patterns of T and B cells differed between healthy and breast cancer lymph nodes, and this could be attributed to the lack of B cell localization in the extrafollicular region of the TDLNs. Conclusions/Significance: Our integrative approach has made quantitative analysis of complex visual data possible. Our results highlight spatial alterations of immune cells within lymph nodes from breast cancer patients as an independent variable from numerical changes. This opens up new areas of investigations in research and medicine. Future application of this approach will lead to a better understanding of immune changes in the tumor microenvironment and TDLNs, and how they affect clinical outcomes.	[Setiadi, A. Francesca; Kohrt, Holbrook E.; Kapelner, Adam; Carcamo-Cavazos, Valeria; Levic, Edina B.; Yadegarynia, Sina; Lee, Peter P.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Ray, Nelson C.; Holmes, Susan] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [van der Loos, Chris M.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Schwartz, Erich J.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Stanford University	Setiadi, AF (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	ppl@stanford.edu		Lee, Peter P./0000-0002-2660-4377; Yadegarynia, Sina/0000-0002-8653-0146; Holmes, Susan/0000-0002-2208-8168	National Institutes of Health (NIH) [R01CA127947, R01GM086884]; Department of Defense [BC01560]; NATIONAL CANCER INSTITUTE [R01CA127947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086884] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (NIH) grant no. R01CA127947 and the Department of Defense Congressionally Directed Medical Research Programs grant no. BC01560 to PPL. SH was supported by NIH grant no. R01GM086884. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Besag J., 1977, J R STAT SOC SER C A, V26, P327, DOI [10.2307/2346974, DOI 10.2307/2346974]; BIVAND R, 2001, R NEWS, V1, P13; Diggle P., 2003, STAT ANAL SPATIAL PO; Dixon P.M., 2002, ENCY ENV, VVolume 3, P1796, DOI DOI 10.1002/9780470057339.VAR046; Domenech A, 2009, Q J NUCL MED MOL IM, V53, P422; Holmes S, 2009, J STAT SOFTW, V30, P1; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Kohrt HE, 2005, PLOS MED, V2, P904, DOI 10.1371/journal.pmed.0020284; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Quan ML, 2009, J SURG ONCOL, V99, P194, DOI 10.1002/jso.21201; Silverman B.W., 1986, DENSITY ESTIMATION S; van der Loos CM, 2008, J HISTOCHEM CYTOCHEM, V56, P313, DOI 10.1369/jhc.2007.950170	15	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12420	10.1371/journal.pone.0012420	http://dx.doi.org/10.1371/journal.pone.0012420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811638	Green Submitted, Green Published, gold			2022-12-27	WOS:000281234700034
J	Wang, P; Bai, HW; Zhu, BT				Wang, Pan; Bai, Hyoung-Woo; Zhu, Bao Ting			Structural Basis for Certain Naturally Occurring Bioflavonoids to Function as Reducing Co-Substrates of Cyclooxygenase I and II	PLOS ONE			English	Article							PROSTAGLANDIN-H SYNTHASE; ENDOPEROXIDE SYNTHASE-2; VESICULAR GLAND; PURIFICATION; ACETYLATION; ANTIOXIDANT; INHIBITION; RECEPTOR; SYNTHETASE; EXPRESSION	Background: Recent studies showed that some of the dietary bioflavonoids can strongly stimulate the catalytic activity of cyclooxygenase (COX) I and II in vitro and in vivo, presumably by facilitating enzyme re-activation. In this study, we sought to understand the structural basis of COX activation by these dietary compounds. Methodology/Principal Findings: A combination of molecular modeling studies, biochemical analysis and site-directed mutagenesis assay was used as research tools. Three-dimensional quantitative structure-activity relationship analysis (QSAR/CoMFA) predicted that the ability of bioflavonoids to activate COX I and II depends heavily on their B-ring structure, a moiety known to be associated with strong antioxidant ability. Using the homology modeling and docking approaches, we identified the peroxidase active site of COX I and II as the binding site for bioflavonoids. Upon binding to this site, bioflavonoid can directly interact with hematin of the COX enzyme and facilitate the electron transfer from bioflavonoid to hematin. The docking results were verified by biochemical analysis, which reveals that when the cyclooxygenase activity of COXs is inhibited by covalent modification, myricetin can still stimulate the conversion of PGG(2) to PGE(2), a reaction selectively catalyzed by the peroxidase activity. Using the site-directed mutagenesis analysis, we confirmed that Q189 at the peroxidase site of COX II is essential for bioflavonoids to bind and re-activate its catalytic activity. Conclusions/Significance: These findings provide the structural basis for bioflavonoids to function as high-affinity reducing co-substrates of COXs through binding to the peroxidase active site, facilitating electron transfer and enzyme re-activation.	[Wang, Pan; Bai, Hyoung-Woo; Zhu, Bao Ting] Univ Kansas, Med Ctr, Sch Med, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Wang, P (corresponding author), Univ Kansas, Med Ctr, Sch Med, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	BTZhu@kumc.edu			National Institutes of Health [ES015242]; NIH, National Center for Research Resources [P20RR021940]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study is supported in part by a grant from the National Institutes of Health (No. ES015242). Some of the analytical and imaging instruments employed in this study are part of the COBRE core facility that is supported by the NIH Grant P20RR021940 from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amic D, 2003, CROAT CHEM ACTA, V76, P55; Bai HW, 2008, J LIPID RES, V49, P2557, DOI 10.1194/jlr.M800358-JLR200; Bai HW, 2010, PROSTAG LEUKOTR ESS, V82, P45, DOI 10.1016/j.plefa.2009.10.006; Bala M, 2008, BIOCHEM PHARMACOL, V75, P1472, DOI 10.1016/j.bcp.2007.12.005; Bambai B, 2000, J BIOL CHEM, V275, P27608; Bors W, 2002, ANN NY ACAD SCI, V957, P57, DOI 10.1111/j.1749-6632.2002.tb02905.x; Burda S, 2001, J AGR FOOD CHEM, V49, P2774, DOI 10.1021/jf001413m; Callan OH, 1996, J BIOL CHEM, V271, P3548; DIETZ R, 1988, EUR J BIOCHEM, V171, P321, DOI 10.1111/j.1432-1033.1988.tb13793.x; HAMBERG M, 1967, J BIOL CHEM, V242, P5344; HARVISON PJ, 1988, CHEM-BIOL INTERACT, V64, P251, DOI 10.1016/0009-2797(88)90101-9; HEMLER ME, 1980, J BIOL CHEM, V255, P6253; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; HSUANYU YC, 1992, J BIOL CHEM, V267, P17649; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; KULMACZ RJ, 1985, PROSTAGLANDINS, V29, P175, DOI 10.1016/0090-6980(85)90200-X; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Kurumbail RG, 2001, CURR OPIN STRUC BIOL, V11, P752, DOI 10.1016/S0959-440X(01)00277-9; Landino LM, 1997, J BIOL CHEM, V272, P21565, DOI 10.1074/jbc.272.34.21565; LECOMTE M, 1994, J BIOL CHEM, V269, P13207; Lee JL, 2005, J INVEST DERMATOL, V125, P818, DOI 10.1111/j.0022-202X.2005.23829.x; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; MIYAMOTO T, 1976, J BIOL CHEM, V251, P2629; OBANION MK, 1991, J BIOL CHEM, V266, P23261; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Silva MM, 2002, FREE RADICAL RES, V36, P1219, DOI 10.1080/198-1071576021000016472; SIROIS J, 1992, J BIOL CHEM, V267, P6382; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sung YM, 2005, CANCER RES, V65, P9304, DOI 10.1158/0008-5472.CAN-05-1015; THOMPSON D, 1989, MOL PHARMACOL, V36, P809; VANDEROUDERAA FJ, 1977, BIOCHIM BIOPHYS ACTA, V487, P315, DOI 10.1016/0005-2760(77)90008-X; WELLS I, 1992, BIOCHEMISTRY-US, V31, P9520, DOI 10.1021/bi00155a002; Wu G, 1999, J BIOL CHEM, V274, P9231, DOI 10.1074/jbc.274.14.9231; Zhu BT, 2006, ENDOCRINOLOGY, V147, P4132, DOI 10.1210/en.2006-0113	35	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12316	10.1371/journal.pone.0012316	http://dx.doi.org/10.1371/journal.pone.0012316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808785	Green Published, Green Submitted, gold			2022-12-27	WOS:000281153500005
J	TeKippe, EM; Allen, IC; Hulseberg, PD; Sullivan, JT; McCann, JR; Sandor, M; Braunstein, M; Ting, JPY				TeKippe, Erin McElvania; Allen, Irving C.; Hulseberg, Paul D.; Sullivan, Jonathan T.; McCann, Jessica R.; Sandor, Matyas; Braunstein, Miriam; Ting, Jenny P. -Y.			Granuloma Formation and Host Defense in Chronic Mycobacterium tuberculosis Infection Requires PYCARD/ASC but Not NLRP3 or Caspase-1	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; IMMUNE-RESPONSE; CELL-DEATH; INFLAMMASOME ACTIVATION; GENE FAMILY; T-CELLS; MICE; ASC; PROTEIN; INTERLEUKIN-1-BETA	The NLR gene family mediates host immunity to various acute pathogenic stimuli, but its role in chronic infection is not known. This paper addressed the role of NLRP3 (NALP3), its adaptor protein PYCARD (ASC), and caspase-1 during infection with Mycobacterium tuberculosis (Mtb). Mtb infection of macrophages in culture induced IL-1 beta secretion, and this requires the inflammasome components PYCARD, caspase-1, and NLRP3. However, in vivo Mtb aerosol infection of Nlrp3(-/-), Casp-1(-/-), and WT mice showed no differences in pulmonary IL-1b production, bacterial burden, or long-term survival. In contrast, a significant role was observed for Pycard in host protection during chronic Mtb infection, as shown by an abrupt decrease in survival of Pycard(-/-) mice. Decreased survival of Pycard(-/-) animals was associated with defective granuloma formation. These data demonstrate that PYCARD exerts a novel inflammasome-independent role during chronic Mtb infection by containing the bacteria in granulomas.	[TeKippe, Erin McElvania; Sullivan, Jonathan T.; McCann, Jessica R.; Braunstein, Miriam; Ting, Jenny P. -Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA; [Allen, Irving C.; Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Hulseberg, Paul D.; Sandor, Matyas] Univ Wisconsin, Dept Pathol & Lab Med, Sch Med & Publ Hlth, Madison, WI USA; [Hulseberg, Paul D.; Sandor, Matyas] Univ Wisconsin, Cellular & Mol Pathol Program, Sch Med & Publ Hlth, Madison, WI USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	TeKippe, EM (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.	panyun@med.unc.edu	, Pathology Services Core/CEZ-2246-2022; Ariel, Pablo/AGJ-4118-2022	McCann, Jessica/0000-0001-6139-7089; Allen, Irving/0000-0001-9573-5250	National Institutes of Health (NIH) [AI057157, AI063031, AI082895]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063031, U54AI057157, F32AI082895] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by grants from the National Institutes of Health (NIH) AI057157 (JT), AI063031 (JT and MB), and AI082895 (IA). IA was supported by a NIH postdoctoral training grant and is currently an American Cancer Society Postdoctoral fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Bean AGD, 1999, J IMMUNOL, V162, P3504; BLACK RA, 1988, J BIOL CHEM, V263, P9437; *CDC, 2009, TUB; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; IOERGER TR, 2010, J BACTERIOL, DOI DOI 10.4049/JIMMUNOL.0904189; IRMLER M, 1995, J EXP MED, V181, P1917, DOI 10.1084/jem.181.5.1917; Juffermans NP, 2000, J INFECT DIS, V182, P902, DOI 10.1086/315771; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Kurtz S, 2006, INFECT IMMUN, V74, P6855, DOI 10.1128/IAI.01022-06; Ladel CH, 1997, INFECT IMMUN, V65, P4843, DOI 10.1128/IAI.65.11.4843-4849.1997; Leemans JC, 2001, J IMMUNOL, V166, P4604, DOI 10.4049/jimmunol.166.7.4604; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; MAYERBARBER KD, J IMMUNOL; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; MIZUTANI H, 1991, J EXP MED, V174, P821, DOI 10.1084/jem.174.4.821; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; ORME IM, 1994, MOUSE MODELS TUBERCU, P807; Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Sugawara I, 1999, INFECT IMMUN, V67, P2585, DOI 10.1128/IAI.67.5.2585-2589.1999; Sugawara I, 2001, MICROBIOL IMMUNOL, V45, P743, DOI 10.1111/j.1348-0421.2001.tb01310.x; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Taxman DJ, 2006, J IMMUNOL, V177, P4252, DOI 10.4049/jimmunol.177.7.4252; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Yamada H, 2000, LAB INVEST, V80, P759, DOI 10.1038/labinvest.3780079; Ye ZM, 2008, CURR OPIN IMMUNOL, V20, P3, DOI 10.1016/j.coi.2008.01.003; [No title captured]	46	98	100	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12320	10.1371/journal.pone.0012320	http://dx.doi.org/10.1371/journal.pone.0012320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808838	gold, Green Published, Green Submitted			2022-12-27	WOS:000281077000014
J	Ruths, D; Al Zamal, F				Ruths, Derek; Al Zamal, Faiyaz			A Method for the Automated, Reliable Retrieval of Publication-Citation Records	PLOS ONE			English	Article							INDEX	Background: Publication records and citation indices often are used to evaluate academic performance. For this reason, obtaining or computing them accurately is important. This can be difficult, largely due to a lack of complete knowledge of an individual's publication list and/or lack of time available to manually obtain or construct the publication-citation record. While online publication search engines have somewhat addressed these problems, using raw search results can yield inaccurate estimates of publication-citation records and citation indices. Methodology: In this paper, we present a new, automated method that produces estimates of an individual's publication-citation record from an individual's name and a set of domain-specific vocabulary that may occur in the individual's publication titles. Because this vocabulary can be harvested directly from a research web page or online (partial) publication list, our method delivers an easy way to obtain estimates of a publication-citation record and the relevant citation indices. Our method works by applying a series of stringent name and content filters to the raw publication search results returned by an online publication search engine. In this paper, our method is run using Google Scholar, but the underlying filters can be easily applied to any existing publication search engine. When compared against a manually constructed data set of individuals and their publication-citation records, our method provides significant improvements over raw search results. The estimated publication-citation records returned by our method have an average sensitivity of 98% and specificity of 72% (in contrast to raw search result specificity of less than 10%). When citation indices are computed using these records, the estimated indices are within 10% of the true value, compared to raw search results which have overestimates of, on average, 75%. Conclusions: These results confirm that our method provides significantly improved estimates over raw search results, and these can either be used directly for large-scale (departmental or university) analysis or further refined manually to quickly give accurate publication-citation records.	[Ruths, Derek; Al Zamal, Faiyaz] McGill Univ, Dept Comp Sci, Montreal, PQ, Canada	McGill University	Ruths, D (corresponding author), McGill Univ, Dept Comp Sci, Montreal, PQ, Canada.	druths@ruthsresearch.org						Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Zhang CT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005429	2	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12133	10.1371/journal.pone.0012133	http://dx.doi.org/10.1371/journal.pone.0012133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808858	Green Published, Green Submitted, gold			2022-12-27	WOS:000281075500002
J	Li, DD; Guo, JF; Huang, JJ; Wang, LL; Deng, R; Liu, JN; Feng, GK; Xiao, DJ; Deng, SZ; Zhang, XS; Zhu, XF				Li, Dan-Dan; Guo, Jing-Feng; Huang, Jia-Jia; Wang, Lin-Lin; Deng, Rong; Liu, Jian-Nan; Feng, Gong-Kan; Xiao, Ding-Jun; Deng, Song-Zhi; Zhang, Xiao-Shi; Zhu, Xiao-Feng			Rhabdastrellic Acid-A Induced Autophagy-Associated Cell Death through Blocking Akt Pathway in Human Cancer Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR FUNCTION; PI3K/AKT PATHWAY; TRITERPENOID SAPONINS; INDUCED APOPTOSIS; PROTEIN; EXPRESSION; BECLIN-1; GLOBOSTELLATA; ACTIVATION; MECHANISMS	Background: Autophagy is an evolutionarily conserved protein degradation pathway. A defect in autophagy may contribute to tumorigenesis. Autophagy inducers could have a potential function in tumor prevention and treatment. Methodology/Principal Findings: Our results showed that Rhabdastrellic acid-A, an isomalabaricane triterpenoid isolated from the sponge Rhabdastrella globostellata, inhibited proliferation of human cancer cell lines Hep3B and A549 and induced caspase-independent cell death in both the cell lines. Further investigation showed that Rhabdastrellic acid-A induced autophagy of cancer cells determined by YFP-LC3 punctation and increased LC3-II. The pretreatment with autophagy inhibitor 3-MA inhibited Rhabdastrellic acid-A-induced cell death. Knockdown of autophagy-related gene Atg5 inhibited Rhabdastrellic acid-A-induced cell death in A549 cells. Also, phospho-Akt and its downstream targets significantly decreased after treatment with Rhabdastrellic acid-A in both cancer cell lines. Transfection of constitutive active Akt plasmid abrogated autophagy and cell death induced by Rhabdastrellic acid-A. Conclusions/Significance: These results suggest that Rhabdastrellic acid-A could induce autophagy-associated cell death through blocking Akt pathway in cancer cells. It also provides the evidence that Rhabdastrellic acid-A deserves further investigation as a potential anticancer or cancer preventive agent.	[Li, Dan-Dan; Huang, Jia-Jia; Wang, Lin-Lin; Deng, Rong; Liu, Jian-Nan; Feng, Gong-Kan; Zhang, Xiao-Shi; Zhu, Xiao-Feng] Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Guo, Jing-Feng] So Med Univ, Affiliated He Xian Mem Hosp, Guangzhou, Guangdong, Peoples R China; [Xiao, Ding-Jun; Deng, Song-Zhi] Chinese Acad Sci, Guangzhou Inst Chem, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Southern Medical University - China; Chinese Academy of Sciences	Li, DD (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	zhuxfeng@mail.sysu.edu.cn			National Nature Science Foundation of China [30873085, 30972882]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by grants from the National Nature Science Foundation of China (30873085, 30972882) (http://www.nsfc.gov.cn/Portal0/default124.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani R, 2006, ONCOGENE, V25, P1743, DOI 10.1038/sj.onc.1209201; Bockbrader KM, 2005, ONCOGENE, V24, P7381, DOI 10.1038/sj.onc.1208888; Carroll J, 2001, J ORG CHEM, V66, P6847, DOI 10.1021/jo015784t; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chen Wong L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P575, DOI 10.2174/156801105774574649; Chu CT, 2007, AUTOPHAGY, V3, P663, DOI 10.4161/auto.4625; Cichy SB, 1998, J BIOL CHEM, V273, P6482, DOI 10.1074/jbc.273.11.6482; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Feng XZ, 2003, PLANTA MED, V69, P1036, DOI 10.1055/s-2003-45152; Foster KA, 1998, EXP CELL RES, V243, P359, DOI 10.1006/excr.1998.4172; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Fu GM, 2005, PLANTA MED, V71, P666, DOI 10.1055/s-2005-871274; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Guo JF, 2008, CELL BIOL INT, V32, P48, DOI 10.1016/j.cellbi.2007.08.009; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; HIRON M, 1992, BIOCHEM J, V287, P255, DOI 10.1042/bj2870255; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim Donghwa, 2005, Curr Opin Investig Drugs, V6, P1250; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liang XH, 2001, CANCER RES, V61, P3443; Liu YH, 2003, J NAT PROD, V66, P1451, DOI 10.1021/np030268e; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Paglin S, 2006, AUTOPHAGY, V2, P291, DOI 10.4161/auto.2835; Parry R, 1997, BIOCHEM SOC T, V25, pS589, DOI 10.1042/bst025s589; Rao ZG, 1997, J NAT PROD, V60, P1163, DOI 10.1021/np960729e; Stephenson I, 2003, LANCET, V362, P1959, DOI 10.1016/S0140-6736(03)15014-3; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tan JH, 2003, CANCER RES, V63, P7663; Tasdemir D, 2002, J NAT PROD, V65, P210, DOI 10.1021/np0104020; Theodoropoulou M, 2006, CANCER RES, V66, P1576, DOI 10.1158/0008-5472.CAN-05-1189; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9	40	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12176	10.1371/journal.pone.0012176	http://dx.doi.org/10.1371/journal.pone.0012176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808909	Green Published, Green Submitted, gold			2022-12-27	WOS:000280968100008
J	Milanovich, JR; Peterman, WE; Nibbelink, NP; Maerz, JC				Milanovich, Joseph R.; Peterman, William E.; Nibbelink, Nathan P.; Maerz, John C.			Projected Loss of a Salamander Diversity Hotspot as a Consequence of Projected Global Climate Change	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; SPECIES DISTRIBUTION; DISTRIBUTION MODELS; FOOD WEBS; ECOLOGY; DESMOGNATHUS; POPULATIONS; NICHE; PLETHODONTIDAE; DISTRIBUTIONS	Background: Significant shifts in climate are considered a threat to plants and animals with significant physiological limitations and limited dispersal abilities. The southern Appalachian Mountains are a global hotspot for plethodontid salamander diversity. Plethodontids are lungless ectotherms, so their ecology is strongly governed by temperature and precipitation. Many plethodontid species in southern Appalachia exist in high elevation habitats that may be at or near their thermal maxima, and may also have limited dispersal abilities across warmer valley bottoms. Methodology/Principal Findings: We used a maximum-entropy approach (program Maxent) to model the suitable climatic habitat of 41 plethodontid salamander species inhabiting the Appalachian Highlands region (33 individual species and eight species included within two species complexes). We evaluated the relative change in suitable climatic habitat for these species in the Appalachian Highlands from the current climate to the years 2020, 2050, and 2080, using both the HADCM3 and the CGCM3 models, each under low and high CO2 scenarios, and using two-model thresholds levels (relative suitability thresholds for determining suitable/unsuitable range), for a total of 8 scenarios per species. Conclusion/Significance: While models differed slightly, every scenario projected significant declines in suitable habitat within the Appalachian Highlands as early as 2020. Species with more southern ranges and with smaller ranges had larger projected habitat loss. Despite significant differences in projected precipitation changes to the region, projections did not differ significantly between global circulation models. CO2 emissions scenario and model threshold had small effects on projected habitat loss by 2020, but did not affect longer-term projections. Results of this study indicate that choice of model threshold and CO2 emissions scenario affect short-term projected shifts in climatic distributions of species; however, these factors and choice of global circulation model have relatively small affects on what is significant projected loss of habitat for many salamander species that currently occupy the Appalachian Highlands.	[Milanovich, Joseph R.; Nibbelink, Nathan P.; Maerz, John C.] Univ Georgia, DB Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Peterman, William E.] Univ Missouri, Dept Biol Sci, Columbia, MO USA	University System of Georgia; University of Georgia; University of Missouri System; University of Missouri Columbia	Milanovich, JR (corresponding author), Univ Georgia, DB Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	milanovichj@warnell.uga.edu	Peterman, William/H-7809-2013	Peterman, William/0000-0001-5229-9268; Maerz, John/0000-0002-1592-5431	National Science Foundation; American Museum of Natural History; North Carolina Herpetological Society	National Science Foundation(National Science Foundation (NSF)); American Museum of Natural History; North Carolina Herpetological Society	The contributions of J. C. Maerz and J. R. Milanovich were partially supported by the Coweeta LTER (http://coweeta.uga.edu/), which is funded by the National Science Foundation and has among its current objectives to understand the role of climate change in patterns of species losses and gains in southern Appalachia. This study was also partially funded by the American Museum of Natural History (http://www.amnh.org/) and the North Carolina Herpetological Society (http://www.ncherps.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, SALAMANDERS US CANAD; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Beamer DA, 2008, MOL PHYLOGENET EVOL, V47, P143, DOI 10.1016/j.ympev.2008.01.015; Beaumont LJ, 2007, GLOBAL CHANGE BIOL, V13, P1368, DOI 10.1111/j.1365-2486.2007.01357.x; Bernardo J, 2007, BIOLOGY LETT, V3, P695, DOI 10.1098/rsbl.2007.0259; Bernardo J, 2006, BIOL LETTERS, V2, P135, DOI 10.1098/rsbl.2005.0417; BONETT RM, 2002, ANAL CONTACT ZONE DU, P344; Buckley LB, 2007, P ROY SOC B-BIOL SCI, V274, P1167, DOI 10.1098/rspb.2006.0436; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Cabe PR, 2007, HEREDITY, V98, P53, DOI 10.1038/sj.hdy.6800905; Camp CD, 2007, BIOL J LINN SOC, V91, P227, DOI 10.1111/j.1095-8312.2007.00793.x; Carr DE, 1996, HERPETOLOGICA, V52, P56; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chippindale PT, 2004, EVOLUTION, V58, P2809; Cramer J.S, 2003, LOGIT MODELS EC OTHE, DOI 10.1017/CBO9780511615412.002; Crespi EJ, 2003, MOL ECOL, V12, P969, DOI 10.1046/j.1365-294X.2003.01797.x; Cunningham HR, 2009, J ANIM ECOL, V78, P52, DOI 10.1111/j.1365-2656.2008.01468.x; Davic RD, 2004, ANNU REV ECOL EVOL S, V35, P405, DOI 10.1146/annurev.ecolsys.35.112202.130116; de Chazal J, 2009, GLOBAL ENVIRON CHANG, V19, P306, DOI 10.1016/j.gloenvcha.2008.09.007; Dormann CF, 2007, BASIC APPL ECOL, V8, P387, DOI 10.1016/j.baae.2006.11.001; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; FEDER ME, 1983, HERPETOLOGICA, V39, P291; Flato GM, 2001, GEOPHYS RES LETT, V28, P195, DOI 10.1029/2000GL012121; Fridley JD, 2009, J APPL METEOROL CLIM, V48, P1033, DOI 10.1175/2008JAMC2084.1; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Gibbs JP, 2006, CONSERV BIOL, V20, P913, DOI 10.1111/j.1523-1739.2006.00375.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Highton R, 2000, BIOLOGY OF PLETHODONTID SALAMANDERS, P31; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Johns TC, 2003, CLIM DYNAM, V20, P583, DOI 10.1007/s00382-002-0296-y; Jones MT, 2006, MOL PHYLOGENET EVOL, V38, P280, DOI 10.1016/j.ympev.2005.05.007; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kettleborough JA, 2007, J CLIMATE, V20, P843, DOI 10.1175/JCLI4012.1; Kozak KH, 2010, AM NAT, V176, P40, DOI 10.1086/653031; Kozak KH, 2005, EVOLUTION, V59, P2000; Lannoo M, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P1; Lawton J. H., 1995, EXTINCTION RATES; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Luoto M, 2005, GLOBAL ECOL BIOGEOGR, V14, P575, DOI 10.1111/j.1466-822x.2005.00186.x; Macey JR, 2005, CLADISTICS, V21, P194, DOI 10.1111/j.1096-0031.2005.00054.x; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; Marshall JL, 2006, ACTA OECOL, V29, P33, DOI 10.1016/j.actao.2005.07.008; McCarthy J.J., 2001, CLIMATE CHANGE 2001; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; Mead LS, 2001, EVOLUTION, V55, P2287; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Mueller RL, 2004, P NATL ACAD SCI USA, V101, P13820, DOI 10.1073/pnas.0405785101; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Reznick DN, 2001, GENETICA, V112, P183, DOI 10.1023/A:1013352109042; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Rissler LJ, 2004, AM NAT, V164, P201, DOI 10.1086/422200; Rissler LJ, 2003, MOL PHYLOGENET EVOL, V27, P197, DOI 10.1016/S1055-7903(02)00405-0; Robertson MP, 2003, ECOL MODEL, V164, P153, DOI 10.1016/S0304-3800(03)00028-0; Sokolov AP, 2009, J CLIMATE, V22, P5175, DOI 10.1175/2009JCLI2863.1; Stein BA, 2000, PRECIOUS HERITAGE ST; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Titus TA, 1996, SYST BIOL, V45, P451, DOI 10.2307/2413525; Trotta-Moreu N, 2010, ENVIRON ENTOMOL, V39, P42, DOI 10.1603/EN08179; Vieites DR, 2007, P NATL ACAD SCI USA, V104, P19903, DOI 10.1073/pnas.0705056104; Walton BM, 2006, PEDOBIOLOGIA, V50, P313, DOI 10.1016/j.pedobi.2006.04.001; Walton BM, 2005, PEDOBIOLOGIA, V49, P51, DOI 10.1016/j.pedobi.2004.07.012; White EM, 2009, LANDSCAPE URBAN PLAN, V89, P37, DOI 10.1016/j.landurbplan.2008.09.004; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wyman RL, 1998, BIODIVERS CONSERV, V7, P641, DOI 10.1023/A:1008856402258	79	125	132	4	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12189	10.1371/journal.pone.0012189	http://dx.doi.org/10.1371/journal.pone.0012189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808442	Green Submitted, Green Published, gold			2022-12-27	WOS:000280968000016
J	Sharma, A; Bartell, SM; Baile, CA; Chen, B; Podolsky, RH; McIndoe, RA; She, JX				Sharma, Ashok; Bartell, Shoshana M.; Baile, Clifton A.; Chen, Bo; Podolsky, Robert H.; McIndoe, Richard A.; She, Jin-Xiong			Hepatic Gene Expression Profiling Reveals Key Pathways Involved in Leptin-Mediated Weight Loss in ob/ob Mice	PLOS ONE			English	Article							STEAROYL-COA DESATURASE-1; FACTOR BINDING PROTEIN-2; BODY-WEIGHT; INSULIN; LIVER; OVEREXPRESSION; GLUCOKINASE; MITONEET; PROTECTS; IGFBP-2	Background: Leptin, a cytokine-like protein, plays an important role in the regulation of body weight through inhibition of food intake and stimulation of energy expenditure. Leptin circulates in blood and acts on the brain, which sends downstream signals to regulate body weight. Leptin therapy has been successful in treating leptin deficient obese patients. However, high levels of leptin have been observed in more common forms of obesity indicating a state of leptin resistance which limits the application of leptin in the treatment of obesity. If the central effect of leptin could be by-passed and genes which respond to leptin treatment could be regulated directly, new therapeutic targets for the treatment of obesity may be possible. The purpose of this study was to identify genes and subsequent pathways correlated with leptin-mediated weight loss. Methodology/Principal Findings: We utilized microarray technology to compare hepatic gene expression changes after two types of leptin administration: one involving a direct stimulatory effect when administered peripherally (subcutaneous: SQ) and another that is indirect, involving a hypothalamic relay that suppresses food intake when leptin is administered centrally (intracerebroventricular: ICV). We identified 214 genes that correlate with leptin mediated weight loss. Several biological processes such as mitochondrial metabolic pathways, lipid metabolic and catabolic processes, lipid biosynthetic processes, carboxylic acid metabolic processes, iron ion binding and glutathione S-transferases were downregulated after leptin administration. In contrast, genes involved in the immune system inflammatory response and lysosomal activity were found to be upregulated. Among the cellular compartments mitochondrion (32 genes), endoplasmic reticulum (22 genes) and vacuole (8 genes) were significantly over represented. Conclusions/Significance: In this study we have identified key molecular pathways and downstream genes which respond to leptin treatment and are involved in leptin-mediated weight loss. Many of these genes have previously been shown to be associated with obesity; however, we have also identified a number of other novel target genes. Further investigation will be required to assess the possible use of these genes and their associated protein products as therapeutic targets for the treatment of obesity.	[Sharma, Ashok; Chen, Bo; Podolsky, Robert H.; McIndoe, Richard A.; She, Jin-Xiong] Med Coll Georgia, Sch Med, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Bartell, Shoshana M.; Baile, Clifton A.] Univ Georgia, Athens, GA 30602 USA; [Podolsky, Robert H.] Med Coll Georgia, Dept Med, Sch Med, Augusta, GA 30912 USA; [McIndoe, Richard A.; She, Jin-Xiong] Med Coll Georgia, Dept Pathol, Sch Med, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; University of Georgia; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Sharma, A (corresponding author), Med Coll Georgia, Sch Med, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA.	jshe@mail.mcg.edu	chen, bo/G-4522-2014; Podolsky, Robert/GRY-0740-2022	McIndoe, Richard/0000-0002-3040-3631; Sharma, Ashok/0000-0001-9597-4374	Georgia Research Alliance (GRA)	Georgia Research Alliance (GRA)	This study was supported by the Georgia Research Alliance (GRA, http://www.gra.org/) Eminent Scholar endowment and two GRA Challenge Grants to JXS and CAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RL, 2007, CANCER EPIDEM BIOMAR, V16, P593, DOI 10.1158/1055-9965.EPI-06-0775; Batra A, 2010, ENDOCRINOLOGY, V151, P56, DOI 10.1210/en.2009-0565; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boutilier RG, 2001, J EXP BIOL, V204, P3171; Caro JF, 1996, LANCET, V348, P159, DOI 10.1016/S0140-6736(96)03173-X; Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318; Choi YH, 2003, PHYSIOL BEHAV, V79, P795, DOI 10.1016/S0031-9384(03)00205-1; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Elam MB, 2009, OBESITY, V17, P1563, DOI 10.1038/oby.2009.49; FAILLA ML, 1988, J NUTR, V118, P46, DOI 10.1093/jn/118.1.46; Ferre T, 2003, DIABETOLOGIA, V46, P1662, DOI 10.1007/s00125-003-1244-z; Friedman JM, 2009, AM J CLIN NUTR, V89, p973S, DOI 10.3945/ajcn.2008.26788B; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fukushima T, 2007, ANTICANCER RES, V27, P3685; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200; Huang W, 2007, J APPL PHYSIOL, V102, P2260, DOI 10.1152/japplphysiol.01449.2006; Inoue Y, 2002, J BIOL CHEM, V277, P25257, DOI 10.1074/jbc.M203126200; Issandou M, 2009, EUR J PHARMACOL, V618, P28, DOI 10.1016/j.ejphar.2009.07.004; Jowsey IR, 2003, BIOCHEM BIOPH RES CO, V312, P1226, DOI 10.1016/j.bbrc.2003.11.068; Kerr KF, 2009, BIOINFORMATICS, V25, P2035, DOI 10.1093/bioinformatics/btp363; Lago F, 2007, NAT CLIN PRACT RHEUM, V3, P716, DOI 10.1038/ncprheum0674; LE GG, 2007, DIABETES RES CLIN PR, V77, P363; Li CS, 2009, BIOORG MED CHEM LETT, V19, P5214, DOI 10.1016/j.bmcl.2009.07.015; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Marucci G, 2008, VIRCHOWS ARCH, V453, P599, DOI 10.1007/s00428-008-0685-7; Munzberg H, 2010, FORUM NUTR, V63, P123, DOI 10.1159/000264400; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Prada PO, 2009, DIABETES, V58, P2910, DOI 10.2337/db08-0506; Ramani K, 2008, HEPATOLOGY, V47, P521, DOI 10.1002/hep.22064; Sharma A, 2009, BIOINFORMATICS, V25, P1152, DOI 10.1093/bioinformatics/btp123; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; So AI, 2008, CLIN CANCER RES, V14, P6944, DOI 10.1158/1078-0432.CCR-08-0408; Wang HM, 2008, BREAST J, V14, P261, DOI 10.1111/j.1524-4741.2008.00572.x; Warensjo E, 2007, OBESITY, V15, P1732, DOI 10.1038/oby.2007.206; Wheatcroft SB, 2007, DIABETES, V56, P285, DOI 10.2337/db06-0436; Wheatcroft SB, 2009, TRENDS ENDOCRIN MET, V20, P153, DOI 10.1016/j.tem.2009.01.002; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	45	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12147	10.1371/journal.pone.0012147	http://dx.doi.org/10.1371/journal.pone.0012147			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808936	gold, Green Published, Green Submitted			2022-12-27	WOS:000280968000005
J	Vanderelst, D; De Mey, F; Peremans, H; Geipel, I; Kalko, E; Firzlaff, U				Vanderelst, Dieter; De Mey, Fons; Peremans, Herbert; Geipel, Inga; Kalko, Elisabeth; Firzlaff, Uwe			What Noseleaves Do for FM Bats Depends on Their Degree of Sensorial Specialization	PLOS ONE			English	Article							BOUNDARY-ELEMENT METHOD; BIG BROWN BAT; EPTESICUS-FUSCUS; ECHOLOCATING BATS; EXTERNAL EAR; PHYLLOSTOMUS-DISCOLOR; SOUND LOCALIZATION; HORSESHOE BAT; EMISSION; SYSTEM	Background: Many bats vocalizing through their nose carry a prominent noseleaf that is involved in shaping the emission beam of these animals. To our knowledge, the exact role of these appendages has not been thoroughly investigated as for no single species both the hearing and the emission spatial sensitivities have been obtained. In this paper, we set out to evaluate the complete spatial sensitivity of two species of New World leaf-nosed bats: Micronycteris microtis and Phyllostomus discolor. From an ecological point of view, these species are interesting as they belong to the same family (Phyllostomidae) and their noseleaves are morphologically similar. They differ vastly in the niche they occupy. Comparing these species allows us to relate differences in function of the noseleaf to the ecological background of bat species. Methodology/Principal Findings: We simulate the spatial sensitivity of both the hearing and the emission subsystems of two species, M. microtis and P. discolor. This technique allows us to evaluate the respective roles played by the noseleaf in the echolocation system of these species. We find that the noseleaf of M. microtis focuses the radiated energy better and yields better control over the emission beam. Conclusions: From the evidence presented we conclude that the noseleaves serve quantitatively different functions for different bats. The main function of the noseleaf is to serve as an energy focusing mechanism that increases the difference between the reflected energy from objects in the focal area and objects in the periphery. However, despite the gross morphological similarities between the noseleaves of the two Phyllostomid species they focus the energy to a different extent, a capability that can be linked to the different ecological niches occupied by the two species.	[Vanderelst, Dieter; De Mey, Fons; Peremans, Herbert] Univ Antwerp, Act Percept Lab, B-2020 Antwerp, Belgium; [Geipel, Inga; Kalko, Elisabeth] Univ Ulm, Inst Expt Ecol, Ulm, Germany; [Kalko, Elisabeth] Smithsonian Trop Res Inst, Balboa, Panama; [Firzlaff, Uwe] Tech Univ Munich, Lehrstuhl Zool, D-8050 Freising Weihenstephan, Germany	University of Antwerp; Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute; Technical University of Munich	Vanderelst, D (corresponding author), Univ Antwerp, Act Percept Lab, B-2020 Antwerp, Belgium.	dieter.vanderelst@ua.ac.be		Firzlaff, Uwe/0000-0003-2803-3587; Geipel, Inga/0000-0003-3118-2460	EU	EU(European Commission)	This work was funded by the EU CHIROPING (Chiroptera, Robots, Sonar) and CILIA (Customized Intelligent Life-inspired Arrays) projects. These projects are funded by the Seventh Framework Programme ICT Challenge 2: "Cognitive Systems, Interaction, Robotics" and the Future and Emergent Technologies arm of the IST Programme in the 6th Framework Programme respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTES RA, 1978, J ACOUST SOC AM, V63, P155, DOI 10.1121/1.381707; Arlettaz R, 2001, NATURE, V414, P742, DOI 10.1038/414742a; Aytekin M, 2004, J ACOUST SOC AM, V116, P3594, DOI 10.1121/1.1811412; AYTEKIN M, 2007, THESIS U MARYLAND; Chiu C, 2007, J ACOUST SOC AM, V121, P2227, DOI 10.1121/1.2434760; De Mey F, 2008, J ACOUST SOC AM, V124, P2123, DOI 10.1121/1.2968703; Firzlaff U, 2004, HEARING RES, V197, P74, DOI 10.1016/j.heares.2004.06.009; Firzlaff U, 2003, HEARING RES, V185, P109, DOI 10.1016/S0378-5955(03)00278-8; Fontaine B, 2009, J ACOUST SOC AM, V125, P3052, DOI 10.1121/1.3101485; FUZESSERY ZM, 1992, J COMP PHYSIOL A, V170, P57; GEIPEL I, 2007, THESIS GEORGAUGUST U; Giannini NP, 2004, OIKOS, V105, P209, DOI 10.1111/j.0030-1299.2004.12690.x; Grace SM, 2008, ACTA ACUST UNITED AC, V94, P310, DOI 10.3813/AAA.918034; Griffin D.R., 1958, LISTENING DARK ACOUS; HARTLEY DJ, 1987, J ACOUST SOC AM, V82, P1892, DOI 10.1121/1.395684; Hartmann WH, 1999, PHYS TODAY, V52, P24, DOI 10.1063/1.882727; Kalka M, 2006, J TROP ECOL, V22, P1, DOI 10.1017/S0266467405002920; Katz BFG, 2001, J ACOUST SOC AM, V110, P2449, DOI 10.1121/1.1412441; Kwiecinski Gary G., 2006, Mammalian Species, P1, DOI 10.1644/801.1; LAWRENCE BD, 1982, SCIENCE, V218, P481, DOI 10.1126/science.7123247; Muller R, 2004, J ACOUST SOC AM, V116, P3701, DOI 10.1121/1.1815133; Neuweiler G., 2000, BIOL BATS; OBRIST MK, 1993, J EXP BIOL, V180, P119; Otani M., 2003, Acoustical Science and Technology, V24, P259, DOI 10.1250/ast.24.259; Otani M, 2006, J ACOUST SOC AM, V119, P2589, DOI 10.1121/1.2191608; Pierce A. D., 1991, ACOUSTICS INTRO ITS; ROTHER G, 1982, Z SAUGETIERKD, V47, P324; SAILLANT PA, 1993, J ACOUST SOC AM, V94, P2691, DOI 10.1121/1.407353; SCHNITZLER HU, 1977, J COMP PHYSIOL, V116, P51, DOI 10.1007/BF00605516; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; SIMMONS JA, 1969, J ACOUST SOC AM, V46, P1054, DOI 10.1121/1.1911804; Skolnik M. I, 1990, RADAR HDB, Vsecond; STROTHER G K, 1970, Journal of the Acoustical Society of America, V48, P1430, DOI 10.1121/1.1912304; SUGA N, 1972, SCIENCE, V177, P82, DOI 10.1126/science.177.4043.82; Walsh T, 2004, J ACOUST SOC AM, V115, P1033, DOI 10.1121/1.1643360; Weinbeer M, 2007, BEHAV ECOL SOCIOBIOL, V61, P1337, DOI 10.1007/s00265-007-0364-8; Wotton JM, 1997, J ACOUST SOC AM, V101, P1723, DOI 10.1121/1.418271; Wotton JM, 1996, J ACOUST SOC AM, V100, P1764, DOI 10.1121/1.416073; Xiao T, 2003, J ACOUST SOC AM, V113, P2434, DOI 10.1121/1.1561495; Zhuang Q, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.218701; Zhuang Q, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051902	42	71	72	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e11893	10.1371/journal.pone.0011893	http://dx.doi.org/10.1371/journal.pone.0011893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808438	Green Published, gold, Green Submitted			2022-12-27	WOS:000280968000001
J	Hall, HI; Espinoza, L; Benbow, N; Hu, YYW				Hall, H. Irene; Espinoza, Lorena; Benbow, Nanette; Hu, Yunyin W.		Urban Areas HIV Surveillance Workg	Epidemiology of HIV Infection in Large Urban Areas in the United States	PLOS ONE			English	Article							US METROPOLITAN-AREAS; PREVALENCE; RISK; TRANSMISSION	Background: While the U.S. HIV epidemic continues to be primarily concentrated in urban area, local epidemiologic profiles may differ and require different approaches in prevention and treatment efforts. We describe the epidemiology of HIV in large urban areas with the highest HIV burden. Methods/Principal Findings: We used data from national HIV surveillance for 12 metropolitan statistical areas (MSAs) to determine disparities in HIV diagnoses and prevalence and changes over time. Overall, 0.3% to 1% of the MSA populations were living with HIV at the end of 2007. In each MSA, prevalence was >1% among blacks; prevalence was >2% in Miami, New York, and Baltimore. Among Hispanics, prevalence was >1% in New York and Philadelphia. The relative percentage differences in 2007 HIV diagnosis rates, compared to whites, ranged from 239 (San Francisco) to 1239 (Baltimore) for blacks and from 15 (Miami) to 413 (Philadelphia) for Hispanics. The epidemic remains concentrated, with more than 50% of HIV diagnoses in 2007 attributed to male-to-male sexual contact in 7 of the 12 MSAs; heterosexual transmission surpassed or equaled male-to-male sexual transmission in Baltimore, Philadelphia, and Washington, DC. Yet in several MSAs, including Baltimore and Washington, DC, AIDS diagnoses increased among men-who-have sex with men in recent years. Conclusions/Significance: These data are useful to identify local drivers of the epidemic and to tailor public health efforts for treatment and prevention services for people living with HIV.	[Hall, H. Irene; Espinoza, Lorena] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Benbow, Nanette] Chicago Dept Publ Hlth, STI HIV Div, Chicago, IL USA; [Hu, Yunyin W.] Los Angeles Cty Dept Publ Hlth, HIV Epidemiol Program, Los Angeles, CA USA	Centers for Disease Control & Prevention - USA; Chicago Department of Public Health; Los Angeles County Department of Public Health	Hall, HI (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	ixh1@cdc.gov						Sifakis F., 2005, Morbidity and Mortality Weekly Report, V54, P597; [Anonymous], [No title captured]; Brady JE, 2008, J URBAN HEALTH, V85, P323, DOI 10.1007/s11524-007-9248-5; Campsmith M. L., 2008, Morbidity and Mortality Weekly Report, V57, P1073; *CDCP, 2009, HIV AIDS SURV REP, V19; *CDCP, 2010, CDC ANN MILL EXP SUC; *CDCP, 2006, MMWR SURVEILL SUMM, V55; Centers for Disease Control and Prevention, 2009, HIV AIDS PREV RES SY; Centers for Disease Control and Prevention, 2006, CAS HIV INF AIDS URB; Centers for Disease Control and Prevention, 1983, ACQ IMM SYNDR AIDS W; Centers for Disease Control and Prevention, 1982, MMWR-MORBID MORTAL W, V31, P507; Centers for Disease Control and Prevention, 2006, MMWR, V55; Cooper HLF, 2008, J URBAN HEALTH, V85, P826, DOI 10.1007/s11524-008-9304-9; Crepaz N, 2006, AIDS, V20, P143, DOI 10.1097/01.aids.0000196166.48518.a0; *DISTR COL DEP HLT, 2008, HIV AIDS EP UPD; El-Sadr WM, 2010, NEW ENGL J MED, V362, P967, DOI 10.1056/NEJMp1000069; *GOV DISTR COL DEP, 2009, HIV AIDS EP UDP 2008; Hall HI, 2008, JAIDS-J ACQ IMM DEF, V49, P294, DOI 10.1097/QAI.0b013e3181893f17; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Harrison KM, 2008, PUBLIC HEALTH REP, V123, P618, DOI 10.1177/003335490812300512; Holtgrave DR, 2009, JAIDS-J ACQ IMM DEF, V50, P236, DOI 10.1097/QAI.0b013e31819001be; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Office of management, 2000, FED REG, V65, P82228; Office of Management and Budget, 2008, OMB B; PURCELL DW, 2010, CALC HIV SYPH RAT RI; Rubin DB, 2004, MULTIPLE IMPUTATION; SHEDLIN MB, 2006, J URBAN HLTH B NEW Y, V83, P143; *US BUR CENS, 2008, ANN EST RES POP INC; *US BUR CENS, 2008, POP EST ENT DAR; WHO Joint United Nations Programme on HIV/AIDS, 2000, GUID 2 GEN HIV SURV; [No title captured]; 2009, PAN ANT GUID AD ADOL	32	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12756	10.1371/journal.pone.0012756	http://dx.doi.org/10.1371/journal.pone.0012756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856793	Green Published, Green Submitted, gold			2022-12-27	WOS:000281815800021
J	Rajasekaran, K; Xiong, V; Fong, L; Gorski, J; Malarkannan, S				Rajasekaran, Kamalakannan; Xiong, Va; Fong, Lee; Gorski, Jack; Malarkannan, Subramaniam			Functional Dichotomy between NKG2D and CD28-Mediated Co-Stimulation in Human CD8(+) T Cells	PLOS ONE			English	Article							DENDRITIC CELLS; CELIAC-DISEASE; KILLER-CELLS; NK CELLS; ACTIVATION; RECEPTOR; LIGANDS; VIRUS; INDUCTION; INFLUENZA	Both CD28 and NKG2D can function as co-stimulatory receptors in human CD8(+) T cells. However, their independent functional contributions in distinct CD8(+) T cell subsets are not well understood. In this study, CD8(+) T cells in human peripheral blood-and lung-derived lymphocytes were analyzed for CD28 and NKG2D expression and function. We found a higher level of CD28 expression in PBMC-derived naive (CD45RA(+)CD27(+)) and memory (CD45RA(-)CD27(+)) CD8(+) T cells (CD28(Hi)), while its expression was significantly lower in effector (CD45RA(+)CD27(-)) CD8(+) T cells (CD28(Lo)). Irrespective of the differences in the CD28 levels, NKG2D expression was comparable in all three CD8(+) T cell subsets. CD28 and NKG2D expressions followed similar patterns in human lung-resident GILGFVFTL/HLA-A2-pentamer positive CD8(+) T cells. Co-stimulation of CD28(Lo) effector T cells via NKG2D significantly increased IFN-gamma and TNF-alpha levels. On the contrary, irrespective of its comparable levels, NKG2D-mediated co-stimulation failed to augment IFN-gamma and TNF-alpha production in CD28(Hi) naive/memory T cells. Additionally, CD28-mediated co-stimulation was obligatory for IL-2 generation and thereby its production was limited only to the CD28(Hi) naive/memory subsets. MICA, a ligand for NKG2D was abundantly expressed in the tracheal epithelial cells, validating the use of NKG2D as the major co-stimulatory receptor by tissue-resident CD8(+) effector T cells. Based on these findings, we conclude that NKG2D may provide an expanded level of co-stimulation to tissue-residing effector CD8(+) T cells. Thus, incorporation of co-stimulation via NKG2D in addition to CD28 is essential to activate tumor or tissue-infiltrating effector CD8(+) T cells. However, boosting a recall immune response via memory CD8(+) T cells or vaccination to stimulate naive CD8(+) T cells would require CD28-mediated co-stimulation.	[Rajasekaran, Kamalakannan; Malarkannan, Subramaniam] Blood Res Inst, Lab Mol Immunol, Milwaukee, WI USA; [Xiong, Va; Fong, Lee; Gorski, Jack] Blood Res Inst, Mol Genet Lab, Milwaukee, WI USA; [Malarkannan, Subramaniam] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; Versiti Blood Center of Wisconsin; Medical College of Wisconsin	Rajasekaran, K (corresponding author), Blood Res Inst, Lab Mol Immunol, Milwaukee, WI USA.	subra.malar@bcw.edu	Malarkannan, Subramaniam/AAQ-3934-2020; RAJASEKARAN, KAMALAKANNAN/F-7350-2015; Malarkannan, Subra/AAQ-9617-2020	Malarkannan, Subramaniam/0000-0002-7511-2731; RAJASEKARAN, KAMALAKANNAN/0000-0001-5634-9007; 	NIH [NO1-HHSN266200500032C, U19 AI062627, R01A1064826]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062627] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported in part by NIH grants NO1-HHSN266200500032C, U19 AI062627, R01A1064826 to S. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon L, 2004, J IMMUNOL, V173, P1078, DOI 10.4049/jimmunol.173.2.1078; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Belz GT, 2007, NAT IMMUNOL, V8, P1060, DOI 10.1038/ni1505; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 1998, P NATL ACAD SCI USA, V95, P13812, DOI 10.1073/pnas.95.23.13812; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Borchers MT, 2006, AM J PHYSIOL-LUNG C, V291, pL222, DOI 10.1152/ajplung.00327.2005; Brimnes MK, 2003, J EXP MED, V198, P133, DOI 10.1084/jem.20030266; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; CAUX C, 1994, J EXP MED, V180, P1841, DOI 10.1084/jem.180.5.1841; Chalupny NJ, 2003, BIOCHEM BIOPH RES CO, V305, P129, DOI 10.1016/S0006-291X(03)00714-9; Conejo-Garcia JR, 2003, CANCER BIOL THER, V2, P446, DOI 10.4161/cbt.2.4.479; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Ehrlich LIR, 2005, J IMMUNOL, V174, P1922, DOI 10.4049/jimmunol.174.4.1922; Evans SE, 2010, ANNU REV PHYSIOL, V72, P413, DOI 10.1146/annurev-physiol-021909-135909; FALK K, 1994, IMMUNOLOGY, V82, P337; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Guo HL, 2008, J EXP MED, V205, P2419, DOI 10.1084/jem.20072327; Haanen JBAG, 2000, NAT MED, V6, P1056, DOI 10.1038/79573; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; JENKINS MK, 1991, J IMMUNOL, V147, P2461; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; Liang L, 2002, CURR OPIN IMMUNOL, V14, P384, DOI 10.1016/S0952-7915(02)00342-4; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Nabeshima S, 2002, CLIN EXP IMMUNOL, V128, P339, DOI 10.1046/j.1365-2249.2002.01819.x; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Textor S, 2008, INT J CANCER, V123, P2343, DOI 10.1002/ijc.23733; Verneris MR, 2004, BLOOD, V103, P3065, DOI 10.1182/blood-2003-06-2125; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059	32	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12635	10.1371/journal.pone.0012635	http://dx.doi.org/10.1371/journal.pone.0012635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844584	Green Submitted, gold, Green Published			2022-12-27	WOS:000281687200005
J	Kim, B; Kan, R; Anguish, L; Nelson, LM; Coonrod, SA				Kim, Boram; Kan, Rui; Anguish, Lynne; Nelson, Lawrence M.; Coonrod, Scott A.			Potential Role for MATER in Cytoplasmic Lattice Formation in Murine Oocytes	PLOS ONE			English	Article							MOUSE EMBRYO; EFFECT GENE; MAMMALIAN EGGS; LIPID DROPLETS; PROTEIN; EXPRESSION; STORAGE; EMBRYOGENESIS; COMPETENCE; TRANSITION	Background: Mater and Padi6 are maternal effect genes that are first expressed during oocyte growth and are required for embryonic development beyond the two-cell stage in the mouse. We have recently found that PADI6 localizes to, and is required for the formation of, abundant fibrillar Triton X-100 (Triton) insoluble structures termed the oocyte cytoplasmic lattices (CPLs). Given their similar expression profiles and mutant mouse phenotypes, we have been testing the hypothesis that MATER also plays a role in CPL formation and/or function. Methodology/Findings: Herein, we show that PADI6 and MATER co-localize throughout the oocyte cytoplasm following Triton extraction, suggesting that MATER co-localizes with PADI6 at the CPLs. Additionally, the solubility of PADI6 was dramatically increased in Mater(tm/tm) oocytes following Triton extraction, suggesting that MATER is involved in CPL nucleation. This prediction is supported by transmission electron microscopic analysis of Mater(+/+) and Mater(tm/tm) germinal vesicle stage oocytes which illustrated that volume fraction of CPLs was reduced by 90% in Mater(tm/tm) oocytes compared to Mater(+/+) oocytes. Conclusions: Taken together, these results suggest that, similar to PADI6, MATER is also required for CPL formation. Given that PADI6 and MATER are essential for female fertility, these results not only strengthen the hypothesis that the lattices play a critical role in mediating events during the oocyte-to-embryo transition but also increase our understanding of the molecular nature of the CPLs.	[Kim, Boram; Kan, Rui; Anguish, Lynne; Coonrod, Scott A.] Cornell Univ, Coll Vet Med, James A Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Nelson, Lawrence M.] NICHHD, Intramural Res Program Reprod & Adult Endocrinol, Bethesda, MD 20892 USA	Cornell University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kim, B (corresponding author), Cornell Univ, Coll Vet Med, James A Baker Inst Anim Hlth, Ithaca, NY 14853 USA.	sac269@cornell.edu			National Institute of Child Health and Human Development [RO1 38353]; Intramural Research Program on Reproductive and Adult Endocrinology; National Science Foundation [DMR-0520404]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000633] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038353] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural Research Program on Reproductive and Adult Endocrinology; National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institute of Child Health and Human Development grant RO1 38353 to SAC and by the Intramural Research Program on Reproductive and Adult Endocrinology to LMN. This study also made use of the Cornell Center for Materials Research Facilities supported by the National Science Foundation under Award Number DMR-0520404. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambruosi B, 2009, THERIOGENOLOGY, V71, P1093, DOI 10.1016/j.theriogenology.2008.12.002; Bachvarova R, 1985, Dev Biol (N Y 1985), V1, P453; BACHVAROVA R, 1981, J EMBRYOL EXP MORPH, V62, P153; Bowerman B, 1998, CURR TOP DEV BIOL, V39, P73, DOI 10.1016/S0070-2153(08)60453-6; BURKHOLDER GD, 1971, EXP CELL RES, V69, P361, DOI 10.1016/0014-4827(71)90236-9; CAPCO DG, 1993, CELL MOTIL CYTOSKEL, V24, P85, DOI 10.1002/cm.970240202; Esposito G, 2007, MOL CELL ENDOCRINOL, V273, P25, DOI 10.1016/j.mce.2007.05.005; FLACH G, 1982, EMBO J, V1, P681, DOI 10.1002/j.1460-2075.1982.tb01230.x; GALLICANO GI, 1991, CELL MOTIL CYTOSKEL, V18, P143; GARCIA RB, 1979, DIFFERENTIATION, V14, P101, DOI 10.1111/j.1432-0436.1979.tb01017.x; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Joshi S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-67; Li L, 2008, DEV CELL, V15, P416, DOI 10.1016/j.devcel.2008.07.010; Maraldi T, 2009, MOL HUM REPROD, V15, P499, DOI 10.1093/molehr/gap048; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; MCGAUGHEY RW, 1989, CELL MOTIL CYTOSKEL, V13, P104, DOI 10.1002/cm.970130205; Nagano M, 2006, ZYGOTE, V14, P299, DOI 10.1017/S0967199406003807; Niimura Sueo, 2004, Reprod Med Biol, V3, P231, DOI 10.1111/j.1447-0578.2004.00075.x; Ohsugi M, 2008, DEVELOPMENT, V135, P259, DOI 10.1242/dev.011445; Pan H, 2005, DEV BIOL, V286, P493, DOI 10.1016/j.ydbio.2005.08.023; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; STERNLICHT AL, 1981, J EXP ZOOL, V215, P191, DOI 10.1002/jez.1402150209; STJOHNSTON D, 1992, CELL, V68, P201; Sturmey RG, 2006, REPRODUCTION, V132, P829, DOI 10.1530/REP-06-0073; Tashiro F, 2010, GENES CELLS, V15, P813, DOI 10.1111/j.1365-2443.2010.01420.x; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tong ZB, 1999, ENDOCRINOLOGY, V140, P3720, DOI 10.1210/en.140.8.3720; Tong ZB, 2004, ENDOCRINOLOGY, V145, P1427, DOI 10.1210/en.2003-1160; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; WASSARMAN PM, 1978, J MORPHOL, V156, P209, DOI 10.1002/jmor.1051560206; WEAKLEY BS, 1969, Z ZELLFORSCH MIK ANA, V97, P438, DOI 10.1007/BF00968849; WEIBEL ER, 1966, J CELL BIOL, V30, P23, DOI 10.1083/jcb.30.1.23; Wright PW, 2003, DEV BIOL, V256, P73, DOI 10.1016/S0012-1606(02)00126-4; Yurttas P, 2008, DEVELOPMENT, V135, P2627, DOI 10.1242/dev.016329; Zamboni L., 1970, Biol. Reprod., V2, P44, DOI 10.1095/biolreprod2.Supplement_2.44; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106	37	39	41	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12587	10.1371/journal.pone.0012587	http://dx.doi.org/10.1371/journal.pone.0012587			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830304	Green Published, Green Submitted, gold			2022-12-27	WOS:000281631300016
J	Noto, CR; Grossman, A				Noto, Christopher R.; Grossman, Ari			Broad-Scale Patterns of Late Jurassic Dinosaur Paleoecology	PLOS ONE			English	Article							BODY-SIZE; SAUROPOD DINOSAURS; WESTERN INTERIOR; FOSSIL RECORD; EVOLUTION; ECOLOGY; NORTH; DIET; PALEOBIOLOGY; CONVERGENCE	Background: There have been numerous studies on dinosaur biogeographic distribution patterns. However, these distribution data have not yet been applied to ecological questions. Ecological studies of dinosaurs have tended to focus on reconstructing individual taxa, usually through comparisons to modern analogs. Fewer studies have sought to determine if the ecological structure of fossil assemblages is preserved and, if so, how dinosaur communities varied. Climate is a major component driving differences between communities. If the ecological structure of a fossil locality is preserved, we expect that dinosaur assemblages from similar environments will share a similar ecological structure. Methodology/Principal Findings: This study applies Ecological Structure Analysis (ESA) to a dataset of 100+ dinosaur taxa arranged into twelve composite fossil assemblages from around the world. Each assemblage was assigned a climate zone (biome) based on its location. Dinosaur taxa were placed into ecomorphological categories. The proportion of each category creates an ecological profile for the assemblage, which were compared using cluster and principal components analyses. Assemblages grouped according to biome, with most coming from arid or semi-arid/seasonal climates. Differences between assemblages are tied to the proportion of large high-browsing vs. small ground-foraging herbivores, which separates arid from semi-arid and moister environments, respectively. However, the effects of historical, taphonomic, and other environmental factors are still evident. Conclusions/Significance: This study is the first to show that the general ecological structure of Late Jurassic dinosaur assemblages is preserved at large scales and can be assessed quantitatively. Despite a broad similarity of climatic conditions, a degree of ecological variation is observed between assemblages, from arid to moist. Taxonomic differences between Asia and the other regions demonstrate at least one case of ecosystem convergence. The proportion of different ecomorphs, which reflects the prevailing climatic and environmental conditions present during fossil deposition, may therefore be used to differentiate Late Jurassic dinosaur fossil assemblages. This method is broadly applicable to different taxa and times, allowing one to address questions of evolutionary, biogeographic, and climatic importance.	[Noto, Christopher R.] Grand Valley State Univ, Dept Biomed Sci, Allendale, MI 49401 USA; [Grossman, Ari] Midwestern Univ, Dept Anat, Glendale, AZ USA	Grand Valley State University; Midwestern University	Noto, CR (corresponding author), Grand Valley State Univ, Dept Biomed Sci, Allendale, MI 49401 USA.	notoc@gvsu.edu	Grossman, Ari/T-4975-2017	Grossman, Ari/0000-0001-5978-9614; Noto, Christopher/0000-0003-1829-2593				Abbink O, 2001, GLOBAL PLANET CHANGE, V30, P231, DOI 10.1016/S0921-8181(01)00101-1; Aberhan Martin, 2002, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V5, P19; ABLER WL, 1992, PALEOBIOLOGY, V18, P161, DOI 10.1017/S0094837300013956; Alexander RM, 2006, P ROY SOC B-BIOL SCI, V273, P1849, DOI 10.1098/rspb.2006.3532; Alonso PD, 2004, NATURE, V430, P666, DOI 10.1038/nature02706; Alroy J, 2003, PALEOBIOLOGY, V29, P26, DOI 10.1666/0094-8373(2003)029<0026:GDWYRM>2.0.CO;2; Andrews P, 1996, BIOL REV, V71, P257, DOI 10.1111/j.1469-185X.1996.tb00749.x; ANTON M, 2003, ESTUDIOS GEOLOGICOS, V59; Antunes MT, 2003, CR PALEVOL, V2, P77, DOI 10.1016/S1631-0683(03)00003-4; Bailey JB, 1997, J PALEONTOL, V71, P1124, DOI 10.1017/S0022336000036076; BAKKER RT, 1972, NATURE, V238, P81, DOI 10.1038/238081a0; Barnosky AD, 2001, CONSERV BIOL, V15, P658, DOI 10.1046/j.1523-1739.2001.015003658.x; Barrett PM, 2002, PALAEONTOLOGY, V45, P1197, DOI 10.1111/1475-4983.00282; BENTON MJ, 1985, SP PAP PALAEONTOL, P185; Bonnan Matthew F., 2005, P346; Bonnan MF, 2004, PALEOBIOLOGY, V30, P444, DOI 10.1666/0094-8373(2004)030<0444:MAOHAF>2.0.CO;2; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Carrano MT, 1999, ACTA PALAEONTOL POL, V44, P237; Carrano MT, 1999, J ZOOL, V247, P29, DOI 10.1111/j.1469-7998.1999.tb00190.x; Christian A, 1996, PALAEONTOLOGY, V39, P801; Christiansen P, 2002, J MORPHOL, V251, P195, DOI 10.1002/jmor.1083; CURRIE RA, 1989, DICKENS QUART, V6, P60; Demko TM, 2004, SEDIMENT GEOL, V167, P115, DOI 10.1016/j.sedgeo.2004.01.003; DiMichele WA, 2004, ANNU REV ECOL EVOL S, V35, P285, DOI 10.1146/annurev.ecolsys.35.120202.110110; DODSON P, 1980, PALEOBIOLOGY, V6, P208, DOI 10.1017/S009483730000676X; Dunagan SP, 2004, SEDIMENT GEOL, V167, P269, DOI 10.1016/j.sedgeo.2004.01.007; Eberth DA, 2001, CAN J EARTH SCI, V38, P1627, DOI 10.1139/e01-067; Engelmann GF, 2004, SEDIMENT GEOL, V167, P297, DOI 10.1016/j.sedgeo.2004.01.008; Fa JE, 1997, J ANIM ECOL, V66, P98, DOI 10.2307/5968; FARLOW JO, 1995, ANNU REV ECOL SYST, V26, P445, DOI 10.1146/annurev.es.26.110195.002305; FARLOW JO, 1975, EVOLUTION, V29, P353, DOI 10.1111/j.1558-5646.1975.tb00214.x; FARLOW JO, 1987, PALEOBIOLOGY, V13, P60; Fastovsky DE, 2004, GEOLOGY, V32, P877, DOI 10.1130/G20695.1; Fiorillo Anthony R., 1998, Historical Biology, V13, P1; FLEAGLE JG, 1980, AM J PHYS ANTHROPOL, V52, P301, DOI 10.1002/ajpa.1330520302; Forster CA, 1999, J AFR EARTH SCI, V28, P169, DOI 10.1016/S0899-5362(99)00023-8; Foster J.R., 2003, NEW MEXICO MUSEUM NA, V23, P1; Garcia AJV, 2005, J S AM EARTH SCI, V19, P243, DOI 10.1016/j.jsames.2005.01.008; Geist NR, 1996, SCIENCE, V272, P712, DOI 10.1126/science.272.5262.712; Graham RW, 1996, SCIENCE, V272, P1601; Greenwood JJD, 1996, PHILOS T R SOC B, V351, P265, DOI 10.1098/rstb.1996.0023; Hadly EA, 2009, P NATL ACAD SCI USA, V106, P19707, DOI 10.1073/pnas.0901648106; HALLAM A, 1985, J GEOL SOC LONDON, V142, P433, DOI 10.1144/gsjgs.142.3.0433; Hallam A, 1998, B SOC GEOL FR, V169, P681; HALLAM A, 1993, PHILOS T ROY SOC B, V341, P287, DOI 10.1098/rstb.1993.0114; HALLAM A, 1984, PALAEOGEOGR PALAEOCL, V47, P195, DOI 10.1016/0031-0182(84)90094-4; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harmon LJ, 2005, EVOLUTION, V59, P409; HEINRICH RE, 1993, ZOOL J LINN SOC-LOND, V108, P179, DOI 10.1111/j.1096-3642.1993.tb00294.x; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P627; HOPSON J A, 1975, Paleobiology, V1, P21; Hummel J, 2008, P ROY SOC B-BIOL SCI, V275, P1015, DOI 10.1098/rspb.2007.1728; Hutchinson JR, 2006, CR PALEVOL, V5, P519, DOI 10.1016/j.crpv.2005.09.002; Hutchinson JR, 2006, NATURE, V440, P292, DOI 10.1038/440292a; Iossa G, 2008, J MAMMAL, V89, P1481, DOI 10.1644/07-MAMM-A-405.1; Jablonski D, 1996, ECOLOGY, V77, P1367, DOI 10.2307/2265534; Jackson JBC, 2006, TRENDS ECOL EVOL, V21, P322, DOI 10.1016/j.tree.2006.03.017; KIDWELL SM, 1995, ANNU REV ECOL SYST, V26, P269, DOI 10.1146/annurev.es.26.110195.001413; Lamouroux N, 2002, ECOLOGY, V83, P1792, DOI 10.2307/3071765; Loeuille N, 2006, ECOL LETT, V9, P171, DOI 10.1111/j.1461-0248.2005.00861.x; Long CA, 2003, J THEOR BIOL, V224, P9, DOI 10.1016/S0022-5193(03)00116-4; Lucas S.G., 2002, CHINESE FOSSIL VERTE; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Manning PL, 2006, BIOL LETTERS, V2, P110, DOI 10.1098/rsbl.2005.0395; Marquet PA, 2005, J EXP BIOL, V208, P1749, DOI 10.1242/jeb.01588; MATEUS O, 2006, NEW MEXICO MUSEUM NA, V36; McCarthy D, 2005, J BIOGEOGR, V32, P2161, DOI 10.1111/j.1365-2699.2005.01355.x; McGill BJ, 2005, P NATL ACAD SCI USA, V102, P16701, DOI 10.1073/pnas.0504225102; Melville J, 2006, P ROY SOC B-BIOL SCI, V273, P557, DOI 10.1098/rspb.2005.3328; Midgley JJ, 2002, EVOL ECOL RES, V4, P1093; Miller ER, 1999, J HUM EVOL, V36, P519, DOI 10.1006/jhev.1998.0286; MILTON K, 1976, NATURE, V259, P459, DOI 10.1038/259459a0; MORRIS PJ, 1995, P NATL ACAD SCI USA, V92, P11269, DOI 10.1073/pnas.92.24.11269; NAKATA H, 1994, AUTOMATIC CONTROL - WORLD CONGRESS 1993, VOL 5, P1; *PAL, 2010, PAL DAT; Peres-Neto PR, 2003, ECOLOGY, V84, P2347, DOI 10.1890/00-0634; Plotnick RE, 2000, PALEOBIOLOGY, V26, P305, DOI 10.1666/0094-8373(2000)26[305:IBEFAI]2.0.CO;2; RAUP DM, 1972, SCIENCE, V177, P1065, DOI 10.1126/science.177.4054.1065; Rayfield EJ, 2005, ZOOL J LINN SOC-LOND, V144, P309, DOI 10.1111/j.1096-3642.2005.00176.x; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Reed Kaye E., 2002, P217; Reed KE, 1998, PALEOBIOLOGY, V24, P384; REED KE, 1996, PALEOECOLOGY MAKAPAN; Rees P, 2005, J VERTEBR PALEONTOL, V25, p103A; Rees PM, 2004, J GEOL, V112, P643, DOI 10.1086/424577; Rees PM, 2000, WARM CLIMATES EARTH, P297, DOI [DOI 10.1017/CB09780511564512.011, 10.1017/CBO9780511564512.011]; Ricklefs RE, 2006, ECOLOGY, V87, pS3, DOI 10.1890/0012-9658(2006)87[3:EDATOO]2.0.CO;2; Rogers RR, 2010, PALEOBIOLOGY, V36, P80, DOI 10.1666/0094-8373-36.1.80; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2002, DOI 10.1139/e93-176; Salgado L, 2008, J VERTEBR PALEONTOL, V28, P529, DOI 10.1671/0272-4634(2008)28[529:FLJDBF]2.0.CO;2; Sanz JL, 1996, NATURE, V382, P442, DOI 10.1038/382442a0; Schiermeier Q, 2003, NATURE, V424, P482, DOI 10.1038/424482a; Seebacher F, 1999, J EXP BIOL, V202, P77; Seebacher F, 2001, J VERTEBR PALEONTOL, V21, P51, DOI 10.1671/0272-4634(2001)021[0051:ANMTCA]2.0.CO;2; Sellers WI, 2007, P ROY SOC B-BIOL SCI, V274, P2711, DOI 10.1098/rspb.2007.0846; Sellwood BW, 2008, P GEOLOGIST ASSOC, V119, P5, DOI 10.1016/S0016-7878(59)80068-7; Sereno Paul C., 1999, National Science Museum Monographs, V15, P249; Smith RMH, 2002, PALAIOS, V17, P249, DOI 10.1669/0883-1351(2002)017<0249:CFEAVT>2.0.CO;2; Sokal R. H., 1995, BIOMETRY PRINCIPLES; Soto M, 2008, J VERTEBR PALEONTOL, V28, P439, DOI 10.1671/0272-4634(2008)28[439:ACDTFT]2.0.CO;2; SPEAKMAN JR, 1993, EVOLUTION, V47, P336, DOI 10.1111/j.1558-5646.1993.tb01226.x; Stevens Kent A., 2005, P212; Taylor MP, 2009, ACTA PALAEONTOL POL, V54, P213, DOI 10.4202/app.2009.0007; Thulborn RA, 2003, NEUES JAHRB GEOL P-A, V229, P61; Turner CE, 2004, SEDIMENT GEOL, V167, P309, DOI 10.1016/j.sedgeo.2004.01.009; Turner Christine E., 1999, P77; Tutken T, 2004, PALAEOGEOGR PALAEOCL, V206, P217, DOI 10.1016/j.palaeo.2004.01.005; Upchurch P, 2002, P ROY SOC B-BIOL SCI, V269, P613, DOI 10.1098/rspb.2001.1921; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; Van Valkenburgh B, 2002, PALEOBIOLOGY, V28, P527, DOI 10.1666/0094-8373(2002)028<0527:DAMPC>2.0.CO;2; VANVALKENBURGH B, 1995, TRENDS ECOL EVOL, V10, P71, DOI 10.1016/S0169-5347(00)88980-6; Vermeij GJ, 2003, PALEOBIOLOGY, V29, P3, DOI 10.1666/0094-8373(2003)029<0003:DGDMA>2.0.CO;2; Weishampel DB, 2004, DINOSAURIA, 2ND EDITION, P517; Wendler J, 2002, PALAEOGEOGR PALAEOCL, V179, P19, DOI 10.1016/S0031-0182(01)00366-2; White CR, 2006, BIOL LETTERS, V2, P125, DOI 10.1098/rsbl.2005.0378; Willis K. J., 2002, EVOLUTION PLANTS; Wright JL, 1999, SP PALAEONT, P209; ZIEGLER AM, 1993, PHILOS T ROY SOC B, V341, P297, DOI 10.1098/rstb.1993.0115	118	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12553	10.1371/journal.pone.0012553	http://dx.doi.org/10.1371/journal.pone.0012553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838442	Green Published, gold			2022-12-27	WOS:000281627700006
J	Brennan, SK; Wang, Q; Tressler, R; Harley, C; Go, N; Bassett, E; Huff, CA; Jones, RJ; Matsui, W				Brennan, Sarah K.; Wang, Qiuju; Tressler, Robert; Harley, Calvin; Go, Ning; Bassett, Ekaterina; Huff, Carol Ann; Jones, Richard J.; Matsui, William			Telomerase Inhibition Targets Clonogenic Multiple Myeloma Cells through Telomere Length-Dependent and Independent Mechanisms	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; REVERSE-TRANSCRIPTASE; IN-VIVO; TEMPLATE ANTAGONIST; GROWTH ARREST; LIFE-SPAN; CANCER; GRN163L; RNA; OLIGONUCLEOTIDE	Background: Plasma cells constitute the majority of tumor cells in multiple myeloma (MM) but lack the potential for sustained clonogenic growth. In contrast, clonotypic B cells can engraft and recapitulate disease in immunodeficient mice suggesting they serve as the MM cancer stem cell (CSC). These tumor initiating B cells also share functional features with normal stem cells such as drug resistance and self-renewal potential. Therefore, the cellular processes that regulate normal stem cells may serve as therapeutic targets in MM. Telomerase activity is required for the maintenance of normal adult stem cells, and we examined the activity of the telomerase inhibitor imetelstat against MM CSC. Moreover, we carried out both long and short-term inhibition studies to examine telomere length-dependent and independent activities. Methodology/Principal Findings: Human MM CSC were isolated from cell lines and primary clinical specimens and treated with imetelstat, a specific inhibitor of the reverse transcriptase activity of telomerase. Two weeks of exposure to imetelstat resulted in a significant reduction in telomere length and the inhibition of clonogenic MM growth both in vitro and in vivo. In addition to these relatively long-term effects, 72 hours of imetelstat treatment inhibited clonogenic growth that was associated with MM CSC differentiation based on expression of the plasma cell antigen CD138 and the stem cell marker aldehyde dehydrogenase. Short-term treatment of MM CSC also decreased the expression of genes typically expressed by stem cells (OCT3/4, SOX2, NANOG, and BMI1) as revealed by quantitative real-time PCR. Conclusions: Telomerase activity regulates the clonogenic growth of MM CSC. Moreover, reductions in MM growth following both long and short-term telomerase inhibition suggest that it impacts CSC through telomere length-dependent and independent mechanisms.	[Brennan, Sarah K.; Wang, Qiuju; Huff, Carol Ann; Jones, Richard J.; Matsui, William] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Tressler, Robert; Harley, Calvin; Go, Ning; Bassett, Ekaterina] Geron Corp, Menlo Pk, CA USA	Johns Hopkins University; Johns Hopkins Medicine; Geron Corporation	Brennan, SK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA.	matsuwi@jhmi.edu		Matsui, William/0000-0002-3088-0964	National Institutes of Health [R01CA127574, P01CA015396, K23CA107040]; Gabrielle Angel Foundation for Cancer Research; Sidney Kimmel Foundation for Cancer Research; Goodwin Foundation; Geron Corporation; NATIONAL CANCER INSTITUTE [K23CA107040, R01CA127574, P01CA015396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle Angel Foundation for Cancer Research; Sidney Kimmel Foundation for Cancer Research; Goodwin Foundation; Geron Corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the National Institutes of Health (R01CA127574, P01CA015396, K23CA107040), the Gabrielle Angel Foundation for Cancer Research, the Sidney Kimmel Foundation for Cancer Research, and the Goodwin Foundation. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding for the research was also provided by the Geron Corporation to W. M. R. T., C. H., N.G., and E. B., who are employees of Geron. This funder therefore had a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Akiyama M, 2003, CANCER RES, V63, P6187; Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Bagheri S, 2006, P NATL ACAD SCI USA, V103, P11306, DOI 10.1073/pnas.0510085103; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; BROWER V, J NATL CANC I, V102, P520; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Dikmen ZG, 2005, CANCER RES, V65, P7866, DOI 10.1158/0008-5472.CAN-05-1215; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Engelhardt M, 2000, CANCER RES, V60, P610; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008; Galderisi U, 1999, J CELL PHYSIOL, V181, P251, DOI 10.1002/(SICI)1097-4652(199911)181:2<251::AID-JCP7>3.0.CO;2-D; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Guo CH, 2001, J UROLOGY, V166, P694, DOI 10.1016/S0022-5347(05)66045-4; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; HarleBachor C, 1996, P NATL ACAD SCI USA, V93, P6476, DOI 10.1073/pnas.93.13.6476; Hashizume R, 2008, NEURO-ONCOLOGY, V10, P112, DOI 10.1215/15228517-2007-052; HIYAMA K, 1995, J IMMUNOL, V155, P3711; Hochreiter AE, 2006, CLIN CANCER RES, V12, P3184, DOI 10.1158/1078-0432.CCR-05-2760; Jackson SR, 2007, CANCER RES, V67, P1121, DOI 10.1158/0008-5472.CAN-06-2306; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kraemer Kai, 2007, V405, P9, DOI 10.1007/978-1-60327-070-0_2; Laubach JP, 2009, LEUKEMIA, V23, P2222, DOI 10.1038/leu.2009.179; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li S, 2005, J BIOL CHEM, V280, P23709, DOI 10.1074/jbc.M502782200; MARIAN CO, CLIN CANC RES, V16, P154; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; Miura N, 1997, CANCER GENET CYTOGEN, V93, P56, DOI 10.1016/S0165-4608(96)00329-9; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rossi A, 2009, INT J CANCER, V125, P235, DOI 10.1002/ijc.24331; Samper E, 2002, BLOOD, V99, P2767, DOI 10.1182/blood.V99.8.2767; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Shammas MA, 2008, LEUKEMIA, V22, P1410, DOI 10.1038/leu.2008.81; Shammas MA, 2004, CLIN CANCER RES, V10, P770, DOI 10.1158/1078-0432.CCR-0793-03; Shammas MA, 2003, MOL CANCER THER, V2, P825; Shay JW, 1997, J CELL PHYSIOL, V173, P266, DOI 10.1002/(SICI)1097-4652(199711)173:2<266::AID-JCP33>3.0.CO;2-B; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shea-Herbert B, 2002, ONCOGENE, V21, P638, DOI 10.1038/sj.onc.1205064; Shiratsuchi M, 2002, CANCER, V94, P2232, DOI 10.1002/cncr.10472; Spisek R, 2007, J EXP MED, V204, P831, DOI 10.1084/jem.20062387; Strahl C, 1996, MOL CELL BIOL, V16, P53; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6; Wang ES, 2004, BLOOD, V103, P258, DOI 10.1182/blood-2003-02-0546; Wright WE, 1996, DEV GENET, V18, P173; Wu KD, 2003, BLOOD, V101, P4982, DOI 10.1182/blood-2002-11-3451; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yokoyama Y, 1998, CANCER RES, V58, P5406; YU GL, 1990, NATURE, V344, P126, DOI 10.1038/344126a0; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Yuan XM, 1999, GENES CELLS, V4, P563, DOI 10.1046/j.1365-2443.1999.00284.x; Yui J, 1998, BLOOD, V91, P3255, DOI 10.1182/blood.V91.9.3255.3255_3255_3262; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	63	60	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12487	10.1371/journal.pone.0012487	http://dx.doi.org/10.1371/journal.pone.0012487			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824134	Green Published, Green Submitted, gold			2022-12-27	WOS:000281456100008
J	Steensland, P; Simms, JA; Nielsen, CK; Holgate, J; Bito-Onon, JJ; Bartlett, SE				Steensland, Pia; Simms, Jeffrey A.; Nielsen, Carsten K.; Holgate, Joan; Bito-Onon, Jade J.; Bartlett, Selena E.			The Neurokinin 1 Receptor Antagonist, Ezlopitant, Reduces Appetitive Responding for Sucrose and Ethanol	PLOS ONE			English	Article							MU-OPIOID RECEPTORS; FOOD-INTAKE; BEHAVIORAL SENSITIZATION; INDUCED REINSTATEMENT; DRUG-ADDICTION; MICE LACKING; LONG-EVANS; SUGAR; CONSUMPTION; MORPHINE	Background: The current obesity epidemic is thought to be partly driven by over-consumption of sugar-sweetened diets and soft drinks. Loss-of-control over eating and addiction to drugs of abuse share overlapping brain mechanisms including changes in motivational drive, such that stimuli that are often no longer 'liked' are still intensely 'wanted' [7,8]. The neurokinin 1 (NK1) receptor system has been implicated in both learned appetitive behaviors and addiction to alcohol and opioids; however, its role in natural reward seeking remains unknown. Methodology/Principal Findings: We sought to determine whether the NK1-receptor system plays a role in the reinforcing properties of sucrose using a novel selective and clinically safe NK1-receptor antagonist, ezlopitant (CJ-11,974), in three animal models of sucrose consumption and seeking. Furthermore, we compared the effect of ezlopitant on ethanol consumption and seeking in rodents. The NK1-receptor antagonist, ezlopitant decreased appetitive responding for sucrose more potently than for ethanol using an operant self-administration protocol without affecting general locomotor activity. To further evaluate the selectivity of the NK1-receptor antagonist in decreasing consumption of sweetened solutions, we compared the effects of ezlopitant on water, saccharin-, and sodium chloride (NaCl) solution consumption. Ezlopitant decreased intake of saccharin but had no effect on water or salty solution consumption. Conclusions/Significance: The present study indicates that the NK1-receptor may be a part of a common pathway regulating the self-administration, motivational and reinforcing aspects of sweetened solutions, regardless of caloric value, and those of substances of abuse. Additionally, these results indicate that the NK1-receptor system may serve as a therapeutic target for obesity induced by over-consumption of natural reinforcers.	[Steensland, Pia; Simms, Jeffrey A.; Nielsen, Carsten K.; Holgate, Joan; Bito-Onon, Jade J.; Bartlett, Selena E.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA; [Steensland, Pia] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; Karolinska Institutet	Steensland, P (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA.	selenab@gallo.ucsf.edu	Bartlett, Selena/J-1345-2012	Bartlett, Selena/0000-0002-1741-3958; Steensland, Pia/0000-0003-4443-5017; Holgate, Joan/0000-0002-7953-0180	State of California for Medical Research through University of California San Francisco (UCSF) and Department of Defense [W81XWH-08-1-0016, W81XWH-07-1-0075]; Sidney Baer Trust; Foundation BLANCEFLOR Boncompagni-Ludovisi; Sweden-America Foundation; Insamlingsstiftelsen Hjarnfonden/The Swedish Brain Foundation; Swedish Research Council; Pfizer Inc.	State of California for Medical Research through University of California San Francisco (UCSF) and Department of Defense; Sidney Baer Trust; Foundation BLANCEFLOR Boncompagni-Ludovisi; Sweden-America Foundation; Insamlingsstiftelsen Hjarnfonden/The Swedish Brain Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Pfizer Inc.(Pfizer)	This work was supported by funding from the State of California for Medical Research through University of California San Francisco (UCSF) and Department of Defense Grant W81XWH-08-1-0016 and W81XWH-07-1-0075 to S. E. B. S. E. B. and C.K.N. were supported in part by the Sidney Baer Trust as a National Alliance for Research on Schizophrenia and Depression Young Investigator. P. S. was supported in part by The Foundation BLANCEFLOR Boncompagni-Ludovisi, nee Bildt, The Sweden-America Foundation, Insamlingsstiftelsen Hjarnfonden/The Swedish Brain Foundation and The Swedish Research Council. The experiments contained herein comply with the current laws of the United States of America. S. E. B. received a research grant from Pfizer Inc. for varenicline studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019; Avena NM, 2005, PHYSIOL BEHAV, V84, P359, DOI 10.1016/j.physbeh.2004.12.016; Avena NM, 2003, NEUROSCIENCE, V122, P17, DOI 10.1016/S0306-4522(03)00502-5; BECZKOWSKA IW, 1992, BRAIN RES, V589, P291, DOI 10.1016/0006-8993(92)91289-Q; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Berthoud HR, 2006, OBESITY, V14, P197; Blundell JE, 2001, OBES RES, V9, p263S, DOI 10.1038/oby.2001.129; Bowers MS, 2008, P NATL ACAD SCI USA, V105, P12533, DOI 10.1073/pnas.0706999105; BRAY GA, 1992, AM J CLIN NUTR, V55, P151; Colantuoni C, 2002, OBES RES, V10, P478, DOI 10.1038/oby.2002.66; Colantuoni C, 2001, NEUROREPORT, V12, P3549, DOI 10.1097/00001756-200111160-00035; Dableh LJ, 2005, EUR J PHARMACOL, V507, P99, DOI 10.1016/j.ejphar.2004.11.024; DAnci KE, 1996, PHARMACOL BIOCHEM BE, V54, P693, DOI 10.1016/0091-3057(96)00016-0; Gadd CA, 2003, J NEUROSCI, V23, P8271, DOI 10.1523/jneurosci.23-23-08271.2003; Galic MA, 2002, PSYCHOL REP, V90, P58, DOI 10.2466/pr0.2002.90.1.58; George DT, 2008, SCIENCE, V319, P1536, DOI 10.1126/science.1153813; GIANOULAKIS C, 2009, CURR TOP MED CHEM; Gosnell BA, 2005, BRAIN RES, V1031, P194, DOI 10.1016/j.brainres.2004.10.037; Grimm JW, 2008, BEHAV PHARMACOL, V19, P777, DOI 10.1097/FBP.0b013e32831c3b18; Grimm JW, 2005, PHYSIOL BEHAV, V84, P73, DOI 10.1016/j.physbeh.2004.10.011; Hajnal A, 2004, AM J PHYSIOL-REG I, V286, pR31, DOI 10.1152/ajpregu.00282.2003; Heilig M, 2007, TRENDS NEUROSCI, V30, P399, DOI 10.1016/j.tins.2007.06.006; Heilig M, 2006, PHARMACOL THERAPEUT, V111, P855, DOI 10.1016/j.pharmthera.2006.02.001; Hesketh PJ, 1999, J CLIN ONCOL, V17, P338, DOI 10.1200/JCO.1999.17.1.338; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Howard BV, 2002, CIRCULATION, V106, P523, DOI 10.1161/01.CIR.0000019552.77778.04; Jabourian M, 2005, EUR J NEUROSCI, V21, P3301, DOI 10.1111/j.1460-9568.2005.04154.x; Kanarek RB, 1997, PHARMACOL BIOCHEM BE, V57, P377, DOI 10.1016/S0091-3057(96)00337-1; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; LIEBLICH I, 1983, SCIENCE, V221, P871, DOI 10.1126/science.6879185; LOWE JA, 1992, J MED CHEM, V35, P2591, DOI 10.1021/jm00092a009; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Mercer ME, 1997, APPETITE, V29, P325, DOI 10.1006/appe.1997.0100; Murtra P, 2000, NATURE, V405, P180, DOI 10.1038/35012069; NAKAYA Y, 1994, J COMP NEUROL, V347, P249, DOI 10.1002/cne.903470208; Nielsen CK, 2008, BIOL PSYCHIAT, V64, P974, DOI 10.1016/j.biopsych.2008.07.018; Pickel VM, 2000, J COMP NEUROL, V423, P500, DOI 10.1002/1096-9861(20000731)423:3<500::AID-CNE12>3.0.CO;2-9; Poulin JF, 2006, J COMP NEUROL, V496, P859, DOI 10.1002/cne.20956; Rada P, 2005, NEUROSCIENCE, V134, P737, DOI 10.1016/j.neuroscience.2005.04.043; Reed-Hagen AE, 1999, BIOPHARM DRUG DISPOS, V20, P429, DOI 10.1002/1099-081X(199912)20:9<429::AID-BDD209>3.0.CO;2-D; Rhodes JS, 2005, PHYSIOL BEHAV, V84, P53, DOI 10.1016/j.physbeh.2004.10.007; Richards JK, 2008, PSYCHOPHARMACOLOGY, V199, P109, DOI 10.1007/s00213-008-1136-5; Ripley TL, 2002, NEUROPHARMACOLOGY, V43, P1258, DOI 10.1016/S0028-3908(02)00295-2; Rudski JM, 1997, PHARMACOL BIOCHEM BE, V58, P679, DOI 10.1016/S0091-3057(97)00019-1; SAMSON HH, 1986, ALCOHOL CLIN EXP RES, V10, P436, DOI 10.1111/j.1530-0277.1986.tb05120.x; Sanchis-Segura C, 2006, ADDICT BIOL, V11, P2, DOI 10.1111/j.1369-1600.2006.00012.x; Seneviratne C, 2009, NEUROPSYCHOPHARMACOL, V34, P2442, DOI 10.1038/npp.2009.65; Shalev U, 2001, J NEUROSCI, V21; Shimura T, 2002, BEHAV BRAIN RES, V134, P123, DOI 10.1016/S0166-4328(01)00461-2; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Spangler R, 2004, MOL BRAIN RES, V124, P134, DOI 10.1016/j.molbrainres.2004.02.013; Steensland P, 2007, P NATL ACAD SCI USA, V104, P12518, DOI 10.1073/pnas.0705368104; Stromberg MF, 2002, PHARMACOL BIOCHEM BE, V72, P483, DOI 10.1016/S0091-3057(02)00721-9; Tanda GL, 1998, EUR J NEUROSCI, V10, P1179, DOI 10.1046/j.1460-9568.1998.00135.x; Tsuchiya M, 2002, PHARMACOLOGY, V66, P144, DOI 10.1159/000063796; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Wang GJ, 2006, P NATL ACAD SCI USA, V103, P15641, DOI 10.1073/pnas.0601977103; Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04; WISE RA, 1973, PSYCHOPHARMACOLOGIA, V29, P203, DOI 10.1007/BF00414034; Yeomans MR, 2002, NEUROSCI BIOBEHAV R, V26, P713, DOI 10.1016/S0149-7634(02)00041-6; Yu YJ, 2009, J NEUROSCI, V29, P222, DOI 10.1523/JNEUROSCI.4315-08.2009	62	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12527	10.1371/journal.pone.0012527	http://dx.doi.org/10.1371/journal.pone.0012527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824145	Green Published, gold, Green Submitted			2022-12-27	WOS:000281456100022
J	Drews, C; Han, WQ				Drews, Carl; Han, Weiqing			Dynamics of Wind Setdown at Suez and the Eastern Nile Delta	PLOS ONE			English	Article							STORM SURGES; RED-SEA; MODEL; ANCIENT; EGYPT; SIMULATIONS; CHANNELS; PELUSIUM; DEMISE; IMPACT	Background: Wind setdown is the drop in water level caused by wind stress acting on the surface of a body of water for an extended period of time. As the wind blows, water recedes from the upwind shore and exposes terrain that was formerly underwater. Previous researchers have suggested wind setdown as a possible hydrodynamic explanation for Moses crossing the Red Sea, as described in Exodus 14. Methodology/Principal Findings: This study analyzes the hydrodynamic mechanism proposed by earlier studies, focusing on the time needed to reach a steady-state solution. In addition, the authors investigate a site in the eastern Nile delta, where the ancient Pelusiac branch of the Nile once flowed into a coastal lagoon then known as the Lake of Tanis. We conduct a satellite and modeling survey to analyze this location, using geological evidence of the ancient bathymetry and a historical description of a strong wind event in 1882. A suite of model experiments are performed to demonstrate a new hydrodynamic mechanism that can cause an angular body of water to divide under wind stress, and to test the behavior of our study location and reconstructed topography. Conclusions/Significance: Under a uniform 28 m/s easterly wind forcing in the reconstructed model basin, the ocean model produces an area of exposed mud flats where the river mouth opens into the lake. This land bridge is 3-4 km long and 5 km wide, and it remains open for 4 hours. Model results indicate that navigation in shallow-water harbors can be significantly curtailed by wind setdown when strong winds blow offshore.	[Drews, Carl; Han, Weiqing] Univ Colorado, Dept Atmospher & Ocean Sci, Boulder, CO 80309 USA; [Drews, Carl] Natl Ctr Atmospher Res, NCAR Earth Syst Lab, Boulder, CO 80307 USA	University of Colorado System; University of Colorado Boulder; National Center Atmospheric Research (NCAR) - USA	Drews, C (corresponding author), Univ Colorado, Dept Atmospher & Ocean Sci, Boulder, CO 80309 USA.	drews@ucar.edu		Drews, Carl/0000-0002-0535-6538	Office of Naval Research (ONR) [N00014-07-1-0413]; NASA [1283568]; NSF [OCE 0847605]; National Science Foundation	Office of Naval Research (ONR)(Office of Naval Research); NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	The authors are grateful to the University Corporation for Atmospheric Research (UCAR/NCAR) for tuition and computational support for the lead author, Carl Drews, and for support by the Office of Naval Research (ONR) N00014-07-1-0413. Weiqing Han is also supported by NASA Ocean Vector Wind Science Team 1283568 and NSF CAREER OCE 0847605. The National Center for Atmospheric Research is sponsored by the National Science Foundation. Any opinions, findings and conclusions or recommendations expressed in the publication are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIETAK M, 1995, AVARIS CAPITAL HYKSO; *BIRDLIFE INT, 2008, BIRDLIFES ONL WORLD; El Mahmoudi A, 2009, ARAB J GEOSCI, V2, P53, DOI 10.1007/s12517-008-0018-9; FITZPATRICK PJ, 2007, 21 C HYDR 87 ANN M A; Goodfriend GA, 1999, GEOLOGY, V27, P147, DOI 10.1130/0091-7613(1999)027<0147:RSPAIT>2.3.CO;2; *GOOGL EARTH PRO, 2009, E NIL DELT; Haidvogel DB, 2000, DYNAM ATMOS OCEANS, V32, P239, DOI 10.1016/S0377-0265(00)00049-X; Han WQ, 2009, DYNAM ATMOS OCEANS, V47, P114, DOI 10.1016/j.dynatmoce.2008.10.007; Hipel KW, 1994, TIME SERIES MODELLIN; Hoffmeier J. K., 2005, ANCIENT ISRAEL SINAI; Jarosz E, 2007, SCIENCE, V315, P1707, DOI 10.1126/science.1136466; KITCHEN KA, 2003, RELIABILITY OLD TEST; LARGE WG, 1981, J PHYS OCEANOGR, V11, P324, DOI 10.1175/1520-0485(1981)011<0324:OOMFMI>2.0.CO;2; MELLOR GL, 1982, REV GEOPHYS, V20, P851, DOI 10.1029/RG020i004p00851; Moore AM, 2004, OCEAN MODEL, V7, P227, DOI 10.1016/j.ocemod.2003.11.001; Moshier SO, 2008, GEOARCHAEOLOGY, V23, P450, DOI 10.1002/gea.20227; MOUSSA AMA, 2007, 11 INT WAT TECHN C T, P423; *NASA WORLD WIND, 2009, E NIL DAT; NOF D, 1992, B AM METEOROL SOC, V73, P305, DOI 10.1175/1520-0477(1992)073<0305:ATOEFT>2.0.CO;2; NOF D, 1994, J APPL METEOROL, V33, P1017, DOI 10.1175/1520-0450(1994)033<1017:SOWOTR>2.0.CO;2; Powell MD, 2003, NATURE, V422, P279, DOI 10.1038/nature01481; PTOLEMY C, 1932, GEOGRAPHY BOOK 4, pCH5; Resio DT, 2008, PHYS TODAY, V61, P33, DOI 10.1063/1.2982120; RIPLEY G, 1875, AM CYCLOPAEDIA POPUL; RITTER DF, 1830, PROCESS GEOMORPHOLOG, pCH7; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; SNEH A, 1975, AM SCI, V63, P542; SNEH A, 1973, SCIENCE, V180, P59, DOI 10.1126/science.180.4081.59; STANLEY DJ, 1993, SCIENCE, V260, P628, DOI 10.1126/science.260.5108.628; Stanley JD, 2008, J COASTAL RES, V24, P451, DOI 10.2112/07A-0021.1; Tulloch A. B., 1896, J T VICTORIA I NOW F, V28, P267; *US GEOL SURV, 2008, NASA SHUTTL RAD TOP; Voltzinger NE, 2003, IZV ATMOS OCEAN PHY+, V39, P482; VONPETERMANN A, 1856, KARTE BAI SUES; Waldron J. C., 1996, NILE DELTA DRILL COR; Wang SY, 2008, OCEAN MODEL, V25, P83, DOI 10.1016/j.ocemod.2008.06.009; Warner JC, 2004, ESTUAR COAST SHELF S, V60, P213, DOI 10.1016/j.ecss.2003.12.011; Weisberg RH, 2006, ESTUAR COAST, V29, P899, DOI 10.1007/BF02798649; HERODOTUS HALICARNAS	39	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12481	10.1371/journal.pone.0012481	http://dx.doi.org/10.1371/journal.pone.0012481			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20827299	gold, Green Published, Green Submitted			2022-12-27	WOS:000281375500014
J	Comunale, MA; Rodemich-Betesh, L; Hafner, J; Wang, MJ; Norton, P; Di Bisceglie, AM; Block, T; Mehta, A				Comunale, Mary Ann; Rodemich-Betesh, Lucy; Hafner, Julie; Wang, Mengjun; Norton, Pamela; Di Bisceglie, Adrian M.; Block, Timothy; Mehta, Anand			Linkage Specific Fucosylation of Alpha-1-Antitrypsin in Liver Cirrhosis and Cancer Patients: Implications for a Biomarker of Hepatocellular Carcinoma	PLOS ONE			English	Article							HIGHLY ENHANCED FUCOSYLATION; SERUM ALPHA-FETOPROTEIN; HEPATITIS-B-VIRUS; PROTEOMIC ANALYSIS; PH GRADIENTS; RISK-FACTORS; GLYCOPROTEINS; DIAGNOSIS; HEPATOMA	Background: We previously reported increased levels of protein-linked fucosylation with the development of liver cancer and identified many of the proteins containing the altered glycan structures. One such protein is alpha-1-antitrypsin (A1AT). To advance these studies, we performed N-linked glycan analysis on the five major isoforms of A1AT and completed a comprehensive study of the glycosylation of A1AT found in healthy controls, patients with hepatitis C-(HCV) induced liver cirrhosis, and in patients infected with HCV with a diagnosis of hepatocellular carcinoma (HCC). Methodology/Principal Findings: Patients with liver cirrhosis and liver cancer had increased levels of triantennary glycan-containing outer arm (alpha-1,3) fucosylation. Increases in core (alpha-1,6) fucosylation were observed only on A1AT from patients with cancer. We performed a lectin fluorophore-linked immunosorbent assay using Aleuria Aurantia lectin (AAL), specific for core and outer arm fucosylation in over 400 patients with liver disease. AAL-reactive A1AT was able to detect HCC with a sensitivity of 70% and a specificity of 86%, which was greater than that observed with the current marker of HCC, alpha-fetoprotein. Glycosylation analysis of the false positives was performed; results indicated that these patients had increases in outer arm fucosylation but not in core fucosylation, suggesting that core fucosylation is cancer specific. Conclusions/Significance: This report details the stepwise change in the glycosylation of A1AT with the progression from liver cirrhosis to cancer and identifies core fucosylation on A1AT as an HCC specific modification.	[Comunale, Mary Ann; Rodemich-Betesh, Lucy; Hafner, Julie; Wang, Mengjun; Norton, Pamela; Block, Timothy; Mehta, Anand] Drexel Univ, Coll Med, Drexel Inst Biotechnol & Virus Res, Dept Microbiol & Immunol, Doylestown, PA USA; [Di Bisceglie, Adrian M.] St Louis Univ, Sch Med, St Louis VA Med Ctr, Div Gastroenterol & Hepatol, St Louis, MO USA	Drexel University; Saint Louis University	Comunale, MA (corresponding author), Drexel Univ, Coll Med, Drexel Inst Biotechnol & Virus Res, Dept Microbiol & Immunol, Doylestown, PA USA.	anand.mehta@drexelmed.edu		Norton, Pamela/0000-0003-1327-9250	National Cancer Institute (NCI) [R01 CA120206-01]; NCI Early Research Detection Network (EDRN) [UO1 CA084951-06]; Hepatitis B Foundation; NATIONAL CANCER INSTITUTE [R01CA120206, U01CA084951] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Early Research Detection Network (EDRN); Hepatitis B Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant R01 CA120206-01 from the National Cancer Institute (NCI), grant UO1 CA084951-06 from the NCI Early Research Detection Network (EDRN), the Hepatitis B Foundation, and an appropriation from The Commonwealth of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Hamid UM, 2008, GLYCOBIOLOGY, V18, P1105, DOI 10.1093/glycob/cwn095; ALPERT ME, 1968, NEW ENGL J MED, V278, P984, DOI 10.1056/NEJM196805022781804; AOYAGI Y, 1993, CANCER-AM CANCER SOC, V72, P615, DOI 10.1002/1097-0142(19930715)72:2<615::AID-CNCR2820720246>3.0.CO;2-T; Aoyagi Y, 1998, CANCER, V83, P2076, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2076::AID-CNCR5>3.0.CO;2-L; Arnold JN, 2008, PROTEOMICS, V8, P3284, DOI 10.1002/pmic.200800163; Block TM, 2005, P NATL ACAD SCI USA, V102, P779, DOI 10.1073/pnas.0408928102; Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557; BROOKS KP, 1985, CLIN BIOCHEM, V18, P280, DOI 10.1016/S0009-9120(85)80032-1; Comunale MA, 2006, J PROTEOME RES, V5, P308, DOI 10.1021/pr050328x; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; DIBISCEGLIE AM, 1989, MED CLIN N AM, V73, P985, DOI 10.1016/S0025-7125(16)30649-6; DIBISCEGLIE AM, 1989, CANCER, V64, P2117, DOI 10.1002/1097-0142(19891115)64:10<2117::AID-CNCR2820641024>3.0.CO;2-7; El-Serag HB, 2001, HEPATOLOGY, V33, P62, DOI 10.1053/jhep.2001.21041; Guile GR, 1996, ANAL BIOCHEM, V240, P210, DOI 10.1006/abio.1996.0351; JEPPSSON JO, 1992, CLIN CHEM, V38, P577; Kolarich D, 2006, PROTEOMICS, V6, P3369, DOI 10.1002/pmic.200500751; Liu XE, 2007, HEPATOLOGY, V46, P1426, DOI 10.1002/hep.21855; Lok ASF, 2001, HEPATOLOGY, V34, P1225, DOI 10.1053/jhep.2001.29401; Marrero JA, 2006, CURR OPIN GASTROEN, V22, P248, DOI 10.1097/01.mog.0000218961.86182.8c; Marrero JA, 2005, J HEPATOL, V43, P1007, DOI 10.1016/j.jhep.2005.05.028; Naitoh A, 1999, J GASTROEN HEPATOL, V14, P436, DOI 10.1046/j.1440-1746.1999.01882.x; Nakagawa T, 2006, J BIOL CHEM, V281, P29797, DOI 10.1074/jbc.M605697200; Noda K, 2003, CANCER RES, V63, P6282; PERACAULA R, 2010, PROTEOMICS IN PRESS; Rudd PM, 1997, CRIT REV BIOCHEM MOL, V32, P1, DOI 10.3109/10409239709085144; RUOSLAHTI E, 1974, BMJ-BRIT MED J, V2, P527, DOI 10.1136/bmj.2.5918.527; SALLIE R, 1994, GASTROENTEROL CLIN N, V23, P567; Sarbah SA, 2004, DIGEST DIS SCI, V49, P850, DOI 10.1023/B:DDAS.0000030098.75759.32; Sherman M, 2005, SEMIN LIVER DIS, V25, P143, DOI 10.1055/s-2005-871194	29	94	99	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12419	10.1371/journal.pone.0012419	http://dx.doi.org/10.1371/journal.pone.0012419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811639	Green Published, gold, Green Submitted			2022-12-27	WOS:000281234700033
J	Clark, J; Clore, EL; Zheng, KN; Adame, A; Masliah, E; Simon, DK				Clark, Joanne; Clore, Elizabeth L.; Zheng, Kangni; Adame, Anthony; Masliah, Eliezer; Simon, David K.			Oral N-Acetyl-Cysteine Attenuates Loss of Dopaminergic Terminals in alpha-Synuclein Overexpressing Mice	PLOS ONE			English	Article							GROWTH-FACTOR-B; PARKINSONS-DISEASE; OXIDATIVE STRESS; KAPPA-B; WILD-TYPE; NEURODEGENERATION; ACETYLCYSTEINE; GLUTATHIONE; MODEL; INDUCTION	Levels of glutathione are lower in the substantia nigra (SN) early in Parkinson's disease (PD) and this may contribute to mitochondrial dysfunction and oxidative stress. Oxidative stress may increase the accumulation of toxic forms of alpha-synuclein (SNCA). We hypothesized that supplementation with n-acetylcysteine (NAC), a source of cysteine - the limiting amino acid in glutathione synthesis, would protect against alpha-synuclein toxicity. Transgenic mice overexpressing wild-type human alpha-synuclein drank water supplemented with NAC or control water supplemented with alanine from ages 6 weeks to 1 year. NAC increased SN levels of glutathione within 5-7 weeks of treatment; however, this increase was not sustained at 1 year. Despite the transient nature of the impact of NAC on brain glutathione, the loss of dopaminergic terminals at 1 year associated with SNCA overexpression was significantly attenuated by NAC supplementation, as measured by immunoreactivity for tyrosine hydroxylase in the striatum (p = 0.007; unpaired, two-tailed t-test), with a similar but nonsignificant trend for dopamine transporter (DAT) immunoreactivity. NAC significantly decreased the levels of human SNCA in the brains of PDGFb-SNCA transgenic mice compared to alanine treated transgenics. This was associated with a decrease in nuclear NF kappa B localization and an increase in cytoplasmic localization of NF kappa B in the NAC-treated transgenics. Overall, these results indicate that oral NAC supplementation decreases SNCA levels in brain and partially protects against loss of dopaminergic terminals associated with overexpression of alpha-synuclein in this model.	[Clark, Joanne; Clore, Elizabeth L.; Zheng, Kangni; Simon, David K.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Clark, Joanne; Simon, David K.] Harvard Univ, Sch Med, Boston, MA USA; [Adame, Anthony; Masliah, Eliezer] Univ So Calif, Dept Neurosci, Sch Med, San Diego, CA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Southern California	Clark, J (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.	dsimon1@bidmc.harvard.edu			American Federation for Aging Research	American Federation for Aging Research	This project was supported by an 'Innovations in Aging Research Award' to Dr. Simon from the American Federation for Aging Research: http://afar.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair JC, 2001, NEUROLOGY, V57, P1515, DOI 10.1212/WNL.57.8.1515; Adams JD, 2001, CURR MED CHEM, V8, P809, DOI 10.2174/0929867013372995; Andreassen OA, 2000, NEUROREPORT, V11, P2491, DOI 10.1097/00001756-200008030-00029; Aoki E, 2009, EXP MOL PATHOL, V86, P57, DOI 10.1016/j.yexmp.2008.10.004; Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; Balansky R, 1996, CANCER RES, V56, P1642; Banaclocha MM, 2001, MED HYPOTHESES, V56, P472, DOI 10.1054/mehy.2000.1194; Banaclocha MM, 2000, BRAIN RES, V859, P173, DOI 10.1016/S0006-8993(00)02005-9; Banaclocha MM, 1997, BRAIN RES, V762, P256, DOI 10.1016/S0006-8993(97)00493-9; Camandola S, 2007, EXPERT OPIN THER TAR, V11, P123, DOI 10.1517/14728222.11.2.123; Cassarino DS, 1997, BBA-MOL BASIS DIS, V1362, P77, DOI 10.1016/S0925-4439(97)00070-7; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chesselet Marie-Francoise, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS84, DOI 10.1016/j.parkreldis.2008.04.004; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; DEXTER DT, 1994, MOVEMENT DISORD, V9, P92, DOI 10.1002/mds.870090115; Dringen R, 1999, NEUROSCI LETT, V259, P79, DOI 10.1016/S0304-3940(98)00894-5; Duda JE, 2000, AM J PATHOL, V157, P1439, DOI 10.1016/S0002-9440(10)64781-5; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Greenamyre JT, 2003, PARKINSONISM RELAT D, V9, pS59, DOI 10.1016/S1353-8020(03)00023-3; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Gu XL, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-12; Gwinn-Hardy K, 2002, MOVEMENT DISORD, V17, P645, DOI 10.1002/mds.10173; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Hashimoto M, 2003, ANN NY ACAD SCI, V991, P171; Hashimoto M, 1999, NEUROREPORT, V10, P717, DOI 10.1097/00001756-199903170-00011; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; KHACHIGIAN LM, 1995, J CLIN INVEST, V96, P1169, DOI 10.1172/JCI118106; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Langston JW, 1996, NEUROLOGY, V47, pS153, DOI 10.1212/WNL.47.6_Suppl_3.153S; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Liu L, 2010, EXP NEUROL, V222, P25, DOI 10.1016/j.expneurol.2009.11.009; Martinez M, 1999, LIFE SCI, V64, P1253, DOI 10.1016/S0024-3205(98)00472-X; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Matsuura K, 1997, J NEUROSCI METH, V73, P45, DOI 10.1016/S0165-0270(96)02211-X; OGAWA N, 1985, RES COMMUN CHEM PATH, V50, P435; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; PERRY TL, 1982, NEUROSCI LETT, V33, P305, DOI 10.1016/0304-3940(82)90390-1; PERRY TL, 1985, NEUROSCI LETT, V60, P109, DOI 10.1016/0304-3940(85)90229-0; Pocernich CB, 2000, NEUROCHEM INT, V36, P185, DOI 10.1016/S0197-0186(99)00126-6; Quilty MC, 2006, EXP NEUROL, V199, P249, DOI 10.1016/j.expneurol.2005.10.018; Ravina BM, 2003, NEUROLOGY, V60, P1234, DOI 10.1212/01.WNL.0000058760.13152.1A; Reliene R, 2004, CANCER RES, V64, P5148, DOI 10.1158/0008-5472.CAN-04-0442; Richfield EK, 2002, EXP NEUROL, V175, P35, DOI 10.1006/exnr.2002.7882; Rochet JC, 2004, J MOL NEUROSCI, V23, P23, DOI 10.1385/JMN:23:1-2:023; Rommelfanger KS, 2007, P NATL ACAD SCI USA, V104, P13804, DOI 10.1073/pnas.0702753104; Schapira AH, 2008, EUR J NEUROL, V15, P1, DOI 10.1111/j.1468-1331.2007.02036.x; SCHAPIRA AHV, 1992, ANN NEUROL, V32, pS116, DOI 10.1002/ana.410320720; Sha D, 2010, HUM MOL GENET, V19, P352, DOI 10.1093/hmg/ddp501; Sharma A, 2007, CELL MOL BIOL, V53, P48, DOI 10.1170/T774; SHEFFNER AL, 1966, BIOCHEM PHARMACOL, V15, P1523, DOI 10.1016/0006-2952(66)90197-3; Sherer TB, 2002, J NEUROSCI, V22, P7006; Shi JR, 2004, J CARDIOVASC PHARM, V44, P26; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Thiruchelvam MJ, 2004, EUR J NEUROSCI, V19, P845, DOI 10.1111/j.0953-816X.2004.03139.x; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tillerson JL, 2002, EXP NEUROL, V178, P80, DOI 10.1006/exnr.2002.8021; VINA J, 1983, EXPERIENTIA, V39, P164; Vornov JJ, 1998, EXP NEUROL, V149, P109, DOI 10.1006/exnr.1997.6673; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zed PJ, 1999, AM J HEALTH-SYST PH, V56, P1081, DOI 10.1093/ajhp/56.11.1081	69	86	88	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12333	10.1371/journal.pone.0012333	http://dx.doi.org/10.1371/journal.pone.0012333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808797	Green Published, gold, Green Submitted			2022-12-27	WOS:000281153500015
J	Santini, E; Sgambato-Faure, V; Li, Q; Savasta, M; Dovero, S; Fisone, G; Bezard, E				Santini, Emanuela; Sgambato-Faure, Veronique; Li, Qin; Savasta, Marc; Dovero, Sandra; Fisone, Gilberto; Bezard, Erwan			Distinct Changes in cAMP and Extracellular Signal-Regulated Protein Kinase Signalling in L-DOPA-Induced Dyskinesia	PLOS ONE			English	Article							LEVODOPA-INDUCED DYSKINESIA; MEDIUM SPINY NEURONS; HEMIPARKINSONIAN MICE; PARKINSONS-DISEASE; PHOSPHORYLATION; SUBUNIT	Background: In rodents, the development of dyskinesia produced by L-DOPA in the dopamine-depleted striatum occurs in response to increased dopamine D1 receptor-mediated activation of the cAMP - protein kinase A and of the Ras-extracellular signal-regulated kinase (ERK) signalling pathways. However, very little is known, in non-human primates, about the regulation of these signalling cascades and their association with the induction, manifestation and/or maintenance of dyskinesia. Methodology/Results: We here studied, in the gold-standard non-human primate model of Parkinson's disease, the changes in PKA-dependent phosphorylation of DARPP-32 and GluR1 AMPA receptor, as well as in ERK and ribosomal protein S6 (S6) phosphorylation, associated to acute and chronic administration of L-DOPA. Increased phosphorylation of DARPP-32 and GluR1 was observed in both L-DOPA first-ever exposed and chronically-treated dyskinetic parkinsonian monkeys. In contrast, phosphorylation of ERK and S6 was enhanced preferentially after acute L-DOPA administration and decreased during the course of chronic treatment. Conclusion: Dysregulation of cAMP signalling is maintained during the course of chronic L-DOPA administration, while abnormal ERK signalling peaks during the initial phase of L-DOPA treatment and decreases following prolonged exposure. While cAMP signalling enhancement is associated with dyskinesia, abnormal ERK signalling is associated with priming.	[Santini, Emanuela] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Sgambato-Faure, Veronique; Savasta, Marc] Grenoble Inst Neurosci, INSERM, U836, Grenoble, France; [Sgambato-Faure, Veronique] Univ Lyon 1, CNRS, Ctr Neurosci Cognit, UMR 5229, Bron, France; [Li, Qin; Dovero, Sandra; Bezard, Erwan] Univ Bordeaux 2, CNRS, Bordeaux Inst Neurosci, UMR 5227, F-33076 Bordeaux, France; [Li, Qin; Bezard, Erwan] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100037, Peoples R China	Karolinska Institutet; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS	Santini, E (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	erwan.bezard@u-bordeaux2.fr	Bezard, Erwan/A-8173-2008; Sgambato, Véronique/G-9062-2017; Bezard, Erwan/ABD-5153-2021; Savasta, Marc/M-4939-2017	Sgambato, Véronique/0000-0002-8792-8586; Fisone, Gilberto/0000-0002-0719-8000; Bezard, Erwan/0000-0002-0410-4638; DOVERO, Sandra/0000-0002-5781-1328	Agence Nationale de la Recherche; Swedish Research Council [20715, 13482]; Swedish Brain Foundation	Agence Nationale de la Recherche(French National Research Agency (ANR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation	This work was supported by an Agence Nationale de la Recherche grant (EB). GF was supported by Swedish Research Council grants 20715 and 13482 and by the Swedish Brain Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000664; Aubert I, 2005, ANN NEUROL, V57, P17, DOI 10.1002/ana.20296; Berton O, 2009, BIOL PSYCHIAT, V66, P554, DOI 10.1016/j.biopsych.2009.04.005; Bezard E, 2001, J NEUROSCI, V21, P6853, DOI 10.1523/JNEUROSCI.21-17-06853.2001; Bezard E, 2003, NAT MED, V9, P762, DOI 10.1038/nm875; Corvol JC, 2004, J NEUROSCI, V24, P7007, DOI 10.1523/JNEUROSCI.0676-04.2004; COTZIAS GC, 1969, NEW ENGL J MED, V280, P337, DOI 10.1056/NEJM196902132800701; FERNAGUT PO, 2010, DOPAMINE TRANS UNPUB; Gerfen CR, 2002, J NEUROSCI, V22, P5042, DOI 10.1523/JNEUROSCI.22-12-05042.2002; Jenner P, 2008, NAT REV NEUROSCI, V9, P665, DOI 10.1038/nrn2471; Kim DS, 2006, NEUROSCIENCE, V137, P1381, DOI 10.1016/j.neuroscience.2005.10.054; Nadjar A, 2006, J NEUROSCI, V26, P8653, DOI 10.1523/JNEUROSCI.2582-06.2006; Pavon N, 2006, BIOL PSYCHIAT, V59, P64, DOI 10.1016/j.biopsych.2005.05.044; Picconi B, 2003, NAT NEUROSCI, V6, P501, DOI 10.1038/nn1040; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Santini E, 2007, J NEUROSCI, V27, P6995, DOI 10.1523/JNEUROSCI.0852-07.2007; Santini E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000308; Santini E, 2009, J NEUROCHEM, V108, P621, DOI 10.1111/j.1471-4159.2008.05831.x; SNYDER GL, 1992, J NEUROSCI, V12, P3071, DOI 10.1523/JNEUROSCI.12-08-03071.1992; Westin JE, 2007, BIOL PSYCHIAT	21	94	94	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12322	10.1371/journal.pone.0012322	http://dx.doi.org/10.1371/journal.pone.0012322			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808799	Green Published, gold			2022-12-27	WOS:000281153500008
J	Lorestani, A; Sheiner, L; Yang, K; Robertson, SD; Sahoo, N; Brooks, CF; Ferguson, DJP; Striepen, B; Gubbels, MJ				Lorestani, Alexander; Sheiner, Lilach; Yang, Kevin; Robertson, Seth D.; Sahoo, Nivedita; Brooks, Carrie F.; Ferguson, David J. P.; Striepen, Boris; Gubbels, Marc-Jan			A Toxoplasma MORN1 Null Mutant Undergoes Repeated Divisions but Is Defective in Basal Assembly, Apicoplast Division and Cytokinesis	PLOS ONE			English	Article							INNER MEMBRANE COMPLEX; FATTY-ACID SYNTHESIS; HOST-CELL INVASION; TETRAHYMENA-THERMOPHILA; GONDII; PROTEIN; MICROTUBULES; EXPRESSION; CYCLE; DIFFERENTIATION	The membrane occupation and recognition nexus protein 1 (MORN1) is highly conserved among apicomplexan parasites and is associated with several structures that have a role in cell division. Here we dissected the role of MORN1 using the relatively simple budding process of Toxoplasma gondii as a model. Ablation of MORN1 in a conditional null mutant resulted in pronounced defects suggesting a central role for MORN1 in apicoplast segregation and in daughter cell budding. Lack of MORN1 resulted in double-headed parasites. These Janus-headed parasites form two complete apical complexes but fail to assemble a basal complex. Moreover, these parasites were capable of undergoing several more budding rounds resulting in the formation of up to 16-headed parasites conjoined at the basal end. Despite this segregation defect, the mother's cytoskeleton was completely disassembled in every budding round. Overall this argues that successful completion of the budding is not required for cell cycle progression. None of the known basal complex components, including a set of recently identified inner membrane complex (IMC) proteins, localized correctly in these multi-headed parasites. These data suggest that MORN1 is essential for assembly of the basal complex, and that lack of the basal complex abolishes the contractile capacity assigned to the basal complex late in daughter formation. Consistent with this hypothesis we observe that MORN1 mutants fail to efficiently constrict and divide the apicoplast. We used the null background provided by the mutant to dissect the function of subdomains of the MORN1 protein. This demonstrated that deletion of a single MORN domain already prevented the function of MORN1 whereas a critical role for the short linker between MORN domains 6 and 7 was identified. In conclusion, MORN1 is required for basal complex assembly and loss of MORN1 results in defects in apicoplast division and daughter segregation.	[Lorestani, Alexander; Yang, Kevin; Robertson, Seth D.; Sahoo, Nivedita; Gubbels, Marc-Jan] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Sheiner, Lilach; Brooks, Carrie F.; Striepen, Boris] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Sheiner, Lilach; Brooks, Carrie F.; Striepen, Boris] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Ferguson, David J. P.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept, Clin Sci Lab, Oxford OX3 9DU, England	Boston College; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Oxford	Lorestani, A (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	gubbelsj@bc.edu		Gubbels, Marc-Jan/0000-0002-2769-8600; Robertson, Seth/0000-0003-0262-1276; Ferguson, David/0000-0001-5045-819X; Striepen, Boris/0000-0002-7426-432X	National Institutes of Health [AI081924, AI64671]; Smith Family Foundation through the Ludcke Foundation; Knights Templar Eye Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081924, R01AI064671] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smith Family Foundation through the Ludcke Foundation; Knights Templar Eye Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a National Institutes of Health grant (AI081924) and a Smith Family Foundation New Investigator research grant through the Ludcke Foundation to MJG, a Knights Templar Eye Foundation grant to NS and a National Institutes of Health grant (AI64671) to BS. Smith Family Foundation: www.smithfamilyfoundation.net; Ludcke Foundation: ludckefoundation.grantsmanagement08.com; NIH: www.nih.gov; Knights Templar Eye Association: www.knightstemplar.org/ktef. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agop-Nersesian C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000270; Agrawal S, 2009, J BIOL CHEM, V284, P33683, DOI 10.1074/jbc.M109.044024; ANDERSONWHITE BR, 2010, CELL MICROB IN PRESS; BROOKS CF, 2009, CELL HOST MICROBE; Brown JM, 1999, CELL BIOL INT, V23, P841, DOI 10.1006/cbir.1999.0480; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; Cuttell L, 2008, CELL, V135, P524, DOI 10.1016/j.cell.2008.08.033; de Miguel N, 2008, BIOL CELL, V100, P479, DOI 10.1042/BC20080004; Ferguson DJP, 2007, INT J PARASITOL, V37, P33, DOI 10.1016/j.ijpara.2006.10.003; FERGUSON DJ, 2008, EUKARYOT CELL; Ferguson DJP, 1999, EXP PARASITOL, V91, P203, DOI 10.1006/expr.1998.4384; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gubbels MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040036; Gubbels MJ, 2006, J CELL SCI, V119, P2236, DOI 10.1242/jcs.02949; Gubbels MJ, 2004, MOL BIOCHEM PARASIT, V137, P99, DOI 10.1016/j.molbiopara.2004.05.007; Hadano S, 2007, NEUROCHEM INT, V51, P74, DOI 10.1016/j.neuint.2007.04.010; Hartmann J, 2006, MOL BIOCHEM PARASIT, V145, P125, DOI 10.1016/j.molbiopara.2005.09.015; Heaslip AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000754; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Hu K, 2006, PLOS PATHOG, V2, P121, DOI 10.1371/journal.ppat.0020013; Hu K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040010; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; JERKADZIADOSZ M, 1995, DEV BIOL, V171, P497, DOI 10.1006/dbio.1995.1299; Ju TK, 2004, BIOL REPROD, V71, P1419, DOI 10.1095/biolreprod.104.030346; Kakizawa S, 2008, CEREBELLUM, V7, P385, DOI 10.1007/s12311-008-0040-1; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Kunita R, 2004, J BIOL CHEM, V279, P38626, DOI 10.1074/jbc.M406120200; Kuroiwa T, 2010, J PLANT RES, V123, P207, DOI 10.1007/s10265-009-0306-9; Lai R, 2003, BIOTECHNIQUES, V34, P52, DOI 10.2144/03341bm07; Legesse-Miller A, 2003, MOL BIOL CELL, V14, P1953, DOI 10.1091/mbc.E02-10-0657; Lim L, 2010, PHILOS T R SOC B, V365, P749, DOI 10.1098/rstb.2009.0273; Ma H, 2006, CELL RES, V16, P466, DOI 10.1038/sj.cr.7310058; Maurer-Stroh S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r55; Mazumdar J, 2006, P NATL ACAD SCI USA, V103, P13192, DOI 10.1073/pnas.0603391103; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Mital J, 2005, MOL BIOL CELL, V16, P4341, DOI 10.1091/mbc.E05-04-0281; Miyagishima SY, 2003, TRENDS PLANT SCI, V8, P432, DOI 10.1016/S1360-1385(03)00193-6; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Morrissette NS, 2002, J CELL SCI, V115, P1017; Morrissette NS, 1997, J CELL SCI, V110, P35; Nagamune K, 2007, EUKARYOT CELL, V6, P2147, DOI 10.1128/EC.00262-07; Nishi M, 2008, J CELL SCI, V121, P1559, DOI 10.1242/jcs.021089; Pelletier L, 2002, NATURE, V418, P548, DOI 10.1038/nature00946; Radke JR, 2001, MOL BIOCHEM PARASIT, V115, P165, DOI 10.1016/S0166-6851(01)00284-5; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Satouh Y, 2005, MOL BIOL CELL, V16, P626, DOI 10.1091/mbc.e04-09-0784; Schweitzer JK, 2004, EXP CELL RES, V295, P1, DOI 10.1016/j.yexcr.2003.12.023; Shaw MK, 2000, J CELL SCI, V113, P1241; SHEFFIELD HG, 1968, J PARASITOL, V54, P209, DOI 10.2307/3276925; Striepen B, 2000, J CELL BIOL, V151, P1423, DOI 10.1083/jcb.151.7.1423; Striepen B, 2007, PLOS PATHOG, V3, P691, DOI 10.1371/journal.ppat.0030078; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Vaishnava S, 2005, J CELL SCI, V118, P3397, DOI 10.1242/jcs.02458; Vaishnava S, 2006, MOL MICROBIOL, V61, P1380, DOI 10.1111/j.1365-2958.2006.05343.x; van Dooren GG, 2008, P NATL ACAD SCI USA, V105, P13574, DOI 10.1073/pnas.0803862105; van Dooren GG, 2009, CURR BIOL, V19, P267, DOI 10.1016/j.cub.2008.12.048	57	70	71	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12302	10.1371/journal.pone.0012302	http://dx.doi.org/10.1371/journal.pone.0012302			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808817	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000281075500026
J	Nerandzic, MM; Donskey, CJ				Nerandzic, Michelle M.; Donskey, Curtis J.			Triggering Germination Represents a Novel Strategy to Enhance Killing of Clostridium difficile Spores	PLOS ONE			English	Article							BACTERIAL-SPORES; EPIDEMIC; EFFICACY; STRAINS; SPORULATION; INITIATION; RADIATION; OUTBREAK	Background: Clostridium difficile is an anaerobic, spore-forming bacterium that is the most common cause of healthcare-associated diarrhea in developed countries. Control of C. difficile is challenging because the spores are resistant to killing by alcohol-based hand hygiene products, antimicrobial soaps, and most disinfectants. Although initiation of germination has been shown to increase susceptibility of spores of other bacterial species to radiation and heat, it was not known if triggering of germination could be a useful strategy to increase susceptibility of C. difficile spores to radiation or other stressors. Principal Findings: Here, we demonstrated that exposure of dormant C. difficile spores to a germination solution containing amino acids, minerals, and taurocholic acid resulted in initiation of germination in room air. Germination of spores in room air resulted in significantly enhanced killing by ultraviolet-C (UV-C) radiation and heat. On surfaces in hospital rooms, application of germination solution resulted in enhanced eradication of spores by UV-C administered by an automated room decontamination device. Initiation of germination under anaerobic, but not aerobic, conditions resulted in increased susceptibility to killing by ethanol, suggesting that exposure to oxygen might prevent spores from progressing fully to outgrowth. Stimulation of germination also resulted in reduced survival of spores on surfaces in room air, possibly due to increased susceptibility to stressors such as oxygen and desiccation. Conclusions: Taken together, these data demonstrate that stimulation of germination could represent a novel method to enhance killing of spores by UV-C, and suggest the possible application of this strategy as a means to enhance killing by other agents.	[Nerandzic, Michelle M.; Donskey, Curtis J.] Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA; [Donskey, Curtis J.] Cleveland Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Cleveland, OH USA	Geriatric Research Education & Clinical Center	Nerandzic, MM (corresponding author), Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA.	curtisd123@yahoo.com			Department of Veterans Affairs; Geriatric Research, Education and Clinical Center, Cleveland Veterans Affairs Medical Center, Cleveland, Ohio	Department of Veterans Affairs(US Department of Veterans Affairs); Geriatric Research, Education and Clinical Center, Cleveland Veterans Affairs Medical Center, Cleveland, Ohio	This work was supported by a Merit Review Grant from the Department of Veterans Affairs to C.J.D. and by the Geriatric Research, Education and Clinical Center, Cleveland Veterans Affairs Medical Center, Cleveland, Ohio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2009, FOOD MICROBIOL, V26, P272, DOI 10.1016/j.fm.2008.12.011; Barbut F, 2009, INFECT CONT HOSP EP, V30, P507, DOI 10.1086/597232; Dumford DM, 2009, AM J INFECT CONTROL, V37, P15, DOI 10.1016/j.ajic.2008.07.009; DUNCAN CL, 1968, APPL MICROBIOL, V16, P82, DOI 10.1128/AEM.16.1.82-89.1968; DURBAN E, 1970, J BACTERIOL, V102, P590, DOI 10.1128/JB.102.2.590-592.1970; Fawley WN, 2007, INFECT CONT HOSP EP, V28, P920, DOI 10.1086/519201; Gerding DN, 2008, CLIN INFECT DIS, V46, pS43, DOI 10.1086/521861; Ghosh S, 2009, J BACTERIOL, V191, P1787, DOI 10.1128/JB.01668-08; GOULD GW, 1968, J APPL BACTERIOL, V31, P357, DOI 10.1111/j.1365-2672.1968.tb00378.x; GOULD GW, 1970, J APPL BACTERIOL, V33, P34, DOI 10.1111/j.1365-2672.1970.tb05232.x; Hamouda T, 2002, LETT APPL MICROBIOL, V34, P86, DOI 10.1046/j.1472-765x.2002.01047.x; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; MUNAKATA N, 1974, J BACTERIOL, V120, P59, DOI 10.1128/JB.120.1.59-65.1974; Nerandzic MM, 2009, J CLIN MICROBIOL, V47, P397, DOI 10.1128/JCM.01591-08; Owens MU, 2005, APPL BIOSAF, V10, P240, DOI DOI 10.1177/153567600501000406; Paidhungat M., 2002, BACILLUS SUBTILIS IT, P537, DOI DOI 10.1128/9781555817992.CH37; Popovich KJ, 2009, INFECT CONT HOSP EP, V30, P959, DOI 10.1086/605925; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; STUY J. H., 1956, ANTONIE VAN LEEUWENHOEK JOUR MICROBIOL AND SEROL, V22, P337, DOI 10.1007/BF02538347; STUY JH, 1956, BIOCHIM BIOPHYS ACTA, V22, P241, DOI 10.1016/0006-3002(56)90146-9; Wheeldon LJ, 2008, J ANTIMICROB CHEMOTH, V62, P522, DOI 10.1093/jac/dkn219; Wilcox MH, 2000, LANCET, V356, P1324, DOI 10.1016/S0140-6736(00)02819-1	24	46	47	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12285	10.1371/journal.pone.0012285	http://dx.doi.org/10.1371/journal.pone.0012285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808871	Green Published, Green Submitted, gold			2022-12-27	WOS:000281075500018
J	Halford, WP; Puschel, R; Rakowski, B				Halford, William P.; Pueschel, Ringo; Rakowski, Brandon			Herpes Simplex Virus 2 ICP0(-) Mutant Viruses Are Avirulent and Immunogenic: Implications for a Genital Herpes Vaccine	PLOS ONE			English	Article							IMMEDIATE-EARLY PROTEIN; WILD-TYPE; VARICELLA VACCINATION; TRIGEMINAL GANGLIA; UBIQUITIN LIGASE; GENE-EXPRESSION; TYPE-1; DISEASE; IMMUNIZATION; INFECTIONS	Herpes simplex virus 1 (HSV-1) ICP0(-) mutants are interferon-sensitive, avirulent, and elicit protective immunity against HSV-1 (Virol J, 2006, 3: 44). If an ICP0(-) mutant of herpes simplex virus 2 (HSV-2) exhibited similar properties, such a virus might be used to vaccinate against genital herpes. The current study was initiated to explore this possibility. Several HSV-2 ICP0(-) mutant viruses were constructed and evaluated in terms of three parameters: i. interferon-sensitivity; ii. virulence in mice; and iii. capacity to elicit protective immunity against HSV-2. One ICP0(-) mutant virus in particular, HSV-2 0 Delta NLS, achieved an optimal balance between avirulence and immunogenicity. HSV-2 0 Delta NLS was interferon-sensitive in cultured cells. HSV-2 0 Delta NLS replicated to low levels in the eyes of inoculated mice, but was rapidly repressed by an innate, Stat 1-dependent host immune response. HSV-2 0 Delta NLS failed to spread from sites of inoculation, and hence produced only inapparent infections. Mice inoculated with HSV-2 0 Delta NLS consistently mounted an HSV-specific IgG antibody response, and were consistently protected against lethal challenge with wild-type HSV-2. Based on their avirulence and immunogenicity, we propose that HSV-2 ICP0(-) mutant viruses merit consideration for their potential to prevent the spread of HSV-2 and genital herpes.	[Halford, William P.; Pueschel, Ringo; Rakowski, Brandon] So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL USA	Southern Illinois University System; Southern Illinois University	Halford, WP (corresponding author), So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL USA.	halford@siumed.edu			Central Research and Excellence in Academic Medicine Committees of the Southern Illinois University School of Medicine; National Institutes of Health [R01 AI51414, R21 AI81072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081072, R01AI051414] Funding Source: NIH RePORTER	Central Research and Excellence in Academic Medicine Committees of the Southern Illinois University School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Central Research and Excellence in Academic Medicine Committees of the Southern Illinois University School of Medicine, as well as grants from the National Institutes of Health to study the Role of the LAT-ICP0 locus in regulating HSV latency (R01 AI51414) and the Development of an Effective Genital Herpes Vaccine (R21 AI81072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Aurelian L, 1999, VACCINE, V17, P1951, DOI 10.1016/S0264-410X(98)00470-8; Bourne N, 2005, J INFECT DIS, V192, P2117, DOI 10.1086/498247; Bourne N, 2003, J INFECT DIS, V187, P542, DOI 10.1086/374002; Boutell C, 2002, J VIROL, V76, P841, DOI 10.1128/JVI.76.2.841-850.2002; Boutell C, 2008, J VIROL, V82, P10647, DOI 10.1128/JVI.01063-08; Canning M, 2004, J BIOL CHEM, V279, P38160, DOI 10.1074/jbc.M402885200; CENTIFANTOFITZGERALD YM, 1982, INFECT IMMUN, V35, P1125, DOI 10.1128/IAI.35.3.1125-1132.1982; CENTIFANTOFITZGERALD YM, 1985, P SOC EXP BIOL MED, V179, P55; CHEN JX, 1992, J VIROL, V66, P5598, DOI 10.1128/JVI.66.9.5598-5602.1992; CIUFO DM, 1994, J VIROL, V68, P3267, DOI 10.1128/JVI.68.5.3267-3282.1994; COREY L, 1983, ANN INTERN MED, V98, P958, DOI 10.7326/0003-4819-98-6-958; Da Costa XJ, 1999, P NATL ACAD SCI USA, V96, P6994, DOI 10.1073/pnas.96.12.6994; Davido DJ, 2005, J VIROL, V79, P1232, DOI 10.1128/JVI.79.2.1232-1243.2005; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Dudek T, 2006, VIROLOGY, V344, P230, DOI 10.1016/j.virol.2005.09.020; ELION GB, 1982, AM J MED, V73, P7, DOI 10.1016/0002-9343(82)90055-9; EVERETT R, 1995, J VIROL, V69, P7339, DOI 10.1128/JVI.69.11.7339-7344.1995; Galea SA, 2008, J INFECT DIS, V197, pS165, DOI 10.1086/522125; Gershon AA, 2001, INFECT DIS CLIN N AM, V15, P65, DOI 10.1016/S0891-5520(05)70268-3; Gottlieb SL, 2004, J INFECT DIS, V190, P1059, DOI 10.1086/423323; Green John, 2004, Herpes, V11, P60; Halford WP, 2007, FUTURE VIROL, V2, P1, DOI 10.2217/17460794.2.1.1; Halford WP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-44; Halford WP, 2005, J THEOR BIOL, V234, P439, DOI 10.1016/j.jtbi.2004.12.007; Halford WP, 1997, VIROLOGY, V238, P53, DOI 10.1006/viro.1997.8806; Halford WP, 2001, J VIROL, V75, P3240, DOI 10.1128/JVI.75.7.3240-3249.2001; Halford WP, 2000, J VIROL, V74, P5957, DOI 10.1128/JVI.74.13.5957-5967.2000; Harle P, 2002, VIROLOGY, V293, P295, DOI 10.1006/viro.2001.1280; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; Hoshino Y, 2008, VACCINE, V26, P4034, DOI 10.1016/j.vaccine.2008.05.022; Jacobs BL, 2009, ANTIVIR RES, V84, P1, DOI 10.1016/j.antiviral.2009.06.006; Janier M, 2006, INT J STD AIDS, V17, P44, DOI 10.1258/095646206775220531; Jones Cheryl A, 2004, Herpes, V11, P12; Jonsson MK, 2004, SCAND J INFECT DIS, V36, P93, DOI 10.1080/00365540310018905; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; KLEIN RJ, 1989, VACCINE, V7, P380, DOI 10.1016/0264-410X(89)90147-3; Krause PR, 2000, NAT MED, V6, P451, DOI 10.1038/74715; Leib DA, 1999, J EXP MED, V189, P663, DOI 10.1084/jem.189.4.663; Liu MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010975; Liu MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008837; Lowhagen GB, 2000, SEX TRANSM INFECT, V76, P179, DOI 10.1136/sti.76.3.179; Mark H, 2009, JOGNN-J OBST GYN NEO, V38, P320, DOI 10.1111/j.1552-6909.2009.01026.x; Morrison LA, 1998, VIROLOGY, V243, P178, DOI 10.1006/viro.1998.9047; Mossman KL, 2000, J VIROL, V74, P2052, DOI 10.1128/JVI.74.4.2052-2056.2000; Nagashunmugam T, 1998, J VIROL, V72, P5351, DOI 10.1128/JVI.72.7.5351-5359.1998; Newton DC, 2008, J HEALTH PSYCHOL, V13, P864, DOI 10.1177/1359105308095058; Nicola AV, 1996, J VIROL, V70, P3815, DOI 10.1128/JVI.70.6.3815-3822.1996; Nieuwenhuis RF, 2006, ACTA DERM-VENEREOL, V86, P129, DOI 10.2340/00015555-0029; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Pasieka TJ, 2009, J VIROL, V83, P2075, DOI 10.1128/JVI.02007-08; Prichard MN, 2005, VACCINE, V23, P5424, DOI 10.1016/j.vaccine.2005.02.028; Reszka NJ, 2010, VACCINE, V28, P2754, DOI 10.1016/j.vaccine.2010.01.030; SABIN AB, 1985, J INFECT DIS, V151, P420, DOI 10.1093/infdis/151.3.420; Samaniego LA, 1998, J VIROL, V72, P3307, DOI 10.1128/JVI.72.4.3307-3320.1998; Sengupta N, 2008, EUR J PEDIATR, V167, P47, DOI 10.1007/s00431-007-0424-0; Singh M, 1998, VACCINE, V16, P1822, DOI 10.1016/S0264-410X(98)00179-0; Solomon L, 2003, SEX TRANSM INFECT, V79, P456, DOI 10.1136/sti.79.6.456; Stanberry Lawrence R, 2004, Herpes, V11 Suppl 3, p161A; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; Stanberry LR, 2000, CLIN INFECT DIS, V30, P549, DOI 10.1086/313687; Straus SE, 1997, J INFECT DIS, V176, P1129, DOI 10.1086/514103; THOMPSON RL, 1986, MICROB PATHOGENESIS, V1, P409, DOI 10.1016/0882-4010(86)90072-0; VANEKDOM LTS, 1982, AM J MED, V73, P161, DOI 10.1016/0002-9343(82)90083-3; Wald A, 1997, J CLIN INVEST, V99, P1092, DOI 10.1172/JCI119237; WATSON RJ, 1982, SCIENCE, V218, P381, DOI 10.1126/science.6289440; WATSON RJ, 1985, PROG MED VIROL, V31, P84; Wharton M, 1990, Infect Dis Clin North Am, V4, P47; Woolery WA, 2008, GERIATRICS-US, V63, P6; Xu F., 2010, Morbidity and Mortality Weekly Report, V59, P456; zur Hausen H, 1979, Dev Biol Stand, V43, P373	71	34	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12251	10.1371/journal.pone.0012251	http://dx.doi.org/10.1371/journal.pone.0012251			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808928	gold, Green Published, Green Submitted			2022-12-27	WOS:000280968100032
J	Kalb, SR; Garcia-Rodriguez, C; Lou, JL; Baudys, J; Smith, TJ; Marks, JD; Smith, LA; Pirkle, JL; Barr, JR				Kalb, Suzanne R.; Garcia-Rodriguez, Consuelo; Lou, Jianlong; Baudys, Jakub; Smith, Theresa J.; Marks, James D.; Smith, Leonard A.; Pirkle, James L.; Barr, John R.			Extraction of BoNT/A,/B,/E, and /F with a Single, High Affinity Monoclonal Antibody for Detection of Botulinum Neurotoxin by Endopep-MS	PLOS ONE			English	Article							CLOSTRIDIUM-BOTULINUM; TOXIN; SUBTYPES	Botulinum neurotoxins (BoNTs) are extremely potent toxins that are capable of causing respiratory failure leading to long-term intensive care or death. The best treatment for botulism includes serotype-specific antitoxins, which are most effective when administered early in the course of the intoxication. Early confirmation of human exposure to any serotype of BoNT is an important public health goal. In previous work, we focused on developing Endopep-MS, a mass spectrometry-based endopeptidase method for detecting and differentiating the seven serotypes (BoNT/A-G) in buffer and BoNT/A, /B, /E, and /F (the four serotypes that commonly affect humans) in clinical samples. We have previously reported the success of antibody-capture to purify and concentrate BoNTs from complex matrices, such as clinical samples. However, to check for any one of the four serotypes of BoNT/A, /B, /E, or /F, each sample is split into 4 aliquots, and tested for the specific serotypes separately. The discovery of a unique monoclonal antibody that recognizes all four serotypes of BoNT/A, /B, /E and /F allows us to perform simultaneous detection of all of them. When applied in conjunction with the Endopep-MS assay, the detection limit for each serotype of BoNT with this multi-specific monoclonal antibody is similar to that obtained when using other serotype-specific antibodies.	[Kalb, Suzanne R.; Pirkle, James L.; Barr, John R.] Ctr Dis Control & Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA; [Garcia-Rodriguez, Consuelo; Lou, Jianlong; Marks, James D.] Univ Calif San Francisco, Dept Anesthesia & Pharmaceut Chem, San Francisco, CA 94143 USA; [Baudys, Jakub] Ctr Dis Control & Prevent, Battelle Mem Inst, Atlanta, GA USA; [Smith, Theresa J.; Smith, Leonard A.] USAMRIID, Ft Detrick, MD USA	Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; United States Army Medical Research Institute of Infectious Diseases	Kalb, SR (corresponding author), Ctr Dis Control & Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA.	jbarr@cdc.gov	Baudys, Jakub/K-7643-2012	Kalb, Suzanne/0000-0002-8067-136X	Centers for Disease Control and Prevention; United States Army Medical Research Institute for Infectious Diseases	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States Army Medical Research Institute for Infectious Diseases	Funding for this work was through the Centers for Disease Control and Prevention and the United States Army Medical Research Institute for Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amersdorfer P, 2002, VACCINE, V20, P1640, DOI 10.1016/S0264-410X(01)00482-0; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Barr JR, 2005, EMERG INFECT DIS, V11, P1578, DOI 10.3201/eid1110.041279; Boyer AE, 2005, ANAL CHEM, V77, P3916, DOI 10.1021/ac050485f; Carter AT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-115; Centers for Disease Control and Prevention, 1998, HDB EP CLIN LAB WORK; Chen Y, 2007, J BACTERIOL, V189, P8643, DOI 10.1128/JB.00784-07; Fischer A, 2008, J BIOL CHEM, V283, P3997, DOI 10.1074/jbc.M707917200; Garcia-Rodriguez C, 2007, NAT BIOTECHNOL, V25, P107, DOI 10.1038/nbt1269; GARCIARODRIGUEZ D, PEDS UNPUB; Gaunt PS, 2007, J VET DIAGN INVEST, V19, P349, DOI 10.1177/104063870701900402; Kalb SR, 2006, ANAL BIOCHEM, V351, P84, DOI 10.1016/j.ab.2006.01.027; Kalb SR, 2005, ANAL CHEM, V77, P6140, DOI 10.1021/ac0511748; Kalb SR, 2008, INT J MASS SPECTROM, V278, P101, DOI 10.1016/j.ijms.2008.04.004; Kalb SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005355; KAUTTER DA, 1977, J ASSOC OFF ANA CHEM, V60, P541; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; Lou J, 2010, PROTEIN ENG DES SEL, V23, P311, DOI 10.1093/protein/gzq001; Mah DCW, 2003, HYBRIDOMA HYBRIDOM, V22, P277, DOI 10.1089/153685903322538791; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; RAPHAEL BH, 2010, APPL ENV MI IN PRESS; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Umeda K, 2009, J CLIN MICROBIOL, V47, P2720, DOI 10.1128/JCM.00077-09; Wang XM, 2000, APPL ENVIRON MICROB, V66, P4992, DOI 10.1128/AEM.66.11.4992-4997.2000	24	44	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12237	10.1371/journal.pone.0012237	http://dx.doi.org/10.1371/journal.pone.0012237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808925	Green Published, gold, Green Submitted			2022-12-27	WOS:000280968100029
J	Kim, N; Goel, PK; Tivarus, ME; Hillier, A; Beversdorf, DQ				Kim, Namhee; Goel, Prem K.; Tivarus, Madalina E.; Hillier, Ashleigh; Beversdorf, David Q.			Independent Component Analysis of the Effect of L-dopa on fMRI of Language Processing	PLOS ONE			English	Article							INFERIOR PREFRONTAL CORTEX; RHESUS-MONKEY; PARKINSONS-DISEASE; BLIND SEPARATION; WORKING-MEMORY; FUNCTIONAL MRI; HUMAN BRAIN; RETRIEVAL; RECEPTORS; REGIONS	L-dopa, which is a precursor for dopamine, acts to amplify strong signals, and dampen weak signals as suggested by previous studies. The effect of L-dopa has been demonstrated in language studies, suggesting restriction of the semantic network. In this study, we aimed to examine the effect of L-dopa on language processing with fMRI using Independent Component Analysis (ICA). Two types of language tasks (phonological and semantic categorization tasks) were tested under two drug conditions (placebo and L-dopa) in 16 healthy subjects. Probabilistic ICA (PICA), part of FSL, was implemented to generate Independent Components (IC) for each subject for the four conditions and the ICs were classified into task-relevant source groups by a correlation threshold criterion. Our key findings include: (i) The highly task-relevant brain regions including the Left Inferior Frontal Gyrus (LIFG), Left Fusiform Gyrus (LFUS), Left Parietal lobe (LPAR) and Superior Temporal Gyrus (STG) were activated with both L-dopa and placebo for both tasks, and (ii) as compared to placebo, L-dopa was associated with increased activity in posterior regions, including the superior temporal area (BA 22), and decreased activity in the thalamus (pulvinar) and inferior frontal gyrus (BA 11/47) for both tasks. These results raise the possibility that L-dopa may exert an indirect effect on posterior regions mediated by the thalamus (pulvinar).	[Kim, Namhee; Goel, Prem K.] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; [Tivarus, Madalina E.] Univ Rochester, Dept Imaging Sci, Rochester, NY USA; [Tivarus, Madalina E.] Univ Rochester, Rochester Ctr Brain Imaging, Rochester, NY USA; [Hillier, Ashleigh] Univ Massachusetts, Dept Psychol, Lowell, MA USA; [Beversdorf, David Q.] Univ Missouri, Dept Radiol, Columbia, MO USA; [Beversdorf, David Q.] Univ Missouri, Dept Neurol, Columbia, MO USA; [Beversdorf, David Q.] Univ Missouri, Dept Psychol, Columbia, MO USA; [Beversdorf, David Q.] Univ Missouri, Thompson Ctr, Columbia, MO USA	University System of Ohio; Ohio State University; University of Rochester; University of Rochester; University of Massachusetts System; University of Massachusetts Lowell; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Kim, N (corresponding author), Ohio State Univ, Dept Stat, Columbus, OH 43210 USA.	beversdorfd@health.missouri.edu	Tivarus, Madalina/ABB-4966-2021; Beversdorf, David Q./M-2786-2016	Beversdorf, David Q./0000-0002-0298-0634; Tivarus, Madalina/0000-0001-7481-5913	National Alliance for Autism Research; National Institute of Neurological Disorders and Stroke (NINDS) [K23 NS43222]; Ohio State University (OSU); OSU Department of Statistics; Wright Center for Innovation; University of Missouri Department of Radiology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS043222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034977] Funding Source: NIH RePORTER	National Alliance for Autism Research; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Ohio State University (OSU)(Ohio State University); OSU Department of Statistics; Wright Center for Innovation; University of Missouri Department of Radiology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research is funded by a Pilot Grant from the National Alliance for Autism Research (now Autism Speaks, www.autismspeaks.org), and by grants from National Institute of Neurological Disorders and Stroke (NINDS) (K23 NS43222) (www.nih.gov), the Ohio State University (OSU) Research Investment Fund, the OSU Department of Statistics Release Time Fund, the Wright Center for Innovation, and the University of Missouri Department of Radiology Research Investment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASANUMA C, 1985, J COMP NEUROL, V241, P357, DOI 10.1002/cne.902410309; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Beversdorf DQ, 1997, CLIN NEUROPATHOL, V16, P328; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chalfin BP, 2007, J COMP NEUROL, V504, P265, DOI 10.1002/cne.21406; Cohen J, 2002, CURR OPIN NEUROBIOL, V12, P223, DOI 10.1016/S0959-4388(02)00314-8; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Dagher A, 2001, BRAIN, V124, P1020, DOI 10.1093/brain/124.5.1020; DEMB JB, 1995, J NEUROSCI, V15, P5870; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Devlin JT, 2003, J COGNITIVE NEUROSCI, V15, P71, DOI 10.1162/089892903321107837; Durstewitz D, 2002, NEURAL NETWORKS, V15, P561, DOI 10.1016/S0893-6080(02)00049-7; Eichele T, 2009, INT J PSYCHOPHYSIOL, V73, P53, DOI 10.1016/j.ijpsycho.2008.12.018; Floresco SB, 2006, NEUROPSYCHOPHARMACOL, V31, P297, DOI 10.1038/sj.npp.1300825; Gold BT, 2002, NEURON, V35, P803, DOI 10.1016/S0896-6273(02)00800-0; HALL H, 1994, NEUROPSYCHOPHARMACOL, V11, P245, DOI 10.1038/sj.npp.1380111; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Kastner Sabine, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P483, DOI 10.3758/CABN.4.4.483; Ketteler D, 2008, NEUROIMAGE, V39, P2002, DOI 10.1016/j.neuroimage.2007.10.023; KIEVIT J, 1977, EXP BRAIN RES, V29, P299; Kischka U, 1996, NEUROPSYCHOLOGIA, V34, P1107, DOI 10.1016/0028-3932(96)00024-3; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; LIDOW MS, 1991, NEUROSCIENCE, V40, P657, DOI 10.1016/0306-4522(91)90003-7; Markowitsch HJ, 1995, BRAIN RES REV, V21, P117, DOI 10.1016/0165-0173(95)00007-0; McDermott KB, 2003, NEUROPSYCHOLOGIA, V41, P293, DOI 10.1016/S0028-3932(02)00162-8; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; Mehta MA, 2001, PSYCHOPHARMACOLOGY, V159, P10, DOI 10.1007/s002130100851; Mehta MA, 2004, PSYCHOPHARMACOLOGY, V176, P331, DOI 10.1007/s00213-004-1899-2; MINKA T, 2000, 514 TR MIT; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Rektorova I, 2008, MOVEMENT DISORD, V23, P1580, DOI 10.1002/mds.22158; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schmithorst VJ, 2004, J MAGN RESON IMAGING, V19, P365, DOI 10.1002/jmri.20009; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Shivde G, 2004, COGN AFFECT BEHAV NE, V4, P10, DOI 10.3758/CABN.4.1.10; Svensen M, 2002, NEUROIMAGE, V16, P551, DOI 10.1006/nimg.2002.1122; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Tivarus ME, 2008, BRAIN LANG, V104, P42, DOI 10.1016/j.bandl.2007.02.007; TROJANOWSKI JQ, 1976, J COMP NEUROL, V169, P371, DOI 10.1002/cne.901690307; Winterer G, 2004, TRENDS NEUROSCI, V27, P683, DOI 10.1016/j.tins.2004.08.002; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	43	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e11933	10.1371/journal.pone.0011933	http://dx.doi.org/10.1371/journal.pone.0011933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808963	gold, Green Published, Green Submitted			2022-12-27	WOS:000280968100001
J	Tschopp, R; Aseffa, A; Schelling, E; Berg, S; Hailu, E; Gadisa, E; Habtamu, M; Argaw, K; Zinsstag, J				Tschopp, Rea; Aseffa, Abraham; Schelling, Esther; Berg, Stefan; Hailu, Elena; Gadisa, Endalamaw; Habtamu, Meseret; Argaw, Kifle; Zinsstag, Jakob			Bovine Tuberculosis at the Wildlife-Livestock-Human Interface in Hamer Woreda, South Omo, Southern Ethiopia	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; CATTLE; IDENTIFICATION; INFECTION; DIAGNOSIS; DIFFERENTIATION; PREVALENCE; DISEASE; REGIONS; GOATS	Bovine tuberculosis (BTB) is endemic in cattle in the Ethiopian Highlands but no studies have been done so far in pastoralists in South Omo. This study assessed the prevalence of bovine tuberculosis (BTB) at an intensive interface of livestock, wildlife and pastoralists in Hamer Woreda (South Omo), Ethiopia. A cross-sectional survey including a comparative intradermal skin testing (CIDT) was conducted in 499 zebu cattle and 186 goats in 12 settlements. Sputum samples from 26 symptomatic livestock owners were cultured for TB. Fifty-one wildlife samples from 13 different species were also collected in the same area and tested with serological (lateral flow assay) and bacteriological (culture of lymph nodes) techniques. Individual BTB prevalence in cattle was 0.8% (CI: 0.3%-2%) with the >4 mm cut-off and 3.4% (CI: 2.1%-5.4%) with the >2 mm cut-off. Herd prevalence was 33.3% and 83% when using the >4 and the >2 mm cut-off respectively. There was no correlation between age, sex, body condition and positive reactors upon univariate analysis. None of the goats were reactors for BTB. Acid fast bacilli (AFB) were detected in 50% of the wildlife cultures, 79.2% of which were identified as Mycobacterium terrae complex. No M. bovis was detected. Twenty-seven percent of tested wildlife were sero-positive. Four sputum cultures (15.4%) yielded AFB positive colonies among which one was M. tuberculosis and 3 non-tuberculous mycobacteria (NTM). The prevalence of M. avium-complex (MAC) was 4.2% in wildlife, 2.5% in cattle and 0.5% in goats. In conclusion, individual BTB prevalence was low, but herd prevalence high in cattle and BTB was not detected in goats, wildlife and humans despite an intensive contact interface. On the contrary, NTMs were highly prevalent and some Mycobacterium spp were more prevalent in specific species. The role of NTMs in livestock and co-infection with BTB need further research.	[Tschopp, Rea; Schelling, Esther; Zinsstag, Jakob] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Tschopp, Rea; Aseffa, Abraham; Hailu, Elena; Gadisa, Endalamaw; Habtamu, Meseret] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Berg, Stefan] Vet Labs Agcy, Addlestone, Surrey, England; [Argaw, Kifle] Ethiopian Wildlife Conservat Author, Addis Ababa, Ethiopia	University of Basel; Swiss Tropical & Public Health Institute; Veterinary Laboratories Agency	Tschopp, R (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	rea.tschopp@unibas.ch	Berg, Stefan/AAU-6463-2020; Schelling, Esther/K-7990-2015; Zinsstag, Jakob/A-8317-2008; Aseffa, Abraham/J-3248-2016; Berg, Stefan O/D-3847-2011	Berg, Stefan/0000-0002-3470-7579; Schelling, Esther/0000-0001-6444-0898; Zinsstag, Jakob/0000-0002-8899-6097; Aseffa, Abraham/0000-0002-8028-1150; 	Wellcome Trust (UK)	Wellcome Trust (UK)(Wellcome Trust)	Source of funding: Wellcome Trust (UK) under their Animal Health in the Developing World Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Wellcome Trust - Animal Health in the Developing World Initiative (UK) as well as AHRI/ALERT and Rift Valley Safaris for the logistic support. Many thanks go to the data management team in AHRI led by L. Yamuah. We thank Bamlaku Tilahun, Tesfaye Erenso, Girum Erenso and Jason Roussos for their valuable help in the field as well as the staff of Murulle lodge.	Alvarez J, 2008, VET MICROBIOL, V128, P72, DOI 10.1016/j.vetmic.2007.08.034; Ameni G, 2003, INT J APPL RES VET M, V1, P1; Ameni G, 2008, CLIN VACCINE IMMUNOL, V15, P1272, DOI 10.1128/CVI.00114-08; Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; ASSEGED B, 2000, B ANIMAL HLTH PRODUC, V80, P67; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Berg S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005068; BONGO NRN, 2009, PREV VET MED, V89, P81; Cleaveland S, 2005, J WILDLIFE DIS, V41, P446, DOI 10.7589/0090-3558-41.2.446; Coleman JD, 2001, TUBERCULOSIS, V81, P191, DOI 10.1054/tube.2001.0291; *CSA, 2007, STAT B CSA, V388; Demelash B, 2009, TROP ANIM HEALTH PRO, V41, P755, DOI 10.1007/s11250-008-9248-9; DONDE BG, 2009, THESIS SWISS TROPICA; El Hussein HA, 2009, TROP ANIM HEALTH PRO, V41, P617, DOI 10.1007/s11250-008-9232-4; Engeman RM, 2007, AFR J ECOL, V45, P184, DOI 10.1111/j.1365-2028.2006.00695.x; *EWD, 2008, COMP WILDL MAN DEP; Fetene T, 2009, TROP ANIM HEALTH PRO, V41, P273, DOI 10.1007/s11250-008-9186-6; GALLAGHER J, 1977, J HYG-CAMBRIDGE, V79, P155, DOI 10.1017/S0022172400052943; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; GUTIERREZ M, 1995, J CLIN MICROBIOL, V33, P2953; Gutierrez M, 1998, VET MICROBIOL, V62, P281, DOI 10.1016/S0378-1135(98)00217-X; Han XY, 2002, AM J CLIN PATHOL, V118, P796, DOI 10.1309/HN44-XQYM-JMAQ-2EDL; Javed MT, 2010, ACTA TROP, V113, P88, DOI 10.1016/j.actatropica.2009.08.026; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Liebana E, 1998, AUST VET J, V76, P50, DOI 10.1111/j.1751-0813.1998.tb15686.x; Lyashchenko KP, 2008, VET MICROBIOL, V132, P283, DOI 10.1016/j.vetmic.2008.05.029; Michel AL, 2007, BMC VET RES, V3, P23, DOI DOI 10.1186/1746-6148-3-23; Mostowy S, 2005, J BACTERIOL, V187, P6386, DOI 10.1128/JB.187.18.6386-6395.2005; Msangi B.S.J., 1999, P M TANZ SOC AN PROD; *OXF, 2009, BUILD BLOCKS PAST FE; Renwick AR, 2007, EPIDEMIOL INFECT, V135, P529, DOI 10.1017/S0950268806007205; Roberts GD, 1991, MANUAL CLIN MICROBIO, P304; Tschopp R, 2010, J WILDLIFE DIS, V46, P753, DOI 10.7589/0090-3558-46.3.753; TSCHOPP R, VET RECORD IN PRESS; Tschopp R, 2009, PREV VET MED, V89, P205, DOI 10.1016/j.prevetmed.2009.02.006; *WHO, 2007, NEW WHO POL; Wilton S, 1992, PCR Methods Appl, V1, P269; Zinsstag J., 2006, MYCOBACTERIUM BOVIS, P68, DOI DOI 10.1002/9780470344538.CH9	39	30	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12205	10.1371/journal.pone.0012205	http://dx.doi.org/10.1371/journal.pone.0012205			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808913	Green Published, Green Submitted, gold			2022-12-27	WOS:000280968100011
J	Christakis, NA; Fowler, JH				Christakis, Nicholas A.; Fowler, James H.			Social Network Sensors for Early Detection of Contagious Outbreaks	PLOS ONE			English	Article							INFLUENZA-A H1N1	Current methods for the detection of contagious outbreaks give contemporaneous information about the course of an epidemic at best. It is known that individuals near the center of a social network are likely to be infected sooner during the course of an outbreak, on average, than those at the periphery. Unfortunately, mapping a whole network to identify central individuals who might be monitored for infection is typically very difficult. We propose an alternative strategy that does not require ascertainment of global network structure, namely, simply monitoring the friends of randomly selected individuals. Such individuals are known to be more central. To evaluate whether such a friend group could indeed provide early detection, we studied a flu outbreak at Harvard College in late 2009. We followed 744 students who were either members of a group of randomly chosen individuals or a group of their friends. Based on clinical diagnoses, the progression of the epidemic in the friend group occurred 13.9 days (95% C. I. 9.9-16.6) in advance of the randomly chosen group (i.e., the population as a whole). The friend group also showed a significant lead time (p<0.05) on day 16 of the epidemic, a full 46 days before the peak in daily incidence in the population as a whole. This sensor method could provide significant additional time to react to epidemics in small or large populations under surveillance. The amount of lead time will depend on features of the outbreak and the network at hand. The method could in principle be generalized to other biological, psychological, informational, or behavioral contagions that spread in networks.	[Christakis, Nicholas A.] Harvard Univ, Fac Arts & Sci, Boston, MA 02115 USA; [Christakis, Nicholas A.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Fowler, James H.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Fowler, James H.] Univ Calif San Diego, Div Social Sci, La Jolla, CA 92093 USA	Harvard University; Harvard University; Harvard Medical School; University of California System; University of California San Diego; University of California System; University of California San Diego	Christakis, NA (corresponding author), Harvard Univ, Fac Arts & Sci, Boston, MA 02115 USA.	christakis@hcp.med.harvard.edu	Christakis, Nicholas A/C-3205-2009; Fowler, James H/C-2750-2008	Fowler, James H/0000-0001-7795-1638	Office of the Provost, Harvard University; National Institute on Aging [P-01AG-031093]; Robert Wood Johnson Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031093] Funding Source: NIH RePORTER	Office of the Provost, Harvard University; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by a grant from the Office of the Provost, Harvard University (Steve Hyman). The analysis was partially supported by grants from the National Institute on Aging (P-01AG-031093) and by a Pioneer Grant from the Robert Wood Johnson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ACHA, 2010, AM COLL HLTH ASS INF; [Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Bahr DB, 2009, OBESITY, V17, P723, DOI 10.1038/oby.2008.615; BATAGELJ V, 2006, PAJEK PROGRAM ANAL V; Bearman PS, 2004, AM J SOCIOL, V110, P44, DOI 10.1086/386272; Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christley RM, 2005, AM J EPIDEMIOL, V162, P1024, DOI 10.1093/aje/kwi308; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Davey VJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002606; Dezso Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.055103; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; FELD SL, 1991, AM J SOCIOL, V96, P1464, DOI 10.1086/229693; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Huet S., 2003, STAT TOOLS NONLINEAR; KAMADA T, 1989, INFORM PROCESSING LE, V31, P113; Khazeni N, 2009, ANN INTERN MED, V151, P829, DOI [10.7326/0000605-200912150-00157, 10.7326/0003-4819-151-12-200912150-00157]; KITSAK M, 2010, 10015285V2 ARXIV; Leskovec J, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P420; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Newman MEJ, 2003, SOC NETWORKS, V25, P83, DOI 10.1016/S0378-8733(02)00039-4; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Polgreen PM, 2007, CLIN INFECT DIS, V44, P272, DOI 10.1086/510427; Rogers E. M., 1964, DIFFUSION INNOVATION; ROSENQUIST JN, 2010, MOL PSYCHIATR, V16, P273, DOI DOI 10.1038/MP.2010.13; Ross R, 1915, BRIT MED J, V1915, P546, DOI 10.1136/bmj.1.2830.546; Scott BA, 2009, J APPL PSYCHOL, V94, P20, DOI 10.1037/a0012951; Smith DMD, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036112; Trifonov V, 2009, NEW ENGL J MED, V361, P115, DOI 10.1056/NEJMp0904572; TURNBULL BW, 1976, J R STAT SOC B, V38, P290; Zuckerman EW, 2001, SOC PSYCHOL QUART, V64, P207, DOI 10.2307/3090112; 2010, MORB MORTAL WEEKLY R, V59, P38	38	257	261	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12948	10.1371/journal.pone.0012948	http://dx.doi.org/10.1371/journal.pone.0012948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	649ZP	20856792	Green Published, Green Submitted, gold			2022-12-27	WOS:000281815800033
J	Fernandez-Rozadilla, C; de Castro, L; Clofent, J; Brea-Fernandez, A; Bessa, X; Abuli, A; Andreu, M; Jover, R; Xicola, R; Llor, X; Castells, A; Castellvi-Bel, S; Carracedo, A; Ruiz-Ponte, C				Fernandez-Rozadilla, Ceres; de Castro, Luisa; Clofent, Juan; Brea-Fernandez, Alejandro; Bessa, Xavier; Abuli, Anna; Andreu, Montserrat; Jover, Rodrigo; Xicola, Rosa; Llor, Xavier; Castells, Antoni; Castellvi-Bel, Sergi; Carracedo, Angel; Ruiz-Ponte, Clara		Spanish Gastroenterological Assoc	Single Nucleotide Polymorphisms in the Wnt and BMP Pathways and Colorectal Cancer Risk in a Spanish Cohort	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BONE MORPHOGENETIC PROTEIN-4; SUSCEPTIBILITY LOCUS; LARGE-SCALE; APC GENE; PREDISPOSITION; VARIANT; 8Q24; RS6983267; SHOWS	Background: Colorectal cancer (CRC) is considered a complex disease, and thus the majority of the genetic susceptibility is thought to lie in the form of low-penetrance variants following a polygenic model of inheritance. Candidate-gene studies have so far been one of the basic approaches taken to identify these susceptibility variants. The consistent involvement of some signaling routes in carcinogenesis provided support for pathway-based studies as a natural strategy to select genes that could potentially harbour new susceptibility loci. Methodology/Principal Findings: We selected two main carcinogenesis-related pathways: Wnt and BMP, in order to screen the implicated genes for new risk variants. We then conducted a case-control association study in 933 CRC cases and 969 controls based on coding and regulatory SNPs. We also included rs4444235 and rs9929218, which did not fulfill our selection criteria but belonged to two genes in the BMP pathway and had consistently been linked to CRC in previous studies. Neither allelic, nor genotypic or haplotypic analyses showed any signs of association between the 37 screened variants and CRC risk. Adjustments for sex and age, and stratified analysis between sporadic and control groups did not yield any positive results either. Conclusions/Significance: Despite the relevance of both pathways in the pathogenesis of the disease, and the fact that this is indeed the first study that considers these pathways as a candidate-gene selection approach, our study does not present any evidence of the presence of low-penetrance variants for the selected markers in any of the considered genes in our cohort.	[Fernandez-Rozadilla, Ceres; Brea-Fernandez, Alejandro; Carracedo, Angel; Ruiz-Ponte, Clara] Univ Santiago Compostela, Hosp Clin, CIBERER, Genom Med Grp,Galician Publ Fdn Genom Med FPGMX, Galicia, Spain; [de Castro, Luisa] Hosp Meixoeiro, Dept Gastroenterol, Vigo, Galicia, Spain; [Clofent, Juan] Hosp La Fe, Dept Gastroenterol, E-46009 Valencia, Spain; [Bessa, Xavier; Abuli, Anna; Andreu, Montserrat] Pompeu Fabra Univ, IMIM, Hosp Mar, Dept Gastroenterol, Barcelona, Catalonia, Spain; [Jover, Rodrigo] Hosp Gen Univ Alicante, Unidad Gastroenterol, Alicante, Spain; [Xicola, Rosa; Llor, Xavier] Univ Illinois, Sect Digest Dis & Nutr, Chicago, IL USA; [Castells, Antoni; Castellvi-Bel, Sergi] Univ Barcelona, Hosp Clin, Dept Gastroenterol, CIBERehd,IDIBAPS, Barcelona, Catalonia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Vigo; Hospital Universitari i Politecnic La Fe; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; General University Hospital of Alicante; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Fernandez-Rozadilla, C (corresponding author), Univ Santiago Compostela, Hosp Clin, CIBERER, Genom Med Grp,Galician Publ Fdn Genom Med FPGMX, Galicia, Spain.	clara.ruiz.ponte@usc.es	Brea-FernÃndez, Alejandro J./GXV-4687-2022; Jover, Rodrigo/ABC-3258-2021; Andreu, Montserrat/D-9911-2015; Ruiz-Ponte, Clara/I-3849-2015; Castells, Antoni/ABC-1002-2021; Carracedo, Angel/D-4257-2012	Jover, Rodrigo/0000-0003-3742-3413; Andreu, Montserrat/0000-0003-4286-1098; Ruiz-Ponte, Clara/0000-0002-2200-0162; Castells, Antoni/0000-0001-8431-2033; Carracedo, Angel/0000-0003-1085-8986; Castellvi-Bel, Sergi/0000-0003-1217-5097; Brea-Fernandez, Alejandro/0000-0003-1527-471X; Fernandez-Rozadilla, Ceres/0000-0001-7330-4804; Bessa Caserras, Xavier/0000-0003-4680-1228	Fondo de Investigacion Sanitaria/FEDER [05/2031, 08/0024, 08/1276, PS09/02368]; Xunta de Galicia [PGIDIT07PXIB9101209PR]; Ministerio de Ciencia e Innovacion [SAF 07-64873]; Asociacion Espanola contra el Cancer (Fundacion Cientifica y Junta de Barcelona); Fundacion de Investigacion Medica Mutua Madrilena.	Fondo de Investigacion Sanitaria/FEDER(Instituto de Salud Carlos IIIEuropean Commission); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Asociacion Espanola contra el Cancer (Fundacion Cientifica y Junta de Barcelona); Fundacion de Investigacion Medica Mutua Madrilena.	This work was supported by grants from the Fondo de Investigacion Sanitaria/FEDER (05/2031, 08/0024, 08/1276, PS09/02368), Xunta de Galicia (PGIDIT07PXIB9101209PR, Ministerio de Ciencia e Innovacion (SAF 07-64873), Asociacion Espanola contra el Cancer (Fundacion Cientifica y Junta de Barcelona), and Fundacion de Investigacion Medica Mutua Madrilena. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Castells A, 2009, GASTROENTEROLOGY, V137, P404, DOI 10.1053/j.gastro.2009.06.015; Cazier JB, 2010, J PATHOL, V220, P255, DOI 10.1002/path.2650; Chen HM, 2009, INT J COLORECTAL DIS, V24, P865, DOI 10.1007/s00384-009-0714-2; Chen SP, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-83; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; Deng HY, 2007, EXP CELL RES, V313, P1033, DOI 10.1016/j.yexcr.2006.12.020; Deng HY, 2009, CANCER LETT, V281, P220, DOI 10.1016/j.canlet.2009.02.046; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; FERLAY J, 2004, MORTALITY PREVALENCE, V8; Half E, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-22; Hazra A, 2008, CANCER CAUSE CONTROL, V19, P975, DOI 10.1007/s10552-008-9164-3; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Houlston RS, 2004, ONCOGENE, V23, P6471, DOI 10.1038/sj.onc.1207951; Huang HC, 2004, CANCER BIOL THER, V3, P676, DOI 10.4161/cbt.3.7.1026; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Kang HJ, 2005, NUCLEIC ACIDS RES, V33, pD518; Kemp Z, 2004, HUM MOL GENET, V13, pR177, DOI 10.1093/hmg/ddh247; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Liu B, 2010, MOL CARCINOGEN, V49, P75, DOI 10.1002/mc.20579; Naccarati A, 2007, MUTAT RES-REV MUTAT, V635, P118, DOI 10.1016/j.mrrev.2007.02.001; Nishanian TG, 2004, CANCER BIOL THER, V3, P667; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Picelli S, 2010, EUR J CANCER, V46, P1041, DOI 10.1016/j.ejca.2010.01.013; Pinol V, 2005, JAMA-J AM MED ASSOC, V293, P1986, DOI 10.1001/jama.293.16.1986; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Ruiz-Ponte C, 2001, J Med Genet, V38, pE33, DOI 10.1136/jmg.38.10.e33; Schafmayer C, 2007, INT J CANCER, V121, P555, DOI 10.1002/ijc.22735; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Slattery ML, 2001, CANCER RES, V61, P1000; Tao H, 2008, CANCER SCI, V99, P355, DOI 10.1111/j.1349-7006.2007.00694.x; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; 2009, GENOTYPING DATA FILT	44	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12673	10.1371/journal.pone.0012673	http://dx.doi.org/10.1371/journal.pone.0012673			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844743	Green Published, gold, Green Submitted			2022-12-27	WOS:000281687200021
J	Castro, H; Romao, S; Carvalho, S; Teixeira, F; Sousa, C; Tomas, AM				Castro, Helena; Romao, Susana; Carvalho, Sandra; Teixeira, Filipa; Sousa, Carla; Tomas, Ana M.			Mitochondrial Redox Metabolism in Trypanosomatids Is Independent of Tryparedoxin Activity	PLOS ONE			English	Article							DEPENDENT PEROXIDE METABOLISM; LEISHMANIA-INFANTUM; DNA-REPLICATION; BINDING-PROTEIN; THIOREDOXIN; BRUCEI; CRUZI; THIOL; OVEREXPRESSION; LOCALIZATION	Tryparedoxins (TXNs) are oxidoreductases unique to trypanosomatids (including Leishmania and Trypanosoma parasites) that transfer reducing equivalents from trypanothione, the major thiol in these organisms, to sulfur-dependent peroxidases and other dithiol proteins. The existence of a TXN within the mitochondrion of trypanosomatids, capable of driving crucial redox pathways, is considered a requisite for normal parasite metabolism. Here this concept is shown not to apply to Leishmania. First, removal of the Leishmania infantum mitochondrial TXN (LiTXN2) by gene-targeting, had no significant effect on parasite survival, even in the context of an animal infection. Second, evidence is presented that no other TXN is capable of replacing LiTXN2. In fact, although a candidate substitute for LiTXN2 (LiTXN3) was found in the genome of L. infantum, this was shown in biochemical assays to be poorly reduced by trypanothione and to be unable to reduce sulfur-containing peroxidases. Definitive conclusion that LiTXN3 cannot directly reduce proteins located within inner mitochondrial compartments was provided by analysis of its subcellular localization and membrane topology, which revealed that LiTXN3 is a tail-anchored (TA) mitochondrial outer membrane protein presenting, as characteristic of TA proteins, its N-terminal end (containing the redox-active domain) exposed to the cytosol. This manuscript further proposes the separation of trypanosomatid TXN sequences into two classes and this is supported by phylogenetic analysis: i) class I, encoding active TXNs, and ii) class II, coding for TA proteins unlikely to function as TXNs. Trypanosoma possess only two TXNs, one belonging to class I (which is cytosolic) and the other to class II. Thus, as demonstrated for Leishmania, the mitochondrial redox metabolism in Trypanosoma may also be independent of TXN activity. The major implication of these findings is that mitochondrial functions previously thought to depend on the provision of electrons by a TXN enzyme must proceed differently.	[Castro, Helena; Romao, Susana; Carvalho, Sandra; Teixeira, Filipa; Sousa, Carla; Tomas, Ana M.] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Tomas, Ana M.] Univ Porto, ICBAS, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Castro, H (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	atomas@ibmc.up.pt	Castro, Helena/J-4794-2013; Teixeira, Filipa/P-1408-2019; Tomas, Ana/J-9919-2013	Castro, Helena/0000-0002-6021-9210; Tomas, Ana/0000-0002-0781-9567; Carvalho, Sandra/0000-0001-6695-1683	Fundacao para a Ciencia e a Tecnologia [PPCDT/SAU-IMI/59560/2004, PTDC/CVT/70275/2006]; Fundacao Calouste Gulbenkian [P-105335]; FCT [SFRH/BPD/20610/2004, SFRH/BD/18452/2004, SFRH/BD/28712/2006]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao Calouste Gulbenkian(European Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was supported by grants PPCDT/SAU-IMI/59560/2004 and PTDC/CVT/70275/2006 from Fundacao para a Ciencia e a Tecnologia (http://alfa.fct.mctes.pt/) and P-105335 from Fundacao Calouste Gulbenkian (http://www.gulbenkian.pt/). HC, SR and SC are recipients of FCT fellowships (SFRH/BPD/20610/2004, SFRH/BD/18452/2004 and SFRH/BD/28712/2006, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Beverley S M, 1993, Methods Mol Biol, V21, P333; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Budde H, 2003, BIOL CHEM, V384, P619, DOI 10.1515/BC.2003.069; BUFFET PA, 1995, ANTIMICROB AGENTS CH, V39, P2167, DOI 10.1128/AAC.39.9.2167; CARNIERI EGS, 1993, MOL BIOCHEM PARASIT, V61, P79, DOI 10.1016/0166-6851(93)90160-Y; Castro H, 2004, MOL BIOCHEM PARASIT, V136, P137, DOI 10.1016/j.molbiopara.2004.02.015; Castro H, 2002, FREE RADICAL BIO MED, V33, P1563, DOI 10.1016/S0891-5849(02)01088-2; Castro H, 2002, FREE RADICAL BIO MED, V33, P1552, DOI 10.1016/S0891-5849(02)01089-4; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Clayton C, 1998, MOL BIOCHEM PARASIT, V97, P221, DOI 10.1016/S0166-6851(98)00115-7; Comini MA, 2008, J BIOL CHEM, V283, P27785, DOI 10.1074/jbc.M802010200; Comini MA, 2007, BIOCHEM J, V402, P43, DOI 10.1042/BJ20061341; Dolai S, 2008, FREE RADICAL BIO MED, V45, P1520, DOI 10.1016/j.freeradbiomed.2008.08.029; Dormeyer M, 2001, J BIOL CHEM, V276, P10602, DOI 10.1074/jbc.M010352200; Filser M, 2008, BIOL CHEM, V389, P21, DOI 10.1515/BC.2007.147; Fulop V, 2009, FEBS J, V276, P2822, DOI 10.1111/j.1742-4658.2009.07005.x; Harder S, 2006, EUKARYOT CELL, V5, P861, DOI 10.1128/EC.5.5.861-870.2006; Hillebrand H, 2003, J BIOL CHEM, V278, P6809, DOI 10.1074/jbc.M210392200; Hofmann B, 2001, BIOL CHEM, V382, P459, DOI 10.1515/BC.2001.056; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; KELLY JM, 1992, NUCLEIC ACIDS RES, V20, P3963, DOI 10.1093/nar/20.15.3963; Konig J, 2007, FEBS J, V274, P5643, DOI 10.1111/j.1742-4658.2007.06087.x; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Lin YC, 2005, MOL BIOCHEM PARASIT, V142, P66, DOI 10.1016/j.molbiopara.2005.03.009; Melchers J, 2008, J BIOL CHEM, V283, P30401, DOI 10.1074/jbc.M803563200; Melchers J, 2007, J BIOL CHEM, V282, P8678, DOI 10.1074/jbc.M608140200; Milman N, 2007, P NATL ACAD SCI USA, V104, P19250, DOI 10.1073/pnas.0706858104; Mkrtchian S, 2006, ANTIOXID REDOX SIGN, V8, P325, DOI 10.1089/ars.2006.8.325; Motyka SA, 2006, J BIOL CHEM, V281, P18499, DOI 10.1074/jbc.M602880200; Nogoceke E, 1997, BIOL CHEM, V378, P827, DOI 10.1515/bchm.1997.378.8.827; Onn I, 2004, EUKARYOT CELL, V3, P277, DOI 10.1128/EC.3.2.277-287.2004; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Requejo R, 2010, FEBS J, V277, P1465, DOI 10.1111/j.1742-4658.2010.07576.x; Romao S, 2009, INT J PARASITOL, V39, P703, DOI 10.1016/j.ijpara.2008.11.009; Schlecker T, 2005, J BIOL CHEM, V280, P14385, DOI 10.1074/jbc.M413338200; Schmidt H, 2003, J BIOL CHEM, V278, P46329, DOI 10.1074/jbc.M305338200; Sela D, 2008, J BIOL CHEM, V283, P32034, DOI 10.1074/jbc.M804417200; Steinert P, 1999, FREE RADICAL BIO MED, V26, P844, DOI 10.1016/S0891-5849(98)00263-9; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tetaud E, 2001, MOL BIOCHEM PARASIT, V116, P171, DOI 10.1016/S0166-6851(01)00320-6; Trujillo M, 2004, J BIOL CHEM, V279, P34175, DOI 10.1074/jbc.M404317200; Vlamis-Gardikas A, 2008, BBA-GEN SUBJECTS, V1780, P1170, DOI 10.1016/j.bbagen.2008.03.013; Walensky LD, 2006, CELL DEATH DIFFER, V13, P1339, DOI 10.1038/sj.cdd.4401992; Wilkinson SM, 2002, J BIOL CHEM, V277, P17062, DOI 10.1074/jbc.M111126200; Wilkinson SR, 2000, J BIOL CHEM, V275, P8220, DOI 10.1074/jbc.275.11.8220; Wilkinson SR, 2003, J BIOL CHEM, V278, P31640, DOI 10.1074/jbc.M303035200; Wilkinson SR, 2003, BIOL CHEM, V384, P517, DOI 10.1515/BC.2003.060	48	35	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12607	10.1371/journal.pone.0012607	http://dx.doi.org/10.1371/journal.pone.0012607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IV	20838623	Green Published, Green Submitted, gold			2022-12-27	WOS:000281687100007
J	Lin, L; Song, HH; Ji, YT; He, ZL; Pu, YT; Zhou, JZ; Xu, J				Lin, Lu; Song, Houhui; Ji, Yuetong; He, Zhili; Pu, Yunting; Zhou, Jizhong; Xu, Jian			Ultrasound-Mediated DNA Transformation in Thermophilic Gram-Positive Anaerobes	PLOS ONE			English	Article							THERMOANAEROBACTER-ETHANOLICUS; PLASMID DNA; CLOSTRIDIUM-THERMOSACCHAROLYTICUM; GENE-TRANSFER; IN-VIVO; ELECTROTRANSFORMATION; STRAIN; SONOPORATION; BACTERIA; ELECTROPORATION	Background: Thermophilic, Gram-positive, anaerobic bacteria (TGPAs) are generally recalcitrant to chemical and electrotransformation due to their special cell-wall structure and the low intrinsic permeability of plasma membranes. Methodology/Principal Findings: Here we established for any Gram-positive or thermophiles an ultrasound-based sonoporation as a simple, rapid, and minimally invasive method to genetically transform TGPAs. We showed that by applying a 40 kHz ultrasound frequency over a 20-second exposure, Texas red-conjugated dextran was delivered with 27% efficiency into Thermoanaerobacter sp. X514, a TGPA that can utilize both pentose and hexose for ethanol production. Experiments that delivered plasmids showed that host-cell viability and plasmid DNA integrity were not compromised. Via sonoporation, shuttle vectors pHL015 harboring a jellyfish gfp gene and pIKM2 encoding a Clostridium thermocellum beta-1,4-glucanase gene were delivered into X514 with an efficiency of 6610 2 transformants/mg of methylated DNA. Delivery into X514 cells was confirmed via detecting the kanamycin-resistance gene for pIKM2, while confirmation of pHL015 was detected by visualization of fluorescence signals of secondary host-cells following a plasmid-rescue experiment. Furthermore, the foreign beta-1,4-glucanase gene was functionally expressed in X514, converting the host into a prototypic thermophilic consolidated bioprocessing organism that is not only ethanologenic but cellulolytic. Conclusions/Significance: In this study, we developed an ultrasound-based sonoporation method in TGPAs. This new DNA-delivery method could significantly improve the throughput in developing genetic systems for TGPAs, many of which are of industrial interest yet remain difficult to manipulate genetically.	[Lin, Lu; Song, Houhui; Ji, Yuetong; Pu, Yunting; Xu, Jian] Chinese Acad Sci, Qingdao Inst BioEnergy & Bioproc Technol, Qingdao, Shandong, Peoples R China; [He, Zhili; Zhou, Jizhong] Univ Oklahoma, Dept Bot & Microbiol, Inst Environm Genom, Norman, OK 73019 USA	Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; University of Oklahoma System; University of Oklahoma - Norman	Lin, L (corresponding author), Chinese Acad Sci, Qingdao Inst BioEnergy & Bioproc Technol, Qingdao, Shandong, Peoples R China.	jzhou@ou.edu; xujian@qibebt.ac.cn	Pu, Yunting/AAG-8749-2020; 吴, 昊/AAB-1620-2020; He, Zhili/C-2879-2012; zheng, yonghong/H-3700-2012; Xu, Jian/G-8430-2012	He, Zhili/0000-0001-8225-7333; Xu, Jian/0000-0002-0548-8477; Pu, Yunting/0000-0001-8744-6141	Chinese Academy of Sciences [KSCX1-YW-11C2]; National Natural Science Foundation of China (NSFC) [30870572, NSFC-30800014]; Ministry of Science and Technology of China; Young Investigator Award of Shandong Province [JQ200822]; Shandong Key Laboratory of Energy Genetics (China); Office Of The Director [0814361] Funding Source: National Science Foundation	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Young Investigator Award of Shandong Province; Shandong Key Laboratory of Energy Genetics (China); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by grants KSCX1-YW-11C2 and Hundred-Scholar Award from Chinese Academy of Sciences to JX, 30870572 from National Natural Science Foundation of China (NSFC) to JX and NSFC-30800014 to HS. It was also funded by the China-Israel Cooperation Project "Designer Cellulosome Systems" from the Ministry of Science and Technology of China, JQ200822 from the Young Investigator Award of Shandong Province, and Shandong Key Laboratory of Energy Genetics (China) to JX and HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Alegre MT, 2004, FEMS MICROBIOL LETT, V241, P73, DOI 10.1016/j.femsle.2004.10.006; Averhoff B, 2004, J BIOENERG BIOMEMBR, V36, P25, DOI 10.1023/B:JOBB.0000019595.66733.fa; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradshaw M, 2010, APPL ENVIRON MICROB, V76, P387, DOI 10.1128/AEM.02005-09; Dong HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009038; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; ELSNER HI, 1989, DNA-J MOLEC CELL BIO, V8, P697, DOI 10.1089/dna.1989.8.697; Fan Z, 2010, J CONTROL RELEASE, V142, P31, DOI 10.1016/j.jconrel.2009.09.031; Feng XY, 2009, APPL ENVIRON MICROB, V75, P5001, DOI 10.1128/AEM.00715-09; GEIER GE, 1979, J BIOL CHEM, V254, P1408; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Han YW, 2007, APPL ENVIRON MICROB, V73, P3677, DOI 10.1128/AEM.00428-07; He Q, 2009, BIORESOURCE TECHNOL, V100, P5955, DOI 10.1016/j.biortech.2009.06.084; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Jennert KCB, 2000, MICROBIOL-SGM, V146, P3071, DOI 10.1099/00221287-146-12-3071; Jones CR, 2002, CURR MICROBIOL, V45, P54, DOI 10.1007/s00284-001-0099-0; Klapatch TR, 1996, APPL MICROBIOL BIOT, V45, P127, DOI 10.1007/s002530050659; Klapatch TR, 1996, J IND MICROBIOL, V16, P342, DOI 10.1007/BF01570112; Kwak J, 2002, FEMS MICROBIOL LETT, V209, P243, DOI 10.1016/S0378-1097(02)00512-8; Larsen L, 1997, ARCH MICROBIOL, V168, P114, DOI 10.1007/s002030050476; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; MACALUSO A, 1991, J BACTERIOL, V173, P1353, DOI 10.1128/jb.173.3.1353-1356.1991; Mai V, 1997, FEMS MICROBIOL LETT, V148, P163, DOI 10.1016/S0378-1097(97)00028-1; Manome Y, 2005, ULTRASOUND MED BIOL, V31, P693, DOI 10.1016/j.ultrasmedbio.2005.01.015; Newman CMH, 2007, GENE THER, V14, P465, DOI 10.1038/sj.gt.3302925; Peng H, 2006, BIOTECHNOL LETT, V28, P1913, DOI 10.1007/s10529-006-9184-6; Rittich B, 1996, BIOELECTROCH BIOENER, V40, P233, DOI 10.1016/0302-4598(96)01915-0; Roberts RJ, 2005, NUCLEIC ACIDS RES, V33, pD230; Roh Y, 2002, APPL ENVIRON MICROB, V68, P6013, DOI 10.1128/AEM.68.12.6013-6020.2002; Shaw AJ, 2008, P NATL ACAD SCI US; Song YZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm710; Tyurin MV, 2005, APPL ENVIRON MICROB, V71, P8069, DOI 10.1128/AEM.71.12.8069-8076.2005; Tyurin MV, 2004, APPL ENVIRON MICROB, V70, P883, DOI 10.1128/AEM.70.2.883-890.2004; WEAVER JC, 1993, J CELL BIOCHEM, V51, P426, DOI 10.1002/jcb.2400510407; WILSON JH, 1994, P NATL ACAD SCI USA, V91, P177, DOI 10.1073/pnas.91.1.177; Zhou Y, 2008, J CONTROL RELEASE, V126, P34, DOI 10.1016/j.jconrel.2007.11.007; Zhou Y, 2009, ULTRASOUND MED BIOL, V35, P1756, DOI 10.1016/j.ultrasmedbio.2009.05.012	40	32	36	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2010	5	9							e12582	10.1371/journal.pone.0012582	http://dx.doi.org/10.1371/journal.pone.0012582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857NY	20838444	Green Published, gold, Green Submitted			2022-12-27	WOS:000297726500001
J	Cheung, CHA; Wu, SY; Lee, TR; Chang, CY; Wu, JS; Hsieh, HP; Chang, JY				Cheung, Chun Hei Antonio; Wu, Su-Ying; Lee, Tian-Ren; Chang, Chi-Yen; Wu, Jian-Sung; Hsieh, Hsing-Pang; Chang, Jang-Yang			Cancer Cells Acquire Mitotic Drug Resistance Properties Through Beta I-Tubulin Mutations and Alterations in the Expression of Beta-Tubulin Isotypes	PLOS ONE			English	Article							BREAST-CANCER; PACLITAXEL RESISTANCE; MICROTUBULE DYNAMICS; ALPHA-TUBULIN; COLCHICINE; TAXOL; SENSITIVITY; EPOTHILONE; LINES; VIVO	Background: Anti-mitotic compounds (microtubule de-stabilizers) such as vincristine and vinblastine have been shown clinically successful in treating various cancers. However, development of drug-resistance cells limits their efficacies in clinical situations. Therefore, experiments were performed to determine possible drug resistance mechanisms related to the application of anti-mitotic cancer therapy. Principal Findings: A KB-derived microtubule de-stabilizer-resistant KB-L30 cancer cell line was generated for this study. KB-L30 cells showed cross-resistance to various microtubule de-stabilizers including BPR0L075, vincristine and colchicine through multiple-drug resistant (MDR)-independent mechanisms. Surprisingly, KB-L30 cells showed hyper-sensitivity to the microtubule-stabilizer, paclitaxel. Results of the RT-PCR analysis revealed that expression of both class II and III beta-tubulin was down-regulated in KB-L30 cells as compared to its parental KB cancer cells. In addition, DNA sequencing analysis revealed six novel mutation sites present in exon four of the beta I-tubulin gene. Computational modeling indicated that a direct relationship exists between beta I-tubulin mutations and alteration in the microtubule assembly and dynamic instability in KB-L30 cells and this predicted model was supported by an increased microtubule assembly and reduced microtubule dynamic instability in KB-L30 cells, as shown by Western blot analysis. Conclusions and Significance: Our study demonstrated that these novel mutations in exon four of the beta I-tubulin induced resistance to microtubule de-stabilizers and hyper-sensitivity to microtubule stabilizer through an alteration in the microtubule assembly and dynamics in cancer cells. Importantly, the current study reveals that cancer cells may acquire drug resistance ability to anti-mitotic compounds through multiple changes in the microtubule networks. This study further provided molecular information in drug selection for patients with specific tubulin mutations.	[Cheung, Chun Hei Antonio; Lee, Tian-Ren; Chang, Chi-Yen; Chang, Jang-Yang] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Wu, Su-Ying; Wu, Jian-Sung; Hsieh, Hsing-Pang] Natl Hlth Res Inst, Div Biotechnol & Pharmaceut Res, Zhunan, Taiwan; [Chang, Jang-Yang] Natl Cheng Kung Univ Hosp, Div Hematol & Oncol, Dept Internal Med, Tainan 70428, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital	Cheung, CHA (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan.	jychang@nhri.org.tw	Hsieh, Hsing-Pang/B-2649-2010; Chang, Jang-Yang/D-2099-2010; Cheung, Chun Hei Antonio/D-4588-2009; Wu, Su-Ying/C-1370-2010	Hsieh, Hsing-Pang/0000-0002-1332-005X; Cheung, Chun Hei Antonio/0000-0003-4181-1435	National Science Council, Taiwan, Republic of China [NSC98-3114-M-006-002, NSC98-2323-B-400-004]; Department of Health, Taiwan, Republic of China [DOH99-TD-C-111-004]; National Health Research Institutes, Taiwan, Republic of China [CA-097-PP-02]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan); Department of Health, Taiwan, Republic of China; National Health Research Institutes, Taiwan, Republic of China(National Health Research Institutes - Taiwan)	This work was supported by intramural grants NSC98-3114-M-006-002 and NSC98-2323-B-400-004 from the National Science Council, Taiwan, Republic of China, DOH99-TD-C-111-004 from the Department of Health, Taiwan, Republic of China and CA-097-PP-02 from the National Health Research Institutes, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrieta O, 2006, CANCER-AM CANCER SOC, V107, P1852, DOI 10.1002/cncr.22198; Cheung CHA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-43; Giannakakou P, 2000, P NATL ACAD SCI USA, V97, P2904, DOI 10.1073/pnas.040546297; Goncalves A, 2001, P NATL ACAD SCI USA, V98, P11737, DOI 10.1073/pnas.191388598; Hari M, 2003, MOL CANCER THER, V2, P597; He LF, 2001, MOL CANCER THER, V1, P3; Huzil JT, 2007, CANCER INFORM, V3, P159; Kamath K, 2005, J BIOL CHEM, V280, P12902, DOI 10.1074/jbc.M414477200; Kim DW, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-28; KOHNO K, 1988, JPN J CANCER RES, V79, P1238, DOI 10.1111/j.1349-7006.1988.tb01550.x; Kuo CC, 2004, CANCER RES, V64, P4621, DOI 10.1158/0008-5472.CAN-03-3474; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Mechetner E, 1998, CLIN CANCER RES, V4, P389; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Ong V, 2008, J PHARMACOL EXP THER, V324, P434, DOI 10.1124/jpet.107.128926; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Seve P, 2007, CANCER CHEMOTH PHARM, V60, P27, DOI 10.1007/s00280-006-0343-1; Seve P, 2010, LUNG CANCER, V67, P136, DOI 10.1016/j.lungcan.2009.09.007; Shalli K, 2005, FASEB J, V19, P1299, DOI 10.1096/fj.04-3178fje; Tanaka Y, 2004, INT J GYNECOL CANCER, V14, P616, DOI 10.1111/j.1048-891X.2004.14409.x; Tommasi S, 2007, INT J CANCER, V120, P2078, DOI 10.1002/ijc.22557; Tseng CY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-131; Urano Naomi, 2003, Gastric Cancer, V6, P108; Valiron O, 2001, CELL MOL LIFE SCI, V58, P2069, DOI 10.1007/PL00000837; Verdier-Pinard P, 2003, BIOCHEMISTRY-US, V42, P5349, DOI 10.1021/bi027293o; Wang YF, 2005, CELL CYCLE, V4, P1847, DOI 10.4161/cc.4.12.2264	27	37	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12564	10.1371/journal.pone.0012564	http://dx.doi.org/10.1371/journal.pone.0012564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838440	Green Published, Green Submitted, gold			2022-12-27	WOS:000281627700016
J	Klein, CJ; Ban, NC; Halpern, BS; Beger, M; Game, ET; Grantham, HS; Green, A; Klein, TJ; Kininmonth, S; Treml, E; Wilson, K; Possingham, HP				Klein, Carissa J.; Ban, Natalie C.; Halpern, Benjamin S.; Beger, Maria; Game, Edward T.; Grantham, Hedley S.; Green, Alison; Klein, Travis J.; Kininmonth, Stuart; Treml, Eric; Wilson, Kerrie; Possingham, Hugh P.			Prioritizing Land and Sea Conservation Investments to Protect Coral Reefs	PLOS ONE			English	Article							CLIMATE-CHANGE; BIODIVERSITY CONSERVATION; HUMAN IMPACTS; MARINE; COSTS; RESILIENCE; NETWORKS; BENEFITS; HOTSPOTS; AREAS	Background: Coral reefs have exceptional biodiversity, support the livelihoods of millions of people, and are threatened by multiple human activities on land (e.g. farming) and in the sea (e.g. overfishing). Most conservation efforts occur at local scales and, when effective, can increase the resilience of coral reefs to global threats such as climate change (e.g. warming water and ocean acidification). Limited resources for conservation require that we efficiently prioritize where and how to best sustain coral reef ecosystems. Methodology/Principal Findings: Here we develop the first prioritization approach that can guide regional-scale conservation investments in land-and sea-based conservation actions that cost-effectively mitigate threats to coral reefs, and apply it to the Coral Triangle, an area of significant global attention and funding. Using information on threats to marine ecosystems, effectiveness of management actions at abating threats, and the management and opportunity costs of actions, we calculate the rate of return on investment in two conservation actions in sixteen ecoregions. We discover that marine conservation almost always trumps terrestrial conservation within any ecoregion, but terrestrial conservation in one ecoregion can be a better investment than marine conservation in another. We show how these results could be used to allocate a limited budget for conservation and compare them to priorities based on individual criteria. Conclusions/Significance: Previous prioritization approaches do not consider both land and sea-based threats or the socioeconomic costs of conserving coral reefs. A simple and transparent approach like ours is essential to support effective coral reef conservation decisions in a large and diverse region like the Coral Triangle, but can be applied at any scale and to other marine ecosystems.	[Klein, Carissa J.; Beger, Maria; Grantham, Hedley S.; Treml, Eric; Wilson, Kerrie; Possingham, Hugh P.] Univ Queensland, Ctr Ecol, St Lucia, Qld, Australia; [Ban, Natalie C.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Halpern, Benjamin S.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA; [Game, Edward T.; Green, Alison] Nature Conservancy, Brisbane, Qld, Australia; [Klein, Travis J.] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Kininmonth, Stuart] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	University of Queensland; James Cook University; National Center for Ecological Analysis & Synthesis; Nature Conservancy; Queensland University of Technology (QUT); Australian Institute of Marine Science	Klein, CJ (corresponding author), Univ Queensland, Ctr Ecol, St Lucia, Qld, Australia.	c.klein@uq.edu.au	Kininmonth, Stuart/N-9299-2013; Possingham, Hugh/B-1337-2008; Beger, Maria/ABC-5975-2022; Beger, Maria/F-9049-2013; Wilson, Kerrie/W-4181-2019; Wilson, Kerrie A/C-8058-2009; Ban, Natalie/C-6938-2009; POSSINGHAM, HUGH/R-8310-2019; Klein, Travis/J-1117-2012; Game, Edward/AAD-2289-2020; Klein, Carissa J/F-1632-2011; Treml, Eric A/C-7580-2013	Kininmonth, Stuart/0000-0001-9198-3396; Possingham, Hugh/0000-0001-7755-996X; Beger, Maria/0000-0003-1363-3571; Beger, Maria/0000-0003-1363-3571; Wilson, Kerrie/0000-0002-0092-935X; Wilson, Kerrie A/0000-0002-0092-935X; POSSINGHAM, HUGH/0000-0001-7755-996X; Klein, Travis/0000-0002-6669-7766; Game, Edward/0000-0003-4707-9281; Klein, Carissa J/0000-0002-6299-6451; Treml, Eric A/0000-0003-4844-4420; Ban, Natalie/0000-0002-4682-2144	Centre for Applied Environmental Decision Analysis; Australian Research Council; University of Queensland Graduate School; World Wildlife Fund	Centre for Applied Environmental Decision Analysis; Australian Research Council(Australian Research Council); University of Queensland Graduate School(University of Queensland); World Wildlife Fund	Funding was provided by the Centre for Applied Environmental Decision Analysis, the Australian Research Council, and a University of Queensland Graduate School Research Travel Grant. EAT was supported by the World Wildlife Fund Fuller Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmford A, 2004, P NATL ACAD SCI USA, V101, P9694, DOI 10.1073/pnas.0403239101; Ban NC, 2009, CONSERV LETT, V2, P206, DOI 10.1111/j.1755-263X.2009.00071.x; Baskett ML, 2010, GLOBAL CHANGE BIOL, V16, P1229, DOI 10.1111/j.1365-2486.2009.02062.x; Beger M, 2010, BIOL CONSERV, V143, P565, DOI 10.1016/j.biocon.2009.11.006; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bode M, 2008, P NATL ACAD SCI USA, V105, P6498, DOI 10.1073/pnas.0710705105; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Carwardine J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002586; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Dodge RE, 2008, SCIENCE, V322, P189, DOI 10.1126/science.322.5899.189b; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Halpern BS, 2009, CONSERV LETT, V2, P189, DOI 10.1111/j.1755-263X.2009.00060.x; Halpern BS, 2009, CONSERV LETT, V2, P138, DOI 10.1111/j.1755-263X.2009.00058.x; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Kark S, 2009, P NATL ACAD SCI USA, V106, P15368, DOI 10.1073/pnas.0901001106; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Klein CJ, 2010, FRONT ECOL ENVIRON, V8, P349, DOI 10.1890/090047; Klein CJ, 2008, CONSERV LETT, V1, P44, DOI 10.1111/j.1755-263X.2008.00005.x; MCCLANAHAN TR, 2008, CONSERV LETT, P53; Moore J, 2004, BIOL CONSERV, V117, P343, DOI 10.1016/j.biocon.2003.12.013; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Naidoo R, 2005, P NATL ACAD SCI USA, V102, P16712, DOI 10.1073/pnas.0508036102; *REG CTI SECR, 2009, REG PLAN ACT COR TRI; Richmond RH, 2007, BIOSCIENCE, V57, P598, DOI 10.1641/B570710; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; Sala E, 2002, SCIENCE, V298, P1991, DOI 10.1126/science.1075284; Smith RJ, 2009, NATURE, V462, P280, DOI 10.1038/462280a; Spalding M. D., 2001, WORLD ATLAS CORAL RE; Stibig HJ, 2004, APPL VEG SCI, V7, P153, DOI 10.1111/j.1654-109X.2004.tb00606.x; Sumaila U. Rashid, 2007, Journal of Bioeconomics, V9, P39, DOI 10.1007/s10818-007-9015-4; VERON J, 2009, GLOBAL CORA IN PRESS; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223	41	64	64	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12431	10.1371/journal.pone.0012431	http://dx.doi.org/10.1371/journal.pone.0012431			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20814570	Green Accepted, Green Published, gold			2022-12-27	WOS:000281375500003
J	Limmathurotsakul, D; Jamsen, K; Arayawichanont, A; Simpson, JA; White, LJ; Lee, SJ; Wuthiekanun, V; Chantratita, N; Cheng, A; Day, NPJ; Verzilli, C; Peacock, SJ				Limmathurotsakul, Direk; Jamsen, Kris; Arayawichanont, Arkhom; Simpson, Julie A.; White, Lisa J.; Lee, Sue J.; Wuthiekanun, Vanaporn; Chantratita, Narisara; Cheng, Allen; Day, Nicholas P. J.; Verzilli, Claudio; Peacock, Sharon J.			Defining the True Sensitivity of Culture for the Diagnosis of Melioidosis Using Bayesian Latent Class Models	PLOS ONE			English	Article							BURKHOLDERIA-PSEUDOMALLEI; PSEUDOMONAS-PSEUDOMALLEI; CASSETTE TEST; TESTS; SPECIFICITY; ACCURACY; ABSENCE; IGM	Background: Culture remains the diagnostic gold standard for many bacterial infections, and the method against which other tests are often evaluated. Specificity of culture is 100% if the pathogenic organism is not found in healthy subjects, but the sensitivity of culture is more difficult to determine and may be low. Here, we apply Bayesian latent class models (LCMs) to data from patients with a single Gram-negative bacterial infection and define the true sensitivity of culture together with the impact of misclassification by culture on the reported accuracy of alternative diagnostic tests. Methods/Principal Findings: Data from published studies describing the application of five diagnostic tests (culture and four serological tests) to a patient cohort with suspected melioidosis were re-analysed using several Bayesian LCMs. Sensitivities, specificities, and positive and negative predictive values (PPVs and NPVs) were calculated. Of 320 patients with suspected melioidosis, 119 (37%) had culture confirmed melioidosis. Using the final model (Bayesian LCM with conditional dependence between serological tests), the sensitivity of culture was estimated to be 60.2%. Prediction accuracy of the final model was assessed using a classification tool to grade patients according to the likelihood of melioidosis, which indicated that an estimated disease prevalence of 61.6% was credible. Estimates of sensitivities, specificities, PPVs and NPVs of four serological tests were significantly different from previously published values in which culture was used as the gold standard. Conclusions/Significance: Culture has low sensitivity and low NPV for the diagnosis of melioidosis and is an imperfect gold standard against which to evaluate alternative tests. Models should be used to support the evaluation of diagnostic tests with an imperfect gold standard. It is likely that the poor sensitivity/specificity of culture is not specific for melioidosis, but rather a generic problem for many bacterial and fungal infections.	[Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Limmathurotsakul, Direk; White, Lisa J.; Lee, Sue J.; Wuthiekanun, Vanaporn; Chantratita, Narisara; Day, Nicholas P. J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Jamsen, Kris; Simpson, Julie A.] Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Carlton, Vic 3053, Australia; [Arayawichanont, Arkhom] Sappasithiprasong Hosp, Dept Med, Ubon Ratchathani, Thailand; [Lee, Sue J.; Day, Nicholas P. J.] Univ Oxford, Churchill Hosp, Nuffield Dept Clin Med, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Chantratita, Narisara; Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Cheng, Allen] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Cheng, Allen] Charles Darwin Univ, Menzies Sch Hlth Res, Casuarina, Australia; [Verzilli, Claudio] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Peacock, Sharon J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Melbourne; University of Oxford; Mahidol University; Monash University; Charles Darwin University; Menzies School of Health Research; University of London; London School of Hygiene & Tropical Medicine; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Limmathurotsakul, D (corresponding author), Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand.	direk@tropmedres.ac	White, Lisa/AAC-9396-2020; Peacock, Sharon J/ABE-6331-2020; Simpson, Julie A/P-7299-2014; Chantratita, Narisara/P-2169-2019	White, Lisa/0000-0002-6523-185X; Cheng, Allen/0000-0003-3152-116X; Limmathurotsakul, Direk/0000-0001-7240-5320; Peacock, Sharon/0000-0002-1718-2782; Simpson, Julie/0000-0002-2660-2013	Wellcome Trust of Great Britain; Mahidol-Oxford Tropical Medicine Research Unit; Sapprasithiprasong Hospital	Wellcome Trust of Great Britain(Wellcome Trust); Mahidol-Oxford Tropical Medicine Research Unit; Sapprasithiprasong Hospital	This study was funded by The Wellcome Trust of Great Britain. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the support provided by staff at the Mahidol-Oxford Tropical Medicine Research Unit and the Sapprasithiprasong Hospital. We thank Jintana Suwannapruk, Varinthorn Praikaew, Pitchayanant Ariyaprasert, Maliwan Hongsuwan, Sukanya Pangmee, and Gumphol Vongsuwan for technical support. This article is an original report that was presented in part at the Joint International Tropical Medicine Meeting (JITMM) in Bangkok, Thailand on December 3-4, 2009.	Alexander B D, 2002, Transpl Infect Dis, V4 Suppl 3, P32, DOI 10.1034/j.1399-3062.4.s3.5.x; Chantratita N, 2007, CLIN VACCINE IMMUNOL, V14, P110, DOI 10.1128/CVI.00289-06; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Cheng AC, 2006, T ROY SOC TROP MED H, V100, P64, DOI 10.1016/j.trstmh.2005.04.019; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cheng Allen C, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS37, DOI 10.1016/S0035-9203(08)70010-5; Dendukuri N, 2001, BIOMETRICS, V57, P158, DOI 10.1111/j.0006-341X.2001.00158.x; Felgner PL, 2009, P NATL ACAD SCI USA, V106, P13499, DOI 10.1073/pnas.0812080106; JOSEPH L, 1995, AM J EPIDEMIOL, V141, P263, DOI 10.1093/oxfordjournals.aje.a117428; KHUPULSUP K, 1986, AM J TROP MED HYG, V35, P366, DOI 10.4269/ajtmh.1986.35.366; Klouche M, 2008, CLIN CHEM LAB MED, V46, P888, DOI 10.1515/CCLM.2008.157; Limmathurotsakul D, 2005, J CLIN MICROBIOL, V43, P2274, DOI 10.1128/JCM.43.5.2274-2276.2005; Limmathurotsakul D, 2010, AM J TROP MED HYG, V82, P1113, DOI 10.4269/ajtmh.2010.10-0038; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Menten J, 2008, STAT MED, V27, P4469, DOI 10.1002/sim.3317; Qu YS, 1998, J AM STAT ASSOC, V93, P920, DOI 10.2307/2669830; Qu YS, 1996, BIOMETRICS, V52, P797, DOI 10.2307/2533043; Rogers GB, 2009, J MED MICROBIOL, V58, P1401, DOI 10.1099/jmm.0.013334-0; Sangchan Apichat, 2003, J Med Assoc Thai, V86, P436; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Toft N, 2005, PREV VET MED, V68, P19, DOI 10.1016/j.prevetmed.2005.01.006; VATCHARAPREECHASAKUL T, 1992, CLIN INFECT DIS, V14, P412, DOI 10.1093/clinids/14.2.412; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; WHITE NJ, 1989, LANCET, V2, P697, DOI 10.1016/S0140-6736(89)90768-X; Wuthiekanun V, 2004, J CLIN MICROBIOL, V42, P3435, DOI 10.1128/JCM.42.8.3435-3437.2004; Wuthiekanun V, 2001, J CLIN MICROBIOL, V39, P3801, DOI 10.1128/JCM.39.10.3801-3802.2001; WUTHIEKANUN V, 1990, J MED MICROBIOL, V33, P121, DOI 10.1099/00222615-33-2-121; Wuthiekanun V, 2007, AM J TROP MED HYG, V77, P812, DOI 10.4269/ajtmh.2007.77.812; Wuthiekanun V, 2006, AM J TROP MED HYG, V74, P1074, DOI 10.4269/ajtmh.2006.74.1074	29	96	98	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12485	10.1371/journal.pone.0012485	http://dx.doi.org/10.1371/journal.pone.0012485			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20830194	gold, Green Published, Green Accepted			2022-12-27	WOS:000281375500015
J	Pessiot, JF; Chiba, H; Hyakkoku, H; Taniguchi, T; Fujibuchi, W				Pessiot, Jean-Francois; Chiba, Hirokazu; Hyakkoku, Hiroto; Taniguchi, Takeaki; Fujibuchi, Wataru			PeakRegressor Identifies Composite Sequence Motifs Responsible for STAT1 Binding Sites and Their Potential rSNPs	PLOS ONE			English	Article								How to identify true transcription factor binding sites on the basis of sequence motif information (e.g., motif pattern, location, combination, etc.) is an important question in bioinformatics. We present "PeakRegressor," a system that identifies binding motifs by combining DNA-sequence data and ChIP-Seq data. PeakRegressor uses L1-norm log linear regression in order to predict peak values from binding motif candidates. Our approach successfully predicts the peak values of STAT1 and RNA Polymerase II with correlation coefficients as high as 0.65 and 0.66, respectively. Using PeakRegressor, we could identify composite motifs for STAT1, as well as potential regulatory SNPs (rSNPs) involved in the regulation of transcription levels of neighboring genes. In addition, we show that among five regression methods, L1-norm log linear regression achieves the best performance with respect to binding motif identification, biological interpretability and computational efficiency.	[Pessiot, Jean-Francois; Chiba, Hirokazu; Hyakkoku, Hiroto; Fujibuchi, Wataru] Adv Ind Sci & Technol AIST, Computat Biol Res Ctr, Tokyo, Japan; [Hyakkoku, Hiroto] Waseda Univ, Tokyo, Japan; [Taniguchi, Takeaki] Mitsubishi Res Inst Inc, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Waseda University; Mitsubishi Research Institute	Pessiot, JF (corresponding author), Adv Ind Sci & Technol AIST, Computat Biol Res Ctr, Tokyo, Japan.	w.fujibuchi@aist.go.jp			National Institute of Advanced Industrial Science and Technology, Japan; Mitsubishi Research Institute, Inc.	National Institute of Advanced Industrial Science and Technology, Japan; Mitsubishi Research Institute, Inc.	This work was supported by general subsidies from the National Institute of Advanced Industrial Science and Technology, Japan. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Takeaki Taniguchi is employed by the Mitsubishi Research Institute, Inc. His wages were funded by the company and he participated in performing the computational experiments. This funder also had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameur A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp381; Bishop C. M, 2006, PATTERN RECOGNITION; BUSSEMAKER HJ, 2001, RECOMB 01; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; CONLON EM, 2003, INTEGRATING REGULATO; Das D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000269; EFRON B, 2004, LEAST ANGLE REGRESSI; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; FRANK IE, 1993, TECHNOMETRICS; Gao F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-31; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x	13	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e11881	10.1371/journal.pone.0011881	http://dx.doi.org/10.1371/journal.pone.0011881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20806061	Green Submitted, Green Published, gold			2022-12-27	WOS:000281301500001
J	Schoell, ED; Bingel, U; Eippert, F; Yacubian, J; Christiansen, K; Andresen, H; May, A; Buechel, C				Schoell, Eszter D.; Bingel, Ulrike; Eippert, Falk; Yacubian, Juliana; Christiansen, Kerrin; Andresen, Hilke; May, Arne; Buechel, Christian			The Effect of Opioid Receptor Blockade on the Neural Processing of Thermal Stimuli	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ANTERIOR CINGULATE CORTEX; PLACEBO ANALGESIA; ENDOGENOUS OPIOIDS; HEALTHY-VOLUNTEERS; HUMAN BRAIN; PREFRONTAL CORTEX; NEURONAL-ACTIVITY; PAIN PERCEPTION; NALOXONE	The endogenous opioid system represents one of the principal systems in the modulation of pain. This has been demonstrated in studies of placebo analgesia and stress-induced analgesia, where anti-nociceptive activity triggered by pain itself or by cognitive states is blocked by opioid antagonists. The aim of this study was to characterize the effect of opioid receptor blockade on the physiological processing of painful thermal stimulation in the absence of cognitive manipulation. We therefore measured BOLD (blood oxygen level dependent) signal responses and intensity ratings to non-painful and painful thermal stimuli in a double-blind, cross-over design using the opioid receptor antagonist naloxone. On the behavioral level, we observed an increase in intensity ratings under naloxone due mainly to a difference in the non-painful stimuli. On the neural level, painful thermal stimulation was associated with a negative BOLD signal within the pregenual anterior cingulate cortex, and this deactivation was abolished by naloxone.	[Schoell, Eszter D.; Eippert, Falk; Yacubian, Juliana; May, Arne; Buechel, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, NeuroImage Nord, Hamburg, Germany; [Bingel, Ulrike; May, Arne] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Schoell, Eszter D.; Christiansen, Kerrin] Univ Hamburg, Dept Human Biol, Hamburg, Germany; [Andresen, Hilke] Univ Med Ctr Hamburg Eppendorf, Dept Forens Med, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Schoell, ED (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, NeuroImage Nord, Hamburg, Germany.	eschoell@uke.de	Eippert, Falk/M-6188-2013	Schoell, Eszter D./0000-0001-9817-521X; Eippert, Falk/0000-0002-3986-1719	Volkswagenstiftung	Volkswagenstiftung(Volkswagen)	This work was supported with a grant from the Volkswagenstiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LJ, 1997, ANESTH ANALG, V84, P120, DOI 10.1097/00000539-199701000-00023; Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Anderson WS, 2002, PAIN, V99, P207, DOI 10.1016/S0304-3959(02)00103-3; [Anonymous], 1990, QUANTITATIVE IMAGING; Becerra L, 2006, ANESTH ANALG, V103, P208, DOI 10.1213/01.ane.0000221457.71536.e0; Benedetti F, 2007, Handb Exp Pharmacol, P393; Bingel U, 2007, PAIN, V131, P21, DOI 10.1016/j.pain.2006.12.005; Bingel U, 2006, PAIN, V120, P8, DOI 10.1016/j.pain.2005.08.027; Bingel U, 2008, PHYSIOLOGY, V23, P371, DOI 10.1152/physiol.00024.2008; Borras MC, 2004, J NEUROPHYSIOL, V91, P2723, DOI 10.1152/jn.00249.2003; BRENNUM J, 1993, PAIN, V52, P75, DOI 10.1016/0304-3959(93)90117-8; Britton KT, 2001, PEPTIDES, V22, P607, DOI 10.1016/S0196-9781(01)00371-0; BUCHSBAUM MS, 1983, PSYCHOPHARMACOLOGY, V79, P99, DOI 10.1007/BF00427792; CARR DJJ, 1995, IMMUNOPHARMACOLOGY, V31, P59, DOI 10.1016/0162-3109(95)00033-6; Casey KL, 2000, J NEUROPHYSIOL, V84, P525, DOI 10.1152/jn.2000.84.1.525; Davis KD, 1995, NEUROREPORT, V7, P321, DOI 10.1097/00001756-199512290-00077; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Eippert F, 2008, J NEUROSCI, V28, P5465, DOI 10.1523/JNEUROSCI.5336-07.2008; Eippert F, 2009, NEURON, V63, P533, DOI 10.1016/j.neuron.2009.07.014; ELSOBKY A, 1976, NATURE, V263, P783, DOI 10.1038/263783a0; Firestone LL, 1996, ANESTH ANALG, V82, P1247, DOI 10.1097/00000539-199606000-00025; FRUHSTORFER H, 1976, J NEUROL NEUROSUR PS, V39, P1071, DOI 10.1136/jnnp.39.11.1071; Giacchino JL, 1998, PROG NEURO-PSYCHOPH, V22, P1157, DOI 10.1016/S0278-5846(98)00053-0; Glascher J, 2009, NEUROINFORMATICS, V7, P73, DOI 10.1007/s12021-008-9042-x; GREVERT P, 1978, SCIENCE, V199, P1093, DOI 10.1126/science.343250; HAEFELY W, 1985, PHARMACOPSYCHIATRY, V18, P163, DOI 10.1055/s-2007-1017356; Hao Y, 2005, BRAIN RES, V1040, P191, DOI 10.1016/j.brainres.2005.01.072; Hebb ALO, 2005, PROG NEURO-PSYCHOPH, V29, P1225, DOI 10.1016/j.pnpbp.2005.08.008; HILL RG, 1981, NEUROSCI LETT, V21, P217, DOI 10.1016/0304-3940(81)90385-2; HOWARD BG, 2005, GOODMAN GILMANS PHAR, P547; JONES AKP, 1991, NEUROSCI LETT, V126, P25, DOI 10.1016/0304-3940(91)90362-W; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Kern D, 2008, PAIN, V135, P291, DOI 10.1016/j.pain.2007.12.001; Koppert W, 2005, J PAIN, V6, P757, DOI 10.1016/j.jpain.2005.07.002; Koppert W, 2003, PAIN, V106, P91, DOI 10.1016/S0304-3959(03)00294-X; Leppa M, 2006, NEUROIMAGE, V31, P661, DOI 10.1016/j.neuroimage.2005.12.019; LEVINE JD, 1984, NATURE, V312, P755, DOI 10.1038/312755a0; LEVINE JD, 1978, NATURE, V272, P826, DOI 10.1038/272826a0; LEVINE JD, 1979, NATURE, V278, P740, DOI 10.1038/278740a0; Lieberman MD, 2004, NEUROIMAGE, V22, P447, DOI 10.1016/j.neuroimage.2004.01.037; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Northoff G, 2007, NAT NEUROSCI, V10, P1515, DOI 10.1038/nn2001; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; POSNER J, 1985, PSYCHOPHARMACOLOGY, V87, P468, DOI 10.1007/BF00432515; Rainville P, 1999, J COGNITIVE NEUROSCI, V11, P110, DOI 10.1162/089892999563175; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Sprenger T, 2007, SCHMERZ, V21, P503, DOI 10.1007/s00482-007-0547-2; Sprenger T, 2006, PAIN, V122, P63, DOI 10.1016/j.pain.2006.01.003; STACHER G, 1988, PAIN, V34, P271, DOI 10.1016/0304-3959(88)90122-4; Standifer KM, 1997, CELL SIGNAL, V9, P237, DOI 10.1016/S0898-6568(96)00174-X; Straube T, 2009, NEUROIMAGE, V44, P975, DOI 10.1016/j.neuroimage.2008.10.022; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, 2007, P NATL ACAD SCI USA, V104, P11056, DOI 10.1073/pnas.0702413104; Wagner KJ, 2001, ANESTHESIOLOGY, V94, P732, DOI 10.1097/00000542-200105000-00008; Wagner KJ, 2007, ANESTHESIOLOGY, V106, P548, DOI 10.1097/00000542-200703000-00020; Wiech K, 2006, J NEUROSCI, V26, P11501, DOI 10.1523/JNEUROSCI.2568-06.2006; WILLER JC, 1981, SCIENCE, V212, P689, DOI 10.1126/science.6261330; Zubieta JK, 2005, J NEUROSCI, V25, P7754, DOI 10.1523/JNEUROSCI.0439-05.2005	61	24	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12344	10.1371/journal.pone.0012344	http://dx.doi.org/10.1371/journal.pone.0012344			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20811582	Green Published, Green Submitted, gold			2022-12-27	WOS:000281301500002
J	Mateo-Tomas, P; Olea, PP				Mateo-Tomas, Patricia; Olea, Pedro P.			Anticipating Knowledge to Inform Species Management: Predicting Spatially Explicit Habitat Suitability of a Colonial Vulture Spreading Its Range	PLOS ONE			English	Article							GYPS-FULVUS; DISTRIBUTION MODELS; NEOPHRON-PERCNOPTERUS; DISTRIBUTIONS; SPAIN; CONSERVATION; PERFORMANCE; SELECTION; RAPTORS	Background: The knowledge of both potential distribution and habitat suitability is fundamental in spreading species to inform in advance management and conservation planning. After a severe decline in the past decades, the griffon vulture (Gyps fulvus) is now spreading its breeding range towards the northwest in Spain and Europe. Because of its key ecological function, anticipated spatial knowledge is required to inform appropriately both vulture and ecosystem management. Methodology/Findings: Here we used maximum entropy (Maxent) models to determine the habitat suitability of potential and current breeding distribution of the griffon vulture using presence-only data (N = 124 colonies) in north-western Spain. The most relevant ecological factors shaping this habitat suitability were also identified. The resulting model had a high predictive performance and was able to predict species' historical distribution. 7.5% (similar to 1,850 km(2)) of the study area resulted to be suitable breeding habitat, most of which (similar to 70%) is already occupied by the species. Cliff availability and livestock density, especially of sheep and goats, around 10 km of the colonies were the fundamental factors determining breeding habitat suitability for this species. Conclusions/Significance: Griffon vultures could still spread 50-60 km towards the west, increasing their breeding range in 1,782 km(2). According to our results, 7.22% of the area suitable for griffon vulture will be affected by wind farms, so our results could help to better plan wind farm locations. The approach here developed could be useful to inform management of reintroductions and recovery programmes currently being implemented for both the griffon vulture and other threatened vulture species.	[Mateo-Tomas, Patricia; Olea, Pedro P.] IE Univ, Sch Biol, Segovia, Spain	IE University	Mateo-Tomas, P (corresponding author), IE Univ, Sch Biol, Segovia, Spain.	rktespejos@gmail.com	Mateo-Tomás, Patricia/L-8471-2014; Olea, Pedro P/M-1502-2014	Mateo-Tomás, Patricia/0000-0001-6762-9514; Olea, Pedro P/0000-0001-5387-9598	Spanish Ministerio de Educacion y Ciencia	Spanish Ministerio de Educacion y Ciencia(Spanish Government)	P. M. T. was partially supported by a PhD scholarship of the Spanish Ministerio de Educacion y Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; BALWIN RA, 2009, ENTROPY, V11, P854; BirdLife International, 2009, IUCN 2010 IUCN RED L; Calix M., 2018, EUROPEAN RED LIST SA; Camina A, 2006, ACTA ORNITHOL, V41, P7, DOI 10.3161/068.041.0106; Cramp S., 1992, BIRDS W PALEARCTIC, VVI; Creel S, 2001, CONSERV BIOL, V15, P271, DOI 10.1046/j.1523-1739.2001.99534.x; *DBG, 2007, TERC INV FOR NAC BAN; de Frutos A, 2007, ECOL MODEL, V200, P33, DOI 10.1016/j.ecolmodel.2006.07.007; de Lucas M, 2008, J APPL ECOL, V45, P1695, DOI 10.1111/j.1365-2664.2008.01549.x; DELMORAL JC, 2009, BUITRE LEVADO ESPANA; Deygout C, 2009, ECOL MODEL, V220, P1826, DOI 10.1016/j.ecolmodel.2009.04.030; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; DONAZAR JA, 1990, BIOL CONSERV, V53, P83, DOI 10.1016/0006-3207(90)90001-6; Donazar JA, 2010, EUR J WILDLIFE RES, V56, P613, DOI 10.1007/s10344-009-0358-0; Donazar JA, 2009, SCIENCE, V326, P664, DOI 10.1126/science.326_664a; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; ELITH J, 2010, METHODS ECOLOGY EVOL, DOI DOI 10.1111/J.2041-210X.2010.00036.X; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; *FAPAS, 1991, BUITR AST EV CENS 19; FERNANDEZ C, 1991, BIRD STUDY, V38, P42, DOI 10.1080/00063659109477065; Franklin J, 2009, MAPPING SPECIES DIST; Garcia-Ripolles C, 2005, ARDEOLA, V52, P287; Garza V., 1990, 2 CENSO NACL BUITRE; Gavashelishvili A, 2006, ANIM CONSERV, V9, P159, DOI 10.1111/j.1469-1795.2005.00017.x; GENERO F, 2006, P INT C CONS MAN VUL; Gibson L, 2007, DIVERS DISTRIB, V13, P704, DOI 10.1111/j.1472-4642.2007.00365.x; GRUBAC B, 1997, ACT 2 C INT AV CARR; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2003, J BIOGEOGR, V30, P1233, DOI 10.1046/j.1365-2699.2003.00914.x; Heikkinen RK, 2004, J APPL ECOL, V41, P824, DOI 10.1111/j.0021-8901.2004.00938.x; *INE, INE POBL EN 2009; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Kadoya T, 2009, BIOL CONSERV, V142, P1011, DOI 10.1016/j.biocon.2009.01.012; Krebs CJ, 2001, ECOLOGY EXPT ANAL DI; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; Telleria JL, 2009, BIRD STUDY, V56, P268, DOI 10.1080/00063650902792056; Marti R., 2001, BUITRE LEONADO PENIN; Mateo-Tomas P, 2010, ORYX, V44, P424, DOI 10.1017/S0030605310000189; Mateo-Tomas P, 2010, ORYX, V44, P434, DOI 10.1017/S0030605310000505; Mateo-Tomas P, 2010, EUR J WILDLIFE RES, V56, P519, DOI 10.1007/s10344-009-0341-9; Mateo-Tomas P, 2009, ACTA OECOL, V35, P489, DOI 10.1016/j.actao.2009.03.004; MATEOTOMAS P, 2009, THESIS U LEON LEON; Millspaugh JJ, 2009, MODELS FOR PLANNING WILDLIFE CONSERVATION IN LARGE LANDSCAPES, P1; Olea Pedro P., 1999, Ardeola, V46, P81; Olea PP, 2009, BIOL CONSERV, V142, P1844, DOI 10.1016/j.biocon.2009.03.024; Rodriguez JP, 2007, DIVERS DISTRIB, V13, P243, DOI 10.1111/j.1472-4642.2007.00356.x; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Prakash V, 2003, BIOL CONSERV, V109, P381, DOI 10.1016/S0006-3207(02)00164-7; R Core Team, 2020, R LANG ENV STAT COMP; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; Rebelo H, 2010, J APPL ECOL, V47, P410, DOI 10.1111/j.1365-2664.2009.01765.x; Rhodes JR, 2006, CONSERV BIOL, V20, P449, DOI 10.1111/j.1523-1739.2006.00330.x; Sarrazin F, 1996, IBIS, V138, P315, DOI 10.1111/j.1474-919X.1996.tb04344.x; Sekercioglu C. H., 2006, HDB BIRDS WORLD, V11, P15; SEO, 1981, ARDEOLA, V26, p165 312; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Wilmers CC, 2003, J ANIM ECOL, V72, P909, DOI 10.1046/j.1365-2656.2003.00766.x; *WWF AD, 2006, VEN ESP 1990 2005 AN; Xirouchakis SM, 2005, ACTA ORNITHOL, V40, P155, DOI 10.3161/068.040.0211	65	30	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12374	10.1371/journal.pone.0012374	http://dx.doi.org/10.1371/journal.pone.0012374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811501	Green Published, gold, Green Submitted			2022-12-27	WOS:000281234700010
J	Champion, C; Guianvarc'h, D; Senamaud-Beaufort, C; Jurkowska, RZ; Jeltsch, A; Ponger, L; Arimondo, PB; Guieysse-Peugeot, AL				Champion, Christine; Guianvarc'h, Dominique; Senamaud-Beaufort, Catherine; Jurkowska, Renata Z.; Jeltsch, Albert; Ponger, Loic; Arimondo, Paola B.; Guieysse-Peugeot, Anne-Laure			Mechanistic Insights on the Inhibition of C5 DNA Methyltransferases by Zebularine	PLOS ONE			English	Article							EPIGENETIC THERAPY; METHYLATION INHIBITOR; CYTIDINE DEAMINASE; MOLECULAR ENZYMOLOGY; RIBOSIDE ZEBULARINE; HHAI METHYLASE; IN-VITRO; CANCER; 5-AZACYTIDINE; 5-AZA-2'-DEOXYCYTIDINE	In mammals DNA methylation occurs at position 5 of cytosine in a CpG context and regulates gene expression. It plays an important role in diseases and inhibitors of DNA methyltransferases (DNMTs)-the enzymes responsible for DNA methylation-are used in clinics for cancer therapy. The most potent inhibitors are 5-azacytidine and 5-azadeoxycytidine. Zebularine (1-(beta-D-ribofuranosyl)-2(1H)-pyrimidinone) is another cytidine analog described as a potent inhibitor that acts by forming a covalent complex with DNMT when incorporated into DNA. Here we bring additional experiments to explain its mechanism of action. First, we observe an increase in the DNA binding when zebularine is incorporated into the DNA, compared to deoxycytidine and 5-fluorodeoxycytidine, together with a strong decrease in the dissociation rate. Second, we show by denaturing gel analysis that the intermediate covalent complex between the enzyme and the DNA is reversible, differing thus from 5-fluorodeoxycytidine. Third, no methylation reaction occurs when zebularine is present in the DNA. We confirm that zebularine exerts its demethylation activity by stabilizing the binding of DNMTs to DNA, hindering the methylation and decreasing the dissociation, thereby trapping the enzyme and preventing turnover even at other sites.	[Champion, Christine; Senamaud-Beaufort, Catherine; Ponger, Loic; Arimondo, Paola B.; Guieysse-Peugeot, Anne-Laure] MNHN CNRS, UMR7196, Paris, France; [Champion, Christine; Senamaud-Beaufort, Catherine; Ponger, Loic; Arimondo, Paola B.; Guieysse-Peugeot, Anne-Laure] INSERM, U565, Paris, France; [Guianvarc'h, Dominique] Univ Paris 06, Lab Biomol, CNRS, ENS,FR, Paris, France; [Jurkowska, Renata Z.; Jeltsch, Albert] Univ Bremen, Sch Sci & Engn, Bremen, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Museum National d'Histoire Naturelle (MNHN); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; University of Bremen	Champion, C (corresponding author), MNHN CNRS, UMR7196, Paris, France.	arimondo@mnhn.fr; guieysse@mnhn.fr	Arimondo, Paola B/R-9095-2017; Jeltsch, Albert/O-7404-2014; Guianvarc'h, Dominique/AAE-5806-2022; Jurkowska, Renata/AAE-2504-2020	Arimondo, Paola B/0000-0001-5175-4396; Jeltsch, Albert/0000-0001-6113-9290; Guianvarc'h, Dominique/0000-0002-7722-370X; Jurkowska, Renata/0000-0002-4507-2222; Ponger, Loic/0000-0001-9222-8907	Agence National de la Recherche [JCJC06_134774]; DeutscheForschungsgemeinschaft [JE 252/6]	Agence National de la Recherche(French National Research Agency (ANR)); DeutscheForschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Agence National de la Recherche JCJC06_134774 grant to PBA and by DeutscheForschungsgemeinschaft grant JE 252/6 to AJ.CC was recipient of an INSERM-CNRS Bourse de Docteur Ingenieur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch C, 2005, MOL CANCER THER, V4, P1505, DOI 10.1158/1535-7163.MCT-05-0216; Cheng JC, 2003, J NATL CANCER I, V95, P399, DOI 10.1093/jnci/95.5.399; Cheng JC, 2004, MOL CELL BIOL, V24, P1270, DOI 10.1128/MCB.24.3.1270-1278.2004; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Clark J, 2003, ANAL BIOCHEM, V321, P50, DOI 10.1016/S0003-2697(03)00402-0; CREUSOT F, 1982, J BIOL CHEM, V257, P2041; Darii MV, 2009, BBA-PROTEINS PROTEOM, V1794, P1654, DOI 10.1016/j.bbapap.2009.07.016; DOERFLER W, 1983, ANNU REV BIOCHEM, V52, P93, DOI 10.1146/annurev.bi.52.070183.000521; Dote H, 2005, CLIN CANCER RES, V11, P4571, DOI 10.1158/1078-0432.CCR-05-0050; DRISCOLL JS, 1991, J MED CHEM, V34, P3280, DOI 10.1021/jm00115a017; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; FLOTHO C, 2009, LEUKEMIA; FRIEDMAN S, 1992, NUCLEIC ACIDS RES, V20, P3241, DOI 10.1093/nar/20.12.3241; GABBARA S, 1995, BIOCHEM J, V307, P87, DOI 10.1042/bj3070087; Gore SD, 2006, NAT REV DRUG DISCOV, V5, P891, DOI 10.1038/nrd2180; Gowher H, 2002, J BIOL CHEM, V277, P20409, DOI 10.1074/jbc.M202148200; Hellebrekers DMEI, 2006, MOL CANCER THER, V5, P467, DOI 10.1158/1535-7163.MCT-05-0417; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Hurd PJ, 1999, J MOL BIOL, V286, P389, DOI 10.1006/jmbi.1998.2491; Issa JPJ, 2005, NAT REV DRUG DISCOV, V4, P275, DOI 10.1038/nrd1698; Jeltsch A, 2006, CURR TOP MICROBIOL, V301, P203; Jeltsch A, 2006, EPIGENETICS-US, V1, P63, DOI 10.4161/epi.1.2.2767; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; JONES PA, 1985, CELL, V40, P485, DOI 10.1016/0092-8674(85)90192-8; KIM CH, 1986, J MED CHEM, V29, P1374, DOI 10.1021/jm00158a009; Laird PW, 2005, HUM MOL GENET, V14, pR65, DOI 10.1093/hmg/ddi113; LALIBERTE J, 1992, CANCER CHEMOTH PHARM, V30, P7, DOI 10.1007/BF00686478; Lee G, 2004, DNA REPAIR, V3, P155, DOI 10.1016/j.dnarep.2003.10.010; Lemaire M, 2009, CANCER CHEMOTH PHARM, V63, P411, DOI 10.1007/s00280-008-0750-6; LIN KT, 1981, J PHARM SCI, V70, P1228, DOI 10.1002/jps.2600701112; Liu K, 2003, MOL CELL BIOL, V23, P2709, DOI 10.1128/MCB.23.8.2709-2719.2003; Marquez VE, 2005, ANN NY ACAD SCI, V1058, P246, DOI 10.1196/annals.1359.037; Marquez VE, 2003, ANN NY ACAD SCI, V1002, P154, DOI 10.1196/annals.1281.014; MI S, 1993, NUCLEIC ACIDS RES, V21, P2459, DOI 10.1093/nar/21.10.2459; NOTARI RE, 1975, J PHARM SCI, V64, P1148, DOI 10.1002/jps.2600640704; OGara M, 1996, J MOL BIOL, V261, P634, DOI 10.1006/jmbi.1996.0489; OSTERMAN DG, 1988, BIOCHEMISTRY-US, V27, P5204, DOI 10.1021/bi00414a039; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; Reither S, 2003, J MOL BIOL, V329, P675, DOI 10.1016/S0022-2836(03)00509-6; Robertson KD, 2000, CARCINOGENESIS, V21, P461, DOI 10.1093/carcin/21.3.461; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Scott SA, 2007, EXP HEMATOL, V35, P263, DOI 10.1016/j.exphem.2006.10.005; Shigdel UK, 2008, J AM CHEM SOC, V130, P17634, DOI 10.1021/ja8064304; Song LG, 2005, ANAL CHEM, V77, P504, DOI 10.1021/ac0489420; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Suzuki M, 2009, CANCER CHEMOTH PHARM, V64, P223, DOI 10.1007/s00280-008-0833-4; TAYLOR C, 1993, BIOCHEM J, V291, P493, DOI 10.1042/bj2910493; TAYLOR SM, 1982, J MOL BIOL, V162, P679, DOI 10.1016/0022-2836(82)90395-3; van Bemmel DM, 2009, BIOCHEM PHARMACOL, V78, P633, DOI 10.1016/j.bcp.2009.05.017; Yokochi T, 2002, J BIOL CHEM, V277, P11735, DOI 10.1074/jbc.M106590200; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Yoo CB, 2004, BIOCHEM SOC T, V32, P910, DOI 10.1042/BST0320910; Yoo CB, 2008, CANCER PREV RES, V1, P233, DOI 10.1158/1940-6207.CAPR-07-0008; Zhang YY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000438; Zhou L, 2002, J MOL BIOL, V321, P591, DOI 10.1016/S0022-2836(02)00676-9	56	77	80	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12388	10.1371/journal.pone.0012388	http://dx.doi.org/10.1371/journal.pone.0012388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808780	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000281154300016
J	Flynn, BP; Bhole, AP; Saeidi, N; Liles, M; DiMarzio, CA; Ruberti, JW				Flynn, Brendan P.; Bhole, Amit P.; Saeidi, Nima; Liles, Melody; DiMarzio, Charles A.; Ruberti, Jeffrey W.			Mechanical Strain Stabilizes Reconstituted Collagen Fibrils against Enzymatic Degradation by Mammalian Collagenase Matrix Metalloproteinase 8 (MMP-8)	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; DERMAL FIBROBLASTS; TENDON COLLAGEN; CROSS-LINKS; I COLLAGEN; TISSUE; EXPRESSION; STRESS; BONE; DIFFUSION	Background: Collagen, a triple-helical, self-organizing protein, is the predominant structural protein in mammals. It is found in bone, ligament, tendon, cartilage, intervertebral disc, skin, blood vessel, and cornea. We have recently postulated that fibrillar collagens (and their complementary enzymes) comprise the basis of a smart structural system which appears to support the retention of molecules in fibrils which are under tensile mechanical strain. The theory suggests that the mechanisms which drive the preferential accumulation of collagen in loaded tissue operate at the molecular level and are not solely cell-driven. The concept reduces control of matrix morphology to an interaction between molecules and the most relevant, physical, and persistent signal: mechanical strain. Methodology/Principal Findings: The investigation was carried out in an environmentally-controlled microbioreactor in which reconstituted type I collagen micronetworks were gently strained between micropipettes. The strained micronetworks were exposed to active matrix metalloproteinase 8 (MMP-8) and relative degradation rates for loaded and unloaded fibrils were tracked simultaneously using label-free differential interference contrast (DIC) imaging. It was found that applied tensile mechanical strain significantly increased degradation time of loaded fibrils compared to unloaded, paired controls. In many cases, strained fibrils were detectable long after unstrained fibrils were degraded. Conclusions/Significance: In this investigation we demonstrate for the first time that applied mechanical strain preferentially preserves collagen fibrils in the presence of a physiologically-important mammalian enzyme: MMP-8. These results have the potential to contribute to our understanding of many collagen matrix phenomena including development, adaptation, remodeling and disease. Additionally, tissue engineering could benefit from the ability to sculpt desired structures from physiologically compatible and mutable collagen.	[Flynn, Brendan P.; Bhole, Amit P.; Saeidi, Nima; Liles, Melody; DiMarzio, Charles A.; Ruberti, Jeffrey W.] Northeastern Univ, Boston, MA 02115 USA; [Saeidi, Nima] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn & Med, Boston, MA USA; [Liles, Melody] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales	Northeastern University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Cardiff University	Flynn, BP (corresponding author), Northeastern Univ, Boston, MA 02115 USA.	j.ruberti@neu.edu			National Institutes of Health National Institute of Arthritis and Musculoskeletal Skin Dieseases (NIH NIAMS) [R21 AR053551-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR053551] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Arthritis and Musculoskeletal Skin Dieseases (NIH NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The research was funded by National Institutes of Health National Institute of Arthritis and Musculoskeletal Skin Dieseases (NIH NIAMS) R21 AR053551-01 (PI Jeff W. Ruberti). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKESON WH, 1987, CLIN ORTHOP RELAT R, P28; Altman GH, 2001, FASEB J, V15, P270, DOI 10.1096/fj.01-0656fje; Arokoski JPA, 2000, SCAND J MED SCI SPOR, V10, P186, DOI 10.1034/j.1600-0838.2000.010004186.x; BAILEY AJ, 1968, BIOCHIM BIOPHYS ACTA, V160, P447, DOI 10.1016/0005-2795(68)90216-X; BAROCAS VH, 1995, J BIOMECH ENG-T ASME, V117, P161, DOI 10.1115/1.2795998; Bass EC, 2004, J BIOMECH, V37, P233, DOI 10.1016/j.jbiomech.2003.07.002; Basser PJ, 1998, ARCH BIOCHEM BIOPHYS, V351, P207, DOI 10.1006/abbi.1997.0507; BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274; BELLOWS CG, 1981, J CELL SCI, V50, P299; Bhole AP, 2009, PHILOS T R SOC A, V367, P3339, DOI 10.1098/rsta.2009.0093; Bishop JE, 1999, CARDIOVASC RES, V42, P27, DOI 10.1016/S0008-6363(99)00021-8; Blain EJ, 2001, ARCH BIOCHEM BIOPHYS, V396, P49, DOI 10.1006/abbi.2001.2575; Bruel A, 1998, ATHEROSCLEROSIS, V140, P135, DOI 10.1016/S0021-9150(98)00130-0; Cawston TE, 2006, BEST PRACT RES CL RH, V20, P983, DOI 10.1016/j.berh.2006.06.007; CHAMAY A, 1972, J BIOMECH, V5, P173, DOI 10.1016/0021-9290(72)90053-X; COMPER WD, 1977, BIOPOLYMERS, V16, P2113, DOI 10.1002/bip.1977.360161004; Cowin SC, 2000, J BIOMECH ENG-T ASME, V122, P553, DOI 10.1115/1.1324665; COWIN SC, 1983, ANN BIOMED ENG, V11, P263, DOI 10.1007/BF02363288; Cowin SC, 2004, ANNU REV BIOMED ENG, V6, P77, DOI 10.1146/annurev.bioeng.6.040803.140250; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Delaisse JM, 2000, CLIN CHIM ACTA, V291, P223, DOI 10.1016/S0009-8981(99)00230-2; Ellsmere JC, 1999, BIOMATERIALS, V20, P1143, DOI 10.1016/S0142-9612(99)00013-7; Fredberg JJ, 2006, ANNU REV PHYSIOL, V68, P507, DOI 10.1146/annurev.physiol.68.072304.114110; Giraud-Guille MM, 2003, J BIOMECH, V36, P1571, DOI 10.1016/S0021-9290(03)00134-9; Goldring SR, 2004, CLIN ORTHOP RELAT R, pS27, DOI 10.1097/01.blo.0000144854.66565.8f; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; Hannafin JA, 2006, J ORTHOP RES, V24, P149, DOI 10.1002/jor.20018; HORMANN H, 1982, KLIN WOCHENSCHR, V60, P1265, DOI 10.1007/BF01727483; HUANG C, 1977, J BIOMED MATER RES, V11, P137, DOI 10.1002/jbm.820110113; Humphrey JD, 2001, J BIOMECH ENG-T ASME, V123, P638, DOI 10.1115/1.1406131; Jeffrey JJ, 1998, BIOL EXTRAC, P15; JONAS M, 2008, BIOPHYS J; Jung JC, 2009, CELL TISSUE RES, V336, P79, DOI 10.1007/s00441-009-0755-4; Karamichos D, 2007, INVEST OPHTH VIS SCI, V48, P5030, DOI 10.1167/iovs.07-0443; Koskinen SOA, 2004, J APPL PHYSIOL, V96, P861, DOI 10.1152/japplphysiol.00489.2003; Krishnan L, 2004, TISSUE ENG, V10, P241, DOI 10.1089/107632704322791880; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; LAURENT GJ, 1987, AM J PHYSIOL, V252, pC1, DOI 10.1152/ajpcell.1987.252.1.C1; Lee SE, 2007, J BIOMECH, V40, P2096, DOI 10.1016/j.jbiomech.2007.04.006; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; LIU X, 1995, J CELL BIOL, V130, P227, DOI 10.1083/jcb.130.1.227; Lotz JC, 2008, EUR SPINE J, V17, P1149, DOI 10.1007/s00586-008-0721-y; LYUBIMOV AV, 1982, CELL BIOL INT REP, V6, P105, DOI 10.1016/0309-1651(82)90086-8; MICHAELI Y, 1994, J PERIODONTAL RES, V29, P25, DOI 10.1111/j.1600-0765.1994.tb01087.x; MICHNA H, 1989, INT ORTHOP, V13, P161, DOI 10.1007/BF00268040; Mudera VC, 2000, CELL MOTIL CYTOSKEL, V45, P1, DOI 10.1002/(SICI)1097-0169(200001)45:1<1::AID-CM1>3.0.CO;2-J; Murray JD, 2003, CR BIOL, V326, P239, DOI 10.1016/S1631-0691(03)00065-9; Nabeshima Y, 1996, J ORTHOP RES, V14, P123, DOI 10.1002/jor.1100140120; Ozerdem B, 1995, J BIOMECH ENG-T ASME, V117, P397, DOI 10.1115/1.2794198; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; Parsons M, 1999, EXP CELL RES, V252, P319, DOI 10.1006/excr.1999.4618; PEARCE RH, 1987, J ORTHOP RES, V5, P198, DOI 10.1002/jor.1100050206; PEPPAS NA, 1983, J MEMBRANE SCI, V15, P275, DOI 10.1016/S0376-7388(00)82304-2; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Petroll WM, 2004, INVEST OPHTH VIS SCI, V45, P3466, DOI 10.1167/iovs.04-0361; Prajapati RT, 2000, WOUND REPAIR REGEN, V8, P226, DOI 10.1046/j.1524-475x.2000.00226.x; RAEBER GP, 2007, BIOMECH MODEL MECHAN; Ragan PM, 1999, J ORTHOPAED RES, V17, P836, DOI 10.1002/jor.1100170608; Robbins JR, 1997, ARCH BIOCHEM BIOPHYS, V342, P203, DOI 10.1006/abbi.1997.0102; Ruberti JW, 2005, BIOCHEM BIOPH RES CO, V336, P483, DOI 10.1016/j.bbrc.2005.08.128; Sander EA, 2009, P NATL ACAD SCI USA, V106, P17675, DOI 10.1073/pnas.0903716106; STOPAK D, 1982, DEV BIOL, V90, P383, DOI 10.1016/0012-1606(82)90388-8; Tarbell JM, 2005, ANN BIOMED ENG, V33, P1719, DOI 10.1007/s10439-005-8775-z; TYN MT, 1990, BIOTECHNOL BIOENG, V35, P327, DOI 10.1002/bit.260350402; Tzafriri AR, 2002, BIOPHYS J, V83, P776, DOI 10.1016/S0006-3495(02)75208-9; WALTON RS, J MAT SCI MAT MED, V21, P451; Wong M, 2003, BONE, V33, P685, DOI 10.1016/S8756-3282(03)00242-4; WU H, 1990, P NATL ACAD SCI USA, V87, P5888, DOI 10.1073/pnas.87.15.5888; Wyatt KEK, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3078177; Zareian R, 2010, LANGMUIR, V26, P9917, DOI 10.1021/la100384e	70	121	122	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12337	10.1371/journal.pone.0012337	http://dx.doi.org/10.1371/journal.pone.0012337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808784	Green Published, Green Submitted, gold			2022-12-27	WOS:000281153500018
J	Abdullaev, IF; Rudkouskaya, A; Mongin, AA; Kuo, YH				Abdullaev, Iskandar F.; Rudkouskaya, Alena; Mongin, Alexander A.; Kuo, Yu-Hung			Calcium-Activated Potassium Channels BK and IK1 Are Functionally Expressed in Human Gliomas but Do Not Regulate Cell Proliferation	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; BREAST-CANCER CELLS; INTERMEDIATE-CONDUCTANCE; BRAIN-TUMOR; GROWTH; CYCLE; EPIDEMIOLOGY; CLOTRIMAZOLE; MODULATION; INHIBITION	Gliomas are morbid brain tumors that are extremely resistant to available chemotherapy and radiology treatments. Some studies have suggested that calcium-activated potassium channels contribute to the high proliferative potential of tumor cells, including gliomas. However, other publications demonstrated no role for these channels or even assigned them antitumorogenic properties. In this work we characterized the expression and functional contribution to proliferation of Ca2+-activated K+ channels in human glioblastoma cells. Quantitative RT-PCR detected transcripts for the big conductance (BK), intermediate conductance (IK1), and small conductance (SK2) K+ channels in two glioblastoma-derived cell lines and a surgical sample of glioblastoma multiforme. Functional expression of BK and IK1 in U251 and U87 glioma cell lines and primary glioma cultures was verified using whole-cell electrophysiological recordings. Inhibitors of BK (paxilline and penitrem A) and IK1 channels (clotrimazole and TRAM-34) reduced U251 and U87 proliferation in an additive fashion, while the selective blocker of SK channels UCL1848 had no effect. However, the antiproliferative properties of BK and IK1 inhibitors were seen at concentrations that were higher than those necessary to inhibit channel activity. To verify specificity of pharmacological agents, we downregulated BK and IK1 channels in U251 cells using gene-specific siRNAs. Although siRNA knockdowns caused strong reductions in the BK and IK1 current densities, neither single nor double gene silencing significantly affected rates of proliferation. Taken together, these results suggest that Ca2+-activated K+ channels do not play a critical role in proliferation of glioma cells and that the effects of pharmacological inhibitors occur through their off-target actions.	[Abdullaev, Iskandar F.; Rudkouskaya, Alena; Mongin, Alexander A.] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Kuo, Yu-Hung] Albany Med Coll, Div Neurosurg, Albany, NY 12208 USA	Albany Medical College; Albany Medical College	Abdullaev, IF (corresponding author), Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA.	mongina@mail.amc.edu	Mongin, Alexander A./A-5526-2008; Abdullaev, Iskandar/AAH-2478-2021	Mongin, Alexander A./0000-0002-2501-3778; Rudkouskaya, Alena/0000-0002-3632-9743	AMC [206-465247]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061953] Funding Source: NIH RePORTER	AMC; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by AMC grant 206-465247 (to AAM and YHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova OA, 2006, CELL MOL BIOL, V52, P71, DOI 10.1170/T763; AMIGORENA S, 1990, J IMMUNOL, V144, P2038; Barnholtz-Sloan JS, 2003, J NEUROSURG, V99, P458, DOI 10.3171/jns.2003.99.3.0458; Basrai D, 2002, NEUROREPORT, V13, P403, DOI 10.1097/00001756-200203250-00008; BENZAQUEN LR, 1995, NAT MED, V1, P534, DOI 10.1038/nm0695-534; Bianchi L, 1998, CANCER RES, V58, P815; Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888; Bloch M, 2007, ONCOGENE, V26, P2525, DOI 10.1038/sj.onc.1210036; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; BRISMAR T, 1995, GLIA, V15, P231, DOI 10.1002/glia.440150305; BRISMAR T, 1989, BRAIN RES, V480, P259, DOI 10.1016/0006-8993(89)90191-1; Cambien B, 2008, INT J CANCER, V123, P365, DOI 10.1002/ijc.23511; Camphausen K, 2005, P NATL ACAD SCI USA, V102, P8287, DOI 10.1073/pnas.0502887102; Chen JQ, 2000, J MED CHEM, V43, P3478, DOI 10.1021/jm000904v; Chin LS, 1997, J NEUROSCI RES, V48, P122, DOI 10.1002/(SICI)1097-4547(19970415)48:2<122::AID-JNR4>3.0.CO;2-E; Coiret G, 2007, MOL PHARMACOL, V71, P843, DOI 10.1124/mol.106.028290; Fioretti B, 2004, EUR J PHARMACOL, V497, P1, DOI 10.1016/j.ejphar.2004.06.034; Fioretti B, 2006, CELL PHYSIOL BIOCHEM, V18, P47, DOI 10.1159/000095135; Gessner G, 2005, J MEMBRANE BIOL, V208, P229, DOI 10.1007/s00232-005-0830-z; Grgic I, 2005, ARTERIOSCL THROM VAS, V25, P704, DOI 10.1161/01.ATV.0000156399.12787.5c; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Han XB, 2008, BIOCHEM BIOPH RES CO, V375, P205, DOI 10.1016/j.bbrc.2008.07.161; Han XB, 2007, APOPTOSIS, V12, P1837, DOI 10.1007/s10495-007-0101-9; Hayashi M, 2004, AM J PHYSIOL-CELL PH, V286, pC635, DOI 10.1152/ajpcell.00283.2003; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Jager H, 2004, MOL PHARMACOL, V65, P630, DOI 10.1124/mol.65.3.630; Khalid MH, 2005, J NEUROSURG, V103, P79, DOI 10.3171/jns.2005.103.1.0079; Khalid MH, 1999, J NEUROSURG, V90, P918, DOI 10.3171/jns.1999.90.5.0918; KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x; KNAUS HG, 1994, BIOCHEMISTRY-US, V33, P5819, DOI 10.1021/bi00185a021; Lang F, 2000, CELL PHYSIOL BIOCHEM, V10, P417, DOI 10.1159/000016367; Liu XJ, 2002, J NEUROSCI, V22, P1840, DOI 10.1523/JNEUROSCI.22-05-01840.2002; NILIUS B, 1992, J PHYSIOL-LONDON, V445, P537, DOI 10.1113/jphysiol.1992.sp018938; Ouadid-Ahidouch H, 2004, AM J PHYSIOL-CELL PH, V287, pC125, DOI 10.1152/ajpcell.00488.2003; Ouadid-Ahidouch H, 2004, BIOCHEM BIOPH RES CO, V316, P244, DOI 10.1016/j.bbrc.2004.02.041; Parihar AS, 2003, EUR J PHARMACOL, V471, P157, DOI 10.1016/S0014-2999(03)01825-9; Pedarzani P, 2008, CELL MOL LIFE SCI, V65, P3196, DOI 10.1007/s00018-008-8216-x; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Sanai N, 2008, NEUROSURGERY, V62, P753, DOI 10.1227/01.neu.0000318159.21731.cf; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Sciaccaluga M, 2010, AM J PHYSIOL-CELL PH, V299, pC175, DOI 10.1152/ajpcell.00344.2009; Si H, 2006, BRIT J PHARMACOL, V148, P909, DOI 10.1038/sj.bjp.0706793; Tao R, 2008, AM J PHYSIOL-CELL PH, V295, pC1409, DOI 10.1152/ajpcell.00268.2008; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Wang ZH, 2007, ONCOGENE, V26, P5107, DOI 10.1038/sj.onc.1210308; Wang ZG, 2004, PFLUG ARCH EUR J PHY, V448, P274, DOI 10.1007/s00424-004-1258-5; Weaver AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/jnr.20240; Weaver AK, 2006, GLIA, V54, P223, DOI 10.1002/glia.20364; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135; WOODFORK KA, 1995, J CELL PHYSIOL, V162, P163, DOI 10.1002/jcp.1041620202; Wrensch M, 2002, NEURO-ONCOLOGY, V4, P278, DOI 10.1093/neuonc/4.4.278; Wulf A, 2002, J MEMBRANE BIOL, V187, P71, DOI 10.1007/s00232-001-0149-3; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758	54	61	63	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12304	10.1371/journal.pone.0012304	http://dx.doi.org/10.1371/journal.pone.0012304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808839	Green Published, gold, Green Submitted			2022-12-27	WOS:000281077000011
J	Joyce, KE; Laurienti, PJ; Burdette, JH; Hayasaka, S				Joyce, Karen E.; Laurienti, Paul J.; Burdette, Jonathan H.; Hayasaka, Satoru			A New Measure of Centrality for Brain Networks	PLOS ONE			English	Article							SMALL-WORLD; ANATOMICAL NETWORKS; IDENTIFICATION; CONNECTIVITY; ORGANIZATION	Recent developments in network theory have allowed for the study of the structure and function of the human brain in terms of a network of interconnected components. Among the many nodes that form a network, some play a crucial role and are said to be central within the network structure. Central nodes may be identified via centrality metrics, with degree, betweenness, and eigenvector centrality being three of the most popular measures. Degree identifies the most connected nodes, whereas betweenness centrality identifies those located on the most traveled paths. Eigenvector centrality considers nodes connected to other high degree nodes as highly central. In the work presented here, we propose a new centrality metric called leverage centrality that considers the extent of connectivity of a node relative to the connectivity of its neighbors. The leverage centrality of a node in a network is determined by the extent to which its immediate neighbors rely on that node for information. Although similar in concept, there are essential differences between eigenvector and leverage centrality that are discussed in this manuscript. Degree, betweenness, eigenvector, and leverage centrality were compared using functional brain networks generated from healthy volunteers. Functional cartography was also used to identify neighborhood hubs (nodes with high degree within a network neighborhood). Provincial hubs provide structure within the local community, and connector hubs mediate connections between multiple communities. Leverage proved to yield information that was not captured by degree, betweenness, or eigenvector centrality and was more accurate at identifying neighborhood hubs. We propose that this metric may be able to identify critical nodes that are highly influential within the network.	[Joyce, Karen E.] Wake Forest Univ, Sch Med, Sch Biomed Engn & Sci, Winston Salem, NC 27109 USA; [Laurienti, Paul J.; Burdette, Jonathan H.; Hayasaka, Satoru] Wake Forest Univ, Sch Med, Dept Radiol, Winston Salem, NC 27109 USA; [Hayasaka, Satoru] Wake Forest Univ, Sch Med, Dept Biostat Sci, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest University; Wake Forest University	Joyce, KE (corresponding author), Wake Forest Univ, Sch Med, Sch Biomed Engn & Sci, Winston Salem, NC 27109 USA.	kajoyce@wfubmc.edu			Translational Science Institute of Wake Forest University; National Institute of Neurological Disorders and Stroke [NS070917]; National Institutes of Health [NS042658]; Roena Kulynych Memory and Cognition Research Center; General Clinical Research Center of Wake Forest University [RR07122]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR007122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070917] Funding Source: NIH RePORTER	Translational Science Institute of Wake Forest University; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roena Kulynych Memory and Cognition Research Center; General Clinical Research Center of Wake Forest University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Translational Science Institute of Wake Forest University (Translational Scholar Award, URL: http://www.wfubmc.edu/TSI.htm) and by the National Institute of Neurological Disorders and Stroke (NS070917, URL: http://www.ninds.nih.gov/). Data collection for this work was supported by the National Institutes of Health (NS042658, URL: http://www.nih.gov/), as well as the Roena Kulynych Memory and Cognition Research Center (URL: http://www.wfubmc.edu/krc/) and the General Clinical Research Center (RR07122, URL: http://www.wfubmc.edu/Research/TSI/Clinical-Research-Unit.htm) of Wake Forest University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Blondel VD, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036114; BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Estrada E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056103; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; GONG G, 2009, CEREBRAL CORETEX, V17, P2407; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Huxham M, 1996, OIKOS, V76, P284, DOI 10.2307/3546201; LIN TY, 2008, DATA MINING FDN PRAC; Lohmann G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010232; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Meunier David, 2009, Front Neuroinform, V3, P37, DOI 10.3389/neuro.11.037.2009; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; NIEMINEN J, 1974, SCAND J PSYCHOL, V15, P332, DOI 10.1111/j.1467-9450.1974.tb00598.x; Peiffer AM, 2009, HUM BRAIN MAPP, V30, P228, DOI 10.1002/hbm.20497; RUAN J, 2007, SUPPLEMENTARY MAT ID; Ruan JH, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016104; Ruhnau B, 2000, SOC NETWORKS, V22, P357, DOI 10.1016/S0378-8733(00)00031-9; SABIDUSSI G, 1966, PSYCHOMETRIKA, V31, P581, DOI 10.1007/BF02289527; Schmitt JE, 2008, CEREB CORTEX, V18, P1737, DOI 10.1093/cercor/bhm211; Shaw ME, 1954, J PSYCHOL, V38, P139, DOI 10.1080/00223980.1954.9712925; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; VALENCIA M, 2009, MODULAR ORG BASIS FU; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	48	177	180	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12200	10.1371/journal.pone.0012200	http://dx.doi.org/10.1371/journal.pone.0012200			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808943	Green Published, Green Submitted, gold			2022-12-27	WOS:000280968000023
J	Avogadri, F; Merghoub, T; Maughan, MF; Hirschhorn-Cymerman, D; Morris, J; Ritter, E; Olmsted, R; Houghton, AN; Wolchok, JD				Avogadri, Francesca; Merghoub, Taha; Maughan, Maureen F.; Hirschhorn-Cymerman, Daniel; Morris, John; Ritter, Erika; Olmsted, Robert; Houghton, Alan N.; Wolchok, Jedd D.			Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity	PLOS ONE			English	Article							SEMLIKI-FOREST-VIRUS; TYROSINASE-RELATED PROTEIN-2; TUMOR-IMMUNITY; DNA VACCINES; DOPACHROME TAUTOMERASE; ANTITUMOR IMMUNITY; T-LYMPHOCYTES; B16 MELANOMA; IMMUNIZATION; RESPONSES	Background: Malignant melanoma is the deadliest form of skin cancer and is refractory to conventional chemotherapy and radiotherapy. Therefore alternative approaches to treat this disease, such as immunotherapy, are needed. Melanoma vaccine design has mainly focused on targeting CD8(+) T cells. Activation of effector CD8(+) T cells has been achieved in patients, but provided limited clinical benefit, due to immune-escape mechanisms established by advanced tumors. We have previously shown that alphavirus-based virus-like replicon particles (VRP) simultaneously activate strong cellular and humoral immunity against the weakly immunogenic melanoma differentiation antigen (MDA) tyrosinase. Here we further investigate the antitumor effect and the immune mechanisms of VRP encoding different MDAs. Methodology/Principal Findings: VRP encoding different MDAs were screened for their ability to prevent the growth of the B16 mouse transplantable melanoma. The immunologic mechanisms of efficacy were investigated for the most effective vaccine identified, focusing on CD8(+) T cells and humoral responses. To this end, ex vivo immune assays and transgenic mice lacking specific immune effector functions were used. The studies identified a potent therapeutic VRP vaccine, encoding tyrosinase related protein 2 (TRP-2), which provided a durable anti-tumor effect. The efficacy of VRP-TRP2 relies on a novel immune mechanism of action requiring the activation of both IgG and CD8(+) T cell effector responses, and depends on signaling through activating Fc gamma receptors. Conclusions/Significance: This study identifies a VRP-based vaccine able to elicit humoral immunity against TRP-2, which plays a role in melanoma immunotherapy and synergizes with tumor-specific CD8(+) T cell responses. These findings will aid in the rational design of future immunotherapy clinical trials.	[Avogadri, Francesca; Merghoub, Taha; Hirschhorn-Cymerman, Daniel; Houghton, Alan N.; Wolchok, Jedd D.] Sloan Kettering Inst, Swim Amer Lab, Program Immunol, New York, NY USA; [Maughan, Maureen F.; Morris, John; Olmsted, Robert] AlphaVax Inc, Res Triangle Pk, NC USA; [Ritter, Erika; Wolchok, Jedd D.] Ludwig Inst Canc Res, New York Branch, New York, NY USA	Memorial Sloan Kettering Cancer Center; Ludwig Institute for Cancer Research	Avogadri, F (corresponding author), Sloan Kettering Inst, Swim Amer Lab, Program Immunol, New York, NY USA.	wolchokj@mskcc.org	Merghoub, Taha/ABD-8362-2021		National Cancer Institute [R01 CA56821, P01 CA33049, P01 CA59350]; Swim Across America; Lita Annenberg Hazen Foundation; Mr. William H. Goodwin and Mrs. Alice Goodwin; Commonwealth Cancer Foundation for Research; NATIONAL CANCER INSTITUTE [R01CA056821, P01CA059350, P01CA033049] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swim Across America; Lita Annenberg Hazen Foundation; Mr. William H. Goodwin and Mrs. Alice Goodwin; Commonwealth Cancer Foundation for Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute (R01 CA56821, P01 CA33049 and P01 CA59350), Swim Across America, the Lita Annenberg Hazen Foundation, and the Mr. William H. Goodwin and Mrs. Alice Goodwin and the Commonwealth Cancer Foundation for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker JC, 2010, EXP DERMATOL, V19, P157, DOI 10.1111/j.1600-0625.2009.00986.x; Berglund P, 1999, VACCINE, V17, P497, DOI 10.1016/S0264-410X(98)00224-2; Bernstein DI, 2009, VACCINE, V28, P484, DOI 10.1016/j.vaccine.2009.09.135; Bloom MB, 1997, J EXP MED, V185, P453, DOI 10.1084/jem.185.3.453; Brandmaier AG, 2009, J IMMUNOTHER, V32, P677, DOI 10.1097/CJI.0b013e3181ab1824; BRICHARD V, 1993, J EXP MED, V178, P489, DOI 10.1084/jem.178.2.489; Bronte V, 2000, CANCER RES, V60, P253; Chen M, 2005, J VIROL, V79, P2964, DOI 10.1128/JVI.79.5.2964-2972.2005; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Colella TA, 2000, J EXP MED, V191, P1221, DOI 10.1084/jem.191.7.1221; Colmenero P, 1999, GENE THER, V6, P1728, DOI 10.1038/sj.gt.3301004; Costin GE, 2005, BIOCHEM J, V391, P249, DOI 10.1042/BJ20042070; Diebold SS, 2009, GENE THER, V16, P359, DOI 10.1038/gt.2008.164; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Durso RJ, 2007, CLIN CANCER RES, V13, P3999, DOI 10.1158/1078-0432.CCR-06-2202; Engelhorn ME, 2006, NAT MED, V12, P198, DOI 10.1038/nm1363; Fleeton MN, 2000, J GEN VIROL, V81, P749, DOI 10.1099/0022-1317-81-3-749; Goldberg SM, 2005, CLIN CANCER RES, V11, P8114, DOI 10.1158/1078-0432.CCR-05-1410; HARA I, 1995, J EXP MED, V182, P1609, DOI 10.1084/jem.182.5.1609; HEARING VJ, 1992, PIGM CELL RES, V5, P264, DOI 10.1111/j.1600-0749.1992.tb00547.x; Hinrichs CS, 2009, BLOOD, V114, P596, DOI 10.1182/blood-2009-02-203935; HOUGHTON AN, 1982, J EXP MED, V156, P1755, DOI 10.1084/jem.156.6.1755; Huang SKS, 1998, J INVEST DERMATOL, V111, P662, DOI 10.1046/j.1523-1747.1998.00354.x; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; KROUMPOUZOS G, 1994, BIOCHEM BIOPH RES CO, V202, P1060, DOI 10.1006/bbrc.1994.2036; Leitner WW, 2006, VACCINE, V24, P5110, DOI 10.1016/j.vaccine.2006.04.059; Leitner WW, 2003, NAT MED, V9, P33, DOI 10.1038/nm813; Lyons JA, 2007, GENE THER, V14, P503, DOI 10.1038/sj.gt.3302889; Negroiu G, 2003, J BIOL CHEM, V278, P27035, DOI 10.1074/jbc.M303167200; Nelson EL, 2003, BREAST CANCER RES TR, V82, P169, DOI 10.1023/B:BREA.0000004373.09678.bb; Ni B, 2005, CANCER IMMUNOL IMMUN, V54, P489, DOI 10.1007/s00262-004-0591-z; Olivares C, 2009, PIGM CELL MELANOMA R, V22, P750, DOI 10.1111/j.1755-148X.2009.00636.x; Otten MA, 2008, J IMMUNOL, V181, P6829, DOI 10.4049/jimmunol.181.10.6829; PAWELEK JM, 1986, CANCER RES, V46, P493; PICHLMAIR A, 2009, J VIROL; Reap EA, 2007, VACCINE, V25, P7441, DOI 10.1016/j.vaccine.2007.08.016; Riezebos-Brilman A, 2006, J CLIN VIROL, V35, P233, DOI 10.1016/j.jcv.2005.12.001; Saenger YM, 2008, CANCER RES, V68, P9884, DOI 10.1158/0008-5472.CAN-08-2233; STEEL KP, 1992, DEVELOPMENT, V115, P1111; Steitz J, 2000, INT J CANCER, V86, P89, DOI 10.1002/(SICI)1097-0215(20000401)86:1<89::AID-IJC14>3.0.CO;2-I; Sundback M, 2005, VIROLOGY, V341, P190, DOI 10.1016/j.virol.2005.07.017; Uchi H, 2006, ADV IMMUNOL, V90, P215, DOI 10.1016/S0065-2776(06)90006-6; van Spriel AB, 2003, BLOOD, V101, P253, DOI 10.1182/blood.V101.1.253; Wang RF, 1996, J EXP MED, V184, P2207, DOI 10.1084/jem.184.6.2207; Weber LW, 1998, J CLIN INVEST, V102, P1258, DOI 10.1172/JCI4004; Weiner LM, 2009, LANCET, V373, P1033, DOI 10.1016/S0140-6736(09)60251-8; Yamaguchi Y, 2007, J BIOL CHEM, V282, P27557, DOI 10.1074/jbc.R700026200; Yuan Jianda, 2010, Cancer Immun, V10, P1; ZHOU XZ, 1995, P NATL ACAD SCI USA, V92, P3009, DOI 10.1073/pnas.92.7.3009	50	48	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12670	10.1371/journal.pone.0012670	http://dx.doi.org/10.1371/journal.pone.0012670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844763	gold, Green Published, Green Submitted			2022-12-27	WOS:000281687300014
J	Boisson, S; Kiyombo, M; Sthreshley, L; Tumba, S; Makambo, J; Clasen, T				Boisson, Sophie; Kiyombo, Mbela; Sthreshley, Larry; Tumba, Saturnin; Makambo, Jacques; Clasen, Thomas			Field Assessment of a Novel Household-Based Water Filtration Device: A Randomised, Placebo-Controlled Trial in the Democratic Republic of Congo	PLOS ONE			English	Article							DRINKING-WATER; DEVELOPING-COUNTRIES; POINT; INTERVENTIONS; DIARRHEA	Background: Household water treatment can improve the microbiological quality of drinking water and may prevent diarrheal diseases. However, current methods of treating water at home have certain shortcomings, and there is evidence of bias in the reported health impact of the intervention in open trial designs. Methods and Findings: We undertook a randomised, double-blinded, placebo-controlled trial among 240 households (1,144 persons) in rural Democratic Republic of Congo to assess the field performance, use and effectiveness of a novel filtration device in preventing diarrhea. Households were followed up monthly for 12 months. Filters and placebos were monitored for longevity and for microbiological performance by comparing thermotolerant coliform (TTC) levels in influent and effluent water samples. Mean longitudinal prevalence of diarrhea was estimated among participants of all ages. Compliance was assessed through self-reported use and presence of water in the top vessel of the device at the time of visit. Over the 12-month follow-up period, data were collected for 11,236 person-weeks of observation (81.8% total possible). After adjusting for clustering within the household, the longitudinal prevalence ratio of diarrhoea was 0.85 (95% confidence interval: 0.61-1.20). The filters achieved a 2.98 log reduction in TTC levels while, for reasons that are unclear, the placebos achieved a 1.05 log reduction (p<0.0001). After 8 months, 68% of intervention households met the study's definition of current users, though most (73% of adults and 95% of children) also reported drinking untreated water the previous day. The filter maintained a constant flow rate over time, though 12.4% of filters were damaged during the course of the study. Conclusions: While the filter was effective in improving water quality, our results provide little evidence that it was protective against diarrhea. The moderate reduction observed nevertheless supports the need for larger studies that measure impact against a neutral placebo.	[Boisson, Sophie; Clasen, Thomas] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Kiyombo, Mbela] Ecole Sante Publ Kinshasa, Kinshasa, DEM REP CONGO; [Sthreshley, Larry; Makambo, Jacques] Communaute Presbyterienne Kinshasa, Kinshasa, DEM REP CONGO	University of London; London School of Hygiene & Tropical Medicine	Boisson, S (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	sophie.boisson@lshtm.ac.uk			Vestergaard-Frandsen	Vestergaard-Frandsen	This study was funded by Vestergaard-Frandsen, the manufacturer of the filter used as the intervention. Apart from supplying the filters, the funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, MANAGING WATER HOME; Arnold BF, 2007, AM J TROP MED HYG, V76, P354, DOI 10.4269/ajtmh.2007.76.354; Bang HJ, 2004, CONTROL CLIN TRIALS, V25, P143, DOI 10.1016/j.cct.2003.10.016; Boisson S, 2009, ENVIRON SCI TECHNOL, V43, P5934, DOI 10.1021/es9000664; Clasen T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004794.pub2; CLASEN T, 2008, SCALING HOUSEHOLD WA; Clasen T, 2009, ENVIRON SCI TECHNOL, V43, P5542, DOI 10.1021/es9008147; Clasen T, 2009, AM J TROP MED HYG, V80, P819, DOI 10.4269/ajtmh.2009.80.819; Colford JM, 2005, AM J EPIDEMIOL, V161, P472, DOI 10.1093/aje/kwi067; Colford JM, 2002, EMERG INFECT DIS, V8, P29, DOI 10.3201/eid0801.001481; Colford JM, 2009, AM J PUBLIC HEALTH, V99, P1988, DOI 10.2105/AJPH.2008.153619; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Hunter PR, 2009, ENVIRON SCI TECHNOL, V43, P8991, DOI 10.1021/es9028217; Hunter PR, 2009, SCI TOTAL ENVIRON, V407, P2621, DOI 10.1016/j.scitotenv.2009.01.018; International MdPeM, 2008, ENQ DEM SANT REP DEM; Jain S, 2010, AM J TROP MED HYG, V82, P16, DOI 10.4269/ajtmh.2010.08-0584; James KE, 1996, STAT MED, V15, P1421; KIRCHHOFF LV, 1985, J HYG-CAMBRIDGE, V94, P173, DOI 10.1017/S0022172400061374; Park J, 2008, COMPLEMENT THER MED, V16, P121, DOI 10.1016/j.ctim.2008.05.001; Pruss-Unstun A, 2008, SAFER WATER BETTER H; Rosa G, 2010, AM J TROP MED HYG, V82, P289, DOI 10.4269/ajtmh.2010.09-0382; Schmidt WP, 2009, ENVIRON SCI TECHNOL, V43, P986, DOI 10.1021/es802232w; Sobsey MD, 2008, ENVIRON SCI TECHNOL, V42, P4261, DOI 10.1021/es702746n; SOPAC, 2008, WORLD WAT DAY SAN HE; Stauber CE, 2006, WATER SCI TECHNOL, V54, P1, DOI 10.2166/wst.2006.440; Tiwari SSK, 2009, TROP MED INT HEALTH, V14, P1374, DOI 10.1111/j.1365-3156.2009.02381.x; Waddington H., 2009, WATER SANITATION HYG; World Health Organisation, 2005, WORLD HLTH REP MAK E; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x; ZAFAR SN, 2009, EPIDEMIOL INFECT, P1; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	31	73	73	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12613	10.1371/journal.pone.0012613	http://dx.doi.org/10.1371/journal.pone.0012613			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20856584	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000281687300004
J	Downes, S; Parker, T; Mahon, R				Downes, Sharon; Parker, Tracey; Mahon, Rod			Incipient Resistance of Helicoverpa punctigera to the Cry2Ab Bt Toxin in Bollgard II (R) Cotton	PLOS ONE			English	Article							ALLELES CONFERRING RESISTANCE; BACILLUS-THURINGIENSIS TOXIN; ARMIGERA LEPIDOPTERA; INSECT RESISTANCE; TRANSGENIC COTTON; AUSTRALIAN POPULATIONS; F-2 SCREEN; NOCTUIDAE; CROPS; FREQUENCY	Combinations of dissimilar insecticidal proteins ("pyramids'') within transgenic plants are predicted to delay the evolution of pest resistance for significantly longer than crops expressing a single transgene. Field-evolved resistance to Bacillus thuringiensis (Bt) transgenic crops has been reported for first generation, single-toxin varieties and the Cry1 class of proteins. Our five year data set shows a significant exponential increase in the frequency of alleles conferring Cry2Ab resistance in Australian field populations of Helicoverpa punctigera since the adoption of a second generation, two-toxin Bt cotton expressing this insecticidal protein. Furthermore, the frequency of cry2Ab resistance alleles in populations from cropping areas is 8-fold higher than that found for populations from non-cropping regions. This report of field evolved resistance to a protein in a dual-toxin Bt-crop has precisely fulfilled the intended function of monitoring for resistance; namely, to provide an early warning of increases in frequencies that may lead to potential failures of the transgenic technology. Furthermore, it demonstrates that pyramids are not 'bullet proof' and that rapid evolution to Bt toxins in the Cry2 class is possible.	[Downes, Sharon; Parker, Tracey] CSIRO Entomol, ACRI, Narrabri, Australia; [Mahon, Rod] CSIRO Entomol, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Downes, S (corresponding author), CSIRO Entomol, ACRI, Narrabri, Australia.	sharon.downes@csiro.au	Downes, Sharon Joy/C-1770-2008	Downes, Sharon Joy/0000-0002-3729-1732; Parker, Tracey/0000-0002-0125-7962	Cotton Research and Development Corporation [CSE0002]	Cotton Research and Development Corporation(Cotton R&D Corp)	This work was funded by the Cotton Research and Development Corporation, http://www.crdc.com.au/, grant CSE0002 to Downes and Mahon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MI, 2007, J ECON ENTOMOL, V100, P921, DOI 10.1603/0022-0493(2007)100[921:SOBATB]2.0.CO;2; Ali MI, 2009, J ECON ENTOMOL, V102, P1935, DOI 10.1603/029.102.0526; Andow DA, 1998, J ECON ENTOMOL, V91, P572, DOI 10.1093/jee/91.3.572; Baker GH, 2008, AUST J AGR RES, V59, P723, DOI 10.1071/AR07421; BAKER GH, 2010, B ENTOMOL R IN PRESS; Clark AG, 1998, GENETICA, V102-3, P41, DOI 10.1023/A:1017074523395; Downes S, 2009, J ECON ENTOMOL, V102, P733, DOI 10.1603/029.102.0234; DOWNES S, 2010, J EC ENTOMO IN PRESS; Downes S, 2007, J INVERTEBR PATHOL, V95, P208, DOI 10.1016/j.jip.2007.03.010; Farrell T., 2008, COTTON PEST MANAGEME; Fitt G, 1998, PEST MANAGEMENT - FUTURE CHALLENGES, VOLS 1 AND 2, PROCEEDINGS, P189; FORRESTER NW, 1993, B ENTOMOL RES S; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Greenplate JT, 2003, J APPL ENTOMOL, V127, P340, DOI 10.1046/j.1439-0418.2003.00766.x; Gunning RV, 1997, PESTIC BIOCHEM PHYS, V58, P155, DOI 10.1006/pest.1997.2295; Jackson RE, 2004, J ECON ENTOMOL, V97, P1719, DOI 10.1603/0022-0493-97.5.1719; JOHNSON A, 2003, COTTON PEST MANAGEME; Liu FY, 2010, PEST MANAG SCI, V66, P155, DOI 10.1002/ps.1849; Mahon RJ, 2007, J ECON ENTOMOL, V100, P1844, DOI 10.1603/0022-0493(2007)100[1844:FOACRT]2.0.CO;2; Mahon RJ, 2007, J ECON ENTOMOL, V100, P894, DOI 10.1603/0022-0493(2007)100[894:RTBTTC]2.0.CO;2; Mahon RJ, 2010, J ECON ENTOMOL, V103, P472, DOI 10.1603/EC09225; Matten Sharlene R., 2008, V5, P27, DOI 10.1007/978-1-4020-8373-0_2; Olsen KM, 2005, J ECON ENTOMOL, V98, P1007, DOI 10.1603/0022-0493-98.3.1007; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Stodola TJ, 2004, J ECON ENTOMOL, V97, P1756, DOI 10.1603/0022-0493-97.5.1756; Tabashnik BE, 2009, ENVIRONMENTAL IMPACT OF GENETICALLY MODIFIED CROPS, P74, DOI 10.1079/9781845934095.0074; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Wenes AL, 2006, HEREDITY, V97, P127, DOI 10.1038/sj.hdy.6800845; Whitburn G., 2009, AUST COTTONGROWER MA, V30, P12; Yue BS, 2008, ENTOMOL EXP APPL, V129, P172, DOI 10.1111/j.1570-7458.2008.00761.x; Zhao JZ, 2003, NAT BIOTECHNOL, V21, P1493, DOI 10.1038/nbt907	33	79	84	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12567	10.1371/journal.pone.0012567	http://dx.doi.org/10.1371/journal.pone.0012567			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830203	gold, Green Submitted, Green Published			2022-12-27	WOS:000281631300007
J	Lord, P; Stevens, R				Lord, Phillip; Stevens, Robert			Adding a Little Reality to Building Ontologies for Biology	PLOS ONE			English	Article							GENE ONTOLOGY	Background: Many areas of biology are open to mathematical and computational modelling. The application of discrete, logical formalisms defines the field of biomedical ontologies. Ontologies have been put to many uses in bioinformatics. The most widespread is for description of entities about which data have been collected, allowing integration and analysis across multiple resources. There are now over 60 ontologies in active use, increasingly developed as large, international collaborations. There are, however, many opinions on how ontologies should be authored; that is, what is appropriate for representation. Recently, a common opinion has been the "realist" approach that places restrictions upon the style of modelling considered to be appropriate. Methodology/Principal Findings: Here, we use a number of case studies for describing the results of biological experiments. We investigate the ways in which these could be represented using both realist and non-realist approaches; we consider the limitations and advantages of each of these models. Conclusions/Significance: From our analysis, we conclude that while realist principles may enable straight-forward modelling for some topics, there are crucial aspects of science and the phenomena it studies that do not fit into this approach; realism appears to be over-simplistic which, perversely, results in overly complex ontological models. We suggest that it is impossible to avoid compromise in modelling ontology; a clearer understanding of these compromises will better enable appropriate modelling, fulfilling the many needs for discrete mathematical models within computational biology.	[Lord, Phillip] Newcastle Univ, Sch Comp Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Stevens, Robert] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England	Newcastle University - UK; University of Manchester	Lord, P (corresponding author), Newcastle Univ, Sch Comp Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	phillip.lord@newcastle.ac.uk		Lord, Phillip/0000-0002-4699-6769				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ceusters Werner, 2006, AMIA Annu Symp Proc, P121; EGANA M, APPL ONTOLOGY DESIGN, P7; Grenon P, 2004, STUD HEALTH TECHNOL, V102, P20; Gruber Th., 1992, WHAT IS ONTOLOGY; Johansson I, 2006, J BIOMED INFORM, V39, P274, DOI 10.1016/j.jbi.2005.08.005; LORD P, 2009, BIOONTOLOGIES 2009 K; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Merrill GH, 2010, APPL ONTOL, V5, P79, DOI 10.3233/AO-2010-0076; *OBO FOUNDR CONS, 2006, OBO FOUNDR PRINC; *OBO FOUNDR CONS, 2008, OBO FOUNDR PRINC; RECTOR A, 2005, REPRESENTING SPECIFI; RUSSELL B, 1946, HIST W PHILOS ROUTLE; Schulz S, 2008, BIOINFORMATICS, V24, pI313, DOI 10.1093/bioinformatics/btn158; SEYED AP, 2009, BIOONTOLOGIES 2009 K; Shrager J, 2003, BIOINFORMATICS, V19, P1934, DOI 10.1093/bioinformatics/btg277; Smith B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r46; SMITH B, 2004, P 3 C FOIS 2004 IOS; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; STEVENS R, 2008, HDB ONTOLOGIES INFOR; Whetzel PL, 2006, BIOINFORMATICS, V22, P866, DOI 10.1093/bioinformatics/btl005; Wolstencroft K, 2006, BIOINFORMATICS, V22, pE530, DOI 10.1093/bioinformatics/btl208; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; [No title captured]	24	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12258	10.1371/journal.pone.0012258	http://dx.doi.org/10.1371/journal.pone.0012258			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838431	gold, Green Submitted, Green Published			2022-12-27	WOS:000281627700001
J	Zhao, TT; Trinh, D; Addison, CL; Dimitroulakos, J				Zhao, Tong T.; Trinh, Diane; Addison, Christina L.; Dimitroulakos, Jim			Lovastatin Inhibits VEGFR and AKT Activation: Synergistic Cytotoxicity in Combination with VEGFR Inhibitors	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SQUAMOUS-CELL CARCINOMA; FACTOR RECEPTOR; MALIGNANT MESOTHELIOMA; MEVALONATE PATHWAY; INDUCED APOPTOSIS; TYROSINE KINASE; CANCER-THERAPY; PHASE-I; INTERNALIZATION	Background: In a recent study, we demonstrated the ability of lovastatin, a potent inhibitor of mevalonate synthesis, to inhibit the function of the epidermal growth factor receptor (EGFR). Lovastatin attenuated ligand-induced receptor activation and downstream signaling through the PI3K/AKT pathway. Combining lovastatin with gefitinib, a potent EGFR inhibitor, induced synergistic cytotoxicity in a variety of tumor derived cell lines. The vascular endothelial growth factor receptor (VEGFR) and EGFR share similar activation, internalization and downstream signaling characteristics. Methodology/Principal Findings: The VEGFRs, particularly VEGFR-2 (KDR, Flt-1), play important roles in regulating tumor angiogenesis by promoting endothelial cell proliferation, survival and migration. Certain tumors, such as malignant mesothelioma (MM), also express both the VEGF ligand and VEGFRs that act in an autocrine loop to directly stimulate tumor cell growth and survival. In this study, we have shown that lovastatin inhibits ligand-induced VEGFR-2 activation through inhibition of receptor internalization and also inhibits VEGF activation of AKT in human umbilical vein endothelial cells (HUVEC) and H28 MM cells employing immunofluorescence and Western blotting. Combinations of lovastatin and a VEGFR-2 inhibitor showed more robust AKT inhibition than either agent alone in the H28 MM cell line. Furthermore, combining 5 mM lovastatin treatment, a therapeutically relevant dose, with two different VEGFR-2 inhibitors in HUVEC and the H28 and H2052 mesothelioma derived cell lines demonstrated synergistic cytotoxicity as demonstrated by MTT cell viability and flow cytometric analyses. Conclusions/Significance: These results highlight a novel mechanism by which lovastatin can regulate VEGFR-2 function and a potential therapeutic approach for MM through combining statins with VEGFR-2 inhibitors.	[Zhao, Tong T.; Trinh, Diane; Addison, Christina L.; Dimitroulakos, Jim] Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada; [Zhao, Tong T.; Addison, Christina L.; Dimitroulakos, Jim] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Zhao, Tong T.; Addison, Christina L.; Dimitroulakos, Jim] Univ Ottawa, Dept Biochem, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Zhao, TT (corresponding author), Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada.	jdimitroulakos@ohri.ca	Dimitroulakos, Jim/AAK-3398-2020		Ontario Institute for Cancer Research [574]; Canadian Institute of Health Research [74558]	Ontario Institute for Cancer Research; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	The Ontario Institute for Cancer Research (574) http://www.oicr.on.ca and the Canadian Institute of Health Research (74558) http://www.cihr.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin ME, 2001, J BIOL CHEM, V276, P44307, DOI 10.1074/jbc.M106188200; Boulougouris P, 2001, ANTICANCER RES, V21, P2769; BRENNER J, 1982, CANCER, V49, P2431, DOI 10.1002/1097-0142(19820601)49:11<2431::AID-CNCR2820491134>3.0.CO;2-W; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Chan KKW, 2003, CLIN CANCER RES, V9, P10; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; CORSINI A, 1995, PHARMACOL RES, V31, P9, DOI 10.1016/1043-6618(95)80042-5; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; Crowell JA, 2007, MOL CANCER THER, V6, P2139, DOI 10.1158/1535-7163.MCT-07-0120; Dimitroulakos J, 1999, BLOOD, V93, P1308, DOI 10.1182/blood.V93.4.1308.404k08_1308_1318; Dimitroulakos J, 2001, CLIN CANCER RES, V7, P158; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Endo A, 2003, J RECEPT SIG TRANSD, V23, P239, DOI 10.1081/RRS-120025567; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a; GIBBS JB, 1994, CELL, V77, P175, DOI 10.1016/0092-8674(94)90308-5; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; HALPIN RA, 1993, DRUG METAB DISPOS, V21, P1003; Herbst RS, 2002, EXPERT OPIN INV DRUG, V11, P837, DOI 10.1517/13543784.11.6.837; KEYOMARSI K, 1991, CANCER RES, V51, P3602; Knox JJ, 2005, EUR J CANCER, V41, P523, DOI 10.1016/j.ejca.2004.12.013; Kumar-Singh S, 1999, J PATHOL, V189, P72, DOI 10.1002/(SICI)1096-9896(199909)189:1<72::AID-PATH401>3.0.CO;2-0; Lee AY, 2007, CANCER-AM CANCER SOC, V109, P1454, DOI 10.1002/cncr.22552; Lunn JA, 2000, AM J PHYSIOL-CELL PH, V279, pC2019, DOI 10.1152/ajpcell.2000.279.6.C2019; Mantha AJ, 2005, CLIN CANCER RES, V11, P2398, DOI 10.1158/1078-0432.CCR-04-1951; Mantha AJ, 2003, J CANCER RES CLIN, V129, P631, DOI 10.1007/s00432-003-0490-2; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Nakamura K, 2004, MOL CANCER THER, V3, P1639; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Ramalingam SS, 2008, J THORAC ONCOL, V3, P1056, DOI 10.1097/JTO.0b013e3181834f66; Ringerike T, 2002, J CELL SCI, V115, P1331; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Santos SCR, 2007, EXP CELL RES, V313, P1561, DOI 10.1016/j.yexcr.2007.02.020; Sebti Said, 1997, Current Opinion in Oncology, V9, P557, DOI 10.1097/00001622-199711000-00011; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; SLIEKER LJ, 1986, J BIOL CHEM, V261, P5233; Strizzi L, 2001, J PATHOL, V193, P468, DOI 10.1002/path.824; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; Thelen KM, 2006, J PHARMACOL EXP THER, V316, P1146, DOI 10.1124/jpet.105.094136; Thibault A, 1996, CLIN CANCER RES, V2, P483; Thomas AL, 2003, SEMIN ONCOL, V30, P32, DOI 10.1016/S0093-7754(03)00123-4; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wang CY, 2010, INT J CANCER, V126, P578, DOI 10.1002/ijc.24760; Wang IK, 2000, ONCOLOGY-BASEL, V59, P245, DOI 10.1159/000012168; ZHAO TT, 2010, ONCOGENE	46	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12563	10.1371/journal.pone.0012563	http://dx.doi.org/10.1371/journal.pone.0012563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838437	gold, Green Published, Green Submitted			2022-12-27	WOS:000281627700015
J	Chun, CD; Madhani, HD				Chun, Cheryl D.; Madhani, Hiten D.			Ctr2 Links Copper Homeostasis to Polysaccharide Capsule Formation and Phagocytosis Inhibition in the Human Fungal Pathogen Cryptococcus neoformans	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; VIRULENCE; MACROPHAGES; IRON; IDENTIFICATION; MUTANTS; TRANSPORTERS; YEAST	Cryptococcus neoformans is a human opportunistic fungal pathogen responsible for similar to 1/3 of HIV/AIDS deaths worldwide. This budding yeast expresses a polysaccharide capsule necessary for virulence. Capsule production inhibits phagocytosis by macrophages. Here we describe results that link copper homeostasis to capsule production and the inhibition of phagocytosis. Specifically, using Agrobacterium-mediated insertional mutagenesis, we identified an insertion in the promoter region of the putative copper transporter-encoding gene CTR2 that results in reduced expression of CTR2 and increased phagocytosis by murine RAW264.7 macrophages. The mutant also displayed sensitivity to copper starvation and defects in polysaccharide capsule production and melanization. These defects were all reversed by genetic correction of the promoter insertion by homologous targeting. Several melanization-defective mutants identified previously, those in the RIM20, RIM101, and VPS25 genes, also display sensitivity to copper starvation, reduced capsule production and increased phagocytosis. Together these results indicate a previously undescribed link between copper homeostasis to polysaccharide capsule production and phagocytosis inhibition in Cryptococcus neoformans.	[Chun, Cheryl D.; Madhani, Hiten D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Chun, CD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	hitenmadhani@gmail.com		Madhani, Hiten/0000-0001-7400-6657	National Institute of Allergy and Infectious Diseases/National Institutes of Health	National Institute of Allergy and Infectious Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institute of Allergy and Infectious Diseases/National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold C, 1991, PCR Methods Appl, V1, P39; Belay T, 1997, INFECT IMMUN, V65, P718, DOI 10.1128/IAI.65.2.718-728.1997; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Boysen JH, 2006, MOL BIOL CELL, V17, P1344, DOI 10.1091/mbc.e05-10-0949; BULMER GS, 1968, J BACTERIOL, V95, P5, DOI 10.1128/JB.95.1.5-8.1968; Chun CD, 2010, METHOD ENZYMOL, V470, P797, DOI 10.1016/S0076-6879(10)70033-1; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; Gebhart D, 2006, EUKARYOT CELL, V5, P935, DOI 10.1128/EC.00028-06; HOOYKAAS PJJ, 1979, J GEN MICROBIOL, V110, P99, DOI 10.1099/00221287-110-1-99; Jo WJ, 2008, TOXICOL SCI, V101, P140, DOI 10.1093/toxsci/kfm226; Jung WH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040045; Jung WH, 2008, CELL MICROBIOL, V10, P277, DOI 10.1111/j.1462-5822.2007.01077.x; KAMPFENKEL K, 1995, J BIOL CHEM, V270, P28479, DOI 10.1074/jbc.270.47.28479; KWONCHUNG KJ, 1982, J BACTERIOL, V150, P1414, DOI 10.1128/JB.150.3.1414-1421.1982; KWONCHUNG KJ, 1986, INFECT IMMUN, V51, P218, DOI 10.1128/IAI.51.1.218-223.1986; LEVITZ SM, 1989, J IMMUNOL, V142, P659; Lin XR, 2006, PLOS GENET, V2, P1801, DOI 10.1371/journal.pgen.0020187; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Lohse MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001473; McClelland CA, 2005, FUNGAL GENET BIOL, V42, P904, DOI 10.1016/j.fgb.2005.07.003; MELCHERS LS, 1989, MOL MICROBIOL, V3, P969, DOI 10.1111/j.1365-2958.1989.tb00246.x; MONGA DP, 1981, INFECT IMMUN, V32, P975, DOI 10.1128/IAI.32.3.975-978.1981; Noverr MC, 2004, INFECT IMMUN, V72, P1693, DOI 10.1128/IAI.72.3.1693-1699.2004; Nyhus KJ, 1999, INFECT IMMUN, V67, P2357, DOI 10.1128/IAI.67.5.2357-2365.1999; O'Meara TR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000776; Osterholzer JJ, 2009, INFECT IMMUN, V77, P3749, DOI 10.1128/IAI.00454-09; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; PAROD RJ, 1983, AM J PHYSIOL, V245, pC220, DOI 10.1152/ajpcell.1983.245.3.C220; Penas MM, 2005, MOL GENET GENOMICS, V274, P402, DOI 10.1007/s00438-005-0033-4; Portnoy ME, 2001, MOL GENET GENOMICS, V265, P873, DOI 10.1007/s004380100482; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Szczypka MS, 1997, YEAST, V13, P1423, DOI 10.1002/(SICI)1097-0061(199712)13:15<1423::AID-YEA190>3.3.CO;2-3; Tejle K, 2002, BIOSCIENCE REP, V22, P529, DOI 10.1023/A:1022025903688; Waterman SR, 2007, J CLIN INVEST, V117, P794, DOI 10.1172/JCI30006; Yoneda A, 2006, MOL BIOL CELL, V17, P5131, DOI 10.1091/mbc.E06-08-0701; Zaragoza O, 2003, EUR J IMMUNOL, V33, P1957, DOI 10.1002/eji.200323848; Zaragoza Oscar, 2004, Biol Proced Online, V6, P10, DOI 10.1251/bpo68	37	39	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12503	10.1371/journal.pone.0012503	http://dx.doi.org/10.1371/journal.pone.0012503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824073	Green Published, gold, Green Submitted			2022-12-27	WOS:000281480900003
J	Uttl, B; Kisinger, K				Uttl, Bob; Kisinger, Kelly			Meaning of Missing Values in Eyewitness Recall and Accident Records	PLOS ONE			English	Article							PSYCHOLOGY	Background: Eyewitness recalls and accident records frequently do not mention the conditions and behaviors of interest to researchers and lead to missing values and to uncertainty about the prevalence of these conditions and behaviors surrounding accidents. Missing values may occur because eyewitnesses report the presence but not the absence of obvious clues/accident features. We examined this possibility. Methodology/Principal Findings: Participants watched car accident videos and were asked to recall as much information as they could remember about each accident. The results showed that eyewitnesses were far more likely to report the presence of present obvious clues than the absence of absent obvious clues even though they were aware of their absence. Conclusions: One of the principal mechanisms causing missing values may be eyewitnesses' tendency to not report the absence of obvious features. We discuss the implications of our findings for both retrospective and prospective analyses of accident records, and illustrate the consequences of adopting inappropriate assumptions about the meaning of missing values using the Avaluator Avalanche Accident Prevention Card.	[Uttl, Bob] Mt Royal Univ, Calgary, AB, Canada; [Kisinger, Kelly] Univ Calgary, Calgary, AB, Canada	Mount Royal University; University of Calgary	Uttl, B (corresponding author), Mt Royal Univ, Calgary, AB, Canada.	uttlbob@gmail.com						Baddeley A., 1997, HUMAN MEMORY THEORY; Bunn TL, 2008, ACCIDENT ANAL PREV, V40, P419, DOI 10.1016/j.aap.2007.07.010; Cooper H, 2008, AM PSYCHOL, V63, P839, DOI 10.1037/0003-066X.63.9.839; FLOYER J, 2008, REV OBVIOUS CLUE MET, P39; Haegeli P., 2006, P INT SNOW SCI WORKS, P1; LINDSAY RCL, 1994, LAW HUMAN BEHAV, V18, P527, DOI 10.1007/BF01499172; Little R. J. A., 1987, STAT ANAL MISSING DA; LITTLE RJA, 1989, SOCIOL METHOD RES, V18, P292, DOI 10.1177/0049124189018002004; McCammon I., 2004, AVALANCHE NEWS, V68, P42; McCammon I, 2006, AVALUATOR AVALANCHE; McCammon I., 2002, P INT SNOW SCI WORKS, P1; MCCAMMON I, 2006, P INT SNOW SCI WORKS, P1; McCammon I, 2007, COLD REG SCI TECHNOL, V47, P193, DOI 10.1016/j.coldregions.2006.08.007; McKnight P. E., 2007, MISSING DATA GENTLE; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; SCHMIDT SR, 1991, MEM COGNITION, V19, P523, DOI 10.3758/BF03197149; UTTL B, 2008, P INT SNOW SCI WORKS, P445; UTTL B, 2006, MEMORY EMOTION, P159; UTTL B, 2008, P INT SNOW SCI WORKS, P538, DOI DOI 10.1016/J.SSRESEARCH.2009.03.004; Uttl B, 2009, ISSW 09 EUROPE: INTERNATIONAL SNOW SCIENCE WORKSHOP, PROCEEDINGS, P619; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594; 2006, AST NEWS, V2, P1	22	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12539	10.1371/journal.pone.0012539	http://dx.doi.org/10.1371/journal.pone.0012539			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	645RB	20824054	Green Submitted, gold, Green Published			2022-12-27	WOS:000281480900021
J	Wu, LC; Chen, HH; Horng, JT; Lin, C; Huang, NE; Cheng, YC; Cheng, KF				Wu, Li-Ching; Chen, Hsin-Hao; Horng, Jorng-Tzong; Lin, Chen; Huang, Norden E.; Cheng, Yu-Che; Cheng, Kuang-Fu			A Novel Preprocessing Method Using Hilbert Huang Transform for MALDI-TOF and SELDI-TOF Mass Spectrometry Data	PLOS ONE			English	Article							WAVELET TRANSFORM; TIME-SERIES; SPECTRA; SERUM; CLASSIFICATION	Motivation: Mass spectrometry is a high throughput, fast, and accurate method of protein analysis. Using the peaks detected in spectra, we can compare a normal group with a disease group. However, the spectrum is complicated by scale shifting and is also full of noise. Such shifting makes the spectra non-stationary and need to align before comparison. Consequently, the preprocessing of the mass data plays an important role during the analysis process. Noises in mass spectrometry data come in lots of different aspects and frequencies. A powerful data preprocessing method is needed for removing large amount of noises in mass spectrometry data. Results: Hilbert-Huang Transformation is a non-stationary transformation used in signal processing. We provide a novel algorithm for preprocessing that can deal with MALDI and SELDI spectra. We use the Hilbert-Huang Transformation to decompose the spectrum and filter-out the very high frequencies and very low frequencies signal. We think the noise in mass spectrometry comes from many sources and some of the noises can be removed by analysis of signal frequence domain. Since the protein in the spectrum is expected to be a unique peak, its frequence domain should be in the middle part of frequence domain and will not be removed. The results show that HHT, when used for preprocessing, is generally better than other preprocessing methods. The approach not only is able to detect peaks successfully, but HHT has the advantage of denoising spectra efficiently, especially when the data is complex. The drawback of HHT is that this approach takes much longer for the processing than the wavlet and traditional methods. However, the processing time is still manageable and is worth the wait to obtain high quality data.	[Wu, Li-Ching; Chen, Hsin-Hao; Horng, Jorng-Tzong; Lin, Chen; Huang, Norden E.] Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Jhongli, Taiwan; [Wu, Li-Ching] Natl Cent Univ, Res Ctr Biotechnol & Biomed Engn, Jhongli, Taiwan; [Horng, Jorng-Tzong] Natl Cent Univ, Dept Comp Sci & Informat Engn, Jhongli, Taiwan; [Horng, Jorng-Tzong] Asia Univ, Dept Bioinformat, Wu Feng, Taiwan; [Huang, Norden E.] Natl Cent Univ, Res Ctr Adapt Data Anal, Jhongli, Taiwan; [Cheng, Yu-Che] Cathay Gen Hosp, Cathay Med Res Inst, Prote Lab, Xizhi, Taiwan; [Cheng, Kuang-Fu] Natl Cent Univ, Grad Inst Stat, Jhongli, Taiwan; [Cheng, Kuang-Fu] China Med Univ, Grad Inst Stat, Taichung, Taiwan	National Central University; National Central University; National Central University; Asia University Taiwan; National Central University; Cathay General Hospital; National Central University; China Medical University Taiwan	Wu, LC (corresponding author), Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Jhongli, Taiwan.	richard@mail.sybbi.ncu.edu.tw		Lin, Chen/0000-0001-6261-8509	Cathay General Hospital; National Central University [97CGH-NCU-A1]; National Science Council [98-2627-M-008-003]	Cathay General Hospital; National Central University; National Science Council(Ministry of Science and Technology, Taiwan)	This project is supported by the Cathay General Hospital (www.cgh.org.tw) and National Central University (www.ncu.edu.tw) Collabaration Project number 97CGH-NCU-A1 and National Science Council Project number 98-2627-M-008-003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyer S, 2006, J PROTEOME RES, V5, P254, DOI 10.1021/pr050279o; Cho William C. S., 2007, Genomics Proteomics & Bioinformatics, V5, P77, DOI 10.1016/S1672-0229(07)60018-7; Cho WCS, 2007, EXPERT REV PROTEOMIC, V4, P401, DOI 10.1586/14789450.4.3.401; Coombes KR, 2005, NAT BIOTECHNOL, V23, P291, DOI 10.1038/nbt0305-291; Cruz-Marcelo A, 2008, BIOINFORMATICS, V24, P2129, DOI 10.1093/bioinformatics/btn398; DIMAGNO EP, 1989, MAYO CLIN PROC, V64, P1226, DOI 10.1016/S0025-6196(12)61285-3; Du P, 2006, BIOINFORMATICS, V22, P2059, DOI 10.1093/bioinformatics/btl355; FUNG ET, 2002, BIOTECHNIQUES S, V34, P40; Ge GT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-275; Hilario M, 2006, MASS SPECTROM REV, V25, P409, DOI 10.1002/mas.20072; Hussong R, 2009, BIOINFORMATICS, V25, P1937, DOI 10.1093/bioinformatics/btp294; Kwon D, 2008, PROTEOMICS, V8, P3019, DOI 10.1002/pmic.200701010; LIXEA, 2005, BIOINFORMATICS COMPU, P99; Malyarenko DI, 2005, CLIN CHEM, V51, P65, DOI 10.1373/clinchem.2004.037283; Mantini D, 2010, J PROTEOMICS, V73, P562, DOI 10.1016/j.jprot.2009.11.004; Meuleman W, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-88; Morris JS, 2005, BIOINFORMATICS, V21, P1764, DOI 10.1093/bioinformatics/bti254; Qu YS, 2003, BIOMETRICS, V59, P143, DOI 10.1111/1541-0420.00017; Randolph TW, 2006, BIOMETRICS, V62, P589, DOI 10.1111/j.1541-0420.2005.00504.x; Salmi J, 2009, PROTEOMICS, V9, P848, DOI 10.1002/pmic.200800517; Shin HJ, 2006, J BIOMED INFORM, V39, P227, DOI 10.1016/j.jbi.2005.04.002; Wong JWH, 2005, BIOINFORMATICS, V21, P2088, DOI 10.1093/bioinformatics/bti300; Wu ZH, 2007, P NATL ACAD SCI USA, V104, P14889, DOI 10.1073/pnas.0701020104	23	13	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12493	10.1371/journal.pone.0012493	http://dx.doi.org/10.1371/journal.pone.0012493			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824164	Green Published, Green Submitted, gold			2022-12-27	WOS:000281405300018
J	Blarquez, O; Carcaillet, C				Blarquez, Olivier; Carcaillet, Christopher			Fire, Fuel Composition and Resilience Threshold in Subalpine Ecosystem	PLOS ONE			English	Article							LAND-USE CHANGE; CLIMATE-CHANGE; SPATIAL VARIABILITY; LANDSCAPE DYNAMICS; LARIX-DECIDUA; SURFACE FIRES; FOREST; VEGETATION; HISTORY; DISTURBANCES	Background: Forecasting the effects of global changes on high altitude ecosystems requires an understanding of the long-term relationships between biota and forcing factors to identify resilience thresholds. Fire is a crucial forcing factor: both fuel build-up from land-abandonment in European mountains, and more droughts linked to global warming are likely to increase fire risks. Methods: To assess the vegetation response to fire on a millennium time-scale, we analyzed evidence of stand-to-local vegetation dynamics derived from sedimentary plant macroremains from two subalpine lakes. Paleobotanical reconstructions at high temporal resolution, together with a fire frequency reconstruction inferred from sedimentary charcoal, were analyzed by Superposed Epoch Analysis to model plant behavior before, during and after fire events. Principal Findings: We show that fuel build-up from arolla pine (Pinus cembra) always precedes fires, which is immediately followed by a rapid increase of birch (Betula sp.), then by ericaceous species after 25-75 years, and by herbs after 50-100 years. European larch (Larix decidua), which is the natural co-dominant species of subalpine forests with Pinus cembra, is not sensitive to fire, while the abundance of Pinus cembra is altered within a 150-year period after fires. A long-term trend in vegetation dynamics is apparent, wherein species that abound later in succession are the functional drivers, loading the environment with fuel for fires. This system can only be functional if fires are mainly driven by external factors (e. g. climate), with the mean interval between fires being longer than the minimum time required to reach the late successional stage, here 150 years. Conclusion: Current global warming conditions which increase drought occurrences, combined with the abandonment of land in European mountain areas, creates ideal ecological conditions for the ignition and the spread of fire. A fire return interval of less than 150 years would threaten the dominant species and might override the resilience of subalpine forests.	[Blarquez, Olivier; Carcaillet, Christopher] Ecole Prat Hautes Etud, Montpellier, France; [Blarquez, Olivier; Carcaillet, Christopher] Univ Montpellier 2, CNRS, Ctr Bioarchaeol & Ecol, Montpellier, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Blarquez, O (corresponding author), Ecole Prat Hautes Etud, Montpellier, France.	olivier.blarquez@univ-montp2.fr	Carcaillet, Christopher/G-1218-2011	Carcaillet, Christopher/0000-0002-6632-1507	ANR/ERA-net BiodivERsA; ARTEMIS; Ecole Pratique des Hautes Etudes (EPHE-Paris); INSU	ANR/ERA-net BiodivERsA(French National Research Agency (ANR)); ARTEMIS(European Commission); Ecole Pratique des Hautes Etudes (EPHE-Paris); INSU(Centre National de la Recherche Scientifique (CNRS))	Financial support was provided by the FIREMAN program (ANR/ERA-net BiodivERsA) and the PALEO-FIRE program (ARTEMIS, INSU) to CC and by grants from the Ecole Pratique des Hautes Etudes (EPHE-Paris) to OB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JB, 2003, NATURE, V426, P274, DOI 10.1038/nature02101; Albert CH, 2008, J APPL ECOL, V45, P659, DOI 10.1111/j.1365-2664.2007.01416.x; Birks HH, 2000, J BIOGEOGR, V27, P31, DOI 10.1046/j.1365-2699.2000.00375.x; BLARQUEZ O, 2010, J ECOLOGY IN PRESS; Blarquez O, 2010, HOLOCENE, V20, P139, DOI 10.1177/0959683609348857; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Brown PM, 2005, ECOLOGY, V86, P3030, DOI 10.1890/05-0034; Caplat P, 2009, J ECOL, V97, P1028, DOI 10.1111/j.1365-2745.2009.01541.x; Carcaillet C, 2009, ECOSCIENCE, V16, P1, DOI 10.2980/16-1-3189; Chauchard S, 2010, FOREST ECOL MANAG, V259, P1406, DOI 10.1016/j.foreco.2010.01.009; CLARK JS, 1990, ECOL MONOGR, V60, P135, DOI 10.2307/1943042; Cleveland R.B., 1990, J OFF STAT, V6, P3; Derose RJ, 2009, ECOSCIENCE, V16, P28, DOI 10.2980/16-1-3160; Dirnbock T, 2003, J BIOGEOGR, V30, P401, DOI 10.1046/j.1365-2699.2003.00839.x; Egler FE, 1954, VEGETATIO ACTA GEOBO, V4, P412, DOI DOI 10.1007/BF00275587; Gavin DG, 2006, ECOLOGY, V87, P1722, DOI 10.1890/0012-9658(2006)87[1722:WCCOSF]2.0.CO;2; Genries A, 2009, ECOLOGY, V90, P476, DOI 10.1890/07-1740.1; Genries A, 2009, ECOSCIENCE, V16, P13, DOI 10.2980/16-1-3180; Genries A, 2009, J ECOL, V97, P728, DOI 10.1111/j.1365-2745.2009.01518.x; Germain D, 2005, CAN J EARTH SCI, V42, P2103, DOI 10.1139/E05-087; Grissino-Mayer HD, 1995, THESIS; HELY C, 2010, GEOPHYS RES IN PRESS; Higuera PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001744; Higuera PE, 2009, ECOL MONOGR, V79, P201, DOI 10.1890/07-2019.1; Hood SM, 2007, INT J WILDLAND FIRE, V16, P679, DOI 10.1071/WF06122; Johnson EA., 2007, PLANT DISTURBANCE EC; Kipfmueller KF, 2000, US FOR SERV RMRS-P, V5, P270; Marozas V, 2007, FOREST ECOL MANAG, V250, P47, DOI 10.1016/j.foreco.2007.03.008; Mooney CZ, 1993, BOOTSTRAPPING NONPAR, DOI DOI 10.4135/9781412983532; Motta R, 2005, CAN J FOREST RES, V35, P1809, DOI 10.1139/x05-107; Motta R, 2009, ECOSCIENCE, V16, pIV, DOI 10.1080/11956860.2009.11649160; Pal JS, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019836; Prichard SJ, 2009, QUATERNARY RES, V72, P57, DOI 10.1016/j.yqres.2009.03.008; ROMME WH, 1982, ECOL MONOGR, V52, P199, DOI 10.2307/1942611; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schimmel J, 1996, ECOLOGY, V77, P1436, DOI 10.2307/2265541; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; Schulze ED, 2007, FLORA, V202, P705, DOI 10.1016/j.flora.2007.05.003; Schulze ED, 2005, OECOLOGIA, V146, P77, DOI 10.1007/s00442-005-0173-6; Schumacher S, 2006, GLOBAL CHANGE BIOL, V12, P1435, DOI 10.1111/j.1365-2486.2006.01188.x; Shang BZ, 2004, ECOL MODEL, V180, P89, DOI 10.1016/j.ecolmodel.2004.01.020; Sheffield J, 2008, CLIM DYNAM, V31, P79, DOI 10.1007/s00382-007-0340-z; SWETNAM TW, 1993, SCIENCE, V262, P885, DOI 10.1126/science.262.5135.885; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Trouet V, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041695; TURNER MG, 1994, LANDSCAPE ECOL, V9, P59, DOI 10.1007/BF00135079; VEBLEN TT, 1994, J ECOL, V82, P125, DOI 10.2307/2261392; Wang GG, 2005, CAN J FOREST RES, V35, P254, DOI [10.1139/x04-177, 10.1139/X04-177]; Wardle DA, 2004, SCIENCE, V305, P509, DOI 10.1126/science.1098778; White P.S., 1985, ECOLOGY NATURAL DIST; Zumbrunnen T, 2009, ECOSYSTEMS, V12, P73, DOI 10.1007/s10021-008-9207-3	51	44	46	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12480	10.1371/journal.pone.0012480	http://dx.doi.org/10.1371/journal.pone.0012480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20814580	Green Submitted, gold, Green Published			2022-12-27	WOS:000281375500013
J	Hurtado, CW; Golden-Mason, L; Brocato, M; Krull, M; Narkewicz, MR; Rosen, HR				Hurtado, Christine Waasdorp; Golden-Mason, Lucy; Brocato, Megan; Krull, Mona; Narkewicz, Michael R.; Rosen, Hugo R.			Innate Immune Function in Placenta and Cord Blood of Hepatitis C - Seropositive Mother-Infant Dyads	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; PLASMACYTOID DENDRITIC CELLS; TO-CHILD TRANSMISSION; VIRUS-INFECTION; PERIPHERAL-BLOOD; SURFACE EXPRESSION; NKT CELLS; ALPHA; SUBSET; CYTOTOXICITY	Vertical transmission accounts for the majority of pediatric cases of hepatitis C viral (HCV) infection. In contrast to the adult population who develop persistent viremia in similar to 80% of cases following exposure, the rate of mother-to-child transmission (2-6%) is strikingly low. Protection from vertical transmission likely requires the coordination of multiple components of the immune system. Placenta and decidua provide a direct connection between mother and infant. We hypothesized that innate immune responses would differ across the three compartments (decidua, placenta and cord blood) and that hepatitis C exposure would modify innate immunity in these tissues. The study was comprised of HCV-infected and healthy control mother and infant pairs from whom cord blood, placenta and decidua were collected with isolation of mononuclear cells. Multiparameter flow cytometry was performed to assess the phenotype, intracellular cytokine production and cytotoxicity of the cells. In keeping with a model where the maternal-fetal interface provides antiviral protection, we found a gradient in proportional frequencies of NKT and gamma delta-T cells being higher in placenta than cord blood. Cytotoxicity of NK and NKT cells was enhanced in placenta and placental NKT cytotoxicity was further increased by HCV infection. HCV exposure had multiple effects on innate cells including a decrease in activation markers (CD69, TRAIL and NKp44) on NK cells and a decrease in plasmacytoid dendritic cells in both placenta and cord blood of exposed infants. In summary, the placenta represents an active innate immunological organ that provides antiviral protection against HCV transmission in the majority of cases; the increased incidence in preterm labor previously described in HCV-seropositive mothers may be related to enhanced cytotoxicity of NKT cells.	[Hurtado, Christine Waasdorp; Narkewicz, Michael R.] Univ Colorado, Sch Med, Dept Pediat Digest Hlth Inst, Sect Pediat Gastroenterol Hepatol & Nutr, Aurora, CO USA; [Golden-Mason, Lucy; Brocato, Megan; Rosen, Hugo R.] Univ Colorado, Sch Med, Div Gastroenterol & Hepatol, Aurora, CO USA; [Golden-Mason, Lucy; Rosen, Hugo R.] Univ Colorado, Integrated Program Immunol, Denver, CO 80202 USA; [Golden-Mason, Lucy; Rosen, Hugo R.] Natl Jewish Hosp, Denver, CO USA; [Krull, Mona] Denver Hlth Med Ctr, Dept Obstet & Gynecol, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Denver; National Jewish Health; Denver Health Medical Center	Hurtado, CW (corresponding author), Univ Colorado, Sch Med, Dept Pediat Digest Hlth Inst, Sect Pediat Gastroenterol Hepatol & Nutr, Aurora, CO USA.	Hugo.Rosen@ucdenver.edu		Golden-Mason, Lucy/0000-0002-2087-4405; Golden-Mason, Lucy/0000-0003-3347-4192	Colorado Center for AIDS Research [P30 AI054907]; NIDDK NIH [T32 DK607009-04]; HCV center [U19 A 1066328-05, RO1 DK060590]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI054907, K24AI083742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060590] Funding Source: NIH RePORTER	Colorado Center for AIDS Research; NIDDK NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); HCV center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	P30 AI054907 Colorado Center for AIDS Research grant (http://www.uchsc.edu/ccfar); NIDDK NIH T32 DK607009-04 (http://www2.niddk.nih.gov/Funding/Grants); U19 A 1066328-05 (HCV center grant) (www.nih.gov) and RO1 DK060590 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2010, GASTROENTEROLOGY, V138, P325, DOI 10.1053/j.gastro.2009.08.066; Airoldi J, 2006, OBSTET GYNECOL SURV, V61, P666, DOI 10.1097/01.ogx.0000238671.13495.33; Aldebert D, 2007, J REPROD IMMUNOL, V73, P11, DOI 10.1016/j.jri.2006.05.002; BANCROFT GJ, 1993, CURR OPIN IMMUNOL, V5, P503, DOI 10.1016/0952-7915(93)90030-V; Boyson JE, 2002, P NATL ACAD SCI USA, V99, P13741, DOI 10.1073/pnas.162491699; Canto E, 2005, TRANSPLANTATION, V80, P850, DOI 10.1097/01.TP.0000174135.32068.65; Capparelli E, 2005, SEMIN FETAL NEONAT M, V10, P161, DOI 10.1016/j.siny.2004.10.001; Cohen SBA, 1999, HUM IMMUNOL, V60, P331, DOI 10.1016/S0198-8859(98)00126-8; Collins MK, 2009, J CLIN INVEST, V119, P2062, DOI 10.1172/JCI38714; Deignan T, 2002, J HEPATOL, V37, P101, DOI 10.1016/S0168-8278(02)00072-7; DITZIANKADANOFF R, 1993, AM J OBSTET GYNECOL, V168, P831, DOI 10.1016/S0002-9378(12)90829-7; Doherty DG, 2000, IMMUNOL REV, V174, P5, DOI 10.1034/j.1600-0528.2002.017416.x; Dolganiuc A, 2006, J IMMUNOL, V177, P6758, DOI 10.4049/jimmunol.177.10.6758; El Costa H, 2009, J REPROD IMMUNOL, V82, P142, DOI 10.1016/j.jri.2009.06.123; Exley M, 1997, J EXP MED, V186, P109, DOI 10.1084/jem.186.1.109; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Fischler B, 2007, SEMIN FETAL NEONAT M, V12, P168, DOI 10.1016/j.siny.2007.01.008; Fox A, 2010, J REPROD IMMUNOL, V84, P52, DOI 10.1016/j.jri.2009.10.003; Golden-Mason L, 2008, GUT, V57, P1121, DOI 10.1136/gut.2007.130963; Golden-Mason L, 2006, LIVER TRANSPLANT, V12, P363, DOI 10.1002/lt.20708; Golden-Mason L, 2007, J VIROL, V81, P9292, DOI 10.1128/JVI.00834-07; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Golden-Mason L, 2009, LIVER TRANSPLANT, V15, P357, DOI 10.1002/lt.21701; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Hayashida A, 2007, J OBSTET GYNAECOL RE, V33, P417, DOI 10.1111/j.1447-0756.2007.00582.x; Huang YC, 2008, J LEUKOCYTE BIOL, V84, P1501, DOI 10.1189/jlb.0408255; Iorio R, 2005, CLIN INFECT DIS, V41, P1431, DOI 10.1086/497141; Jonas MM, 2002, HEPATOLOGY, V36, pS173, DOI 10.1053/jhep.2002.36799; Kanto T, 2004, J INFECT DIS, V190, P1919, DOI 10.1086/425425; Kanto T, 2007, HEPATOL RES, V37, pS319, DOI 10.1111/j.1872-034X.2007.00236.x; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Le Bouteiller P, 2008, AM J REPROD IMMUNOL, V59, P401, DOI 10.1111/j.1600-0897.2008.00597.x; Le Bouteiller P, 2006, NAT MED, V12, P991, DOI 10.1038/nm0906-991; McIntyre J, 2006, CURR OPIN INFECT DIS, V19, P33, DOI 10.1097/01.qco.0000200290.99790.72; Meier UC, 2005, J VIROL, V79, P12365, DOI 10.1128/JVI.79.19.12365-12374.2005; Mengshol JA, 2009, GUT, V58, P964, DOI 10.1136/gut.2008.168948; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Nattermann J, 2006, GUT, V55, P869, DOI 10.1136/gut.2005.076463; Nomura A, 2001, EXP HEMATOL, V29, P1169, DOI 10.1016/S0301-472X(01)00689-0; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Pereira L, 2005, TRENDS MICROBIOL, V13, P164, DOI 10.1016/j.tim.2005.02.009; Saito K, 2008, J VIROL, V82, P3320, DOI 10.1128/JVI.02547-07; Santoni A, 2007, AM J REPROD IMMUNOL, V58, P280, DOI 10.1111/j.1600-0897.2007.00513.x; Selin LK, 2001, J IMMUNOL, V166, P6784, DOI 10.4049/jimmunol.166.11.6784; SIMMS J, 1993, SEMIN PERINATOL, V17, P384; Smyk-Pearson S, 2008, J INFECT DIS, V197, P46, DOI 10.1086/523651; Szekeres-Bartho J, 2001, SEMIN IMMUNOL, V13, P229, DOI 10.1006/smim.2000.0318; Tabiasco J, 2006, PLACENTA, V27, pS34, DOI 10.1016/j.placenta.2006.01.009; Tsuda H, 2001, AM J REPROD IMMUNOL, V45, P295, DOI 10.1111/j.8755-8920.2001.450505.x; Wang T, 2006, J IMMUNOL, V177, P1825, DOI 10.4049/jimmunol.177.3.1825; Wilczynski JR, 2003, EUR J OBSTET GYN R B, V109, P8, DOI 10.1016/S0301-2115(02)00350-0; Yonkers NL, 2007, J IMMUNOL, V178, P4436, DOI 10.4049/jimmunol.178.7.4436; Zamai L, 1998, J EXP MED, V188, P2375, DOI 10.1084/jem.188.12.2375; Zanetti AR, 1999, J HEPATOL, V31, P96, DOI 10.1016/S0168-8278(99)80383-3	55	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12232	10.1371/journal.pone.0012232	http://dx.doi.org/10.1371/journal.pone.0012232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20814429	gold, Green Submitted, Green Published			2022-12-27	WOS:000281375500001
J	Abdul-Nabi, AM; Yassin, ER; Varghese, N; Deshmukh, H; Yaseen, NR				Abdul-Nabi, Anmaar M.; Yassin, Enas R.; Varghese, Nobish; Deshmukh, Hrishikesh; Yaseen, Nabeel R.			In Vitro Transformation of Primary Human CD34+Cells by AML Fusion Oncogenes: Early Gene Expression Profiling Reveals Possible Drug Target in AML	PLOS ONE			English	Article							ACUTE-MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; HUMAN CD34(+) CELLS; ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; TUMOR-SUPPRESSOR; MALIGNANT HEMATOPOIESIS; MLL REARRANGEMENT; AML1-ETO	Different fusion oncogenes in acute myeloid leukemia (AML) have distinct clinical and laboratory features suggesting different modes of malignant transformation. Here we compare the in vitro effects of representatives of 4 major groups of AML fusion oncogenes on primary human CD34+ cells. As expected from their clinical similarities, MLL-AF9 and NUP98-HOXA9 had very similar effects in vitro. They both caused erythroid hyperplasia and a clear block in erythroid and myeloid maturation. On the other hand, AML1-ETO and PML-RARA had only modest effects on myeloid and erythroid differentiation. All oncogenes except PML-RARA caused a dramatic increase in long-term proliferation and self-renewal. Gene expression profiling revealed two distinct temporal patterns of gene deregulation. Gene deregulation by MLL-AF9 and NUP98-HOXA9 peaked 3 days after transduction. In contrast, the vast majority of gene deregulation by AML1-ETO and PML-RARA occurred within 6 hours, followed by a dramatic drop in the numbers of deregulated genes. Interestingly, the p53 inhibitor MDM2 was upregulated by AML1-ETO at 6 hours. Nutlin-3, an inhibitor of the interaction between MDM2 and p53, specifically inhibited the proliferation and self-renewal of primary human CD34+ cells transduced with AML1-ETO, suggesting that MDM2 upregulation plays a role in cell transformation by AML1-ETO. These data show that differences among AML fusion oncogenes can be recapitulated in vitro using primary human CD34+ cells and that early gene expression profiling in these cells can reveal potential drug targets in AML.	[Abdul-Nabi, Anmaar M.; Yassin, Enas R.; Varghese, Nobish; Deshmukh, Hrishikesh; Yaseen, Nabeel R.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL)	Abdul-Nabi, AM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	nyaseen@wustl.edu		Yaseen, Nabeel/0000-0001-6902-5116	NIH [R01HL082549, K02HL084179, T32CA009547]; NCI Cancer Center [P30CA91842]; NATIONAL CANCER INSTITUTE [P30CA091842, T32CA009547] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL084179, R01HL082549] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants R01HL082549 and K02HL084179 (N.R. Yaseen), and T32CA009547 (A.M. Abdul-Nabi). The Siteman Cancer Center is supported in part by an NCI Cancer Center Support Grant #P30CA91842. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banker DE, 1998, CLIN CANCER RES, V4, P3051; Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Baum B, 2008, SEMIN CELL DEV BIOL, V19, P294, DOI 10.1016/j.semcdb.2008.02.001; Brunning RD, 2008, WHO CLASSIFICATION T, P87; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Chi YQ, 2008, ARCH PATHOL LAB MED, V132, P1835, DOI 10.1043/1543-2165-132.11.1835; Choi YJ, 2006, CANCER RES, V66, P2990, DOI 10.1158/0008-5472.CAN-05-2944; CHOU WC, 2009, ACUTE MYELOID LEUKEM; Chung KY, 2006, CANCER RES, V66, P11781, DOI 10.1158/0008-5472.CAN-06-0706; Debernardi S, 2003, GENE CHROMOSOME CANC, V37, P149, DOI 10.1002/gcc.10198; Drabkin H, 2002, LEUKEMIA, V16, P186, DOI 10.1038/sj.leu.2402354; Eklund EA, 2007, CURR OPIN HEMATOL, V14, P85, DOI 10.1097/MOH.0b013e32801684b6; Elagib KE, 2007, CANCER LETT, V251, P179, DOI 10.1016/j.canlet.2006.10.010; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; Grignani F, 2000, BLOOD, V96, P1531, DOI 10.1182/blood.V96.4.1531.h8001531_1531_1537; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Haferlach T, 2005, BLOOD, V106, P1189, DOI 10.1182/blood-2004-12-4938; Isufi I, 2007, J INTERF CYTOK RES, V27, P543, DOI 10.1089/jir.2007.0009; Kojima K, 2005, BLOOD, V106, P3150, DOI 10.1182/blood-2005-02-0553; Krejci O, 2008, BLOOD, V111, P2190, DOI 10.1182/blood-2007-06-093682; Krug U, 2002, ONCOGENE, V21, P3475, DOI 10.1038/sj.onc.1205322; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lam DH, 2001, LEUKEMIA, V15, P1689, DOI 10.1038/sj.leu.2402269; Lee S, 2006, P NATL ACAD SCI USA, V103, P1030, DOI 10.1073/pnas.0509878103; Li ZJ, 2009, CANCER RES, V69, P1109, DOI 10.1158/0008-5472.CAN-08-3381; Lin HK, 2005, ONCOGENE, V24, P5693, DOI 10.1038/sj.onc.1208923; Linggi B, 2002, NAT MED, V8, P743, DOI 10.1038/nm726; Long JT, 2010, BLOOD, V116, P71, DOI 10.1182/blood-2010-01-261628; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; McCormack E, 2008, ONCOGENE, V27, P3765, DOI 10.1038/onc.2008.16; MEYER C, 2009, NEW INSIGHTS MLL REC; Mikesch JH, 2007, LEUKEMIA, V21, P1638, DOI 10.1038/sj.leu.2404732; Moll UM, 2003, MOL CANCER RES, V1, P1001; Mulloy JC, 2005, P NATL ACAD SCI USA, V102, P4016, DOI 10.1073/pnas.0404701102; Mulloy JC, 2002, BLOOD, V99, P15, DOI 10.1182/blood.V99.1.15; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Romana SP, 2006, LEUKEMIA, V20, P696, DOI 10.1038/sj.leu.2404130; Rowley JD, 2002, GENE CHROMOSOME CANC, V33, P331, DOI 10.1002/gcc.10040; Schoch C, 2003, BLOOD, V102, P2395, DOI 10.1182/blood-2003-02-0434; Schoch C, 2002, P NATL ACAD SCI USA, V99, P10008, DOI 10.1073/pnas.142103599; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Shih LY, 2006, LEUKEMIA, V20, P218, DOI 10.1038/sj.leu.2404024; Slany RK, 2009, HAEMATOL-HEMATOL J, V94, P984, DOI 10.3324/haematol.2008.002436; SUTHERLAND HJ, 1990, P NATL ACAD SCI USA, V87, P3584, DOI 10.1073/pnas.87.9.3584; Takeda A, 2006, CANCER RES, V66, P6628, DOI 10.1158/0008-5472.CAN-06-0458; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tonks A, 2004, LEUKEMIA, V18, P1238, DOI 10.1038/sj.leu.2403396; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Van Vlierberghe P, 2008, BLOOD, V111, P4668, DOI 10.1182/blood-2007-09-111872; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vitoux D, 2007, INT J BIOCHEM CELL B, V39, P1063, DOI 10.1016/j.biocel.2007.01.028; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Westervelt P, 2003, BLOOD, V102, P1857, DOI 10.1182/blood-2002-12-3779; Wilson CS, 2006, BLOOD, V108, P685, DOI 10.1182/blood-2004-12-4633; Wunderlich M, 2006, BLOOD, V108, P1690, DOI 10.1182/blood-2005-12-012773; Wunderlich Mark, 2009, V538, P263, DOI 10.1007/978-1-59745-418-6_13; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	60	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12464	10.1371/journal.pone.0012464	http://dx.doi.org/10.1371/journal.pone.0012464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805992	Green Published, Green Submitted, gold			2022-12-27	WOS:000281301500028
J	Chaudhury, S; Igoshin, OA				Chaudhury, Srabanti; Igoshin, Oleg A.			Dynamic Disorder in Quasi-Equilibrium Enzymatic Systems	PLOS ONE			English	Article							SINGLE-MOLECULE KINETICS; PROTEIN	Conformations and catalytic rates of enzymes fluctuate over a wide range of timescales. Despite these fluctuations, there exist some limiting cases in which the enzymatic catalytic rate follows the macroscopic rate equation such as the Michaelis-Menten law. In this paper we investigate the applicability of macroscopic rate laws for fluctuating enzyme systems in which catalytic transitions are slower than ligand binding-dissociation reactions. In this quasi-equilibrium limit, for an arbitrary reaction scheme we show that the catalytic rate has the same dependence on ligand concentrations as obtained from mass-action kinetics even in the presence of slow conformational fluctuations. These results indicate that the timescale of conformational dynamics-no matter how slow-will not affect the enzymatic rate in quasi-equilibrium limit. Our numerical results for two enzyme-catalyzed reaction schemes involving multiple substrates and inhibitors further support our general theory.	[Chaudhury, Srabanti; Igoshin, Oleg A.] Rice Univ, Dept Bioengn, Houston, TX 77251 USA	Rice University	Chaudhury, S (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.	igoshin@rice.edu	Igoshin, Oleg/P-3937-2014	Igoshin, Oleg/0000-0002-1449-4772	Rice University; National Science Foundation [MCB-0920463]; Div Of Molecular and Cellular Bioscience [0920463] Funding Source: National Science Foundation	Rice University; National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The research is supported by a start-up fund from Rice University and partially supported by National Science Foundation award and MCB-0920463. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5627, DOI 10.1021/bi00670a031; BENNER SA, 1989, CHEM REV, V89, P789, DOI 10.1021/cr00094a004; Cao JS, 2000, CHEM PHYS LETT, V327, P38, DOI 10.1016/S0009-2614(00)00809-5; Chaudhury S, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2768059; Chaudhury S, 2009, J PHYS CHEM B, V113, P13421, DOI 10.1021/jp907908d; English BP, 2006, NAT CHEM BIOL, V2, P87, DOI 10.1038/nchembio759; FERSHT A, 1982, ENZYME STRUCTURE MEC; Garrett R.H., 2009, BIOCHEMISTRY; Hanson SM, 2008, J PHYS CHEM A, V112, P8654, DOI 10.1021/jp8026226; HEINEKEN F. G., 1967, MATH BIOSCI, V1, P95, DOI 10.1016/0025-5564(67)90029-6; Kou SC, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.180603; LAIDLER KJ, 1955, CAN J CHEM, V33, P1614, DOI 10.1139/v55-195; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Michaelis L, 1913, BIOCHEM Z, V49, P333; Min W, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198302; Min W, 2006, J PHYS CHEM B, V110, P20093, DOI 10.1021/jp065187g; Segel IH., 1993, ENZYME KINETICS BEHA; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Wang HY, 2003, J THEOR BIOL, V221, P491, DOI 10.1006/jtbi.2003.3200; Xing JH, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.168103; Xue X, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.030902; Yang H, 2003, SCIENCE, V302, P262, DOI 10.1126/science.1086911; Yang SL, 2002, J CHEM PHYS, V117, P10996, DOI 10.1063/1.1521155; ZWANZIG R, 1992, J CHEM PHYS, V97, P3587, DOI 10.1063/1.462993; ZWANZIG R, 1990, ACCOUNTS CHEM RES, V23, P148, DOI 10.1021/ar00173a005	25	4	5	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12364	10.1371/journal.pone.0012364	http://dx.doi.org/10.1371/journal.pone.0012364			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808776	gold, Green Submitted, Green Published			2022-12-27	WOS:000281154300007
J	Lussier, CR; Brial, F; Roy, SAB; Langlois, MJ; Verdu, EF; Rivard, N; Perreault, N; Boudreau, F				Lussier, Carine R.; Brial, Francois; Roy, Sebastien A. B.; Langlois, Marie-Josee; Verdu, Elena F.; Rivard, Nathalie; Perreault, Nathalie; Boudreau, Francois			Loss of Hepatocyte-Nuclear-Factor-1 alpha Impacts on Adult Mouse Intestinal Epithelial Cell Growth and Cell Lineages Differentiation	PLOS ONE			English	Article							HEPATOCYTE NUCLEAR FACTOR-1-ALPHA; STEM-CELLS; TUMOR SUPPRESSION; GENE; MICE; AUTOPHAGY; TRANSCRIPTION; CDX2; METABOLISM; COMMITMENT	Background and Aims: Although Hnf1 alpha is crucial for pancreas and liver functions, it is believed to play a limited functional role for intestinal epithelial functions. The aim of this study was to assess the consequences of abrogating Hnf1 alpha on the maintenance of adult small intestinal epithelial functions. Methodology/Principal Findings: An Hnf1 alpha knockout mouse model was used. Assessment of histological abnormalities, crypt epithelial cell proliferation, epithelial barrier, glucose transport and signalling pathways were measured in these animals. Changes in global gene expression were also analyzed. Mice lacking Hnf1 alpha displayed increased crypt proliferation and intestinalomegaly as well as a disturbance of intestinal epithelial cell lineages production during adult life. This phenotype was associated with a decrease of the mucosal barrier function and lumen-to-blood glucose delivery. The mammalian target of rapamycin (mTOR) signalling pathway was found to be overly activated in the small intestine of adult Hnf1a mutant mice. The intestinal epithelium of Hnf1 alpha null mice displayed a reduction of the enteroendocrine cell population. An impact was also observed on proper Paneth cell differentiation with abnormalities in the granule exocytosis pathway. Conclusions/Significance: Together, these results unravel a functional role for Hnf1 alpha in regulating adult intestinal growth and sustaining the functions of intestinal epithelial cell lineages.	[Lussier, Carine R.; Brial, Francois; Roy, Sebastien A. B.; Langlois, Marie-Josee; Rivard, Nathalie; Perreault, Nathalie; Boudreau, Francois] Univ Sherbrooke, Dept Anat & Biol Cellulaire, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada; [Verdu, Elena F.] McMaster Univ, Div Gastroenterol, Hamilton, ON, Canada	University of Sherbrooke; McMaster University	Lussier, CR (corresponding author), Univ Sherbrooke, Dept Anat & Biol Cellulaire, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada.	francois.boudreau@usherbrooke.ca	Brial, Francois/ABF-2794-2020	Brial, Francois/0000-0002-2418-1614	Canadian Institute of Health Research (CIHR) [MOP-89770]; FRSQ; Natural Sciences and Engineering Research Council of Canada (NSERC); McMaster University Department of Medicine	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); McMaster University Department of Medicine	This work was supported by the Canadian Institute of Health Research (CIHR) (MOP-89770 to F.B.). F.B. is a Senior scholar from the Fonds de la recherche en sante du Quebec (FRSQ). F.B., N.P. and N.R. are members of the FRSQ-funded Centre de Recherche Clinique Etienne-Le Bel. N.R. is a recipient of a Canadian Research Chair in Signaling and Digestive Physiopathology. C.R.L. is a recipient of a Natural Sciences and Engineering Research Council of Canada (NSERC) fellowship. E. Verdu holds a McMaster University Department of Medicine Internal Career Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babeu JP, 2009, AM J PHYSIOL-GASTR L, V297, pG124, DOI 10.1152/ajpgi.90690.2008; Bagnat M, 2007, NAT CELL BIOL, V9, P954, DOI 10.1038/ncb1621; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Battle MA, 2008, GASTROENTEROLOGY, V135, P1676, DOI 10.1053/j.gastro.2008.07.074; BAUMHUETER S, 1990, GENE DEV, V4, P372, DOI 10.1101/gad.4.3.372; BLUMENFELD M, 1991, DEVELOPMENT, V113, P589; Bosse T, 2006, AM J PHYSIOL-GASTR L, V290, pG1016, DOI 10.1152/ajpgi.00359.2005; BOSSE T, 2007, AM J PHYSL GASTROINT; Boudreau F, 2002, J BIOL CHEM, V277, P31909, DOI 10.1074/jbc.M204622200; Boudreau F., 2007, FASEB J; Boulanger J, 2005, J BIOL CHEM, V280, P18095, DOI 10.1074/jbc.M502184200; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; CHENG H, 1985, ANAT REC, V211, P420, DOI 10.1002/ar.1092110408; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; D'Angelo A, 2010, DEVELOPMENT, V137, P1573, DOI 10.1242/dev.044420; Darsigny M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007609; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Fujishita T, 2008, P NATL ACAD SCI USA, V105, P13544, DOI 10.1073/pnas.0800041105; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Gautier-Stein A, 2006, J BIOL CHEM, V281, P31268, DOI 10.1074/jbc.M603258200; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Hiraiwa H, 2001, J BIOL CHEM, V276, P7963, DOI 10.1074/jbc.M010523200; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Langlois MJ, 2009, FASEB J, V23, P1835, DOI 10.1096/fj.08-123125; Lee YH, 1998, MOL CELL BIOL, V18, P3059, DOI 10.1128/MCB.18.5.3059; Lussier CR, 2008, AM J PHYSIOL-GASTR L, V294, pG418, DOI 10.1152/ajpgi.00418.2007; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Menard D, 2006, CELL SIGNALING AND GROWTH FACTORS IN DEVELOPMENT: FROM MOLECULES TO ORGANOGENESIS, P755; Novak JP, 2002, GENOMICS, V79, P104, DOI 10.1006/geno.2001.6675; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Pontoglio M, 1998, J CLIN INVEST, V101, P2215, DOI 10.1172/JCI2548; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; SEMENZA G, 1985, ANN NY ACAD SCI, V456, P83, DOI 10.1111/j.1749-6632.1985.tb14848.x; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Tamura A, 2008, GASTROENTEROLOGY, V134, P523, DOI 10.1053/j.gastro.2007.11.040; Traber Peter G., 1995, P21; Wasan HS, 1998, J PATHOL, V185, P246; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	43	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12378	10.1371/journal.pone.0012378	http://dx.doi.org/10.1371/journal.pone.0012378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808783	Green Published, Green Submitted, gold			2022-12-27	WOS:000281154300013
J	Rhein, V; Giese, M; Baysang, G; Meier, F; Rao, S; Schulz, KL; Hamburger, M; Eckert, A				Rhein, Virginie; Giese, Maria; Baysang, Ginette; Meier, Fides; Rao, Stefania; Schulz, Kathrin L.; Hamburger, Matthias; Eckert, Anne			Ginkgo Biloba Extract Ameliorates Oxidative Phosphorylation Performance and Rescues A beta-Induced Failure	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; TRANSGENIC MOUSE MODEL; CYTOCHROME-C-OXIDASE; ALZHEIMERS-DISEASE; MITOCHONDRIAL-FUNCTION; DOUBLE-BLIND; EGB 761; NEUROPSYCHIATRIC FEATURES; HIPPOCAMPAL-NEURONS; RESPIRATORY-CHAIN	Background: Energy deficiency and mitochondrial failure have been recognized as a prominent, early event in Alzheimer's disease (AD). Recently, we demonstrated that chronic exposure to amyloid-beta (A beta) in human neuroblastoma cells over-expressing human wild-type amyloid precursor protein (APP) resulted in (i) activity changes of complexes III and IV of the oxidative phosphorylation system (OXPHOS) and in (ii) a drop of ATP levels which may finally instigate loss of synapses and neuronal cell death in AD. Therefore, the aim of the present study was to investigate whether standardized Ginkgo biloba extract LI 1370 (GBE) is able to rescue A beta-induced defects in energy metabolism. Methodology/Principal Findings: We used a high-resolution respiratory protocol to evaluate OXPHOS respiratory capacity under physiological condition in control (stably transfected with the empty vector) and APP cells after treatment with GBE. In addition, oxygen consumption of isolated mitochondria, activities of mitochondrial respiratory enzymes, ATP and reactive oxygen species (ROS) levels as well as mitochondrial membrane mass and mitochondrial DNA content were determined. We observed a general antioxidant effect of GBE leading to an increase of the coupling state of mitochondria as well as energy homeostasis and a reduction of ROS levels in control cells and in APP cells. GBE effect on OXPHOS was even preserved in mitochondria after isolation from treated cells. Moreover, these functional data were paralleled by an up-regulation of mitochondrial DNA. Improvement of the OXPHOS efficiency was stronger in APP cells than in control cells. In APP cells, the GBE-induced amelioration of oxygen consumption most likely arose from the modulation and respective normalization of the A beta-induced disturbance in the activity of mitochondrial complexes III and IV restoring impaired ATP levels possibly through decreasing A beta and oxidative stress level. Conclusions/Significance: Although the underlying molecular mechanisms of the mode of action of GBE remain to be determined, our study clearly highlights the beneficial effect of GBE on the cellular OXPHOS performance and restoration of A beta-induced mitochondrial dysfunction.	[Rhein, Virginie; Giese, Maria; Baysang, Ginette; Meier, Fides; Rao, Stefania; Schulz, Kathrin L.; Eckert, Anne] Univ Basel, Neurobiol Lab Brain Aging & Mental Hlth, Psychiat Univ Clin, Basel, Switzerland; [Hamburger, Matthias] Univ Basel, Inst Pharmaceut Biol, Basel, Switzerland	University of Basel; University of Basel	Rhein, V (corresponding author), Univ Basel, Neurobiol Lab Brain Aging & Mental Hlth, Psychiat Univ Clin, Basel, Switzerland.	anne.eckert@upkbs.ch		Eckert, Anne/0000-0002-9341-3669	SNSF (Swiss National Science Foundation) [310000-108223]; Vifor SA, Switzerland	SNSF (Swiss National Science Foundation)(Swiss National Science Foundation (SNSF)); Vifor SA, Switzerland	This research was supported by a grant from the SNSF (Swiss National Science Foundation) #310000-108223 to A. E. and an unrestricted research grant from Vifor SA, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Kader R, 2007, PHARMACOL RES, V56, P493, DOI 10.1016/j.phrs.2007.09.011; Augustin S, 2009, ARCH BIOCHEM BIOPHYS, V481, P177, DOI 10.1016/j.abb.2008.10.032; Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8; Bai RK, 2004, ANN NY ACAD SCI, V1011, P304, DOI 10.1196/annals.1293.029; Bastianetto S, 2000, EUR J NEUROSCI, V12, P1882, DOI 10.1046/j.1460-9568.2000.00069.x; Blass JP, 2003, NEUROL RES, V25, P556, DOI 10.1179/016164103101201995; Cardoso SM, 2004, J NEUROCHEM, V89, P1417, DOI 10.1111/j.1471-4159.2004.02438.x; Cardoso SM, 2004, NEUROBIOL AGING, V25, P105, DOI 10.1016/S0197-4580(03)00033-2; Carvalho C, 2009, J BIOENERG BIOMEMBR, V41, P433, DOI 10.1007/s10863-009-9247-1; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Colciaghi F, 2004, NEUROBIOL DIS, V16, P454, DOI 10.1016/j.nbd.2004.03.011; Cote HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035; D'Aurelio M, 2006, HUM MOL GENET, V15, P2157, DOI 10.1093/hmg/ddl141; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; David DC, 2005, J BIOL CHEM, V280, P23802, DOI 10.1074/jbc.M500356200; DeKosky ST, 2008, JAMA-J AM MED ASSOC, V300, P2253, DOI 10.1001/jama.2008.683; Devore EE, 2010, ARCH NEUROL-CHICAGO, V67, P819, DOI 10.1001/archneurol.2010.144; Djafarzadeh R, 2000, BBA-BIOENERGETICS, V1459, P230, DOI 10.1016/S0005-2728(00)00154-7; DOUSSIERE J, 1984, BIOCHIM BIOPHYS ACTA, V766, P492, DOI 10.1016/0005-2728(84)90265-2; Eckert A, 2005, ANN NY ACAD SCI, V1056, P474, DOI 10.1196/annals.1352.023; Eckert A, 2003, PHARMACOPSYCHIATRY, V36, pS15; Eckert A, 2008, J MOL MED, V86, P1255, DOI 10.1007/s00109-008-0391-6; Eckert A, 2010, MOL NEUROBIOL, V41, P107, DOI 10.1007/s12035-010-8109-5; Fernandez-Vizarra P, 2004, HISTOL HISTOPATHOL, V19, P823, DOI 10.14670/HH-19.823; Gibson GE, 1998, J NEURAL TRANSM, V105, P855, DOI 10.1007/s007020050099; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005; Hou Y, 2010, NEUROPHARMACOLOGY, V58, P911, DOI 10.1016/j.neuropharm.2009.11.002; Iijima-Ando K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008310; Janssens D, 1999, BIOCHEM PHARMACOL, V58, P109, DOI 10.1016/S0006-2952(99)00061-1; JANSSENS D, 1995, BIOCHEM PHARMACOL, V50, P991, DOI 10.1016/0006-2952(95)00227-Q; Kanowski S, 1996, PHARMACOPSYCHIATRY, V29, P47, DOI 10.1055/s-2007-979544; Keil U, 2004, J BIOL CHEM, V279, P50310, DOI 10.1074/jbc.M405600200; KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x; KUROIWA T, 1994, MICROSC RES TECHNIQ, V27, P220, DOI 10.1002/jemt.1070270304; Laurin D, 2004, AM J EPIDEMIOL, V159, P959, DOI 10.1093/aje/kwh124; LeBars PL, 1997, JAMA-J AM MED ASSOC, V278, P1327, DOI 10.1001/jama.278.16.1327; Leuner K, 2007, ANTIOXID REDOX SIGN, V9, P1659, DOI 10.1089/ars.2007.1763; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo Y, 2002, P NATL ACAD SCI USA, V99, P12197, DOI 10.1073/pnas.182425199; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; McCarney R, 2008, INT J GERIATR PSYCH, V23, P1222, DOI 10.1002/gps.2055; Mix JA, 2002, HUM PSYCHOPHARM CLIN, V17, P267, DOI 10.1002/hup.412; Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P212, DOI 10.1016/j.bbadis.2009.10.007; Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P2, DOI 10.1016/j.bbadis.2009.10.006; Napryeyenko O, 2007, ARZNEIMITTELFORSCH, V57, P4; Navarro A, 2005, AM J PHYSIOL-REG I, V289, pR1392, DOI 10.1152/ajpregu.00834.2004; Plecita-Hlavata L, 2009, INT J BIOCHEM CELL B, V41, P1697, DOI 10.1016/j.biocel.2009.02.015; Rhein V, 2009, CELL MOL NEUROBIOL, V29, P1063, DOI 10.1007/s10571-009-9398-y; Rhein Virginie, 2007, Archives of Physiology and Biochemistry, V113, P131, DOI 10.1080/13813450701572288; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Schindowski K, 2001, J NEURAL TRANSM, V108, P969, DOI 10.1007/s007020170016; Shi QL, 2007, ALZ DIS ASSOC DIS, V21, P276, DOI 10.1097/WAD.0b013e31815721c3; Smith JV, 2002, CELL MOL BIOL, V48, P699; Tchantchou F, 2007, FASEB J, V21, P2400, DOI 10.1096/fj.06-7649com; Tchantchou F, 2009, J ALZHEIMERS DIS, V18, P787, DOI 10.3233/JAD-2009-1189; Tendi EA, 2002, NEUROCHEM RES, V27, P319, DOI 10.1023/A:1014963313559; Trumbeckaite S, 2007, J ETHNOPHARMACOL, V111, P512, DOI 10.1016/j.jep.2006.12.028; Valla J, 2001, J NEUROSCI, V21, P4923, DOI 10.1523/JNEUROSCI.21-13-04923.2001; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Yancheva S, 2009, AGING MENT HEALTH, V13, P183, DOI 10.1080/13607860902749057; Yao ZX, 2001, BRAIN RES, V889, P181, DOI 10.1016/S0006-8993(00)03131-0	63	52	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12359	10.1371/journal.pone.0012359	http://dx.doi.org/10.1371/journal.pone.0012359			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808761	Green Published, Green Submitted, gold			2022-12-27	WOS:000281154300003
J	Redemann, S; Pecreaux, J; Goehring, NW; Khairy, K; Stelzer, EHK; Hyman, AA; Howard, J				Redemann, Stefanie; Pecreaux, Jacques; Goehring, Nathan W.; Khairy, Khaled; Stelzer, Ernst H. K.; Hyman, Anthony A.; Howard, Jonathon			Membrane Invaginations Reveal Cortical Sites that Pull on Mitotic Spindles in One-Cell C. elegans Embryos	PLOS ONE			English	Article							ANTERIOR-POSTERIOR POLARITY; CAENORHABDITIS-ELEGANS; EARLY EMBRYOGENESIS; MOLECULAR MOTORS; FORCE GENERATORS; ERM PROTEINS; PAR PROTEINS; CYTOKINESIS; POSITION; ACTIN	Asymmetric positioning of the mitotic spindle in C. elegans embryos is mediated by force-generating complexes that are anchored at the plasma membrane and that pull on microtubules growing out from the spindle poles. Although asymmetric distribution of the force generators is thought to underlie asymmetric positioning of the spindle, the number and location of the force generators has not been well defined. In particular, it has not been possible to visualize individual force generating events at the cortex. We discovered that perturbation of the acto-myosin cortex leads to the formation of long membrane invaginations that are pulled from the plasma membrane toward the spindle poles. Several lines of evidence show that the invaginations, which also occur in unperturbed embryos though at lower frequency, are pulled by the same force generators responsible for spindle positioning. Thus, the invaginations serve as a tool to localize the sites of force generation at the cortex and allow us to estimate a lower limit on the number of cortical force generators within the cell.	[Redemann, Stefanie; Pecreaux, Jacques; Goehring, Nathan W.; Hyman, Anthony A.; Howard, Jonathon] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Khairy, Khaled; Stelzer, Ernst H. K.] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL)	Redemann, S (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	redemann@mpi-cbg.de; jacques.pecreaux@m4x.org; hyman@mpi-cbg.de; howard@mpi-cbg.de	Khairy, Khaled/T-4623-2018; Redemann, Stefanie/C-9256-2016; Goehring, Nathan/AAC-7310-2020; Howard, Jonathon/J-7492-2016; Hyman, Tony/F-1923-2011; Hyman, Anthony A/B-3917-2017; Stelzer, Ernst H K/A-7648-2011; Pecreaux, Jacques/A-4248-2008; Howard, Jonathon/D-4229-2011; Redemann, Stefanie/AAG-1683-2021	Goehring, Nathan/0000-0001-8710-4467; Howard, Jonathon/0000-0003-0086-1196; Hyman, Anthony A/0000-0003-3664-154X; Stelzer, Ernst H K/0000-0003-1545-0736; Pecreaux, Jacques/0000-0001-9998-4844; Howard, Jonathon/0000-0003-0086-1196; Redemann, Stefanie/0000-0003-2334-7309	Human Frontier Science Program [LT00563/2005-C]; Alexander von Humboldt Foundation; European Commission [219286]	Human Frontier Science Program(Human Frontier Science Program); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre)	JP was supported by the Human Frontier Science Program (LT00563/2005-C), NWG was supported by the Alexander von Humboldt Foundation and a Marie Curie Grant (219286) from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar K, 2010, DEVELOPMENT, V137, P237, DOI 10.1242/dev.042754; Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124; BRENNER S, 1974, GENETICS, V77, P71; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bringmann H, 2007, CURR BIOL, V17, P185, DOI 10.1016/j.cub.2006.11.070; Brochard-Wyart F, 2006, P NATL ACAD SCI USA, V103, P7660, DOI 10.1073/pnas.0602012103; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Couwenbergs C, 2007, J CELL BIOL, V179, P15, DOI 10.1083/jcb.200707085; Derenyi I, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.238101; Dogterom M, 2005, CURR OPIN CELL BIOL, V17, P67, DOI 10.1016/j.ceb.2004.12.011; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gautreau A, 2002, CURR OPIN CELL BIOL, V14, P104, DOI 10.1016/S0955-0674(01)00300-3; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Goulding MB, 2007, J CELL BIOL, V178, P1177, DOI 10.1083/jcb.200703159; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Grill SW, 2005, DEV CELL, V8, P461, DOI 10.1016/j.devcel.2005.03.014; Hammond GRV, 2009, J CELL BIOL, V184, P297, DOI 10.1083/jcb.200809073; Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4; HOWARD J, 2001, MECH MOTOR PROTEINS, V16, P367; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Kachur TM, 2008, DEV BIOL, V314, P287, DOI 10.1016/j.ydbio.2007.11.028; Koster G, 2003, P NATL ACAD SCI USA, V100, P15583, DOI 10.1073/pnas.2531786100; Kozlowski C, 2007, CELL, V129, P499, DOI 10.1016/j.cell.2007.03.027; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Labbe JC, 2004, J CELL BIOL, V167, P245, DOI 10.1083/jcb.200406008; Leduc C, 2004, P NATL ACAD SCI USA, V101, P17096, DOI 10.1073/pnas.0406598101; Motegi F, 2006, NAT CELL BIOL, V8, P978, DOI 10.1038/ncb1459; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P728, DOI 10.1073/pnas.87.2.728; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nance J, 2003, DEVELOPMENT, V130, P5339, DOI 10.1242/dev.00735; Panbianco C, 2008, DEV CELL, V15, P198, DOI 10.1016/j.devcel.2008.06.002; PECREAUX J, 2006, TENSION BENDING, P1949; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Piekny AJ, 2002, J CELL SCI, V115, P2271; Portier N, 2007, DEV CELL, V12, P515, DOI 10.1016/j.devcel.2007.01.019; Praitis V, 2001, GENETICS, V157, P1217; Rappleye Chad A, 2003, BMC Dev Biol, V3, P8, DOI 10.1186/1471-213X-3-8; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Roux A, 2002, P NATL ACAD SCI USA, V99, P5394, DOI 10.1073/pnas.082107299; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Schonegg S, 2007, P NATL ACAD SCI USA, V104, P14976, DOI 10.1073/pnas.0706941104; Schonegg S, 2006, DEVELOPMENT, V133, P3507, DOI 10.1242/dev.02527; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Shelton CA, 1999, J CELL BIOL, V146, P439, DOI 10.1083/jcb.146.2.439; Snedecor GW, 1967, STAT METHODS, p[593, xiv]; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Tabdanov E, 2009, BIOPHYS J, V96, P2457, DOI 10.1016/j.bpj.2008.11.059; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tolic-Norrelykke IM, 2004, CURR BIOL, V14, P1181, DOI 10.1016/j.cub.2004.06.029; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Velarde N, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-142; Zonies S, 2010, DEVELOPMENT, V137, P1669, DOI 10.1242/dev.045823	56	66	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12301	10.1371/journal.pone.0012301	http://dx.doi.org/10.1371/journal.pone.0012301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808841	Green Published, gold, Green Submitted			2022-12-27	WOS:000281077000009
J	Dasgupta, A; Sureka, K; Mitra, D; Saha, B; Sanyal, S; Das, AK; Chakrabarti, P; Jackson, M; Gicquel, B; Kundu, M; Basu, J				Dasgupta, Arunava; Sureka, Kamakshi; Mitra, Devrani; Saha, Baisakhee; Sanyal, Sourav; Das, Amit K.; Chakrabarti, Parul; Jackson, Mary; Gicquel, Brigitte; Kundu, Manikuntala; Basu, Joyoti			An Oligopeptide Transporter of Mycobacterium tuberculosis Regulates Cytokine Release and Apoptosis of Infected Macrophages	PLOS ONE			English	Article							BACILLUS-SUBTILIS; BINDING PROTEIN; SYSTEM; METHYLGLYOXAL; GLUTATHIONE; OPPA; ARCHITECTURE; MUTANT; CELLS	Background: The Mycobacterium tuberculosis genome encodes two peptide transporters encoded by Rv3665c-Rv3662c and Rv1280c-Rv1283c. Both belong to the family of ABC transporters containing two nucleotide-binding subunits, two integral membrane proteins and one substrate-binding polypeptide. However, little is known about their functions in M. tuberculosis. Here we report functional characterization of the Rv1280c-Rv1283c-encoded transporter and its substrate-binding polypeptide OppA(MTB). Methodology/Principal Findings: OppA(MTB) was capable of binding the tripeptide glutathione and the nonapeptide bradykinin, indicative of a somewhat broad substrate specificity. Amino acid residues G109, N110, N230, D494 and F496, situated at the interface between domains I and III of OppA, were required for optimal peptide binding. Complementaton of an oppA knockout mutant of M. smegmatis with OppA(MTB) confirmed the role of this transporter in importing glutathione and the importance of the aforesaid amino acid residues in peptide transport. Interestingly, this transporter regulated the ability of M. tuberculosis to lower glutathione levels in infected compared to uninfected macrophages. This ability was partly offset by inactivation of oppD. Concomitantly, inactivation of oppD was associated with lowered levels of methyl glyoxal in infected macrophages and reduced apoptosis-inducing ability of the mutant. The ability to induce the production of the cytokines IL-1 beta, IL-6 and TNF-alpha was also compromised after inactivation of oppD. Conclusions: Taken together, these studies uncover the novel observations that this peptide transporter modulates the innate immune response of macrophages infected with M. tuberculosis.	[Dasgupta, Arunava; Jackson, Mary; Gicquel, Brigitte] Inst Pasteur, Unite Genet Mycobacterienne, Paris, France; [Sureka, Kamakshi; Sanyal, Sourav; Chakrabarti, Parul; Kundu, Manikuntala; Basu, Joyoti] Bose Inst, Dept Chem, Kolkata, India; [Mitra, Devrani; Saha, Baisakhee; Das, Amit K.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Department of Science & Technology (India); Bose Institute; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Dasgupta, A (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany.	joyoti@vsnl.com	Sureka, Kamakshi/ABE-4125-2021; Jackson, Mary/D-5345-2017	Sureka, Kamakshi/0000-0003-3093-5299; Jackson, Mary/0000-0002-9212-0258	Indo-French Centre for the Promotion of Advanced Research; Council of Scientific and Industrial Research; Indian Council of Medical Research	Indo-French Centre for the Promotion of Advanced Research(French National Research Agency (ANR)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported in part by grants from the Indo-French Centre for the Promotion of Advanced Research to B.G. and J.B., the Council of Scientific and Industrial Research to P.C. and the Indian Council of Medical Research to J.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abordo EA, 1997, IMMUNOL LETT, V58, P139, DOI 10.1016/S0165-2478(97)00080-1; Flores-Valdez MA, 2009, FASEB J, V23, P4091, DOI 10.1096/fj.09-132407; ALLOING G, 1994, J MOL BIOL, V241, P44, DOI 10.1006/jmbi.1994.1472; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; Berntsson RPA, 2009, EMBO J, V28, P1332, DOI 10.1038/emboj.2009.65; Biemans-Oldehinkel E, 2006, FEBS LETT, V580, P1023, DOI 10.1016/j.febslet.2005.11.079; Davidson SD, 2002, UROL RES, V30, P116, DOI 10.1007/s00240-002-0244-7; Detmers FJM, 2000, P NATL ACAD SCI USA, V97, P12487, DOI 10.1073/pnas.220308797; Gaora PO, 1997, MED PRIN PRACT, V6, P91; Green RM, 2000, INFECT IMMUN, V68, P429, DOI 10.1128/IAI.68.2.429-436.2000; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Levdikov VM, 2005, J MOL BIOL, V345, P879, DOI 10.1016/j.jmb.2004.10.089; Mahenthiralingam E, 1998, INFECT IMMUN, V66, P3626, DOI 10.1128/IAI.66.8.3626-3634.1998; Nickitenko AV, 1995, BIOCHEMISTRY-US, V34, P16585, DOI 10.1021/bi00051a006; Nodwell JR, 1996, MOL MICROBIOL, V22, P881, DOI 10.1046/j.1365-2958.1996.01540.x; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pelicic V, 1996, MOL MICROBIOL, V20, P919, DOI 10.1111/j.1365-2958.1996.tb02533.x; PEREGO M, 1991, MOL MICROBIOL, V5, P173, DOI 10.1111/j.1365-2958.1991.tb01838.x; Prade L, 1997, BIOL CHEM, V378, P317; Rachman H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000029; RUDNER DZ, 1991, J BACTERIOL, V173, P1388, DOI 10.1128/jb.173.4.1388-1398.1991; Saurin W, 1999, J MOL EVOL, V48, P22, DOI 10.1007/PL00006442; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Tame JRH, 1995, STRUCTURE, V3, P1395, DOI 10.1016/S0969-2126(01)00276-3; Tanabe M, 2007, ACTA CRYSTALLOGR D, V63, P1185, DOI 10.1107/S0907444907048299; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; THORNALLEY PJ, 1988, BIOCHEM J, V254, P751, DOI 10.1042/bj2540751; TYNKKYNEN S, 1993, J BACTERIOL, V175, P7523, DOI 10.1128/JB.175.23.7523-7532.1993; Venketaraman V, 2008, MICROB PATHOGENESIS, V44, P255, DOI 10.1016/j.micpath.2007.09.002; Wang XG, 2004, J BACTERIOL, V186, P51, DOI 10.1128/JB.186.1.51-60.2004	32	35	37	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12225	10.1371/journal.pone.0012225	http://dx.doi.org/10.1371/journal.pone.0012225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808924	Green Submitted, Green Published, gold			2022-12-27	WOS:000280968100023
J	Hung, TH; Chen, SF; Li, MJ; Yeh, YL; Hsieh, TT				Hung, Tai-Ho; Chen, Szu-Fu; Li, Meng-Jen; Yeh, Yi-Lin; Hsieh, T'sang-T'ang			Differential Effects of Concomitant Use of Vitamins C and E on Trophoblast Apoptosis and Autophagy between Normoxia and Hypoxia-Reoxygenation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; OXIDATIVE STRESS; HUMAN PLACENTA; PREGNANT-WOMEN; CELL-DEATH; IN-VITRO; PREECLAMPSIA; EXPLANTS; RISK; RELEASE	Background: Concomitant supplementation of vitamins C and E during pregnancy has been reportedly associated with low birth weight, the premature rupture of membranes and fetal loss or perinatal death in women at risk for preeclampsia; however, the cause is unknown. We surmise that hypoxia-reoxygenation (HR) within the intervillous space due to abnormal placentation is the mechanism and hypothesize that concomitant administration of aforementioned vitamin antioxidants detrimentally affects trophoblast cells during HR. Methodology/Principal Findings: Using villous explants, concomitant administration of 50 mu M of vitamins C and E was observed to reduce apoptotic and autophagic changes in the trophoblast layer at normoxia (8% oxygen) but to cause more prominent apoptosis and autophagy during HR. Furthermore, increased levels of Bcl-2 and Bcl-xL in association with a decrease in the autophagy-related protein LC3-II were noted in cytotrophoblastic cells treated with vitamins C and E under standard culture conditions. In contrast, vitamin treatment decreased Bcl-2 and Bcl-xL as well as increased mitochondrial Bak and cytosolic LC3-II in cytotrophoblasts subjected to HR. Conclusions/Significance: Our results indicate that concomitant administration of vitamins C and E has differential effects on the changes of apoptosis, autophagy and the expression of Bcl-2 family of proteins in the trophoblasts between normoxia and HR. These changes may probably lead to the impairment of placental function and suboptimal growth of the fetus.	[Hung, Tai-Ho; Li, Meng-Jen; Yeh, Yi-Lin; Hsieh, T'sang-T'ang] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Taipei 10591, Taiwan; [Hung, Tai-Ho] Chang Gung Univ, Coll Med, Dept Chinese Med, Tao Yuan, Taiwan; [Chen, Szu-Fu] Cheng Hsin Rehabil Med Ctr, Dept Phys Med & Rehabil, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Hung, TH (corresponding author), Chang Gung Mem Hosp, Dept Obstet & Gynecol, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	thh20@adm.cgmh.org.tw	Hung, Tai-Ho/C-7584-2011; Hung, Tai-Ho/ABD-1800-2020; Chen, Szu-Fu/K-5040-2012	Hung, Tai-Ho/0000-0003-2354-7060; 	National Science Council, Taiwan [NSC96-2314-B182A-061-MY3, NSC96-2314-B-182A-065-MY2]; Chang Gung Memorial Hospital [NMRPG166021]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by the National Science Council, Taiwan (NSC96-2314-B182A-061-MY3 to THH, NSC96-2314-B-182A-065-MY2 to TTH) and Chang Gung Memorial Hospital (NMRPG166021 to THH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almog B, 2002, PLACENTA, V23, P331, DOI 10.1053/plac.2002.0788; Aris A, 2008, J OBSTET GYNAECOL RE, V34, P504, DOI 10.1111/j.1447-0756.2008.00722.x; CHAN AC, 1993, CAN J PHYSIOL PHARM, V71, P725, DOI 10.1139/y93-109; Chappell LC, 1999, LANCET, V354, P810, DOI 10.1016/S0140-6736(99)80010-5; Cindrova-Davies T, 2007, AM J PATHOL, V170, P1511, DOI 10.2353/ajpath.2007.061035; Crocker IP, 2004, J PATHOL, V204, P11, DOI 10.1002/path.1610; Crocker IP, 2003, AM J PATHOL, V162, P637, DOI 10.1016/S0002-9440(10)63857-6; Hubel CA, 1999, P SOC EXP BIOL MED, V222, P222, DOI 10.1046/j.1525-1373.1999.d01-139.x; Humphrey RG, 2008, ENDOCRINOLOGY, V149, P2131, DOI 10.1210/en.2007-1253; Hung TH, 2008, PLACENTA, V29, P565, DOI 10.1016/j.placenta.2008.03.005; Hung TH, 2008, REPROD SCI, V15, P195, DOI 10.1177/1933719107310709; Hung Tai-Ho, 2006, Taiwan J Obstet Gynecol, V45, P189; Hung TH, 2002, CIRC RES, V90, P1274, DOI 10.1161/01.RES.0000024411.22110.AA; Hung TH, 2004, AM J PATHOL, V164, P1049, DOI 10.1016/S0002-9440(10)63192-6; Hung TH, 2001, AM J PATHOL, V159, P1031, DOI 10.1016/S0002-9440(10)61778-6; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kumar D, 2004, PLACENTA, V25, P573, DOI 10.1016/j.placenta.2003.12.005; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Oh SY, 2008, REPROD SCI, V15, P912, DOI 10.1177/1933719108319159; Poston L, 2006, LANCET, V367, P1145, DOI 10.1016/S0140-6736(06)68433-X; Rumbold AR, 2006, NEW ENGL J MED, V354, P1796, DOI 10.1056/NEJMoa054186; Shen ZY, 2008, PLACENTA, V29, P956, DOI 10.1016/j.placenta.2008.09.001; Siman CM, 2001, AM J PHYSIOL-REG I, V280, pR1116, DOI 10.1152/ajpregu.2001.280.4.R1116; Smith SC, 1997, AM J OBSTET GYNECOL, V177, P1395, DOI 10.1016/S0002-9378(97)70081-4; Spinnato JA, 2007, OBSTET GYNECOL, V110, P1311, DOI 10.1097/01.AOG.0000289576.43441.1f; Spinnato JA, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.011; Tanir H. Mete, 2005, Archives of Gynecology and Obstetrics, V273, P98, DOI 10.1007/s00404-005-0028-8; Tannetta DS, 2008, PLACENTA, V29, P680, DOI 10.1016/j.placenta.2008.04.009; Tjoa ML, 2006, AM J PATHOL, V169, P400, DOI 10.2353/ajpath.2006.060161; Villar J, 2009, BJOG-INT J OBSTET GY, V116, P780, DOI 10.1111/j.1471-0528.2009.02158.x; Xu HR, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.050	32	33	36	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12202	10.1371/journal.pone.0012202	http://dx.doi.org/10.1371/journal.pone.0012202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808946	Green Published, gold, Green Submitted			2022-12-27	WOS:000280968000025
J	Li, MD; Yoon, D; Lee, JY; Han, BG; Niu, T; Payne, TJ; Ma, JZ; Park, T				Li, Ming D.; Yoon, Dankyu; Lee, Jong-Young; Han, Bok-Ghee; Niu, Tianhua; Payne, Thomas J.; Ma, Jennie Z.; Park, Taesung			Associations of Variants in CHRNA5/A3/B4 Gene Cluster with Smoking Behaviors in a Korean Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LUNG-CANCER RISK; NICOTINE DEPENDENCE; RECEPTOR GENES; SUSCEPTIBILITY LOCUS; EUROPEAN-AMERICANS; TOBACCO INITIATION; CIGARETTE-SMOKING; LINKAGE ANALYSES; HEAVY SMOKING	Multiple genome-wide and targeted association studies reveal a significant association of variants in the CHRNA5-CHRNA3-CHRNB4 (CHRNA5/A3/B4) gene cluster on chromosome 15 with nicotine dependence. The subjects examined in most of these studies had a European origin. However, considering the distinct linkage disequilibrium patterns in European and other ethnic populations, it would be of tremendous interest to determine whether such associations could be replicated in populations of other ethnicities, such as Asians. In this study, we performed comprehensive association and interaction analyses for 32 single-nucleotide polymorphisms (SNPs) in CHRNA5/A3/B4 with smoking initiation (SI), smoking quantity (SQ), and smoking cessation (SC) in a Korean sample (N = 8,842). We found nominally significant associations of 7 SNPs with at least one smoking-related phenotype in the total sample (SI: P = 0.015 similar to 0.023; SQ: P = 0.008 similar to 0.028; SC: P = 0.018 similar to 0.047) and the male sample (SI: P = 0.001 similar to 0.023; SQ: P = 0.001 similar to 0.046; SC: P = 0.01). A spectrum of haplotypes formed by three consecutive SNPs located between rs16969948 in CHRNA5 and rs6495316 in the intergenic region downstream from the 5' end of CHRNB4 was associated with these three smoking-related phenotypes in both the total and the male sample. Notably, associations of these variants and haplotypes with SC appear to be much weaker than those with SI and SQ. In addition, we performed an interaction analysis of SNPs within the cluster using the generalized multifactor dimensionality reduction method and found a significant interaction of SNPs rs7163730 in LOC123688, rs6495308 in CHRNA3, and rs7166158, rs8043123, and rs11072793 in the intergenic region downstream from the 5' end of CHRNB4 to be influencing SI in the male sample. Considering that fewer than 5% of the female participants were smokers, we did not perform any analysis on female subjects specifically. Together, our detected associations of variants in the CHRNA5/A3/B4 cluster with SI, SQ, and SC in the Korean smoker samples provide strong evidence for the contribution of this cluster to the etiology of SI, ND, and SC in this Asian population.	[Li, Ming D.; Niu, Tianhua] Univ Virginia, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22903 USA; [Yoon, Dankyu] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Lee, Jong-Young; Han, Bok-Ghee] Natl Inst Hlth, Ctr Genome Sci, Seoul, South Korea; [Payne, Thomas J.] Univ Mississippi, Med Ctr, Dept Otolaryngol & Communicat Sci, Jackson, MS 39216 USA; [Ma, Jennie Z.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Park, Taesung] Seoul Natl Univ, Coll Nat Sci, Dept Stat, Seoul 151742, South Korea	University of Virginia; Seoul National University (SNU); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; University of Mississippi; University of Mississippi Medical Center; University of Virginia; Seoul National University (SNU)	Li, MD (corresponding author), Univ Virginia, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22903 USA.	Ming_Li@virginia.edu; tspark@stats.snu.ac.kr	Lee, Jong-Young/M-6319-2013; Payne, Thomas/R-4290-2019	Lee, Jong-Young/0000-0002-0092-9958; Payne, Thomas/0000-0002-9839-6255	Korea Science and Engineering Foundation [M10500000126]; National Institute of Health of Korea [2008-E00355-00]; National Institutes of Health [DA-12844, DA-13783]; Consortium for Large Scale Genome Wide Association Study [2008-E00355-00]; National Research Foundation [KRF-2008-313-C00086]; Ministry of Education; Korea National Institute of Health (Korea Center for Disease Control, Ministry for Health, Welfare and Family Affairs), Republic of Korea [4845-301]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012844, R01DA013783] Funding Source: NIH RePORTER	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); National Institute of Health of Korea; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consortium for Large Scale Genome Wide Association Study; National Research Foundation; Ministry of Education; Korea National Institute of Health (Korea Center for Disease Control, Ministry for Health, Welfare and Family Affairs), Republic of Korea; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the National Research Laboratory Program of the Korea Science and Engineering Foundation (M10500000126), a grant from the National Institute of Health of Korea (2008-E00355-00) to TP, and National Institutes of Health grants DA-12844 and DA-13783 to MDL. The work of TP was supported by the Consortium for Large Scale Genome Wide Association Study (2008-E00355-00), the National Research Foundation (KRF-2008-313-C00086) and the Brain Korea 21 Project of the Ministry of Education. The KARE data analyzed in this study were obtained from the Korean Genome Analysis Project (4845-301) which was funded by a grant from the Korea National Institute of Health (Korea Center for Disease Control, Ministry for Health, Welfare and Family Affairs), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; APA, 1994, DIAGN STAT MAN MENT; Baker TB, 2009, NICOTINE TOB RES, V11, P785, DOI 10.1093/ntr/ntp064; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bender R, 1997, J ROY COLL PHYS LOND, V31, P546; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Breitling LP, 2009, BIOL PSYCHIAT, V65, P691, DOI 10.1016/j.biopsych.2008.10.004; Broms U, 2006, TWIN RES HUM GENET, V9, P64, DOI 10.1375/183242706776403046; Caporaso N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004653; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Carter BL, 2004, NICOTINE TOB RES, V6, P221, DOI 10.1080/14622200410001676387; Chen XN, 2009, AM J MED GENET B, V150B, P926, DOI 10.1002/ajmg.b.30919; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Diaz FJ, 2005, AUST NZ J PSYCHIAT, V39, P161, DOI 10.1111/j.1440-1614.2005.01538.x; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gaimarri A, 2007, BRAIN RES REV, V55, P134, DOI 10.1016/j.brainresrev.2007.02.005; Ge YC, 2008, STAT SINICA, V18, P881; Greenbaum L, 2006, MOL PSYCHIATR, V11, P312, DOI 10.1038/sj.mp.4001774; HEATHERTON TF, 1989, BRIT J ADDICT, V84, P791; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jee SH, 2004, CANCER CAUSE CONTROL, V15, P341, DOI 10.1023/B:CACO.0000027481.48153.97; *KASH, 1991, SURV SMOK HAB KOR 19, P6; Kendler KS, 1999, PSYCHOL MED, V29, P299, DOI 10.1017/S0033291798008022; Keskitalo K, 2009, HUM MOL GENET, V18, P4007, DOI 10.1093/hmg/ddp322; Le Marchand L, 2008, CANCER RES, V68, P9137, DOI 10.1158/0008-5472.CAN-08-2271; Lerman C, 1998, CANCER EPIDEM BIOMAR, V7, P253; Lessov CN, 2004, PSYCHOL MED, V34, P865, DOI 10.1017/S0033291703001582; Lessov-Schlaggar CN, 2008, BIOCHEM PHARMACOL, V75, P178, DOI 10.1016/j.bcp.2007.08.018; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Li MD, 2008, HUM GENET, V123, P119, DOI 10.1007/s00439-008-0473-0; Li MD, 2010, AM J MED GENET B, V153B, P745, DOI 10.1002/ajmg.b.31043; Li MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007055; Li MD, 2009, NAT REV GENET, V10, P225, DOI 10.1038/nrg2536; Li MD, 2008, BIOL PSYCHIAT, V64, P951, DOI 10.1016/j.biopsych.2008.04.026; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Lips EH, 2010, INT J EPIDEMIOL, V39, P563, DOI 10.1093/ije/dyp288; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Maes HH, 2004, PSYCHOL MED, V34, P1251, DOI 10.1017/S0033291704002405; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Picciotto MR, 2000, NEUROPSYCHOPHARMACOL, V22, P451, DOI 10.1016/S0893-133X(99)00146-3; Piper ME, 2004, J CONSULT CLIN PSYCH, V72, P139, DOI 10.1037/0022-006X.72.2.139; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Saccone NL, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-58; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schlaelpfer IR, 2008, BIOL PSYCHIAT, V63, P1039, DOI 10.1016/j.biopsych.2007.10.024; Sherva R, 2008, ADDICTION, V103, P1544, DOI 10.1111/j.1360-0443.2008.02279.x; Shiffman S, 2004, NICOTINE TOB RES, V6, P327, DOI 10.1080/1462220042000202481; Shiraishi K, 2009, CARCINOGENESIS, V30, P65, DOI 10.1093/carcin/bgn257; Stevens VL, 2008, CANCER EPIDEM BIOMAR, V17, P3517, DOI 10.1158/1055-9965.EPI-08-0585; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P683, DOI 10.1001/archpsyc.65.6.683; Vink JM, 2009, AM J HUM GENET, V84, P367, DOI 10.1016/j.ajhg.2009.02.001; Watkins S S, 2000, Nicotine Tob Res, V2, P19; Weiss RB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000125; Wipfli H, 2009, CLIN PHARMACOL THER, V86, P263, DOI 10.1038/clpt.2009.93; Wu C, 2009, CANCER RES, V69, P5065, DOI 10.1158/0008-5472.CAN-09-0081; Xian H, 2003, NICOTINE TOB RES, V5, P245, DOI 10.1080/1462220031000073667; Zhang H, 2003, RESPIROLOGY, V8, P17, DOI 10.1046/j.1440-1843.2003.00433.x; Zuo LJ, 2009, PHARMACOGENET GENOM, V19, P437, DOI 10.1097/FPC.0b013e32832b9cfc	64	96	98	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12183	10.1371/journal.pone.0012183	http://dx.doi.org/10.1371/journal.pone.0012183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808433	Green Submitted, Green Published, gold			2022-12-27	WOS:000280968000012
J	Carvalho, KI; Melo, KM; Bruno, FR; Snyder-Cappione, JE; Nixon, DF; Costa-Carvalho, BT; Kallas, EG				Carvalho, Karina I.; Melo, Karina M.; Bruno, Fernanda R.; Snyder-Cappione, Jennifer E.; Nixon, Douglas F.; Costa-Carvalho, Beatriz T.; Kallas, Esper G.			Skewed Distribution of Circulating Activated Natural Killer T (NKT) Cells in Patients with Common Variable Immunodeficiency Disorders (CVID)	PLOS ONE			English	Article							MEMORY B-CELLS; CHEMOKINE RECEPTOR EXPRESSION; CD1D EXPRESSION; CUTTING EDGE; SUBSETS; DEFICIENCY; INFECTION; TRAFFICKING; RESPONSES; CAPACITY	Common variable immunodeficiency disorder (CVID) is the commonest cause of primary antibody failure in adults and children, and characterized clinically by recurrent bacterial infections and autoimmune manifestations. Several innate immune defects have been described in CVID, but no study has yet investigated the frequency, phenotype or function of the key regulatory cell population, natural killer T (NKT) cells. We measured the frequencies and subsets of NKT cells in patients with CVID and compared these to healthy controls. Our results show a skewing of NKT cell subsets, with CD4+ NKT cells at higher frequencies, and CD8+ NKT cells at lower frequencies. However, these cells were highly activated and expression CD161. The NKT cells had a higher expression of CCR5 and concomitantly expression of CCR5+CD69+CXCR6 suggesting a compensation of the remaining population of NKT cells for rapid effector action.	[Carvalho, Karina I.; Bruno, Fernanda R.; Kallas, Esper G.] Univ Sao Paulo, Sao Paulo, Brazil; [Melo, Karina M.; Costa-Carvalho, Beatriz T.; Kallas, Esper G.] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Snyder-Cappione, Jennifer E.] Univ Calif San Francisco, San Francisco Gen Hosp, Div Expt Med, San Francisco, CA USA	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Carvalho, KI (corresponding author), Univ Sao Paulo, Sao Paulo, Brazil.	esper.kallas@gmail.com	Kallas, Esper G/C-9539-2012; Carvalho, Karina IL/J-6789-2012; Nixon, Douglas/AAU-5734-2020	Carvalho, Karina IL/0000-0002-7763-8139; Nixon, Douglas/0000-0002-2801-1786; Kallas, Esper/0000-0003-2026-6925; Snyder-Cappione, Jennifer/0000-0002-0941-5582	National Institutes of Health [R01-AI52731, AI060379]; Fogarty International Center [D43 TW00003]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazilian Ministry of Science and Technology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060379, R01AI052731, R21AI060379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazilian Ministry of Science and Technology(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health, grant #R01-AI52731 and AI060379 and The Fogarty International Center, grant #D43 TW00003. KIC's Ph.D. scholarship has been provided by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazilian Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agematsu K, 2002, CLIN IMMUNOL, V103, P34, DOI 10.1006/clim.2001.5197; Aspalter RM, 2000, CLIN EXP IMMUNOL, V121, P506, DOI 10.1046/j.1365-2249.2000.01317.x; Au-Yeung BB, 2007, J IMMUNOL, V179, P111, DOI 10.4049/jimmunol.179.1.111; Bayry J, 2004, BLOOD, V104, P2441, DOI 10.1182/blood-2004-04-1325; Berzins SP, 2005, EUR J IMMUNOL, V35, P1399, DOI 10.1002/eji.200425958; Carnaud C, 1999, J IMMUNOL, V163, P4647; Chan WL, 2003, IMMUNOL LETT, V85, P159, DOI 10.1016/S0165-2478(02)00223-7; CHAPEL H, 2008, BLOOD; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Falcone M, 2004, J IMMUNOL, V172, P5908, DOI 10.4049/jimmunol.172.10.5908; Fulcher DA, 2009, CLIN EXP IMMUNOL, V157, P365, DOI 10.1111/j.1365-2249.2009.03973.x; Galli G, 2007, P NATL ACAD SCI USA, V104, P3984, DOI 10.1073/pnas.0700191104; Germanov E, 2008, J IMMUNOL, V181, P81, DOI 10.4049/jimmunol.181.1.81; Haymore BR, 2008, AUTOIMMUN REV, V7, P309, DOI 10.1016/j.autrev.2007.11.024; Jiang XF, 2005, J IMMUNOL, V175, P2051, DOI 10.4049/jimmunol.175.4.2051; Johnston B, 2003, J IMMUNOL, V171, P2960, DOI 10.4049/jimmunol.171.6.2960; Kim CH, 2001, J CLIN INVEST, V107, P595, DOI 10.1172/JCI11902; Kim CH, 2002, BLOOD, V100, P11, DOI 10.1182/blood-2001-12-0196; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Lang GA, 2008, BLOOD, V111, P2158, DOI 10.1182/blood-2007-10-117309; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Lin YL, 2005, EUR J IMMUNOL, V35, P879, DOI 10.1002/eji.200425495; Livaditi O, 2007, IMMUNOL LETT, V114, P103, DOI 10.1016/j.imlet.2007.09.006; Oishi Y, 2001, J RHEUMATOL, V28, P275; Petri B, 2008, J IMMUNOL, V180, P6439, DOI 10.4049/jimmunol.180.10.6439; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; Roederer M, 2001, CYTOMETRY, V45, P194, DOI 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C; Rolf J, 2008, MOL IMMUNOL, V45, P2607, DOI 10.1016/j.molimm.2007.12.022; Sandberg JK, 2004, P NATL ACAD SCI USA, V101, P7058, DOI 10.1073/pnas.0305986101; Sandberg JK, 2003, EUR J IMMUNOL, V33, P588, DOI 10.1002/eji.200323707; Seino K, 2005, J EXP MED, V202, P1623, DOI 10.1084/jem.20051600; Snyder-Cappione JE, 2007, J INFECT DIS, V195, P1361, DOI 10.1086/513567; Thomas SY, 2003, J IMMUNOL, V171, P2571, DOI 10.4049/jimmunol.171.5.2571; van der Vliet HJJ, 2002, J IMMUNOL, V168, P1490, DOI 10.4049/jimmunol.168.3.1490; Viallard JF, 2006, CLIN IMMUNOL, V119, P51, DOI 10.1016/j.clim.2005.11.011; Vodjgani M, 2007, J INVEST ALLERG CLIN, V17, P321; Yanagihara Y, 1999, CLIN EXP IMMUNOL, V118, P131; Zhang L, 2007, J ALLERGY CLIN IMMUN, V120, P1178, DOI 10.1016/j.jaci.2007.10.001	38	29	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12652	10.1371/journal.pone.0012652	http://dx.doi.org/10.1371/journal.pone.0012652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844745	Green Published, Green Submitted, gold			2022-12-27	WOS:000281687200015
J	Rybina, OY; Pasyukova, EG				Rybina, Olga Yu.; Pasyukova, Elena G.			A Naturally Occurring Polymorphism at Drosophila melanogaster Lim3 Locus, a Homolog of Human LHX3/4, Affects Lim3 Transcription and Fly Lifespan	PLOS ONE			English	Article							POLYCOMB GROUP PROTEINS; CENTRAL-NERVOUS-SYSTEM; REAL-TIME PCR; GENE-EXPRESSION; TATA-BOX; STATISTICAL-ANALYSIS; REGULATORY REGIONS; ADAPTIVE EVOLUTION; PROMOTER ELEMENT; CORE PROMOTER	Lim3 encodes an RNA polymerase II transcription factor with a key role in neuron specification. It was also identified as a candidate gene that affects lifespan. These pleiotropic effects indicate the fundamental significance of the potential interplay between neural development and lifespan control. The goal of this study was to analyze the causal relationships between Lim3 structural variations, and gene expression and lifespan changes, and to provide insights into regulatory pathways controlling lifespan. Fifty substitution lines containing second chromosomes from a Drosophila natural population were used to analyze the association between lifespan and sequence variation in the 5'-regulatory region, and first exon and intron of Lim3A, in which we discovered multiple transcription start sites (TSS). The core and proximal promoter organization for Lim3A and a previously unknown mRNA named Lim3C were described. A haplotype of two markers in the Lim3A regulatory region was significantly associated with variation in lifespan. We propose that polymorphisms in the regulatory region affect gene transcription, and consequently lifespan. Indeed, five polymorphic markers located within 380 to 680 bp of the Lim3A major TSS, including two markers associated with lifespan variation, were significantly associated with the level of Lim3A transcript, as evaluated by real time RT-PCR in embryos, adult heads, and testes. A naturally occurring polymorphism caused a six-fold change in gene transcription and a 25% change in lifespan. Markers associated with long lifespan and intermediate Lim3A transcription were present in the population at high frequencies. We hypothesize that polymorphic markers associated with Lim3A expression are located within the binding sites for proteins that regulate gene function, and provide general rather than tissue-specific regulation of transcription, and that intermediate levels of Lim3A expression confer a selective advantage and longer lifespan.	[Rybina, Olga Yu.; Pasyukova, Elena G.] RAS, Inst Mol Genet, Moscow 117901, Russia	Russian Academy of Sciences	Rybina, OY (corresponding author), RAS, Inst Mol Genet, Moscow 117901, Russia.	egpas@rambler.ru	Pasyukova, Elena G/I-8377-2017; Rybina, Olga/AAL-4026-2021	Rybina, Olga/0000-0002-3431-162X	Russian Fund of Basic Research (RFBR) [09-04-01181-a]; Russian Academy of Sciences (RAS); Ministry of Education and Science of RF [II317]	Russian Fund of Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences (RAS)(Russian Academy of Sciences); Ministry of Education and Science of RF(Ministry of Education and Science, Russian Federation)	Russian Fund of Basic Research (RFBR) grant #09-04-01181-a for EGP; Grant form Russian Academy of Sciences (RAS) Program "Biodiversity'' for EGP; Ministry of Education and Science of RF Program "Scientific and Educational Human Resources of Innovative Russia'' Contract #II317. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Babu M. Madan, 2007, V3, P66, DOI 10.1159/000107604; Bedford T, 2009, P NATL ACAD SCI USA, V106, P1133, DOI 10.1073/pnas.0812009106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blastyak A, 2006, MOL CELL BIOL, V26, P1434, DOI 10.1128/MCB.26.4.1434-1444.2006; Brody T, 2000, DEV BIOL, V226, P34, DOI 10.1006/dbio.2000.9829; Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Carbone MA, 2006, CURR BIOL, V16, P912, DOI 10.1016/j.cub.2006.03.051; Cenci C, 2005, DEVELOPMENT, V132, P3835, DOI 10.1242/dev.01932; Certel SJ, 2004, DEVELOPMENT, V131, P5429, DOI 10.1242/dev.01418; Chavous DA, 2001, P NATL ACAD SCI USA, V98, P14814, DOI 10.1073/pnas.251446498; Davis W, 2000, DEV BIOL, V218, P275, DOI 10.1006/dbio.1999.9486; De Luca M, 2003, NAT GENET, V34, P429, DOI 10.1038/ng1218; De Velasco B, 2004, DEV BIOL, V274, P280, DOI 10.1016/j.ydbio.2004.07.015; Duan ZJ, 2002, P NATL ACAD SCI USA, V99, P5509, DOI 10.1073/pnas.072084499; FU YX, 1993, GENETICS, V133, P693; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Jordan KW, 2006, GENETICS, V174, P271, DOI 10.1534/genetics.106.058099; Kuchar Jennifer, 2007, BIOS, V78, P62, DOI 10.1893/0005-3155(2007)78[62:RAHSFC]2.0.CO;2; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Landgraf M, 2006, INT REV NEUROBIOL, V75, P33, DOI 10.1016/S0074-7742(06)75002-4; MACKAY TFC, 2005, HDB BIOL AGING, P181; Maeder ML, 2007, GENETICS, V177, P1377, DOI 10.1534/genetics.107.070425; Moriyama EN, 1996, MOL BIOL EVOL, V13, P261, DOI 10.1093/oxfordjournals.molbev.a025563; Morrow G, 2004, FASEB J, V18, P598, DOI 10.1096/fj.03-0860fje; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Mullen RD, 2007, MOL CELL ENDOCRINOL, V265, P190, DOI 10.1016/j.mce.2006.12.019; NEI M, 1981, GENETICS, V97, P145; Netchine I, 2000, NAT GENET, V25, P182, DOI 10.1038/76041; Papatsenko DA, 2002, GENOME RES, V12, P470, DOI 10.1101/gr.212502. Article published online before print in February ; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003; Pfaeffle RW, 2007, J CLIN ENDOCR METAB, V92, P1909, DOI 10.1210/jc.2006-2177; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Roshina NV, 2007, RUSS J GENET+, V43, P275, DOI 10.1134/S1022795407030088; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schmidt PS, 2000, P NATL ACAD SCI USA, V97, P10861, DOI 10.1073/pnas.190338897; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Sharma VK, 2007, PHYSIOL GENOMICS, V31, P96, DOI 10.1152/physiolgenomics.00183.2006; Shen Jie, 2009, BMC Geriatr, V9, P56, DOI 10.1186/1471-2318-9-56; Sloop KW, 1999, MOL ENDOCRINOL, V13, P2212, DOI 10.1210/me.13.12.2212; Spokony RF, 2009, J COMP NEUROL, V517, P15, DOI 10.1002/cne.22119; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; TAJIMA F, 1989, GENETICS, V123, P585; Tajima T, 2007, ENDOCR J, V54, P637, DOI 10.1507/endocrj.K06-200; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Tuckfield A, 2002, MOL CELL BIOL, V22, P1936, DOI 10.1128/MCB.22.6.1936-1946.2002; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wech I, 1999, DEV GENES EVOL, V209, P370, DOI 10.1007/s004270050266; Yaden BC, 2006, ENDOCRINOLOGY, V147, P324, DOI 10.1210/en.2005-0970; Yasuhara JC, 2005, P NATL ACAD SCI USA, V102, P10958, DOI 10.1073/pnas.0503424102; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	56	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12621	10.1371/journal.pone.0012621	http://dx.doi.org/10.1371/journal.pone.0012621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20838645	Green Published, Green Submitted, gold			2022-12-27	WOS:000281631300041
J	Scherling, C; Roscher, C; Giavalisco, P; Schulze, ED; Weckwerth, W				Scherling, Christian; Roscher, Christiane; Giavalisco, Patrick; Schulze, Ernst-Detlef; Weckwerth, Wolfram			Metabolomics Unravel Contrasting Effects of Biodiversity on the Performance of Individual Plant Species	PLOS ONE			English	Article							EXPERIMENTAL GRASSLANDS; MASS-SPECTROMETRY; PRODUCTIVITY RELATIONSHIP; GAS-CHROMATOGRAPHY; DIVERSITY; ECOSYSTEMS; RICHNESS; NITROGEN; TIME; MANIPULATIONS	In spite of evidence for positive diversity-productivity relationships increasing plant diversity has highly variable effects on the performance of individual plant species, but the mechanisms behind these differential responses are far from being understood. To gain deeper insights into the physiological responses of individual plant species to increasing plant diversity we performed systematic untargeted metabolite profiling on a number of herbs derived from a grassland biodiversity experiment (Jena Experiment). The Jena Experiment comprises plots of varying species number (1, 2, 4, 8, 16 and 60) and number and composition of functional groups (1 to 4; grasses, legumes, tall herbs, small herbs). In this study the metabolomes of two tall-growing herbs (legume: Medicago x varia; non-legume: Knautia arvensis) and three small-growing herbs (legume: Lotus corniculatus; non-legumes: Bellis perennis, Leontodon autumnalis) in plant communities of increasing diversity were analyzed. For metabolite profiling we combined gas chromatography coupled to time-of-flight mass spectrometry (GC-TOF-MS) and UPLC coupled to FT-ICR-MS (LC-FT-MS) analyses from the same sample. This resulted in several thousands of detected m/z-features. ANOVA and multivariate statistical analysis revealed 139 significantly changed metabolites (30 by GC-TOF-MS and 109 by LC-FT-MS). The small-statured plants L. autumnalis, B. perennis and L. corniculatus showed metabolic response signatures to increasing plant diversity and species richness in contrast to tall-statured plants. Key-metabolites indicated C-and N-limitation for the non-leguminous small-statured species B. perennis and L. autumnalis, while the metabolic signature of the small-statured legume L. corniculatus indicated facilitation by other legumes. Thus, metabolomic analysis provided evidence for negative effects of resource competition on the investigated small-statured herbs that might mechanistically explain their decreasing performance with increasing plant diversity. In contrast, taller species often becoming dominant in mixed plant communities did not show modified metabolite profiles in response to altered resource availability with increasing plant diversity. Taken together, our study demonstrates that metabolite profiling is a strong diagnostic tool to assess individual metabolic phenotypes in response to plant diversity and ecophysiological adjustment.	[Scherling, Christian] Tech Univ Carolo Wilhelmina Braunschweig, Dept Bioinformat & Biochem, Braunschweig, Germany; [Roscher, Christiane; Schulze, Ernst-Detlef] Max Planck Inst Biogeochem, Jena, Germany; [Roscher, Christiane] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Giavalisco, Patrick] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Weckwerth, Wolfram] Univ Vienna, Dept Mol Syst Biol MOSYS, Vienna, Austria	Braunschweig University of Technology; Max Planck Society; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Max Planck Society; University of Vienna	Scherling, C (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Dept Bioinformat & Biochem, Braunschweig, Germany.	wolfram.weckwerth@univie.ac.at	Weckwerth, Wolfram/G-5811-2010; Schulze, Ernst-Detlef/K-9627-2014	Weckwerth, Wolfram/0000-0002-9719-6358	German Science Foundation [FOR 456]; Friedrich Schiller University Jena; Max Planck Society; University of Vienna	German Science Foundation(German Research Foundation (DFG)); Friedrich Schiller University Jena; Max Planck Society(Max Planck Society); University of Vienna	The Jena Experiment is funded by the German Science Foundation (FOR 456) with additional support from the Friedrich Schiller University Jena and the Max Planck Society. The presented project was further financially supported by the Max Planck Society and the University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Dassler A, 2008, PLANT BIOLOGY, V10, P573, DOI 10.1111/j.1438-8677.2008.00073.x; Ellenberg H., 1988, VEGETATION ECOLOGY C; Erban Alexander, 2007, V358, P19, DOI 10.1007/978-1-59745-244-1_2; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; GAUDET CL, 1988, NATURE, V334, P242, DOI 10.1038/334242a0; Giavalisco P, 2009, ANAL CHEM, V81, P6546, DOI 10.1021/ac900979e; Giavalisco P, 2008, ANAL CHEM, V80, P9417, DOI 10.1021/ac8014627; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; HilleRisLambers J, 2004, ECOL LETT, V7, P661, DOI 10.1111/j.1461-0248.2004.00623.x; Hoehenwarter W, 2008, PROTEOMICS, V8, P4214, DOI 10.1002/pmic.200701047; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Kind T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-234; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Koricheva J, 2000, OECOLOGIA, V125, P271, DOI 10.1007/s004420000450; Lorentzen S, 2008, PERSPECT PLANT ECOL, V10, P73, DOI 10.1016/j.ppees.2007.12.001; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Marquard E, 2009, J ECOL, V97, P696, DOI 10.1111/j.1365-2745.2009.01521.x; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Morgenthal K, 2005, METABOLOMICS, V1, P109, DOI 10.1007/s11306-005-4430-9; Muller-Westermeier G, 2000, BERICHTE DTSCH WETTE, V213; Oelmann Y, 2007, J ENVIRON QUAL, V36, P396, DOI 10.2134/jeq2006.0217; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2011, PLANT BIOLOGY, V13, P134, DOI 10.1111/j.1438-8677.2010.00338.x; Roscher C, 2007, OECOLOGIA, V154, P535, DOI 10.1007/s00442-007-0846-4; Roscher C, 2011, OECOLOGIA, V165, P437, DOI 10.1007/s00442-010-1735-9; ROTHMALER R, 2002, EXKURSIONSFLORA DEUT, V4; Spehn EM, 2000, FUNCT ECOL, V14, P326, DOI 10.1046/j.1365-2435.2000.00437.x; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Stitt M, 1999, PLANT CELL ENVIRON, V22, P583, DOI 10.1046/j.1365-3040.1999.00386.x; STITT M, 1994, PLANT CELL ENVIRON, V17, P465, DOI 10.1111/j.1365-3040.1994.tb00144.x; Temperton VM, 2007, OECOLOGIA, V151, P190, DOI 10.1007/s00442-006-0576-z; Thein S, 2008, BASIC APPL ECOL, V9, P475, DOI 10.1016/j.baae.2007.08.004; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Viant MR, 2008, MOL BIOSYST, V4, P980, DOI 10.1039/b805354e; Weckwerth W, 2004, PROTEOMICS, V4, P78, DOI 10.1002/pmic.200200500; Weckwerth W, 2003, ANNU REV PLANT BIOL, V54, P669, DOI 10.1146/annurev.arplant.54.031902.135014; Weinig C, 2000, AM J BOT, V87, P1660, DOI 10.2307/2656743	42	68	68	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12569	10.1371/journal.pone.0012569	http://dx.doi.org/10.1371/journal.pone.0012569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830202	Green Published, gold			2022-12-27	WOS:000281631300009
J	van Eekelen, M; Overvoorde, J; van Rooijen, C; den Hertog, J				van Eekelen, Mark; Overvoorde, John; van Rooijen, Carina; den Hertog, Jeroen			Identification and Expression of the Family of Classical Protein-Tyrosine Phosphatases in Zebrafish	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; GENE; MAINTENANCE; MUTATIONS; KINASES; DOMAIN; MEG2; IA-2; LAR	Protein-tyrosine phosphatases (PTPs) have an important role in cell survival, differentiation, proliferation, migration and other cellular processes in conjunction with protein-tyrosine kinases. Still relatively little is known about the function of PTPs in vivo. We set out to systematically identify all classical PTPs in the zebrafish genome and characterize their expression patterns during zebrafish development. We identified 48 PTP genes in the zebrafish genome by BLASTing of human PTP sequences. We verified all in silico hits by sequencing and established the spatio-temporal expression patterns of all PTPs by in situ hybridization of zebrafish embryos at six distinct developmental stages. The zebrafish genome encodes 48 PTP genes. 14 human orthologs are duplicated in the zebrafish genome and 3 human orthologs were not identified. Based on sequence conservation, most zebrafish orthologues of human PTP genes were readily assigned. Interestingly, the duplicated form of ptpn23, a catalytically inactive PTP, has lost its PTP domain, indicating that PTP activity is not required for its function, or that ptpn23b has lost its PTP domain in the course of evolution. All 48 PTPs are expressed in zebrafish embryos. Most PTPs are maternally provided and are broadly expressed early on. PTP expression becomes progressively restricted during development. Interestingly, some duplicated genes retained their expression pattern, whereas expression of other duplicated genes was distinct or even mutually exclusive, suggesting that the function of the latter PTPs has diverged. In conclusion, we have identified all members of the family of classical PTPs in the zebrafish genome and established their expression patterns. This is the first time the expression patterns of all members of the large family of PTP genes have been established in a vertebrate. Our results provide the first step towards elucidation of the function of the family of classical PTPs.	[van Eekelen, Mark; Overvoorde, John; van Rooijen, Carina; den Hertog, Jeroen] Hubrecht Inst, KNAW, Utrecht, Netherlands; [van Eekelen, Mark; Overvoorde, John; van Rooijen, Carina; den Hertog, Jeroen] Univ Med Ctr Utrecht, Utrecht, Netherlands; [den Hertog, Jeroen] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University - Excl LUMC	van Eekelen, M (corresponding author), Hubrecht Inst, KNAW, Utrecht, Netherlands.	j.denhertog@hubrecht.eu	van Eekelen, Mark/A-6225-2010		Research Council for Earth and Life Sciences [ALW 815.02.007]; Netherlands Organisation for Scientific Research (NWO)	Research Council for Earth and Life Sciences(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported in part by a grant from the Research Council for Earth and Life Sciences (ALW 815.02.007) with financial aid from the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerne B, 2004, DEVELOPMENT, V131, P3391, DOI 10.1242/dev.01222; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Cai T, 2001, DIABETOLOGIA, V44, P81, DOI 10.1007/s001250051583; Cao LG, 1998, J BIOL CHEM, V273, P21077, DOI 10.1074/jbc.273.33.21077; Chiusaroli R, 2004, MOL BIOL CELL, V15, P234, DOI 10.1091/mbc.e03-04-0207; Cho CY, 2006, CELL METAB, V3, P367, DOI 10.1016/j.cmet.2006.03.006; Driever W, 1996, DEVELOPMENT, V123, P37; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Faucherre A, 2008, ONCOGENE, V27, P1079, DOI 10.1038/sj.onc.1210730; Flicek Paul, 2010, Nucleic Acids Res, V38, pD557, DOI 10.1093/nar/gkp972; Force A, 1999, GENETICS, V151, P1531; Gingras MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005105; Haffter P, 1996, DEVELOPMENT, V123, P1; Hendriks WJAJ, 2008, FEBS J, V275, P816, DOI 10.1111/j.1742-4658.2008.06249.x; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jopling C, 2007, PLOS GENET, V3, P2468, DOI 10.1371/journal.pgen.0030225; KIMMEL CB, 1986, SCIENCE, V231, P365, DOI 10.1126/science.231.4736.365; KIMMEL CB, 1989, NATURE, V337, P358, DOI 10.1038/337358a0; LAFORGIA S, 1991, P NATL ACAD SCI USA, V88, P5036, DOI 10.1073/pnas.88.11.5036; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Saito K, 2007, J BIOL CHEM, V282, P15170, DOI 10.1074/jbc.M608682200; Tamura H, 2006, NEUROSCI LETT, V399, P33, DOI 10.1016/j.neulet.2006.01.045; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; van der Sar A, 2001, MECH DEVELOP, V109, P423, DOI 10.1016/S0925-4773(01)00545-7; Van Vactor D, 1998, CURR OPIN GENET DEV, V8, P112, DOI 10.1016/S0959-437X(98)80070-1; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; VANEEKELEN M, 2010, DEV BIOL; Wang YC, 2005, J EXP MED, V202, P1587, DOI 10.1084/jem.20051108; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Whited JL, 2007, DEVELOPMENT, V134, P43, DOI 10.1242/dev.02718; Wienholds E, 2002, SCIENCE, V297, P99, DOI 10.1126/science.1071762; Wyatt L, 2007, J CELL BIOL, V178, P1223, DOI 10.1083/jcb.200705035; Zahn TR, 2001, J COMP NEUROL, V429, P127, DOI 10.1002/1096-9861(20000101)429:1&lt;127::AID-CNE10&gt;3.0.CO;2-H	39	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12573	10.1371/journal.pone.0012573	http://dx.doi.org/10.1371/journal.pone.0012573			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838449	gold, Green Published			2022-12-27	WOS:000281627700020
J	Pereira, ER; Liao, N; Neale, GA; Hendershot, LM				Pereira, Ethel R.; Liao, Nan; Neale, Geoff A.; Hendershot, Linda M.			Transcriptional and Post-Transcriptional Regulation of Proangiogenic Factors by the Unfolded Protein Response	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ENDOPLASMIC-RETICULUM STRESS; PLASMA-CELL DIFFERENTIATION; MESSENGER-RNA STABILITY; NF-KAPPA-B; TUMOR-GROWTH; FACTOR XBP-1; IN-VIVO; TRANSMEMBRANE PROTEIN; ANGIOGENIC FACTORS	Background: Inadequate extracellular conditions can adversely affect the environment of the ER and impinge on the maturation of nascent proteins. The resultant accumulation of unfolded proteins activates a signal transduction pathway, known as the unfolded protein response, which serves primarily to protect the cell during stress and helps restore homeostasis to the ER. Principal Findings: Microarray analysis of the unfolded protein response in a human medulloblastoma cell line treated with thapsigargin revealed that, in addition to known targets, a large number of proangiogenic factors were up-regulated. RealTime PCR analyses confirmed that four of these factors, VEGFA, FGF2, angiogenin and IL8, were transcriptionally upregulated in multiple cell lines by various ER stress inducers. Our studies on VEGFA regulation revealed that XBP-1(S), a UPRinducible transcription factor, bound to two regions on the VEGFA promoter, and analysis of XBP-1 null mouse embryonic fibroblasts revealed that it contributes to VEGFA expression in response to ER stress. ATF4, another UPR-inducible transcription factor, also binds to the VEGFA gene, although its contribution to VEGFA transcription appeared to be fairly modest. We also found that VEGFA mRNA stability is increased in response to UPR activation, via activation of AMP kinase, demonstrating that increased mRNA levels occur at two regulatory points. In keeping with the mRNA levels, we found that VEGFA protein is secreted at levels as high as or higher than that achieved in response to hypoxia. Conclusions and Significance: Our results indicate that the UPR plays a significant role in inducing positive regulators of angiogenesis. It also regulates VEGFA expression at transcriptional, post-transcriptional and post-translational levels and is likely to have widespread implications for promoting angiogenesis in response to normal physiological cues as well as in pathological conditions like cancer.	[Pereira, Ethel R.; Liao, Nan; Hendershot, Linda M.] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Pereira, Ethel R.; Liao, Nan; Hendershot, Linda M.] Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA; [Neale, Geoff A.] St Jude Childrens Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Pereira, ER (corresponding author), St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.	linda.hendershot@stjude.org	Hendershot, Linda/N-8124-2018	Hendershot, Linda/0000-0002-5473-0274; Pereira, Ethel/0000-0003-0562-4536	National Institutes of Health [CA23099]; Cancer Center CORE [CA21765]; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765, P01CA023099] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center CORE; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA23099 (LMH), the Cancer Center CORE Grant CA21765, and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chakraborty G, 2008, CANCER RES, V68, P152, DOI 10.1158/0008-5472.CAN-07-2126; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Drogat B, 2007, CANCER RES, V67, P6700, DOI 10.1158/0008-5472.CAN-06-3235; DuRose JB, 2009, MOL CELL BIOL, V29, P4295, DOI 10.1128/MCB.00260-09; Eggert A, 2000, CLIN CANCER RES, V6, P1900; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2001, ACTA HAEMATOL-BASEL, V106, P148, DOI 10.1159/000046610; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Ghosh R, PLOS ONE, V5, pe9575; Grobben B, 2002, CELL TISSUE RES, V310, P257, DOI 10.1007/s00441-002-0651-7; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; HENDERSHOT LM, 1995, MOL BIOL CELL, V6, P283, DOI 10.1091/mbc.6.3.283; Hickey MM, 2006, CURR TOP DEV BIOL, V76, P217, DOI 10.1016/S0070-2153(06)76007-0; Hu M, 2008, EUR J CANCER, V44, P2760, DOI 10.1016/j.ejca.2008.09.038; IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; JACOBSEN PF, 1985, J NEUROPATH EXP NEUR, V44, P472, DOI 10.1097/00005072-198509000-00003; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Levy AP, 1996, J BIOL CHEM, V271, P2746, DOI 10.1074/jbc.271.5.2746; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Linn T, 2006, CLIN EXP IMMUNOL, V144, P179, DOI 10.1111/j.1365-2249.2006.03066.x; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Nissen NN, 1998, AM J PATHOL, V152, P1445; Oskolkova OV, 2008, BLOOD, V112, P330, DOI 10.1182/blood-2007-09-112870; Ozawa K, 2001, CANCER RES, V61, P4206; Ozawa K, 2001, J CLIN INVEST, V108, P41, DOI 10.1172/JCI11772; Pages G, 2000, J BIOL CHEM, V275, P26484, DOI 10.1074/jbc.M002104200; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Relf M, 1997, CANCER RES, V57, P963; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Romero-Ramirez L, 2009, TRANSL ONCOL, V2, P31, DOI 10.1593/tlo.08211; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roybal CN, 2005, J BIOL CHEM, V280, P20331, DOI 10.1074/jbc.M411275200; Roybal CN, 2004, J BIOL CHEM, V279, P14844, DOI 10.1074/jbc.M312948200; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shen Y, 2007, J IMMUNOL, V179, P2969, DOI 10.4049/jimmunol.179.5.2969; STEIN I, 1995, MOL CELL BIOL, V15, P5363; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yen ML, 2005, MOL PHARMACOL, V68, P1061, DOI 10.1124/mol.104.010082; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yun H, 2005, J BIOL CHEM, V280, P9963, DOI 10.1074/jbc.M412994200; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002	65	106	109	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12521	10.1371/journal.pone.0012521	http://dx.doi.org/10.1371/journal.pone.0012521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824063	Green Published, gold, Green Submitted			2022-12-27	WOS:000281480900009
J	Boyden, SE; Kunkel, LM				Boyden, Steven E.; Kunkel, Louis M.			High-Density Genomewide Linkage Analysis of Exceptional Human Longevity Identifies Multiple Novel Loci	PLOS ONE			English	Article							SYNDROME GENE-PRODUCT; GENETICALLY COMPLEX TRAITS; APOLIPOPROTEIN-E GENOTYPE; AFFECTED RELATIVE PAIRS; MONTE-CARLO PROCEDURES; TOLL-LIKE RECEPTOR-4; LIFE-SPAN EXTENSION; EMPIRICAL P-VALUES; SACCHAROMYCES-CEREVISIAE; MYOCARDIAL-INFARCTION	Background: Human lifespan is approximately 25% heritable, and genetic factors may be particularly important for achieving exceptional longevity. Accordingly, siblings of centenarians have a dramatically higher probability of reaching extreme old age than the general population. Methodology/Principal Findings: To map the loci conferring a survival advantage, we performed the second genomewide linkage scan on human longevity and the first using a high-density marker panel of single nucleotide polymorphisms. By systematically testing a range of minimum age cutoffs in 279 families with multiple long-lived siblings, we identified a locus on chromosome 3p24-22 with a genomewide significant allele-sharing LOD score of 4.02 (empirical P = 0.037) and a locus on chromosome 9q31-34 with a highly suggestive LOD score of 3.89 (empirical P = 0.054). The empirical P value for the combined result was 0.002. A third novel locus with a LOD score of 4.05 on chromosome 12q24 was detected in a subset of the data, and we also obtained modest evidence for a previously reported interval on chromosome 4q22-25. Conclusions/Significance: Our linkage data should facilitate the discovery of both common and rare variants that determine genetic variability in lifespan.	[Boyden, Steven E.; Kunkel, Louis M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Boyden, Steven E.; Kunkel, Louis M.] Childrens Hosp Boston, Div Genet, Program Genom, Boston, MA USA; [Boyden, Steven E.; Kunkel, Louis M.] Childrens Hosp Boston, Manton Ctr Orphan Dis Res, Boston, MA USA; [Kunkel, Louis M.] Childrens Hosp Boston, Howard Hughes Med Inst, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Boyden, SE (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	kunkel@enders.tch.harvard.edu			Howard Hughes Medical Institute; Intellectual and Developmental Disabilities Research Center [NIH-P30-HD18655]; Neuromuscular Disease Project [NIH-P50-NS40828]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS040828] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intellectual and Developmental Disabilities Research Center; Neuromuscular Disease Project; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Howard Hughes Medical Institute. Microarray genotyping experiments were performed using equipment in the Microarray Core Facility of the Molecular Genetics Core Facility at Children's Hospital Boston, supported by NIH-P30-HD18655 through the Intellectual and Developmental Disabilities Research Center and NIH-P50-NS40828 through the Neuromuscular Disease Project. LMK is an investigator with the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Anselmi CV, 2009, REJUV RES, V12, P95, DOI 10.1089/rej.2008.0827; Balistreri CR, 2009, J CLIN IMMUNOL, V29, P406, DOI 10.1007/s10875-009-9297-5; Balistreri CR, 2004, JAMA-J AM MED ASSOC, V292, P2339, DOI 10.1001/jama.292.19.2339; BARR CS, 1994, LANCET, V343, P327, DOI 10.1016/S0140-6736(94)91164-9; Bathum L, 2005, EUR J HUM GENET, V13, P1154, DOI 10.1038/sj.ejhg.5201468; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beekman M, 2006, J GERONTOL A-BIOL, V61, P355, DOI 10.1093/gerona/61.4.355; Bell F.C., 2005, NUMBER 11 11536 SOCI, P26; Boyles AL, 2005, HUM HERED, V59, P220, DOI 10.1159/000087122; Broman KW, 2003, AM J HUM GENET, V72, P496, DOI 10.1086/346175; Browner WS, 2004, AM J MED, V117, P851, DOI 10.1016/j.amjmed.2004.06.033; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cordell HJ, 2004, AM J HUM GENET, V74, P1294, DOI 10.1086/421476; Cournil A, 2001, TRENDS GENET, V17, P233, DOI 10.1016/S0168-9525(01)02306-X; Davignon J, 1988, Trans Am Clin Climatol Assoc, V99, P100; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Ewens WJ, 2003, AM J HUM GENET, V72, P496, DOI 10.1086/346174; FISHMAN PM, 1978, AM J HUM GENET, V30, P308; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Franceschi C, 2007, ANN NY ACAD SCI, V1100, P21, DOI 10.1196/annals.1395.003; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Geesaman BJ, 2003, P NATL ACAD SCI USA, V100, P14115, DOI 10.1073/pnas.1936249100; Gerdes LU, 2000, GENET EPIDEMIOL, V19, P202, DOI 10.1002/1098-2272(200010)19:3<202::AID-GEPI2>3.0.CO;2-Q; Gessert CE, 2002, J AM GERIATR SOC, V50, P1561, DOI 10.1046/j.1532-5415.2002.50413.x; Gudmundsson H, 2000, EUR J HUM GENET, V8, P743, DOI 10.1038/sj.ejhg.5200527; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Harikumar KB, 2008, CELL CYCLE, V7, P1020, DOI 10.4161/cc.7.8.5740; Hayden KM, 2005, J AM GERIATR SOC, V53, P935, DOI 10.1111/j.1532-5415.2005.53301.x; Hitt R, 1999, LANCET, V354, P652, DOI 10.1016/S0140-6736(99)01987-X; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Humbert N, 2009, CANCER RES, V69, P4101, DOI 10.1158/0008-5472.CAN-08-2864; Jo JY, 2005, J AGR FOOD CHEM, V53, P2489, DOI 10.1021/jf048524w; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Karasik D, 2004, J GERONTOL A-BIOL, V59, P218; Kerber RA, 2001, J GERONTOL A-BIOL, V56, pB130, DOI 10.1093/gerona/56.3.B130; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; KRUGLYAK L, 1995, AM J HUM GENET, V56, P1212; Kuningas M, 2007, EUR J HUM GENET, V15, P294, DOI 10.1038/sj.ejhg.5201766; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lebel M, 1999, J BIOL CHEM, V274, P37795, DOI 10.1074/jbc.274.53.37795; Lewis SJ, 2004, INT J EPIDEMIOL, V33, P962, DOI 10.1093/ije/dyh214; LI Y, 2009, HUM MOL GENET; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lunetta KL, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S13; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Martin GM, 2007, PLOS GENET, V3, P1121, DOI 10.1371/journal.pgen.0030125; Michishita E, 1998, BIOCHEM BIOPH RES CO, V253, P667, DOI 10.1006/bbrc.1998.9832; Middleton FA, 2004, AM J HUM GENET, V74, P886, DOI 10.1086/420775; Mohler PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001051; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Nebel A, 2005, P NATL ACAD SCI USA, V102, P7906, DOI 10.1073/pnas.0408670102; Nebel A, 2007, MECH AGEING DEV, V128, P409, DOI 10.1016/j.mad.2007.04.001; Nemani M, 2000, MECH AGEING DEV, V119, P25, DOI 10.1016/S0047-6374(00)00165-2; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Neville MJ, 2007, J GERONTOL A-BIOL, V62, P202, DOI 10.1093/gerona/62.2.202; North BV, 2003, AM J HUM GENET, V72, P498, DOI 10.1086/346173; North BV, 2002, AM J HUM GENET, V71, P439, DOI 10.1086/341527; Novelli V, 2008, BIOGERONTOLOGY, V9, P85, DOI 10.1007/s10522-007-9116-4; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Perls TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/pnas.122587599; Puca AA, 2001, P NATL ACAD SCI USA, V98, P10505, DOI 10.1073/pnas.181337598; PUDDU PE, 1986, J ELECTROCARDIOL, V19, P203, DOI 10.1016/S0022-0736(86)80030-9; Reed T, 2004, J GERONTOL A-BIOL, V59, P227; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1992, AM J HUM GENET, V51, P673; RISCH N, 1996, SCIENCE, V273, P1517; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; SAURO J, 2005, P HUM FACT ERG SOC 4, V5, P2100; Sawcer SJ, 2004, HUM MOL GENET, V13, P1943, DOI 10.1093/hmg/ddh202; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; SCHOUTEN EG, 1991, CIRCULATION, V84, P1516, DOI 10.1161/01.CIR.84.4.1516; Sedlacek K, 2008, CIRC-CARDIOVASC GENE, V1, P93, DOI 10.1161/CIRCGENETICS.108.792192; Shojaee S, 2008, AM J HUM GENET, V82, P1375, DOI 10.1016/j.ajhg.2008.05.005; Tan QH, 2004, GENET EPIDEMIOL, V26, P245, DOI 10.1002/gepi.10304; Tan QH, 2006, AGEING RES REV, V5, P371, DOI 10.1016/j.arr.2005.10.002; Temime-Smaali N, 2008, EMBO J, V27, P1513, DOI 10.1038/emboj.2008.74; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; UTERMANN G, 1984, HUM GENET, V65, P237, DOI 10.1007/BF00286509; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; VAUPEL JW, 1985, AM STAT, V39, P176, DOI 10.2307/2683925; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855; Wang T, 2005, HUM HERED, V60, P134, DOI 10.1159/000089867; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	96	17	20	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12432	10.1371/journal.pone.0012432	http://dx.doi.org/10.1371/journal.pone.0012432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824210	Green Submitted, Green Published, gold			2022-12-27	WOS:000281405300009
J	Cernuda-Morollon, E; Millan, J; Shipman, M; Marelli-Berg, FM; Ridley, AJ				Cernuda-Morollon, Eva; Millan, Jaime; Shipman, Mark; Marelli-Berg, Federica M.; Ridley, Anne J.			Rac Activation by the T-Cell Receptor Inhibits T Cell Migration	PLOS ONE			English	Article							RHO-GTPASES; IMMUNOLOGICAL SYNAPSE; MICROTUBULE GROWTH; CRUCIAL ROLE; PHOSPHORYLATION; POLARITY; ERM; POLARIZATION; LYMPHOCYTES; SIGNALS	Background: T cell migration is essential for immune responses and inflammation. Activation of the T-cell receptor (TCR) triggers a migration stop signal to facilitate interaction with antigen-presenting cells and cell retention at inflammatory sites, but the mechanisms responsible for this effect are not known. Methodology/Principal Findings: Migrating T cells are polarized with a lamellipodium at the front and uropod at the rear. Here we show that transient TCR activation induces prolonged inhibition of T-cell migration. TCR pre-activation leads to cells with multiple lamellipodia and lacking a uropod even after removal of the TCR signal. A similar phenotype is induced by expression of constitutively active Rac1, and TCR signaling activates Rac1. TCR signaling acts via Rac to reduce phosphorylation of ezrin/radixin/moesin proteins, which are required for uropod formation, and to increase stathmin phosphorylation, which regulates microtubule stability. T cell polarity and migration is partially restored by inhibiting Rac or by expressing constitutively active moesin. Conclusions/Significance: We propose that transient TCR signaling induces sustained inhibition of T cell migration via Rac1, increased stathmin phosphorylation and reduced ERM phosphorylation which act together to inhibit T-cell migratory polarity.	[Cernuda-Morollon, Eva] Hosp Univ Cent Asturias, Histocompatibil & Transplantat Unit, Oviedo, Spain; [Millan, Jaime] Ctr Biol Mol Severo Ochoa, Dept Cell Biol & Immunol, Canto Blanco, Spain; [Shipman, Mark] Univ Oxford, Ludwig Inst Canc Res, Oxford, England; [Marelli-Berg, Federica M.] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London, England; [Ridley, Anne J.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	Central University Hospital Asturias; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Ludwig Institute for Cancer Research; University of Oxford; Imperial College London; University of London; King's College London	Cernuda-Morollon, E (corresponding author), Hosp Univ Cent Asturias, Histocompatibil & Transplantat Unit, Oviedo, Spain.	anne.ridley@kcl.ac.uk		Millan, Jaime/0000-0003-3107-147X; Ridley, Anne/0000-0001-8186-5708	British Heart Foundation Funding Source: Medline; MRC [G0901084] Funding Source: UKRI; British Heart Foundation [RG/09/002/26425] Funding Source: researchfish; Medical Research Council [G0901084] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Croker BA, 2002, IMMUNOL CELL BIOL, V80, P231, DOI 10.1046/j.1440-1711.2002.01077.x; del Pozo MA, 1999, EUR J IMMUNOL, V29, P3609; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gardiner EM, 2002, CURR BIOL, V12, P2029, DOI 10.1016/S0960-9822(02)01334-9; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Geisler C, 2004, CRIT REV IMMUNOL, V24, P67; Gomez TS, 2008, ADV IMMUNOL, V97, P1, DOI 10.1016/S0065-2776(08)00001-1; Guo F, 2008, BLOOD, V112, P1767, DOI 10.1182/blood-2008-01-132068; Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kaminuma O, 2001, MOL CELL BIOL, V21, P3126, DOI 10.1128/MCB.21.9.3126-3136.2001; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lord GM, 2002, J LEUKOCYTE BIOL, V72, P330; Marelli-Berg FM, 1999, J IMMUNOL, V162, P696; Millan J, 2006, NAT CELL BIOL, V8, P113, DOI 10.1038/ncb1356; Mirenda V, 2007, BLOOD, V109, P2968, DOI 10.1182/blood-2006-10-050724; Mustelin T, 2006, SCIENCE, V313, P1902, DOI 10.1126/science.1133578; Nijhara R, 2004, J IMMUNOL, V173, P4985, DOI 10.4049/jimmunol.173.8.4985; Nishihara H, 2002, BIOCHEM BIOPH RES CO, V296, P716, DOI 10.1016/S0006-291X(02)00931-2; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Ratner S, 1997, J IMMUNOL, V159, P1063; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sanchez-Madrid F, 2009, NAT REV MOL CELL BIO, V10, P353, DOI 10.1038/nrm2680; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Stepanova T, 2003, J NEUROSCI, V23, P2655; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; STRAHLER JR, 1992, J IMMUNOL, V149, P1191; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Wells Claire M., 2004, V294, P31; Wells CM, 2004, J CELL SCI, V117, P1259, DOI 10.1242/jcs.00997; Westermann J, 2001, ANN INTERN MED, V135, P279, DOI 10.7326/0003-4819-135-4-200108210-00013; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yu H, 2001, J EXP MED, V194, P915, DOI 10.1084/jem.194.7.915	51	44	46	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12393	10.1371/journal.pone.0012393	http://dx.doi.org/10.1371/journal.pone.0012393			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811629	gold, Green Published, Green Submitted			2022-12-27	WOS:000281234700018
J	Yin, JX; Tu, JL; Lin, HJ; Shi, FD; Liu, RL; Zhao, CB; Coons, SW; Kuniyoshi, S; Shi, JO				Yin, Jun-xiang; Tu, Jiang-long; Lin, Hao-jie; Shi, Fu-dong; Liu, Ru-lan; Zhao, Chong-bo; Coons, Stephen W.; Kuniyoshi, Sandra; Shi, Jiong			Centrally Administered Pertussis Toxin Inhibits Microglia Migration to the Spinal Cord and Prevents Dissemination of Disease in an EAE Mouse Model	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; PROGRESSIVE MULTIPLE-SCLEROSIS; AUTOREACTIVE T-CELLS; SENSITIZED B6 MICE; IN-VITRO; INTRACEREBRAL INJECTION; ACTIVATION	Experimental autoimmune encephalomyelitis (EAE) models are important vehicles for studying the effect of infectious elements such as Pertussis toxin (PTx) on disease processes related to acute demyelinating encephalomyelitis (ADEM) or multiple sclerosis (MS). PTx has pleotropic effects on the immune system. This study was designed to investigate the effects of PTx administered intracerebroventricularly (icv) in preventing downstream immune cell infiltration and demyelination of the spinal cord. Methods and Findings: EAE was induced in C57BL/6 mice with MOG35-55. PTx icv at seven days post MOG immunization resulted in mitigation of clinical motor symptoms, minimal T cell infiltration, and the marked absence of axonal loss and demyelination of the spinal cord. Integrity of the blood brain barrier was compromised in the brain whereas spinal cord BBB integrity remained intact. PTx icv markedly increased microglia numbers in the brain preventing their migration to the spinal cord. An in vitro transwell study demonstrated that PTx inhibited migration of microglia. Conclusion: Centrally administered PTx abrogated migration of microglia in EAE mice, limiting the inflammatory cytokine milieu to the brain and prevented dissemination of demyelination. The effects of PTx icv warrants further investigation and provides an attractive template for further study regarding the pleotropic effects of infectious elements such as PTx in the pathogenesis of autoimmune disorders.	[Yin, Jun-xiang; Tu, Jiang-long; Lin, Hao-jie; Shi, Fu-dong; Liu, Ru-lan; Zhao, Chong-bo; Kuniyoshi, Sandra; Shi, Jiong] Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA; [Coons, Stephen W.] Barrow Neurol Inst, Dept Pathol, Phoenix, AZ 85013 USA	Barrow Neurological Institute; Barrow Neurological Institute	Yin, JX (corresponding author), Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA.	jiong.shi@chw.edu			NIAID NIH HHS [R01 AI083294] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083294] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahn M, 2001, NEUROSCI LETT, V308, P41, DOI 10.1016/S0304-3940(01)01979-6; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Bai B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007869; Bhasin M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-10; Brown DA, 2007, J COMP NEUROL, V502, P236, DOI 10.1002/cne.21307; Carson MJ, 2002, GLIA, V40, P218, DOI 10.1002/glia.10145; Chen X, 2006, EUR J IMMUNOL, V36, P671, DOI 10.1002/eji.200535353; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Floden AM, 2007, J NEUROSCI METH, V164, P218, DOI 10.1016/j.jneumeth.2007.04.018; GITIK M, 2010, FASEB J; Giuliani F, 2005, J NEUROIMMUNOL, V165, P83, DOI 10.1016/j.jneuroim.2005.04.020; Guo X, 2007, NEUROSCI RES, V59, P457, DOI 10.1016/j.neures.2007.08.014; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Herrero-Herranz E, 2008, NEUROBIOL DIS, V30, P162, DOI 10.1016/j.nbd.2008.01.001; Ho TS, 1997, J BIOMED SCI, V4, P300, DOI 10.1007/BF02258354; Hofstetter HH, 2002, J IMMUNOL, V169, P117, DOI 10.4049/jimmunol.169.1.117; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Jack C, 2005, J NEUROSCI RES, V81, P363, DOI 10.1002/jnr.20482; Kerfoot SM, 2004, J IMMUNOL, V173, P7070, DOI 10.4049/jimmunol.173.11.7070; Kuerten S, 2007, J NEUROIMMUNOL, V189, P31, DOI 10.1016/j.jneuroim.2007.06.016; Matyszak MK, 1999, EUR J IMMUNOL, V29, P3063, DOI 10.1002/(SICI)1521-4141(199910)29:10<3063::AID-IMMU3063>3.0.CO;2-G; Merodio M, 2000, J DRUG TARGET, V8, P289, DOI 10.3109/10611860008997907; Muller DM, 2005, J NEUROIMMUNOL, V160, P162, DOI 10.1016/j.jneuroim.2004.11.011; MUNOZ JJ, 1984, CELL IMMUNOL, V86, P541, DOI 10.1016/0008-8749(84)90410-6; Nolte C, 1996, NEUROSCIENCE, V73, P1091, DOI 10.1016/0306-4522(96)00106-6; Nutile-McMenemy N, 2007, J NEUROCHEM, V103, P2035, DOI 10.1111/j.1471-4159.2007.04889.x; Okuda Y, 1999, J NEUROIMMUNOL, V101, P188, DOI 10.1016/S0165-5728(99)00139-3; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Prineas JW, 2001, ANN NEUROL, V50, P646, DOI 10.1002/ana.1255; Raivich G, 1998, J NEUROSCI, V18, P5804; Raivich G, 2004, BRAIN RES REV, V46, P261, DOI 10.1016/j.brainresrev.2004.06.006; RAKIC LM, 1989, METAB BRAIN DIS, V4, P9, DOI 10.1007/BF00999488; Saito H, 2004, PROG LIPID RES, V43, P350, DOI 10.1016/j.plipres.2004.05.002; Shi FD, 2000, J IMMUNOL, V165, P3099, DOI 10.4049/jimmunol.165.6.3099; STERNBERGER LA, 1986, J HISTOCHEM CYTOCHEM, V34, P599, DOI 10.1177/34.5.3517144; Tanuma N, 2006, ACTA NEUROPATHOL, V112, P195, DOI 10.1007/s00401-006-0083-7; Tonra JR, 2001, J COMP NEUROL, V430, P131; Tran EH, 1998, J IMMUNOL, V161, P3767; Tsai CY, 1997, CLIN EXP IMMUNOL, V109, P127, DOI 10.1046/j.1365-2249.1997.4251326.x	41	33	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12400	10.1371/journal.pone.0012400	http://dx.doi.org/10.1371/journal.pone.0012400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811645	Green Published, gold, Green Submitted			2022-12-27	WOS:000281234700024
J	Krueger, BJ; Varzavand, K; Cooper, JJ; Price, DH				Krueger, Brian J.; Varzavand, Katayoun; Cooper, Jeffrey J.; Price, David H.			The Mechanism of Release of P-TEFb and HEXIM1 from the 7SK snRNP by Viral and Cellular Activators Includes a Conformational Change in 7SK	PLOS ONE			English	Article							POLYMERASE-II TRANSCRIPTION; RNA-POLYMERASE; HIV-1 TAT; CYCLIN T1; POL-II; INTERACTING DOMAIN; ANDROGEN RECEPTOR; ELONGATION; PROTEIN; COMPLEX	Background: The positive transcription elongation factor, P-TEFb, is required for the production of mRNAs, however the majority of the factor is present in the 7SK snRNP where it is inactivated by HEXIM1. Expression of HIV-1 Tat leads to release of P-TEFb and HEXIM1 from the 7SK snRNP in vivo, but the release mechanisms are unclear. Methodology/Principal Findings: We developed an in vitro P-TEFb release assay in which the 7SK snRNP immunoprecipitated from HeLa cell lysates using antibodies to LARP7 was incubated with potential release factors. We found that P-TEFb was directly released from the 7SK snRNP by HIV-1 Tat or the P-TEFb binding region of the cellular activator Brd4. Glycerol gradient sedimentation analysis was used to demonstrate that the same Brd4 protein transfected into HeLa cells caused the release of P-TEFb and HEXIM1 from the 7SK snRNP in vivo. Although HEXIM1 binds tightly to 7SK RNA in vitro, release of P-TEFb from the 7SK snRNP is accompanied by the loss of HEXIM1. Using a chemical modification method, we determined that concomitant with the release of HEXIM1, 7SK underwent a major conformational change that blocks re-association of HEXIM1. Conclusions/Significance: Given that promoter proximally paused polymerases are present on most human genes, understanding how activators recruit P-TEFb to those genes is critical. Our findings reveal that the two tested activators can extract P-TEFb from the 7SK snRNP. Importantly, we found that after P-TEFb is extracted a dramatic conformational change occurred in 7SK concomitant with the ejection of HEXIM1. Based on our findings, we hypothesize that reincorporation of HEXIM1 into the 7SK snRNP is likely the regulated step of reassembly of the 7SK snRNP containing P-TEFb.	[Krueger, Brian J.; Price, David H.] Univ Iowa, Mol & Cellular Biol Program, Iowa City, IA 52242 USA; [Varzavand, Katayoun; Cooper, Jeffrey J.; Price, David H.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Krueger, BJ (corresponding author), Univ Iowa, Mol & Cellular Biol Program, Iowa City, IA 52242 USA.	david-price@uiowa.edu	Price, David H/F-6173-2010	Price, David/0000-0002-5597-385X	National Institutes of Health [GM35500]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI074392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM35500 to D. H. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Bark-Jones SJ, 2006, ONCOGENE, V25, P1775, DOI 10.1038/sj.onc.1209205; Barrandon C, 2007, MOL CELL BIOL, V27, P6996, DOI 10.1128/MCB.00975-07; Bayfield MA, 2010, BBA-GENE REGUL MECH, V1799, P365, DOI 10.1016/j.bbagrm.2010.01.011; Belanger F, 2009, J MOL BIOL, V386, P1094, DOI 10.1016/j.jmb.2009.01.015; Bhattacharya R, 2002, GENE EXPRESSION, V10, P243, DOI 10.3727/000000002783992398; Bieniasz PD, 1998, EMBO J, V17, P7056, DOI 10.1093/emboj/17.23.7056; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; Byers SA, 2005, J BIOL CHEM, V280, P16360, DOI 10.1074/jbc.M500424200; Byun JS, 2009, P NATL ACAD SCI USA, V106, P19292, DOI 10.1073/pnas.0905469106; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen B, 2008, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2008/01/007; Chen YH, 2000, RNA, V6, P1277, DOI 10.1017/S1355838200000285; CHIN DJ, 1991, J VIROL, V65, P1758, DOI 10.1128/JVI.65.4.1758-1764.1991; Cho SY, 2009, EMBO J, V28, P1407, DOI 10.1038/emboj.2009.99; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Diribarne G, 2009, RNA BIOL, V6, P122, DOI 10.4161/rna.6.2.8115; DOW EC, 2010, J CELL; Durand LO, 2008, J VIROL, V82, P10591, DOI 10.1128/JVI.01242-08; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; Egloff S, 2006, MOL CELL BIOL, V26, P630, DOI 10.1128/MCB.26.2.630-642.2006; Endo S, 1989, Virus Genes, V3, P99; Fan H, 1997, CELL, V88, P707, DOI 10.1016/S0092-8674(00)81913-3; Garber ME, 1998, COLD SPRING HARB SYM, V63, P371, DOI 10.1101/sqb.1998.63.371; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Giacinti C, 2006, J CELL PHYSIOL, V206, P807, DOI 10.1002/jcp.20523; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; He N, 2008, MOL CELL, V29, P588, DOI 10.1016/j.molcel.2008.01.003; Hogg JR, 2007, RNA, V13, P868, DOI 10.1261/rna.565207; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Kanamaru H, 2001, NEUROSCI LETT, V300, P9, DOI 10.1016/S0304-3940(01)01527-0; Kanazawa S, 2003, ONCOGENE, V22, P5707, DOI 10.1038/sj.onc.1206800; Kanazawa S, 2000, IMMUNITY, V12, P61, DOI 10.1016/S1074-7613(00)80159-4; Krueger BJ, 2008, NUCLEIC ACIDS RES, V36, P2219, DOI 10.1093/nar/gkn061; KUPPUSWAMY M, 1989, NUCLEIC ACIDS RES, V17, P3551, DOI 10.1093/nar/17.9.3551; Lee DK, 2003, J STEROID BIOCHEM, V84, P41, DOI 10.1016/S0960-0760(03)00005-0; Lee DK, 2001, J BIOL CHEM, V276, P9978, DOI 10.1074/jbc.M002285200; Li QT, 2007, NUCLEIC ACIDS RES, V35, P2503, DOI 10.1093/nar/gkm150; Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Markert A, 2008, EMBO REP, V9, P569, DOI 10.1038/embor.2008.72; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; MARZ M, 2009, MOL BIOL EVOL; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2008, CELL CYCLE, V7, P1539, DOI 10.4161/cc.7.11.6006; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; RUBEN S, 1989, J VIROL, V63, P1; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Simone C, 2002, ONCOGENE, V21, P4137, DOI 10.1038/sj.onc.1205493; Sinha KM, 1998, J BIOL CHEM, V273, P6853, DOI 10.1074/jbc.273.12.6853; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Urano E, 2008, FEBS LETT, V582, P4053, DOI 10.1016/j.febslet.2008.10.047; Van Herreweghe E, 2007, EMBO J, V26, P3570, DOI 10.1038/sj.emboj.7601783; WASSARMAN DA, 1991, MOL CELL BIOL, V11, P3432, DOI 10.1128/MCB.11.7.3432; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wittmann BM, 2005, ONCOGENE, V24, P5576, DOI 10.1038/sj.onc.1208728; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhou MS, 2006, J VIROL, V80, P4781, DOI 10.1128/JVI.80.10.4781-4791.2006; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181	73	76	91	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12335	10.1371/journal.pone.0012335	http://dx.doi.org/10.1371/journal.pone.0012335			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808803	Green Published, Green Submitted, gold			2022-12-27	WOS:000281153500017
J	Bergmann-Leitner, ES; Mease, RM; De La Vega, P; Savranskaya, T; Polhemus, M; Ockenhouse, C; Angov, E				Bergmann-Leitner, Elke S.; Mease, Ryan M.; De La Vega, Patricia; Savranskaya, Tatyana; Polhemus, Mark; Ockenhouse, Christian; Angov, Evelina			Immunization with Pre-Erythrocytic Antigen CelTOS from Plasmodium falciparum Elicits Cross-Species Protection against Heterologous Challenge with Plasmodium berghei	PLOS ONE			English	Article							CIRCUMSPOROZOITE PROTEIN; MALARIA INFECTION; GENETIC DIVERSITY; IMMUNE-RESPONSES; VACCINE; SPOROZOITES; EFFICACY; PARASITES; CHILDREN; AFFINITY	Background: The Plasmodium protein Cell-traversal protein for ookinetes and sporozoites (CelTOS) plays an important role in cell traversal of host cells in both, mosquito and vertebrates, and is required for successful malaria infections. CelTOS is highly conserved among the Plasmodium species, suggesting an important functional role across all species. Therefore, targeting the immune response to this highly conserved protein and thus potentially interfering with its biological function may result in protection against infection even by heterologous species of Plasmodium. Methodology/Principal Findings: To test this hypothesis, we developed a recombinant codon-harmonized P. falciparum CelTOS protein that can be produced to high yields in the E. coli expression system. Inbred Balb/c and outbred CD-1 mice were immunized with various doses of the recombinant protein adjuvanted with Montanide ISA 720 and characterized using in vitro and in vivo analyses. Conclusions/Significance: Immunization with PfCelTOS resulted in potent humoral and cellular immune responses and most importantly induced sterile protection against a heterologous challenge with P. berghei sporozoites in a proportion of both inbred and outbred mice. The biological activity of CelTOS-specific antibodies against the malaria parasite is likely linked to the impairment of sporozoite motility and hepatocyte infectivity. The results underscore the potential of this antigen as a pre-erythrocytic vaccine candidate and demonstrate for the first time a malaria vaccine that is cross-protective between species.	[Bergmann-Leitner, Elke S.; Mease, Ryan M.; De La Vega, Patricia; Polhemus, Mark; Ockenhouse, Christian; Angov, Evelina] Walter Reed Army Inst Res, Div Malaria Vaccine Dev, US Mil Malaria Vaccine Program, Silver Spring, MD USA; [Savranskaya, Tatyana] Walter Reed Army Inst Res, Div Entomol, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Bergmann-Leitner, ES (corresponding author), Walter Reed Army Inst Res, Div Malaria Vaccine Dev, US Mil Malaria Vaccine Program, Silver Spring, MD USA.	Elke.BergmannLeitner@us.army.mil	Bergmann-Leitner, Elke/I-5431-2019; Bergmann-Leitner, Elke S./B-3548-2011	Bergmann-Leitner, Elke/0000-0002-8571-8956; Bergmann-Leitner, Elke S./0000-0002-8571-8956	United States Agency for International Development [936-3118, GHA-T-00-08-00007-01]; United States Army Medical Research and Material Command	United States Agency for International Development(United States Agency for International Development (USAID)); United States Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported by the United States Agency for International Development under project number 936-3118, award number GHA-T-00-08-00007-01, and by the United States Army Medical Research and Material Command. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Bergmann-Leitner ES, 2005, INT IMMUNOL, V17, P245, DOI 10.1093/intimm/dxh205; COCHRANE AH, 1976, J IMMUNOL, V116, P859; Darko CA, 2005, INFECT IMMUN, V73, P287, DOI 10.1128/IAI.73.1.287-297.2005; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Kaiser K, 2004, MOL MICROBIOL, V51, P1221, DOI 10.1046/j.1365-2958.2003.03909.x; Kariu T, 2006, MOL MICROBIOL, V59, P1369, DOI 10.1111/j.1365-2958.2005.05024.x; KIM YT, 1974, CLIN EXP IMMUNOL, V17, P329; Leitner WW, 1997, J IMMUNOL, V159, P6112; LEITNER WW, 2010, MAL J, V9, pE145; NUSSENZWEIG RS, 1969, NATURE, V222, P488, DOI 10.1038/222488a0; Ockenhouse EB, 2009, AM J TROP MED HYG, V81, P260; OZAKI LS, 1984, J PARASITOL, V70, P831, DOI 10.2307/3281779; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Sacarlal J, 2009, J INFECT DIS, V200, P329, DOI 10.1086/600119; Scheiblhofer S, 2001, EUR J IMMUNOL, V31, P692, DOI 10.1002/1521-4141(200103)31:3&lt;692::AID-IMMU692&gt;3.0.CO;2-Y; Sharma Shobhona, 2008, Journal of Vector Borne Diseases, V45, P1; SINA BJ, 1983, EXPT PARASITOL, V77, P122; STEWART MJ, 1988, J PROTOZOOL, V35, P389, DOI 10.1111/j.1550-7408.1988.tb04115.x; Takala SL, 2009, PARASITE IMMUNOL, V31, P560, DOI 10.1111/j.1365-3024.2009.01138.x; Vulliet R, 1996, BIOTECHNIQUES, V20, P797; Weiss R, 2000, INFECT IMMUN, V68, P5914, DOI 10.1128/IAI.68.10.5914-5919.2000	23	81	92	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12294	10.1371/journal.pone.0012294	http://dx.doi.org/10.1371/journal.pone.0012294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808868	Green Submitted, gold, Green Published			2022-12-27	WOS:000281075500022
J	Teramoto, W; Hidaka, S; Sugita, Y				Teramoto, Wataru; Hidaka, Souta; Sugita, Yoichi			Sounds Move a Static Visual Object	PLOS ONE			English	Article							MOTION PERCEPTION; AUDITORY MOTION; INTEGRATION; DIRECTION; CAPTURE; VISION; CORTEX	Background: Vision provides the most salient information with regard to stimulus motion, but audition can also provide important cues that affect visual motion perception. Here, we show that sounds containing no motion or positional cues can induce illusory visual motion perception for static visual objects. Methodology/Principal Findings: Two circles placed side by side were presented in alternation producing apparent motion perception and each onset was accompanied by a tone burst of a specific and unique frequency. After exposure to this visual apparent motion with tones for a few minutes, the tones became drivers for illusory motion perception. When the flash onset was synchronized to tones of alternating frequencies, a circle blinking at a fixed location was perceived as lateral motion in the same direction as the previously exposed apparent motion. Furthermore, the effect lasted at least for a few days. The effect was well observed at the retinal position that was previously exposed to apparent motion with tone bursts. Conclusions/Significance: The present results indicate that strong association between sound sequence and visual motion is easily formed within a short period and that, after forming the association, sounds are able to trigger visual motion perception for a static visual object.	[Teramoto, Wataru] Tohoku Univ, Dept Psychol, Grad Sch Arts & Letters, Sendai, Miyagi 980, Japan; [Teramoto, Wataru] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi 980, Japan; [Hidaka, Souta] Rikkyo Univ, Dept Psychol, Niiza, Saitama, Japan; [Sugita, Yoichi] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki, Japan	Tohoku University; Tohoku University; Rikkyo University; National Institute of Advanced Industrial Science & Technology (AIST)	Teramoto, W (corresponding author), Tohoku Univ, Dept Psychol, Grad Sch Arts & Letters, Sendai, Miyagi 980, Japan.	y.sugita@aist.go.jp	Hidaka, Souta/L-6393-2019	Hidaka, Souta/0000-0001-6727-5322	Ministry of Education, Science, and Culture, JAPAN [19001004]	Ministry of Education, Science, and Culture, JAPAN(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Specially Promoted Research (19001004) of the Ministry of Education, Science, and Culture, JAPAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Alais D, 2004, COGNITIVE BRAIN RES, V19, P185, DOI 10.1016/j.cogbrainres.2003.11.011; Alink A, 2008, J NEUROSCI, V28, P2690, DOI 10.1523/JNEUROSCI.2980-07.2008; Backus BT, 2007, VISION RES, V47, P919, DOI 10.1016/j.visres.2006.12.008; Dong CJ, 1999, NAT NEUROSCI, V2, P863, DOI 10.1038/13161; FAVREAU OE, 1972, SCIENCE, V176, P78, DOI 10.1126/science.176.4030.78; Freeman E, 2008, CURR BIOL, V18, P1262, DOI 10.1016/j.cub.2008.07.066; Hidaka S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008188; Lewis JW, 2000, CEREB CORTEX, V10, P873, DOI 10.1093/cercor/10.9.873; Meyer GF, 2001, NEUROREPORT, V12, P2557, DOI 10.1097/00001756-200108080-00053; Qi HJ, 2006, P NATL ACAD SCI USA, V103, P483, DOI 10.1073/pnas.0506728103; Seitz AR, 2007, CURR OPIN NEUROBIOL, V17, P148, DOI 10.1016/j.conb.2007.02.004; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Shams L, 2008, TRENDS COGN SCI, V12, P411, DOI 10.1016/j.tics.2008.07.006; Shimojo S, 1997, VISION RES, V37, P1575, DOI 10.1016/S0042-6989(96)00313-6; Soto-Faraco S, 2004, J EXP PSYCHOL HUMAN, V30, P330, DOI 10.1037/0096-1523.30.2.330; TERAMOTO W, 2010, NEUROSCI LE IN PRESS; Vroomen J, 2003, PSYCHOL SCI, V14, P357, DOI 10.1111/1467-9280.24431; Watanabe K, 2001, PSYCHOL SCI, V12, P109, DOI 10.1111/1467-9280.00319	19	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12255	10.1371/journal.pone.0012255	http://dx.doi.org/10.1371/journal.pone.0012255			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	640TN	20808861	Green Published, Green Submitted, gold			2022-12-27	WOS:000281075500005
J	Charlton, NL; Houston, AI				Charlton, Nicholas L.; Houston, Alasdair I.			What Currency Do Bumble Bees Maximize?	PLOS ONE			English	Article							LIFE-SPAN; FLIGHT SPEED; ENERGY; TIME; EFFICIENCY; COLONY; SIZE; CONSTRAINTS; PERFORMANCE; COSTS	In modelling bumble bee foraging, net rate of energetic intake has been suggested as the appropriate currency. The foraging behaviour of honey bees is better predicted by using efficiency, the ratio of energetic gain to expenditure, as the currency. We re-analyse several studies of bumble bee foraging and show that efficiency is as good a currency as net rate in terms of predicting behaviour. We suggest that future studies of the foraging of bumble bees should be designed to distinguish between net rate and efficiency maximizing behaviour in an attempt to discover which is the more appropriate currency.	[Charlton, Nicholas L.; Houston, Alasdair I.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Bristol	Charlton, NL (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	Nic.Charlton@bristol.ac.uk			Biotechnology and Biological Sciences Research Council (BBSRC)	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is part of a PhD studentship funded by the Biotechnology and Biological Sciences Research Council (BBSRC) (http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENTON T, 2006, BUMBLEBEES NATURAL H, V11; BEST LS, 1982, EVOLUTION, V36, P70, DOI 10.1111/j.1558-5646.1982.tb05011.x; CARTAR RV, 1990, BEHAV ECOL SOCIOBIOL, V27, P377, DOI 10.1007/BF00164009; CARTAR RV, 1992, J ANIM ECOL, V61, P225, DOI 10.2307/5525; CRESSWELL JE, 1990, OECOLOGIA, V82, P450, DOI 10.1007/BF00319785; Cresswell JE, 2000, ECOL ENTOMOL, V25, P249, DOI 10.1046/j.1365-2311.2000.00264.x; Denny AJ, 2001, ANIM BEHAV, V62, P139, DOI 10.1006/anbe.2001.1718; Dyer AG, 2006, NATURE, V442, P525, DOI 10.1038/442525a; FEWELL JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P401, DOI 10.1007/BF00294977; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; HEDENSTROM A, 1995, PHILOS T ROY SOC B, V348, P471, DOI 10.1098/rstb.1995.0082; HEINRICH B, 1983, AM ZOOL, V23, P273; HODGES CM, 1981, ANIM BEHAV, V29, P1166, DOI 10.1016/S0003-3472(81)80068-1; HOUSTON A, 1988, AM NAT, V131, P107, DOI 10.1086/284776; HOUSTON AI, 1987, J THEOR BIOL, V124, P251, DOI 10.1016/S0022-5193(87)80115-7; Houston AI, 1995, BEHAV ECOL, V6, P393, DOI 10.1093/beheco/6.4.393; Houston AI, 2006, J AVIAN BIOL, V37, P545; KACELNIK A, 1986, BEHAV ECOL SOCIOBIOL, V19, P19, DOI 10.1007/BF00303838; KACELNIK A, 1984, ANIM BEHAV, V32, P609, DOI 10.1016/S0003-3472(84)80298-5; KACELNIK A, 1984, J ANIM ECOL, V53, P283, DOI 10.2307/4357; KAMMER AE, 1974, J EXP BIOL, V61, P219; McNamara JM, 1997, AM NAT, V150, P603, DOI 10.1086/286084; NEUKIRCH A, 1982, J COMP PHYSIOL, V146, P35, DOI 10.1007/BF00688714; Pelletier L, 2003, OIKOS, V103, P688, DOI 10.1034/j.1600-0706.2003.12592.x; PLOWRIGHT RC, 1968, INSECT SOC, V15, P171, DOI 10.1007/BF02223465; PYKE GH, 1979, ANIM BEHAV, V27, P1167, DOI 10.1016/0003-3472(79)90064-2; PYKE GH, 1980, THEOR POPUL BIOL, V17, P232, DOI 10.1016/0040-5809(80)90008-8; Rands SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002007; Schmid-Hempel R, 1998, FUNCT ECOL, V12, P22, DOI 10.1046/j.1365-2435.1998.00153.x; SCHMIDHEMPEL P, 1985, BEHAV ECOL SOCIOBIOL, V17, P61, DOI 10.1007/BF00299430; SCHMIDHEMPEL P, 1988, J ANIM ECOL, V57, P509, DOI 10.2307/4921; Shepard ELC, 2009, P ROY SOC B-BIOL SCI, V276, P3149, DOI 10.1098/rspb.2009.0683; Spaethe J, 2002, INSECT SOC, V49, P142, DOI 10.1007/s00040-002-8293-z; Stephens D.W., 1986, pi; Tofilski A, 2009, INSECT SOC, V56, P359, DOI 10.1007/s00040-009-0031-3; van Gils JA, 2006, ARDEA, V94, P409; WADDINGTON KD, 1989, J INSECT BEHAV, V2, P91, DOI 10.1007/BF01053620; WELHAM CVJ, 1988, BEHAV ECOL SOCIOBIOL, V23, P75, DOI 10.1007/BF00299890; WILSON EO, 1971, INSECT SOC, V11; WOLF TJ, 1989, J ANIM ECOL, V58, P943, DOI 10.2307/5134; YDENBERG RC, 1994, BEHAV ECOL, V5, P28, DOI 10.1093/beheco/5.1.28	41	19	19	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12186	10.1371/journal.pone.0012186	http://dx.doi.org/10.1371/journal.pone.0012186			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808437	gold, Green Published, Green Submitted			2022-12-27	WOS:000280968000013
J	Yoneda, M; Guillaume, V; Sato, H; Fujita, K; Georges-Courbot, MC; Ikeda, F; Omi, M; Muto-Terao, Y; Wild, TF; Kai, C				Yoneda, Misako; Guillaume, Vanessa; Sato, Hiroki; Fujita, Kentaro; Georges-Courbot, Marie-Claude; Ikeda, Fusako; Omi, Mio; Muto-Terao, Yuri; Wild, T. Fabian; Kai, Chieko			The Nonstructural Proteins of Nipah Virus Play a Key Role in Pathogenicity in Experimentally Infected Animals	PLOS ONE			English	Article							NEWCASTLE-DISEASE-VIRUS; ACCESSORY C PROTEINS; VIRAL-RNA SYNTHESIS; V-PROTEIN; SENDAI-VIRUS; NUCLEAR ACCUMULATION; INTERFERON EVASION; PREVENTING STAT1; W-PROTEIN; PARAMYXOVIRUS	Nipah virus (NiV) P gene encodes P protein and three accessory proteins (V, C and W). It has been reported that all four P gene products have IFN antagonist activity when the proteins were transiently expressed. However, the role of those accessory proteins in natural infection with NiV remains unknown. We generated recombinant NiVs lacking V, C or W protein, rNiV(V-), rNiV(C-), and rNiV(W-), respectively, to analyze the functions of these proteins in infected cells and the implications in in vivo pathogenicity. All the recombinants grew well in cell culture, although the maximum titers of rNiV(V-) and rNiV(C-) were lower than the other recombinants. The rNiV(V-), rNiV(C-) and rNiV(W-) suppressed the IFN response as well as the parental rNiV, thereby indicating that the lack of each accessory protein does not significantly affect the inhibition of IFN signaling in infected cells. In experimentally infected golden hamsters, rNiV(V-) and rNiV(C-) but not the rNiV(W-) virus showed a significant reduction in virulence. These results suggest that V and C proteins play key roles in NiV pathogenicity, and the roles are independent of their IFN-antagonist activity. This is the first report that identifies the molecular determinants of NiV in pathogenicity in vivo.	[Yoneda, Misako; Sato, Hiroki; Ikeda, Fusako; Omi, Mio; Kai, Chieko] Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Tokyo 108, Japan; [Fujita, Kentaro; Muto-Terao, Yuri; Kai, Chieko] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo, Japan; [Guillaume, Vanessa; Wild, T. Fabian] INSERM, U758, F-69008 Lyon, France; [Georges-Courbot, Marie-Claude] Lab P4 INSERM Jean Merieux, Lyon, France	University of Tokyo; University of Tokyo; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Yoneda, M (corresponding author), Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Tokyo 108, Japan.	yone@ims.u-tokyo.ac.jp; ckai@ims.u-tokyo.ac.jp			Ministry of Education, Science, Culture, and Sports of Japan	Ministry of Education, Science, Culture, and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants in aid from the Ministry of Education, Science, Culture, and Sports of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664; Butler D, 2004, NATURE, V429, P7, DOI 10.1038/429007b; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; CURRAN J, 1992, VIROLOGY, V189, P647, DOI 10.1016/0042-6822(92)90588-G; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; Enserink M, 2004, SCIENCE, V303, P1121; Epstein JH, 2006, EMERG INFECT DIS, V12, P1178, DOI 10.3201/eid1207.050799; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Garcin D, 1999, J VIROL, V73, P6559, DOI 10.1128/JVI.73.8.6559-6565.1999; Garcin D, 1997, VIROLOGY, V238, P424, DOI 10.1006/viro.1997.8836; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Gotoh B, 1999, FEBS LETT, V459, P205, DOI 10.1016/S0014-5793(99)01241-7; Hagmaier K, 2006, J GEN VIROL, V87, P3649, DOI 10.1099/vir.0.82261-0; Harcourt BH, 2000, VIROLOGY, V271, P334, DOI 10.1006/viro.2000.0340; Harcourt BH, 2005, EMERG INFECT DIS, V11, P1594, DOI 10.3201/eid1110.050513; Hasan MK, 2000, J VIROL, V74, P5619, DOI 10.1128/JVI.74.12.5619-5628.2000; Horikami SM, 1997, VIROLOGY, V235, P261, DOI 10.1006/viro.1997.8702; Horvath CM, 1996, MOL CELL BIOL, V16, P6957; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; Ihle JN, 1995, ADV IMMUNOL, V60, P1, DOI 10.1016/S0065-2776(08)60582-9; *INT CTR DIARR DIS, 2005, HLTH SCI B, V3, P1; Kato A, 1997, EMBO J, V16, P578, DOI 10.1093/emboj/16.3.578; Kurotani A, 1998, GENES CELLS, V3, P111, DOI 10.1046/j.1365-2443.1998.00170.x; Ludlow LE, 2008, J VIROL, V82, P6259, DOI 10.1128/JVI.00409-08; Mebatsion T, 2001, J VIROL, V75, P420, DOI 10.1128/JVI.75.1.420-428.2001; Nanda SK, 2006, J VIROL, V80, P7555, DOI 10.1128/JVI.02720-05; Palosaari H, 2003, J VIROL, V77, P7635, DOI 10.1128/JVI.77.13.7635-7644.2003; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Patterson JB, 2000, VIROLOGY, V267, P80, DOI 10.1006/viro.1999.0118; Reutter GL, 2001, VIROLOGY, V285, P100, DOI 10.1006/viro.2001.0962; Rodriguez JJ, 2004, J VIROL, V78, P5358, DOI 10.1128/JVI.78.10.5358-5367.2004; Rodriguez JJ, 2003, J VIROL, V77, P11842, DOI 10.1128/JVI.77.21.11842-11845.2003; Rodriguez JJ, 2002, J VIROL, V76, P11476, DOI 10.1128/JVI.76.22.11476-11483.2002; Shaffer JA, 2003, VIROLOGY, V315, P389, DOI 10.1016/S0042-6822(03)00537-3; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shaw ML, 2005, J VIROL, V79, P6078, DOI 10.1128/JVI.79.10.6078-6088.2005; Shaw ML, 2004, J VIROL, V78, P5633, DOI 10.1128/JVI.78.11.5633-5641.2004; Sugahara F, 2004, VIROLOGY, V325, P1, DOI 10.1016/j.virol.2004.04.019; Takeuchi K, 2003, FEBS LETT, V545, P177, DOI 10.1016/S0014-5793(03)00528-3; von Messling V, 2006, J VIROL, V80, P6084, DOI 10.1128/JVI.00357-06; Wang LF, 2001, MICROBES INFECT, V3, P279, DOI 10.1016/S1286-4579(01)01381-8; Wong KT, 2003, AM J PATHOL, V163, P2127, DOI 10.1016/S0002-9440(10)63569-9; Yoneda M, 2006, P NATL ACAD SCI USA, V103, P16508, DOI 10.1073/pnas.0606972103	47	57	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12709	10.1371/journal.pone.0012709	http://dx.doi.org/10.1371/journal.pone.0012709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856799	gold, Green Submitted, Green Published			2022-12-27	WOS:000281815800009
J	Miller, MA; Kudela, RM; Mekebri, A; Crane, D; Oates, SC; Tinker, MT; Staedler, M; Miller, WA; Toy-Choutka, S; Dominik, C; Hardin, D; Langlois, G; Murray, M; Ward, K; Jessup, DA				Miller, Melissa A.; Kudela, Raphael M.; Mekebri, Abdu; Crane, Dave; Oates, Stori C.; Tinker, M. Timothy; Staedler, Michelle; Miller, Woutrina A.; Toy-Choutka, Sharon; Dominik, Clare; Hardin, Dane; Langlois, Gregg; Murray, Michael; Ward, Kim; Jessup, David A.			Evidence for a Novel Marine Harmful Algal Bloom: Cyanotoxin (Microcystin) Transfer from Land to Sea Otters	PLOS ONE			English	Article							CYANOBACTERIUM MICROCYSTIS; COASTAL CALIFORNIA; TOXOPLASMA-GONDII; AERUGINOSA; WATER; LR; FOOD; LAKE; TOXICITY; EXPOSURE	"Super-blooms'' of cyanobacteria that produce potent and environmentally persistent biotoxins (microcystins) are an emerging global health issue in freshwater habitats. Monitoring of the marine environment for secondary impacts has been minimal, although microcystin-contaminated freshwater is known to be entering marine ecosystems. Here we confirm deaths of marine mammals from microcystin intoxication and provide evidence implicating land-sea flow with trophic transfer through marine invertebrates as the most likely route of exposure. This hypothesis was evaluated through environmental detection of potential freshwater and marine microcystin sources, sea otter necropsy with biochemical analysis of tissues and evaluation of bioaccumulation of freshwater microcystins by marine invertebrates. Ocean discharge of freshwater microcystins was confirmed for three nutrient-impaired rivers flowing into the Monterey Bay National Marine Sanctuary, and microcystin concentrations up to 2,900 ppm (2.9 million ppb) were detected in a freshwater lake and downstream tributaries to within 1 km of the ocean. Deaths of 21 southern sea otters, a federally listed threatened species, were linked to microcystin intoxication. Finally, farmed and free-living marine clams, mussels and oysters of species that are often consumed by sea otters and humans exhibited significant biomagnification (to 107 times ambient water levels) and slow depuration of freshwater cyanotoxins, suggesting a potentially serious environmental and public health threat that extends from the lowest trophic levels of nutrient-impaired freshwater habitat to apex marine predators. Microcystin-poisoned sea otters were commonly recovered near river mouths and harbors and contaminated marine bivalves were implicated as the most likely source of this potent hepatotoxin for wild otters. This is the first report of deaths of marine mammals due to cyanotoxins and confirms the existence of a novel class of marine "harmful algal bloom'' in the Pacific coastal environment; that of hepatotoxic shellfish poisoning (HSP), suggesting that animals and humans are at risk from microcystin poisoning when consuming shellfish harvested at the land-sea interface.	[Miller, Melissa A.; Oates, Stori C.; Toy-Choutka, Sharon; Jessup, David A.] Calif Dept Fish & Game, Marine Wildlife Vet Care & Res Ctr, Off Spill Prevent & Response, Santa Cruz, CA USA; [Miller, Melissa A.; Kudela, Raphael M.] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; [Mekebri, Abdu; Crane, Dave] Calif Dept Fish & Game, Water Pollut Control Lab, Off Spill Prevent & Response, Rancho Cordova, CA USA; [Tinker, M. Timothy] US Geol Survey, Western Ecol Res Ctr, Long Marine Lab, Santa Cruz, CA USA; [Staedler, Michelle; Murray, Michael] Monterey Bay Aquarium, Monterey, CA USA; [Miller, Woutrina A.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA; [Dominik, Clare; Hardin, Dane] Appl Marine Sci, Livermore, CA USA; [Langlois, Gregg] Calif Dept Publ Hlth, Richmond, CA USA; [Ward, Kim] State Water Resources Control Board, Div Water Qual, Sacramento, CA USA	University of California System; University of California Santa Cruz; United States Department of the Interior; United States Geological Survey; Monterey Bay Aquarium Research Institute; University of California System; University of California Davis; California Department of Public Health	Miller, MA (corresponding author), Calif Dept Fish & Game, Marine Wildlife Vet Care & Res Ctr, Off Spill Prevent & Response, Santa Cruz, CA USA.	mmiller@ospr.dfg.ca.gov	Tinker, Martin T/D-3249-2018	Tinker, Martin T/0000-0002-3314-839X; Oates, Samantha/0000-0001-9309-7873	California Division of Water Quality, State Water Resources Control Board (SWRCB); California Department of Fish and Game, Division of Spill Prevention and Respons; CDFG Water Pollution Control Laboratory	California Division of Water Quality, State Water Resources Control Board (SWRCB); California Department of Fish and Game, Division of Spill Prevention and Respons; CDFG Water Pollution Control Laboratory	Financial assistance was provided by the California Division of Water Quality, State Water Resources Control Board (SWRCB), the California Department of Fish and Game, Division of Spill Prevention and Response and the CDFG Water Pollution Control Laboratory. Co-Author Kim Ward of the SWRCB assisted with basic concepts of study design and data analysis in relation to ongoing statewide research on microcystins, but the various funding agencies had no directive or editorial role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amorim A, 1999, TOXICON, V37, P1041, DOI 10.1016/S0041-0101(98)00231-1; ASHWORTH CT, 1946, AM J PATHOL, V22, P369; Backer LC, 2008, MAR DRUGS, V6, P389, DOI 10.3390/md20080018; BISHOP CT, 1959, CAN J BIOCHEM PHYS, V37, P453, DOI 10.1139/o59-047; Carmichael WW, 2001, ENVIRON HEALTH PERSP, V109, P663, DOI 10.2307/3454781; CHEN DZX, 1993, TOXICON, V31, P1407, DOI 10.1016/0041-0101(93)90206-X; Chen J, 2006, AQUACULTURE, V261, P1026, DOI 10.1016/j.aquaculture.2006.08.028; Davis TW, 2009, HARMFUL ALGAE, V8, P715, DOI 10.1016/j.hal.2009.02.004; Dawson RM, 1998, TOXICON, V36, P953, DOI 10.1016/S0041-0101(97)00102-5; DEMOTT WR, 1991, ECOLOGY, V72, P1820, DOI 10.2307/1940981; Domingos P, 1999, ENVIRON TOXICOL, V14, P31, DOI 10.1002/(SICI)1522-7278(199902)14:1<31::AID-TOX6>3.3.CO;2-2; Estes JA, 2004, B MAR SCI, V74, P621; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; Estes James A., 2005, P61; Fischer WJ, 2000, TOXICOL APPL PHARM, V164, P73, DOI 10.1006/taap.1999.8861; Flewelling LJ, 2005, NATURE, V435, P755, DOI 10.1038/nature435755a; FULTON RS, 1987, J PLANKTON RES, V9, P837, DOI 10.1093/plankt/9.5.837; Ger KA, 2009, SCI TOTAL ENVIRON, V407, P4852, DOI 10.1016/j.scitotenv.2009.05.043; Gilroy DJ, 2000, ENVIRON HEALTH PERSP, V108, P435, DOI 10.2307/3454384; Goldberg J.D., 2003, THESIS CALIFORNIA ST; Guo L, 2007, SCIENCE, V317, P1166, DOI 10.1126/science.317.5842.1166; HANAZATO T, 1987, HYDROBIOLOGIA, V144, P251, DOI 10.1007/BF00005559; Humpage AR, 1999, ENVIRON TOXICOL, V14, P61; Jacoby JM, 2000, CAN J FISH AQUAT SCI, V57, P231, DOI 10.1139/cjfas-57-1-231; Jessup DA, 2007, JAVMA-J AM VET MED A, V231, P1648, DOI 10.2460/javma.231.11.1648; Jochimsen EM, 1998, NEW ENGL J MED, V338, P873, DOI 10.1056/NEJM199803263381304; Johnson CK, 2009, P NATL ACAD SCI USA, V106, P2242, DOI 10.1073/pnas.0806449106; Johnston BR, 2003, HYDROBIOLOGIA, V495, P79, DOI 10.1023/A:1025496922050; Kohoutek J, 2008, ANAL BIOANAL CHEM, V390, P1167, DOI 10.1007/s00216-007-1785-y; Kotak BG, 1996, CAN J FISH AQUAT SCI, V53, P1974, DOI 10.1139/cjfas-53-9-1974; Lankoff A, 2004, TOXICOLOGY, V204, P23, DOI 10.1016/j.tox.2004.05.016; Lehman PW, 2005, HYDROBIOLOGIA, V541, P87, DOI 10.1007/s10750-004-4670-0; MacKenzie L, 2004, TOXICON, V44, P901, DOI 10.1016/j.toxicon.2004.08.020; Malbrouck C, 2006, ENVIRON TOXICOL CHEM, V25, P72, DOI 10.1897/05-029R.1; Matthiensen A, 2000, PHYTOCHEMISTRY, V55, P383, DOI 10.1016/S0031-9422(00)00335-6; Mekebri A, 2009, J CHROMATOGR A, V1216, P3147, DOI 10.1016/j.chroma.2009.01.095; Miller MA, 2008, INT J PARASITOL, V38, P1319, DOI 10.1016/j.ijpara.2008.02.005; Miller MA, 2002, INT J PARASITOL, V32, P997, DOI 10.1016/S0020-7519(02)00069-3; Miller MA, 2010, VET RES, V41, DOI 10.1051/vetres/2009049; Miller WA, 2006, MICROB ECOL, V52, P198, DOI 10.1007/s00248-006-9080-6; Moisander PH, 2009, HARMFUL ALGAE, V8, P889, DOI 10.1016/j.hal.2009.04.005; Moisander PH, 2009, AQUAT MICROB ECOL, V57, P19, DOI 10.3354/ame01320; Nasri H, 2008, ECOTOX ENVIRON SAFE, V71, P535, DOI 10.1016/j.ecoenv.2007.12.009; O'Connor TP, 2006, MAR ENVIRON RES, V62, P261, DOI 10.1016/j.marenvres.2006.04.067; Oudra B, 2001, TOXICON, V39, P1375, DOI 10.1016/S0041-0101(01)00093-9; Ozawa K, 2003, LIMNOLOGY, V4, P131, DOI 10.1007/s10201-003-0106-1; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; REINIKAINEN M, 1994, LIMNOL OCEANOGR, V39, P424, DOI 10.4319/lo.1994.39.2.0424; Richardson LL, 2007, FEMS MICROBIOL LETT, V272, P182, DOI 10.1111/j.1574-6968.2007.00751.x; Robson BJ, 2003, MAR FRESHWATER RES, V54, P139, DOI 10.1071/MF02090; Scholin CA, 2000, NATURE, V403, P80, DOI 10.1038/47481; Tinker MT, 2008, P NATL ACAD SCI USA, V105, P560, DOI 10.1073/pnas.0709263105; Tonk L, 2007, AQUAT MICROB ECOL, V46, P117, DOI 10.3354/ame046117; TSUJI K, 1994, ENVIRON SCI TECHNOL, V28, P173, DOI 10.1021/es00050a024; Vasconcelos V, 2001, TOXICON, V39, P1461, DOI 10.1016/S0041-0101(01)00105-2; Vasconcelos VM, 1999, BRAZ J MED BIOL RES, V32, P249, DOI 10.1590/S0100-879X1999000300001; Welker M, 2000, ENVIRON SCI TECHNOL, V34, P3415, DOI 10.1021/es991274t; *WHO, 1996, CYAN TOX MICR LR DRI; Williams DE, 1997, TOXICON, V35, P1617, DOI 10.1016/S0041-0101(97)00039-1; *YUR TRIB ENV PROG, FETCH K FIN 2007 KLA; ZEHNDER A, 1960, CAN J MICROBIOL, V6, P645, DOI 10.1139/m60-077; Zimba PV, 2006, AQUACULTURE, V261, P1048, DOI 10.1016/j.aquaculture.2006.08.037	62	220	227	2	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12576	10.1371/journal.pone.0012576	http://dx.doi.org/10.1371/journal.pone.0012576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844747	Green Published, gold			2022-12-27	WOS:000281687300002
J	Santos, N; Geraldes, M; Afonso, A; Almeida, V; Correia-Neves, M				Santos, Nuno; Geraldes, Margarida; Afonso, Andreia; Almeida, Virgilio; Correia-Neves, Margarida			Diagnosis of Tuberculosis in the Wild Boar (Sus scrofa): A Comparison of Methods Applicable to Hunter-Harvested Animals	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS INFECTION; FREE-RANGING WILDLIFE; WHITE-TAILED DEER; RAPID DETECTION; RED DEER; COMPLEX; PCR; PATHOLOGY; LESIONS; EUROPE	Background: To obtain robust epidemiological information regarding tuberculosis (TB) in wildlife species, appropriate diagnostic methods need to be used. Wild boar (Sus scrofa) recently emerged as a major maintenance host for TB in some European countries. Nevertheless, no data is available to evaluate TB post-mortem diagnostic methods in hunter-harvested wild boar. Methodology/Principal Findings: Six different diagnostic methods for TB were evaluated in parallel in 167 hunter-harvested wild boar. Compared to bacteriological culture, estimates of sensitivity of histopathology was 77.8%, gross pathology 72.2%, PCR for the MPB70 gene 66.7%, detection of acid-fast bacilli (AFB) in tissue contact smears 55.6% and in histopathology slides 16.7% (estimated specificity was 96.7%, 100%, 100%, 94.4% and 100%, respectively). Combining gross pathology with stained smears in parallel increased estimated sensitivity to 94.4% (94.4% specificity). Four probable bacteriological culture false-negative animals were identified by Discriminant Function Analysis. Recalculating the parameters considering these animals as infected generated estimated values for sensitivity of bacteriology and histopathology of 81.8%, gross pathology 72.7%, PCR for the MPB70 gene 63.6%, detection of AFB in tissue contact smears 54.5% and in histopathology slides 13.6% (estimated specificity was 100% for gross pathology, PCR, bacteriology and detection of AFB in histopathology slides, 96.7% for histopathology and 94.4% for stained smears). Conclusions/Significance: These results show that surveys for TB in wild boar based exclusively on gross pathology considerably underestimate prevalence, while combination of tests in parallel much improves sensitivity and negative predictive values. This finding should thus be considered when planning future surveys and game meat inspection schemes. Although bacteriological culture is the reference test for TB diagnosis, it can generate false-negative results and this should be considered when interpreting data.	[Santos, Nuno; Afonso, Andreia; Correia-Neves, Margarida] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal; [Santos, Nuno] Pygargus Lda, Povoa Lanhoso, Portugal; [Santos, Nuno; Almeida, Virgilio] Univ Tecn Lisboa, CIISA FMV, Lisbon, Portugal; [Geraldes, Margarida] Natl Inst Biol Resources, Vet Res Natl Lab LNIV, Vairao, Portugal	Universidade do Minho; Universidade de Lisboa	Santos, N (corresponding author), Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal.	pygargusvet@sapo.pt	Santos, Nuno/D-6742-2016; Correia-Neves, Margarida/AAH-4636-2020; Correia-Neves, Margarida/C-9122-2009; Fernandes Afonso, Andrea Luísa/AAF-2812-2019; Santos, Nuno/M-8650-2013	Santos, Nuno/0000-0002-1676-107X; Correia-Neves, Margarida/0000-0002-2202-5431; Correia-Neves, Margarida/0000-0002-2202-5431; Fernandes Afonso, Andrea Luísa/0000-0002-8858-1617; Almeida, Virgilio/0000-0002-5902-132X	Life and Health Sciences Research Institute (ICVS); School of Health Sciences; University of Minho	Life and Health Sciences Research Institute (ICVS); School of Health Sciences; University of Minho	This study was funded by laboratory funds from Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alvarez AH, 2009, VET RES, V40, DOI 10.1051/vetres/2009005; Artois M, 2001, VET J, V162, P141, DOI 10.1053/tvjl.2001.0601; Baker MG, 2006, EPIDEMIOL INFECT, V134, P1068, DOI 10.1017/S0950268806005930; Banoo S, 2006, NAT REV MICROBIOL, V4, pS17; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bartos M, 2006, J MICROBIOL METH, V64, P333, DOI 10.1016/j.mimet.2005.05.009; Bollo E, 2000, J VET MED B, V47, P337, DOI 10.1046/j.1439-0450.2000.00354.x; CORNER LA, 1995, NEW ZEAL VET J, V43, P129, DOI 10.1080/00480169.1995.35871; COUSINS DV, 1992, J CLIN MICROBIOL, V30, P255, DOI 10.1128/JCM.30.1.255-258.1992; CRUFT H, 1968, APPL MICROBIOL, V16, P355, DOI 10.1128/AEM.16.2.355-357.1968; de Lisle GW, 2002, REV SCI TECH OIE, V21, P317, DOI 10.20506/rst.21.2.1339; Fitzgerald SD, 2000, J VET DIAGN INVEST, V12, P322, DOI 10.1177/104063870001200404; Gavier-Widen D, 2009, NEW ZEAL VET J, V57, P122, DOI 10.1080/00480169.2009.36891; Gortazar C, 2003, VET REC, V152, P779, DOI 10.1136/vr.152.25.779; GUERRERO C, 1995, J CLIN MICROBIOL, V33, P304, DOI 10.1128/JCM.33.2.304-307.1995; Hosek J, 2006, VET MED-CZECH, V51, P180, DOI 10.17221/5538-VETMED; Huard RC, 2003, J CLIN MICROBIOL, V41, P1637, DOI 10.1128/JCM.41.4.1637-1650.2003; LIEBANA E, 1995, J CLIN MICROBIOL, V33, P33; Lin CS, 1999, GENE, V236, P107, DOI 10.1016/S0378-1119(99)00247-4; Lyashchenko KP, 2008, VET MICROBIOL, V132, P283, DOI 10.1016/j.vetmic.2008.05.029; Machackova M, 2003, VET MED-CZECH, V48, P51, DOI 10.17221/5750-VETMED; Martin-Hernando MP, 2007, TUBERCULOSIS, V87, P360, DOI 10.1016/j.tube.2007.02.003; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; O'Brien DJ, 2004, J WILDLIFE DIS, V40, P42, DOI 10.7589/0090-3558-40.1.42; Parra A, 2006, RES VET SCI, V80, P140, DOI 10.1016/j.rvsc.2005.05.010; Rohonczy EB, 1996, CAN J VET RES, V60, P108; Santos N, 2009, J WILDLIFE DIS, V45, P1048, DOI 10.7589/0090-3558-45.4.1048; Vicente J, 2006, VET RES, V37, P107, DOI 10.1051/vetres:2005044; Young JS, 2005, APPL ENVIRON MICROB, V71, P1946, DOI 10.1128/AEM.71.4.1946-1952.2005; Zanella G, 2008, VET REC, V163, P43, DOI 10.1136/vr.163.2.43	30	32	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12663	10.1371/journal.pone.0012663	http://dx.doi.org/10.1371/journal.pone.0012663			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844754	Green Published, gold, Green Submitted			2022-12-27	WOS:000281687300009
J	Solmesky, L; Lefler, S; Jacob-Hirsch, J; Bulvik, S; Rechavi, G; Weil, M				Solmesky, Leonardo; Lefler, Sharon; Jacob-Hirsch, Jasmine; Bulvik, Shlomo; Rechavi, Gideon; Weil, Miguel			Serum Free Cultured Bone Marrow Mesenchymal Stem Cells as a Platform to Characterize the Effects of Specific Molecules	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; EPIDERMAL-GROWTH-FACTOR; RETINOIC ACID; OSTEOGENIC DIFFERENTIATION; ERK ACTIVATION; STROMAL CELLS; PROLIFERATION; PATHWAYS; RECEPTOR; FIBROBLASTS	Human mesenchymal stem cells (hMSC) are easily isolated from the bone marrow by adherence to plastic surfaces. These cells show self-renewal capacity and multipotency. A unique feature of hMSC is their capacity to survive without serum. Under this condition hMSC neither proliferate nor differentiate but maintain their biological properties unaffected. Therefore, this should be a perfect platform to study the biological effects of defined molecules on these human stem cells. We show that hMSC treated for five days with retinoic acid (RA) in the absence of serum undergo several transcriptional changes causing an inhibition of ERK related pathways. We found that RA induces the loss of hMSC properties such as differentiation potential to either osteoblasts or adipocytes. We also found that RA inhibits cell cycle progression in the presence of proliferating signals such as epidermal growth factor (EGF) combined with basic fibroblast growth factor (bFGF). In the same manner, RA showed to cause a reduction in cell adhesion and cell migration. In contrast to these results, the addition of EGF+bFGF to serum free cultures was enough to upregulate ERK activity and induce hMSC proliferation and cell migration. Furthermore, the addition of these factors to differentiation specific media instead of serum was enough to induce either osteogenesis or adipogenesis. Altogether, our results show that hMSC's ability to survive without serum enables the identification of signaling factors and pathways that are involved in their stem cell biological characteristics without possible serum interferences.	[Solmesky, Leonardo; Lefler, Sharon; Weil, Miguel] Tel Aviv Univ, Dept Cell Res & Immunol, Fac Life Sci, IL-69978 Tel Aviv, Israel; [Bulvik, Shlomo] Laniado Hosp, Dept Hematol, Netanya, Israel; [Jacob-Hirsch, Jasmine; Rechavi, Gideon] Chaim Sheba Med Ctr, Canc Res Ctr, Ramat Gan, Israel	Tel Aviv University; Chaim Sheba Medical Center	Solmesky, L (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, Fac Life Sci, IL-69978 Tel Aviv, Israel.	miguelw@tauex.tau.ac.il			IsrALS [4521]	IsrALS	This work was supported by a grant from IsrALS (grant #4521) (http://www.israls.org.il). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam AHMK, 2010, CELL BIOL INT, V34, P631, DOI 10.1042/CBI20090332; Blondheim NR, 2006, STEM CELLS DEV, V15, P141, DOI 10.1089/scd.2006.15.141; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; Cai SY, 2010, J LIPID RES; Canestro C, 2007, DEV BIOL, V305, P522, DOI 10.1016/j.ydbio.2007.02.032; Chen Z, 2010, PATHOBIOLOGY, V77, P88, DOI 10.1159/000278290; Coutu DL, 2008, J BIOL CHEM, V283, P17991, DOI 10.1074/jbc.M708029200; Fiorilli P, 2008, LAB INVEST, V88, P1143, DOI 10.1038/labinvest.2008.89; Gregory C. A., 2005, SCI STKE, ppe37; He S, 2010, BRIT J DERMATOL, V162, P538, DOI 10.1111/j.1365-2133.2009.09511.x; Holland LZ, 2007, NATURE, V447, P153, DOI 10.1038/447153a; Ibanez A, 2006, J IMMUNOL, V177, P1152, DOI 10.4049/jimmunol.177.2.1152; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Kothapalli D, 2008, J BIOL CHEM, V283, P31823, DOI 10.1074/jbc.M802934200; KOUSSOULAKOU DS, 2010, PATHOPHYSIOLOGY; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Kumar N, 2007, J BIOL CHEM, V282, P9244, DOI 10.1074/jbc.M605571200; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; LI Y, 2010, TISSUE ENG C; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Makino T, 2010, BRIT J DERMATOL, V162, P717, DOI 10.1111/j.1365-2133.2009.09581.x; Manohar A, 2004, J CELL SCI, V117, P4043, DOI 10.1242/jcs.01277; Mruthyunjaya S, 2010, BIOCHEM BIOPH RES CO, V391, P43, DOI 10.1016/j.bbrc.2009.10.158; Ng KY, 2010, STEM CELL REV; Nguyen NM, 2006, DEV BIOL, V294, P271, DOI 10.1016/j.ydbio.2006.03.032; Pardo OE, 2009, CANCER RES, V69, P8645, DOI 10.1158/0008-5472.CAN-09-1576; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pochampally RR, 2004, BLOOD, V103, P1647, DOI 10.1182/blood-2003-06-1967; Pytlik R, 2009, BIOMATERIALS, V30, P3415, DOI 10.1016/j.biomaterials.2009.03.001; Rani KGA, 2010, GROWTH FACTORS, V28, P157, DOI 10.3109/08977190903512628; Sakamoto K, 2010, EUR J PHARMACOL, V635, P56, DOI 10.1016/j.ejphar.2010.03.001; Salasznyk RM, 2004, CELL COMMUN ADHES, V11, P137, DOI 10.1080/15419060500242836; Sanders MA, 2000, J BIOL CHEM, V275, P38040, DOI 10.1074/jbc.M003871200; Seib FP, 2009, EUR J CELL BIOL, V88, P257, DOI 10.1016/j.ejcb.2009.01.003; Sensebe L, 2009, TRANSPLANTATION, V87, pS49, DOI 10.1097/TP.0b013e3181a28635; Solmesky LJ, 2009, STEM CELLS DEV, V18, P1283, DOI 10.1089/scd.2009.0020; Toby IT, 2010, AM J PHYSIOL-LUNG C, V298, pL600, DOI 10.1152/ajplung.00122.2009; Ward DF, 2007, STEM CELLS DEV, V16, P467, DOI 10.1089/scd.2007.0034; Yang JB, 2004, J CELL BIOL, V165, P881, DOI 10.1083/jcb.200403174	39	24	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12689	10.1371/journal.pone.0012689	http://dx.doi.org/10.1371/journal.pone.0012689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844755	Green Submitted, Green Published, gold			2022-12-27	WOS:000281687300021
J	De Vooght, V; Vanoirbeek, JAJ; Luyts, K; Haenen, S; Nemery, B; Hoet, PHM				De Vooght, Vanessa; Vanoirbeek, Jeroen A. J.; Luyts, Katrien; Haenen, Steven; Nemery, Benoit; Hoet, Peter H. M.			Choice of Mouse Strain Influences the Outcome in a Mouse Model of Chemical-Induced Asthma	PLOS ONE			English	Article							TOLUENE DIISOCYANATE; OCCUPATIONAL ASTHMA; AIRWAY HYPERRESPONSIVENESS; IMMUNOLOGICAL DETERMINANTS; DERMAL SENSITIZATION; MURINE MODEL; MICE; RESPONSES; INFLAMMATION; DISEASE	Background: The development of occupational asthma is the result of interactions between environmental factors and individual susceptibility. We assessed how our model of chemical-induced asthma is influenced by using different mouse strains. Methodology/Principal Findings: On days 1 and 8, male mice of 7 different strains (BALB/c, BP/2, A/J, C57Bl/6, DBA/2, CBA and AKR) were dermally treated with toluene-2,4-diisocyanate (TDI) (0.3%) or vehicle (acetone/olive oil, AOO, 2: 3) on each ear (20 mu l). On day 15, they received an oropharyngeal instillation of TDI (0.01%) or AOO (1: 4). Airway reactivity to methacholine, total and differential cell counts in bronchoalveolar lavage (BAL) and total serum IgE and IgG(2a) levels were measured. Lymphocyte subpopulations in auricular lymph nodes and in vitro release of cytokines by ConA stimulated lymphocytes were assessed. In TDI-sensitized and challenged mice, airway hyper-reactivity was only observed in BALB/c, BP/2, A/J and AKR mice; airway inflammation was most pronounced in BALB/c mice; numbers of T-helper (CD4(+)), T-activated (CD4(+) CD25(+)), T-cytotoxic (CD8(+)) and B-lymphocytes (CD19(+)) were increased in the auricular lymph nodes of BALB/c, BP/2, A/J and CBA mice; elevated concentrations of IL-4, IL-10, IL-13 and IFN-gamma were detected in supernatant of lymphocytes from BALB/c, BP/2, A/J, C57Bl/6 and CBA mice cultured with concanavaline A, along with an increase in total serum IgE. Conclusion: The used mouse strain has considerable and variable impacts on different aspects of the asthma phenotype. The human phenotypical characteristics of chemically-induced occupational asthma were best reproduced in Th2-biased mice and in particular in BALB/c mice.	[De Vooght, Vanessa; Vanoirbeek, Jeroen A. J.; Luyts, Katrien; Haenen, Steven; Nemery, Benoit; Hoet, Peter H. M.] Katholieke Univ Leuven, Res Unit Lung Toxicol, Louvain, Belgium	KU Leuven	De Vooght, V (corresponding author), Katholieke Univ Leuven, Res Unit Lung Toxicol, Louvain, Belgium.	peter.hoet@med.kuleuven.be	Hoet, Peter/H-9987-2013; Nemery, Benoit/N-3155-2019; Nemery, Benoit/D-1224-2013; Vanoirbeek, Jeroen/D-5183-2016	Hoet, Peter/0000-0002-0292-6603; Nemery, Benoit/0000-0003-0571-4689; Vanoirbeek, Jeroen/0000-0001-5508-3518	Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO) [FWO G.0547.08]; Belgian Science Policy [P6/35]	Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); Belgian Science Policy(Belgian Federal Science Policy Office)	The project was supported by a grant of the Interuniversity Attraction Pole Program, Belgian State, Belgian Science Policy P6/35 and from the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO), FWO G.0547.08. J.V. is a post-doctoral fellow of the FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Qadi-Nassar B, 2007, FUND CLIN PHARMACOL, V21, P611, DOI 10.1111/j.1472-8206.2007.00523.x; Brewer JP, 1999, AM J RESP CRIT CARE, V160, P1150, DOI 10.1164/ajrccm.160.4.9806034; CHANYEUNG M, 1995, NEW ENGL J MED, V333, P107, DOI 10.1056/NEJM199507133330207; Commins SP, 2010, J ALLERGY CLIN IMMUN, V125, pS53, DOI 10.1016/j.jaci.2009.07.008; Dallas M, 2009, J ALLERGY CLIN IMMUN, V124, pS72; De Vooght V, 2009, TOXICOLOGY, V259, P84, DOI 10.1016/j.tox.2009.02.007; Dearman RJ, 2009, CLIN EXP ALLERGY, V39, P458, DOI 10.1111/j.1365-2222.2008.03194.x; Fukunaga J, 2007, INT IMMUNOPHARMACOL, V7, P1852, DOI 10.1016/j.intimp.2007.07.010; Hadeiba H, 2000, J IMMUNOL, V164, P4933, DOI 10.4049/jimmunol.164.9.4933; Herrick CA, 2003, J ALLERGY CLIN IMMUN, V111, P1087, DOI 10.1067/mai.2003.1413; Jones MG, 2006, J ALLERGY CLIN IMMUN, V117, P663, DOI 10.1016/j.jaci.2005.09.053; Liu Q, 2003, ANN ALLERG ASTHMA IM, V90, P35, DOI 10.1016/S1081-1206(10)61647-X; Mapp CE, 2005, AM J RESP CRIT CARE, V172, P280, DOI 10.1164/rccm.200311-1575SO; Matheson JM, 2005, TOXICOL SCI, V84, P99, DOI 10.1093/toxsci/kfi051; Matheson JM, 2005, TOXICOL SCI, V84, P88, DOI 10.1093/toxsci/kfi050; Soutiere SE, 2004, RESP PHYSIOL NEUROBI, V140, P283, DOI 10.1016/j.resp.2004.02.003; Tankersley CG, 1999, J APPL PHYSIOL, V86, P1764, DOI 10.1152/jappl.1999.86.6.1764; Tarkowski M, 2007, AM J PHYSIOL-LUNG C, V292, pL207, DOI 10.1152/ajplung.00157.2005; Tumes DJ, 2007, J LEUKOCYTE BIOL, V81, P1362, DOI 10.1189/jlb.0106046; Van Hove CL, 2009, INT ARCH ALLERGY IMM, V149, P195, DOI 10.1159/000199715; Vanoirbeek JAJ, 2004, TOXICOL SCI, V80, P310, DOI 10.1093/toxsci/kfh155; Vanoirbeek JAJ, 2008, J ALLERGY CLIN IMMUN, V121, P456, DOI 10.1016/j.jaci.2007.09.006; Vanoirbeek JAJ, 2006, J ALLERGY CLIN IMMUN, V117, P1090, DOI 10.1016/j.jaci.2006.01.027; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Vanoirbeek JAJ, 2009, TOXICOLOGY, V257, P144, DOI 10.1016/j.tox.2008.12.020; Vogelsang P, 2009, SCAND J IMMUNOL, V70, P541, DOI 10.1111/j.1365-3083.2009.02327.x; Wenzel S, 2006, AM J RESP CRIT CARE, V174, P1173, DOI 10.1164/rccm.2609002; Whitehead GS, 2003, AM J PHYSIOL-LUNG C, V285, pL32, DOI 10.1152/ajplung.00390.2002; Willis-Owen SAG, 2009, J ALLERGY CLIN IMMUN, V123, P14, DOI 10.1016/j.jaci.2008.09.016; WillsKarp M, 1997, AM J RESP CRIT CARE, V156, pS89, DOI 10.1164/ajrccm.156.4.12-tac-3; Zhu WY, 2009, IMMUNOGENETICS, V61, P199, DOI 10.1007/s00251-008-0353-8	31	51	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12581	10.1371/journal.pone.0012581	http://dx.doi.org/10.1371/journal.pone.0012581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830207	Green Published, Green Submitted, gold			2022-12-27	WOS:000281631300013
J	Kochzius, M; Seidel, C; Antoniou, A; Botla, SK; Campo, D; Cariani, A; Vazquez, EG; Hauschild, J; Hervet, C; Hjorleifsdottir, S; Hreggvidsson, G; Kappel, K; Landi, M; Magoulas, A; Marteinsson, V; Nolte, M; Planes, S; Tinti, F; Turan, C; Venugopal, MN; Weber, H; Blohm, D				Kochzius, Marc; Seidel, Christian; Antoniou, Aglaia; Botla, Sandeep Kumar; Campo, Daniel; Cariani, Alessia; Garcia Vazquez, Eva; Hauschild, Janet; Hervet, Caroline; Hjorleifsdottir, Sigridur; Hreggvidsson, Gudmundur; Kappel, Kristina; Landi, Monica; Magoulas, Antonios; Marteinsson, Viggo; Noelte, Manfred; Planes, Serge; Tinti, Fausto; Turan, Cemal; Venugopal, Moleyur N.; Weber, Hannes; Blohm, Dietmar			Identifying Fishes through DNA Barcodes and Microarrays	PLOS ONE			English	Article							SPECIES IDENTIFICATION; MOLECULAR-IDENTIFICATION; GENETIC IDENTIFICATION; CYTOCHROME-B; HYBRIDIZATION; POSITION; REVEALS; PCR; DIFFERENTIATION; DISCRIMINATION	Background: International fish trade reached an import value of 62.8 billion Euro in 2006, of which 44.6% are covered by the European Union. Species identification is a key problem throughout the life cycle of fishes: from eggs and larvae to adults in fisheries research and control, as well as processed fish products in consumer protection. Methodology/Principal Findings: This study aims to evaluate the applicability of the three mitochondrial genes 16S rRNA (16S), cytochrome b (cyt b), and cytochrome oxidase subunit I (COI) for the identification of 50 European marine fish species by combining techniques of "DNA barcoding'' and microarrays. In a DNA barcoding approach, neighbour Joining (NJ) phylogenetic trees of 369 16S, 212 cyt b, and 447 COI sequences indicated that cyt b and COI are suitable for unambiguous identification, whereas 16S failed to discriminate closely related flatfish and gurnard species. In course of probe design for DNA microarray development, each of the markers yielded a high number of potentially species-specific probes in silico, although many of them were rejected based on microarray hybridisation experiments. None of the markers provided probes to discriminate the sibling flatfish and gurnard species. However, since 16S-probes were less negatively influenced by the "position of label'' effect and showed the lowest rejection rate and the highest mean signal intensity, 16S is more suitable for DNA microarray probe design than cty b and COI. The large portion of rejected COI-probes after hybridisation experiments (>90%) renders the DNA barcoding marker as rather unsuitable for this high-throughput technology. Conclusions/Significance: Based on these data, a DNA microarray containing 64 functional oligonucleotide probes for the identification of 30 out of the 50 fish species investigated was developed. It represents the next step towards an automated and easy-to-handle method to identify fish, ichthyoplankton, and fish products.	[Kochzius, Marc; Seidel, Christian; Botla, Sandeep Kumar; Hauschild, Janet; Kappel, Kristina; Weber, Hannes; Blohm, Dietmar] Univ Bremen, Ctr Appl Gene Sensor Technol CAG, FB2 UFT, Bremen, Germany; [Kochzius, Marc] Free Univ Brussels VUB, Brussels, Belgium; [Antoniou, Aglaia; Magoulas, Antonios] Hellen Ctr Marine Res, Inst Marine Biol & Genet, Iraklion, Crete, Greece; [Campo, Daniel; Garcia Vazquez, Eva] Univ Oviedo, Dept Funct Biol, Oviedo, Spain; [Cariani, Alessia; Landi, Monica; Tinti, Fausto] Univ Bologna, Dept Expt Evolutionary Biol, Bologna, Italy; [Hervet, Caroline; Planes, Serge] Univ Perpignan, CNRS, EPHE, UPVD,UMR 5244, F-66025 Perpignan, France; [Hjorleifsdottir, Sigridur; Hreggvidsson, Gudmundur; Marteinsson, Viggo] Prokaria, Matis Ohf, Reykjavik, Iceland; [Hreggvidsson, Gudmundur] Univ Iceland, Fac Life & Environm Sci, Reykjavik, Iceland; [Noelte, Manfred] Univ Bremen, Zentrum Technomath ZeTeM, Bremen, Germany; [Turan, Cemal] Mustafa Kemal Univ, Fac Fisheries, Iskenderun, Hatay, Turkey; [Venugopal, Moleyur N.] Univ Agr Sci Mangalore, Coll Fisheries, Mangalore 575002, Karnataka, India	University of Bremen; Vrije Universiteit Brussel; Hellenic Centre for Marine Research; University of Oviedo; University of Bologna; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; University of Iceland; University of Bremen; Mustafa Kemal University; College of Fisheries, Mangalore; University of Agricultural Sciences Bangalore	Kochzius, M (corresponding author), Univ Bremen, Ctr Appl Gene Sensor Technol CAG, FB2 UFT, Bremen, Germany.	marc.kochzius@vub.ac.be	Landi, Monica/J-3611-2012; Turan, Cemal/Q-7638-2019; Tinti, Fausto/D-4847-2012; Kochzius, Marc/AAN-3799-2021; Cariani, Alessia/L-3459-2016; PLANES, Serge/ABF-1360-2021	Landi, Monica/0000-0003-2180-5062; Turan, Cemal/0000-0001-9584-0261; Tinti, Fausto/0000-0002-8649-5387; Cariani, Alessia/0000-0002-5513-0086; Antoniou, Aglaia (Cilia)/0000-0003-1119-9820; Marteinsson, Viggo/0000-0001-8340-821X; Kochzius, Marc/0000-0001-8953-4719; Botla, Sandeep/0000-0001-9937-0455; Hreggvidsson, Gudmundur Oli/0000-0002-4958-1673; Nolte, Manfred/0000-0002-8029-4162	European Commission [505491]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The research project "Fish & Chips (Towards DNA chip technology as a standard analytical tool for the identification of marine organisms in biodiversity and ecosystem research)'' (www.fish-and-chips.uni-bremen.de) was funded by the European Commission in the Framework of the 6th Framework Programme (http://ec.europa.eu/research/fp6/index_en.cfm) under the contract no. 505491. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto S, 2002, FISHERIES SCI, V68, P1242, DOI 10.1046/j.1444-2906.2002.00561.x; Aoyama J, 1999, MAR ECOL PROG SER, V188, P193, DOI 10.3354/meps188193; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Branham WS, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-8; Chen W, 2009, MOL ECOL RESOUR, V9, P114, DOI 10.1111/j.1755-0998.2009.02638.x; Cohen NJ, 2009, J FOOD PROTECT, V72, P810, DOI 10.4315/0362-028X-72.4.810; Ducree J., 2000, Proceedings IEEE Thirteenth Annual International Conference on Micro Electro Mechanical Systems (Cat. No.00CH36308), P317, DOI 10.1109/MEMSYS.2000.838536; Espineira M, 2008, J AGR FOOD CHEM, V56, P8954, DOI 10.1021/jf800570r; Fare TL, 2003, ANAL CHEM, V75, P4672, DOI 10.1021/ac034241b; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fox CJ, 2005, MOL ECOL, V14, P879, DOI 10.1111/j.1365-294X.2005.02439.x; Greig TW, 2005, FISH B-NOAA, V103, P516; Hajibabaei M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-24; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoelzel AR, 2001, CONSERV GENET, V2, P69, DOI 10.1023/A:1011590517389; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Holmes BH, 2009, FISH RES, V95, P280, DOI 10.1016/j.fishres.2008.09.036; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hutchison CA, 2007, NUCLEIC ACIDS RES, V35, P6227, DOI 10.1093/nar/gkm688; Jerome M, 2008, J AGR FOOD CHEM, V56, P3460, DOI 10.1021/jf703704m; Kijewska A, 2009, ICES J MAR SCI, V66, P902, DOI 10.1093/icesjms/fsp110; Kochzius M, 2008, MAR BIOTECHNOL, V10, P207, DOI 10.1007/s10126-007-9068-3; Kochzius M, 2003, MOL PHYLOGENET EVOL, V28, P396, DOI 10.1016/S1055-7903(02)00444-X; Kochzius M, 2009, FISH FISH SER, V31, P453, DOI 10.1007/978-1-4020-9210-7_24; Korimbocus J, 2005, J CLIN MICROBIOL, V43, P3779, DOI 10.1128/JCM.43.8.3779-3787.2005; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lemer S, 2007, CR BIOL, V330, P86, DOI 10.1016/j.crvi.2006.09.002; Marko PB, 2004, NATURE, V430, P309, DOI 10.1038/430309b; De Astarloa JMD, 2008, ZOOTAXA, P35, DOI 10.11646/zootaxa.1921.1.3; MCCLURE MR, 1992, COPEIA, P1039, DOI 10.2307/1446635; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Moura T, 2008, MAR FRESHWATER RES, V59, P214, DOI 10.1071/MF07192; NOLTE M, 2002, THESIS U BREMEN GERM; Ogden R, 2008, FISH FISH, V9, P462, DOI 10.1111/j.1467-2979.2008.00305.x; Peplies J, 2003, APPL ENVIRON MICROB, V69, P1397, DOI 10.1128/AEM.69.3.1397-1407.2003; Peytavi R, 2005, BIOTECHNIQUES, V39, P89, DOI 10.2144/05391RR01; Pozhitkov A, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl133; PROBER JM, 1987, SCIENCE, V238, P336, DOI 10.1126/science.2443975; Quinteiro J, 1998, J AGR FOOD CHEM, V46, P1662, DOI 10.1021/jf970552+; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Richardson DE, 2007, MOL ECOL NOTES, V7, P199, DOI 10.1111/j.1471-8286.2006.01620.x; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Rocha-Olivares A, 2000, FISH B-NOAA, V98, P353; Ronning SB, 2005, J AGR FOOD CHEM, V53, P8874, DOI 10.1021/jf0514569; Santaclara FJ, 2006, EUR FOOD RES TECHNOL, V223, P609, DOI 10.1007/s00217-005-0241-5; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Sevilla RG, 2007, MOL ECOL NOTES, V7, P730, DOI 10.1111/j.1471-8286.2007.01863.x; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; Smith PJ, 2008, J FISH BIOL, V73, P1170, DOI 10.1111/j.1095-8649.2008.01957.x; Smith PJ, 2008, J FISH BIOL, V72, P464, DOI 10.1111/j.1095-8649.2007.01745.x; Sotelo CG, 2001, J AGR FOOD CHEM, V49, P4562, DOI 10.1021/jf010452a; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Teletchea F, 2008, J APPL ECOL, V45, P967, DOI 10.1111/j.1365-2664.2007.01415.x; Teletchea F, 2009, REV FISH BIOL FISHER, V19, P265, DOI 10.1007/s11160-009-9107-4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timm J, 2008, MOL PHYLOGENET EVOL, V49, P268, DOI 10.1016/j.ympev.2008.04.024; Tobler NE, 2006, J MICROBIOL METH, V66, P116, DOI 10.1016/j.mimet.2005.10.016; TODT S, 2005, THESIS U BREMEN; *UN FAO, 2009, STAT WORLD FISH AQ; Ward RD, 2008, J FISH BIOL, V72, P458, DOI 10.1111/j.1095-8649.2007.01703.x; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Warsen AE, 2004, APPL ENVIRON MICROB, V70, P4216, DOI 10.1128/AEM.70.7.4216-4221.2004; Wong EHK, 2008, FOOD RES INT, V41, P828, DOI 10.1016/j.foodres.2008.07.005; Yancy HF, 2008, J FOOD PROTECT, V71, P210, DOI 10.4315/0362-028X-71.1.210; Yoon HK, 2009, BIOCHIP J, V3, P87; Yoon HK, 2008, BIOCHIP J, V2, P287; Zemlak TS, 2009, MOL ECOL RESOUR, V9, P237, DOI 10.1111/j.1755-0998.2009.02649.x; Zhang L, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni156	74	122	135	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12620	10.1371/journal.pone.0012620	http://dx.doi.org/10.1371/journal.pone.0012620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20838643	Green Published, gold			2022-12-27	WOS:000281631300040
J	Van der Auwera, I; Yu, W; Suo, LP; Van Neste, L; van Dam, P; van Marck, EA; Pauwels, P; Vermeulen, PB; Dirix, LY; Van Laere, SJ				Van der Auwera, Ilse; Yu, Wayne; Suo, Liping; Van Neste, Leander; van Dam, Peter; van Marck, Eric A.; Pauwels, Patrick; Vermeulen, Peter B.; Dirix, Luc Y.; Van Laere, Steven J.			Array-Based DNA Methylation Profiling for Breast Cancer Subtype Discrimination	PLOS ONE			English	Article							CPG ISLAND HYPERMETHYLATION; HORMONE-RECEPTOR STATUS; TUMOR-SUPPRESSOR GENES; ABERRANT METHYLATION; COLORECTAL-CANCER; POOR-PROGNOSIS; PROMOTER HYPERMETHYLATION; UNFAVORABLE PROGNOSIS; MULTIPLE GENES; EXPRESSION	Background: Abnormal DNA methylation is well established for breast cancer and contributes to its progression by silencing tumor suppressor genes. DNA methylation profiling platforms might provide an alternative approach to expression microarrays for accurate breast tumor subtyping. We sought to determine whether the distinction of the inflammatory breast cancer (IBC) phenotype from the non-IBC phenotype by transcriptomics could be sustained by methylomics. Methodology/Principal Findings: We performed methylation profiling on a cohort of IBC (N = 19) and non-IBC (N = 43) samples using the Illumina Infinium Methylation Assay. These results were correlated with gene expression profiles. Methylation values allowed separation of breast tumor samples into high and low methylation groups. This separation was significantly related to DNMT3B mRNA levels. The high methylation group was enriched for breast tumor samples from patients with distant metastasis and poor prognosis, as predicted by the 70-gene prognostic signature. Furthermore, this tumor group tended to be enriched for IBC samples (54% vs. 24%) and samples with a high genomic grade index (67% vs. 38%). A set of 16 CpG loci (14 genes) correctly classified 97% of samples into the low or high methylation group. Differentially methylated genes appeared to be mainly related to focal adhesion, cytokine-cytokine receptor interactions, Wnt signaling pathway, chemokine signaling pathways and metabolic processes. Comparison of IBC with non-IBC led to the identification of only four differentially methylated genes (TJP3, MOGAT2, NTSR2 and AGT). A significant correlation between methylation values and gene expression was shown for 4,981 of 6,605 (75%) genes. Conclusions/Significance: A subset of clinical samples of breast cancer was characterized by high methylation levels, which coincided with increased DNMT3B expression. Furthermore, an association was observed with molecular signatures indicative of poor patient prognosis. The results of the current study also suggest that aberrant DNA methylation is not the main force driving the molecular biology of IBC.	[Van der Auwera, Ilse; van Dam, Peter; van Marck, Eric A.; Pauwels, Patrick; Vermeulen, Peter B.; Dirix, Luc Y.; Van Laere, Steven J.] Univ Antwerp, Pathol Lab, Translat Canc Res Grp, Univ Antwerp Hosp,Oncol Ctr, B-2020 Antwerp, Belgium; [Yu, Wayne; Suo, Liping] Johns Hopkins Univ, Sidney Kimmel Canc Ctr, DNA Microarray Core, Baltimore, MD USA; [Van Neste, Leander] Oncomethylome Sci SA, Liege, Belgium	University of Antwerp; Johns Hopkins University	Van der Auwera, I (corresponding author), Univ Antwerp, Pathol Lab, Translat Canc Res Grp, Univ Antwerp Hosp,Oncol Ctr, B-2020 Antwerp, Belgium.	steven.vanlaere@gza.be	Van Laere, Steven/GQA-8872-2022; Dirix, Luc/AAI-8880-2020	Van Laere, Steven/0000-0002-2640-0040; 	Fund for Scientific Research Flanders [G.0473.08]	Fund for Scientific Research Flanders(FWO)	This work was supported by the Fund for Scientific Research Flanders (G.0473.08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, CANCER RES, V65, P828; Bae YK, 2004, CLIN CANCER RES, V10, P5998, DOI 10.1158/1078-0432.CCR-04-0667; Baylin SB, 2000, J NATL CANCER I, V92, P1460, DOI 10.1093/jnci/92.18.1460; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bouquet C, 2006, MOL THER, V14, P175, DOI 10.1016/j.ymthe.2006.01.017; Colpaert CG, 2003, BRIT J CANCER, V88, P718, DOI 10.1038/sj.bjc.6600807; Dahlin AM, 2010, CLIN CANCER RES, V16, P1845, DOI 10.1158/1078-0432.CCR-09-2594; Eads CA, 2000, CANCER RES, V60, P5021; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fackler MJ, 2003, INT J CANCER, V107, P970, DOI 10.1002/ijc.11508; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Feng W, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1762; Garcia JM, 2004, GENE CHROMOSOME CANC, V41, P117, DOI 10.1002/gcc.20062; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Holm K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2590; JAIYESIMI IA, 1992, J CLIN ONCOL, V10, P1014, DOI 10.1200/JCO.1992.10.6.1014; Kaneko Y, 2003, GUT, V52, P641, DOI 10.1136/gut.52.5.641; Kleer CG, 2000, BREAST CANCER RES, V2, P423, DOI 10.1186/bcr89; LI B, 2010, ANN SURG ONCOL, V17, P790; Li SY, 2006, CANCER LETT, V237, P272, DOI 10.1016/j.canlet.2005.06.011; Liang G, 1998, GENOMICS, V53, P260, DOI 10.1006/geno.1998.5502; Martin TA, 2004, EUR J CANCER, V40, P2717, DOI 10.1016/j.ejca.2004.08.008; McRonald FE, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-31; Melki JR, 1999, CANCER RES, V59, P3730; Moody TW, 2003, CURR PHARM DESIGN, V9, P495, DOI 10.2174/1381612033391621; Mori K, 2009, INT J ONCOL, V34, P1593, DOI 10.3892/ijo_00000289; Mulero-Navarro S, 2008, CRIT REV ONCOL HEMAT, V68, P1, DOI 10.1016/j.critrevonc.2008.03.001; Nosho K, 2009, CLIN CANCER RES, V15, P3663, DOI 10.1158/1078-0432.CCR-08-2383; O'Riain C, 2009, LEUKEMIA, V23, P1858, DOI 10.1038/leu.2009.114; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Roll JD, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-15; Sakuma M, 2007, CANCER SCI, V98, P380, DOI 10.1111/j.1349-7006.2007.00394.x; Sato H, 2010, AM J PATHOL, V176, P402, DOI 10.2353/ajpath.2010.090236; Shen LL, 2002, J NATL CANCER I, V94, P755, DOI 10.1093/jnci/94.10.755; Singletary SE, 2002, J CLIN ONCOL, V20, P3628, DOI 10.1200/JCO.2002.02.026; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Strathdee G, 2001, AM J PATHOL, V158, P1121, DOI 10.1016/S0002-9440(10)64059-X; Sunami E, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2098; Tanemura A, 2009, CLIN CANCER RES, V15, P1801, DOI 10.1158/1078-0432.CCR-08-1361; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Toyota M, 1999, CANCER RES, V59, P5438; Ueki T, 2000, CANCER RES, V60, P1835; Van der Auwera I, 2008, BRIT J CANCER, V99, P1735, DOI 10.1038/sj.bjc.6604705; Van der Auwera I, 2004, CLIN CANCER RES, V10, P7965, DOI 10.1158/1078-0432.CCR-04-0063; Van der Auwera I, 2009, CANCER BIOL THER, V8, P2252; Van Laere S, 2007, BRIT J CANCER, V97, P1165, DOI 10.1038/sj.bjc.6603967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Veeck J, 2006, ONCOGENE, V25, P3479, DOI 10.1038/sj.onc.1209386; Veeck J, 2008, CARCINOGENESIS, V29, P991, DOI 10.1093/carcin/bgn076; Vincent F, 2009, CANCER RES, V69, P2853, DOI 10.1158/0008-5472.CAN-08-2484; Wendt MK, 2008, ONCOGENE, V27, P1461, DOI 10.1038/sj.onc.1210751; Widschwendter M, 2004, CANCER RES, V64, P3807, DOI 10.1158/0008-5472.CAN-03-3852; Yagi K, 2010, CLIN CANCER RES, V16, P21, DOI 10.1158/1078-0432.CCR-09-2006; Yan PS, 2000, CLIN CANCER RES, V6, P1432; Zhou W, 2009, J CANCER RES CLIN, V135, P91, DOI 10.1007/s00432-008-0435-x	57	67	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12616	10.1371/journal.pone.0012616	http://dx.doi.org/10.1371/journal.pone.0012616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830311	gold, Green Published, Green Submitted			2022-12-27	WOS:000281631300036
J	Fernandez-Duque, E; de la Iglesia, H; Erkert, HG				Fernandez-Duque, Eduardo; de la Iglesia, Horacio; Erkert, Hans G.			Moonstruck Primates: Owl Monkeys (Aotus) Need Moonlight for Nocturnal Activity in Their Natural Environment	PLOS ONE			English	Article							LEMUR EULEMUR-FULVUS; CIRCADIAN PACEMAKERS; CATHEMERAL ACTIVITY; FUNCTIONAL-ANALYSIS; ACTIVITY RHYTHMS; NIGHT MONKEYS; ENTRAINMENT; AZARAI; GENES; GRISEIMEMBRA	Primates show activity patterns ranging from nocturnality to diurnality, with a few species showing activity both during day and night. Among anthropoids (monkeys, apes and humans), nocturnality is only present in the Central and South American owl monkey genus Aotus. Unlike other tropical Aotus species, the Azara's owl monkeys (A. azarai) of the subtropics have switched their activity pattern from strict nocturnality to one that also includes regular diurnal activity. Harsher climate, food availability, and the lack of predators or diurnal competitors, have all been proposed as factors favoring evolutionary switches in primate activity patterns. However, the observational nature of most field studies has limited an understanding of the mechanisms responsible for this switch in activity patterns. The goal of our study was to evaluate the hypothesis that masking, namely the stimulatory and/or inhibitory/disinhibitory effects of environmental factors on synchronized circadian locomotor activity, is a key determinant of the unusual activity pattern of Azara's owl monkeys. We use continuous long-term (6-18 months) 5-min-binned activity records obtained with actimeter collars fitted to wild owl monkeys (n = 10 individuals) to show that this different pattern results from strong masking of activity by the inhibiting and enhancing effects of ambient luminance and temperature. Conclusive evidence for the direct masking effect of light is provided by data showing that locomotor activity was almost completely inhibited when moonlight was shadowed during three lunar eclipses. Temperature also negatively masked locomotor activity, and this masking was manifested even under optimal light conditions. Our results highlight the importance of the masking of circadian rhythmicity as a determinant of nocturnality in wild owl monkeys and suggest that the stimulatory effects of dim light in nocturnal primates may have been selected as an adaptive response to moonlight. Furthermore, our data indicate that changes in sensitivity to specific environmental stimuli may have been an essential key for evolutionary switches between diurnal and nocturnal habits in primates.	[Fernandez-Duque, Eduardo] Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA; [Fernandez-Duque, Eduardo] CECOAL Conicet, Corrientes, Argentina; [de la Iglesia, Horacio] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Erkert, Hans G.] Univ Tubingen, Dept Zool, Tubingen, Germany	University of Pennsylvania; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Washington; University of Washington Seattle; Eberhard Karls University of Tubingen	Fernandez-Duque, E (corresponding author), Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA.	eduardof@sas.upenn.edu			Wenner-Gren Foundation; L.S.B. Leakey Foundation; National Geographic Society; National Science Foundation [BCS-0621020]; Zoological Society of San Diego; CONICET of Argentina [PIP0051-98]; University of Pennsylvania; Deutsche Forschungsgemeinschaft [SFB 307-C5]; NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES [R01IP000051] Funding Source: NIH RePORTER	Wenner-Gren Foundation; L.S.B. Leakey Foundation; National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); Zoological Society of San Diego; CONICET of Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Pennsylvania; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	EFD received financial support from the Wenner-Gren Foundation, the L.S.B. Leakey Foundation, the National Geographic Society, the National Science Foundation (BCS-0621020), the Zoological Society of San Diego, the CONICET of Argentina (PIP0051-98) and the University of Pennsylvania. Grants from the Deutsche Forschungsgemeinschaft to HGE (SFB 307-C5) and technical support from the Institute for Zoology of the Tubingen University, Germany, enabled the activity recordings in the field. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankel-Simons F, 2008, YEARB PHYS ANTHROPOL, V51, P100, DOI 10.1002/ajpa.20957; Brandt MJ, 2007, ACTA THERIOL, V52, P13, DOI 10.1007/BF03194195; Brandt MJ, 2005, ACTA THERIOL, V50, P67, DOI 10.1007/BF03192620; CHIESA JJ, J BIOL RHYT IN PRESS; Colquhoun IC, 2007, DEV PRIMATOL-PROG PR, P146, DOI 10.1007/978-0-387-34810-0_7; Colquhoun IC, 1998, FOLIA PRIMATOL, V69, P22; Curtis DJ, 2006, FOLIA PRIMATOL, V77, P178, DOI 10.1159/000089703; Curtis DJ, 1999, AM J PRIMATOL, V47, P279, DOI 10.1002/(SICI)1098-2345(1999)47:4<279::AID-AJP2>3.0.CO;2-U; DAAN S, 1978, J THEOR BIOL, V70, P297, DOI 10.1016/0022-5193(78)90378-8; Donati G, 2001, AM J PRIMATOL, V53, P69, DOI 10.1002/1098-2345(200102)53:2<69::AID-AJP2>3.0.CO;2-R; Donati G, 2007, BEHAV ECOL SOCIOBIOL, V61, P1237, DOI 10.1007/s00265-007-0354-x; Donati G, 2009, ANIM BEHAV, V77, P317, DOI 10.1016/j.anbehav.2008.09.033; Erkert HG, 2008, BIOL RHYTHM RES, V39, P229, DOI 10.1080/09291010701683391; Erkert HG, 2006, FOLIA PRIMATOL, V77, P87, DOI 10.1159/000089697; ERKERT HG, 1986, FOLIA PRIMATOL, V47, P171, DOI 10.1159/000156276; ERKERT HG, 1983, COMP BIOCHEM PHYS A, V74, P307, DOI 10.1016/0300-9629(83)90605-9; ERKERT HG, 1976, FOLIA PRIMATOL, V25, P186, DOI 10.1159/000155712; ERKERT HG, 1974, OECOLOGIA, V14, P269, DOI 10.1007/BF01039797; Fernandez-Duque E, 2006, FOLIA PRIMATOL, V77, P123, DOI 10.1159/000089699; Fernandez-Duque E, 2003, INT J PRIMATOL, V24, P1113, DOI 10.1023/A:1026284430453; Fernandez-Duque E, 2003, BEHAV ECOL SOCIOBIOL, V54, P431, DOI 10.1007/s00265-003-0637-9; Fernandez-Duque E, 2009, BEHAVIOUR, V146, P583, DOI 10.1163/156853908X397925; Fernandez-Duque E, 2001, AM J PRIMATOL, V53, P99, DOI 10.1002/1098-2345(200103)53:3<99::AID-AJP1>3.0.CO;2-N; Fernandez-Duque E., 2007, PRIMATES PERSPECTIVE, P139; Gursky S, 2003, INT J PRIMATOL, V24, P351, DOI 10.1023/A:1023053301059; Halle S., 2000, ACTIVITY PATTERNS SM; Jacobs GH, 1996, P ROY SOC B-BIOL SCI, V263, P705, DOI 10.1098/rspb.1996.0105; Johnson CH, 2003, CHRONOBIOL INT, V20, P741, DOI 10.1081/CBI-120024211; Kappeler PM, 2003, BEHAV ECOL SOCIOBIOL, V54, P359, DOI 10.1007/s00265-003-0652-x; Levenson DH, 2007, AM J PRIMATOL, V69, P757, DOI 10.1002/ajp.20402; Martin R.D., 1990, PRIMATE ORIGINS EVOL; Martin RD, 2005, PRIMATE VISUAL SYSTEM: A COMPARATIVE APPROACH, P1; Mrosovsky N, 2005, J COMP PHYSIOL A, V191, P1011, DOI 10.1007/s00359-005-0017-1; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Nash L.T., 1986, P357; Nash LT, 2007, DEV PRIMATOL-PROG PR, P173, DOI 10.1007/978-0-387-34810-0_8; Overdorff DJ, 1995, CREATURES OF THE DARK, P61; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; RAUTHWIDMANN B, 1991, CHRONOBIOL INT, V8, P251, DOI 10.3109/07420529109063930; Tan Y, 2005, P NATL ACAD SCI USA, V102, P14712, DOI 10.1073/pnas.0507042102; Tarnaud L, 2006, FOLIA PRIMATOL, V77, P166, DOI 10.1159/000089702; TATTERSALL I, 1987, FOLIA PRIMATOL, V49, P200, DOI 10.1159/000156323; WRIGHT PC, 1989, J HUM EVOL, V18, P635, DOI 10.1016/0047-2484(89)90098-5; Zielinski WJ, 2000, ECOL STU AN, V141, P95	45	73	74	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12572	10.1371/journal.pone.0012572	http://dx.doi.org/10.1371/journal.pone.0012572			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838447	Green Published, gold			2022-12-27	WOS:000281627700019
J	van Kuijk, AWR; DeGroot, J; Koeman, RC; Sakkee, N; Baeten, DL; Gerlag, DM; Tak, PP				van Kuijk, Arno W. R.; DeGroot, Jeroen; Koeman, Rishma C.; Sakkee, Nico; Baeten, Dominique L.; Gerlag, Danielle M.; Tak, Paul P.			Soluble Biomarkers of Cartilage and Bone Metabolism in Early Proof of Concept Trials in Psoriatic Arthritis: Effects of Adalimumab Versus Placebo	PLOS ONE			English	Article							EARLY RHEUMATOID-ARTHRITIS; PREDICT RADIOGRAPHIC PROGRESSION; MELANOMA INHIBITORY-ACTIVITY; JOINT DAMAGE; DISEASE-ACTIVITY; INFLAMMATORY ARTHRITIS; SYNOVIAL BIOMARKERS; CLINICAL-TRIALS; MARKERS; DEGRADATION	Background: There is growing interest in soluble biomarkers that could be used on the group level for screening purposes in small proof of principle studies during early drug development. We investigated early changes in serum levels of several candidate biomarkers involved in cartilage and bone metabolism following the initiation of adalimumab as a prototypic active treatment in psoriatic arthritis (PsA) compared to placebo. Materials and Methods: Twenty-four PsA patients were randomized to receive either adalimumab 40 mg s.c. every other week or placebo for 4 weeks, followed by an open label extension phase. Serum samples were obtained at baseline and after 4 and 12 weeks of treatment and analyzed for levels of CPII and PINP (synthesis of type II and type I procollagen), melanoma inhibitory activity (MIA) (chondrocyte anabolism), matrix metalloproteinase (MMP)-3, C2C and cartilage oligomeric matrix protein (COMP) (type II collagen degradation), osteocalcin (OC) (bone formation), NTX-I and ICTP (both type I collagen degradation). Results: After 4 weeks, there was a significant decrease in serum MMP-3 levels in adalimumab-treated patients (P<0.005), while no change was observed in the placebo group. A significant increase in serum MIA was noted after adalimumab therapy (P<0.005) but not after placebo treatment. After 12 weeks, there was a marked reduction in serum MMP-3 in both groups (P<0.005), whereas other markers did not show significant changes compared to baseline. Conclusion: MMP-3 and MIA could serve as soluble biomarkers associated with inflammation as well as joint remodelling and destruction and may, together with clinical evaluation and in combination with other biomarkers, assist in distinguishing between effective and ineffective therapy in small, proof-of-principle studies of short duration in PsA.	[van Kuijk, Arno W. R.; Koeman, Rishma C.; Baeten, Dominique L.; Gerlag, Danielle M.; Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, Amsterdam, Netherlands; [DeGroot, Jeroen; Sakkee, Nico] Netherlands Org Appl Sci Res TNO Qual Life, Business Unit Biosci, Leiden, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Organization Applied Science Research	van Kuijk, AWR (corresponding author), Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, F4-218, Amsterdam, Netherlands.	P.P.Tak@amc.uva.nl			Abbott	Abbott(Abbott Laboratories)	The study was funded by Abbott (www.abbott.com), after agreement to the protocol. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chopin F, 2008, ANN RHEUM DIS, V67, P353, DOI 10.1136/ard.2007.076604; DEGROOT J, 2008, KELLEYS TXB RHEUMATO, P475; den Broeder AA, 2002, ANN RHEUM DIS, V61, P311, DOI 10.1136/ard.61.4.311; Fransen J, 2006, ANN RHEUM DIS, V65, P1373, DOI 10.1136/ard.2006.051706; Garnero P, 2004, CURR OPIN RHEUMATOL, V16, P428, DOI 10.1097/01.moo.0000127830.72761.00; Garnero P, 2003, CLIN EXP RHEUMATOL, V21, pS54; Garnero P, 2003, J BONE MINER RES, V18, P859, DOI 10.1359/jbmr.2003.18.5.859; Garnero P, 2002, ARTHRITIS RHEUM, V46, P2847, DOI 10.1002/art.10616; Gerlag DM, 2008, BEST PRACT RES CL RH, V22, P311, DOI 10.1016/j.berh.2008.02.002; Gottlieb A, 2009, LANCET, V373, P633, DOI 10.1016/S0140-6736(09)60140-9; Green MJ, 2003, RHEUMATOLOGY, V42, P83, DOI 10.1093/rheumatology/keg037; Jensen T, 2004, J RHEUMATOL, V31, P1698; Kane D, 2003, RHEUMATOLOGY, V42, P1460, DOI 10.1093/rheumatology/keg384; Kruithof E, 2005, ARTHRITIS RHEUM-US, V52, P3898, DOI 10.1002/art.21426; Kruithof E, 2006, ARTHRITIS RHEUM-US, V54, P1795, DOI 10.1002/art.21914; Landewe R, 2004, ARTHRITIS RHEUM-US, V50, P1390, DOI 10.1002/art.20222; Landewe RBM, 2006, ANN RHEUM DIS, V65, P40, DOI 10.1136/ard.2004.035196; Maksymowych WP, 2008, J RHEUMATOL, V35, P2030; Mease P, 2004, ANN RHEUM DIS, V63, P755, DOI 10.1136/ard.2004.020719; MOLL J M H, 1973, Seminars in Arthritis and Rheumatism, V3, P55, DOI 10.1016/0049-0172(73)90035-8; Mullan RH, 2007, ARTHRITIS RHEUM, V56, P2919, DOI 10.1002/art.22843; Muller-Ladner U, 1999, RHEUMATOLOGY, V38, P148, DOI 10.1093/rheumatology/38.2.148; Poole AR, 2004, J IMMUNOL METHODS, V294, P145, DOI 10.1016/j.jim.2004.09.005; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Rahman P, 2001, J RHEUMATOL, V28, P1041; Ribbens C, 2002, ANN RHEUM DIS, V61, P161, DOI 10.1136/ard.61.2.161; Roux-Lombard P, 2001, RHEUMATOLOGY, V40, P544, DOI 10.1093/rheumatology/40.5.544; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Tchetverikov I, 2003, ANN RHEUM DIS, V62, P1094, DOI 10.1136/ard.62.11.1094; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; van Kuijk AWR, 2009, ANN RHEUM DIS, V68, P1303, DOI 10.1136/ard.2008.091389; Vandooren B, 2004, ARTHRITIS RHEUM-US, V50, P2942, DOI 10.1002/art.20477; Vandooren B, 2009, ANN RHEUM DIS, V68, P1044, DOI 10.1136/ard.2007.085837; Verstappen SMM, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1882; Vis M, 2003, ARTHRITIS RHEUM, V48, P2996, DOI 10.1002/art.11292; Yamanaka H, 2000, ARTHRITIS RHEUM, V43, P852, DOI 10.1002/1529-0131(200004)43:4<852::AID-ANR16>3.0.CO;2-7; YOSHIHARA Y, 1995, ARTHRITIS RHEUM, V38, P969, DOI 10.1002/art.1780380713; Young-Min S, 2007, ARTHRITIS RHEUM-US, V56, P3236, DOI 10.1002/art.22923	38	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12556	10.1371/journal.pone.0012556	http://dx.doi.org/10.1371/journal.pone.0012556			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20844595	Green Published, gold, Green Submitted			2022-12-27	WOS:000281627700009
J	Xue, MS; Craig, TK; Shin, OH; Li, LY; Brautigam, CA; Tomchick, DR; Sudhof, TC; Rosenmund, C; Rizo, J				Xue, Mingshan; Craig, Timothy K.; Shin, Ok-Ho; Li, Liyi; Brautigam, Chad A.; Tomchick, Diana R.; Suedhof, Thomas C.; Rosenmund, Christian; Rizo, Josep			Structural and Mutational Analysis of Functional Differentiation between Synaptotagmins-1 and-7	PLOS ONE			English	Article							C2B DOMAIN; PHOSPHOLIPID-BINDING; C(2)A DOMAIN; CA2+ BINDING; NEUROTRANSMITTER RELEASE; CONFORMATIONAL SWITCH; GENETIC-ANALYSIS; SINGLE-MOLECULE; MEMBRANE-FUSION; SNARE FUNCTION	Synaptotagmins are known to mediate diverse forms of Ca 2+-triggered exocytosis through their C2 domains, but the principles underlying functional differentiation among them are unclear. Synaptotagmin-1 functions as a Ca 2+ sensor in neurotransmitter release at central nervous system synapses, but synaptotagmin-7 does not, and yet both isoforms act as Ca 2+ sensors in chromaffin cells. To shed light into this apparent paradox, we have performed rescue experiments in neurons from synaptotagmin-1 knockout mice using a chimera that contains the synaptotagmin-1 sequence with its C2B domain replaced by the synaptotagmin-7 C2B domain (Syt1/7). Rescue was not achieved either with the WT Syt1/7 chimera or with nine mutants where residues that are distinct in synaptotagmin-7 were restored to those present in synaptotagmin1. To investigate whether these results arise because of unique conformational features of the synaptotagmin-7 C2B domain, we determined its crystal structure at 1.44 A resolution. The synaptotagmin-7 C2B domain structure is very similar to that of the synaptotagmin-1 C2B domain and contains three Ca 2+-binding sites. Two of the Ca 2+-binding sites of the synaptotagmin-7 C2B domain are also present in the synaptotagmin-1 C2B domain and have analogous ligands to those determined for the latter by NMR spectroscopy, suggesting that a discrepancy observed in a crystal structure of the synaptotagmin-1 C2B domain arose from crystal contacts. Overall, our results suggest that functional differentiation in synaptotagmins arises in part from subtle sequence changes that yield dramatic functional differences.	[Xue, Mingshan; Li, Liyi; Rosenmund, Christian] Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; [Craig, Timothy K.; Brautigam, Chad A.; Tomchick, Diana R.; Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Craig, Timothy K.; Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Shin, Ok-Ho] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX USA; [Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Suedhof, Thomas C.] Stanford Univ, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA; [Suedhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94304 USA; [Li, Liyi; Rosenmund, Christian] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Rosenmund, Christian] Charite, Neurosci Res Ctr, D-13353 Berlin, Germany	Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Southwestern Medical Center Dallas; Stanford University; Howard Hughes Medical Institute; Stanford University; Baylor College of Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Xue, MS (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	christian.rosenmund@charite.de; jose@arnie.swmed.edu	Tomchick, Diana/HGV-2018-2022; Rosenmund, Christian/AAC-3596-2020	Rosenmund, Christian/0000-0002-3905-2444; Tomchick, Diana/0000-0002-7529-4643; Xue, Mingshan/0000-0003-1463-8884; Brautigam, Chad/0000-0001-6563-1338; Craig, Timothy/0000-0002-4625-444X	Baylor College of Medicine Mental Retardation and Developmental Disabilities Research Center; Welch Foundation [I-1304]; National Institutes of Health [NS50655, NS40944]; German Research Council [DFG Exc 257]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040944, R01NS050655] Funding Source: NIH RePORTER	Baylor College of Medicine Mental Retardation and Developmental Disabilities Research Center; Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Council(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Baylor College of Medicine Mental Retardation and Developmental Disabilities Research Center, by a grant from the Welch Foundation (I-1304), by National Institutes of Health grants NS50655 (to CR) and NS40944 (to JR), and by the German Research Council grant DFG Exc 257 (CR). URLs: http://mrrc.bcm.tmc.edu/index.html, http://www.welch1.org,http://www.nih.gov/and http://www.dfg.de/en/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Bhalla A, 2008, J BIOL CHEM, V283, P21799, DOI 10.1074/jbc.M709628200; Bowen ME, 2005, BIOPHYS J, V89, P690, DOI 10.1529/biophysj.104.054064; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; CHAPMAN ER, 2008, ANN REV BIOCH; Cheng Y, 2004, PROTEIN SCI, V13, P2665, DOI 10.1110/ps.04832604; Choi UB, 2010, NAT STRUCT MOL BIOL, V17, P318, DOI 10.1038/nsmb.1763; Corbalan-Garcia S, 2010, BIOFACTORS, V36, P1, DOI 10.1002/biof.68; Dai H, 2004, NAT STRUCT MOL BIOL, V11, P844, DOI 10.1038/nsmb817; Dai H, 2007, J MOL BIOL, V367, P848, DOI 10.1016/j.jmb.2007.01.040; DE WH, 2009, CELL, V138, P935; Dulubova I, 2005, EMBO J, V24, P2839, DOI 10.1038/sj.emboj.7600753; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2002, J NEUROSCI, V22, P8438; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Garcia J, 2004, NAT STRUCT MOL BIOL, V11, P45, DOI 10.1038/nsmb707; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Han WP, 2004, NEURON, V41, P85, DOI 10.1016/S0896-6273(03)00820-1; Hui EF, 2005, P NATL ACAD SCI USA, V102, P5210, DOI 10.1073/pnas.0500941102; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Lee HK, 2010, SCIENCE, V328, P760, DOI 10.1126/science.1187722; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu J, 2006, PLOS BIOL, V4, P1159, DOI 10.1371/journal.pbio.0040192; Lynch KL, 2007, J CELL SCI, V120, P617, DOI 10.1242/jcs.03375; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Maximov A, 2008, P NATL ACAD SCI USA, V105, P3986, DOI 10.1073/pnas.0712372105; Michaut M, 2001, DEV BIOL, V235, P521, DOI 10.1006/dbio.2001.0316; Nishiki T, 2004, J NEUROSCI, V24, P8542, DOI 10.1523/JNEUROSCI.2545-04.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rhee JS, 2005, P NATL ACAD SCI USA, V102, P18664, DOI 10.1073/pnas.0509153102; Rickman C, 2004, BIOCHEM J, V378, P681, DOI 10.1042/BJ20031407; Rickman C, 2004, J BIOL CHEM, V279, P12574, DOI 10.1074/jbc.M310710200; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Schonn JS, 2008, P NATL ACAD SCI USA, V105, P3998, DOI 10.1073/pnas.0712373105; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; Stevens CF, 2003, NEURON, V39, P299, DOI 10.1016/S0896-6273(03)00432-X; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sugita S, 2001, NEURON, V30, P459, DOI 10.1016/S0896-6273(01)00290-2; Sutton RB, 1998, STRUCTURE, V6, P1395, DOI 10.1016/S0969-2126(98)00139-7; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Ubach J, 1999, NAT CELL BIOL, V1, P106, DOI 10.1038/10076; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Vrljic M, 2010, NAT STRUCT MOL BIOL, V17, P325, DOI 10.1038/nsmb.1764; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Xue MS, 2008, NAT STRUCT MOL BIOL, V15, P1160, DOI 10.1038/nsmb.1508; Xue MS, 2008, P NATL ACAD SCI USA, V105, P7875, DOI 10.1073/pnas.0803012105; Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292; Zhang XY, 1998, BIOCHEMISTRY-US, V37, P12395, DOI 10.1021/bi9807512	63	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12544	10.1371/journal.pone.0012544	http://dx.doi.org/10.1371/journal.pone.0012544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824061	Green Submitted, gold, Green Published			2022-12-27	WOS:000281480900025
J	Zhao, SL; Zhou, Y; Gross, J; Miao, P; Qiu, L; Wang, DQ; Chen, QA; Feng, GP				Zhao, Shengli; Zhou, Yang; Gross, Jimmy; Miao, Pei; Qiu, Li; Wang, Dongqing; Chen, Qian; Feng, Guoping			Fluorescent Labeling of Newborn Dentate Granule Cells in GAD67-GFP Transgenic Mice: A Genetic Tool for the Study of Adult Neurogenesis	PLOS ONE			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL NEUROGENESIS; SYNAPTIC PLASTICITY; GLUTAMIC-ACID; FUNCTIONAL IMPLICATIONS; GABAERGIC PHENOTYPE; SUBVENTRICULAR ZONE; GYRUS; NEURONS	Neurogenesis in the adult hippocampus is an important form of structural plasticity in the brain. Here we report a line of BAC transgenic mice (GAD67-GFP mice) that selectively and transitorily express GFP in newborn dentate granule cells of the adult hippocampus. These GFP+ cells show a high degree of colocalization with BrdU-labeled nuclei one week after BrdU injection and express the newborn neuron marker doublecortin and PSA-NCAM. Compared to mature dentate granule cells, these newborn neurons show immature morphological features: dendritic beading, fewer dendritic branches and spines. These GFP+ newborn neurons also show immature electrophysiological properties: higher input resistance, more depolarized resting membrane potentials, small and non-typical action potentials. The bright labeling of newborn neurons with GFP makes it possible to visualize the details of dendrites, which reach the outer edge of the molecular layer, and their axon (mossy fiber) terminals, which project to the CA3 region where they form synaptic boutons. GFP expression covers the whole developmental stage of newborn neurons, beginning within the first week of cell division and disappearing as newborn neurons mature, about 4 weeks postmitotic. Thus, the GAD67-GFP transgenic mice provide a useful genetic tool for studying the development and regulation of newborn dentate granule cells.	[Zhao, Shengli; Gross, Jimmy; Miao, Pei; Qiu, Li; Wang, Dongqing; Chen, Qian; Feng, Guoping] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Feng, Guoping] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Zhou, Yang] Chinese Acad Sci, Inst Neurosci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Zhou, Yang] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai, Peoples R China	Duke University; Duke University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhao, SL (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	feng@neuro.duke.edu	Feng, Guoping/Y-2827-2019		Arnold and Mabel Beckman Foundation	Arnold and Mabel Beckman Foundation	This work was supported by a Beckman Young Investigator Award from the Arnold and Mabel Beckman Foundation (to G. F.; http://www.beckmanfoundation.com/), and a Broad Fellowship from the Ruth K. Broad Biomedical Research Foundation (to S.Z.; http://broadfoundation.som.duke.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Acsady L, 1998, J NEUROSCI, V18, P3386; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Balu DT, 2009, NEUROSCI BIOBEHAV R, V33, P232, DOI 10.1016/j.neubiorev.2008.08.007; Beech RD, 2004, J COMP NEUROL, V475, P128, DOI 10.1002/cne.20179; Bruel-Jungerman E, 2007, REV NEUROSCIENCE, V18, P93; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; Couillard-Despres S, 2006, EUR J NEUROSCI, V24, P1535, DOI 10.1111/j.1460-9568.2006.05039.x; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; CRAWFORD IL, 1973, NATURE, V244, P442, DOI 10.1038/244442a0; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feng GP, 2004, METH MOLEC MED, P255; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Gutierrez R, 2003, PROG NEUROBIOL, V71, P337, DOI 10.1016/j.pneurobio.2003.11.004; Gutierrez R, 2003, J NEUROSCI, V23, P5594; Jagasia R, 2006, TRENDS MOL MED, V12, P400, DOI 10.1016/j.molmed.2006.07.006; Jones SP, 2003, HIPPOCAMPUS, V13, P413, DOI 10.1002/hipo.10121; Karten YJG, 2006, HIPPOCAMPUS, V16, P312, DOI 10.1002/hipo.20165; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lehmann H, 1996, NEUROSCI LETT, V212, P41, DOI 10.1016/0304-3940(96)12777-4; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Maqueda J, 2003, NEUROSCI LETT, V353, P69, DOI 10.1016/j.neulet.2003.08.077; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mizrahi A, 2006, P NATL ACAD SCI USA, V103, P1912, DOI 10.1073/pnas.0506297103; Nam SC, 2007, J COMP NEUROL, V505, P190, DOI 10.1002/cne.21473; Noh J, 2010, NAT NEUROSCI, V13, P232, DOI 10.1038/nn.2478; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P2326, DOI 10.1523/JNEUROSCI.4111-05.2006; Platel JC, 2008, J PHYSIOL-LONDON, V586, P3783, DOI 10.1113/jphysiol.2008.155879; SANDLER R, 1991, J COMP NEUROL, V303, P177, DOI 10.1002/cne.903030202; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; SCHWARZER C, 1995, NEUROSCIENCE, V69, P705, DOI 10.1016/0306-4522(95)00348-M; Seal RP, 2006, CURR OPIN PHARMACOL, V6, P114, DOI 10.1016/j.coph.2005.12.001; Shapiro LA, 2005, BRAIN RES REV, V48, P43, DOI 10.1016/j.brainresrev.2004.08.003; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sloviter RS, 1996, J COMP NEUROL, V373, P593; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	65	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12506	10.1371/journal.pone.0012506	http://dx.doi.org/10.1371/journal.pone.0012506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824075	Green Published, gold, Green Submitted			2022-12-27	WOS:000281480900004
J	Frank, MO; Kaufman, J; Tian, SY; Suarez-Farinas, M; Parveen, S; Blachere, NE; Morris, MJ; Slovin, S; Scher, HI; Albert, ML; Darnell, RB				Frank, Mayu O.; Kaufman, Julia; Tian, Suyan; Suarez-Farinas, Mayte; Parveen, Salina; Blachere, Nathalie E.; Morris, Michael J.; Slovin, Susan; Scher, Howard I.; Albert, Matthew L.; Darnell, Robert B.			Harnessing Naturally Occurring Tumor Immunity: A Clinical Vaccine Trial in Prostate Cancer	PLOS ONE			English	Article							PULSED DENDRITIC CELLS; PARANEOPLASTIC CEREBELLAR DEGENERATION; NECROSIS-FACTOR-ALPHA; APOPTOTIC CELLS; T-CELLS; EFFICIENT PRESENTATION; METASTATIC MELANOMA; CROSS-PRESENTATION; MALIGNANT GLIOMA; ANTIGEN	Background: Studies of patients with paraneoplastic neurologic disorders (PND) have revealed that apoptotic tumor serves as a potential potent trigger for the initiation of naturally occurring tumor immunity. The purpose of this study was to assess the feasibility, safety, and immunogenicity of an apoptotic tumor-autologous dendritic cell (DC) vaccine. Methods and Findings: We have modeled PND tumor immunity in a clinical trial in which apoptotic allogeneic prostate tumor cells were used to generate an apoptotic tumor-autologous dendritic cell vaccine. Twenty-four prostate cancer patients were immunized in a Phase I, randomized, single-blind, placebo-controlled study to assess the safety and immunogenicity of this vaccine. Vaccinations were safe and well tolerated. Importantly, we also found that the vaccine was immunogenic, inducing delayed type hypersensitivity (DTH) responses and CD4+ and CD8+ T cell proliferation, with no effect on FoxP3+ regulatory T cells. A statistically significant increase in T cell proliferation responses to prostate tumor cells in vitro (p = 0.002), decrease in prostate specific antigen (PSA) slope (p = 0.016), and a two-fold increase in PSA doubling time (p = 0.003) were identified when we compared data before and after vaccination. Conclusions: An apoptotic cancer cell vaccine modeled on naturally occurring tumor immune responses in PND patients provides a safe and immunogenic tumor vaccine. (ClinicalTrials. gov number NCT00289341).	[Frank, Mayu O.; Kaufman, Julia; Parveen, Salina; Blachere, Nathalie E.; Albert, Matthew L.; Darnell, Robert B.] Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10021 USA; [Tian, Suyan; Suarez-Farinas, Mayte] Rockefeller Univ, Ctr Clin & Translat Sci, New York, NY 10021 USA; [Blachere, Nathalie E.; Darnell, Robert B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Morris, Michael J.; Slovin, Susan; Scher, Howard I.] Mem Sloan Kettering Canc Ctr, Dept Med, Genitourinary Oncol Serv, New York, NY 10021 USA; [Darnell, Robert B.] Mem Sloan Kettering Canc Ctr, Dept Neurooncol, New York, NY 10021 USA	Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Frank, MO (corresponding author), Rockefeller Univ, Mol Neurooncol Lab, 1230 York Ave, New York, NY 10021 USA.	darnelr@rockefeller.edu	Darnell, Robert B/B-9022-2008; Albert, Matthew L/C-9782-2009; Suarez-Farinas, Mayte/I-3558-2012; Tian, Suyan/W-3273-2019	Darnell, Robert B/0000-0002-5134-8088; Suarez-Farinas, Mayte/0000-0001-8712-3553; Tian, Suyan/0000-0002-5942-1542; Frank, Mayu/0000-0002-5597-4828; Morris, Michael J./0000-0002-9454-0096	Burroughs Wellcome Fund; Doris Duke Foundation; National Institutes of Health (NIH) [R01 CA85784]; Rockefeller University Hospital; National Center for Research Resources at the NIH [UL1 RR024143]; Leslie Misrock Memorial Fund; NATIONAL CANCER INSTITUTE [R01CA085784] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University Hospital; National Center for Research Resources at the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Leslie Misrock Memorial Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Burroughs Wellcome Fund and Doris Duke Foundation (MLA), the National Institutes of Health (NIH) (R01 CA85784 to RBD), the Rockefeller University Hospital Clinical and Translational Science Awards (CTSA)(grant UL1 RR024143) from the National Center for Research Resources at the NIH, the Leslie Misrock Memorial Fund, and David H. Koch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; Albert ML, 2001, NAT IMMUNOL, V2, P1010, DOI 10.1038/ni722; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Albert ML, 1998, NAT MED, V4, P1321, DOI 10.1038/3315; Albert ML, 2000, ANN NEUROL, V47, P9; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Banchereau J, 2001, CANCER RES, V61, P6451; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Benencia F, 2008, ADV EXP MED BIOL, V622, P221, DOI 10.1007/978-0-387-68969-2_18; Blacher NE, 2005, PLOS BIOL, V3, P1070, DOI 10.1371/journal.pbio.0030185; Bui JD, 2007, CURR OPIN IMMUNOL, V19, P203, DOI 10.1016/j.coi.2007.02.001; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Darnell RB, 2003, NAT IMMUNOL, V4, P201, DOI 10.1038/ni0303-201; Darnell RB, 1996, P NATL ACAD SCI USA, V93, P4529, DOI 10.1073/pnas.93.10.4529; Darnell RB, 2003, NEW ENGL J MED, V349, P1543, DOI 10.1056/NEJMra023009; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Fong L, 2001, J IMMUNOL, V166, P4254, DOI 10.4049/jimmunol.166.6.4254; Fong L, 2009, CANCER RES, V69, P609, DOI 10.1158/0008-5472.CAN-08-3529; Geiger JD, 2001, CANCER RES, V61, P8513; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Koido S, 2005, GYNECOL ONCOL, V99, P462, DOI 10.1016/j.ygyno.2005.07.019; Li M, 2001, J IMMUNOL, V166, P6099, DOI 10.4049/jimmunol.166.10.6099; Neidhardt-Berard EM, 2004, BREAST CANCER RES, V6, pR322, DOI 10.1186/bcr794; Okada H, 2001, HUM GENE THER, V12, P575; Orange DE, 2004, PROSTATE CANCER P D, V7, P63, DOI 10.1038/sj.pcan.4500694; Palucka AK, 2007, IMMUNOL REV, V220, P129, DOI 10.1111/j.1600-065X.2007.00575.x; Palucka AK, 2005, J CLIN IMMUNOL, V25, P288, DOI 10.1007/s10875-005-4089-z; Palucka AK, 2006, J IMMUNOTHER, V29, P545, DOI 10.1097/01.cji.0000211309.90621.8b; Peggs KS, 2006, CURR OPIN IMMUNOL, V18, P206, DOI 10.1016/j.coi.2006.01.011; Putz T, 2004, J CLIN IMMUNOL, V24, P653, DOI 10.1007/s10875-004-6237-2; Raychaudhuri S, 1998, NAT BIOTECHNOL, V16, P1025, DOI 10.1038/3469; Rieser C, 1997, J EXP MED, V186, P1603, DOI 10.1084/jem.186.9.1603; Rutkowski S, 2004, BRIT J CANCER, V91, P1656, DOI 10.1038/sj.bjc.6602195; Saito H, 2006, HEMATOL ONCOL CLIN N, V20, P689, DOI 10.1016/j.hoc.2006.02.011; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Simons JW, 1999, CANCER RES, V59, P5160; Wheeler CJ, 2008, CANCER RES, V68, P5955, DOI 10.1158/0008-5472.CAN-07-5973; Yamanaka R, 2005, CLIN CANCER RES, V11, P4160, DOI 10.1158/1078-0432.CCR-05-0120; Yu JS, 2004, CANCER RES, V64, P4973, DOI 10.1158/0008-5472.CAN-03-3505; Zang XX, 2007, CLIN CANCER RES, V13, P5271, DOI 10.1158/1078-0432.CCR-07-1030	40	13	18	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12367	10.1371/journal.pone.0012367	http://dx.doi.org/10.1371/journal.pone.0012367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824184	Green Published, gold			2022-12-27	WOS:000281456100002
J	Katouli, AA; Komarova, NL				Katouli, Allen A.; Komarova, Natalia L.			Optimizing Combination Therapies with Existing and Future CML Drugs	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; CHROMOSOME-POSITIVE LEUKEMIAS; CHRONIC MYELOGENOUS LEUKEMIA; ABL INHIBITORS IMATINIB; BCR-ABL; GENE AMPLIFICATION; AURORA KINASES; DASATINIB BMS-354825; CANCER-CHEMOTHERAPY; MATHEMATICAL-MODELS	Small-molecule inhibitors imatinib, dasatinib and nilotinib have been developed to treat Chromic Myeloid Leukemia (CML). The existence of a triple-cross-resistant mutation, T315I, has been a challenging problem, which can be overcome by finding new inhibitors. Many new compounds active against T315I mutants are now at different stages of development. In this paper we develop an algorithm which can weigh different combination treatment protocols according to their cross-resistance properties, and find the protocols with the highest probability of treatment success. This algorithm also takes into account drug toxicity by minimizing the number of drugs used, and their concentration. Although our methodology is based on a stochastic model of CML microevolution, the algorithm itself does not require measurements of any parameters (such as mutation rates, or division/death rates of cells), and can be used by medical professionals without a mathematical background. For illustration, we apply this algorithm to the mutation data obtained in [1,2].	[Katouli, Allen A.; Komarova, Natalia L.] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA	University of California System; University of California Irvine	Katouli, AA (corresponding author), Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA.	komarova@uci.edu			National Institutes of Health [R01 CA129286]; NATIONAL CANCER INSTITUTE [R01CA129286] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to gratefully acknowledge the generous support of the National Institutes of Health grant R01 CA129286. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apperley JF, 2007, LANCET ONCOL, V8, P1018, DOI 10.1016/S1470-2045(07)70342-X; Bradeen HA, 2006, BLOOD, V108, P2332, DOI 10.1182/blood-2006-02-004580; Branford S, 2009, BLOOD, V114, P5426, DOI 10.1182/blood-2009-08-215939; BYRNE HM, 1995, MATH BIOSCI, V130, P151, DOI 10.1016/0025-5564(94)00117-3; Calabretta B, 2004, BLOOD, V103, P4010, DOI 10.1182/blood-2003-12-4111; Cohen RB, 2009, CLIN CANCER RES, V15, P6694, DOI 10.1158/1078-0432.CCR-09-1445; COJOCARU L, 1992, MATH BIOSCI, V109, P85, DOI 10.1016/0025-5564(92)90053-Y; COLDMAN AJ, 1983, MATH BIOSCI, V65, P291, DOI 10.1016/0025-5564(83)90066-4; COLDMAN AJ, 1986, B MATH BIOL, V48, P279, DOI 10.1016/S0092-8240(86)90028-5; COLDMAN AJ, 1985, CANCER TREAT REP, V69, P1041; Daub H, 2004, NAT REV DRUG DISCOV, V3, P1001, DOI 10.1038/nrd1579; de Pillis LG, 2007, MATH BIOSCI, V209, P292, DOI 10.1016/j.mbs.2006.05.003; Deguchi Y, 2008, LEUKEMIA RES, V32, P980, DOI 10.1016/j.leukres.2007.11.008; Deininger MWN, 2007, EXP HEMATOL, V35, P144, DOI 10.1016/j.exphem.2007.01.023; Deininger MWN, 2003, J CLIN ONCOL, V21, P1637, DOI 10.1200/JCO.2003.11.143; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Druker BJ, 2003, MOL CANCER THER, V2, P225; Gaffney EA, 2005, B MATH BIOL, V67, P563, DOI 10.1016/j.bulm.2004.09.002; Gaffney EA, 2004, J MATH BIOL, V48, P375, DOI 10.1007/s00285-003-0246-2; Gambacorti-Passerini CB, 2003, LANCET ONCOL, V4, P75, DOI 10.1016/S1470-2045(03)00979-3; Gardner SN, 2003, MOL CANCER THER, V2, P1079; Giles FJ, 2007, BLOOD, V109, P500, DOI 10.1182/blood-2006-05-025049; GOLDIE JH, 1983, CANCER TREAT REP, V67, P923; GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727; Gontarewicz A, 2008, BLOOD, V111, P4355, DOI 10.1182/blood-2007-09-113175; Gontarewicz A, 2010, RECENT RESULTS CANC, V184, P199, DOI 10.1007/978-3-642-01222-8_14; Hantschel O, 2008, LEUKEMIA LYMPHOMA, V49, P615, DOI 10.1080/10428190801896103; HARNEVO LE, 1993, MUTAT RES, V292, P17, DOI 10.1016/0165-1161(93)90004-J; HARNEVO LE, 1991, MATH BIOSCI, V103, P115, DOI 10.1016/0025-5564(91)90094-Y; Jackson TL, 2000, MATH BIOSCI, V164, P17, DOI 10.1016/S0025-5564(99)00062-0; JAFFREZOU JP, 1994, J NATL CANCER I, V86, P1152, DOI 10.1093/jnci/86.15.1152; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; KATOULI AA, 2009, THESIS U CALIFORNIA; Kendal W S, 1988, Adv Exp Med Biol, V233, P1; KIMMEL M, 1994, B MATH BIOL, V56, P337, DOI 10.1016/S0092-8240(05)80262-9; KIMMEL M, 1990, GENETICS, V125, P633; Komarova N, 2006, J THEOR BIOL, V239, P351, DOI 10.1016/j.jtbi.2005.08.003; Komarova NL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000990; Komarova NL, 2007, THEOR POPUL BIOL, V72, P523, DOI 10.1016/j.tpb.2007.08.003; Komarova NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004423; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Loriaux M, 2004, LEUKEMIA LYMPHOMA, V45, P2197, DOI 10.1080/10428190410001723278; McKinnell R. G., 1998, BIOL BASIS CANC; Melo Junia V, 2003, Hematology Am Soc Hematol Educ Program, P132; Michor F, 2006, CURR PHARM DESIGN, V12, P261, DOI 10.2174/138161206775201956; Modugno M, 2007, CANCER RES, V67, P7987, DOI 10.1158/0008-5472.CAN-07-1825; MOLONEY WC, 1987, BLOOD, V70, P905; MOOLGAVKAR SH, 1988, RISK ANAL, V8, P383, DOI 10.1111/j.1539-6924.1988.tb00502.x; MOOLGAVKAR SH, 1981, J NATL CANCER I, V66, P1037, DOI 10.1093/jnci/66.6.1037; MOOLGAVKAR SH, 1989, CELL BIOL TOXICOL, V5, P445, DOI 10.1007/BF00118413; Nardi V, 2004, CURR OPIN HEMATOL, V11, P35, DOI 10.1097/00062752-200401000-00006; Noronha G, 2008, CURR TOP MED CHEM, V8, P905, DOI 10.2174/156802608784911635; O'Hare T, 2008, P NATL ACAD SCI USA, V105, P5507, DOI 10.1073/pnas.0800587105; O'Hare T, 2007, BLOOD, V110, P2242, DOI 10.1182/blood-2007-03-066936; Quintas-Cardama A, 2007, BLOOD, V109, P497, DOI 10.1182/blood-2006-07-035493; Redaelli S, 2009, J CLIN ONCOL, V27, P469, DOI 10.1200/JCO.2008.19.8853; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Roeder I, 2008, J MOL MED, V86, P17, DOI 10.1007/s00109-007-0241-y; Shannon KM, 2002, CANCER CELL, V2, P99, DOI 10.1016/S1535-6108(02)00101-0; Shet AS, 2002, LEUKEMIA, V16, P1402, DOI 10.1038/sj.leu.2402577; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Weisberg E, 2007, BLOOD, V109, P2112, DOI 10.1182/BLOOD-2006-06-026377; Xie Y, 2003, CANCER-AM CANCER SOC, V97, P2229, DOI 10.1002/cncr.11316; Yoshida C, 2004, INT J HEMATOL, V79, P420, DOI 10.1532/IJH97.04032; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhou TJ, 2007, CHEM BIOL DRUG DES, V70, P171, DOI 10.1111/j.1747-0285.2007.00556.x	68	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12300	10.1371/journal.pone.0012300	http://dx.doi.org/10.1371/journal.pone.0012300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808800	Green Published, gold			2022-12-27	WOS:000281153500002
J	Yin, J; Hu, S; Jiang, W; Liu, LA; Lan, SM; Song, XG; Liu, CL				Yin, Jun; Hu, Si; Jiang, Wei; Liu, Liang; Lan, Shemin; Song, Xuegang; Liu, Changlin			DNA-Triggered Aggregation of Copper, Zinc Superoxide Dismutase in the Presence of Ascorbate	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ALS-LINKED SOD1; MUTANT CU,ZN-SUPEROXIDE DISMUTASE; MOTOR-NEURON DEGENERATION; FAMILIAL ALS; OXIDATIVE STRESS; WILD-TYPE; IN-VITRO; MUTATIONS; TOXICITY	The oxidative damage hypothesis proposed for the function gain of copper, zinc superoxide dismutase (SOD1) maintains that both mutant and wild-type (WT) SOD1 catalyze reactions with abnormal substrates that damage cellular components critical for viability of the affected cells. However, whether the oxidative damage of SOD1 is involved in the formation of aggregates rich in SOD1 or not remains elusive. Here, we sought to explore the oxidative aggregation of WT SOD1 exposed to environments containing both ascorbate (Asc) and DNA under neutral conditions. The results showed that the WT SOD1 protein was oxidized in the presence of Asc. The oxidation results in the higher affinity of the modified protein for DNA than that of the unmodified protein. The oxidized SOD1 was observed to be more prone to aggregation than the WT SOD1, and the addition of DNA can significantly accelerate the oxidative aggregation. Moreover, a reasonable relationship can be found between the oxidation, increased hydrophobicity, and aggregation of SOD1 in the presence of DNA. The crucial step in aggregation is neutralization of the positive charges on some SOD1 surfaces by DNA binding. This study might be crucial for understanding molecular forces driving the protein aggregation.	[Yin, Jun] Cent China Normal Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Wuhan, Peoples R China; Cent China Normal Univ, Sch Chem, Wuhan, Peoples R China	Central China Normal University; Central China Normal University	Yin, J (corresponding author), Cent China Normal Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Wuhan, Peoples R China.	liuchl@mail.ccnu.edu.cn			National Natural Science Foundation of China [20971049]; Key Laboratory of Pesticide and Chemical Biology, Ministry of Education, Central China Normal University [200601A04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Pesticide and Chemical Biology, Ministry of Education, Central China Normal University(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China (grant 20971049) and by Key Laboratory of Pesticide and Chemical Biology, Ministry of Education, Central China Normal University (200601A04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; Barbosa LF, 2010, BBA-MOL BASIS DIS, V1802, P462, DOI 10.1016/j.bbadis.2010.01.011; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; BOWLING AC, 1993, J NEUROCHEM, V61, P2322, DOI 10.1111/j.1471-4159.1993.tb07478.x; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Calamai M, 2006, BIOCHEMISTRY-US, V45, P12806, DOI 10.1021/bi0610653; CHANG Y, 2008, PLOS ONE, V3, pE2489; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chen Q, 2007, P NATL ACAD SCI USA, V104, P8749, DOI 10.1073/pnas.0702854104; Cherny D, 2004, J MOL BIOL, V344, P929, DOI 10.1016/j.jmb.2004.09.096; Choi J, 2005, J BIOL CHEM, V280, P11648, DOI 10.1074/jbc.M414327200; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; Cozzolino M, 2009, ANTIOXID REDOX SIGN, V11, P1547, DOI 10.1089/ARS.2009.2545; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Ferri A, 2006, P NATL ACAD SCI USA, V103, P13860, DOI 10.1073/pnas.0605814103; FRIDOVICH I, 1975, ANNU REV BIOCHEM, V44, P147, DOI 10.1146/annurev.bi.44.070175.001051; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Ge WW, 2005, J BIOL CHEM, V280, P118, DOI 10.1074/jbc.M405065200; Gros-Louis F, 2006, BBA-MOL BASIS DIS, V1762, P956, DOI 10.1016/j.bbadis.2006.01.004; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hart PJ, 2006, CURR OPIN CHEM BIOL, V10, P131, DOI 10.1016/j.cbpa.2006.02.034; Ihara Y, 2005, NEUROL RES, V27, P105, DOI 10.1179/016164105X18430; Jaarsma D, 2000, NEUROBIOL DIS, V7, P623, DOI 10.1006/nbdi.2000.0299; Jiang W, 2008, BIOPOLYMERS, V89, P1154, DOI 10.1002/bip.21067; Jiang W, 2007, BIOCHEMISTRY-US, V46, P5911, DOI 10.1021/bi062234m; Jiang W, 2006, J BIOL INORG CHEM, V11, P835, DOI 10.1007/s00775-006-0127-4; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kawamata H, 2008, HUM MOL GENET, V17, P3303, DOI 10.1093/hmg/ddn226; Khare SD, 2004, P NATL ACAD SCI USA, V101, P15094, DOI 10.1073/pnas.0406650101; Kim YJ, 2005, J BIOL CHEM, V280, P21515, DOI 10.1074/jbc.M502230200; Kinnula VL, 2004, FREE RADICAL BIO MED, V36, P718, DOI 10.1016/j.freeradbiomed.2003.12.010; Kurahashi T, 2001, J AM CHEM SOC, V123, P9268, DOI 10.1021/ja015953r; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Li XL, 2009, J NEUROCHEM, V108, P1032, DOI 10.1111/j.1471-4159.2008.05856.x; LIPPARD SJ, 1977, BIOCHEMISTRY-US, V16, P1136, DOI 10.1021/bi00625a017; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Ogusucu R, 2009, J BIOL CHEM, V284, P5546, DOI 10.1074/jbc.M805526200; PARDO CA, 1995, P NATL ACAD SCI USA, V92, P954, DOI 10.1073/pnas.92.4.954; Potter SZ, 2003, J BIOL INORG CHEM, V8, P373, DOI 10.1007/s00775-003-0447-6; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X; Roberts BR, 2007, J MOL BIOL, V373, P877, DOI 10.1016/j.jmb.2007.07.043; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Shaw BF, 2008, J BIOL CHEM, V283, P8340, DOI 10.1074/jbc.M707751200; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Simpson CL, 2006, BBA-MOL BASIS DIS, V1762, P973, DOI 10.1016/j.bbadis.2006.08.001; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Tiwari A, 2005, J BIOL CHEM, V280, P29771, DOI 10.1074/jbc.M504039200; Valentine JS, 2002, FREE RADICAL BIO MED, V33, P1314, DOI 10.1016/S0891-5849(02)01080-8; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; WANG L, 2002, SCI STKE, V138, P1; Zhang FJ, 2006, BBA-GEN SUBJECTS, V1760, P404, DOI 10.1016/j.bbagen.2005.11.024	70	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12328	10.1371/journal.pone.0012328	http://dx.doi.org/10.1371/journal.pone.0012328			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808835	gold, Green Published, Green Submitted			2022-12-27	WOS:000281077000017
J	Yu, ACL				Yu, Alan C. L.			Perceptual Compensation Is Correlated with Individuals' "Autistic" Traits: Implications for Models of Sound Change	PLOS ONE			English	Article							SPECTRUM QUOTIENT AQ; HIGH-FUNCTIONING AUTISM; ASPERGER-SYNDROME; COGNITIVE STYLES; SEX; POPULATION; DOMINANCE; GENDER; ADULTS	Variation is a ubiquitous feature of speech. Listeners must take into account context-induced variation to recover the interlocutor's intended message. When listeners fail to normalize for context-induced variation properly, deviant percepts become seeds for new perceptual and production norms. In question is how deviant percepts accumulate in a systematic fashion to give rise to sound change (i.e., new pronunciation norms) within a given speech community. The present study investigated subjects' classification of /s/ and /integral/ before /a/ or /u/ spoken by a male or a female voice. Building on modern cognitive theories of autism-spectrum condition, which see variation in autism-spectrum condition in terms of individual differences in cognitive processing style, we established a significant correlation between individuals' normalization for phonetic context (i.e., whether the following vowel is /a/ or /u/) and talker voice variation (i.e., whether the talker is male or female) in speech and their "autistic" traits, as measured by the Autism Spectrum Quotient (AQ). In particular, our mixed-effect logistic regression models show that women with low AQ (i.e., the least "autistic") do not normalize for phonetic coarticulation as much as men and high AQ women. This study provides first direct evidence that variability in human's ability to compensate for context-induced variations in speech perceptually is governed by the individual's sex and cognitive processing style. These findings lend support to the hypothesis that the systematic infusion of new linguistic variants (i.e., the deviant percepts) originate from a sub-segment of the speech community that consistently under-compensates for contextual variation in speech.	Univ Chicago, Dept Linguist, Phonol Lab, Chicago, IL 60637 USA	University of Chicago	Yu, ACL (corresponding author), Univ Chicago, Dept Linguist, Phonol Lab, Chicago, IL 60637 USA.	aclyu@uchicago.edu			National Science Foundation [BCS-0949754]; Direct For Social, Behav & Economic Scie [0949754] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work is partially funded by National Science Foundation grant BCS-0949754. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; *APA, 1994, DSM 4 DIAGN STAT MAN; AUSBURN LJ, 1978, ECTJ-EDUC COMMUN TEC, V26, P337; Austin EJ, 2005, PERS INDIV DIFFER, V38, P451, DOI 10.1016/j.paid.2004.04.022; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S., 2001, J DEV LEARNING DISOR, V5, P47, DOI DOI 10.1111/J.1467-7687.2008.00720.X; Baron-Cohen S, 2009, ANN NY ACAD SCI, V1156, P68, DOI 10.1111/j.1749-6632.2009.04467.x; Bates D., 2009, IME4 LINEAR MIXED EF; Beddor PS, 2009, LANGUAGE, V85, P785; Blevins Juliette, 2004, EVOLUTIONARY PHONOLO; Bonnel A, 2003, J COGNITIVE NEUROSCI, V15, P226, DOI 10.1162/089892903321208169; Chambers Jack K., 1995, SOCIOLINGUISTIC THEO; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Constantino JN, 2003, ARCH GEN PSYCHIAT, V60, P524, DOI 10.1001/archpsyc.60.5.524; COURCHESNE E, 1994, BEHAV NEUROSCI, V108, P848, DOI 10.1037/0735-7044.108.5.848; Deutsch, 1985, LEFT BRAIN RIGHT BRA; ECKERT P, 1988, LANG SOC, V17, P183, DOI 10.1017/S0047404500012756; ECKERT P, 1999, LINGUISTIC VARIATION; Eckert Penelope, 1989, LANG VAR CHANGE, V1, P245, DOI DOI 10.1017/S095439450000017X; Emberts Zachary, 2020, EVOLUTION, V74, P897, DOI [10.1111/evo.13948, DOI 10.1111/EVO.13580]; Gordon M, 1998, CURR ANTHROPOL, V39, P421, DOI 10.1086/204758; Groen W, 2008, J AUTISM DEV DISORD, V38, P1819, DOI 10.1007/s10803-008-0572-8; Happe F, 1999, TRENDS COGN SCI, V3, P216, DOI 10.1016/S1364-6613(99)01318-2; Hoekstra RA, 2008, J AUTISM DEV DISORD, V38, P1555, DOI 10.1007/s10803-008-0538-x; Hoekstra RA, 2007, ARCH PEDIAT ADOL MED, V161, P372, DOI 10.1001/archpedi.161.4.372; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Labov William, 1990, LANG VAR CHANGE, V2, P205, DOI [10. 1017/S09543945 00000338, DOI 10.1017/S0954394500000338]; Lindblom Bjorn E. F., 1995, RIV LINGUISTICA, V7, P5; MANN VA, 1980, PERCEPT PSYCHOPHYS, V28, P407, DOI 10.3758/BF03204884; Messick S., 1976, INDIVIDUALITY LEARNI; Mitterer H, 2006, PERCEPT PSYCHOPHYS, V68, P1227, DOI 10.3758/BF03193723; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Mufwene Salikoko S., 2008, LANGUAGE EVOLUTION C; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; OHala J.J., 1993, HIST LINGUISTICS PRO, P237; Schilling-Estes N., 2002, J ENGL LINGUIST, V30, P122, DOI DOI 10.1177/007242030002003; Soulieres I, 2007, J AUTISM DEV DISORD, V37, P481, DOI 10.1007/s10803-006-0172-4; SPERRY RW, 1964, SCI AM, V210, P42, DOI 10.1038/scientificamerican0164-42; Stewart ME, 2008, COGNITION, V109, P157, DOI 10.1016/j.cognition.2008.07.010; Strand EA, 1996, NATURAL LANGUAGE PROCESSING AND SPEECH TECHNOLOGY, P14; Strand EA, 1999, J LANG SOC PSYCHOL, V18, P86, DOI 10.1177/0261927X99018001006; Uskul AK, 2008, P NATL ACAD SCI USA, V105, P8552, DOI 10.1073/pnas.0803874105; Wakabayashi A, 2006, PERS INDIV DIFFER, V41, P873, DOI 10.1016/j.paid.2006.04.003; Wakabayashi A, 2006, J AUTISM DEV DISORD, V36, P263, DOI 10.1007/s10803-005-0061-2; Walenski M., 2006, UNDERSTANDING AUTISM, P175, DOI 10.1201/9781420004205.ch9; Walenski M, 2008, J AUTISM DEV DISORD, V38, P1395, DOI 10.1007/s10803-007-0513-y; Weinreich Uriel, 1968, DIRECTIONS HIST LING, P95; William Labov, 2001, PRINCIPLES LINGUISTI, V2; WITKIN HA, 1977, REV EDUC RES, V47, P1; World Health Organization, 2022, INT CLASS DIS, V11th; ZENHAUSERN R, 1979, B PSYCHONOMIC SOC, V14, P71; ZENHAUSERN R, 1978, B PSYCHONOMIC SOC, V12, P381; [No title captured]; [No title captured]; [No title captured]; [No title captured]	59	57	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e11950	10.1371/journal.pone.0011950	http://dx.doi.org/10.1371/journal.pone.0011950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	640TN	20808859	gold, Green Published, Green Submitted			2022-12-27	WOS:000281075500001
J	Glynn, JR; Alghamdi, S; Mallard, K; McNerney, R; Ndlovu, R; Munthali, L; Houben, RM; Fine, PEM; French, N; Crampin, AC				Glynn, Judith R.; Alghamdi, Saad; Mallard, Kim; McNerney, Ruth; Ndlovu, Richard; Munthali, Lumbani; Houben, Rein M.; Fine, Paul E. M.; French, Neil; Crampin, Amelia C.			Changes in Mycobacterium tuberculosis Genotype Families Over 20 Years in a Population-Based Study in Northern Malawi	PLOS ONE			English	Article							BEIJING GENOTYPE; STRAINS; HIV; EPIDEMIOLOGY; TRANSMISSION; INFECTION; EMERGENCE; BACTERIA; AFRICA	Background: Despite increasing interest in possible differences in virulence and transmissibility between different genotypes of M. tuberculosis, very little is known about how genotypes within a population change over decades, or about relationships to HIV infection. Methods and Principal Findings: In a population-based study in rural Malawi we have examined smears and cultures from tuberculosis patients over a 20-year period using spoligotyping. Isolates were grouped into spoligotype families and lineages following previously published criteria. Time trends, HIV status, drug resistance and outcome were examined by spoligotype family and lineage. In addition, transmissibility was examined among pairs of cases with known epidemiological contact by assessing the proportion of transmissions confirmed for each lineage, on the basis of IS6110 RFLP similarity of the M tuberculosis strains. 760 spoligotypes were obtained from smears from 518 patients from 1986-2002, and 377 spoligotypes from cultures from 347 patients from 2005-2008. There was good consistency in patients with multiple specimens. Among 781 patients with first episode tuberculosis, the majority (76%) had Lineage 4 ("European/American'') strains; 9% had Lineage 3 ("East-African/Indian''); 8% Lineage 1 ("Indo-Oceanic''); and 2% Lineage 2 ("East-Asian''); others unclassifiable. Over time the proportion of Lineage 4 decreased from >90% to 60%, with an increase in the other 3 lineages (p<0.001). Lineage 1 strains were more common in those with HIV infection, even after adjusting for age, sex and year. There were no associations with drug resistance or outcome, and no differences by lineage in the proportion of pairs in which transmission was confirmed. Conclusions: This is the first study to describe long term trends in the four M. tuberculosis lineages in a population. Lineage 4 has probably been longstanding in this population, with relatively recent introductions and spread of Lineages1-3, perhaps influenced by the HIV epidemic.	[Glynn, Judith R.; Alghamdi, Saad; Mallard, Kim; McNerney, Ruth; Houben, Rein M.; Fine, Paul E. M.; French, Neil; Crampin, Amelia C.] London Sch Hyg & Trop Med, London WC1, England; [Ndlovu, Richard; Munthali, Lumbani] Karonga Prevent Study, Chilumba, Malawi	University of London; London School of Hygiene & Tropical Medicine; Malawi Epidemiology and Intervention Research Unit	Glynn, JR (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	judith.glynn@lshtm.ac.uk	French, Neil/A-2994-2012; Alghamdi, Saad/AAJ-7072-2021; Alghamdi, Saad/AAJ-7063-2021	Alghamdi, Saad/0000-0003-4532-9128; Alghamdi, Saad/0000-0003-4532-9128; French, Neil/0000-0003-4814-8293; Crampin, Amelia/0000-0002-1513-4330; MCNERNEY, Ruth/0000-0002-1957-443X	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The study was funded by the Wellcome Trust, with contributions from LEPRA (The British Leprosy Association), DFID (UK Department for International Development, via the TARGETS Research Consortium), and the Ministry of Health and Government of the Kingdom of Saudi Arabia (for S Alghamdi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown T, 2010, EMERG INFECT DIS, V16, P272, DOI 10.3201/eid1602.091032; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Chihota V, 2007, INT J TUBERC LUNG D, V11, P311; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; Crampin AC, 2006, EMERG INFECT DIS, V12, P729; Dale JW, 2001, INT J TUBERC LUNG D, V5, P216; de Boer AS, 1999, J INFECT DIS, V180, P1238, DOI 10.1086/314979; Easterbrook PJ, 2004, J CLIN MICROBIOL, V42, P4536, DOI 10.1128/JCM.42.10.4536-4544.2004; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Glynn JR, 2005, J INFECT DIS, V192, P480, DOI 10.1086/431517; Glynn JR, 2005, EMERG INFECT DIS, V11, P150, DOI 10.3201/eid1101.040869; Glynn JR, 2004, AIDS, V18, P1459, DOI 10.1097/01.aids.0000131336.15301.06; Glynn JR, 2008, EMERG INFECT DIS, V14, P1060, DOI 10.3201/eid1407.060468; Houben RMGJ, 2009, T ROY SOC TROP MED H, V103, P1187, DOI 10.1016/j.trstmh.2009.03.013; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Narayanan S, 2008, INFECT GENET EVOL, V8, P474, DOI 10.1016/j.meegid.2007.09.007; Newton SM, 2006, P NATL ACAD SCI USA, V103, P15594, DOI 10.1073/pnas.0604283103; Palanisamy GS, 2009, TUBERCULOSIS, V89, P203, DOI 10.1016/j.tube.2009.01.005; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; van der Zanden AGM, 1998, J CLIN PATHOL-MOL PA, V51, P209, DOI 10.1136/mp.51.4.209; Yeh RW, 1998, J INFECT DIS, V177, P1107, DOI 10.1086/517406	24	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12259	10.1371/journal.pone.0012259	http://dx.doi.org/10.1371/journal.pone.0012259			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808874	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000280968100034
J	Li, ZS; Mulligan, MK; Wang, XS; Miles, MF; Lu, L; Williams, RW				Li, Zhengsheng; Mulligan, Megan K.; Wang, Xusheng; Miles, Michael F.; Lu, Lu; Williams, Robert W.			A Transposon in Comt Generates mRNA Variants and Causes Widespread Expression and Behavioral Differences among Mice	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; COMPLEX TRAIT ANALYSIS; GENE-EXPRESSION; FUNCTIONAL POLYMORPHISM; DOPAMINE RELEASE; INBRED STRAINS; WORKING-MEMORY; DEFICIENT MICE; COGNITION; SCHIZOPHRENIA	Background: Catechol-O-methyltransferase (COMT) is a key enzyme responsible for the degradation of dopamine and norepinephrine. COMT activity influences cognitive and emotional states in humans and aggression and drug responses in mice. This study identifies the key sequence variant that leads to differences in Comt mRNA and protein levels among mice, and that modulates synaptic function and pharmacological and behavioral traits. Methodology/Principal Findings: We examined Comt expression in multiple tissues in over 100 diverse strains and several genetic crosses. Differences in expression map back to Comt and are generated by a 230 nt insertion of a B2 short interspersed element (B2 SINE) in the proximal 3' UTR of Comt in C57BL/6J. This transposon introduces a premature polyadenylation signal and creates a short 3' UTR isoform. The B2 SINE is shared by a subset of strains, including C57BL/6J, A/J, BALB/cByJ, and AKR/J, but is absent in others, including DBA/2J, FVB/NJ, SJL/J, and wild subspecies. The short isoform is associated with increased protein expression in prefrontal cortex and hippocampus relative to the longer ancestral isoform. The Comt variant causes downstream differences in the expression of genes involved in synaptic function, and also modulates phenotypes such as dopamine D1 and D2 receptor binding and pharmacological responses to haloperidol. Conclusions/Significance: We have precisely defined the B2 SINE as the source of variation in Comt and demonstrated that a transposon in a 3' UTR can alter mRNA isoform use and modulate behavior. The recent fixation of the variant in a subset of strains may have contributed to the rapid divergence of inbred strains.	[Li, Zhengsheng; Mulligan, Megan K.; Wang, Xusheng; Lu, Lu; Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Ctr Integrat & Translat Genom, Memphis, TN USA; [Miles, Michael F.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA USA	University of Tennessee System; University of Tennessee Health Science Center; Virginia Commonwealth University	Li, ZS (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Ctr Integrat & Translat Genom, Memphis, TN USA.	rwilliam@nb.utmem.edu	lu, lu/HII-7530-2022; lu, lu/HGA-0894-2022; Williams, Robert W./H-8789-2016	Williams, Robert W./0000-0001-8924-4447; Mulligan, Megan/0000-0003-4909-635X	National Institute on Drug Abuse [P20-DA 21131]; National Institute on Alcohol Abuse and Alcoholism [U01AA13499, U24AA13513, U01AA016667, U01AA014425]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016667, U01AA014425, U01AA016662, P20AA017828, R01AA013678, U01AA013499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA021131] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute on Drug Abuse (P20-DA 21131) and the National Institute on Alcohol Abuse and Alcoholism (U01AA13499, U24AA13513, U01AA016667, and U01AA014425) to RWW, MFM, and LL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilder RM, 2002, BIOL PSYCHIAT, V52, P701, DOI 10.1016/S0006-3223(02)01416-6; Buckholtz JW, 2007, MOL PSYCHIATR, V12, P893, DOI 10.1038/sj.mp.4002008; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Chesler EJ, 2004, NAT NEUROSCI, V7, P485, DOI 10.1038/nn0504-485; Demarest K, 1999, J NEUROSCI, V19, P549; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Fernandes C, 2004, EUR J NEUROSCI, V19, P2576, DOI 10.1111/j.0953-816X.2004.03358.x; Ferrigno O, 2001, NAT GENET, V28, P77, DOI 10.1038/ng0501-77; GEORGIEV GP, 1984, EUR J BIOCHEM, V145, P203, DOI 10.1111/j.1432-1033.1984.tb08541.x; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Goldman-Rakic P S, 1998, Adv Pharmacol, V42, P707; Grice DE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-76; Hosak L, 2007, EUR PSYCHIAT, V22, P276, DOI 10.1016/j.eurpsy.2007.02.002; Huotari M, 2002, EUR J NEUROSCI, V15, P246, DOI 10.1046/j.0953-816x.2001.01856.x; Jones BC, 1999, PHARMACOGENETICS, V9, P607, DOI 10.1097/01213011-199910000-00007; Kanes S, 1996, J PHARMACOL EXP THER, V277, P1016; KAROUM F, 1994, J NEUROCHEM, V63, P972, DOI 10.1046/j.1471-4159.1994.63030972.x; Koide T, 2000, MAMM GENOME, V11, P664, DOI 10.1007/s003350010129; KRESS M, 1984, SCIENCE, V226, P974, DOI 10.1126/science.6095445; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Lee JY, 2008, NUCLEIC ACIDS RES, V36, P5581, DOI 10.1093/nar/gkn540; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Malhotra AK, 2002, AM J PSYCHIAT, V159, P652, DOI 10.1176/appi.ajp.159.4.652; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Nicodemus KK, 2007, HUM GENET, V120, P889, DOI 10.1007/s00439-006-0257-3; OVERALL RW, 2009, FRONTIERS NEUROGENET, V1; Papaleo F, 2008, J NEUROSCI, V28, P8709, DOI 10.1523/JNEUROSCI.2077-08.2008; PHILIP VM, 2009, GENES BRAIN BEHAV; Puls I, 2008, BIOL PSYCHOL, V79, P126, DOI 10.1016/j.biopsycho.2008.03.001; ROTH JA, 1992, REV PHYSIOL BIOCH P, V120, P1, DOI 10.1007/BFb0036121; Savitz J, 2006, GENES BRAIN BEHAV, V5, P311, DOI 10.1111/j.1601-183X.2005.00163.x; Straub RE, 2007, MOL PSYCHIATR, V12, P854, DOI 10.1038/sj.mp.4001988; Tan HY, 2007, P NATL ACAD SCI USA, V104, P12536, DOI 10.1073/pnas.0610125104; TENHUNEN J, 1993, BIOCHEM J, V296, P595, DOI 10.1042/bj2960595; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Tunbridge EM, 2004, J NEUROSCI, V24, P5331, DOI 10.1523/JNEUROSCI.1124-04.2004; Uetani N, 2000, EMBO J, V19, P2775, DOI 10.1093/emboj/19.12.2775; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wang J, 1999, MOL CELL NEUROSCI, V14, P370, DOI 10.1006/mcne.1999.0789; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	44	35	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12181	10.1371/journal.pone.0012181	http://dx.doi.org/10.1371/journal.pone.0012181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808911	Green Published, Green Submitted, gold			2022-12-27	WOS:000280968100009
J	Shiojiri, K; Ozawa, R; Kugimiya, S; Uefune, M; van Wijk, M; Sabelis, MW; Takabayashi, J				Shiojiri, Kaori; Ozawa, Rika; Kugimiya, Soichi; Uefune, Masayoshi; van Wijk, Michiel; Sabelis, Maurice W.; Takabayashi, Junji			Herbivore-Specific, Density-Dependent Induction of Plant Volatiles: Honest or "Cry Wolf'' Signals?	PLOS ONE			English	Article							COTESIA-PLUTELLAE HYMENOPTERA; DIAMONDBACK MOTH; PARASITIC WASPS; TRITROPHIC INTERACTION; TETRANYCHUS-URTICAE; GENETIC-VARIATION; INFESTED PLANTS; PREDATORY MITE; PREY; LEPIDOPTERA	Plants release volatile chemicals upon attack by herbivorous arthropods. They do so commonly in a dose-dependent manner: the more herbivores, the more volatiles released. The volatiles attract predatory arthropods and the amount determines the probability of predator response. We show that seedlings of a cabbage variety (Brassica oleracea var. capitata, cv Shikidori) also show such a response to the density of cabbage white (Pieris rapae) larvae and attract more (naive) parasitoids (Cotesia glomerata) when there are more herbivores on the plant. However, when attacked by diamondback moth (Plutella xylostella) larvae, seedlings of the same variety (cv Shikidori) release volatiles, the total amount of which is high and constant and thus independent of caterpillar density, and naive parasitoids (Cotesia vestalis) of diamondback moth larvae fail to discriminate herbivore-rich from herbivore-poor plants. In contrast, seedlings of another cabbage variety of B. oleracea (var. acephala: kale) respond in a dose-dependent manner to the density of diamondback moth larvae and attract more parasitoids when there are more herbivores. Assuming these responses of the cabbage cultivars reflect behaviour of at least some genotypes of wild plants, we provide arguments why the behaviour of kale (B. oleracea var acephala) is best interpreted as an honest signaling strategy and that of cabbage cv Shikidori (B. oleracea var capitata) as a "cry wolf'' signaling strategy, implying a conflict of interest between the plant and the enemies of its herbivores: the plant profits from being visited by the herbivore's enemies, but the latter would be better off by visiting other plants with more herbivores. If so, evolutionary theory on alarm signaling predicts consequences of major interest to students of plant protection, tritrophic systems and communication alike.	[Shiojiri, Kaori; Ozawa, Rika; Uefune, Masayoshi; Takabayashi, Junji] Kyoto Univ, Ctr Ecol Res, Shiga, Japan; [Shiojiri, Kaori] Kyoto Univ, Hakubi Ctr, Kyoto, Japan; [Kugimiya, Soichi] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 305, Japan; [van Wijk, Michiel; Sabelis, Maurice W.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	Kyoto University; Kyoto University; National Institute for Agro-Environmental Sciences (NIAES) Japan; University of Amsterdam	Shiojiri, K (corresponding author), Kyoto Univ, Ctr Ecol Res, Shiga, Japan.	M.W.Sabelis@uva.nl; junji@ecology.kyoto-u.ac.jp	Takabayashi, Junji/G-2212-2010	Takabayashi, Junji/0000-0002-3575-9952; Uefune, Masayoshi/0000-0002-9570-8938	Bio-oriented Technology Research Advancement Institution; Subsidy nr [9101009]; Global Center for Excellence, Kyoto University; Grants-in-Aid for Scientific Research [19101009] Funding Source: KAKEN	Bio-oriented Technology Research Advancement Institution; Subsidy nr; Global Center for Excellence, Kyoto University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Bio-oriented Technology Research Advancement Institution, by Grant-in-Aid for Scientific Research (Subsidy nr 9101009), by the Global Center for Excellence Program entitled similar to Formation of a Strategic Base for Biodiversity and Evolutionary Research: From Genome to Ecosystem (Kyoto University) and by a Kyoto University grant to MWS for a visiting professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNAMALAI S, 1988, RES POPUL ECOL, V30, P329, DOI 10.1007/BF02513253; Choh Y, 2006, OECOLOGIA, V147, P455, DOI 10.1007/s00442-005-0289-8; Choh Y, 2008, ECOL ENTOMOL, V33, P565, DOI 10.1111/j.1365-2311.2008.01003.x; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; DICKE M, 1988, NETH J ZOOL, V38, P148, DOI 10.1163/156854288X00111; DICKE M, 1990, J CHEM ECOL, V16, P3091, DOI 10.1007/BF00979614; Gols R, 2003, J CHEM ECOL, V29, P2651, DOI 10.1023/B:JOEC.0000008010.40606.b0; Gu H, 2000, J INSECT BEHAV, V13, P141, DOI 10.1023/A:1007723811573; Hassell M P, 1984, IMA J Math Appl Med Biol, V1, P123, DOI 10.1093/imammb/1.1.123; HASSELL MP, 1974, J ANIM ECOL, V43, P567, DOI 10.2307/3384; Horiuchi J, 2003, APPL ENTOMOL ZOOL, V38, P109, DOI 10.1303/aez.2003.109; Jansen VAA, 2006, NATURE, V440, P663, DOI 10.1038/nature04387; Jia F, 2002, HEREDITY, V89, P371, DOI 10.1038/sj.hdy.6800145; Kappers IF, 2005, SCIENCE, V309, P2070, DOI 10.1126/science.1116232; Kawaguchi M, 1999, APPL ENTOMOL ZOOL, V34, P213, DOI 10.1303/aez.34.213; Khan ZR, 1997, NATURE, V388, P631, DOI 10.1038/41681; Liu SS, 2002, ENVIRON ENTOMOL, V31, P221, DOI 10.1603/0046-225X-31.2.221; Maeda T, 2001, EXP APPL ACAROL, V25, P55, DOI 10.1023/A:1010667812788; Margolies DC, 1997, J INSECT BEHAV, V10, P695, DOI 10.1007/BF02765387; Mitsunaga T, 2004, APPL ENTOMOL ZOOL, V39, P691, DOI 10.1303/aez.2004.691; MUNN CA, 1986, NATURE, V319, P143, DOI 10.1038/319143a0; MURDOCH WW, 1989, AM NAT, V134, P288, DOI 10.1086/284981; OHSAKI N, 1994, ECOLOGY, V75, P59, DOI 10.2307/1939382; Papaj D.R., 1993, INSECT LEARNING ECOL; Sabelis Maurice W., 2005, P109, DOI 10.1017/CBO9780511542220.005; Sabelis Maurice W., 2007, P188, DOI 10.1017/CBO9780511542701.010; Sabelis MW, 2005, ADV ECOL RES, V37, P183, DOI 10.1016/S0065-2504(04)37006-6; SABELIS MW, 1988, OIKOS, V53, P247, DOI 10.2307/3566070; Sato Y, 1999, APPL ENTOMOL ZOOL, V34, P333, DOI 10.1303/aez.34.333; SCHOONHOVEN LM, 1990, J CHEM ECOL, V16, P3043, DOI 10.1007/BF00979611; Shi ZH, 2002, BIOCONTROL, V47, P499, DOI 10.1023/A:1016577406820; Shiojiri K, 2000, APPL ENTOMOL ZOOL, V35, P519, DOI 10.1303/aez.2000.519; Shiojiri K, 2003, ECOL ENTOMOL, V28, P573, DOI 10.1046/j.1365-2311.2003.00539.x; Shiojiri K, 2002, ECOL LETT, V5, P186, DOI 10.1046/j.1461-0248.2002.00292.x; Shiojiri K, 2006, P NATL ACAD SCI USA, V103, P16672, DOI 10.1073/pnas.0607780103; Sokal RR, 1995, BIOMETRY; TURLINGS TCJ, 1995, P NATL ACAD SCI USA, V92, P4169, DOI 10.1073/pnas.92.10.4169; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; van Baalen M, 2003, P ROY SOC B-BIOL SCI, V270, P69, DOI 10.1098/rspb.2002.2151; van Baalen M, 1999, AM NAT, V154, P69, DOI 10.1086/303215; VANBAALEN M, 1993, AM NAT, V142, P646, DOI 10.1086/285562; WILGENBURG E, 2006, FRONTIERS ZOOLOGY, V3, P1; Wright GA, 2005, P ROY SOC B-BIOL SCI, V272, P2417, DOI 10.1098/rspb.2005.3252; Zayed A, 2005, P NATL ACAD SCI USA, V102, P10742, DOI 10.1073/pnas.0502271102	44	110	112	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12161	10.1371/journal.pone.0012161	http://dx.doi.org/10.1371/journal.pone.0012161			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808961	Green Submitted, gold, Green Published			2022-12-27	WOS:000280968100005
J	Rodriguez, E; Aburjania, N; Priedigkeit, NM; Difeo, A; Martignetti, JA				Rodriguez, Estefania; Aburjania, Nana; Priedigkeit, Nolan M.; DiFeo, Analisa; Martignetti, John A.			Nucleo-Cytoplasmic Localization Domains Regulate Kruppel-Like Factor 6 (KLF6) Protein Stability and Tumor Suppressor Function	PLOS ONE			English	Article							CELL LUNG-CANCER; NUCLEAR-LOCALIZATION; TRANSCRIPTION FACTORS; GENE; EXPORT; SEQUENCE; SIGNAL; POLYMORPHISM; INHIBITION; IMPORT	Background: The tumor suppressor KLF6 and its oncogenic cytoplasmic splice variant KLF6-SV1 represent a paradigm in cancer biology in that their antagonistic cancer functions are encoded within the same gene. As a consequence of splicing, KLF6-SV1 loses both the C-terminus C2H2 three zinc finger (ZF) domain, which characterizes all KLF proteins, as well as the adjacent 5' basic region (5BR), a putative nuclear localization signal (NLS). It has been hypothesized that this NLS is a functional domain critical to direct the distinct subcellular localization of the tumor suppressor and its splice variant. Methodology/Principal Findings: In this study, we demonstrate using EGFP fusion constructs that KLF6/KLF6-SV1 nucleocytoplasmic transport is not regulated by the 5' basic region but activated by a novel NLS encoded within the ZF domain, and a nuclear export signal (NES) located in the first 16 amino acids of the shared N-terminus sequence. We demonstrate KLF6 nuclear export to be Crm1-dependent. The dysregulation of nucleo-cytoplasmic transport when disrupting the KLF6 NLS using site-directed mutagenesis showed that its integrity is necessary for appropriate protein stability. Moreover, these mutations impaired transcriptional induction of two KLF6 well-characterized target genes, E-cadherin and p21, as shown by RT-PCR and luciferase promoter assays. The addition of the ZF domain to KLF6-SV1 results in its nuclear localization and a markedly decreased half-life similar to wild type KLF6. Conclusions/Significance: We describe the domains that control KLF6 nucleo-cytoplasmic shuttling and how these domains play a role in KLF6 protein half-life and tumor suppressor function. The results begin to mechanistically explain, at least in part, the opposing functions of KLF6 and KLF6-SV1 in cancer.	[Rodriguez, Estefania; Aburjania, Nana; Priedigkeit, Nolan M.; DiFeo, Analisa; Martignetti, John A.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Martignetti, John A.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Rodriguez, E (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA.	john.martignetti@mssm.edu		Priedigkeit, Nolan/0000-0001-8330-5210	Department of Defense [PC080135]; National Institutes of Health [RO1 CA122332]; NATIONAL CANCER INSTITUTE [R01CA122332] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by Department of Defense PC080135 (to E. R.) and National Institutes of Health RO1 CA122332 (to J.A.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; ADAM SA, 1991, CELL, V66, P837, DOI 10.1016/0092-8674(91)90431-W; Banck MS, 2006, FEBS LETT, V580, P6981, DOI 10.1016/j.febslet.2006.10.077; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BOULIKAS T, 1994, J CELL BIOCHEM, V55, P32, DOI 10.1002/jcb.240550106; Camacho-Vanegas O, 2007, INT J CANCER, V121, P1390, DOI 10.1002/ijc.22809; Chen CS, 2003, AM J PATHOL, V162, P1349, DOI 10.1016/S0002-9440(10)63930-2; Chen Han-kui, 2002, Ai Zheng, V21, P1047; Cho YG, 2008, NEOPLASMA, V55, P47; Cho YG, 2005, ONCOGENE, V24, P4588, DOI 10.1038/sj.onc.1208670; Difeo A, 2006, ONCOGENE, V25, P6026, DOI 10.1038/sj.onc.1209611; Difeo A, 2008, CANCER RES, V68, P965, DOI 10.1158/0008-5472.CAN-07-2604; Difeo A, 2006, CLIN CANCER RES, V12, P3730, DOI 10.1158/1078-0432.CCR-06-0054; Difeo A, 2009, CANCER RES, V69, P4733, DOI 10.1158/0008-5472.CAN-08-4282; Du JX, 2008, J BIOL CHEM, V283, P31991, DOI 10.1074/jbc.M803612200; Fabbro M, 2003, EXP CELL RES, V282, P59, DOI 10.1016/S0014-4827(02)00019-8; Fabbro M, 2002, J BIOL CHEM, V277, P21315, DOI 10.1074/jbc.M200769200; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Hartel M, 2008, EUR J CANCER, V44, P1895, DOI 10.1016/j.ejca.2008.06.030; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Ito G, 2004, CANCER RES, V64, P3838, DOI 10.1158/0008-5472.CAN-04-0185; Jeng YM, 2003, INT J CANCER, V105, P625, DOI 10.1002/ijc.11123; Jiao W, 2008, ONCOGENE, V27, P3156, DOI 10.1038/sj.onc.1210970; Jiao W, 2006, J BIOL CHEM, V281, P38098, DOI 10.1074/jbc.M605271200; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kettunen E, 2004, CANCER GENET CYTOGEN, V149, P98, DOI 10.1016/s0165-4608(03)00300-5; Kremer-Tal S, 2004, HEPATOLOGY, V40, P1047, DOI 10.1002/hep.20460; Kremer-Tal S, 2007, J HEPATOL, V46, P645, DOI 10.1016/j.jhep.2006.10.012; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Manabe I, 2009, BIOLOGY OF KRUPPEL-LIKE FACTORS, P245, DOI 10.1007/978-4-431-87775-2_18; Mehta TS, 2009, CELL RES, V19, P1098, DOI 10.1038/cr.2009.64; Narla G, 2005, CANCER RES, V65, P5761, DOI 10.1158/0008-5472.CAN-05-0217; Narla G, 2005, CANCER RES, V65, P1213, DOI 10.1158/0008-5472.CAN-04-4249; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Narla G, 2008, J CLIN INVEST, V118, P2711, DOI 10.1172/JCI34780; ONEILL RE, 1995, J BIOL CHEM, V270, P22701, DOI 10.1074/jbc.270.39.22701; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Pandya K, 2002, J BIOL CHEM, V277, P16304, DOI 10.1074/jbc.M200866200; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Quadrini KJ, 2002, J BIOL CHEM, V277, P32243, DOI 10.1074/jbc.M205677200; Reeves HL, 2004, GASTROENTEROLOGY, V126, P1090, DOI 10.1053/j.gastro.2004.01.005; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Salmena L, 2007, NAT REV CANCER, V7, P409, DOI 10.1038/nrc2145; Shields JM, 1997, J BIOL CHEM, V272, P18504, DOI 10.1074/jbc.272.29.18504; Spinola M, 2007, CANCER LETT, V251, P311, DOI 10.1016/j.canlet.2006.11.029; Teixeira MS, 2007, INT J CANCER, V121, P1976, DOI 10.1002/ijc.22926; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yin D, 2007, INT J ONCOL, V30, P65	55	16	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12639	10.1371/journal.pone.0012639	http://dx.doi.org/10.1371/journal.pone.0012639			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844588	Green Submitted, Green Published, gold			2022-12-27	WOS:000281687200008
J	Sripadi, P; Shrestha, B; Easley, RL; Carpio, L; Kehn-Hall, K; Chevalier, S; Mahieux, R; Kashanchi, F; Vertes, A				Sripadi, Prabhakar; Shrestha, Bindesh; Easley, Rebecca L.; Carpio, Lawrence; Kehn-Hall, Kylene; Chevalier, Sebastien; Mahieux, Renaud; Kashanchi, Fatah; Vertes, Akos			Direct Detection of Diverse Metabolic Changes in Virally Transformed and Tax-Expressing Cells by Mass Spectrometry	PLOS ONE			English	Article							ABLATION ELECTROSPRAY-IONIZATION; VIRUS TYPE-I; ATMOSPHERIC-PRESSURE; AMBIENT CONDITIONS; GLUTATHIONE METABOLISM; ANTIVIRAL THERAPY; PROSTATE-CANCER; HIGH-THROUGHPUT; ENERGY-CHARGE; FATTY-ACIDS	Background: Viral transformation of a cell starts at the genetic level, followed by changes in the proteome and the metabolome of the host. There is limited information on the broad metabolic changes in HTLV transformed cells. Methods and Principal Findings: Here, we report the detection of key changes in metabolites and lipids directly from human T-lymphotropic virus type 1 and type 3 (HTLV1 and HTLV3) transformed, as well as Tax1 and Tax3 expressing cell lines by laser ablation electrospray ionization (LAESI) mass spectrometry (MS). Comparing LAESI-MS spectra of non-HTLV1 transformed and HTLV1 transformed cells revealed that glycerophosphocholine (PC) lipid components were dominant in the non-HTLV1 transformed cells, and PC(O-32:1) and PC(O-34:1) plasmalogens were displaced by PC(30: 0) and PC(32: 0) species in the HTLV1 transformed cells. In HTLV1 transformed cells, choline, phosphocholine, spermine and glutathione, among others, were downregulated, whereas creatine, dopamine, arginine and AMP were present at higher levels. When comparing metabolite levels between HTLV3 and Tax3 transfected 293T cells, there were a number of common changes observed, including decreased choline, phosphocholine, spermine, homovanillic acid, and glycerophosphocholine and increased spermidine and N-acetyl aspartic acid. These results indicate that the lipid metabolism pathway as well as the creatine and polyamine biosynthesis pathways are commonly deregulated after expression of HTLV3 and Tax3, indicating that the noted changes are likely due to Tax3 expression. N-acetyl aspartic acid is a novel metabolite that is upregulated in all cell types and all conditions tested. Conclusions and Significance: We demonstrate the high throughput in situ metabolite profiling of HTLV transformed and Tax expressing cells, which facilitates the identification of virus-induced perturbations in the biochemical processes of the host cells. We found virus type-specific (HTLV1 vs. HTLV3), expression-specific (Tax1 vs. Tax3) and cell-type-specific (T lymphocytes vs. kidney epithelial cells) changes in the metabolite profiles. The new insight on the affected metabolic pathways can be used to better understand the molecular mechanisms of HTLV induced transformation, which in turn can result in new treatment strategies.	[Sripadi, Prabhakar; Shrestha, Bindesh; Vertes, Akos] George Washington Univ, Dept Chem, WM Keck Inst Prote Techol & Applicat, Washington, DC 20052 USA; [Easley, Rebecca L.; Carpio, Lawrence] George Washington Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC 20052 USA; [Kehn-Hall, Kylene; Kashanchi, Fatah] George Mason Univ, Natl Ctr Biodef & Infect Dis, Dept Mol & Microbiol, Manassas, VA USA; [Chevalier, Sebastien] NCI, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA; [Mahieux, Renaud] INSERM, Ecole Normale Super Lyon, U758, Equipe Oncogenese Retrovirale, F-69008 Lyon, France	George Washington University; George Washington University; George Mason University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm)	Sripadi, P (corresponding author), Indian Inst Chem Technol, Natl Ctr Mass Spectrometry, Hyderabad 500007, Andhra Pradesh, India.	vertes@gwu.edu	Kehn-Hall, Kylene/I-5752-2013; Shrestha, Bindesh/B-8821-2008; Vertes, Akos/B-7159-2008	Shrestha, Bindesh/0000-0002-7595-3506; Vertes, Akos/0000-0001-5186-5352; mahieux, renaud/0000-0002-5129-6804; Kehn-Hall, Kylene/0000-0001-8036-7213	National Science Foundation [0719232]; W. M. Keck Foundation [041904]; Protea Biosciences, Inc.; George Washington University (GWU)	National Science Foundation(National Science Foundation (NSF)); W. M. Keck Foundation(W.M. Keck Foundation); Protea Biosciences, Inc.; George Washington University (GWU)	This work was supported, in whole and in part, by the National Science Foundation (Grant 0719232), the W. M. Keck Foundation (Grant 041904), Protea Biosciences, Inc., and the George Washington University (GWU) Selective Excellence Funds. The opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the funding organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Banerjee S, 2008, BIOMED CHROMATOGR, V22, P250, DOI 10.1002/bmc.919; Baricordi OR, 1996, BLOOD, V87, P682, DOI 10.1182/blood.V87.2.682.bloodjournal872682; Beckmann M, 2008, NAT PROTOC, V3, P486, DOI 10.1038/nprot.2007.500; Bera S, 2008, FEBS J, V275, P5899, DOI 10.1111/j.1742-4658.2008.06718.x; Cody RB, 2005, ANAL CHEM, V77, P2297, DOI 10.1021/ac050162j; Coyle JT, 2006, ADV EXP MED BIOL, V576, P1; COYLE JT, 2006, ADV EXPT MED BIOL, V576, P361; Denkert C, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-72; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; FERRER A, 1985, BIOCHEM BIOPH RES CO, V132, P497, DOI 10.1016/0006-291X(85)91161-1; Fraternale A, 2009, MOL ASPECTS MED, V30, P99, DOI 10.1016/j.mam.2008.09.001; Friesen C, 2004, CELL DEATH DIFFER, V11, pS73, DOI 10.1038/sj.cdd.4401431; Furuke K, 1997, CANCER RES, V57, P4916; Gazi E, 2009, VIB SPECTROSC, V50, P99, DOI 10.1016/j.vibspec.2008.09.006; GESSAIN A, 1985, LANCET, V2, P407; Go EP, 2006, J PROTEOME RES, V5, P2405, DOI 10.1021/pr060215t; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Hall AG, 1999, EUR J CLIN INVEST, V29, P238; Harrigan GG, 2004, TOXICOL LETT, V146, P197, DOI 10.1016/j.toxlet.2003.09.011; Hollywood K, 2006, PROTEOMICS, V6, P4716, DOI 10.1002/pmic.200600106; Josefsson E, 1996, IMMUNOLOGY, V88, P140, DOI 10.1046/j.1365-2567.1996.d01-653.x; KAMMERMEIER H, 1993, BASIC RES CARDIOL, V88, P380, DOI 10.1007/BF00795405; Kind T, 2007, ANAL BIOCHEM, V363, P185, DOI 10.1016/j.ab.2007.01.028; Lepoutre V, 2009, FRONT BIOSCI-LANDMRK, V14, P1152, DOI 10.2741/3300; Lerner A, 2000, LEUKEMIA LYMPHOMA, V37, P39, DOI 10.3109/10428190009057627; Levite M, 2008, CURR OPIN PHARMACOL, V8, P460, DOI 10.1016/j.coph.2008.05.001; Li Y, 2008, ANAL CHEM, V80, P407, DOI 10.1021/ac701703f; Li Y, 2007, ANAL CHEM, V79, P523, DOI 10.1021/ac061577n; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Matalon R, 2000, FRONT BIOSCI-LANDMRK, V5, pD307, DOI 10.2741/Matalon; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Mattos K, 1993, Arq Neuropsiquiatr, V51, P134; MOCHIZUKI M, 1994, BRIT J OPHTHALMOL, V78, P149, DOI 10.1136/bjo.78.2.149; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Munger J, 2006, PLOS PATHOG, V2, P1165, DOI 10.1371/journal.ppat.0020132; Nemes P, 2008, ANAL CHEM, V80, P4575, DOI 10.1021/ac8004082; Nemes P, 2007, ANAL CHEM, V79, P8098, DOI 10.1021/ac071181r; Nemes P, 2010, ANAL CHEM, V82, P982, DOI 10.1021/ac902245p; Nemes P, 2009, ANAL CHEM, V81, P6668, DOI 10.1021/ac900745e; Pierce CY, 2007, CHEM COMMUN, P807, DOI 10.1039/b613200f; Qiu YH, 2004, NEUROIMMUNOMODULAT, V11, P75, DOI 10.1159/000075316; Ramautar R, 2009, ELECTROPHORESIS, V30, P276, DOI 10.1002/elps.200800512; Rasheed S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003003; Ringrose J, 2008, J VIROL, V82, P4320, DOI 10.1128/JVI.01819-07; RODRIGUEZ PC, 2008, ARGININE AVAILABILIT, P219; ROSENBLATT JD, 1990, BLOOD, V76, P409; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; SHERMAN MP, 1995, ARTHRITIS RHEUM, V38, P690, DOI 10.1002/art.1780380518; Shimizu M, 2003, ANAL SCI, V19, P49, DOI 10.2116/analsci.19.49; Shrestha B, 2008, METABOLOMICS, V4, P297, DOI 10.1007/s11306-008-0120-8; Shrestha B, 2010, ANALYST, V135, P751, DOI 10.1039/b922854c; Shrestha B, 2009, ANAL CHEM, V81, P8265, DOI 10.1021/ac901525g; Sidelmann UG, 2001, J PHARMACEUT BIOMED, V24, P569, DOI 10.1016/S0731-7085(00)00482-9; Song YS, 2007, CHEM COMMUN, P61, DOI 10.1039/b615724f; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Sripadi P, 2009, METABOLOMICS, V5, P263, DOI 10.1007/s11306-008-0147-x; Suschek CV, 2003, CIRCULATION, V107, P2607, DOI 10.1161/01.CIR.0000066909.13953.F1; Szende Bela, 2001, Cancer Cell Int, V1, P3, DOI 10.1186/1475-2867-1-3; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Takats Z, 2004, SCIENCE, V306, P471, DOI 10.1126/science.1104404; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Vallejo M, 2009, ANAL BIOANAL CHEM, V394, P1517, DOI 10.1007/s00216-009-2610-6; Vertes A, 2008, APPL PHYS A-MATER, V93, P885, DOI 10.1007/s00339-008-4750-5; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wikoff WR, 2007, CLIN CHEM, V53, P2169, DOI 10.1373/clinchem.2007.089011; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Xue RY, 2009, CLIN CHEM LAB MED, V47, P305, DOI 10.1515/CCLM.2009.083; Yasunaga Jun-ichirou, 2007, Cancer Control, V14, P133; YEH LA, 1980, J BIOL CHEM, V255, P2308; Zulak KG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-5; zur Nedden S, 2009, ANAL BIOCHEM, V388, P108, DOI 10.1016/j.ab.2009.02.017	75	25	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12590	10.1371/journal.pone.0012590	http://dx.doi.org/10.1371/journal.pone.0012590			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830293	Green Published, gold			2022-12-27	WOS:000281631300018
J	Hildenbrand, ZL; Molugu, SK; Stock, D; Bernal, RA				Hildenbrand, Zacariah L.; Molugu, Sudheer K.; Stock, Daniela; Bernal, Ricardo A.			The C-H Peripheral Stalk Base: A Novel Component in V-1-ATPase Assembly	PLOS ONE			English	Article							YEAST V-ATPASE; PROTON-TRANSLOCATING ATPASE; SITE-DIRECTED MUTAGENESIS; ELECTRON-MICROSCOPY; VACUOLAR ATPASE; THERMUS-THERMOPHILUS; CROSS-LINKING; SUBUNIT-H; CRYOELECTRON MICROSCOPY; 3-DIMENSIONAL STRUCTURE	Vacuolar ATPases (V-ATPases) are molecular machines responsible for creating electrochemical gradients and preserving pH-dependent cellular compartments by way of proton translocation across the membrane. V-ATPases employ a dynamic rotary mechanism that is driven by ATP hydrolysis and the central rotor stalk. Regulation of this rotational catalysis is the result of a reversible V1Vo-domain dissociation that is required to preserve ATP during instances of cellular starvation. Recently the method by which the free V-1-ATPase abrogates the hydrolytic breakdown of ATP upon dissociating from the membrane has become increasingly clear. In this instance the central stalk subunit F adopts an extended conformation to engage in a bridging interaction tethering the rotor and stator components together. However, the architecture by which this mechanism is stabilized has remained ambiguous despite previous work. In an effort to elucidate the method by which the rotational catalysis is maintained, the architecture of the peripheral stalks and their respective binding interactions was investigated using cryo-electron microscopy. In addition to confirming the bridging interaction exuded by subunit F for the first time in a eukaryotic V-ATPase, subunits C and H are seen interacting with one another in a tight interaction that provides a base for the three EG peripheral stalks. The formation of a CE(3)G(3)H sub-assembly appears to be unique to the dissociated V-ATPase and highlights the stator architecture in addition to revealing a possible intermediate in the assembly mechanism of the free V-1-ATPase.	[Hildenbrand, Zacariah L.; Molugu, Sudheer K.; Bernal, Ricardo A.] Univ Texas El Paso, Dept Chem, El Paso, TX 79968 USA; [Stock, Daniela] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Stock, Daniela] Univ New S Wales, Fac Med, Sydney, NSW, Australia	University of Texas System; University of Texas El Paso; Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Hildenbrand, ZL (corresponding author), Univ Texas El Paso, Dept Chem, El Paso, TX 79968 USA.	rbernal@utep.edu	Bernal, Ricardo A/B-2124-2010	Bernal, Ricardo A./0000-0001-5849-8647; Molugu, Sudheer Kumar/0000-0001-9939-1950	University of Texas; MRC [MC_U105170645] Funding Source: UKRI; Medical Research Council [MC_U105170645] Funding Source: researchfish	University of Texas; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Only University startup funds were used to support the work presented here. The University of Texas at El Paso had no role in study, design, data collection and analysis, decision to publish or preparation of the manuscript.	Armbruster A, 2004, FEBS LETT, V570, P119, DOI 10.1016/j.febslet.2004.06.029; Bernal RA, 2004, STRUCTURE, V12, P1789, DOI 10.1016/j.str.2004.07.017; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Crider BP, 2003, J BIOL CHEM, V278, P44281, DOI 10.1074/jbc.M307372200; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Diepholz M, 2008, BIOCHEM SOC T, V36, P1027, DOI 10.1042/BST0361027; Diepholz M, 2008, STRUCTURE, V16, P1789, DOI 10.1016/j.str.2008.09.010; Domgall I, 2002, J BIOL CHEM, V277, P13115, DOI 10.1074/jbc.M112011200; Drory O, 2006, BBA-BIOENERGETICS, V1757, P297, DOI 10.1016/j.bbabio.2006.03.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flannery AR, 2008, J BIOL CHEM, V283, P29099, DOI 10.1074/jbc.M803280200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Gregorini M, 2007, J STRUCT BIOL, V158, P445, DOI 10.1016/j.jsb.2007.01.002; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; Hong-Hermesdorf A, 2006, FEBS LETT, V580, P932, DOI 10.1016/j.febslet.2006.01.018; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Inoue T, 2003, J BIOENERG BIOMEMBR, V35, P291, DOI 10.1023/A:1025720713747; Jefferies KC, 2008, ARCH BIOCHEM BIOPHYS, V476, P33, DOI 10.1016/j.abb.2008.03.025; Kane PM, 2003, J BIOENERG BIOMEMBR, V35, P313, DOI 10.1023/A:1025724814656; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; Liu Q, 1996, J BIOL CHEM, V271, P2018, DOI 10.1074/jbc.271.4.2018; Liu Q, 1997, J BIOL CHEM, V272, P11750, DOI 10.1074/jbc.272.18.11750; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maegawa Y, 2006, ACTA CRYSTALLOGR D, V62, P483, DOI 10.1107/S0907444906006329; Makyio H, 2005, EMBO J, V24, P3974, DOI 10.1038/sj.emboj.7600859; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Muench SP, 2009, J MOL BIOL, V386, P989, DOI 10.1016/j.jmb.2009.01.014; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435; Sennoune SR, 2007, J BIOENERG BIOMEMBR, V39, P427, DOI 10.1007/s10863-007-9108-8; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Suzuki T, 2000, J BIOL CHEM, V275, P37902, DOI 10.1074/jbc.M007075200; Tomashek JJ, 1997, J BIOL CHEM, V272, P26787, DOI 10.1074/jbc.272.42.26787; Tomashek JJ, 1997, J BIOL CHEM, V272, P16618, DOI 10.1074/jbc.272.26.16618; Vasilyeva E, 2000, J BIOL CHEM, V275, P255, DOI 10.1074/jbc.275.1.255; Venzke D, 2005, J MOL BIOL, V349, P659, DOI 10.1016/j.jmb.2005.04.033; Visentin L, 2000, J CLIN INVEST, V106, P309, DOI 10.1172/JCI6145; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zhang ZY, 2003, J BIOL CHEM, V278, P47299, DOI 10.1074/jbc.M309445200	55	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12588	10.1371/journal.pone.0012588	http://dx.doi.org/10.1371/journal.pone.0012588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838636	Green Submitted, Green Published, gold			2022-12-27	WOS:000281627700025
J	Hosoi, T; Yokoyama, S; Matsuo, S; Akira, S; Ozawa, K				Hosoi, Toru; Yokoyama, Shota; Matsuo, Suguru; Akira, Shizuo; Ozawa, Koichiro			Myeloid Differentiation Factor 88 (MyD88)-Deficiency Increases Risk of Diabetes in Mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INDUCED INSULIN-RESISTANCE; TOLL-LIKE RECEPTOR-4; DIET-INDUCED OBESITY; LEPTIN RESISTANCE; ADIPOSE-TISSUE; IKK-BETA; MYD88; INFLAMMATION; CHOLESTEROL	Background: Multiple lines of evidence suggest innate immune response pathways to be involved in the development of obesity-associated diabetes although the molecular mechanism underling the disease is unknown. Recent observations suggest that saturated fatty acids can act as a ligand for toll-like receptor (TLR) 4, which is thought to mediate obesityassociated insulin resistance. Myeloid differentiation factor 88 (MyD88) is an adapter protein for TLR/IL-1 receptor signaling, which is involved in the activation of inflammatory pathways. To evaluate molecular mechanisms linking obesity-associated diabetes down-stream of TLR4, we investigated physiological role of MyD88 in high-fat diet (HFD)-induced obesity. Methodology/Principal Findings: In the present study, we found MyD88-deficient mice fed a HFD had increased circulating levels of insulin, leptin and cholesterol, as well as liver dysfunction (increased induction of ALT levels, increased activation of JNK and cleavage of PARP), which were linked to the onset of severe diabetes. On the other hand, TNF-a would not be involved in HFD-induced diabetes in MyD88-deficient mice, because TNF-a level was attenuated in MyD88-deficient mice fed with HFD. Conclusions/Significance: The present finding of an unexpected role for MyD88 in preventing diabetes may provide a potential novel target/strategy for treating metabolic syndrome.	[Hosoi, Toru; Yokoyama, Shota; Matsuo, Suguru; Ozawa, Koichiro] Hiroshima Univ, Dept Pharmacotherapy, Grad Sch Biomed Sci, Hiroshima, Japan; [Akira, Shizuo] Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Osaka, Japan	Hiroshima University; Osaka University	Hosoi, T (corresponding author), Hiroshima Univ, Dept Pharmacotherapy, Grad Sch Biomed Sci, Hiroshima, Japan.	toruh@hiroshima-u.ac.jp; ozawak@hiroshima-u.ac.jp	Akira, Shizuo/C-3134-2009; Hosoi, Toru/A-7954-2018	Hosoi, Toru/0000-0003-4831-487X				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; BROWN MS, 1981, SCIENCE, V212, P628, DOI 10.1126/science.6261329; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; FEINSTEIN R, 1993, J BIOL CHEM, V268, P26055; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hosoi T, 2008, MOL PHARMACOL, V74, P1610, DOI 10.1124/mol.108.050070; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HULTMARK D, 1994, BIOCHEM BIOPH RES CO, V199, P144, DOI 10.1006/bbrc.1994.1206; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; LANG CH, 1992, ENDOCRINOLOGY, V130, P43, DOI 10.1210/en.130.1.43; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; LORD KA, 1990, ONCOGENE, V5, P387; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nakatani Y, 2004, J BIOL CHEM, V279, P45803, DOI 10.1074/jbc.M406963200; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Sandoval DA, 2009, NAT REV DRUG DISCOV, V8, P386, DOI 10.1038/nrd2874; Schulthess FT, 2009, CELL METAB, V9, P125, DOI 10.1016/j.cmet.2009.01.003; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Suganami T, 2007, BIOCHEM BIOPH RES CO, V354, P45, DOI 10.1016/j.bbrc.2006.12.190; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; WESTWICK JK, 1994, J BIOL CHEM, V269, P26396; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0	32	73	79	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12537	10.1371/journal.pone.0012537	http://dx.doi.org/10.1371/journal.pone.0012537			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824098	gold, Green Published, Green Submitted			2022-12-27	WOS:000281480900020
J	Hwang, SK; Piao, L; Lim, HT; Minai-Tehrani, A; Yu, KN; Ha, YC; Chae, CH; Lee, KH; Beck, GR; Park, J; Cho, MH				Hwang, Soon-Kyung; Piao, Longzhen; Lim, Hwang-Tae; Minai-Tehrani, Arash; Yu, Kyeong-Nam; Ha, Youn-Cheol; Chae, Chan-Hee; Lee, Kee-Ho; Beck, George R., Jr.; Park, Jongsun; Cho, Myung-Haing			Suppression of Lung Tumorigenesis by Leucine Zipper/EF Hand-Containing Transmembrane-1	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; RAS NULL MICE; CELL-CYCLE PROGRESSION; AEROSOL DELIVERY; MAMMALIAN TARGET; MITOCHONDRIA; CANCER; APOPTOSIS; GROWTH; PATHWAY	Background: Leucine zipper/EF hand-containing transmembrane-1 (LETM1) encodes for the human homologue of yeast Mdm38p, which is a mitochondria-shaping protein of unclear function. However, a previous study demonstrated that LETM1 served as an anchor protein for complex formation between mitochondria and ribosome, and regulated mitochondrial biogenesis. Methodology/Principal Findings: Therefore, we examine the possibility that LETM1 may function to regulate mitochondria and lung tumor growth. In this study, we addressed this question by studying in the effect of adenovirus-mediated LETM1 in the lung cancer cell and lung cancer model mice. To investigate the effects of adenovirus-LETM1 in vitro, we infected with adenovirus-LETM1 in A549 cells. Additionally, in vivo effects of LETM1 were evaluated on K-ras LA1 mice, human non-small cell lung cancer model mice, by delivering the LETM1 via aerosol through nose-only inhalation system. The effects of LETM1 on lung cancer growth and AMPK related signals were evaluated. Adenovirus-mediated overexpression of LETM1 could induce destruction of mitochondria of lung cancer cells through depleting ATP and AMPK activation. Furthermore, adenoviral-LETM1 also altered Akt signaling and inhibited the cell cycle while facilitating apoptosis. Theses results demonstrated that adenovirus-LETM1 suppressed lung cancer cell growth in vitro and in vivo. Conclusions/Significance: Adenovirus-mediated LETM1 may provide a useful target for designing lung tumor prevention and treatment.	[Hwang, Soon-Kyung; Lim, Hwang-Tae; Minai-Tehrani, Arash; Yu, Kyeong-Nam; Cho, Myung-Haing] Seoul Natl Univ, Coll Vet Med, Toxicol Lab, Seoul, South Korea; [Lim, Hwang-Tae; Cho, Myung-Haing] Seoul Natl Univ, Nano Syst Inst, Natl Core Res Ctr, Seoul, South Korea; [Cho, Myung-Haing] Seoul Natl Univ, Grad Grp Tumor Biol, Seoul, South Korea; [Piao, Longzhen] Yanbian Univ, Affiliated Hosp, Dept Oncol, Jilin, Peoples R China; [Ha, Youn-Cheol; Chae, Chan-Hee] Seoul Natl Univ, Coll Vet Med, Dept Vet Pathol, Seoul, South Korea; [Lee, Kee-Ho] Korea Inst Radiol & Med Sci, Lab Radiat Mol Oncol, Seoul, South Korea; [Beck, George R., Jr.] Emory Univ, Sch Med, Div Endocrinol Metab & Lipids, Atlanta, GA USA; [Park, Jongsun] Chungnam Natl Univ, Dept Pharmacol, Daejeon Reg Canc Ctr, Canc Res Inst,Res Inst Med Sci,Coll Med, Taejon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Yanbian University; Seoul National University (SNU); Korea Institute of Radiological & Medical Sciences; Emory University; Chungnam National University	Hwang, SK (corresponding author), Seoul Natl Univ, Coll Vet Med, Toxicol Lab, Seoul, South Korea.	insulin@cnu.ac.kr; mchotox@snu.ac.kr	Park, Jongsun/E-7465-2010; Beck, George/AAO-2117-2020; Cho, Myung-Haing/B-7362-2014	Park, Jongsun/0000-0002-4690-1854; Cho, Myung-Haing/0000-0002-3993-2011	Ministry of Education, Science and Technology in Korea [2010-0000784]; Nano Systems Institute-National Core Research Center (NSI-NCRC); National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) [FG03-0601-003-1-0-0, AR056090, CA136059]; Korea Government (MEST) [2010-0001354]; NATIONAL CANCER INSTITUTE [R03CA136059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056090] Funding Source: NIH RePORTER	Ministry of Education, Science and Technology in Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Nano Systems Institute-National Core Research Center (NSI-NCRC); National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Korea Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported partially by grants from the NRL (# 2010-0000784) of the Ministry of Education, Science and Technology in Korea. MHC was also supported by the Nano Systems Institute-National Core Research Center (NSI-NCRC) program of KOSEF and Research Institute for Veterinary Science, Seoul National University, Korea. SKH, AMT, HTL are also grateful for the award of the BK21 fellowship. KHL was supported by 21C Frontier Functional Human Genome Project (FG03-0601-003-1-0-0) and National Nuclear R& D Program from Ministry of Science and Technology. GRB Jr was supported in part by grants from National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) (AR056090) and National Institutes of Health/National Cancer Institute (NIH/NCI) (CA136059). Jongsun Park was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MEST) (No. 2010-0001354). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki N, 2006, BIOL PHARM BULL, V29, P1962, DOI 10.1248/bpb.29.1962; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Densmore Charles L., 2006, Current Drug Delivery, V3, P55, DOI 10.2174/156720106775197547; Dias N, 2005, BIOCHEM PHARMACOL, V70, P1, DOI 10.1016/j.bcp.2005.03.021; Don AS, 2004, TRENDS MOL MED, V10, P372, DOI 10.1016/j.molmed.2004.06.005; Frazier AE, 2006, J CELL BIOL, V172, P553, DOI 10.1083/jcb.200505060; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; HEIDI MM, 2006, CURR BIOL, V16, pR551; Hwang SK, 2007, GENE THER, V14, P1721, DOI 10.1038/sj.gt.3303042; Hwang SK, 2009, AM J RESP CRIT CARE, V179, P1131, DOI 10.1164/rccm.200810-1553OC; Jiang HL, 2009, BIOMATERIALS, V30, P5844, DOI 10.1016/j.biomaterials.2009.07.017; Jin H, 2006, MOL CANCER THER, V5, P1041, DOI 10.1158/1535-7163.MCT-05-0433; Jin Q, 2007, CANCER RES, V67, P11630, DOI 10.1158/0008-5472.CAN-07-2401; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Kim HW, 2004, CANCER RES, V64, P7971, DOI 10.1158/0008-5472.CAN-04-1231; Kim TH, 2000, J BIOL CHEM, V275, P39474, DOI 10.1074/jbc.M003370200; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Margineantu DH, 2002, MITOCHONDRION, V1, P425, DOI 10.1016/S1567-7249(02)00006-5; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; O'Neill J, 2004, BBA-REV CANCER, V1705, P43, DOI 10.1016/j.bbcan.2004.09.004; Piao LZ, 2009, CELL SIGNAL, V21, P767, DOI 10.1016/j.cellsig.2009.01.020; Rauch A, 2001, AM J MED GENET, V99, P338, DOI 10.1002/ajmg.1203; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Schieke SM, 2008, CELL CYCLE, V7, P1782, DOI 10.4161/cc.7.12.6067; Singh RP, 2006, J NATL CANCER I, V98, P846, DOI 10.1093/jnci/djj231; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang CG, 2006, P NATL ACAD SCI USA, V103, P11567, DOI 10.1073/pnas.0603363103; Wang XD, 2001, GENE DEV, V15, P2922; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu CX, 2008, AM J RESP CRIT CARE, V178, P60, DOI 10.1164/rccm.200707-1022OC; Zhou J, 2009, ONCOGENE, V28, P1993, DOI 10.1038/onc.2009.63	39	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12535	10.1371/journal.pone.0012535	http://dx.doi.org/10.1371/journal.pone.0012535			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824095	Green Submitted, Green Published, gold			2022-12-27	WOS:000281480900018
J	Mehra, S; Pahar, B; Dutta, NK; Conerly, CN; Philippi-Falkenstein, K; Alvarez, X; Kaushal, D				Mehra, Smriti; Pahar, Bapi; Dutta, Noton K.; Conerly, Cecily N.; Philippi-Falkenstein, Kathrine; Alvarez, Xavier; Kaushal, Deepak			Transcriptional Reprogramming in Nonhuman Primate Rhesus Macaque) Tuberculosis Granulomas	PLOS ONE			English	Article							T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; GUINEA-PIGS; CHEMOKINES; INFECTION; LUNG; EXPRESSION; EFFICACY; VACCINE; MODEL	Background: In response to Mtb infection, the host remodels the infection foci into a dense mass of cells known as the granuloma. The key objective of the granuloma is to contain the spread of Mtb into uninfected regions of the lung. However, it appears that Mtb has evolved mechanisms to resist killing in the granuloma. Profiling granuloma transcriptome will identify key immune signaling pathways active during TB infection. Such studies are not possible in human granulomas, due to various confounding factors. Nonhuman Primates (NHPs) infected with Mtb accurately reflect human TB in clinical and pathological contexts. Methodology/Principal Findings: We studied transcriptomics of granuloma lesions in the lungs of NHPs exhibiting active TB, during early and late stages of infection. Early TB lesions were characterized by a highly pro-inflammatory environment, expressing high levels of immune signaling pathways involving IFN gamma, TNF alpha, JAK, STAT and C-C/C-X-C chemokines. Late TB lesions, while morphologically similar to the early ones, exhibited an overwhelming silencing of the inflammatory response. Reprogramming of the granuloma transcriptome was highly significant. The expression of, two-thirds of all genes induced in early lesions was later repressed. Conclusions/Significance: The transcriptional characteristics of TB granulomas undergo drastic changes during the course of infection. The overwhelming reprogramming of the initial pro-inflammatory surge in late lesions may be a host strategy to limit immunopathology. We propose that these host profiles can predict changes in bacterial replication and physiology, perhaps serving as markers for latency and reactivation.	[Mehra, Smriti; Dutta, Noton K.; Kaushal, Deepak] Tulane Natl Primate Res Ctr, Div Bacteriol, Covington, LA USA; [Mehra, Smriti; Dutta, Noton K.; Kaushal, Deepak] Tulane Natl Primate Res Ctr, Div Parasitol, Covington, LA USA; [Mehra, Smriti; Kaushal, Deepak] Tulane Natl Primate Res Ctr, DNA Microarray & Express Core, Covington, LA USA; [Pahar, Bapi; Conerly, Cecily N.; Alvarez, Xavier] Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA; [Philippi-Falkenstein, Kathrine] Tulane Natl Primate Res Ctr, Div Vet Med, Covington, LA USA; [Kaushal, Deepak] Tulane Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, New Orleans, LA 70118 USA	Tulane University; Tulane University; Tulane University; Tulane University; Tulane University; Tulane University	Mehra, S (corresponding author), Tulane Natl Primate Res Ctr, Div Bacteriol, Covington, LA USA.	dkaushal@tulane.edu	Dutta, Noton K./K-5202-2012; Pahar, Bapi/AFM-3129-2022	Dutta, Noton K./0000-0002-5066-3342; Pahar, Bapi/0000-0003-1949-973X	National Institutes of Health [AI091457, AI089323, RR026006, RR164]; Tulane Research Enhancement Fund; Louisiana Vaccine Center; Tulane Center for Infectious Diseases; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020159, R21RR026006, P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI091457, R01AI089323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane Research Enhancement Fund; Louisiana Vaccine Center; Tulane Center for Infectious Diseases; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health grants AI091457 (DK), AI089323 (DK), RR026006 (DK) and RR164 and by awards from Tulane Research Enhancement Fund (DK), Louisiana Vaccine Center (DK) and Tulane Center for Infectious Diseases (SM and NKD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algood HMS, 2004, J IMMUNOL, V173, P3287; Aly S, 2007, J PATHOL, V212, P295, DOI 10.1002/path.2185; Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055; Basaraba RJ, 2008, TUBERCULOSIS, V88, pS35, DOI 10.1016/S1472-9792(08)70035-0; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Chen CY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000392; Collins CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000430; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Dutta NK, 2010, J INFECT DIS, V201, P1743, DOI 10.1086/652497; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Ericsson A, 2006, J IMMUNOL, V176, P3642, DOI 10.4049/jimmunol.176.6.3642; Ferrara G, 2008, SCAND J IMMUNOL, V68, P668, DOI 10.1111/j.1365-3083.2008.02182.x; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Fuller CL, 2003, INFECT IMMUN, V71, P7023, DOI 10.1128/IAI.71.12.7023-7034.2003; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Hasan Z, 2003, TUBERCULOSIS, V83, P299, DOI 10.1016/S1472-9792(03)00003-9; Kaufman M, 2002, PRESERVATION, V54, P8; Kaufmann SHE, 2005, J EXP MED, V201, P1693, DOI 10.1084/jem.20050842; KAUSHAL D, 2004, CURR PROTOC BIOINFOR, V7, P9; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kinhikar AG, 2010, MOL MICROBIOL, V75, P92, DOI 10.1111/j.1365-2958.2009.06959.x; Larsen MH, 2009, VACCINE, V27, P4709, DOI 10.1016/j.vaccine.2009.05.050; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Mayanja-Kizza H, 2001, J INFECT DIS, V183, P1801, DOI 10.1086/320724; McMurray DN, 2003, TUBERCULOSIS, V83, P131, DOI 10.1016/S1472-9792(02)00079-3; Nedeltchev GG, 2009, INFECT IMMUN, V77, P598, DOI 10.1128/IAI.01132-08; ORME IM, 1995, TRENDS MICROBIOL, V3, P401, DOI 10.1016/S0966-842X(00)88987-8; Orme IM, 2003, TUBERCULOSIS, V83, P112, DOI 10.1016/S1472-9792(02)00069-0; Pahar B, 2007, VIROLOGY, V363, P36, DOI 10.1016/j.virol.2007.01.010; Paige C, 2010, CELL MICROBIOL, V12, P301, DOI 10.1111/j.1462-5822.2009.01424.x; PHILIPS JA, 2005, SCIENCE, V309, P5738; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Sadek MI, 1998, AM J RESP CELL MOL, V19, P513, DOI 10.1165/ajrcmb.19.3.2815; Salam N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002869; Saukkonen JJ, 2002, INFECT IMMUN, V70, P1684, DOI 10.1128/IAI.70.4.1684-1693.2002; Sauty A, 1999, J IMMUNOL, V162, P3549; Seiler P, 2003, EUR J IMMUNOL, V33, P2676, DOI 10.1002/eji.200323956; Taylor M, 2005, SIGHT SOUND, V15, P70; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663	42	71	73	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12266	10.1371/journal.pone.0012266	http://dx.doi.org/10.1371/journal.pone.0012266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824205	Green Published, Green Submitted, gold			2022-12-27	WOS:000281405300004
J	Resendis-Antonio, O; Checa, A; Encarnacion, S				Resendis-Antonio, Osbaldo; Checa, Alberto; Encarnacion, Sergio			Modeling Core Metabolism in Cancer Cells: Surveying the Topology Underlying the Warburg Effect	PLOS ONE			English	Article							ESCHERICHIA-COLI; AEROBIC GLYCOLYSIS; TUMOR SUPPRESSORS; DRUG-RESISTANCE; GROWTH; RECONSTRUCTION; CONSTRAINTS; INHIBITION; NETWORKS; BALANCE	Background: Alterations on glucose consumption and biosynthetic activity of amino acids, lipids and nucleotides are metabolic changes for sustaining cell proliferation in cancer cells. Irrevocable evidence of this fact is the Warburg effect which establishes that cancer cells prefers glycolysis over oxidative phosphorylation to generate ATP. Regulatory action over metabolic enzymes has opened a new window for designing more effective anti-cancer treatments. This enterprise is not trivial and the development of computational models that contribute to identifying potential enzymes for breaking the robustness of cancer cells is a priority. Methodology/Principal Findings: This work presents a constraint-base modeling of the most experimentally studied metabolic pathways supporting cancer cells: glycolysis, TCA cycle, pentose phosphate, glutaminolysis and oxidative phosphorylation. To evaluate its predictive capacities, a growth kinetics study for Hela cell lines was accomplished and qualitatively compared with in silico predictions. Furthermore, based on pure computational criteria, we concluded that a set of enzymes (such as lactate dehydrogenase and pyruvate dehydrogenase) perform a pivotal role in cancer cell growth, findings supported by an experimental counterpart. Conclusions/Significance: Alterations on metabolic activity are crucial to initiate and sustain cancer phenotype. In this work, we analyzed the phenotype capacities emerged from a constructed metabolic network conformed by the most experimentally studied pathways sustaining cancer cell growth. Remarkably, in silico model was able to resemble the physiological conditions in cancer cells and successfully identified some enzymes currently studied by its therapeutic effect. Overall, we supplied evidence that constraint-based modeling constitutes a promising computational platform to: 1) integrate high throughput technology and establish a crosstalk between experimental validation and in silico prediction in cancer cell phenotype; 2) explore the fundamental metabolic mechanism that confers robustness in cancer; and 3) suggest new metabolic targets for anticancer treatments. All these issues being central to explore cancer cell metabolism from a systems biology perspective.	[Resendis-Antonio, Osbaldo; Checa, Alberto; Encarnacion, Sergio] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca 62191, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Resendis-Antonio, O (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca 62191, Morelos, Mexico.	resendis@ccg.unam.mx	RESENDIS, OSBALDO/ADE-5280-2022	RESENDIS, OSBALDO/0000-0001-5220-541X	National Council of Science and Technology (CONACyT-Mexico) [83461]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica-Universidad Nacional Autonoma de Mexico (PAPIIT) [IN203809-3]	National Council of Science and Technology (CONACyT-Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica-Universidad Nacional Autonoma de Mexico (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	This work was partially supported by National Council of Science and Technology (CONACyT-Mexico: grant 83461) and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica-Universidad Nacional Autonoma de Mexico (PAPIIT: grant IN203809-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachtiary B, 2006, CLIN CANCER RES, V12, P5632, DOI 10.1158/1078-0432.CCR-06-0357; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Cascante M, 2002, NAT BIOTECHNOL, V20, P243, DOI 10.1038/nbt0302-243; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; KREEGER PK, 2009, CANC SYSTEMS BIOL NE; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; PALSSON B, 2009, FEBS LETT; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Price ND, 2004, BIOPHYS J, V87, P2172, DOI 10.1529/biophysj.104.043000; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Ramos-Montoya A, 2006, INT J CANCER, V119, P2733, DOI 10.1002/ijc.22227; Resendis-Antonio O, 2007, PLOS COMPUT BIOL, V3, P1887, DOI 10.1371/journal.pcbi.0030192; Resendis-Antonio O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004967; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weinberg RA, 2007, BIOL CANC; Wiback SJ, 2004, J THEOR BIOL, V228, P437, DOI 10.1016/j.jtbi.2004.02.006; WOLKENHAUER O, CANC RES, V70, P12; Xu RH, 2005, CANCER RES, V65, P613; Zhang Y, 2009, SCIENCE, V325, P1544, DOI 10.1126/science.1174671	42	52	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12383	10.1371/journal.pone.0012383	http://dx.doi.org/10.1371/journal.pone.0012383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811631	gold, Green Published, Green Submitted			2022-12-27	WOS:000281234700013
J	Wikramaratna, PS; Simmons, CP; Gupta, S; Recker, M				Wikramaratna, Paul S.; Simmons, Cameron P.; Gupta, Sunetra; Recker, Mario			The Effects of Tertiary and Quaternary Infections on the Epidemiology of Dengue	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; HEMORRHAGIC-FEVER; PLASMODIUM-FALCIPARUM; DEPENDENT ENHANCEMENT; VIRUS-INFECTION; HUMAN MOVEMENT; AEDES-AEGYPTI; ANTIBODY; DISEASE; PATTERN	The epidemiology of dengue is characterised by irregular epidemic outbreaks and desynchronised dynamics of its four co-circulating virus serotypes. Whilst infection by one serotype appears to convey life-long protection to homologous infection, it is believed to be a risk factor for severe disease manifestations upon secondary, heterologous infection due to the phenomenon of Antibody-Dependent Enhancement (ADE). Subsequent clinical infections are rarely reported and, since the majority of dengue infections are generally asymptomatic, it is not clear if and to what degree tertiary or quaternary infections contribute to dengue epidemiology. Here we investigate the effect of third and subsequent infections on the transmission dynamics of dengue and show that although the qualitative patterns are largely equivalent, the system more readily exhibits the desynchronised serotype oscillations and multi-annual epidemic outbreaks upon their inclusion. More importantly, permitting third and fourth infections significantly increases the force of infection without resorting to high basic reproductive numbers. Realistic age-prevalent patterns and seroconversion rates are therefore easier reconciled with a low value of dengue's transmission potential if allowing for more than two infections; this should have important consequences for dengue control and intervention measures.	[Wikramaratna, Paul S.; Gupta, Sunetra; Recker, Mario] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Simmons, Cameron P.] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam	University of Oxford; University of Oxford	Wikramaratna, PS (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	mario.recker@zoo.ox.ac.uk	Simmons, Cameron P/ABA-3896-2021	Simmons, Cameron P/0000-0002-9039-7392; Recker, Mario/0000-0001-9489-1315	BBSRC; Royal Society	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London)	This work was funded by the BBSRC (PSW) and the Royal Society (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B, 2006, P NATL ACAD SCI USA, V103, P14234, DOI 10.1073/pnas.0602768103; Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763; Aguiar M, 2008, MATH MODEL NAT PHENO, V3, P48, DOI 10.1051/mmnp:2008070; Anderson KB, 2007, LANCET, V369, P1452, DOI 10.1016/S0140-6736(07)60671-0; Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616; Cummings DAT, 2005, P NATL ACAD SCI USA, V102, P15259, DOI 10.1073/pnas.0507320102; Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139; Favier C, 2006, TROP MED INT HEALTH, V11, P332, DOI 10.1111/j.1365-3156.2006.01560.x; Ferguson N, 1999, P NATL ACAD SCI USA, V96, P790, DOI 10.1073/pnas.96.2.790; Ferguson NM, 1999, PHILOS T R SOC B, V354, P757, DOI 10.1098/rstb.1999.0428; Gibbons RV, 2007, AM J TROP MED HYG, V77, P910, DOI 10.4269/ajtmh.2007.77.910; Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104; GUPTA S, 1994, PARASITE IMMUNOL, V16, P361, DOI 10.1111/j.1365-3024.1994.tb00361.x; GUPTA S, 1994, SCIENCE, V263, P961, DOI 10.1126/science.8310293; Halstead SB, 2001, AM J TROP MED HYG, V65, P180, DOI 10.4269/ajtmh.2001.65.180; Halstead SB, 2005, EMERG INFECT DIS, V11, P740, DOI 10.3201/eid1105.050346; HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Kongsomboon K., 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P913; KOOPMAN JS, 1991, AM J EPIDEMIOL, V133, P1168, DOI 10.1093/oxfordjournals.aje.a115829; Kuno Goro, 1997, P61; Massad E, 2003, REV SAUDE PUBL, V37, P477, DOI 10.1590/S0034-89102003000400013; Nagao Y, 2008, P NATL ACAD SCI USA, V105, P2238, DOI 10.1073/pnas.0709029105; Nisalak A, 2003, AM J TROP MED HYG, V68, P191, DOI 10.4269/ajtmh.2003.68.191; Recker M, 2007, P NATL ACAD SCI USA, V104, P7711, DOI 10.1073/pnas.0702154104; Recker M, 2009, P ROY SOC B-BIOL SCI, V276, P2541, DOI 10.1098/rspb.2009.0331; Schwartz IB, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.066201; Shepard DS, 2004, VACCINE, V22, P1275, DOI 10.1016/j.vaccine.2003.09.019; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Thein S, 1997, AM J TROP MED HYG, V56, P566, DOI 10.4269/ajtmh.1997.56.566; TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103	35	43	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12347	10.1371/journal.pone.0012347	http://dx.doi.org/10.1371/journal.pone.0012347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808806	gold, Green Published			2022-12-27	WOS:000281153500025
J	Chichlowski, M; Westwood, GS; Abraham, SN; Hale, LP				Chichlowski, Maciej; Westwood, Greg S.; Abraham, Soman N.; Hale, Laura P.			Role of Mast Cells in Inflammatory Bowel Disease and Inflammation-Associated Colorectal Neoplasia in IL-10-Deficient Mice	PLOS ONE			English	Article							CROHNS-DISEASE; INTESTINAL PERMEABILITY; ULCERATIVE-COLITIS; PROTECTIVE ROLE; DEFICIENT MICE; MURINE MODEL; W-SH; CANCER; MODULATION; EXPRESSION	Background: Inflammatory bowel disease (IBD) is hypothesized to result from stimulation of immune responses against resident intestinal bacteria within a genetically susceptible host. Mast cells may play a critical role in IBD pathogenesis, since they are typically located just beneath the intestinal mucosal barrier and can be activated by bacterial antigens. Methodology/Principal Findings: This study investigated effects of mast cells on inflammation and associated neoplasia in IBD-susceptible interleukin (IL)-10-deficient mice with and without mast cells. IL-10-deficient mast cells produced more pro-inflammatory cytokines in vitro both constitutively and when triggered, compared with wild type mast cells. However despite this enhanced in vitro response, mast cell-sufficient Il10(-/-) mice actually had decreased cecal expression of tumor necrosis factor (TNF) and interferon (IFN)-gamma mRNA, suggesting that mast cells regulate inflammation in vivo. Mast cell deficiency predisposed Il10(-/-) mice to the development of spontaneous colitis and resulted in increased intestinal permeability in vivo that preceded the development of colon inflammation. However, mast cell deficiency did not affect the severity of IBD triggered by non-steroidal anti-inflammatory agents (NSAID) exposure or helicobacter infection that also affect intestinal permeability. Conclusions/Significance: Mast cells thus appear to have a primarily protective role within the colonic microenvironment by enhancing the efficacy of the mucosal barrier. In addition, although mast cells were previously implicated in progression of sporadic colon cancers, mast cells did not affect the incidence or severity of colonic neoplasia in this inflammation-associated model.	[Chichlowski, Maciej; Westwood, Greg S.; Abraham, Soman N.; Hale, Laura P.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Abraham, Soman N.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Abraham, Soman N.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Hale, Laura P.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Chichlowski, M (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	laura.hale@duke.edu			National Institutes of Health [R21-DK075522, 1R01-CA115480]; NATIONAL CANCER INSTITUTE [R01CA115480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075522, R01DK077159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the National Institutes of Health R21-DK075522 and 1R01-CA115480. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg DJ, 2002, GASTROENTEROLOGY, V123, P1527, DOI 10.1053/gast.2002.1231527; Berrozpe G, 1999, BLOOD, V94, P2658, DOI 10.1182/blood.V94.8.2658.420k23_2658_2666; Bischoff SC, 2009, SEMIN IMMUNOPATHOL, V31, P185, DOI 10.1007/s00281-009-0165-4; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Burich A, 2001, AM J PHYSIOL-GASTR L, V281, pG764, DOI 10.1152/ajpgi.2001.281.3.G764; Cardoso CR, 2008, CLIN EXP ALLERGY, V38, P338; Chichlowski M, 2008, COMPARATIVE MED, V58, P534; Chichlowski M, 2008, AM J PHYSIOL-GASTR L, V295, pG1139, DOI 10.1152/ajpgi.90516.2008; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; FOX CC, 1990, GASTROENTEROLOGY, V99, P119, DOI 10.1016/0016-5085(90)91238-2; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Gassler N, 2001, AM J PHYSIOL-GASTR L, V281, pG216, DOI 10.1152/ajpgi.2001.281.1.G216; GIBSON P, 1995, GUT, V36, P857, DOI 10.1136/gut.36.6.857; Gounaris E, 2007, P NATL ACAD SCI USA, V104, P19977, DOI 10.1073/pnas.0704620104; Groschwitz KR, 2009, P NATL ACAD SCI USA, V106, P22381, DOI 10.1073/pnas.0906372106; Hale LP, 2007, HELICOBACTER, V12, P598, DOI 10.1111/j.1523-5378.2007.00552.x; Hale LP, 2005, INFLAMM BOWEL DIS, V11, P1060, DOI 10.1097/01.MIB.0000187582.90423.bc; Hale LP, 2005, CLIN IMMUNOL, V116, P135, DOI 10.1016/j.clim.2005.04.011; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; HEATLEY RV, 1975, GUT, V16, P559, DOI 10.1136/gut.16.7.559; Hofmann AM, 2009, CURR OPIN IMMUNOL, V21, P679, DOI 10.1016/j.coi.2009.09.007; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; INABA Y, 2010, INFLAMMATORY BOWEL D, V9999; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Madsen KL, 1999, INFLAMM BOWEL DIS, V5, P262, DOI 10.1097/00054725-199911000-00004; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005; Mekori YA, 1999, J ALLERGY CLIN IMMUN, V104, P517, DOI 10.1016/S0091-6749(99)70316-7; NAKAMURA J, 1985, CHEM PHARM BULL, V33, P3527; Nigrovic PA, 2008, AM J PATHOL, V173, P1693, DOI 10.2353/ajpath.2008.080407; NOLTE H, 1990, GUT, V31, P791, DOI 10.1136/gut.31.7.791; Peeters M, 1997, GASTROENTEROLOGY, V113, P802, DOI 10.1016/S0016-5085(97)70174-4; RAITHEL M, 1995, INT ARCH ALLERGY IMM, V108, P127, DOI 10.1159/000237129; Santos J, 2008, PSYCHONEUROENDOCRINO, V33, P1248, DOI 10.1016/j.psyneuen.2008.07.002; Shen Z, 1997, INT J SYST BACTERIOL, V47, P627, DOI 10.1099/00207713-47-3-627; Shin JS, 2006, J IMMUNOL, V177, P5791, DOI 10.4049/jimmunol.177.9.5791; Sinnamon MJ, 2008, CARCINOGENESIS, V29, P880, DOI 10.1093/carcin/bgn040; Soderholm JD, 1999, GUT, V44, P96, DOI 10.1136/gut.44.1.96; Sollid LM, 2008, PLOS MED, V5, P1338, DOI 10.1371/journal.pmed.0050198; Suenaert P, 2002, AM J GASTROENTEROL, V97, P2000; Thuijls Geertje, 2010, J Clin Gastroenterol, V44, pe14, DOI 10.1097/MCG.0b013e31819f5652; WEIDNER N, 1991, J INVEST DERMATOL, V96, pS26, DOI 10.1111/1523-1747.ep12468966; Wolters PJ, 2005, CLIN EXP ALLERGY, V35, P82, DOI 10.1111/j.1365-2222.2005.02136.x; Wood JD, 2004, GASTROENTEROLOGY, V127, P635, DOI 10.1053/j.gastro.2004.02.017	48	58	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12220	10.1371/journal.pone.0012220	http://dx.doi.org/10.1371/journal.pone.0012220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808919	gold, Green Published			2022-12-27	WOS:000280968100019
J	Fellenberg, J; Kunz, P; Sahr, H; Depeweg, D				Fellenberg, Joerg; Kunz, Pierre; Saehr, Heiner; Depeweg, Daniela			Overexpression of Inosine 5 '-Monophosphate Dehydrogenase Type II Mediates Chemoresistance to Human Osteosarcoma Cells	PLOS ONE			English	Article							MULTIPLE-MYELOMA CELLS; DRUG-REGULATED GENES; IMP-DEHYDROGENASE; MONOPHOSPHATE DEHYDROGENASE; LEUKEMIA-CELLS; CANCER CELLS; CYCLE ARREST; APOPTOSIS; CHEMOTHERAPY; EXPRESSION	Background: Chemoresistance is the principal reason for poor survival and disease recurrence in osteosarcoma patients. Inosine 5'-monophosphate dehydrogenase type II (IMPDH2) encodes the rate-limiting enzyme in the de novo guanine nucleotide biosynthesis and has been linked to cell growth, differentiation, and malignant transformation. In a previous study we identified IMPDH2 as an independent prognostic factor and observed frequent IMPDH2 overexpression in osteosarcoma patients with poor response to chemotherapy. The aim of this study was to provide evidence for direct involvement of IMPDH2 in the development of chemoresistance. Methodology/Principal Findings: Stable cell lines overexpressing IMPDH2 and IMPDH2 knock-down cells were generated using the osteosarcoma cell line Saos-2 as parental cell line. Chemosensitivity, proliferation, and the expression of apoptosis-related proteins were analyzed by flow cytometry, WST-1-assay, and western blot analysis. Overexpression of IMPDH2 in Saos-2 cells induced strong chemoresistance against cisplatin and methotrexate. The observed chemoresistance was mediated at least in part by increased expression of the anti-apoptotic proteins Bcl-2, Mcl-1, and XIAP, reduced activation of caspase-9, and, consequently, reduced cleavage of the caspase substrate PARP. Pharmacological inhibition of IMPDH induced a moderate reduction of cell viability and a strong decrease of cell proliferation, but no increase in chemosensitivity. However, chemoresistant IMPDH2-overexpressing cells could be resensitized by RNA interference-mediated downregulation of IMPDH2. Conclusions: IMPDH2 is directly involved in the development of chemoresistance in osteosarcoma cells, suggesting that targeting of IMPDH2 by RNAi or more effective pharmacological inhibitors in combination with chemotherapy might be a promising means of overcoming chemoresistance in osteosarcomas with high IMPDH2 expression.	[Fellenberg, Joerg; Kunz, Pierre; Saehr, Heiner; Depeweg, Daniela] Orthoped Univ Hosp Heidelberg, Dept Expt Orthoped, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Fellenberg, J (corresponding author), Orthoped Univ Hosp Heidelberg, Dept Expt Orthoped, Heidelberg, Germany.	joerg.fellenberg@med.uni-heidelberg.de			Deutsche Krebshilfe e.V; EuroBoNeT	Deutsche Krebshilfe e.V(Deutsche Krebshilfe); EuroBoNeT(European CommissionEuropean Commission Joint Research Centre)	This study was supported by a grant from the Deutsche Krebshilfe e.V and the EuroBoNeT. The Department of Experimental Orthopedics, Orthopedic University Hospital Heidelberg is a partner of the EuroBoNeT consortium, a European Commission-granted Network of Excellence for studying the pathology and genetics of bone tumors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen LQ, 2007, CURR OPIN DRUG DISC, V10, P403; Fellenberg J, 2003, INT J CANCER, V105, P636, DOI 10.1002/ijc.11135; Fellenberg J, 2007, MODERN PATHOL, V20, P1085, DOI 10.1038/modpathol.3800937; Franchetti P, 1996, FARMACO, V51, P457; GHAREHBAGHI K, 1994, LEUKEMIA, V8, P1257; GOORIN AM, 1991, J CLIN ONCOL, V9, P600, DOI 10.1200/JCO.1991.9.4.600; Ishitsuka K, 2005, ONCOGENE, V24, P5888, DOI 10.1038/sj.onc.1208739; ITOH O, 1989, CANCER RES, V49, P996; JACKSON RC, 1975, NATURE, V256, P331, DOI 10.1038/256331a0; Jayaram HN, 1999, CURR MED CHEM, V6, P561; Kempf-Bielack B, 2005, J CLIN ONCOL, V23, P559, DOI 10.1200/JCO.2005.04.063; Khanna N, 2004, LIFE SCI, V75, P179, DOI 10.1016/j.lfs.2003.11.026; KNIGHT RD, 1987, BLOOD, V69, P634; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Messina E, 2004, INT J CANCER, V108, P812, DOI 10.1002/ijc.11642; MEYERS PA, 1992, J CLIN ONCOL, V10, P5, DOI 10.1200/JCO.1992.10.1.5; NAGAI M, 1991, CANCER RES, V51, P3886; NAGAI M, 1992, CANCER RES, V52, P258; NATSUMEDA Y, 1993, ANN NY ACAD SCI, V696, P88; OLAH E, 1988, P NATL ACAD SCI USA, V85, P6533, DOI 10.1073/pnas.85.17.6533; Penuelas S, 2005, FEBS J, V272, P696, DOI 10.1111/j.1742-4658.2004.04504.x; Penuelas S, 2005, MED SCI MONITOR, V11, pBR6; Provisor AJ, 1997, J CLIN ONCOL, V15, P76, DOI 10.1200/JCO.1997.15.1.76; Ratcliffe AJ, 2006, CURR OPIN DRUG DISC, V9, P595; SIDI Y, 1988, BRIT J CANCER, V58, P61, DOI 10.1038/bjc.1988.162; Sun XX, 2008, J BIOL CHEM, V283, P12387, DOI 10.1074/jbc.M801387200; Takebe N, 2006, MOL CANCER THER, V5, P457, DOI 10.1158/1535-7163.MCT-05-0340; TRICOT GJ, 1989, CANCER RES, V49, P3696; URIBEBOTERO G, 1977, AM J CLIN PATHOL, V67, P427; Wright DG, 1996, ANTICANCER RES, V16, P3349; Yalowitz JA, 2000, ANTICANCER RES, V20, P2329; Zimmermann A, 1996, ADV ENZYME REGUL, V36, P75, DOI 10.1016/0065-2571(95)00012-7	32	33	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12179	10.1371/journal.pone.0012179	http://dx.doi.org/10.1371/journal.pone.0012179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808934	Green Published, Green Submitted, gold			2022-12-27	WOS:000280968000010
J	Ciccolella, CO; Raynard, NA; Mei, JHM; Church, DC; Ludwig, RA				Ciccolella, Christopher O.; Raynard, Nathan A.; Mei, John H-M.; Church, Derek C.; Ludwig, Robert A.			Symbiotic Legume Nodules Employ Both Rhizobial Exo- and Endo-Hydrogenases to Recycle Hydrogen Produced by Nitrogen Fixation	PLOS ONE			English	Article							AZORHIZOBIUM-CAULINODANS ORS571; COMPLEX-I; WILD-TYPE; JAPONICUM; LEGUMINOSARUM; METABOLISM; MUTANTS; STRAINS; OXYGEN; BACTEROIDS	Background: In symbiotic legume nodules, endosymbiotic rhizobia (bacteroids) fix atmospheric N(2), an ATP-dependent catalytic process yielding stoichiometric ammonium and hydrogen gas (H(2)). While in most legume nodules this H(2) is quantitatively evolved, which loss drains metabolic energy, certain bacteroid strains employ uptake hydrogenase activity and thus evolve little or no H(2). Rather, endogenous H(2) is efficiently respired at the expense of O(2), driving oxidative phosphorylation, recouping ATP used for H(2) production, and increasing the efficiency of symbiotic nodule N(2) fixation. In many ensuing investigations since its discovery as a physiological process, bacteroid uptake hydrogenase activity has been presumed a single entity. Methodology/Principal Findings: Azorhizobium caulinodans, the nodule endosymbiont of Sesbania rostrata stems and roots, possesses both orthodox respiratory (exo-)hydrogenase and novel (endo-)hydrogenase activities. These two respiratory hydrogenases are structurally quite distinct and encoded by disparate, unlinked gene-sets. As shown here, in S. rostrata symbiotic nodules, haploid A. caulinodans bacteroids carrying single knockout alleles in either exo- or-endohydrogenase structural genes, like the wild-type parent, evolve no detectable H(2) and thus are fully competent for endogenous H(2) recycling. Whereas, nodules formed with A. caulinodans exo-, endo- hydrogenase double-mutants evolve endogenous H(2) quantitatively and thus suffer complete loss of H(2) recycling capability. More generally, from bioinformatic analyses, diazotrophic microaerophiles, including rhizobia, which respire H(2) may carry both exo- and endo- hydrogenase gene-sets. Conclusions/Significance: In symbiotic S. rostrata nodules, A. caulinodans bacteroids can use either respiratory hydrogenase to recycle endogenous H(2) produced by N(2) fixation. Thus, H(2) recycling by symbiotic legume nodules may involve multiple respiratory hydrogenases.	[Ciccolella, Christopher O.; Raynard, Nathan A.; Mei, John H-M.; Church, Derek C.; Ludwig, Robert A.] Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Ciccolella, CO (corresponding author), Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA.	rludwig@ucsc.edu			California Energy Commission	California Energy Commission	This work was supported by the California Energy Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT SL, 1979, SCIENCE, V203, P1255, DOI 10.1126/science.203.4386.1255; Baginsky C, 2004, FEMS MICROBIOL LETT, V237, P399, DOI 10.1016/j.femsle.2004.07.003; BEDMAR EJ, 1984, CAN J BOT, V62, P1682, DOI 10.1139/b84-227; BERNHARD M, 2004, EUR J BIOCHEM, V16, P179; BOOGERD FC, 1994, APPL ENVIRON MICROB, V60, P1859, DOI 10.1128/AEM.60.6.1859-1866.1994; Brito B, 1997, P NATL ACAD SCI USA, V94, P6019, DOI 10.1073/pnas.94.12.6019; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Burris R. H., 1980, Nitrogen fixation [Proceedings of the Phytochemical Society of Europe Symposium Sussex, UK, September, 1979]., P37; CAUVIN B, 1991, MOL MICROBIOL, V5, P2519, DOI 10.1111/j.1365-2958.1991.tb02098.x; DEVRIES W, 1988, ARCH MICROBIOL, V150, P595, DOI 10.1007/BF00408256; DIXON ROD, 1972, ARCH MIKROBIOL, V85, P193, DOI 10.1007/BF00408844; DIXON ROD, 1968, ARCH MIKROBIOL, V62, P272, DOI 10.1007/BF00413898; DONALD RGK, 1986, J BACTERIOL, V165, P72, DOI 10.1128/jb.165.1.72-81.1986; DREVON JJ, 1982, PLANT PHYSIOL, V70, P1341, DOI 10.1104/pp.70.5.1341; DREYFUS BL, 1981, FEMS MICROBIOL LETT, V10, P313; EISBRENNER G, 1983, ANNU REV PLANT PHYS, V34, P105, DOI 10.1146/annurev.pp.34.060183.000541; HYNDMAN LA, 1953, J BACTERIOL, V65, P522, DOI 10.1128/JB.65.5.522-531.1953; LEPO JE, 1981, J BACTERIOL, V146, P614, DOI 10.1128/JB.146.2.614-620.1981; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; LOPEZ M, 1983, PLANT SCI LETT, V9, P191; LOROCH AI, 1995, J BACTERIOL, V177, P7210, DOI 10.1128/jb.177.24.7210-7221.1995; MAIER RJ, 1982, J BACTERIOL, V150, P161, DOI 10.1128/JB.150.1.161-167.1982; NELSON LM, 1985, FEMS MICROBIOL LETT, V30, P53; Ng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004695; Ohnishi T, 2005, FEBS LETT, V579, P4555, DOI 10.1016/j.febslet.2005.06.086; Phelps AS, 1941, P SOC EXP BIOL MED, V47, P473; RUIZARGUESO T, 1978, ARCH MICROBIOL, V116, P113, DOI 10.1007/BF00406025; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; SCHUBERT KR, 1976, P NATL ACAD SCI USA, V73, P1207, DOI 10.1073/pnas.73.4.1207; Thorneley R. N. F., 1985, MOLYBDENUM ENZYMES, P221; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; VREMAN HJ, 1988, CLIN CHEM, V34, P2562	33	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12094	10.1371/journal.pone.0012094	http://dx.doi.org/10.1371/journal.pone.0012094			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20838423	Green Published, Green Submitted, gold			2022-12-27	WOS:000280811900032
J	Bauch, CT; Bhattacharyya, S; Ball, RF				Bauch, Chris T.; Bhattacharyya, Samit; Ball, Robert F.			Rapid Emergence of Free-Riding Behavior in New Pediatric Immunization Programs	PLOS ONE			English	Article							VACCINATING BEHAVIOR; SELF-INTEREST; DYNAMICS; EPIDEMIOLOGY; SPREAD; SAFETY	Background: Mathematical models have formalized how free-rider effects can threaten the stability of high vaccine coverage levels under established voluntary vaccination programs. However, little research has addressed the question of when free-riding begins to develop when a new vaccine is first introduced in a population. Methodology/Principal Findings: Here, we combine a game theoretical model of vaccinating behavior with an age-structured compartmental model to analyze rational vaccinating behavior in the first years of a universal immunization program, where a new vaccine is free to all children of a specified age. The model captures how successive birth cohorts face different epidemiological landscapes that have been shaped by the vaccinating decisions of previous birth cohorts, resulting in a strategic interaction between individuals in different birth cohorts. The model predicts a Nash equilibrium coverage level of 100% for the first few birth cohorts under the new program. However, free-riding behavior emerges very quickly, with the Nash equilibrium vaccine coverage dropping significantly within 2-5 years after program initiation. Subsequently, a rich set of coupled dynamics between infection prevalence and vaccinating behaviors is possible, ranging from relatively stable (but reduced) coverage in later birth cohorts to wide fluctuations in vaccine coverage from one birth cohort to the next. Individual tolerance for vaccine risk also starts out at relatively high levels before dropping significantly within a few years. Conclusions/Significance: These results suggest that even relatively new immunization programs can be vulnerable to drops in vaccine coverage caused by vaccine scares and exacerbated by herd immunity effects, necessitating vigilance from the start.	[Bauch, Chris T.; Bhattacharyya, Samit] Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada; [Ball, Robert F.] US FDA, Off Biostat & Epidemiol, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA	University of Guelph; US Food & Drug Administration (FDA)	Bauch, CT (corresponding author), Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada.	cbauch@uoguelph.ca		Bhattacharyya, Samit/0000-0002-7357-7949	Ministry of Research and Innovation of Ontario; United States Food and Drug Administration; University of Guelph	Ministry of Research and Innovation of Ontario(Ministry of Research and Innovation, Ontario); United States Food and Drug Administration; University of Guelph	This work was funded by the Ministry of Research and Innovation of Ontario, the United States Food and Drug Administration, and the University of Guelph. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball LK, 2004, NEW GENERATION VACCI, P127; Barrett S, 2007, PUBLIC CHOICE, V130, P179, DOI 10.1007/s11127-006-9079-z; Basu S, 2008, P NATL ACAD SCI USA, V105, P19018, DOI 10.1073/pnas.0808114105; Bauch CT, 2005, P ROY SOC B-BIOL SCI, V272, P1669, DOI 10.1098/rspb.2005.3153; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Bauch CT, 2003, P NATL ACAD SCI USA, V100, P10564, DOI 10.1073/pnas.1731324100; Braun MM, 2008, PEDIATRICS, V121, P625, DOI 10.1542/peds.2007-3846; Breban R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031127; BRITO DL, 1991, J PUBLIC ECON, V45, P69, DOI 10.1016/0047-2727(91)90048-7; Chen Frederick H., 2009, Journal of Biological Dynamics, V3, P357, DOI 10.1080/17513750802344246; COJOCARU M, 2009, J INEQUALITIES PURE, V9; d'Onofrio A, 2007, THEOR POPUL BIOL, V71, P301, DOI 10.1016/j.tpb.2007.01.001; EGLESE RW, 1990, EUR J OPER RES, V46, P271, DOI 10.1016/0377-2217(90)90001-R; Ellenberg SS, 2005, AM J PUBLIC HEALTH, V95, P800, DOI 10.2105/AJPH.2004.039438; Farrington CP, 2005, J AM STAT ASSOC, V100, P370, DOI 10.1198/016214504000001754; FINE PEM, 1986, AM J EPIDEMIOL, V124, P1012, DOI 10.1093/oxfordjournals.aje.a114471; Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106; Galvani AP, 2007, P NATL ACAD SCI USA, V104, P5692, DOI 10.1073/pnas.0606774104; Hoyle R. B., 2006, PATTERN FORMATION IN; Maynard Smith J., 1982, pi; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Perisic A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-77; Perisic A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000280; Reluga TC, 2006, MATH BIOSCI, V204, P185, DOI 10.1016/j.mbs.2006.08.015; Reluga Timothy C., 2009, Journal of Biological Dynamics, V3, P515, DOI 10.1080/17513750802638399; Salathe M, 2008, J R SOC INTERFACE, V5, P1505, DOI 10.1098/rsif.2008.0271; Sterman JD, 2006, AM J PUBLIC HEALTH, V96, P505, DOI 10.2105/AJPH.2005.066043; Taira AV, 2004, EMERG INFECT DIS, V10, P1915, DOI 10.3201/eid1011.040222; Vardavas R, 2007, PLOS COMPUT BIOL, V3, P796, DOI 10.1371/journal.pcbi.0030085	29	21	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12594	10.1371/journal.pone.0012594	http://dx.doi.org/10.1371/journal.pone.0012594			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	649ZP	20856798	Green Submitted, Green Published, gold			2022-12-27	WOS:000281815800003
J	Jogi, A; Rono, B; Lund, IK; Nielsen, BS; Ploug, M; Hoyer-Hansen, G; Romer, J; Lund, LR				Jogi, Annika; Rono, Birgitte; Lund, Ida K.; Nielsen, Boye S.; Ploug, Michael; Hoyer-Hansen, Gunilla; Romer, John; Lund, Leif R.			Neutralisation of uPA with a Monoclonal Antibody Reduces Plasmin Formation and Delays Skin Wound Healing in tPA-Deficient Mice	PLOS ONE			English	Article							UROKINASE-TYPE; MATRIX METALLOPROTEINASES; FUNCTIONAL OVERLAP; ACTIVATOR; CANCER; RECEPTOR; GENE; KERATINOCYTES; EXPRESSION; SYSTEMS	Background: Proteolytic degradation by plasmin and metalloproteinases is essential for epidermal regeneration in skin wound healing. Plasminogen deficient mice have severely delayed wound closure as have mice simultaneously lacking the two plasminogen activators, urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator (tPA). In contrast, individual genetic deficiencies in either uPA or tPA lead to wound healing kinetics with no or only slightly delayed closure of skin wounds. Methodology/Principal Findings: To evaluate the therapeutic potential in vivo of a murine neutralizing antibody directed against mouse uPA we investigated the efficacy in skin wound healing of tPA-deficient mice. Systemic administration of the anti-mouse uPA monoclonal antibody, mU1, to tPA-deficient mice caused a dose-dependent delay of skin wound closure almost similar to the delayed kinetics observed in uPA; tPA double-deficient mice. Analysis of wound extracts showed diminished levels of plasmin in the mU1-treated tPA-deficent mice. Immunohistochemistry revealed that fibrin accumulated in the wounds of such mU1-treated tPA-deficent mice and that keratinocyte tongues were aberrant. Together these abnormalities lead to compromised epidermal closure. Conclusions/Significance: Our findings demonstrate that inhibition of uPA activity with a monoclonal antibody in adult tPA-deficient mice mimics the effect of simultaneous genetic ablation of uPA and tPA. Thus, application of the murine inhibitory mU1 antibody provides a new and highly versatile tool to interfere with uPA-activity in vivo in mouse models of disease.	[Jogi, Annika; Rono, Birgitte; Lund, Ida K.; Nielsen, Boye S.; Ploug, Michael; Hoyer-Hansen, Gunilla; Romer, John; Lund, Leif R.] Copenhagen Univ Hosp, Copenhagen Bioctr, Finsen Lab, Copenhagen, Denmark	University of Copenhagen	Jogi, A (corresponding author), Lund Univ, Ctr Mol Pathol, Skane Univ Hosp Malmo, Malmo, Sweden.	lrlund@sund.ku.dk		Jogi, Annika/0000-0003-1697-8030; Ploug, Michael/0000-0003-2215-4265	Swedish Cancer Society; Svenska Medicinsk Forskning; European Union [201279]; MICROENVIMET; Aage Bangs Foundation; "Grosserer Alfred Nielsen og Hustrus Foundation, Danish Cancer Society, the Danish Cancer Research Foundation"; Agnes og Poul Friis Foundation; Lundbeck Foundation	Swedish Cancer Society(Swedish Cancer Society); Svenska Medicinsk Forskning; European Union(European Commission); MICROENVIMET; Aage Bangs Foundation; "Grosserer Alfred Nielsen og Hustrus Foundation, Danish Cancer Society, the Danish Cancer Research Foundation"; Agnes og Poul Friis Foundation; Lundbeck Foundation(Lundbeckfonden)	Research grants supporting this work: Swedish Cancer Society and Svenska Medicinsk Forskning (Fellowship to A.J.), European Union Grant 201279, MICROENVIMET, Aage Bangs Foundation, "Grosserer Alfred Nielsen og Hustrus Foundation, Danish Cancer Society, the Danish Cancer Research Foundation," Agnes og Poul Friis Foundation, and the Lundbeck Foundation. The funders, had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript. There is no restriction in the authors' right to follow all PLoS ONE policies on sharing data and materials.	Bugge TH, 1996, P NATL ACAD SCI USA, V93, P5899, DOI 10.1073/pnas.93.12.5899; Bugge TH, 1998, ONCOGENE, V16, P3097, DOI 10.1038/sj.onc.1201869; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; Collen D, 2005, THROMB HAEMOSTASIS, V93, P627, DOI 10.1160/TH04-11-0724; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Dano K, 1999, APMIS, V107, P120, DOI 10.1111/j.1699-0463.1999.tb01534.x; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; Drew AF, 1998, BLOOD, V91, P1616, DOI 10.1182/blood.V91.5.1616.1616_1616_1624; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Green KA, 2008, J INVEST DERMATOL, V128, P2092, DOI 10.1038/jid.2008.54; GRONDAHLHANSEN J, 1988, J INVEST DERMATOL, V90, P790, DOI 10.1111/1523-1747.ep12461511; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Harbeck Nadia, 2004, Clin Breast Cancer, V5, P348, DOI 10.3816/CBC.2004.n.040; Illemann M, 2009, INT J CANCER, V124, P1860, DOI 10.1002/ijc.24166; Jogi A, 2007, J THROMB HAEMOST, V5, P1936, DOI 10.1111/j.1538-7836.2007.02653.x; Lijnen HR, 1998, ARTERIOSCL THROM VAS, V18, P1035, DOI 10.1161/01.ATV.18.7.1035; Lund IK, 2008, J BIOL CHEM, V283, P32506, DOI 10.1074/jbc.M801924200; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; Lund LR, 1999, EMBO J, V18, P4645, DOI 10.1093/emboj/18.17.4645; Lund LR, 2000, DEVELOPMENT, V127, P4481; Madlener M, 1998, EXP CELL RES, V242, P201, DOI 10.1006/excr.1998.4049; Mingers AM, 1997, SEMIN THROMB HEMOST, V23, P259, DOI 10.1055/s-2007-996099; Nielsen BS, 2007, INT J CANCER, V120, P2086, DOI 10.1002/ijc.22340; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Resnati M, 1996, EMBO J, V15, P1572, DOI 10.1002/j.1460-2075.1996.tb00502.x; ROMER J, 1994, J INVEST DERMATOL, V102, P519, DOI 10.1111/1523-1747.ep12373187; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; ROMER J, 1991, J INVEST DERMATOL, V97, P803, DOI 10.1111/1523-1747.ep12486833; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Scott KA, 2003, MOL CANCER THER, V2, P445; Selvarajan S, 2001, NAT CELL BIOL, V3, P267, DOI 10.1038/35060059; SHULMAN M, 1978, NATURE, V276, P269, DOI 10.1038/276269a0; Solberg H, 2003, DEVELOPMENT, V130, P4439, DOI 10.1242/dev.00642; Weinberg RA, 2007, BIOL CANC	37	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12746	10.1371/journal.pone.0012746	http://dx.doi.org/10.1371/journal.pone.0012746			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856796	gold, Green Submitted, Green Published			2022-12-27	WOS:000281815800017
J	Bulgarelli, D; Biselli, C; Collins, NC; Consonni, G; Stanca, AM; Schulze-Lefert, P; Vale, G				Bulgarelli, Davide; Biselli, Chiara; Collins, Nicholas C.; Consonni, Gabriella; Stanca, Antonio M.; Schulze-Lefert, Paul; Vale, Giampiero			The CC-NB-LRR-Type Rdg2a Resistance Gene Confers Immunity to the Seed-Borne Barley Leaf Stripe Pathogen in the Absence of Hypersensitive Cell Death	PLOS ONE			English	Article							RACE-SPECIFIC RESISTANCE; POWDERY MILDEW FUNGUS; PYRENOPHORA-GRAMINEA; VIRUS-RESISTANCE; PLANT; EXPRESSION; IDENTIFICATION; EVOLUTION; WHEAT; DIVERSITY	Background: Leaf stripe disease on barley (Hordeum vulgare) is caused by the seed-transmitted hemi-biotrophic fungus Pyrenophora graminea. Race-specific resistance to leaf stripe is controlled by two known Rdg (Resistance to Drechslera graminea) genes: the H. spontaneum-derived Rdg1a and Rdg2a, identified in H. vulgare. The aim of the present work was to isolate the Rdg2a leaf stripe resistance gene, to characterize the Rdg2a locus organization and evolution and to elucidate the histological bases of Rdg2a-based leaf stripe resistance. Principal Findings: We describe here the positional cloning and functional characterization of the leaf stripe resistance gene Rdg2a. At the Rdg2a locus, three sequence-related coiled-coil, nucleotide-binding site, and leucine-rich repeat (CC-NB-LRR) encoding genes were identified. Sequence comparisons suggested that paralogs of this resistance locus evolved through recent gene duplication, and were subjected to frequent sequence exchange. Transformation of the leaf stripe susceptible cv. Golden Promise with two Rdg2a-candidates under the control of their native 5' regulatory sequences identified a member of the CC-NB-LRR gene family that conferred resistance against the Dg2 leaf stripe isolate, against which the Rdg2a-gene is effective. Histological analysis demonstrated that Rdg2a-mediated leaf stripe resistance involves autofluorescing cells and prevents pathogen colonization in the embryos without any detectable hypersensitive cell death response, supporting a cell wall reinforcement-based resistance mechanism. Conclusions: This work reports about the cloning of a resistance gene effective against a seed borne disease. We observed that Rdg2a was subjected to diversifying selection which is consistent with a model in which the R gene co-evolves with a pathogen effector(s) gene. We propose that inducible responses giving rise to physical and chemical barriers to infection in the cell walls and intercellular spaces of the barley embryo tissues represent mechanisms by which the CC-NB-LRR-encoding Rdg2a gene mediates resistance to leaf stripe in the absence of hypersensitive cell death.	[Bulgarelli, Davide; Biselli, Chiara; Stanca, Antonio M.; Vale, Giampiero] CRA GPG, Genom Res Ctr, Fiorenzuola Darda, Italy; [Bulgarelli, Davide; Schulze-Lefert, Paul] Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, D-5000 Cologne, Germany; [Collins, Nicholas C.] Univ Adelaide, Australian Ctr Plant Funct Genom, Sch Agr Food & Wine, Glen Osmond, SA, Australia; [Consonni, Gabriella] Univ Milan, DiPROVE, Milan, Italy	Max Planck Society; University of Adelaide; University of Milan	Bulgarelli, D (corresponding author), CRA GPG, Genom Res Ctr, Fiorenzuola Darda, Italy.	giampiero.vale@entecra.it	Schulze-Lefert, Paul/B-6707-2011; Valè, Giampiero/ABF-1492-2020	Valè, Giampiero/0000-0003-2158-9726; Bulgarelli, Davide/0000-0002-2020-6642	Ministero per le Politiche Agricole, Alimentari e Forestali; MiPAF	Ministero per le Politiche Agricole, Alimentari e Forestali; MiPAF	This study was funded by grants from Ministero per le Politiche Agricole, Alimentari e Forestali, MiPAF, (PROTEO-STRESS and AGRO-NANOTECH projects) to GV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PA, 1997, PLANT CELL, V9, P641, DOI 10.1105/tpc.9.4.641; Arru L, 2002, GENOME, V45, P460, DOI [10.1139/g02-004, 10.1139/G02-004]; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Bergelson J, 2001, SCIENCE, V292, P2281, DOI 10.1126/science.1061337; Bhat RA, 2005, P NATL ACAD SCI USA, V102, P3135, DOI 10.1073/pnas.0500012102; Bhullar NK, 2009, P NATL ACAD SCI USA, V106, P9519, DOI 10.1073/pnas.0904152106; Bieri S, 2004, PLANT CELL, V16, P3480, DOI 10.1105/tpc.104.026682; Biselli C, 2010, THEOR APPL GENET, V120, P1207, DOI 10.1007/s00122-009-1248-2; Bryan GT, 2000, PLANT CELL, V12, P2033, DOI 10.1105/tpc.12.11.2033; Bulgarelli D, 2004, THEOR APPL GENET, V108, P1401, DOI 10.1007/s00122-003-1557-9; Cao YL, 2007, GENETICS, V177, P523, DOI 10.1534/genetics.107.075176; Dangl JL, 2006, P NATL ACAD SCI USA, V103, P8575, DOI 10.1073/pnas.0603183103; Delogu G., 1995, Rachis, V14, P29; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P14789, DOI 10.1073/pnas.97.26.14789; Dodds PN, 2004, PLANT CELL, V16, P755, DOI 10.1105/tpc.020040; Ellis J, 2000, CURR OPIN PLANT BIOL, V3, P278, DOI 10.1016/S1369-5266(00)00080-7; Feuillet C, 2003, P NATL ACAD SCI USA, V100, P15253, DOI 10.1073/pnas.2435133100; FREIALDENHOVEN A, 1994, PLANT CELL, V6, P983; Gassmann W, 2005, MOL PLANT MICROBE IN, V18, P1054, DOI 10.1094/MPMI-18-1054; GATTI A, 1992, Journal of Genetics and Breeding, V46, P179; Giuliani C, 2002, ANN BOT-LONDON, V90, P287, DOI 10.1093/aob/mcf173; GORG R, 1993, PLANT J, V3, P857, DOI 10.1111/j.1365-313X.1993.00857.x; HAEGI A, 1995, PHYSIOL MOL PLANT P, V46, P429, DOI 10.1006/pmpp.1995.1033; Haegi A, 2008, MOL PLANT PATHOL, V9, P463, DOI 10.1111/J.1364-3703.2008.00479.X; Halterman D, 2001, PLANT J, V25, P335, DOI 10.1046/j.1365-313x.2001.00982.x; Halterman DA, 2003, PLANT PHYSIOL, V131, P558, DOI 10.1104/pp.014407; HAMMOUDA AM, 1988, ACTA PHYTOPATHOL HUN, V23, P73; Hayashi K, 2009, PLANT J, V57, P413, DOI 10.1111/j.1365-313X.2008.03694.x; Huckelhoven R, 1999, PLANT PHYSIOL, V119, P1251, DOI 10.1104/pp.119.4.1251; Jones DA, 1997, ADV BOT RES, V24, P89; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kohler RH, 1998, TRENDS PLANT SCI, V3, P317, DOI 10.1016/S1360-1385(98)01276-X; Kramer LC, 2009, MOL PLANT MICROBE IN, V22, P447, DOI 10.1094/MPMI-22-4-0447; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; Levy M, 2004, PLANT PHYSIOL, V135, P2392, DOI 10.1104/pp.104.044859; Liu J, 2008, MOL PLANT, V1, P411, DOI 10.1093/mp/ssn010; Mangelsen E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-194; McDowell JM, 2008, DEV COMP IMMUNOL, V32, P736, DOI 10.1016/j.dci.2007.11.005; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; Mueller KJ, 2003, J PLANT PATHOL, V85, P9; Pecchioni N, 1996, THEOR APPL GENET, V93, P97, DOI 10.1007/BF00225733; Platenkamp R., 1976, R VET AGR U YB, P49; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Rose LE, 2004, GENETICS, V166, P1517, DOI 10.1534/genetics.166.3.1517; Ryerson DE, 1996, PLANT CELL, V8, P393, DOI 10.1105/tpc.8.3.393; Sakata K, 2002, NUCLEIC ACIDS RES, V30, P98, DOI 10.1093/nar/30.1.98; Seeholzer S, 2010, MOL PLANT MICROBE IN, V23, P497, DOI 10.1094/MPMI-23-4-0497; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Shirasu K, 1999, PLANT J, V17, P293, DOI 10.1046/j.1365-313X.1999.00376.x; Solovyev VV, 2003, NUCLEIC ACIDS RES, V31, P3540, DOI 10.1093/nar/gkg525; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Tacconi G, 2001, THEOR APPL GENET, V102, P1286, DOI 10.1007/s001220000510; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Van der Hoorn RAL, 2002, TRENDS PLANT SCI, V7, P67, DOI 10.1016/S1360-1385(01)02188-4; Wang M, 1996, PLANT MOL BIOL, V32, P1125, DOI 10.1007/BF00041396; Wang MB, 1998, ACTA HORTIC, P401, DOI 10.17660/ActaHortic.1998.461.46; Wei FS, 1999, GENETICS, V153, P1929; Wulff BBH, 2009, MOL PLANT MICROBE IN, V22, P1191, DOI 10.1094/MPMI-22-10-1191; Yahiaoui N, 2006, PLANT J, V47, P85, DOI 10.1111/j.1365-313X.2006.02772.x; Yahiaoui N, 2009, PLANT J, V57, P846, DOI 10.1111/j.1365-313X.2008.03731.x; Yu Y, 2000, THEOR APPL GENET, V101, P1093, DOI 10.1007/s001220051584; Zhou FS, 2001, PLANT CELL, V13, P337, DOI 10.1105/tpc.13.2.337	66	40	48	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12599	10.1371/journal.pone.0012599	http://dx.doi.org/10.1371/journal.pone.0012599			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844752	Green Published, gold			2022-12-27	WOS:000281687300003
J	Diaz-Ferguson, E; Haney, R; Wares, J; Silliman, B				Diaz-Ferguson, Edgardo; Haney, Robert; Wares, John; Silliman, Brian			Population Genetics of a Trochid Gastropod Broadens Picture of Caribbean Sea Connectivity	PLOS ONE			English	Article							ROCKY INTERTIDAL INVERTEBRATES; CITTARIUM-PICA GASTROPODA; LARVAL DISPERSAL; BIODIVERSITY HOTSPOTS; MARINE; CORAL; FLOW; PHYLOGEOGRAPHY; SPECIATION; ATLANTIC	Background: Regional genetic connectivity models are critical for successful conservation and management of marine species. Even though rocky shore invertebrates have been used as model systems to understand genetic structure in some marine environments, our understanding of connectivity in Caribbean communities is based overwhelmingly on studies of tropical fishes and corals. In this study, we investigate population connectivity and diversity of Cittarium pica, an abundant rocky shore trochid gastropod that is commercially harvested across its natural range, from the Bahamas to Venezuela. Methodology/Principal Findings: We tested for genetic structure using DNA sequence variation at the mitochondrial COI and 16S loci, AMOVA and distance-based methods. We found substantial differentiation among Caribbean sites. Yet, genetic differentiation was associated only with larger geographic scales within the Caribbean, and the pattern of differentiation only partially matched previous assessments of Caribbean connectivity, including those based on larval dispersal from hydrodynamic models. For instance, the Bahamas, considered an independent region by previous hydrodynamic studies, showed strong association with Eastern Caribbean sites in our study. Further, Bonaire (located in the east and close to the meridional division of the Caribbean basin) seems to be isolated from other Eastern sites. Conclusions/Significance: The significant genetic structure and observed in C. pica has some commonalities in pattern with more commonly sampled taxa, but presents features, such as the differentiation of Bonaire, that appear unique. Further, the level of differentiation, together with regional patterns of diversity, has important implications for the application of conservation and management strategies in this commercially harvested species.	[Diaz-Ferguson, Edgardo; Silliman, Brian] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Haney, Robert] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Wares, John] Univ Georgia, Dept Genet, Athens, GA 30602 USA	State University System of Florida; University of Florida; University of Chicago; University System of Georgia; University of Georgia	Diaz-Ferguson, E (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	edgard03@ufl.edu		Silliman, Brian/0000-0001-6360-650X; Wares, John/0000-0003-1827-0669; Diaz-Ferguson, Edgardo/0000-0002-2314-5021; Haney, Robert/0000-0002-3742-3395	Andrew Mellon Foundation	Andrew Mellon Foundation	Publication costs will be covered by the Andrew Mellon Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ayre DJ, 2009, MOL ECOL, V18, P1887, DOI 10.1111/j.1365-294X.2009.04127.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Bertness MD., 1999, ECOLOGY ATLANTIC SHO; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; CHAPMAN L, 2008, ITME RES REPORTS, V27, P31; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Dawson MN, 2006, SCIENCE, V313, P43; Dethier MN, 2003, CONSERV BIOL, V17, P1024, DOI 10.1046/j.1523-1739.2003.01606.x; Diaz-Ferguson E, 2010, ESTUAR COAST, V33, P828, DOI 10.1007/s12237-009-9220-6; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Gilg MR, 2003, ECOLOGY, V84, P2989, DOI 10.1890/02-0498; Gutierrez-Rodriguez C, 2004, MOL ECOL, V13, P2211, DOI 10.1111/j.1365-294X.2004.02247.x; Haney RA, 2007, HEREDITY, V98, P294, DOI 10.1038/sj.hdy.6800940; Hellberg ME, 2007, CORAL REEFS, V26, P463, DOI 10.1007/s00338-007-0205-2; Hellberg ME, 2002, B MAR SCI, V70, P273; Hidas EZ, 2007, MAR FRESHWATER RES, V58, P835, DOI 10.1071/MF06235; HUDSON RR, 1992, GENETICS, V132, P583; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Kirkendale LA, 2004, MOL ECOL, V13, P2749, DOI 10.1111/j.1365-294X.2004.02284.x; Lee T, 2005, EVOLUTION, V59, P2139; Lessios HA, 2001, P ROY SOC B-BIOL SCI, V268, P2347, DOI 10.1098/rspb.2001.1806; Lessios HA, 1998, P ROY SOC B-BIOL SCI, V265, P583, DOI 10.1098/rspb.1998.0334; Lessios HA, 2003, EVOLUTION, V57, P2026, DOI 10.1554/02-681; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; McCartney MA, 2000, MOL ECOL, V9, P1391, DOI 10.1046/j.1365-294x.2000.01022.x; MENGE BA, 1991, J EXP MAR BIOL ECOL, V146, P69, DOI 10.1016/0022-0981(91)90255-U; MENGE BA, 1990, TRENDS ECOL EVOL, V5, P52, DOI 10.1016/0169-5347(90)90048-I; MITTON JB, 1989, BIOL BULL-US, V177, P356, DOI 10.2307/1541595; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Osorno Arango Adriana, 2006, Bol. Invest. Mar. Cost., V35, P133; Palumbi SR, 2003, ECOL APPL, V13, pS146; Palumbi Stephen R., 1996, P205; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; Raffaelli D., 1999, INTERTIDAL ECOLOGY; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Robertson R, 2003, P ACAD NAT SCI PHILA, V153, P27, DOI 10.1635/0097-3157(2003)153[0027:TEWIWC]2.0.CO;2; Rocha LA, 2005, P ROY SOC B-BIOL SCI, V272, P573, DOI 10.1098/2004.3005; Rocha LA, 2002, MOL ECOL, V11, P243, DOI 10.1046/j.0962-1083.2001.01431.x; Rocha LA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-157; Rogers CS, 2001, ENVIRON CONSERV, V28, P312, DOI 10.1017/S0376892901000340; Sale PF, 2004, INTEGR COMP BIOL, V44, P390, DOI 10.1093/icb/44.5.390; Schmidt S, 2002, REV BIOL TROP, V50, P1079; Shanks AL, 2003, ECOL APPL, V13, pS159; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; SILBERMAN JD, 1994, MAR BIOL, V120, P601, DOI 10.1007/BF00350081; Small MP, 2000, HEREDITY, V84, P692, DOI 10.1046/j.1365-2540.2000.00717.x; Steneck RS, 2006, SCIENCE, V311, P480, DOI 10.1126/science.1123541; TAJIMA F, 1989, GENETICS, V123, P585; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Toller Wes, 2005, POPULATION SURVEY W; VERON JEN, 1995, CORALS SPACE TIME BI; Vollmer SV, 2007, J HERED, V98, P40, DOI 10.1093/jhered/esl057; Wares JP, 2002, MOL ECOL, V11, P1131, DOI 10.1046/j.1365-294X.2002.01510.x; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Williams ST, 2004, EVOLUTION, V58, P2227	65	32	32	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12675	10.1371/journal.pone.0012675	http://dx.doi.org/10.1371/journal.pone.0012675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844767	Green Published, Green Submitted, gold			2022-12-27	WOS:000281687300016
J	Downes, K; Pekalski, M; Angus, KL; Hardy, M; Nutland, S; Smyth, DJ; Walker, NM; Wallace, C; Todd, JA				Downes, Kate; Pekalski, Marcin; Angus, Karen L.; Hardy, Matthew; Nutland, Sarah; Smyth, Deborah J.; Walker, Neil M.; Wallace, Chris; Todd, John A.			Reduced Expression of IFIH1 Is Protective for Type 1 Diabetes	PLOS ONE			English	Article							RIG-I; HELICASE; MDA5; IDENTIFICATION; ASSOCIATION; GENES	IFIH1 (interferon induced with helicase C domain 1), also known as MDA5 (melanoma differentiation-associated protein 5), is one of a family of intracellular proteins known to recognise viral RNA and mediate the innate immune response. IFIH1 is causal in type 1 diabetes based on the protective associations of four rare variants, where the derived alleles are predicted to reduce gene expression or function. Originally, however, T1D protection was mapped to the common IFIH1 nsSNP, rs1990760 or Thr946Ala. This common amino acid substitution does not cause a loss of function and evidence suggests the protective allele, Ala(946), may mark a haplotype with reduced expression of IFIH1 in line with the protection conferred by the four rare loss of function alleles. We have performed allele specific expression analysis that supports this hypothesis: the T1D protective haplotype correlates with reduced IFIH1 transcription in interferon-beta stimulated peripheral blood mononuclear cells (overall p = 0.012). In addition, we have used multiflow cytometry analysis and quantitative PCR assays to prove reduced expression of IFIH1 in individuals heterozygous for three of the T1D-associated rare alleles: a premature stop codon, rs35744605 (Glu627X) and predicted splice variants, rs35337543 (IVS8+1) and rs35732034 (IVS14+1). We also show that the nsSNP, Ile923V, does not alter pre-mRNA levels of IFIH1. These results confirm and extend the new autoimmune disease pathway of reduced IFIH1 expression and protein function protecting from T1D.	[Downes, Kate; Pekalski, Marcin; Angus, Karen L.; Hardy, Matthew; Nutland, Sarah; Smyth, Deborah J.; Walker, Neil M.; Wallace, Chris; Todd, John A.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res,Wellcome Trust Diabet & In, Juvenile Diabet Res Fdn,Dept Med Genet, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Downes, K (corresponding author), Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res,Wellcome Trust Diabet & In, Juvenile Diabet Res Fdn,Dept Med Genet, Cambridge CB2 2QQ, England.	john.todd@cimr.cam.ac.uk	Todd, John/A-3542-2010	Todd, John/0000-0003-2740-8148; Walker, Neil/0000-0001-9796-7688; Wallace, Chris/0000-0001-9755-1703; Angus-Cole, Karen/0000-0002-6262-4041; smyth, deborah/0000-0002-6330-2669; Hardy, Matthew/0000-0001-6420-1715	Juvenile Diabetes Research Foundation International; Wellcome Trust [079895]; National Institute for Health Research Cambridge Biomedical Centre; National Institutes of Health (USA) [P01 AI39671]; JDRF UK Centre for Diabetes Genes, Autoimmunity and Prevention (DGAP) [4-2007-1003]; National Institute for Health Research [NF-SI-0508-10275] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Cambridge Biomedical Centre(National Institute for Health Research (NIHR)); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF UK Centre for Diabetes Genes, Autoimmunity and Prevention (DGAP); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Juvenile Diabetes Research Foundation International, the Wellcome Trust and the National Institute for Health Research Cambridge Biomedical Centre. The Cambridge Institute for Medical Research (CIMR) is in receipt of a Wellcome Trust Strategic Award (079895). This work was also supported by a National Institutes of Health (USA) grant P01 AI39671 and a grant from the JDRF UK Centre for Diabetes Genes, Autoimmunity and Prevention (DGAP; 4-2007-1003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ge B, 2005, GENOME RES, V15, P1584, DOI 10.1101/gr.4023805; Gitlin L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000734; Heap GA, 2009, HUM MOL GENET, V18, pR101, DOI [10.1093/hmg/ddp001, 10.1093/hmg/ddp473]; Hyoty H, 2002, DIABETOLOGIA, V45, P1353, DOI 10.1007/s00125-002-0852-3; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Liu S, 2009, HUM MOL GENET, V18, P358, DOI 10.1093/hmg/ddn342; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Marinou I, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2179; Martinez A, 2008, ANN RHEUM DIS, V67, P137, DOI 10.1136/ard.2007.073213; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Patterson CC, 1996, DIABETOLOGIA, V39, P1063, DOI 10.1007/BF00400655; Sato M, 1998, FEBS LETT, V425, P112, DOI 10.1016/S0014-5793(98)00210-5; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shigemoto T, 2009, J BIOL CHEM, V284, P13348, DOI 10.1074/jbc.M809449200; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; von Herrath M, 2009, NATURE, V459, P518, DOI 10.1038/459518a; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Zouk H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011564	22	68	69	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12646	10.1371/journal.pone.0012646	http://dx.doi.org/10.1371/journal.pone.0012646			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844740	gold, Green Submitted, Green Published			2022-12-27	WOS:000281687200011
J	Khiabanian, H; Holmes, AB; Kelly, BJ; Gururaj, M; Hripcsak, G; Rabadan, R				Khiabanian, Hossein; Holmes, Antony B.; Kelly, Brendan J.; Gururaj, Mrinalini; Hripcsak, George; Rabadan, Raul			Signs of the 2009 Influenza Pandemic in the New York-Presbyterian Hospital Electronic Health Records	PLOS ONE			English	Article							A H1N1 VIRUS; CARE; CODES; CHILDREN; SURVEILLANCE; CHALLENGES; INFECTION; VACCINE; STROKE; CITY	Background: In June of 2009, the World Health Organization declared the first influenza pandemic of the 21(st) century, and by July, New York City's New York-Presbyterian Hospital (NYPH) experienced a heavy burden of cases, attributable to a novel strain of the virus (H1N1pdm). Methods and Results: We present the signs in the NYPH electronic health records (EHR) that distinguished the 2009 pandemic from previous seasonal influenza outbreaks via various statistical analyses. These signs include (1) an increase in the number of patients diagnosed with influenza, (2) a preponderance of influenza diagnoses outside of the normal flu season, and (3) marked vaccine failure. The NYPH EHR also reveals distinct age distributions of patients affected by seasonal influenza and the pandemic strain, and via available longitudinal data, suggests that the two may be associated with distinct sets of comorbid conditions as well. In particular, we find significantly more pandemic flu patients with diagnoses associated with asthma and underlying lung disease. We further observe that the NYPH EHR is capable of tracking diseases at a resolution as high as particular zip codes in New York City. Conclusion: The NYPH EHR permits early detection of pandemic influenza and hypothesis generation via identification of those significantly associated illnesses. As data standards develop and databases expand, EHRs will contribute more and more to disease detection and the discovery of novel disease associations.	[Khiabanian, Hossein; Holmes, Antony B.; Hripcsak, George; Rabadan, Raul] Columbia Univ, Coll Phys & Surg, Dept Biomed Informat, New York, NY 10027 USA; [Khiabanian, Hossein; Holmes, Antony B.; Gururaj, Mrinalini; Rabadan, Raul] Columbia Univ, Coll Phys & Surg, Ctr Computat Biol & Bioinformat, New York, NY USA; [Kelly, Brendan J.] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY USA	Columbia University; Columbia University; Columbia University	Khiabanian, H (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Biomed Informat, New York, NY 10027 USA.	hossein@c2b2.columbia.edu	Khiabanian, Hossein/N-7207-2019; Rabadan, Raul/AAZ-7367-2020	Khiabanian, Hossein/0000-0003-1446-4394; Kelly, Brendan/0000-0003-2023-646X; Rabadan, Raul/0000-0001-7946-9255	Northeast Biodefence Center [U54-AI057158]; National Library of Medicine Eureka [1R01LM010140-01]; Centers for Disease Control and Prevention Center of Excellence [P01 HK000029]; National Library of Medicine [R01LM006910]; NATIONAL LIBRARY OF MEDICINE [R01LM006910, R01LM010140] Funding Source: NIH RePORTER	Northeast Biodefence Center; National Library of Medicine Eureka(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Centers for Disease Control and Prevention Center of Excellence; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	RR acknowledges support by the Northeast Biodefence Center grant U54-AI057158 and the National Library of Medicine Eureka grant 1R01LM010140-01. GH is supported by the Centers for Disease Control and Prevention Center of Excellence grant P01 HK000029 and by National Library of Medicine grant R01LM006910. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burd RS, 2008, ACAD EMERG MED, V15, P466, DOI 10.1111/j.1553-2712.2008.00105.x; *CDCP, 2009, H1N1 EARL OUTBR DIS; *CDCP, 2010, CDC FLU HOM; *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P8; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005; *EUR CDCP, 2010, EUR INFL SURV NETW E; Flahault A, 1998, JAMA-J AM MED ASSOC, V280, P1330, DOI 10.1001/jama.280.15.1330; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Glance LG, 2009, ANN SURG, V249, P1032, DOI 10.1097/SLA.0b013e3181a38f28; Goldstein LB, 1998, STROKE, V29, P1602, DOI 10.1161/01.STR.29.8.1602; Gulliford MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007168; Hendy J, 2005, BMJ-BRIT MED J, V331, P331, DOI 10.1136/bmj.331.7512.331; Hivert MF, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-170; Kelly H, 2009, INFLUENZA OTHER RESP, V3, P183, DOI 10.1111/j.1750-2659.2009.00088.x; Keren R, 2006, EMERG INFECT DIS, V12, P1603, DOI 10.3201/eid1210.051525; Khiabanian H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006832; Li Li, 2008, AMIA Annu Symp Proc, P404; Lobach DF, 2007, AM J PREV MED, V32, pS104, DOI 10.1016/j.amepre.2007.01.018; Lombardo J, 2003, J URBAN HEALTH, V80, pI32; McCarthy EP, 2000, MED CARE, V38, P868, DOI 10.1097/00005650-200008000-00010; Miroballi Y, 2010, ARCH PEDIAT ADOL MED, V164, P24, DOI 10.1001/archpediatrics.2009.259; Ndifon W, 2009, VACCINE, V27, P2447, DOI 10.1016/j.vaccine.2009.02.047; *NY CIT DEP HLTH M, 2009, NEW YORK CIT DEP HLT; *NY CIT DEP HLTH M, 2010, NYC INFL INF VACC; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Ritzwoller DP, 2005, PEDIATRICS, V116, P153, DOI 10.1542/peds.2005-0049; Shea S, 2010, NEW ENGL J MED, V362, P192, DOI 10.1056/NEJMp0910140; Slopen M. E., 2010, Morbidity and Mortality Weekly Report, V58, P1436; Steinbrook R, 2009, NEW ENGL J MED, V360, P1057, DOI 10.1056/NEJMp0900665; Trifonov V, 2009, NEW ENGL J MED, V361, P115, DOI 10.1056/NEJMp0904572; Tsui FC, 2001, J AM MED INFORM ASSN, P711; Wang L, 2009, LANCET ONCOL, V10, P9, DOI 10.1016/S1470-2045(08)70321-8; *WHO, 2010, WHO FLUNET; World Health Organization, 2009, WORLD NOW START 2009; World Health Organization (WHO), 2009, INFL A H1N1 UPD 47; Zarychanski R, 2010, CAN MED ASSOC J, V182, P257, DOI 10.1503/cmaj.091884	37	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12658	10.1371/journal.pone.0012658	http://dx.doi.org/10.1371/journal.pone.0012658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844592	Green Published, Green Submitted, gold			2022-12-27	WOS:000281687200019
J	Bernthal, NM; Stavrakis, AI; Billi, F; Cho, JS; Kremen, TJ; Simon, SI; Cheung, AL; Finerman, GA; Lieberman, JR; Adams, JS; Miller, LS				Bernthal, Nicholas M.; Stavrakis, Alexandra I.; Billi, Fabrizio; Cho, John S.; Kremen, Thomas J.; Simon, Scott I.; Cheung, Ambrose L.; Finerman, Gerald A.; Lieberman, Jay R.; Adams, John S.; Miller, Lloyd S.			A Mouse Model of Post-Arthroplasty Staphylococcus aureus Joint Infection to Evaluate In Vivo the Efficacy of Antimicrobial Implant Coatings	PLOS ONE			English	Article							TOTAL HIP-ARTHROPLASTY; SURGICAL-SITE INFECTION; ANTIBIOTIC-IMPREGNATED CEMENT; TOTAL KNEE ARTHROPLASTY; REVISION TOTAL HIP; UNITED-STATES; NEUTROPHIL RECRUITMENT; TITANIUM IMPLANTS; CANINE MODEL; BIOFILMS	Background: Post-arthroplasty infections represent a devastating complication of total joint replacement surgery, resulting in multiple reoperations, prolonged antibiotic use, extended disability and worse clinical outcomes. As the number of arthroplasties in the U. S. will exceed 3.8 million surgeries per year by 2030, the number of post-arthroplasty infections is projected to increase to over 266,000 infections annually. The treatment of these infections will exhaust healthcare resources and dramatically increase medical costs. Methodology/Principal Findings: To evaluate novel preventative therapeutic strategies against post-arthroplasty infections, a mouse model was developed in which a bioluminescent Staphylococcus aureus strain was inoculated into a knee joint containing an orthopaedic implant and advanced in vivo imaging was used to measure the bacterial burden in real-time. Mice inoculated with 5 x 10(3) and 5 x 10(4) CFUs developed increased bacterial counts with marked swelling of the affected leg, consistent with an acute joint infection. In contrast, mice inoculated with 5 x 10(2) CFUs developed a low-grade infection, resembling a more chronic infection. Ex vivo bacterial counts highly correlated with in vivo bioluminescence signals and EGFP-neutrophil fluorescence of LysEGFP mice was used to measure the infection-induced inflammation. Furthermore, biofilm formation on the implants was visualized at 7 and 14 postoperative days by variable-pressure scanning electron microscopy (VP-SEM). Using this model, a minocycline/rifampin-impregnated bioresorbable polymer implant coating was effective in reducing the infection, decreasing inflammation and preventing biofilm formation. Conclusions/Significance: Taken together, this mouse model may represent an alternative pre-clinical screening tool to evaluate novel in vivo therapeutic strategies before studies in larger animals and in human subjects. Furthermore, the antibiotic-polymer implant coating evaluated in this study was clinically effective, suggesting the potential for this strategy as a therapeutic intervention to combat post-arthroplasty infections.	[Bernthal, Nicholas M.; Stavrakis, Alexandra I.; Billi, Fabrizio; Kremen, Thomas J.; Finerman, Gerald A.; Adams, John S.; Miller, Lloyd S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, Orthopaed Hosp Res Ctr,Orthopaed Hosp, Los Angeles, CA 90095 USA; [Cho, John S.; Miller, Lloyd S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA; [Simon, Scott I.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Cheung, Ambrose L.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Microbiol & Immunol, Hanover, NH 03756 USA; [Lieberman, Jay R.] Univ Connecticut, Ctr Hlth, Dept Orthopaed Surg, New England Musculoskeletal Inst, Farmington, CT USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Davis; Dartmouth College; University of Connecticut	Bernthal, NM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, Orthopaed Hosp Res Ctr,Orthopaed Hosp, Los Angeles, CA 90095 USA.	lloydmiller@mednet.ucla.edu	Billi, Fabrizio/AAJ-4830-2021; Adams, John S/I-3365-2013	Billi, Fabrizio/0000-0003-2217-7694; Adams, John S/0000-0001-9607-5020; Miller, Lloyd/0000-0002-8332-2210; Kremen, Thomas/0000-0003-1643-4869	Orthopaedic Hospital Research Center; National Institutes of Health (NIH) [R24 CA92865]; NATIONAL CANCER INSTITUTE [R24CA092865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047294] Funding Source: NIH RePORTER	Orthopaedic Hospital Research Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Orthopaedic Hospital Research Center and by the UCLA Small Animal Imaging Resource Program (SAIRP) R24 CA92865 from the National Institutes of Health (NIH). The antibiotic-coated implants were provided by TyRx Pharma, Inc. No experimental costs, consulting fees or other monetary support was supplied by TyRx Pharma, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt V, 2006, BIOMATERIALS, V27, P4627, DOI 10.1016/j.biomaterials.2006.04.035; Antoci V, 2007, CLIN ORTHOP RELAT R, P88, DOI 10.1097/BLO.0b013e318073c2b2; Antoci V, 2007, J ORTHOP RES, V25, P858, DOI 10.1002/jor.20348; Bargiotas Konstantinos, 2007, J Bone Joint Surg Am, V89 Suppl 2 Pt.1, P103; Belmatoug N, 1996, J INFECT DIS, V174, P414, DOI 10.1093/infdis/174.2.414; Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P45, DOI 10.1007/s11999-009-0945-0; Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155; Bozic KJ, 2005, J BONE JOINT SURG AM, V87A, P1746, DOI 10.2106/JBJS.D.02937; Brady RA, 2008, FEMS IMMUNOL MED MIC, V52, P13, DOI 10.1111/j.1574-695X.2007.00357.x; Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06; Bragg B, 2008, J BIOMED MATER RES B, V84B, P559, DOI 10.1002/jbm.b.30904; Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044; Chiu FY, 2009, J BONE JOINT SURG AM, V91A, P628, DOI 10.2106/JBJS.G.01570; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Conway JD, 2004, J BONE JOINT SURG AM, V86A, P835, DOI 10.2106/00004623-200404000-00027; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Costerton JW, 2005, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000175128.44966.d9; Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI200320365; Craig MR, 2005, J ORTHOP RES, V23, P1100, DOI 10.1016/j.orthres.2005.03.007; Cui QJ, 2007, J BONE JOINT SURG AM, V89A, P871, DOI 10.2106/JBJS.E.01070; Darouiche RO, 2007, J BONE JOINT SURG AM, V89A, P792, DOI 10.2106/JBJS.F.00414; Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415; Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029; Diwanji SR, 2008, J ARTHROPLASTY, V23, P656, DOI 10.1016/j.arth.2007.06.007; Engelsman AF, 2009, J BIOMED MATER RES B, V88B, P123, DOI 10.1002/jbm.b.31158; Epstein NJ, 2005, J ORTHOP RES, V23, P501, DOI 10.1016/j.orthres.2004.10.004; FITZGERALD RH, 1983, J BONE JOINT SURG AM, V65, P371, DOI 10.2106/00004623-198365030-00013; Fulkerson E, 2006, J BONE JOINT SURG AM, V88A, P1231, DOI 10.2106/JBJS.E.00004; Hansen LK, 2009, PACE, V32, P898, DOI 10.1111/j.1540-8159.2009.02406.x; Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b; Jiranek WA, 2006, J BONE JOINT SURG AM, V88A, P2487, DOI 10.2106/JBJS.E.01126; Kim MH, 2008, J INVEST DERMATOL, V128, P1812, DOI 10.1038/sj.jid.5701223; Kim MH, 2009, AM J PHYSIOL-CELL PH, V296, pC848, DOI 10.1152/ajpcell.00520.2008; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Kurtz SM, 2008, J ARTHROPLASTY, V23, P984, DOI 10.1016/j.arth.2007.10.017; Kurtz SM, 2007, J BONE JOINT SURG AM, V89A, P144, DOI 10.2106/JBJS.G.00587; Lauderdale KJ, 2010, J ORTHOP RES, V28, P55, DOI 10.1002/jor.20943; Lee J, 2006, J BONE JOINT SURG AM, V88A, P1705, DOI 10.2106/JBJS.E.01156; Li D, 2008, J ORTHOP RES, V26, P96, DOI 10.1002/jor.20452; Lucke M, 2003, BONE, V32, P521, DOI 10.1016/S8756-3282(03)00050-4; MarcellinLittle DJ, 1996, AM J VET RES, V57, P720; McGarry SA, 2004, INFECT CONT HOSP EP, V25, P461, DOI 10.1086/502422; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Mittal Y, 2007, J BONE JOINT SURG AM, V89A, P1227, DOI 10.2106/JBJS.E.01192; Moojen DJF, 2009, J ORTHOP RES, V27, P1002, DOI 10.1002/jor.20854; Moojen DJF, 2009, J ORTHOP RES, V27, P710, DOI 10.1002/jor.20808; Nishimura S, 2006, J ORTHOP SCI, V11, P46, DOI 10.1007/s00776-005-0968-7; PETTY W, 1988, J BONE JOINT SURG AM, V70A, P536, DOI 10.2106/00004623-198870040-00009; Pulido L, 2008, CLIN ORTHOP RELAT R, V466, P1710, DOI 10.1007/s11999-008-0209-4; Salgado CD, 2007, CLIN ORTHOP RELAT R, P48, DOI 10.1097/BLO.0b013e3181123d4e; Sarda L, 2002, J NUCL MED, V43, P239; Sheehan E, 2004, J ORTHOP RES, V22, P39, DOI 10.1016/S0736-0266(03)00152-9; Sierra RJ, 2003, J BONE JOINT SURG AM, V85A, P1000, DOI 10.2106/00004623-200306000-00003; Sjollema J, 2010, BIOMATERIALS, V31, P1984, DOI 10.1016/j.biomaterials.2009.11.068; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Stoodley P, 2008, J BONE JOINT SURG AM, V90A, P1751, DOI 10.2106/JBJS.G.00838; Toulson C, 2009, J ARTHROPLASTY, V24, P1051, DOI 10.1016/j.arth.2008.07.004; Trampuz A, 2006, CURR OPIN INFECT DIS, V19, P349, DOI 10.1097/01.qco.0000235161.85925.e8; Urquhart DM, 2010, J ARTHROPLASTY, V25, P1216, DOI 10.1016/j.arth.2009.08.011; Walls RJ, 2008, J BONE JOINT SURG BR, V90B, P292, DOI 10.1302/0301-620X.90B3.20155; Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181	63	152	164	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12580	10.1371/journal.pone.0012580	http://dx.doi.org/10.1371/journal.pone.0012580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830204	gold, Green Published, Green Submitted			2022-12-27	WOS:000281631300012
J	Leimu, R; Fischer, M				Leimu, Roosa; Fischer, Markus			Between-Population Outbreeding Affects Plant Defence	PLOS ONE			English	Article							LYCHNIS-FLOS-CUCULI; INBREEDING DEPRESSION; ARIANTA-ARBUSTORUM; MIMULUS-GUTTATUS; GENETIC RESCUE; HYBRID PLANTS; RESISTANCE; TOLERANCE; HERBIVORY; FITNESS	Between-population crosses may replenish genetic variation of populations, but may also result in outbreeding depression. Apart from direct effects on plant fitness, these outbreeding effects can also alter plant-herbivore interactions by influencing plant tolerance and resistance to herbivory. We investigated effects of experimental within-and between-population outbreeding on herbivore resistance, tolerance and plant fitness using plants from 13 to 19 Lychnis flos-cuculi populations. We found no evidence for outbreeding depression in resistance reflected by the amount of leaf area consumed. However, herbivore performance was greater when fed on plants from between-population compared to within-population crosses. This can reflect outbreeding depression in resistance and/or outbreeding effects on plant quality for the herbivores. The effects of type of cross on the relationship between herbivore damage and plant fitness varied among populations. This demonstrates how between-population outbreeding effects on tolerance range from outbreeding depression to outbreeding benefits among plant populations. Finally, herbivore damage strengthened the observed outbreeding effects on plant fitness in several populations. These results raise novel considerations on the impact of outbreeding on the joint evolution of resistance and tolerance, and on the evolution of multiple defence strategies.	[Leimu, Roosa; Fischer, Markus] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Fischer, Markus] Univ Bern, Oeschger Ctr, Bern, Switzerland; [Fischer, Markus] Univ Bern, Bot Garden, Bern, Switzerland	University of Potsdam; University of Bern; University of Bern; University of Bern	Leimu, R (corresponding author), Univ Oxford, Dept Plant Sci, Oxford, England.	roosa.leimu@plants.ox.ac.uk	Fischer, Markus/C-6411-2008	Fischer, Markus/0000-0002-5589-5900	Marie Curie Intra-European Fellowship; Academy of Finland [108784]; Swiss National Science Foundation [31-56809.99, 31-67876.02]	Marie Curie Intra-European Fellowship(European Commission); Academy of Finland(Academy of Finland); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was financially supported by a Marie Curie Intra-European Fellowship for R.L., grant 108784 of the Academy of Finland to R.L. and grants 31-56809.99 and 31-67876.02 of the Swiss National Science Foundation to M.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SAS MIXED MODELS; Biere A, 1996, PLANT SOIL, V182, P313, DOI 10.1007/BF00029062; Bowman G, 2008, J ECOL, V96, P1056, DOI 10.1111/j.1365-2745.2008.01417.x; BURLA H, 1983, GENETICA, V62, P95; Carr DE, 2002, EVOLUTION, V56, P22, DOI 10.1111/j.0014-3820.2002.tb00846.x; CATES RG, 1980, OECOLOGIA, V46, P22, DOI 10.1007/BF00346961; Crawley M. J., 1983, HERBIVORY DYNAMICS A; DUDASH M, 2000, GENETICS DEMOGRAPHY; ELMQVIST T, 1988, OECOLOGIA, V77, P225, DOI 10.1007/BF00379190; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fenster CB, 2000, CONSERV BIOL, V14, P1406, DOI 10.1046/j.1523-1739.2000.99234.x; Fenster CB, 2000, EVOLUTION, V54, P1157, DOI 10.1111/j.0014-3820.2000.tb00551.x; Fischer M, 1997, AM J BOT, V84, P1685, DOI 10.2307/2446466; Fritz RS, 1999, ECOLOGY, V80, P382, DOI 10.1890/0012-9658(1999)080[0382:ROHPTH]2.0.CO;2; Fritz RS, 1999, ANNU REV ECOL SYST, V30, P565, DOI 10.1146/annurev.ecolsys.30.1.565; Galeuchet DJ, 2005, ECOLOGY, V86, P1002, DOI 10.1890/03-0762; Galeuchet DJ, 2005, MOL ECOL, V14, P991, DOI 10.1111/j.1365-294X.2005.02485.x; GALEUCHET DJ, 2003, THESIS U ZURICH; Hagele BF, 2001, OECOLOGIA, V128, P228, DOI 10.1007/s004420100644; HAUSER TP, 1994, J EVOLUTION BIOL, V7, P609, DOI 10.1046/j.1420-9101.1994.7050609.x; Hauser TP, 2000, J EVOLUTION BIOL, V13, P446; Hayes CN, 2004, OECOLOGIA, V140, P601, DOI 10.1007/s00442-004-1623-2; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; HOEHN S, 2006, THESIS U ZURICH; Hufford KM, 2003, TRENDS ECOL EVOL, V18, P147, DOI 10.1016/S0169-5347(03)00002-8; Hull-Sanders HM, 2005, ECOLOGY, V86, P897, DOI 10.1890/04-0935; Ivey CT, 2004, ECOLOGY, V85, P567, DOI 10.1890/02-0730; Jessup CM, 2008, ECOL LETT, V11, P947, DOI 10.1111/j.1461-0248.2008.01205.x; Keller M, 2000, J APPL ECOL, V37, P647, DOI 10.1046/j.1365-2664.2000.00517.x; Kery M, 2001, J ECOL, V89, P418, DOI 10.1046/j.1365-2745.2001.00550.x; Lehtila K, 2003, EVOLUTION, V57, P677, DOI 10.1111/j.0014-3820.2003.tb01559.x; Leimu R, 2006, OIKOS, V112, P1, DOI 10.1111/j.0030-1299.2006.41023.x; Leimu R, 2008, ECOL LETT, V11, P1101, DOI 10.1111/j.1461-0248.2008.01222.x; Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; MARQUIS RJ, 1990, EVOLUTION, V44, P104, DOI 10.1111/j.1558-5646.1990.tb04282.x; Mauricio R, 2000, EVOL ECOL, V14, P491, DOI 10.1023/A:1010909829269; Nunez-Farfan J, 2007, ANNU REV ECOL EVOL S, V38, P541, DOI 10.1146/annurev.ecolsys.38.091206.095822; PAINTER RH, 1958, ANNU REV ENTOMOL, V3, P267, DOI 10.1146/annurev.en.03.010158.001411; PERRET C, 2003, THESIS U ZURICH; Rausher M.D., 1992, P20; Schierup MH, 1996, HEREDITY, V77, P461, DOI 10.1038/hdy.1996.172; Schoonhoven L. M., 2005, Insect-plant biology; SIMMS EL, 1987, AM NAT, V130, P570, DOI 10.1086/284731; SPEISER B, 1991, OIKOS, V62, P306, DOI 10.2307/3545495; Steffan-Dewenter I, 2002, BIOL CONSERV, V104, P275, DOI 10.1016/S0006-3207(01)00192-6; Stephenson AG, 2004, ECOLOGY, V85, P3023, DOI 10.1890/04-0005; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Templeton A.R., 1986, P105; Tiffin P, 2000, EVOL ECOL, V14, P523, DOI 10.1023/A:1010881317261; TIFFIN P, 1999, AM NAT, V6, P700; WASER NM, 1989, EVOLUTION, V43, P1097, DOI [10.2307/2409589, 10.1111/j.1558-5646.1989.tb02554.x]; Waser NM, 1993, NATURAL HIST INBREED; WASER NM, 2000, AM NAT, V6, P700; WHITE T C R, 1969, Ecology (Washington D C), V50, P905, DOI 10.2307/1933707; Willi Y, 2005, HEREDITY, V95, P437, DOI 10.1038/sj.hdy.6800732; Willi Y, 2007, P ROY SOC B-BIOL SCI, V274, P2357, DOI 10.1098/rspb.2007.0768; Wirooks Ludger, 1999, Melanargia, V11, P93; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	62	17	17	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12614	10.1371/journal.pone.0012614	http://dx.doi.org/10.1371/journal.pone.0012614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20838662	Green Published, gold			2022-12-27	WOS:000281631300034
J	Das, M; Mukhopadhyay, S; De, RK				Das, Mouli; Mukhopadhyay, Subhasis; De, Rajat K.			Gradient Descent Optimization in Gene Regulatory Pathways	PLOS ONE			English	Article							ENHANCED HYDROGEN-PRODUCTION; ESCHERICHIA-COLI STRAINS; ALPHA-MEDIATED APOPTOSIS; FLUX BALANCE ANALYSIS; METABOLIC PATHWAYS; NETWORK; EXPRESSION; DISEASE; PROTEIN; CELLS	Background: Gene Regulatory Networks (GRNs) have become a major focus of interest in recent years. Elucidating the architecture and dynamics of large scale gene regulatory networks is an important goal in systems biology. The knowledge of the gene regulatory networks further gives insights about gene regulatory pathways. This information leads to many potential applications in medicine and molecular biology, examples of which are identification of metabolic pathways, complex genetic diseases, drug discovery and toxicology analysis. High-throughput technologies allow studying various aspects of gene regulatory networks on a genome-wide scale and we will discuss recent advances as well as limitations and future challenges for gene network modeling. Novel approaches are needed to both infer the causal genes and generate hypothesis on the underlying regulatory mechanisms. Methodology: In the present article, we introduce a new method for identifying a set of optimal gene regulatory pathways by using structural equations as a tool for modeling gene regulatory networks. The method, first of all, generates data on reaction flows in a pathway. A set of constraints is formulated incorporating weighting coefficients. Finally the gene regulatory pathways are obtained through optimization of an objective function with respect to these weighting coefficients. The effectiveness of the present method is successfully tested on ten gene regulatory networks existing in the literature. A comparative study with the existing extreme pathway analysis also forms a part of this investigation. The results compare favorably with earlier experimental results. The validated pathways point to a combination of previously documented and novel findings. Conclusions: We show that our method can correctly identify the causal genes and effectively output experimentally verified pathways. The present method has been successful in deriving the optimal regulatory pathways for all the regulatory networks considered. The biological significance and applicability of the optimal pathways has also been discussed. Finally the usefulness of the present method on genetic engineering is depicted with an example.	[Das, Mouli; De, Rajat K.] Indian Stat Inst, Machine Intelligence Unit, Kolkata, India; [Mukhopadhyay, Subhasis] Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, India	Indian Statistical Institute; Indian Statistical Institute Kolkata; University of Calcutta	Das, M (corresponding author), Indian Stat Inst, Machine Intelligence Unit, Kolkata, India.	rajat@isical.ac.in			Department of Biotechnology, Government of India [BT/BI/04/001/93, BT/BI/10/019/99]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	One of the authors, Dr. Subhasis Mukhopadhyay, gratefully acknowledges the financial assistance received in the form of a grant, BT/BI/04/001/93 and BT/BI/10/019/99 from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman RB, 2001, CURR OPIN STRUC BIOL, V11, P340, DOI 10.1016/S0959-440X(00)00212-8; Anderson DG, 1998, CELL, V95, P975, DOI 10.1016/S0092-8674(00)81721-3; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Braun P, 2008, P NATL ACAD SCI USA, V105, P9849, DOI 10.1073/pnas.0805644105; Bulfone-Paus S, 1999, FASEB J, V13, P1575, DOI 10.1096/fasebj.13.12.1575; Carlini LE, 1997, MOL MICROBIOL, V24, P129, DOI 10.1046/j.1365-2958.1997.3431694.x; Chang HY, 2000, MICROBIOL MOL BIOL R, V64, P821, DOI 10.1128/MMBR.64.4.821-846.2000; Chao W, 2002, J BIOL CHEM, V277, P31639, DOI 10.1074/jbc.M204104200; Chen C, 2007, BIOPHYS J, V92, P4304, DOI 10.1529/biophysj.106.099606; Chen Z, 2002, BIOCHEM BIOPH RES CO, V290, P66, DOI 10.1006/bbrc.2001.6147; Cicin-Sain L, 2008, J VIROL, V82, P2056, DOI 10.1128/JVI.01803-07; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Covert MW, 2003, J THEOR BIOL, V221, P309, DOI 10.1006/jtbi.2003.3071; Craver MPJ, 2007, MOL BIOCHEM PARASIT, V153, P149, DOI 10.1016/j.molbiopara.2007.02.013; D'haeseleer P, 1999, Pac Symp Biocomput, P41; Datta S, 2001, GENE EXPRESSION, V9, P249, DOI 10.3727/000000001783992498; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Eimon PM, 2006, CELL DEATH DIFFER, V13, P1619, DOI 10.1038/sj.cdd.4402015; Fan ZM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004432; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Fiucci G, 2002, ONCOGENE, V21, P2365, DOI 10.1038/sj.onc.1205300; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Garg A, 2008, BIOINFORMATICS, V24, P1917, DOI 10.1093/bioinformatics/btn336; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Gianchandani EP, 2006, PLOS COMPUT BIOL, V2, P902, DOI 10.1371/journal.pcbi.0020101; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hauser MA, 2003, HUM MOL GENET, V12, P671, DOI 10.1093/hmg/ddg070; Ishizawa YH, 2006, BIOL CELL, V98, P465, DOI 10.1042/BC20050091; Kai WC, 2001, AM J PATHOL, V159, P1635, DOI 10.1016/S0002-9440(10)63010-6; Kieser A, 2008, BIOL CHEM, V389, P1261, DOI 10.1515/BC.2008.144; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Lee JM, 2006, BRIEF BIOINFORM, V7, P140, DOI 10.1093/bib/bbl007; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; Ma HW, 2004, NUCLEIC ACIDS RES, V32, P6643, DOI 10.1093/nar/gkh1009; MacFarlane M, 2004, EMBO REP, V5, P674, DOI 10.1038/sj.embor.7400191; Manna SK, 2000, J IMMUNOL, V165, P4927, DOI 10.4049/jimmunol.165.9.4927; Martinez R, 2007, CARCINOGENESIS, V28, P1264, DOI 10.1093/carcin/bgm014; Mendoza L, 2006, BIOSYSTEMS, V84, P101, DOI 10.1016/j.biosystems.2005.10.004; Mendoza L, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-13; Mongiat M, 2007, MOL CELL BIOL, V27, P7176, DOI 10.1128/MCB.00696-07; Morgan M, 2002, J CELL BIOL, V157, P975, DOI 10.1083/jcb.200204039; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Palsson BO, 2003, TRENDS BIOTECHNOL, V21, P195, DOI 10.1016/S0167-7799(03)00080-5; Putcha GV, 2002, J CELL BIOL, V157, P441, DOI 10.1083/jcb.200110108; Rokudai S, 2002, MOL CELL BIOL, V22, P8695, DOI 10.1128/MCB.22.24.8695-8708.2002; Saito K, 2006, J VIROL, V80, P4372, DOI 10.1128/JVI.80.9.4372-4379.2006; Santoni D, 2008, BIOINFORMATICS, V24, P1374, DOI 10.1093/bioinformatics/btn135; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schilling CH, 2000, J THEOR BIOL, V203, P229, DOI 10.1006/jtbi.2000.1073; Schilling CH, 2000, BIOTECHNOL BIOENG, V71, P286, DOI 10.1002/1097-0290(2000)71:4<286::AID-BIT1018>3.0.CO;2-R; Schwartz JM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-186; Shivapurkar N, 2003, J CELL BIOCHEM, V88, P885, DOI 10.1002/jcb.10440; Siwkowski AM, 2004, MOL PHARMACOL, V66, P572; SOMOGYI R, 1995, J NEUROSCI, V15, P2575; Stork O, 2000, BRAIN RES, V865, P45, DOI 10.1016/S0006-8993(00)02206-X; Takashina T, 2007, MOL CANCER THER, V6, P1793, DOI 10.1158/1535-7163.MCT-06-0522; Troein C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000855; Urbanczik R, 2005, BIOINFORMATICS, V21, P1203, DOI 10.1093/bioinformatics/bti127; Volanakis JE, 1996, PROTEIN SCI, V5, P553; Wagner C, 2005, BIOPHYS J, V89, P3837, DOI 10.1529/biophysj.104.055129; Wong ETL, 1999, BLOOD, V94, P3730, DOI 10.1182/blood.V94.11.3730.423a15_3730_3736; Xiong MM, 2004, BIOINFORMATICS, V20, P2056, DOI 10.1093/bioinformatics/bth201; Xiong MM, 2004, GENETICS, V166, P1037, DOI 10.1534/genetics.166.2.1037; Yamanaka T, 2004, ENVIRON HEALTH PERSP, V112, P1614, DOI [10.1289/txg.7105, 10.1289/ehp.7105]; Yoshida A, 2005, APPL ENVIRON MICROB, V71, P6762, DOI 10.1128/AEM.71.11.6762-6768.2005; Yoshida A, 2006, APPL MICROBIOL BIOT, V73, P67, DOI 10.1007/s00253-006-0456-9	66	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12475	10.1371/journal.pone.0012475	http://dx.doi.org/10.1371/journal.pone.0012475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838430	Green Published, Green Submitted, gold			2022-12-27	WOS:000281627700003
J	Yamamoto, D; Shima, K; Matsuo, K; Nishioka, T; Chen, CY; Hu, GF; Sasaki, A; Tsuji, T				Yamamoto, Daisuke; Shima, Kaori; Matsuo, Kou; Nishioka, Takashi; Chen, Chang Yan; Hu, Guo-fu; Sasaki, Akira; Tsuji, Takanori			Ornithine Decarboxylase Antizyme Induces Hypomethylation of Genome DNA and Histone H3 Lysine 9 Dimethylation (H3K9me2) in Human Oral Cancer Cell Line	PLOS ONE			English	Article							METHYLTRANSFERASE ACTIVITY; METHYLATION PATTERNS; NEUROSPORA-CRASSA; G9A; CHROMATIN; PROTEIN; GENES; POLYAMINES; HP1; DIFFERENTIATION	Background: Methylation of CpG islands of genome DNA and lysine residues of histone H3 and H4 tails regulates gene transcription. Inhibition of polyamine synthesis by ornithine decarboxylase antizyme-1 (OAZ) in human oral cancer cell line resulted in accumulation of decarboxylated S-adenosylmethionine (dcSAM), which acts as a competitive inhibitor of methylation reactions. We anticipated that accumulation of dcSAM impaired methylation reactions and resulted in hypomethylation of genome DNA and histone tails. Methodology/Principal Findings: Global methylation state of genome DNA and lysine residues of histone H3 and H4 tails were assayed by Methylation by Isoschizomers (MIAMI) method and western blotting, respectively, in the presence or absence of OAZ expression. Ectopic expression of OAZ mediated hypomethylation of CpG islands of genome DNA and histone H3 lysine 9 dimethylation (H3K9me2). Protein level of DNA methyltransferase 3B (DNMT3B) and histone H3K9me specific methyltransferase G9a were down-regulated in OAZ transfectant. Conclusions/Significance: OAZ induced hypomethylation of CpG islands of global genome DNA and H3K9me2 by down-regulating DNMT3B and G9a protein level. Hypomethylation of CpG islands of genome DNA and histone H3K9me2 is a potent mechanism of induction of the genes related to tumor suppression and DNA double strand break repair.	[Yamamoto, Daisuke; Nishioka, Takashi; Chen, Chang Yan; Tsuji, Takanori] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Sch Med, Boston, MA 02215 USA; [Yamamoto, Daisuke; Sasaki, Akira] Okayama Univ, Dept Oral & Maxillofacial Surg, Grad Sch, Okayama, Japan; [Shima, Kaori] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Matsuo, Kou] Kyushu Dent Coll, Div Oral Pathol, Dept Biosci, Kitakyushu, Fukuoka 803, Japan; [Hu, Guo-fu] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Okayama University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Kyushu Dental University; Harvard University; Harvard Medical School	Yamamoto, D (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Sch Med, Boston, MA 02215 USA.	ttsuji@bidmc.harvard.edu		Nishioka, Takashi/0000-0002-1144-3881	National Institutes of Health (National Cancer Institute) [RO1-CA10044]	National Institutes of Health (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health (National Cancer Institute) Research Grant RO1-CA10044 for Takanori Tsuji. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Beaulieu N, 2002, J BIOL CHEM, V277, P28176, DOI 10.1074/jbc.M204734200; Belinsky SA, 1996, P NATL ACAD SCI USA, V93, P4045, DOI 10.1073/pnas.93.9.4045; Boner W, 2002, VIRUS RES, V90, P113, DOI 10.1016/S0168-1702(02)00145-4; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Deng T, 2009, BIOMED PHARMACOTHER, V63, P492, DOI 10.1016/j.biopha.2008.08.013; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Freitag M, 2004, MOL CELL, V13, P427, DOI 10.1016/S1097-2765(04)00024-3; Frostesjo L, 1997, J BIOL CHEM, V272, P4359, DOI 10.1074/jbc.272.7.4359; FUJITA K, 1982, BIOCHEM J, V204, P647, DOI 10.1042/bj2040647; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hayashi S, 1996, TRENDS BIOCHEM SCI, V21, P27, DOI 10.1016/0968-0004(96)80882-6; HEBY O, 1988, PROGR POLYAMINE RES, P291; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; Ikegami K, 2007, GENES CELLS, V12, P1, DOI 10.1111/j.1365-2443.2006.01029.x; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Koike C, 1999, CANCER RES, V59, P6109; Kondo Y, 2004, P NATL ACAD SCI USA, V101, P7398, DOI 10.1073/pnas.0306641101; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li Q, 2009, MOL PHARMACOL, V76, P1072, DOI 10.1124/mol.109.056291; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; MCCANN PP, 1997, BIOCHEM BIOPH RES CO, V75, P948; Miao F, 2005, MOL CELL BIOL, V25, P4650, DOI 10.1128/MCB.25.11.4650-4661.2005; MURAKAMI Y, 1985, BIOCHEM J, V226, P893, DOI 10.1042/bj2260893; Murakami Y, 1996, J BIOL CHEM, V271, P3340, DOI 10.1074/jbc.271.7.3340; Nakayama Shuko, 1998, Invasion and Metastasis, V18, P219, DOI 10.1159/000024515; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Smallwood A, 2007, GENE DEV, V21, P1169, DOI 10.1101/gad.1536807; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tamaru H, 2003, NAT GENET, V34, P75, DOI 10.1038/ng1143; Tsuji T, 2001, ONCOGENE, V20, P24, DOI 10.1038/sj.onc.1204051; Tsuji T, 2007, BIOCHEMISTRY-US, V46, P8920, DOI 10.1021/bi7000328; Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	53	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12554	10.1371/journal.pone.0012554	http://dx.doi.org/10.1371/journal.pone.0012554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838441	Green Published, gold, Green Submitted			2022-12-27	WOS:000281627700007
J	Benny, O; Nakai, K; Yoshimura, T; Bazinet, L; Akula, JD; Nakao, S; Hafezi-Moghadam, A; Panigrahy, D; Pakneshan, P; D'Amato, RJ				Benny, Ofra; Nakai, Kei; Yoshimura, Takeru; Bazinet, Lauren; Akula, James D.; Nakao, Shintaro; Hafezi-Moghadam, Ali; Panigrahy, Dipak; Pakneshan, Pouya; D'Amato, Robert J.			Broad Spectrum Antiangiogenic Treatment for Ocular Neovascular Diseases	PLOS ONE			English	Article							MACULAR DEGENERATION; CHOROIDAL NEOVASCULARIZATION; CYTOKINE EXPRESSION; ACTIVATION STEPS; PHOTOTRANSDUCTION; ANGIOGENESIS; RANIBIZUMAB; RETINOPATHY; RPE; ROD	Pathological neovascularization is a hallmark of late stage neovascular (wet) age-related macular degeneration (AMD) and the leading cause of blindness in people over the age of 50 in the western world. The treatments focus on suppression of choroidal neovascularization (CNV), while current approved therapies are limited to inhibiting vascular endothelial growth factor (VEGF) exclusively. However, this treatment does not address the underlying cause of AMD, and the loss of VEGF's neuroprotective can be a potential side effect. Therapy which targets the key processes in AMD, the pathological neovascularization, vessel leakage and inflammation could bring a major shift in the approach to disease treatment and prevention. In this study we have demonstrated the efficacy of such broad spectrum antiangiogenic therapy on mouse model of AMD. Methods and Findings: Lodamin, a polymeric formulation of TNP-470, is a potent broad-spectrum antiangiogenic drug. Lodamin significantly reduced key processes involved in AMD progression as demonstrated in mice and rats. Its suppressive effects on angiogenesis, vascular leakage and inflammation were studied in a wide array of assays including; a Matrigel, delayed-type hypersensitivity (DTH), Miles assay, laser-induced CNV and corneal micropocket assay. Lodamin significantly suppressed the secretion of various pro-inflammatory cytokines in the CNV lesion including monocyte chemotactic protein-1 (MCP-1/Ccl2). Importantly, Lodamin was found to regress established CNV lesions, unlike soluble fms-like tyrosine kinase-1 (sFlk-1). The drug was found to be safe in mice and have little toxicity as demonstrated by electroretinography (ERG) assessing retinal and by histology. Conclusions: Lodamin, a polymer formulation of TNP-470, was identified as a first in its class, broad-spectrum antiangiogenic drug that can be administered orally or locally to treat corneal and retinal neovascularization. Several unique properties make Lodamin especially beneficial for ophthalmic use. Our results support the concept that broad spectrum antiangiogenic drugs are promising agents for AMD treatment and prevention.	[Benny, Ofra; Nakai, Kei; Yoshimura, Takeru; Bazinet, Lauren; Panigrahy, Dipak; Pakneshan, Pouya; D'Amato, Robert J.] Harvard Univ, Sch Med, Childrens Hosp Boston, Vasc Biol Program, Boston, MA 02115 USA; [Benny, Ofra; Nakai, Kei; Yoshimura, Takeru; Bazinet, Lauren; Panigrahy, Dipak; Pakneshan, Pouya; D'Amato, Robert J.] Harvard Univ, Sch Med, Dept Surg, Childrens Hosp Boston, Boston, MA 02115 USA; [Benny, Ofra; Nakai, Kei; Yoshimura, Takeru; Bazinet, Lauren; Akula, James D.; Pakneshan, Pouya; D'Amato, Robert J.] Harvard Univ, Sch Med, Dept Ophthalmol, Childrens Hosp Boston, Boston, MA USA; [Nakao, Shintaro; Hafezi-Moghadam, Ali] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Benny, O (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Vasc Biol Program, Boston, MA 02115 USA.	ofra.bennyratsaby@childrens.harvard.edu	Benny, Ofra/AAB-3294-2021	Akula, James/0000-0001-8049-1812; Yoshimura, Takeru/0000-0002-5983-7193; Hafezi-Moghadam, Ali/0000-0002-5336-0697	Departmental support fund	Departmental support fund	Departmental support fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis AP, 2009, RETINA-J RET VIT DIS, V29, pS42, DOI 10.1097/IAE.0b013e3181ad2500; Adini A, 2009, J IMMUNOL METHODS, V342, P78, DOI 10.1016/j.jim.2008.11.016; Akula JD, 2007, INVEST OPHTH VIS SCI, V48, P5788, DOI 10.1167/iovs.07-0881; Akula JD, 2008, MOL VIS, V14, P2499; Augustin AJ, 2009, EXPERT OPIN THER TAR, V13, P641, DOI 10.1517/14728220902942322; Benny O, 2008, NAT BIOTECHNOL, V26, P799, DOI 10.1038/nbt1415; Black C A, 1999, Dermatol Online J, V5, P7; Campochiaro PA, 2007, DRUG TODAY, V43, P529, DOI 10.1358/dot.2007.43.8.1120868; Clark AF, 2003, NAT REV DRUG DISCOV, V2, P448, DOI 10.1038/nrd1106; *CLINICALTRIALS GO, 2009, NCT00605943 CLINICAL; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; El-Asrar Ahmed M. Abu, 1997, American Journal of Ophthalmology, V123, P599; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; Garber K, 2010, NAT BIOTECHNOL, V28, P311, DOI 10.1038/nbt0410-311; Greish K, 2007, J DRUG TARGET, V15, P457, DOI 10.1080/10611860701539584; Hartge Martin M, 2007, Diab Vasc Dis Res, V4, P84; Higgins GT, 2003, INVEST OPHTH VIS SCI, V44, P1775, DOI 10.1167/iovs.02-0742; HOOD DC, 1994, INVEST OPHTH VIS SCI, V35, P2948; HOOD DC, 1993, EARLY VISUAL DEV NOR, P517; JAFFE GJ, 1995, EXP EYE RES, V60, P533, DOI 10.1016/S0014-4835(05)80068-5; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Marneros AG, 2007, FASEB J, V21, P3809, DOI 10.1096/fj.07-8422com; Narayanan R, 2006, NAT REV DRUG DISCOV, V5, P815, DOI 10.1038/nrd2157; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Regenfuss Birgit, 2008, Lymphatic Research and Biology, V6, P191, DOI 10.1089/lrb.2008.6348; Rogers MS, 2007, NAT PROTOC, V2, P2545, DOI 10.1038/nprot.2007.368; Rollins BJ, 1996, MOL MED TODAY, V2, P198, DOI 10.1016/1357-4310(96)88772-7; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Sugita S, 2003, J EXP MED, V198, P161, DOI 10.1084/jem.20030097; Tobe T, 1998, AM J PATHOL, V153, P1641, DOI 10.1016/S0002-9440(10)65753-7; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Weymouth AE, 2008, PROG RETIN EYE RES, V27, P1, DOI 10.1016/j.preteyeres.2007.09.003	32	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12515	10.1371/journal.pone.0012515	http://dx.doi.org/10.1371/journal.pone.0012515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824139	Green Submitted, Green Published, gold			2022-12-27	WOS:000281456100016
J	Chial, HJ; Lenart, P; Chen, YQ				Chial, Heidi J.; Lenart, Peter; Chen, Yong Q.			APPL Proteins FRET at the BAR: Direct Observation of APPL1 and APPL2 BAR Domain-Mediated Interactions on Cell Membranes Using FRET Microscopy	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; KINASE; YFP; PHOTOCONVERSION; TRAFFICKING; TRKA; PH	Background: Human APPL1 and APPL2 are homologous RAB5 effectors whose binding partners include a diverse set of transmembrane receptors, signaling proteins, and phosphoinositides. APPL proteins associate dynamically with endosomal membranes and are proposed to function in endosome-mediated signaling pathways linking the cell surface to the cell nucleus. APPL proteins contain an N-terminal Bin/Amphiphysin/Rvs (BAR) domain, a central pleckstrin homology (PH) domain, and a C-terminal phosphotyrosine binding (PTB) domain. Previous structural and biochemical studies have shown that the APPL BAR domains mediate homotypic and heterotypic APPL-APPL interactions and that the APPL1 BAR domain forms crescent-shaped dimers. Although previous studies have shown that APPL minimal BAR domains associate with curved cell membranes, direct interaction between APPL BAR domains on cell membranes in vivo has not been reported. Methodology: Herein, we used a laser-scanning confocal microscope equipped with a spectral detector to carry out fluorescence resonance energy transfer (FRET) experiments with cyan fluorescent protein/yellow fluorescent protein (CFP/YFP) FRET donor/acceptor pairs to examine interactions between APPL minimal BAR domains at the subcellular level. This comprehensive approach enabled us to evaluate FRET levels in a single cell using three methods: sensitized emission, standard acceptor photobleaching, and sequential acceptor photobleaching. We also analyzed emission spectra to address an outstanding controversy regarding the use of CFP donor/YFP acceptor pairs in FRET acceptor photobleaching experiments, based on reports that photobleaching of YFP converts it into a CFP-like species. Conclusions: All three methods consistently showed significant FRET between APPL minimal BAR domain FRET pairs, indicating that they interact directly in a homotypic (i.e., APPL1-APPL1 and APPL2-APPL2) and heterotypic (i.e., APPL1-APPL2) manner on curved cell membranes. Furthermore, the results of our experiments did not show photoconversion of YFP into a CFP-like species following photobleaching, supporting the use of CFP donor/YFP acceptor FRET pairs in acceptor photobleaching studies.	[Chial, Heidi J.; Chen, Yong Q.] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27109 USA; [Lenart, Peter] European Mol Biol Lab, Cell Biol & Biophys Programme, Heidelberg, Germany	Wake Forest University; Wake Forest Baptist Medical Center; European Molecular Biology Laboratory (EMBL)	Chial, HJ (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27109 USA.	chial.heidi@gmail.com	Chen, Yong Q/AAI-9864-2021	Chen, Yong Q/0000-0003-4747-4708; Lenart, Peter/0000-0002-3927-248X	Marine Biological Laboratory (MBL); National Institutes of Health (NIH) [F32CA108196, NIH P01CA106742, NIH R01CA107668]; NATIONAL CANCER INSTITUTE [P01CA106742, R01CA107668, F32CA108196] Funding Source: NIH RePORTER	Marine Biological Laboratory (MBL); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by a Surdna Foundation Scholarship for the Marine Biological Laboratory (MBL) 2005 Summer Neurobiology Course (H. J. Chial), an MBL Post-Course Research Scholarship (H. J. Chial), National Institutes of Health (NIH) F32CA108196 (H. J. Chial), NIH P01CA106742 (Y. Q. Chen), and NIH R01CA107668 (Y. Q. Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banach-Orlowska M, 2009, BIOCHEM J, V423, P389, DOI 10.1042/BJ20090086; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Bastiaens PIH, 1996, P NATL ACAD SCI USA, V93, P8407, DOI 10.1073/pnas.93.16.8407; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Calleja V, 2003, BIOCHEM J, V372, P33, DOI 10.1042/BJ20030358; Cheng KKY, 2007, DIABETES, V56, P1387, DOI 10.2337/db06-1580; Chial HJ, 2008, TRAFFIC, V9, P215, DOI 10.1111/j.1600-0854.2007.00680.x; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Fang X, 2009, DIABETOLOGIA, V52, P2190, DOI 10.1007/s00125-009-1462-0; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Gregoratto D, 2004, NUCL FUSION, V44, P1, DOI 10.1088/0029-5515/44/1/001; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Kirber MT, 2007, NAT METHODS, V4, P767, DOI 10.1038/nmeth1007-767; Li J, 2007, STRUCTURE, V15, P525, DOI 10.1016/j.str.2007.03.011; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Liu J, 2002, J BIOL CHEM, V277, P26281, DOI 10.1074/jbc.M204679200; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; MCCREA HJ, 2008, BIOCH BIOPHYS RES CO; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Nechamen CA, 2004, BIOL REPROD, V71, P629, DOI 10.1095/biolreprod.103.025833; Nechamen CA, 2007, MOL CELL ENDOCRINOL, V260, P93, DOI 10.1016/j.mce.2006.08.014; Rashid S, 2009, J BIOL CHEM, V284, P18115, DOI 10.1074/jbc.M109.007237; Saito T, 2007, J BIOL CHEM, V282, P32280, DOI 10.1074/jbc.M704150200; SIEGEL RM, 2000, SCI STKE, pPL1; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Thaler C, 2006, NAT METHODS, V3, P491, DOI 10.1038/NMETH0706-491A; Valentin G, 2005, NAT METHODS, V2, P801, DOI 10.1038/nmeth1105-801; Valentin G, 2006, NAT METHODS, V3, P492, DOI 10.1038/nmeth0706-492; Van Munster EB, 2005, J MICROSC-OXFORD, V218, P253, DOI 10.1111/j.1365-2818.2005.01483.x; Varsano T, 2006, MOL CELL BIOL, V26, P8942, DOI 10.1128/MCB.00305-06; Verrier SE, 2006, NAT METHODS, V3, P491, DOI 10.1038/NMETH0706-491B; WANG C, 2009, J BIOL CHEM; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771	40	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12471	10.1371/journal.pone.0012471	http://dx.doi.org/10.1371/journal.pone.0012471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20814572	Green Submitted, Green Published, gold			2022-12-27	WOS:000281375500006
J	Ulanet, DB; Hanahan, D				Ulanet, Danielle B.; Hanahan, Douglas			Loss of p19(Arf) Facilitates the Angiogenic Switch and Tumor Initiation in a Multi-Stage Cancer Model via p53-Dependent and Independent Mechanisms	PLOS ONE			English	Article							CELL-CYCLE ARREST; NF-KAPPA-B; ENDOTHELIAL-CELLS; TRANSGENIC MICE; MOUSE MODEL; SUPPRESSOR; ARF; P53; TUMORIGENESIS; APOPTOSIS	The Arf tumor suppressor acts as a sensor of oncogenic signals, countering aberrant proliferation in large part via activation of the p53 transcriptional program, though a number of p53-independent functions have been described. Mounting evidence suggests that, in addition to promoting tumorigenesis via disruptions in the homeostatic balance between cell proliferation and apoptosis of overt cancer cells, genetic alterations leading to tumor suppressor loss of function or oncogene gain of function can also incite tumor development via effects on the tumor microenvironment. In a transgenic mouse model of multi-stage pancreatic neuroendocrine carcinogenesis (PNET) driven by inhibition of the canonical p53 and Rb tumor suppressors with SV40 large T-antigen (Tag), stochastic progression to tumors is limited in part by a requirement for initiation of an angiogenic switch. Despite inhibition of p53 by Tag in this mouse PNET model, concomitant disruption of Arf via genetic knockout resulted in a significantly accelerated pathway to tumor formation that was surprisingly not driven by alterations in tumor cell proliferation or apoptosis, but rather via earlier activation of the angiogenic switch. In the setting of a constitutional p53 gene knockout, loss of Arf also accelerated tumor development, albeit to a lesser degree. These findings demonstrate that Arf loss of function can promote tumorigenesis via facilitating angiogenesis, at least in part, through p53-independent mechanisms.	[Ulanet, Danielle B.; Hanahan, Douglas] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Hanahan, Douglas] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Hanahan, Douglas] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Ulanet, DB (corresponding author), Agios Pharmaceut Inc, Cambridge, MA USA.	dh@epfl.ch			National Cancer Institute [R01CA45234]; A.P. Giannini Foundation for Medical Research; NATIONAL CANCER INSTITUTE [R01CA045234] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); A.P. Giannini Foundation for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by a grant from the National Cancer Institute (D.H.; R01CA45234) and the A.P. Giannini Foundation for Medical Research (D.B.U.; http://www.apgianninifoundation.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Chen ZB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000053; CHRISTOFORI G, 1994, SEMIN CANCER BIOL, V5, P3; CHRISTOFORI G, 1994, NATURE, V369, P414, DOI 10.1038/369414a0; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Eymin B, 2003, ONCOGENE, V22, P1822, DOI 10.1038/sj.onc.1206303; Fatyol K, 2001, J BIOL CHEM, V276, P28421, DOI 10.1074/jbc.M102847200; FOLKMAN J, 2006, SCI STKE, pPE35; Fulci G, 2000, ONCOGENE, V19, P3816, DOI 10.1038/sj.onc.1203700; Giuriato S, 2006, P NATL ACAD SCI USA, V103, P16266, DOI 10.1073/pnas.0608017103; Ha L, 2007, P NATL ACAD SCI USA, V104, P10968, DOI 10.1073/pnas.0611638104; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Hemmati PG, 2002, ONCOGENE, V21, P3149, DOI 10.1038/sj.onc.1205458; Herzig M, 1999, BIOL CHEM, V380, P203, DOI 10.1515/BC.1999.028; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kawagishi H, 2010, CANCER RES, V70, P4749, DOI 10.1158/0008-5472.CAN-10-0368; Kelly-Spratt KS, 2004, PLOS BIOL, V2, P1138, DOI 10.1371/journal.pbio.0020242; LESSARD F, MOL CELL, V38, P539; Lopez T, 2002, CANCER CELL, V1, P339, DOI 10.1016/S1535-6108(02)00055-7; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; McKeller RN, 2002, P NATL ACAD SCI USA, V99, P3848, DOI 10.1073/pnas.052484199; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018; Normand G, 2005, J BIOL CHEM, V280, P7118, DOI 10.1074/jbc.M412330200; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; PARANGI S, 1995, CANCER RES, V55, P6071; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; QUELLE DE, 1995, CELL, V83, P993; Rocha S, 2003, MOL CELL, V12, P15, DOI 10.1016/S1097-2765(03)00223-5; Shchors K, 2007, CANCER RES, V67, P7059, DOI 10.1158/0008-5472.CAN-07-2053; Shchors K, 2006, GENE DEV, V20, P2527, DOI 10.1101/gad.1455706; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Silva RLA, 2005, EMBO J, V24, P2803, DOI 10.1038/sj.emboj.7600751; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Teodoro JG, 2006, SCIENCE, V313, P968, DOI 10.1126/science.1126391; Thornton JD, 2007, INVEST OPHTH VIS SCI, V48, P491, DOI 10.1167/iovs.06-0765; Tsuji K, 2002, BIOCHEM BIOPH RES CO, V295, P621, DOI 10.1016/S0006-291X(02)00723-4; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Watnick RS, 2003, CANCER CELL, V3, P219, DOI 10.1016/S1535-6108(03)00030-8; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424; Zindy F, 2003, P NATL ACAD SCI USA, V100, P15930, DOI 10.1073/pnas.2536808100	48	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12454	10.1371/journal.pone.0012454	http://dx.doi.org/10.1371/journal.pone.0012454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805995	gold, Green Published, Green Submitted			2022-12-27	WOS:000281301500020
J	Frere, CH; Krzyszczyk, E; Patterson, EM; Hunter, S; Ginsburg, A; Mann, J				Frere, Celine H.; Krzyszczyk, Ewa; Patterson, Eric M.; Hunter, Sue; Ginsburg, Alison; Mann, Janet			Thar She Blows! A Novel Method for DNA Collection from Cetacean Blow	PLOS ONE			English	Article							POPULATION-STRUCTURE; MITOCHONDRIAL-DNA; DOLPHINS; MICROSATELLITE; TESTOSTERONE; EVOLUTION; BEHAVIOR; SALIVA	Background: Molecular tools are now widely used to address crucial management and conservation questions. To date, dart biopsying has been the most commonly used method for collecting genetic data from cetaceans; however, this method has some drawbacks. Dart biopsying is considered inappropriate for young animals and has recently come under scrutiny from ethical boards, conservationists, and the general public. Thus, identifying alternative genetic collection techniques for cetaceans remains a priority, especially for internationally protected species. Methodology/Principal Findings: In this study, we investigated whether blow-sampling, which involves collecting exhalations from the blowholes of cetaceans, could be developed as a new less invasive method for DNA collection. Our current methodology was developed using six bottlenose dolphins, Tursiops truncatus, housed at the National Aquarium, Baltimore (USA), from which we were able to collect both blow and blood samples. For all six individuals, we found that their mitochondrial and microsatellite DNA profile taken from blow, matched their corresponding mitochondrial and microsatellite DNA profile collected from blood. This indicates that blow-sampling is a viable alternative method for DNA collection. Conclusion/Significance: In this study, we show that blow-sampling provides a viable and less invasive method for collection of genetic data, even for small cetaceans. In contrast to dart biopsying, the advantage of this method is that it capitalizes on the natural breathing behaviour of dolphins and can be applied to even very young dolphins. Both biopsy and blow-sampling require close proximity of the boat, but blow-sampling can be achieved when dolphins voluntarily bow-ride and involves no harmful contact.	[Frere, Celine H.] Univ Queensland, Sch Vet Sci, Brisbane, Qld, Australia; [Krzyszczyk, Ewa; Patterson, Eric M.; Mann, Janet] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Krzyszczyk, Ewa; Patterson, Eric M.; Mann, Janet] Georgetown Univ, Dept Psychol, Washington, DC 20057 USA; [Hunter, Sue; Ginsburg, Alison] Natl Aquarium, Baltimore, MD USA	University of Queensland; Georgetown University; Georgetown University	Frere, CH (corresponding author), Univ Queensland, Sch Vet Sci, Brisbane, Qld, Australia.	c.frere@uq.edu.au	Mann, Janet/L-2311-2019; Frere, Celine Henria/B-4905-2013; Frere, Celine Henria/GYJ-3882-2022	Frere, Celine Henria/0000-0002-9671-2138; 	Georgetown University; National Science Foundation [0847922]	Georgetown University; National Science Foundation(National Science Foundation (NSF))	All research was approved and permitted through the Georgetown University Animal Care and Use Committee (Georgetown GUACUC 07-041). Funding was provided by Georgetown University and the National Science Foundation grant number 0847922. The authors thank the National Aquarium in Baltimore, USA for extensive logistical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2010, ANIM CONSERV, V13, P217, DOI 10.1111/j.1469-1795.2009.00326.x; Baker CS, 2010, BIOL LETTERS, V6, P647, DOI 10.1098/rsbl.2010.0239; BAKER CS, 1993, P NATL ACAD SCI USA, V90, P8239, DOI 10.1073/pnas.90.17.8239; Bearzi Giovanni, 2000, Journal of Cetacean Research and Management, V2, P217; Bernhard W, 2001, COMP BIOCHEM PHYS A, V129, P173, DOI 10.1016/S1095-6433(01)00314-2; BERTA A, 2006, MARINE MAMMALS EVOLU; Bilgmann K, 2008, ANIM CONSERV, V11, P518, DOI 10.1111/j.1469-1795.2008.00213.x; Cassens I, 2005, MOL ECOL, V14, P107, DOI 10.1111/j.1365-294X.2004.02407.x; CONNOR RC, 1985, J MAMMAL, V66, P398, DOI 10.2307/1381260; Frere CH, 2008, MAR FRESHWATER RES, V59, P259, DOI 10.1071/MF07120; Gero S, 2007, MAR MAMMAL SCI, V23, P398, DOI 10.1111/j.1748-7692.2007.00113.x; Gorgone AM, 2008, J WILDLIFE MANAGE, V72, P926, DOI 10.2193/2007-202; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Harlin AD, 1999, MAR MAMMAL SCI, V15, P409, DOI 10.1111/j.1748-7692.1999.tb00810.x; Hogg CJ, 2005, J CHROMATOGR B, V814, P339, DOI 10.1016/j.jchromb.2004.10.058; HOGG CJ, 2005, THESIS U SYDNEY SYDN; Hooker SK, 2001, FISH B-NOAA, V99, P303; Jefferson Thomas A., 2008, Aquatic Mammals, V34, P310, DOI 10.1578/AM.34.3.2008.310; Krutzen M, 2002, MAR MAMMAL SCI, V18, P863, DOI 10.1111/j.1748-7692.2002.tb01078.x; Krutzen M, 2004, MAR MAMMAL SCI, V20, P28, DOI 10.1111/j.1748-7692.2004.tb01139.x; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Parsons KM, 1999, MOL ECOL, V8, P1766, DOI 10.1046/j.1365-294x.1999.00723-8.x; PAULA AC, 2008, PAN AM J AQU SCI, V3, P130; Rosel PE, 2009, MOL ECOL, V18, P5030, DOI 10.1111/j.1365-294X.2009.04413.x; SMOLKER RA, 1992, BEHAVIOUR, V123, P38, DOI 10.1163/156853992X00101; Takemoto M, 2001, IEEE T IND APPL, V37, P26, DOI 10.1109/28.903123; Trout GJ, 2008, J CHROMATOGR B, V863, P192, DOI 10.1016/j.jchromb.2007.12.018; WARTZOK D, 2002, ENCY MAINE MAMMALS; Wells R., 1999, HDB MARINE MAMMALS, V6, P137; Wells R.S., 1991, P199; Wells R.S., 1987, Current Mammalogy, V1, P247	31	36	36	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12299	10.1371/journal.pone.0012299	http://dx.doi.org/10.1371/journal.pone.0012299			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811619	gold, Green Published			2022-12-27	WOS:000281234700005
J	Riess, TH; Achieng, MM; Otieno, S; Ndinya-Achola, JO; Bailey, RC				Riess, Thomas H.; Achieng, Maryline M.; Otieno, Samuel; Ndinya-Achola, J. O.; Bailey, Robert C.			"When I Was Circumcised I Was Taught Certain Things": Risk Compensation and Protective Sexual Behavior among Circumcised Men in Kisumu, Kenya	PLOS ONE			English	Article							CONDOM USE; HIV PREVENTION; DISINHIBITION; REDUCTION; TRIAL	Background: Male circumcision has been shown to reduce the transmission of HIV from women to men through vaginal sex by approximately 60%. There is concern that men may engage in risk compensation after becoming circumcised, diminishing the benefits of male circumcision. Methods and Findings: We conducted qualitative interviews with 30 sexually active circumcised men in Kisumu, Kenya from March to November 2008. Most respondents reported no behavior change or increasing protective sexual behaviors including increasing condom use and reducing the number of sexual partners. A minority of men reported engaging in higher risk behaviors either not using condoms or increasing the number of sex partners. Circumcised respondents described being able to perform more rounds of sex, easier condom use, and fewer cuts on the penis during sex. Conclusions: Results illustrate that information about MC's protection against HIV has disseminated into the larger community and MC accompanied by counseling and HIV testing can foster positive behavior change and maintain sexual behavior.	[Riess, Thomas H.; Bailey, Robert C.] Univ Illinois, Sch Publ Hlth, Chicago, IL 60607 USA; [Achieng, Maryline M.; Otieno, Samuel] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Res Care & Training Program, Kisumu, Kenya; [Ndinya-Achola, J. O.] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Kenya Medical Research Institute; University of Nairobi	Riess, TH (corresponding author), Univ Illinois, Sch Publ Hlth, Chicago, IL 60607 USA.	vonriess@yahoo.com			Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health [AI50440]; U.S. Centers for Disease Control and Prevention [2 T01 CD000189-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI050440] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, CENTERS FOR DISEASE CONTROL &PREVENTION [T01CD000189] Funding Source: NIH RePORTER	Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, CENTERS FOR DISEASE CONTROL &PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was supported in part by Grant No. AI50440 from the Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). T. H. Riess was supported in part by the U.S. Centers for Disease Control and Prevention Training Program Grant #2 T01 CD000189-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agot KE, 2007, JAIDS-J ACQ IMM DEF, V44, P66, DOI 10.1097/01.qai.0000242455.05274.20; [Anonymous], 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Chesney MA, 1997, J ACQ IMMUN DEF SYND, V16, P266, DOI 10.1097/00042560-199712010-00007; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Eaton Lisa A, 2007, Curr HIV/AIDS Rep, V4, P165, DOI 10.1007/s11904-007-0024-7; Farley TA, 2003, SEX TRANSM DIS, V30, P844, DOI 10.1097/01.OLQ.0000086604.54282.F2; Ferguson A, 2004, SEX TRANSM INFECT, V80, P435, DOI 10.1136/sti.2004.010462; Glaser B.G., 1968, DISCOV GROUNDED THEO; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hogben M, 2008, SEX TRANSM DIS, V35, P1009, DOI 10.1097/OLQ.0b013e31818eb752; Kajubi P, 2005, JAIDS-J ACQ IMM DEF, V40, P77, DOI 10.1097/01.qai.0000157391.63127.b2; Kalichman S, 2007, PLOS MED, V4, P597, DOI 10.1371/journal.pmed.0040138; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; *KEN CENTR BUR STA, 2003, KEN DEM HLTH SURV; Kretzschmar M., 2000, MATH POPUL STUD, V8, P109, DOI [10.1080/08898480009525478, DOI 10.1080/08898480009525478]; Mah TL, 2010, AIDS BEHAV, V14, P11, DOI 10.1007/s10461-008-9433-x; Mattson CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002443; Meekers D, 2003, AIDS BEHAV, V7, P413, DOI 10.1023/B:AIBE.0000004733.26053.c8; Mehta SD, 2010, J UROLOGY, V184, P203, DOI 10.1016/j.juro.2010.03.015; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; National AIDS and STI Control Programme, 2008, KEN AIDS IND SURV 20; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Pinkerton SD, 2001, RISK ANAL, V21, P727, DOI 10.1111/0272-4332.214146; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; Van Rossem R, 2001, AIDS EDUC PREV, V13, P252, DOI 10.1521/aeap.13.3.252.19745; Westercamp N, 2010, AIDS BEHAV, V14, P949, DOI 10.1007/s10461-008-9458-1; Wilde G. J. S., 1994, TARGET RISK	31	50	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12366	10.1371/journal.pone.0012366	http://dx.doi.org/10.1371/journal.pone.0012366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	642RO	20811622	Green Published, gold, Green Submitted			2022-12-27	WOS:000281234700006
J	Al-Anzi, B; Zinn, K				Al-Anzi, Bader; Zinn, Kai			Colorimetric Measurement of Triglycerides Cannot Provide an Accurate Measure of Stored Fat Content in Drosophila	PLOS ONE			English	Article							TRIACYLGLYCEROL; DIACYLGLYCEROLS	Drosophila melanogaster has recently emerged as a useful model system in which to study the genetic basis of regulation of fat storage. One of the most frequently used methods for evaluating the levels of stored fat (triglycerides) in flies is a coupled colorimetric assay available as a kit from several manufacturers. This is an aqueous-based enzymatic assay that is normally used for measurement of mammalian serum triglycerides, which are present in soluble lipoprotein complexes. In this short communication, we show that coupled colorimetric assay kits cannot accurately measure stored triglycerides in Drosophila. First, they fail to give accurate readings when tested on insoluble triglyceride mixtures with compositions like that of stored fat, or on fat extracted from flies with organic solvents. This is probably due to an inability of the lipase used in the kits to efficiently cleave off the glycerol head group from fat molecules in insoluble samples. Second, the measured final products of the kits are quinoneimines, which absorb visible light in the same wavelength range as Drosophila eye pigments. Thus, when extracts from crushed flies are assayed, much of the measured signal is actually due to eye pigments. Finally, the lipoprotein lipases used in colorimetric assays also cleave non-fat glycerides. The glycerol backbones liberated from all classes of glycerides are measured through the remaining reactions in the assay. As a consequence, when these assay kits are used to evaluate tissue extracts, the observed signal actually represents the amount of free glycerols together with all types of glycerides. For these reasons, findings obtained through use of coupled colorimetric assays on Drosophila samples must be interpreted with caution. We also show here that using thin-layer chromatography to measure stored triglycerides in flies eliminates all of these problems.	[Al-Anzi, Bader; Zinn, Kai] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Al-Anzi, B (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	zinnk@caltech.edu; alanzi@caltech.edu			NIH [DK0170154, NS28182]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH RO1 grants DK0170154, NS28182. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2009, NEURON, V63, P329, DOI 10.1016/j.neuron.2009.07.021; Barsh GS, 2002, NAT REV GENET, V3, P589, DOI [10.1038/nrn902, 10.1038/nrg862]; Bharucha KN, 2009, PEDIATR RES, V65, P132, DOI 10.1203/PDR.0b013e318191fc68; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Harbison ST, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006211; JUMBOLUCIONI P, 2010, SYSTEMS GENETICS ANA, V11, P297; MORLEY NH, 1975, J BIOL CHEM, V250, P3414; NILSSONEHLE P, 1974, LIPIDS, V9, P548, DOI 10.1007/BF02532503; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Schwartz DM, 2007, J LIPID RES, V48, P2514, DOI 10.1194/jlr.D700017-JLR200; Sieber MH, 2009, CELL METAB, V10, P481, DOI 10.1016/j.cmet.2009.10.010; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Song W, 2010, CELL METAB, V11, P427, DOI 10.1016/j.cmet.2010.04.002; Vieu C, 1996, J LIPID RES, V37, P1153; WOOD P, 2006, FAT WORKS, P38; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1	17	19	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12353	10.1371/journal.pone.0012353	http://dx.doi.org/10.1371/journal.pone.0012353			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808765	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000281154300002
J	Tikhmyanova, N; Tulin, AV; Roegiers, F; Golemis, EA				Tikhmyanova, Nadezhda; Tulin, Alexei V.; Roegiers, Fabrice; Golemis, Erica A.			Dcas Supports Cell Polarization and Cell-Cell Adhesion Complexes in Development	PLOS ONE			English	Article							POLARITY GENE ARMADILLO; DROSOPHILA E-CADHERIN; CAS FAMILY-MEMBER; HUMAN B-CELLS; PROTEASOMAL DEGRADATION; ANTIGEN RECEPTOR; DOCKING PROTEIN; FILAMENTATION 1; HUMAN ENHANCER; BREAST-CANCER	Mammalian Cas proteins regulate cell migration, division and survival, and are often deregulated in cancer. However, the presence of four paraiogous Cas family members in mammals (BCAR1/p130Cas, EFS/Sin1, NEDD9/HEF1/Cas-L, and CASS4/HEPL) has limited their analysis in development. We deleted the single Drosophila Cas gene, Dcas, to probe the developmental function of Dcas. Loss of Dcas had limited effect on embryonal development. However, we found that Dcas is an important modulator of the severity of the developmental phenotypes of mutations affecting integrins (If and mew) and their downstream effectors Fak56D or Src42A. Strikingly, embryonic lethal Fak56D-Dcas double mutant embryos had extensive cell polarity defects, including mislocalization and reduced expression of E-cadherin. Further genetic analysis established that loss of Dcas modified the embryonal lethal phenotypes of embryos with mutations in E-cadherin (Shg) or its signaling partners p120- and beta-catenin (Arm). These results support an important role for Cas proteins in cell-cell adhesion signaling in development.	[Tikhmyanova, Nadezhda; Tulin, Alexei V.; Roegiers, Fabrice; Golemis, Erica A.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Tikhmyanova, Nadezhda] Drexel Univ, Sch Med, Dept Biochem, Philadelphia, PA 19104 USA	Fox Chase Cancer Center; Drexel University	Tikhmyanova, N (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Fabrice.Roegiers@fccc.edu; ea_golemis@fccc.edu		Golemis, Erica/0000-0003-3618-3673	National Institutes of Health (NIH) [CA63366, CA113342, CA06927]; Pennsylvania Tobacco Settlement Funds; Commonwealth of Pennsylvania; Pew Charitable Fund;  [R01 GM077452];  [R01 NS059971]; NATIONAL CANCER INSTITUTE [R01CA063366, R01CA113342, P30CA006927, R29CA063366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059971] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Tobacco Settlement Funds; Commonwealth of Pennsylvania; Pew Charitable Fund; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) R01s CA63366 and CA113342, and by Pennsylvania Tobacco Settlement Funds (to EAG), and by an appropriation from the Commonwealth of Pennsylvania, by NIH core grant CA06927 (to Fox Chase Cancer Center) and support from the Pew Charitable Fund (to Fox Chase Cancer Center). Alexei Tulin was supported by R01 GM077452, and FR by R01 NS059971. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AQUINO JB, 2009, NEUROSCIENCE; Astier A, 1997, LEUKEMIA LYMPHOMA, V28, P65, DOI 10.3109/10428199709058332; Beaty TH, 2005, GENETICS, V171, P259, DOI 10.1534/genetics.105.043075; Bloor JW, 1998, GENETICS, V148, P1127; Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Brinkman A, 2000, JNCI-J NATL CANCER I, V92, P112, DOI 10.1093/jnci/92.2.112; Bui LC, 2009, ONCOGENE, V28, P3642, DOI 10.1038/onc.2009.224; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; Cai DP, 2003, J IMMUNOL, V170, P969, DOI 10.4049/jimmunol.170.2.969; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; CHO SY, 2002, J CELL BIOL IN PRESS; Cox RT, 1999, DEVELOPMENT, V126, P1327; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Donaldson JC, 2000, EXP CELL RES, V256, P168, DOI 10.1006/excr.2000.4822; Dumstrei K, 2002, DEVELOPMENT, V129, P3983; Fashena SJ, 2002, J CELL SCI, V115, P99; Feng Biao, 2004, Med Immunol, V3, P1, DOI 10.1186/1476-9433-3-1; Grabbe C, 2004, DEVELOPMENT, V131, P5795, DOI 10.1242/dev.01462; Honda H, 1999, BIOCHEM BIOPH RES CO, V262, P25, DOI 10.1006/bbrc.1999.1162; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Huang ZY, 2007, DEVELOPMENT, V134, P2337, DOI 10.1242/dev.004242; INAMOTO S, 2006, ONCOGENE; Ishino M, 1995, ONCOGENE, V11, P2331; Izumchenko E, 2009, CANCER RES, V69, P7198, DOI 10.1158/0008-5472.CAN-09-0795; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kim SH, 2010, CANCER RES, V70, P4054, DOI 10.1158/0008-5472.CAN-09-2110; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Law SF, 1996, MOL CELL BIOL, V16, P3327; Liu XH, 2000, EMBO J, V19, P6759, DOI 10.1093/emboj/19.24.6759; Lu XY, 1999, DEV BIOL, V208, P233, DOI 10.1006/dbio.1999.9196; LUCAS JT, 2010, ONCOGENE; Manie SN, 1997, J BIOL CHEM, V272, P4230, DOI 10.1074/jbc.272.7.4230; Minegishi M, 1996, J EXP MED, V184, P1365, DOI 10.1084/jem.184.4.1365; Murakami S, 2007, DEVELOPMENT, V134, P1539, DOI 10.1242/dev.001529; Myster SH, 2003, J CELL BIOL, V160, P433, DOI 10.1083/jcb.200211083; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; Natarajan M, 2003, CANCER J, V9, P126, DOI 10.1097/00130404-200303000-00008; Nourry C, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-20; O'Neill GM, 2007, CANCER RES, V67, P8975, DOI 10.1158/0008-5472.CAN-07-1328; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Reuver SM, 1998, J CELL SCI, V111, P1071; Rivera GM, 2006, P NATL ACAD SCI USA, V103, P9536, DOI 10.1073/pnas.0603786103; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sattler M, 1997, J BIOL CHEM, V272, P14320, DOI 10.1074/jbc.272.22.14320; Schock F, 2002, DEV BIOL, V248, P29, DOI 10.1006/dbio.2002.0698; Seo S, 2005, J IMMUNOL, V175, P3492, DOI 10.4049/jimmunol.175.6.3492; Shindo M, 2008, DEVELOPMENT, V135, P1355, DOI 10.1242/dev.015982; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Singh MK, 2008, MOL BIOL CELL, V19, P1627, DOI 10.1091/mbc.E07-09-0953; Singh MK, 2007, CELL BIOCHEM BIOPHYS, V48, P54, DOI 10.1007/s12013-007-0036-3; Takahashi M, 2005, DEVELOPMENT, V132, P2547, DOI 10.1242/dev.01850; Tateno M, 2000, SCIENCE, V287, P324, DOI 10.1126/science.287.5451.324; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; TIKHMYANOVA N, 2009, CELL MOL LIFE SCI; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; van der Flier S, 2000, JNCI-J NATL CANCER I, V92, P120, DOI 10.1093/jnci/92.2.120; van Seventer GA, 2001, EUR J IMMUNOL, V31, P1417, DOI 10.1002/1521-4141(200105)31:5<1417::AID-IMMU1417>3.0.CO;2-C; VOGEL T, 2009, CEREB CORTEX; WARN RM, 1983, EXP CELL RES, V143, P103, DOI 10.1016/0014-4827(83)90113-1; WIESCHAUS E, 1987, CELL, V49, P177, DOI 10.1016/0092-8674(87)90558-7; Wong EWP, 2008, P NATL ACAD SCI USA, V105, P9657, DOI 10.1073/pnas.0801527105; Xie HB, 2004, GENETICS, V168, P1477, DOI 10.1534/genetics.104.030882; Zheng MZ, 2002, J BIOL CHEM, V277, P39599, DOI 10.1074/jbc.M202263200	72	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12369	10.1371/journal.pone.0012369	http://dx.doi.org/10.1371/journal.pone.0012369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808771	Green Published, gold, Green Submitted			2022-12-27	WOS:000281154300010
J	Zaragoza, MV; Fass, J; Diegoli, M; Lin, DW; Arbustini, E				Zaragoza, Michael V.; Fass, Joseph; Diegoli, Marta; Lin, Dawei; Arbustini, Eloisa			Mitochondrial DNA Variant Discovery and Evaluation in Human Cardiomyopathies through Next-Generation Sequencing	PLOS ONE			English	Article							PCR AMPLIFICATION; MUTATIONS; GENOME; HETEROPLASMY; INHERITANCE; REDUCTION; FREQUENCY; CELLS	Mutations in mitochondrial DNA (mtDNA) may cause maternally-inherited cardiomyopathy and heart failure. In homoplasmy all mtDNA copies contain the mutation. In heteroplasmy there is a mixture of normal and mutant copies of mtDNA. The clinical phenotype of an affected individual depends on the type of genetic defect and the ratios of mutant and normal mtDNA in affected tissues. We aimed at determining the sensitivity of next-generation sequencing compared to Sanger sequencing for mutation detection in patients with mitochondrial cardiomyopathy. We studied 18 patients with mitochondrial cardiomyopathy and two with suspected mitochondrial disease. We "shotgun'' sequenced PCR-amplified mtDNA and multiplexed using a single run on Roche's 454 Genome Sequencer. By mapping to the reference sequence, we obtained 1,300x average coverage per case and identified high-confidence variants. By comparing these to >400 mtDNA substitution variants detected by Sanger, we found 98% concordance in variant detection. Simulation studies showed that >95% of the homoplasmic variants were detected at a minimum sequence coverage of 20x while heteroplasmic variants required >200x coverage. Several Sanger "misses'' were detected by 454 sequencing. These included the novel heteroplasmic 7501T>C in tRNA serine 1 in a patient with sudden cardiac death. These results support a potential role of next-generation sequencing in the discovery of novel mtDNA variants with heteroplasmy below the level reliably detected with Sanger sequencing. We hope that this will assist in the identification of mtDNA mutations and key genetic determinants for cardiomyopathy and mitochondrial disease.	[Zaragoza, Michael V.] Univ Calif Irvine, Dept Pediat, Genet & Metab Div, Irvine, CA 92717 USA; [Zaragoza, Michael V.] Univ Calif Irvine, Ctr Mitochondrial & Mol Med & Genet MAMMAG, Irvine, CA 92717 USA; [Fass, Joseph; Lin, Dawei] Univ Calif Davis, UC Davis Genome Ctr, Davis, CA 95616 USA; [Diegoli, Marta; Arbustini, Eloisa] IRCCS Fdn Policlin San Mateo, Ctr Inherited Cardiovasc Dis, Pavia, Italy	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Davis; IRCCS Fondazione San Matteo	Zaragoza, MV (corresponding author), Univ Calif Irvine, Dept Pediat, Genet & Metab Div, Irvine, CA 92717 USA.	mzaragoz@uci.edu	Arbustini, Eloisa/K-8174-2016	Arbustini, Eloisa/0000-0003-2948-7994	National Institutes of Health, National Heart, Lung, and Blood Institute [HL081222]; Ministry of Health for Inherited Cardiomyopathies; EC [241924, Health-2009-2.4.2-3]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL081222] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ministry of Health for Inherited Cardiomyopathies; EC(European CommissionEuropean Commission Joint Research Centre); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Financial support was provided by the National Institutes of Health K08 award HL081222 from National Heart, Lung, and Blood Institute to MVZ and by grants "Cariplo'' and RC from the Ministry of Health for Inherited Cardiomyopathies and EC INHERITANCE project 241924, Health-2009-2.4.2-3 awarded to EA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Arbustini E, 1998, HEART, V80, P548, DOI 10.1136/hrt.80.6.548; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bordoni R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-464; Brandon MC, 2009, HUM MUTAT, V30, P1, DOI 10.1002/humu.20801; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Clarke LA, 2001, J CLIN PATHOL-MOL PA, V54, P351, DOI 10.1136/mp.54.5.351; Cree LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/j.bbadis.2009.03.002; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Hancock DK, 2005, GENOMICS, V86, P446, DOI 10.1016/j.ygeno.2005.06.006; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Hu M, 2007, NAT PROTOC, V2, P2339, DOI 10.1038/nprot.2007.358; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jex AR, 2010, NUCLEIC ACIDS RES, V38, P522, DOI 10.1093/nar/gkp883; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McCaughan F, 2010, J PATHOL, V220, P297, DOI 10.1002/path.2647; Meyer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm566; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; Pereira L, 2009, AM J HUM GENET, V84, P628, DOI 10.1016/j.ajhg.2009.04.013; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5467; Schrijver I, 2009, GENET MED, V11, P118, DOI 10.1097/GIM.0b013e318190356b; Szibor R, 2007, INT J LEGAL MED, V121, P207, DOI 10.1007/s00414-006-0096-8; Tang S, 2010, BIOTECHNIQUES, V48, P287, DOI 10.2144/000113389; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Vasta V, 2009, GENOME MED, V1, DOI 10.1186/gm100; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955; Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548	35	65	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12295	10.1371/journal.pone.0012295	http://dx.doi.org/10.1371/journal.pone.0012295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808834	Green Published, gold			2022-12-27	WOS:000281077000008
J	Huang, MH; Lin, SC; Hsiao, CH; Chao, HJ; Yang, HR; Liao, CC; Chuang, PW; Wu, HP; Huang, CY; Leng, CH; Liu, SJ; Chen, HW; Chou, AH; Hu, AYC; Chong, PL				Huang, Ming-Hsi; Lin, Su-Chen; Hsiao, Chia-Hsin; Chao, Hsin-Ju; Yang, Hung-Ren; Liao, Chien-Chun; Chuang, Po-Wei; Wu, Huang-Pi; Huang, Chiung-Yi; Leng, Chih-Hsiang; Liu, Shih-Jen; Chen, Hsin-Wei; Chou, Ai-Hsiang; Hu, Alan Yung-Chih; Chong, Pele			Emulsified Nanoparticles Containing Inactivated Influenza Virus and CpG Oligodeoxynucleotides Critically Influences the Host Immune Responses in Mice	PLOS ONE			English	Article							EFFECTIVE DELIVERY-SYSTEM; VACCINE ADJUVANTS; POTENT ANTIBODY; SAFETY	Background: Antigen sparing and cross-protective immunity are regarded as crucial in pandemic influenza vaccine development. Both targets can be achieved by adjuvantation strategy to elicit a robust and broadened immune response. We assessed the immunogenicity of an inactivated H5N1 whole-virion vaccine (A/Vietnam/1194/2004 NIBRG-14, clade 1) formulated with emulsified nanoparticles and investigated whether it can induce cross-clade protecting immunity. Methodology/Principal Findings: After formulation with PELC, a proprietary water-in-oil-in-water nanoemulsion comprising of bioresorbable polymer/Span (R) 85/squalene, inactivated virus was intramuscularly administered to mice in either one-dose or two-dose schedule. We found that the antigen-specific serum antibody responses elicited after two doses of non-adjuvanted vaccine were lower than those observed after a single dose of adjuvanted vaccine, PELC and the conventional alum adjuvant as well. Moreover, 5 mu g HA of PELC-formulated inactivated virus were capable of inducing higher antibodies than those obtained from alum-adjuvanted vaccine. In single-dose study, we found that encapsulating inactivated virus into emulsified PELC nanoparticles could induce better antibody responses than those formulated with PELC-adsorbed vaccine. However, the potency was rather reduced when the inactivated virus and CpG (an immunostimulatory oligodeoxynucleotide containing unmethylated cytosine-guanosine motifs) were co-encapsulated within the emulsion. Finally, the mice who received PELC/CpG(adsorption)-vaccine could easily and quickly reach 100% of seroprotection against a homologous virus strain and effective cross-protection against a heterologous virus strain (A/Whooper swan/Mongolia/244/2005, clade 2.2). Conclusions/Significance: Encapsulating inactivated H5N1 influenza virus and CpG into emulsified nanoparticles critically influences the humoral responses against pandemic influenza. These results demonstrated that the use of PELC could be as antigen-sparing in preparation for a potential shortage of prophylactic vaccines against local infectious diseases, in particular pandemic influenza. Moreover, the cross-clade neutralizing antibody responses data verify the potential of such adjuvanted H5N1 candidate vaccine as an effective tool in pre-pandemic preparedness.	[Huang, Ming-Hsi; Lin, Su-Chen; Hsiao, Chia-Hsin; Chao, Hsin-Ju; Yang, Hung-Ren; Liao, Chien-Chun; Chuang, Po-Wei; Wu, Huang-Pi; Huang, Chiung-Yi; Leng, Chih-Hsiang; Liu, Shih-Jen; Chen, Hsin-Wei; Chou, Ai-Hsiang; Hu, Alan Yung-Chih; Chong, Pele] Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan Town, Taiwan	National Health Research Institutes - Taiwan	Huang, MH (corresponding author), Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan Town, Taiwan.	huangminghsi@nhri.org.tw; pelechong@nhri.org.tw	Hu, Alan Yung-Chih/G-3708-2011; Chen, Hsin-Wei/C-3304-2009; Huang, Ming-Hsi/E-3872-2010; Chen, Hsin-Wei/ABA-7436-2021; Liu, Shih-Jen/E-3942-2010; Liu, Shih-Jen/AAV-1931-2021; Leng, Chih-Hsiang/E-3874-2010; Chong, Pele/E-3855-2010	Huang, Ming-Hsi/0000-0002-9670-3821; Chen, Hsin-Wei/0000-0002-3207-2397; Liu, Shih-Jen/0000-0002-8736-1452; 	Department of Health [98A1-VCSPBC]; Taiwan Centers for Disease Control, Taiwan [97A1-VCSP31-019]; National Science Council [NSC-99-2218-E-400-001]	Department of Health; Taiwan Centers for Disease Control, Taiwan; National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by Department of Health (grant no. 98A1-VCSPBC) to the Vaccine Research and Development Center, National Health Research Institutes, and by the Taiwan Centers for Disease Control, Taiwan pandemic influenza vaccine research and development program (grant no. 97A1-VCSP31-019), and from National Science Council (to MHH, grant no. NSC-99-2218-E-400-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WHO REC PAND H1N1 20; Aucouturier Jerome, 2002, Expert Rev Vaccines, V1, P111, DOI 10.1586/14760584.1.1.111; Baudner BC, 2009, PHARM RES-DORDR, V26, P1477, DOI 10.1007/s11095-009-9859-5; Cooper CL, 2004, VACCINE, V22, P3136, DOI 10.1016/j.vaccine.2004.01.058; Del Giudice G, 2006, CLIN VACCINE IMMUNOL, V13, P1010, DOI 10.1128/CVI.00191-06; Garcon N, 2009, SCI AM, V301, P72, DOI 10.1038/scientificamerican1009-72; Gupta RK, 1998, ADV DRUG DELIVER REV, V32, P155, DOI 10.1016/S0169-409X(98)00008-8; Hu AYC, 2008, VACCINE, V26, P5736, DOI 10.1016/j.vaccine.2008.08.015; Huang MH, 2009, MICROBES INFECT, V11, P654, DOI 10.1016/j.micinf.2009.03.003; Huang MH, 2009, PHARM RES-DORD, V26, P1856, DOI 10.1007/s11095-009-9898-y; Huang MH, 2009, J BIOMED MATER RES B, V90B, P832, DOI 10.1002/jbm.b.31352; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Kovacs-Nolan J, 2009, VACCINE, V27, P2055, DOI 10.1016/j.vaccine.2009.01.118; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; Newman MJ, 1998, ADV DRUG DELIVER REV, V32, P199, DOI 10.1016/S0169-409X(98)00011-8; Ninomiya A, 2007, VACCINE, V25, P3554, DOI 10.1016/j.vaccine.2007.01.083; Schubert C, 2009, NAT MED, V15, P984, DOI [10.1038/nm0909-986, 10.1038/nm0909-985, 10.1038/nm0909-984]; Schultze V, 2008, VACCINE, V26, P3209, DOI 10.1016/j.vaccine.2008.03.093; Singh M, 2001, PHARM RES-DORDR, V18, P1476, DOI 10.1023/A:1012269226066; Weeratna RD, 2000, VACCINE, V18, P1755, DOI 10.1016/S0264-410X(99)00526-5; WHO, 2010, ANT GEN CHAR INFL A	22	37	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12279	10.1371/journal.pone.0012279	http://dx.doi.org/10.1371/journal.pone.0012279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808862	Green Published, gold, Green Submitted			2022-12-27	WOS:000281075500013
J	Lee, S; Lee, J; Hohng, S				Lee, Sanghwa; Lee, Jinwoo; Hohng, Sungchul			Single-Molecule Three-Color FRET with Both Negligible Spectral Overlap and Long Observation Time	PLOS ONE			English	Article							ALTERNATING-LASER EXCITATION; RESONANCE ENERGY-TRANSFER; HOLLIDAY JUNCTION; SPECTROSCOPY; DYNAMICS	Full understanding of complex biological interactions frequently requires multi-color detection capability in doing single-molecule fluorescence resonance energy transfer (FRET) experiments. Existing single-molecule three-color FRET techniques, however, suffer from severe photobleaching of Alexa 488, or its alternative dyes, and have been limitedly used for kinetics studies. In this work, we developed a single-molecule three-color FRET technique based on the Cy3-Cy5-Cy7 dye trio, thus providing enhanced observation time and improved data quality. Because the absorption spectra of three fluorophores are well separated, real-time monitoring of three FRET efficiencies was possible by incorporating the alternating laser excitation (ALEX) technique both in confocal microscopy and in total-internal-reflection fluorescence (TIRF) microscopy.	[Lee, Sanghwa; Lee, Jinwoo; Hohng, Sungchul] Seoul Natl Univ, Dept Phys & Astron, Seoul, South Korea; [Hohng, Sungchul] Seoul Natl Univ, Dept Biophys & Chem Biol, Seoul, South Korea; [Lee, Sanghwa; Lee, Jinwoo; Hohng, Sungchul] Seoul Natl Univ, Natl Ctr Creat Res Initiat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, S (corresponding author), Seoul Natl Univ, Dept Phys & Astron, Seoul, South Korea.	shohng@snu.ac.kr		Hohng, Sungchul/0000-0002-7131-2138; Lee, Sanghwa/0000-0001-6986-7583	Creative Research Initiatives (Physical Genetics Laboratory) of National Research Foundation of Korea [2009-0081562]; World Class University, Ministry of Education, Science & Technology of Korea [R31-2009-100320]; Seoul Scholarship Foundation	Creative Research Initiatives (Physical Genetics Laboratory) of National Research Foundation of Korea; World Class University, Ministry of Education, Science & Technology of Korea; Seoul Scholarship Foundation	This work was supported by Creative Research Initiatives (Physical Genetics Laboratory, 2009-0081562) of National Research Foundation of Korea, and by the World Class University project (R31-2009-100320) of the Ministry of Education, Science & Technology of Korea, and by Hi Seoul Science (Humanities) Fellowship from Seoul Scholarship Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Clamme JP, 2005, CHEMPHYSCHEM, V6, P74, DOI 10.1002/cphc.200400261; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; DUCKETT DR, 1988, CELL, V55, P79, DOI 10.1016/0092-8674(88)90011-6; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha T, 2001, METHODS, V25, P78, DOI 10.1006/meth.2001.1217; Hohng S, 2004, BIOPHYS J, V87, P1328, DOI 10.1529/biophysj.104.043935; Hohng S, 2007, SCIENCE, V318, P279, DOI 10.1126/science.1146113; Iqbal A, 2008, P NATL ACAD SCI USA, V105, P11176, DOI 10.1073/pnas.0801707105; Joo C, 2004, J MOL BIOL, V341, P739, DOI 10.1016/j.jmb.2004.06.024; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Lee M, 2010, P NATL ACAD SCI USA, V107, P4985, DOI 10.1073/pnas.0911528107; Lee NK, 2007, BIOPHYS J, V92, P303, DOI 10.1529/biophysj.106.093211; Margeat E, 2006, BIOPHYS J, V90, P1419, DOI 10.1529/biophysj.105.069252; McKinney SA, 2003, NAT STRUCT BIOL, V10, P93, DOI 10.1038/nsb883; MURCHIE AIH, 1989, NATURE, V341, P763, DOI 10.1038/341763a0; Ortiz-Lombardia M, 1999, NAT STRUCT BIOL, V6, P913; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Ross J, 2007, J PHYS CHEM B, V111, P321, DOI 10.1021/jp066082g; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Shroff H, 2005, NANO LETT, V5, P1509, DOI 10.1021/nl050875h; Tarsa PB, 2007, ANGEW CHEM INT EDIT, V46, P1999, DOI 10.1002/anie.200604546	22	77	82	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12270	10.1371/journal.pone.0012270	http://dx.doi.org/10.1371/journal.pone.0012270			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808851	Green Published, gold, Green Submitted			2022-12-27	WOS:000281075500009
J	Castiello, U; Giordano, BL; Begliomini, C; Ansuini, C; Grassi, M				Castiello, Umberto; Giordano, Bruno L.; Begliomini, Chiara; Ansuini, Caterina; Grassi, Massimo			When Ears Drive Hands: The Influence of Contact Sound on Reaching to Grasp	PLOS ONE			English	Article							AUDITORY EVENT PERCEPTION; FEEDBACK-CONTROL; MIRROR NEURONS; MOVEMENTS; IDENTIFICATION; REPRESENTATION; PREHENSION; LOCATION; VISION; PLATES	Background: Most research on the roles of auditory information and its interaction with vision has focused on perceptual performance. Little is known on the effects of sound cues on visually-guided hand movements. Methodology/Principal Findings: We recorded the sound produced by the fingers upon contact as participants grasped stimulus objects which were covered with different materials. Then, in a further session the pre-recorded contact sounds were delivered to participants via headphones before or following the initiation of reach-to-grasp movements towards the stimulus objects. Reach-to-grasp movement kinematics were measured under the following conditions: (i) congruent, in which the presented contact sound and the contact sound elicited by the to-be-grasped stimulus corresponded; (ii) incongruent, in which the presented contact sound was different to that generated by the stimulus upon contact; (iii) control, in which a synthetic sound, not associated with a real event, was presented. Facilitation effects were found for congruent trials; interference effects were found for incongruent trials. In a second experiment, the upper and the lower parts of the stimulus were covered with different materials. The presented sound was always congruent with the material covering either the upper or the lower half of the stimulus. Participants consistently placed their fingers on the half of the stimulus that corresponded to the presented contact sound. Conclusions/Significance: Altogether these findings offer a substantial contribution to the current debate about the type of object representations elicited by auditory stimuli and on the multisensory nature of the sensorimotor transformations underlying action.	[Castiello, Umberto; Begliomini, Chiara; Ansuini, Caterina; Grassi, Massimo] Univ Padua, Dipartimento Psicol Gen, Padua, Italy; [Giordano, Bruno L.] McGill Univ, Schulic Sch Mus, Montreal, PQ, Canada	University of Padua; McGill University	Castiello, U (corresponding author), Univ Padua, Dipartimento Psicol Gen, Piazza Capitaniato 3, Padua, Italy.	umberto.castiello@unipd.it	BEGLIOMINI, CHIARA/D-1516-2014; Giordano, Bruno L./A-4398-2008; Grassi, Massimo/I-8234-2012	BEGLIOMINI, CHIARA/0000-0001-7433-0414; Giordano, Bruno L./0000-0001-7002-0486; Grassi, Massimo/0000-0002-3784-2784; Castiello, Umberto/0000-0003-0629-1286	Ministero dell'Istruzione, dell'Universita e della Ricerca [N. 23432]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	The study has been funded by a grant from the Ministero dell'Istruzione, dell'Universita e della Ricerca (N. 23432). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp MS, 2008, NEUROIMAGE, V41, P1011, DOI 10.1016/j.neuroimage.2008.03.015; Brouwer AM, 2006, EXP BRAIN RES, V173, P629, DOI 10.1007/s00221-006-0406-x; Carello C, 1998, PSYCHOL SCI, V9, P211, DOI 10.1111/1467-9280.00040; Castiello U, 2006, CHEM SENSES, V31, P665, DOI 10.1093/chemse/bjl007; CROSSMAN ERFW, 1983, Q J EXP PSYCHOL-A, V35, P251, DOI 10.1080/14640748308402133; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Fogassi L, 2004, HDB MULTISENSORY PRO, P425; GAVER WW, 1993, ECOL PSYCHOL, V5, P1, DOI 10.1207/s15326969eco0501_1; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Gentilucci M, 1998, NEUROREPORT, V9, P887, DOI 10.1097/00001756-199803300-00023; Giordano BL, 2006, J ACOUST SOC AM, V119, P1171, DOI 10.1121/1.2149839; Glover S, 2004, BEHAV BRAIN SCI, V27, P3; Grassi M, 2005, PERCEPT PSYCHOPHYS, V67, P274, DOI 10.3758/BF03206491; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; Guest S, 2002, EXP BRAIN RES, V146, P161, DOI 10.1007/s00221-002-1164-z; Gygi B, 2004, J ACOUST SOC AM, V115, P1252, DOI 10.1121/1.1635840; JAKOBSON LS, 1991, EXP BRAIN RES, V86, P199; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; Keysers C, 2003, EXP BRAIN RES, V153, P628, DOI 10.1007/s00221-003-1603-5; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Kunkler-Peck AJ, 2000, J EXP PSYCHOL HUMAN, V26, P279, DOI 10.1037/0096-1523.26.1.279; Lederman SJ, 2003, EXP BRAIN RES, V152, P156, DOI 10.1007/s00221-003-1522-5; Lederman SJ, 2002, 10TH SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P97, DOI 10.1109/HAPTIC.2002.998946; LI XF, 1991, J ACOUST SOC AM, V90, P3036, DOI 10.1121/1.401778; Lukos J, 2007, J NEUROSCI, V27, P3894, DOI 10.1523/JNEUROSCI.4693-06.2007; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pastore RE, 2008, PERCEPT PSYCHOPHYS, V70, P13, DOI 10.3758/PP.70.1.13; Patchay S, 2003, PSYCHON B REV, V10, P924, DOI 10.3758/BF03196553; PATCHAY S, 2005, EXP BRAIN RES, V23, P1; Plamondon R, 1997, BEHAV BRAIN SCI, V20, P279, DOI 10.1017/S0140525X97001441; REPP BH, 1987, J ACOUST SOC AM, V81, P1100, DOI 10.1121/1.394630; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Tubaldi F, 2008, CHEM SENSES, V33, P433, DOI 10.1093/chemse/bjn010; Tubaldi F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001795; Wing AM, 1998, J EXP PSYCHOL HUMAN, V24, P1571, DOI 10.1037/0096-1523.24.6.1571; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; ZAHARIEV MA, 2003, P 5 INT C MULT INT I, P273; Zahariev MA, 2008, EXP BRAIN RES, V186, P619, DOI 10.1007/s00221-008-1269-0	42	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12240	10.1371/journal.pone.0012240	http://dx.doi.org/10.1371/journal.pone.0012240			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	639II	20808929	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000280968100030
J	Corona, E; Dudley, JT; Butte, AJ				Corona, Erik; Dudley, Joel T.; Butte, Atul J.			Extreme Evolutionary Disparities Seen in Positive Selection across Seven Complex Diseases	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; NATURAL-SELECTION; POPULATION DIFFERENTIATION; TUBERCULOSIS; VARIANTS; GENETICS; PATIENT; BLOCKS; GENOME; GENES	Positive selection is known to occur when the environment that an organism inhabits is suddenly altered, as is the case across recent human history. Genome-wide association studies (GWASs) have successfully illuminated disease-associated variation. However, whether human evolution is heading towards or away from disease susceptibility in general remains an open question. The genetic-basis of common complex disease may partially be caused by positive selection events, which simultaneously increased fitness and susceptibility to disease. We analyze seven diseases studied by the Wellcome Trust Case Control Consortium to compare evidence for selection at every locus associated with disease. We take a large set of the most strongly associated SNPs in each GWA study in order to capture more hidden associations at the cost of introducing false positives into our analysis. We then search for signs of positive selection in this inclusive set of SNPs. There are striking differences between the seven studied diseases. We find alleles increasing susceptibility to Type 1 Diabetes (T1D), Rheumatoid Arthritis (RA), and Crohn's Disease (CD) underwent recent positive selection. There is more selection in alleles increasing, rather than decreasing, susceptibility to T1D. In the 80 SNPs most associated with T1D (p-value <7.01 x 10(-5)) showing strong signs of positive selection, 58 alleles associated with disease susceptibility show signs of positive selection, while only 22 associated with disease protection show signs of positive selection. Alleles increasing susceptibility to RA are under selection as well. In contrast, selection in SNPs associated with CD favors protective alleles. These results inform the current understanding of disease etiology, shed light on potential benefits associated with the genetic-basis of disease, and aid in the efforts to identify causal genetic factors underlying complex disease.	[Corona, Erik; Dudley, Joel T.; Butte, Atul J.] Lucile Packard Childrens Hosp, Stanford, CA USA; [Corona, Erik; Dudley, Joel T.; Butte, Atul J.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA	Lucile Packard Children's Hospital (LPCH); Stanford University	Corona, E (corresponding author), Lucile Packard Childrens Hosp, Stanford, CA USA.	abutte@stanford.edu			Lucile Packard Foundation for Children's Health; Hewlett Packard Foundation; Armin and Linda Miller Fellowship Fund; National Library of Medicine [T15 LM 007033]; National Institute of General Medical Sciences [R01 GM079719]; National Science Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079719] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	Lucile Packard Foundation for Children's Health; Hewlett Packard Foundation; Armin and Linda Miller Fellowship Fund; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Lucile Packard Foundation for Children's Health, the Hewlett Packard Foundation, the Armin and Linda Miller Fellowship Fund, the National Library of Medicine (T15 LM 007033), the National Institute of General Medical Sciences (R01 GM079719), a National Science Foundation Graduate Research Fellowship, and the Howard Hughes Medical Institute. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial funder provided funds for hardware equipment and unrestricted funds for research. No commercial organization had any role in the research design, implementation, or findings.	Arbiza L, 2006, J MOL BIOL, V358, P1390, DOI 10.1016/j.jmb.2006.02.067; Askling J, 2005, ARTHRITIS RHEUM-US, V52, P1986, DOI 10.1002/art.21137; Babbitt CC, 2010, GENOME BIOL EVOL, V2, P67, DOI 10.1093/gbe/evq002; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Butty V, 2007, P NATL ACAD SCI USA, V104, P570, DOI 10.1073/pnas.0610124104; Chevin LM, 2008, GENETICS, V180, P301, DOI 10.1534/genetics.108.089706; Costamagna P., 2004, Morbidity and Mortality Weekly Report, V53, P683; Currat M, 2002, AM J HUM GENET, V70, P207, DOI 10.1086/338304; Di Rienzo A, 2006, CURR OPIN GENET DEV, V16, P630, DOI 10.1016/j.gde.2006.10.002; Ding KY, 2008, PHARMACOGENET GENOM, V18, P169, DOI 10.1097/FPC.0b013e3282f44d99; Fabre S, 2005, J RHEUMATOL, V32, P2432; Filler SG, 2005, CLIN INFECT DIS, V41, pS208, DOI 10.1086/430000; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GUINAN KJ, 2010, GENES IMMUN; Jimenez FG, 2005, J INFECTION, V50, P370, DOI 10.1016/j.jinf.2004.12.016; Kirsner JB, 2001, WORLD J GASTROENTERO, V7, P175; MADDOX J, 1994, NATURE, V372, P32; Mobley JL, 2004, MED HYPOTHESES, V62, P839, DOI 10.1016/j.mehy.2003.12.006; Myles S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-22; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Podder S, 2010, MOL BIOL EVOL, V27, P934, DOI 10.1093/molbev/msp297; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; ROTHSCHILD BM, 1992, SEMIN ARTHRITIS RHEU, V22, P181, DOI 10.1016/0049-0172(92)90018-9; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schaub MA, 2009, BIOINFORMATICS, V25, pI21, DOI 10.1093/bioinformatics/btp226; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sirota M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000792; Spencer CCA, 2006, PLOS GENET, V2, P1375, DOI 10.1371/journal.pgen.0020148; Thomas PD, 2004, P NATL ACAD SCI USA, V101, P15398, DOI 10.1073/pnas.0404380101; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Walsh EC, 2006, HUM GENET, V119, P92, DOI 10.1007/s00439-005-0090-0; Zhang K, 2005, BIOINFORMATICS, V21, P131, DOI 10.1093/bioinformatics/bth482	39	42	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12236	10.1371/journal.pone.0012236	http://dx.doi.org/10.1371/journal.pone.0012236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808933	Green Published, gold, Green Submitted			2022-12-27	WOS:000280968100028
J	Dozmorov, MG; Guthridge, JM; Hurst, RE; Dozmorov, IM				Dozmorov, Mikhail G.; Guthridge, Joel M.; Hurst, Robert E.; Dozmorov, Igor M.			A Comprehensive and Universal Method for Assessing the Performance of Differential Gene Expression Analyses	PLOS ONE			English	Article							NORMALIZATION METHODS; MICROARRAY DATA; ROC ANALYSIS; VARIANCE; ERROR; TESTS	The number of methods for pre-processing and analysis of gene expression data continues to increase, often making it difficult to select the most appropriate approach. We present a simple procedure for comparative estimation of a variety of methods for microarray data pre-processing and analysis. Our approach is based on the use of real microarray data in which controlled fold changes are introduced into 20% of the data to provide a metric for comparison with the unmodified data. The data modifications can be easily applied to raw data measured with any technological platform and retains all the complex structures and statistical characteristics of the real-world data. The power of the method is illustrated by its application to the quantitative comparison of different methods of normalization and analysis of microarray data. Our results demonstrate that the method of controlled modifications of real experimental data provides a simple tool for assessing the performance of data preprocessing and analysis methods.	[Dozmorov, Mikhail G.; Guthridge, Joel M.; Dozmorov, Igor M.] Oklahoma Med Res Fdn, Dept Arthrit & Immunol, Oklahoma City, OK 73104 USA; [Hurst, Robert E.] Univ Oklahoma, Hlth Sci Ctr, Dept Urol, Oklahoma City, OK USA; [Hurst, Robert E.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Dozmorov, MG (corresponding author), Oklahoma Med Res Fdn, Dept Arthrit & Immunol, 825 NE 13th St, Oklahoma City, OK 73104 USA.	igor-dozmorov@omrf.org	Dozmorov, Mikhail/B-1374-2009	Dozmorov, Mikhail/0000-0002-0086-8358; Hurst, Robert/0000-0003-0370-1817; Guthridge, Joel/0000-0002-9308-237X	National Institutes of Health [R01DK069808, P20 RR020143, R01 AI045050, P30 AR053483, RR015577, N01AI000026, AI031584, AR053483]; National Institutes of Health/National Center for Research Resources Centers of Biomedical Research Excellence [IRG-05-066-04]; American Cancer Society [IRG-05-066-04]; Oklahoma Center for the Advancement of Science Technology [HR08-037]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020143, P20RR015577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031584, N01AI000026, R01AI045050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Center for Research Resources Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Cancer Society(American Cancer Society); Oklahoma Center for the Advancement of Science Technology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health [grant R01DK069808 REH; grant P20 RR020143, IMD and JG; grant R01 AI045050, IMD; Grant P30 AR053483, IMD; RR015577, JG; N01AI000026, JG; AI031584, JG, AR053483, JG], the National Institutes of Health/National Center for Research Resources Centers of Biomedical Research Excellence [grant IRG-05-066-04, IMD and REH], the American Cancer Society [grant IRG-05-066-04, IMD], and the Office for Human Research Studies award # HR08-037 from the Oklahoma Center for the Advancement of Science & Technology (JG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker A B, 1976, Anaesth Intensive Care, V4, P53; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chiogna M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-61; Dozmorov I, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh146; Dozmorov I, 2003, BIOINFORMATICS, V19, P204, DOI 10.1093/bioinformatics/19.2.204; Dozmorov I, 2009, NUCLEIC ACIDS RES, V37, P6323, DOI 10.1093/nar/gkp706; Dozmorov M, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-152; Gribskov M, 1996, COMPUT CHEM, V20, P25, DOI 10.1016/S0097-8485(96)80004-0; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Johnson DS, 2008, GENOME RES, V18, P393, DOI 10.1101/gr.7080508; Khodarev NN, 2003, GENOMICS, V81, P202, DOI 10.1016/S0888-7543(02)00042-3; Li JL, 2008, BIOSTATISTICS, V9, P566, DOI 10.1093/biostatistics/kxm050; MAKHOUL J., 1999, P DARPA BROADC NEWS; MCNEIL BJ, 1984, MED DECIS MAKING, V4, P137, DOI 10.1177/0272989X8400400203; Mehta T, 2004, NAT GENET, V36, P943, DOI 10.1038/ng1422; Oshlack A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r2; Park T, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-33; Qin LX, 2004, NUCLEIC ACIDS RES, V32, P5471, DOI 10.1093/nar/gkh866; Rocke DM, 2001, J COMPUT BIOL, V8, P557, DOI 10.1089/106652701753307485; Ryden P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-300; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Song S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-502; Vardhanabhuti S, 2006, OMICS, V10, P555, DOI 10.1089/omi.2006.10.555; Wang D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-110; Wu W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-191	27	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12657	10.1371/journal.pone.0012657	http://dx.doi.org/10.1371/journal.pone.0012657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844739	Green Published, gold, Green Submitted			2022-12-27	WOS:000281687200018
J	Zhang, Z; Liu, JF; Ding, XD; Bijma, P; de Koning, DJ; Zhang, Q				Zhang, Zhe; Liu, Jianfeng; Ding, Xiangdong; Bijma, Piter; de Koning, Dirk-Jan; Zhang, Qin			Best Linear Unbiased Prediction of Genomic Breeding Values Using a Trait-Specific Marker-Derived Relationship Matrix	PLOS ONE			English	Article							GENETIC-RELATIONSHIP INFORMATION; SELECTION; ACCURACY; WIDE; IMPACT; ANIMALS; SNP	Background: With the availability of high density whole-genome single nucleotide polymorphism chips, genomic selection has become a promising method to estimate genetic merit with potentially high accuracy for animal, plant and aquaculture species of economic importance. With markers covering the entire genome, genetic merit of genotyped individuals can be predicted directly within the framework of mixed model equations, by using a matrix of relationships among individuals that is derived from the markers. Here we extend that approach by deriving a marker-based relationship matrix specifically for the trait of interest. Methodology/Principal Findings: In the framework of mixed model equations, a new best linear unbiased prediction (BLUP) method including a trait-specific relationship matrix (TA) was presented and termed TABLUP. The TA matrix was constructed on the basis of marker genotypes and their weights in relation to the trait of interest. A simulation study with 1,000 individuals as the training population and five successive generations as candidate population was carried out to validate the proposed method. The proposed TABLUP method outperformed the ridge regression BLUP (RRBLUP) and BLUP with realized relationship matrix (GBLUP). It performed slightly worse than BayesB with an accuracy of 0.79 in the standard scenario. Conclusions/Significance: The proposed TABLUP method is an improvement of the RRBLUP and GBLUP method. It might be equivalent to the BayesB method but it has additional benefits like the calculation of accuracies for individual breeding values. The results also showed that the TA-matrix performs better in predicting ability than the classical numerator relationship matrix and the realized relationship matrix which are derived solely from pedigree or markers without regard to the trait. This is because the TA-matrix not only accounts for the Mendelian sampling term, but also puts the greater emphasis on those markers that explain more of the genetic variance in the trait.	[Zhang, Zhe; Liu, Jianfeng; Ding, Xiangdong; Zhang, Qin] China Agr Univ, Minist Agr, Coll Anim Sci & Technol, Key Lab Anim Genet & Breeding, Beijing 100094, Peoples R China; [Zhang, Zhe; de Koning, Dirk-Jan] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Zhang, Zhe; de Koning, Dirk-Jan] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Bijma, Piter] Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands	China Agricultural University; Ministry of Agriculture & Rural Affairs; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Wageningen University & Research	Zhang, Z (corresponding author), China Agr Univ, Minist Agr, Coll Anim Sci & Technol, Key Lab Anim Genet & Breeding, Beijing 100094, Peoples R China.	dj.dekoning@roslin.ed.ac.uk; qzhang@cau.edu.cn	Zhang, Zhe/AAG-9641-2019; de Koning, Dirk Jan/F-3399-2013	Zhang, Zhe/0000-0001-7338-7718; de Koning, Dirk Jan/0000-0001-6343-8155	State High-Tech Development Plan [2008AA101002]; National Natural Science Foundation of China [30800776]; National Key Basic Research Program of China [2006CB102104]; National Transgenic Major projecct [2009ZX08009-146B]; Biotechnology and Biological Sciences Research Council (BBSRC) through the Institute Strategic Program; BBSRC [BBS/E/R/00001606] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/R/00001606] Funding Source: researchfish	State High-Tech Development Plan(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); National Transgenic Major projecct; Biotechnology and Biological Sciences Research Council (BBSRC) through the Institute Strategic Program(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the State High-Tech Development Plan (Grant No. 2008AA101002), the National Natural Science Foundation of China (Grant No. 30800776), the National Key Basic Research Program of China (Grant No. 2006CB102104) and the National Transgenic Major projecct (2009ZX08009-146B). DJK acknowledges support from the Biotechnology and Biological Sciences Research Council (BBSRC) through the Institute Strategic Program Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calus MPL, 2007, J ANIM BREED GENET, V124, P362, DOI 10.1111/j.1439-0388.2007.00691.x; Calus MPL, 2010, ANIMAL, V4, P157, DOI 10.1017/S1751731109991352; Christensen OF, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-2; Daetwyler HD, 2007, J ANIM BREED GENET, V124, P369, DOI 10.1111/j.1439-0388.2007.00693.x; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Eding H, 2001, J ANIM BREED GENET, V118, P141, DOI 10.1046/j.1439-0388.2001.00290.x; Falconer D. S., 1996, Introduction to quantitative genetics.; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Habier D, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-5; Hayes B, 2001, GENET SEL EVOL, V33, P209, DOI 10.1051/gse:2001117; Hayes BJ, 2008, J ANIM SCI, V86, P2089, DOI 10.2527/jas.2007-0733; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes BJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-51; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; HENDERSON CR, 1975, J DAIRY SCI, V58, P1727, DOI 10.3168/jds.S0022-0302(75)84776-X; Jacquard A., 1974, GENETIC STRUCTURE PO; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; KIMURA M, 1964, GENETICS, V49, P725; Lee SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000231; Legarra A, 2009, J DAIRY SCI, V92, P4656, DOI 10.3168/jds.2009-2061; Long N, 2007, J ANIM BREED GENET, V124, P377, DOI 10.1111/j.1439-0388.2007.00694.x; Luan T, 2009, GENETICS, V183, P1119, DOI 10.1534/genetics.109.107391; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-35; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-2; Muir WM, 2007, J ANIM BREED GENET, V124, P342, DOI 10.1111/j.1439-0388.2007.00700.x; NejatiJavaremi A, 1997, J ANIM SCI, V75, P1738; Nielsen HM, 2009, AQUACULTURE, V289, P259, DOI 10.1016/j.aquaculture.2009.01.027; Schaeffer LR, 2006, J ANIM BREED GENET, V123, P218, DOI 10.1111/j.1439-0388.2006.00595.x; Solberg TR, 2008, J ANIM SCI, V86, P2447, DOI 10.2527/jas.2007-0010; Solberg TR, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-29; Sonesson AK, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-37; Stranden I, 2009, J DAIRY SCI, V92, P2971, DOI 10.3168/jds.2008-1929; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Whittaker JC, 2000, GENET RES, V75, P249, DOI 10.1017/S0016672399004462; Xu SZ, 2003, GENETICS, V163, P789; Zhong SQ, 2009, GENETICS, V182, P355, DOI 10.1534/genetics.108.098277	42	127	140	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12648	10.1371/journal.pone.0012648	http://dx.doi.org/10.1371/journal.pone.0012648			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844593	Green Published, Green Submitted, gold			2022-12-27	WOS:000281687200013
J	Dias, JP; Talbot, S; Senecal, J; Carayon, P; Couture, R				Dias, Jenny Pena; Talbot, Sebastien; Senecal, Jacques; Carayon, Pierre; Couture, Rejean			Kinin B-1 Receptor Enhances the Oxidative Stress in a Rat Model of Insulin Resistance: Outcome in Hypertension, Allodynia and Metabolic Complications	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITION; ALPHA-LIPOIC ACID; ANGIOTENSIN-II; SUPEROXIDE-PRODUCTION; BRADYKININ B1; PHARMACOLOGICAL BLOCKADE; SENSORY ABNORMALITIES; MYOCARDIAL-ISCHEMIA; ANTIOXIDANT ENZYMES; OXIDASE ACTIVATION	Background: Kinin B-1 receptor (B1R) is induced by the oxidative stress in models of diabetes mellitus. This study aims at determining whether B1R activation could perpetuate the oxidative stress which leads to diabetic complications. Methods and Findings: Young Sprague-Dawley rats were fed with 10% D-Glucose or tap water (controls) for 8-12 weeks. A selective B1R antagonist (SSR240612) was administered acutely (3-30 mg/kg) or daily for a period of 7 days (10 mg/kg) and the impact was measured on systolic blood pressure, allodynia, protein and/or mRNA B1R expression, aortic superoxide anion (O-2(center dot-)) production and expression of superoxide dismutase (MnSOD) and catalase. SSR240612 reduced dose-dependently (3-30 mg/kg) high blood pressure in 12-week glucose-fed rats, but had no effect in controls. Eight-week glucose-fed rats exhibited insulin resistance (HOMA index), hypertension, tactile and cold allodynia and significant increases of plasma levels of glucose and insulin. This was associated with higher aortic levels of O-2(center dot-), NADPH oxidase activity, MnSOD and catalase expression. All these abnormalities including B1R overexpression (spinal cord, aorta, liver and gastrocnemius muscle) were normalized by the prolonged treatment with SSR240612. The production of O-2(center dot-) in the aorta of glucose-fed rats was also measured in the presence and absence of inhibitors (10-100 mu M) of NADPH oxidase (apocynin), xanthine oxidase (allopurinol) or nitric oxide synthase (L-NAME) with and without Sar[D-Phe(8)]des-Arg(9)-BK (20 mu M; B1R agonist). Data show that the greater aortic O-2(center dot-) production induced by the B1R agonist was blocked only by apocynin. Conclusions: Activation of kinin B1R increased O-2(center dot-) through the activation of NADPH oxidase in the vasculature. Prolonged blockade of B1R restored cardiovascular, sensory and metabolic abnormalities by reducing oxidative stress and B1R gene expression in this model.	[Dias, Jenny Pena; Talbot, Sebastien; Senecal, Jacques; Couture, Rejean] Univ Montreal, Fac Med, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [Carayon, Pierre] Sanofi Aventis R&D, Montpellier, France	Universite de Montreal; Sanofi-Aventis; Sanofi France	Dias, JP (corresponding author), Univ Montreal, Fac Med, Dept Physiol, Montreal, PQ H3C 3J7, Canada.	rejean.couture@umontreal.ca			Canadian Diabetes Association [OG-3-07-2428]; Canadian Institutes of Health Research [MOP-79471]; Fonds de la Recherche en Sante du Quebec	Canadian Diabetes Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was funded by Grants-in-Aid from the Canadian Diabetes Association (OG-3-07-2428) and the Canadian Institutes of Health Research (MOP-79471). Studentships Awards were obtained from the Canadian Diabetes Association (JPD), the Fonds de la Recherche en Sante du Quebec (JPD, ST) and the Canadian Institutes of Health Research (JPD). Dr Pierre Carayon at Sanofi-Aventis R&D provided SSR240612 and approved the submission of the article with intellectual contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANANDSRIVASTAVA MB, 1993, AM J HYPERTENS, V6, P72, DOI 10.1093/ajh/6.1.72; Aoki S, 2002, J NEUROSCI, V22, P10751; Buleon M, 2008, AM J PHYSIOL-RENAL, V294, pF1249, DOI 10.1152/ajprenal.00501.2007; Calixto JB, 2004, BRIT J PHARMACOL, V143, P803, DOI 10.1038/sj.bjp.0706012; Campos MM, 2006, TRENDS PHARMACOL SCI, V27, P646, DOI 10.1016/j.tips.2006.10.007; Cavarape A, 2001, J ENDOCRINOL INVEST, V24, P838, DOI 10.1007/BF03343940; Ceravolo GS, 2007, HYPERTENSION, V50, P756, DOI 10.1161/HYPERTENSIONAHA.107.094706; Ceriello A, 1996, DIABETES, V45, P471, DOI 10.2337/diabetes.45.4.471; Chao JL, 2008, HYPERTENSION, V52, P715, DOI 10.1161/HYPERTENSIONAHA.108.114587; Chao J, 2010, BIOL CHEM, V391, P345, DOI 10.1515/BC.2010.042; CLERCH LB, 1993, J CLIN INVEST, V91, P499, DOI 10.1172/JCI116228; Cloutier F, 2002, BRIT J PHARMACOL, V135, P1641, DOI 10.1038/sj.bjp.0704632; Couture R, 2004, EUR J PHARMACOL, V500, P467, DOI 10.1016/j.ejphar.2004.07.045; Csiszar A, 2008, J APPL PHYSIOL, V105, P1333, DOI 10.1152/japplphysiol.90470.2008; Dias JP, 2007, BRIT J PHARMACOL, V152, P280, DOI 10.1038/sj.bjp.0707388; DIAS JP, 2008, THESIS U MONTREAL; DRAPEAU G, 1993, J PHARMACOL EXP THER, V266, P192; Duka A, 2008, HYPERTENSION, V51, P1352, DOI 10.1161/HYPERTENSIONAHA.107.108506; Duka I, 2001, CIRC RES, V88, P275, DOI 10.1161/01.RES.88.3.275; El Midaoui A, 2005, PEPTIDES, V26, P1323, DOI 10.1016/j.peptides.2005.03.028; El Midaoui A, 2005, J HYPERTENS, V23, P581; El Midaoui A, 2002, HYPERTENSION, V39, P303, DOI 10.1161/hy0202.104345; El Midaoui A, 2002, J HYPERTENS, V20, P1407, DOI 10.1097/00004872-200207000-00028; Fernandes L, 2006, REGUL PEPTIDES, V136, P92, DOI 10.1016/j.regpep.2006.04.018; Gabra BH, 2006, BIOL CHEM, V387, P127, DOI 10.1515/BC.2006.018; Gao L, 2009, CARDIOVASC RES, V82, P9, DOI 10.1093/cvr/cvp031; Gariepy HD, 2010, NEUROPEPTIDES, V44, P191, DOI 10.1016/j.npep.2009.12.011; Gougat J, 2004, J PHARMACOL EXP THER, V309, P661, DOI 10.1124/jpet.103.059527; HALL CE, 1966, P SOC EXP BIOL MED, V122, P362, DOI 10.3181/00379727-122-31135; Heitzer T, 1999, KIDNEY INT, V55, P252, DOI 10.1046/j.1523-1755.1999.00229.x; HWANG IS, 1987, HYPERTENSION, V10, P512, DOI 10.1161/01.HYP.10.5.512; Ismael MA, 2008, EUR J PHARMACOL, V589, P66, DOI 10.1016/j.ejphar.2008.05.006; Kakoki M, 2006, J CLIN INVEST, V116, P1302, DOI 10.1172/JCI26958; Kakoki M, 2004, P NATL ACAD SCI USA, V101, P13302, DOI 10.1073/pnas.0405449101; Kakoki M, 2010, P NATL ACAD SCI USA, V107, P10190, DOI 10.1073/pnas.1005144107; Kakoki M, 2009, KIDNEY INT, V75, P1019, DOI 10.1038/ki.2008.647; Kintsurashvili E, 2001, AM J PHYSIOL-HEART C, V281, pH1778, DOI 10.1152/ajpheart.2001.281.4.H1778; Lagneux C, 2002, INT IMMUNOPHARMACOL, V2, P815, DOI 10.1016/S1567-5769(02)00022-X; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Li Y, 2008, AM J PHYSIOL-HEART C, V294, pH2845, DOI 10.1152/ajpheart.91422.2007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loomis ED, 2005, J PHARMACOL EXP THER, V315, P1058, DOI 10.1124/jpet.105.091728; Lungu C, 2007, NEUROPEPTIDES, V41, P375, DOI 10.1016/j.npep.2007.09.005; Majithiya JB, 2005, J CARDIOVASC PHARM, V46, P697, DOI 10.1097/01.fjc.0000183720.85014.24; Marceau F, 2002, INT IMMUNOPHARMACOL, V2, P1729, DOI 10.1016/S1567-5769(02)00189-3; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Messadi-Laribi E, 2008, CLIN EXP PHARMACOL P, V35, P489, DOI 10.1111/j.1440-1681.2008.04902.x; Methner C, 2009, ACTA PHYSIOL, V197, P265, DOI 10.1111/j.1748-1716.2009.02018.x; Miller FJ, 1998, CIRC RES, V82, P1298, DOI 10.1161/01.RES.82.12.1298; Mori MA, 2008, DIABETES, V57, P1491, DOI 10.2337/db07-1508; MUNZEL T, 1995, J CLIN INVEST, V95, P187, DOI 10.1172/JCI117637; NAZARALI AJ, 1989, J NEUROSCI METH, V30, P247, DOI 10.1016/0165-0270(89)90135-0; Nyby MD, 2007, HYPERTENS RES, V30, P451, DOI 10.1291/hypres.30.451; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Pesquero JB, 2000, P NATL ACAD SCI USA, V97, P8140, DOI 10.1073/pnas.120035997; Petcu M, 2005, PEPTIDES, V26, P1331, DOI 10.1016/j.peptides.2005.03.047; Pop-Busui R, 2006, DIABETES-METAB RES, V22, P257, DOI 10.1002/dmrr.625; Quintao NLM, 2008, J NEUROSCI, V28, P2856, DOI 10.1523/JNEUROSCI.4389-07.2008; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Regoli D, 1998, EUR J PHARMACOL, V348, P1, DOI 10.1016/S0014-2999(98)00165-4; Rodrigues ES, 2009, BIOL CHEM, V390, P907, DOI 10.1515/BC.2009.081; RODRIGUES ES, 2010, BASIC CLIN PHARM S1, V107; Rodriguez AI, 2006, BIOCHEM BIOPH RES CO, V345, P652, DOI 10.1016/j.bbrc.2006.04.127; San Martin A, 2007, AM J PHYSIOL-HEART C, V292, pH2073, DOI 10.1152/ajpheart.00943.2006; Savvatis K, 2010, NEUROPEPTIDES, V44, P119, DOI 10.1016/j.npep.2009.11.007; Seguin T, 2008, INT IMMUNOPHARMACOL, V8, P217, DOI 10.1016/j.intimp.2007.08.008; Shariat-Madar Z, 2006, BLOOD, V108, P192, DOI 10.1182/blood-2006-01-0094; Sharpe PC, 1998, DIABETES, V47, P801, DOI 10.2337/diabetes.47.5.801; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Tawfik HE, 2008, AM J PHYSIOL-HEART C, V295, pH1736, DOI 10.1152/ajpheart.87.2008; Thirunavukkarasu V, 2004, EXP DIABESITY RES, V5, P195, DOI 10.1080/15438600490486778; Tong X, 2009, FREE RADICAL BIO MED, V47, P1578, DOI 10.1016/j.freeradbiomed.2009.08.026; Vasdev S, 2004, CLIN BIOCHEM, V37, P1, DOI 10.1016/j.clinbiochem.2003.09.003; VASDEV S, 1999, ARTERY, V23, P10; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Wang PHM, 2009, INT IMMUNOPHARMACOL, V9, P653, DOI 10.1016/j.intimp.2008.10.018; WANG PH, 2009, INT IMMUNOPHARMACOL, V9, pS1567; Xu J, 2005, HYPERTENSION, V45, P747, DOI 10.1161/01.HYP.0000153322.04859.81	79	52	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12622	10.1371/journal.pone.0012622	http://dx.doi.org/10.1371/journal.pone.0012622			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830306	Green Published, gold, Green Submitted			2022-12-27	WOS:000281631300042
J	Soechting, JF; Rao, HM; Juveli, JZ				Soechting, John F.; Rao, Hrishikesh M.; Juveli, John Z.			Incorporating Prediction in Models for Two-Dimensional Smooth Pursuit	PLOS ONE			English	Article							VISUAL-MOTION; EYE-MOVEMENTS; TRANSIENT DISAPPEARANCE; MST NEURONS; OCULAR PURSUIT; TARGET MOTION; TRACKING; MT; EXTRAPOLATION; ACCELERATION	A predictive component can contribute to the command signal for smooth pursuit. This is readily demonstrated by the fact that low frequency sinusoidal target motion can be tracked with zero time delay or even with a small lead. The objective of this study was to characterize the predictive contributions to pursuit tracking more precisely by developing analytical models for predictive smooth pursuit. Subjects tracked a small target moving in two dimensions. In the simplest case, the periodic target motion was composed of the sums of two sinusoidal motions (SS), along both the horizontal and the vertical axes. Motions following the same or similar paths, but having a richer spectral composition, were produced by having the target follow the same path but at a constant speed (CS), and by combining the horizontal SS velocity with the vertical CS velocity and vice versa. Several different quantitative models were evaluated. The predictive contribution to the eye tracking command signal could be modeled as a low-pass filtered target acceleration signal with a time delay. This predictive signal, when combined with retinal image velocity at the same time delay, as in classical models for the initiation of pursuit, gave a good fit to the data. The weighting of the predictive acceleration component was different in different experimental conditions, being largest when target motion was simplest, following the SS velocity profiles.	[Soechting, John F.; Rao, Hrishikesh M.; Juveli, John Z.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Soechting, JF (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	soech001@umn.edu			National Institutes of Health [NS-15018]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS015018, R01NS015018] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant NS-15018 (http://www.ninds.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES GR, 1987, J PHYSIOL-LONDON, V389, P111, DOI 10.1113/jphysiol.1987.sp016649; Batschelet E, 1981, CIRCULAR STAT BIOL; BECKER W, 1985, EXP BRAIN RES, V57, P562; Bennett SJ, 2007, J NEUROPHYSIOL, V98, P1405, DOI 10.1152/jn.00132.2007; Bennett SJ, 2004, J NEUROPHYSIOL, V92, P578, DOI 10.1152/jn.01188.2003; Bennett SJ, 2003, J NEUROPHYSIOL, V90, P2504, DOI 10.1152/jn.01145.2002; Brouwer AM, 2002, PERCEPT PSYCHOPHYS, V64, P1160, DOI 10.3758/BF03194764; Chukoskie L, 2009, J NEUROPHYSIOL, V102, P3225, DOI 10.1152/jn.90692.2008; Churchland MM, 2001, J NEUROPHYSIOL, V86, P741, DOI 10.1152/jn.2001.86.2.741; COLLEWIJN H, 1984, J PHYSIOL-LONDON, V351, P217, DOI 10.1113/jphysiol.1984.sp015242; DENO DC, 1995, BIOSYSTEMS, V34, P107, DOI 10.1016/0303-2647(94)01446-E; deSperati C, 1997, J NEUROSCI, V17, P3932; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Engel KC, 2000, J NEUROPHYSIOL, V83, P3483, DOI 10.1152/jn.2000.83.6.3483; Inaba N, 2007, J NEUROPHYSIOL, V97, P3473, DOI 10.1152/jn.01054.2006; Kettner RE, 1996, EXP BRAIN RES, V108, P221; KOWLER E, 1989, VISION RES, V29, P1049, DOI 10.1016/0042-6989(89)90052-7; KOWLER E, 1984, VISION RES, V24, P197, DOI 10.1016/0042-6989(84)90122-6; Kramer KA, 2006, INT J NEURAL SYST, V16, P1, DOI 10.1142/S0129065706000457; Krauzlis R J, 1994, J Comput Neurosci, V1, P265, DOI 10.1007/BF00961876; LACQUANITI F, 1983, ACTA PSYCHOL, V54, P115, DOI 10.1016/0001-6918(83)90027-6; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; Lisberger SG, 1999, J NEUROSCI, V19, P2224; Mrotek LA, 2007, J NEUROSCI, V27, P7297, DOI 10.1523/JNEUROSCI.2046-07.2007; Mrotek LA, 2006, EXP BRAIN RES, V172, P175, DOI 10.1007/s00221-005-0326-1; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; Osborne LC, 2009, J NEUROPHYSIOL, V102, P2013, DOI 10.1152/jn.00611.2009; Port NL, 1997, EXP BRAIN RES, V116, P406, DOI 10.1007/PL00005769; Press W. H., 1992, ART SCI COMPUTING; Puccini GD, 2007, PLOS COMPUT BIOL, V3, P813, DOI 10.1371/journal.pcbi.0030082; RINGACH DL, 1995, BIOL CYBERN, V73, P561, DOI 10.1007/BF00199548; ROBINSON DA, 1986, BIOL CYBERN, V55, P43, DOI 10.1007/BF00363977; Schlack A, 2007, J NEUROSCI, V27, P11009, DOI 10.1523/JNEUROSCI.3165-07.2007; Soechting JF, 2005, EXP BRAIN RES, V160, P245, DOI 10.1007/s00221-004-2010-2; Soechting JF, 2008, J NEUROPHYSIOL, V99, P2956, DOI 10.1152/jn.90308.2008; Soechting JF, 2009, J NEUROPHYSIOL, V102, P1491, DOI 10.1152/jn.00398.2009; Tavassoli A, 2009, J NEUROPHYSIOL, V102, P110, DOI 10.1152/jn.91320.2008; VIVIANI P, 1992, J EXP PSYCHOL HUMAN, V18, P603, DOI 10.1037/0096-1523.18.3.603; VIVIANI P, 1985, J EXP PSYCHOL HUMAN, V11, P828, DOI 10.1037/0096-1523.11.6.828; WELCH G, 2003, 95041 U N CAR; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585; YASUI S, 1984, J PHYSIOL-LONDON, V347, P17, DOI 10.1113/jphysiol.1984.sp015050; Zago M, 2004, J NEUROPHYSIOL, V91, P1620, DOI 10.1152/jn.00862.2003; Zago M, 2009, EXP BRAIN RES, V192, P571, DOI 10.1007/s00221-008-1691-3	45	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12574	10.1371/journal.pone.0012574	http://dx.doi.org/10.1371/journal.pone.0012574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838450	Green Published, Green Submitted, gold			2022-12-27	WOS:000281627700021
J	de Campos-Nebel, M; Larripa, I; Gonzalez-Cid, M				de Campos-Nebel, Marcelo; Larripa, Irene; Gonzalez-Cid, Marcela			Topoisomerase II-Mediated DNA Damage Is Differently Repaired during the Cell Cycle by Non-Homologous End Joining and Homologous Recombination	PLOS ONE			English	Article							STRAND BREAK REPAIR; DEPENDENT PROTEIN-KINASE; HISTONE H2AX; PATHWAYS; ROLES; BETA; EXPRESSION; COMPLEX; ALPHA; PHOSPHORYLATION	Topoisomerase II (Top2) is a nuclear enzyme involved in several metabolic processes of DNA. Chemotherapy agents that poison Top2 are known to induce persistent protein-mediated DNA double strand breaks (DSB). In this report, by using knock down experiments, we demonstrated that Top2a was largely responsible for the induction of cH2AX and cytotoxicity by the Top2 poisons idarubicin and etoposide in normal human cells. As DSB resulting from Top2 poisons-mediated damage may be repaired by non-homologous end joining (NHEJ) or homologous recombination (HR), we aimed to analyze both DNA repair pathways. We found that DNA-PKcs was rapidly activated in human cells, as evidenced by autophosphorylation at serine 2056, following Top2-mediated DNA damage. The chemical inhibition of DNA-PKcs by wortmannin and vanillin resulted in an increased accumulation of DNA DSB, as evaluated by the comet assay. This was supported by a hypersensitive phenotype to Top2 poisons of Ku80-and DNA-PKcs-defective Chinese hamster cell lines. We also showed that Rad51 protein levels, Rad51 foci formation and sister chromatid exchanges were increased in human cells following Top2-mediated DNA damage. In support, BRCA2-and Rad51C-defective Chinese hamster cells displayed hypersensitivity to Top2 poisons. The analysis by immunofluorescence of the DNA DSB repair response in synchronized human cell cultures revealed activation of DNA-PKcs throughout the cell cycle and Rad51 foci formation in S and late S/G2 cells. Additionally, we found an increase of DNA-PKcs-mediated residual repair events, but not Rad51 residual foci, into micronucleated and apoptotic cells. Therefore, we conclude that in human cells both NHEJ and HR are required, with cell cycle stage specificity, for the repair of Top2-mediated reversible DNA damage. Moreover, NHEJ-mediated residual repair events are more frequently associated to irreversibly damaged cells.	[de Campos-Nebel, Marcelo; Larripa, Irene; Gonzalez-Cid, Marcela] Acad Nacl Med Buenos Aires, Dept Genet, Inst Invest Hematol Mariano R Castex, Buenos Aires, DF, Argentina	Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas	de Campos-Nebel, M (corresponding author), Acad Nacl Med Buenos Aires, Dept Genet, Inst Invest Hematol Mariano R Castex, Buenos Aires, DF, Argentina.	mnebel@hematologia.anm.edu.ar						Adachi N, 2005, DNA CELL BIOL, V24, P388, DOI 10.1089/dna.2005.24.388; Adachi N, 2003, J BIOL CHEM, V278, P35897, DOI 10.1074/jbc.M306500200; Adachi N, 2004, BIOCHEM BIOPH RES CO, V318, P856, DOI 10.1016/j.bbrc.2004.04.099; Agarwal S, 2006, DNA REPAIR, V5, P1075, DOI 10.1016/j.dnarep.2006.05.029; Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Angelis KJ, 1999, ELECTROPHORESIS, V20, P2133, DOI 10.1002/(SICI)1522-2683(19990701)20:10<2133::AID-ELPS2133>3.0.CO;2-Q; Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; Betti CJ, 2003, CANCER RES, V63, P1377; Betti CJ, 2001, CANCER RES, V61, P4550; BIGIONI M, 1994, NUCLEIC ACIDS RES, V22, P2274, DOI 10.1093/nar/22.12.2274; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Burden DA, 1996, J BIOL CHEM, V271, P29238, DOI 10.1074/jbc.271.46.29238; Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105; CALDECOTT K, 1990, CANCER RES, V50, P5778; Calsou P, 2003, J MOL BIOL, V326, P93, DOI 10.1016/S0022-2836(02)01328-1; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Fan JR, 2008, DNA REPAIR, V7, P452, DOI 10.1016/j.dnarep.2007.12.002; Felix CA, 2006, DNA REPAIR, V5, P1093, DOI 10.1016/j.dnarep.2006.05.031; Grue P, 1998, J BIOL CHEM, V273, P33660, DOI 10.1074/jbc.273.50.33660; Haaf T, 1999, J CELL BIOL, V144, P11, DOI 10.1083/jcb.144.1.11; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Hendrickson EA, 1997, AM J HUM GENET, V61, P795, DOI 10.1086/514895; Huang X, 2004, CYTOM PART A, V58A, P99, DOI 10.1002/cyto.a.20018; Imyanitov EN, 2007, CLIN CHIM ACTA, V379, P1, DOI 10.1016/j.cca.2007.01.006; Jensen Lars H., 2004, BMC Pharmacology, V4, P31, DOI 10.1186/1471-2210-4-31; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; KIMURA K, 1994, J BIOL CHEM, V269, P1173; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; Malik M, 2006, MOL CANCER THER, V5, P1405, DOI 10.1158/1535-7163.MCT-05-0263; Mao Y, 2001, J BIOL CHEM, V276, P40652, DOI 10.1074/jbc.M104009200; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Mukherjee B, 2006, DNA REPAIR, V5, P575, DOI 10.1016/j.dnarep.2006.01.011; Raderschall E, 2002, J CELL SCI, V115, P153; Rassool FV, 2003, CANCER LETT, V193, P1, DOI 10.1016/S0304-3835(02)00692-4; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sakaguchi A, 2004, J CELL SCI, V117, P1047, DOI 10.1242/jcs.00977; Schonn I, 2010, APOPTOSIS, V15, P162, DOI 10.1007/s10495-009-0440-9; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Toyoda E, 2008, J BIOL CHEM, V283, P23711, DOI 10.1074/jbc.M803936200; Treszezamsky AD, 2007, CANCER RES, V67, P7078, DOI 10.1158/0008-5472.CAN-07-0601; Turley H, 1997, BRIT J CANCER, V75, P1340, DOI 10.1038/bjc.1997.227; UEMATSU N, 2005, MOL CELL BIOL, V25, P10842; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Warburton PE, 1997, BIOESSAYS, V19, P97, DOI 10.1002/bies.950190203	57	30	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12541	10.1371/journal.pone.0012541	http://dx.doi.org/10.1371/journal.pone.0012541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824055	Green Submitted, Green Published, gold			2022-12-27	WOS:000281480900023
J	Stoop, MP; Singh, V; Dekker, LJ; Titulaer, MK; Stingl, C; Burgers, PC; Smitt, PAES; Hintzen, RQ; Luider, TM				Stoop, Marcel P.; Singh, Vaibhav; Dekker, Lennard J.; Titulaer, Mark K.; Stingl, Christoph; Burgers, Peter C.; Smitt, Peter A. E. Sillevis; Hintzen, Rogier Q.; Luider, Theo M.			Proteomics Comparison of Cerebrospinal Fluid of Relapsing Remitting and Primary Progressive Multiple Sclerosis	PLOS ONE			English	Article							D-BINDING PROTEIN; AUTOIMMUNE-DISEASE PREVALENCE; VITAMIN-D; DIAGNOSTIC-CRITERIA; APOLIPOPROTEIN-D; JAGGED1; CSF; 25-HYDROXYVITAMIN-D; REMYELINATION; DEMYELINATION	Background: Based on clinical representation of disease symptoms multiple sclerosis (MScl) patients can be divided into two major subtypes; relapsing remitting (RR) MScl (85-90%) and primary progressive (PP) MScl (10-15%). Proteomics analysis of cerebrospinal fluid (CSF) has detected a number of proteins that were elevated in MScl patients. Here we specifically aimed to differentiate between the PP and RR subtypes of MScl by comparing CSF proteins. Methodology/Principal Findings: CSF samples (n = 31) were handled according to the same protocol for quantitative mass spectrometry measurements we reported previously. In the comparison of PP MScl versus RR MScl we observed a number of differentially abundant proteins, such as protein jagged-1 and vitamin D-binding protein. Protein jagged-1 was over three times less abundant in PP MScl compared to RR MScl. Vitamin D-binding protein was only detected in the RR MScl samples. These two proteins were validated by independent techniques (western blot and ELISA) as differentially abundant in the comparison between both MScl types. Conclusions/Significance: The main finding of this comparative study is the observation that the proteome profiles of CSF in PP and RR MScl patients overlap to a large extent. Still, a number of differences could be observed. Protein jagged-1 is a ligand for multiple Notch receptors and involved in the mediation of Notch signaling. It is suggested in literature that the Notch pathway is involved in the remyelination of MScl lesions. Aberration of normal homeostasis of Vitamin D, of which approximately 90% is bound to vitamin D-binding protein, has been widely implicated in MScl for some years now. Vitamin D directly and indirectly regulates the differentiation, activation of CD4+ T-lymphocytes and can prevent the development of autoimmune processes, and so it may be involved in neuroprotective elements in MScl.	[Stoop, Marcel P.; Singh, Vaibhav; Dekker, Lennard J.; Titulaer, Mark K.; Stingl, Christoph; Burgers, Peter C.; Smitt, Peter A. E. Sillevis; Hintzen, Rogier Q.; Luider, Theo M.] Erasmus Univ, Med Ctr, Dept Neurol, Labs Neuro Oncol Clin & Canc Proteom, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Stoop, MP (corresponding author), Erasmus Univ, Med Ctr, Dept Neurol, Labs Neuro Oncol Clin & Canc Proteom, Rotterdam, Netherlands.	t.luider@erasmusmc.nl	singh, vaibhav/AAD-6960-2022	singh, vaibhav/0000-0001-5075-8045	Netherlands Multiple Sclerosis Research Foundation; Netherlands Organization for Scientific research (ZON-MW); Hersenstichting Nederland; Top Institute Pharma [D4-102-1]; UEPHA-MS (EU) [PITN-GA-2008-212877]	Netherlands Multiple Sclerosis Research Foundation; Netherlands Organization for Scientific research (ZON-MW)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Hersenstichting Nederland; Top Institute Pharma; UEPHA-MS (EU)(European Commission)	This work was supported by a program grant provided by the Netherlands Multiple Sclerosis Research Foundation (nonprofit organisation) to the Rotterdam Multiple Sclerosis research Center, ErasMS, ErasmusMC, Rotterdam, The Netherlands, the Netherlands Organization for Scientific research (ZON-MW, RQH), Hersenstichting Nederland (non-profit organisation), the Top Institute Pharma grant D4-102-1 (a Dutch governmental organisation supporting pre-clinical research) and the UEPHA-MS grant PITN-GA-2008-212877 (EU supported grant Marie Curie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2001, J CHEMOTHERAPY, V13, P219, DOI 10.1179/joc.2001.13.3.219; BAN M, 2006, J NEUROIMMUNOL, V179, P108, DOI DOI 10.1016/J.JNEUROIM.2006.06.003; BIKLE DD, 1985, J CLIN ENDOCR METAB, V61, P969, DOI 10.1210/jcem-61-5-969; BIKLE DD, 1986, J CLIN ENDOCR METAB, V63, P954, DOI 10.1210/jcem-63-4-954; Cantorna MT, 2004, EXP BIOL MED, V229, P1136, DOI 10.1177/153537020422901108; Cantorna MT, 2000, P SOC EXP BIOL MED, V223, P230, DOI 10.1046/j.1525-1373.2000.22333.x; Chiasserini D, 2008, EUR J NEUROL, V15, P998, DOI 10.1111/j.1468-1331.2008.02239.x; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Di Pauli F, 2010, J NEUROL SCI, V288, P147, DOI 10.1016/j.jns.2009.09.016; Do Carmo S, 2008, J NEUROSCI, V28, P10330, DOI 10.1523/JNEUROSCI.2644-08.2008; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Gomme PT, 2004, TRENDS BIOTECHNOL, V22, P340, DOI 10.1016/j.tibtech.2004.05.001; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Hoppenbrouwers IA, 2007, MULT SCLER, V13, P17, DOI 10.1177/1352458506071216; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Kijima M, 2009, J IMMUNOL, V182, P3566, DOI 10.4049/jimmunol.0803765; Lassmann H, 2007, CURR NEUROL NEUROSCI, V7, P239, DOI 10.1007/s11910-007-0036-0; Lehmensiek V, 2007, MULT SCLER, V13, P840, DOI 10.1177/1352458507076406; Lips P, 2004, J STEROID BIOCHEM, V89-90, P611, DOI 10.1016/j.jsbmb.2004.03.040; Liu SL, 2009, J CELL MOL MED, V13, P1586, DOI 10.1111/j.1582-4934.2009.00850.x; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Miller DH, 2007, LANCET NEUROL, V6, P903, DOI 10.1016/S1474-4422(07)70243-0; Montalban X, 2009, MULT SCLER J, V15, P1459, DOI 10.1177/1352458509348422; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ouardouz M, 2009, ANN NEUROL, V65, P151, DOI 10.1002/ana.21533; Palacios R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001222; Presslauer S, 2008, J NEUROL, V255, P1508, DOI 10.1007/s00415-008-0954-z; Qin ZY, 2009, CELL MOL NEUROBIOL, V29, P203, DOI 10.1007/s10571-008-9312-z; Raghuwanshi A, 2008, J CELL BIOCHEM, V105, P338, DOI 10.1002/jcb.21858; Reindl M, 2001, J NEUROIMMUNOL, V119, P327, DOI 10.1016/S0165-5728(01)00378-2; Richards R G, 2002, Health Technol Assess, V6, P1; Seifert T, 2007, ACTA NEUROPATHOL, V113, P195, DOI 10.1007/s00401-006-0170-9; Shah AB, 2006, MOL IMMUNOL, V43, P1109, DOI 10.1016/j.molimm.2005.07.023; Stidworthy MF, 2004, BRAIN, V127, P1928, DOI 10.1093/brain/awh217; Stoop MP, 2008, PROTEOMICS, V8, P1576, DOI 10.1002/pmic.200700446; Stoop MP, 2009, J PROTEOME RES, V8, P1404, DOI 10.1021/pr8010155; Szodoray P, 2008, SCAND J IMMUNOL, V68, P261, DOI 10.1111/j.1365-3083.2008.02127.x; Tumani H, 2009, NEUROSCI LETT, V452, P214, DOI 10.1016/j.neulet.2009.01.057; Weiner HL, 2009, ANN NEUROL, V65, P239, DOI 10.1002/ana.21640; You JS, 2005, PROTEOMICS, V5, P290, DOI 10.1002/pmic.200400889	40	52	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12442	10.1371/journal.pone.0012442	http://dx.doi.org/10.1371/journal.pone.0012442			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805994	Green Published, gold, Green Submitted			2022-12-27	WOS:000281301500011
J	Benameur, T; Tual-Chalot, S; Andriantsitohaina, R; Martinez, MC				Benameur, Tarek; Tual-Chalot, Simon; Andriantsitohaina, Ramaroson; Martinez, Maria Carmen			PPAR alpha Is Essential for Microparticle-Induced Differentiation of Mouse Bone Marrow-Derived Endothelial Progenitor Cells and Angiogenesis	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED-RECEPTOR; STEM-CELLS; CIRCULATING MICROPARTICLES; MONONUCLEAR-CELLS; NEOVASCULARIZATION; RECRUITMENT; GROWTH; GAMMA; MICROVESICLES; TRANSCRIPTION	Background: Bone marrow-derived endothelial progenitor cells (EPCs) are critical for neovascularization. We hypothesized that microparticles (MPs), small fragments generated from the plasma membrane, can activate angiogenic programming of EPCs. Methodology/Principal Findings: We studied the effects of MPs obtained from wild type (MPs(PPARa+/+)) and knock-out (MPs(PPAR alpha-/-)) mice on EPC differentiation and angiogenesis. Bone marrow-derived cells were isolated from WT or KO mice and were cultured in the presence of MPs(PPARa+/+) or MPs(PPAR alpha-/-) obtained from blood of mice. Only MPs(PPARa+/+) harboring PPAR a significantly increased EPC, but not monocytic, differentiation. Bone marrow-derived cells treated with MPs(PPARa+/+) displayed increased expression of pro-angiogenic genes and increased in vivo angiogenesis. MPs(PPARa+/+) increased capillarylike tube formation of endothelial cells that was associated with enhanced expressions of endothelial cell-specific markers. Finally, the effects of MPs(PPARa+/+) were mediated by NF-kB-dependent mechanisms. Conclusions/Significance: Our results underscore the obligatory role of PPARa carried by MPs for EPC differentiation and angiogenesis. PPARa-NF-kB-Akt pathways may play a pivotal stimulatory role for neovascularization, which may, at least in part, be mediated by bone marrow-derived EPCs. Improvement of EPC differentiation may represent a useful strategy during reparative neovascularization.	[Benameur, Tarek; Tual-Chalot, Simon; Andriantsitohaina, Ramaroson; Martinez, Maria Carmen] CNRS, UMR 6214, Angers, France; [Benameur, Tarek; Tual-Chalot, Simon; Andriantsitohaina, Ramaroson; Martinez, Maria Carmen] INSERM, U771, Angers, France; [Benameur, Tarek; Tual-Chalot, Simon; Andriantsitohaina, Ramaroson; Martinez, Maria Carmen] Univ Angers, Fac Med, Angers, France	Centre National de la Recherche Scientifique (CNRS); Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers	Benameur, T (corresponding author), CNRS, UMR 6214, Angers, France.	carmen.martinez@univ-angers.fr	B, T/ABD-6713-2020; ANDRIANTSITOHAINA, Ramaroson/H-5286-2018; BENAMEUR, TAREK/P-9053-2019	Tual-Chalot, Simon/0000-0002-9307-7175; andriantsitohaina, ramaroson/0000-0002-4770-3585; Martinez, M Carmen/0000-0003-3897-7397				Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Agouni A, 2008, AM J PATHOL, V173, P1210, DOI 10.2353/ajpath.2008.080228; Asahara T, 2004, AM J PHYSIOL-CELL PH, V287, pC572, DOI 10.1152/ajpcell.00330.2003; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Benameur T, 2009, PHARMACOL REP, V61, P49, DOI 10.1016/S1734-1140(09)70006-4; Biscetti F, 2008, DIABETES, V57, P1394, DOI 10.2337/db07-0765; Biscetti F, 2009, J VASC RES, V46, P103, DOI 10.1159/000143793; Brill A, 2005, CARDIOVASC RES, V67, P30, DOI 10.1016/j.cardiores.2005.04.007; Cimini A, 2008, STEM CELL REV, V4, P293, DOI 10.1007/s12015-008-9024-2; De Bosscher K, 2006, ONCOGENE, V25, P6868, DOI 10.1038/sj.onc.1209935; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Ding L, 2007, CELL BIOL INT, V31, P1002, DOI 10.1016/j.cellbi.2007.03.013; Duan SZ, 2008, CIRC RES, V102, P283, DOI 10.1161/CIRCRESAHA.107.164384; Fadini GP, 2006, EUR HEART J, V27, P2247, DOI 10.1093/eurheartj/ehl198; Fujiyama S, 2003, CIRC RES, V93, P980, DOI 10.1161/01.RES.0000099245.08637.CE; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Han SW, 2008, AM J PHYSIOL-LUNG C, V294, pL1238, DOI 10.1152/ajplung.00017.2008; Hanley K, 1998, J INVEST DERMATOL, V110, P368, DOI 10.1046/j.1523-1747.1998.00139.x; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Jin H, 2006, J CLIN INVEST, V116, P652, DOI 10.1172/JCI24751; Jones DC, 2003, J IMMUNOL, V171, P196, DOI 10.4049/jimmunol.171.1.196; Jones DC, 2002, J BIOL CHEM, V277, P6838, DOI 10.1074/jbc.M106908200; Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817; Kaplanski C, 2000, CANCER RES, V60, P580; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kim SJ, 2009, AM J PATHOL, V174, P1972, DOI 10.2353/ajpath.2009.080819; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138; Lacroix R, 2007, BLOOD, V110, P2432, DOI 10.1182/blood-2007-02-069997; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Mezentsev A, 2005, AM J PHYSIOL-HEART C, V289, pH1106, DOI 10.1152/ajpheart.00265.2005; Mostefai HA, 2008, AM J RESP CRIT CARE, V178, P1148, DOI 10.1164/rccm.200712-1835OC; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ray DM, 2008, THROMB HAEMOSTASIS, V99, P86, DOI 10.1160/TH07-05-0328; Ridnour LA, 2005, P NATL ACAD SCI USA, V102, P13147, DOI 10.1073/pnas.0502979102; Sharifpanah F, 2008, STEM CELLS, V26, P64, DOI 10.1634/stemcells.2007-0532; Soleti R, 2009, CARCINOGENESIS, V30, P580, DOI 10.1093/carcin/bgp030; Steinmetz M, 2010, HYPERTENSION, V55, P593, DOI 10.1161/HYPERTENSIONAHA.109.134213; Szmitko PE, 2003, CIRCULATION, V107, P3093, DOI 10.1161/01.CIR.0000074242.66719.4A; Tabernero Antonia, 2002, BMC Pharmacol, V2, P10, DOI 10.1186/1471-2210-2-10; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wang CH, 2004, CIRCULATION, V109, P1392, DOI 10.1161/01.CIR.0000123231.49594.21; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814	49	43	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12392	10.1371/journal.pone.0012392	http://dx.doi.org/10.1371/journal.pone.0012392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811625	Green Published, gold			2022-12-27	WOS:000281234700017
J	Giannone, RJ; McDonald, HW; Hurst, GB; Shen, RF; Wang, YS; Liu, Y				Giannone, Richard J.; McDonald, Hayes W.; Hurst, Gregory B.; Shen, Rong-Fong; Wang, Yisong; Liu, Yie			The Protein Network Surrounding the Human Telomere Repeat Binding Factors TRF1, TRF2, and POT1	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; DOUBLE-STRAND BREAKS; MAMMALIAN TELOMERES; HOMOLOGOUS RECOMBINATION; DYSFUNCTIONAL TELOMERES; INDUCED PHOSPHORYLATION; IMPORTIN-ALPHA; HUMAN-CELLS; HUMAN RAP1; COMPLEX	Telomere integrity (including telomere length and capping) is critical in overall genomic stability. Telomere repeat binding factors and their associated proteins play vital roles in telomere length regulation and end protection. In this study, we explore the protein network surrounding telomere repeat binding factors, TRF1, TRF2, and POT1 using dual-tag affinity purification in combination with multidimensional protein identification technology liquid chromatography - tandem mass spectrometry (MudPIT LC-MS/MS). After control subtraction and data filtering, we found that TRF2 and POT1 co-purified all six members of the telomere protein complex, while TRF1 identified five of six components at frequencies that lend evidence towards the currently accepted telomere architecture. Many of the known TRF1 or TRF2 interacting proteins were also identified. Moreover, putative associating partners identified for each of the three core components fell into functional categories such as DNA damage repair, ubiquitination, chromosome cohesion, chromatin modification/remodeling, DNA replication, cell cycle and transcription regulation, nucleotide metabolism, RNA processing, and nuclear transport. These putative protein-protein associations may participate in different biological processes at telomeres or, intriguingly, outside telomeres.	[Giannone, Richard J.; Wang, Yisong] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA; [Giannone, Richard J.; Hurst, Gregory B.] Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN USA; [McDonald, Hayes W.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Shen, Rong-Fong; Liu, Yie] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Wang, Yisong] NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Giannone, RJ (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA.	yisong.wang@nih.gov; liuyie@mail.nih.gov	Liu, Yie/AAO-2092-2020; Giannone, Richard/ABC-8247-2020	Giannone, Richard/0000-0001-8551-0138; Hurst, Gregory/0000-0002-7650-8009	National Institute on Aging, National Institutes of Health; Oak Ridge National Laboratory; Office of Biological and Environmental Research, U.S. Department of Energy [DE-AC05-00OR22725]	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Oak Ridge National Laboratory(United States Department of Energy (DOE)); Office of Biological and Environmental Research, U.S. Department of Energy(United States Department of Energy (DOE))	This study was supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. Y.W. and R.J.G. acknowledge the support of the Laboratory Directed Research and Development Program (LDRD), Oak Ridge National Laboratory, and the Office of Biological and Environmental Research, U.S. Department of Energy (DE-AC05-00OR22725). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; Atanasiu C, 2006, EMBO REP, V7, P716, DOI 10.1038/sj.embor.7400730; Ballal RD, 2009, J BIOL CHEM, V284, P36083, DOI 10.1074/jbc.M109.025825; Barbash O, 2008, CANCER CELL, V14, P68, DOI 10.1016/j.ccr.2008.05.017; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Bradshaw PS, 2005, NAT GENET, V37, P193, DOI 10.1038/ng1506; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Canudas S, 2007, EMBO J, V26, P4867, DOI 10.1038/sj.emboj.7601903; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Chen LY, 2007, MOL CELL BIOL, V27, P5898, DOI 10.1128/MCB.00603-07; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng Z, 2003, J VIROL, V77, P11992, DOI 10.1128/JVI.77.22.11992-12001.2003; di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504; Dynek JN, 2004, SCIENCE, V304, P97, DOI 10.1126/science.1094754; Forwood JK, 2002, BIOCHEMISTRY-US, V41, P9333, DOI 10.1021/bi025548s; Giannone RJ, 2007, BIOTECHNIQUES, V43, P296, DOI 10.2144/000112550; Gomez M, 2006, MOL BIOL CELL, V17, P1686, DOI 10.1091/mbc.E05-07-0672; Greider CW, 1996, SCI AM, V274, P92, DOI 10.1038/scientificamerican0296-92; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Huda N, 2009, MOL CELL BIOL, V29, P3597, DOI 10.1128/MCB.00944-08; Karlseder J, 2004, PLOS BIOL, V2, P1150, DOI 10.1371/journal.pbio.0020240; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Koering CE, 2002, EMBO REP, V3, P1055, DOI 10.1093/embo-reports/kvf215; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee TH, 2009, NAT CELL BIOL, V11, P97, DOI 10.1038/ncb1818; Lee TH, 2006, J BIOL CHEM, V281, P759, DOI 10.1074/jbc.M509855200; Lenain C, 2006, CURR BIOL, V16, P1303, DOI 10.1016/j.cub.2006.05.021; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Linger BR, 2009, CRIT REV BIOCHEM MOL, V44, P434, DOI 10.3109/10409230903307329; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Longhese MP, 2008, GENE DEV, V22, P125, DOI 10.1101/gad.1626908; Mao ZY, 2007, P NATL ACAD SCI USA, V104, P13068, DOI 10.1073/pnas.0702410104; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Nakamura M, 2001, CURR BIOL, V11, P1512, DOI 10.1016/S0960-9822(01)00456-0; Nijjar T, 2005, ONCOGENE, V24, P3369, DOI 10.1038/sj.onc.1208482; O'Connor MS, 2004, J BIOL CHEM, V279, P28585, DOI 10.1074/jbc.M312913200; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Saharia A, 2008, CURR BIOL, V18, P496, DOI 10.1016/j.cub.2008.02.071; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Song K, 2000, FEBS LETT, V481, P81, DOI 10.1016/S0014-5793(00)01958-X; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tanaka H, 2005, P NATL ACAD SCI USA, V102, P15539, DOI 10.1073/pnas.0507915102; Tatsumi Y, 2008, GENES CELLS, V13, P1045, DOI 10.1111/j.1365-2443.2008.01224.x; TEMIMESMAALI N, 2008, EMBO J; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Xin HW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-232; Xu Yi-yi, 2007, Zhejiang Da Xue Xue Bao Yi Xue Ban, V36, P325; Yang Q, 2005, MOL CELL BIOL, V25, P1070, DOI 10.1128/MCB.25.3.1070-1080.2005; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; Zeng SC, 2009, NAT CELL BIOL, V11, P616, DOI 10.1038/ncb1867; Zhang P, 2008, CURR BIOL, V18, P1489, DOI 10.1016/j.cub.2008.08.048; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	75	41	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12407	10.1371/journal.pone.0012407	http://dx.doi.org/10.1371/journal.pone.0012407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811636	Green Published, Green Submitted, gold			2022-12-27	WOS:000281234700028
J	Goh, LL; Manser, E				Goh, Liuh Ling; Manser, Ed			The RhoA GEF Syx Is a Target of Rnd3 and Regulated via a Raf1-Like Ubiquitin-Related Domain	PLOS ONE			English	Article							NUCLEOTIDE-EXCHANGE FACTORS; IN-VIVO; ROCK-I; VERTEBRATE GASTRULATION; CONVERGENT EXTENSION; XENOPUS GASTRULATION; ACTS DOWNSTREAM; CELL-ADHESION; STEM-CELLS; PROTEIN	Background: Rnd3 (RhoE) protein belongs to the unique branch of Rho family GTPases that has low intrinsic GTPase activity and consequently remains constitutively active [1,2]. The current consensus is that Rnd1 and Rnd3 function as important antagonists of RhoA signaling primarily by activating the ubiquitous p190 RhoGAP [3], but not by inhibiting the ROCK family kinases. Methodology/Principal Findings: Rnd3 is abundant in mouse embryonic stem (mES) cells and in an unbiased two-step affinity purification screen we identified a new Rnd3 target, termed synectin-binding RhoA exchange factor (Syx), by mass spectrometry. The Syx interaction with Rnd3 does not occur through the Syx DH domain but utilizes a region similar to the classic Raf1 Ras-binding domain (RBD), and most closely related to those in RGS12 and RGS14. We show that Syx behaves as a genuine effector of Rnd3 (and perhaps Rnd1), with binding characteristics similar to p190-RhoGAP. Morpholino-oligonucleotide knockdown of Syx in zebrafish at the one cell stage resulted in embryos with shortened anterior-posterior body axis: this phenotype was effectively rescued by introducing mouse Syx1b mRNA. A Rnd3-binding defective mutant of Syx1b mutated in the RBD (E164A/R165D) was more potent in rescuing the embryonic defects than wild-type Syx1b, showing that Rnd3 negatively regulates Syx activity in vivo. Conclusions/Significance: This study uncovers a well defined Rnd3 effector Syx which is widely expressed and directly impacts RhoA activation. Experiments conducted in vivo indicate that Rnd3 negatively regulates Syx, and that as a RhoA-GEF it plays a key role in early embryonic cell shape changes. Thus a connection to signaling via the planar cell polarity pathway is suggested.	[Goh, Liuh Ling; Manser, Ed] Inst Med Biol, Rho GTPases Stem Cells RGS Grp, Singapore, Singapore; [Manser, Ed] IMCB, Small G Prot Signaling & Kinases sGSK Grp, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Goh, LL (corresponding author), Inst Med Biol, Rho GTPases Stem Cells RGS Grp, Singapore, Singapore.	ed.manser@imb.a-star.edu.sg	Manser, Edward/ABD-2301-2020		Agency for Science, Technology and Research (A-STAR)	Agency for Science, Technology and Research (A-STAR)(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology and Research (A-STAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; De Toledo M, 2001, ONCOGENE, V20, P7307, DOI 10.1038/sj.onc.1204921; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; Fortier M, 2008, CELL DEATH DIFFER, V15, P1221, DOI 10.1038/cdd.2008.34; Foster R, 1996, MOL CELL BIOL, V16, P2689; Garnaas MK, 2008, CIRC RES, V103, P710, DOI 10.1161/CIRCRESAHA.108.181388; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hansen SH, 2000, MOL CELL BIOL, V20, P9364, DOI 10.1128/MCB.20.24.9364-9375.2000; Harb N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003001; Jopling C, 2005, EMBO REP, V6, P426, DOI 10.1038/sj.embor.7400386; Katoh H, 2002, MOL CELL BIOL, V22, P2952, DOI 10.1128/MCB.22.9.2952-2964.2002; Kiel C, 2007, J MOL BIOL, V370, P1020, DOI 10.1016/j.jmb.2007.05.015; Klein RM, 2008, MOL BIOL CELL, V19, P498, DOI 10.1091/mbc.E07-09-0895; Komander D, 2008, EMBO J, V27, P3175, DOI 10.1038/emboj.2008.226; Koyanagi M, 2008, J NEUROSCI RES, V86, P270, DOI 10.1002/jnr.21502; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Liu ML, 2006, MOL BIOL CELL, V17, P1880, DOI 10.1091/mbc.E06-01-0002; Madigan JP, 2009, BIOCHEM J, V424, P153, DOI 10.1042/BJ20082377; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Marx R, 2005, J NEUROCHEM, V92, P850, DOI 10.1111/j.1471-4159.2004.02930.x; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Ongusaha PP, 2006, CURR BIOL, V16, P2466, DOI 10.1016/j.cub.2006.10.056; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rubenstein NM, 2005, EXP CELL RES, V305, P74, DOI 10.1016/j.yexcr.2004.12.010; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Stam J C, 1999, Prog Mol Subcell Biol, V22, P51; Tahinci E, 2003, DEV BIOL, V259, P318, DOI 10.1016/S0012-1606(03)00206-9; TALENSVISCONTI R, 2009, J NEUROCHEM; Tanegashima K, 2008, EMBO J, V27, P606, DOI 10.1038/emboj.2008.9; Tong YF, 2009, J BIOL CHEM, V284, P35962, DOI 10.1074/jbc.M109.056275; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Wunnenberg-Stapleton K, 1999, DEVELOPMENT, V126, P5339; Zhu SZ, 2006, CELL SIGNAL, V18, P359, DOI 10.1016/j.cellsig.2005.05.019	42	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12409	10.1371/journal.pone.0012409	http://dx.doi.org/10.1371/journal.pone.0012409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811643	gold, Green Submitted, Green Published			2022-12-27	WOS:000281234700030
J	Nookaew, I; Gabrielsson, BG; Holmang, A; Sandberg, AS; Nielsen, J				Nookaew, Intawat; Gabrielsson, Britt G.; Holmang, Agneta; Sandberg, Ann-Sofie; Nielsen, Jens			Identifying Molecular Effects of Diet through Systems Biology: Influence of Herring Diet on Sterol Metabolism and Protein Turnover in Mice	PLOS ONE			English	Article							FISH-OIL; LDL RECEPTOR; OXYGEN-CONSUMPTION; SKELETAL-MUSCLE; ADIPOSE-TISSUE; GENE ONTOLOGY; FATTY-ACIDS; IN-VIVO; ATHEROSCLEROSIS; CHOLESTEROL	Background: Changes in lifestyle have resulted in an epidemic development of obesity-related diseases that challenge the healthcare systems worldwide. To develop strategies to tackle this problem the focus is on diet to prevent the development of obesity-associated diseases such as cardiovascular disease (CVD). This will require methods for linking nutrient intake with specific metabolic processes in different tissues. Methodology/Principal Finding: Low-density lipoprotein receptor-deficient (Ldlr -/-) mice were fed a high fat/high sugar diet to mimic a westernized diet, being a major reason for development of obesity and atherosclerosis. The diets were supplemented with either beef or herring, and matched in macronutrient contents. Body composition, plasma lipids and aortic lesion areas were measured. Transcriptomes of metabolically important tissues, e.g. liver, muscle and adipose tissue were analyzed by an integrated approach with metabolic networks to directly map the metabolic effects of diet in these different tissues. Our analysis revealed a reduction in sterol metabolism and protein turnover at the transcriptional level in herring-fed mice. Conclusion: This study shows that an integrated analysis of transcriptome data using metabolic networks resulted in the identification of signature pathways. This could not have been achieved using standard clustering methods. In particular, this systems biology analysis could enrich the information content of biomedical or nutritional data where subtle changes in several tissues together affects body metabolism or disease progression. This could be applied to improve diets for subjects exposed to health risks associated with obesity.	[Nookaew, Intawat; Gabrielsson, Britt G.; Sandberg, Ann-Sofie; Nielsen, Jens] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Holmang, Agneta] Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden	Chalmers University of Technology; University of Gothenburg	Nookaew, I (corresponding author), Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden.	nielsenj@chalmers.se	Gabrielsson, Britt/B-9870-2011; sandberg, ann-sofie/B-6857-2016; Nielsen, Jens/Q-1347-2017	Gabrielsson, Britt/0000-0003-4318-8704; sandberg, ann-sofie/0000-0002-9681-3342; Nielsen, Jens/0000-0002-9955-6003	National Board of Fisheries Sweden (EU); Knut and Alice Wallenberg Foundation; Novo Nordisk Foundation; Swedish Medical Research Council [12206]; Swedish Diabetes Association Research Foundation; Swedish federal government; Vastra Gotaland Region; Chalmers Foundation	National Board of Fisheries Sweden (EU)(European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Diabetes Association Research Foundation; Swedish federal government; Vastra Gotaland Region; Chalmers Foundation	This work received financial support from the National Board of Fisheries Sweden (EU Structural Funds), the Chalmers Foundation and the Knut and Alice Wallenberg Foundation, the Novo Nordisk Foundation, the Swedish Medical Research Council (Project No. 12206), the Swedish Diabetes Association Research Foundation, the Swedish federal government under the LUA/ALF agreement and The Vastra Gotaland Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BANG HO, 1980, AM J CLIN NUTR, V33, P2657, DOI 10.1093/ajcn/33.12.2657; Barber MD, 2000, CLIN SCI, V98, P389, DOI 10.1042/CS19990273; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bjorkbacka H, 2006, CURR OPIN LIPIDOL, V17, P527; Bourghardt J, 2007, ENDOCRINOLOGY, V148, P4128, DOI 10.1210/en.2007-0259; Brostrom MA, 2003, CELL CALCIUM, V34, P345, DOI 10.1016/S0143-4160(03)00127-1; Chapkin RS, 2009, PROSTAG LEUKOTR ESS, V81, P187, DOI 10.1016/j.plefa.2009.05.010; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; DULLOO AG, 1994, METABOLISM, V43, P931, DOI 10.1016/0026-0495(94)90169-4; Dupasquier CMC, 2007, AM J PHYSIOL-HEART C, V293, pH2394, DOI 10.1152/ajpheart.01104.2006; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Elvevoll EO, 2008, ATHEROSCLEROSIS, V200, P396, DOI 10.1016/j.atherosclerosis.2007.12.021; Goldberg RB, 2008, CURR OPIN ENDOCRINOL, V15, P167, DOI 10.1097/MED.0b013e3282f76728; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Le Lay S, 2001, J BIOL CHEM, V276, P16904, DOI 10.1074/jbc.M010955200; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lionetti L, 2009, NUTR METAB CARDIOVAS, V19, P146, DOI 10.1016/j.numecd.2008.10.010; Muller M, 2003, NAT REV GENET, V4, P315, DOI 10.1038/nrg1047; Nagahuedi S, 2009, J EXP BIOL, V212, P1106, DOI 10.1242/jeb.027888; Oliveira AP, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-17; Patil KR, 2005, P NATL ACAD SCI USA, V102, P2685, DOI 10.1073/pnas.0406811102; Peoples GE, 2008, J CARDIOVASC PHARM, V52, P540, DOI 10.1097/FJC.0b013e3181911913; Pepe S, 2002, CIRCULATION, V105, P2303, DOI 10.1161/01.CIR.0000015604.88808.74; Quek LE, 2008, GENOME INFORM SER, V21, P89; Rasmussen BB, 2009, J APPL PHYSIOL, V106, P1365, DOI 10.1152/japplphysiol.00081.2009; Ruxton CHS, 2004, J HUM NUTR DIET, V17, P449, DOI 10.1111/j.1365-277X.2007.00770.x; Ryan AM, 2009, ANN SURG, V249, P355, DOI 10.1097/SLA.0b013e31819a4789; Saraswathi V, 2007, J NUTR, V137, P1776, DOI 10.1093/jn/137.7.1776; Schreyer SA, 2002, AM J PHYSIOL-ENDOC M, V282, pE207, DOI 10.1152/ajpendo.2002.282.1.E207; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Shukla A, 2006, BRIT J NUTR, V96, P674, DOI 10.1079/BJN20061895; Sjogren K, 2001, J NUTR, V131, P2963, DOI 10.1093/jn/131.11.2963; SOHAL PS, 1992, BIOCHEM J, V286, P405, DOI 10.1042/bj2860405; Van Assche T, 2007, CELL CALCIUM, V41, P295, DOI 10.1016/j.ceca.2006.06.010; VanderLaan PA, 2009, J LIPID RES, V50, P376, DOI 10.1194/jlr.M800284-JLR200; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Wu L, 2006, J LIPID RES, V47, P2215, DOI 10.1194/jlr.M600146-JLR200; Yudkin JS, 2003, INT J OBESITY, V27, pS25, DOI 10.1038/sj.ijo.0802496; Zampolli A, 2006, ATHEROSCLEROSIS, V184, P78, DOI 10.1016/j.atherosclerosis.2005.04.018; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	45	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12361	10.1371/journal.pone.0012361	http://dx.doi.org/10.1371/journal.pone.0012361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808764	gold, Green Published			2022-12-27	WOS:000281154300004
J	Chan, S; Head, SI				Chan, Stephen; Head, Stewart I.			Age- and Gender-Related Changes in Contractile Properties of Non-Atrophied EDL Muscle	PLOS ONE			English	Article							EXTENSOR DIGITORUM LONGUS; SINGLE MOTOR UNITS; SKELETAL-MUSCLE; MDX MOUSE; LENGTHENING CONTRACTIONS; HISTOCHEMICAL PROPERTIES; MECHANICAL-PROPERTIES; INDUCED INJURY; FEMALE MICE; FAST-FIBERS	Background: In humans, ageing causes skeletal muscles to become atrophied, weak, and easily fatigued. In rodent studies, ageing has been associated with significant muscle atrophy and changes in the contractile properties of the muscles. However, it is not entirely clear whether these changes in contractile properties can occur before there is significant atrophy, and whether males and females are affected differently. Methods and Results: We investigated various contractile properties of whole isolated fast-twitch EDL muscles from adult (2-6 months-old) and aged (12-22 months-old) male and female mice. Atrophy was not present in the aged mice. Compared with adult mice, EDL muscles of aged mice had significantly lower specific force, longer tetanus relaxation times, and lower fatiguability. In the properties of absolute force and muscle relaxation times, females were affected by ageing to a greater extent than males. Additionally, EDL muscles from a separate group of male mice were subjected to eccentric contractions of 15% strain, and larger force deficits were found in aged than in adult mice. Conclusion: Our findings provide further insight into the muscle atrophy, weakness and fatiguability experienced by the elderly. We have shown that even in the absence of muscle atrophy, there are definite alterations in the physiological properties of whole fast-twitch muscle from ageing mice, and for some of these properties the alterations are more pronounced in female mice than in male mice.	[Chan, Stephen; Head, Stewart I.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia	University of New South Wales Sydney	Chan, S (corresponding author), Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia.	s.head@unsw.edu.au	Head, Stewart I/F-4435-2010; Head, Stewart/O-7016-2019	Head, Stewart/0000-0002-6891-7590	National Health and Medical Research Council of Australia; University of New South Wales School of Medical Sciences	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of New South Wales School of Medical Sciences	The authors acknowledge the National Health and Medical Research Council of Australia and the University of New South Wales School of Medical Sciences for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akima H, 2001, MED SCI SPORT EXER, V33, P220; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; ANDERSON JE, 1988, J MUSCLE RES CELL M, V9, P499, DOI 10.1007/BF01738755; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Bilodeau M, 2001, J APPL PHYSIOL, V91, P2654, DOI 10.1152/jappl.2001.91.6.2654; Bortz WM, 2002, J GERONTOL A-BIOL, V57, pM283, DOI 10.1093/gerona/57.5.M283; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Brooks SV, 1996, J PHYSIOL-LONDON, V497, P573, DOI 10.1113/jphysiol.1996.sp021790; BROOKS SV, 1995, J PHYSIOL-LONDON, V488, P459, DOI 10.1113/jphysiol.1995.sp020980; Brown M, 1996, J GERONTOL A-BIOL, V51, pB117, DOI 10.1093/gerona/51A.2.B117; Dickstein DL, 2007, AGING CELL, V6, P275, DOI 10.1111/j.1474-9726.2007.00289.x; EDSTROM L, 1987, J PHYSIOL-LONDON, V392, P129, DOI 10.1113/jphysiol.1987.sp016773; Faulkner JA, 1995, ADV EXP MED BIOL, V384, P471; Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x; FLITNEY FW, 1978, J PHYSIOL-LONDON, V276, P449, DOI 10.1113/jphysiol.1978.sp012246; FRONTERA WR, 1991, J APPL PHYSIOL, V71, P644, DOI 10.1152/jappl.1991.71.2.644; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gonzalez E, 2000, J MEMBRANE BIOL, V178, P175, DOI 10.1007/s002320010025; Gonzalez E, 2001, MECH AGEING DEV, V122, P1019, DOI 10.1016/S0047-6374(01)00229-9; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; HEAD SI, 1992, P ROY SOC B-BIOL SCI, V248, P163, DOI 10.1098/rspb.1992.0058; Imagita H, 2009, BIOMED RES-TOKYO, V30, P337, DOI 10.2220/biomedres.30.337; ISHIHARA A, 1988, MECH AGEING DEV, V45, P213, DOI 10.1016/0047-6374(88)90003-6; Jimenez-Moreno R, 2008, BIOPHYS J, V94, P3178, DOI 10.1529/biophysj.107.118786; Kadhiresan VA, 1996, J PHYSIOL-LONDON, V493, P543, DOI 10.1113/jphysiol.1996.sp021402; KARPATI G, 1988, MUSCLE NERVE, V11, P795, DOI 10.1002/mus.880110802; LARSSON L, 1986, J NEUROL SCI, V76, P69, DOI 10.1016/0022-510X(86)90143-7; Larsson L, 2000, DRUG AGING, V17, P303, DOI 10.2165/00002512-200017040-00006; Lowe DA, 2002, AM J PHYSIOL-CELL PH, V283, pC187, DOI 10.1152/ajpcell.00008.2002; Lowe DA, 2001, AM J PHYSIOL-CELL PH, V280, pC540, DOI 10.1152/ajpcell.2001.280.3.C540; Lowe DA, 2010, EXERC SPORT SCI REV, V38, P61, DOI 10.1097/JES.0b013e3181d496bc; Luff AR, 1998, ANN NY ACAD SCI, V854, P92, DOI 10.1111/j.1749-6632.1998.tb09895.x; Lynch GS, 2008, AM J PHYSIOL-CELL PH, V295, pC249, DOI 10.1152/ajpcell.90640.2007; MCCULLY KK, 1986, J APPL PHYSIOL, V61, P293, DOI 10.1152/jappl.1986.61.1.293; Moran AL, 2006, J APPL PHYSIOL, V100, P548, DOI 10.1152/japplphysiol.01029.2005; Moran AL, 2005, EXP GERONTOL, V40, P966, DOI 10.1016/j.exger.2005.09.005; Moran AL, 2007, J APPL PHYSIOL, V102, P1387, DOI 10.1152/japplphysiol.01305.2006; Motulsky H, 2003, PRACTICAL GUIDE CURV; Oliviero A, 2006, NEUROSCI RES, V55, P74, DOI 10.1016/j.neures.2006.02.002; Pagala MK, 1998, MUSCLE NERVE, V21, P1729, DOI 10.1002/(SICI)1097-4598(199812)21:12<1729::AID-MUS16>3.0.CO;2-V; Payne AM, 2003, J APPL PHYSIOL, V95, P2554, DOI 10.1152/japplphysiol.00758.2003; Payne AM, 2009, EXP GERONTOL, V44, P261, DOI 10.1016/j.exger.2008.09.013; Pinniger GJ, 2006, J PHYSIOL-LONDON, V573, P627, DOI 10.1113/jphysiol.2005.095448; PINNIGER GJ, 2006, PHYSL NEWS, V65, P13; Plant DR, 2002, J PHYSIOL-LONDON, V543, P169, DOI 10.1113/jphysiol.2002.022418; RACK PMH, 1974, J PHYSIOL-LONDON, V240, P331, DOI 10.1113/jphysiol.1974.sp010613; Rader EP, 2006, J APPL PHYSIOL, V100, P656, DOI 10.1152/japplphysiol.00663.2005; Rader EP, 2006, J APPL PHYSIOL, V101, P887, DOI 10.1152/japplphysiol.00380.2006; Renganathan M, 1997, J MEMBRANE BIOL, V157, P247, DOI 10.1007/s002329900233; Stackhouse SKS, 2001, PHYS THER, V81, P1102, DOI 10.1093/ptj/81.5.1102; Sugiura M, 2004, J NEUROPHYSIOL, V92, P1357, DOI 10.1152/jn.00947.2003; TINETTI ME, 1986, AM J MED, V80, P429, DOI 10.1016/0002-9343(86)90717-5; WESTERBLAD H, 1991, J PHYSIOL-LONDON, V434, P323, DOI 10.1113/jphysiol.1991.sp018472; Westerblad H, 2002, CURR OPIN RHEUMATOL, V14, P648, DOI 10.1097/00002281-200211000-00003; Yoon T, 2008, MUSCLE NERVE, V37, P457, DOI 10.1002/mus.20969	55	48	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12345	10.1371/journal.pone.0012345	http://dx.doi.org/10.1371/journal.pone.0012345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808812	gold, Green Published, Green Submitted			2022-12-27	WOS:000281153500024
J	Mora, JS; Assi, SA; Fernandez-Fuentes, N				Mora, Joan Segura; Assi, Salam A.; Fernandez-Fuentes, Narcis			Presaging Critical Residues in Protein interfaces-Web Server (PCRPi-W): A Web Server to Chart Hot Spots in Protein Interfaces	PLOS ONE			English	Article								Background: It is well established that only a portion of residues that mediate protein-protein interactions (PPIs), the so-called hot spot, contributes the most to the total binding energy, and thus its identification is an important and relevant question that has clear applications in drug discovery and protein design. The experimental identification of hot spots is however a lengthy and costly process, and thus there is an interest in computational tools that can complement and guide experimental efforts. Principal Findings: Here, we present Presaging Critical Residues in Protein interfaces-Web server (http://www.bioinsilico.org/PCRPi), a web server that implements a recently described and highly accurate computational tool designed to predict critical residues in protein interfaces: PCRPi. PRCPi depends on the integration of structural, energetic, and evolutionary-based measures by using Bayesian Networks (BNs). Conclusions: PCRPi-W has been designed to provide an easy and convenient access to the broad scientific community. Predictions are readily available for download or presented in a web page that includes among other information links to relevant files, sequence information, and a Jmol applet to visualize and analyze the predictions in the context of the protein structure.	[Mora, Joan Segura; Assi, Salam A.; Fernandez-Fuentes, Narcis] Univ Leeds, Leeds Inst Mol Med, Sect Expt Therapeut, Leeds, W Yorkshire, England	University of Leeds	Mora, JS (corresponding author), Univ Leeds, Leeds Inst Mol Med, Sect Expt Therapeut, Leeds, W Yorkshire, England.	N.Fernandez-Fuentes@leeds.ac.uk		Segura, Joan/0000-0001-5593-735X; Fernandez-Fuentes, Narcis/0000-0002-6421-1080	Research Councils United Kingdom Academic Fellow scheme; Wellcome; Leeds Institute of Molecular Medicine	Research Councils United Kingdom Academic Fellow scheme; Wellcome; Leeds Institute of Molecular Medicine	This work was supported by the Research Councils United Kingdom Academic Fellow scheme (to NFF), Wellcome ViP award (to SAS), and an internal scholarship awarded by the Leeds Institute of Molecular Medicine (to JSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Assi SA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1158; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; JIN L, 1994, PROTEIN SCI, V3, P2351, DOI 10.1002/pro.5560031219; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Lo Conte L, 1999, J MOL BIOL, V285, P2177; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Tanaka T, 2007, EMBO J, V26, P3250, DOI 10.1038/sj.emboj.7601744; Tuncbag N, 2009, BIOINFORMATICS, V25, P1513, DOI 10.1093/bioinformatics/btp240; Wang Q, 2008, NAT PROTOC, V3, P1832, DOI 10.1038/nprot.2008.184; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526	18	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12352	10.1371/journal.pone.0012352	http://dx.doi.org/10.1371/journal.pone.0012352			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808810	Green Published, gold			2022-12-27	WOS:000281153500028
J	Visscher, AM; Paul, AL; Kirst, M; Guy, CL; Schuerger, AC; Ferl, RJ				Visscher, Anne M.; Paul, Anna-Lisa; Kirst, Matias; Guy, Charles L.; Schuerger, Andrew C.; Ferl, Robert J.			Growth Performance and Root Transcriptome Remodeling of Arabidopsis in Response to Mars-Like Levels of Magnesium Sulfate	PLOS ONE			English	Article							TRANSPORT; PROTEIN; SYSTEM; GENES; IDENTIFICATION; MERIDIANI; PLANTS	Background: Martian regolith (unconsolidated surface material) is a potential medium for plant growth in bioregenerative life support systems during manned missions on Mars. However, hydrated magnesium sulfate mineral levels in the regolith of Mars can reach as high as 10 wt%, and would be expected to be highly inhibitory to plant growth. Methodology and Principal Findings: Disabling ion transporters AtMRS2-10 and AtSULTR1;2, which are plasma membrane localized in peripheral root cells, is not an effective way to confer tolerance to magnesium sulfate soils. Arabidopsis mrs2-10 and sel1-10 knockout lines do not mitigate the growth inhibiting impacts of high MgSO4 center dot 7H(2)O concentrations observed with wildtype plants. A global approach was used to identify novel genes with potential to enhance tolerance to high MgSO4 center dot 7H(2)O (magnesium sulfate) stress. The early Arabidopsis root transcriptome response to elevated concentrations of magnesium sulfate was characterized in Col-0, and also between Col-0 and the mutant line cax1-1, which was confirmed to be relatively tolerant of high levels of MgSO4 center dot 7H(2)O in soil solution. Differentially expressed genes in Col-0 treated for 45 min. encode enzymes primarily involved in hormone metabolism, transcription factors, calcium-binding proteins, kinases, cell wall related proteins and membrane-based transporters. Over 200 genes encoding transporters were differentially expressed in Col-0 up to 180 min. of exposure, and one of the first down-regulated genes was CAX1. The importance of this early response in wildtype Arabidopsis is exemplified in the fact that only four transcripts were differentially expressed between Col-0 and cax1-1 at 180 min. after initiation of treatment. Conclusions/Significance: The results provide a solid basis for the understanding of the metabolic response of plants to elevated magnesium sulfate soils; it is the first transcriptome analysis of plants in this environment. The results foster the development of Mars soil-compatible plants by showing that cax1 mutants exhibit partial tolerance to magnesium sulfate, and by elucidating a small subset (500 vs. >10,000) of candidate genes for mutation or metabolic engineering that will enhance tolerance to magnesium sulfate soils.	[Visscher, Anne M.; Paul, Anna-Lisa; Ferl, Robert J.] Univ Florida, Dept Hort Sci, Gainesville, FL USA; [Kirst, Matias] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; [Guy, Charles L.] Univ Florida, Dept Environm Hort, Gainesville, FL 32611 USA; [Schuerger, Andrew C.] Univ Florida, Kennedy Space Ctr, Gainesville, FL USA; [Ferl, Robert J.] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Visscher, AM (corresponding author), Univ Oxford, Dept Plant Sci, Oxford, England.	robferl@ufl.edu		Paul, Anna-Lisa/0000-0003-2211-2604; Ferl, Robert/0000-0003-4178-764X	Prins Bernard Cultuurfonds of the Netherlands; NASA [NNX07AH27G]	Prins Bernard Cultuurfonds of the Netherlands; NASA(National Aeronautics & Space Administration (NASA))	Prins Bernard Cultuurfonds of the Netherlands. NASA NNX07AH27G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, METH MOL B, V236, P177; Arvidson RE, 2005, SCIENCE, V307, P1591, DOI 10.1126/science.1109509; Barber S.A., 1995, SOIL NUTRIENT BIOAVA; BARTA DJ, 1994, ADV SPACE RES, V14, P403, DOI 10.1016/0273-1177(94)90329-8; Baxter I, 2007, PLANT PHYSIOL, V143, P600, DOI 10.1104/pp.106.092528; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Bradshaw HD, 2005, NEW PHYTOL, V167, P81, DOI 10.1111/j.1469-8137.2005.01408.x; Brooks R. R., 1987, SERPENTINE ITS VEGET; Buchner P, 2004, J EXP BOT, V55, P1765, DOI 10.1093/jxb/erh206; Chen WE, 2005, WIREL NETW MOB COMP, V1, P3; Cheng NH, 2003, PLANT CELL, V15, P347, DOI 10.1105/tpc.007385; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Ciftci-Yilmaz S, 2007, J BIOL CHEM, V282, P9260, DOI 10.1074/jbc.M611093200; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Deng W, 2006, J EXP BOT, V57, P4235, DOI 10.1093/jxb/erl201; Edmond C, 2009, BIOCHEM J, V418, P145, DOI 10.1042/BJ20081814; Fontes EPB, 2004, GENE DEV, V18, P2545, DOI 10.1101/gad.1245904; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Haskin LA, 2005, NATURE, V436, P66, DOI 10.1038/nature03640; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Koiwa H, 2006, J EXP BOT, V57, P1119, DOI 10.1093/jxb/erj093; Laurie S, 2002, PLANT J, V32, P139, DOI 10.1046/j.1365-313X.2002.01410.x; Li LG, 2001, PLANT CELL, V13, P2761, DOI 10.1105/tpc.13.12.2761; Ma SS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r49; Ma SS, 2006, J EXP BOT, V57, P1097, DOI 10.1093/jxb/erj098; Mao DD, 2008, J INTEGR PLANT BIOL, V50, P1530, DOI 10.1111/j.1744-7909.2008.00770.x; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Maruyama-Nakashita A, 2003, PLANT PHYSIOL, V132, P597, DOI 10.1104/pp.102.019802; Maruyama-Nakashita A, 2006, PLANT CELL, V18, P3235, DOI 10.1105/tpc.106.046458; Ming D. W., 1989, LUNAR BASE AGR SOILS; Ming DW, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002560; Pandey GK, 2007, CELL RES, V17, P411, DOI 10.1038/cr.2007.39; Roberts SK, 2000, J EXP BOT, V51, P1585, DOI 10.1093/jexbot/51.350.1585; Schuerger Andrew C, 2002, Life Support Biosph Sci, V8, P137; Shaul O, 2002, BIOMETALS, V15, P309, DOI 10.1023/A:1016091118585; Smeets K, 2008, PLANT PHYSIOL BIOCH, V46, P212, DOI 10.1016/j.plaphy.2007.09.014; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tocquin Pierre, 2003, BMC Plant Biology, V3, P2, DOI 10.1186/1471-2229-3-2; Ulker B, 2007, PLANTA, V226, P125, DOI 10.1007/s00425-006-0474-y; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Yoshimoto N, 2002, PLANT J, V29, P465, DOI 10.1046/j.0960-7412.2001.01231.x; Zhao J, 2009, J BIOL CHEM, V284, P4605, DOI 10.1074/jbc.M804462200	42	40	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12348	10.1371/journal.pone.0012348	http://dx.doi.org/10.1371/journal.pone.0012348			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808807	gold, Green Submitted, Green Published			2022-12-27	WOS:000281153500026
J	Le Bras, A; Samson, C; Trentini, M; Caetano, B; Lelievre, E; Mattot, V; Beermann, F; Soncin, F				Le Bras, Alexandra; Samson, Chantal; Trentini, Matteo; Caetano, Bertrand; Lelievre, Etienne; Mattot, Virginie; Beermann, Friedrich; Soncin, Fabrice			VE-statin/egfl7 Expression in Endothelial Cells Is Regulated by a Distal Enhancer and a Proximal Promoter under the Direct Control of Erg and GATA-2	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ETS-1 TRANSCRIPTION FACTOR; TIE GENE PROMOTER; BINDING-SITES; VE-CADHERIN; IN-VIVO; MICRORNA MIR-126; TRANSGENIC MICE; ROBO4 PROMOTER; ANGIOGENESIS	Angiogenesis is the process by which new blood vessels arise from existing ones by the budding out of endothelial cell capillaries from the luminal side of blood vessels. Blood vessel formation is essential for organ development during embryogenesis and is associated with several physiological and pathological processes, such as wound healing and tumor development. The VE-statin/egfl7 gene is specifically expressed in endothelial cells during embryonic development and in the adult. We studied here the regulatory mechanisms that control this tissue-specific expression. RT-qPCR analyses showed that the specificity of expression of VE-statin/egfl7 in endothelial cells is not shared with its closest neighbor genes notch1 and agpat2 on the mouse chromosome 2. Chromatin-immunoprecipitation analysis of histone modifications at the VE-statin/egfl7 locus showed that the chromatin is specifically opened in endothelial cells, but not in fibroblasts at the transcription start sites. A 13 kb genomic fragment of promoter was cloned and analyzed by gene reporter assays which showed that two conserved regions are important for the specific expression of VE-statin/egfl7 in endothelial cells; a -8409/-7563 enhancer and the -252/+38 region encompassing the exon-1b transcription start site. The latter contains essential GATA and ETS-binding sites, as assessed by linker-scanning analysis and site-directed mutagenesis. An analysis of expression of the ETS and GATA transcription factors showed that Erg, Fli-1 and GATA-2 are the most highly expressed factors in endothelial cells. Erg and GATA-2 directly control the expression of the endogenous VE-statin/egfl7 while Fli-1 probably exerts an indirect control, as assessed by RNA interference and chromatin immunoprecipitation. This first detailed analysis of the mechanisms that govern the expression of the VE-statin/egfl7 gene in endothelial cells pinpoints the specific importance of ETS and GATA factors in the specific regulation of genes in this cell lineage.	[Le Bras, Alexandra; Samson, Chantal; Trentini, Matteo; Caetano, Bertrand; Lelievre, Etienne; Mattot, Virginie; Soncin, Fabrice] Inst Biol Lille, CNRS, UMR 8161, Equipe Iabellise La Ligue, Lille, France; [Le Bras, Alexandra; Samson, Chantal; Trentini, Matteo; Caetano, Bertrand; Lelievre, Etienne; Mattot, Virginie; Soncin, Fabrice] Univ Lille Nord France, Lille, France; [Le Bras, Alexandra; Samson, Chantal; Trentini, Matteo; Caetano, Bertrand; Lelievre, Etienne; Mattot, Virginie; Soncin, Fabrice] Inst Pasteur, F-59019 Lille, France; [Beermann, Friedrich] Swiss Fed Inst Technol, Sch Life Sci, CPG, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Le Bras, A (corresponding author), Inst Biol Lille, CNRS, UMR 8161, Equipe Iabellise La Ligue, Lille, France.	fabrice.soncin@ibl.fr	SONCIN, Fabrice/A-1475-2009	SONCIN, Fabrice/0000-0001-6312-0673; Le Bras, Alexandra/0000-0001-7898-4618; Lelievre, Etienne/0000-0003-0452-1578	Ligue Nationale Contre le Cancer; Association for International Cancer Research; Oncosuisse; Swiss National Science Foundation	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Association for International Cancer Research; Oncosuisse; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Ligue Nationale Contre le Cancer (Equipe Labellisee La Ligue 2005- and 2008-) and Association for International Cancer Research. FB was supported by Oncosuisse and the Swiss National Science Foundation. ALB and BC were supported by Ligue Nationale contre le Cancer PhD fellowships. MT was an European ERASMUS program student. EL and FS are scientists from the Institut National de la Sante et de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayadi A, 2001, EMBO J, V20, P5139, DOI 10.1093/emboj/20.18.5139; Barton K, 1998, IMMUNITY, V9, P555, DOI 10.1016/S1074-7613(00)80638-X; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Campagnolo L, 2008, GENE EXPR PATTERNS, V8, P389, DOI 10.1016/j.gep.2008.05.001; Chan Y, 2004, J BIOL CHEM, V279, P35087, DOI 10.1074/jbc.M405063200; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Cowan PJ, 1998, J BIOL CHEM, V273, P11737, DOI 10.1074/jbc.273.19.11737; CULLEN KE, 1993, SCIENCE, V261, P203, DOI 10.1126/science.8327891; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Dejana E, 2007, BBA-REV CANCER, V1775, P298, DOI 10.1016/j.bbcan.2007.05.003; DELAMO FF, 1992, DEVELOPMENT, V115, P737; Deleuze V, 2007, MOL CELL BIOL, V27, P2687, DOI 10.1128/MCB.00493-06; DHORDAIN P, 1995, MECH DEVELOP, V50, P17, DOI 10.1016/0925-4773(94)00322-E; Donaldson IJ, 2005, HUM MOL GENET, V14, P595, DOI 10.1093/hmg/ddi056; Dong QG, 1997, ARTERIOSCL THROM VAS, V17, P1599, DOI 10.1161/01.ATV.17.8.1599; DORFMAN DM, 1992, J BIOL CHEM, V267, P1279; Dube A, 1999, CIRC RES, V84, P1177, DOI 10.1161/01.RES.84.10.1177; Eberhardt C, 1997, J BIOL CHEM, V272, P20299, DOI 10.1074/jbc.272.32.20299; Ferdous A, 2009, P NATL ACAD SCI USA, V106, P814, DOI 10.1073/pnas.0807583106; Fish JE, 2005, J BIOL CHEM, V280, P24824, DOI 10.1074/jbc.M502115200; GARLANDA C, 1994, P NATL ACAD SCI USA, V91, P7291, DOI 10.1073/pnas.91.15.7291; Gory S, 1998, J BIOL CHEM, V273, P6750, DOI 10.1074/jbc.273.12.6750; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Iljin K, 1999, FASEB J, V13, P377, DOI 10.1096/fasebj.13.2.377; JAHROUDI N, 1994, MOL CELL BIOL, V14, P999, DOI 10.1128/MCB.14.2.999; Kappel A, 2000, BLOOD, V96, P3078; Kappel A, 1999, BLOOD, V93, P4284, DOI 10.1182/blood.V93.12.4284.412k25_4284_4292; KORHONEN J, 1995, BLOOD, V86, P1828, DOI 10.1182/blood.V86.5.1828.bloodjournal8651828; Krebs LT, 2000, GENE DEV, V14, P1343; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Lelievre E, 2002, J BIOL CHEM, V277, P25143, DOI 10.1074/jbc.M201628200; Lelievre E, 2001, INT J BIOCHEM CELL B, V33, P391, DOI 10.1016/S1357-2725(01)00025-5; Lelievre E, 2000, ONCOGENE, V19, P2438, DOI 10.1038/sj.onc.1203563; Lelievre E, 2008, EMBO J, V27, P1658, DOI 10.1038/emboj.2008.103; Liu F, 2008, CIRC RES, V103, P1147, DOI 10.1161/CIRCRESAHA.108.179713; Loughran SJ, 2008, NAT IMMUNOL, V9, P810, DOI 10.1038/ni.1617; Mager AM, 1998, INT J DEV BIOL, V42, P561; Meireles ACA, 2009, CURR OPIN GENET DEV, V19, P565, DOI 10.1016/j.gde.2009.10.006; Mollica LR, 2006, BLOOD, V108, P1251, DOI 10.1182/blood-2006-02-001461; MORISHITA K, 1995, J BIOL CHEM, V270, P27948, DOI 10.1074/jbc.270.46.27948; MURTHY SCS, 1985, P NATL ACAD SCI USA, V82, P2230, DOI 10.1073/pnas.82.8.2230; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Okada Y, 2008, BLOOD, V112, P2336, DOI 10.1182/blood-2008-01-135079; Okada Y, 2007, CIRC RES, V100, P1712, DOI 10.1161/01.RES.0000269779.10644.dc; Parker LH, 2004, NATURE, V428, P754, DOI 10.1038/nature02416; Peng YW, 2003, J BIOL CHEM, V278, P8385, DOI 10.1074/jbc.M213156200; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P17692, DOI 10.1073/pnas.0707045104; Pimanda JE, 2006, BLOOD, V107, P4737, DOI 10.1182/blood-2005-12-4929; Sambrook J., 2002, MOL CLONING LAB MANU; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Schmidt M, 2007, DEVELOPMENT, V134, P2913, DOI 10.1242/dev.002576; Schmidt MHH, 2009, NAT CELL BIOL, V11, P873, DOI 10.1038/ncb1896; Soncin F, 2003, EMBO J, V22, P5700, DOI 10.1093/emboj/cdg549; VANDENBUNDER B, 1989, DEVELOPMENT, V107, P265; Wakiya K, 1996, J BIOL CHEM, V271, P30823, DOI 10.1074/jbc.271.48.30823; Wang LC, 1997, EMBO J, V16, P4374, DOI 10.1093/emboj/16.14.4374; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; WEI G, 2009, BLOOD IN PRESS, P18701; WILSON DB, 1990, MOL CELL BIOL, V10, P4854, DOI 10.1128/MCB.10.9.4854; Wozniak RJ, 2007, J BIOL CHEM, V282, P14665, DOI 10.1074/jbc.M700792200; Wu J, 2005, MOL CELL BIOL, V25, P1458, DOI 10.1128/MCB.25.4.1458-1474.2005; ZHANG R, 1995, J BIOL CHEM, V270, P15320, DOI 10.1074/jbc.270.25.15320	67	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12156	10.1371/journal.pone.0012156	http://dx.doi.org/10.1371/journal.pone.0012156			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808444	gold, Green Published, Green Submitted			2022-12-27	WOS:000280968000007
J	Matsuda, A; Shao, L; Boulanger, J; Kervrann, C; Carlton, PM; Kner, P; Agard, D; Sedat, JW				Matsuda, Atsushi; Shao, Lin; Boulanger, Jerome; Kervrann, Charles; Carlton, Peter M.; Kner, Peter; Agard, David; Sedat, John W.			Condensed Mitotic Chromosome Structure at Nanometer Resolution Using PALM and EGFP- Histones	PLOS ONE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; GREEN FLUORESCENT PROTEIN; SUPERRESOLUTION MICROSCOPY; CRYOELECTRON MICROSCOPY; ILLUMINATION MICROSCOPY; LOCALIZATION ANALYSIS; NUCLEAR ARCHITECTURE; DIFFRACTION-LIMIT; LIGHT; PHOTOACTIVATION	Photoactivated localization microscopy (PALM) and related fluorescent biological imaging methods are capable of providing very high spatial resolutions (up to 20 nm). Two major demands limit its widespread use on biological samples: requirements for photoactivatable/photoconvertible fluorescent molecules, which are sometimes difficult to incorporate, and high background signals from autofluorescence or fluorophores in adjacent focal planes in three-dimensional imaging which reduces PALM resolution significantly. We present here a high-resolution PALM method utilizing conventional EGFP as the photoconvertible fluorophore, improved algorithms to deal with high levels of biological background noise, and apply this to imaging higher order chromatin structure. We found that the emission wavelength of EGFP is efficiently converted from green to red when exposed to blue light in the presence of reduced riboflavin. The photon yield of red-converted EGFP using riboflavin is comparable to other bright photoconvertible fluorescent proteins that allow,20 nm resolution. We further found that image pre-processing using a combination of denoising and deconvolution of the raw PALM images substantially improved the spatial resolution of the reconstruction from noisy images. Performing PALM on Drosophila mitotic chromosomes labeled with H2AvD-EGFP, a histone H2A variant, revealed filamentous components of,70 nm. This is the first observation of fine chromatin filaments specific for one histone variant at a resolution approximating that of conventional electron microscope images (10-30 nm). As demonstrated by modeling and experiments on a challenging specimen, the techniques described here facilitate super-resolution fluorescent imaging with common biological samples.	[Matsuda, Atsushi; Shao, Lin; Carlton, Peter M.; Kner, Peter; Agard, David; Sedat, John W.] Univ Calif San Francisco, Dept Biochem & Biophys, Keck Ctr Adv Microscopy, San Francisco, CA 94143 USA; [Boulanger, Jerome] Inst Curie, Ctr Rech, Paris, France; [Kervrann, Charles] INRIA Rennes Bretagne Atlantique, Rennes, France; [Agard, David] Univ Calif San Francisco, Howard Hughes Med Inst, Keck Ctr Adv Microscopy, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Matsuda, A (corresponding author), Natl Inst Commun Techonol, Kobe Adv ICT Ctr, Kobe, Hyogo, Japan.	sedat@msg.ucsf.edu	Carlton, Peter/AAD-2403-2021	Carlton, Peter/0000-0002-5320-6024; Matsuda, Atsushi/0000-0003-0510-213X; Boulanger, Jerome/0000-0003-0237-3743	National Institutes of Health (NIH) [GM25101, R01 GM085502]; Grants-in-Aid for Scientific Research [22870042] Funding Source: KAKEN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025101, R01GM085502] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health (NIH) grant GM25101 (to JSW) and by NIH grant R01 GM085502 (to JSW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARD DA, 1989, METHOD CELL BIOL, V30, P353; Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; BELMONT AS, 1994, J CELL BIOL, V127, P287, DOI 10.1083/jcb.127.2.287; BELMONT AS, 1987, J CELL BIOL, V105, P77, DOI 10.1083/jcb.105.1.77; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Biteen JS, 2008, NAT METHODS, V5, P947, DOI 10.1038/nmeth.1258; Bogdanov AM, 2009, NAT CHEM BIOL, V5, P459, DOI 10.1038/nchembio.174; Bouchet-Marquis C, 2006, HISTOCHEM CELL BIOL, V125, P43, DOI 10.1007/s00418-005-0093-x; Boulanger J, 2010, IEEE T MED IMAGING, V29, P442, DOI 10.1109/TMI.2009.2033991; CARLTON PM, 2010, P NATL ACAD SCI US; Clarkson M, 1999, DNA CELL BIOL, V18, P457, DOI 10.1089/104454999315178; DELATOUR EB, 1988, CELL, V55, P937, DOI 10.1016/0092-8674(88)90239-5; Dertinger T, 2009, P NATL ACAD SCI USA, V106, P22287, DOI 10.1073/pnas.0907866106; EDMONDSON DE, 1983, TOP CURR CHEM, V108, P109; Egner A, 2007, BIOPHYS J, V93, P3285, DOI 10.1529/biophysj.107.112201; Elowitz MB, 1997, CURR BIOL, V7, P809, DOI 10.1016/S0960-9822(06)00342-3; Eltsov M, 2008, P NATL ACAD SCI USA, V105, P19732, DOI 10.1073/pnas.0810057105; Foe Victoria E., 1993, P149; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; FRISELL WR, 1959, J BIOL CHEM, V234, P1297; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Heilemann M, 2009, ANGEW CHEM INT EDIT, V48, P6903, DOI 10.1002/anie.200902073; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Henderson GP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000749; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; HIRAOKA Y, 1990, BIOPHYS J, V57, P325, DOI 10.1016/S0006-3495(90)82534-0; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Horowitz-Scherer RA, 2006, CHROMOSOMA, V115, P1, DOI 10.1007/s00412-005-0035-3; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jakobs S, 2003, FEBS LETT, V554, P194, DOI 10.1016/S0014-5793(03)01170-0; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Kireeva N, 2004, J CELL BIOL, V166, P775, DOI 10.1083/jcb.200406049; Konig P, 2007, CHROMOSOMA, V116, P349, DOI 10.1007/s00412-007-0101-0; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Leach TJ, 2000, J BIOL CHEM, V275, P23267, DOI 10.1074/jbc.M910206199; Maeshima K, 2003, DEV CELL, V4, P467, DOI 10.1016/S1534-5807(03)00092-3; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P1, DOI 10.1021/bi00594a001; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Mortensen KI, 2010, NAT METHODS, V7, P377, DOI [10.1038/nmeth.1447, 10.1038/NMETH.1447]; PALMER D, 1980, P NATL ACAD SCI-BIOL, V77, P2671, DOI 10.1073/pnas.77.5.2671; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; Pavani SRP, 2009, P NATL ACAD SCI USA, V106, P2995, DOI 10.1073/pnas.0900245106; Poirier MG, 2002, MOL BIOL CELL, V13, P2170, DOI 10.1091/mbc.01-08-0401; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sacchetti A, 1999, CURR BIOL, V9, pR391, DOI 10.1016/S0960-9822(99)80250-4; Sawin KE, 1997, CURR BIOL, V7, pR606, DOI 10.1016/S0960-9822(06)00313-7; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; SEDAT J, 1977, COLD SPRING HARB SYM, V42, P331, DOI 10.1101/SQB.1978.042.01.035; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Smith CS, 2010, NAT METHODS, V7, P373, DOI [10.1038/NMETH.1449, 10.1038/nmeth.1449]; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Taddei A, 2004, ANNU REV GENET, V38, P305, DOI 10.1146/annurev.genet.37.110801.142705; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Vogelsang J, 2009, P NATL ACAD SCI USA, V106, P8107, DOI 10.1073/pnas.0811875106; Yamanaka M, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2992595	61	65	69	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12768	10.1371/journal.pone.0012768	http://dx.doi.org/10.1371/journal.pone.0012768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856676	Green Published, gold, Green Submitted			2022-12-27	WOS:000281815800029
J	Ashworth, S; Teng, B; Kaufeld, J; Miller, E; Tossidou, I; Englert, C; Bollig, F; Staggs, L; Roberts, ISD; Park, JK; Haller, H; Schiffer, M				Ashworth, Sharon; Teng, Beina; Kaufeld, Jessica; Miller, Emily; Tossidou, Irini; Englert, Christoph; Bollig, Frank; Staggs, Lynne; Roberts, Ian S. D.; Park, Joon-Keun; Haller, Hermann; Schiffer, Mario			Cofilin-1 Inactivation Leads to Proteinuria - Studies in Zebrafish, Mice and Humans	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; ACTIN-DEPOLYMERIZING FACTOR; TGF-BETA; PODOCYTES; ALPHA-ACTININ-4; DYNAMICS; DISEASE; IDENTIFICATION; CYTOSKELETON; MECHANISMS	Background: Podocytes are highly specialized epithelial cells on the visceral side of the glomerulus. Their interdigitating primary and secondary foot processes contain an actin based contractile apparatus that can adjust to changes in the glomerular perfusion pressure. Thus, the dynamic regulation of actin bundles in the foot processes is critical for maintenance of a well functioning glomerular filtration barrier. Since the actin binding protein, cofilin-1, plays a significant role in the regulation of actin dynamics, we examined its role in podocytes to determine the impact of cofilin-1 dysfunction on glomerular filtration. Methods and Findings: We evaluated zebrafish pronephros function by dextran clearance and structure by TEM in cofilin-1 morphant and mutant zebrafish and we found that cofilin-1 deficiency led to foot process effacement and proteinuria. In vitro studies in murine and human podocytes revealed that PMA stimulation induced activation of cofilin-1, whereas treatment with TGF-beta resulted in cofilin-1 inactivation. Silencing of cofilin-1 led to an accumulation of F-actin fibers and significantly decreased podocyte migration ability. When we analyzed normal and diseased murine and human glomerular tissues to determine cofilin-1 localization and activity in podocytes, we found that in normal kidney tissues unphosphorylated, active cofilin-1 was distributed throughout the cell. However, in glomerular diseases that affect podocytes, cofilin-1 was inactivated by phosphorylation and observed in the nucleus. Conclusions: Based on these in vitro and in vivo studies we concluded cofilin-1 is an essential regulator for actin filament recycling that is required for the dynamic nature of podocyte foot processes. Therefore, we describe a novel pathomechanism of proteinuria development.	[Ashworth, Sharon] Univ Maine, Dept Biochem Microbiol & Mol Biol, Orono, ME 04469 USA; [Ashworth, Sharon] Univ Maine, Sch Biol & Ecol, Orono, ME USA; [Teng, Beina; Kaufeld, Jessica; Miller, Emily; Tossidou, Irini; Bollig, Frank; Staggs, Lynne; Park, Joon-Keun; Haller, Hermann; Schiffer, Mario] Hannover Med Sch, Dept Med Nephrol, D-3000 Hannover, Germany; [Ashworth, Sharon; Kaufeld, Jessica; Staggs, Lynne; Haller, Hermann; Schiffer, Mario] Mt Desert Isl Biol Labs, Salsbury Cove, ME USA; [Englert, Christoph] Fritz Lipmann Inst eV FLI, Leibniz Inst Age Res, Jena, Germany; [Roberts, Ian S. D.] John Radcliffe Hosp, Dept Cellular Pathol, Oxford OX3 9DU, England	University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; Hannover Medical School; Mount Desert Island Biological Laboratory; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Oxford	Ashworth, S (corresponding author), Univ Maine, Dept Biochem Microbiol & Mol Biol, Orono, ME 04469 USA.	schiffer.mario@mh-hannover.de	Schiffer, Mario/U-7050-2019	Schiffer, Mario/0000-0002-8414-1470; Englert, Christoph/0000-0002-5931-3189	German Research Council (DFG) [Schi587/2]; University of Maine; Mount Desert Island Biological Laboratory (MDIBL); MDIBL-INBRE (IDeA Network of Biomedical Research Excellence)	German Research Council (DFG)(German Research Foundation (DFG)); University of Maine; Mount Desert Island Biological Laboratory (MDIBL); MDIBL-INBRE (IDeA Network of Biomedical Research Excellence)	This work was supported by a German Research Council (DFG) - grant (Schi587/2) to M.S., University of Maine Faculty Research Award and start-up funds to S.A., Mount Desert Island Biological Laboratory (MDIBL) New Investigator Awards to S.A. and M.S., and a MDIBL-INBRE (IDeA Network of Biomedical Research Excellence) award to E.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bollig F, 2006, DEV DYNAM, V235, P554, DOI 10.1002/dvdy.20645; Djafarzadeh S, 1997, EXP CELL RES, V236, P427, DOI 10.1006/excr.1997.3731; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Garg P, 2010, J BIOL CHEM, V285, P22676, DOI 10.1074/jbc.M110.122929; Gurniak CB, 2005, DEV BIOL, V278, P231, DOI 10.1016/j.ydbio.2004.11.010; Hentschel DM, 2007, AM J PHYSIOL-RENAL, V293, pF1746, DOI 10.1152/ajprenal.00009.2007; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Kriz W, 2004, KIDNEY INT, V65, P333, DOI 10.1111/j.1523-1755.2004.00421.x; KRIZ W, 1994, CONTRIB NEPHROL, V107, P1; Kriz W, 1996, KIDNEY INT, V49, P1570, DOI 10.1038/ki.1996.227; Kriz W, 1999, CURR OPIN NEPHROL HY, V8, P489, DOI 10.1097/00041552-199907000-00014; Mundel P, 1996, EXP NEPHROL, V4, P263; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Peters I, 2006, J AM SOC NEPHROL, V17, P1644, DOI 10.1681/ASN.2005111209; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schiffer M, 2006, DEUT MED WOCHENSCHR, V131, P1541, DOI 10.1055/s-2006-947793; Schiffer M, 2004, J BIOL CHEM, V279, P37004, DOI 10.1074/jbc.M403534200; Schiffer M, 2002, J AM SOC NEPHROL, V13, P2657, DOI 10.1097/01.ASN.0000033276.06451.50; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Van T. M., 2008, EUR J CELL BIOL, V87, P649; Vartiainen MK, 2002, MOL BIOL CELL, V13, P183, DOI 10.1091/mbc.01-07-0331; Weins A, 2005, J AM SOC NEPHROL, V16, P3694, DOI 10.1681/ASN.2005070706; Weins A, 2007, P NATL ACAD SCI USA, V104, P16080, DOI 10.1073/pnas.0702451104; Wiggan O, 2005, NAT CELL BIOL, V7, P8, DOI 10.1038/ncb0105-8; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076	34	54	55	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12626	10.1371/journal.pone.0012626	http://dx.doi.org/10.1371/journal.pone.0012626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IV	20838616	gold, Green Submitted, Green Published			2022-12-27	WOS:000281687100009
J	Quah-Smith, I; Sachdev, PS; Wen, W; Chen, XH; Williams, MA				Quah-Smith, Im; Sachdev, Perminder S.; Wen, Wei; Chen, Xiaohua; Williams, Mark A.			The Brain Effects of Laser Acupuncture in Healthy Individuals: An fMRI Investigation	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; STIMULATION; DEPRESSION; ACTIVATION; HUMANS; ELECTROACUPUNCTURE; COMPLEMENTARY; HYPOTHALAMUS; CONNECTIVITY; MODULATION	Background: As laser acupuncture is being increasingly used to treat mental disorders, we sought to determine whether it has a biologically plausible effect by using functional magnetic resonance imaging (fMRI) to investigate the cerebral activation patterns from laser stimulation of relevant acupoints. Methodology/Principal Findings: Ten healthy subjects were randomly stimulated with a fibreoptic infrared laser on 4 acupoints (LR14, CV14, LR8 and HT7) used for depression following the principles of Traditional Chinese Medicine (TCM), and 1 control non-acupoint (sham point) in a blocked design (alternating verum laser and placebo laser/rest blocks), while the blood oxygenation level-dependent (BOLD) fMRI response was recorded from the whole brain on a 3T scanner. Many of the acupoint laser stimulation conditions resulted in different patterns of neural activity. Regions with significantly increased activation included the limbic cortex (cingulate) and the frontal lobe (middle and superior frontal gyrus). Laser acupuncture tended to be associated with ipsilateral brain activation and contralateral deactivation that therefore cannot be simply attributed to somatosensory stimulation. Conclusions/Significance: We found that laser stimulation of acupoints lead to activation of frontal-limbic-striatal brain regions, with the pattern of neural activity somewhat different for each acupuncture point. This is the first study to investigate laser acupuncture on a group of acupoints useful in the management of depression. Differing activity patterns depending on the acupoint site were demonstrated, suggesting that neurological effects vary with the site of stimulation. The mechanisms of activation and deactivation and their effects on depression warrant further investigation.	[Quah-Smith, Im; Sachdev, Perminder S.; Wen, Wei; Chen, Xiaohua] Univ New S Wales, Fac Med, Sch Psychiat, Randwick, NSW, Australia; [Sachdev, Perminder S.; Wen, Wei; Chen, Xiaohua] Prince Wales Hosp, Inst Neuropsychiat, Randwick, NSW 2031, Australia; [Sachdev, Perminder S.; Wen, Wei; Chen, Xiaohua] Univ New S Wales, Brain & Ageing Res Program, Sch Psychiat, Randwick, NSW, Australia; [Williams, Mark A.] Macquarie Univ, Macquarie Ctr Cognit Sci, Sydney, NSW 2109, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Macquarie University	Quah-Smith, I (corresponding author), Univ New S Wales, Fac Med, Sch Psychiat, Randwick, NSW, Australia.	p.sachdev@unsw.edu.au	Sachdev, Perminder/ABC-1137-2020	Sachdev, Perminder/0000-0002-9595-3220; Williams, Mark/0000-0002-3897-5167; Wen, Wei/0000-0003-2753-3870	Louise and Gary Dobson; James Fairfax; Thyne Reid Foundation	Louise and Gary Dobson; James Fairfax; Thyne Reid Foundation	The authors acknowledge financial support from Louise and Gary Dobson, James Fairfax and the Thyne Reid Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelink MW, 2003, FORTSCHR NEUROL PSYC, V71, P141, DOI 10.1055/s-2003-37756; Aung SKH, 2007, CLIN INTRO MED ACUPU, P99; Campbell Anthony, 2006, Acupunct Med, V24, P118; Chang S, 2008, CHINESE J PHYSIOL, V51, P167; Dhond RP, 2008, PAIN, V136, P407, DOI 10.1016/j.pain.2008.01.011; Fang JL, 2004, NEURORADIOLOGY, V46, P359, DOI 10.1007/s00234-003-1125-7; GENG L, 2006, J MAGN RESON IMAGING, V24, P1018; George M. S., 1996, ADV BIOL PSYCHIAT, P63; Goldapple K, 2004, ARCH GEN PSYCHIAT, V61, P34, DOI 10.1001/archpsyc.61.1.34; Haker E, 2000, J AUTONOM NERV SYST, V79, P52, DOI 10.1016/S0165-1838(99)00090-9; Hsieh JC, 2001, NEUROSCI LETT, V307, P105, DOI 10.1016/S0304-3940(01)01952-8; Hui KKS, 2005, NEUROIMAGE, V27, P479, DOI 10.1016/j.neuroimage.2005.04.037; Jorm AF, 2002, MED J AUSTRALIA, V176, pS84; Kessler RC, 2001, AM J PSYCHIAT, V158, P289, DOI 10.1176/appi.ajp.158.2.289; Kong J, 2007, NEUROIMAGE, V34, P1171, DOI 10.1016/j.neuroimage.2006.10.019; Lund Irene, 2009, Chin Med, V4, P1, DOI 10.1186/1749-8546-4-1; Lundeberg T, 2009, ACUPUNCT MED, V27, P31, DOI 10.1136/aim.2008.000133; Maciocia G., 1994, PRACTICE CHINESE MED, P197; MacPherson H, 2008, NEUROSCI LETT, V434, P144, DOI 10.1016/j.neulet.2008.01.058; Napadow V, 2007, PAIN, V130, P254, DOI 10.1016/j.pain.2006.12.003; Napadow V, 2005, HUM BRAIN MAPP, V24, P193, DOI 10.1002/hbm.20081; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Pariente J, 2005, NEUROIMAGE, V25, P1161, DOI 10.1016/j.neuroimage.2005.01.016; Paterson C, 2005, BMJ-BRIT MED J, V330, P1202, DOI 10.1136/bmj.330.7501.1202; Paterson C, 2008, J ALTERN COMPLEM MED, V14, P199, DOI 10.1089/acm.2007.0682; Qin W, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-55; Quah-Smith Joo Im, 2005, Acupunct Med, V23, P103; Reiman EM, 1997, J CLIN PSYCHIAT, V58, P4; RINDGE D, 2009, ACUPUNCTURE TODAY, V11, P5; Rogers BP, 2007, MAGN RESON IMAGING, V25, P1347, DOI 10.1016/j.mri.2007.03.007; Sheline YI, 2003, BIOL PSYCHIAT, V54, P338, DOI 10.1016/S0006-3223(03)00347-0; Siedentopf CM, 2005, LASER MED SCI, V20, P68, DOI 10.1007/s10103-005-0340-3; Siedentopf CM, 2002, NEUROSCI LETT, V327, P53, DOI 10.1016/S0304-3940(02)00383-X; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Tsukayama H, 2006, CLIN J PAIN, V22, P346, DOI 10.1097/01.ajp.0000176359.94644.mL; Napadow V, 2005, P ANN INT IEEE EMBS, P4496, DOI 10.1109/IEMBS.2005.1615466; Wu JH, 2009, PHOTOMED LASER SURG, V27, P273, DOI 10.1089/pho.2007.2235; Wu MT, 1999, RADIOLOGY, V212, P133, DOI 10.1148/radiology.212.1.r99jl04133; Yan B, 2005, NEUROSCI LETT, V383, P236, DOI 10.1016/j.neulet.2005.04.021; Yoo SS, 2004, NEUROIMAGE, V22, P932, DOI 10.1016/j.neuroimage.2004.02.017; Zhang WT, 2004, NEUROSCI LETT, V354, P50, DOI 10.1016/j.neulet.2003.09.080; Zhang WT, 2003, BRAIN RES, V982, P168, DOI 10.1016/S0006-8993(03)02983-4	42	37	41	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12619	10.1371/journal.pone.0012619	http://dx.doi.org/10.1371/journal.pone.0012619			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20838644	gold, Green Published			2022-12-27	WOS:000281631300039
J	Daly, MJ; Gaidamakova, EK; Matrosova, VY; Kiang, JG; Fukumoto, R; Lee, DY; Wehr, NB; Viteri, GA; Berlett, BS; Levine, RL				Daly, Michael J.; Gaidamakova, Elena K.; Matrosova, Vera Y.; Kiang, Juliann G.; Fukumoto, Risaku; Lee, Duck-Yeon; Wehr, Nancy B.; Viteri, Gabriela A.; Berlett, Barbara S.; Levine, Rodney L.			Small-Molecule Antioxidant Proteome-Shields in Deinococcus radiodurans	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; RADIATION-RESISTANCE; IONIZING-RADIATION; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; MICROCOCCUS-RADIODURANS; SALMONELLA-TYPHIMURIUM; SHEWANELLA-ONEIDENSIS; SUPEROXIDE-DISMUTASE; COMPARATIVE GENOMICS	For Deinococcus radiodurans and other bacteria which are extremely resistant to ionizing radiation, ultraviolet radiation, and desiccation, a mechanistic link exists between resistance, manganese accumulation, and protein protection. We show that ultrafiltered, protein-free preparations of D. radiodurans cell extracts prevent protein oxidation at massive doses of ionizing radiation. In contrast, ultrafiltrates from ionizing radiation-sensitive bacteria were not protective. The D. radiodurans ultrafiltrate was enriched in Mn, phosphate, nucleosides and bases, and peptides. When reconstituted in vitro at concentrations approximating those in the D. radiodurans cytosol, peptides interacted synergistically with Mn(2+) and orthophosphate, and preserved the activity of large, multimeric enzymes exposed to 50,000 Gy, conditions which obliterated DNA. When applied ex vivo, the D. radiodurans ultrafiltrate protected Escherichia coli cells and human Jurkat T cells from extreme cellular insults caused by ionizing radiation. By establishing that Mn(2+)-metabolite complexes of D. radiodurans specifically protect proteins against indirect damage caused by gamma-rays delivered in vast doses, our findings provide the basis for a new approach to radioprotection and insight into how surplus Mn budgets in cells combat reactive oxygen species.	[Daly, Michael J.; Gaidamakova, Elena K.; Matrosova, Vera Y.] Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA; [Kiang, Juliann G.; Fukumoto, Risaku] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Bethesda, MD 20814 USA; [Lee, Duck-Yeon; Wehr, Nancy B.; Viteri, Gabriela A.; Berlett, Barbara S.; Levine, Rodney L.] NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; United States Department of Defense; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Daly, MJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	mdaly@usuhs.edu; rlevine@nih.gov	Levine, Rodney L/D-9885-2011; Matrosova, Vera/AAX-4125-2020		Air Force Office of Scientific Research [FA9550-07-1-0218]; National Heart, Lung, and Blood Institute, National Institutes of Health; National Institute of Allergy and Infectious Diseases; AFRRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000225, ZIAHL006071] Funding Source: NIH RePORTER	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AFRRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work of E.K.G., V.Y.M. and M.J.D. was supported by the Air Force Office of Scientific Research (Grant FA9550-07-1-0218). The work of B.S.B., G.A.V., N.B.W., D.-Y.L. and R.L.L. was supported by the Intramural Research Program of the National Heart, Lung, and Blood Institute, National Institutes of Health. The work of J.G.K. and R.F. was supported by the National Institute of Allergy and Infectious Diseases, and the Intramural Program of the AFRRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; [Anonymous], 2010, ENVIRON MICROBIOL, V13, P1192, DOI [DOI 10.1111/J.1462-2920.2010.02268.X, 10.1111/j.1462-2920.2010.02419.x]; ARCHIBALD FS, 1982, ARCH BIOCHEM BIOPHYS, V214, P452, DOI 10.1016/0003-9861(82)90049-2; Barnese K, 2008, J AM CHEM SOC, V130, P4604, DOI 10.1021/ja710162n; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; BERGMEYER HU, 1974, METHOD ENZYMAT AN, V2, P1072; BERLETT BS, 1990, P NATL ACAD SCI USA, V87, P389, DOI 10.1073/pnas.87.1.389; BLOK J, 1973, Current Topics in Radiation Research Quarterly, V9, P165; Brim H, 2000, NAT BIOTECHNOL, V18, P85, DOI 10.1038/71986; Brim H, 2003, APPL ENVIRON MICROB, V69, P4575, DOI 10.1128/AEM.69.8.4575-4582.2003; BRUCE AK, 1964, RADIAT RES, V22, P155, DOI 10.2307/3571706; Burgoyne PS, 2007, BIOESSAYS, V29, P974, DOI 10.1002/bies.20639; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Dale Walter M., 1943, BRIT JOUR RADIOL, V16, P171; Dale Walter M., 1942, BIOCHEM JOUR, V36, P80; Dale WM, 1940, BIOCHEM J, V34, P1367, DOI 10.1042/bj0341367; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; Datta SK, 2006, IMMUNITY, V25, P143, DOI 10.1016/j.immuni.2006.05.013; DAVIES R, 1973, J BACTERIOL, V113, P133, DOI 10.1128/JB.113.1.133-144.1973; Fredrickson JK, 2008, ISME J, V2, P393, DOI 10.1038/ismej.2007.116; Ghosal D, 2005, FEMS MICROBIOL REV, V29, P361, DOI 10.1016/j.fmrre.2004.12.007; Gladyshev E, 2008, P NATL ACAD SCI USA, V105, P5139, DOI 10.1073/pnas.0800966105; Gunter TE, 2009, NEUROTOXICOLOGY, V30, P727, DOI 10.1016/j.neuro.2009.05.003; He Y, 2009, J IND MICROBIOL BIOT, V36, P539, DOI 10.1007/s10295-008-0524-5; HEITMAN J, 1989, P NATL ACAD SCI USA, V86, P2281, DOI 10.1073/pnas.86.7.2281; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; ITAYA K, 1966, CLIN CHIM ACTA, V14, P361, DOI 10.1016/0009-8981(66)90114-8; JONES BN, 1983, J CHROMATOGR, V266, P471, DOI 10.1016/S0021-9673(01)90918-5; Kehres DG, 2000, MOL MICROBIOL, V36, P1085, DOI 10.1046/j.1365-2958.2000.01922.x; Kiang JG, 2009, RADIAT RES, V172, P321, DOI 10.1667/RR1585.1; Knobloch B, 2005, P NATL ACAD SCI USA, V102, P7459, DOI 10.1073/pnas.0501446102; KRISCH RE, 1991, RADIAT RES, V126, P251, DOI 10.2307/3577826; KRISKO A, 2010, P NATL ACAD SCI US; LAZZARINO G, 1991, ANAL BIOCHEM, V197, P191, DOI 10.1016/0003-2697(91)90378-7; LEIBOWITZ PJ, 1976, PHOTOCHEM PHOTOBIOL, V23, P45; Lin JY, 1999, SCIENCE, V285, P1558, DOI 10.1126/science.285.5433.1558; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; MCNAUGHTON RL, 2010, P NATL ACAD SCI US; Omar B A, 1992, Adv Pharmacol, V23, P109, DOI 10.1016/S1054-3589(08)60964-3; Omelchenko MV, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-57; Oren A, 2007, FEMS MICROBIOL LETT, V269, P1, DOI 10.1111/j.1574-6968.2007.00650.x; PARISI A, 1974, APPL MICROBIOL, V28, P41, DOI 10.1128/AEM.28.1.41-46.1974; Qiu XY, 2006, J BACTERIOL, V188, P1199, DOI 10.1128/JB.188.3.1199-1204.2006; REPINE JE, 1981, P NATL ACAD SCI-BIOL, V78, P1001, DOI 10.1073/pnas.78.2.1001; Requena JR, 2003, AMINO ACIDS, V25, P221, DOI 10.1007/s00726-003-0012-1; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Schachman H.K., 1959, ULTRACENTRIFUGATION; Setlow B, 2006, J BACTERIOL, V188, P3740, DOI 10.1128/JB.00212-06; Shashidhar R, 2010, CAN J MICROBIOL, V56, P195, DOI [10.1139/W09-118, 10.1139/w09-118]; Shirkey B, 2003, NUCLEIC ACIDS RES, V31, P2995, DOI 10.1093/nar/gkg404; Shuryak I, 2009, J THEOR BIOL, V261, P305, DOI 10.1016/j.jtbi.2009.08.003; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Stadtman E. R., 2006, REDOX PROTEOMICS PRO, P3; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Stadtman ER, 2001, J BIOL CHEM, V276, P44357, DOI 10.1074/jbc.R100055200; Syljuasen RG, 1996, RADIAT RES, V146, P276, DOI 10.2307/3579457; ULMER KM, 1979, J BACTERIOL, V138, P475, DOI 10.1128/JB.138.2.475-485.1979; Vilenchik MM, 2006, P NATL ACAD SCI USA, V103, P17874, DOI 10.1073/pnas.0607995103; vonFrijtag JK, 1996, DRUG DEVELOP RES, V37, P48, DOI 10.1002/(SICI)1098-2299(199601)37:1<48::AID-DDR3>3.0.CO;2-M; Wang S, 2009, INORG CHEM, V48, P719, DOI 10.1021/ic8003068; Wolfe-Simon F, 2006, PLANT PHYSIOL, V142, P1701, DOI 10.1104/pp.106.088963; Woodward C., 2007, 59896297EN AG TECHN	65	214	223	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12570	10.1371/journal.pone.0012570	http://dx.doi.org/10.1371/journal.pone.0012570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838443	Green Submitted, gold, Green Published			2022-12-27	WOS:000281627700017
J	Studerus, E; Gamma, A; Vollenweider, FX				Studerus, Erich; Gamma, Alex; Vollenweider, Franz X.			Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)	PLOS ONE			English	Article							TRAIT ANXIETY INVENTORY; COVARIANCE STRUCTURE-ANALYSIS; GENDER DIFFERENCES; DOUBLE-BLIND; MODEL; NUMBER; PSILOCYBIN; N,N-DIMETHYLTRYPTAMINE; RELIABILITY; EXPERIENCES	Background: The OAV questionnaire has been developed to integrate research on altered states of consciousness (ASC). It measures three primary and one secondary dimensions of ASC that are hypothesized to be invariant across ASC induction methods. The OAV rating scale has been in use for more than 20 years and applied internationally in a broad range of research fields, yet its factorial structure has never been tested by structural equation modeling techniques and its psychometric properties have never been examined in large samples of experimentally induced ASC. Methodology/Principal Findings: The present study conducted a psychometric evaluation of the OAV in a sample of psilocybin (n = 327), ketamine (n = 162), and MDMA (n = 102) induced ASC that was obtained by pooling data from 43 experimental studies. The factorial structure was examined by confirmatory factor analysis, exploratory structural equation modeling, hierarchical item clustering (ICLUST), and multiple indicators multiple causes (MIMIC) modeling. The originally proposed model did not fit the data well even if zero-constraints on non-target factor loadings and residual correlations were relaxed. Furthermore, ICLUST suggested that the "oceanic boundlessness'' and "visionary restructuralization'' factors could be combined on a high level of the construct hierarchy. However, because these factors were multidimensional, we extracted and examined 11 new lower order factors. MIMIC modeling indicated that these factors were highly measurement invariant across drugs, settings, questionnaire versions, and sexes. The new factors were also demonstrated to have improved homogeneities, satisfactory reliabilities, discriminant and convergent validities, and to differentiate well among the three drug groups. Conclusions/Significance: The original scales of the OAV were shown to be multidimensional constructs. Eleven new lower order scales were constructed and demonstrated to have desirable psychometric properties. The new lower order scales are most likely better suited to assess drug induced ASC.	[Studerus, Erich; Vollenweider, Franz X.] Univ Hosp Psychiat Zurich, Heffter Res Ctr, Zurich, Switzerland; [Gamma, Alex] Univ Hosp Psychiat Zurich, Dept Clin & Social Psychiat, Zurich, Switzerland		Studerus, E (corresponding author), Univ Hosp Psychiat Zurich, Heffter Res Ctr, Zurich, Switzerland.	erich.studerus@bli.uzh.ch	Studerus, Erich/AAB-1632-2020	Studerus, Erich/0000-0003-4233-0182	Heffter Research Institute, Santa Fe, New Mexico, United States of America; Swiss Neuromatrix Foundation, Switzerland	Heffter Research Institute, Santa Fe, New Mexico, United States of America; Swiss Neuromatrix Foundation, Switzerland	This work was supported by the Heffter Research Institute, Santa Fe, New Mexico, United States of America (http://www.heffter.org), and the Swiss Neuromatrix Foundation, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1981, HALLUZINOGENE PSYCHI; [Anonymous], 1985, GERMAN J PSYCHOL; [Anonymous], 1962, EXPT PSYCHOSE; Asparouhov T, 2009, STRUCT EQU MODELING, V16, P397, DOI 10.1080/10705510903008204; Bacon DR, 2001, STRUCT EQU MODELING, V8, P397, DOI 10.1207/S15328007SEM0803_4; BARRETT PT, 2006, ORTHOSIM 2 VERSION 2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BODMER I, 1999, ERINNERUNG AUSSERGEW; Bodmer Ines, 1994, WELTEN BEWUSSTSEINS, V3, P45; Brown T.A., 2015, CONFIRMATORY FACTOR, V2nd ed., DOI DOI 10.5860/CHOICE.44-2769; CARROLL JB, 1945, PSYCHOMETRIKA, V10, P1; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chan W, 1999, PSYCHOL METHODS, V4, P378, DOI 10.1037/1082-989X.4.4.378; Cooksey RW, 2006, ORGAN RES METHODS, V9, P78, DOI 10.1177/1094428105283939; CRAWFORD AV, 2010, ED PSYCHOL IN PRESS; Debus G., 1978, EIGENSCHAFTSWORTERLI; Dittrich A, 1998, PHARMACOPSYCHIATRY, V31, P80, DOI 10.1055/s-2007-979351; DITTRICH A, 1994, 50 YEARS OF LSD, P101; DITTRICH A, 1975, Z KL PSYCH PSYCHOTH, V23, P12; DITTRICH A, 1996, ATIOLOGIE UNABHANGIG; Dittrich A., 1985, ATIOLOGIE UNABHANGIG; Dittrich A., 2010, 5D ASC QUESTIONNAIRE; Dittrich A., 2006, 5D ABZ FRAGEBOGEN ER; Duhachek A, 2004, J APPL PSYCHOL, V89, P792, DOI 10.1037/0021-9010.89.5.792; ENDLER NS, 1992, J PERS SOC PSYCHOL, V63, P832, DOI 10.1037/0022-3514.63.5.832; Fahrenberg J, 1984, FREIBURGER PERSONLIC; Fleishman JA, 2002, J GERONTOL B-PSYCHOL, V57, pS275, DOI 10.1093/geronb/57.5.S275; Geyer MA, 2008, TRENDS PHARMACOL SCI, V29, P445, DOI 10.1016/j.tips.2008.06.006; Gouzoulis-Mayfrank E, 1998, EUR PSYCHIAT, V13, P399, DOI 10.1016/S0924-9338(99)80686-5; Gouzoulis-Mayfrank E, 2005, PHARMACOPSYCHIATRY, V38, P301, DOI 10.1055/s-2005-916185; Green SB, 2009, PSYCHOMETRIKA, V74, P155, DOI 10.1007/s11336-008-9099-3; Griffiths RR, 2006, PSYCHOPHARMACOLOGY, V187, P268, DOI 10.1007/s00213-006-0457-5; Gros DF, 2007, PSYCHOL ASSESSMENT, V19, P369, DOI 10.1037/1040-3590.19.4.369; Hasler F, 2004, PSYCHOPHARMACOLOGY, V172, P145, DOI 10.1007/s00213-003-1640-6; Hasler F, 2009, J PSYCHOPHARMACOL, V23, P923, DOI 10.1177/0269881108094650; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Hubner C., 2007, MUSIC THER TODAY, V8, P257; Iwata N, 2000, J PERS ASSESS, V74, P48, DOI 10.1207/S15327752JPA740104; JANKE W, 1986, INT SKALEN PSYCHIAT, P43; Johnson MW, 2008, J PSYCHOPHARMACOL, V22, P603, DOI 10.1177/0269881108093587; Kjellgren A, 2004, SOC BEHAV PERSONAL, V32, P103, DOI 10.2224/sbp.2004.32.2.103; Kubinger K., 2003, PSYCHOL SCI, V45, P106, DOI DOI 10.1177/014662169101500105; Kvaal K, 2001, INT J GERIATR PSYCH, V16, P980, DOI 10.1002/gps.458; Laux L., 1981, STATE TRAIT ANGSTINV; Liechti ME, 2000, EUR NEUROPSYCHOPHARM, V10, P289, DOI 10.1016/S0924-977X(00)00086-9; Liechti ME, 2001, PSYCHOPHARMACOLOGY, V154, P161, DOI 10.1007/s002130000648; Little TD, 2002, STRUCT EQU MODELING, V9, P151, DOI 10.1207/S15328007SEM0902_1; Malitz S, 1962, HALLUCINATIONS, P50; Marsh HW, 2009, STRUCT EQU MODELING, V16, P439, DOI 10.1080/10705510903008220; MARSH HW, 2010, PSYCHOL ASS IN PRESS; Mavromatis A., 1987, HYPNAGOGIA UNIQUE ST; McDonald, 1999, TEST THEORY UNIFIED, DOI DOI 10.4324/9781410601087; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Muthen L.K., 2020, MPLUS; Muthen LK, 2002, STRUCT EQU MODELING, V9, P599, DOI 10.1207/S15328007SEM0904_8; Northoff G, 2005, SCHIZOPHR RES, V72, P235, DOI 10.1016/j.schres.2004.04.009; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Paunonen SV, 1997, EDUC PSYCHOL MEAS, V57, P33, DOI 10.1177/0013164497057001003; PEKALA RJ, 1986, PERCEPT MOTOR SKILL, V63, P983, DOI 10.2466/pms.1986.63.2.983; R Core Team, 2021, R LANGUAGE ENV STAT; RAICHE G, 2009, NFACTORS PARALLEL AN; Raykov T, 2004, STRUCT EQU MODELING, V11, P621, DOI 10.1207/s15328007sem1104_7; Raykov T, 2001, BRIT J MATH STAT PSY, V54, P315, DOI 10.1348/000711001159582; Raykov T, 2009, MEAS EVAL COUNS DEV, V42, P223, DOI 10.1177/0748175609344096; Reise SP, 2000, PSYCHOL ASSESSMENT, V12, P287, DOI 10.1037//1040-3590.12.3.287; REVELLE W, 1978, BEHAV RES METH INSTR, V10, P739, DOI 10.3758/BF03205389; Revelle W, 1979, Multivariate Behav Res, V14, P403, DOI 10.1207/s15327906mbr1404_2; REVELLE W, 1979, MULTIVAR BEHAV RES, V14, P57, DOI 10.1207/s15327906mbr1401_4; Revelle W., 2009, PSYCH PROCEDURES PSY; Rossiter JR, 2002, INT J RES MARK, V19, P305, DOI 10.1016/S0167-8116(02)00097-6; Russell JA, 1999, PSYCHOL BULL, V125, P3, DOI 10.1037/0033-2909.125.1.3; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Spielberger CD., 1983, STAI MANUAL STATE TR, DOI DOI 10.1037/T06496-000; Stace Walter T., 1961, MYSTICISM PHILOS; STRASSMAN RJ, 1994, ARCH GEN PSYCHIAT, V51, P98; Umbricht D, 2002, BIOL PSYCHIAT, V51, P400, DOI 10.1016/S0006-3223(01)01242-2; VELICER FW, 2000, PROBLEMS SOLUTIONS H; VELICER WF, 1976, PSYCHOMETRIKA, V41, P321, DOI 10.1007/BF02293557; Vigneau F, 2008, J PERS ASSESS, V90, P280, DOI 10.1080/00223890701885027; Vollenweider FX, 1999, NEUROPSYCHOPHARMACOL, V20, P424, DOI 10.1016/S0893-133X(98)00108-0; Vollenweider FX, 2001, BRAIN RES BULL, V56, P495, DOI 10.1016/S0361-9230(01)00646-3; Walach H, 1998, BEHAV MED, V24, P107, DOI 10.1080/08964289809596388; Weber CS, 2007, SCAND J PSYCHOL, V48, P459, DOI 10.1111/j.1467-9450.2007.00612.x; Wiswede D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005754; Woods CM, 2009, J PSYCHOPATHOL BEHAV, V31, P320, DOI 10.1007/s10862-008-9118-9; Woods CM, 2009, MULTIVAR BEHAV RES, V44, P1, DOI 10.1080/00273170802620121; Yuan KH, 2000, SOCIOL METHODOL, V30, P165, DOI 10.1111/0081-1750.00078; Zinbarg RE, 2005, PSYCHOMETRIKA, V70, P123, DOI 10.1007/s11336-003-0974-7; Zinbarg RE, 2007, APPL PSYCH MEAS, V31, P135, DOI 10.1177/0146621606291558	90	238	241	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12412	10.1371/journal.pone.0012412	http://dx.doi.org/10.1371/journal.pone.0012412			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	644TX	20824211	Green Submitted, Green Published, gold			2022-12-27	WOS:000281405300008
J	Biarnes, X; Marchiori, A; Giorgetti, A; Lanzara, C; Gasparini, P; Carloni, P; Born, S; Brockhoff, A; Behrens, M; Meyerhof, W				Biarnes, Xevi; Marchiori, Alessandro; Giorgetti, Alejandro; Lanzara, Carmela; Gasparini, Paolo; Carloni, Paolo; Born, Stephan; Brockhoff, Anne; Behrens, Maik; Meyerhof, Wolfgang			Insights into the Binding of Phenyltiocarbamide (PTC) Agonist to Its Target Human TAS2R38 Bitter Receptor	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; TASTE; SEQUENCE; FAMILY; SENSITIVITY; RHODOPSIN; REVEALS; LIGANDS; PATTERN	Humans' bitter taste perception is mediated by the hTAS2R subfamily of the G protein-coupled membrane receptors (GPCRs). Structural information on these receptors is currently limited. Here we identify residues involved in the binding of phenylthiocarbamide (PTC) and in receptor activation in one of the most widely studied hTAS2Rs (hTAS2R38) by means of structural bioinformatics and molecular docking. The predictions are validated by site-directed mutagenesis experiments that involve specific residues located in the putative binding site and trans-membrane (TM) helices 6 and 7 putatively involved in receptor activation. Based on our measurements, we suggest that (i) residue N103 participates actively in PTC binding, in line with previous computational studies. (ii) W99, M100 and S259 contribute to define the size and shape of the binding cavity. (iii) W99 and M100, along with F255 and V296, play a key role for receptor activation, providing insights on bitter taste receptor activation not emerging from the previously reported computational models.	[Biarnes, Xevi; Carloni, Paolo] Int Sch Adv Studies SISSA ISAS, Trieste, Italy; [Born, Stephan; Brockhoff, Anne; Behrens, Maik; Meyerhof, Wolfgang] German Inst Human Nutr Potsdam Rebrucke DIfE, Dept Mol Genet, Nuthetal, Germany; [Giorgetti, Alejandro] Univ Verona, Dept Biotechnol, I-37100 Verona, Italy; [Biarnes, Xevi; Carloni, Paolo] DEMOCRITOS Modeling Ctr Res Atomist Simulat, Trieste, Italy; [Carloni, Paolo] German Res Sch Simulat Sci, Aachen, Germany; [Marchiori, Alessandro; Lanzara, Carmela; Gasparini, Paolo] Univ Trieste, Dept Reprod & Dev Sci, Trieste, Italy; [Lanzara, Carmela; Gasparini, Paolo] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy	International School for Advanced Studies (SISSA); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Verona; University of Trieste; IRCCS Burlo Garofolo	Biarnes, X (corresponding author), Int Sch Adv Studies SISSA ISAS, Trieste, Italy.	alejandro.giorgetti@univr.it; p.carloni@grs-sim.de	Gasparini, Paolo/B-6173-2014; Behrens, Maik/B-6753-2016; Carloni, Paolo/H-8736-2013; Biarnés, Xevi/AAA-3107-2019	Behrens, Maik/0000-0003-2082-8860; Biarnés, Xevi/0000-0003-4121-9474; Born, Stephan/0000-0001-6841-1410; Gasparini, Paolo/0000-0002-0859-0856; Giorgetti, Alejandro/0000-0001-8738-6150; Carloni, Paolo/0000-0002-9010-0149				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; BALLESTEROS JA, 1992, BIOPHYS J, V62, P107, DOI 10.1016/S0006-3495(92)81794-0; Battey JND, 2007, PROTEINS, V69, P68, DOI 10.1002/prot.21761; Behrens M, 2009, RESULTS PROBL CELL D, V47, P203, DOI 10.1007/400_2008_5; Behrens M, 2007, J NEUROSCI, V27, P12630, DOI 10.1523/JNEUROSCI.1168-07.2007; Brockhoff A, 2010, P NATL ACAD SCI USA, V107, P11110, DOI 10.1073/pnas.0913862107; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Clapp TR, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-6; Costanzi S, 2008, J MED CHEM, V51, P2907, DOI 10.1021/jm800044k; Floriano WB, 2006, J MOL MODEL, V12, P931, DOI 10.1007/s00894-006-0102-6; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Khafizov K, 2007, J MOL MODEL, V13, P401, DOI 10.1007/s00894-006-0160-9; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Kleinau G, 2007, MOL ENDOCRINOL, V21, P574, DOI 10.1210/me.2006-0309; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Meyerhof W, 2005, REV PHYSIOL BIOCH P, V154, P37, DOI 10.1007/s10254-005-0041-0; Miguet L, 2006, J RECEPT SIG TRANSD, V26, P611, DOI 10.1080/10799890600928210; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Pronin AN, 2004, CHEM SENSES, V29, P583, DOI 10.1093/chemse/bjh064; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Ropelewski A. J., 2004, CURR PROTOC BIOINFOR; SAKURAI T, 2010, J BIOL CHEM IN PRESS; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shi P, 2006, MOL BIOL EVOL, V23, P292, DOI 10.1093/molbev/msj028; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soranzo N, 2005, CURR BIOL, V15, P1257, DOI 10.1016/j.cub.2005.06.042; Ueda T, 2005, CHEM SENSES, V30, pI16, DOI 10.1093/chemse/bjh090; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Worth CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007011; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161	41	79	83	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12394	10.1371/journal.pone.0012394	http://dx.doi.org/10.1371/journal.pone.0012394			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811630	gold, Green Published, Green Submitted			2022-12-27	WOS:000281234700019
J	Lee, TMC; Lee, TMY; Raine, A; Chan, CCH				Lee, Tatia M. C.; Lee, Tiffany M. Y.; Raine, Adrian; Chan, Chetwyn C. H.			Lying about the Valence of Affective Pictures: An fMRI Study	PLOS ONE			English	Article							FUNCTIONAL MAGNETIC-RESONANCE; VERBAL WORKING-MEMORY; EVENT-RELATED FMRI; PREFRONTAL CORTEX; FRONTAL-CORTEX; EXECUTIVE PROCESSES; FACIAL EXPRESSIONS; BRAIN ACTIVITY; LIE DETECTION; DECEPTION	The neural correlates of lying about affective information were studied using a functional magnetic resonance imaging (fMRI) methodology. Specifically, 13 healthy right-handed Chinese men were instructed to lie about the valence, positive or negative, of pictures selected from the International Affective Picture System (IAPS) while their brain activity was scanned by a 3T Philip Achieva scanner. The key finding is that the neural activity associated with deception is valence-related. Comparing to telling the truth, deception about the valence of the affectively positive pictures was associated with activity in the inferior frontal, cingulate, inferior parietal, precuneus, and middle temporal regions. Lying about the valence of the affectively negative pictures, on the other hand, was associated with activity in the orbital and medial frontal regions. While a clear valence-related effect on deception was observed, common neural regions were also recruited for the process of deception about the valence of the affective pictures. These regions included the lateral prefrontal and inferior parietal regions. Activity in these regions has been widely reported in fMRI studies on deception using affectively-neutral stimuli. The findings of this study reveal the effect of valence on the neural activity associated with deception. Furthermore, the data also help to illustrate the complexity of the neural mechanisms underlying deception.	[Lee, Tatia M. C.; Lee, Tiffany M. Y.] Univ Hong Kong, Neuropsychol Lab, Hong Kong, Hong Kong, Peoples R China; [Lee, Tatia M. C.; Lee, Tiffany M. Y.] Univ Hong Kong, Lab Cognit Affect Neurosci, Hong Kong, Hong Kong, Peoples R China; [Lee, Tatia M. C.] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Raine, Adrian] Univ Penn, Dept Criminol, Philadelphia, PA 19104 USA; [Raine, Adrian] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Raine, Adrian] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Chan, Chetwyn C. H.] Hong Kong Polytech Univ, Dept Rehabil Sci, Appl Cognit Neurosci Lab, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Hong Kong Polytechnic University	Lee, TMC (corresponding author), Univ Hong Kong, Neuropsychol Lab, Hong Kong, Hong Kong, Peoples R China.	tmclee@hkusua.hku.hk		Chan, Chetwyn C. H./0000-0003-0307-6337	University of Hong Kong; National Natural Science Foundation of China [30828012]	University of Hong Kong(University of Hong Kong); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the May Endowed Professorship of The University of Hong Kong and the National Natural Science Foundation of China (#30828012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2006, CEREB CORTEX, V16, P192, DOI 10.1093/cercor/bhi097; ABE N, 2009, CURR OPIN N IN PRESS; Abe N, 2008, CEREB CORTEX, V18, P2811, DOI 10.1093/cercor/bhn037; Abe N, 2007, J COGNITIVE NEUROSCI, V19, P287, DOI 10.1162/jocn.2007.19.2.287; Amos A, 2000, J COGNITIVE NEUROSCI, V12, P505, DOI 10.1162/089892900562174; AUGUSTINE S, 1948, OPUSCULES, V2, P244; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Britton JC, 2006, NEUROIMAGE, V31, P906, DOI 10.1016/j.neuroimage.2005.12.050; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.0.CO;2-0; Cacioppo JT, 1999, ANNU REV PSYCHOL, V50, P191, DOI 10.1146/annurev.psych.50.1.191; CACIOPPO JT, 1994, PSYCHOL BULL, V115, P401, DOI 10.1037/0033-2909.115.3.401; Canli T, 1998, NEUROREPORT, V9, P3233, DOI 10.1097/00001756-199810050-00019; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Chen J, 2008, NEUROSCI LETT, V445, P135, DOI 10.1016/j.neulet.2008.08.061; Christ SE, 2009, CEREB CORTEX, V19, P1557, DOI 10.1093/cercor/bhn189; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Critchley HD, 2002, NEURON, V33, P653, DOI 10.1016/S0896-6273(02)00588-3; Crottaz-Herbette S, 2004, NEUROIMAGE, V21, P340, DOI 10.1016/j.neuroimage.2003.09.019; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Davidson RJ, 1995, BRAIN ASYMMETRY; Dolcos F, 2004, NEUROIMAGE, V23, P64, DOI 10.1016/j.neuroimage.2004.05.015; Eippert F, 2007, HUM BRAIN MAPP, V28, P409, DOI 10.1002/hbm.20291; Ekman P., 2001, TELLING LIES CLUES D, V3rd; Eling PATM, 2006, INT J GERIATR PSYCH, V21, P831, DOI 10.1002/gps.1568; Foland LC, 2008, PSYCHIAT RES-NEUROIM, V162, P27, DOI 10.1016/j.pscychresns.2007.04.007; Ganis G, 2003, CEREB CORTEX, V13, P830, DOI 10.1093/cercor/13.8.830; Gombos VA, 2006, GENET SOC GEN PSYCH, V132, P197, DOI 10.3200/MONO.132.3.197-214; Grimm S, 2006, NEUROIMAGE, V30, P325, DOI 10.1016/j.neuroimage.2005.09.006; Habel U, 2005, NEUROIMAGE, V26, P206, DOI 10.1016/j.neuroimage.2005.01.014; Hakun JG, 2009, SOC NEUROSCI-UK, V4, P518, DOI 10.1080/17470910802188370; Han SH, 2005, HUM BRAIN MAPP, V26, P199, DOI 10.1002/hbm.20157; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; Kozel FA, 2005, BIOL PSYCHIAT, V58, P605, DOI 10.1016/j.biopsych.2005.07.040; Lamm C, 2010, J COGNITIVE NEUROSCI, V22, P362, DOI 10.1162/jocn.2009.21186; Lang P. J., 1997, NIMH CTR STUDY EMOTI, P39; Langleben DD, 2005, HUM BRAIN MAPP, V26, P262, DOI 10.1002/hbm.20191; Langleben DD, 2002, NEUROIMAGE, V15, P727, DOI 10.1006/nimg.2001.1003; Leclerc CM, 2008, COGN AFFECT BEHAV NE, V8, P153, DOI 10.3758/CABN.8.2.153; Lee TMC, 2009, J CLIN PSYCHIAT, V70, P36, DOI 10.4088/JCP.08m04143; Lee TMC, 2009, BRAIN COGNITION, V69, P406, DOI 10.1016/j.bandc.2008.09.002; Lee TMY, 2009, BRAIN COGNITION, V71, P354, DOI 10.1016/j.bandc.2009.06.006; Lee TMC, 2005, NEUROIMAGE, V28, P305, DOI 10.1016/j.neuroimage.2005.06.051; Lee TMC, 2005, MOL PSYCHIATR, V10, P450, DOI 10.1038/sj.mp.4001595; Lee TMC, 2002, NEUROSCI LETT, V333, P13, DOI 10.1016/S0304-3940(02)00965-5; Lee TMC, 2002, HUM BRAIN MAPP, V15, P157, DOI 10.1002/hbm.10020; Lee TMC, 2001, NEUROSCI LETT, V309, P109, DOI 10.1016/S0304-3940(01)02043-2; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; Maguire EA, 1999, BRAIN, V122, P1839, DOI 10.1093/brain/122.10.1839; Mak AKY, 2009, NEUROSCI LETT, V457, P101, DOI 10.1016/j.neulet.2009.03.094; Mourao-Miranda J, 2003, NEUROIMAGE, V20, P1955, DOI 10.1016/j.neuroimage.2003.08.011; Northoff G, 2000, CEREB CORTEX, V10, P93, DOI 10.1093/cercor/10.1.93; Nunez JM, 2005, NEUROIMAGE, V25, P267, DOI 10.1016/j.neuroimage.2004.10.041; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phan KL, 2005, ACAD RADIOL, V12, P164, DOI 10.1016/j.acra.2004.11.023; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Priori A, 2008, CEREB CORTEX, V18, P451, DOI 10.1093/cercor/bhm088; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; SCHNEIDER RJ, 1993, BRAIN RES, V621, P116, DOI 10.1016/0006-8993(93)90305-7; Semrud-Clikeman M, 2000, J AM ACAD CHILD PSY, V39, P477, DOI 10.1097/00004583-200004000-00017; Smith MR, 1996, CURR PROB CANCER, V20, P6, DOI 10.1016/S0147-0272(96)80303-5; Spence SA, 2004, PHILOS T R SOC B, V359, P1755, DOI 10.1098/rstb.2004.1555; Spence SA, 2001, NEUROREPORT, V12, P2849, DOI 10.1097/00001756-200109170-00019; Spence SA, 2008, EUR PSYCHIAT, V23, P309, DOI 10.1016/j.eurpsy.2007.09.001; Spence SA, 2008, NEUROIMAGE, V40, P1411, DOI 10.1016/j.neuroimage.2008.01.035; Stenberg G, 1998, COGNITION EMOTION, V12, P755, DOI 10.1080/026999398379420	70	36	38	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12291	10.1371/journal.pone.0012291	http://dx.doi.org/10.1371/journal.pone.0012291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811624	Green Published, gold			2022-12-27	WOS:000281234700004
J	Pearton, M; Kang, SM; Song, JM; Anstey, AV; Ivory, M; Compans, RW; Birchall, JC				Pearton, Marc; Kang, Sang-Moo; Song, Jae-Min; Anstey, Alexander V.; Ivory, Matthew; Compans, Richard W.; Birchall, James C.			Changes in Human Langerhans Cells Following Intradermal Injection of Influenza Virus-Like Particle Vaccines	PLOS ONE			English	Article							DERMAL DENDRITIC CELLS; ANTIBODY-RESPONSES; MICROINJECTION SYSTEM; IMMUNE-RESPONSES; IMMUNOGENICITY; VACCINATION; DELIVERY; SKIN; SAFETY; MOUSE	There is a significant gap in our fundamental understanding of early morphological and migratory changes in human Langerhans cells (LCs) in response to vaccine stimulation. As the vast majority of LCs studies are conducted in small animal models, substantial interspecies variation in skin architecture and immunity must be considered when extrapolating the results to humans. This study aims to determine whether excised human skin, maintained viable in organ culture, provides a useful human model for measuring and understanding early immune response to intradermally delivered vaccine candidates. Excised human breast skin was maintained viable in air-liquid-interface organ culture. This model was used for the first time to show morphological changes in human LCs stimulated with influenza virus-like particle (VLP) vaccines delivered via intradermal injection. Immunohistochemistry of epidermal sheets and skin sections showed that LCs in VLP treated skin lost their typical dendritic morphology. The cells were more dispersed throughout the epidermis, often in close proximity to the basement membrane, and appeared vertically elongated. Our data provides for increased understanding of the complex morphological, spatial and temporal changes that occur to permit LC migration through the densely packed keratinocytes of the epidermis following exposure to vaccine. Significantly, the data not only supports previous animal data but also provides new and essential evidence of host response to this vaccination strategy in the real human skin environment.	[Pearton, Marc; Ivory, Matthew; Birchall, James C.] Cardiff Univ, Welsh Sch Pharm, Cardiff, S Glam, Wales; [Kang, Sang-Moo; Song, Jae-Min; Compans, Richard W.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Anstey, Alexander V.] Aneurin Bevan Hlth Board Royal Gwent Hosp, Newport, Gwent, Wales	Cardiff University; Emory University; Royal Gwent Hospital	Pearton, M (corresponding author), Cardiff Univ, Welsh Sch Pharm, Cardiff, S Glam, Wales.	birchalljc@cardiff.ac.uk	Birchall, James/N-1711-2014; Compans, Richard W/I-4087-2013; Ivory, Matthew Owen/B-7646-2015	Birchall, James/0000-0001-8521-6924; Compans, Richard W/0000-0003-2360-335X; Ivory, Matthew Owen/0000-0002-8736-395X	National Institutes of Health [EB006369]; NIH/NIAID [AI0680003]; Georgia Research Alliance; Korea Research Foundation [KRF-2007-357-C00088]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006369] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Georgia Research Alliance; Korea Research Foundation(National Research Foundation of Korea); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by the National Institutes of Health Grant EB006369, and also partially supported by NIH/NIAID grant AI0680003 (R.W.C.) and by funds from the Georgia Research Alliance (S.M.K.) and the Korea Research Foundation Grant KRF-2007-357-C00088 (J.M.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auewarakul P, 2007, VACCINE, V25, P659, DOI 10.1016/j.vaccine.2006.08.026; Baldwin SL, 2009, VACCINE, V27, P3063, DOI 10.1016/j.vaccine.2009.03.018; Belshe RB, 2004, NEW ENGL J MED, V351, P2286, DOI 10.1056/NEJMoa043555; Beran J, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-13; Birchall J, 2005, J DRUG TARGET, V13, P415, DOI 10.1080/10611860500383705; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Chiu SS, 2007, PEDIATRICS, V119, P1076, DOI 10.1542/peds.2006-3176; Chowell G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008164; Cutts FT, 1997, BIOLOGICALS, V25, P323, DOI 10.1006/biol.1997.0103; de Jong MAWP, 2010, METHODS MOL BIOL, V595, P55, DOI 10.1007/978-1-60761-421-0_4; Dearman RJ, 2004, EXP DERMATOL, V13, P452, DOI 10.1111/j.0906-6705.2004.00199.x; Francis T, 1937, J Exp Med, V65, P251, DOI 10.1084/jem.65.2.251; Furio L, 2010, J INVEST DERMATOL, V130, P1345, DOI 10.1038/jid.2009.424; Griffiths CEM, 2005, CYTOKINE, V32, P67, DOI 10.1016/j.cyto.2005.07.011; GSCHWANDTNER M, 2009, ALLERGY IN PRESS; Haynes JR, 2009, VACCINE, V27, P530, DOI 10.1016/j.vaccine.2008.11.011; Holland D, 2008, J INFECT DIS, V198, P650, DOI 10.1086/590434; Kang SM, 2009, VIRUS RES, V143, P140, DOI 10.1016/j.virusres.2009.04.005; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Lambert PH, 2008, VACCINE, V26, P3197, DOI 10.1016/j.vaccine.2008.03.095; LARSEN CP, 1990, J EXP MED, V172, P1483, DOI 10.1084/jem.172.5.1483; Laurent PE, 2007, VACCINE, V25, P8833, DOI 10.1016/j.vaccine.2007.10.020; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; MILLER KD, 1983, LANCET, V2, P1454, DOI 10.1016/S0140-6736(83)90800-0; Ng KW, 2009, VACCINE, V27, P5948, DOI 10.1016/j.vaccine.2009.07.088; Nirmal S, 1998, VACCINE, V16, P928, DOI 10.1016/S0264-410X(97)00293-4; Nishibu A, 2007, J DERMATOL SCI, V45, P23, DOI 10.1016/j.jdermsci.2006.10.003; PEARTON M, 2010, VACCINE IN PRESS; Quan FS, 2009, J VIROL, V83, P4489, DOI 10.1128/JVI.02035-08; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Quan FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007152; RAMBUKKANA A, 1995, LAB INVEST, V73, P521; Schwarz A, 2010, J INVEST DERMATOL, V130, P1419, DOI 10.1038/jid.2009.429; Shklovskaya E, 2008, J IMMUNOL, V181, P418, DOI 10.4049/jimmunol.181.1.418; Stutte S, 2008, J INVEST DERMATOL, V128, P1470, DOI 10.1038/sj.jid.5701228; Sugimura T, 2008, VACCINE, V26, P2700, DOI 10.1016/j.vaccine.2008.03.016; Swetman CA, 2002, EUR J IMMUNOL, V32, P2074, DOI 10.1002/1521-4141(200207)32:7<2074::AID-IMMU2074>3.0.CO;2-S; TRAN JN, 2010, EXP DERMATO IN PRESS; Van Damme P, 2009, VACCINE, V27, P454, DOI 10.1016/j.vaccine.2008.10.077; VANWILSEM EJG, 1994, J INVEST DERMATOL, V103, P217, DOI 10.1111/1523-1747.ep12393088; Wang BH, 1999, J LEUKOCYTE BIOL, V66, P33, DOI 10.1002/jlb.66.1.33; WHO Publication, 2010, Vaccine, V28, P589, DOI 10.1016/j.vaccine.2009.10.110; Wu XF, 2009, VACCINE, V27, P7202, DOI 10.1016/j.vaccine.2009.09.025	45	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12410	10.1371/journal.pone.0012410	http://dx.doi.org/10.1371/journal.pone.0012410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811642	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000281234700031
J	Itskovich, I; Roudebush, B				Itskovich, Igor; Roudebush, Brad			Using Re-Sampling Methods in Mortality Studies	PLOS ONE			English	Article							PRINCIPAL RESPONSE CURVES	Traditional methods of computing standardized mortality ratios (SMR) in mortality studies rely upon a number of conventional statistical propositions to estimate confidence intervals for obtained values. Those propositions include a common but arbitrary choice of the confidence level and the assumption that observed number of deaths in the test sample is a purely random quantity. The latter assumption may not be fully justified for a series of periodic "overlapping" studies. We propose a new approach to evaluating the SMR, along with its confidence interval, based on a simple re-sampling technique. The proposed method is most straightforward and requires neither the use of above assumptions nor any rigorous technique, employed by modern re-sampling theory, for selection of a sample set. Instead, we include all possible samples that correspond to the specified time window of the study in the re-sampling analysis. As a result, directly obtained confidence intervals for repeated overlapping studies may be tighter than those yielded by conventional methods. The proposed method is illustrated by evaluating mortality due to a hypothetical risk factor in a life insurance cohort. With this method used, the SMR values can be forecast more precisely than when using the traditional approach. As a result, the appropriate risk assessment would have smaller uncertainties.	[Itskovich, Igor; Roudebush, Brad] NW Mutual Life Insurance Co, Underwriting Stand Dept, Milwaukee, WI USA		Itskovich, I (corresponding author), NW Mutual Life Insurance Co, Underwriting Stand Dept, Milwaukee, WI USA.	igoritskovich@northwesternmutual.com			Northwestern Mutual Life Insurance	Northwestern Mutual Life Insurance	Northwestern Mutual Life Insurance funded this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P. D., 1995, SURVIVAL ANAL USING; [Anonymous], 1982, JACKKNIFE BOOTSTRAP; Breslow NE., 1987, STAT METHODS CANC RE, P81; COX DR, 1972, J R STAT SOC B, V187, P220; Davison AC, 1997, BOOTSTRAP METHODS TH; Elandt-Johnson R C, 1980, SURVIVAL MODELS DATA; Fleiss J. L., 1981, STAT METHODS RATES P, V2; MOONEY CZ, 1993, BOOTSTRAPING NONPARA; Timmerman ME, 2008, COMPUT STAT DATA AN, V52, P1837, DOI 10.1016/j.csda.2007.05.032; Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI [10.1897/1551-5028(1999)018&lt;0138:PRCAOT&gt;2.3.CO;2, 10.1002/etc.5620180207]	10	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12340	10.1371/journal.pone.0012340	http://dx.doi.org/10.1371/journal.pone.0012340			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808787	Green Published, gold, Green Submitted			2022-12-27	WOS:000281153500020
J	Jiang, YH; Pan, YZ; Zhu, L; Landa, L; Yoo, J; Spencer, C; Lorenzo, I; Brilliant, M; Noebels, J; Beaudet, AL				Jiang, Yong-hui; Pan, Yanzhen; Zhu, Li; Landa, Luis; Yoo, Jong; Spencer, Corinne; Lorenzo, Isabel; Brilliant, Murray; Noebels, Jeffrey; Beaudet, Arthur L.			Altered Ultrasonic Vocalization and Impaired Learning and Memory in Angelman Syndrome Mouse Model with a Large Maternal Deletion from Ube3a to Gabrb3	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; PRADER-WILLI-SYNDROME; GENOMIC REARRANGEMENTS; BEHAVIORAL PHENOTYPES; IMPRINTED EXPRESSION; LANGUAGE DISORDER; UBIQUITIN LIGASE; MUTANT MICE; GENE; ATP10C	Angelman syndrome (AS) is a neurobehavioral disorder associated with mental retardation, absence of language development, characteristic electroencephalography (EEG) abnormalities and epilepsy, happy disposition, movement or balance disorders, and autistic behaviors. The molecular defects underlying AS are heterogeneous, including large maternal deletions of chromosome 15q11-q13 (70%), paternal uniparental disomy (UPD) of chromosome 15 (5%), imprinting mutations (rare), and mutations in the E6-AP ubiquitin ligase gene UBE3A (15%). Although patients with UBE3A mutations have a wide spectrum of neurological phenotypes, their features are usually milder than AS patients with deletions of 15q11-q13. Using a chromosomal engineering strategy, we generated mutant mice with a 1.6-Mb chromosomal deletion from Ube3a to Gabrb3, which inactivated the Ube3a and Gabrb3 genes and deleted the Atp10a gene. Homozygous deletion mutant mice died in the perinatal period due to a cleft palate resulting from the null mutation in Gabrb3 gene. Mice with a maternal deletion (m-/p+) were viable and did not have any obvious developmental defects. Expression analysis of the maternal and paternal deletion mice confirmed that the Ube3a gene is maternally expressed in brain, and showed that the Atp10a and Gabrb3 genes are biallelically expressed in all brain sub-regions studied. Maternal (m-/p+), but not paternal (m+/p-), deletion mice had increased spontaneous seizure activity and abnormal EEG. Extensive behavioral analyses revealed significant impairment in motor function, learning and memory tasks, and anxiety-related measures assayed in the light-dark box in maternal deletion but not paternal deletion mice. Ultrasonic vocalization (USV) recording in newborns revealed that maternal deletion pups emitted significantly more USVs than wild-type littermates. The increased USV in maternal deletion mice suggests abnormal signaling behavior between mothers and pups that may reflect abnormal communication behaviors in human AS patients. Thus, mutant mice with a maternal deletion from Ube3a to Gabrb3 provide an AS mouse model that is molecularly more similar to the contiguous gene deletion form of AS in humans than mice with Ube3a mutation alone. These mice will be valuable for future comparative studies to mice with maternal deficiency of Ube3a alone.	[Jiang, Yong-hui; Pan, Yanzhen; Landa, Luis; Spencer, Corinne; Lorenzo, Isabel; Beaudet, Arthur L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Jiang, Yong-hui; Zhu, Li] Duke Univ, Sch Med, Dept Pediat & Neurobiol, Div Med Genet, Durham, NC USA; [Yoo, Jong; Noebels, Jeffrey] Baylor Coll Med, Neurogenet Lab, Dept Neurol, Houston, TX 77030 USA; [Brilliant, Murray] Univ Arizona, Hlth Sci Ctr, Dept Pediat, Tucson, AZ 85721 USA	Baylor College of Medicine; Duke University; Baylor College of Medicine; University of Arizona; University of Arizona Health Sciences	Jiang, YH (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	yong-hui.jiang@duke.edu		Noebels, Jeffrey/0000-0002-2887-0839	National Institutes of Health (NIH) [HD-37283]; Angelman Syndrome Foundation; Duke University Institute for Brain Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037283, K12HD043494] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Angelman Syndrome Foundation; Duke University Institute for Brain Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health (NIH) grant HD-37283 to ALB and Angelman Syndrome Foundation grant and Duke University Institute for Brain Science to YHJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Bi WM, 2007, HUM MOL GENET, V16, P1802, DOI 10.1093/hmg/ddm128; BRADLEY A, 2005, MOUSE CHROMOSOME ENG; Branchi I, 2001, BEHAV BRAIN RES, V125, P49, DOI 10.1016/S0166-4328(01)00277-7; Chai JH, 2003, AM J HUM GENET, V73, P898, DOI 10.1086/378816; Clayton-Smith J, 2003, J MED GENET, V40, P87, DOI 10.1136/jmg.40.2.87; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; Dhar MS, 2006, J NUTR BIOCHEM, V17, P811, DOI 10.1016/j.jnutbio.2006.01.002; Dhar MS, 2004, J NUTR, V134, P799, DOI 10.1093/jn/134.4.799; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Dubose AJ, 2009, NEUROGENETICS; Fujita E, 2008, P NATL ACAD SCI USA, V105, P3117, DOI 10.1073/pnas.0712298105; Galvan-Manso M, 2005, EPILEPTIC DISORD, V7, P19; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; Hahn ME, 2005, BEHAV GENET, V35, P31, DOI 10.1007/s10519-004-0854-7; Hahn ME, 2002, BEHAV GENET, V32, P267, DOI 10.1023/A:1019728813891; Heck DH, 2008, HUM MOL GENET, V17, P2181, DOI 10.1093/hmg/ddn117; Herzing LBK, 2001, AM J HUM GENET, V68, P1501, DOI 10.1086/320616; Hofer Myron A, 2002, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0814s17; Hogan C., 2007, Searcher, V15, P13; Hogart A, 2008, HUM GENET, V124, P235, DOI 10.1007/s00439-008-0546-0; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; Horsler K, 2006, AM J MENT RETARD, V111, P311, DOI 10.1352/0895-8017(2006)111[311:EIOTBP]2.0.CO;2; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; JAMAIN S, 2008, P NATL ACAD SCI US; Jedele Kerry Baldwin, 2007, Semin Pediatr Neurol, V14, P108, DOI 10.1016/j.spen.2007.07.002; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jiang YH, 1999, AM J HUM GENET, V65, P1, DOI 10.1086/302473; Jiang YH, 2008, BMC GENOMICS, V9, DOI [10.1186/1471-2164-9-50, 10.1186/1471-2164-9-S1-S6]; Kashiwagi A, 2003, J HUM GENET, V48, P194, DOI 10.1007/s10038-003-0009-3; Kayashima T, 2003, J HUM GENET, V48, P492, DOI 10.1007/s10038-003-0061-z; Kayashima T, 2003, GENOMICS, V81, P644, DOI 10.1016/S0888-7543(03)00077-6; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Liljelund P, 2005, DEV BRAIN RES, V157, P150, DOI 10.1016/j.devbrainres.2005.03.014; Lossie AC, 2001, J MED GENET, V38, P834, DOI 10.1136/jmg.38.12.834; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Meguro M, 1997, HUM MOL GENET, V6, P2127, DOI 10.1093/hmg/6.12.2127; Meguro M, 2001, NAT GENET, V28, P19, DOI 10.1038/ng0501-19; Minassian BA, 1998, ANN NEUROL, V43, P485, DOI 10.1002/ana.410430412; Miura K, 2002, NEUROBIOL DIS, V9, P149, DOI 10.1006/nbdi.2001.0463; Moles A, 2004, SCIENCE, V304, P1983, DOI 10.1126/science.1095943; Moy SS, 2006, AM J MED GENET C, V142C, P40, DOI 10.1002/ajmg.c.30081; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; NICHOLLS RD, 1993, P NATL ACAD SCI USA, V90, P2050, DOI 10.1073/pnas.90.5.2050; Nishijima I, 2003, GENESIS, V36, P142, DOI 10.1002/gene.10207; Oliver C, 2002, AM J MENT RETARD, V107, P194, DOI 10.1352/0895-8017(2002)107<0194:EOEEOS>2.0.CO;2; Oliver C, 2007, J CHILD PSYCHOL PSYC, V48, P571, DOI 10.1111/j.1469-7610.2007.01736.x; Paprocka J, 2007, NEUROLOGIST, V13, P305, DOI 10.1097/01.nrl.0000253067.32759.aa; Paylor R, 2006, PHYSIOL BEHAV, V87, P95, DOI 10.1016/j.physbeh.2005.09.002; Peters SU, 2004, CLIN GENET, V66, P530, DOI 10.1111/j.1399-0004.2004.00362.x; Picker JD, 2006, NEUROREPORT, V17, P541, DOI 10.1097/01.wnr.0000208995.38695.2f; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; SCATTONI ML, 2008, NEUROSCI BIOBEHAV RE; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Stankiewicz P, 2007, CURR OPIN GENET DEV, V17, P182, DOI 10.1016/j.gde.2007.04.009; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; VANWOERDEN GM, 2007, NAT NEUROSCI; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Veltman MWM, 2005, PSYCHIAT GENET, V15, P243, DOI 10.1097/00041444-200512000-00006; Walz K, 2003, MOL CELL BIOL, V23, P3646, DOI 10.1128/MCB.23.10.3646-3655.2003; Walz K, 2006, J CLIN INVEST, V116, P3035, DOI 10.1172/JCI28953; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; YOUNG DM, 2007, P NATL ACAD SCI USA, V107, P11079; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000	70	117	119	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12278	10.1371/journal.pone.0012278	http://dx.doi.org/10.1371/journal.pone.0012278			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808828	Green Submitted, Green Published, gold			2022-12-27	WOS:000281077000004
J	Popesku, JT; Martyniuk, CJ; Denslow, ND; Trudeau, VL				Popesku, Jason T.; Martyniuk, Christopher J.; Denslow, Nancy D.; Trudeau, Vance L.			Rapid Dopaminergic Modulation of the Fish Hypothalamic Transcriptome and Proteome	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; GOLDFISH CARASSIUS-AURATUS; S-TRANSFERASE-PI; GENE-EXPRESSION; MOLECULAR-CLONING; FEMALE GOLDFISH; AFRICAN CATFISH; MESSENGER-RNA; GLUTATHIONE; PITUITARY	Background: Dopamine (DA) is a major neurotransmitter playing an important role in the regulation of vertebrate reproduction. We developed a novel method for the comparison of transcriptomic and proteomic data obtained from in vivo experiments designed to study the neuroendocrine actions of DA. Methods and Findings: Female goldfish were injected (i.p.) with DA agonists (D1-specific; SKF 38393, or D2-specific; LY 171555) and sacrificed after 5 h. Serum LH levels were reduced by 57% and 75% by SKF 38393 and LY 171555, respectively, indicating that the treatments produced physiologically relevant responses in vivo. Bioinformatic strategies and a ray-finned fish database were established for microarray and iTRAQ proteomic analysis of the hypothalamus, revealing a total of 3088 mRNAs and 42 proteins as being differentially regulated by the treatments. Twenty one proteins and mRNAs corresponding to these proteins appeared on both lists. Many of the mRNAs and proteins affected by the treatments were grouped into the Gene Ontology categorizations of protein complex, signal transduction, response to stimulus, and regulation of cellular processes. There was a 57% and 14% directional agreement between the differentially-regulated mRNAs and proteins for SKF 38393 and LY 171555, respectively. Conclusions: The results demonstrate the applicability of advanced high-throughput genomic and proteomic analyses in an amendable well-studied teleost model species whose genome has yet to be sequenced. We demonstrate that DA rapidly regulates multiple hypothalamic pathways and processes that are also known to be involved in pathologies of the central nervous system.	[Popesku, Jason T.; Trudeau, Vance L.] Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON, Canada; [Martyniuk, Christopher J.; Denslow, Nancy D.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA; [Martyniuk, Christopher J.; Denslow, Nancy D.] Univ Florida, Ctr Environm & Human Toxicol, Gainesville, FL USA	University of Ottawa; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Popesku, JT (corresponding author), Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON, Canada.	trudeauv@uottawa.ca	Trudeau, Vance L./P-5542-2019	Trudeau, Vance L./0000-0002-0845-9444; Martyniuk, Christopher J./0000-0003-0921-4796	Ontario Graduate Scholarship; Parkinson's Research Consortium; NSERC [203152]; National Institute of Environmental Health Sciences [RO1 ES015449]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015449] Funding Source: NIH RePORTER	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Parkinson's Research Consortium; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported financially by an Ontario Graduate Scholarship (JTP), the Parkinson's Research Consortium (JTP, VLT), NSERC Grant 203152 (VLT) and National Institute of Environmental Health Sciences Superfund Research Program RO1 ES015449 (NDD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen J, 2005, GEN COMP ENDOCR, V142, P212, DOI 10.1016/j.ygcen.2005.01.002; Altar CA, 2009, NEUROPSYCHOPHARMACOL, V34, P18, DOI 10.1038/npp.2008.172; Babin PJ, 1997, P NATL ACAD SCI USA, V94, P8622, DOI 10.1073/pnas.94.16.8622; BARBEAU A, 1970, CAN MED ASSOC J, V103, P824; BHANDARI B, 1988, P NATL ACAD SCI USA, V85, P5789, DOI 10.1073/pnas.85.16.5789; Bolognani F, 2008, J NEUROSCI RES, V86, P481, DOI 10.1002/jnr.21473; Chang JP, 2009, GEN COMP ENDOCR, V161, P42, DOI 10.1016/j.ygcen.2008.09.005; CHANG JP, 1984, GEN COMP ENDOCR, V55, P351, DOI 10.1016/0016-6480(84)90003-0; CHANG JP, 1983, GEN COMP ENDOCR, V49, P22, DOI 10.1016/0016-6480(83)90004-7; CHANG JP, 1983, NEUROENDOCRINOLOGY, V36, P351, DOI 10.1159/000123480; Choudhury M, 2009, ACTA BIOCH BIOPH SIN, V41, P370, DOI 10.1093/abbs/gmp015; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DELEEUW R, 1986, GEN COMP ENDOCR, V63, P171, DOI 10.1016/0016-6480(86)90153-X; DELEEUW R, 1988, GEN COMP ENDOCR, V72, P408, DOI 10.1016/0016-6480(88)90163-3; Dihal AA, 2008, PROTEOMICS, V8, P45, DOI 10.1002/pmic.200700364; Dourado DFAR, 2008, CURR PROTEIN PEPT SC, V9, P325, DOI 10.2174/138920308785132677; Dufour S, 2005, ANN NY ACAD SCI, V1040, P9, DOI 10.1196/annals.1327.002; DUFOUR S, 1988, GEN COMP ENDOCR, V70, P20, DOI 10.1016/0016-6480(88)90090-1; Finch CE, 2003, NEUROBIOL AGING, V24, pS123, DOI 10.1016/S0197-4580(03)00051-4; Giraudo CG, 2009, SCIENCE, V323, P512, DOI 10.1126/science.1166500; GOPING G, 1995, BRAIN RES, V687, P35, DOI 10.1016/0006-8993(95)00391-3; Hack Catherine Jane, 2004, Briefings in Functional Genomics & Proteomics, V3, P212, DOI 10.1093/bfgp/3.3.212; Henderson CJ, 2000, P NATL ACAD SCI USA, V97, P12741, DOI 10.1073/pnas.220176997; HORNBY PJ, 1990, BRAIN BEHAV EVOLUT, V35, P49, DOI 10.1159/000115856; Huo LF, 2004, ENDOCRINOLOGY, V145, P5056, DOI 10.1210/en.2004-0584; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ishisaki A, 2001, J NEUROCHEM, V77, P1362, DOI 10.1046/j.1471-4159.2001.00351.x; KAH O, 1992, NEUROENDOCRINOLOGY, V55, P396, DOI 10.1159/000126150; KEBABIAN JW, 1979, NATURE, V277, P93, DOI 10.1038/277093a0; Kondo H, 2005, GENE, V346, P257, DOI 10.1016/j.gene.2004.11.015; Levavi-Sivan B, 2006, BIOL REPROD, V75, P642, DOI 10.1095/biolreprod.106.051540; Maiya R, 2007, GENES BRAIN BEHAV, V6, P97, DOI 10.1111/j.1601-183X.2006.00236.x; Marlatt VL, 2008, MOL CELL ENDOCRINOL, V283, P38, DOI 10.1016/j.mce.2007.10.013; Martyniuk CJ, 2007, J NEUROENDOCRINOL, V19, P390, DOI 10.1111/j.1365-2826.2007.01543.x; Martyniuk CJ, 2006, PHYSIOL GENOMICS, V27, P328, DOI 10.1152/physiolgenomics.00090.2006; Martyniuk CJ, 2009, GEN COMP ENDOCR, V164, P135, DOI 10.1016/j.ygcen.2009.01.023; Martyniuk CJ, 2009, J PROTEOME RES, V8, P2186, DOI 10.1021/pr800627n; Masserano JM, 1996, MOL PHARMACOL, V50, P1309; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; Mennigen JA, 2008, PHYSIOL GENOMICS, V35, P273, DOI 10.1152/physiolgenomics.90263.2008; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Otto CJ, 1999, REGUL PEPTIDES, V83, P97, DOI 10.1016/S0167-0115(99)00052-X; PETER RE, 1980, NEUROENDOCRINOLOGY, V31, P133, DOI 10.1159/000123064; PETER RE, 1984, GEN COMP ENDOCR, V55, P337, DOI 10.1016/0016-6480(84)90001-7; PETER RE, 1975, J COMP NEUROL, V159, P69, DOI 10.1002/cne.901590106; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Popesku J, 2008, BIOL REPROD, P53; Popesku JT, 2008, MOL CELL ENDOCRINOL, V293, P43, DOI 10.1016/j.mce.2008.06.017; Saligaut C, 1998, GEN COMP ENDOCR, V109, P302, DOI 10.1006/gcen.1997.7033; Shi M, 2009, AM J PATHOL, V175, P54, DOI 10.2353/ajpath.2009.081019; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Smeyne M, 2007, P NATL ACAD SCI USA, V104, P1977, DOI 10.1073/pnas.0610978104; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; Takeuchi Y, 2002, J NEUROCHEM, V83, P784, DOI 10.1046/j.1471-4159.2002.01180.x; Trudeau V L, 1997, Rev Reprod, V2, P55, DOI 10.1530/ror.0.0020055; Trudeau VL, 2000, BIOCHEM CELL BIOL, V78, P241, DOI 10.1139/bcb-78-3-241; TRUDEAU VL, 1993, AM J PHYSIOL, V265, pR348, DOI 10.1152/ajpregu.1993.265.2.R348; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vitale ML, 2004, J HISTOCHEM CYTOCHEM, V52, P517, DOI 10.1177/002215540405200410; Williams DR, 2008, J FISH BIOL, V72, P2095, DOI 10.1111/j.1095-8649.2008.01875.x; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Xiong HL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-25; Yamamoto K, 2010, MOL CELL NEUROSCI, V43, P394, DOI 10.1016/j.mcn.2010.01.006; Zhang DP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005816; Zhao E, 2006, NEUROPEPTIDES, V40, P275, DOI 10.1016/j.npep.2006.05.002; Zhou L, 2005, COMP BIOCHEM PHYS B, V142, P432, DOI 10.1016/j.cbpb.2005.09.007	70	30	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12338	10.1371/journal.pone.0012338	http://dx.doi.org/10.1371/journal.pone.0012338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808832	gold, Green Published, Green Submitted			2022-12-27	WOS:000281077000019
J	Ruckert, F; Dawelbait, G; Winter, C; Hartmann, A; Denz, A; Ammerpohl, O; Schroeder, M; Schackert, HK; Sipos, B; Kloppel, G; Kalthoff, H; Saeger, HD; Pilarsky, C; Grutzmann, R				Rueckert, Felix; Dawelbait, Gihan; Winter, Christof; Hartmann, Arndt; Denz, Axel; Ammerpohl, Ole; Schroeder, Michael; Schackert, Hans Konrad; Sipos, Bence; Kloeppel, Guenter; Kalthoff, Holger; Saeger, Hans-Detlev; Pilarsky, Christian; Gruetzmann, Robert			Examination of Apoptosis Signaling in Pancreatic Cancer by Computational Signal Transduction Analysis	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; CARCINOMA CELL-LINES; PROTEIN INTERFACES; FAS LIGAND; EXPRESSION; CHEMORESISTANCE; GEMCITABINE; RESISTANCE; ADENOCARCINOMA; CHEMOTHERAPY	Background: Pancreatic ductal adenocarcinoma (PDAC) remains an important cause of cancer death. Changes in apoptosis signaling in pancreatic cancer result in chemotherapy resistance and aggressive growth and metastasizing. The aim of this study was to characterize the apoptosis pathway in pancreatic cancer computationally by evaluation of experimental data from high-throughput technologies and public data bases. Therefore, gene expression analysis of microdissected pancreatic tumor tissue was implemented in a model of the apoptosis pathway obtained by computational protein interaction prediction. Methodology/Principal Findings: Apoptosis pathway related genes were assembled from electronic databases. To assess expression of these genes we constructed a virtual subarray from a whole genome analysis from microdissected native tumor tissue. To obtain a model of the apoptosis pathway, interactions of members of the apoptosis pathway were analysed using public databases and computational prediction of protein interactions. Gene expression data were implemented in the apoptosis pathway model. 19 genes were found differentially expressed and 12 genes had an already known pathophysiological role in PDAC, such as Survivin/BIRC5, BNIP3 and TNF-R1. Furthermore we validated differential expression of IL1R2 and Livin/BIRC7 by RT-PCR and immunohistochemistry. Implementation of the gene expression data in the apoptosis pathway map suggested two higher level defects of the pathway at the level of cell death receptors and within the intrinsic signaling cascade consistent with references on apoptosis in PDAC. Protein interaction prediction further showed possible new interactions between the single pathway members, which demonstrate the complexity of the apoptosis pathway. Conclusions/Significance: Our data shows that by computational evaluation of public accessible data an acceptable virtual image of the apoptosis pathway might be given. By this approach we could identify two higher level defects of the apoptosis pathway in PDAC. We could further for the first time identify IL1R2 as possible candidate gene in PDAC.	[Rueckert, Felix; Denz, Axel; Saeger, Hans-Detlev; Pilarsky, Christian; Gruetzmann, Robert] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Visceral Thorac & Vasc Surg, Dresden, Germany; [Dawelbait, Gihan; Winter, Christof; Schroeder, Michael] Tech Univ Dresden, Bioinformat Grp, Ctr Biotechnol, Dresden, Germany; [Hartmann, Arndt] Univ Erlangen Nurnberg, Dept Pathol, Erlangen, Germany; [Ammerpohl, Ole; Kalthoff, Holger] Schleswig Holstein Univ Hosp, Div Mol Oncol, Clin Gen Surg & Thorac Surg, Kiel, Germany; [Schackert, Hans Konrad] Tech Univ Dresden, Dept Surg Res, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Sipos, Bence; Kloeppel, Guenter] Schleswig Holstein Univ Hosp, Div Mol Oncol, Inst Expt Canc Res, Kiel, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; University of Erlangen Nuremberg; University of Kiel; Schleswig Holstein University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Kiel; Schleswig Holstein University Hospital	Ruckert, F (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Visceral Thorac & Vasc Surg, Dresden, Germany.	Felix.Rueckert@uniklinikum-dresden.de	Schroeder, Michael/A-3040-2010; Winter, Christof/A-1887-2011; Kalthoff, Holger/B-1618-2010; Ammerpohl, Ole/G-2691-2010; Winter, Christof/AAF-1860-2020	Winter, Christof/0000-0002-0253-9056; Winter, Christof/0000-0002-0253-9056; Pilarsky, Christian/0000-0002-7968-3283	Deutsche Krebshilfe; medical faculty of Technische Universitat Dresden	Deutsche Krebshilfe(Deutsche Krebshilfe); medical faculty of Technische Universitat Dresden	This study was supported by Deutsche Krebshilfe and the MedDrive38 program of the medical faculty of Technische Universitat Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akada M, 2005, CLIN CANCER RES, V11, P3094, DOI 10.1158/1078-0432.CCR-04-1785; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arlt A, 2002, CANCER RES, V62, P910; Bai JR, 2005, CANCER RES, V65, P2344, DOI 10.1158/0008-5472.CAN-04-3502; Bernstorff WV, 2002, CANCER, V94, P2552, DOI 10.1002/cncr.10549; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Dupraz P, 2000, J BIOL CHEM, V275, P37672, DOI 10.1074/jbc.M005150200; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Fink L, 1998, NAT MED, V4, P1329, DOI 10.1038/3327; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Grutzmann R, 2004, NEOPLASIA, V6, P611, DOI 10.1593/neo.04295; Grutzmann R, 2004, INT J COLORECTAL DIS, V19, P401, DOI 10.1007/s00384-003-0563-3; HEPPNER GH, 1984, CANCER RES, V44, P2259; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; KARIKARI CA, 2007, MOL CANC THER; Lopes RB, 2007, INT J CANC; Lowenfels AB, 2006, BEST PRACT RES CL GA, V20, P197, DOI 10.1016/j.bpg.2005.10.001; Mahon PC, 2007, CANCER RES, V67, P6786, DOI 10.1158/0008-5472.CAN-07-0440; Matsuo Y, 2004, PANCREAS, V28, P344, DOI 10.1097/00006676-200404000-00025; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Miyamoto Y, 1999, ONCOLOGY-BASEL, V56, P73, DOI 10.1159/000011933; Mori T, 2005, SURGERY, V138, P71, DOI 10.1016/j.surg.2005.03.001; Pilarsky C, 2008, J CELL MOL MED, V12, P2823, DOI 10.1111/j.1582-4934.2008.00289.x; Ringel B, 1999, ANN NY ACAD SCI, V880, P175, DOI 10.1111/j.1749-6632.1999.tb09521.x; Ruckdeschel K, 2002, J IMMUNOL, V168, P4601, DOI 10.4049/jimmunol.168.9.4601; Ruckert F, 2009, CURR CANCER THER REV, V5, P122, DOI 10.2174/157339409788166760; Rupnow BA, 1999, APOPTOSIS, V4, P115, DOI 10.1023/A:1009675028784; Schniewind B, 2004, INT J CANCER, V109, P182, DOI 10.1002/ijc.11679; Shi X, 2002, ONCOLOGY-BASEL, V62, P354, DOI 10.1159/000065068; Stoehr R, 2004, LAB INVEST, V84, P465, DOI 10.1038/labinvest.3700068; Tsai CJ, 1996, J MOL BIOL, V260, P604, DOI 10.1006/jmbi.1996.0424; Tsuji S, 2003, INT J CANCER, V106, P17, DOI 10.1002/ijc.11170; Ungefroren H, 1999, ANN NY ACAD SCI, V880, P243, DOI 10.1111/j.1749-6632.1999.tb09529.x; Vogler M, 2007, ONCOGENE, V26, P248, DOI 10.1038/sj.onc.1209776; Winter C, 2006, NUCLEIC ACIDS RES, V34, pD310, DOI 10.1093/nar/gkj099; Wolff RA, 2000, INVEST NEW DRUG, V18, P43, DOI 10.1023/A:1006383831045; Wright CW, 2005, J CLIN INVEST, V115, P2673, DOI 10.1172/JCI26251; Yamamoto S, 2004, CLIN CANCER RES, V10, P2846, DOI 10.1158/1078-0432.CCR-02-1441; Yoshida Y, 2004, J BIOL CHEM, V279, P1768, DOI 10.1074/jbc.M311498200	41	25	26	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12243	10.1371/journal.pone.0012243	http://dx.doi.org/10.1371/journal.pone.0012243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808857	Green Published, Green Submitted, gold			2022-12-27	WOS:000281075500004
J	Conteh, L; Patouillard, E; Kweku, M; Legood, R; Greenwood, B; Chandramohan, D				Conteh, Lesong; Patouillard, Edith; Kweku, Margaret; Legood, Rosa; Greenwood, Brian; Chandramohan, Daniel			Cost Effectiveness of Seasonal Intermittent Preventive Treatment Using Amodiaquine & Artesunate or Sulphadoxine-Pyrimethamine in Ghanaian Children	PLOS ONE			English	Article							HOME-BASED MANAGEMENT; PRODUCTIVITY COSTS; MALARIA CONTROL; VECTOR CONTROL; HEALTH; HOUSEHOLD; DELIVERY; TRIAL; CARE; CHEMOPROPHYLAXIS	Background: Intermittent preventive treatment for malaria in children (IPTc) involves the administration of a full course of an anti-malarial treatment to children under 5 years old at specified time points regardless of whether or not they are known to be infected, in areas where malaria transmission is seasonal. It is important to determine the costs associated with IPTc delivery via community based volunteers and also the potential savings to health care providers and caretakers due to malaria episodes averted as a consequence of IPTc. Methods: Two thousand four hundred and fifty-one children aged 3-59 months were randomly allocated to four groups to receive: three days of artesunate plus amodiaquine (AS+AQ) monthly, three days of AS+AQ bimonthly, one dose of sulphadoxine-pyrimethamine (SP) bi-monthly or placebo. This paper focuses on incremental cost effectiveness ratios (ICERs) of the three IPTc drug regimens as delivered by community based volunteers (CBV) in Hohoe, Ghana compared to current practice, i.e. case management in the absence of IPTc. Financial and economic costs from the publicly funded health system perspective are presented. Treatment costs borne by patients and their caretakers are also estimated to present societal costs. The costs and effects of IPTc during the intervention period were considered with and without a one year follow up. Probabilistic sensitivity analysis was undertaken to account for uncertainty. Results: Economic costs per child receiving at least the first dose of each course of IPTc show SP bimonthly, at US$ 8.19, is the cheapest to deliver, followed by AS+AQ bimonthly at US$ 10.67 and then by AS+AQ monthly at US$ 14.79. Training, drug delivery and supervision accounted for approximately 20-30% each of total unit costs. During the intervention period AS & AQ monthly was the most cost effective IPTc drug regimen at US$ 67.77 (61.71-74.75, CI 95%) per malaria case averted based on intervention costs only, US$ 64.93 (58.92-71.92, CI 95%) per malaria case averted once the provider cost savings are included and US$ 61.00 (54.98, 67.99, CI 95%) when direct household cost savings are also taken into account. SP bimonthly was US$ 105.35 (75.01-157.31, CI 95%) and AS & AQ bimonthly US$ 211.80 (127.05-399.14, CI 95%) per malaria case averted based on intervention costs only. The incidence of malaria in the post intervention period was higher in children who were <1 year old when they received AS+AQ monthly compared to the placebo group leading to higher cost effectiveness ratios when one year follow up is included. The cost per child enrolled fell considerably when modelled to district level as compared to those encountered under trial conditions. Conclusions: We demonstrate how cost-effective IPTc is using three different drug regimens and the possibilities for reducing costs further if the intervention was to be scaled up to the district level. The need for effective training, drug delivery channels and supervision to support a strong network of community based volunteers is emphasised.	[Conteh, Lesong; Patouillard, Edith; Kweku, Margaret; Legood, Rosa; Greenwood, Brian; Chandramohan, Daniel] London Sch Hyg & Trop Med, London WC1, England; [Conteh, Lesong] Univ London Imperial Coll Sci Technol & Med, London, England; [Kweku, Margaret] Univ Ghana, Ghana Hlth Serv, Legon, Accra, Ghana	University of London; London School of Hygiene & Tropical Medicine; Imperial College London; Ghana Health Service; University of Ghana	Conteh, L (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	l.conteh@imperial.ac.uk	Legood, Rosa/GQZ-9121-2022; Conteh, Lesong/ABE-9550-2020; Agyemang, Samuel/H-8377-2014	Legood, Rosa/0000-0003-2761-5227; Conteh, Lesong/0000-0002-0719-3672; Patouillard, Edith/0000-0001-7347-2824	Gates Malaria Partnership	Gates Malaria Partnership	The overall effectiveness study had ClinicalTrials.gov Identifier: NCT00119132. This work was funded by the Gates Malaria Partnership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi IO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-190; Asante Felix Ankomah, 2003, EC BURDEN MALARIA GH; AsensoOkyere WK, 1997, SOC SCI MED, V45, P659, DOI 10.1016/S0277-9536(96)00383-8; BECKER GS, 1965, ECON J, V75, P493, DOI 10.2307/2228949; Brooker S, 2008, HEALTH POLICY PLANN, V23, P24, DOI 10.1093/heapol/czm041; Brouwer WBF, 1997, HEALTH ECON, V6, P511, DOI 10.1002/(SICI)1099-1050(199709)6:5<511::AID-HEC297>3.3.CO;2-B; BUDLENDER D, 2002, WHY SHOULD WE CARE U; Chinbuah AM, 2006, TROP MED INT HEALTH, V11, P1003, DOI 10.1111/j.1365-3156.2006.01654.x; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Cisse B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007164; Conteh L, 2004, TROP MED INT HEALTH, V9, P125, DOI 10.1046/j.1365-3156.2003.01150.x; Creese A, 1994, COST ANAL PRIMARY HL; Deressa W, 2007, TROP MED INT HEALTH, V12, P1148, DOI 10.1111/j.1365-3156.2007.01901.x; DIALLO D, 2009, 5 MIM PAN AFR MAL C; DICKO A, 2004, AM J TROP MED HYG, V71, P1; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Fenwick E, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-52; *GHAN MIN HLTH, 2007, HOH DISTR MED HLTH A; Gonzalez MA, 2000, B WORLD HEALTH ORGAN, V78, P97; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; *INT MON FUND, 2009, DAT MAPP; JAMES J, 2007, AFRICAN J HLTH SCI, V14, P70; Johns B, 2005, HEALTH POLICY PLANN, V20, P1, DOI 10.1093/heapol/czi001; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Kidane G, 2000, LANCET, V356, P550, DOI 10.1016/S0140-6736(00)02580-0; Kiszewski A, 2007, B WORLD HEALTH ORGAN, V85, P623, DOI 10.2471/BLT.06.039529; Kolaczinski J, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-37; KOOPMANSCHAP MA, 1995, J HEALTH ECON, V14, P171, DOI 10.1016/0167-6296(94)00044-5; Kweku M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004000; Lewin S, 2008, LANCET, V372, P928, DOI 10.1016/S0140-6736(08)61403-8; Manzi F, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-165; Mbonye AK, 2008, T ROY SOC TROP MED H, V102, P685, DOI 10.1016/j.trstmh.2008.04.016; Molyneux DH, 2009, LANCET, V373, P296, DOI 10.1016/S0140-6736(09)60089-1; Morel CM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-166; Mueller DH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-73; Nyonator F., 2008, SCALING HLTH SERVICE; Nyonator FK, 2005, HEALTH POLICY PLANN, V20, P25, DOI 10.1093/heapol/czi003; Owusu-Agyei S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-103; Pagnoni F, 2005, TROP MED INT HEALTH, V10, P621; Phillips M., 1993, GUIDELINES COST EFFE; PICARD J, 1992, T ROY SOC TROP MED H, V86, P580, DOI 10.1016/0035-9203(92)90135-Y; Sachs JD, 2001, MACR HLTH INV HLTH E; SICURI E, HLTH POLICY PL UNPUB; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sokhna C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001471; Temperley M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-196; Tiono AB, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-201; Weinstein MC, 1997, HEALTH ECON, V6, P505, DOI 10.1002/(SICI)1099-1050(199709)6:5<505::AID-HEC294>3.0.CO;2-I; *WHO, 2000, TECHN REP SER WHO, V892; Wiseman V, 2006, TROP MED INT HEALTH, V11, P419, DOI 10.1111/j.1365-3156.2006.01586.x; Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258	51	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12223	10.1371/journal.pone.0012223	http://dx.doi.org/10.1371/journal.pone.0012223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808923	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000280968100022
J	Fasanella, A; Scasciamacchia, S; Garofolo, G; Giangaspero, A; Tarsitano, E; Adone, R				Fasanella, Antonio; Scasciamacchia, Silvia; Garofolo, Giuliano; Giangaspero, Annunziata; Tarsitano, Elvira; Adone, Rosanna			Evaluation of the House Fly Musca domestica as a Mechanical Vector for an Anthrax	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; HELICOBACTER-PYLORI; MAJOR EPIDEMIC; TRANSMISSION; ECOLOGY; FLIES	Anthrax is a disease of human beings and animals caused by the encapsulated, spore-forming, Bacillus anthracis. The potential role of insects in the spread of B. anthracis to humans and domestic animals during an anthrax outbreak has been confirmed by many studies. Among insect vectors, the house fly Musca domestica is considered a potential agent for disease transmission. In this study, laboratory-bred specimens of Musca domestica were infected by feeding on anthrax-infected rabbit carcass or anthrax contaminated blood, and the presence of anthrax spores in their spots (faeces and vomitus) was microbiologically monitored. It was also evaluated if the anthrax spores were able to germinate and replicate in the gut content of insects. These results confirmed the role of insects in spreading anthrax infection. This role, although not major, given the huge size of fly populations often associated with anthrax epidemics in domestic animals, cannot be neglected from an epidemiological point of view and suggest that fly control should be considered as part of anthrax control programs.	[Fasanella, Antonio; Scasciamacchia, Silvia; Garofolo, Giuliano] Anthrax Reference Inst, Ist Zooprofilatt Sperimentale Puglia & Basilicata, Foggia, Italy; [Giangaspero, Annunziata] Univ Foggia, Fac Agr, Foggia, Italy; [Tarsitano, Elvira] Univ Bari, Dept Publ Hlth & Anim Sci, Fac Vet Med, Bari, Italy; [Adone, Rosanna] Ist Super Sanita, I-00161 Rome, Italy	IZS Puglia e Basilicata; University of Foggia; Universita degli Studi di Bari Aldo Moro; Istituto Superiore di Sanita (ISS)	Fasanella, A (corresponding author), Anthrax Reference Inst, Ist Zooprofilatt Sperimentale Puglia & Basilicata, Foggia, Italy.	a.fasanella@izsfg.it	Giangaspero, Annunziata/ABB-3727-2021; Garofolo, Giuliano/B-8551-2016; FRANCIA, MASSIMILIANO/C-7035-2015	Garofolo, Giuliano/0000-0001-7017-3888; FRANCIA, MASSIMILIANO/0000-0002-0672-8639; Giangaspero, Annunziata/0000-0002-3357-8672	Founds Ministry of Health of Italy [IZSPB 004/08 RC]	Founds Ministry of Health of Italy	Founds Ministry of Health of Italy: Ricerca corrente 2008. Title of the research: "Modello sperimentale per la valutazione di Musca domestica come potenziale vettore di Bacillus anthracis.'' Code: IZSPB 004/08 RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosioni P, 1948, CLIN VET, V71, P143; DAVIES JCA, 1985, CENT AFR J MED, V31, P176; DAVIES JCA, 1983, CENT AFR J MED, V29, P8; DEVOS V, 1998, P S LIONS LEOP GAM R, P198; DRAGON DC, 1995, CAN VET J, V36, P295; Dragon DC, 1999, J APPL MICROBIOL, V87, P208, DOI 10.1046/j.1365-2672.1999.00872.x; ESTEN WN, 2008, CONNECTICUT AGR EXPT, V51, P94; Fasanella A, 2005, J CLIN MICROBIOL, V43, P3398, DOI 10.1128/JCM.43.7.3398-3401.2005; Fasanella A, 2001, VACCINE, V19, P4214, DOI 10.1016/S0264-410X(01)00159-1; Fasanella A, 2007, EMERG INFECT DIS, V13, P1118, DOI 10.3201/eid1307.061465; Fasanella A, 2010, NEW MICROBIOL, V33, P83; Fasanella A, 2009, VET MICROBIOL, V133, P208, DOI 10.1016/j.vetmic.2008.06.012; Fortini D, 2007, CLIN CHEM, V53, P1377, DOI 10.1373/clinchem.2007.085993; GREENBERG B, 1965, SCI AM, V213, P92, DOI 10.1038/scientificamerican0765-92; Greenberg B, 1971, FLIES DIS; Harwood RF, 1979, ENTOMOLOGY HUMAN ANI, P248; Hugh-Jones ME, 2002, REV SCI TECH OIE, V21, P359, DOI 10.20506/rst.21.2.1336; Karthikeyan K, 2001, Indian Pediatr, V38, P777; KELLY SM, 1994, GASTROENTEROLOGY, V107, P1671, DOI 10.1016/0016-5085(94)90806-0; Kozel TR, 2007, INFECT IMMUN, V75, P152, DOI 10.1128/IAI.01133-06; LAFORCE FM, 1994, CLIN INFECT DIS, V19, P1009, DOI 10.1093/clinids/19.6.1009; MCKENDRICK DRA, 1980, CENT AFR J MED, V26, P126; MERYL N, 1978, ANTHRAX EPIZOOTIC ZI; Mitzmain MB, 1914, PUBLIC HEALTH REP, V29, P75, DOI 10.2307/4570379; MORRIS H, 1920, J AM VET MED ASSOC, V56, P606; NANZI WA, 2005, TROPICAL BIOMEDICINE, V22, P225; RAO NSK, 1958, INDIAN VET J, V35, P348; RICHARDS CS, 1969, B WORLD HEALTH ORGAN, V41, P952; Sen S. K., 1944, INDIAN JOUR VET SCI AND ANIMAL HUSBANDRY, V14, P149; Tellam R. L., 1996, P86; THOMAS JE, 1992, LANCET, V340, P1194, DOI 10.1016/0140-6736(92)92894-L; TURELL MJ, 1987, INFECT IMMUN, V55, P1859, DOI 10.1128/IAI.55.8.1859-1861.1987; Turnbull P., 1990, Topley & Wilson's Principles of bacteriology, virology and immunity. Volume 2. Systematic bacteriology., P187; TURNER M, 1980, CENT AFR J MED, V26, P160; VANNESS GB, 1971, SCIENCE, V172, P1303, DOI 10.1126/science.172.3990.1303; [No title captured]	36	40	42	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12219	10.1371/journal.pone.0012219	http://dx.doi.org/10.1371/journal.pone.0012219			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808920	Green Submitted, gold, Green Published			2022-12-27	WOS:000280968100018
J	Wan, YW; Sabbagh, E; Raese, R; Qian, Y; Luo, DJ; Denvir, J; Vallyathan, V; Castranova, V; Guo, NL				Wan, Ying-Wooi; Sabbagh, Ebrahim; Raese, Rebecca; Qian, Yong; Luo, Dajie; Denvir, James; Vallyathan, Val; Castranova, Vincent; Guo, Nancy Lan			Hybrid Models Identified a 12-Gene Signature for Lung Cancer Prognosis and Chemoresponse Prediction	PLOS ONE			English	Article							GENE-EXPRESSION; CELL; SURVIVAL; ADENOCARCINOMA; PROFILES	Background: Lung cancer remains the leading cause of cancer-related deaths worldwide. The recurrence rate ranges from 35-50% among early stage non-small cell lung cancer patients. To date, there is no fully-validated and clinically applied prognostic gene signature for personalized treatment. Methodology/Principal Findings: From genome-wide mRNA expression profiles generated on 256 lung adenocarcinoma patients, a 12-gene signature was identified using combinatorial gene selection methods, and a risk score algorithm was developed with Naive Bayes. The 12-gene model generates significant patient stratification in the training cohort HLM & UM (n = 256; log-rank P = 6.96e-7) and two independent validation sets, MSK (n = 104; log-rank P = 9.88e-4) and DFCI (n = 82; log-rank P = 2.57e-4), using Kaplan-Meier analyses. This gene signature also stratifies stage I and IB lung adenocarcinoma patients into two distinct survival groups (log-rank P<0.04). The 12-gene risk score is more significant (hazard ratio = 4.19, 95% CI: [2.08, 8.46]) than other commonly used clinical factors except tumor stage (III vs. I) in multivariate Cox analyses. The 12-gene model is more accurate than previously published lung cancer gene signatures on the same datasets. Furthermore, this signature accurately predicts chemoresistance/chemosensitivity to Cisplatin, Carboplatin, Paclitaxel, Etoposide, Erlotinib, and Gefitinib in NCl-60 cancer cell lines (P<0.017). The identified 12 genes exhibit curated interactions with major lung cancer signaling hallmarks in functional pathway analysis. The expression patterns of the signature genes have been confirmed in RT-PCR analyses of independent tumor samples. Conclusions/Significance: The results demonstrate the clinical utility of the identified gene signature in prognostic categorization. With this 12-gene risk score algorithm, early stage patients at high risk for tumor recurrence could be identified for adjuvant chemotherapy; whereas stage I and II patients at low risk could be spared the toxic side effects of chemotherapeutic drugs.	[Wan, Ying-Wooi; Sabbagh, Ebrahim; Raese, Rebecca; Luo, Dajie; Denvir, James; Guo, Nancy Lan] W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; [Qian, Yong; Vallyathan, Val; Castranova, Vincent] NIOSH, Pathol & Physiol Res Branch, Hlth Effects Lab Div, Morgantown, WV USA	West Virginia University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Wan, YW (corresponding author), W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA.	lguo@hsc.wvu.edu			NIH/NLM [R01LM009500]; NCRR [P20RR16440]; NIH/NCRR [P2016477]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440, P20RR016477] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009500] Funding Source: NIH RePORTER	NIH/NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study is supported by NIH/NLM R01LM009500 (PI: Guo) and NCRR P20RR16440 and Supplement (PD: Guo). The software license and training for IPA and Pathway Studio was supported by NIH/NCRR P2016477. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2005, CANC FACTS FIG 2005; Baker Stuart G, 2002, BMC Med Res Methodol, V2, P4, DOI 10.1186/1471-2288-2-4; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Borczuk AC, 2005, AM J RESP CRIT CARE, V172, P729, DOI 10.1164/rccm.200504-615OC; Boutros PC, 2009, P NATL ACAD SCI USA, V106, P2824, DOI 10.1073/pnas.0809444106; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Dalton WS, 2006, SCIENCE, V312, P1165, DOI 10.1126/science.1125948; Emir B, 1998, STAT MED, V17, P2563, DOI 10.1002/(SICI)1097-0258(19981130)17:22<2563::AID-SIM952>3.0.CO;2-O; Guo L, 2006, CLIN CANCER RES, V12, P3344, DOI 10.1158/1078-0432.CCR-05-2336; Guo NL, 2008, CLIN CANCER RES, V14, P8213, DOI 10.1158/1078-0432.CCR-08-0095; Hall MA, 2003, IEEE T KNOWL DATA EN, V15, P1437, DOI 10.1109/TKDE.2003.1245283; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Lau SK, 2007, J CLIN ONCOL, V25, P5562, DOI 10.1200/JCO.2007.12.0352; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Ma Y, 2006, CLIN CANCER RES, V12, P4583, DOI 10.1158/1078-0432.CCR-06-0290; Ma Y, 2009, INT J ONCOL, V34, P107, DOI 10.3892/ijo_00000134; MITCHELL TM, 1997, MACH LEARN, P413; NARUKE T, 1988, J THORAC CARDIOV SUR, V96, P440; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Potti A, 2006, NEW ENGL J MED, V355, P570, DOI 10.1056/NEJMoa060467; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian J, 2010, JNCI-J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Witten I. H., 2005, DATA MINING PRACTICA; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683	36	42	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12222	10.1371/journal.pone.0012222	http://dx.doi.org/10.1371/journal.pone.0012222			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808922	Green Published, gold, Green Submitted			2022-12-27	WOS:000280968100021
J	Devlin, AM; Brain, U; Austin, J; Oberlander, TF				Devlin, Angela M.; Brain, Ursula; Austin, Jehannine; Oberlander, Tim F.			Prenatal Exposure to Maternal Depressed Mood and the MTHFR C677T Variant Affect SLC6A4 Methylation in Infants at Birth	PLOS ONE			English	Article							REUPTAKE INHIBITOR ANTIDEPRESSANTS; GENOMIC DNA METHYLATION; METHYLENETETRAHYDROFOLATE REDUCTASE; EPIGENETIC REGULATION; COMMON MUTATION; GLUCOCORTICOID-RECEPTOR; MAJOR DEPRESSION; SEROTONIN; HOMOCYSTEINE; POLYMORPHISM	Background: Prenatal and early postnatal exposure to maternal depression may "program" childhood behavior via epigenetic processes such as DNA methylation. Methylenetetrahydro-folate reductase (MTHFR) is an important enzyme in the generation of methyl groups for DNA methylation. The common MTHFR C677T variant is associated with depression in men and non-pregnant women, and with global changes in DNA methylation. This study investigated the effect of maternal MTHFR C677T genotype on antenatal maternal mood, and their impact on the gene-specific methylation in pregnant women and their newborn infants. The methylation status of SLC6A4, which encodes the transmembrane serotonin transporter, and BDNF, which encodes brain derived neurotrophic factor, were assessed because of their potential role in behaviour. Methods/Principal Findings: Depressed mood was assessed by the Edinburgh Postnatal Depression Scale (EPDS) and the Hamilton Rating Scale for Depression (HAM-D) in women (n = 82, all taking folate) during the 2(nd) and 3(rd) trimesters of pregnancy. The methylation status of SLC6A4 and BDNF were assessed in 3rd trimester maternal peripheral leukocytes and in umbilical cord leukocytes collected from their infants at birth. Women with the MTHFR 677TT genotype had greater 2(nd) trimester depressed mood (p<0.05). Increased 2(nd) trimester maternal depressed mood (EPDS scores) was associated with decreased maternal and infant SLC6A4 promoter methylation (p<0.05), but had no effect on BDNF promoter methylation. Conclusions: These findings show that the MTHFR C677T variant is associated with greater depressed mood during pregnancy. We further showed that prenatal exposure to maternal depressed mood affects gene-specific DNA methylation patterns. These findings support the concept that alterations in epigenetic processes may contribute to developmental programming of behaviour by maternal depression.	[Devlin, Angela M.; Oberlander, Tim F.] Univ British Columbia, Dept Pediat, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada; [Brain, Ursula; Oberlander, Tim F.] Univ British Columbia, Early Human Experience Unit, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada; [Austin, Jehannine] Univ British Columbia, Dept Psychiat, Child & Family Res Inst, Vancouver, BC, Canada	Child & Family Research Institute; University of British Columbia; Child & Family Research Institute; University of British Columbia; Child & Family Research Institute; University of British Columbia	Devlin, AM (corresponding author), Univ British Columbia, Dept Pediat, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada.	angela.devlin@ubc.ca		Oberlander, Tim/0000-0003-4781-6579; Devlin, Angela/0000-0002-1390-6587; Austin, Jehannine/0000-0003-0338-7055	Canadian Institutes for Health Research; Heart and Stroke Foundation of Canada	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by grants from the Canadian Institutes for Health Research (T.F.O.). A. M. D. holds a New Investigator Salary Award from the Heart and Stroke Foundation of Canada. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida OP, 2008, ARCH GEN PSYCHIAT, V65, P1286, DOI 10.1001/archpsyc.65.11.1286; Ansorge MS, 2008, J NEUROSCI, V28, P199, DOI 10.1523/JNEUROSCI.3973-07.2008; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Bjelland I, 2003, ARCH GEN PSYCHIAT, V60, P618, DOI 10.1001/archpsyc.60.6.618; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Castro R, 2004, J MED GENET, V41, P454, DOI 10.1136/jmg.2003.017244; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Devlin AM, 2006, AM J CLIN NUTR, V83, P708, DOI 10.1093/ajcn.83.3.708; Dupont JM, 2004, ANAL BIOCHEM, V333, P119, DOI 10.1016/j.ab.2004.05.007; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gilbody S, 2007, AM J EPIDEMIOL, V165, P1, DOI 10.1093/aje/kwj347; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Heils A, 1996, J NEUROCHEM, V66, P2621; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hwang JP, 2006, NEUROBIOL AGING, V27, P1834, DOI 10.1016/j.neurobiolaging.2005.10.013; Jacques PF, 1996, CIRCULATION, V93, P7, DOI 10.1161/01.CIR.93.1.7; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jans LAW, 2007, MOL PSYCHIATR, V12, P522, DOI 10.1038/sj.mp.4001920; Kendler KS, 2005, ARCH GEN PSYCHIAT, V62, P529, DOI 10.1001/archpsyc.62.5.529; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 1998, BIOL PSYCHIAT, V44, P179, DOI 10.1016/S0006-3223(98)00121-8; Lewis SJ, 2006, MOL PSYCHIATR, V11, P352, DOI 10.1038/sj.mp.4001790; Lopez-Leon S, 2008, MOL PSYCHIATR, V13, P772, DOI 10.1038/sj.mp.4002088; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Mortensen OV, 1999, MOL BRAIN RES, V68, P141, DOI 10.1016/S0169-328X(99)00083-2; O'Connor TG, 2002, BRIT J PSYCHIAT, V180, P502, DOI 10.1192/bjp.180.6.502; Oberlander TF, 2008, MOL PSYCHIATR, V13, P65, DOI 10.1038/sj.mp.4002007; Oberlander TF, 2008, EARLY HUM DEV, V84, P689, DOI 10.1016/j.earlhumdev.2008.06.008; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Oberlander TF, 2006, ARCH GEN PSYCHIAT, V63, P898, DOI 10.1001/archpsyc.63.8.898; Oberlander TF, 2010, ARCH PEDIAT ADOL MED, V164, P444, DOI 10.1001/archpediatrics.2010.51; Philibert R, 2007, AM J MED GENET B, V144B, P101, DOI 10.1002/ajmg.b.30414; Philibert RA, 2008, AM J MED GENET B, V147B, P543, DOI 10.1002/ajmg.b.30657; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Sohn KJ, 2009, INT J CANCER, V124, P1999, DOI 10.1002/ijc.24003; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; WhitakerAzmitia PM, 1996, BEHAV BRAIN RES, V73, P19	43	211	218	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12201	10.1371/journal.pone.0012201	http://dx.doi.org/10.1371/journal.pone.0012201			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808944	gold, Green Submitted, Green Published			2022-12-27	WOS:000280968000024
J	Klopp, AH; Lacerda, L; Gupta, A; Debeb, BG; Solley, T; Li, L; Spaeth, E; Xu, W; Zhang, XM; Lewis, MT; Reuben, JM; Krishnamurthy, S; Ferrari, M; Gaspar, R; Buchholz, TA; Cristofanilli, M; Marini, F; Andreeff, M; Woodward, WA				Klopp, Ann H.; Lacerda, Lara; Gupta, Anshul; Debeb, Bisrat G.; Solley, Travis; Li, Li; Spaeth, Erika; Xu, Wei; Zhang, Xiaomei; Lewis, Michael T.; Reuben, James M.; Krishnamurthy, Savitri; Ferrari, Mauro; Gaspar, Rogerio; Buchholz, Thomas A.; Cristofanilli, Massimo; Marini, Frank; Andreeff, Michael; Woodward, Wendy A.			Mesenchymal Stem Cells Promote Mammosphere Formation and Decrease E-Cadherin in Normal and Malignant Breast Cells	PLOS ONE			English	Article							TENASCIN-C EXPRESSION; STEM/PROGENITOR CELLS; TUMOR STROMA; CANCER CELLS; IN-VITRO; BONE; METASTASIS; TRANSITION; CARCINOMA; DELIVERY	Introduction: Normal and malignant breast tissue contains a rare population of multi-potent cells with the capacity to self-renew, referred to as stem cells, or tumor initiating cells (TIC). These cells can be enriched by growth as "mammospheres" in three-dimensional cultures. Objective: We tested the hypothesis that human bone-marrow derived mesenchymal stem cells (MSC), which are known to support tumor growth and metastasis, increase mammosphere formation. Results: We found that MSC increased human mammary epithelial cell (HMEC) mammosphere formation in a dose-dependent manner. A similar increase in sphere formation was seen in human inflammatory (SUM149) and non-inflammatory breast cancer cell lines (MCF-7) but not in primary inflammatory breast cancer cells (MDA-IBC-3). We determined that increased mammosphere formation can be mediated by secreted factors as MSC conditioned media from MSC spheroids significantly increased HMEC, MCF-7 and SUM149 mammosphere formation by 6.4 to 21-fold. Mammospheres grown in MSC conditioned media had lower levels of the cell adhesion protein, E-cadherin, and increased expression of N-cadherin in SUM149 and HMEC cells, characteristic of a pro-invasive mesenchymal phenotype. Co-injection with MSC in vivo resulted in a reduced latency time to develop detectable MCF-7 and MDA-IBC-3 tumors and increased the growth of MDA-IBC-3 tumors. Furthermore, E-cadherin expression was decreased in MDA-IBC-3 xenografts with co-injection of MSC. Conclusions: MSC increase the efficiency of primary mammosphere formation in normal and malignant breast cells and decrease E-cadherin expression, a biologic event associated with breast cancer progression and resistance to therapy.	[Klopp, Ann H.; Lacerda, Lara; Gupta, Anshul; Debeb, Bisrat G.; Solley, Travis; Li, Li; Xu, Wei; Woodward, Wendy A.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Lacerda, Lara; Gaspar, Rogerio] Univ Lisbon, Fac Farm, IMed UL, Lisbon, Portugal; [Lacerda, Lara; Ferrari, Mauro] Univ Texas Hlth Sci Ctr Houston, Dept Nanomed & Biomed Engn, Houston, TX USA; [Spaeth, Erika; Marini, Frank; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplant & Cellular Therapy, Houston, TX 77030 USA; [Zhang, Xiaomei; Lewis, Michael T.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Reuben, James M.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Krishnamurthy, Savitri] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Universidade de Lisboa; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Klopp, AH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA.	wwoodward@mdanderson.org	Gaspar, Rogerio S./F-6238-2014; Lacerda, Lara/E-2639-2015; iMed.ULisboa, InTraCellADD/B-4826-2014; Woodward, Wendy/AAX-6593-2020; Lewis, Michael T/A-9572-2009	Gaspar, Rogerio S./0000-0002-5950-0291; Woodward, Wendy/0000-0002-7935-739X; Spaeth, Erika/0000-0002-5397-3493	National Institutes of Health [R01CA138239-01]; State of Texas Grant for Rare and Aggressive Cancers; University of Texas M.D. Anderson Cancer Center; University of Texas Health Sciences Center [KL2RR024149]; National Cancer Institute [RC1CA146381, CA109451, CA116199]; Portuguese Foundation for Science and Technology (FCT/MCTES) [SFRH/BPD/46854/2008]; NATIONAL CANCER INSTITUTE [R01CA138239, R01CA127857, P50CA116199, RC1CA146381, P30CA016672, R01CA109451] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024149] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Texas Grant for Rare and Aggressive Cancers; University of Texas M.D. Anderson Cancer Center; University of Texas Health Sciences Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Portuguese Foundation for Science and Technology (FCT/MCTES)(Portuguese Foundation for Science and Technology); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institutes of Health R01CA138239-01; The State of Texas Grant for Rare and Aggressive Cancers; The University of Texas M.D. Anderson Cancer Center Institutional Research Grant; The University of Texas Health Sciences Center KL2RR024149. This work was supported in part by grants from the National Cancer Institute (RC1CA146381, CA109451 and CA116199 for FM). L. Lacerda is grateful to the Portuguese Foundation for Science and Technology (FCT/MCTES) for the award of a postdoctoral fellowship (Ref.: SFRH/BPD/46854/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alpaugh ML, 2002, ONCOGENE, V21, P3631, DOI 10.1038/sj.onc.1205389; Bakker AHF, 2004, OBES RES, V12, P488, DOI 10.1038/oby.2004.55; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; CHUNG CY, 1995, J BIOL CHEM, V270, P29012, DOI 10.1074/jbc.270.48.29012; Dittmer A, 2009, CELL MOL LIFE SCI, V66, P3053, DOI 10.1007/s00018-009-0089-0; Dontu G, 2005, J MAMMARY GLAND BIOL, V10, P75, DOI 10.1007/s10911-005-2542-5; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hay ED, 1995, ACTA ANAT, V154, P8; Hutchison N, 2009, CELL SIGNAL, V21, P1522, DOI 10.1016/j.cellsig.2009.05.012; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kleer CG, 2004, BREAST CANCER RES, V6, pR110, DOI 10.1186/bcr755; Kleer CG, 2001, MODERN PATHOL, V14, P458, DOI 10.1038/modpathol.3880334; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Li Y, 2005, J MAMMARY GLAND BIOL, V10, P17, DOI 10.1007/s10911-005-2537-2; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lundin M, 2007, ONCOLOGY-BASEL, V72, P403, DOI 10.1159/000113490; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MARTIN FT, BREAST CANC RES TREA, P18701; Mohammadizadeh F, 2009, CANCER BIOMARK, V5, P1, DOI 10.3233/CBM-2009-0551; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Pittenger MF, 2000, CURR TOP MICROBIOL, V251, P3; RHODES LV, BREAST CANC RES TREA, V121, P293; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Studeny M, 2002, CANCER RES, V62, P3603; Walker MR, 2009, J PATHOL, V217, P169, DOI 10.1002/path.2474; Wiksten JP, 2003, ONCOLOGY-BASEL, V64, P245, DOI 10.1159/000069305	31	128	134	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12180	10.1371/journal.pone.0012180	http://dx.doi.org/10.1371/journal.pone.0012180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808935	Green Submitted, Green Published, gold			2022-12-27	WOS:000280968000011
J	Llorens-Martin, M; Tejeda, GS; Trejo, JL				Llorens-Martin, Maria; Tejeda, Gonzalo S.; Trejo, Jose L.			Differential Regulation of the Variations Induced by Environmental Richness in Adult Neurogenesis as a Function of Time: A Dual Birthdating Analysis	PLOS ONE			English	Article							HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; PHYSICAL-ACTIVITY; ENRICHED ENVIRONMENT; CELL-PROLIFERATION; SYNAPTIC PLASTICITY; TRANSGENIC MICE; MEMORY; NEURONS; BEHAVIOR	Adult hippocampal neurogenesis (AHN) augments after environmental enrichment (EE) and it has been related to some of the anxiolytic, antidepressant and neuroprotective effects of EE. Indeed, it has been suggested that EE specifically modulates hippocampal neurogenic cell populations over the course of time. Here we have used dual-birthdating to study two subpopulations of newborn neuron in mice (Mus musculus): those born at the beginning and at the end of enrichment. In this way, we demonstrate that while short-term cell survival is upregulated after an initial 1 week period of enrichment in 2 month old female mice, after long-term enrichment (2 months) neither cell proliferation nor the survival of the younger newly born cell populations are distinguishable from that observed in non-enriched control mice. In addition, we show that the survival of older newborn neurons alone (i.e. those born at the beginning of the enrichment) is higher than in controls, due to the significantly lower levels of cell death. Indeed, these parameters are rapidly adjusted to the sudden cessation of the EE conditions. These findings suggest both an early selective, long-lasting effect of EE on the neurons born in the initial stages of enrichment, and a quick response when the environment again becomes impoverished. Therefore, EE induces differential effects on distinct subpopulations of newborn neurons depending on the age of the immature cells and on the duration of the EE itself. The interaction of these two parameters constitutes a new, specific regulation of these neurogenic populations that might account for the long-term enrichment's behavioral effects.	[Llorens-Martin, Maria; Trejo, Jose L.] Ctr Invest Red Enfermedades Neurodegenerat CIBERN, Madrid, Spain; [Llorens-Martin, Maria; Tejeda, Gonzalo S.; Trejo, Jose L.] CSIC, Inst Cajal, E-28002 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Llorens-Martin, M (corresponding author), Ctr Invest Red Enfermedades Neurodegenerat CIBERN, Madrid, Spain.	jltrejo@cajal.csic.es	Llorens-Martin, Maria/R-4613-2017; Trejo, Jose Luis/F-5518-2016	Llorens-Martin, Maria/0000-0001-9129-5198; Tejeda, Gonzalo S./0000-0002-2900-6276	Ministerio de Educacion y Ciencia [BFU2007-60195/BFI]	Ministerio de Educacion y Ciencia(Spanish Government)	Grant awarded to J.L.T. from the Ministerio de Educacion y Ciencia. Grant number: BFU2007-60195/BFI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Ambrogini P, 2004, BRAIN RES, V1017, P21, DOI 10.1016/j.brainres.2004.05.039; Balu DT, 2009, NEUROSCI BIOBEHAV R, V33, P232, DOI 10.1016/j.neubiorev.2008.08.007; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Bruel-Jungerman E, 2007, REV NEUROSCIENCE, V18, P93; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Catlow BJ, 2009, BRAIN RES, V1256, P173, DOI 10.1016/j.brainres.2008.12.028; Choi SH, 2008, NEURON, V59, P568, DOI 10.1016/j.neuron.2008.07.033; Deng W, NAT REV NEUROSCI, V11, P339; Dhanushkodi A, 2008, NEUROSCI BIOBEHAV R, V32, P657, DOI 10.1016/j.neubiorev.2007.10.004; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Ehninger D, 2003, CEREB CORTEX, V13, P845, DOI 10.1093/cercor/13.8.845; Eisch AJ, 2008, J NEUROSCI, V28, P11785, DOI 10.1523/JNEUROSCI.3798-08.2008; Fabel K, 2008, NEUROMOL MED, V10, P59, DOI 10.1007/s12017-008-8031-4; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Herring A, 2009, EXP NEUROL, V216, P184, DOI 10.1016/j.expneurol.2008.11.027; Howard C, 1998, UNBIASED STEREOLOGY; Hutchinson E, 2005, ILAR J, V46, P148, DOI 10.1093/ilar.46.2.148; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kempermann G, 2006, ADULT NEUROGENESIS; Kempermann G, 2008, CURR OPIN PSYCHIATR, V21, P290, DOI 10.1097/YCO.0b013e3282fad375; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Kohl Z, 2002, GENES BRAIN BEHAV, V1, P46, DOI 10.1046/j.1601-1848.2001.00009.x; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lazic SE, 2006, EUR J NEUROSCI, V23, P1829, DOI 10.1111/j.1460-9568.2006.04715.x; Leal-Galicia P, 2008, NEUROBIOL LEARN MEM, V90, P511, DOI 10.1016/j.nlm.2008.07.005; Leuner B, 2009, J COMP NEUROL, V517, P123, DOI 10.1002/cne.22107; Li Y, 2009, CURR TOP DEV BIOL, V87, P149, DOI 10.1016/S0070-2153(09)01205-8; Llorens-Martin M, 2006, HIPPOCAMPUS, V16, P480, DOI 10.1002/hipo.20175; Llorens-Martin MV, 2007, NEUROSCIENCE, V147, P631, DOI 10.1016/j.neuroscience.2007.04.054; LLorens-Martin M, 2009, NEUROSCIENTIST, V15, P134, DOI 10.1177/1073858408331371; LLORENSMARTIN M, MOL CELL NEUROSCI, V44, P109; Martinez-Cue C, 2002, BEHAV BRAIN RES, V134, P185, DOI 10.1016/S0166-4328(02)00026-8; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Milgram NW, 2006, AGEING RES REV, V5, P354, DOI 10.1016/j.arr.2006.04.004; MIROCHNIC S, 2009, HIPPOCAMPUS; Navailles S, 2008, J COMP NEUROL, V509, P372, DOI 10.1002/cne.21775; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Olson AK, 2006, HIPPOCAMPUS, V16, P250, DOI 10.1002/hipo.20157; PAKKENBERG B, 1988, J MICROSC-OXFORD, V150, P20; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; Steiner B, 2008, NEUROSCIENCE, V154, P521, DOI 10.1016/j.neuroscience.2008.04.023; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Trejo JI, 2007, MOL PSYCHIATR, V12, P1118, DOI 10.1038/sj.mp.4002076; Trejo JL, 2008, MOL CELL NEUROSCI, V37, P402, DOI 10.1016/j.mcn.2007.10.016; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Williams BM, 2001, PHYSIOL BEHAV, V73, P649, DOI 10.1016/S0031-9384(01)00543-1; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562	62	33	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12188	10.1371/journal.pone.0012188	http://dx.doi.org/10.1371/journal.pone.0012188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808440	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000280968000015
J	Liebl, FLW; McKeown, C; Yao, Y; Hing, HK				Liebl, Faith L. W.; McKeown, Cassandra; Yao, Ying; Hing, Huey K.			Mutations in Wnt2 Alter Presynaptic Motor Neuron Morphology and Presynaptic Protein Localization at the Drosophila Neuromuscular Junction	PLOS ONE			English	Article							SYNAPTIC VESICLE CYCLE; ACTIVE ZONE; SIGNALING PATHWAY; FUNCTIONAL COMPONENTS; REGULATES DEVELOPMENT; ADHESION MOLECULES; GENETIC DISSECTION; MULTIPLE FUNCTIONS; CELL-ADHESION; AXON GUIDANCE	Wnt proteins are secreted proteins involved in a number of developmental processes including neural development and synaptogenesis. We sought to determine the role of the Drosophila Wnt7b ortholog, Wnt2, using the neuromuscular junction (NMJ). Mutations in wnt2 produce an increase in the number of presynaptic branches and a reduction in immunolabeling of the active zone proteins, Bruchpilot and synaptobrevin, at the NMJ. There was no change, however, in immunolabeling for the presynaptic proteins cysteine-string protein (CSP) and synaptotagmin, nor the postsynaptic proteins GluRIIA and DLG at the NMJ. Consistent with the presynaptic defects, wnt2 mutants exhibit approximately a 50% reduction in evoked excitatory junctional currents. Rescue, RNAi, and tissue-specific qRT-PCR experiments indicate that Wnt2 is expressed by the postsynaptic cell where it may serve as a retrograde signal that regulates presynaptic morphology and the localization of presynaptic proteins.	[Liebl, Faith L. W.; McKeown, Cassandra] So Illinois Univ, Dept Biol Sci, Edwardsville, IL 62026 USA; [Yao, Ying] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Hing, Huey K.] SUNY Coll Brockport, Dept Biol, Brockport, NY 14420 USA	Southern Illinois University System; Southern Illinois University Edwardsville; University of Washington; University of Washington Seattle; State University of New York (SUNY) System	Liebl, FLW (corresponding author), So Illinois Univ, Dept Biol Sci, Edwardsville, IL 62026 USA.	fliebl@siue.edu			NIH NRSA (NIH/NIDCD) [1 F32 DC08443-01]; NIH [1R15NS063315-01]; NIH/NIDCD [DC5408-01]; Roy J. Carver Charitable Trust [03-27]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS063315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005408] Funding Source: NIH RePORTER	NIH NRSA (NIH/NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Roy J. Carver Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	NIH NRSA (NIH/NIDCD, 1 F32 DC08443-01 to F. L.), http://grants.nih.gov/training/nrsa.htm; NIH Academic Research Enhancement Award (1R15NS063315-01 to F. L.), http://grants.nih.gov/grants/funding/area.htm; NIH/NIDCD (DC5408-01 to H. H.), http://www.nidcd.nih.gov/funding/foa/; Roy J. Carver Charitable Trust (#03-27 to H. H.), https://www.carvertrust.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Ataman B, 2006, P NATL ACAD SCI USA, V103, P7841, DOI 10.1073/pnas.0600387103; Augustin H, 2007, J NEUROSCI, V27, P111, DOI 10.1523/JNEUROSCI.4770-06.2007; Bronk P, 2005, J NEUROSCI, V25, P2204, DOI 10.1523/JNEUROSCI.3610-04.2005; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Burden SJ, 2000, CELL, V100, P495, DOI 10.1016/S0092-8674(00)80685-6; Cerpa W, 2008, J BIOL CHEM, V283, P5918, DOI 10.1074/jbc.M705943200; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Ciani L, 2004, J CELL BIOL, V164, P243, DOI 10.1083/jcb.200309096; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Collins CA, 2007, CURR OPIN NEUROBIOL, V17, P35, DOI 10.1016/j.conb.2007.01.001; Davis EK, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-32; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; Deguchi-Tawarada M, 2004, GENES CELLS, V9, P15, DOI 10.1111/j.1356-9597.2004.00697.x; Deitcher DL, 1998, J NEUROSCI, V18, P2028; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Fradkin LG, 2004, DEV BIOL, V272, P362, DOI 10.1016/j.ydbio.2004.04.034; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Gottmann K, 2008, J NEUROSCI RES, V86, P223, DOI 10.1002/jnr.21484; Graf ER, 2009, NEURON, V64, P663, DOI 10.1016/j.neuron.2009.11.002; Gramates LS, 1999, INT REV NEUROBIOL, V43, P93, DOI 10.1016/S0074-7742(08)60542-5; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Han K, 2008, PROG NEUROBIOL, V84, P263, DOI 10.1016/j.pneurobio.2007.10.011; Ille F, 2005, CELL MOL LIFE SCI, V62, P1100, DOI 10.1007/s00018-005-4552-2; Inoue T, 2004, CELL, V118, P795, DOI 10.1016/j.cell.2004.09.001; Kawasaki A, 2007, CELL SIGNAL, V19, P2498, DOI 10.1016/j.cellsig.2007.07.023; Kidokoro Y, 2003, NEUROSIGNALS, V12, P13, DOI 10.1159/000068912; Kirikoshi H, 2001, INT J ONCOL, V19, P779; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Korkut C, 2009, NAT REV NEUROSCI, V10, P627, DOI 10.1038/nrn2681; Kozopas KM, 1998, GENE DEV, V12, P1155, DOI 10.1101/gad.12.8.1155; Kozopas KM, 2002, DEV BIOL, V243, P312, DOI 10.1006/dbio.2002.0572; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Kwiatkowski AV, 2007, CURR OPIN CELL BIOL, V19, P551, DOI 10.1016/j.ceb.2007.08.005; Lang Thorsten, 2008, V184, P107; Liebl FLW, 2008, DEV NEUROBIOL, V68, P152, DOI 10.1002/dneu.20562; Liebl FLW, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-27; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Marques G, 2005, J NEUROBIOL, V64, P417, DOI 10.1002/neu.20165; Marrus SB, 2004, CURR BIOL, V14, P924, DOI 10.1016/j.cub.2004.05.047; Mathew D, 2005, SCIENCE, V310, P1344, DOI 10.1126/science.1117051; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Micheva KD, 2003, NAT NEUROSCI, V6, P925, DOI 10.1038/nn1114; Miech C, 2008, J NEUROSCI, V28, P10875, DOI 10.1523/JNEUROSCI.0164-08.2008; MINAMI Y, 2009, DEV DYN; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pielage J, 2008, NEURON, V58, P195, DOI 10.1016/j.neuron.2008.02.017; Purro SA, 2008, J NEUROSCI, V28, P8644, DOI 10.1523/JNEUROSCI.2320-08.2008; Regalado MP, 2006, J NEUROSCI, V26, P2343, DOI 10.1523/JNEUROSCI.5247-05.2006; Sakurai M, 2009, J NEUROSCI, V29, P4972, DOI 10.1523/JNEUROSCI.2821-08.2009; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Salinas PC, 2005, BIOCHEM SOC T, V33, P1295, DOI 10.1042/BST0331295; Sato A, 1999, DEVELOPMENT, V126, P4421; Schmid A, 2008, NAT NEUROSCI, V11, P659, DOI 10.1038/nn.2122; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; Schoch S, 2006, CELL TISSUE RES, V326, P379, DOI 10.1007/s00441-006-0244-y; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; Sorensen JB, 2005, TRENDS NEUROSCI, V28, P453, DOI 10.1016/j.tins.2005.06.007; Stanley EF, 1997, TRENDS NEUROSCI, V20, P404, DOI 10.1016/S0166-2236(97)01091-6; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Wu CH, 2002, J BIOL CHEM, V277, P41762, DOI 10.1074/jbc.M207850200; Yao Y, 2007, NAT NEUROSCI, V10, P1423, DOI 10.1038/nn1993; Yoshihara M, 2004, NEUROSCIENTIST, V10, P566, DOI 10.1177/1073858404268770; Yoshihara M, 2005, SCIENCE, V310, P858, DOI 10.1126/science.1117541; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X; Zou YM, 2004, TRENDS NEUROSCI, V27, P528, DOI 10.1016/j.tins.2004.06.015	82	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12778	10.1371/journal.pone.0012778	http://dx.doi.org/10.1371/journal.pone.0012778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856675	gold, Green Published, Green Submitted			2022-12-27	WOS:000281815800031
J	Dozot, M; Poncet, S; Nicolas, C; Copin, R; Bouraoui, H; Maze, A; Deutscher, J; De Bolle, X; Letesson, JJ				Dozot, Marie; Poncet, Sandrine; Nicolas, Cecile; Copin, Richard; Bouraoui, Houda; Maze, Alain; Deutscher, Josef; De Bolle, Xavier; Letesson, Jean-Jacques			Functional Characterization of the Incomplete Phosphotransferase System (PTS) of the Intracellular Pathogen Brucella melitensis	PLOS ONE			English	Article							IV SECRETION SYSTEM; 2-COMPONENT REGULATORY SYSTEM; PROTEIN-PROTEIN INTERACTION; SMALL-COLONY-VARIANT; CARBON CATABOLITE REPRESSION; GRAM-POSITIVE BACTERIA; TERMINAL GAF DOMAIN; ESCHERICHIA-COLI; AGROBACTERIUM-TUMEFACIENS; HPR KINASE/PHOSPHORYLASE	Background: In many bacteria, the phosphotransferase system (PTS) is a key player in the regulation of the assimilation of alternative carbon sources notably through catabolic repression. The intracellular pathogens Brucella spp. possess four PTS proteins (EINtr, NPr, EIIA(Ntr) and an EIIA of the mannose family) but no PTS permease suggesting that this PTS might serve only regulatory functions. Methodology/Principal Findings: In vitro biochemical analyses and in vivo detection of two forms of EIIA(Ntr) (phosphorylated or not) established that the four PTS proteins of Brucella melitensis form a functional phosphorelay. Moreover, in vitro the protein kinase HprK/P phosphorylates NPr on a conserved serine residue, providing an additional level of regulation to the B. melitensis PTS. This kinase activity was inhibited by inorganic phosphate and stimulated by fructose-1,6 bisphosphate. The genes encoding HprK/P, an EIIA(Man)-like protein and NPr are clustered in a locus conserved among a-proteobacteria and also contain the genes for the crucial two-component system BvrR-BvrS. RT-PCR revealed a transcriptional link between these genes suggesting an interaction between PTS and BvrR-BvrS. Mutations leading to the inactivation of EINtr or NPr significantly lowered the synthesis of VirB proteins, which form a type IV secretion system. These two mutants also exhibit a small colony phenotype on solid media. Finally, interaction partners of PTS proteins were identified using a yeast two hybrid screen against the whole B. melitensis ORFeome. Both NPr and HprK/P were shown to interact with an inorganic pyrophosphatase and the EIIA(Man)-like protein with the E1 component (SucA) of 2-oxoglutarate dehydrogenase. Conclusions/Significance: The B. melitensis can transfer the phosphoryl group from PEP to the EIIAs and a link between the PTS and the virulence of this organism could be established. Based on the protein interaction data a preliminary model is proposed in which this regulatory PTS coordinates also C and N metabolism.	[Dozot, Marie; Nicolas, Cecile; Copin, Richard; De Bolle, Xavier; Letesson, Jean-Jacques] Univ Namur, Res Unit Mol Biol, Namur, Belgium; [Poncet, Sandrine; Bouraoui, Houda; Maze, Alain; Deutscher, Josef] INRA CNRS AgroParisTech, Lab Microbiol & Genet Mol, Thiverval Grignon, France	University of Namur; AgroParisTech; INRAE	Dozot, M (corresponding author), Univ Namur, Res Unit Mol Biol, Namur, Belgium.	jean-jacques.letesson@fundp.ac.be	Jean-Jacques, LETESSON/AHB-6921-2022	LETESSON, Jean-Jacques/0000-0002-5838-0224; PONCET, Sandrine/0000-0002-2813-0793; copin, richard/0000-0001-7717-2183; De Bolle, Xavier/0000-0002-3845-3043; Maze, Alain/0000-0003-0873-3690	Fonds de la Recherche Fondamentale Collective (FRFC, Belgium) [2.4521.04]; Action de recherche concertee [04/09-325, 08/13-015]; Commisariat general aux Relations internationales de la Communaute franc, aise de Belgique Fonds National pour la Recherche Scientifique - Centre National de la Recherche Scientifique (CGRI-FNRS-CNRS) [PVB/ADK/FR/ad/2681]; Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)	Fonds de la Recherche Fondamentale Collective (FRFC, Belgium)(Fonds de la Recherche Scientifique - FNRS); Action de recherche concertee; Commisariat general aux Relations internationales de la Communaute franc, aise de Belgique Fonds National pour la Recherche Scientifique - Centre National de la Recherche Scientifique (CGRI-FNRS-CNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by Fonds de la Recherche Fondamentale Collective (FRFC, Belgium, convention 2.4521.04), by Action de recherche concertee (ARC, No. 04/09-325 and 08/13-015) and by an agreement with Commisariat general aux Relations internationales de la Communaute franc, aise de Belgique Fonds National pour la Recherche Scientifique - Centre National de la Recherche Scientifique (CGRI-FNRS-CNRS, reference PVB/ADK/FR/ad/2681). M. Dozot held a PhD fellowship from the Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allen GS, 2003, J MOL BIOL, V326, P1203, DOI 10.1016/S0022-2836(02)01378-5; ANDERSON JD, 1965, J GEN MICROBIOL, V38, P109, DOI 10.1099/00221287-38-1-109; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Audette GF, 2000, J MOL BIOL, V303, P545, DOI 10.1006/jmbi.2000.4166; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Boel G, 2003, J MOL MICROB BIOTECH, V5, P206, DOI 10.1159/000071072; Boschiroli ML, 2002, P NATL ACAD SCI USA, V99, P1544, DOI 10.1073/pnas.032514299; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; Bruckner R, 2002, FEMS MICROBIOL LETT, V209, P141; Cases I, 1999, J BIOL CHEM, V274, P15562, DOI 10.1074/jbc.274.22.15562; Cases I, 2007, RES MICROBIOL, V158, P666, DOI 10.1016/j.resmic.2007.08.002; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; CHARLES TC, 1993, J BACTERIOL, V175, P6614, DOI 10.1128/jb.175.20.6614-6625.1993; Cheng HP, 1998, J BACTERIOL, V180, P20, DOI 10.1128/JB.180.1.20-26.1998; CLOECKAERT A, 1990, INFECT IMMUN, V58, P3980, DOI 10.1128/IAI.58.12.3980-3987.1990; Comerci DJ, 2001, CELL MICROBIOL, V3, P159, DOI 10.1046/j.1462-5822.2001.00102.x; Commichau FM, 2006, CURR OPIN MICROBIOL, V9, P167, DOI 10.1016/j.mib.2006.01.001; Delrue RM, 2005, CELL MICROBIOL, V7, P1151, DOI 10.1111/j.1462-5822.2005.00543.x; Delrue RM, 2004, FEMS MICROBIOL LETT, V231, P1, DOI 10.1016/S0378-1097(03)00963-7; DelVecchio VG, 2002, P NATL ACAD SCI USA, V99, P443, DOI 10.1073/pnas.221575398; DEUTSCHER J, 1986, BIOCHEMISTRY-US, V25, P6543, DOI 10.1021/bi00369a031; DEUTSCHER J, 1983, P NATL ACAD SCI-BIOL, V80, P6790, DOI 10.1073/pnas.80.22.6790; DEUTSCHER J, 1995, MOL MICROBIOL, V15, P1049, DOI 10.1111/j.1365-2958.1995.tb02280.x; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Ding ZY, 2002, J BACTERIOL, V184, P5572, DOI 10.1128/JB.184.20.5572-5582.2002; Dozot M, 2006, CELL MICROBIOL, V8, P1791, DOI 10.1111/j.1462-5822.2006.00749.x; Dricot A, 2004, GENOME RES, V14, P2201, DOI 10.1101/gr.2456204; Edwards DH, 2000, EMBO J, V19, P2719, DOI 10.1093/emboj/19.11.2719; Essenberg RC, 2002, VET MICROBIOL, V90, P249, DOI 10.1016/S0378-1135(02)00212-2; Fieulaine S, 2001, EMBO J, V20, P3917, DOI 10.1093/emboj/20.15.3917; Flores A, 1999, P NATL ACAD SCI USA, V96, P7815, DOI 10.1073/pnas.96.14.7815; Flores N, 2008, J MOL MICROB BIOTECH, V14, P176, DOI 10.1159/000109945; Galperin MY, 2004, ENVIRON MICROBIOL, V6, P552, DOI 10.1111/j.1462-2920.2004.00633.x; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gonzalez CF, 2005, BIOCHEMISTRY-US, V44, P598, DOI 10.1021/bi048412y; Haine V, 2005, INFECT IMMUN, V73, P5578, DOI 10.1128/IAI.73.9.5578-5586.2005; Halbedel S, 2006, J BIOL CHEM, V281, P26253, DOI 10.1074/jbc.M605010200; Hallez R, 2007, EMBO J, V26, P1444, DOI 10.1038/sj.emboj.7601577; Halling SM, 2005, J BACTERIOL, V187, P2715, DOI 10.1128/JB.187.8.2715-2726.2005; Hogema BM, 1998, MOL MICROBIOL, V30, P487, DOI 10.1046/j.1365-2958.1998.01053.x; Hu KY, 2002, RES MICROBIOL, V153, P405, DOI 10.1016/S0923-2508(02)01339-6; Jacob J, 2006, MICROBES INFECT, V8, P363, DOI 10.1016/j.micinf.2005.07.003; Jault JM, 2000, J BIOL CHEM, V275, P1773, DOI 10.1074/jbc.275.3.1773; JONES DHA, 1994, MICROBIOL-SGM, V140, P1035, DOI 10.1099/13500872-140-5-1035; KAMBEROV ES, 1995, J BIOL CHEM, V270, P17797, DOI 10.1074/jbc.270.30.17797; Kohler S, 2002, P NATL ACAD SCI USA, V99, P15711, DOI 10.1073/pnas.232454299; Lamontagne J, 2007, J PROTEOME RES, V6, P1519, DOI 10.1021/pr060636a; Lee CR, 2005, MOL MICROBIOL, V58, P334, DOI 10.1111/j.1365-2958.2005.04834.x; Little R, 2003, J BIOL CHEM, V278, P28711, DOI 10.1074/jbc.M301992200; Liu KY, 2003, MICROBIOL-SGM, V149, P1829, DOI 10.1099/mic.0.26234-0; Liu P, 2005, J BACTERIOL, V187, P6039, DOI 10.1128/JB.187.17.6039-6045.2005; Luttmann D, 2009, MOL MICROBIOL, V72, P978, DOI 10.1111/j.1365-2958.2009.06704.x; Martinez-Argudo I, 2004, MOL MICROBIOL, V52, P1731, DOI 10.1111/j.1365-2958.2004.04089.x; MERRICK MJ, 1989, MOL MICROBIOL, V3, P1765, DOI 10.1111/j.1365-2958.1989.tb00162.x; Michiels J, 1998, J BACTERIOL, V180, P1729, DOI 10.1128/JB.180.7.1729-1740.1998; Mijakovic I, 2002, P NATL ACAD SCI USA, V99, P13442, DOI 10.1073/pnas.212410399; Monedero V, 2001, EMBO J, V20, P3928, DOI 10.1093/emboj/20.15.3928; MORENO E, 1990, J BACTERIOL, V172, P3569, DOI 10.1128/jb.172.7.3569-3576.1990; Ninfa AJ, 2005, CURR OPIN MICROBIOL, V8, P168, DOI 10.1016/j.mib.2005.02.011; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; OSTERAS M, 1995, J BACTERIOL, V177, P1452, DOI 10.1128/jb.177.6.1452-1460.1995; Paulsen IT, 2002, P NATL ACAD SCI USA, V99, P13148, DOI 10.1073/pnas.192319099; Pelletier M, 1998, BIOCHEMISTRY-US, V37, P1604, DOI 10.1021/bi9721647; Pfluger-Grau K, 2010, TRENDS MICROBIOL, V18, P205, DOI 10.1016/j.tim.2010.02.003; Pinedo CA, 2008, J BACTERIOL, V190, P2947, DOI 10.1128/JB.01917-07; Pinedo CA, 2009, J BACTERIOL, V191, P298, DOI 10.1128/JB.01115-08; Poncet S, 2004, BBA-PROTEINS PROTEOM, V1697, P123, DOI 10.1016/j.bbapap.2003.11.018; Poncet S, 2009, CONTRIB MICROBIOL, V16, P88, DOI 10.1159/000219374; POWELL BS, 1995, J BIOL CHEM, V270, P4822, DOI 10.1074/jbc.270.9.4822; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Quebatte M, 2010, J BACTERIOL, V192, P3352, DOI 10.1128/JB.01676-09; Rabus R, 1999, J BIOL CHEM, V274, P26185, DOI 10.1074/jbc.274.37.26185; REIZER J, 1992, PROTEIN SCI, V1, P722, DOI 10.1002/pro.5560010604; Reizer J, 1996, GENE, V181, P103, DOI 10.1016/S0378-1119(96)00481-7; RHIEL E, 1994, BIOL CHEM H-S, V375, P551, DOI 10.1515/bchm3.1994.375.8.551; ROOSSIEN FF, 1983, BIOCHIM BIOPHYS ACTA, V760, P185, DOI 10.1016/0304-4165(83)90141-1; Rouot B, 2003, INFECT IMMUN, V71, P1075, DOI 10.1128/IAI.71.3.1075-1082.2003; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; SGANGA MW, 1992, P NATL ACAD SCI USA, V89, P6328, DOI 10.1073/pnas.89.14.6328; Sieira R, 2000, J BACTERIOL, V182, P4849, DOI 10.1128/JB.182.17.4849-4855.2000; Sieira R, 2010, J BACTERIOL, V192, P217, DOI 10.1128/JB.01124-09; Sola-Landa A, 1998, MOL MICROBIOL, V29, P125, DOI 10.1046/j.1365-2958.1998.00913.x; Sun JB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-36; Tchieu JH, 2001, J MOL MICROB BIOTECH, V3, P329; UZUREAU S, 2010, J PROTEOME RES, DOI DOI 10.1021/PR100068; Van Mullem V, 2003, YEAST, V20, P739, DOI 10.1002/yea.999; Vaudaux P, 2002, INFECT IMMUN, V70, P5428, DOI 10.1128/IAI.70.10.5428-5437.2002; Viadas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010216; von Eiff C, 2006, J BACTERIOL, V188, P687, DOI 10.1128/JB.188.2.687-693.2006; vonEiff C, 1997, J BACTERIOL, V179, P4706, DOI 10.1128/jb.179.15.4706-4712.1997; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; WEIGEL N, 1982, J BIOL CHEM, V257, P4477; WITTEKIND M, 1989, BIOCHEMISTRY-US, V28, P9908, DOI 10.1021/bi00452a005; Wu QM, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-102; YOUNG EJ, 1995, CLIN INFECT DIS, V21, P283, DOI 10.1093/clinids/21.2.283	95	37	38	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12679	10.1371/journal.pone.0012679	http://dx.doi.org/10.1371/journal.pone.0012679			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844759	Green Published, Green Submitted, gold			2022-12-27	WOS:000281687300018
J	Feliziani, S; Lujan, AM; Moyano, AJ; Sola, C; Bocco, JL; Montanaro, P; Canigia, LF; Argarana, CE; Smania, AM				Feliziani, Sofia; Lujan, Adela M.; Moyano, Alejandro J.; Sola, Claudia; Bocco, Jose L.; Montanaro, Patricia; Fernandez Canigia, Liliana; Argarana, Carlos E.; Smania, Andrea M.			Mucoidy, Quorum Sensing, Mismatch Repair and Antibiotic Resistance in Pseudomonas aeruginosa from Cystic Fibrosis Chronic Airways Infections	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; DNA-POLYMERASE-IV; ESCHERICHIA-COLI; GENETIC ADAPTATION; LASR MUTANTS; ANTIMICROBIAL RESISTANCE; PULMONARY INFECTION; MUTATOR ALLELES; LUNG INFECTIONS; HIGH-FREQUENCY	Survival of Pseudomonas aeruginosa in cystic fibrosis (CF) chronic infections is based on a genetic adaptation process consisting of mutations in specific genes, which can produce advantageous phenotypic switches and ensure its persistence in the lung. Among these, mutations inactivating the regulators MucA (alginate biosynthesis), LasR (quorum sensing) and MexZ (multidrug-efflux pump MexXY) are the most frequently observed, with those inactivating the DNA mismatch repair system (MRS) being also highly prevalent in P. aeruginosa CF isolates, leading to hypermutator phenotypes that could contribute to this adaptive mutagenesis by virtue of an increased mutation rate. Here, we characterized the mutations found in the mucA, lasR, mexZ and MRS genes in P. aeruginosa isolates obtained from Argentinean CF patients, and analyzed the potential association of mucA, lasR and mexZ mutagenesis with MRS-deficiency and antibiotic resistance. Thus, 38 isolates from 26 chronically infected CF patients were characterized for their phenotypic traits, PFGE genotypic patterns, mutations in the mucA, lasR, mexZ, mutS and mutL gene coding sequences and antibiotic resistance profiles. The most frequently mutated gene was mexZ (79%), followed by mucA (63%) and lasR (39%) as well as a high prevalence (42%) of hypermutators being observed due to loss-of-function mutations in mutL (60%) followed by mutS (40%). Interestingly, mutational spectra were particular to each gene, suggesting that several mechanisms are responsible for mutations during chronic infection. However, no link could be established between hypermutability and mutagenesis in mucA, lasR and mexZ, indicating that MRS-deficiency was not involved in the acquisition of these mutations. Finally, although inactivation of mucA, lasR and mexZ has been previously shown to confer resistance/tolerance to antibiotics, only mutations in MRS genes could be related to an antibiotic resistance increase. These results help to unravel the mutational dynamics that lead to the adaptation of P. aeruginosa to the CF lung.	[Feliziani, Sofia; Lujan, Adela M.; Moyano, Alejandro J.; Argarana, Carlos E.; Smania, Andrea M.] Univ Nacl Cordoba, CIQUIBIC, CONICET, Dept Quim Biol,Fac Ciencias Quim, RA-5000 Cordoba, Argentina; [Sola, Claudia; Bocco, Jose L.] Univ Nacl Cordoba, CIBICI, CONICET, Dept Bioquim Clin,Fac Ciencias Quim, RA-5000 Cordoba, Argentina; [Montanaro, Patricia] Hosp Ninos Santisima Trinidad, Cordoba, Argentina; [Fernandez Canigia, Liliana] Hosp Aleman, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Hospital Aleman; University of Buenos Aires	Feliziani, S (corresponding author), Univ Nacl Cordoba, CIQUIBIC, CONICET, Dept Quim Biol,Fac Ciencias Quim, RA-5000 Cordoba, Argentina.	asmania@mail.fcq.unc.edu.ar	Smania, Andrea/AAG-1105-2022; Smania, Andrea/AFK-2800-2022; Lujan, Adela M/K-6707-2015; Moyano, Alejandro/AAB-9092-2019	Moyano, Alejandro/0000-0002-4976-7611; Bocco, Jose Luis/0000-0002-9682-1270; Smania, Andrea/0000-0002-6527-7719; Lujan, Adela Maria/0000-0002-0365-6828	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT) [PICT-2005-33589, PICT-2007-00687]; Secretaria de Ciencia y Tecnica [05/C486]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT)(ANPCyT); Secretaria de Ciencia y Tecnica(Secretaria de Ciencia y Tecnologia (SECYT))	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT) Grants PICT-2005-33589 and PICT-2007-00687 (http://www.agencia.gov.ar/), and Secretaria de Ciencia y Tecnica (SECYT-UNC) Grant 05/C486 (http://www.secyt.unc.edu.ar/) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTH AL, 1995, J CLIN MICROBIOL, V33, P37, DOI 10.1128/JCM.33.1.37-40.1995; Boucher JC, 1997, INFECT IMMUN, V65, P3838, DOI 10.1128/IAI.65.9.3838-3846.1997; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Ciofu O, 2005, ANTIMICROB AGENTS CH, V49, P2276, DOI 10.1128/AAC.49.6.2276-2282.2005; Ciofu O, 2008, MICROBIOL-SGM, V154, P103, DOI 10.1099/mic.0.2007/010421-0; Ciofu O, 2010, MICROBIOL-SGM, V156, P1108, DOI 10.1099/mic.0.033993-0; D'Argenio DA, 2007, MOL MICROBIOL, V64, P512, DOI 10.1111/j.1365-2958.2007.05678.x; Ferroni A, 2009, PEDIATR PULM, V44, P820, DOI 10.1002/ppul.21076; Garibyan L, 2003, DNA REPAIR, V2, P593, DOI 10.1016/S1568-7864(03)00024-7; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; GOVAN JRW, 1978, J ANTIMICROB CHEMOTH, V4, P233, DOI 10.1093/jac/4.3.233; Gutierrez O, 2004, ANTIMICROB AGENTS CH, V48, P3573, DOI 10.1128/AAC.48.9.3573-3575.2004; HANCOCK REW, 1983, INFECT IMMUN, V42, P170, DOI 10.1128/IAI.42.1.170-177.1983; Henrichfreise B, 2007, ANTIMICROB AGENTS CH, V51, P4062, DOI 10.1128/AAC.00148-07; Hoffman LR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000712; Hoffman LR, 2009, J CYST FIBROS, V8, P66, DOI 10.1016/j.jcf.2008.09.006; Hogardt M, 2007, J INFECT DIS, V195, P70, DOI 10.1086/509821; Hogardt M, 2006, INT J MED MICROBIOL, V296, P313, DOI 10.1016/j.ijmm.2005.12.018; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jacquelin DK, 2005, BIOCHEM J, V388, P879, DOI 10.1042/BJ20042073; Kenna DT, 2007, MICROBIOL-SGM, V153, P1852, DOI 10.1099/mic.0.2006/005082-0; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; LeClerc JE, 1996, SCIENCE, V274, P1208, DOI 10.1126/science.274.5290.1208; Levy DD, 2001, MUTAT RES-FUND MOL M, V474, P1, DOI 10.1016/S0027-5107(00)00169-X; Lujan AM, 2007, MICROBIOL-SGM, V153, P225, DOI 10.1099/mic.0.29021-0; LUZAR MA, 1985, INFECT IMMUN, V50, P577, DOI 10.1128/IAI.50.2.577-582.1985; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Macia MD, 2005, ANTIMICROB AGENTS CH, V49, P3382, DOI 10.1128/AAC.49.8.3382-3386.2005; Macia MD, 2004, ANTIMICROB AGENTS CH, V48, P2665, DOI 10.1128/AAC.48.7.2665-2672.2004; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Mandsberg LF, 2009, ANTIMICROB AGENTS CH, V53, P2483, DOI 10.1128/AAC.00428-08; MARTIN C, 1995, J CLIN MICROBIOL, V33, P1461, DOI 10.1128/JCM.33.6.1461-1466.1995; MARTIN DW, 1993, P NATL ACAD SCI USA, V90, P8377, DOI 10.1073/pnas.90.18.8377; Mena A, 2008, J BACTERIOL, V190, P7910, DOI 10.1128/JB.01147-08; Montanari S, 2007, MICROBIOL-SGM, V153, P1445, DOI 10.1099/mic.0.2006/003400-0; Moyano AJ, 2007, MOL MICROBIOL, V64, P547, DOI 10.1111/j.1365-2958.2007.05675.x; Moyano AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008203; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nguyen D, 2006, P NATL ACAD SCI USA, V103, P8305, DOI 10.1073/pnas.0602526103; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Oliver A, 2004, ANTIMICROB AGENTS CH, V48, P4226, DOI 10.1128/AAC.48.11.4226-4233.2004; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Oliver A, 2002, MOL MICROBIOL, V43, P1641, DOI 10.1046/j.1365-2958.2002.02855.x; Pezza RJ, 2002, NUCLEIC ACIDS RES, V30, P4700, DOI 10.1093/nar/gkf606; Pezza RJ, 2002, BIOCHEM J, V361, P87, DOI 10.1042/0264-6021:3610087; Plasencia V, 2007, ANTIMICROB AGENTS CH, V51, P2574, DOI 10.1128/AAC.00174-07; ROMLING U, 1994, APPL ENVIRON MICROB, V60, P1734; Romling U, 2000, J CLIN MICROBIOL, V38, P464; Sanders LH, 2006, J BACTERIOL, V188, P8573, DOI 10.1128/JB.01481-06; SCHAAPER RM, 1987, P NATL ACAD SCI USA, V84, P6220, DOI 10.1073/pnas.84.17.6220; Shaver AC, 2002, GENETICS, V162, P557; Smania AM, 2004, MICROBIOL-SGM, V150, P1327, DOI 10.1099/mic.0.26751-0; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sobel ML, 2003, ANTIMICROB AGENTS CH, V47, P3202, DOI 10.1128/AAC.47.10.3202-3207.2003; Taddei F, 1997, NATURE, V387, P700, DOI 10.1038/42696; Taddei F, 1997, TRENDS MICROBIOL, V5, P427, DOI 10.1016/S0966-842X(97)01157-8; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Vogne C, 2004, ANTIMICROB AGENTS CH, V48, P1676, DOI 10.1128/AAC.48.5.1676-1680.2004; Waine DJ, 2008, J CLIN MICROBIOL, V46, P3491, DOI 10.1128/JCM.00357-08; Westbrock-Wadman S, 1999, ANTIMICROB AGENTS CH, V43, P2975, DOI 10.1128/AAC.43.12.2975	62	69	69	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12669	10.1371/journal.pone.0012669	http://dx.doi.org/10.1371/journal.pone.0012669			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844762	gold, Green Published, Green Submitted			2022-12-27	WOS:000281687300013
J	Karn, RC; Young, JM; Laukaitis, CM				Karn, Robert C.; Young, Janet M.; Laukaitis, Christina M.			A Candidate Subspecies Discrimination System Involving a Vomeronasal Receptor Gene with Different Alleles Fixed in M. m. domesticus and M. m. musculus	PLOS ONE			English	Article							ANDROGEN-BINDING-PROTEIN; ACCESSORY OLFACTORY SYSTEMS; MUS-MUSCULUS; HYBRID STERILITY; SEXUAL SELECTION; HOUSE MOUSE; PHYLOGENETIC ANALYSIS; ADAPTIVE EVOLUTION; ABP; SPECIATION	Assortative mating, a potentially efficient prezygotic reproductive barrier, may prevent loss of genetic potential by avoiding the production of unfit hybrids (i.e., because of hybrid infertility or hybrid breakdown) that occur at regions of secondary contact between incipient species. In the case of the mouse hybrid zone, where two subspecies of Mus musculus (M. m. domesticus and M. m. musculus) meet and exchange genes to a limited extent, assortative mating requires a means of subspecies recognition. We based the work reported here on the hypothesis that, if there is a pheromone sufficiently diverged between M. m. domesticus and M. m. musculus to mediate subspecies recognition, then that process must also require a specific receptor(s), also sufficiently diverged between the subspecies, to receive the signal and elicit an assortative mating response. We studied the mouse V1R genes, which encode a large family of receptors in the vomeronasal organ (VNO), by screening Perlegen SNP data and identified one, Vmn1r67, with 24 fixed SNP differences most of which (15/24) are nonsynonymous nucleotide substitutions between M. m. domesticus and M. m. musculus. We observed substantial linkage disequilibrium (LD) between Vmn1r67 and Abpa27, a mouse salivary androgen-binding protein gene that encodes a proteinaceous pheromone (ABP) capable of mediating assortative mating, perhaps in conjunction with its bound small lipophilic ligand. The LD we observed is likely a case of association rather than residual physical linkage from a very recent selective sweep, because an intervening gene, Vmn1r71, shows significant intra(sub) specific polymorphism but no inter(sub) specific divergence in its nucleotide sequence. We discuss alternative explanations of these observations, for example that Abpa27 and Vmn1r67 are coevolving as signal and receptor to reinforce subspecies hybridization barriers or that the unusually divergent Vmn1r67 allele was not a product of fast positive selection, but was derived from an introgressed allele, possibly from Mus spretus.	[Karn, Robert C.; Laukaitis, Christina M.] Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85721 USA; [Young, Janet M.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA	University of Arizona; Fred Hutchinson Cancer Center	Karn, RC (corresponding author), Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85721 USA.	rkarn@butler.edu	Laukaitis, Christina/ABF-1739-2021; Laukaitis, Christina/AAW-2510-2020; Laukaitis, Christina M/AAL-5865-2021	Laukaitis, Christina M/0000-0003-1466-7941	National Institutes of Health [DC004209]; National Cancer Institute [P50 CA95060]; NATIONAL CANCER INSTITUTE [P50CA095060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	JMY was supported by National Institutes of Health grant DC004209 to Barbara Trask. CML was supported by career development funding from a National Cancer Institute Specialized Program of Research Excellence in Gastrointestinal Cancer (P50 CA95060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum MJ, 2009, ANNU REV PHYSIOL, V71, P141, DOI 10.1146/annurev.physiol.010908.163137; Beauchamp GK, 2003, BIOCHEM SOC T, V31, P147; Bielawski Joseph P., 2003, Journal of Structural and Functional Genomics, V3, P201, DOI 10.1023/A:1022642807731; Bimova B, 2005, BIOL J LINN SOC, V84, P349, DOI 10.1111/j.1095-8312.2005.00439.x; BIMOVA BV, MOL ECOL IN PRESS; BOURSOT P, 1993, ANNU REV ECOL SYST, V24, P119, DOI 10.1146/annurev.es.24.110193.001003; Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; Britton-Davidian J, 2005, GENET RES, V86, P171, DOI 10.1017/S0016672305007809; BUTLIN RK, 1995, TRENDS ECOL EVOL, V10, P432, DOI 10.1016/S0169-5347(00)89173-9; Chevret P, 2005, BIOL J LINN SOC, V84, P417, DOI 10.1111/j.1095-8312.2005.00444.x; Coyne J.A., 2004, SPECIATION; Cutler G, 2007, GENOME RES, V17, P1743, DOI 10.1101/gr.6754607; DLOUHY SR, 1983, BIOCHEM GENET, V21, P1057, DOI 10.1007/BF00488459; DLOUHY SR, 1987, GENETICS, V115, P535; Dobzhansky T, 1940, AM NAT, V74, P312, DOI 10.1086/280899; Dod B, 2005, BIOL J LINN SOC, V84, P447, DOI 10.1111/j.1095-8312.2005.00446.x; DOD B, 1993, J EVOLUTION BIOL, V6, P529, DOI 10.1046/j.1420-9101.1993.6040529.x; Emes RD, 2004, GENOME RES, V14, P1516, DOI 10.1101/gr.2540304; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; FOREJT J, 1974, GENET RES, V24, P189, DOI 10.1017/S0016672300015214; Forejt J, 1996, TRENDS GENET, V12, P412, DOI 10.1016/0168-9525(96)10040-8; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Good JM, 2008, EVOLUTION, V62, P50, DOI 10.1111/j.1558-5646.2007.00257.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HOWARD DJ, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P46; Hurst JL, 2009, BEHAV BRAIN RES, V200, P295, DOI 10.1016/j.bbr.2008.12.020; Hwang JM, 1997, J HERED, V88, P93, DOI 10.1093/oxfordjournals.jhered.a023083; Johnsen JM, 2009, MOL BIOL EVOL, V26, P567, DOI 10.1093/molbev/msn284; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Karn RC, 1999, MOL BIOL EVOL, V16, P1192, DOI 10.1093/oxfordjournals.molbev.a026209; Karn RC, 1998, BIOCHEM GENET, V36, P105, DOI 10.1023/A:1018708404789; Karn RC, 1999, BIOCHEM GENET, V37, P187, DOI 10.1023/A:1018786622052; Karn RC, 2003, BIOCHEMISTRY-US, V42, P7162, DOI 10.1021/bi027424l; Karn RC, 2002, MOL BIOL EVOL, V19, P462, DOI 10.1093/oxfordjournals.molbev.a004102; KARN RC, 1991, J HERED, V82, P453, DOI 10.1093/oxfordjournals.jhered.a111127; Karn RC, 2008, MOL BIOL EVOL, V25, P2301, DOI 10.1093/molbev/msn182; Karn RC, 2009, GENOME BIOL EVOL, V1, P494, DOI 10.1093/gbe/evp049; Keller M, 2009, BEHAV BRAIN RES, V200, P268, DOI 10.1016/j.bbr.2009.01.020; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Kimoto H, 2007, CURR BIOL, V17, P1879, DOI 10.1016/j.cub.2007.09.042; Kirkpatrick M, 2002, AM NAT, V159, pS22, DOI 10.1086/338370; Krieger J, 1999, J BIOL CHEM, V274, P4655, DOI 10.1074/jbc.274.8.4655; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Laukaitis CM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-46; Laukaitis CM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-40; Laukaitis CM, 2003, MAMM GENOME, V14, P679, DOI 10.1007/s00335-003-2291-y; Laukaitis CM, 1997, EVOLUTION, V51, P2000, DOI [10.2307/2411020, 10.1111/j.1558-5646.1997.tb05121.x]; Laurie CC, 2007, PLOS GENET, V3, P1487, DOI 10.1371/journal.pgen.0030144; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Macholan M, 2003, ACTA THERIOL, V48, P177, DOI 10.1007/BF03194157; Macholan M, 2007, EVOLUTION, V61, P746, DOI 10.1111/j.1558-5646.2007.00065.x; Macholan M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-271; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Nielsen R, 1998, GENETICS, V148, P929; Nozawa M, 2008, CYTOGENET GENOME RES, V123, P263, DOI 10.1159/000184716; Oka A, 2004, GENETICS, V166, P913, DOI 10.1534/genetics.166.2.913; Panhuis TM, 2001, TRENDS ECOL EVOL, V16, P364, DOI 10.1016/S0169-5347(01)02160-7; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; Ptacek MB, 2002, GENETICA, V116, P329, DOI 10.1023/A:1021201030017; Raufaste N, 2005, BIOL J LINN SOC, V84, P593, DOI 10.1111/j.1095-8312.2005.00457.x; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; SAGE RD, 1993, SYST BIOL, V42, P523, DOI 10.2307/2992487; SAGE RD, 1981, MOUSE BIOMEDICAL RES, V1, P39; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Storchova R, 2004, MAMM GENOME, V15, P515, DOI 10.1007/s00335-004-2386-0; Swanson WJ, 2003, CURR OPIN GENET DEV, V13, P617, DOI 10.1016/j.gde.2003.10.007; Talley HM, 2001, EVOLUTION, V55, P631, DOI 10.1554/0014-3820(2001)055[0631:FPFMSI]2.0.CO;2; Tirindelli R, 2009, PHYSIOL REV, V89, P921, DOI 10.1152/physrev.00037.2008; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; TUCKER PK, 1992, MAMM GENOME, V3, P254, DOI 10.1007/BF00292153; TUCKER PK, 1992, MAMM GENOME, V3, P28, DOI 10.1007/BF00355838; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; VANLERBERGHE F, 1986, GENET RES, V48, P191, DOI 10.1017/S0016672300025003; Vyskocilova M, 2005, BIOL J LINN SOC, V84, P663, DOI 10.1111/j.1095-8312.2005.00463.x; Vyskocilova M, 2009, MAMM GENOME, V20, P83, DOI 10.1007/s00335-008-9164-3; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wells MM, 1998, ENDLESS FORMS, P217; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, MOL BIOL EVOL, V17, P1446, DOI 10.1093/oxfordjournals.molbev.a026245; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Young JM, 2010, GENOME RES, V20, P10, DOI 10.1101/gr.098913.109; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	85	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12638	10.1371/journal.pone.0012638	http://dx.doi.org/10.1371/journal.pone.0012638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844586	Green Published, gold			2022-12-27	WOS:000281687200007
J	Lee, DH; Singh, P; Tsark, WMK; Szabo, PE				Lee, Dong-Hoon; Singh, Purnima; Tsark, Walter M. K.; Szabo, Piroska E.			Complete Biallelic Insulation at the H19/Igf2 Imprinting Control Region Position Results in Fetal Growth Retardation and Perinatal Lethality	PLOS ONE			English	Article							ENHANCER-BLOCKING ACTIVITY; SILVER-RUSSELL-SYNDROME; BETA-GLOBIN INSULATOR; DIRECT REPEAT ELEMENT; CTCF BINDING-SITES; TRANSCRIPTION FACTOR; METHYLATION IMPRINT; DNA METHYLATION; FUNCTIONAL-CHARACTERIZATION; DIFFERENTIAL METHYLATION	Background: The H19/Igf2 imprinting control region (ICR) functions as an insulator exclusively in the unmethylated maternal allele, where enhancer-blocking by CTCF protein prevents the interaction between the Igf2 promoter and the distant enhancers. DNA methylation inhibits CTCF binding in the paternal ICR allele. Two copies of the chicken b-globin insulator (Ch beta GI)(2) are capable of substituting for the enhancer blocking function of the ICR. Insulation, however, now also occurs upon paternal inheritance, because unlike the H19 ICR, the (Ch beta GI)(2) does not become methylated in fetal male germ cells. The (Ch beta GI)(2) is a composite insulator, exhibiting enhancer blocking by CTCF and chromatin barrier functions by USF1 and VEZF1. We asked the question whether these barrier proteins protected the (Ch beta GI)(2) sequences from methylation in the male germ line. Methodology/Principal Findings: We genetically dissected the Ch beta GI in the mouse by deleting the binding sites USF1 and VEZF1. The methylation of the mutant versus normal (Ch beta GI)(2) significantly increased from 11% to 32% in perinatal male germ cells, suggesting that the barrier proteins did have a role in protecting the (Ch beta GI)(2) from methylation in the male germ line. Contrary to the H19 ICR, however, the mutant (mCh beta GI)(2) lacked the potential to attain full de novo methylation in the germ line and to maintain methylation in the paternal allele in the soma, where it consequently functioned as a biallelic insulator. Unexpectedly, a stricter enhancer blocking was achieved by CTCF alone than by a combination of the CTCF, USF1 and VEZF1 sites, illustrated by undetectable Igf2 expression upon paternal transmission. Conclusions/Significance: In this in vivo model, hypomethylation at the ICR position together with fetal growth retardation mimicked the human Silver-Russell syndrome. Importantly, late fetal/perinatal death occurred arguing that strict biallelic insulation at the H19/Igf2 ICR position is not tolerated in development.	[Lee, Dong-Hoon; Singh, Purnima; Szabo, Piroska E.] City Hope Natl Med Ctr, Dept Mol & Cellular Biol, Duarte, CA 91010 USA; [Tsark, Walter M. K.] City Hope Natl Med Ctr, Transgenic Mouse Facil, Duarte, CA 91010 USA	City of Hope; City of Hope	Lee, DH (corresponding author), City Hope Natl Med Ctr, Dept Mol & Cellular Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	pszabo@coh.org		Szabo, Piroska/0000-0001-9314-7009; Singh, Purnima/0000-0002-4968-7398	National Institute of General Medical Sciences [GM064378]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064378] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Service grant GM064378 from the National Institute of General Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitsebaomo J, 2001, J BIOL CHEM, V276, P39197, DOI 10.1074/jbc.M105166200; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Beechey CV, 1997, MAMM GENOME, V8, P236, DOI 10.1007/s003359900400; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bowman AB, 2003, MOL CELL BIOL, V23, P8345, DOI [10.1128/MCB.23.22.8345-8351.2003, 10.1128/mcb.23.22.8345-8351.2003]; Bruce S, 2009, J CLIN ENDOCR METAB, V94, P579, DOI 10.1210/jc.2008-1805; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; CLARK SP, 1990, NUCLEIC ACIDS RES, V18, P5119, DOI 10.1093/nar/18.17.5119; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Dickson J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000804; Dilworth MR, 2010, P NATL ACAD SCI USA, V107, P3894, DOI 10.1073/pnas.0911710107; Dorman ER, 2007, SEMIN CELL DEV BIOL, V18, P682, DOI 10.1016/j.semcdb.2007.08.009; Eggermann T, 2008, TRENDS GENET, V24, P195, DOI 10.1016/j.tig.2008.01.003; Engel N, 2004, NAT GENET, V36, P883, DOI 10.1038/ng1399; Engel N, 2006, HUM MOL GENET, V15, P2945, DOI 10.1093/hmg/ddl237; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Gebert C, 2010, MOL CELL BIOL, V30, P1108, DOI 10.1128/MCB.00575-09; Gerasimova TI, 1996, CURR OPIN GENET DEV, V6, P185, DOI 10.1016/S0959-437X(96)80049-9; Gowher H, 2008, GENE DEV, V22, P2075, DOI 10.1101/gad.1658408; Han L, 2008, MOL CELL BIOL, V28, P1124, DOI 10.1128/MCB.01361-07; Han L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000803; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Haun WJ, 2008, PLANT J, V56, P903, DOI 10.1111/j.1365-313X.2008.03649.x; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Jurinke C, 2005, MUTAT RES-FUND MOL M, V573, P83, DOI 10.1016/j.mrfmmm.2005.01.007; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kanduri M, 2002, MOL CELL BIOL, V22, P3339, DOI 10.1128/MCB.22.10.3339-3344.2002; Katz DJ, 2005, MOL CELL BIOL, V25, P3855, DOI 10.1128/MCB.25.10.3855-3863.2005; Kawahara M, 2007, FEBS LETT, V581, P5178, DOI 10.1016/j.febslet.2007.10.004; KOYANONAKAGAWA N, 1994, MOL CELL BIOL, V14, P5099, DOI 10.1128/MCB.14.8.5099; Kuhnert F, 2005, DEV BIOL, V283, P140, DOI 10.1016/j.ydbio.2005.04.003; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; Lewis A, 2004, MOL CELL BIOL, V24, P5650, DOI 10.1128/MCB.24.13.5650-5656.2004; LEWIS CD, 1988, GENE DEV, V2, P863, DOI 10.1101/gad.2.7.863; Li T, 2008, MOL CELL BIOL, V28, P6473, DOI 10.1128/MCB.00204-08; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Monk D, 2006, HUM MOL GENET, V15, P1259, DOI 10.1093/hmg/ddl041; Moon H, 2005, EMBO REP, V6, P165, DOI 10.1038/sj.embor.7400334; Moore GE, 2001, DIABETES, V50, P199, DOI 10.2337/diabetes.50.1.199; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; Murrell A, 2001, EMBO REP, V2, P1101, DOI 10.1093/embo-reports/kve248; Mutskov VJ, 2002, GENE DEV, V16, P1540, DOI 10.1101/gad.988502; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Pant V, 2004, MOL CELL BIOL, V24, P3497, DOI 10.1128/MCB.24.8.3497-3504.2004; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Park KY, 2004, MOL CELL BIOL, V24, P3588, DOI 10.1128/MCB.24.9.3588-3595.2004; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Reed MR, 2001, MAMM GENOME, V12, P873, DOI 10.1007/s00335-001-2027-9; REIK W, 1987, NATURE, V328, P248, DOI 10.1038/328248a0; Reinhart B, 2002, MOL CELL BIOL, V22, P2089, DOI 10.1128/MCB.22.7.2089-2098.2002; SAPIENZA C, 1987, NATURE, V328, P251, DOI 10.1038/328251a0; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; SEARLE AG, 1990, GENET RES, V56, P237, DOI 10.1017/S0016672300035333; Srivastava M, 2000, GENE DEV, V14, P1186; Stadnick MP, 1999, DEV GENES EVOL, V209, P239, DOI 10.1007/s004270050248; SWAIN JL, 1987, CELL, V50, P719, DOI 10.1016/0092-8674(87)90330-8; Szabo PE, 2006, CYTOGENET GENOME RES, V113, P238, DOI 10.1159/000090838; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; Szabo PE, 2004, MOL CELL BIOL, V24, P4858, DOI 10.1128/MCB.24.11.4858-4868.2004; Szabo PE, 2004, MOL CELL BIOL, V24, P4791, DOI 10.1128/MCB.24.11.4791-4800.2004; SZABO PE, 1995, GENE DEV, V9, P1857, DOI 10.1101/gad.9.15.1857; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Szabo PE, 2002, DEVELOPMENT, V129, P897; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Tanimoto K, 2005, P NATL ACAD SCI USA, V102, P10250, DOI 10.1073/pnas.0409541102; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; UEDA T, 1992, DEVELOPMENT, V116, P831; Ueda T, 2000, GENES CELLS, V5, P649, DOI 10.1046/j.1365-2443.2000.00351.x; Varli IH, 2008, ACTA OBSTET GYN SCAN, V87, P1202, DOI 10.1080/00016340802460271; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; Xiong JW, 1999, DEV BIOL, V206, P123, DOI 10.1006/dbio.1998.9144	89	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12630	10.1371/journal.pone.0012630	http://dx.doi.org/10.1371/journal.pone.0012630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IV	20838620	Green Published, Green Submitted, gold			2022-12-27	WOS:000281687100011
J	Smith, AD; Smith, SM; de Jager, CA; Whitbread, P; Johnston, C; Agacinski, G; Oulhaj, A; Bradley, KM; Jacoby, R; Refsum, H				Smith, A. David; Smith, Stephen M.; de Jager, Celeste A.; Whitbread, Philippa; Johnston, Carole; Agacinski, Grzegorz; Oulhaj, Abderrahim; Bradley, Kevin M.; Jacoby, Robin; Refsum, Helga			Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial	PLOS ONE			English	Article							PLASMA HOMOCYSTEINE; OLDER-ADULTS; MRI; PROGRESSION; DEMENTIA; DECLINE; DISEASE; SUPPLEMENTATION; PREVALENCE; CONVERSION	Background: An increased rate of brain atrophy is often observed in older subjects, in particular those who suffer from cognitive decline. Homocysteine is a risk factor for brain atrophy, cognitive impairment and dementia. Plasma concentrations of homocysteine can be lowered by dietary administration of B vitamins. Objective: To determine whether supplementation with B vitamins that lower levels of plasma total homocysteine can slow the rate of brain atrophy in subjects with mild cognitive impairment in a randomised controlled trial (VITACOG, ISRCTN 94410159). Methods and Findings: Single-center, randomized, double-blind controlled trial of high-dose folic acid, vitamins B-6 and B-12 in 271 individuals (of 646 screened) over 70 y old with mild cognitive impairment. A subset (187) volunteered to have cranial MRI scans at the start and finish of the study. Participants were randomly assigned to two groups of equal size, one treated with folic acid (0.8 mg/d), vitamin B-12 (0.5 mg/d) and vitamin B-6 (20 mg/d), the other with placebo; treatment was for 24 months. The main outcome measure was the change in the rate of atrophy of the whole brain assessed by serial volumetric MRI scans. Results: A total of 168 participants (85 in active treatment group; 83 receiving placebo) completed the MRI section of the trial. The mean rate of brain atrophy per year was 0.76% [95% CI, 0.63-0.90] in the active treatment group and 1.08% [0.94-1.22] in the placebo group (P = 0.001). The treatment response was related to baseline homocysteine levels: the rate of atrophy in participants with homocysteine >13 mu mol/L was 53% lower in the active treatment group (P = 0.001). A greater rate of atrophy was associated with a lower final cognitive test scores. There was no difference in serious adverse events according to treatment category. Conclusions and Significance: The accelerated rate of brain atrophy in elderly with mild cognitive impairment can be slowed by treatment with homocysteine-lowering B vitamins. Sixteen percent of those over 70 y old have mild cognitive impairment and half of these develop Alzheimer's disease. Since accelerated brain atrophy is a characteristic of subjects with mild cognitive impairment who convert to Alzheimer's disease, trials are needed to see if the same treatment will delay the development of Alzheimer's disease.	[Smith, A. David; de Jager, Celeste A.; Whitbread, Philippa; Johnston, Carole; Agacinski, Grzegorz; Oulhaj, Abderrahim; Refsum, Helga] Univ Oxford, OPTIMA, Oxford, England; [Smith, A. David; Johnston, Carole; Refsum, Helga] Univ Oxford, Univ Dept Pharmacol, Oxford, England; [Smith, A. David; Johnston, Carole; Refsum, Helga] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Smith, Stephen M.] Univ Oxford, Dept Clin Neurol, Oxford Ctr Funct Magnet Resonance Imaging Brain, Oxford, England; [Bradley, Kevin M.] Oxford Radcliffe Hosp NHS Trust, Dept Radiol & Nucl Med, Oxford, England; [Jacoby, Robin] Univ Oxford, Univ Dept Psychiat, Oxford, England; [Refsum, Helga] Univ Oslo, Dept Nutr, Inst Basic Med Sci, Oslo, Norway	University of Oxford; University of Oxford; University of Oxford; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; University of Oslo	Smith, AD (corresponding author), Univ Oxford, OPTIMA, Oxford, England.	david.smith@pharm.ox.ac.uk	Refsum, Helga/A-4073-2010; Smith, Anthony D./A-4233-2010	Smith, Anthony D./0000-0002-1095-6722; Smith, Stephen/0000-0001-8166-069X; Bradley, Kevin/0000-0003-1911-3382	Charles Wolfson Charitable Trust; Medical Research Council; Alzheimer's Research Trust; Henry Smith Charity; John Coates Charitable Trust; Thames Valley Dementias and Neurodegenerative Diseases Research Network of the National Institute for Health Research, UK; Sidney and Elizabeth Corob Charitable Trust; Meda AB/Recip AB, Solna, Sweden; MRC [G0700399] Funding Source: UKRI; Alzheimers Research UK [ART-PG2004B-2] Funding Source: researchfish; Medical Research Council [G0700399] Funding Source: researchfish	Charles Wolfson Charitable Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research Trust; Henry Smith Charity; John Coates Charitable Trust; Thames Valley Dementias and Neurodegenerative Diseases Research Network of the National Institute for Health Research, UK; Sidney and Elizabeth Corob Charitable Trust; Meda AB/Recip AB, Solna, Sweden; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Charles Wolfson Charitable Trust, Medical Research Council, Alzheimer's Research Trust, Henry Smith Charity, John Coates Charitable Trust, Thames Valley Dementias and Neurodegenerative Diseases Research Network of the National Institute for Health Research, UK, and the Sidney and Elizabeth Corob Charitable Trust, and Meda AB/Recip AB, Solna, Sweden. None of the funders or the sponsor (University of Oxford) played any role in the design and conduct of the study, collection, management, analysis, and interpretation of the data; nor in the preparation, review, or approval of the manuscript.	Aisen PS, 2008, JAMA-J AM MED ASSOC, V300, P1774, DOI 10.1001/jama.300.15.1774; Aisen PS, 2008, NEUROLOGY, V70, P2020, DOI 10.1212/01.wnl.0000313380.89894.54; Anstey KJ, 2006, PSYCHOSOM MED, V68, P778, DOI 10.1097/01.psy.0000237779.56500.af; Bleie O, 2004, AM J CLIN NUTR, V80, P641; Bradley KM, 2002, BRIT J RADIOL, V75, P506, DOI 10.1259/bjr.75.894.750506; BRANDT J, 1993, ARCH NEUROL-CHICAGO, V50, P599, DOI 10.1001/archneur.1993.00540060039014; Carlson NE, 2008, NEUROLOGY, V70, P828, DOI 10.1212/01.wnl.0000280577.43413.d9; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; Clarke R, 2005, AM J CLIN NUTR, V82, P806, DOI 10.1093/ajcn/82.4.806; de Jager CA, 2003, INT J GERIATR PSYCH, V18, P318, DOI 10.1002/gps.830; DeCarli C, 2003, LANCET NEUROL, V2, P15, DOI 10.1016/S1474-4422(03)00262-X; den Heijer T, 2003, BRAIN, V126, P170, DOI 10.1093/brain/awg006; den Heijer T, 2003, DIABETOLOGIA, V46, P1604, DOI 10.1007/s00125-003-1235-0; Durga J, 2007, LANCET, V369, P208, DOI 10.1016/S0140-6736(07)60109-3; Enzinger C, 2005, NEUROLOGY, V64, P1704, DOI 10.1212/01.WNL.0000161871.83614.BB; Erickson KI, 2008, BRAIN RES, V1199, P20, DOI 10.1016/j.brainres.2008.01.030; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox NC, 1999, NEUROLOGY, V52, P1687, DOI 10.1212/WNL.52.8.1687; Jack CR, 2005, NEUROLOGY, V65, P1227, DOI 10.1212/01.wnl.0000180958.22678.91; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Killiany RJ, 2000, ANN NEUROL, V47, P430, DOI 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I; McCaddon A, 1998, INT J GERIATR PSYCH, V13, P235, DOI 10.1002/(SICI)1099-1166(199804)13:4<235::AID-GPS761>3.0.CO;2-8; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Petersen RC, 2009, ARCH NEUROL-CHICAGO, V66, P1447, DOI 10.1001/archneurol.2009.266; Pfeiffer CM, 2008, CLIN CHEM, V54, P801, DOI 10.1373/clinchem.2007.100214; Plassman BL, 2008, ANN INTERN MED, V148, P427, DOI 10.7326/0003-4819-148-6-200803180-00005; Refsum H, 2004, CLIN CHEM, V50, P3, DOI 10.1373/clinchem.2003.021634; Refsum H, 2006, J NUTR, V136, p1731S, DOI 10.1093/jn/136.6.1731S; Resnick SM, 2003, J NEUROSCI, V23, P3295; Ries ML, 2008, J AM GERIATR SOC, V56, P920, DOI 10.1111/j.1532-5415.2008.01684.x; Risacher SL, 2009, CURR ALZHEIMER RES, V6, P347, DOI 10.2174/156720509788929273; Roth M, 1988, CAMDEX CAMBRIDGE EXA; Sachdev PS, 2002, NEUROLOGY, V58, P1539, DOI 10.1212/WNL.58.10.1539; Seshadri S, 2008, ARCH NEUROL-CHICAGO, V65, P642, DOI 10.1001/archneur.65.5.642; Seshadri S, 2006, J ALZHEIMERS DIS, V9, P393; Skoog I, 1998, HYPERTENSION, V32, P404, DOI 10.1161/01.HYP.32.3.404; Sluimer JD, 2008, RADIOLOGY, V248, P590, DOI 10.1148/radiol.2482070938; Smith AD, 2008, FOOD NUTR BULL, V29, pS143, DOI 10.1177/15648265080292S119; Smith AD, 2002, P NATL ACAD SCI USA, V99, P4135, DOI 10.1073/pnas.082107399; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Vogiatzoglou A, 2008, NEUROLOGY, V71, P826, DOI 10.1212/01.wnl.0000325581.26991.f2; Wedderburn C, 2008, J NEUROL NEUROSUR PS, V79, P500, DOI 10.1136/jnnp.2007.122028; Williams JH, 2002, AGE AGEING, V31, P440, DOI 10.1093/ageing/31.6.440; Yang LK, 2007, J AM COLL NUTR, V26, P272, DOI 10.1080/07315724.2007.10719611; ZYLBERSTEIN DE, 2009, NEUROBIOL AGING	45	447	464	3	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12244	10.1371/journal.pone.0012244	http://dx.doi.org/10.1371/journal.pone.0012244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IV	20838622	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000281687100001
J	Gilbert, GL; Cretikos, MA; Hueston, L; Doukas, G; O'Toole, B; Dwyer, DE				Gilbert, Gwendolyn L.; Cretikos, Michelle A.; Hueston, Linda; Doukas, George; O'Toole, Brian; Dwyer, Dominic E.			Influenza A (H1N1) 2009 Antibodies in Residents of New South Wales, Australia, after the First Pandemic Wave in the 2009 Southern Hemisphere Winter	PLOS ONE			English	Article							INFECTION; SAMPLE	Background: The first wave of pandemic influenza A(H1N1) 2009 (pH1N1) reached New South Wales (NSW), Australia in May 2009, and led to high rates of influenza-related hospital admission of infants and young to middle-aged adults, but no increase in influenza-related or all-cause mortality. Methodology/Principal Findings: To assess the population rate of pH1N1 infection in NSW residents, pH1N1-specific haemagglutination inhibition (HI) antibody prevalence was measured in specimens collected opportunistically before (2007-2008; 474 specimens) and after (August-September 2009; 1247 specimens) the 2009 winter, and before the introduction of the pH1N1 monovalent vaccine. Age-and geographically-weighted population changes in seroprevalence were calculated. HI antibodies against four recent seasonal influenza A viruses were measured to assess cross-reactions. Pre- and post-pandemic pH1N1 seroprevalences were 12.8%, and 28.4%, respectively, with an estimated overall infection rate of 15.6%. pH1N1 antibody prevalence increased significantly -20.6% overall -in people born since 1944 (26.9% in those born between 1975 and 1997) but not in those born in or before 1944. People born before 1925 had a significantly higher pH1N1 seroprevalence than any other age-group, and against any seasonal influenza A virus. Sydney residents had a significantly greater change in prevalence of antibodies against pH1N1 than other NSW residents (19.3% vs 9.6%). Conclusions/Significance: Based on increases in the pH1N1 antibody prevalence before and after the first pandemic wave, 16% of NSW residents were infected by pH1N1 in 2009; the highest infection rates (27%) were among adolescents and young adults. Past exposure to the antigenically similar influenza A/H1N1(1918) is the likely basis for a very high prevalence (49%) of prepandemic cross-reacting pH1N1 antibody and sparing from pH1N1 infection among people over 85 years. Unless pre-season vaccine uptake is high, there are likely to be at least moderate rates including some life-threatening cases of pH1N1 infection among young people during subsequent winters.	[Gilbert, Gwendolyn L.; Hueston, Linda; O'Toole, Brian; Dwyer, Dominic E.] Univ Sydney, Inst Clin Pathol & Med Res, Ctr Infect Dis & Microbiol, Sydney, NSW 2006, Australia; [Cretikos, Michelle A.; Doukas, George] New S Wales Dept Hlth, Ctr Epidemiol & Res, Sydney, NSW, Australia; [Cretikos, Michelle A.] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia	University of Sydney; University of Sydney	Gilbert, GL (corresponding author), Univ Sydney, Inst Clin Pathol & Med Res, Ctr Infect Dis & Microbiol, Sydney, NSW 2006, Australia.	lyn.gilbert@sydney.edu.au	Gilbert, Gwendolyn/B-7733-2013; O'Toole, Brian/G-9366-2011	Gilbert, Gwendolyn/0000-0001-7490-6727; O'Toole, Brian/0000-0002-3825-0772	Population Health Division of the New South Wales Department of Health Australia; NSW Department of Health	Population Health Division of the New South Wales Department of Health Australia; NSW Department of Health	This study was funded by the Population Health Division of the New South Wales Department of Health Australia. The study sponsor represented by author Michelle Cretikos, had a major role in study design, analysis and interpretation of data and preparation of the manuscript. The corresponding author had full access to all the data in the study and final responsibility for the decision to submit for publication.; Michelle Cretikos is employed by the NSW Department of Health, which funded the study. She owns shares in CSL Ltd, which manufactures influenza vaccines. None of the other authors have any conflicts of interest.	Australian Bureau of Statistics, 2006, STAT GEOGR, V1; Bishop JF, 2009, NEW ENGL J MED, V361, P2591, DOI 10.1056/NEJMp0910445; Blyth CC, 2010, EURO SURVEILL, V15; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Efron B., 1993, INTRO BOOTSTRAP, P168; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gelman A, 2001, SURVEY NONRESPONSE, P289; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Ikonen N, 2010, EURO SURVEILL, V15; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Izrael D., 2004, 29 ANN SAS US GROUP, P207; Janjua NZ, 2010, LANCET, V375, P801, DOI 10.1016/S0140-6736(10)60338-8; Janjua NZ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4972; Kelly H, 2002, VACCINE, V20, P3130, DOI 10.1016/S0264-410X(02)00255-4; Kelly HA, 2010, MED J AUSTRALIA, V192, P81, DOI 10.5694/j.1326-5377.2010.tb03423.x; Lohr S. L., 1999, SAMPLING DESIGN ANAL, P265; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; *NSW PUBL HLTH NET, 2009, EURO SURVEILL, V14; Pan CE, 2010, PLOS ONE, V5, pA31, DOI 10.1371/journal.pone.0009549; Reed C, 2010, LANCET, V375, P1062, DOI 10.1016/S0140-6736(09)62194-2; Stephan FF, 1942, ANN MATH STAT, V13, P166, DOI 10.1214/aoms/1177731604; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481	26	81	84	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12562	10.1371/journal.pone.0012562	http://dx.doi.org/10.1371/journal.pone.0012562			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830210	Green Submitted, Green Published, gold			2022-12-27	WOS:000281631300004
J	Ojaveer, H; Jaanus, A; MacKenzie, BR; Martin, G; Olenin, S; Radziejewska, T; Telesh, I; Zettler, ML; Zaiko, A				Ojaveer, Henn; Jaanus, Andres; MacKenzie, Brian R.; Martin, Georg; Olenin, Sergej; Radziejewska, Teresa; Telesh, Irena; Zettler, Michael L.; Zaiko, Anastasija			Status of Biodiversity in the Baltic Sea	PLOS ONE			English	Review							GENETIC POPULATION-STRUCTURE; COD GADUS-MORHUA; PLAICE PLEURONECTES-PLATESSA; REPRODUCTIVE SUCCESS; MNEMIOPSIS-LEIDYI; BENTHIC HABITATS; MARINE FISHES; NORTH-SEA; BELT SEA; DIVERSITY		[Ojaveer, Henn] Univ Tartu, Estonian Marine Inst, Pamu, Estonia; [Jaanus, Andres; Martin, Georg] Univ Tartu, Estonian Marine Inst, Tallinn, Estonia; [MacKenzie, Brian R.] Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark; [Olenin, Sergej] Uni Res AS, Uni Miljo, Bergen, Norway; [Olenin, Sergej; Zaiko, Anastasija] Klaipeda Univ, Coastal Res & Planning Inst, Klaipeda, Lithuania; [Radziejewska, Teresa] Univ Szczecin, Palaeoceanol Unit, Szczecin, Poland; [Telesh, Irena] Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia; [Zettler, Michael L.] Leibniz Inst Balt Sea Res, Dept Biol, Warnemunde, Germany	University of Tartu; Estonian Marine Institute; University of Tartu; Estonian Marine Institute; Technical University of Denmark; University of Bergen; Klaipeda University; University of Szczecin; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Leibniz Institut fur Ostseeforschung Warnemunde	Ojaveer, H (corresponding author), Univ Tartu, Estonian Marine Inst, Pamu, Estonia.	henn.ojaveer@ut.ee	MacKenzie, Brian R./T-9379-2019; Radziejewska, Teresa/AAK-8233-2021; Telesh, Irena V./N-4342-2016; Ojaveer, Henn/K-2160-2016; Zaiko, Anastasija/J-2665-2014; Zettler, Michael Lothar/R-3186-2019	MacKenzie, Brian R./0000-0002-4798-0363; Telesh, Irena V./0000-0002-4167-3821; Ojaveer, Henn/0000-0003-2742-6063; Zettler, Michael Lothar/0000-0002-5437-5495; Olenin, Sergej/0000-0002-0773-1442	Marine Ecosystem Evolution in a Changing Environment (MEECE) [212085]; European Census of Marine Life; Total Foundation; Alfred P. Sloan Foundation; Estonian Government [SF0180005s10]; Program on 'Leading Scientific Schools' [1993.2008.4]; Russian Academy of Sciences Presidium; Climate Change: Causes, Impacts and Projections' [C-04/2008/2]	Marine Ecosystem Evolution in a Changing Environment (MEECE); European Census of Marine Life; Total Foundation(Total SA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Estonian Government; Program on 'Leading Scientific Schools'; Russian Academy of Sciences Presidium(Russian Academy of Sciences); Climate Change: Causes, Impacts and Projections'	The current paper is mostly based on research financed through various national as well as regional and European-wide research projects and programs. All these projects and programs are gratefully acknowledged, while stressing a few larger projects, such as European Union Sixth Framework Programme (EU FP6) projects Marine Biodiversity and Ecosystem Functioning (MarBEF), European Network of Excellence for Ocean Ecosystems Analysis (EUR-OCEANS), and EU Seventh Framework Programme (EU FP7) project Marine Ecosystem Evolution in a Changing Environment (MEECE) (contract 212085). The authors gratefully acknowledge the support given by the European Census of Marine Life, the Total Foundation, and the Alfred P. Sloan Foundation. The current work of HO was supported by the Estonian Government (grant no. SF0180005s10). IT was supported by the Program on 'Leading Scientific Schools' (grant 1993.2008.4) and the Russian Academy of Sciences Presidium Program on 'Scientific Basics for Biodiversity Conservation in Russia'. SO and AZ would like to acknowledge the project on 'Biological Invasions in Lithuanian Ecosystems under the Climate Change: Causes, Impacts and Projections' (contract C-04/2008/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKEFORS H, 1969, I MAR RES LYSEKIL SE, V18, P139; ACKEFORS H, 1981, BALTIC SEA, P238; ACKEFORS HANS, 1965, OPHELIA, V2, P269; Adjers K, 2006, BOREAL ENVIRON RES, V11, P13; Ankar S., 1976, Contributions Asko Lab, VNo. 11, P1; [Anonymous], 2008, STATE EVOLUTION BALT, DOI DOI 10.1002/9780470283134.CH2; ARLT G, 1983, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V110, P45; *BALT HMAP, 2001, 1 BALT HIST MAR AN P; Bartsch I., 1972, Abhandlungen Verh naturw Ver Hamburg, V16, P155; Bastrop Ralf, 1997, Aquatic Ecology, V31, P119, DOI 10.1023/A:1009994102526; BEHRENDS G, 1990, BALT SEA ENV B, V35, P181; Benecke B., 1881, FISCHE FISCHEREI FIS; BEUSEKOM JEE, INT J EARTH SCI; Bonsdorff E, 2006, J EXP MAR BIOL ECOL, V330, P383, DOI 10.1016/j.jembe.2005.12.041; BUSCH A, 1992, CRUSTACEANA, V62, P13, DOI 10.1163/156854092X00028; Carstensen J, 2005, ESTUAR COAST SHELF S, V62, P595, DOI 10.1016/j.ecss.2004.09.026; CARSTENSEN J, 2004, BALTIC SEA TYPOLOGY, V4, P55; Carstensen J, 2007, MAR ECOL PROG SER, V336, P29, DOI 10.3354/meps336029; Casini M, 2009, P NATL ACAD SCI USA, V106, P197, DOI 10.1073/pnas.0806649105; Costello MJ, 2006, MAR ECOL PROG SER, V316, P257, DOI 10.3354/meps316257; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Dippner JW, 2001, ICES J MAR SCI, V58, P569, DOI 10.1006/jmsc.2001.1048; Drgas A, 1998, MAR ECOL-P S Z N I, V19, P209, DOI 10.1111/j.1439-0485.1998.tb00463.x; DRZYCIMSKI I, 1975, Merentutkimuslaitoksen Julkaisu, V239, P41; DRZYCIMSKI I, 1974, Fragmenta Faunistica (Warsaw), V20, P61; DRZYCIMSKI I, 2000, BALTIC OCEANOL STUD, V42, P29; DRZYCIMSKI I, 1967, FRAGM FAUN, V13, P389; Ducrotoy JP, 2008, MAR POLLUT BULL, V57, P8, DOI 10.1016/j.marpolbul.2008.04.030; Eero M, 2007, FISH RES, V87, P155, DOI 10.1016/j.fishres.2007.02.015; Eero M, 2007, ICES J MAR SCI, V64, P1257, DOI 10.1093/icesjms/fsm114; Eero M, 2008, CAN J FISH AQUAT SCI, V65, P2728, DOI 10.1139/F08-176; ELMGREN R, 1975, Merentutkimuslaitoksen Julkaisu, V239, P265; Enghoff IB, 2007, FISH RES, V87, P167, DOI 10.1016/j.fishres.2007.03.004; FEISTEL R, 2010, DENSITY ABSOLUTE SAL, V24, P2006; Fonselius S, 2003, J SEA RES, V49, P229, DOI 10.1016/S1385-1101(03)00035-2; Frenzel P, 2005, STUD GEOL POLON, V124, P67; Galil BS, 2009, BIOL INVASIONS, V11, P359, DOI 10.1007/s10530-008-9253-y; Garstecki T, 2000, FRESHWATER BIOL, V45, P147, DOI 10.1046/j.1365-2427.2000.00676.x; Gaumiga R, 2007, FISH RES, V87, P120, DOI 10.1016/j.fishres.2007.04.003; Giere O, 2009, MEIOBENTHOLOGY MICRO, P527, DOI [DOI 10.1007/978-3-540-68661-3, 10.1007/978-3-540-68661-3]; Gorokhova E, 2009, LIMNOL OCEANOGR, V54, P2025, DOI 10.4319/lo.2009.54.6.2025; Granskog M, 2006, ESTUAR COAST SHELF S, V70, P145, DOI 10.1016/j.ecss.2006.06.001; HAGMEIER A., 1930, BER DEUTSCH WISS KOMM MEERESJORSCH, V5, P156; HAGMEIER A, 1926, BERICHTE DTSCH WISSE, V2, P304; Hajdu S, 2005, HARMFUL ALGAE, V4, P471, DOI 10.1016/j.hal.2004.08.004; HAJDU S, 2007, HAVET, P47; Hajdu S., 2006, UNUSUAL PHYTOPLANKTO; Halinen K, 2008, FEMS MICROBIOL ECOL, V64, P199, DOI 10.1111/j.1574-6941.2008.00461.x; Hallfors G., 2004, BALT SEA ENV P, V95; HALLFORS H, 2008, CHANGES PHYTOPLANKTO; HAMMER G, 2008, FISH STOCK DEV HYDRO, P543; Hansen Michael Moller, 2007, J Biol, V6, P6, DOI 10.1186/jbiol59; Harding KC, 1999, AMBIO, V28, P619; Heino Raino, 2008, P35; HELCOM, 2007, BALT SEA ENV P, V113; HELCOM, 2006, BALT SEA ENV P A, V103; *HELCOM, 2009, BALT SEA ENV P B, V116; HELCOM, 2007, HELCOM BALT SEA ACT; HELCOM, 2007, BALT SEA ENV P; *HELCOM, 2007, BALTIC SEA BALTIC SE, V109, P40; Hemmer-Hansen J, 2007, MOL ECOL, V16, P3104, DOI 10.1111/j.1365-294X.2007.03367.x; HERNROTH L, 1979, ZOOPLANKTON BALTIC P, V2, P60; HERTLING H, 1928, BERICHTE DTSCH WISSE, V4, P120; HESSLE C, 1924, BOTTENBONITORINGAR I, V250, P1; HESSLE C, 1923, UNDERSO  KNINGAR RO, V243, P144; HIGGINS RP, 1988, MANUAL STUDY MEIOFAU; Holm P, 2002, OCEANOL ACTA, V25, P207, DOI 10.1016/S0399-1784(02)01200-8; *ICES, 2009, ICES ADV; *ICES, 2006, 2006BCC06 ICES CM; *IFAO, 2006, AUT ATL BENTH WIRB T; *IUCN, 1999, NEWSLETTER SPECIES S, V31, P28; Jaanus A, 2007, SHIFTS BALTIC SEA SU; Jansson B. O., 1972, B ECOL RES COM, V16, P1; Javidpour J, 2009, J PLANKTON RES, V31, P729, DOI 10.1093/plankt/fbp021; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Jonczyk E., 1984, Limnologica, V15, P421; Jorgensen HBH, 2005, MOL ECOL, V14, P3219, DOI 10.1111/j.1365-294X.2005.02658.x; KANDLER R, 1938, BERICHTE DTSCH WISSE, V9, P541; Karling T, 1974, FAUNA FENN HELSINKI, V27, P1; KHLEBOVICH TV, 1987, NEVA BAY HYDROBIOLOG, P77; KLIE WALTER, 1929, ZOOL JAHRB ABT SYST OKOL U GEOGR TIERE, V57, P329; KNIPOWITSCH NM, 1909, OTCETCH RABOTACH BAL, V14, P131; Koie M, 1999, ICES J MAR SCI, V56, P157, DOI 10.1006/jmsc.1999.0463; Koster F.W, 2009, J NW ATLANTIC FISHER, V41, P205, DOI DOI 10.2960/J.V41.M636; Koster FW, 2003, SCI MAR, V67, P129, DOI 10.3989/scimar.2003.67s1129; KREMP A, 2000, BALTIC SEA W  A NOTT, V22, P1; KUNZ H, 1971, KIELER MEERESFORSCH, V27, P72; Laikre L, 2005, AMBIO, V34, P111, DOI 10.1639/0044-7447(2005)034[0111:GPSOFI]2.0.CO;2; Laine AO, 2003, ESTUAR COAST SHELF S, V57, P87, DOI 10.1016/S0272-7714(02)00333-5; LANG T, 2000, ICES CRR, V241, P201; Leasi F, 2010, J MAR BIOL ASSOC UK, V90, P645, DOI 10.1017/S0025315409991068; Lehtimaki J, 2000, INT J SYST EVOL MICR, V50, P1043, DOI 10.1099/00207713-50-3-1043; LENZ H, 1874, WIRBELLOSEN TIERE TR, V4, P1; Leppakoski E, 2002, CENT E EUR DEV STUD, P253; Leppakoski E, 2002, CAN J FISH AQUAT SCI, V59, P1175, DOI 10.1139/F02-089; Leppakoski E, 2001, AMBIO, V30, P202, DOI 10.1579/0044-7447-30.4.202; LEPPAKOSKI E, 2005, OCEANOL HYDROBIOL S1, V34, P6; Leppakoski Erkki, 2001, Proceedings of the Estonian Academy of Sciences Biology Ecology, V50, P66; Limborg MT, 2009, MAR ECOL PROG SER, V379, P213, DOI 10.3354/meps07889; MacKenzie BR, 2002, CAN J FISH AQUAT SCI, V59, P173, DOI 10.1139/F01-201; Mackenzie BR, 2007, GLOBAL CHANGE BIOL, V13, P1348, DOI 10.1111/j.1365-2486.2007.01369.x; Martin G., 2000, PHYTOBENTHIC COMMUNI; Mironova EI, 2009, INLAND WATER BIOL, V2, P13, DOI 10.1134/S1995082909010039; MOBIUS K, 1873, THIERE OSTSEE JAHRES, V1, P97; Modig H, 2000, MAR ECOL PROG SER, V202, P125, DOI 10.3354/meps202125; Mollmann C, 2008, ICES J MAR SCI, V65, P302, DOI 10.1093/icesjms/fsm197; MOLLMANN C, 2003, ICES MAR SCI S, V219, P294; Muus B.J., 1999, SCANDINAVIAN FISHING; MUUS BJ, 1967, FISK HAVUNDERS NY SE, V5, P316; NAUMENKO EN, 2008, P ZOOL I RAS, V312, P155; Nielsen E, 1998, J SEA RES, V39, P11, DOI 10.1016/S1385-1101(97)00014-2; Nielsen EE, 2004, MOL ECOL, V13, P585, DOI 10.1046/j.1365-294X.2004.02097.x; Nielsen EE, 2003, MOL ECOL, V12, P1497, DOI 10.1046/j.1365-294X.2003.01819.x; Nielsen R., 1995, ACTA BOT FENN, V155, P55; Nissling A, 1997, MAR ECOL PROG SER, V152, P261, DOI 10.3354/meps152261; Nissling A, 2002, ICES J MAR SCI, V59, P93, DOI 10.1006/jmsc.2001.1134; NORDQUIST O, 1890, BIDRAG KA  NNEDOMEN, V17, P83; Occhipinti-Ambrogi A, 2004, MAR POLLUT BULL, V49, P688, DOI 10.1016/j.marpolbul.2004.08.011; Oeberst R, 2009, ICES J MAR SCI, V66, P1667, DOI 10.1093/icesjms/fsp143; OJAVEER E, 1995, FISHES ESTONIA; Ojaveer E, 2008, J MARINE SYST, V74, P672, DOI 10.1016/j.jmarsys.2008.07.001; Ojaveer H, 2004, HYDROBIOLOGIA, V522, P261, DOI 10.1023/B:HYDR.0000029927.91756.41; Ojaveer H, 2007, FISH RES, V87, P102, DOI 10.1016/j.fishres.2007.08.011; Ojaveer Henn, 2004, Proceedings of the Estonian Academy of Sciences Biology Ecology, V53, P116; Olenin S, 1999, HYDROBIOLOGIA, V393, P233, DOI 10.1023/A:1003511003766; Olenin Sergej, 2009, V3, P129; Paavola M, 2005, ESTUAR COAST SHELF S, V64, P738, DOI 10.1016/j.ecss.2005.03.021; Palm H.W., 1999, BERICHTE I MEERESKUN, V307, P148; Pereyra RT, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-70; Perry RI, 2010, J MARINE SYST, V79, P427, DOI 10.1016/j.jmarsys.2008.12.017; PETERSEN CG, 1913, REPORT DANISH BIOL S, V21, P3; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; Planque B, 2010, J MARINE SYST, V79, P403, DOI 10.1016/j.jmarsys.2008.12.018; POSTEL L, 1995, BERLIN HEIDELBERG NE, P150; POSTEL L, 1996, THIRD PERIODIC ASSES, P215; RADZIEJEWSKA T, 1989, P 21 EMBS POL AC SCI, P403; RAHM G, 1928, TIERWELT NORD OSTSEE; REIBISCH J, 2002, ABH DT SEEFISCH VER, V7, P142; REIMER L, 1963, OSTSEE ZOOL ANZ, V171, P440; REMANE A., 1927, ZEITSCHR WISS BIOL ABT A ZEITSCHR MORPH U OKOL TIERE, V7, P643, DOI 10.1007/BF00540535; Remane A., 1949, Kieler Meeresforschungen, V6, P59; Rokicka-Praxmajer Joanna, 1998, Oceanologia, V40, P243; ROKICKAPRAXMAJE.J, 2002, ACTA SCI POLONORUM P, V1, P85; Ronnberg C, 2004, HYDROBIOLOGIA, V514, P227, DOI 10.1023/B:HYDR.0000019238.84989.7f; Rumohr H, 1996, ARCH FISH MAR RES, V44, P179; SCHIEMER F, 1983, ANN ZOOL FENN, V20, P277; Schiewer U., 2008, ECOLOGY BALTIC COAST; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; SCHUBERT H, 2003, BMB PUBL, V19; SCHWINGHAMER P, 1981, CAN J FISH AQUAT SCI, V38, P1255, DOI 10.1139/f81-167; SEGERSTRALE SG, 1933, COMMENTAT BIOL, V4, P1; SEWELL RB, 1948, SWIMMING PLANKTONIC, P1; Sorensen MV, 2001, HYDROBIOLOGIA, V452, P121, DOI 10.1023/A:1011932128728; STRODTMANN S, 1926, BERICHTE DTSCH WISSE, P276; Suikkanen S, 2007, ESTUAR COAST SHELF S, V71, P580, DOI 10.1016/j.ecss.2006.09.004; SYWULA T, 1966, Przeglad Zoologiczny, V10, P287; Tarand A, 2001, CLIMATIC CHANGE, V48, P189, DOI 10.1023/A:1005673628980; TELESH I, 2009, BMB PUBL, V21; TELESH I, 2008, BMB PUBLICATION, V20; Telesh I. V., 2004, ATLAS ESTUARINE ZO 2; Telesh I.V., 2002, ATLAS ESTUARINE ZO 1; Telesh IV, 2004, MAR POLLUT BULL, V49, P206, DOI 10.1016/j.marpolbul.2004.02.009; THANE-FENCHEL A, 1968, Ophelia, V5, P299; THOMSEN HA, 1992, PLANKTON I INDRE DAN; THORE S, 1993, TECHNOLOGY KNOWLEDGE, V1, P1; THULIN G, 1924, SVENSKA HYDROGR BIOL, V6, P1; Torn K, 2006, AQUAT BOT, V84, P53, DOI 10.1016/j.aquabot.2005.07.011; Urban-Malinga B, 2006, ESTUAR COAST SHELF S, V70, P224, DOI 10.1016/j.ecss.2006.06.020; Urho L, 2008, FISH SPECIES FINLAND; Vahtera E, 2007, AMBIO, V36, P186, DOI 10.1579/0044-7447(2007)36[186:IEFENC]2.0.CO;2; Vallin L, 1999, AMBIO, V28, P92; Valovirta E. J., 1935, Annales Zoologici Societatis Zoologico-Botanicae Fennicae Vanamo, V1, P12; VIETS K, 1927, TIERWELT NORD OSTSEE; Vitins Maris, 2001, Proceedings of the Estonian Academy of Sciences Biology Ecology, V50, P85; Vuorinen I, 1998, ICES J MAR SCI, V55, P767, DOI 10.1006/jmsc.1998.0398; Waite AM, 2006, MAR ECOL PROG SER, V326, P77, DOI 10.3354/meps326077; Wang JY, 1997, MAR BIOL, V127, P531, DOI 10.1007/s002270050042; Wasmund N, 2008, STATE EVOLUTION BALT, P441; Wasmund N, 2008, J MARINE SYST, V73, P300, DOI 10.1016/j.jmarsys.2006.09.009; WITEK Z, 1995, BIOL PRODUCTION ITS, P145; Yarincik K, 2005, SCI MAR, V69, P201, DOI 10.3989/scimar.2005.69s1201; Zettler M. L., 2008, STATE EVOLUTION BALT, P517; 2009, BALTIC SEA ALIEN SPE	183	204	210	3	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12467	10.1371/journal.pone.0012467	http://dx.doi.org/10.1371/journal.pone.0012467			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824189	Green Published, gold			2022-12-27	WOS:000281456100005
J	Poulou, M; Bell, D; Bozonelos, K; Alexiou, M; Gavalas, A; Lovell-Badge, R; Remboutsika, E				Poulou, Maria; Bell, Donald; Bozonelos, Kostas; Alexiou, Maria; Gavalas, Anthony; Lovell-Badge, Robin; Remboutsika, Eumorphia			Development of a Chromosomally Integrated Metabolite-Inducible Leu3p-alpha-IPM "Off-On'' Gene Switch	PLOS ONE			English	Article							MAMMALIAN-CELLS; TRANSGENIC MICE; ALPHA-ISOPROPYLMALATE; LEUCINE BIOSYNTHESIS; CRE RECOMBINASE; IN-VITRO; EXPRESSION; YEAST; SYSTEM; LEU3P	Background: Present technology uses mostly chimeric proteins as regulators and hormones or antibiotics as signals to induce spatial and temporal gene expression. Methodology/Principal Findings: Here, we show that a chromosomally integrated yeast 'Leu3p-alpha-IRM' system constitutes a ligand-inducible regulatory "off-on'' genetic switch with an extensively dynamic action area. We find that Leu3p acts as an active transcriptional repressor in the absence and as an activator in the presence of alpha-isopropylmalate (alpha-IRM) in primary fibroblasts isolated from double transgenic mouse embryos bearing ubiquitously expressing Leu3p and a Leu3p regulated GFP reporter. In the absence of the branched amino acid biosynthetic pathway in animals, metabolically stable alpha-IPM presents an EC(50) equal to 0.8837 mM and fast "OFF-ON" kinetics (t(50)ON = 43 min, t(50)OFF = 2.18 h), it enters the cells via passive diffusion, while it is non-toxic to mammalian cells and to fertilized mouse eggs cultured ex vivo. Conclusions/Significance: Our results demonstrate that the `Leu3p-alpha-IPM' constitutes a simpler and safer system for inducible gene expression in biomedical applications.	[Poulou, Maria; Remboutsika, Eumorphia] Biomed Sci Res Ctr Alexander Fleming, Inst Mol Biol & Genet, Stem Cell Biol Lab, Attica, Greece; [Bell, Donald; Lovell-Badge, Robin; Remboutsika, Eumorphia] Natl Inst Med Res, MRC, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England; [Bozonelos, Kostas; Alexiou, Maria] Biomed Sci Res Ctr Alexander Fleming, Inst Immunol, Transgen Unit, Attica, Greece; [Gavalas, Anthony] Natl Inst Med Res, MRC, Div Dev Neurobiol, London NW7 1AA, England	Alexander Fleming Biomedical Sciences Research Center; MRC National Institute for Medical Research; Alexander Fleming Biomedical Sciences Research Center; MRC National Institute for Medical Research	Poulou, M (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Inst Mol Biol & Genet, Stem Cell Biol Lab, Attica, Greece.	remboutsika@fleming.gr	Gavalas, Anthony/F-5817-2015; Remboutsika, Eumorphia/L-2718-2019	Remboutsika, Eumorphia/0000-0002-1243-9569; Bell, Donald/0000-0002-3788-1580; Gavalas, Anthony/0000-0003-4897-0359; Lovell-Badge, Robin/0000-0001-9364-4179	Greek Secretariat for Research and Technology of Greece [PENED 03ED394]; Medical Research Council (UK) [U117512772]; Medical Research Council [MC_U117562207] Funding Source: researchfish; MRC [MC_U117562207] Funding Source: UKRI	Greek Secretariat for Research and Technology of Greece; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Greek Secretariat for Research and Technology (PENED 03ED394) of Greece (www.gsrt.gr) and the Medical Research Council (UK) www.nimr.mrc.ac.uk (MRC file reference U117512772). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrand PO, 1998, NUCLEIC ACIDS RES, V26, P3263, DOI 10.1093/nar/26.13.3263; Aubel D, 2001, J ANTIBIOT, V54, P44, DOI 10.7164/antibiotics.54.44; Auricchio A, 2002, MOL THER, V6, P238, DOI 10.1006/mthe.2002.0660; BAICHWAL VR, 1983, CURR GENET, V7, P369, DOI 10.1007/BF00445877; Caulin C, 2007, J CLIN INVEST, V117, P1893, DOI 10.1172/JCI31721; Chiba H, 2000, EXP CELL RES, V260, P334, DOI 10.1006/excr.2000.5022; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Gao X, 1999, NEUROCHEM RES, V24, P1181, DOI 10.1023/A:1020772706279; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Guo H, 1996, FEBS LETT, V390, P191, DOI 10.1016/0014-5793(96)00653-9; Hong SB, 2006, LAB INVEST, V86, P664, DOI 10.1038/labinvest.3700431; Hummel Thomas, 2008, V420, P97, DOI 10.1007/978-1-59745-583-1_6; Jaisser F, 2000, J AM SOC NEPHROL, V11, pS95; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kohlhaw GB, 2003, MICROBIOL MOL BIOL R, V67, P1, DOI 10.1128/MMBR.67.1.1-15.2003; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Magari SR, 1997, J CLIN INVEST, V100, P2865, DOI 10.1172/JCI119835; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Meissner U, 2003, PHARMACOLOGY, V69, P74, DOI 10.1159/000072359; Morimoto M, 2009, DEV BIOL, V325, P171, DOI 10.1016/j.ydbio.2008.10.013; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; No D, 1996, P NATL ACAD SCI USA, V93, P3346, DOI 10.1073/pnas.93.8.3346; OPAS J, 1977, J EMBRYOL EXP MORPH, V37, P65; REMBOUTSIKA E, 1994, MOL CELL BIOL, V14, P5547, DOI 10.1128/MCB.14.8.5547; Remboutsika E., 1994, THESIS PURDUE U US; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; SPRENGEL R, 2007, HDB EXPT PHARM; SZE JY, 1993, MOL CELL BIOL, V13, P5702, DOI 10.1128/MCB.13.9.5702; SZE JY, 1992, SCIENCE, V258, P1143, DOI 10.1126/science.1439822; Traven A, 2006, EMBO REP, V7, P496, DOI 10.1038/sj.embor.7400679; Wang D, 1999, J BIOL CHEM, V274, P19017, DOI 10.1074/jbc.274.27.19017; Wunderlich FT, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.10.e47	33	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12488	10.1371/journal.pone.0012488	http://dx.doi.org/10.1371/journal.pone.0012488			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824215	Green Submitted, gold, Green Published			2022-12-27	WOS:000281405300014
J	Chen, PE; Willner, KM; Butani, A; Dorsey, S; George, M; Stewart, A; Lentz, SM; Cook, CE; Akmal, A; Price, LB; Keim, PS; Mateczun, A; Brahmbhatt, TN; Bishop-Lilly, KA; Zwick, ME; Read, TD; Sozhamannan, S				Chen, Peter E.; Willner, Kristin M.; Butani, Amy; Dorsey, Shakia; George, Matroner; Stewart, Andrew; Lentz, Shannon M.; Cook, Christopher E.; Akmal, Arya; Price, Lance B.; Keim, Paul S.; Mateczun, Alfred; Brahmbhatt, Trupti N.; Bishop-Lilly, Kimberly A.; Zwick, Michael E.; Read, Timothy D.; Sozhamannan, Shanmuga			Rapid Identification of Genetic Modifications in Bacillus anthracis Using Whole Genome Draft Sequences Generated by 454 Pyrosequencing	PLOS ONE			English	Article							INHALATIONAL ANTHRAX; TECHNOLOGIES; CEREUS; BIOTERRORISM; EVOLUTION; STRAIN	Background: The anthrax letter attacks of 2001 highlighted the need for rapid identification of biothreat agents not only for epidemiological surveillance of the intentional outbreak but also for implementing appropriate countermeasures, such as antibiotic treatment, in a timely manner to prevent further casualties. It is clear from the 2001 cases that survival may be markedly improved by administration of antimicrobial therapy during the early symptomatic phase of the illness; i. e., within 3 days of appearance of symptoms. Microbiological detection methods are feasible only for organisms that can be cultured in vitro and cannot detect all genetic modifications with the exception of antibiotic resistance. Currently available immuno or nucleic acid-based rapid detection assays utilize known, organism-specific proteins or genomic DNA signatures respectively. Hence, these assays lack the ability to detect novel natural variations or intentional genetic modifications that circumvent the targets of the detection assays or in the case of a biological attack using an antibiotic resistant or virulence enhanced Bacillus anthracis, to advise on therapeutic treatments. Methodology/ Principal Findings: We show here that the Roche 454-based pyrosequencing can generate whole genome draft sequences of deep and broad enough coverage of a bacterial genome in less than 24 hours. Furthermore, using the unfinished draft sequences, we demonstrate that unbiased identification of known as well as heretofore-unreported genetic modifications that include indels and single nucleotide polymorphisms conferring antibiotic and phage resistances is feasible within the next 12 hours. Conclusions/ Significance: Second generation sequencing technologies have paved the way for sequence-based rapid identification of both known and previously undocumented genetic modifications in cultured, conventional and newly emerging biothreat agents. Our findings have significant implications in the context of whole genome sequencing-based routine clinical diagnostics as well as epidemiological surveillance of natural disease outbreaks caused by bacterial and viral agents.	[Chen, Peter E.; Willner, Kristin M.; Butani, Amy; Dorsey, Shakia; George, Matroner; Stewart, Andrew; Lentz, Shannon M.; Cook, Christopher E.; Akmal, Arya; Mateczun, Alfred; Brahmbhatt, Trupti N.; Bishop-Lilly, Kimberly A.; Sozhamannan, Shanmuga] USN, Med Res Ctr, Biol Def Res Directorate, Silver Spring, MD USA; [Price, Lance B.; Keim, Paul S.] Translat Genom Res Inst, Flagstaff, AZ USA; [Keim, Paul S.] No Arizona Univ, Flagstaff, AZ 86011 USA; [Zwick, Michael E.; Read, Timothy D.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Read, Timothy D.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA	United States Department of Defense; United States Navy; Translational Genomics Research Institute; Northern Arizona University; Emory University; Emory University	Chen, PE (corresponding author), USN, Med Res Ctr, Biol Def Res Directorate, Silver Spring, MD USA.	Shanmuga.Sozhamannan@med.navy.mil	Sozhamannan, Shanmuga/AAN-7809-2020; Keim, Paul S/A-2269-2010; Read, Timothy/E-6240-2011; Sozhamannan, Shanmuga/AGF-2410-2022	Sozhamannan, Shanmuga/0000-0002-6762-7874; Bishop-Lilly, Kimberly/0000-0002-5744-8493; Read, Timothy/0000-0001-8966-9680				ABRAMOVA FA, 1993, P NATL ACAD SCI USA, V90, P2291, DOI 10.1073/pnas.90.6.2291; Athamna A, 2004, J ANTIMICROB CHEMOTH, V54, P424, DOI 10.1093/jac/dkh258; Bartlett JG, 2002, CLIN INFECT DIS, V35, P851, DOI 10.1086/341902; Brachman P S, 1980, Ann N Y Acad Sci, V353, P83, DOI 10.1111/j.1749-6632.1980.tb18910.x; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chen PE, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r1; Cowan ST, 2003, COWAN STEELS MANUAL; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Davis BM, 2009, NUCLEIC ACIDS RES, V37, P5757, DOI 10.1093/nar/gkp568; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hobert O, 2010, GENETICS, V184, P317, DOI 10.1534/genetics.109.112938; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Klee SR, 2006, J BACTERIOL, V188, P5333, DOI 10.1128/JB.00303-06; La Scola B, 2008, GENOME RES, V18, P742, DOI 10.1101/gr.071266.107; Lim DV, 2005, CLIN MICROBIOL REV, V18, P583, DOI 10.1128/CMR.18.4.583-607.2005; Lipkin WI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000002; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Miller JM, 1997, J CLIN MICROBIOL, V35, P504, DOI 10.1128/JCM.35.2.504-507.1997; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Okinaka R, 2006, PLOS PATHOG, V2, P1025, DOI 10.1371/journal.ppat.0020122; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; POMERANTSEV AP, 1992, ANTIBIOT KHIMIOTERAP, V37, P31; Price LB, 2003, ANTIMICROB AGENTS CH, V47, P2362, DOI 10.1128/AAC.47.7.2362-2365.2003; SERIZAWA M, 2010, ANTIMICROB AGENTS CH; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sozhamannan S, 2008, APPL ENVIRON MICROB, V74, P6792, DOI 10.1128/AEM.01124-08; Srivatsan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000139; Steinberg KM, 2008, ANAL CHEM, V80, P520, DOI 10.1021/ac086027z; Sternbach G, 2003, J EMERG MED, V24, P463, DOI 10.1016/S0736-4679(03)00079-9; Stewart AC, 2009, BIOINFORMATICS, V25, P962, DOI 10.1093/bioinformatics/btp097; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Van Ert MN, 2007, J CLIN MICROBIOL, V45, P47, DOI 10.1128/JCM.01233-06; Weiner M, 2003, J BACTERIOL, V185, P1462, DOI 10.1128/JB.185.4.1462-1464.2003; Zwick ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002513	44	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12397	10.1371/journal.pone.0012397	http://dx.doi.org/10.1371/journal.pone.0012397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811637	Green Published, gold, Green Submitted			2022-12-27	WOS:000281234700021
J	Clifton, JD; Lucumi, E; Myers, MC; Napper, A; Hama, K; Farber, SA; Smith, AB; Huryn, DM; Diamond, SL; Pack, M				Clifton, Justin D.; Lucumi, Edinson; Myers, Michael C.; Napper, Andrew; Hama, Kotaro; Farber, Steven A.; Smith, Amos B., III; Huryn, Donna M.; Diamond, Scott L.; Pack, Michael			Identification of Novel Inhibitors of Dietary Lipid Absorption Using Zebrafish	PLOS ONE			English	Article							SMALL MOLECULES; OBESE-PATIENTS; EZETIMIBE; CHOLESTEROL; GENE; PROTEIN; CHOLECYSTOKININ; COMBINATION; ORLISTAT; NPC1L1	Pharmacological inhibition of dietary lipid absorption induces favorable changes in serum lipoprotein levels in patients that are at risk for cardiovascular disease and is considered an adjuvant or alternative treatment with HMG-CoA reductase inhibitors (statins). Here we demonstrate the feasibility of identifying novel inhibitors of intestinal lipid absorption using the zebrafish system. A pilot screen of an unbiased chemical library identified novel compounds that inhibited processing of fluorescent lipid analogues in live zebrafish larvae. Secondary assays identified those compounds suitable for testing in mammals and provided insight into mechanism of action, which for several compounds could be distinguished from ezetimibe, a drug used to inhibit cholesterol absorption in humans that broadly inhibited lipid absorption in zebrafish larvae. These findings support the utility of zebrafish screening assays to identify novel compounds that target complex physiological processes.	[Clifton, Justin D.; Pack, Michael] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Lucumi, Edinson; Smith, Amos B., III; Huryn, Donna M.; Diamond, Scott L.] Univ Penn, Inst Med & Engn, Penn Ctr Mol Discovery, Philadelphia, PA 19104 USA; [Myers, Michael C.; Napper, Andrew; Smith, Amos B., III; Huryn, Donna M.; Diamond, Scott L.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Hama, Kotaro; Farber, Steven A.] Carnegie Inst, Dept Embryol, Baltimore, MD USA; [Pack, Michael] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Carnegie Institution for Science; University of Pennsylvania	Clifton, JD (corresponding author), Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA.	mpack@mail.med.upenn.edu	Clifton, Justin/ABG-5610-2021; Farber, Steven A/G-5851-2012	Farber, Steven A/0000-0002-8037-7312; Huryn, Donna/0000-0001-5542-4968; Clifton, Justin David/0000-0001-9664-107X	National Institutes of Health; National Human Genome Research Institute [HG003915]; National Institute of Diabetes, Digestive and Kidney Diseases [DK54942]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK054942, R01DK054942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the National Institutes of Health. This includes the National Human Genome Research Institute (grant HG003915) and the National Institute of Diabetes, Digestive and Kidney Diseases (grant DK54942). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Athyros VG, 2008, AM J CARDIOL, V101, P483, DOI 10.1016/j.amjcard.2007.09.096; Bayliss PE, 2006, NAT CHEM BIOL, V2, P265, DOI 10.1038/nchembio778; Beaslas O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004278; Brown BG, 2008, NEW ENGL J MED, V358, P1504, DOI 10.1056/NEJMe0801608; Burns CG, 2005, NAT CHEM BIOL, V1, P263, DOI 10.1038/nchembio732; Cheng ZJ, 2001, J BIOL CHEM, V276, P48040, DOI 10.1074/jbc.M105668200; Davies JP, 2006, CURR OPIN LIPIDOL, V17, P221, DOI 10.1097/01.mol.0000226112.12684.5e; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Dujovne CA, 2002, AM J CARDIOL, V90, P1092, DOI 10.1016/S0002-9149(02)02798-4; Esengil H, 2007, NAT CHEM BIOL, V3, P154, DOI 10.1038/nchembio858; Farber SA, 2001, SCIENCE, V292, P1385, DOI 10.1126/science.1060418; FARELL JJ, 2006, SLEISENGER FORDTRANS, P2150; Fazio S, 2010, AM J CARDIOL, V105, P487, DOI 10.1016/j.amjcard.2009.10.001; Field FJ, 2007, J LIPID RES, V48, P1735, DOI 10.1194/jlr.M700029-JLR200; Field SK, 2003, CHEST, V124, P1482, DOI 10.1378/chest.124.4.1482; Gaffield MA, 2006, NAT PROTOC, V1, P2916, DOI 10.1038/nprot.2006.476; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Guerciolini R, 1997, INT J OBESITY, V21, pS12; Hama K, 2009, AM J PHYSIOL-GASTR L, V296, pG445, DOI 10.1152/ajpgi.90513.2008; Hawes BE, 2007, MOL PHARMACOL, V71, P19, DOI 10.1124/mol.106.027896; Jones SC, 2008, DRUG ALCOHOL REV, V27, P5, DOI 10.1080/09595230701710787; Kadereit B, 2008, P NATL ACAD SCI USA, V105, P94, DOI 10.1073/pnas.0708579105; Kampf JP, 2007, PHYSIOLOGY, V22, P7, DOI 10.1152/physiol.00011.2006; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Kiortsis DN, 2005, DIABETES METAB, V31, P15, DOI 10.1016/S1262-3636(07)70161-1; Labonte ED, 2008, AM J PHYSIOL-GASTR L, V295, pG776, DOI 10.1152/ajpgi.90275.2008; Liu YJ, 2008, J HUM GENET, V53, P709, DOI 10.1007/s10038-008-0302-2; Matthews RP, 2005, DEVELOPMENT, V132, P5295, DOI 10.1242/dev.02140; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Miller LJ, 2007, CURR TOP MED CHEM, V7, P1166; Mitka M, 2010, JAMA-J AM MED ASSOC, V303, P211, DOI 10.1001/jama.2009.1915; Nakou ES, 2008, CURR MED RES OPIN, V24, P1919, DOI [10.1185/03007990802177150, 10.1185/03007990802177150 ]; Nakou ES, 2008, EXPERT OPIN PHARMACO, V9, P3151, DOI 10.1517/14656560802548430 ; Ostrom Rennolds S., 2007, V400, P459; Parizhskaya M, 2001, J PEDIATR-US, V138, P574, DOI 10.1067/mpd.2001.111327; Perez-Martinez P, 2004, J MOL ENDOCRINOL, V32, P237, DOI 10.1677/jme.0.0320237; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Schlegel A, 2006, BIOCHEMISTRY-US, V45, P15179, DOI 10.1021/bi0619268; SHERIDAN MA, 1986, COMP BIOCH PHYSL B, V90, P679; Shestopalov IA, 2007, NAT CHEM BIOL, V3, P650, DOI 10.1038/nchembio.2007.30; Stern HM, 2005, NAT CHEM BIOL, V1, P366, DOI 10.1038/nchembio749; Tanaka T, 2007, J NUTR, V137, P578, DOI 10.1093/jn/137.3.578; Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9; Weinglass AB, 2008, P NATL ACAD SCI USA, V105, P11140, DOI 10.1073/pnas.0800936105; Yamaoka-Tojo M, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-41; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	50	65	66	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12386	10.1371/journal.pone.0012386	http://dx.doi.org/10.1371/journal.pone.0012386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811635	Green Published, Green Submitted, gold			2022-12-27	WOS:000281234700014
J	Tang, XX; Chen, H; Yu, S; Zhang, L; Caplan, MJ; Chan, HC				Tang, Xiao Xiao; Chen, Hao; Yu, Sidney; Zhang, Li; Caplan, Michael J.; Chan, Hsiao Chang			Lymphocytes Accelerate Epithelial Tight Junction Assembly: Role of AMP-Activated Protein Kinase (AMPK)	PLOS ONE			English	Article							CELLS; BARRIER	The tight junctions (TJs), characteristically located at the apicolateral borders of adjacent epithelial cells, are required for the proper formation of epithelial cell polarity as well as for sustaining the mucosal barrier to the external environment. The observation that lymphocytes are recruited by epithelial cells to the sites of infection [1] suggests that they may play a role in the modulation of epithelial barrier function and thus contribute to host defense. To test the ability of lymphocytes to modulate tight junction assembly in epithelial cells, we set up a lymphocyte-epithelial cell co-culture system, in which Madin-Darby canine kidney (MDCK) cells, a well-established model cell line for studying epithelial TJ assembly [2], were co-cultured with mouse lymphocytes to mimic an infection state. In a typical calcium switch experiment, the TJ assembly in co-culture was found to be accelerated compared to that in MDCK cells alone. This accelaration was found to be mediated by AMP-activated protein kinase (AMPK). AMPK activation was independent of changes in cellular ATP levels but it was found to be activated by the pro-inflammatory cytokine TNF-alpha. Forced suppression of AMPK, either with a chemical inhibitor or by knockdown, abrogated the accelerating effect of lymphocytes on TJ formation. Similar results were also observed in a co-culture with lymphocytes and Calu-3 human airway epithelial cells, suggesting that the activation of AMPK may be a general mechanism underlying lymphocyte-accelerated TJ assembly in different epithelia. These results suggest that signals from lymphocytes, such as cytokines, facilitate TJ assembly in epithelial cells via the activation of AMPK.	[Tang, Xiao Xiao; Chen, Hao; Yu, Sidney; Chan, Hsiao Chang] Chinese Univ Hong Kong, Epithelial Cell Biol Res Ctr, Sch Biomed Sci, Fac Med, Shatin, Hong Kong, Peoples R China; [Zhang, Li; Caplan, Michael J.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT USA; [Chan, Hsiao Chang] Minist Educ China, Key Lab Regenerat Med, Guangzhou, Guangdong, Peoples R China	Chinese University of Hong Kong; Yale University; Ministry of Education, China	Tang, XX (corresponding author), Chinese Univ Hong Kong, Epithelial Cell Biol Res Ctr, Sch Biomed Sci, Fac Med, Shatin, Hong Kong, Peoples R China.	michael.caplan@yale.edu; hsiaocchan@cuhk.edu.hk	Chan, Hsiao Chang/E-1507-2016; Chen, Hao/D-3425-2012; Bin Sidney Yu, Siu/R-4936-2018; Zhang, Li/N-3674-2013; Chen, Hao/AAH-4124-2020	Chen, Hao/0000-0001-8319-8101; Bin Sidney Yu, Siu/0000-0001-9643-2729; Chen, Hao/0000-0001-8319-8101; Caplan, Michael/0000-0001-5768-4405	National 973 project [2009CB522102]; National Institutes of Health [DK17433]; Global Scholarship Program for Research Excellence; Focused Investment Scheme of The Chinese University of Hong Kong; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK017433, R01DK072614] Funding Source: NIH RePORTER	National 973 project(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Global Scholarship Program for Research Excellence; Focused Investment Scheme of The Chinese University of Hong Kong(Chinese University of Hong Kong); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National 973 project (No. 2009CB522102), National Institutes of Health grant (DK17433 MJC), Global Scholarship Program for Research Excellence and the Focused Investment Scheme of The Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenman JE, 2007, CELL CYCLE, V6, P2755, DOI 10.4161/cc.6.22.4927; CEREIJIDO M, 1978, J CELL BIOL, V77, P853, DOI 10.1083/jcb.77.3.853; Chen J, 2004, WORLD J GASTROENTERO, V10, P1594, DOI 10.3748/wjg.v10.i11.1594; Chen ML, 2002, J BIOL CHEM, V277, P4247, DOI 10.1074/jbc.M109254200; CONTRERAS RG, 1992, AM J PHYSIOL, V263, P313; Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1, DOI 10.1152/ajprenal.1998.274.1.F1; GONZALEZMARISCAL L, 1990, AM J PHYSIOL, V259, pC978, DOI 10.1152/ajpcell.1990.259.6.C978; GUMBINER B, 1986, J CELL BIOL, V102, P457, DOI 10.1083/jcb.102.2.457; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Herard AL, 1996, AM J RESP CELL MOL, V15, P624, DOI 10.1165/ajrcmb.15.5.8918369; Ho LS, 2006, CELL BIOL INT, V30, P977, DOI 10.1016/j.cellbi.2006.07.004; HO LS, 2010, CELL BIOL I IN PRESS; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Nava P, 2004, J CELL SCI, V117, P5509, DOI 10.1242/jcs.01425; ROBBINS RA, 1989, AM J PHYSIOL, V257, pL109, DOI 10.1152/ajplung.1989.257.2.L109; Sanz P, 2008, CURR PROTEIN PEPT SC, V9, P478, DOI 10.2174/138920308785915254; Steinberg GR, 2009, FRONT BIOSCI-LANDMRK, V14, P1902, DOI 10.2741/3350; Su RY, 2007, MOL CANCER THER, V6, P1562, DOI 10.1158/1535-7163.MCT-06-0800; Utech M, 2005, MOL BIOL CELL, V16, P5040, DOI 10.1091/mbc.E05-03-0193; Zhang L, 2006, P NATL ACAD SCI USA, V103, P17272, DOI 10.1073/pnas.0608531103; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104	23	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12343	10.1371/journal.pone.0012343	http://dx.doi.org/10.1371/journal.pone.0012343			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808811	Green Published, Green Submitted, gold			2022-12-27	WOS:000281153500023
J	Rajasekaran, S; Mi, TA; Merlin, JC; Oommen, A; Gradie, P; Schiller, MR				Rajasekaran, Sanguthevar; Mi, Tian; Merlin, Jerlin Camilus; Oommen, Aaron; Gradie, Patrick; Schiller, Martin R.			Partitioning of Minimotifs Based on Function with Improved Prediction Accuracy	PLOS ONE			English	Article							WIDE PREDICTION; MINER; TOOL	Background: Minimotifs are short contiguous peptide sequences in proteins that are known to have a function in at least one other protein. One of the principal limitations in minimotif prediction is that false positives limit the usefulness of this approach. As a step toward resolving this problem we have built, implemented, and tested a new data-driven algorithm that reduces false-positive predictions. Methodology/Principal Findings: Certain domains and minimotifs are known to be strongly associated with a known cellular process or molecular function. Therefore, we hypothesized that by restricting minimotif predictions to those where the minimotif containing protein and target protein have a related cellular or molecular function, the prediction is more likely to be accurate. This filter was implemented in Minimotif Miner using function annotations from the Gene Ontology. We have also combined two filters that are based on entirely different principles and this combined filter has a better predictability than the individual components. Conclusions/Significance: Testing these functional filters on known and random minimotifs has revealed that they are capable of separating true motifs from false positives. In particular, for the cellular function filter, the percentage of known minimotifs that are not removed by the filter is similar to 4.6 times that of random minimotifs. For the molecular function filter this ratio is similar to 2.9. These results, together with the comparison with the published frequency score filter, strongly suggest that the new filters differentiate true motifs from random background with good confidence. A combination of the function filters and the frequency score filter performs better than these two individual filters.	[Rajasekaran, Sanguthevar; Mi, Tian; Merlin, Jerlin Camilus; Oommen, Aaron] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA; [Gradie, Patrick; Schiller, Martin R.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA	University of Connecticut; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Rajasekaran, S (corresponding author), Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA.	rajasek@engr.uconn.edu; martin.schiller@unlv.edu		Schiller, Martin R/0000-0003-1671-6823	National Institutes of Health [GM079689]; National Science Foundation (NSF) [0829916]; University of Nevada Las Vegas; University of Connecticut; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079689] Funding Source: NIH RePORTER; Division of Computing and Communication Foundations [0829916] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); University of Nevada Las Vegas; University of Connecticut; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by National Institutes of Health grant number GM079689 to M.R.S., National Science Foundation (NSF) Grant 0829916 to S.R., by the University of Nevada Las Vegas, and by the University of Connecticut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; R Core Team, 2020, R LANG ENV STAT COMP; Rajasekaran S, 2009, NUCLEIC ACIDS RES, V37, pD185, DOI 10.1093/nar/gkn865; Rodriguez MC, 2008, FRONT BIOSCI-LANDMRK, V13, P5905, DOI 10.2741/3125; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Via A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-351; Vyas J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-360; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yaffe MB, 2000, METHOD ENZYMOL, V328, P157, DOI 10.1016/S0076-6879(00)28397-3; Zhou SY, 1998, METH MOL B, V87, P87	15	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12276	10.1371/journal.pone.0012276	http://dx.doi.org/10.1371/journal.pone.0012276			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808856	Green Published, gold			2022-12-27	WOS:000281075500011
J	Chen, JHK; Wong, KH; Chen, ZW; Chan, K; Lam, HY; To, SWC; Cheng, VCC; Yuen, KY; Yam, WC				Chen, Jonathan Hon-Kwan; Wong, Ka-Hing; Chen, Zhiwei; Chan, Kenny; Lam, Ho-Yin; To, Sabrina Wai-Chi; Cheng, Vincent Chi-Chung; Yuen, Kwok-Yung; Yam, Wing-Cheong			Increased Genetic Diversity of HIV-1 Circulating in Hong Kong	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; DRUG-USERS; SUBTYPE-B; CRF01-AE; INFECTION; ACCURACY	HIV-1 group M strains are characterized into 9 pure subtypes and 48 circulating recombinant forms (CRFs). Recent studies have identified the presence of new HIV-1 recombinants in Hong Kong and their complexity continues to increase. This study aims to characterize the HIV-1 genetic diversity in Hong Kong. Phylogenetic analyses were performed by using HIV-1 pol sequences including protease and partial reverse transcriptase isolated from 1045 local patients in Hong Kong from 2003 to 2008. For the pol sequences with unassigned genotype, the evidence of recombination was determined by using sliding-window based bootscan plots and their env C2V3 region were also sequenced. Epidemiological background of these patients was further collected. The pol phylogenetic analyses highlighted the extent of HIV-1 genetic diversity in Hong Kong. Subtype B (450/1045; 43.1%) and CRF01_AE (469/1045; 44.9%) variants were clearly predominant. Other genotypes (126/1045; 12.1%) including 3 defined subtypes, 10 CRFs, 1 unassigned subtype and 33 recombinants with 11 different mosaic patterns were observed. Recombinants of subtype B and CRF01_AE were mainly found among local Chinese MSM throughout 2004 to 2008, while the CRF02_AG and subtype G recombinants were circulating among non-Chinese Asian population in Hong Kong through heterosexual transmission starting from 2008. Our study demonstrated the complex recombination of HIV-1 in Hong Kong and the need in developing surveillance system for tracking the distribution of new HIV-1 genetic variants.	[Chen, Jonathan Hon-Kwan; Lam, Ho-Yin; To, Sabrina Wai-Chi; Cheng, Vincent Chi-Chung; Yuen, Kwok-Yung; Yam, Wing-Cheong] Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Chen, Jonathan Hon-Kwan; Chen, Zhiwei] Univ Hong Kong, AIDS Inst, Hong Kong, Hong Kong, Peoples R China; [Wong, Ka-Hing; Chan, Kenny] Ctr Hlth Protect, Special Prevent Programme, Integrated Treatment Ctr, Dept Hlth, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Chen, JHK (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	wcyam@hkucc.hku.hk	Chen, Zhiwei/B-7793-2019	Chen, Zhiwei/0000-0002-4511-2888; CHENG, Vincent Chi-Chung/0000-0003-1765-7706; Yuen, Kwok-yung/0000-0002-2083-1552	Hong Kong Special Administrative Region Government [MSS-155R, MSS-164R]	Hong Kong Special Administrative Region Government	The study was supported by the AIDS Trust Fund of Hong Kong Special Administrative Region Government (Grant MSS-155R and MSS-164R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen JHK, 2008, AIDS RES HUM RETROV, V24, P537, DOI 10.1089/aid.2007.0231; Chen JHK, 2007, J CLIN VIROL, V39, P125, DOI 10.1016/j.jcv.2007.03.008; Chen JHK, 2009, JAIDS-J ACQ IMM DEF, V51, P530, DOI 10.1097/QAI.0b013e3181aac516; Chen YJ, 2010, JAIDS-J ACQ IMM DEF, V53, P425, DOI 10.1097/QAI.0b013e3181ccba1a; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gueudin M, 2007, JAIDS-J ACQ IMM DEF, V44, P500, DOI 10.1097/QAI.0b013e31803260df; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Leitner T, 2005, HIV 1 SUBTYPE CIRCUL; Leung TWC, 2008, AIDS RES HUM RETROV, V24, P903, DOI 10.1089/aid.2007.0272; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; McCutchan FE, 2006, J MED VIROL, V78, pS7, DOI 10.1002/jmv.20599; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Thomson MM, 2005, AIDS REV, V7, P210; Xiridou M, 2007, JAIDS-J ACQ IMM DEF, V45, P468, DOI 10.1097/QAI.0b013e318093dea5; Zhang X, 2006, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2005/01/003	17	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12198	10.1371/journal.pone.0012198	http://dx.doi.org/10.1371/journal.pone.0012198			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808942	Green Published, gold			2022-12-27	WOS:000280968000022
J	De Franchi, E; Schalon, C; Messa, M; Onofri, F; Benfenati, F; Rognan, D				De Franchi, Enrico; Schalon, Claire; Messa, Mirko; Onofri, Franco; Benfenati, Fabio; Rognan, Didier			Binding of Protein Kinase Inhibitors to Synapsin I Inferred from Pair-Wise Binding Site Similarity Measurements	PLOS ONE			English	Article							SILICO PHARMACOLOGY; STRUCTURAL GENOMICS; DRUG DISCOVERY; ATP-BINDING; PHOSPHORYLATION; TARGETS; ACTIN; IDENTIFICATION; DOCKING; ROSCOVITINE	Predicting off-targets by computational methods is getting increasing importance in early drug discovery stages. We herewith present a computational method based on binding site three-dimensional comparisons, which prompted us to investigate the cross-reaction of protein kinase inhibitors with synapsin I, an ATP-binding protein regulating neurotransmitter release in the synapse. Systematic pair-wise comparison of the staurosporine-binding site of the protooncogene Pim-1 kinase with 6,412 druggable protein-ligand binding sites suggested that the ATP-binding site of synapsin I may recognize the pan-kinase inhibitor staurosporine. Biochemical validation of this hypothesis was realized by competition experiments of staurosporine with ATP-gamma S-35 for binding to synapsin I. Staurosporine, as well as three other inhibitors of protein kinases (cdk2, Pim-1 and casein kinase type 2), effectively bound to synapsin I with nanomolar affinities and promoted synapsin-induced F-actin bundling. The selective Pim-1 kinase inhibitor quercetagetin was shown to be the most potent synapsin I binder (IC50 = 0.15 mu M), in agreement with the predicted binding site similarities between synapsin I and various protein kinases. Other protein kinase inhibitors (protein kinase A and chk1 inhibitor), kinase inhibitors (diacylglycerolkinase inhibitor) and various other ATP-competitors (DNA topoisomerase II and HSP-90 alpha inhibitors) did not bind to synapsin I, as predicted from a lower similarity of their respective ATP-binding sites to that of synapsin I. The present data suggest that the observed downregulation of neurotransmitter release by some but not all protein kinase inhibitors may also be contributed by a direct binding to synapsin I and phosphorylation-independent perturbation of synapsin I function. More generally, the data also demonstrate that cross-reactivity with various targets may be detected by systematic pair-wise similarity measurement of ligand-annotated binding sites.	[De Franchi, Enrico; Messa, Mirko; Benfenati, Fabio] Italian Inst Technol, Dept Neurosci & Brain Technol, Genoa, Italy; [Schalon, Claire; Rognan, Didier] Univ Strasbourg, Lab Therapeut Innovat, CNRS, UMR 7200, Illkirch Graffenstaden, France; [Onofri, Franco; Benfenati, Fabio] Univ Genoa, Dept Expt Med, Genoa, Italy; [Onofri, Franco; Benfenati, Fabio] Ist Nazl Neurosci, Genoa, Italy	Istituto Italiano di Tecnologia - IIT; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Genoa	De Franchi, E (corresponding author), Italian Inst Technol, Dept Neurosci & Brain Technol, Genoa, Italy.	rognan@unistra.fr	Rognan, Didier/B-9939-2014		French Ministry of Research and Technology; Ministry of the University and Research; Compagnia di San Paolo Torino; Telethon-Italy [GCP09134]	French Ministry of Research and Technology; Ministry of the University and Research(Ministry of Education, Universities and Research (MIUR)); Compagnia di San Paolo Torino(Compagnia di San Paolo); Telethon-Italy(Fondazione Telethon)	The project was supported by the French Ministry of Research and Technology (Ph.D. grant to C. S.), the Ministry of the University and Research (PRIN 2008 grant), The Compagnia di San Paolo Torino and Telethon-Italy (GCP09134 grant to F. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ACC LTD, PIP PIL V7 5; Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; BAHLER M, 1987, NATURE, V326, P704, DOI 10.1038/326704a0; BAHLER M, 1989, J CELL BIOL, V108, P1841, DOI 10.1083/jcb.108.5.1841; Bajorath J, 2008, CURR OPIN CHEM BIOL, V12, P352, DOI 10.1016/j.cbpa.2008.01.044; BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; BENFENATI F, 1992, NEURON, V8, P377, DOI 10.1016/0896-6273(92)90303-U; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonanomi D, 2005, J NEUROSCI, V25, P7299, DOI 10.1523/JNEUROSCI.1573-05.2005; Brautigam CA, 2004, J BIOL CHEM, V279, P11948, DOI 10.1074/jbc.M312015200; Brehmer D, 2005, CANCER RES, V65, P379; Cai JH, 2006, PROTEIN SCI, V15, P2071, DOI 10.1110/ps.062238406; Caron PR, 2001, CURR OPIN CHEM BIOL, V5, P464, DOI 10.1016/S1367-5931(00)00229-5; CECCALDI PE, 1995, J CELL BIOL, V128, P905, DOI 10.1083/jcb.128.5.905; *CHEMAXON KFT, 1037 CHEMAXON KFT; Chen YZ, 2001, PROTEINS, V43, P217, DOI 10.1002/1097-0134(20010501)43:2<217::AID-PROT1032>3.0.CO;2-G; Chi P, 2003, NEURON, V38, P69, DOI 10.1016/S0896-6273(03)00151-X; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; Dessailly BH, 2009, STRUCTURE, V17, P869, DOI 10.1016/j.str.2009.03.015; Do Quoc-Tuan, 2005, Curr Drug Discov Technol, V2, P161, DOI 10.2174/1570163054866873; Durrant JD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000648; Ekins S, 2007, BRIT J PHARMACOL, V152, P9, DOI 10.1038/sj.bjp.0707305; Esser L, 1998, EMBO J, V17, P977, DOI 10.1093/emboj/17.4.977; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fdez E, 2006, BRAIN CELL BIOL, V35, P107, DOI 10.1007/s11068-007-9013-4; Ferrara P, 2004, J MED CHEM, V47, P3032, DOI 10.1021/jm030489h; Gold ND, 2006, J MOL BIOL, V355, P1112, DOI 10.1016/j.jmb.2005.11.044; Grant S, 2009, CELL MOL LIFE SCI, V66, P1163, DOI 10.1007/s00018-008-8539-7; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Hilfiker S, 2005, J NEUROSCI, V25, P2658, DOI 10.1523/JNEUROSCI.4278-04.2005; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hosaka M, 1999, J BIOL CHEM, V274, P16747, DOI 10.1074/jbc.274.24.16747; Hosaka M, 1998, J BIOL CHEM, V273, P13371, DOI 10.1074/jbc.273.22.13371; Hosaka M, 1998, J BIOL CHEM, V273, P1425, DOI 10.1074/jbc.273.3.1425; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Jovanovic JN, 2001, J NEUROSCI, V21, P7944, DOI 10.1523/JNEUROSCI.21-20-07944.2001; Kao HT, 1999, J EXP ZOOL, V285, P360, DOI 10.1002/(SICI)1097-010X(19991215)285:4<360::AID-JEZ4>3.3.CO;2-V; Kao HT, 2002, NAT NEUROSCI, V5, P431, DOI 10.1038/nn840; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kellenberger E, 2006, J CHEM INF MODEL, V46, P717, DOI 10.1021/ci050372x; Kellenberger E, 2008, CURR COMPUT-AID DRUG, V4, P209, DOI 10.2174/157340908785747401; Kellenberger E, 2008, J CHEM INF MODEL, V48, P1014, DOI 10.1021/ci800023x; Kinnings SL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000423; Klabunde T, 2005, CHEMBIOCHEM, V6, P876, DOI 10.1002/cbic.200400369; Knockaert M, 2002, J BIOL CHEM, V277, P25493, DOI 10.1074/jbc.M202651200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lane-Guermonprez L, 2005, J NEUROCHEM, V93, P1401, DOI 10.1111/j.1471-4159.2005.03125.x; Li HL, 2006, NUCLEIC ACIDS RES, V34, pW219, DOI 10.1093/nar/gkl114; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martin YC, 2002, J MED CHEM, V45, P4350, DOI 10.1021/jm020155c; MCGUINNESS TL, 1985, J BIOL CHEM, V260, P1696; Menegon A, 2006, J NEUROSCI, V26, P11670, DOI 10.1523/JNEUROSCI.3321-06.2006; Mestres J, 2006, J CHEM INF MODEL, V46, P2725, DOI 10.1021/ci600300k; *MOL NETW GMBH, D91052 MOL NETW GMBH; Morton D, 2009, ANGEW CHEM INT EDIT, V48, P104, DOI 10.1002/anie.200804486; Muller P, 2006, J MED CHEM, V49, P6768, DOI 10.1021/jm0606589; Nair Rajesh, 2009, Journal of Structural and Functional Genomics, V10, P181, DOI 10.1007/s10969-008-9055-6; Nettles JH, 2006, J MED CHEM, V49, P6802, DOI 10.1021/jm060902w; Nidhi, 2006, J CHEM INF MODEL, V46, P1124, DOI 10.1021/ci060003g; Nielsen TE, 2008, ANGEW CHEM INT EDIT, V47, P48, DOI 10.1002/anie.200703073; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Onofri F, 2007, J BIOL CHEM, V282, P15754, DOI 10.1074/jbc.M701051200; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Paul N, 2004, PROTEINS, V54, P671, DOI 10.1002/prot.10625; Peltason L, 2007, J MED CHEM, V50, P5571, DOI 10.1021/jm0705713; Rognan D, 2007, BRIT J PHARMACOL, V152, P38, DOI 10.1038/sj.bjp.0707307; Rognan D, 2010, MOL INFORM, V29, P176, DOI 10.1002/minf.200900081; Sakurada K, 2002, J BIOL CHEM, V277, P45473, DOI 10.1074/jbc.M206673200; Schalon C, 2008, PROTEINS, V71, P1755, DOI 10.1002/prot.21858; Schneider M, 2009, J PROTEOMICS, V72, P567, DOI 10.1016/j.jprot.2008.11.010; Schuster D, 2005, CURR PHARM DESIGN, V11, P3545, DOI 10.2174/138161205774414510; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Shoshan MC, 2008, EXPERT OPIN DRUG MET, V4, P273, DOI [10.1517/17425255.4.3.273, 10.1517/17425255.4.3.273 ]; Shulman-Peleg A, 2004, J MOL BIOL, V339, P607, DOI 10.1016/j.jmb.2004.04.012; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stauch B, 2009, P NATL ACAD SCI USA, V106, P12079, DOI 10.1073/pnas.0900979106; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; Tang L, 2005, J BIOL CHEM, V280, P31220, DOI 10.1074/jbc.M500805200; Triballeau N, 2005, J MED CHEM, V48, P2534, DOI 10.1021/jm049092j; VALTORTA F, 1992, J BIOL CHEM, V267, P11281; Wallach I, 2009, BIOINFORMATICS, V25, pI296, DOI 10.1093/bioinformatics/btp204; Wang RX, 2004, J MED CHEM, V47, P2977, DOI 10.1021/jm030580l; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Weill N, 2010, J CHEM INF MODEL, V50, P123, DOI 10.1021/ci900349y; Weisel M, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-7; Wermuth CG, 2006, DRUG DISCOV TODAY, V11, P348, DOI 10.1016/j.drudis.2006.02.006; Xie L, 2007, PLOS COMPUT BIOL, V3, P2324, DOI 10.1371/journal.pcbi.0030217; Xie L, 2008, P NATL ACAD SCI USA, V105, P5441, DOI 10.1073/pnas.0704422105; Yang L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000441; Yeturu K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-543; Zahler S, 2007, CHEM BIOL, V14, P1207, DOI 10.1016/j.chembiol.2007.10.010	95	65	67	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12214	10.1371/journal.pone.0012214	http://dx.doi.org/10.1371/journal.pone.0012214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808948	gold, Green Published, Green Submitted			2022-12-27	WOS:000280968000029
J	Dvorak-Ewell, M; Wendt, D; Hague, C; Christianson, T; Koppaka, V; Crippen, D; Kakkis, E; Vellard, M				Dvorak-Ewell, Melita; Wendt, Dan; Hague, Chuck; Christianson, Terri; Koppaka, Vish; Crippen, Danielle; Kakkis, Emil; Vellard, Michel			Enzyme Replacement in a Human Model of Mucopolysaccharidosis IVA In Vitro and Its Biodistribution in the Cartilage of Wild Type Mice	PLOS ONE			English	Article							N-ACETYLGALACTOSAMINE-6-SULFATE SULFATASE; MORQUIO-SYNDROME; KERATAN SULFATE; MATRIX COMPONENTS; MURINE MODEL; MPS IVA; DISEASE; DEFICIENCY; GENE; PURIFICATION	Mucopolysaccharidosis IVA (MPS IVA; Morquio A syndrome) is a lysosomal storage disorder caused by deficiency of N-acetylgalactosamine-6-sulfatase (GALNS), an enzyme that degrades keratan sulfate (KS). Currently no therapy for MPS IVA is available. We produced recombinant human (rh) GALNS as a potential enzyme replacement therapy for MPS IVA. Chinese hamster ovary cells stably overexpressing GALNS and sulfatase modifying factor-1 were used to produce active (similar to 2 U/mg) and pure (>= 97%) rhGALNS. The recombinant enzyme was phosphorylated and was dose-dependently taken up by mannose-6-phosphate receptor (K-uptake = 2.5 nM), thereby restoring enzyme activity in MPS IVA fibroblasts. In the absence of an animal model with a skeletal phenotype, we established chondrocytes isolated from two MPS IVA patients as a disease model in vitro. MPS IVA chondrocyte GALNS activity was not detectable and the cells exhibited KS storage up to 11-fold higher than unaffected chondrocytes. MPS IVA chondrocytes internalized rhGALNS into lysosomes, resulting in normalization of enzyme activity and decrease in KS storage. rhGALNS treatment also modulated gene expression, increasing expression of chondrogenic genes Collagen II, Collagen X, Aggrecan and Sox9 and decreasing abnormal expression of Collagen I. Intravenous administration of rhGALNS resulted in biodistribution throughout all layers of the heart valve and the entire thickness of the growth plate in wild-type mice. We show that enzyme replacement therapy with recombinant human GALNS results in clearance of keratan sulfate accumulation, and that such treatment ameliorates aberrant gene expression in human chondrocytes in vitro. Penetration of the therapeutic enzyme throughout poorly vascularized, but clinically relevant tissues, including growth plate cartilage and heart valve, as well as macrophages and hepatocytes in wild-type mouse, further supports development of rhGALNS as enzyme replacement therapy for MPS IVA.	[Dvorak-Ewell, Melita; Wendt, Dan; Hague, Chuck; Christianson, Terri; Koppaka, Vish; Kakkis, Emil; Vellard, Michel] BioMarin Pharmaceut Inc, Novato, CA USA; [Crippen, Danielle] Buck Inst, Novato, CA USA	BioMarin Pharmaceutical Inc.; Buck Institute for Research on Aging	Dvorak-Ewell, M (corresponding author), BioMarin Pharmaceut Inc, Novato, CA USA.	mvellard@bmrn.com			BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.	This study was funded by BioMarin Pharmaceutical Inc. the employer of all the authors except DC. The described study was a part of the drug development program at BioMarin. The internal publication review committee approved the manuscript for publication.	ANDERSON CE, 1962, J BONE JOINT SURG AM, V44, P295, DOI 10.2106/00004623-196244020-00006; Bank RA, 2009, MOL GENET METAB, V97, P196, DOI 10.1016/j.ymgme.2009.03.008; Beck M, 2001, J INHERIT METAB DIS, V24, P47, DOI 10.1023/A:1012463605992; BIELICKI J, 1995, BIOCHEM J, V311, P333, DOI 10.1042/bj3110333; Castaneda JA, 2008, ACTA NEUROPATHOL, V115, P159, DOI 10.1007/s00401-007-0296-4; CHAN D, 1995, J BIOL CHEM, V270, P1747, DOI 10.1074/jbc.270.4.1747; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; Dangel JH, 1998, EUR J PEDIATR, V157, P534, DOI 10.1007/s004310050872; De Franceschi L, 2007, OSTEOARTHR CARTILAGE, V15, P1311, DOI 10.1016/j.joca.2007.04.008; ELIMA K, 1989, FEBS LETT, V258, P195, DOI 10.1016/0014-5793(89)81651-5; ENGFELDT B, 1982, ACTA PAEDIATR SCAND, V71, P353, DOI 10.1111/j.1651-2227.1982.tb09434.x; FACTOR SM, 1978, VIRCHOWS ARCH A, V379, P1, DOI 10.1007/BF00432778; Fraldi A, 2007, BIOCHEM J, V403, P305, DOI 10.1042/BJ20061783; Funderburgh ML, 2008, MOL VIS, V14, P308; Gagne TA, 2000, J ORTHOPAED RES, V18, P882, DOI 10.1002/jor.1100180606; Goldring MB, 2006, BEST PRACT RES CL RH, V20, P1003, DOI 10.1016/j.berh.2006.06.003; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Grande-Allen KJ, 2004, GLYCOBIOLOGY, V14, P621, DOI 10.1093/glycob/cwh076; HAMMON JW, 1974, J THORAC CARDIOV SUR, V68, P352; HOLLISTER DW, 1975, JOHNS HOPKINS MED J, V137, P176; JOHN RM, 1990, ARCH DIS CHILD, V65, P746, DOI 10.1136/adc.65.7.746; Kakkis ED, 2002, EXPERT OPIN INV DRUG, V11, P675, DOI 10.1517/13543784.11.5.675; Landgrebe J, 2003, GENE, V316, P47, DOI 10.1016/S0378-1119(03)00746-7; MARODI L, 1995, BLOOD, V86, P4645, DOI 10.1182/blood.V86.12.4645.bloodjournal86124645; MASUE M, 1991, J BIOCHEM-TOKYO, V110, P965, DOI 10.1093/oxfordjournals.jbchem.a123697; MCCLURE J, 1986, PATHOLOGY, V18, P217, DOI 10.3109/00313028609059462; Melching LI, 1999, MATRIX BIOL, V18, P381, DOI 10.1016/S0945-053X(99)00033-5; MINAMI R, 1979, CLIN CHIM ACTA, V93, P207; MINAMI R, 1983, TOHOKU J EXP MED, V139, P321, DOI 10.1620/tjem.139.321; Montano AM, 2007, J INHERIT METAB DIS, V30, P165, DOI 10.1007/s10545-007-0529-7; MONTANO AM, 2008, IMPLICATIONS ABSENCE; Mundlos S, 1997, FASEB J, V11, P227, DOI 10.1096/fasebj.11.4.9068611; NEUFELD EF, 1995, METABOLIC MOL BASIS; Northover H, 1996, J INHERIT METAB DIS, V19, P357, DOI 10.1007/BF01799267; Peters C, 2003, BONE MARROW TRANSPL, V31, P229, DOI 10.1038/sj.bmt.1703839; SHIM SS, 1986, CLIN ORTHOP RELAT R, P119; STEVENS JM, 1991, J BONE JOINT SURG BR, V73, P851, DOI 10.1302/0301-620X.73B5.1910048; Tomatsu S, 2005, HUM MOL GENET, V14, P3321, DOI 10.1093/hmg/ddi364; Tomatsu S, 2003, HUM MOL GENET, V12, P3349, DOI 10.1093/hmg/ddg366; TOMATSU S, MOL THER; Tomatsu S, 2008, HUM MOL GENET, V17, P815, DOI 10.1093/hmg/ddm353; Tomatsu S, 2007, MOL GENET METAB, V91, P251, DOI 10.1016/j.ymgme.2007.02.009; Tomatsu S, 2007, MOL GENET METAB, V91, P69, DOI 10.1016/j.ymgme.2007.01.004; VANDIGGELEN OP, 1990, CLIN CHIM ACTA, V187, P131, DOI 10.1016/0009-8981(90)90339-T; Vogler C, 1987, Am J Med Genet Suppl, V3, P243	46	47	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12194	10.1371/journal.pone.0012194	http://dx.doi.org/10.1371/journal.pone.0012194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808938	gold, Green Published, Green Submitted			2022-12-27	WOS:000280968000019
J	Dawes, FE; Kuzevski, A; Bettelheim, KA; Hornitzky, MA; Djordjevic, SP; Walker, MJ				Dawes, Fay E.; Kuzevski, Alexander; Bettelheim, Karl A.; Hornitzky, Michael A.; Djordjevic, Steven P.; Walker, Mark J.			Distribution of Class 1 Integrons with IS26-Mediated Deletions in Their 3 '-Conserved Segments in Escherichia coli of Human and Animal Origin	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; CLASS-I INTEGRONS; ANTIBIOTIC-RESISTANCE; GENE CASSETTES; MULTIDRUG-RESISTANCE; SITE; ENTEROBACTERIACEAE; ELEMENTS	Class 1 integrons play a role in the emergence of multi-resistant bacteria by facilitating the recruitment of gene cassettes encoding antibiotic resistance genes. 512 E. coli strains sourced from humans (n = 202), animals (n = 304) and the environment (n = 6) were screened for the presence of the intl1 gene. In 31/79 integron positive E. coli strains, the gene cassette regions could not be PCR amplified using standard primers. DNA sequence analysis of 6 serologically diverse strains revealed atypical integrons harboured the dfrA5 cassette gene and only 24 bp of the integron 3'-conserved segment (CS) remained, due to the insertion of IS26. PCR targeting intl1 and IS26 followed by restriction fragment length polymorphism (RFLP) analysis identified the integron-dfrA5-IS26 element in 27 E. coli strains of bovine origin and 4 strains of human origin. Southern hybridization and transformation studies revealed the integron-dfrA5-IS26 gene arrangement was either chromosomally located or plasmid borne. Plasmid location in 4/9 E. coli strains and PCR linkage of Tn21 transposition genes with the intl1 gene in 20/31 strains, suggests this element is readily disseminated by horizontal transfer.	[Dawes, Fay E.; Walker, Mark J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Kuzevski, Alexander; Bettelheim, Karl A.] Univ Melbourne, Dept Microbiol & Immunol, Microbiol Diagnost Unit, Parkville, Vic 3052, Australia; [Hornitzky, Michael A.; Djordjevic, Steven P.] Elizabeth Macarthur Agr Inst, Microbiol & Immunol Sect, Menangle, NSW, Australia; [Djordjevic, Steven P.] Univ Technol Sydney, Ithree Inst, Sydney, NSW 2007, Australia; [Walker, Mark J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia	University of Wollongong; University of Melbourne; University of Technology Sydney; University of Queensland	Dawes, FE (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia.	mark.walker@uq.edu.au	Djordjevic, Steven/A-2024-2013; djordjevic, steven/GNP-4000-2022; Walker, Mark J./F-6940-2011	Djordjevic, Steven/0000-0001-9301-5372; djordjevic, steven/0000-0001-9301-5372; Walker, Mark/0000-0001-7423-2769	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by an Australian Research Council Linkage grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelheim KA, 2003, J MED MICROBIOL, V52, P155, DOI 10.1099/jmm.0.04903-0; Chen J, 1998, LETT APPL MICROBIOL, V27, P369, DOI 10.1046/j.1472-765X.1998.00445.x; COLLIS CM, 1993, MOL MICROBIOL, V9, P41, DOI 10.1111/j.1365-2958.1993.tb01667.x; Dichi I, 2009, FASEB J, V23; Gallego L, 2001, J MED MICROBIOL, V50, P71, DOI 10.1099/0022-1317-50-1-71; Goldmann DA, 1999, ECOSYST HEALTH, V5, P158, DOI 10.1046/j.1526-0992.1999.09925.x; Leverstein-van Hall MA, 2003, J INFECT DIS, V187, P251, DOI 10.1086/345880; LEVESQUE C, 1994, GENE, V142, P49, DOI 10.1016/0378-1119(94)90353-0; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Maguire AJ, 2001, ANTIMICROB AGENTS CH, V45, P1022, DOI 10.1128/AAC.45.4.1022-1029.2001; MOLLET B, 1985, MOL GEN GENET, V201, P198, DOI 10.1007/BF00425660; Partridge SR, 2000, MICROBIOL-UK, V146, P2855, DOI 10.1099/00221287-146-11-2855; PAULSEN IT, 1993, ANTIMICROB AGENTS CH, V37, P761, DOI 10.1128/AAC.37.4.761; Recchia GD, 1995, MICROBIOL-UK, V141, P3015, DOI 10.1099/13500872-141-12-3015; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schmitz FJ, 2001, J CLIN MICROBIOL, V39, P3724, DOI 10.1128/JCM.39.10.3724-3726.2001; STOKES HW, 1989, MOL MICROBIOL, V3, P1669, DOI 10.1111/j.1365-2958.1989.tb00153.x; SUNDSTROM L, 1988, MOL GEN GENET, V213, P191, DOI 10.1007/BF00339581; Thungapathra M, 2002, ANTIMICROB AGENTS CH, V46, P2948, DOI 10.1128/AAC.46.9.2948-2955.2002; Toussaint A, 2002, PLASMID, V47, P26, DOI 10.1006/plas.2001.1552; White PA, 2001, ANTIMICROB AGENTS CH, V45, P2658, DOI 10.1128/AAC.45.9.2658-2661.2001	22	71	72	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12754	10.1371/journal.pone.0012754	http://dx.doi.org/10.1371/journal.pone.0012754			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856797	Green Published, gold			2022-12-27	WOS:000281815800020
J	Bol, V; Desjardins, F; Reusens, B; Balligand, JL; Remacle, C				Bol, Vanesa; Desjardins, Fanny; Reusens, Brigitte; Balligand, Jen-Luc; Remacle, Claude			Does Early Mismatched Nutrition Predispose to Hypertension and Atherosclerosis, in Male Mice?	PLOS ONE			English	Article							CATCH-UP GROWTH; DIET-INDUCED OBESITY; PROTEIN RESTRICTION; BLOOD-PRESSURE; RECEPTOR EXPRESSION; METABOLIC SYNDROME; GENE-EXPRESSION; ADIPOSE-TISSUE; DEVELOPMENTAL ORIGINS; CIRCADIAN-RHYTHMS	Background: A link between early mismatched nutritional environment and development of components of the metabolic syndrome later in life has been shown in epidemiological and animal data. The aim of this study was to investigate whether an early mismatched nutrition produced by catch-up growth after fetal protein restriction could induce the appearance of hypertension and/or atherosclerosis in adult male mice. Methodology/Principal Findings: Wild-type C57BL6/J or LDLr-/- dams were fed a low protein (LP) or a control (C) diet during gestation. Catch-up growth was induced in LP offspring by feeding dams with a control diet and by culling the litter to 4 pups against 8 in controls. At weaning, male mice were fed either standard chow or an obesogenic diet (OB), leading to 4 experimental groups. Blood pressure (BP) and heart rate (HR) were assessed in conscious unrestrained wild-type mice by telemetry. Atherosclerosis plaque area was measured in aortic root sections of LDLr-/- mice. We found that: (1) postnatal OB diet increased significantly BP (P<0.0001) and HR (P<0.008) in 3-month old OB-C and OB-LP offspring, respectively; (2) that maternal LP diet induced a significant higher BP (P<0.009) and HR (P<0.004) and (3) an altered circadian rhythm in addition to higher plasma corticosterone concentration in 9 months-old LP offspring; (4) that, although LP offspring showed higher plasma total cholesterol than control offspring, atherosclerosis assessed in aortic roots of 6-mo old mice featured increased plaque area due to OB feeding but not due to early mismatched nutrition. Conclusions/Significance: These results indicate a long-term effect of early mismatched nutrition on the appearance of hypertension independently of obesity, while no effect on atherosclerosis was noticed at this age.	[Bol, Vanesa; Reusens, Brigitte; Remacle, Claude] Catholic Univ Louvain, Inst Life Sci, Cell Biol Lab, B-1348 Louvain, Belgium; [Desjardins, Fanny; Balligand, Jen-Luc] Catholic Univ Louvain, Unit Pharmacol & Theurapeut, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Bol, V (corresponding author), Catholic Univ Louvain, Inst Life Sci, Cell Biol Lab, B-1348 Louvain, Belgium.	claude.remacle@uclouvain.be	Balligand, Jean-Luc J/D-7543-2012	BALLIGAND, Jean-Luc/0000-0002-0522-4156	European Commission [FOOD-CT-2005-007036]; Partenon Trust (London, UK); Belgian Fonds National de la Recherche Scientifique (FNRS); Politique Scientifique Federale [PAI-P6/30]; Belgian Fonds pour la Recherche dans l'Industrie et l'Agriculture (FRIA)	European Commission(European CommissionEuropean Commission Joint Research Centre); Partenon Trust (London, UK); Belgian Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Politique Scientifique Federale; Belgian Fonds pour la Recherche dans l'Industrie et l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the European Commission (FOOD-CT-2005-007036), the Partenon Trust (London, UK), the Belgian Fonds National de la Recherche Scientifique (FNRS), Politique Scientifique Federale (PAI-P6/30) and the Belgian Fonds pour la Recherche dans l'Industrie et l'Agriculture (FRIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2003, HYPERTENSION, V41, P451, DOI 10.1161/01.HYP.0000054212.23528.B2; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; BARKER DJP, 1989, LANCET, V2, P577; Bieswal F, 2004, J NUTR, V134, P1493, DOI 10.1093/jn/134.6.1493; Bieswal F, 2006, OBESITY, V14, P1330, DOI 10.1038/oby.2006.151; Bol VV, 2009, AM J PHYSIOL-REG I, V297, pR291, DOI 10.1152/ajpregu.90497.2008; Boullu-Ciocca S, 2005, DIABETES, V54, P197, DOI 10.2337/diabetes.54.1.197; Breton C, 2009, AM J PHYSIOL-ENDOC M, V296, pE462, DOI 10.1152/ajpendo.90740.2008; BROUBRED F, 2009, AM J PHYSIOL-RENAL, V297, pF943; Cleal JK, 2007, P NATL ACAD SCI USA, V104, P9529, DOI 10.1073/pnas.0610373104; Cole TJ, 2007, ACTA PAEDIATR, V96, P2, DOI 10.1111/j.1651-2227.2007.00162.x; Coupe B, 2010, ENDOCRINOLOGY, V151, P702, DOI 10.1210/en.2009-0893; Coupe B, 2009, AM J PHYSIOL-REG I, V297, pR813, DOI 10.1152/ajpregu.00201.2009; Erhuma A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1702, DOI 10.1152/ajpendo.00605.2006; Fantuzzi G, 2007, ARTERIOSCL THROM VAS, V27, P996, DOI 10.1161/ATVBAHA.106.131755; Fernandez-Twinn DS, 2006, AM J PHYSIOL-REG I, V291, pR429, DOI 10.1152/ajpregu.00608.2005; Gluckman PD, 2005, MATERN CHILD NUTR, V1, P130, DOI 10.1111/j.1740-8709.2005.00020.x; Goharkhay N, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.08.002; Goldberg IJ, 2008, DIABETES, V57, P1674, DOI 10.2337/db08-0083; Groot PHE, 1996, ARTERIOSCL THROM VAS, V16, P926, DOI 10.1161/01.ATV.16.8.926; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; HALES CN, 2005, BR MED B, V60, P5; Hasty AH, 2001, J BIOL CHEM, V276, P37402, DOI 10.1074/jbc.M010176200; Hoppe CC, 2007, AM J PHYSIOL-REG I, V292, pR462, DOI 10.1152/ajpregu.00079.2006; Langley-Evans SC, 2001, P NUTR SOC, V60, P505, DOI 10.1079/PNS2001111; Langley-Evans SC, 1998, NUTRITION, V14, P39, DOI 10.1016/S0899-9007(97)00391-2; Li P, 1999, AM J PHYSIOL-REG I, V276, pR500, DOI 10.1152/ajpregu.1999.276.2.R500; Lucas A, 1996, BRIT J NUTR, V76, P605, DOI 10.1079/BJN19960066; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; McMullen S, 2005, HYPERTENSION, V46, P1374, DOI 10.1161/01.HYP.0000188702.96256.46; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Mistlberger RE, 1999, PHYSIOL BEHAV, V66, P329, DOI 10.1016/S0031-9384(98)00311-4; Mistlberger RE, 1998, APPETITE, V30, P255, DOI 10.1006/appe.1997.0134; Napoli C, 2002, CIRCULATION, V105, P1360, DOI 10.1161/01.CIR.0000013090.96919.FA; O'Regan D, 2008, J ENDOCRINOL, V196, P343, DOI 10.1677/JOE-07-0327; Painter RC, 2005, REPROD TOXICOL, V20, P345, DOI 10.1016/j.reprotox.2005.04.005; Petry C J, 2001, Int J Exp Diabetes Res, V2, P139; Petry CJ, 2000, DIABETIC MED, V17, P848, DOI 10.1046/j.1464-5491.2000.00392.x; Phillips DIW, 2006, ANN NY ACAD SCI, V1083, P28, DOI 10.1196/annals.1367.027; Poulos SP, 2010, MOL CELL ENDOCRINOL, V323, P20, DOI 10.1016/j.mce.2009.12.011; Remacle C, 2004, INT J OBESITY, V28, pS46, DOI 10.1038/sj.ijo.0802800; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Russell JC, 2006, CARDIOVASC PATHOL, V15, P318, DOI 10.1016/j.carpath.2006.09.001; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Sathishkumar K, 2009, J VASC RES, V46, P229, DOI 10.1159/000166390; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Staessen JA, 2003, LANCET, V361, P1629, DOI 10.1016/S0140-6736(03)13302-8; Stanner S A, 2001, Twin Res, V4, P287, DOI 10.1375/1369052012498; Stanner SA, 1997, BMJ-BRIT MED J, V315, P1342, DOI 10.1136/bmj.315.7119.1342; Sugden MC, 2001, EUR J ENDOCRINOL, V145, P529, DOI 10.1530/eje.0.1450529; Tonkiss J, 1998, HYPERTENSION, V32, P108, DOI 10.1161/01.HYP.32.1.108; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Watkins AJ, 2008, BIOL REPROD, V78, P299, DOI 10.1095/biolreprod.107.064220; Yates Z, 2009, BRIT J NUTR, V101, P1185, DOI 10.1017/S0007114508066786; Young ME, 2006, AM J PHYSIOL-HEART C, V290, pH1, DOI 10.1152/ajpheart.00582.2005	55	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12656	10.1371/journal.pone.0012656	http://dx.doi.org/10.1371/journal.pone.0012656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844591	Green Published, Green Submitted, gold			2022-12-27	WOS:000281687200017
J	Blaveri, E; Kelly, F; Mallei, A; Harris, K; Taylor, A; Reid, J; Razzoli, M; Carboni, L; Piubelli, C; Musazzi, L; Racagni, G; Mathe, A; Popoli, M; Domenici, E; Bates, S				Blaveri, Ekaterini; Kelly, Fiona; Mallei, Alessandra; Harris, Kriss; Taylor, Adam; Reid, Juliet; Razzoli, Maria; Carboni, Lucia; Piubelli, Chiara; Musazzi, Laura; Racagni, Girogio; Mathe, Aleksander; Popoli, Maurizio; Domenici, Enrico; Bates, Stewart			Expression Profiling of a Genetic Animal Model of Depression Reveals Novel Molecular Pathways Underlying Depressive-Like Behaviours	PLOS ONE			English	Article							FLINDERS SENSITIVE LINE; INCREASED CHOLINERGIC FUNCTION; MAJOR DEPRESSION; PREFRONTAL CORTEX; SUICIDE VICTIMS; RAT-BRAIN; ANTIDEPRESSANT TREATMENT; SYNAPTIC PLASTICITY; POSTMORTEM BRAINS; RECEPTOR-BINDING	Background: The Flinders model is a validated genetic rat model of depression that exhibits a number of behavioural, neurochemical and pharmacological features consistent with those observed in human depression. Principal Findings: In this study we have used genome-wide microarray expression profiling of the hippocampus and prefrontal/frontal cortex of Flinders Depression Sensitive (FSL) and control Flinders Depression Resistant (FRL) lines to understand molecular basis for the differences between the two lines. We profiled two independent cohorts of Flinders animals derived from the same colony six months apart, each cohort statistically powered to allow independent as well as combined analysis. Using this approach, we were able to validate using real-time-PCR a core set of gene expression differences that showed statistical significance in each of the temporally distinct cohorts, representing consistently maintained features of the model. Small but statistically significant increases were confirmed for cholinergic (chrm2, chrna7) and serotonergic receptors (Htr1a, Htr2a) in FSL rats consistent with known neurochemical changes in the model. Much larger gene changes were validated in a number of novel genes as exemplified by TMEM176A, which showed 35-fold enrichment in the cortex and 30-fold enrichment in hippocampus of FRL animals relative to FSL. Conclusions: These data provide significant insights into the molecular differences underlying the Flinders model, and have potential relevance to broader depression research.	[Blaveri, Ekaterini] Canc Res UK, London, England; [Kelly, Fiona; Harris, Kriss; Taylor, Adam; Reid, Juliet; Bates, Stewart] GlaxoSmithKline Inc, Med Res Ctr, Stevenage, Herts, England; [Mallei, Alessandra; Musazzi, Laura; Racagni, Girogio; Popoli, Maurizio] Univ Milan, Dept Pharmacol Sci, Ctr Neuropharmacol, Milan, Italy; [Mallei, Alessandra; Musazzi, Laura; Racagni, Girogio; Popoli, Maurizio] Univ Milan, Ctr Excellence Neurodegenerat Dis, Milan, Italy; [Razzoli, Maria; Carboni, Lucia; Piubelli, Chiara; Racagni, Girogio; Domenici, Enrico] GlaxoSmithKline Med Res Ctr, Neurosci CEDD, Verona, Italy; [Racagni, Girogio; Mathe, Aleksander] Karolinska Inst, Huddinge Hosp, S-10401 Stockholm, Sweden; [Racagni, Girogio] Inst Ricoverio & Cura Carattere Sci, Brescia, Italy	Cancer Research UK; GlaxoSmithKline; University of Milan; University of Milan; GlaxoSmithKline; Karolinska Institutet	Blaveri, E (corresponding author), Canc Res UK, London, England.	Stewart.A.Bates@gsk.com	Domenici, Enrico/K-8194-2016; Piubelli, Chiara/J-7881-2016; Racagni, Giorgio A./B-5826-2011; Piubelli, Chiara/AAM-7183-2021; Carboni, Lucia/AAY-9824-2021	Domenici, Enrico/0000-0001-7436-6919; Piubelli, Chiara/0000-0002-5739-3795; Piubelli, Chiara/0000-0002-5739-3795; Carboni, Lucia/0000-0001-9335-3312; Mallei, Alessandra/0000-0001-6955-4755; RAZZOLI, Maria/0000-0001-5911-4633; Taylor, Adam/0000-0002-6566-8234	EU; GlaxoSmithKline; European Commission [LSHB-CT-2003-503428]; Swedish Medical Research Council [10414]; Karolinska Institutet; NATIONAL EYE INSTITUTE [R01EY013250] Funding Source: NIH RePORTER	EU(European Commission); GlaxoSmithKline(GlaxoSmithKline); European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Karolinska Institutet(Karolinska Institutet); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was part of a larger integrated project on genome-based therapeutic drugs for depression (GENDEP-http://gendep.iop.kcl.ac.uk/) funded by the EU Framework VI Program. This project was partly funded by GlaxoSmithKline, which, under EU framework VI rules for commercial contributors, shared funds for study costs and salaries for the components of the work in which GSK directly contributed. The study was also supported by the European Commission, Contract number LSHB-CT-2003-503428 and by the Swedish Medical Research Council grant 10414 and the Karolinska Institutet. The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, which decisions were taken by the authors alone.	ABEL EL, 1993, PHYSIOL BEHAV, V54, P309, DOI 10.1016/0031-9384(93)90116-W; Andriamampandry C, 2002, MOL PHARMACOL, V62, P1332, DOI 10.1124/mol.62.6.1332; ARANGO V, 1995, BRAIN RES, V688, P121, DOI 10.1016/0006-8993(95)00523-S; Aston C, 2005, MOL PSYCHIATR, V10, P309, DOI 10.1038/sj.mp.4001565; Barbon A, 2006, BIOL PSYCHIAT, V59, P713, DOI 10.1016/j.biopsych.2005.10.018; Baskys A, 2007, ANN NY ACAD SCI, V1122, P313, DOI 10.1196/annals.1403.023; Bond BC, 2002, MOL BRAIN RES, V106, P101, DOI 10.1016/S0169-328X(02)00417-5; Choudary PV, 2005, P NATL ACAD SCI USA, V102, P15653, DOI 10.1073/pnas.0507901102; Chow Tiffany W, 2007, Neuropsychiatr Dis Treat, V3, P627; COHENCOLE S, 1985, AM J PSYCHIAT, V142, P1224; Comings DE, 2002, AM J MED GENET, V114, P527, DOI 10.1002/ajmg.10406; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; Gass P, 2008, J NEUROSCI RES, V86, P3184, DOI 10.1002/jnr.21753; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; JANOWSKY DS, 1994, AM J MED GENET, V54, P335, DOI 10.1002/ajmg.1320540412; JANOWSKY DS, 1972, LANCET, V2, P632; Jimenez-Vasquez PA, 2007, EUR NEUROPSYCHOPHARM, V17, P298, DOI 10.1016/j.euroneuro.2006.06.011; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Khait VD, 2005, NEUROPSYCHOPHARMACOL, V30, P166, DOI 10.1038/sj.npp.1300578; Klempan TA, 2009, MOL PSYCHIATR, V14, P175, DOI 10.1038/sj.mp.4002110; Kohen R, 2005, PHARMACOGENOMICS J, V5, P278, DOI 10.1038/sj.tpj.6500322; Kroes RA, 2006, NEUROSCIENCE, V137, P37, DOI 10.1016/j.neuroscience.2005.08.076; Lemonde S, 2003, J NEUROSCI, V23, P8788; LESCH KP, 1990, FORTSCHR NEUROL PSYC, V58, P427, DOI 10.1055/s-2007-1001206; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; MANN JJ, 1986, ARCH GEN PSYCHIAT, V43, P954; Mathe AA, 2007, PHYSIOL BEHAV, V92, P226, DOI 10.1016/j.physbeh.2007.05.016; MOLZER B, 1992, WIEN KLIN WOCHENSCHR, V104, P665; Nakatani N, 2004, PHARMACOGENOMICS J, V4, P114, DOI 10.1038/sj.tpj.6500234; Nestler EJ, 2002, BIOL PSYCHIAT, V52, P503, DOI 10.1016/S0006-3223(02)01405-1; Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401; Nishi K, 2009, NEUROCHEM INT, V54, P299, DOI 10.1016/j.neuint.2008.12.011; Orsetti M, 2008, EUR J NEUROSCI, V27, P2156, DOI 10.1111/j.1460-9568.2008.06155.x; Osterlund MK, 1999, MOL BRAIN RES, V74, P158; OVERSTREET DH, 1986, BIOL PSYCHIAT, V21, P49, DOI 10.1016/0006-3223(86)90007-7; OVERSTREET DH, 1993, NEUROSCI BIOBEHAV R, V17, P51, DOI 10.1016/S0149-7634(05)80230-1; OVERSTREET DH, 1995, PSYCHOPHARMACOLOGY, V121, P27, DOI 10.1007/BF02245589; OVERSTREET DH, 1982, PSYCHOPHARMACOLOGY, V78, P150, DOI 10.1007/BF00432254; Overstreet DH, 2002, BEHAV GENET, V32, P335, DOI 10.1023/A:1020262205227; Overstreet DH, 2005, NEUROSCI BIOBEHAV R, V29, P739, DOI 10.1016/j.neubiorev.2005.03.015; Pandey GN, 2002, AM J PSYCHIAT, V159, P419, DOI 10.1176/appi.ajp.159.3.419; Pearson KA, 2006, NEUROPSYCHOPHARMACOL, V31, P2449, DOI 10.1038/sj.npp.1301100; PETTY F, 1994, CLIN CHEM, V40, P296; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; ROY A, 1991, PSYCHOL MED, V21, P613, DOI 10.1017/S0033291700022248; Sakane A, 2006, P NATL ACAD SCI USA, V103, P10029, DOI 10.1073/pnas.0600304103; Sanacora G, 1999, ARCH GEN PSYCHIAT, V56, P1043, DOI 10.1001/archpsyc.56.11.1043; Sequeira A, 2006, ARCH GEN PSYCHIAT, V63, P35, DOI 10.1001/archpsyc.63.1.35; Serova L, 1998, MOL BRAIN RES, V63, P133, DOI 10.1016/S0169-328X(98)00270-8; Takahashi K, 2008, J PHARMACOL SCI, V108, P320, DOI 10.1254/jphs.08149FP; Thakker-Varia S, 2001, J NEUROSCI, V21, P6782, DOI 10.1523/JNEUROSCI.21-17-06782.2001; Tochigi M, 2008, NEUROSCI RES, V60, P184, DOI 10.1016/j.neures.2007.10.010; Uriguen L, 2008, GENES BRAIN BEHAV, V7, P649, DOI 10.1111/j.1601-183X.2008.00402.x; WALLIS E, 1988, PHARMACOL BIOCHEM BE, V31, P345, DOI 10.1016/0091-3057(88)90356-5; Wehr H, 1991, Neurol Neurochir Pol, V25, P769; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Zangen A, 1997, J NEUROCHEM, V69, P2477	57	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12596	10.1371/journal.pone.0012596	http://dx.doi.org/10.1371/journal.pone.0012596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830301	gold, Green Submitted, Green Published			2022-12-27	WOS:000281631300023
J	Plett, D; Safwat, G; Gilliham, M; Moller, IS; Roy, S; Shirley, N; Jacobs, A; Johnson, A; Tester, M				Plett, Darren; Safwat, Gehan; Gilliham, Matthew; Moller, Inge Skrumsager; Roy, Stuart; Shirley, Neil; Jacobs, Andrew; Johnson, Alexander; Tester, Mark			Improved Salinity Tolerance of Rice Through Cell Type-Specific Expression of AtHKT1;1	PLOS ONE			English	Article							SALT TOLERANCE; SODIUM TRANSPORTER; HKT TRANSPORTERS; NA+ EXCLUSION; DURUM-WHEAT; ARABIDOPSIS; PLANTS; GENE; STRESS	Previously, cell type-specific expression of AtHKT1;1, a sodium transporter, improved sodium (Na(+)) exclusion and salinity tolerance in Arabidopsis. In the current work, AtHKT1;1, was expressed specifically in the root cortical and epidermal cells of an Arabidopsis GAL4-GFP enhancer trap line. These transgenic plants were found to have significantly improved Na(+) exclusion under conditions of salinity stress. The feasibility of a similar biotechnological approach in crop plants was explored using a GAL4-GFP enhancer trap rice line to drive expression of AtHKT1; 1 specifically in the root cortex. Compared with the background GAL4-GFP line, the rice plants expressing AtHKT1;1 had a higher fresh weight under salinity stress, which was related to a lower concentration of Na(+) in the shoots. The root-to-shoot transport of 22 Na(+) was also decreased and was correlated with an upregulation of OsHKT1;5, the native transporter responsible for Na(+) retrieval from the transpiration stream. Interestingly, in the transgenic Arabidopsis plants overexpressing AtHKT1;1 in the cortex and epidermis, the native AtHKT1;1 gene responsible for Na(+) retrieval from the transpiration stream, was also upregulated. Extra Na(+) retrieved from the xylem was stored in the outer root cells and was correlated with a significant increase in expression of the vacuolar pyrophosphatases (in Arabidopsis and rice) the activity of which would be necessary to move the additional stored Na(+) into the vacuoles of these cells. This work presents an important step in the development of abiotic stress tolerance in crop plants via targeted changes in mineral transport.	[Plett, Darren; Safwat, Gehan; Moller, Inge Skrumsager; Roy, Stuart; Shirley, Neil; Jacobs, Andrew; Johnson, Alexander; Tester, Mark] Univ Adelaide, Australian Ctr Plant Funct Genom, Glen Osmond, SA, Australia; [Plett, Darren; Safwat, Gehan; Gilliham, Matthew; Moller, Inge Skrumsager; Roy, Stuart; Shirley, Neil; Jacobs, Andrew; Johnson, Alexander; Tester, Mark] Univ Adelaide, Sch Agr Food & Wine, Waite Res Inst, Glen Osmond, SA, Australia	University of Adelaide; University of Adelaide	Plett, D (corresponding author), Univ Adelaide, Australian Ctr Plant Funct Genom, Glen Osmond, SA, Australia.	mark.tester@acpfg.com.au	Gilliham, Matthew/Y-4403-2019; Tester, Mark/J-2368-2017; Jacobs, Andrew/F-4237-2013; Gilliham, Matthew/C-1998-2013	Gilliham, Matthew/0000-0003-0666-3078; Tester, Mark/0000-0002-5085-8801; Gilliham, Matthew/0000-0003-0666-3078; Shirley, Neil/0000-0001-8114-9891; Plett, Darren/0000-0002-9551-8755; JOHNSON, ALEXANDER/0000-0002-1209-6447; Roy, Stuart/0000-0003-0411-9431	Biotechnology and Biological Research Sciences Council; Australian Research Council [FF0348367, DP0557920]; International Postgraduate Research Scholarship; BP Egypt-Cambridge scholarship; Danish Research Council	Biotechnology and Biological Research Sciences Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Australian Research Council(Australian Research Council); International Postgraduate Research Scholarship(Australian Government); BP Egypt-Cambridge scholarship; Danish Research Council(Det Frie Forskningsrad (DFF))	This work was supported by a Biotechnology and Biological Research Sciences Council (http://www.bbsrc.ac.uk) grant to MT and Australian Research Council (http://www.arc.gov.au) grants FF0348367 and DP0557920 to MT. PhD students were supported by an International Postgraduate Research Scholarship (DP), a BP Egypt-Cambridge scholarship (GS) and the Danish Research Council (ISM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burton RA, 2004, PLANT PHYSIOL, V134, P224, DOI 10.1104/pp.103.032904; Byrt CS, 2007, PLANT PHYSIOL, V143, P1918, DOI 10.1104/pp.106.093476; Davenport R, 2005, PLANT PHYSIOL, V137, P807, DOI 10.1104/pp.104.057307; Davenport RJ, 2007, PLANT CELL ENVIRON, V30, P497, DOI 10.1111/j.1365-3040.2007.01637.x; Garciadeblas B, 2003, PLANT J, V34, P788, DOI 10.1046/j.1365-313X.2003.01764.x; Haseloff J, 1999, METHOD CELL BIOL, V58, P139; Hauser F, 2010, PLANT CELL ENVIRON, V33, P552, DOI 10.1111/j.1365-3040.2009.02056.x; Huang SB, 2006, PLANT PHYSIOL, V142, P1718, DOI 10.1104/pp.106.088864; Johnson AAT, 2005, PLANT J, V41, P779, DOI 10.1111/j.1365-313X.2005.02339.x; Moller IS, 2009, PLANT CELL, V21, P2163, DOI 10.1105/tpc.108.064568; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Rus A, 2004, PLANT PHYSIOL, V136, P2500, DOI 10.1104/pp.104.042234; Sallaud C, 2004, PLANT J, V39, P450, DOI 10.1111/j.1365-313X.2004.02145.x; Sallaud C, 2003, THEOR APPL GENET, V106, P1396, DOI 10.1007/s00122-002-1184-x; Sottosanto JB, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-18; Sunarpi, 2005, PLANT J, V44, P928, DOI 10.1111/j.1365-313X.2005.02595.x; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Wu XL, 2002, GENE DEV, V16, P151, DOI 10.1101/gad.952002; YEO AR, 1987, J EXP BOT, V38, P1141, DOI 10.1093/jxb/38.7.1141	20	100	106	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12571	10.1371/journal.pone.0012571	http://dx.doi.org/10.1371/journal.pone.0012571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838445	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000281627700018
J	Brelidze, TI; Carlson, AE; Davies, DR; Stewart, LJ; Zagotta, WN				Brelidze, Tinatin I.; Carlson, Anne E.; Davies, Douglas R.; Stewart, Lance J.; Zagotta, William N.			Identifying Regulators for EAG1 Channels with a Novel Electrophysiology and Tryptophan Fluorescence Based Screen	PLOS ONE			English	Article							HERG POTASSIUM CHANNEL; A-GO-GO; K+ CHANNELS; MELANOMA-CELLS; DROSOPHILA; ETHER; BINDING; TECHNOLOGIES; EXPRESSION; CANCER	Background: Ether-a-go-go (EAG) channels are expressed throughout the central nervous system and are also crucial regulators of cell cycle and tumor progression. The large intracellular amino-and carboxy-terminal domains of EAG1 each share similarity with known ligand binding motifs in other proteins, yet EAG1 channels have no known regulatory ligands. Methodology/Principal Findings: Here we screened a library of small biologically relevant molecules against EAG1 channels with a novel two-pronged screen to identify channel regulators. In one arm of the screen we used electrophysiology to assess the functional effects of the library compounds on full-length EAG1 channels. In an orthogonal arm, we used tryptophan fluorescence to screen for binding of the library compounds to the isolated C-terminal region. Conclusions/Significance: Several compounds from the flavonoid, indole and benzofuran chemical families emerged as binding partners and/or regulators of EAG1 channels. The two-prong screen can aid ligand and drug discovery for ligandbinding domains of other ion channels.	[Brelidze, Tinatin I.; Carlson, Anne E.; Zagotta, William N.] Univ Washington, Dept Physiol & Biophys, Sch Med, Seattle, WA 98195 USA; [Davies, Douglas R.; Stewart, Lance J.] Emerald BioStruct Inc, Bainbridge Isl, WA USA	University of Washington; University of Washington Seattle	Brelidze, TI (corresponding author), Univ Washington, Dept Physiol & Biophys, Sch Med, Seattle, WA 98195 USA.	zagotta@u.washington.edu	Carlson, Anne/I-9495-2019	Carlson, Anne/0000-0003-2724-1325; Brelidze, Tinatin/0000-0003-3046-8184	Howard Hughes Medical Institute; National Institutes of Health [R01 EY010329, F32 HL095241]; NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL095241] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Howard Hughes Medical Institute, the National Institutes of Health grant R01 EY010329 (W.N.Z.), and the National Institutes of Health grant F32 HL095241 (A. E. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Bruford EA, 2008, NUCLEIC ACIDS RES, V36, pD445, DOI 10.1093/nar/gkm881; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Camacho J, 2006, CANCER LETT, V233, P1, DOI 10.1016/j.canlet.2005.02.016; Chen GQ, 1997, PROTEIN ENG, V10, P1061, DOI 10.1093/protein/10.9.1061; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Davies DR, 2009, J MED CHEM, V52, P4694, DOI 10.1021/jm900259h; de Jong LAA, 2005, J CHROMATOGR B, V829, P1, DOI 10.1016/j.jchromb.2005.10.002; de Queiroz FM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-42; Fan F, 2007, ASSAY DRUG DEV TECHN, V5, P127, DOI 10.1089/adt.2006.053; Farias LMB, 2004, CANCER RES, V64, P6996, DOI 10.1158/0008-5472.CAN-04-1204; Fox S, 2004, J BIOMOL SCREEN, V9, P354, DOI 10.1177/1087057104265290; Ganetzky B, 1999, ANN NY ACAD SCI, V868, P356, DOI 10.1111/j.1749-6632.1999.tb11297.x; Gavrilova-Ruch O, 2002, J MEMBRANE BIOL, V188, P137, DOI 10.1007/s00232-001-0181-3; Gessner G, 2007, EUR J PHARMACOL, V555, P185, DOI 10.1016/j.ejphar.2006.10.053; Gomez-Varela D, 2007, CANCER RES, V67, P7343, DOI 10.1158/0008-5472.CAN-07-0107; GUY HR, 1991, SCIENCE, V254, P730, DOI 10.1126/science.1658932; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hertzberg RP, 2000, CURR OPIN CHEM BIOL, V4, P445, DOI 10.1016/S1367-5931(00)00110-1; Kamiya K, 2001, CIRCULATION, V103, P1317; Kawasaki K, 2003, BIOORG MED CHEM LETT, V13, P87, DOI 10.1016/S0960-894X(02)00844-2; Kelemen K, 2007, BIOCHEM BIOPH RES CO, V364, P429, DOI 10.1016/j.bbrc.2007.10.001; Kema IP, 2000, J CHROMATOGR B, V747, P33, DOI 10.1016/S0378-4347(00)00341-8; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P56; LUDWIG J, 1994, EMBO J, V13, P4451, DOI 10.1002/j.1460-2075.1994.tb06767.x; Makara GM, 2005, CURR OPIN BIOTECH, V16, P666, DOI 10.1016/j.copbio.2005.10.007; Meyer R, 1999, J MEMBRANE BIOL, V171, P107, DOI 10.1007/s002329900563; Middleton E, 2000, PHARMACOL REV, V52, P673; Ousingsawat J, 2007, CLIN CANCER RES, V13, P824, DOI 10.1158/1078-0432.CCR-06-1940; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Rozario AO, 2009, BBA-BIOMEMBRANES, V1788, P1939, DOI 10.1016/j.bbamem.2009.06.003; Scholz EP, 2007, NUTR METAB CARDIOVAS, V17, P666, DOI 10.1016/j.numecd.2006.06.002; Scholz EP, 2005, N-S ARCH PHARMACOL, V371, P516, DOI 10.1007/s00210-005-1069-z; Shelat AA, 2007, NAT CHEM BIOL, V3, P442, DOI 10.1038/nchembio0807-442; Spector PS, 1996, CIRC RES, V78, P499, DOI 10.1161/01.RES.78.3.499; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Weber C, 2006, J BIOL CHEM, V281, P13030, DOI 10.1074/jbc.M600883200; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; Zheng W, 2004, ASSAY DRUG DEV TECHN, V2, P543, DOI 10.1089/adt.2004.2.543; Zitron E, 2005, CIRCULATION, V111, P835, DOI 10.1161/01.CIR.0000155617.54749.09	42	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12523	10.1371/journal.pone.0012523	http://dx.doi.org/10.1371/journal.pone.0012523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824064	Green Published, Green Submitted, gold			2022-12-27	WOS:000281480900010
J	Kumar, S; Sardesai, AA; Basu, D; Muniyappa, K; Hasnain, SE				Kumar, Sandeep; Sardesai, Abhijit A.; Basu, Debashree; Muniyappa, Kalappagowda; Hasnain, Seyed E.			DNA Clasping by Mycobacterial HU: The C-Terminal Region of HupB Mediates Increased Specificity of DNA Binding	PLOS ONE			English	Article							HISTONE-LIKE PROTEIN; ESCHERICHIA-COLI; CRUCIFORM DNA; IN-VITRO; TUBERCULOSIS; REPLICATION; FORM; RECOMBINATION; TRANSCRIPTION; BACTERIA	Background: HU a small, basic, histone like protein is a major component of the bacterial nucleoid. E. coli has two subunits of HU coded by hupA and hupB genes whereas Mycobacterium tuberculosis (Mtb) has only one subunit of HU coded by ORF Rv2986c (hupB gene). One noticeable feature regarding Mtb HupB, based on sequence alignment of HU orthologs from different bacteria, was that HupB(Mtb) bears at its C-terminal end, a highly basic extension and this prompted an examination of its role in Mtb HupB function. Methodology/Principal Findings: With this objective two clones of Mtb HupB were generated; one expressing full length HupB protein (HupB(Mtb)) and another which expresses only the N terminal region (first 95 amino acid) of hupB (HupB(MtbN)). Gel retardation assays revealed that HupBMtbN is almost like E. coli HU (heat stable nucleoid protein) in terms of its DNA binding, with a binding constant (K(d)) for linear dsDNA greater than 1000 nM, a value comparable to that obtained for the HU alpha alpha and HU alpha beta forms. However CTR (C-terminal Region) of HupB(Mtb) imparts greater specificity in DNA binding. HupB(Mtb) protein binds more strongly to supercoiled plasmid DNA than to linear DNA, also this binding is very stable as it provides DNase I protection even up to 5 minutes. Similar results were obtained when the abilities of both proteins to mediate protection against DNA strand cleavage by hydroxyl radicals generated by the Fenton's reaction, were compared. It was also observed that both the proteins have DNA binding preference for A: T rich DNA which may occur at the regulatory regions of ORFs and the oriC region of Mtb. Conclusions/Significance: These data thus point that HupB(Mtb) may participate in chromosome organization in-vivo, it may also play a passive, possibly an architectural role.	[Kumar, Sandeep] Ctr DNA Fingerprinting & Diagnost, Mol & Cellular Biol Lab, Hyderabad, Andhra Pradesh, India; [Sardesai, Abhijit A.] Ctr DNA Fingerprinting & Diagnost, Lab Bacterial Genet, Hyderabad, Andhra Pradesh, India; [Basu, Debashree] Ctr DNA Fingerprinting & Diagnost, Struct Biol Lab, Hyderabad, Andhra Pradesh, India; [Muniyappa, Kalappagowda] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Hasnain, Seyed E.] Univ Hyderabad Campus, Inst Life Sci, Hyderabad 500134, Andhra Pradesh, India; [Hasnain, Seyed E.] Univ Hyderabad, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India; [Hasnain, Seyed E.] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Indian Institute of Science (IISC) - Bangalore; University of Hyderabad; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Kumar, S (corresponding author), Ctr DNA Fingerprinting & Diagnost, Mol & Cellular Biol Lab, Hyderabad, Andhra Pradesh, India.	seh@uohyd.ernet.in	KUMAR, SANDEEP/GZA-7182-2022	Hasnain, Seyed/0000-0002-2967-0791	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India; Council of Scientific and Industrial Research (CSIR), Government of India	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was partly supported by research grant under the "Centre of Excellence" to SEH from the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India; SK and DB thank the Council of Scientific and Industrial Research (CSIR), Government of India for Senior Research Fellowships. KM and SEH are JC Bose National Fellows. SEH is a Robert Koch Fellow of the Robert Koch Institute, Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN A, 1979, BIOCHEM BIOPH RES CO, V91, P461, DOI 10.1016/0006-291X(79)91544-4; Azam TA, 2000, GENES CELLS, V5, P613, DOI 10.1046/j.1365-2443.2000.00350.x; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; BONNEFOY E, 1991, EMBO J, V10, P687, DOI 10.1002/j.1460-2075.1991.tb07998.x; BOUBRIK F, 1995, P NATL ACAD SCI USA, V92, P3958, DOI 10.1073/pnas.92.9.3958; BRAMHILL D, 1988, CELL, V54, P915, DOI 10.1016/0092-8674(88)90102-X; Claret L, 1997, J MOL BIOL, V273, P93, DOI 10.1006/jmbi.1997.1310; Dame RT, 2005, MOL MICROBIOL, V56, P858, DOI 10.1111/j.1365-2958.2005.04598.x; DRLICA K, 1987, MICROBIOL REV, V51, P301, DOI 10.1128/MMBR.51.3.301-319.1987; Furugen M, 2001, MICROB PATHOGENESIS, V30, P129, DOI 10.1006/mpat.2000.0416; Ghosh S, 2004, BIOTECHNIQUES, V37, P418, DOI 10.2144/04373ST07; HODGESGARCIA Y, 1989, J BIOL CHEM, V264, P14621; HWANG DS, 1992, J BIOL CHEM, V267, P23083; JOHNSON RC, 1986, CELL, V46, P531, DOI 10.1016/0092-8674(86)90878-0; Kamashev D, 1999, EMBO J, V18, P5434, DOI 10.1093/emboj/18.19.5434; Kamashev D, 2000, EMBO J, V19, P6527, DOI 10.1093/emboj/19.23.6527; Kar S, 2006, J BIOL CHEM, V281, P40144, DOI 10.1074/jbc.M605576200; Kumar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004139; Lavoie BD, 1996, CELL, V85, P761, DOI 10.1016/S0092-8674(00)81241-6; Li SS, 1998, J BACTERIOL, V180, P3750, DOI 10.1128/JB.180.15.3750-3756.1998; MICKA B, 1991, J BACTERIOL, V173, P3191, DOI 10.1128/JB.173.10.3191-3198.1991; Mueller-Ortiz SL, 2002, INFECT IMMUN, V70, P6751, DOI 10.1128/IAI.70.12.6751-6760.2002; Mukherjee A, 2008, BIOCHEMISTRY-US, V47, P8744, DOI 10.1021/bi800010s; PACI M, 1984, EUR J BIOCHEM, V138, P193, DOI 10.1111/j.1432-1033.1984.tb07899.x; PETTIJOHN DE, 1976, CRC CR REV BIOCH MOL, V4, P175, DOI 10.3109/10409237609105458; Pinson V, 1999, J MOL BIOL, V287, P485, DOI 10.1006/jmbi.1999.2631; PONTIGGIA A, 1993, MOL MICROBIOL, V7, P343, DOI 10.1111/j.1365-2958.1993.tb01126.x; Prabhakar S, 2004, J CLIN MICROBIOL, V42, P2724, DOI 10.1128/JCM.42.6.2724-2732.2004; Prabhakar S., 1998, Tubercle and Lung Disease, V79, P43, DOI 10.1054/tuld.1998.0004; Prakash P, 2005, J BIOL CHEM, V280, P19641, DOI 10.1074/jbc.M413026200; Ross MA, 2000, J BACTERIOL, V182, P1942, DOI 10.1128/JB.182.7.1942-1948.2000; ROUVIEREYANIV J, 1975, P NATL ACAD SCI USA, V72, P3428, DOI 10.1073/pnas.72.9.3428; ROUVIEREYANIV J, 1979, CELL, V17, P265, DOI 10.1016/0092-8674(79)90152-1; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SHINDO H, 1992, NUCLEIC ACIDS RES, V20, P1553, DOI 10.1093/nar/20.7.1553; STENZEL TT, 1987, CELL, V49, P709, DOI 10.1016/0092-8674(87)90547-2; Swinger KK, 2007, J MOL BIOL, V365, P1005, DOI 10.1016/j.jmb.2006.10.024; Swinger KK, 2003, EMBO J, V22, P3749, DOI 10.1093/emboj/cdg351; Wery M, 2001, BIOCHIMIE, V83, P193, DOI 10.1016/S0300-9084(01)01254-8	39	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12551	10.1371/journal.pone.0012551	http://dx.doi.org/10.1371/journal.pone.0012551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824060	Green Submitted, Green Published, gold			2022-12-27	WOS:000281480900029
J	Reganold, JP; Andrews, PK; Reeve, JR; Carpenter-Boggs, L; Schadt, CW; Alldredge, JR; Ross, CF; Davies, NM; Zhou, JZ				Reganold, John P.; Andrews, Preston K.; Reeve, Jennifer R.; Carpenter-Boggs, Lynne; Schadt, Christopher W.; Alldredge, J. Richard; Ross, Carolyn F.; Davies, Neal M.; Zhou, Jizhong			Fruit and Soil Quality of Organic and Conventional Strawberry Agroecosystems	PLOS ONE			English	Article							NUTRITIONAL QUALITY; ENZYME-ACTIVITIES; FOOD; BIODIVERSITY; ANTIOXIDANTS; COMMUNITIES; PERFORMANCE; MICROARRAY; FLAVONOIDS; VEGETABLES	Background: Sale of organic foods is one of the fastest growing market segments within the global food industry. People often buy organic food because they believe organic farms produce more nutritious and better tasting food from healthier soils. Here we tested if there are significant differences in fruit and soil quality from 13 pairs of commercial organic and conventional strawberry agroecosystems in California. Methodology/Principal Findings: At multiple sampling times for two years, we evaluated three varieties of strawberries for mineral elements, shelf life, phytochemical composition, and organoleptic properties. We also analyzed traditional soil properties and soil DNA using microarray technology. We found that the organic farms had strawberries with longer shelf life, greater dry matter, and higher antioxidant activity and concentrations of ascorbic acid and phenolic compounds, but lower concentrations of phosphorus and potassium. In one variety, sensory panels judged organic strawberries to be sweeter and have better flavor, overall acceptance, and appearance than their conventional counterparts. We also found the organically farmed soils to have more total carbon and nitrogen, greater microbial biomass and activity, and higher concentrations of micronutrients. Organically farmed soils also exhibited greater numbers of endemic genes and greater functional gene abundance and diversity for several biogeochemical processes, such as nitrogen fixation and pesticide degradation. Conclusions/Significance: Our findings show that the organic strawberry farms produced higher quality fruit and that their higher quality soils may have greater microbial functional capability and resilience to stress. These findings justify additional investigations aimed at detecting and quantifying such effects and their interactions.	[Reganold, John P.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Andrews, Preston K.] Washington State Univ, Dept Hort & Landscape Architecture, Pullman, WA 99164 USA; [Reeve, Jennifer R.] Utah State Univ, Dept Plants Soils & Climate, Logan, UT 84322 USA; [Carpenter-Boggs, Lynne] Washington State Univ, Ctr Sustaining Agr & Nat Resources, Pullman, WA 99164 USA; [Schadt, Christopher W.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [Alldredge, J. Richard] Washington State Univ, Dept Stat, Pullman, WA 99164 USA; [Ross, Carolyn F.] Washington State Univ, Sch Food Sci, Pullman, WA 99164 USA; [Davies, Neal M.] Washington State Univ, Dept Pharmaceut Sci, Pullman, WA 99164 USA; [Zhou, Jizhong] Univ Oklahoma, Dept Bot & Microbiol, Inst Environm Genom, Norman, OK 73019 USA	Washington State University; Washington State University; Utah System of Higher Education; Utah State University; Washington State University; United States Department of Energy (DOE); Oak Ridge National Laboratory; Washington State University; Washington State University; Washington State University; University of Oklahoma System; University of Oklahoma - Norman	Reganold, JP (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	reganold@wsu.edu	Reeve, Jennifer/G-7148-2011; Davies, Neal M/J-5811-2013; Schadt, Christopher W./B-7143-2008; Schadt, Christopher/M-8746-2019; 吴, 昊/AAB-1620-2020	Schadt, Christopher W./0000-0001-8759-2448; Schadt, Christopher/0000-0001-8759-2448; Carpenter-Boggs, Lynne/0000-0002-3903-406X	United States Department of Agriculture through the National Science Foundation/U.S. Department of Agriculture Microbial Observatories Program; Department of Energy Office of Biological and Environmental Research; Organic Center	United States Department of Agriculture through the National Science Foundation/U.S. Department of Agriculture Microbial Observatories Program; Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); Organic Center	The project was supported by the United States Department of Agriculture through the National Science Foundation/U.S. Department of Agriculture Microbial Observatories Program, the Department of Energy Office of Biological and Environmental Research, and The Organic Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADASKAVEG JD, 2009, EFFICACY TIMING FUNG; ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; Andren O., 1995, The significance and regulation of soil biodiversity: Proceedings International Symposium Michigan State University, East Lansing, May 3-6, 1993., P141; Andrews PK, 2004, PHYSIOL PLANTARUM, V120, P519, DOI 10.1111/j.0031-9317.2004.0279.x; Arnao MB, 2001, FOOD CHEM, V73, P239, DOI 10.1016/S0308-8146(00)00324-1; Baker BP, 2002, FOOD ADDIT CONTAM, V19, P427, DOI 10.1080/02652030110113799; Benbrook C., 2008, NEW EVIDENCE CONFIRM; Boulanger B, 2009, J CHROMATOGR B, V877, P2235, DOI 10.1016/j.jchromb.2009.06.019; Bourn D, 2002, CRIT REV FOOD SCI, V42, P1, DOI 10.1080/10408690290825439; Branch SK, 2005, J PHARMACEUT BIOMED, V38, P798, DOI 10.1016/j.jpba.2005.02.037; Brandt K, 2001, J SCI FOOD AGR, V81, P924, DOI 10.1002/jsfa.903; BRINGHURST FR, 1998, WILLIAMS TXB ENDOCRI, P1155; Cano A, 1998, PHYTOCHEM ANALYSIS, V9, P196, DOI 10.1002/(SICI)1099-1565(199807/08)9:4&lt;196::AID-PCA395&gt;3.0.CO;2-W; Chun OK, 2005, J SCI FOOD AGR, V85, P1715, DOI 10.1002/jsfa.2176; Curl CL, 2003, ENVIRON HEALTH PERSP, V111, P377, DOI 10.1289/ehp.5754; Dangour AD, 2009, AM J CLIN NUTR, V90, P680, DOI 10.3945/ajcn.2009.28041; DORAN JW, 1994, SSSA SPEC PUBL, P3; Drewnowski A, 2005, AM J CLIN NUTR, V82, P721, DOI 10.1093/ajcn/82.4.721; Engelen B, 1998, APPL ENVIRON MICROB, V64, P2814; Food and Agriculture Organization, 2009, FAOSTAT; [Food and Nutrition Board Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference Intakes], 1997, DIET REF INT CALC PH, DOI 10.17226/5776; FOYER C, 1983, PLANTA, V157, P239, DOI 10.1007/BF00405188; GAVLAK R, 2003, PUBLICATION COLORADO; Granatstein D., 1992, American Journal of Alternative Agriculture, V7, P12, DOI 10.1017/S0889189300004380; Greene C., 2009, EMERGING ISSUES US O; GUERENA M, 2007, STRAWBERRIES ORGANIC; Halliwell B, 2005, AM J CLIN NUTR, V81, p268S, DOI 10.1093/ajcn/81.1.268S; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; Ibekwe AM, 2001, APPL ENVIRON MICROB, V67, P3245, DOI 10.1128/AEM.67.7.3245-3257.2001; Ibekwe AM, 2004, ADV AGRON, V83, P1, DOI 10.1016/S0065-2113(04)83001-3; ISO, 2003, 4121 ISO; Kalbfleisch R.L, 2011, STAT ANAL FAILURE TI; Kilcher L, 2009, WORLD ORGANIC AGR ST, P25; Klose S, 2004, SOIL BIOL BIOCHEM, V36, P1625, DOI 10.1016/j.soilbio.2004.07.009; LADD J N, 1972, Soil Biology and Biochemistry, V4, P19, DOI 10.1016/0038-0717(72)90038-7; LAIRON D, 2010, AGRON SUSTAIN DEV, V30, P33, DOI DOI 10.1051/AGRO/2009019; Lockie S, 2006, ORGANIC AGRICULTURE: A GLOBAL PERSPECTIVE, P245, DOI 10.1079/9781845931698.0245; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lu CS, 2006, ENVIRON HEALTH PERSP, V114, P260, DOI 10.1289/ehp.8418; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Magkos F, 2003, INT J FOOD SCI NUTR, V54, P357, DOI [10.1080/09637480120092071, 10.1080/096374803767755814]; MCCANCE RA, 2002, COMPOSITION FOODS; MCGUIRE RG, 1992, HORTSCIENCE, V27, P1254, DOI 10.21273/HORTSCI.27.12.1254; Olsson ME, 2006, J AGR FOOD CHEM, V54, P1248, DOI 10.1021/jf0524776; Otten J.J., 2006, DIETARY REFERENCE IN, DOI DOI 10.17226/11537; Reeve JR, 2010, ISME J, V4, P1099, DOI 10.1038/ismej.2010.42; Reganold JP, 2001, NATURE, V410, P926, DOI 10.1038/35073574; REGANOLD JP, 1993, SCIENCE, V260, P344, DOI 10.1126/science.260.5106.344; Rembialkowska E, 2007, J SCI FOOD AGR, V87, P2757, DOI 10.1002/jsfa.3000; Rhee SK, 2004, APPL ENVIRON MICROB, V70, P4303, DOI 10.1128/AEM.70.7.4303-4317.2004; Scalbert A, 2005, AM J CLIN NUTR, V81, p215S, DOI 10.1093/ajcn/81.1.215S; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Smith J.L., 2002, ENCY ENV MICROBIOLOG, P2944; Soil Association, 2000, ORG FARM FOOD QUAL H; Southgate DAT, 1976, DETERMINATION FOOD C; Stromberger ME, 2005, SOIL SCI SOC AM J, V69, P1987, DOI 10.2136/sssaj2005.0076; SYLVIA DM, 1994, METHODS SOIL ANAL 2, P351; Tabatabai M. A., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P903; Torres CA, 2005, J AGR FOOD CHEM, V53, P9536, DOI 10.1021/jf051176t; Trewavas A, 2004, CROP PROT, V23, P757, DOI 10.1016/j.cropro.2004.01.009; TRUSWELL A S, 1991, Journal of Food Composition and Analysis, V4, P18, DOI 10.1016/0889-1575(91)90045-8; USDA Agricultural Research Service, 2009, USDA NAT NUTR DAT ST; van Eijk T, 2000, HISTORY OF FARMING SYSTEMS RESEARCH, P323, DOI 10.1079/9780851994055.0323; Weil R. R., 2004, Soil organic matter in sustainable agriculture, P1, DOI 10.1201/9780203496374.ch1; *WHO, 2004, WHO FAO PUBL; Williams CM, 2002, P NUTR SOC, V61, P19, DOI 10.1079/PNS2001126; WOODWARD JR, 1972, J SCI FOOD AGR, V23, P465, DOI 10.1002/jsfa.2740230406; Worthington V, 2001, J ALTERN COMPLEM MED, V7, P161, DOI 10.1089/107555301750164244; Wu LY, 2006, APPL ENVIRON MICROB, V72, P4931, DOI 10.1128/AEM.02738-05; Yanez JA, 2005, J PHARMACEUT BIOMED, V39, P164, DOI 10.1016/j.jpba.2005.02.025; Zak DR, 2006, TRENDS ECOL EVOL, V21, P288, DOI 10.1016/j.tree.2006.04.003; Zelles L, 1997, SOIL BIOL BIOCHEM, V29, P1325, DOI 10.1016/S0038-0717(97)00062-X; Zhou JZ, 2008, P NATL ACAD SCI USA, V105, P7768, DOI 10.1073/pnas.0709016105; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	74	139	145	4	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12346	10.1371/journal.pone.0012346	http://dx.doi.org/10.1371/journal.pone.0012346			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824185	Green Published, gold			2022-12-27	WOS:000281456100001
J	Reveiz, L; Chan, AW; Krleza-Jeric, K; Granados, CE; Pinart, M; Etxeandia, I; Rada, D; Martinez, M; Bonfill, X; Cardona, AF				Reveiz, Ludovic; Chan, An-Wen; Krleza-Jeric, Karmela; Eduardo Granados, Carlos; Pinart, Mariona; Etxeandia, Itziar; Rada, Diego; Martinez, Monserrat; Bonfill, Xavier; Felipe Cardona, Andres			Reporting of Methodologic Information on Trial Registries for Quality Assessment: A Study of Trial Records Retrieved from the WHO Search Portal	PLOS ONE			English	Article							RANDOMIZED-TRIALS; INTERNATIONAL-COMMITTEE; CLINICAL-TRIALS; REGISTRATION; STATEMENT; PROTOCOLS; TRANSPARENCY; PUBLICATIONS; OUTCOMES	Background: Although randomized clinical trials (RCTs) are considered the gold standard of evidence, their reporting is often suboptimal. Trial registries have the potential to contribute important methodologic information for critical appraisal of study results. Methods and Findings: The objective of the study was to evaluate the reporting of key methodologic study characteristics in trial registries. We identified a random sample (n=265) of actively recruiting RCTs using the World Health Organization International Clinical Trials Registry Platform (ICTRP) search portal in 2008. We assessed the reporting of relevant domains from the Cochrane Collaboration's 'Risk of bias' tool and other key methodological aspects. Our primary outcomes were the proportion of registry records with adequate reporting of random sequence generation, allocation concealment, blinding, and trial outcomes. Two reviewers independently assessed each record. Weighted overall proportions in the ICTRP search portal for adequate reporting of sequence generation, allocation concealment, blinding (including and excluding open label RCT) and primary outcomes were 5.7% (95% CI 3.0-8.4%), 1.4% (0-2.8%), 41% (35-47%), 8.4% (4.1-13%), and 66% (60-72%), respectively. The proportion of adequately reported RCTs was higher for registries that used specific methodological fields for describing methods of randomization and allocation concealment compared to registries that did not. Concerning other key methodological aspects, weighted overall proportions of RCTs with adequately reported items were as follows: eligibility criteria (81%), secondary outcomes (46%), harm (5%) follow-up duration (62%), description of the interventions (53%) and sample size calculation (1%). Conclusions: Trial registries currently contain limited methodologic information about registered RCTs. In order to permit adequate critical appraisal of trial results reported in journals and registries, trial registries should consider requesting details on key RCT methods to complement journal publications. Full protocols remain the most comprehensive source of methodologic information and should be made publicly available.	[Reveiz, Ludovic] Sanitas Univ Fdn, Res Inst, Bogota, Colombia; [Chan, An-Wen] Univ Toronto, Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Krleza-Jeric, Karmela] Canadian Inst Hlth Res, Knowledge Synth & Exchange Branch, Ottawa, ON, Canada; [Eduardo Granados, Carlos] Univ Nacl Colombia, Res Inst, Bogota, Colombia; [Pinart, Mariona] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis Sect, London, England; [Etxeandia, Itziar] Cruces Hosp, Clin Epidemiol Unit, Bilbao, Spain; [Etxeandia, Itziar] Osteba Basque Off HTA, Dept Hlth, Bilbao, Spain; [Rada, Diego] Unidad Invest Atenc Primaria, Bilbao, Spain; [Martinez, Monserrat] Univ Lleida, Inst Recerca Biomed Lleida, Catalonia, Spain; [Bonfill, Xavier] Hosp Santa Creu & Sant Pau, Serv Epidemiol Clin & Salud Publ, Barcelona, Spain; [Felipe Cardona, Andres] Fdn Santa Fe Bogota, Clin & Translat Oncol Grp, Bogota, Colombia	University of Toronto; University Toronto Affiliates; Womens College Hospital; Institute for Work & Health; Universidad Nacional de Colombia; Imperial College London; Hospital Universitario Cruces; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; Hospital of Santa Creu i Sant Pau; Clinica del Country - Unidad Medica	Reveiz, L (corresponding author), Sanitas Univ Fdn, Res Inst, Bogota, Colombia.	lreveiz@yahoo.com	ETXEANDIA-IKOBALTZETA, ITZIAR/AFK-4845-2022; Pinart Gilberga, Mariona/GLS-8842-2022; Pinart, Mariona/L-1931-2015; ETXEANDIA-IKOBALTZETA, ITZIAR/AAG-3519-2022; Martínez-Alonso, Montserrat/B-5582-2009; Krleza-Jeric, Karmela/M-5253-2018	ETXEANDIA-IKOBALTZETA, ITZIAR/0000-0001-6606-649X; Pinart Gilberga, Mariona/0000-0002-8223-1325; Pinart, Mariona/0000-0002-8223-1325; ETXEANDIA-IKOBALTZETA, ITZIAR/0000-0001-6606-649X; Martínez-Alonso, Montserrat/0000-0003-1504-8552; Rada, Diego/0000-0002-9109-1088; Krleza-Jeric, Karmela/0000-0001-9377-0917; Granados, Carlos E/0000-0002-1663-4273; Bonfill Cosp, Xavier/0000-0003-1530-3509; Cardona, Andres/0000-0003-3525-4126	Ibero-American Cochrane Centre	Ibero-American Cochrane Centre	The authors wish to acknowledge the Ibero-American Cochrane Centre for his support. Ludovic Reveiz is a PhD candidate at the Universitat Autonoma de Barcelona.	Al-Marzouki S, 2008, LANCET, V372, P201, DOI 10.1016/S0140-6736(08)61060-0; [Anonymous], 2010, LANCET, V375, P1225, DOI 10.1016/S0140-6736(10)60523-5; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Chan AW, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2299; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; De Angelis CD, 2005, ANN INTERN MED, V143, P146, DOI 10.7326/0003-4819-143-2-200507190-00016; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Drazen JM, 2007, NEW ENGL J MED, V356, P184, DOI 10.1056/NEJMe068291; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Krleza-Jeric K, 2005, BMJ-BRIT MED J, V330, P956, DOI 10.1136/bmj.330.7497.956; Krleza-Jeric K, 2009, CROAT MED J, V50, P105, DOI 10.3325/cmj.2009.50.105; Krleza-Jeric Karmela, 2008, Croat Med J, V49, P267; Laine C, 2007, ANN INTERN MED, V147, P275, DOI 10.7326/0003-4819-147-4-200708210-00166; Marusic A, 2008, CROAT MED J, V49, P582, DOI 10.3325/cmj.2008.5.582; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Moja Lorenzo P, 2009, Trials, V10, P56, DOI 10.1186/1745-6215-10-56; Pildal J, 2005, BMJ-BRIT MED J, V330, P1049, DOI 10.1136/bmj.38414.422650.8F; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Scharf O, 2006, J CLIN ONCOL, V24, P3933, DOI 10.1200/JCO.2005.05.3959; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Sekeres M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001610; Sim I, 2006, LANCET, V367, P1631, DOI 10.1016/S0140-6736(06)68708-4; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; WHO, 2006, WHO INT CLIN TRIALS; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234; 2006, NEWSLETTER VHL  0901	28	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12484	10.1371/journal.pone.0012484	http://dx.doi.org/10.1371/journal.pone.0012484			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824212	Green Published, gold, Green Submitted			2022-12-27	WOS:000281405300012
J	Hsu, HJ; Lee, CF; Locke, A; Vanderzyl, SQ; Kaunas, R				Hsu, Hui-Ju; Lee, Chin-Fu; Locke, Andrea; Vanderzyl, Susan Q.; Kaunas, Roland			Stretch-Induced Stress Fiber Remodeling and the Activations of JNK and ERK Depend on Mechanical Strain Rate, but Not FAK	PLOS ONE			English	Article							FOCAL ADHESION KINASE; SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; MAPK ACTIVATION; TYROSINE PHOSPHORYLATION; DYNAMIC REORIENTATION; CYCLIC STRETCH; FIBROBLASTS; ACTIN; RESPONSES	Background: Cells within tissues are subjected to mechanical forces caused by extracellular matrix deformation. Cells sense and dynamically respond to stretching of the matrix by reorienting their actin stress fibers and by activating intracellular signaling proteins, including focal adhesion kinase (FAK) and the mitogen-activated proteins kinases (MAPKs). Theoretical analyses predict that stress fibers can relax perturbations in tension depending on the rate of matrix strain. Thus, we hypothesized stress fiber organization and MAPK activities are altered to an extent dependent on stretch frequency. Principal Findings: Bovine aortic endothelial cells and human osteosarcoma cells expressing GFP-actin were cultured on elastic membranes and subjected to various patterns of stretch. Cyclic stretching resulted in strain rate-dependent increases in stress fiber alignment, cell retraction, and the phosphorylation of the MAPKs JNK, ERK and p38. Transient step changes in strain rate caused proportional transient changes in the levels of JNK and ERK phosphorylations without affecting stress fiber organization. Disrupting stress fiber contractile function with cytochalasin D or Y27632 decreased the levels of JNK and ERK phosphorylation. Previous studies indicate that FAK is required for stretch-induced cell alignment and MAPK activations. However, cyclic uniaxial stretching induced stress fiber alignment and the phosphorylation of JNK, ERK and p38 to comparable levels in FAK-null and FAK-expressing mouse embryonic fibroblasts. Conclusions: These results indicate that cyclic stretch-induced stress fiber alignment, cell retraction, and MAPK activations occur as a consequence of perturbations in fiber strain. These findings thus shed new light into the roles of stress fiber relaxation and reorganization in maintenance of tensional homeostasis in a dynamic mechanical environment.	[Hsu, Hui-Ju; Lee, Chin-Fu; Locke, Andrea; Vanderzyl, Susan Q.; Kaunas, Roland] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Hsu, HJ (corresponding author), Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.	rkaunas@tamu.edu			American Heart Association [0730238N]; National Science Foundation [0854129]; Directorate For Engineering [0854129] Funding Source: National Science Foundation	American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was funded by grants from the American Heart Association (0730238N) and the National Science Foundation (0854129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa R, 2002, HYPERTENSION, V39, P233, DOI 10.1161/hy0202.102699; Brown RA, 1998, J CELL PHYSIOL, V175, P323, DOI 10.1002/(SICI)1097-4652(199806)175:3<323::AID-JCP10>3.0.CO;2-6; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Costa KD, 2002, CELL MOTIL CYTOSKEL, V52, P266, DOI 10.1002/cm.10056; De R, 2007, NAT PHYS, V3, P655, DOI 10.1038/nphys680; Deguchi S, 2006, J BIOMECH, V39, P2603, DOI 10.1016/j.jbiomech.2005.08.026; Gavara N, 2008, BIOPHYS J, V95, P464, DOI 10.1529/biophysj.107.124180; Goeckeler ZM, 2008, AM J PHYSIOL-CELL PH, V295, pC994, DOI 10.1152/ajpcell.00318.2008; Hayakawa K, 2001, EXP CELL RES, V268, P104, DOI 10.1006/excr.2001.5270; Hoefen RJ, 2002, VASC PHARMACOL, V38, P271, DOI 10.1016/S1537-1891(02)00251-3; Hosokawa H, 2002, BIOL PHARM BULL, V25, P1588, DOI 10.1248/bpb.25.1588; Hsu HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004853; Humphrey JD., 2002, CARDIOVASCULAR SOLID; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Jungbauer S, 2008, BIOPHYS J, V95, P3470, DOI 10.1529/biophysj.107.128611; Katsumi A, 2005, J BIOL CHEM, V280, P16546, DOI 10.1074/jbc.C400455200; Kaunas R, 2006, CELL SIGNAL, V18, P1924, DOI 10.1016/j.cellsig.2006.02.008; Kito H, 2000, J APPL PHYSIOL, V89, P2391, DOI 10.1152/jappl.2000.89.6.2391; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Lu L, 2008, CELL MOTIL CYTOSKEL, V65, P281, DOI 10.1002/cm.20260; MacKenna DA, 1998, J CLIN INVEST, V101, P301, DOI 10.1172/JCI1026; Martineau LC, 2001, J APPL PHYSIOL, V91, P693, DOI 10.1152/jappl.2001.91.2.693; Mofrad M R Kaazempur, 2004, Mech Chem Biosyst, V1, P253; Nadruz W, 2005, CARDIOVASC RES, V68, P87, DOI 10.1016/j.cardiores.2005.05.011; Naruse K, 1998, ONCOGENE, V17, P455, DOI 10.1038/sj.onc.1201950; Nekouzadeh A, 2008, J BIOMECH, V41, P2964, DOI 10.1016/j.jbiomech.2008.07.033; NEREM RM, 1981, J BIOMECH ENG-T ASME, V103, P172, DOI 10.1115/1.3138275; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Petzold T, 2009, AM J PHYSIOL-CELL PH, V297, pC814, DOI 10.1152/ajpcell.00226.2009; Pradhan S, 2004, FRONT BIOSCI-LANDMRK, V9, P3276, DOI 10.2741/1480; Qu MJ, 2007, J VASC RES, V44, P345, DOI 10.1159/000102278; Sai XR, 1999, J CELL SCI, V112, P1365; Sato K, 2005, J BIOMECH, V38, P1895, DOI 10.1016/j.jbiomech.2004.08.012; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Shemesh T, 2005, P NATL ACAD SCI USA, V102, P12383, DOI 10.1073/pnas.0500254102; Tilghman RW, 2008, SEMIN CANCER BIOL, V18, P45, DOI 10.1016/j.semcancer.2007.08.002; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Wang JG, 2001, BIOCHEM BIOPH RES CO, V288, P356, DOI 10.1006/bbrc.2001.5775	39	123	124	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12470	10.1371/journal.pone.0012470	http://dx.doi.org/10.1371/journal.pone.0012470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20814573	Green Submitted, Green Published, gold			2022-12-27	WOS:000281375500005
J	Nickens, DG; Bardiya, N; Patterson, JT; Burke, DH				Nickens, David G.; Bardiya, Nirmala; Patterson, James T.; Burke, Donald H.			Template-Directed Ligation of Tethered Mononucleotides by T4 DNA Ligase for Kinase Ribozyme Selection	PLOS ONE			English	Article							PHOSPHORYLATING DNA; NUCLEIC-ACID; RNA; STABILIZATION; MECHANISM; PRIMERS; GROWTH; BASES; MOTIF	Background: In vitro selection of kinase ribozymes for small molecule metabolites, such as free nucleosides, will require partition systems that discriminate active from inactive RNA species. While nucleic acid catalysis of phosphoryl transfer is well established for phosphorylation of 5' or 2' OH of oligonucleotide substrates, phosphorylation of diffusible small molecules has not been demonstrated. Methodology/Principal Findings: This study demonstrates the ability of T4 DNA ligase to capture RNA strands in which a tethered monodeoxynucleoside has acquired a 5' phosphate. The ligation reaction therefore mimics the partition step of a selection for nucleoside kinase (deoxy)ribozymes. Ligation with tethered substrates was considerably slower than with nicked, fully duplex DNA, even though the deoxynucleotides at the ligation junction were Watson-Crick base paired in the tethered substrate. Ligation increased markedly when the bridging template strand contained unpaired spacer nucleotides across from the flexible tether, according to the trends: A(2)>A(1)>A(3)>A(4)>A(0)>A(6)>A(8)>A(10) and T-2>T-3>T-4>T-6 approximate to T-1>T-8>T-10. Bridging T's generally gave higher yield of ligated product than bridging A's. ATP concentrations above 33 mu M accumulated adenylated intermediate and decreased yields of the gap-sealed product, likely due to re-adenylation of dissociated enzyme. Under optimized conditions, T4 DNA ligase efficiently (>90%) joined a correctly paired, or T:G wobble-paired, substrate on the 3' side of the ligation junction while discriminating approximately 100-fold against most mispaired substrates. Tethered dC and dG gave the highest ligation rates and yields, followed by tethered deoxyinosine (dl) and dT, with the slowest reactions for tethered dA. The same kinetic trends were observed in ligase-mediated capture in complex reaction mixtures with multiple substrates. The "universal" analog 5-nitroindole (dNI) did not support ligation when used as the tethered nucleotide. Conclusions/Significance: Our results reveal a novel activity for T4 DNA ligase (template-directed ligation of a tethered mononucleotide) and establish this partition scheme as being suitable for the selection of ribozymes that phosphorylate mononucleoside substrates.	[Nickens, David G.; Patterson, James T.; Burke, Donald H.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Nickens, David G.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Bardiya, Nirmala; Burke, Donald H.] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO USA; [Bardiya, Nirmala; Burke, Donald H.] Univ Missouri, Dept Biochem, Columbia, MO USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Nickens, DG (corresponding author), Indiana Univ, Dept Chem, Bloomington, IN 47405 USA.	burkedh@missouri.edu		Patterson, James/0000-0001-6006-7184	National Aeronautics and Space Administration (NASA) [NAG5-12360]; David and Lucille Packard Foundation	National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); David and Lucille Packard Foundation(The David & Lucile Packard Foundation)	This work was supported by National Aeronautics and Space Administration (NASA) Exobiology award NAG5-12360 and by an Interdisciplinary Science Award from the David and Lucille Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RC, 2003, NUCLEIC ACIDS RES, V31, P3208, DOI 10.1093/nar/gkg415; Ball S, 1998, NUCLEIC ACIDS RES, V26, P5225, DOI 10.1093/nar/26.22.5225; BIONDI E, 2010, NUCL ACIDS IN PRESS; Burke DH, 2004, MOL B INT U, P48; Chen IA, 2004, BIOPHYS J, V87, P988, DOI 10.1529/biophysj.104.039875; Chen X, 2007, CHEM BIODIVERS, V4, P633, DOI 10.1002/cbdv.200790055; Cherepanov AV, 2003, EUR J BIOCHEM, V270, P4315, DOI 10.1046/j.1432-1033.2003.03824.x; Chiuman W, 2002, BIOORG CHEM, V30, P332, DOI 10.1016/S0045-2068(02)00018-4; Cho BR, 2007, B KOR CHEM SOC, V28, P689; Cho B, 2006, RNA, V12, P2118, DOI 10.1261/rna.173506; Curtis EA, 2005, NAT STRUCT MOL BIOL, V12, P994, DOI 10.1038/nsmb1003; Doherty AJ, 2000, NUCLEIC ACIDS RES, V28, P4051, DOI 10.1093/nar/28.21.4051; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; Ho CK, 1997, J VIROL, V71, P1931, DOI 10.1128/JVI.71.3.1931-1937.1997; Jarvius Jonas, 2003, Methods Mol Biol, V212, P215; Jaschke A, 2001, CURR OPIN STRUC BIOL, V11, P321, DOI 10.1016/S0959-440X(00)00208-6; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; LANDEGREN U, 1988, SCIENCE, V241, P1077, DOI 10.1126/science.3413476; LEHMAN IR, 1974, SCIENCE, V186, P790; Li YF, 1999, P NATL ACAD SCI USA, V96, P2746, DOI 10.1073/pnas.96.6.2746; Liu PF, 2004, NUCLEIC ACIDS RES, V32, P4503, DOI 10.1093/nar/gkh781; LOAKES D, 1995, NUCLEIC ACIDS RES, V23, P2361, DOI 10.1093/nar/23.13.2361; LOAKES D, 1994, NUC ACIDS RES, V22; LORSCH JR, 1995, BIOCHEMISTRY-US, V34, P15315, DOI 10.1021/bi00046a041; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; Nilsson M, 2001, NUCLEIC ACIDS RES, V29, P578, DOI 10.1093/nar/29.2.578; RHEE S, 2010, ACTIVE SITE AS UNPUB; Rhee SS, 2004, ANAL BIOCHEM, V325, P137, DOI 10.1016/j.ab.2003.10.019; Rossi R, 1997, NUCLEIC ACIDS RES, V25, P2106, DOI 10.1093/nar/25.11.2106; Rumbaugh JA, 1997, J BIOL CHEM, V272, P22591, DOI 10.1074/jbc.272.36.22591; Saikia M, 2006, RNA, V12, P2025, DOI 10.1261/rna.208906; Saran D, 2005, BIOCHEMISTRY-US, V44, P15007, DOI 10.1021/bi051086h; Saran D, 2006, NUCLEIC ACIDS RES, V34, P3201, DOI 10.1093/nar/gkl413; Seelig B, 1999, CHEM BIOL, V6, P167, DOI 10.1016/S1074-5521(99)89008-5; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P525, DOI 10.1093/nar/26.2.525; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P4618, DOI 10.1093/nar/26.20.4618; Vallone PM, 1999, NUCLEIC ACIDS RES, V27, P3589, DOI 10.1093/nar/27.17.3589; Wang W, 2002, CHEM BIOL, V9, P507, DOI 10.1016/S1074-5521(02)00127-8; Wang Y, 2007, BIOCHEMISTRY-US, V46, P4962, DOI 10.1021/bi0621516	39	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12368	10.1371/journal.pone.0012368	http://dx.doi.org/10.1371/journal.pone.0012368			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20811490	Green Published, gold, Green Submitted			2022-12-27	WOS:000281154300009
J	Marsit, CJ; Houseman, EA; Christensen, BC; Gagne, L; Wrensch, MR; Nelson, HH; Wiemels, J; Zheng, SC; Wiencke, JK; Andrew, AS; Schned, AR; Karagas, MR; Kelsey, KT				Marsit, Carmen J.; Houseman, E. Andres; Christensen, Brock C.; Gagne, Luc; Wrensch, Margaret R.; Nelson, Heather H.; Wiemels, Joseph; Zheng, Shichun; Wiencke, John K.; Andrew, Angeline S.; Schned, Alan R.; Karagas, Margaret R.; Kelsey, Karl T.			Identification of Methylated Genes Associated with Aggressive Bladder Cancer	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; DNA METHYLATION; PROMOTER HYPERMETHYLATION; EPIGENETIC INACTIVATION; PROGNOSTIC MARKER; SFRP GENES; P53; PROGRESSION; EXPRESSION; PATTERNS	Approximately 500,000 individuals diagnosed with bladder cancer in the U. S. require routine cystoscopic follow-up to monitor for disease recurrences or progression, resulting in over $2 billion in annual expenditures. Identification of new diagnostic and monitoring strategies are clearly needed, and markers related to DNA methylation alterations hold great promise due to their stability, objective measurement, and known associations with the disease and with its clinical features. To identify novel epigenetic markers of aggressive bladder cancer, we utilized a high-throughput DNA methylation bead-array in two distinct population-based series of incident bladder cancer (n = 73 and n = 264, respectively). We then validated the association between methylation of these candidate loci with tumor grade in a third population (n = 245) through bisulfite pyrosequencing of candidate loci. Array based analyses identified 5 loci for further confirmation with bisulfite pyrosequencing. We identified and confirmed that increased promoter methylation of HOXB2 is significantly and independently associated with invasive bladder cancer and methylation of HOXB2, KRT13 and FRZB together significantly predict high-grade non-invasive disease. Methylation of these genes may be useful as clinical markers of the disease and may point to genes and pathways worthy of additional examination as novel targets for therapeutic treatment.	[Marsit, Carmen J.; Christensen, Brock C.; Gagne, Luc; Kelsey, Karl T.] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA; [Marsit, Carmen J.; Houseman, E. Andres; Christensen, Brock C.; Kelsey, Karl T.] Brown Univ, Dept Community Hlth, Ctr Environm Hlth & Technol, Providence, RI 02912 USA; [Wrensch, Margaret R.; Wiemels, Joseph; Zheng, Shichun; Wiencke, John K.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Nelson, Heather H.] Univ Minnesota, Div Epidemiol & Community Hlth, Mason Canc Ctr, Minneapolis, MN USA; [Andrew, Angeline S.; Karagas, Margaret R.] Dartmouth Med Sch, Epidemiol & Biostat Sect, Dept Community & Family Med, Lebanon, NH USA; [Schned, Alan R.] Dartmouth Med Sch, Dept Pathol, Lebanon, NH USA	Brown University; Brown University; University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; Dartmouth College; Dartmouth College	Marsit, CJ (corresponding author), Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.	carmen_marsit@brown.edu	Kelsey, Karl T/I-1252-2014; Gagne, Luc/G-5528-2010; Christensen, Brock/B-8460-2009	Gagne, Luc/0000-0003-2998-1132; Houseman, Eugene Andres/0000-0003-0703-1830; Nelson, Heather/0000-0003-1901-9513; Marsit, Carmen/0000-0003-4566-150X	Flight Attendant Medical Research Institute [YCSA 052341]; National Institutes of Health [R01CA121147, K07CA102327, P42ES007373]; NATIONAL CANCER INSTITUTE [K07CA102327, R01CA121147, P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007373] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Flight Attendant Medical Research Institute [YCSA 052341 to C.J.M.]; and the National Institutes of Health [R01CA121147, K07CA102327, and P42ES007373]. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Aleman A, 2008, BRIT J CANCER, V98, P466, DOI 10.1038/sj.bjc.6604143; Aleman A, 2008, CLIN CANCER RES, V14, P8236, DOI 10.1158/1078-0432.CCR-08-0778; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Baris D, 2009, JNCI-J NATL CANCER I, V101, P1553, DOI 10.1093/jnci/djp361; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carrilho C, 2004, HUM PATHOL, V35, P546, DOI 10.1016/j.humpath.2004.01.021; Cashen AF, 2008, CANCER CHEMOTH PHARM, V61, P759, DOI 10.1007/s00280-007-0531-7; Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744; Christensen BC, 2009, CANCER RES, V69, P227, DOI 10.1158/0008-5472.CAN-08-2586; Dinney CPN, 2004, CANCER CELL, V6, P111, DOI 10.1016/j.ccr.2004.08.002; Esteller M, 2003, ADV EXP MED BIOL, V532, P39; Esuvaranathan K, 2007, CANCER-AM CANCER SOC, V109, P1097, DOI 10.1002/cncr.22503; Fleshner N, 2000, J UROLOGY, V164, P1177, DOI 10.1016/S0022-5347(05)67136-4; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; GARDINER RA, 1994, BRIT J UROL, V73, P526, DOI 10.1111/j.1464-410X.1994.tb07638.x; Grossman HB, 1998, CLIN CANCER RES, V4, P829; Hemal AK, 2003, UROL INT, V70, P42, DOI 10.1159/000067703; Hoque MO, 2006, JNCI-J NATL CANCER I, V98, P996, DOI 10.1093/jnci/djj265; Houseman EA, 2006, BIOMETRICS, V62, P1062, DOI 10.1111/j.1541-0420.2006.00566.x; Houseman EA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-365; Iacobuzio-Donahue CA, 2009, ANNU REV PATHOL-MECH, V4, P229, DOI 10.1146/annurev.pathol.3.121806.151442; Jarmalaite S, 2008, ONCOLOGY-BASEL, V75, P145, DOI 10.1159/000158665; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ji Y, 2005, BIOINFORMATICS, V21, P2118, DOI 10.1093/bioinformatics/bti318; Karagas MR, 1998, ENVIRON HEALTH PERSP, V106, P1047, DOI 10.1289/ehp.98106s41047; Kelsey KT, 2005, INT J CANCER, V117, P370, DOI 10.1002/ijc.21195; Kelsey KT, 2004, BRIT J CANCER, V90, P1572, DOI 10.1038/sj.bjc.6601748; Khin SS, 2009, INT J CANCER, V125, P328, DOI 10.1002/ijc.24318; Killian JK, 2009, CANCER RES, V69, P758, DOI 10.1158/0008-5472.CAN-08-2984; Kim EJ, 2008, J UROLOGY, V180, P1141, DOI 10.1016/j.juro.2008.05.002; Kim YK, 2009, INT J UROL, V16, P17, DOI 10.1111/j.1442-2042.2008.02143.x; Malats W, 2005, LANCET ONCOL, V6, P678; Marsit CJ, 2007, CARCINOGENESIS, V28, P1745, DOI 10.1093/carcin/bgm116; Marsit CJ, 2006, CANCER RES, V66, P10621, DOI 10.1158/0008-5472.CAN-06-1687; Marsit CJ, 2009, CARCINOGENESIS, V30, P416, DOI 10.1093/carcin/bgp006; Marsit CJ, 2005, CANCER RES, V65, P7081, DOI 10.1158/0008-5472.CAN-05-0267; Mathews LA, 2009, DIFFERENTIATION, V78, P1, DOI 10.1016/j.diff.2009.04.002; OCKRIM JL, 2007, UROLOGICAL CANCERS C, P75; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sathyanarayana UG, 2004, CANCER RES, V64, P1425, DOI 10.1158/0008-5472.CAN-03-0701; SERTH J, 1995, BRIT J CANCER, V71, P201, DOI 10.1038/bjc.1995.41; Siegmund KD, 2004, BIOINFORMATICS, V20, P1896, DOI 10.1093/bioinformatics/bth176; Stoehr R, 2004, LAB INVEST, V84, P465, DOI 10.1038/labinvest.3700068; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Urakami S, 2006, CLIN CANCER RES, V12, P2109, DOI 10.1158/1078-0432.CCR-05-2468; Watanabe R, 1994, Int J Urol, V1, P43, DOI 10.1111/j.1442-2042.1994.tb00007.x; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Yates DR, 2007, CLIN CANCER RES, V13, P2046, DOI 10.1158/1078-0432.CCR-06-2476; Yates DR, 2006, ONCOGENE, V25, P1984, DOI 10.1038/sj.onc.1209209; Yu J, 2007, CLIN CANCER RES, V13, P7296, DOI 10.1158/1078-0432.CCR-07-0861	53	68	68	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12334	10.1371/journal.pone.0012334	http://dx.doi.org/10.1371/journal.pone.0012334			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808801	Green Submitted, Green Published, gold			2022-12-27	WOS:000281153500016
J	Zahid, M; Phillips, BE; Albers, SM; Giannoukakis, N; Watkins, SC; Robbins, PD				Zahid, Maliha; Phillips, Brett E.; Albers, Sean M.; Giannoukakis, Nick; Watkins, Simon C.; Robbins, Paul D.			Identification of a Cardiac Specific Protein Transduction Domain by In Vivo Biopanning Using a M13 Phage Peptide Display Library in Mice	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; NATIONAL REGISTRY; SELECTION; DELIVERY; TISSUE		[Zahid, Maliha; Robbins, Paul D.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Phillips, Brett E.; Giannoukakis, Nick] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Albers, Sean M.; Watkins, Simon C.] Univ Pittsburgh, Sch Med, Ctr Biol Imaging, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zahid, M (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	probb@pitt.edu	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552; Phillips, Brett/0000-0001-6062-4892	DOD [17-03-1-0488, 17-03-0142]	DOD(United States Department of Defense)	This work was supported by DOD grants 17-03-1-0488 and 17-03-0142 to P.D.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Hyun S, 2008, BIOORG MED CHEM LETT, V18, P4011, DOI 10.1016/j.bmcl.2008.06.003; Kawano S, 2006, AM J PHYSIOL-HEART C, V291, pH1337, DOI 10.1152/ajpheart.01175.2005; Kelly KA, 2006, MOL IMAGING BIOL, V8, P201, DOI 10.1007/s11307-006-0043-6; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; McGuire MJ, 2004, J MOL BIOL, V342, P171, DOI 10.1016/j.jmb.2004.06.029; Mi ZB, 2003, MOL THER, V8, P295, DOI 10.1016/S1525-0016(03)00181-3; Molenaar TJM, 2002, VIROLOGY, V293, P182, DOI 10.1006/viro.2001.1254; Pachori AS, 2004, P NATL ACAD SCI USA, V101, P12282, DOI 10.1073/pnas.0404616101; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Segvich SJ, 2009, BIOMATERIALS, V30, P1287, DOI 10.1016/j.biomaterials.2008.11.008; Wiviott SD, 2004, J AM COLL CARDIOL, V44, P783, DOI 10.1016/j.jacc.2004.05.045; Yao VJ, 2005, AM J PATHOL, V166, P625, DOI 10.1016/S0002-9440(10)62283-3; Zhang LL, 2005, CIRCULATION, V112, P1601, DOI 10.1161/CIRCULATIONAHA.104.529537	15	50	56	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12252	10.1371/journal.pone.0012252	http://dx.doi.org/10.1371/journal.pone.0012252			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808875	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000280968100033
J	Nettle, D; Cockerill, M				Nettle, Daniel; Cockerill, Maria			Development of Social Variation in Reproductive Schedules: A Study from an English Urban Area	PLOS ONE			English	Article							LIFE-HISTORY; FATHER ABSENCE; FAMILY ENVIRONMENT; TEENAGE PREGNANCY; NATURAL-SELECTION; EARLY STRESS; CHILD; MENARCHE; BIRTH; SEX	Background: There is striking social variation in the timing of the onset of childbearing in contemporary England, with the mean age at first motherhood about 8 years earlier in the most deprived compared to the least deprived neighbourhoods. However, relatively little is known about how these social differences in reproductive schedule develop in childhood. Methodology/Principal Findings: We studied the development of differences in reproductive schedules, using a cross-sectional survey over 1000 school students aged 9-15 in the metropolitan borough of North Tyneside. Students from more deprived neighbourhoods had earlier ideal ages for parenthood than those from more affluent ones, and these differences were fully apparent by age 11. We found evidence consistent with three mechanisms playing a role in maintaining the socioeconomic gradient. These were: vertical intergenerational transmission (students whose own parents were younger at their birth wanted children younger); oblique intergenerational transmission (students in neighbourhoods where parents were younger in general wanted children earlier); and low parental investment (students who did not feel emotionally supported by their own parents wanted children at a younger age). Conclusions/Significance: Our results shed some light on the proximate factors which may be involved in maintaining early childbearing in disadvantaged communities. They help understand why educational initiatives aimed at adolescents tend to have no effect, whereas improving the well-being of poor families with young children may do so. Our results also suggest that there will be considerable intergenerational inertia in the response of reproductive schedules to changing socioecological conditions.	[Nettle, Daniel] Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Cockerill, Maria] N Tyneside Council, Sch Improvement Serv, Wallsend, Tyne & Wear, England	Newcastle University - UK	Nettle, D (corresponding author), Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	daniel.nettle@ncl.ac.uk	Cockerill, Maria/HCH-1489-2022; Nettle, Daniel/B-2259-2008	Nettle, Daniel/0000-0001-9089-2599; Cockerill, Maria/0000-0002-9780-3859	North Tyneside Council [KH092651]	North Tyneside Council	This work was partially supported by North Tyneside Council (http://www.northtyneside.gov.uk/) under grant KH092651 to Daniel Nettle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvergne A, 2008, PHYSIOL BEHAV, V95, P625, DOI 10.1016/j.physbeh.2008.09.005; Arai L, 2009, TEENAGE PREGNANCY: THE MAKING AND UNMAKING OF A PROBLEM, P1; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BELSKY J, 1991, CHILD DEV, V62, P647, DOI 10.1111/j.1467-8624.1991.tb01558.x; Belsky J, 2007, CHILD DEV, V78, P1302, DOI 10.1111/j.1467-8624.2007.01067.x; Bereczkei T, 2001, INT J BEHAV DEV, V25, P501, DOI 10.1080/01650250042000573; Bogaert AF, 2008, J BIOSOC SCI, V40, P623, DOI 10.1017/S0021932007002386; Boyd R., 1985, CULTURE EVOLUTIONARY; BROOKSGUNN J, 1993, AM J SOCIOL, V99, P353, DOI 10.1086/230268; Burton L M, 1990, Hum Nat, V1, P123, DOI 10.1007/BF02692149; Byars SG, 2010, P NATL ACAD SCI USA, V107, P1787, DOI 10.1073/pnas.0906199106; Chisholm JS, 1999, HUM NATURE-INT BIOS, V10, P51, DOI 10.1007/s12110-999-1001-1; Chisholm JS, 2005, HUM NATURE-INT BIOS, V16, P233, DOI 10.1007/s12110-005-1009-0; CHISHOLM JS, 1993, CURR ANTHROPOL, V34, P1, DOI 10.1086/204131; Cohan CL, 2002, J FAM PSYCHOL, V16, P14, DOI 10.1037//0893-3200.16.1.14; Davis J, 2007, EVOL HUM BEHAV, V28, P228, DOI 10.1016/j.evolhumbehav.2007.02.003; *DCLG, 2010, IND DEPR 2007; Duncan S, 2007, CRIT SOC POLICY, V27, P307, DOI 10.1177/0261018307078845; Ellis BJ, 2003, CHILD DEV, V74, P801, DOI 10.1111/1467-8624.00569; Ellis BJ, 2004, PSYCHOL BULL, V130, P920, DOI 10.1037/0033-2909.130.6.920; Gaudie J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-63; Geronimus AT, 1996, HUM NATURE-INT BIOS, V7, P323, DOI 10.1007/BF02732898; Harden A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4254; Henderson M, 2007, BMJ-BRIT MED J, V334, P133, DOI 10.1136/bmj.39014.503692.55; Henrich J, 2003, EVOL ANTHROPOL, V12, P123, DOI 10.1002/evan.10110; Jewell D, 2000, FAM PRACT, V17, P522, DOI 10.1093/fampra/17.6.522; Kim K, 1997, EVOL HUM BEHAV, V18, P109, DOI 10.1016/S1090-5138(96)00114-6; Lawlor DA, 2003, AM J PUBLIC HEALTH, V93, P266, DOI 10.2105/AJPH.93.2.266; Lawson DW, 2009, EVOL HUM BEHAV, V30, P170, DOI 10.1016/j.evolhumbehav.2008.12.001; Low BS, 2008, CROSS-CULT RES, V42, P201, DOI 10.1177/1069397108317669; Mathews P., 2008, J EVOLUTIONARY PSYCH, V6, P155, DOI [10.1556/JEP.6.2008.3.1, DOI 10.1556/JEP.6.2008.3.1]; McCulloch A, 2001, J EPIDEMIOL COMMUN H, V55, P16, DOI 10.1136/jech.55.1.16; McElreath R, 2008, CURR ANTHROPOL, V49, P307, DOI 10.1086/524364; Meade CS, 2008, HEALTH PSYCHOL, V27, P419, DOI 10.1037/0278-6133.27.4.419; Mikach SM, 1999, EVOL HUM BEHAV, V20, P141, DOI 10.1016/S1090-5138(98)00045-2; NETTLE D, P ROYAL S B IN PRESS; Nettle D., PHILOS T B IN PRESS; Nettle D, 2010, AM J HUM BIOL, V22, P172, DOI 10.1002/ajhb.20970; Nettle D, 2010, BEHAV ECOL, V21, P387, DOI 10.1093/beheco/arp202; *ONS, 2010, IND MULT DEPR WARDS; Pesonen AK, 2008, AM J HUM BIOL, V20, P345, DOI 10.1002/ajhb.20735; Quinlan RJ, 2003, EVOL HUM BEHAV, V24, P376, DOI 10.1016/S1090-5138(03)00039-4; Rasbash J., 2010, USERS GUIDE MLWIN VE; RASBASH J, 2010, MLWIN VERSION 2 19; Rodgers JL, 2005, DEMOGRAPHY, V42, P675, DOI 10.1353/dem.2005.0034; Smith Debbie M, 2006, Psychol Health Med, V11, P399, DOI 10.1080/13548500500429353; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI 10.2307/270723; Tither JM, 2008, DEV PSYCHOL, V44, P1409, DOI 10.1037/a0013065; Wardle J, 2003, J EPIDEMIOL COMMUN H, V57, P440, DOI 10.1136/jech.57.6.440; Wilson M, 1997, BRIT MED J, V314, P1271, DOI 10.1136/bmj.314.7089.1271; Zhou XY, 2009, ASIAN J SOC PSYCHOL, V12, P40, DOI 10.1111/j.1467-839X.2008.01268.x	51	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12690	10.1371/journal.pone.0012690	http://dx.doi.org/10.1371/journal.pone.0012690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	649ZP	20856795	Green Published, Green Submitted, gold			2022-12-27	WOS:000281815800005
J	Li, Q; Zhang, F; Li, X; Chen, FS				Li, Qin; Zhang, Feng; Li, Xin; Chen, Fengshan			Genome Scan for Locus Involved in Mandibular Prognathism in Pedigrees from China	PLOS ONE			English	Article							LINKAGE ANALYSIS; GENE	Background: It is well known that genetic components play an important role in the etiology of mandibular prognathism, but few susceptibility loci have been mapped. Methodology: In order to identify linkage regions for mandibular prognathism, we analyzed two Chinese pedigrees with 6,090 genome-wide single-nucleotide polymorphism (SNP) markers from Illumina Linkage-12 DNA Analysis Kit (average spacing 0.58 cM). Multipoint parametric and non-parametric (model-free) linkage analyses were used for the pedigrees. Principal Finding: The most statistically significant linkage results were with markers on chromosome 4 (LOD = 3.166 and NPL = 3.65 with rs 875864, 4p16.1, 8.38 cM). Candidate genes within the 4p16.1 include EVC, EVC2. Conclusion: We detected a novel suggestive linkage locus for mandibular prognathism in two Chinese pedigrees, and this linkage region provides target for susceptibility gene identification, a process that will provide important insights into the molecular and cellular basis of mandibular prognathism.	[Li, Qin; Chen, Fengshan] Tongji Univ, Dept Orthodont, Sch Dent, Shanghai 200092, Peoples R China; [Zhang, Feng; Li, Xin] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China	Tongji University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Li, Q (corresponding author), Tongji Univ, Dept Orthodont, Sch Dent, Shanghai 200092, Peoples R China.	Orthodboy@126.com			Shanghai Pujiang Program [07pj14081]; Shanghai Key Basic Research Program [10JC1415500]	Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai Key Basic Research Program	This research was sponsored by Shanghai Pujiang Program, 07pj14081 and Shanghai Key Basic Research Program, 10JC1415500. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Alexander AEZ, 2009, AM J ORTHOD DENTOFAC, V135, DOI 10.1016/j.ajodo.2008.06.025; Ball AD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-218; Bukhary Mohammed Taher, 2005, J Oral Sci, V47, P83, DOI 10.2334/josnusd.47.83; Chang HP, 2006, J FORMOS MED ASSOC, V105, P781, DOI 10.1016/S0929-6646(09)60264-3; CHEN YJ, 2010, CHONGQING MED, V39, P358; Cruz RM, 2008, AM J MED GENET A, V146A, P71, DOI 10.1002/ajmg.a.32062; El-Gheriani AA, 2003, J DENT RES, V82, P523, DOI 10.1177/154405910308200707; Frazier-Bowers S, 2009, J DENT RES, V88, P56, DOI 10.1177/0022034508327817; FU MK, 2005, ORTHODONTICS; Jena A K, 2005, J Indian Soc Pedod Prev Dent, V23, P27; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LITTON SF, 1970, AMER J ORTHODONTICS, V58, P565, DOI 10.1016/0002-9416(70)90145-4; MCNAMARA JA, 1984, AM J ORTHOD DENTOFAC, V86, P449, DOI 10.1016/S0002-9416(84)90352-X; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; PASCOE J J, 1960, J Oral Surg Anesth Hosp Dent Serv, V18, P21; Ruiz-Perez VL, 2003, AM J HUM GENET, V72, P728, DOI 10.1086/368063; Staudt CB, 2009, AM J ORTHOD DENTOFAC, V136, P715, DOI 10.1016/j.ajodo.2007.10.061; Ulucan H, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-92; Watanabe M, 2005, AM J ORTHOD DENTOFAC, V128, P466, DOI 10.1016/j.ajodo.2004.09.018; WOLFF G, 1993, J MED GENET, V30, P112, DOI 10.1136/jmg.30.2.112; Yamaguchi T, 2005, J DENT RES, V84, P255, DOI 10.1177/154405910508400309	22	32	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12678	10.1371/journal.pone.0012678	http://dx.doi.org/10.1371/journal.pone.0012678			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844756	gold, Green Submitted, Green Published			2022-12-27	WOS:000281687300017
J	Laiakis, EC; Morris, GAJ; Fornace, AJ; Howie, SRC				Laiakis, Evagelia C.; Morris, Gerard A. J.; Fornace, Albert J., Jr.; Howie, Stephen R. C.			Metabolomic Analysis in Severe Childhood Pneumonia in The Gambia, West Africa: Findings from a Pilot Study	PLOS ONE			English	Article							GAMMA-RADIATION EXPOSURE; URIC-ACID; GUT MICROBIOTA; BIOMARKERS; CHILDREN; INFLAMMATION; NUCLEOTIDES; MORTALITY; PROFILES; ETIOLOGY	Background: Pneumonia remains the leading cause of death in young children globally and improved diagnostics are needed to better identify cases and reduce case fatality. Metabolomics, a rapidly evolving field aimed at characterizing metabolites in biofluids, has the potential to improve diagnostics in a range of diseases. The objective of this pilot study is to apply metabolomic analysis to childhood pneumonia to explore its potential to improve pneumonia diagnosis in a high-burden setting. Methodology/Principal Findings: Eleven children with World Health Organization (WHO)-defined severe pneumonia of non-homogeneous aetiology were selected in The Gambia, West Africa, along with community controls. Metabolomic analysis of matched plasma and urine samples was undertaken using Ultra Performance Liquid Chromatography (UPLC) coupled to Time-of-Flight Mass Spectrometry (TOFMS). Biomarker extraction was done using SIMCA-P+ and Random Forests (RF). 'Unsupervised' (blinded) data were analyzed by Principal Component Analysis (PCA), while 'supervised' (unblinded) analysis was by Partial Least Squares-Discriminant Analysis (PLS-DA) and Orthogonal Projection to Latent Structures (OPLS). Potential markers were extracted from S-plots constructed following analysis with OPLS, and markers were chosen based on their contribution to the variation and correlation within the data set. The dataset was additionally analyzed with the machine-learning algorithm RF in order to address issues of model overfitting and markers were selected based on their variable importance ranking. Unsupervised PCA analysis revealed good separation of pneumonia and control groups, with even clearer separation of the groups with PLS-DA and OPLS analysis. Statistically significant differences (p<0.05) between groups were seen with the following metabolites: uric acid, hypoxanthine and glutamic acid were higher in plasma from cases, while L-tryptophan and adenosine-5'-diphosphate (ADP) were lower; uric acid and L-histidine were lower in urine from cases. The key limitation of this study is its small size. Conclusions/Significance: Metabolomic analysis clearly distinguished severe pneumonia patients from community controls. The metabolites identified are important for the host response to infection through antioxidant, inflammatory and antimicrobial pathways, and energy metabolism. Larger studies are needed to determine whether these findings are pneumonia-specific and to distinguish organism-specific responses. Metabolomics has considerable potential to improve diagnostics for childhood pneumonia.	[Laiakis, Evagelia C.; Fornace, Albert J., Jr.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC USA; [Laiakis, Evagelia C.; Fornace, Albert J., Jr.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC USA; [Morris, Gerard A. J.; Howie, Stephen R. C.] Med Res Council UK Labs, Bacterial Dis Programme, Banjul, Gambia; [Fornace, Albert J., Jr.] Dankook Univ, WCU Res Ctr Nanobiomed Sci, Cheonan, South Korea	Georgetown University; Georgetown University; University of London; London School of Hygiene & Tropical Medicine; Dankook University	Laiakis, EC (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC USA.	showie@mrc.gm	Fornace, Albert J/A-7407-2008	Fornace, Albert J/0000-0001-9695-085X; Laiakis, Evagelia/0000-0002-4924-9013	Georgetown University; Medical Research Council (UK); Ministry of Education, Science and Technology [R31-10069]; MRC [MC_U190088478] Funding Source: UKRI; Medical Research Council [MC_U190088478] Funding Source: researchfish	Georgetown University; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by Georgetown University and the Medical Research Council (UK). This work was supported in part by grant R31-10069 (WCU program) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burian K, 2003, IMMUNOL LETT, V89, P229, DOI 10.1016/S0165-2478(03)00154-8; CASIMIR GJ, 2009, SHOCK; Cassiday Laura, 2009, J Proteome Res, V8, P5409, DOI 10.1021/pr9009832; Combes A, 2009, CRIT CARE MED, V37, P2506, DOI 10.1097/CCM.0b013e3181a569df; Fabre JE, 1999, NAT MED, V5, P1199, DOI 10.1038/13522; *GAMB CENTR STAT D, 2003, 2003 CENS; Garenne Michel, 1992, World Health Statistics Quarterly, V45, P180; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Gear ARL, 2001, BLOOD, V97, P937, DOI 10.1182/blood.V97.4.937; GREENWOOD BM, 1987, ANN TROP PAEDIATR, V7, P91, DOI 10.1080/02724936.1987.11748482; Greenwood B, 2008, B WORLD HEALTH ORGAN, V86, P322, DOI 10.2471/BLT.08.053348; Griffin JL, 2007, J PROTEOME RES, V6, P498, DOI 10.1021/pr060464h; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Hendriksen WT, 2008, INFECT IMMUN, V76, P1230, DOI 10.1128/IAI.01004-07; Himmelreich U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005328; Howie SRC, 2006, LANCET, V368, P1646, DOI 10.1016/S0140-6736(06)69687-6; JABS CM, 1995, EUR J SURG, V161, P147; Jaffar S, 1997, TROP MED INT HEALTH, V2, P28, DOI 10.1046/j.1365-3156.1997.d01-131.x; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Jordan KW, 2007, EXPERT REV PROTEOMIC, V4, P389, DOI 10.1586/14789450.4.3.389; Kinross J, 2009, CURR PHARM DESIGN, V15, P1537, DOI 10.2174/138161209788168119; Lanz C, 2009, RADIAT RES, V172, P198, DOI 10.1667/RR1796.1; Mahadevan S, 2008, ANAL CHEM, V80, P7562, DOI 10.1021/ac800954c; MATHERS CSC, GLOBAL BURDEN DIS 20; Mene P, 2008, J HYPERTENS, V26, P2085, DOI 10.1097/HJH.0b013e32830e4945; Morris GAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001773; Mulholland K, 2003, PEDIATR PULM, V36, P469, DOI 10.1002/ppul.10344; Mulholland K, 2007, LANCET, V370, P285, DOI 10.1016/S0140-6736(07)61130-1; MULLER A, 2008, J CELL MOL MED; Murugappan S, 2006, FRONT BIOSCI-LANDMRK, V11, P1977, DOI 10.2741/1939; PATTERSON AD, 2009, MASS SPECTROM REV; Patterson AD, 2008, ANAL CHEM, V80, P665, DOI 10.1021/ac701807v; QAZI SWM, 2008, GLOBAL ACTION PLAN P; Reade MC, 2009, CRIT CARE MED, V37, P1655, DOI 10.1097/CCM.0b013e31819da853; RODRIGUEZNUNEZ A, 1993, ACTA PAEDIATR, V82, P849, DOI 10.1111/j.1651-2227.1993.tb12577.x; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Schmidt H, 1997, J SURG RES, V71, P61, DOI 10.1006/jsre.1997.5098; Scott JAG, 2008, PLOS MED, V5, P548, DOI 10.1371/journal.pmed.0050086; Serkova NJ, 2008, AM J PHYSIOL-LUNG C, V295, pL152, DOI 10.1152/ajplung.00515.2007; Serkova Natalie J., 2009, V520, P273, DOI 10.1007/978-1-60327-811-9_20; Sintchenko V, 2007, NAT REV MICROBIOL, V5, P464, DOI 10.1038/nrmicro1656; Slupsky CM, 2009, J PROTEOME RES, V8, P3029, DOI 10.1021/pr900103y; Slupsky CM, 2009, J PROTEOME RES, V8, P5550, DOI 10.1021/pr9006427; Smith-Vaughan H, 2006, BMC EAR NOSE THROAT, V6, DOI 10.1186/1472-6815-6-10; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Tuohy KM, 2009, CURR PHARM DESIGN, V15, P1415, DOI 10.2174/138161209788168182; Tyburski JB, 2008, RADIAT RES, V170, P1, DOI 10.1667/RR1265.1; Tyburski JB, 2009, RADIAT RES, V172, P42, DOI 10.1667/RR1703.1; *UN SECR GEN, 2001, ROAD MAP IMPL UN MIL; Waldram A, 2009, J PROTEOME RES, V8, P2361, DOI 10.1021/pr8009885; *WHO, 2003, WHOFCHCAH039; *WHO, 2002, REV GLOB BURD DIS GB, P2005; Xu XA, 2006, J EXP MED, V203, P2907, DOI 10.1084/jem.20061232; YUE S, HUNAN YI KE DA XUE X, V24, P287	58	74	78	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12655	10.1371/journal.pone.0012655	http://dx.doi.org/10.1371/journal.pone.0012655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844590	Green Published, gold, Green Submitted			2022-12-27	WOS:000281687200016
J	Rydzak, CE; Cotich, KL; Sax, PE; Hsu, HE; Wang, BX; Losina, E; Freedberg, KA; Weinstein, MC; Goldie, SJ				Rydzak, Chara E.; Cotich, Kara L.; Sax, Paul E.; Hsu, Heather E.; Wang, Bingxia; Losina, Elena; Freedberg, Kenneth A.; Weinstein, Milton C.; Goldie, Sue J.		CEPAC Investigators	Assessing the Performance of a Computer-Based Policy Model of HIV and AIDS	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; CD4 CELL COUNTS; MULTIPLE VIROLOGICAL FAILURES; MYCOBACTERIUM-AVIUM COMPLEX; SEQUENTIAL 3-DRUG REGIMENS; WOMENS INTERAGENCY HIV; SOCIETY-USA PANEL; COST-EFFECTIVENESS; UNITED-STATES; OPPORTUNISTIC INFECTIONS	Background: Model-based analyses, conducted within a decision analytic framework, provide a systematic way to combine information about the natural history of disease and effectiveness of clinical management strategies with demographic and epidemiological characteristics of the population. Among the challenges with disease-specific modeling include the need to identify influential assumptions and to assess the face validity and internal consistency of the model. Methods and Findings: We describe a series of exercises involved in adapting a computer-based simulation model of HIV disease to the Women's Interagency HIV Study (WIHS) cohort and assess model performance as we re-parameterized the model to address policy questions in the U.S. relevant to HIV-infected women using data from the WIHS. Empiric calibration targets included 24-month survival curves stratified by treatment status and CD4 cell count. The most influential assumptions in untreated women included chronic HIV-associated mortality following an opportunistic infection, and in treated women, the 'clinical effectiveness' of HAART and the ability of HAART to prevent HIV complications independent of virologic suppression. Good-fitting parameter sets required reductions in the clinical effectiveness of 1(st) and 2(nd) line HAART and improvements in 3(rd) and 4(th) line regimens. Projected rates of treatment regimen switching using the calibrated cohort-specific model closely approximated independent analyses published using data from the WIHS. Conclusions: The model demonstrated good internal consistency and face validity, and supported cohort heterogeneities that have been reported in the literature. Iterative assessment of model performance can provide information about the relative influence of uncertain assumptions and provide insight into heterogeneities within and between cohorts. Description of calibration exercises can enhance the transparency of disease-specific models.	[Rydzak, Chara E.; Hsu, Heather E.; Freedberg, Kenneth A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Rydzak, Chara E.; Cotich, Kara L.; Freedberg, Kenneth A.; Weinstein, Milton C.; Goldie, Sue J.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Sax, Paul E.] Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Hsu, Heather E.; Wang, Bingxia; Losina, Elena; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Dept Med, Div Gen Med, Boston, MA 02114 USA; [Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Freedberg, Kenneth A.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Boston University; Boston University; Harvard University; Massachusetts General Hospital	Rydzak, CE (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	sue_goldie@harvard.edu		Losina, ELENA/0000-0002-3424-0892; Hsu, Heather/0000-0002-5863-1804; Lipsitch, Marc/0000-0003-1504-9213	National Institute of Allergy and Infectious Diseases [R37 AI042006, K24 AI062476]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI062476, R37AI042006] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the National Institute of Allergy and Infectious Diseases (R37 AI042006, K24 AI062476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastos K, 2005, JAIDS-J ACQ IMM DEF, V39, P537; Anastos K, 1999, AIDS, V13, P1717, DOI 10.1097/00002030-199909100-00016; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8; Cole SR, 2003, AM J EPIDEMIOL, V158, P687, DOI 10.1093/aje/kwg206; Deeks SG, 2009, CLIN INFECT DIS, V49, P1582, DOI 10.1086/644768; Detels R, 2001, AIDS, V15, P347, DOI 10.1097/00002030-200102160-00008; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; *DHHS HJ KAIS FAM, 2001, GUID US ANT AG HIV I; El-Sadr WM, 1999, CLIN INFECT DIS, V29, P775, DOI 10.1086/520433; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Grabar S, 2005, JAIDS-J ACQ IMM DEF, V39, P284, DOI 10.1097/01.qai.0000160925.33935.72; Grant LA, 2001, AIDS, V15, P2101, DOI 10.1097/00002030-200111090-00005; Gulick RM, 2006, JAMA-J AM MED ASSOC, V296, P769, DOI 10.1001/jama.296.7.769; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Havlir DV, 1996, NEW ENGL J MED, V335, P392, DOI 10.1056/NEJM199608083350604; Johnson M, 2006, AIDS, V20, P711, DOI 10.1097/01.aids.0000216371.76689.63; Johnson M, 2005, AIDS, V19, P685, DOI 10.1097/01.aids.0000166091.39317.99; Kimmel AD, 2005, ANTIVIR THER, V10, P41; Kirstein LM, 2002, J ACQ IMMUN DEF SYND, V29, P495, DOI 10.1097/00126334-200204150-00010; Kleeberger CA, 2004, AIDS, V18, P683, DOI 10.1097/00002030-200403050-00013; Kleeberger CA, 2001, J ACQ IMMUN DEF SYND, V26, P82, DOI 10.1097/00126334-200101010-00012; Kousignian I, 2008, CLIN INFECT DIS, V46, P296, DOI 10.1086/524753; LALEZARI J, 2007, EFFICACY SAFETY MARA; Lampe FC, 2006, ARCH INTERN MED, V166, P521, DOI 10.1001/archinte.166.5.521; Losina E, 2006, SAMJ S AFR MED J, V96, P526; MacArthur RD, 2006, LANCET, V368, P2125, DOI 10.1016/S0140-6736(06)69861-9; May M, 2005, J CLIN EPIDEMIOL, V58, P1033, DOI 10.1016/j.jclinepi.2005.02.015; May MT, 2006, LANCET, V368, P451, DOI 10.1016/S0140-6736(06)69152-6; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mocroft A, 2004, J INFECT DIS, V190, P1947, DOI 10.1086/425424; Mocroft A, 2001, AIDS, V15, P185, DOI 10.1097/00002030-200101260-00007; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Moore RD, 2005, JAIDS-J ACQ IMM DEF, V39, P195; *NAT TECHN INF SER, MULT AIDS COH STUD M; Nelson M, 2005, JAIDS-J ACQ IMM DEF, V40, P404, DOI 10.1097/01.qai.0000185314.56556.c3; NIGHTINGALE SD, 1993, NEW ENGL J MED, V329, P828, DOI 10.1056/NEJM199309163291202; PACHL C, 1995, J ACQ IMMUN DEF SYND, V8, P446, DOI 10.1097/00042560-199504120-00003; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Paltiel AD, 1998, MED DECIS MAKING, V18, pS93, DOI 10.1177/0272989X9801800211; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Podlekareva D, 2006, J INFECT DIS, V194, P633, DOI 10.1086/506366; Porter K, 2008, JAIDS-J ACQ IMM DEF, V47, P202, DOI 10.1097/QAI.0b013e31815b1291; Pozniak AL, 2006, JAIDS-J ACQ IMM DEF, V43, P535; Robbins GK, 2003, NEW ENGL J MED, V349, P2293, DOI 10.1056/NEJMoa030264; SAAG MS, 1998, 12 WORLD AIDS C GEN; Schackman BR, 2001, AM J PUBLIC HEALTH, V91, P1456, DOI 10.2105/AJPH.91.9.1456; Seage GR, 2002, J ACQ IMMUN DEF SYND, V30, P421, DOI [10.1097/01.QAI.0000021700.48448.69, 10.1097/00042560-200208010-00008]; Shafer RW, 2003, NEW ENGL J MED, V349, P2304, DOI 10.1056/NEJMoa030265; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; TODD J, 1995, J ACQUIR IMMUNE D S2, V10, P35; *U CA, WOM INT HIV STUD; van Roon EN, 1999, J ACQ IMMUN DEF SYND, V20, P290, DOI 10.1097/00042560-199903010-00012; Walensky RP, 2007, CLIN INFECT DIS, V45, pS248, DOI 10.1086/522546; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Weinstein M C, 2001, Value Health, V4, P348, DOI 10.1046/j.1524-4733.2001.45061.x; Weinstein MC, 2001, ANN INTERN MED, V134, P440, DOI 10.7326/0003-4819-134-6-200103200-00008; Weinstein MC, 2003, VALUE HEALTH, V6, P9, DOI 10.1046/j.1524-4733.2003.00234.x; Weinstein MC, 2006, PHARMACOECONOMICS, V24, P1043, DOI 10.2165/00019053-200624110-00002; Wolf LL, 2007, JAIDS-J ACQ IMM DEF, V46, P463, DOI 10.1097/QAI.0b013e3181594c38; Yamashita TE, 2001, AIDS, V15, P735, DOI 10.1097/00002030-200104130-00009; Yazdanpanah Y, 2005, AIDS, V19, P1299, DOI 10.1097/01.aids.0000180101.80888.c6; Yazdanpanah Y, 2003, CLIN INFECT DIS, V36, P86, DOI 10.1086/344902; Yeni P, 2006, LANCET, V368, P287, DOI 10.1016/S0140-6736(06)69074-0; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222	69	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12647	10.1371/journal.pone.0012647	http://dx.doi.org/10.1371/journal.pone.0012647			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844741	gold, Green Published, Green Submitted			2022-12-27	WOS:000281687200012
J	Gavriouchkina, D; Fischer, S; Ivacevic, T; Stolte, J; Benes, V; Dekens, MPS				Gavriouchkina, Daria; Fischer, Sabine; Ivacevic, Tomi; Stolte, Jens; Benes, Vladimir; Dekens, Marcus P. S.			Thyrotroph Embryonic Factor Regulates Light-Induced Transcription of Repair Genes in Zebrafish Embryonic Cells	PLOS ONE			English	Article							LEUCINE-ZIPPER PROTEINS; CIRCADIAN-CLOCK; DNA-DAMAGE; EXPRESSION; CYCLE; TEF; VERTEBRATE; PHOTOLYASE; PATHWAYS; IDENTIFICATION	Numerous responses are triggered by light in the cell. How the light signal is detected and transduced into a cellular response is still an enigma. Each zebrafish cell has the capacity to directly detect light, making this organism particularly suitable for the study of light dependent transcription. To gain insight into the light signalling mechanism we identified genes that are activated by light exposure at an early embryonic stage, when specialised light sensing organs have not yet formed. We screened over 14,900 genes using micro-array GeneChips, and identified 19 light-induced genes that function primarily in light signalling, stress response, and DNA repair. Here we reveal that PAR Response Elements are present in all promoters of the light-induced genes, and demonstrate a pivotal role for the PAR bZip transcription factor Thyrotroph embryonic factor (Tef) in regulating the majority of light-induced genes. We show that tef beta transcription is directly regulated by light while transcription of tef alpha is under circadian clock control at later stages of development. These data leads us to propose their involvement in light-induced UV tolerance in the zebrafish embryo.	[Gavriouchkina, Daria; Fischer, Sabine; Ivacevic, Tomi; Stolte, Jens; Benes, Vladimir; Dekens, Marcus P. S.] European Mol Biol Lab, Genom Core Unit, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Gavriouchkina, D (corresponding author), European Mol Biol Lab, Genom Core Unit, Heidelberg, Germany.	benes@embl.de; marcus.dekens@gmail.com	Gavriouchkina, Daria/K-8471-2019; Gavriouchkina, Daria/K-8256-2019	Gavriouchkina, Daria/0000-0002-7488-5898; Benes, Vladimir/0000-0002-0352-2547; Dekens, Marcus P.S./0000-0003-1689-3491	European Molecular Biology Laboratory	European Molecular Biology Laboratory	This work was funded by the European Molecular Biology Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Bedo G, 2005, INT J DEV BIOL, V49, P431, DOI 10.1387/ijdb.041901gb; Carayon P, 1996, BLOOD, V87, P3170, DOI 10.1182/blood.V87.8.3170.bloodjournal8783170; Carr AJF, 2005, NAT CELL BIOL, V7, P319, DOI 10.1038/ncb1232; Cermakian N, 2002, CURR BIOL, V12, P844, DOI 10.1016/S0960-9822(02)00835-7; Chen Z, 2007, CELL CYCLE, V6, P2906, DOI 10.4161/cc.6.23.5041; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Dekens MPS, 2008, EMBO J, V27, P2757, DOI 10.1038/emboj.2008.183; Dekens MPS, 2003, CURR BIOL, V13, P2051, DOI 10.1016/j.cub.2003.10.022; Delaunay F, 2003, GENE EXPR PATTERNS, V3, P319, DOI 10.1016/S1567-133X(03)00050-4; DROLET DW, 1991, GENE DEV, V5, P1739, DOI 10.1101/gad.5.10.1739; Essen LO, 2006, CURR OPIN STRUC BIOL, V16, P51, DOI 10.1016/j.sbi.2006.01.004; FALVEY E, 1995, EMBO J, V14, P4307, DOI 10.1002/j.1460-2075.1995.tb00105.x; Fonjallaz P, 1996, EMBO J, V15, P351, DOI 10.1002/j.1460-2075.1996.tb00365.x; Gachon F, 2004, GENE DEV, V18, P1397, DOI 10.1101/gad.301404; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gehring W, 2003, J MOL EVOL, V57, pS286, DOI 10.1007/s00239-003-0038-8; HAAS NB, 1995, MOL CELL BIOL, V15, P1923; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hirayama J, 2005, P NATL ACAD SCI USA, V102, P10194, DOI 10.1073/pnas.0502610102; Hirayama J, 2007, P NATL ACAD SCI USA, V104, P15747, DOI 10.1073/pnas.0705614104; Hirayama J, 2009, CELL CYCLE, V8, P2794, DOI 10.4161/cc.8.17.9447; Ishikawa T, 2002, GENES CELLS, V7, P1073, DOI 10.1046/j.1365-2443.2002.00579.x; Kang TH, 2009, P NATL ACAD SCI USA, V106, P2864, DOI 10.1073/pnas.0812638106; Kobayashi Y, 2000, GENES CELLS, V5, P725, DOI 10.1046/j.1365-2443.2000.00364.x; Menger GJ, 2005, PHYSIOL GENOMICS, V21, P370, DOI 10.1152/physiolgenomics.00224.2004; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Porterfield VM, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-98; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Sancar A, 2004, ADV PROTEIN CHEM, V69, P73; Tamai TK, 2007, P NATL ACAD SCI USA, V104, P14712, DOI 10.1073/pnas.0704588104; Tamai TK, 2004, CURR BIOL, V14, pR104, DOI 10.1016/j.cub.2004.01.014; Tanida H, 2005, FEBS J, V272, P6098, DOI 10.1111/j.1742-4658.2005.05004.x; Tew KD, 2007, BIOCHEM PHARMACOL, V73, P1257, DOI 10.1016/j.bcp.2006.09.027; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Todo T, 1996, SCIENCE, V272, P109, DOI 10.1126/science.272.5258.109; Vatine G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000223; Wager-Smith K, 2000, NAT GENET, V26, P23, DOI 10.1038/79134; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Xu XZ, 1998, BBA-GENE STRUCT EXPR, V1395, P13, DOI 10.1016/S0167-4781(97)00150-4; Ziv L, 2005, J NEUROENDOCRINOL, V17, P314, DOI 10.1111/j.1365-2826.2005.01315.x	48	46	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12542	10.1371/journal.pone.0012542	http://dx.doi.org/10.1371/journal.pone.0012542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830285	Green Published, Green Submitted, gold			2022-12-27	WOS:000281631300003
J	Cresci, S; Huss, JM; Beitelshees, AL; Jones, PG; Minton, MR; Dorn, GW; Kelly, DP; Spertus, JA; McLeod, HL				Cresci, Sharon; Huss, Janice M.; Beitelshees, Amber L.; Jones, Philip G.; Minton, Matt R.; Dorn, Gerald W., II; Kelly, Daniel P.; Spertus, John A.; McLeod, Howard L.			A PPAR alpha Promoter Variant Impairs ERR-Dependent Transactivation and Decreases Mortality after Acute Coronary Ischemia in Patients with Diabetes	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; ACUTE MYOCARDIAL-INFARCTION; FATTY-ACID OXIDATION; GENE-EXPRESSION; TRANSCRIPTIONAL CONTROL; INSULIN-RESISTANCE; ENERGY-METABOLISM; NUCLEAR RECEPTORS; UNSTABLE ANGINA; HEART-DISEASE	Activation of peroxisome proliferator-activated receptor alpha (PPAR alpha) occurs in animal models of diabetes (DM) and is implicated in pathological responses to myocardial ischemia. Using bioinformatics, we identified a single nucleotide polymorphism (SNP) in the PPAR alpha gene promoter (PPARA -54,642 G>A; rs135561) that altered the consensus sequence for a nuclear receptor binding site. Electrophoretic mobility shift assays showed that the domain bound two known PPARA transcriptional activators, estrogen-related receptor (ERR)-alpha and -gamma and that PPARA G bound with greater affinity than PPARA A (>2-fold; P<0.05). Likewise, promoter-reporter analyses showed enhanced transcriptional activity for PPARA G vs. PPARA A for both ERR-alpha and -gamma (3.1 vs. 1.9-fold; P,0.05). Since PPAR alpha activation impairs post-ischemic cardiac function in experimental models of DM, we tested whether decreased PPARA transcription in PPARA A carriers favorably impacted outcome after acute coronary ischemia in 705 patients hospitalized with acute coronary syndromes (ACS; 552 Caucasian, 106 African American). PPARA A allele frequencies were similar to non-diseased subjects. However, PPARA genotype correlated with 5-year mortality in diabetic (22.2% AA vs. 18.8% AG vs. 39.5% GG; P = 0.008), but not non-diabetic (P = 0.96) subjects (genotype by diabetes interaction P = 0.008). In the diabetic ACS subjects, PPARA A carriers had strikingly reduced all-cause mortality compared to PPARA G homozygotes, (unadjusted HR 0.44, 95% CI 0.26-0.75; P = 0.003; adjusted HR 0.48, 95% CI 0.27-0.83; P = 0.009). Consistent with previous descriptions of PPARa in experimental models and human disease, we describe a novel PPARA promoter SNP that decreases transcriptional activation of PPARA and protects against mortality in diabetic patients after ACS.	[Cresci, Sharon; Minton, Matt R.; Dorn, Gerald W., II] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Huss, Janice M.] City Hope Natl Med Ctr, Duarte, CA 91010 USA; [Beitelshees, Amber L.] Univ Maryland, Baltimore, MD 21201 USA; [Jones, Philip G.; Spertus, John A.] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Jones, Philip G.; Spertus, John A.] Univ Missouri, Kansas City, MO 64110 USA; [Kelly, Daniel P.] Burnham Inst Med Res, Orlando, FL USA; [McLeod, Howard L.] Univ N Carolina, Inst Pharmacogenom & Individualized Therapy, Chapel Hill, NC USA	Washington University (WUSTL); City of Hope; University System of Maryland; University of Maryland Baltimore; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Sanford Burnham Prebys Medical Discovery Institute; University of North Carolina; University of North Carolina Chapel Hill	Cresci, S (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	scresci@dom.wustl.edu	Spertus, John/ABD-3075-2021; Kelly, Daniel/ABG-2056-2021; McLeod, Howard/ABD-8364-2021	McLeod, Howard/0000-0002-9004-9232	National Institutes of Health (NIH) Specialized Center for Clinically-Oriented Research (SCCOR) in Cardiac Dysfunction and Disease [1 P50 HL077113]; NIH Pharmacogenetics Research Network [U01 GM63340]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM063340] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Specialized Center for Clinically-Oriented Research (SCCOR) in Cardiac Dysfunction and Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH Pharmacogenetics Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been funded by the National Institutes of Health (NIH) Specialized Center for Clinically-Oriented Research (SCCOR) in Cardiac Dysfunction and Disease # 1 P50 HL077113 and NIH Pharmacogenetics Research Network grant U01 GM63340. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Barger PM, 2000, J CLIN INVEST, V105, P1723, DOI 10.1172/JCI9056; Behar S, 1997, AM HEART J, V133, P290, DOI 10.1016/S0002-8703(97)70222-9; Bouhanick B, 2006, DIABETES METAB, V32, P460, DOI 10.1016/S1262-3636(07)70304-X; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; BRAUNWALD E, 1989, CIRCULATION, V80, P410, DOI 10.1161/01.CIR.80.2.410; Buchanan J, 2005, ENDOCRINOLOGY, V146, P5341, DOI 10.1210/en.2005-0938; Chen S, 2004, PHARMACOGENETICS, V14, P61, DOI 10.1097/00008571-200401000-00007; Chew CH, 2003, BIOCHEM BIOPH RES CO, V305, P235, DOI 10.1016/S0006-291X(03)00731-9; Cresci S, 1999, J BIOL CHEM, V274, P25668, DOI 10.1074/jbc.274.36.25668; Cubbon RM, 2007, EUR HEART J, V28, P540, DOI 10.1093/eurheartj/ehl510; Djouadi F, 1998, J CLIN INVEST, V102, P1083, DOI 10.1172/JCI3949; Donahoe SM, 2007, JAMA-J AM MED ASSOC, V298, P765, DOI 10.1001/jama.298.7.765; Doney Alex S F, 2005, Nucl Recept, V3, P4, DOI 10.1186/1478-1336-3-4; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Flavell DM, 2005, DIABETES, V54, P582, DOI 10.2337/diabetes.54.2.582; Flavell DM, 2000, DIABETOLOGIA, V43, P673, DOI 10.1007/s001250051357; Franklin K, 2004, ARCH INTERN MED, V164, P1457, DOI 10.1001/archinte.164.13.1457; Fujiwara K, 2002, CIRC J, V66, P800, DOI 10.1253/circj.66.800; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Guerre-Millo M, 2001, DIABETES, V50, P2809, DOI 10.2337/diabetes.50.12.2809; GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hansen HHT, 2007, SCAND CARDIOVASC J, V41, P19, DOI 10.1080/14017430601099238; Heard DJ, 2000, MOL ENDOCRINOL, V14, P382, DOI 10.1210/me.14.3.382; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; Huss JM, 2001, J BIOL CHEM, V276, P27605, DOI 10.1074/jbc.M100277200; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Jamshidi Y, 2002, CIRCULATION, V105, P950, DOI 10.1161/hc0802.104535; Lanfear DE, 2005, JAMA-J AM MED ASSOC, V294, P1526, DOI 10.1001/jama.294.12.1526; Lemberger T, 1996, J BIOL CHEM, V271, P1764, DOI 10.1074/jbc.271.3.1764; Lemberger T, 1996, ANNU REV CELL DEV BI, V12, P335, DOI 10.1146/annurev.cellbio.12.1.335; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Madsen MM, 2005, AM J CARDIOL, V96, P1469, DOI 10.1016/j.amjcard.2005.07.053; Mak KH, 1997, J AM COLL CARDIOL, V30, P171, DOI 10.1016/S0735-1097(97)00118-6; Malmberg K, 2000, CIRCULATION, V102, P1014, DOI 10.1161/01.CIR.102.9.1014; MALMBERG K, 1988, EUR HEART J, V9, P259, DOI 10.1093/oxfordjournals.eurheartj.a062494; Marsh S, 2005, METH MOL B, V311, P97; Miettinen H, 1998, DIABETES CARE, V21, P69, DOI 10.2337/diacare.21.1.69; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Panagia M, 2005, AM J PHYSIOL-HEART C, V288, pH2677, DOI 10.1152/ajpheart.00200.2004; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambandam N, 2006, AM J PHYSIOL-HEART C, V290, pH87, DOI 10.1152/ajpheart.00285.2005; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Spertus J, 2005, J AM COLL CARDIOL, V46, P1838, DOI 10.1016/j.jacc.2005.05.092; Svensson AM, 2004, SCAND CARDIOVASC J, V38, P229, DOI 10.1080/14017430410016297; Tai ES, 2005, J NUTR, V135, P397, DOI 10.1093/jn/135.3.397; Tai ES, 2002, ARTERIOSCL THROM VAS, V22, P805, DOI 10.1161/01.ATV.0000012302.11991.42; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; Vega RB, 1997, J BIOL CHEM, V272, P31693, DOI 10.1074/jbc.272.50.31693; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zhao T, 2004, HUM MUTAT, V23, P534, DOI 10.1002/humu.20049	61	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12584	10.1371/journal.pone.0012584	http://dx.doi.org/10.1371/journal.pone.0012584			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838448	Green Published, Green Submitted, gold			2022-12-27	WOS:000281627700024
J	Jeanmougin, M; de Reynies, A; Marisa, L; Paccard, C; Nuel, G; Guedj, M				Jeanmougin, Marine; de Reynies, Aurelien; Marisa, Laetitia; Paccard, Caroline; Nuel, Gregory; Guedj, Mickael			Should We Abandon the t-Test in the Analysis of Gene Expression Microarray Data: A Comparison of Variance Modeling Strategies	PLOS ONE			English	Article							SAM	High-throughput post-genomic studies are now routinely and promisingly investigated in biological and biomedical research. The main statistical approach to select genes differentially expressed between two groups is to apply a t-test, which is subject of criticism in the literature. Numerous alternatives have been developed based on different and innovative variance modeling strategies. However, a critical issue is that selecting a different test usually leads to a different gene list. In this context and given the current tendency to apply the t-test, identifying the most efficient approach in practice remains crucial. To provide elements to answer, we conduct a comparison of eight tests representative of variance modeling strategies in gene expression data: Welch's t-test, ANOVA [1], Wilcoxon's test, SAM [2], RVM [3], limma [4], VarMixt [5] and SMVar [6]. Our comparison process relies on four steps (gene list analysis, simulations, spike-in data and re-sampling) to formulate comprehensive and robust conclusions about test performance, in terms of statistical power, false-positive rate, execution time and ease of use. Our results raise concerns about the ability of some methods to control the expected number of false positives at a desirable level. Besides, two tests (limma and VarMixt) show significant improvement compared to the t-test, in particular to deal with small sample sizes. In addition limma presents several practical advantages, so we advocate its application to analyze gene expression data.	[Jeanmougin, Marine; de Reynies, Aurelien; Marisa, Laetitia; Guedj, Mickael] Ligue Natl Canc, Programme Cartes Identite Tumeurs CIT, Paris, France; [Jeanmougin, Marine; Paccard, Caroline; Guedj, Mickael] Dept Biostat, Paris, France; [Jeanmougin, Marine; Nuel, Gregory] Paris Descartes Univ, Dept Appl Math MAPS, UMR CNRS 8145, Paris, France; [Jeanmougin, Marine] Univ Evry, Stat & Genome Lab, UMR CNRS 8071, Evry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay	Jeanmougin, M (corresponding author), Ligue Natl Canc, Programme Cartes Identite Tumeurs CIT, Paris, France.	marine.jeanmougin@genopole.cnrs.fr	de Reyniès, Aurélien/Q-8640-2017; Jeanmougin, Marine/H-2035-2018	de Reyniès, Aurélien/0000-0002-1328-5290; Jeanmougin, Marine/0000-0001-6239-4357	Ligue Nationale Contre le Cancer	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was funded by the Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertheau P, 2007, PLOS MED, V4, P585, DOI 10.1371/journal.pmed.0040090; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Chessel D., 2004, R NEWS, V4, P5; Delmar P, 2005, BIOINFORMATICS, V21, P502, DOI 10.1093/bioinformatics/bti023; DUDOIT S, 2002, MULTIPLE HYPOTHESIS; HUANG X, 2002, FUNCTIONAL INTEGRATI, V2; Jaffrezic F, 2007, GENET RES, V89, P19, DOI 10.1017/S0016672307008646; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Kooperberg C, 2005, STAT MED, V24, P2281, DOI 10.1002/sim.2109; Lamant L, 2007, BLOOD, V109, P2156, DOI 10.1182/blood-2006-06-028969; Marot G, 2009, BIOINFORMATICS, V25, P2692, DOI 10.1093/bioinformatics/btp444; MARYHUARD T, INTRO STAT METHODS M; McCall MN, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn430; Murie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-45; Pepe MS, 2003, BIOMETRICS, V59, P133, DOI 10.1111/1541-0420.00016; Pirooznia M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S13; Rickman DS, 2008, ONCOGENE, V27, P6607, DOI 10.1038/onc.2008.251; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Soulier J, 2005, BLOOD, V106, P274, DOI 10.1182/blood-2004-10-3900; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Wu BL, 2005, BIOINFORMATICS, V21, P1565, DOI 10.1093/bioinformatics/bti217; Yauk CL, 2007, ENVIRON MOL MUTAGEN, V48, P380, DOI 10.1002/em.20290; Zhang SP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-230; Zhou L, 2005, BIOINFORMATICS, V21, P3983, DOI 10.1093/bioinformatics/bti665	33	94	94	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12336	10.1371/journal.pone.0012336	http://dx.doi.org/10.1371/journal.pone.0012336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838429	Green Submitted, gold, Green Published			2022-12-27	WOS:000281627700002
J	Bonifacio, LN; Jarstfer, MB				Bonifacio, Laura N.; Jarstfer, Michael B.			MiRNA Profile Associated with Replicative Senescence, Extended Cell Culture, and Ectopic Telomerase Expression in Human Foreskin Fibroblasts	PLOS ONE			English	Article							TUMOR-SUPPRESSOR NETWORK; UP-REGULATION; DNA METHYLATION; GROWTH ARREST; P53; MICRORNAS; PATHWAY; CANCER; IMMORTALIZATION; PROLIFERATION	Senescence is a highly regulated process that limits cellular replication by enforcing a G1 arrest in response to various stimuli. Replicative senescence occurs in response to telomeric DNA erosion, and telomerase expression can offset replicative senescence leading to immortalization of many human cells. Limited data exists regarding changes of microRNA (miRNA) expression during senescence in human cells and no reports correlate telomerase expression with regulation of senescence-related miRNAs. We used miRNA microarrays to provide a detailed account of miRNA profiles for early passage and senescent human foreskin (BJ) fibroblasts as well as early and late passage immortalized fibroblasts (BJ-hTERT) that stably express the human telomerase reverse transcriptase subunit hTERT. Selected miRNAs that were differentially expressed in senescence were assayed for expression in quiescent cells to identify miRNAs that are specifically associated with senescence-associated growth arrest. From this group of senescence-associated miRNAs, we confirmed the ability of miR-143 to induce growth arrest after ectopic expression in young fibroblasts. Remarkably, miR-143 failed to induce growth arrest in BJ-hTERT cells. Importantly, the comparison of late passage immortalized fibroblasts to senescent wild type fibroblasts reveals that miR-146a, a miRNA with a validated role in regulating the senescence associated secretory pathway, is also regulated during extended cell culture independently of senescence. The discovery that miRNA expression is impacted by expression of ectopic hTERT as well as extended passaging in immortalized fibroblasts contributes to a comprehensive understanding of the connections between telomerase expression, senescence and processes of cellular aging.	[Bonifacio, Laura N.; Jarstfer, Michael B.] Univ N Carolina, Div Med Chem & Nat Prod, Eshelman Sch Pharm, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Bonifacio, LN (corresponding author), Univ N Carolina, Div Med Chem & Nat Prod, Eshelman Sch Pharm, Chapel Hill, NC 27515 USA.	jarstfer@unc.edu			American Foundation for Aging Research; American Foundation for Pharmaceutical Research; National Science Foundation [MCB-0751372]	American Foundation for Aging Research; American Foundation for Pharmaceutical Research; National Science Foundation(National Science Foundation (NSF))	Supported by the American Foundation for Aging Research, an American Foundation for Pharmaceutical Research predoctoral fellowship to LNB, and the National Science Foundation (MCB-0751372). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAO Y, 2010, CANC GENE THER; Akao Y, 2006, ONCOL REP, V16, P845; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Blasco MA, 2002, NAT REV CANCER, V2, P627, DOI 10.1038/nrc862; Brosh R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.65; Chhabra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005848; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Katoh M, 2002, INT J ONCOL, V20, P1247; Lafferty-Whyte K, 2009, BBA-MOL BASIS DIS, V1792, P341, DOI 10.1016/j.bbadis.2009.02.003; LI G, 2010, INVEST OPHTHALMOL VI; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Maes OC, 2009, J CELL PHYSIOL, V221, P109, DOI 10.1002/jcp.21834; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Noren Hooten N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010724; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Pereira CP, 2009, CURR ATHEROSCLER REP, V11, P236, DOI 10.1007/s11883-009-0036-4; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Takakura M, 2005, MOL CELL BIOL, V25, P8037, DOI 10.1128/MCB.25.18.8037-8043.2005; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200; ZHAO T, 2010, AM J PHYSL ENDOCRINO	37	62	67	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12519	10.1371/journal.pone.0012519	http://dx.doi.org/10.1371/journal.pone.0012519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824140	Green Published, gold, Green Submitted			2022-12-27	WOS:000281456100019
J	Perez-Garay, M; Arteta, B; Pages, L; de Llorens, R; de Bolos, C; Vidal-Vanaclocha, F; Peracaula, R				Perez-Garay, Marta; Arteta, Beatriz; Pages, Lluis; de Llorens, Rafael; de Bolos, Carme; Vidal-Vanaclocha, Fernando; Peracaula, Rosa			alpha 2,3-Sialyltransferase ST3Gal III Modulates Pancreatic Cancer Cell Motility and Adhesion In Vitro and Enhances Its Metastatic Potential In Vivo	PLOS ONE			English	Article							SIALYL-LEWIS-X; BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; SINUSOIDAL ENDOTHELIAL-CELLS; MESSENGER-RNA EXPRESSION; HUMAN COLORECTAL-CANCER; NATURAL-KILLER-CELLS; HUMAN HEPATOCARCINOMA; FUCOSYL-TRANSFERASE; BREAST-CANCER; TUMOR-CELLS	Background: Cell surface sialylation is emerging as an important feature of cancer cell metastasis. Sialyltransferase expression has been reported to be altered in tumours and may account for the formation of sialylated tumour antigens. We have focused on the influence of alpha-2,3-sialyltransferase ST3Gal III in key steps of the pancreatic tumorigenic process. Methodology/Principal Findings: ST3Gal III overexpressing pancreatic adenocarcinoma cell lines Capan-1 and MDAPanc-28 were generated. They showed an increase of the tumour associated antigen sialyl-Lewis(x). The transfectants' E-selectin binding capacity was proportional to cell surface sialyl-Lewis(x) levels. Cellular migration positively correlated with ST3Gal III and sialyl-Lewis(x) levels. Moreover, intrasplenic injection of the ST3Gal III transfected cells into athymic nude mice showed a decrease in survival and higher metastasis formation when compared to the mock cells. Conclusion: In summary, the overexpression of ST3Gal III in these pancreatic adenocarcinoma cell lines underlines the role of this enzyme and its product in key steps of tumour progression such as adhesion, migration and metastasis formation.	[Perez-Garay, Marta; Pages, Lluis; de Llorens, Rafael; Peracaula, Rosa] Univ Girona, Biochem & Mol Biol Unit, Dept Biol, Girona, Spain; [Arteta, Beatriz; Vidal-Vanaclocha, Fernando] Univ Basque Country, Dept Cell Biol & Histol, Sch Med & Dent, Leioa, Spain; [de Bolos, Carme] Hosp del Mar, IMIM, Canc Res Program, Barcelona, Spain	Universitat de Girona; University of Basque Country; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Perez-Garay, M (corresponding author), Univ Girona, Biochem & Mol Biol Unit, Dept Biol, Girona, Spain.	rosa.peracaula@udg.edu	Arteta, Beatriz/N-4353-2015; Arteta, Beatriz/I-4161-2019	Arteta, Beatriz/0000-0003-3253-3162; Peracaula, Rosa/0000-0003-3513-524X	La Marato de TV3 foundation [050932]; Spanish Ministerio de Ciencia e Innovacion [BIO 2007-61323]; Government of Catalonia [2005SGR00065]; Comision Interministerial de Ciencia y Tecnologi-a (CICYT) of the Spanish Government in Madrid [SAF2006-09341]; Basque Country Government [IT-487-07]; Fundacio La Marato; University of Girona	La Marato de TV3 foundation; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Government of Catalonia(Generalitat de Catalunya); Comision Interministerial de Ciencia y Tecnologi-a (CICYT) of the Spanish Government in Madrid(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Basque Country Government(Basque Government); Fundacio La Marato; University of Girona	This work was supported by La Marato de TV3 foundation (grant 050932, awarded to R. P.), Spanish Ministerio de Ciencia e Innovacion (grant BIO 2007-61323, awarded to R. P.), the Government of Catalonia (grant 2005SGR00065, awarded to R. L.), the Comision Interministerial de Ciencia y Tecnologi-a (CICYT) of the Spanish Government in Madrid (no. SAF2006-09341, awarded to F. V. V.) and the Basque Country Government (no. IT-487-07 awarded to F. V. V.). M. P.-G. thanks Fundacio La Marato for a pre-doctoral fellowship and University of Girona for a short-term mobility fellowship. The funders have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amado M, 1998, GASTROENTEROLOGY, V114, P462, DOI 10.1016/S0016-5085(98)70529-3; Aubert M, 2000, CANCER RES, V60, P1449; Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; Blixt O, 2008, GLYCOCONJUGATE J, V25, P59, DOI 10.1007/s10719-007-9062-z; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bresalier RS, 1996, GASTROENTEROLOGY, V110, P1354, DOI 10.1053/gast.1996.v110.pm8613039; CARVALHO AS, 2009, INT J BIOCH CELL BIO; Chandrasekaran EV, 2005, BIOCHEMISTRY-US, V44, P15619, DOI 10.1021/bi050246m; Cho M, 1997, EUR J CANCER, V33, P931, DOI 10.1016/S0959-8049(96)00520-5; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; Dimitroff CJ, 1999, BIOCHEM BIOPH RES CO, V256, P631, DOI 10.1006/bbrc.1999.0388; Edwards S, 2005, HEPATOLOGY, V41, P451, DOI 10.1002/hep.20585; Gretschel S, 2003, ONCOLOGY-BASEL, V65, P139, DOI 10.1159/000072339; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Hebbar M, 2003, INT J BIOL MARKER, V18, P116, DOI 10.1177/172460080301800204; Hosono J, 1998, J SURG ONCOL, V67, P77, DOI 10.1002/(SICI)1096-9098(199802)67:2<77::AID-JSO2>3.0.CO;2-I; Hsu CC, 2005, GYNECOL ONCOL, V96, P415, DOI 10.1016/j.ygyno.2004.10.010; Huang S, 2009, MOL CELL BIOCHEM, V331, P81, DOI 10.1007/s11010-009-0147-9; Ito H, 1997, INT J CANCER, V71, P556, DOI 10.1002/(SICI)1097-0215(19970516)71:4<556::AID-IJC9>3.3.CO;2-J; Jin Xiao-Ling, 2004, Hepatobiliary Pancreat Dis Int, V3, P292; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Kannagi R, 1997, GLYCOCONJUGATE J, V14, P577, DOI 10.1023/A:1018532409041; Kawarada Y, 2000, PATHOL RES PRACT, V196, P259, DOI 10.1016/S0344-0338(00)80075-8; Khatib AM, 1999, CANCER RES, V59, P1356; Kim YJ, 1996, BIOCHEM BIOPH RES CO, V228, P324, DOI 10.1006/bbrc.1996.1660; KIM YS, 1988, CANCER RES, V48, P475; Kishimoto T, 1996, INT J CANCER, V69, P290, DOI 10.1002/(SICI)1097-0215(19960822)69:4<290::AID-IJC9>3.0.CO;2-S; KITAGAWA H, 1994, J BIOL CHEM, V269, P1394; KITANO H, 1993, GENETIC ALGORITHM, V1, P3; Kobayashi H, 2007, CURR MED CHEM, V14, P377, DOI 10.2174/092986707779941032; Krzewinski-Recchi MA, 2003, EUR J BIOCHEM, V270, P950, DOI 10.1046/j.1432-1033.2003.03458.x; Lalor PF, 2002, J IMMUNOL, V169, P983, DOI 10.4049/jimmunol.169.2.983; Liu F, 2002, J CANCER RES CLIN, V128, P189, DOI 10.1007/s00432-001-0314-1; Liu F, 2001, BRIT J CANCER, V84, P1556, DOI 10.1054/bjoc.2001.1815; Liu F, 2001, EUR J BIOCHEM, V268, P3501, DOI 10.1046/j.1432-1327.2001.02254.x; Magnani JL, 2004, ARCH BIOCHEM BIOPHYS, V426, P122, DOI 10.1016/j.abb.2004.04.008; Martin-Satue N, 1999, BRIT J CANCER, V80, P1169, DOI 10.1038/sj.bjc.6690482; Mas E, 1998, GLYCOBIOLOGY, V8, P605, DOI 10.1093/glycob/8.6.605; Matsushita Y, 1998, CANCER LETT, V133, P151, DOI 10.1016/S0304-3835(98)00220-1; Matsuura N, 1997, JPN J CLIN ONCOL, V27, P135, DOI 10.1093/jjco/27.3.135; Mejias-Luque R, 2007, CANCER SCI, V98, P1000, DOI 10.1111/j.1349-7006.2007.00484.x; Nakamori S, 1997, DIS COLON RECTUM, V40, P420, DOI 10.1007/BF02258386; Nakashio T, 1997, ANTICANCER RES, V17, P293; Ohyama C, 2002, P NATL ACAD SCI USA, V99, P13789, DOI 10.1073/pnas.212456599; Ohyama C, 1999, EMBO J, V18, P1516, DOI 10.1093/emboj/18.6.1516; Olaso E, 2003, HEPATOLOGY, V37, P674, DOI 10.1053/jhep.2003.50068; Paschos KA, 2010, J CELL MOL MED, V14, P165, DOI 10.1111/j.1582-4934.2009.00852.x; Peracaula R, 2005, GLYCOCONJUGATE J, V22, P135, DOI 10.1007/s10719-005-0734-2; Petretti T, 2000, GUT, V46, P359, DOI 10.1136/gut.46.3.359; Recchi MA, 1998, CANCER RES, V58, P4066; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rohfritsch PF, 2006, BBA-GEN SUBJECTS, V1760, P685, DOI 10.1016/j.bbagen.2005.12.012; ROUGER P, 1987, REV FR TRANSFUS IMMU, V30, P699, DOI 10.1016/S0338-4535(87)80138-1; Rozen S, 2000, Methods Mol Biol, V132, P365; Saito S, 2002, ONCOL REP, V9, P1251; SAKAMOTO J, 1986, CANCER RES, V46, P1553; SATOMURA Y, 1991, PANCREAS, V6, P448, DOI 10.1097/00006676-199107000-00012; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; SINN HP, 1992, INT J PANCREATOL, V11, P125; Takashima S, 2002, J BIOL CHEM, V277, P45719, DOI 10.1074/jbc.M206808200; VanDorst JALM, 1996, EUR J BIOCHEM, V242, P674; Varki A., 2008, ESSENTIALS GLYCOBIOL; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Vazquez-Martin C, 2005, ONCOLOGY-BASEL, V69, P436, DOI 10.1159/000089999; VIDALVANACLOCHA F, 1994, CANCER RES, V54, P2667; VIDALVANACLOCHA F, 1993, SEMIN LIVER DIS, V13, P60, DOI 10.1055/s-2007-1007338; Videira PA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-357; Wang PH, 2003, GYNECOL ONCOL, V89, P395, DOI 10.1016/S0090-8258(03)00127-6; Wang PH, 2002, GYNECOL ONCOL, V86, P45, DOI 10.1006/gyno.2002.6714; WEINSTEIN J, 1982, J BIOL CHEM, V257, P13845; WEN DX, 1992, J BIOL CHEM, V267, P21011; WLASICHUK KB, 1993, J BIOL CHEM, V268, P13971; Wu SL, 2003, MOL CELL BIOCHEM, V254, P193, DOI 10.1023/A:1027392212341; Yamamoto H, 2001, CANCER RES, V61, P6822; Zhang Y, 2002, J CANCER RES CLIN, V128, P617, DOI 10.1007/s00432-002-0382-x; Zhang Ying, 2002, Shi Yan Sheng Wu Xue Bao, V35, P271	79	67	71	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12524	10.1371/journal.pone.0012524	http://dx.doi.org/10.1371/journal.pone.0012524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824144	Green Published, gold			2022-12-27	WOS:000281456100021
J	Mutch, CA; Schulte, JD; Olson, E; Chenn, A				Mutch, Christopher A.; Schulte, Jessica D.; Olson, Eric; Chenn, Anjen			Beta-Catenin Signaling Negatively Regulates Intermediate Progenitor Population Numbers in the Developing Cortex	PLOS ONE			English	Article							POLYPOSIS-COLI PROTEIN; RADIAL GLIAL-CELLS; SUBVENTRICULAR ZONE; ASYMMETRIC DIVISION; CEREBRAL-CORTEX; NEURONS ARISE; COUP-TFI; EXPRESSION; MOUSE; NEUROGENESIS	Intermediate progenitor cells constitute a second proliferative cell type in the developing mammalian cerebral cortex. Little is known about the factors that govern the production of intermediate progenitors. Although persistent expression of stabilized beta-catenin was found to delay the maturation of radial glial progenitors into intermediate progenitors, the relationship between beta-catenin signaling and intermediate progenitors remains poorly understood. Using a transgenic reporter mouse for Axin2, a direct target of Wnt/beta-catenin signaling, we observed that beta-catenin signaling is decreased in intermediate progenitor cells relative to radial glial progenitors. Conditional deletion of beta-catenin from mouse cortical neural progenitors increased intermediate progenitor numbers, while conditional expression of stabilized beta-catenin reduced the intermediate progenitor population. Together, these findings provide evidence that beta-catenin signaling in radial progenitors negatively regulates intermediate progenitor cell number during cortical development.	[Mutch, Christopher A.; Schulte, Jessica D.; Chenn, Anjen] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Olson, Eric] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY USA	Northwestern University; Feinberg School of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Mutch, CA (corresponding author), Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA.	achenn@northwestern.edu		Mutch, Christopher/0000-0003-4556-8460	National Institute of Neurological Disorders and Stroke (NINDS) [RO1 NS047191]; Sontag Foundation Distinguished Scientist Award; March of Dimes Research [6-FY07-401, F30NS051864]; Northwestern University Cellular; Molecular Basis of Disease Training [GM-08061]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS051864, R01NS047191] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Sontag Foundation Distinguished Scientist Award; March of Dimes Research(March of Dimes); Northwestern University Cellular; Molecular Basis of Disease Training; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disorders and Stroke (NINDS) RO1 NS047191, Sontag Foundation Distinguished Scientist Award, and March of Dimes Research Grant 6-FY07-401 (A. C.), F30NS051864 (C. M.). J.D.S. is a fellow of the Northwestern University Cellular and Molecular Basis of Disease Training Grant (GM-08061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2007, STEM CELLS, V25, P2827, DOI 10.1634/stemcells.2007-0177; Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408; Attardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002388; Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Barolo S, 2006, ONCOGENE, V25, P7505, DOI 10.1038/sj.onc.1210057; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Bayatti N, 2008, EUR J NEUROSCI, V28, P1449, DOI 10.1111/j.1460-9568.2008.06475.x; Brault V, 2001, DEVELOPMENT, V128, P1253; Brill MS, 2009, NAT NEUROSCI, V12, P1524, DOI 10.1038/nn.2416; Britz O, 2006, CEREB CORTEX, V16, pI138, DOI 10.1093/cercor/bhj168; Bulfone A, 1999, MECH DEVELOP, V84, P133, DOI 10.1016/S0925-4773(99)00053-2; Castro DS, 2006, DEV CELL, V11, P831, DOI 10.1016/j.devcel.2006.10.006; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Faedo A, 2008, CEREB CORTEX, V18, P2117, DOI 10.1093/cercor/bhm238; Farkas LM, 2008, NEURON, V60, P40, DOI 10.1016/j.neuron.2008.09.020; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Huttner WB, 1997, CURR OPIN NEUROBIOL, V7, P29, DOI 10.1016/S0959-4388(97)80117-1; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kan LX, 2004, DEV BIOL, V269, P580, DOI 10.1016/j.ydbio.2004.02.005; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kormish JD, 2010, DEV DYNAM, V239, P56, DOI 10.1002/dvdy.22046; KOWALCZYK T, 2009, CEREB CORTEX; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kuwahara A, 2010, DEVELOPMENT, V137, P1035, DOI 10.1242/dev.046417; Liu Q, 2000, J NEUROSCI, V20, P7682; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Machon O, 2007, DEV BIOL, V311, P223, DOI 10.1016/j.ydbio.2007.08.038; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Martinez-Cerdeno V, 2006, CEREB CORTEX, V16, pI152, DOI 10.1093/cercor/bhk017; Martinez-Morales PL, 2010, EMBO REP, V11, P466, DOI 10.1038/embor.2010.61; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Mutch CA, 2009, J NEUROSCI, V29, P13710, DOI 10.1523/JNEUROSCI.3022-09.2009; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Quinn JC, 2007, DEV BIOL, V302, P50, DOI 10.1016/j.ydbio.2006.08.035; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Siegenthaler JA, 2008, CEREB CORTEX, V18, P1865, DOI 10.1093/cercor/bhm209; Sinner D, 2004, DEVELOPMENT, V131, P3069, DOI 10.1242/dev.01176; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; SMART IHM, 1973, J ANAT, V116, P67; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; TAKAHASHI T, 1995, J NEUROSCI, V15, P6058; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Weimer JM, 2009, DEVELOPMENT, V136, P2965, DOI 10.1242/dev.036616; Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006; Wrobel CN, 2007, DEV BIOL, V309, P285, DOI 10.1016/j.ydbio.2007.07.013; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Yokota Y, 2009, NEURON, V61, P42, DOI 10.1016/j.neuron.2008.10.053; Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4; Zhang JN, 2010, DEV CELL, V18, P472, DOI 10.1016/j.devcel.2009.12.025	69	53	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12376	10.1371/journal.pone.0012376	http://dx.doi.org/10.1371/journal.pone.0012376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811503	gold, Green Published, Green Submitted			2022-12-27	WOS:000281234700012
J	Huntington, BE; Karnauskas, M; Babcock, EA; Lirman, D				Huntington, Brittany E.; Karnauskas, Mandy; Babcock, Elizabeth A.; Lirman, Diego			Untangling Natural Seascape Variation from Marine Reserve Effects Using a Landscape Approach	PLOS ONE			English	Article							REEF FISH COMMUNITIES; PROTECTED AREAS; CORAL; ENVIRONMENT; DIVERSITY	Distinguishing management effects from the inherent variability in a system is a key consideration in assessing reserve efficacy. Here, we demonstrate how seascape heterogeneity, defined as the spatial configuration and composition of coral reef habitats, can mask our ability to discern reserve effects. We then test the application of a landscape approach, utilizing advances in benthic habitat mapping and GIS techniques, to quantify this heterogeneity and alleviate the confounding influence during reserve assessment. Seascape metrics were quantified at multiple spatial scales using a combination of spatial image analysis and in situ surveys at 87 patch reef sites in Glover's Reef Lagoon, Belize, within and outside a marine reserve enforced since 1998. Patch reef sites were then clustered into classes sharing similar seascape attributes using metrics that correlated significantly to observed variations in both fish and coral communities. When the efficacy of the marine reserve was assessed without including landscape attributes, no reserve effects were detected in the diversity and abundance of fish and coral communities, despite 10 years of management protection. However, grouping sites based on landscape attributes revealed significant reserve effects between site classes. Fish had higher total biomass (1.5x) and commercially important biomass (1.75x) inside the reserve and coral cover was 1.8 times greater inside the reserve, though direction and degree of response varied by seascape class. Our findings show that the application of a landscape classification approach vastly improves our ability to evaluate the efficacy of marine reserves by controlling for confounding effects of seascape heterogeneity and suggests that landscape heterogeneity should be considered in future reserve design.	[Huntington, Brittany E.; Karnauskas, Mandy; Babcock, Elizabeth A.; Lirman, Diego] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	University of Miami	Huntington, BE (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	bhuntington@rsmas.miami.edu	Babcock, Elizabeth A/E-7753-2013	Karnauskas, Mandy/0000-0002-6631-0592; Babcock, Elizabeth A/0000-0002-2279-6762	Pew Institute for Ocean Science; University of Miami; Explorer's Club	Pew Institute for Ocean Science; University of Miami; Explorer's Club	The Pew Institute for Ocean Science and University of Miami Fellowships provided support to BH and MK. An Explorer's Club Exploration Grant awarded to BH provided additional funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta CA, 2002, MAR ECOL PROG SER, V227, P87, DOI 10.3354/meps227087; Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Ault TR, 1998, ECOL MONOGR, V68, P25, DOI 10.1890/0012-9615(1998)068[0025:SATPFO]2.0.CO;2; Balasubramanian H, 2007, MAR ECOL PROG SER, V345, P229, DOI 10.3354/meps06782; Bell SS, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P625; Bohnsack J.A., 1988, NOAA (National Oceanic Atmospheric Administration) Technical Memorandum NMFS (National Marine Fisheries Service) SEFC (Southeast Fisheries Center), P1; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Cushman SA, 2004, ECOL APPL, V14, P1090, DOI 10.1890/03-5131; Davis JD, 2007, LANDSCAPE ECOL, V22, P1341, DOI 10.1007/s10980-007-9111-9; Fraschetti S, 2002, MAR ECOL-P S Z N I, V23, P190, DOI 10.1111/j.1439-0485.2002.tb00018.x; Friedlander AM, 2007, ECOL APPL, V17, P715, DOI 10.1890/06-0536; Garcia-Charton JA, 2000, ENVIRON CONSERV, V27, P159, DOI 10.1017/S0376892900000199; GIBSON J, 2006, MANAGEMENT EFFECTIVE, P1; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Grober-Dunsmore R, 2007, CORAL REEFS, V26, P201, DOI 10.1007/s00338-006-0180-z; Grober-Dunsmore R, 2008, LANDSCAPE ECOL, V23, P37, DOI 10.1007/s10980-007-9147-x; Grober-Dunsmore R, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P493, DOI 10.1007/978-90-481-2406-0_14; Halpern BS, 2003, ECOL APPL, V13, pS117; Hamilton SL, 2010, P NATL ACAD SCI USA, V107, P18272, DOI 10.1073/pnas.0908091107; Harborne AR, 2008, J APPL ECOL, V45, P1010, DOI 10.1111/j.1365-2664.2008.01490.x; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; LUBCHENCO J, 2003, ECOL APPL, V13, P3, DOI DOI 10.1890/1051-0761(2003)013[0003:PAHITO]2.0.CO;2; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Mellin C, 2009, MAR POLLUT BULL, V58, P11, DOI 10.1016/j.marpolbul.2008.10.010; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Osenberg CW., 2006, FDN RESTORATION ECOL, P280; Overholtzer-McLeod KL, 2006, ECOLOGY, V87, P1017, DOI 10.1890/0012-9658(2006)87[1017:COPRSF]2.0.CO;2; Pande A, 2009, AQUAT CONSERV, V19, P237, DOI 10.1002/aqc.984; Pittman SJ, 2004, MAR ECOL PROG SER, V283, P233, DOI 10.3354/meps283233; ROHNSACK JA, 1986, STATIONARY VISUAL CE, P1; Russ Garry R., 2002, P421, DOI 10.1016/B978-012615185-5/50024-4; Starr RM, 2007, MAR ECOL PROG SER, V343, P239, DOI 10.3354/meps06897; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; Wallace RJ, 1975, THESIS PRINCETON U P; Willis TJ, 2003, ENVIRON CONSERV, V30, P97, DOI 10.1017/S0376892903000092; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3	41	39	41	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12327	10.1371/journal.pone.0012327	http://dx.doi.org/10.1371/journal.pone.0012327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808833	Green Submitted, Green Published, gold			2022-12-27	WOS:000281077000016
J	von Burstin, J; Reichert, M; Wescott, MP; Rustgi, AK				von Burstin, Johannes; Reichert, Maximilian; Wescott, Melanie P.; Rustgi, Anil K.			The Pancreatic and Duodenal Homeobox Protein PDX-1 Regulates the Ductal Specific Keratin 19 through the Degradation of MEIS1 and DNA Binding	PLOS ONE			English	Article							HOMEODOMAIN TRANSCRIPTION FACTOR; SYNTHASE EXON 1C; GENE-TRANSCRIPTION; PROTEASOMAL DEGRADATION; HISTONE DEACETYLASES; PBX COMPLEXES; IN-VIVO; CELLS; EXPRESSION; PROMOTER	Background: Pancreas organogenesis is the result of well-orchestrated and balanced activities of transcription factors. The homeobox transcription factor PDX-1 plays a crucial role in the development and function of the pancreas, both in the maintenance of progenitor cells and in determination and maintenance of differentiated endocrine cells. However, the activity of homeobox transcription factors requires coordination with co-factors, such as PBX and MEIS proteins. PBX and MEIS proteins belong to the family of three amino acid loop extension (TALE) homeodomain proteins. In a previous study we found that PDX-1 negatively regulates the transcriptional activity of the ductal specific keratin 19 (Krt19). In this study, we investigate the role of different domains of PDX-1 and elucidate the functional interplay of PDX-1 and MEIS1 necessary for Krt19 regulation. Methodology/Principal Findings: Here, we demonstrate that PDX-1 exerts a dual manner of regulation of Krt19 transcriptional activity. Deletion studies highlight that the NH(2)-terminus of PDX-1 is functionally relevant for the down-regulation of Krt19, as it is required for DNA binding of PDX-1 to the Krt19 promoter. Moreover, this effect occurs independently of PBX. Second, we provide insight on how PDX-1 regulates the Hox co-factor MEIS1 post-transcriptionally. We find specific binding of MEIS1 and MEIS2 to the Krt19 promoter using IP-EMSA, and siRNA mediated silencing of Meis1, but not Meis2, reduces transcriptional activation of Krt19 in primary pancreatic ductal cells. Over-expression of PDX-1 leads to a decreased level of MEIS1 protein, and this decrease is prevented by inhibition of the proteasome. Conclusions/Significance: Taken together, our data provide evidence for a dual mechanism of how PDX-1 negatively regulates Krt19 ductal specific gene expression. These findings imply that transcription factors may efficiently regulate target gene expression through diverse, non-redundant mechanisms.	[von Burstin, Johannes] Univ Penn, Div Gastroenterol, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Div Gastroenterol, Dept Genet, Abramson Canc Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	von Burstin, J (corresponding author), Univ Penn, Div Gastroenterol, Dept Med, Philadelphia, PA 19104 USA.	anil2@mail.med.upenn.edu	Reichert, Maximilian/GOH-1246-2022		National Institutes of Health [R01-DK060694]; National Pancreas Foundation; Deutsche Forschungsgemeinschaft [JvB BU 2412-1/1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060694, P30DK050306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Pancreas Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant R01-DK060694 (AKR, JvB, MR), National Pancreas Foundation (MR, MPW), and the Deutsche Forschungsgemeinschaft (JvB BU 2412-1/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Bossis G, 2003, MOL CELL BIOL, V23, P7425, DOI 10.1128/MCB.23.20.7425-7436.2003; Brembeck FH, 2000, J BIOL CHEM, V275, P28230; Choe SK, 2009, DEV CELL, V17, P561, DOI 10.1016/j.devcel.2009.08.007; Deramaudt TB, 2006, J BIOL CHEM, V281, P38385, DOI 10.1074/jbc.M605891200; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Dutta S, 2001, P NATL ACAD SCI USA, V98, P1065, DOI 10.1073/pnas.031561298; Esparza SD, 2008, LEUKEMIA, V22, P665, DOI 10.1038/sj.leu.2404933; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Hale MA, 2005, DEV BIOL, V286, P225, DOI 10.1016/j.ydbio.2005.07.026; Heine P, 2008, DEVELOPMENT, V135, P805, DOI 10.1242/dev.012088; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Jamaluddin M, 2005, J VIROL, V79, P15302, DOI 10.1128/JVI.79.24.15302-15313.2005; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kim SK, 2002, NAT GENET, V30, P430, DOI 10.1038/ng860; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Mojsin M, 2010, BIOCHEM J, V425, P107, DOI 10.1042/BJ20090694; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; MOSKOW JJ, 1995, MOL CELL BIOL, V15, P5434; Mosley AL, 2004, J BIOL CHEM, V279, P54241, DOI 10.1074/jbc.M410379200; Offield MF, 1996, DEVELOPMENT, V122, P983; OHLSSON H, 1991, MOL ENDOCRINOL, V5, P897, DOI 10.1210/mend-5-7-897; Peng HZ, 2000, J BIOL CHEM, V275, P18000, DOI 10.1074/jbc.M001499200; Peshavaria M, 1997, MOL CELL BIOL, V17, P3987, DOI 10.1128/MCB.17.7.3987; Petersen HV, 1998, FEBS LETT, V431, P362, DOI 10.1016/S0014-5793(98)00776-5; Pillay LM, 2010, DEV BIOL; Qiu Y, 2002, MOL CELL BIOL, V22, P412, DOI 10.1128/MCB.22.2.412-420.2002; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Saleh M, 2000, MOL CELL BIOL, V20, P8623, DOI 10.1128/MCB.20.22.8623-8633.2000; Saur D, 2004, P NATL ACAD SCI USA, V101, P1662, DOI 10.1073/pnas.0305473101; Saur D, 2002, J BIOL CHEM, V277, P25798, DOI 10.1074/jbc.M109802200; Schreiber FS, 2004, GASTROENTEROLOGY, V127, P250, DOI 10.1053/j.gastro.2004.03.058; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Shanmugam K, 1999, MOL CELL BIOL, V19, P7577; Shen WF, 1999, MOL CELL BIOL, V19, P3051; Steeman S, 1997, GENOME RES, V7, P142, DOI 10.1101/gr.7.2.142; Stoffers DA, 1997, TRENDS ENDOCRIN MET, V8, P145, DOI 10.1016/S1043-2760(97)00008-8; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Wescott MP, 2009, MOL BIOL CELL, V20, P4838, DOI 10.1091/mbc.E09-03-0203; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhang X, 2006, DEV BIOL, V300, P748, DOI 10.1016/j.ydbio.2006.06.030	46	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12311	10.1371/journal.pone.0012311	http://dx.doi.org/10.1371/journal.pone.0012311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808819	Green Published, gold, Green Submitted			2022-12-27	WOS:000281075500028
J	Shi, ZD; Abraham, G; Tarbell, JM				Shi, Zhong-Dong; Abraham, Giya; Tarbell, John M.			Shear Stress Modulation of Smooth Muscle Cell Marker Genes in 2-D and 3-D Depends on Mechanotransduction by Heparan Sulfate Proteoglycans and ERK1/2	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; INTERSTITIAL FLOW; FLUID-FLOW; NEOINTIMA FORMATION; COLLAGEN I; PROLIFERATION; EXPRESSION; FIBROBLAST; DIFFERENTIATION; MIGRATION	Background: During vascular injury, vascular smooth muscle cells (SMCs) and fibroblasts/myofibroblasts (FBs/MFBs) are exposed to altered luminal blood flow or transmural interstitial flow. We investigate the effects of these two types of fluid flows on the phenotypes of SMCs and MFBs and the underlying mechanotransduction mechanisms. Methodology/Principal Findings: Exposure to 8 dyn/cm(2) laminar flow shear stress (2-dimensional, 2-D) for 15 h significantly reduced expression of alpha-smooth muscle actin (alpha-SMA), smooth muscle protein 22 (SM22), SM myosin heavy chain (SM-MHC), smoothelin, and calponin. Cells suspended in collagen gels were exposed to interstitial flow (1 cmH(2)O, similar to 0.05 dyn/cm(2), 3-D), and after 6 h of exposure, expression of SM-MHC, smoothelin, and calponin were significantly reduced, while expression of alpha-SMA and SM22 were markedly enhanced. PD98059 (an ERK1/2 inhibitor) and heparinase III (an enzyme to cleave heparan sulfate) significantly blocked the effects of laminar flow on gene expression, and also reversed the effects of interstitial flow on SM-MHC, smoothelin, and calponin, but enhanced interstitial flow-induced expression of alpha-SMA and SM22. SMCs and MFBs have similar responses to fluid flow. Silencing ERK1/2 completely blocked the effects of both laminar flow and interstitial flow on SMC marker gene expression. Western blotting showed that both types of flows induced ERK1/2 activation that was inhibited by disruption of heparan sulfate proteoglycans (HSPGs). Conclusions/Significance: The results suggest that HSPG-mediated ERK1/2 activation is an important mechanotransduction pathway modulating SMC marker gene expression when SMCs and MFBs are exposed to flow. Fluid flow may be involved in vascular remodeling and lesion formation by affecting phenotypes of vascular wall cells. This study has implications in understanding the flow-related mechanobiology in vascular lesion formation, tumor cell invasion, and stem cell differentiation.	[Shi, Zhong-Dong; Abraham, Giya; Tarbell, John M.] CUNY, City Coll New York, Dept Biomed Engn, New York, NY 10021 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Shi, ZD (corresponding author), CUNY, City Coll New York, Dept Biomed Engn, New York, NY 10021 USA.	zdshi@hotmail.com; tarbell@ccny.cuny.edu	Shi, Zhong-Dong/A-7212-2012		NIH NHLBI [RO1 HL 57093, RO1 HL 094889]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057093, R01HL094889] Funding Source: NIH RePORTER	NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH NHLBI grants RO1 HL 57093 (JMT) and RO1 HL 094889 (JMT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie KM, 2005, J APPL PHYSIOL, V98, P242, DOI 10.1152/japplphysiol.01006.2003; Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583; Asada H, 2005, J VASC SURG, V42, P772, DOI 10.1016/j.jvs.2005.05.046; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Chambers RC, 2003, AM J PATHOL, V162, P533, DOI 10.1016/S0002-9440(10)63847-3; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Fitzgerald TN, 2008, J CELL PHYSIOL, V216, P389, DOI 10.1002/jcp.21404; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Garanich JS, 2007, AM J PHYSIOL-HEART C, V292, pH3128, DOI 10.1152/ajpheart.00578.2006; Garanich JS, 2005, AM J PHYSIOL-HEART C, V288, pH2244, DOI 10.1152/ajpheart.00428.2003; Gennaro G, 2003, ARTERIOSCL THROM VAS, V23, P204, DOI 10.1161/01.ATV.0000053182.58636.BE; Haga M, 2003, J VASC SURG, V37, P1277, DOI 10.1016/S0741-5214(03)00329-X; Harfouche R, 2009, CIRCULATION, V120, P1883, DOI 10.1161/CIRCULATIONAHA.108.837724; Hinz B, 2003, MOL BIOL CELL, V14, P2508, DOI 10.1091/mbc.E02-11-0729; Hosseinkhani H, 2005, TISSUE ENG, V11, P1476, DOI 10.1089/ten.2005.11.1476; Hu YH, 1997, ARTERIOSCL THROM VAS, V17, P2808, DOI 10.1161/01.ATV.17.11.2808; Kharebava G, 2008, J NEUROSCI, V28, P11409, DOI 10.1523/JNEUROSCI.2135-08.2008; Kirkpatrick CA, 2007, J CELL SCI, V120, P1829, DOI 10.1242/jcs.03432; Koyama H, 1999, THROMB HAEMOSTASIS, V82, P806, DOI 10.1055/s-0037-1615915; Lai KH, 1996, J CLIN INVEST, V98, P1560, DOI 10.1172/JCI118949; Lawson D, 1997, CELL MOTIL CYTOSKEL, V38, P250, DOI 10.1002/(SICI)1097-0169(1997)38:3<250::AID-CM3>3.0.CO;2-9; Leguillette R, 2009, AM J RESP CRIT CARE, V179, P194, DOI 10.1164/rccm.200609-1367OC; LEVICK JR, 1987, Q J EXP PHYSIOL CMS, V72, P409, DOI 10.1113/expphysiol.1987.sp003085; Li CH, 2007, CELL SIGNAL, V19, P881, DOI 10.1016/j.cellsig.2007.01.004; Louis H, 2006, CLIN EXP PHARMACOL P, V33, P131, DOI 10.1111/j.1440-1681.2006.04339.x; Low RB, 1999, DIFFERENTIATION, V65, P151, DOI 10.1046/j.1432-0436.1999.6530151.x; Muslin AJ, 2008, CLIN SCI, V115, P203, DOI 10.1042/CS20070430; Ng CP, 2005, J CELL SCI, V118, P4731, DOI 10.1242/jcs.02605; Ni J, 2010, J BIOL CHEM, V285, P4038, DOI 10.1074/jbc.M109.078345; Oishi K, 2002, J PHYSIOL-LONDON, V540, P139, DOI 10.1113/jphysiol.2001.013278; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; PARK F, 1997, AM J PHYSIOL-REG I, V273, pR1742; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Rensen SSM, 2006, CARDIOVASC RES, V70, P136, DOI 10.1016/j.cardiores.2005.12.018; Rizzo V, 2009, AM J PHYSIOL-HEART C, V297, pH1196, DOI 10.1152/ajpheart.00499.2009; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Roy J, 2001, DIFFERENTIATION, V67, P50, DOI 10.1046/j.1432-0436.2001.067001050.x; Rutkowski JM, 2007, TRENDS CELL BIOL, V17, P44, DOI 10.1016/j.tcb.2006.11.007; Sartore S, 2001, CIRC RES, V89, P1111, DOI 10.1161/hh2401.100844; Shi Y, 1996, CIRCULATION, V94, P1655, DOI 10.1161/01.CIR.94.7.1655; Shi ZD, 2010, AM J PHYSIOL-HEART C, V298, pH127, DOI 10.1152/ajpheart.00732.2009; Shi ZD, 2009, AM J PHYSIOL-HEART C, V297, pH1225, DOI 10.1152/ajpheart.00369.2009; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Stegemann JP, 2005, J APPL PHYSIOL, V98, P2321, DOI 10.1152/japplphysiol.01114.2004; STERPETTI AV, 1993, SURGERY, V113, P691; Swartz MA, 2007, ANNU REV BIOMED ENG, V9, P229, DOI 10.1146/annurev.bioeng.9.060906.151850; Tada S, 2002, AM J PHYSIOL-HEART C, V282, pH576, DOI 10.1152/ajpheart.00751.2001; TAKEUCHI K, 1991, J BIOCHEM, V109, P311; Tarbell JM, 2006, J INTERN MED, V259, P339, DOI 10.1111/j.1365-2796.2006.01620.x; Tsai RYL, 2000, J NEUROSCI, V20, P3725, DOI 10.1523/JNEUROSCI.20-10-03725.2000; Ueba H, 1997, ARTERIOSCL THROM VAS, V17, P1512, DOI 10.1161/01.ATV.17.8.1512; van Eys GJ, 2007, TRENDS CARDIOVAS MED, V17, P26, DOI 10.1016/j.tcm.2006.11.001; Vera RH, 2009, TISSUE ENG PT A, V15, P175, DOI 10.1089/ten.tea.2007.0314; Walsh MJ, 2003, FASEB J, V17, pA1007; Wang H, 2006, BIOCHEM BIOPH RES CO, V346, P860, DOI 10.1016/j.bbrc.2006.05.196; Wang S, 2000, ARTERIOSCL THROM VAS, V20, P2220, DOI 10.1161/01.ATV.20.10.2220; WANG WJ, 1995, J VIB ACOUST, V117, P363, DOI 10.1115/1.2874462; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007	61	55	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12196	10.1371/journal.pone.0012196	http://dx.doi.org/10.1371/journal.pone.0012196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808940	Green Published, gold			2022-12-27	WOS:000280968000020
J	Dhodda, V; Godiska, R; VanWye, JD; Mead, D; Hochstein, R; Sheets, L; Zande, SV; Niebauer, C; Crawford, DL; Oleksiak, MF				Dhodda, Vinay; Godiska, Ronald; VanWye, Jeffrey D.; Mead, David; Hochstein, Rebecca; Sheets, Lynne; Zande, Sarah Vande; Niebauer, Chris; Crawford, Douglas L.; Oleksiak, Marjorie F.			ExCyto PCR Amplification	PLOS ONE			English	Article							HIGH-EFFICIENCY TRANSFORMATION; POLYMERASE CHAIN-REACTION; ESCHERICHIA-COLI; ENZYMATIC AMPLIFICATION; DNA INVITRO	Background: ExCyto PCR cells provide a novel and cost effective means to amplify DNA transformed into competent bacterial cells. ExCyto PCR uses host E. coli with a chromosomally integrated gene encoding a thermostable DNA polymerase to accomplish robust, hot-start PCR amplification of cloned sequences without addition of exogenous enzyme. Results: Because the thermostable DNA polymerase is stably integrated into the bacterial chromosome, ExCyto cells can be transformed with a single plasmid or complex library, and then the expressed thermostable DNA polymerase can be used for PCR amplification. We demonstrate that ExCyto cells can be used to amplify DNA from different templates, plasmids with different copy numbers, and master mixes left on ice for up to two hours. Further, PCR amplification with ExCyto cells is comparable to amplification using commercial DNA polymerases. The ability to transform a bacterial strain and use the endogenously expressed protein for PCR has not previously been demonstrated. Conclusions: ExCyto PCR reduces pipetting and greatly increases throughput for screening EST, genomic, BAC, cDNA, or SNP libraries. This technique is also more economical than traditional PCR and thus broadly useful to scientists who utilize analysis of cloned DNAs in their research.	[Dhodda, Vinay; Godiska, Ronald; Mead, David; Hochstein, Rebecca; Sheets, Lynne; Zande, Sarah Vande; Niebauer, Chris] Lucigen Corp, Middleton, WI USA; [VanWye, Jeffrey D.; Crawford, Douglas L.; Oleksiak, Marjorie F.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Biol & Fisheries, Miami, FL 33149 USA	University of Miami	Dhodda, V (corresponding author), Lucigen Corp, Middleton, WI USA.	moleksiak@rsmas.miami.edu	Godiska, Ronald/V-7489-2017	Godiska, Ronald/0000-0003-0101-6365; MEAD, David/0000-0003-1982-9356; Crawford, Douglas/0000-0002-6239-4012	National Science Foundation; Lucigen Corporation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R43HG003076] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Lucigen Corporation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by a National Science Foundation Postdoctoral Fellowship to MFO and by Lucigen Corporation. The National Science Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors of this manuscript affiliated with Lucigen Corporation (VD, RG, DM, RH, LS, SVZ, and CN) did have a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; ERLICH HA, 1991, SCIENCE, V252, P1643, DOI 10.1126/science.2047872; HAWKINS TL, 1994, NUCLEIC ACIDS RES, V22, P4543, DOI 10.1093/nar/22.21.4543; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980	8	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12629	10.1371/journal.pone.0012629	http://dx.doi.org/10.1371/journal.pone.0012629			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IV	20838619	Green Published, gold, Green Submitted			2022-12-27	WOS:000281687100010
J	Malinovsky, FG; Brodersen, P; Fiil, BK; McKinney, LV; Thorgrimsen, S; Beck, M; Nielsen, HB; Pietra, S; Zipfel, C; Robatzek, S; Petersen, M; Hofius, D; Mundy, J				Malinovsky, Frederikke G.; Brodersen, Peter; Fiil, Berthe Katrine; McKinney, Lea Vig; Thorgrimsen, Stephan; Beck, Martina; Nielsen, H. Bjorn; Pietra, Stefano; Zipfel, Cyril; Robatzek, Silke; Petersen, Morten; Hofius, Daniel; Mundy, John			Lazarus1, a DUF300 Protein, Contributes to Programmed Cell Death Associated with Arabidopsis acd11 and the Hypersensitive Response	PLOS ONE			English	Article							NB-LRR PROTEIN; DISEASE RESISTANCE; SALICYLIC-ACID; GENE; DEFENSE; ACCUMULATION; EXPRESSION; AVRRPT2; TOBACCO; EDS1	Background: Programmed cell death (PCD) is a necessary part of the life of multi-cellular organisms. A type of plant PCD is the defensive hypersensitive response (HR) elicited via recognition of a pathogen by host resistance (R) proteins. The lethal, recessive accelerated cell death 11 (acd11) mutant exhibits HR-like accelerated cell death, and cell death execution in acd11 shares genetic requirements for HR execution triggered by one subclass of R proteins. Methodology/Principal Findings: To identify genes required for this PCD pathway, we conducted a genetic screen for suppressors of acd11, here called lazarus (laz) mutants. In addition to known suppressors of R protein-mediated HR, we isolated 13 novel complementation groups of dominant and recessive laz mutants. Here we describe laz1, which encodes a protein with a domain of unknown function (DUF300), and demonstrate that LAZ1 contributes to HR PCD conditioned by the Toll/interleukin-1 (TIR)-type R protein RPS4 and by the coiled-coil (CC)-type R protein RPM1. Using a yeast-based topology assay, we also provide evidence that LAZ1 is a six transmembrane protein with structural similarities to the human tumor suppressor TMEM34. Finally, we demonstrate by transient expression of reporter fusions in protoplasts that localization of LAZ1 is distributed between the cytosol, the plasma membrane and FM4-64 stained vesicles. Conclusions/Significance: Our findings indicate that LAZ1 functions as a regulator or effector of plant PCD associated with the HR, in addition to its role in acd11-related death. Furthermore, the similar topology of a plant and human DUF300 proteins suggests similar functions in PCD across the eukaryotic kingdoms, although a direct role for TMEM34 in cell death control remains to be established. Finally, the subcellular localization pattern of LAZ1 suggests that it may have transport functions for yet unknown, death-related signaling molecules at the plasma membrane and/or endosomal compartments. In summary, our results validate the utility of the large-scale suppressor screen to identify novel components with functions in plant PCD, which may also have implications for deciphering cell death mechanisms in other organisms.	[Malinovsky, Frederikke G.; Brodersen, Peter; Fiil, Berthe Katrine; McKinney, Lea Vig; Thorgrimsen, Stephan; Pietra, Stefano; Petersen, Morten; Hofius, Daniel; Mundy, John] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Malinovsky, Frederikke G.; Beck, Martina; Zipfel, Cyril; Robatzek, Silke] Sainsbury Lab, Norwich, Norfolk, England; [Nielsen, H. Bjorn] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark	University of Copenhagen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Technical University of Denmark	Malinovsky, FG (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England.	mundy@bio.ku.dk	McKinney, Lea Vig/B-7309-2015; Robatzek, Silke/B-6844-2013; mundy, john/A-2361-2013; ZIPFEL, CYRIL/ABD-5076-2021; mailnovsky, frederikke gro/C-1959-2015; Petersen, Morten/J-5023-2014; ZIPFEL, CYRIL B/D-7103-2011; Nielsen, Henrik Bjorn/B-8961-2019	McKinney, Lea Vig/0000-0001-6601-4614; mundy, john/0000-0001-7490-4588; ZIPFEL, CYRIL/0000-0003-4935-8583; mailnovsky, frederikke gro/0000-0002-9833-7968; Petersen, Morten/0000-0002-3035-5991; ZIPFEL, CYRIL B/0000-0003-4935-8583; Pietra, Stefano/0000-0003-4417-8153; Nielsen, Henrik Bjorn/0000-0003-2281-5713; Fiil, Berthe Katrine/0000-0002-9499-4848	Danish Research Council [274-06-0460, 272-06-0049]; European Union [LSHG-CT-2004-511983]; Danish Agricultural Research Council [23-02-0101, 23-04-0143]	Danish Research Council(Det Frie Forskningsrad (DFF)); European Union(European Commission); Danish Agricultural Research Council	This work was funded by grants to JM from the Danish Research Council (274-06-0460, 272-06-0049), and the European Union (LSHG-CT-2004-511983) and to MP (23-02-0101) and DH (23-04-0143) from the Danish Agricultural Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Akaishi J, 2007, J CANCER RES CLIN, V133, P213, DOI 10.1007/s00432-006-0159-8; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Axtell MJ, 2001, MOL PLANT MICROBE IN, V14, P181, DOI 10.1094/MPMI.2001.14.2.181; Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Best D, 2008, DEVELOPMENT, V135, P1415, DOI 10.1242/dev.019497; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brodersen P, 2002, GENE DEV, V16, P490, DOI 10.1101/gad.218202; Brodersen P, 2005, PLANT PHYSIOL, V138, P1037, DOI 10.1104/pp.105.059303; Clough SJ, 2000, P NATL ACAD SCI USA, V97, P9323, DOI 10.1073/pnas.150005697; Eitas TK, 2008, P NATL ACAD SCI USA, V105, P6475, DOI 10.1073/pnas.0802157105; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Geldner N, 2008, PLANT PHYSIOL, V147, P1565, DOI 10.1104/pp.108.120287; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Gilroy EM, 2007, PLANT J, V52, P1, DOI 10.1111/j.1365-313X.2007.03226.x; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; HOFIUS D, 2009, CELL IN PRESS   0515; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jurkowski GI, 2004, MOL PLANT MICROBE IN, V17, P511, DOI 10.1094/MPMI.2004.17.5.511; Kim H, 2003, J BIOL CHEM, V278, P10208, DOI 10.1074/jbc.M300163200; Koga J, 2006, PLANT PHYSIOL, V140, P1475, DOI 10.1104/pp.105.070334; Kosters A, 2008, XENOBIOTICA, V38, P1043, DOI [10.1080/00498250802040584, 10.1080/00498250802040584 ]; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Lemon WJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r67; Liang H, 2003, GENE DEV, V17, P2636, DOI 10.1101/gad.1140503; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Muller J, 2007, PLANT PHYSIOL, V145, P293, DOI 10.1104/pp.107.102863; Murphy AS, 2005, ANNU REV PLANT BIOL, V56, P221, DOI 10.1146/annurev.arplant.56.032604.144150; Nakashita H, 2003, PLANT J, V33, P887, DOI 10.1046/j.1365-313X.2003.01675.x; Peart JR, 2005, CURR BIOL, V15, P968, DOI 10.1016/j.cub.2005.04.053; Pinan-Lucarre R, 2003, MOL MICROBIOL, V47, P321, DOI 10.1046/j.1365-2958.2003.03208.x; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Takahashi Y, 2009, MOL PLANT MICROBE IN, V22, P31, DOI 10.1094/MPMI-22-1-0031; Tornero P, 2002, PLANT CELL, V14, P435, DOI 10.1105/tpc.010393; Tornero P, 2002, PLANT CELL, V14, P1005, DOI 10.1105/tpc.001032; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Zhang Yuelin, 2007, Methods Mol Biol, V354, P69	44	20	24	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12586	10.1371/journal.pone.0012586	http://dx.doi.org/10.1371/journal.pone.0012586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830211	Green Published, gold, Green Submitted			2022-12-27	WOS:000281631300015
J	Figueira, ACM; Polikarpov, I; Veprintsev, D; Santos, GM				Migliorini Figueira, Ana Carolina; Polikarpov, Igor; Veprintsev, Dmitry; Santos, Guilherme Martins			Dissecting the Relation between a Nuclear Receptor and GATA: Binding Affinity Studies of Thyroid Hormone Receptor and GATA2 on TSH beta Promoter	PLOS ONE			English	Article							RETINOID-X-RECEPTOR; THYROTROPIN GENE-EXPRESSION; DNA-BINDING; GLUCOCORTICOID-RECEPTOR; NEGATIVE REGULATION; RESPONSE ELEMENTS; CROSS-TALK; IN-VIVO; FLUORESCENCE ANISOTROPY; ESTROGEN-RECEPTOR	Background: Much is known about how genes regulated by nuclear receptors (NRs) are switched on in the presence of a ligand. However, the molecular mechanism for gene down-regulation by liganded NRs remains a conundrum. The interaction between two zinc-finger transcription factors, Nuclear Receptor and GATA, was described almost a decade ago as a strategy adopted by the cell to up-or down-regulate gene expression. More recently, cell-based assays have shown that the Zn-finger region of GATA2 (GATA2-Zf) has an important role in down-regulation of the thyrotropin gene (TSH beta) by liganded thyroid hormone receptor (TR). Methodology/Principal Findings: In an effort to better understand the mechanism that drives TSH beta down-regulation by a liganded TR and GATA2, we have carried out equilibrium binding assays using fluorescence anisotropy to study the interaction of recombinant TR and GATA2-Zf with regulatory elements present in the TSH beta promoter. Surprisingly, we observed that ligand (T3) weakens TR binding to a negative regulatory element (NRE) present in the TSH beta promoter. We also show that TR may interact with GATA2-Zf in the absence of ligand, but T3 is crucial for increasing the affinity of this complex for different GATA response elements (GATA-REs). Importantly, these results indicate that TR complex formation enhances DNA binding of the TR-GATA2 in a ligand-dependent manner. Conclusions: Our findings extend previous results obtained in vivo, further improving our understanding of how liganded nuclear receptors down-regulate gene transcription, with the cooperative binding of transcription factors to DNA forming the core of this process.	[Migliorini Figueira, Ana Carolina; Polikarpov, Igor] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Paulo, Brazil; [Veprintsev, Dmitry] Paul Scherrer Inst, Biomol Res Lab, Villigen, Switzerland; [Santos, Guilherme Martins] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	Universidade de Sao Paulo; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; MRC Laboratory Molecular Biology	Figueira, ACM (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, Sao Paulo, Brazil.	gsantos@mrc-lmb.cam.ac.uk	Polikarpov, Igor/D-2575-2012; Figueira, Ana Carolina/X-1649-2019; Veprintsev, Dmitry B/H-2228-2012	Figueira, Ana Carolina/0000-0002-7023-8490; Veprintsev, Dmitry B/0000-0002-3583-5409; Polikarpov, Igor/0000-0001-9496-4174	Medical Research Council, UK; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Medical Research Council, UK, and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON ML, 1992, NUCLEIC ACIDS RES, V20, P4803, DOI 10.1093/nar/20.18.4803; Barros AC, 1998, NEUROREPORT, V9, P2933, DOI 10.1097/00001756-199809140-00003; Bhardwaj A, 2008, MOL CELL BIOL, V28, P2138, DOI 10.1128/MCB.01170-07; CARR FE, 1992, J BIOL CHEM, V267, P18689; CARR FE, 1994, J BIOL CHEM, V269, P4175; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; CHATTERJEE VKK, 1989, P NATL ACAD SCI USA, V86, P9114, DOI 10.1073/pnas.86.23.9114; CHIN WW, 1993, RECENT PROG HORM RES, V48, P393; Clabby ML, 2003, J BIOL CHEM, V278, P5760, DOI 10.1074/jbc.M208173200; COHEN O, 1995, J BIOL CHEM, V270, P13899, DOI 10.1074/jbc.270.23.13899; Conti E, 2009, CURR OPIN STRUC BIOL, V19, P62, DOI 10.1016/j.sbi.2009.01.003; DARLING DS, 1989, MOL ENDOCRINOL, V3, P1359, DOI 10.1210/mend-3-9-1359; Dasen JS, 1999, CELL, V97, P587, DOI 10.1016/S0092-8674(00)80770-9; De Bosscher K, 2006, ONCOGENE, V25, P6868, DOI 10.1038/sj.onc.1209935; DESVERGNE B, 1994, MOL CELL ENDOCRINOL, V100, P125, DOI 10.1016/0303-7207(94)90291-7; Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947; Figueira ACM, 2006, CELL BIOCHEM BIOPHYS, V44, P453, DOI 10.1385/CBB:44:3:453; Fischer H, 2003, J BIOL CHEM, V278, P16030, DOI 10.1074/jbc.M206953200; Flores-Morales A, 2002, MOL ENDOCRINOL, V16, P1257, DOI 10.1210/me.16.6.1257; Gordon DF, 1997, J BIOL CHEM, V272, P24339, DOI 10.1074/jbc.272.39.24339; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; Heck S, 1997, EMBO J, V16, P4698, DOI 10.1093/emboj/16.15.4698; Herrlich P, 2001, ONCOGENE, V20, P2465, DOI 10.1038/sj.onc.1204388; KERSTEN S, 1995, P NATL ACAD SCI USA, V92, P8645, DOI 10.1073/pnas.92.19.8645; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; KUROKAWA R, 1993, GENE DEV, V7, P1423, DOI 10.1101/gad.7.7b.1423; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lima LMTR, 2004, J BIOL CHEM, V279, P47968, DOI 10.1074/jbc.M407696200; Lonard DM, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.113pe16; Magklara A, 2009, MOL ENDOCRINOL, V23, P61, DOI 10.1210/me.2008-0028; MARTIN J, 1990, ORGAN SCI, V1, P1; Matozo HC, 2007, BIOPHYS J, V92, P4424, DOI 10.1529/biophysj.106.094961; Matsushita A, 2007, MOL ENDOCRINOL, V21, P865, DOI 10.1210/me.2006-0208; Figueira ACM, 2010, BIOCHEMISTRY-US, V49, P893, DOI 10.1021/bi901282s; MIYAMOTO T, 1993, MOL ENDOCRINOL, V7, P224, DOI 10.1210/me.7.2.224; Nagayama K, 2008, J ENDOCRINOL, V199, P113, DOI 10.1677/JOE-08-0128; Nakano K, 2004, BIOCHEM J, V378, P549, DOI 10.1042/BJ20031592; Ozers MS, 1997, J BIOL CHEM, V272, P30405, DOI 10.1074/jbc.272.48.30405; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; RIBEIRO RC, 1992, MOL ENDOCRINOL, V6, P1142, DOI 10.1210/me.6.7.1142; Sasaki S, 1999, EMBO J, V18, P5389, DOI 10.1093/emboj/18.19.5389; SCHMITZ A, 1978, J MOL BIOL, V123, P431, DOI 10.1016/0022-2836(78)90089-X; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; Shibusawa N, 2003, J CLIN INVEST, V112, P588, DOI 10.1172/JCI200318377; Shibusawa N, 2003, J BIOL CHEM, V278, P732, DOI 10.1074/jbc.M207264200; Tsuzuki S, 2004, MOL CELL BIOL, V24, P6824, DOI 10.1128/mcb.24.15.6824-6836.2004; Velasco LFR, 2007, J BIOL CHEM, V282, P12458, DOI 10.1074/jbc.M610700200; Weitzel JM, 2003, J MOL ENDOCRINOL, V31, P291, DOI 10.1677/jme.0.0310291; Weitzel JM, 2001, NUCLEIC ACIDS RES, V29, P5148, DOI 10.1093/nar/29.24.5148; Weitzel JM, 2008, THYROID RES, V1, DOI 10.1186/1756-6614-1-4; WONDISFORD FE, 1989, J BIOL CHEM, V264, P14601; WONDISFORD FE, 1993, J BIOL CHEM, V268, P2749; Xu Z, 2008, P NATL ACAD SCI USA, V105, P2421, DOI 10.1073/pnas.0707082105; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V	54	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12628	10.1371/journal.pone.0012628	http://dx.doi.org/10.1371/journal.pone.0012628			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20838640	Green Published, Green Submitted, gold			2022-12-27	WOS:000281631300045
J	Savas, S; Briollais, L; Ibrahim-zada, I; Jarjanazi, H; Choi, YH; Musquera, M; Fleshner, N; Venkateswaran, V; Ozcelik, H				Savas, Sevtap; Briollais, Laurent; Ibrahim-zada, Irada; Jarjanazi, Hamdi; Choi, Yun Hee; Musquera, Mireia; Fleshner, Neil; Venkateswaran, Vasundara; Ozcelik, Hilmi			A Whole-Genome SNP Association Study of NCI60 Cell Line Panel Indicates a Role of Ca2+ Signaling in Selenium Resistance	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASES; CA(2+)ACTIVATED K+ CHANNELS; PREVENTION TRIAL SELECT; PROSTATE-CANCER; LARGE-CONDUCTANCE; VASCULAR SMOOTH; KCNMA1 GENE; VITAMIN-E; A-KINASE; IN-VIVO	Epidemiological studies have suggested an association between selenium intake and protection from a variety of cancer. Considering this clinical importance of selenium, we aimed to identify the genes associated with resistance to selenium treatment. We have applied a previous methodology developed by our group, which is based on the genetic and pharmacological data publicly available for the NCI60 cancer cell line panel. In short, we have categorized the NCI60 cell lines as selenium resistant and sensitive based on their growth inhibition (GI50) data. Then, we have utilized the Affymetrix 125K SNP chip data available and carried out a genome-wide case-control association study for the selenium sensitive and resistant NCI60 cell lines. Our results showed statistically significant association of four SNPs in 5q33-34, 10q11.2, 10q22.3 and 14q13.1 with selenium resistance. These SNPs were located in introns of the genes encoding for a kinase-scaffolding protein (AKAP6), a membrane protein (SGCD), a channel protein (KCNMA1), and a protein kinase (PRKG1). The knock-down of KCNMA1 by siRNA showed increased sensitivity to selenium in both LNCaP and PC3 cell lines. Furthermore, SNP-SNP interaction (epistasis) analysis indicated the interactions of the SNPs in AKAP6 with SGCD as well as SNPs in AKAP6 with KCNMA1 with each other, assuming additive genetic model. These genes were also all involved in the Ca2+ signaling, which has a direct role in induction of apoptosis and induction of apoptosis in tumor cells is consistent with the chemopreventive action of selenium. Once our findings are further validated, this knowledge can be translated into clinics where individuals who can benefit from the chemopreventive characteristics of the selenium supplementation will be easily identified using a simple DNA analysis.	[Savas, Sevtap; Ibrahim-zada, Irada; Jarjanazi, Hamdi; Ozcelik, Hilmi] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred A Litwin Ctr Canc Genet, Toronto, ON M5G 1X5, Canada; [Savas, Sevtap; Ibrahim-zada, Irada; Jarjanazi, Hamdi; Ozcelik, Hilmi] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Savas, Sevtap; Ibrahim-zada, Irada; Jarjanazi, Hamdi; Ozcelik, Hilmi] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Briollais, Laurent; Choi, Yun Hee] Mt Sinai Hosp, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada; [Musquera, Mireia; Venkateswaran, Vasundara] Sunnybrook Hlth Sci Ctr, Div Urol, Toronto, ON M4N 3M5, Canada; [Fleshner, Neil] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Savas, S (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred A Litwin Ctr Canc Genet, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	vasundara.venkateswaran@sunnybrook.ca; ozcelik@mshri.on.ca	Ozcelik, Hilmi/A-3952-2011; Briollais, Laurent/A-2941-2013; Jarjanazi, Hamdi/B-6221-2011	Jarjanazi, Hamdi/0000-0001-8652-2560; Musquera Felip, Mireia/0000-0002-5915-9935; Savas, Sevtap/0000-0002-7324-938X	Prostate cancer foundation; Canadian Breast Cancer Foundation - Ontario Chapter	Prostate cancer foundation; Canadian Breast Cancer Foundation - Ontario Chapter	This study was supported by grants from prostate cancer foundation (H. Ozcelik). Y.H. Choi is supported by a fellowship from the Canadian Breast Cancer Foundation - Ontario Chapter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alioua A, 1998, J BIOL CHEM, V273, P32950, DOI 10.1074/jbc.273.49.32950; Amberg GC, 2003, J CLIN INVEST, V112, P717, DOI 10.1172/JC1200318684; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bloch M, 2007, ONCOGENE, V26, P2525, DOI 10.1038/sj.onc.1210036; Brinkman M, 2006, EUR J CANCER, V42, P2463, DOI 10.1016/j.ejca.2006.02.027; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Calderone V, 2002, CURR MED CHEM, V9, P1385, DOI 10.2174/0929867023369871; Chigbrow M, 2001, ANTI-CANCER DRUG, V12, P43, DOI 10.1097/00001813-200101000-00006; Combs GF, 2004, BRIT J CANCER, V91, P195, DOI 10.1038/sj.bjc.6601974; Diwadkar-Navsariwala V, 2004, J NUTR, V134, P2899, DOI 10.1093/jn/134.11.2899; Dodge-Kafka KL, 2006, EUR J CELL BIOL, V85, P593, DOI 10.1016/j.ejcb.2006.01.007; Duffield-Lillico AJ, 2003, BJU INT, V91, P608, DOI 10.1046/j.1464-410X.2003.04167.x; Efferth T, 2005, PHARMACOL THERAPEUT, V107, P155, DOI 10.1016/j.pharmthera.2005.02.005; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fukao M, 2001, MOL PHARMACOL, V59, P16, DOI 10.1124/mol.59.1.16; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Ghatta S, 2006, PHARMACOL THERAPEUT, V110, P103, DOI 10.1016/j.pharmthera.2005.10.007; Grunnet M, 2004, J BIOL CHEM, V279, P36445, DOI 10.1074/jbc.M402254200; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hofmann F, 2005, J BIOL CHEM, V280, P1, DOI 10.1074/jbc.R400035200; Jackson MI, 2008, CURR OPIN CLIN NUTR, V11, P718, DOI 10.1097/MCO.0b013e3283139674; Jarjanazi H, 2008, HUM MUTAT, V29, P461, DOI 10.1002/humu.20732; Kerb R, 2006, CANCER LETT, V234, P4, DOI 10.1016/j.canlet.2005.06.051; Khaitan D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-258; Koo SH, 2006, CLIN EXP PHARMACOL P, V33, P525, DOI 10.1111/j.1440-1681.2006.04402.x; Letavayova L, 2006, TOXICOLOGY, V227, P1, DOI 10.1016/j.tox.2006.07.017; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Lippman SM, 2005, JNCI-J NATL CANCER I, V97, P94, DOI 10.1093/jnci/dji009; Lipskaia L, 2007, AM J PATHOL, V171, P162, DOI 10.2353/ajpath.2007.070054; Lohmann SM, 1997, TRENDS BIOCHEM SCI, V22, P307, DOI 10.1016/S0968-0004(97)01086-4; MCCARTNEY S, 1995, J BIOL CHEM, V270, P9327, DOI 10.1074/jbc.270.16.9327; Menter DG, 2000, CANCER EPIDEM BIOMAR, V9, P1171; Meuillet E, 2004, J CELL BIOCHEM, V91, P443, DOI 10.1002/jcb.10728; Micke O, 2009, MOLECULES, V14, P3975, DOI 10.3390/molecules14103975; Moss SB, 2001, TRENDS ENDOCRIN MET, V12, P434, DOI 10.1016/S1043-2760(01)00493-3; Nadiminty N, 2008, MOL NUTR FOOD RES, V52, P1247, DOI 10.1002/mnfr.200700369; Neill MG, 2006, CURR OPIN UROL, V16, P132, DOI 10.1097/01.mou.0000193388.31727.d2; NOGUCHI S, 1994, CANCER, V74, P872, DOI 10.1002/1097-0142(19940801)74:3<872::AID-CNCR2820740313>3.0.CO;2-P; Ochiai T, 1996, Gan To Kagaku Ryoho, V23 Suppl 2, P182; Ozawa E, 2005, MUSCLE NERVE, V32, P563, DOI 10.1002/mus.20349; PAPP LV, 2009, SELENIUM SELENOPROTE; Platz EA, 2001, EPIDEMIOL REV, V23, P93, DOI 10.1093/oxfordjournals.epirev.a000801; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; ROH S, 2007, J INVEST DERMATOL; Ruth P, 1999, PHARMACOL THERAPEUT, V82, P355, DOI 10.1016/S0163-7258(98)00067-9; Sanmartin C, 2008, MINI-REV MED CHEM, V8, P1020, DOI 10.2174/138955708785740625; SELENIUS M, 2009, ANTIOXID REDOX SIGNA; Shastry BS, 2002, J HUM GENET, V47, P561, DOI 10.1007/s100380200086; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Tian L, 2004, P NATL ACAD SCI USA, V101, P11897, DOI 10.1073/pnas.0402590101; Ueyama T, 1998, AM J PHYSIOL-HEART C, V274, pH1, DOI 10.1152/ajpheart.1998.274.1.H1; UGUZ AC, 2009, J MEMBR BIOL; Venkateswaran V, 2002, CANCER RES, V62, P2540; Vinceti Marco, 2009, Reviews on Environmental Health, V24, P231; Wang Shufang, 2002, Zhonghua Bing Li Xue Za Zhi, V31, P107; Whanger PD, 2004, BRIT J NUTR, V91, P11, DOI 10.1079/BJN20031015; Wheeler MT, 2003, TRENDS CARDIOVAS MED, V13, P238, DOI 10.1016/S1050-1738(03)00101-4; ZENG H, 2007, J NUTR BIOCH; Zheng Y, 2005, J CELL PHYSIOL, V205, P97, DOI 10.1002/jcp.20378	60	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12601	10.1371/journal.pone.0012601	http://dx.doi.org/10.1371/journal.pone.0012601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830292	Green Submitted, gold, Green Published			2022-12-27	WOS:000281631300025
J	Cooper, LAD; Gutman, DA; Long, Q; Johnson, BA; Cholleti, SR; Kurc, T; Saltz, JH; Brat, DJ; Moreno, CS				Cooper, Lee A. D.; Gutman, David A.; Long, Qi; Johnson, Brent A.; Cholleti, Sharath R.; Kurc, Tahsin; Saltz, Joel H.; Brat, Daniel J.; Moreno, Carlos S.			The Proneural Molecular Signature Is Enriched in Oligodendrogliomas and Predicts Improved Survival among Diffuse Gliomas	PLOS ONE			English	Article							GLIOBLASTOMA; GROWTH; CANCER; DIFFERENTIATION; ANGIOGENESIS; EXPRESSION; CENTROIDS; PATHWAYS; SUBTYPES; VEGF	The Cancer Genome Atlas Project (TCGA) has produced an extensive collection of '-omic' data on glioblastoma (GBM), resulting in several key insights on expression signatures. Despite the richness of TCGA GBM data, the absence of lower grade gliomas in this data set prevents analysis genes related to progression and the uncovering of predictive signatures. A complementary dataset exists in the form of the NCI Repository for Molecular Brain Neoplasia Data (Rembrandt), which contains molecular and clinical data for diffuse gliomas across the full spectrum of histologic class and grade. Here we present an investigation of the significance of the TCGA consortium's expression classification when applied to Rembrandt gliomas. We demonstrate that the proneural signature predicts improved clinical outcome among 176 Rembrandt gliomas that includes all histologies and grades, including GBMs (log rank test p = 1.16e-6), but also among 75 grade II and grade III samples (p = 2.65e-4). This gene expression signature was enriched in tumors with oligodendroglioma histology and also predicted improved survival in this tumor type (n = 43, p = 1.25e-4). Thus, expression signatures identified in the TCGA analysis of GBMs also have intrinsic prognostic value for lower grade oligodendrogliomas, and likely represent important differences in tumor biology with implications for treatment and therapy. Integrated DNA and RNA analysis of low-grade and high-grade proneural gliomas identified increased expression and gene amplification of several genes including GLIS3, TGFB2, TNC, AURKA, and VEGFA in proneural GBMs, with corresponding loss of DLL3 and HEY2. Pathway analysis highlights the importance of the Notch and Hedgehog pathways in the proneural subtype. This demonstrates that the expression signatures identified in the TCGA analysis of GBMs also have intrinsic prognostic value for low-grade oligodendrogliomas, and likely represent important differences in tumor biology with implications for treatment and therapy.	[Cooper, Lee A. D.; Gutman, David A.; Cholleti, Sharath R.; Kurc, Tahsin; Saltz, Joel H.; Brat, Daniel J.; Moreno, Carlos S.] Emory Univ, Ctr Comprehens Informat, Atlanta, GA 30322 USA; [Saltz, Joel H.; Brat, Daniel J.; Moreno, Carlos S.] Emory Univ, Sch Med, Atlanta, GA USA; [Long, Qi; Saltz, Joel H.; Brat, Daniel J.; Moreno, Carlos S.] Emory Winship Canc Inst, Atlanta, GA USA; [Long, Qi; Johnson, Brent A.] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Cooper, LAD (corresponding author), Emory Univ, Ctr Comprehens Informat, Atlanta, GA 30322 USA.	cmoreno@emory.edu	Gutman, David/U-2713-2018; Moreno, Carlos S/B-3863-2009	Gutman, David/0000-0002-1386-8701; Moreno, Carlos S/0000-0002-5582-0028; Long, Qi/0000-0003-0660-5230	National Cancer Institute (NCI) [S09-094]; Center for Comprehensive Informatics, Emory University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P20EB000591] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011119] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Comprehensive Informatics, Emory University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported in part by contract S09-094 from the National Cancer Institute (NCI) administered through NCI Science Applications International Corporation (SAIC) Frederick campus, and the Center for Comprehensive Informatics, Emory University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; [CBTRUS C.B.T.R.o.t.U. States], 2010, CBTRUS STAT REP PRIM; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Dabney AR, 2006, BIOINFORMATICS, V22, P122, DOI 10.1093/bioinformatics/bti756; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Febbo PG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-461; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Minamizato T, 2007, BIOCHEM BIOPH RES CO, V354, P567, DOI 10.1016/j.bbrc.2007.01.029; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; PEARSON CA, 1988, EMBO J, V7, P2977, DOI 10.1002/j.1460-2075.1988.tb03160.x; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Sakamoto K, 2002, J BIOL CHEM, V277, P29399, DOI 10.1074/jbc.M203727200; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sarangi A, 2009, ONCOGENE, V28, P3468, DOI 10.1038/onc.2009.208; Sarkar S, 2006, CANCER RES, V66, P11771, DOI 10.1158/0008-5472.CAN-05-0470; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; TAVERAS JM, 1962, AMER J ROENTGENOL RA, V87, P473; The WHO, 2020, CLASSIFICATION TUMOU; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Zagzag D, 2000, LAB INVEST, V80, P837, DOI 10.1038/labinvest.3780088; ZHAO Y, 1995, AM J PHYSIOL-LUNG C, V268, pL173, DOI 10.1152/ajplung.1995.268.2.L173	32	106	114	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12548	10.1371/journal.pone.0012548	http://dx.doi.org/10.1371/journal.pone.0012548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838435	Green Published, Green Submitted, gold			2022-12-27	WOS:000281627700004
J	Gu, R; Shampang, A; Nashar, T; Patil, M; Fuller, DH; Ramsingh, AI				Gu, Rui; Shampang, Anae; Nashar, Toufic; Patil, Manisha; Fuller, Deborah H.; Ramsingh, Arlene I.			Oral Immunization with a Live Coxsackievirus/HIV Recombinant Induces Gag p24-Specific T Cell Responses	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES VACCINE; HUMAN-IMMUNODEFICIENCY-VIRUS; PREEXISTING IMMUNITY; HIV-1 VACCINE; AIDS VACCINE; B4-INDUCED PANCREATITIS; GASTROINTESTINAL-TRACT; POLIOVIRUS VACCINE; CAPSID PROTEIN; INFECTION	Background: The development of an HIV/AIDS vaccine has proven to be elusive. Because human vaccine trials have not yet demonstrated efficacy, new vaccine strategies are needed for the HIV vaccine pipeline. We have been developing a new HIV vaccine platform using a live enterovirus, coxsackievirus B4 (CVB4) vector. Enteroviruses are ideal candidates for development as a vaccine vector for oral delivery, because these viruses normally enter the body via the oral route and survive the acidic environment of the stomach. Methodology/Principal Findings: We constructed a live coxsackievirus B4 recombinant, CVB4/p24(73(3)), that expresses seventy-three amino acids of the gag p24 sequence (HXB2) and assessed T cell responses after immunization of mice. The CVB4 recombinant was physically stable, replication-competent, and genetically stable. Oral or intraperitoneal immunization with the recombinant resulted in strong systemic gag p24-specific T cell responses as determined by the IFN-gamma ELISPOT assay and by multiparameter flow cytometry. Oral immunization with CVB4/p24(73(3)) resulted in a short-lived, localized infection of the gut without systemic spread. Because coxsackieviruses are ubiquitous in the human population, we also evaluated whether the recombinant was able to induce gag p24-specific T cell responses in mice pre-immunized with the CVB4 vector. We showed that oral immunization with CVB4/p24(73(3)) induced gag p24-specific immune responses in vector-immune mice. Conclusions/Significance: The CVB4/p24(73(3)) recombinant retained the physical and biological characteristics of the parental CVB4 vector. Oral immunization with the CVB4 recombinant was safe and resulted in the induction of systemic HIV-specific T cell responses. Furthermore, pre-existing vector immunity did not preclude the development of gag p24-specific T cell responses. As the search continues for new vaccine strategies, the present study suggests that live CVB4/HIV recombinants are potential new vaccine candidates for HIV.	[Gu, Rui; Shampang, Anae; Nashar, Toufic; Patil, Manisha; Ramsingh, Arlene I.] New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY USA; [Fuller, Deborah H.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	State University of New York (SUNY) System; Wadsworth Center; Albany Medical College	Gu, R (corresponding author), New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY USA.	ramsingh@wadsworth.org		Fuller, Deborah/0000-0001-7315-2441	Public Health Service [AI066938]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066938] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by Public Health Service grant AI066938. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDINO R, 1994, SCIENCE, V265, P1448, DOI 10.1126/science.8073288; Arnold GF, 2009, J VIROL, V83, P5087, DOI 10.1128/JVI.00184-09; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Belyakov IM, 2008, TRENDS IMMUNOL, V29, P574, DOI 10.1016/j.it.2008.07.010; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; CAGGANA M, 1993, J VIROL, V67, P4797, DOI 10.1128/JVI.67.8.4797-4803.1993; Chapman NM, 1997, CURR TOP MICROBIOL, V223, P227; Chumakov K, 2007, NAT REV MICROBIOL, V5, P952, DOI 10.1038/nrmicro1769; Crotty S, 2001, J VIROL, V75, P7435, DOI 10.1128/JVI.75.16.7435-7452.2001; Crotty S, 2004, ADV DRUG DELIVER REV, V56, P835, DOI 10.1016/j.addr.2003.10.042; Croyle MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003548; CZERKINSKY C, 1988, J IMMUNOL METHODS, V110, P29, DOI 10.1016/0022-1759(88)90079-8; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Fultz PN, 2003, VIROLOGY, V315, P425, DOI 10.1016/S0042-6822(03)00546-4; Gu R, 2009, VIROLOGY, V395, P77, DOI 10.1016/j.virol.2009.09.005; Halim SS, 2000, VACCINE, V19, P958, DOI 10.1016/S0264-410X(00)00214-0; Halim SS, 2000, AIDS RES HUM RETROV, V16, P1551, DOI 10.1089/088922200750006074; Howley PM, 2007, FIELDS VIROLOGY, V1, P839; Huber S, 2008, CURR TOP MICROBIOL, V323, P199; Huber S, 2004, VIRAL IMMUNOL, V17, P358, DOI 10.1089/vim.2004.17.358; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; Letvin NL, 2002, ANNU REV IMMUNOL, V20, P73, DOI 10.1146/annurev.immunol.20.081501.094854; Mandl S, 1998, P NATL ACAD SCI USA, V95, P8216, DOI 10.1073/pnas.95.14.8216; Mata M, 1998, J IMMUNOL, V161, P2985; Mata M, 1999, J IMMUNOL, V163, P1449; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Ostrowski SE, 2004, J VIROL, V78, P8229, DOI 10.1128/JVI.78.15.8229-8237.2004; PALLANSCH MA, 1997, CURR TOP MICROBIOL, V223, P13; Potvin DM, 2003, J VIROL, V77, P8272, DOI 10.1128/JVI.77.15.8272-8279.2003; Ramsingh AI, 2008, CURR TOP MICROBIOL, V323, P241; Ramsingh AI, 1999, J VIROL, V73, P3080, DOI 10.1128/JVI.73.4.3080-3086.1999; Ramsingh AI, 1997, J VIROL, V71, P8690, DOI 10.1128/JVI.71.11.8690-8697.1997; Robert-Guroff M, 2007, CURR OPIN BIOTECH, V18, P546, DOI 10.1016/j.copbio.2007.10.010; Stevens R, 2005, VACCINE, V23, P1479, DOI 10.1016/j.vaccine.2004.09.033; Uberla K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000114; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; Xiang ZQ, 2003, J VIROL, V77, P10780, DOI 10.1128/JVI.77.20.10780-10789.2003	42	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12499	10.1371/journal.pone.0012499	http://dx.doi.org/10.1371/journal.pone.0012499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824074	Green Published, Green Submitted, gold			2022-12-27	WOS:000281480900002
J	Acharyya, S; Sharma, SM; Cheng, AS; Ladner, KJ; He, W; Kline, W; Wang, HT; Ostrowski, MC; Huang, TH; Guttridge, DC				Acharyya, Swarnali; Sharma, Sudarshana M.; Cheng, Alfred S.; Ladner, Katherine J.; He, Wei; Kline, William; Wang, Huating; Ostrowski, Michael C.; Huang, Tim H.; Guttridge, Denis C.			TNF Inhibits Notch-1 in Skeletal Muscle Cells by Ezh2 and DNA Methylation Mediated Repression: Implications in Duchenne Muscular Dystrophy	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; GENE-EXPRESSION; FACTOR-ALPHA; MOLECULAR-MECHANISMS; SIGNALING PATHWAYS; PROGENITOR CELLS; SELF-RENEWAL; STEM-CELLS; ACTIVATION	Background: Classical NF-kappa B signaling functions as a negative regulator of skeletal myogenesis through potentially multiple mechanisms. The inhibitory actions of TNF alpha on skeletal muscle differentiation are mediated in part through sustained NF-kappa B activity. In dystrophic muscles, NF-kappa B activity is compartmentalized to myofibers to inhibit regeneration by limiting the number of myogenic progenitor cells. This regulation coincides with elevated levels of muscle derived TNF alpha that is also under IKK beta and NF-kappa B control. Methodology/Principal Findings: Based on these findings we speculated that in DMD, TNF alpha secreted from myotubes inhibits regeneration by directly acting on satellite cells. Analysis of several satellite cell regulators revealed that TNF alpha is capable of inhibiting Notch-1 in satellite cells and C2C12 myoblasts, which was also found to be dependent on NF-kappa B. Notch-1 inhibition occurred at the mRNA level suggesting a transcriptional repression mechanism. Unlike its classical mode of action, TNF alpha stimulated the recruitment of Ezh2 and Dnmt-3b to coordinate histone and DNA methylation, respectively. Dnmt-3b recruitment was dependent on Ezh2. Conclusions/Significance: We propose that in dystrophic muscles, elevated levels of TNF alpha and NF-kappa B inhibit the regenerative potential of satellite cells via epigenetic silencing of the Notch-1 gene.	[Acharyya, Swarnali; Sharma, Sudarshana M.; Ladner, Katherine J.; He, Wei; Kline, William; Huang, Tim H.; Guttridge, Denis C.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Sharma, Sudarshana M.; Ostrowski, Michael C.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Cheng, Alfred S.; Wang, Huating] Chinese Univ Hong Kong, Prince Wales Hosp, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Cheng, Alfred S.; Wang, Huating] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Ostrowski, Michael C.; Huang, Tim H.; Guttridge, Denis C.] Ohio State Univ, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Acharyya, S (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	denis.guttridge@osumc.edu	Cheng, Alfred SL/C-3327-2014; He, Wei/J-6275-2016; Wang, Huating/C-6719-2014; Sharma, Sudarshana Mangalore/AAI-2475-2019; Ostrowski, Michael/H-3108-2011	Cheng, Alfred SL/0000-0003-2345-6951; Wang, Huating/0000-0001-5474-2905; Ostrowski, Michael/0000-0003-2948-6297; Guttridge, Denis/0000-0002-7276-6609; Sharma, Sudarshana/0000-0002-9745-0061	Muscular Dystrophy Association award (DCG); OSU; NATIONAL CANCER INSTITUTE [R01CA053271] Funding Source: NIH RePORTER	Muscular Dystrophy Association award (DCG)(Muscular Dystrophy Association); OSU; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this study was obtained from a Muscular Dystrophy Association award (DCG) and an OSU University Presidential Fellowship (SA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Argiles JM, 2000, EUR CYTOKINE NETW, V11, P552; Bakkar N, 2008, J CELL BIOL, V180, P787, DOI 10.1083/jcb.200707179; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Carlson ME, 2007, CURR OPIN PHARMACOL, V7, P303, DOI 10.1016/j.coph.2007.02.004; Chen SE, 2007, AM J PHYSIOL-CELL PH, V292, pC1660, DOI 10.1152/ajpcell.00486.2006; Cheng ASL, 2008, CANCER RES, V68, P1786, DOI 10.1158/0008-5472.CAN-07-5547; Coletti D, 2005, GENESIS, V43, P120, DOI 10.1002/gene.20160; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Cossu G, 2007, TRENDS MOL MED, V13, P520, DOI 10.1016/j.molmed.2007.10.003; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; Dirks AJ, 2006, J NUTR BIOCHEM, V17, P501, DOI 10.1016/j.jnutbio.2005.11.002; Goodson Michael, 2005, Nucl Recept Signal, V3, pe003; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grounds MD, 2004, FASEB J, V18, P676, DOI 10.1096/fj.03-1024com; Grounds MD, 2008, CLIN EXP PHARMACOL P, V35, P846, DOI 10.1111/j.1440-1681.2007.04868.x; Guttridge DC, 2004, CURR OPIN CLIN NUTR, V7, P443, DOI 10.1097/01.mco.0000134364.61406.26; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; HACKER H, 2006, SCI STKE, V357, pRE13, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Ladner KJ, 2003, J BIOL CHEM, V278, P2294, DOI 10.1074/jbc.M207129200; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; Le Grand F, 2007, DEVELOPMENT, V134, P3953, DOI 10.1242/dev.005934; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mourkioti F, 2008, J MOL MED, V86, P747, DOI 10.1007/s00109-008-0308-4; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Ndlovu MN, 2009, MOL CELL BIOL, V29, P5488, DOI 10.1128/MCB.01657-08; Nephew KP, 2003, CANCER LETT, V190, P125, DOI 10.1016/S0304-3835(02)00511-6; Nickoloff BJ, 2003, ONCOGENE, V22, P6598, DOI 10.1038/sj.onc.1206758; Ohm JE, 2007, CELL CYCLE, V6, P1040, DOI 10.4161/cc.6.9.4210; OLIFF A, 1987, CELL, V50, P555, DOI 10.1016/0092-8674(87)90028-6; Parker MH, 2006, MOL CELL BIOL, V26, P5771, DOI 10.1128/MCB.02404-05; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pogribny IP, 2000, CANCER RES, V60, P588; Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263; Radley HG, 2008, NEUROMUSCULAR DISORD, V18, P227, DOI 10.1016/j.nmd.2007.11.002; Reynolds PA, 2006, J BIOL CHEM, V281, P24790, DOI 10.1074/jbc.M604175200; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Stolzing A, 2004, REJUV RES, V7, P9, DOI 10.1089/154916804323105035; Thaloor D, 1999, AM J PHYSIOL-CELL PH, V277, pC320, DOI 10.1152/ajpcell.1999.277.2.C320; Tidball JG, 2005, CURR OPIN RHEUMATOL, V17, P707, DOI 10.1097/01.bor.0000179948.65895.1a; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467; Vasyutina E, 2007, CELL CYCLE, V6, P1451; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang CY, 1999, MOL CELL BIOL, V19, P5923; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Ziegler E. C., 2005, SCI STKE, pre6, DOI DOI 10.1126/STKE.2842005RE6	62	93	97	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12479	10.1371/journal.pone.0012479	http://dx.doi.org/10.1371/journal.pone.0012479			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20814569	Green Submitted, Green Published, gold			2022-12-27	WOS:000281375500012
J	Hardell, S; Tilander, H; Welfinger-Smith, G; Burger, J; Carpenter, DO				Hardell, Sara; Tilander, Hanna; Welfinger-Smith, Gretchen; Burger, Joanna; Carpenter, David O.			Levels of Polychlorinated Biphenyls (PCBs) and Three Organochlorine Pesticides in Fish from the Aleutian Islands of Alaska	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; POLYBROMINATED DIPHENYL ETHERS; PUFFIN FRATERCULA-CIRRHATA; EIDER SOMATERIA-MOLLISSIMA; AMCHITKA ISLAND; ATLANTIC SALMON; POTENTIAL RISK; HUMAN HEALTH; ADAK ISLAND; EXPOSURE	Persistent organic pollutants (POPs), including polychlorinated biphenyls (PCBs) and chlorinated pesticides, have been shown to have many adverse human health effects. These contaminants therefore may pose a risk to Alaska Natives that follow a traditional diet high in marine mammals and fish, in which POPs bioaccumulate. Methods and Findings: This study examined the levels of PCBs and three pesticides [p, p9-DDE, mirex, and hexachlorobenzene (HCB)] in muscle tissue from nine fish species from several locations around the Aleutian Islands of Alaska. The highest median PCB level was found in rock sole (Lepidopsetta bilineata, 285 ppb, wet weight), while the lowest level was found in rock greenling (Hexagrammos lagocephalus, 104 ppb, wet weight). Lipid adjusted PCB values were also calculated and significant interspecies differences were found. Again, rock sole had the highest level (68,536 ppb, lipid weight). Concerning the PCB congener patterns, the more highly chlorinated congeners were most common as would be expected due to their greater persistence. Among the pesticides, p, p9-DDE generally dominated, and the highest level was found in sockeye salmon (Oncorhynchus nerka, 6.9 ppb, wet weight). The methodology developed by U. S. Environmental Protection Agency (USEPA) was used to calculate risk-based consumption limits for the analyzed fish species. For cancer health endpoints for PCBs, all species would trigger strict advisories of between two and six meals per year, depending upon species. For noncancer effects by PCBs, advisories of between seven and twenty-two meals per year were triggered. None of the pesticides triggered consumption limits. Conclusion: The fish analyzed, mainly from Adak, contain significant concentrations of POPs, in particular PCBs, which raises the question whether these fish are safe to eat, particularly for sensitive populations. However when assessing any risk of the traditional diet, one must also consider the many health and cultural benefits from eating fish.	[Hardell, Sara; Tilander, Hanna] Linkoping Univ, Fac Hlth Sci, Linkoping, Sweden; [Hardell, Sara; Tilander, Hanna; Welfinger-Smith, Gretchen; Carpenter, David O.] SUNY Albany, Inst Hlth & Environm, Rensselaer, NY USA; [Burger, Joanna] Rutgers State Univ, Dept Environm & Occupat Hlth, New Brunswick, NJ 08903 USA; [Carpenter, David O.] SUNY Albany, Sch Publ Hlth, Dept Environm Hlth Sci, Rensselaer, NY USA	Linkoping University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Rutgers State University New Brunswick; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Hardell, S (corresponding author), Linkoping Univ, Fac Hlth Sci, Linkoping, Sweden.	carpent@uamail.albany.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER; NIEHS NIH HHS [30ES005022, P30 ES005022] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AMAP, 1998, AMAP ASS REP ARCT PO; Arnold SM, 2005, AM J PUBLIC HEALTH, V95, P393, DOI 10.2105/AJPH.2004.042879; Bernes C., 1998, PERSISTENT ORGANIC P; Besselink HT, 1996, ENVIRON POLLUT, V92, P267, DOI 10.1016/0269-7491(95)00116-6; Braune BM, 2005, SCI TOTAL ENVIRON, V351, P4, DOI 10.1016/j.scitotenv.2004.10.034; Breivik K, 2004, ENVIRON POLLUT, V128, P3, DOI 10.1016/j.envpol.2003.08.031; Breivik K, 2007, SCI TOTAL ENVIRON, V377, P296, DOI 10.1016/j.scitotenv.2007.02.026; Burger J, 2006, ENVIRON RES, V101, P34, DOI 10.1016/j.envres.2005.07.003; Burger J, 2007, J ENVIRON RADIOACTIV, V98, P315, DOI 10.1016/j.jenvrad.2007.06.002; Burger J, 2007, SCI TOTAL ENVIRON, V384, P93, DOI 10.1016/j.scitotenv.2007.05.004; Burger J, 2007, J TOXICOL ENV HEAL A, V70, P1897, DOI 10.1080/15287390701551159; Burger J, 2007, J ENVIRON MANAGE, V85, P232, DOI 10.1016/j.jenvman.2006.10.005; Burger J, 2007, ENVIRON RES, V103, P62, DOI 10.1016/j.envres.2006.02.005; Burger J, 2009, ENVIRON RES, V109, P503, DOI 10.1016/j.envres.2009.01.002; Burger J, 2009, ENVIRON MONIT ASSESS, V152, P357, DOI 10.1007/s10661-008-0321-7; Burger J, 2009, ARCH ENVIRON CON TOX, V56, P596, DOI 10.1007/s00244-008-9207-5; Burger J, 2009, ENVIRON RES, V109, P343, DOI 10.1016/j.envres.2008.12.002; Burkow IC, 2000, TOXICOL LETT, V112, P87, DOI 10.1016/S0378-4274(99)00254-4; Carpenter David O, 2005, Int J Circumpolar Health, V64, P322; Carpenter David O., 2006, Reviews on Environmental Health, V21, P1; Chiu A, 2004, J ENVIRON SCI HEAL C, V22, P13, DOI 10.1081/GNC-120038004; Cook PM, 2003, ENVIRON SCI TECHNOL, V37, P3864, DOI 10.1021/es034045m; DAY GE, 2010, INT J CIRCUMPOL HEAL, V86, P69; DeCaprio AP, 2000, J ANAL TOXICOL, V24, P403, DOI 10.1093/jat/24.6.403; DEUTCH B, 2002, RECENTLY DIETARY STU; Dewailly E, 2008, FOOD ADDIT CONTAM A, V25, P1328, DOI 10.1080/02652030802175285; Domingo JL, 2007, ENVIRON INT, V33, P397, DOI 10.1016/j.envint.2006.12.004; DUFRESNE J, 2006, LONELY PLANET ALASKA; Egeland G.M., 1998, USE TRADITIONAL FOOD; ERICKSON MD, 2001, RECENT ADV ENV TOXIC; FALL JA, 1996, HARVEST USE FISH WIL; Friborg JT, 2008, LANCET ONCOL, V9, P892, DOI 10.1016/S1470-2045(08)70231-6; HAMRICK K, 2003, SUBSISTENCE FOOD USE; Hardell L, 2006, INT J ANDROL, V29, P228, DOI 10.1111/j.1365-2605.2005.00622.x; HARPER BL, 2008, EPASTARJ1R831046; HERTZPICCIOTTO I, 2008, ENV HLTH, V7, P1; Hodgson E, 1996, ENVIRON HEALTH PERSP, V104, P97, DOI 10.2307/3432700; HOLOUBEK I, 2001, RECENT ADV ENV TOXIC, P17; Huang XY, 2006, ENVIRON RES, V101, P263, DOI 10.1016/j.envres.2005.08.011; Isosaari P, 2006, ENVIRON POLLUT, V141, P213, DOI 10.1016/j.envpol.2005.08.055; JACOBSON JL, 2001, RECENT ADV ENV TOXIC, P127; Jones KC, 1999, ENVIRON POLLUT, V100, P209, DOI 10.1016/S0269-7491(99)00098-6; Jung JH, 2005, MAR POLLUT BULL, V51, P794, DOI 10.1016/j.marpolbul.2005.07.013; Kelly J, 2008, INT J CIRCUMPOL HEAL, V67, P408, DOI 10.3402/ijch.v67i5.18349; KORRICK SA, 2001, RECENT ADV ENV TOXIC, P143; Lerner DT, 2007, AQUAT TOXICOL, V81, P329, DOI 10.1016/j.aquatox.2006.12.018; Lohmann R, 2007, ENVIRON POLLUT, V150, P150, DOI 10.1016/j.envpol.2007.06.051; Longnecker MP, 1997, ANNU REV PUBL HEALTH, V18, P211, DOI 10.1146/annurev.publhealth.18.1.211; MACKAY D, 1995, SCI TOTAL ENVIRON, V160-61, P25, DOI 10.1016/0048-9697(95)04342-X; McLaughlin JB, 2004, JAMA-J AM MED ASSOC, V291, P2545, DOI 10.1001/jama.291.21.2545; MIDDAUGH J, 2001, STATE ALASKA EPIDEMI, V5; *NOAA, NOAA FISH WATCH US S; NOBMANN ED, 1992, AM J CLIN NUTR, V55, P1024, DOI 10.1093/ajcn/55.5.1024; Odland JO, 2003, ACTA PAEDIATR, V92, P1255, DOI 10.1080/08035250310005602; Rubin C H, 2001, Int J Circumpolar Health, V60, P157; Shaw SD, 2006, ENVIRON SCI TECHNOL, V40, P5347, DOI 10.1021/es061006c; STONGE M, 2009, ENERGY DIGITAL   JUN, P1; Stout JH, 2002, J WILDLIFE DIS, V38, P511, DOI 10.7589/0090-3558-38.3.511; Suk WA, 2004, ENVIRON HEALTH PERSP, V112, P113, DOI 10.1289/ehp.6383; Svendsen TC, 2007, J ENVIRON MONITOR, V9, P1213, DOI 10.1039/b707658d; Tan YS, 2004, TOXICOL SCI, V80, P54, DOI 10.1093/toxsci/kfh119; TRAVIS CC, 1991, ENVIRON SCI TECHNOL, V25, P814, DOI 10.1021/es00017a001; United States Environmental Protection Agency (USEPA), 2000, EPA GUID DEV FISH AD; *USEPA, NPL SIT NARR AD NAV; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Verbrugge L., 2007, FISH CONSUMPTION ADV; VERBRUGGE LA, 2004, USE TRADITIONAL FOOD, V1; WANIA F, 1995, SCI TOTAL ENVIRON, V160-61, P211, DOI 10.1016/0048-9697(95)04358-8; Wania F, 1998, ENVIRON POLLUT, V102, P25, DOI 10.1016/S0269-7491(98)00073-6; ZAMZOW K, 2002, CONTAMINANTS WILDLIF	70	44	50	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12396	10.1371/journal.pone.0012396	http://dx.doi.org/10.1371/journal.pone.0012396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811633	Green Published, Green Submitted, gold			2022-12-27	WOS:000281234700020
J	Wuchty, S; Siwo, G; Ferdig, MT				Wuchty, Stefan; Siwo, Geoffrey; Ferdig, Michael T.			Viral Organization of Human Proteins	PLOS ONE			English	Article							INTERACTION DATABASE; INTERACTION MAP; PHOSPHORYLATION NETWORKS; SACCHAROMYCES-CEREVISIAE; INTERACTOME; COMPLEXES; IDENTIFICATION; INFECTION; LANDSCAPE; PATHWAYS	Although maps of intracellular interactions are increasingly well characterized, little is known about large-scale maps of host-pathogen protein interactions. The investigation of host-pathogen interactions can reveal features of pathogenesis and provide a foundation for the development of drugs and disease prevention strategies. A compilation of experimentally verified interactions between HIV-1 and human proteins and a set of HIV-dependency factors (HDF) allowed insights into the topology and intricate interplay between viral and host proteins on a large scale. We found that targeted and HDF proteins appear predominantly in rich-clubs, groups of human proteins that are strongly intertwined among each other. These assemblies of proteins may serve as an infection gateway, allowing the virus to take control of the human host by reaching protein pathways and diversified cellular functions in a pronounced and focused way. Particular transcription factors and protein kinases facilitate indirect interactions between HDFs and viral proteins. Discerning the entanglement of directly targeted and indirectly interacting proteins may uncover molecular and functional sites that can provide novel perspectives on the progression of HIV infection and highlight new avenues to fight this virus.	[Wuchty, Stefan] NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA; [Siwo, Geoffrey; Ferdig, Michael T.] Univ Notre Dame, Dept Biol, Eck Inst Global Hlth, Notre Dame, IN 46556 USA	National Institutes of Health (NIH) - USA; University of Notre Dame	Wuchty, S (corresponding author), NIH, Natl Ctr Biotechnol Informat, Bldg 10, Bethesda, MD 20892 USA.	wuchtys@ncbi.nlm.nih.gov	Ferdig, Michael/C-6627-2016		NCBI/NLM/NIH; NIH [AI071121]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071121] Funding Source: NIH RePORTER	NCBI/NLM/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SW was supported by NCBI/NLM/NIH. MTF and GS are supported by NIH grant AI071121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; BANDYOPADHYAY S, 2006, DISCOVERING REGULATE, P354; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Francesconi M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S4-S9; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lehner B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r63; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Linding R, 2008, NUCLEIC ACIDS RES, V36, pD695, DOI 10.1093/nar/gkm902; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Ramani AK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-R40; Reguly Teresa, 2006, J Biol, V5, P11, DOI 10.1186/jbiol36; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Sprinzak E, 2006, P NATL ACAD SCI USA, V103, P14718, DOI 10.1073/pnas.0603352103; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tan SL, 2007, NAT BIOTECHNOL, V25, P1383, DOI 10.1038/nbt1207-1383; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Wuchty S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000335	31	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e11796	10.1371/journal.pone.0011796	http://dx.doi.org/10.1371/journal.pone.0011796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20827298	Green Published, Green Submitted, gold			2022-12-27	WOS:000281234700001
J	Nicholls, MER; Loetscher, T; Rademacher, M				Nicholls, Michael E. R.; Loetscher, Tobias; Rademacher, Maxwell			Miss to the Right: The Effect of Attentional Asymmetries on Goal-Kicking	PLOS ONE			English	Article							LINE-BISECTION JUDGMENTS; VISUOSPATIAL ATTENTION; FAR SPACE; TOOL USE; SPATIAL NEGLECT; PSEUDONEGLECT; ADAPTATION; COLLISIONS; TASK; BIAS	Cerebral asymmetries for spatial attention generate a bias of attention - causing lines to be bisected to the left or right in near (within reach) and far (outside reach) space, respectively. This study explored whether the rightward deviation for bisecting lines in far space extends to tasks where a ball is aimed between two goal-posts. Kicking was assessed in a laboratory and a real-life setting. In the laboratory setting, 212 participants carried out three conditions: (a) kick a soccer ball at a single goal post, (b) kick a soccer ball between two goal posts and (c) use a stick to indicate the middle between two goal posts. The goals were placed at a distance of 4.0 m. There was no deviation in the one-goal kicking condition demonstrating that no asymmetries exist in the perceptual motor system when aiming at a single point. When kicking or pointing at the middle between two goal posts, rightward deviations were observed. In the real-world setting, the number of misses to the left or right of goal (behinds) in the Australian Rules football for the 2005-2009 seasons was assessed. The data showed more rightward deviations for kicks at goal. Combined, the studies suggest that the rightward deviation for lines placed in far space extends to the kicking of a football in laboratory and real-life settings. This asymmetry in kicking builds on a body of research showing that attentional asymmetries impact everyday activities.	[Nicholls, Michael E. R.] Flinders Univ S Australia, Sch Psychol, Bedford Pk, SA 5042, Australia; [Loetscher, Tobias; Rademacher, Maxwell] Univ Melbourne, Dept Psychol Sci, Parkville, Vic 3052, Australia	Flinders University South Australia; University of Melbourne	Nicholls, MER (corresponding author), Flinders Univ S Australia, Sch Psychol, Bedford Pk, SA 5042, Australia.	mike.nicholls@flinders.edu.au	Loetscher, Tobias/I-1865-2019	Loetscher, Tobias/0000-0003-1967-2926; Nicholls, Mike/0000-0002-7072-3744				Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; Bjoertomt O, 2002, BRAIN, V125, P2012, DOI 10.1093/brain/awf211; BOWERS D, 1980, NEUROPSYCHOLOGIA, V18, P491, DOI 10.1016/0028-3932(80)90151-7; Bultitude JH, 2006, NEUROPSYCHOLOGIA, V44, P1849, DOI 10.1016/j.neuropsychologia.2006.03.001; Colby CL, 1998, NEURON, V20, P15, DOI 10.1016/S0896-6273(00)80429-8; CORBETTA M, 1993, J NEUROSCI, V13, P1202; COREN S, 1979, Journal of Clinical Neuropsychology, V1, P55, DOI 10.1080/01688637908401098; Foxe JJ, 2003, NEUROIMAGE, V19, P710, DOI 10.1016/S1053-8119(03)00057-0; Gamberini L, 2008, NEUROPSYCHOLOGIA, V46, P1298, DOI 10.1016/j.neuropsychologia.2007.12.016; HEILMAN KM, 1993, NEGLECT RELATED DISO, P279; Iriki A, 1996, NEUROREPORT, V7, P2325; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Loftus AM, 2008, COGNITION, V107, P1048, DOI 10.1016/j.cognition.2007.09.007; Loftus AM, 2009, CORTEX, V45, P537, DOI 10.1016/j.cortex.2007.12.011; Longo MR, 2006, NEUROPSYCHOLOGIA, V44, P977, DOI 10.1016/j.neuropsychologia.2005.09.003; LUH KE, 1995, NEUROPSYCHOLOGY, V9, P435, DOI 10.1037/0894-4105.9.4.435; McCourt ME, 2001, NEUROPSYCHOLOGIA, V39, P1065, DOI 10.1016/S0028-3932(01)00044-6; McCourt ME, 1999, NEUROPSYCHOLOGIA, V37, P843, DOI 10.1016/S0028-3932(98)00140-7; NICHELLI P, 1989, BRAIN COGNITION, V9, P57, DOI 10.1016/0278-2626(89)90044-4; NICHOLLS MER, ATTENTION P IN PRESS; Nicholls MER, 2008, BRAIN COGNITION, V68, P166, DOI 10.1016/j.bandc.2008.04.003; Nicholls MER, 2007, NEUROPSYCHOLOGIA, V45, P1122, DOI 10.1016/j.neuropsychologia.2006.07.015; PROVINS KA, 1972, NEUROPSYCHOLOGIA, V10, P199, DOI 10.1016/0028-3932(72)90060-7; Roberts R, 2010, J SPORT SCI, V28, P369, DOI 10.1080/02640410903536467; TROMP E, 1995, NEUROPSYCHOL REHABIL, V5, P319, DOI 10.1080/09602019508401475; Turnbull OH, 1998, BRAIN COGNITION, V37, P31; Waberski TD, 2008, NEUROPSYCHOLOGIA, V46, P1201, DOI 10.1016/j.neuropsychologia.2007.10.024; WEBSTER JS, 1995, ARCH PHYS MED REHAB, V76, P924, DOI 10.1016/S0003-9993(95)80068-9; WEBSTER JS, 1994, J CLIN EXP NEUROPSYC, V16, P129, DOI 10.1080/01688639408402623; Weiss PH, 2000, BRAIN, V123, P2531, DOI 10.1093/brain/123.12.2531	30	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12363	10.1371/journal.pone.0012363	http://dx.doi.org/10.1371/journal.pone.0012363			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808774	gold, Green Published			2022-12-27	WOS:000281154300006
J	Tawfeek, H; Bedi, B; Li, JY; Adams, J; Kobayashi, T; Weitzmann, MN; Kronenberg, HM; Pacifici, R				Tawfeek, Hesham; Bedi, Brahmchetna; Li, Jau-Yi; Adams, Jonathan; Kobayashi, Tatsuya; Weitzmann, M. Neale; Kronenberg, Henry M.; Pacifici, Roberto			Disruption of PTH Receptor 1 in T Cells Protects against PTH-Induced Bone Loss	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; MILD PRIMARY HYPERPARATHYROIDISM; HUMAN PARATHYROID-HORMONE; NECROSIS-FACTOR-ALPHA; ESTROGEN DEFICIENCY; TUBEROINFUNDIBULAR PEPTIDE; MECHANICAL-PROPERTIES; POSTMENOPAUSAL WOMEN; IFN-GAMMA; TNF-ALPHA	Background: Hyperparathyroidism in humans and continuous parathyroid hormone (cPTH) treatment in mice cause bone loss by regulating the production of RANKL and OPG by stromal cells (SCs) and osteoblasts (OBs). Recently, it has been reported that T cells are required for cPTH to induce bone loss as the binding of the T cell costimulatory molecule CD40L to SC receptor CD40 augments SC sensitivity to cPTH. However it is unknown whether direct PTH stimulation of T cells is required for cPTH to induce bone loss, and whether T cells contribute to the bone catabolic activity of PTH with mechanisms other than induction of CD40 signaling in SCs. Methodology/Principal Findings: Here we show that silencing of PTH receptor 1 (PPR) in T cells blocks the bone loss and the osteoclastic expansion induced by cPTH, thus demonstrating that PPR signaling in T cells is central for PTH-induced reduction of bone mass. Mechanistic studies revealed that PTH activation of the T cell PPR stimulates T cell production of the osteoclastogenic cytokine tumor necrosis factor a (TNF). Attesting to the relevance of this effect, disruption of T cell TNF production prevents PTH-induced bone loss. We also show that a novel mechanism by which TNF mediates PTH induced osteoclast formation is upregulation of CD40 expression in SCs, which increases their RANKL/OPG production ratio. Conclusions/Significance: These findings demonstrate that PPR signaling in T cells plays an essential role in PTH induced bone loss by promoting T cell production of TNF. A previously unknown effect of TNF is to increase SC expression of CD40, which in turn increases SC osteoclastogenic activity by upregulating their RANKL/OPG production ratio. PPR-dependent stimulation of TNF production by T cells and the resulting TNF regulation of CD40 signaling in SCs are potential new therapeutic targets for the bone loss of hyperparathyroidism.	[Tawfeek, Hesham; Bedi, Brahmchetna; Li, Jau-Yi; Adams, Jonathan; Weitzmann, M. Neale; Pacifici, Roberto] Emory Univ, Dept Med, Div Endocrinol Metab & Lipids, Atlanta, GA 30322 USA; [Pacifici, Roberto] Emory Univ, Immunol & Mol Pathogenesis Program, Atlanta, GA 30322 USA; [Kobayashi, Tatsuya; Kronenberg, Henry M.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Weitzmann, M. Neale] Atlanta VA Med Ctr, Decatur, GA USA	Emory University; Emory University; Harvard University; Massachusetts General Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center	Tawfeek, H (corresponding author), Emory Univ, Dept Med, Div Endocrinol Metab & Lipids, Atlanta, GA 30322 USA.	roberto.pacifici@emory.edu	Tawfeek, Hesham A/W-9530-2019	Tawfeek, Hesham A/0000-0002-6673-7393; Kobayashi, Tatsuya/0000-0003-4264-5117	National Institutes of Health [AR54625, AR49649, AR053607, AR056090, AR059364, DK007298, P30-AR46031]; Biomedical Laboratory Research & Development Service of the VA Office of Research and Development [5I01BX000105]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR053607, R01AR056090, R01AR059364, R01AR054625, P30AR046031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007298] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Laboratory Research & Development Service of the VA Office of Research and Development; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported, in part, by grants from the National Institutes of Health (AR54625 and AR49649). NMW was supported in part by grants from the National Institutes of Health (AR053607, AR056090 and AR059364) and by a grant from the Biomedical Laboratory Research & Development Service of the VA Office of Research and Development (5I01BX000105). BB is supported by a training grant from the National Institutes of Health (DK007298). The authors are grateful to the University of Alabama at Birmingham, Center for Metabolic Bone Disease-Histomorphometry and Molecular Analysis Core Laboratory, NIH Grant P30-AR46031 for the histomorphometric analysis presented herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja SS, 2003, ENDOCRINOLOGY, V144, P1761, DOI 10.1210/en.2002-221136; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Brodt MD, 1999, J BONE MINER RES, V14, P2159, DOI 10.1359/jbmr.1999.14.12.2159; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Canalis E, 2007, NEW ENGL J MED, V357, P905, DOI 10.1056/NEJMra067395; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Cenci S, 2003, P NATL ACAD SCI USA, V100, P10405, DOI 10.1073/pnas.1533207100; Corbi AL, 1997, LEUKEMIA LYMPHOMA, V25, P415, DOI 10.3109/10428199709039028; Dempster DW, 1999, J CLIN ENDOCR METAB, V84, P1562, DOI 10.1210/jc.84.5.1562; Divieti P, 2005, ENDOCRINOLOGY, V146, P1863, DOI 10.1210/en.2004-1262; Eichinger A, 2002, ENDOCRINOLOGY, V143, P3036, DOI 10.1210/en.143.8.3036; Everts V, 2002, J BONE MINER RES, V17, P77, DOI 10.1359/jbmr.2002.17.1.77; Galli C, 2009, J BIOL CHEM, V284, P12654, DOI 10.1074/jbc.M806628200; Gao Y, 2008, CELL METAB, V8, P132, DOI 10.1016/j.cmet.2008.07.001; GEFFNER ME, 1995, PEDIATR RES, V37, P507, DOI 10.1203/00006450-199504000-00021; Grassi F, 2007, P NATL ACAD SCI USA, V104, P15087, DOI 10.1073/pnas.0703610104; Grey A, 1996, J CLIN ENDOCR METAB, V81, P3450, DOI 10.1210/jc.81.10.3450; Grey AB, 1996, CLIN ENDOCRINOL, V44, P697; Hoare SRJ, 2000, J BIOL CHEM, V275, P27274; HOCK JM, 1992, J BONE MINER RES, V7, P65, DOI 10.1002/jbmr.5650070110; Hory BG, 2000, J ENDOCRINOL INVEST, V23, P273, DOI 10.1007/BF03343723; Iida-Klein A, 2005, J ENDOCRINOL, V186, P549, DOI 10.1677/joe.1.06270; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Kimble RB, 1996, J BIOL CHEM, V271, P28890, DOI 10.1074/jbc.271.46.28890; Kobayashi T, 2002, DEVELOPMENT, V129, P2977; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lanske B, 1999, J CLIN INVEST, V104, P399, DOI 10.1172/JCI6629; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lotinun S, 2004, J BONE MINER RES, V19, P1165, DOI 10.1359/JBMR.040404; Ma YFL, 2001, ENDOCRINOLOGY, V142, P4047, DOI 10.1210/en.142.9.4047; MCCAULEY LK, 1992, ENDOCRINOLOGY, V130, P300, DOI 10.1210/en.130.1.300; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; PACIFICI R, 2010, BONE; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Parisien M., 2001, HISTOMORPHOMETRIC AN, P423; Potts J, 1998, METABOLIC BONE DIS, P411; Qin L, 2004, TRENDS ENDOCRIN MET, V15, P60, DOI 10.1016/j.tem.2004.01.006; RIGGS BL, 1986, NEW ENGL J MED, V314, P1676, DOI 10.1056/NEJM198606263142605; Roggia C, 2001, P NATL ACAD SCI USA, V98, P13960, DOI 10.1073/pnas.251534698; SILVERBERG SJ, 1989, J BONE MINER RES, V4, P283, DOI 10.1002/jbmr.5650040302; STOJCEVATANEVA O, 1993, NEPHRON, V64, P592, DOI 10.1159/000187406; Tanaka Y, 2000, J BONE MINER RES, V15, P1912, DOI 10.1359/jbmr.2000.15.10.1912; Terauchi M, 2009, CELL METAB, V10, P229, DOI 10.1016/j.cmet.2009.07.010; Usdin TB, 1999, NAT NEUROSCI, V2, P941, DOI 10.1038/14724; Weir EC, 1996, J BONE MINER RES, V11, P1474; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550; Young N, 2005, J IMMUNOL, V175, P8287, DOI 10.4049/jimmunol.175.12.8287; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	49	59	64	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12290	10.1371/journal.pone.0012290	http://dx.doi.org/10.1371/journal.pone.0012290			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808842	gold, Green Submitted, Green Published			2022-12-27	WOS:000281077000006
J	Frimpong-Boateng, K; van Rooijen, N; Geiben-Lynn, R				Frimpong-Boateng, Kwesi; van Rooijen, Nico; Geiben-Lynn, Ralf			Regulatory T Cells Suppress Natural Killer Cells during Plasmid DNA Vaccination in Mice, Blunting the CD8(+) T Cell Immune Response by the Cytokine TGF beta	PLOS ONE			English	Article							EXPRESSION IN-VIVO; ANTIGEN-EXPRESSION; MONOCLONAL-ANTIBODY; TUMOR-IMMUNITY; CUTTING EDGE; DEPLETION; INDUCTION; TOLERANCE; CANCER; LYMPHOCYTES	Background: CD4(+)CD25(+) regulatory T cells (Tregs) suppress adaptive T cell-mediated immune responses to self- and foreign-antigens. Tregs may also suppress early innate immune responses to vaccine antigens and might decrease vaccine efficacy. NK and NKT cells are the first responders after plasmid DNA vaccination and are found at the site of inoculation. Earlier reports demonstrated that NKT cells could improve plasmid DNA efficacy, a phenomenon not found for NK cells. In fact, it has been shown that under certain disease conditions, NK cells are suppressed by Tregs via their release of IL-10 and/or TGF beta. Therefore, we tested the hypothesis that NK cell function is suppressed by Tregs in the setting of plasmid DNA vaccination. Methodology/Principal Findings: In this study we show that Tregs directly inhibit NK cell function during plasmid DNA vaccination by suppressing the potentially 10-fold, NK cell-mediated, augmentation of plasmid DNA antigen-specific CD8(+) T cells. We found that this phenomenon is dependent on the secretion of cytokine TGF beta by Tregs, and independent of IL-10. Conclusions: Our data indicate a crucial function for Tregs in blocking plasmid DNA vaccine-elicited immune responses, revealing potentially novel strategies for improving the efficiency of plasmid DNA vaccines including chemical- or antibody-induced localized blockage of Treg-mediated suppression of NK cells at the site of plasmid DNA vaccine inoculation.	[Frimpong-Boateng, Kwesi; Geiben-Lynn, Ralf] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Viral Pathogenesis, Boston, MA 02215 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, Dept Mol Cell Biol, Med Ctr, Amsterdam, Netherlands	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Vrije Universiteit Amsterdam	Frimpong-Boateng, K (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Viral Pathogenesis, Boston, MA 02215 USA.	rgeibenl@bidmc.harvard.edu	Van Rooijen, Nico/Z-1578-2019		National Institute of Allergy and Infectious Diseases Center for HIV/AIDS Vaccine Immunology [AI067854]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067854, U19AI067854] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases Center for HIV/AIDS Vaccine Immunology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases Center for HIV/AIDS Vaccine Immunology, AI067854. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma T, 2003, CANCER RES, V63, P4516; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Borg C, 2004, BLOOD, V104, P3267, DOI 10.1182/blood-2004-01-0380; Chuang CM, 2009, VACCINE, V27, P684, DOI 10.1016/j.vaccine.2008.11.042; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Davis HL, 1997, GENE THER, V4, P181, DOI 10.1038/sj.gt.3300380; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; GALLIN JI, 1974, BLOOD, V43, P201, DOI 10.1182/blood.V43.2.201.201; Geiben-Lynn R, 2008, CLIN VACCINE IMMUNOL, V15, P691, DOI 10.1128/CVI.00418-07; Geiben-Lynn R, 2009, J BIOL CHEM, V284, P33800, DOI 10.1074/jbc.M109.019638; Geiben-Lynn R, 2008, BLOOD, V112, P4585, DOI 10.1182/blood-2008-06-165803; Ghiringhelli F, 2006, IMMUNOL REV, V214, P229, DOI 10.1111/j.1600-065X.2006.00445.x; Greenland JR, 2007, J IMMUNOL, V178, P5652, DOI 10.4049/jimmunol.178.9.5652; Hovav AH, 2007, J IMMUNOL, V179, P6725, DOI 10.4049/jimmunol.179.10.6725; Kohm AP, 2006, J IMMUNOL, V176, P3301, DOI 10.4049/jimmunol.176.6.3301; Kullberg MC, 2002, J EXP MED, V196, P505, DOI 10.1084/jem.20020556; LaRosa DF, 2007, IMMUNOL LETT, V108, P183, DOI 10.1016/j.imlet.2006.12.007; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; Liu RL, 2005, J IMMUNOL, V175, P7898, DOI 10.4049/jimmunol.175.12.7898; Lundqvist A, 2009, BLOOD, V113, P6120, DOI 10.1182/blood-2008-11-190421; MACATANGAY BJ, PLOS ONE, V5, pE9852; MIETHKE AG, J HEPATOL, V52, P718; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Nishimura E, 2004, INT IMMUNOL, V16, P1189, DOI 10.1093/intimm/dxh122; Onizuka S, 1999, CANCER RES, V59, P3128; Orlans FB, 1997, ETHICS BEHAV, V7, P163, DOI 10.1207/s15327019eb0702_7; Perou CM, 1996, NAT GENET, V13, P303, DOI 10.1038/ng0796-303; Piccirillo CA, 2004, SEMIN IMMUNOL, V16, P81, DOI 10.1016/j.smim.2003.12.003; Ralainirina N, 2007, J LEUKOCYTE BIOL, V81, P144, DOI 10.1189/jlb.0606409; RODER J, 1979, NATURE, V278, P451, DOI 10.1038/278451a0; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shimizu J, 1999, J IMMUNOL, V163, P5211; SHIRAHATA T, 1994, J VET MED SCI, V56, P293, DOI 10.1292/jvms.56.293; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; Smyth MJ, 2006, J IMMUNOL, V176, P1582, DOI 10.4049/jimmunol.176.3.1582; Smyth MJ, 2002, NAT REV CANCER, V2, P850, DOI 10.1038/nrc928; Stan AC, 2001, EUR J IMMUNOL, V31, P301, DOI 10.1002/1521-4141(200101)31:1<301::AID-IMMU301>3.0.CO;2-K; Steitz J, 2001, CANCER RES, V61, P8643; Taams LS, 2005, HUM IMMUNOL, V66, P222, DOI 10.1016/j.humimm.2004.12.006; Trenado A, 2003, J CLIN INVEST, V112, P1688, DOI 10.1172/JCI17702; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Wing K, 2005, IMMUNOLOGY, V115, P516, DOI 10.1111/j.1365-2567.2005.02186.x; Woo EY, 2001, CANCER RES, V61, P4766; Zimmer J, 2008, EUR J IMMUNOL, V38, P2942, DOI 10.1002/eji.200838813	46	20	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12281	10.1371/journal.pone.0012281	http://dx.doi.org/10.1371/journal.pone.0012281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808850	Green Published, gold, Green Submitted			2022-12-27	WOS:000281075500015
J	Pendergrass, SA; Hayes, E; Farina, G; Lemaire, R; Farber, HW; Whitfield, ML; Lafyatis, R				Pendergrass, Sarah A.; Hayes, Everett; Farina, Giuseppina; Lemaire, Raphael; Farber, Harrison W.; Whitfield, Michael L.; Lafyatis, Robert			Limited Systemic Sclerosis Patients with Pulmonary Arterial Hypertension Show Biomarkers of Inflammation and Vascular Injury	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INTERSTITIAL LUNG-DISEASE; GENE-EXPRESSION; SCLERODERMA SKIN; FACTOR-ALPHA; CUTANEOUS INVOLVEMENT; RHEUMATOID-ARTHRITIS; PERIPHERAL-BLOOD; ASSOCIATION; PROFILES	Background: Pulmonary arterial hypertension (PAH) is a common complication for individuals with limited systemic sclerosis (lSSc). The identification and characterization of biomarkers for lSSc-PAH should lead to less invasive screening, a better understanding of pathogenesis, and improved treatment. Methods and Findings: Forty-nine PBMC samples were obtained from 21 lSSc subjects without PAH (lSSc-noPAH), 15 lSSc subjects with PAH (lSSc-PAH), and 10 healthy controls; three subjects provided PBMCs one year later. Genome-wide gene expression was measured for each sample. The levels of 89 cytokines were measured in serum from a subset of subjects by Multi-Analyte Profiling (MAP) immunoassays. Gene expression clearly distinguished lSSc samples from healthy controls, and separated lSSc-PAH from lSSc-NoPAH patients. Real-time quantitative PCR confirmed increased expression of 9 genes (ICAM1, IFNGR1, IL1B, IL13Ra1, JAK2, AIF1, CCR1, ALAS2, TIMP2) in lSSc-PAH patients. Increased circulating cytokine levels of inflammatory mediators such as TNF-alpha, IL1-beta, ICAM-1, and IL-6, and markers of vascular injury such as VCAM-1, VEGF, and von Willebrand Factor were found in lSSc-PAH subjects. Conclusions and Significance: The gene expression and cytokine profiles of lSSc-PAH patients suggest the presence of activated monocytes, and show markers of vascular injury and inflammation. These genes and factors could serve as biomarkers of PAH involvement in lSSc.	[Pendergrass, Sarah A.; Whitfield, Michael L.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Genet, Hanover, NH 03756 USA; [Hayes, Everett; Farina, Giuseppina; Lemaire, Raphael; Lafyatis, Robert] Boston Univ, Sch Med, Ctr Arthritis, Rheumatol Sect, Boston, MA 02118 USA; [Farber, Harrison W.] Boston Univ, Sch Med, Pulm Sect, Boston, MA 02118 USA	Dartmouth College; Boston University; Boston University	Pendergrass, SA (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Genet, Hanover, NH 03756 USA.	michael.whitfield@dartmouth.edu; lafyatis@bu.edu	Farina, Giuseppina/B-1800-2019; Whitfield, Michael/AAC-5010-2020	Farina, Giuseppina/0000-0002-3948-6920; Farber, Harrison/0000-0002-0297-7902; Pendergrass, Rion/0000-0002-0565-6522; Lafyatis, Robert/0000-0002-9398-5034	Actelion Pharmaceuticals Ltd; Arthritis Foundation; NIAMS [T32 AR007575-11]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR062721, R01AR051089, P50AR060780] Funding Source: NIH RePORTER	Actelion Pharmaceuticals Ltd; Arthritis Foundation; NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work has been supported by a grant from Actelion Pharmaceuticals Ltd (www.actelion.com) to RAL and a Hulda Irene Duggan Arthritis Investigator Award from the Arthritis Foundation to MLW (http://www.arthritis.org/). SAP was supported by the NIAMS Autoimmunity and Connective Tissue Training Grant T32 AR007575-11 and by funds from the Arthritis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADERKA D, 1992, J EXP MED, V175, P323, DOI 10.1084/jem.175.2.323; ANDREWS BS, 1987, J RHEUMATOL, V14, P930; Bae YH, 2009, BIOCHEM BIOPH RES CO, V379, P206, DOI 10.1016/j.bbrc.2008.12.042; Bargagli E, 2008, RESPIRATION, V75, P346, DOI 10.1159/000090248; Browning JL, 2008, IMMUNOL REV, V223, P202, DOI 10.1111/j.1600-065X.2008.00633.x; Bull TM, 2004, AM J RESP CRIT CARE, V170, P911, DOI 10.1164/rccm.200312-1686OC; Bull TM, 2007, CURR OPIN RHEUMATOL, V19, P598, DOI 10.1097/BOR.0b013e3282ec67d4; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chaouat A, 2009, CHEST, V136, P678, DOI 10.1378/chest.08-2420; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Cool CD, 1997, HUM PATHOL, V28, P434, DOI 10.1016/S0046-8177(97)90032-0; Del Galdo F, 2006, CURR OPIN RHEUMATOL, V18, P588, DOI 10.1097/01.bor.0000245724.94887.c4; Denton CP, 2009, ANN RHEUM DIS, V68, P1433, DOI 10.1136/ard.2008.096123; Dorfmuller P, 2007, HUM PATHOL, V38, P893, DOI 10.1016/j.humpath.2006.11.022; Duan H, 2008, ARTHRITIS RHEUM-US, V58, P1465, DOI 10.1002/art.23451; Faller DV, 1999, CLIN EXP PHARMACOL P, V26, P74, DOI 10.1046/j.1440-1681.1999.02992.x; Farina G, 2009, ANN RHEUM DIS, V68, P435, DOI 10.1136/ard.2007.086850; Fisher MR, 2006, ARTHRITIS RHEUM-US, V54, P3043, DOI 10.1002/art.22069; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Fujita M, 2002, J APPL PHYSIOL, V93, P2162, DOI 10.1152/japplphysiol.00083.2002; GARCOVICH A, 1989, PANMINERVA MED, V31, P76; Gardner H, 2006, ARTHRITIS RHEUM-US, V54, P1961, DOI 10.1002/art.21894; Goh NSL, 2008, AM J RESP CRIT CARE, V177, P1248, DOI 10.1164/rccm.200706-877OC; Grigoryev DN, 2008, TRANSL RES, V151, P197, DOI 10.1016/j.trsl.2007.12.010; Haider AS, 2008, J INVEST DERMATOL, V128, P606, DOI 10.1038/sj.jid.5701067; Hasegawa M, 1997, J RHEUMATOL, V24, P663; Herlitz J, 2008, Acute Card Care, V10, P197, DOI 10.1080/17482940802409662; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; HORVATH CJ, 1988, P NATL ACAD SCI USA, V85, P9219, DOI 10.1073/pnas.85.23.9219; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Itoh T, 2006, RESPIROLOGY, V11, P158, DOI 10.1111/j.1440-1843.2006.00821.x; Ivakhno SS, 2004, EXP ONCOL, V26, P250; Kawut SM, 2003, CHEST, V123, P344, DOI 10.1378/chest.123.2.344; KOMINATO Y, 1995, MOL CELL BIOL, V15, P58; Launay D, 2007, J RHEUMATOL, V34, P1005; LEROY EC, 1988, J RHEUMATOL, V15, P202; Liu Y, 2008, J AM STAT ASSOC, V103, P1281, DOI 10.1198/016214508000000454; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsushita Y, 2007, J IMMUNOL, V179, P698, DOI 10.4049/jimmunol.179.1.698; Mcgoon MD, 2008, MAYO CLIN PROC, V83, P923, DOI 10.4065/83.8.923; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Milano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002696; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Perros F, 2007, EUR RESPIR J, V29, P462, DOI 10.1183/09031936.00094706; Quarck R, 2009, J AM COLL CARDIOL, V53, P1211, DOI 10.1016/j.jacc.2008.12.038; Sacks DG, 1996, J RHEUMATOL, V23, P639; Savale L, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-6; Steen V, 2003, ARTHRITIS RHEUM, V48, P516, DOI 10.1002/art.10775; Steen VD, 1996, RHEUM DIS CLIN N AM, V22, P861, DOI 10.1016/S0889-857X(05)70305-7; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teixeira VH, 2008, J CLIN IMMUNOL, V28, P115, DOI 10.1007/s10875-007-9143-6; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; Weinlander K, 2008, FASEB J, V22, P4168, DOI 10.1096/fj.08-107524; Whitfield ML, 2003, P NATL ACAD SCI USA, V100, P12319, DOI 10.1073/pnas.1635114100; Wort SJ, 2009, J BIOL CHEM, V284, P24297, DOI 10.1074/jbc.M109.032524; Zhang HG, 2004, ARTHRITIS RHEUM-US, V50, P420, DOI 10.1002/art.20037; Zhu JH, 2008, RESP MED, V102, P1073, DOI 10.1016/j.rmed.2007.12.030	61	102	105	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12106	10.1371/journal.pone.0012106	http://dx.doi.org/10.1371/journal.pone.0012106			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808962	Green Submitted, gold, Green Published			2022-12-27	WOS:000280968100003
J	Alvarez, S; Suela, J; Valencia, A; Fernandez, A; Wunderlich, M; Agirre, X; Prosper, F; Martin-Subero, JI; Maiques, A; Acquadro, F; Perales, SR; Calasanz, MJ; Roman-Gomez, J; Siebert, R; Mulloy, JC; Cervera, J; Sanz, MA; Esteller, M; Cigudosa, JC				Alvarez, Sara; Suela, Javier; Valencia, Ana; Fernandez, Agustin; Wunderlich, Mark; Agirre, Xabier; Prosper, Felipe; Ignacio Martin-Subero, Jose; Maiques, Alba; Acquadro, Francesco; Rodriguez Perales, Sandra; Jose Calasanz, Maria; Roman-Gomez, Jose; Siebert, Reiner; Mulloy, James C.; Cervera, Jose; Angel Sanz, Miguel; Esteller, Manel; Cigudosa, Juan C.			DNA Methylation Profiles and Their Relationship with Cytogenetic Status in Adult Acute Myeloid Leukemia	PLOS ONE			English	Article							CPG ISLAND METHYLATION; PREDICTS SURVIVAL; GENE DBCCR1; CELLS; MALIGNANCIES; CANCER; EXPRESSION; DBC1; EPIGENETICS; NEOPLASMS	Background: Aberrant promoter DNA methylation has been shown to play a role in acute myeloid leukemia (AML) pathophysiology. However, further studies to discuss the prognostic value and the relationship of the epigenetic signatures with defined genomic rearrangements in acute myeloid leukemia are required. Methodology/Principal Findings: We carried out high-throughput methylation profiling on 116 de novo AML cases and we validated the significant biomarkers in an independent cohort of 244 AML cases. Methylation signatures were associated with the presence of a specific cytogenetic status. In normal karyotype cases, aberrant methylation of the promoter of DBC1 was validated as a predictor of the disease-free and overall survival. Furthermore, DBC1 expression was significantly silenced in the aberrantly methylated samples. Patients with chromosome rearrangements showed distinct methylation signatures. To establish the role of fusion proteins in the epigenetic profiles, 20 additional samples of human hematopoietic stem/progenitor cells (HSPC) transduced with common fusion genes were studied and compared with patient samples carrying the same rearrangements. The presence of MLL rearrangements in HSPC induced the methylation profile observed in the MLL-positive primary samples. In contrast, fusion genes such as AML1/ETO or CBFB/MYH11 failed to reproduce the epigenetic signature observed in the patients. Conclusions/Significance: Our study provides a comprehensive epigenetic profiling of AML, identifies new clinical markers for cases with a normal karyotype, and reveals relevant biological information related to the role of fusion proteins on the methylation signature.	[Alvarez, Sara; Suela, Javier; Maiques, Alba; Acquadro, Francesco; Rodriguez Perales, Sandra; Cigudosa, Juan C.] Ctr Invest Enfermedades Raras CIBERER, CNIO, Mol Cytogenet Grp, Madrid, Spain; [Valencia, Ana; Cervera, Jose; Angel Sanz, Miguel] Hosp Univ La Fe, Hematol Serv, Valencia, Spain; [Fernandez, Agustin; Ignacio Martin-Subero, Jose; Esteller, Manel] Bellvitge Inst Biomed Res Catalan Inst Oncol IDIB, Canc Epigenet & Biol Program, Barcelona, Spain; [Wunderlich, Mark; Mulloy, James C.] Univ Cincinnati, Coll Med, Div Expt Hematol, Cincinnati Childrens Hosp,Med Ctr, Cincinnati, OH USA; [Agirre, Xabier; Prosper, Felipe] Univ Navarra, Clin Univ, Fdn Appl Med Res, Div Canc, E-31080 Pamplona, Spain; [Agirre, Xabier; Prosper, Felipe] Univ Navarra, Clin Univ, Fdn Appl Med Res, Area Cell Therapy, E-31080 Pamplona, Spain; [Agirre, Xabier; Prosper, Felipe] Univ Navarra, Clin Univ, Fdn Appl Med Res, Hematol Serv, E-31080 Pamplona, Spain; [Jose Calasanz, Maria] Univ Navarra, Dept Genet, E-31080 Pamplona, Spain; [Roman-Gomez, Jose] Hosp Univ Reina Sofia, Hematol Serv, Cordoba, Spain; [Ignacio Martin-Subero, Jose; Siebert, Reiner] Univ Kiel, Inst Human Genet, Univ Hosp Schleswig Holstein, Kiel, Germany	Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitari i Politecnic La Fe; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Navarra; University of Navarra; University of Navarra; University of Navarra; Hospital Universitario Reina Sofia - Cordoba; University of Kiel; Schleswig Holstein University Hospital	Alvarez, S (corresponding author), Ctr Invest Enfermedades Raras CIBERER, CNIO, Mol Cytogenet Grp, Madrid, Spain.	salvarez@cnio.es; jccigudosa@cnio.es	Cervera, Jose/ABF-2143-2020; Cigudosa, Juan C/E-4105-2016; SUELA, JAVIER/K-3968-2016; Siebert, Reiner/A-8049-2010; Prosper, Felipe/H-6859-2017; Rodriguez-Perales, Sandra/T-7667-2017; Esteller, Manel/L-5956-2014; Agirre, Xabier/ABE-4110-2020; Calasanz, MJ/R-5813-2016; Fernandez, Agustin F./N-7302-2014; Sanz, Miguel A./F-7485-2018	Cervera, Jose/0000-0001-8252-1106; Prosper, Felipe/0000-0001-6115-8790; Rodriguez-Perales, Sandra/0000-0001-7221-3636; Esteller, Manel/0000-0003-4490-6093; Calasanz, MJ/0000-0002-0374-3008; Fernandez, Agustin F./0000-0002-3792-4085; Sanz, Miguel A./0000-0003-1489-1177; Martin-Subero, Jose Ignacio/0000-0001-8809-5195; Maiques-Diaz, Alba/0000-0002-3365-3775	Spanish Fondo de Investigacion Sanitaria (FIS) [PI040555, PI080440, PI080878]; Spanish Ministry of Health and Consumer Affairs; KinderKrebsInitiative Buchholz/Holm-Seppensen; Kiel University Medical Faculty; Miguel Servet Initiative (FIS); Red Tematica de Investigacion sobre Cancer (RETIC) [PI060657, RD06/0020]	Spanish Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Spanish Ministry of Health and Consumer Affairs(Spanish Government); KinderKrebsInitiative Buchholz/Holm-Seppensen; Kiel University Medical Faculty; Miguel Servet Initiative (FIS)(Instituto de Salud Carlos III); Red Tematica de Investigacion sobre Cancer (RETIC)	This work was partially financed by grants PI040555, PI080440, and PI080878 from the Spanish Fondo de Investigacion Sanitaria (FIS) and the Spanish Ministry of Health and Consumer Affairs awarded to JCC and SA. Funding was also awarded to RS and JIMS by KinderKrebsInitiative Buchholz/Holm-Seppensen and Kiel University Medical Faculty. SA is supported by a contract from the Miguel Servet Initiative (FIS). The validation studies were partially supported by grants PI060657 and RD06/0020 from Red Tematica de Investigacion sobre Cancer (RETIC) and FIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Boultwood J, 2007, BRIT J HAEMATOL, V138, P3, DOI 10.1111/j.1365-2141.2007.06604.x; Bullinger L, 2010, BLOOD, V115, P636, DOI 10.1182/blood-2009-03-211003; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Diaz-Uriarte R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-30; Esteller M, 2002, SCIENCE, V297, P1807; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; FIGUEROA ME, 2010, CANC CELL, P18701; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Frohling S, 2005, J CLIN ONCOL, V23, P6285, DOI 10.1200/JCO.2005.05.010; Galm O, 2006, BLOOD REV, V20, P1, DOI 10.1016/j.blre.2005.01.006; Gilliland DG, 2001, CURR OPIN HEMATOL, V8, P189, DOI 10.1097/00062752-200107000-00001; Gronbaek K, 2008, MODERN PATHOL, V21, P632, DOI 10.1038/modpathol.2008.27; Habuchi T, 1998, GENOMICS, V48, P277, DOI 10.1006/geno.1997.5165; Hess CJ, 2008, LEUKEMIA LYMPHOMA, V49, P1132, DOI 10.1080/10428190802035990; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Izumi H, 2005, HUM MOL GENET, V14, P997, DOI 10.1093/hmg/ddi092; Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2008-06-163246; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kroeger H, 2008, BLOOD, V112, P1366, DOI 10.1182/blood-2007-11-126227; Li ZJ, 2009, CANCER RES, V69, P1109, DOI 10.1158/0008-5472.CAN-08-3381; MARTIN V, 2009, CANC SCI, P18701; Martin-Subero JI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006986; Martin-Subero JI, 2009, BLOOD, V113, P2488, DOI 10.1182/blood-2008-04-152900; Mulloy JC, 2002, BLOOD, V99, P15, DOI 10.1182/blood.V99.1.15; Nishiyama H, 2001, ONCOGENE, V20, P2956, DOI 10.1038/sj.onc.1204432; Opavsky R, 2007, PLOS GENET, V3, P1757, DOI 10.1371/journal.pgen.0030167; Rosu-Myles M, 2008, BLOOD CELL MOL DIS, V40, P406, DOI 10.1016/j.bcmd.2007.09.005; San Jose-Eneriz E, 2006, BRIT J HAEMATOL, V134, P137, DOI 10.1111/j.1365-2141.2006.06131.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen LL, 2010, J CLIN ONCOL, V28, P605, DOI 10.1200/JCO.2009.23.4781; Suarez L, 2005, HAEMATOLOGICA, V90, P54; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Toyota M, 2001, BLOOD, V97, P2823, DOI 10.1182/blood.V97.9.2823; Valencia A, 2009, LEUKEMIA, V23, P1658, DOI 10.1038/leu.2009.86; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Wong IHN, 2000, BLOOD, V95, P1942, DOI 10.1182/blood.V95.6.1942; Wunderlich M, 2006, BLOOD, V108, P1690, DOI 10.1182/blood-2005-12-012773; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2	39	60	63	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12197	10.1371/journal.pone.0012197	http://dx.doi.org/10.1371/journal.pone.0012197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808941	Green Published, gold			2022-12-27	WOS:000280968000021
J	Ye, NH; Li, DM; Chen, LM; Zhang, XW; Xu, D				Ye, Naihao; Li, Demao; Chen, Limei; Zhang, Xiaowen; Xu, Dong			Comparative Studies of the Pyrolytic and Kinetic Characteristics of Maize Straw and the Seaweed Ulva pertusa	PLOS ONE			English	Article							BEHAVIOR; BIOMASS; WOOD	Seaweed has attracted considerable attention as a potential biofuel feedstock. The pyrolytic and kinetic characteristics of maize straw and the seaweed Ulva pertusa were studied and compared using heating rates of 10, 30 and 50 degrees C min(-1) under an inert atmosphere. The activation energy, and pre-exponential factors were calculated by the Flynn-Wall-Ozawa (FWO), Kissinger-Akahira-Sunose (KAS) and Popescu methods. The kinetic mechanism was deduced by the Popescu method. The results indicate that there are three stages to the pyrolysis; dehydration, primary devolatilization and residual decomposition. There were significant differences in average activation energy, thermal stability, final residuals and reaction rates between the two materials. The primary devolatilization stage of U. pertusa can be described by the Avramic-Erofeev equation (n=3), whereas that of maize straw can be described by the Mampel Power Law (n=2). The average activation energy of maize straw and U. pertusa were 153.0 and 148.7 KJ mol(-1,) respectively. The pyrolysis process of U.pertusa would be easier than maize straw. And co-firing of the two biomass may be require less external heat input and improve process stability. There were minor kinetic compensation effects between the pre-exponential factors and the activation energy.	[Ye, Naihao; Zhang, Xiaowen; Xu, Dong] Chinese Acad Fishery Sci, Key Lab Sustainable Utilizat Marine Fishery Resou, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China; [Li, Demao; Chen, Limei] Liaocheng Univ, Dept Food Sci, Coll Agr, Liaocheng, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Liaocheng University	Ye, NH (corresponding author), Chinese Acad Fishery Sci, Key Lab Sustainable Utilizat Marine Fishery Resou, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China.	demaoli@gmail.com			National Natural Science Foundation of China [40706050, 40706048, 30700619]; National Science & Technology Pillar Program [2006BAD01A13, 2008BAC49B04]; National special fund for transgenic [2009ZX08009-019B]; Natural Science Foundation of Shandong Province [2009ZRA02075]; Qingdao Municipal Science and Technology [09-2-5-8-hy]; Hi-TechResearch and Development Program (863) of China [2006AA10Z414]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program; National special fund for transgenic; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Qingdao Municipal Science and Technology; Hi-TechResearch and Development Program (863) of China(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (40706050, 40706048 and 30700619), the National Science & Technology Pillar Program (2006BAD01A13 and 2008BAC49B04), National special fund for transgenic project (2009ZX08009-019B), Natural Science Foundation of Shandong Province (2009ZRA02075), Qingdao Municipal Science and Technology plan project (09-2-5-8-hy) and the Hi-TechResearch and Development Program (863) of China (2006AA10Z414). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, E175501 ASTM; [Anonymous], 2004, D586504 ASTM; [Anonymous], 2006, E87182 ASTM; ASTM International, 2006, E87282 ASTM; Friedman H., 1966, J POLYM SCI B, V4, P323, DOI DOI 10.1002/POL.1966.110040504; Fu P, 2009, BIORESOURCE TECHNOL, V100, P4877, DOI 10.1016/j.biortech.2009.05.009; Hu R.Z., 2001, THERMAL ANAL KINETIC, P127; KISSINGER HE, 1957, ANAL CHEM, V29, P1702, DOI 10.1021/ac60131a045; Li DM, 2010, BIORESOURCE TECHNOL, V101, P7131, DOI 10.1016/j.biortech.2010.03.145; Li DM, 2010, CHEM ENG RES DES, V88, P647, DOI 10.1016/j.cherd.2009.10.011; Liao CP, 2004, BIOMASS BIOENERG, V27, P111, DOI [10.1016/j.biombioe.2003.10.009, 10.1016/j.biombioc.2003.10.009]; Muller-Hagedorn A, 2007, J ANAL APPL PYROL, V79, P136, DOI 10.1016/j.jaap.2006.12.008; OZAWA T, 1965, B CHEM SOC JPN, V38, P1881, DOI 10.1246/bcsj.38.1881; PAPPA AA, 1995, THERMOCHIM ACTA, V261, P165, DOI 10.1016/0040-6031(95)02385-F; Percival E., 1981, PLANT CARBOHYDRATES, P277; Popescu C, 1996, THERMOCHIM ACTA, V285, P309, DOI 10.1016/0040-6031(96)02916-4; Ross AB, 2008, BIORESOURCE TECHNOL, V99, P6494, DOI 10.1016/j.biortech.2007.11.036; Ross AB, 2009, J ANAL APPL PYROL, V85, P3, DOI 10.1016/j.jaap.2008.11.004; Sharma A, 1999, BIORESOURCE TECHNOL, V67, P53, DOI 10.1016/S0960-8524(99)00073-5; Wang J, 2006, PROCESS BIOCHEM, V41, P1883, DOI 10.1016/j.procbio.2006.03.018; Xiu SN, 2006, FUEL, V85, P664, DOI 10.1016/j.fuel.2005.08.044; Zabaniotou AA, 2008, BIORESOURCE TECHNOL, V99, P3174, DOI 10.1016/j.biortech.2007.05.060; Zheng JL, 2008, J ANAL APPL PYROL, V83, P205, DOI 10.1016/j.jaap.2008.08.005	23	35	36	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12641	10.1371/journal.pone.0012641	http://dx.doi.org/10.1371/journal.pone.0012641			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844751	Green Submitted, Green Published, gold			2022-12-27	WOS:000281687300005
J	Santos, BA; Arroyo-Rodriguez, V; Moreno, CE; Tabarelli, M				Santos, Braulio A.; Arroyo-Rodriguez, Victor; Moreno, Claudia E.; Tabarelli, Marcelo			Edge-Related Loss of Tree Phylogenetic Diversity in the Severely Fragmented Brazilian Atlantic Forest	PLOS ONE			English	Article							HABITAT FRAGMENTATION; NONRANDOM EXTINCTION; EVOLUTIONARY; BIODIVERSITY; CONSERVATION; LANDSCAPE; EROSION; DECAY	Deforestation and forest fragmentation are known major causes of nonrandom extinction, but there is no information about their impact on the phylogenetic diversity of the remaining species assemblages. Using a large vegetation dataset from an old hyper-fragmented landscape in the Brazilian Atlantic rainforest we assess whether the local extirpation of tree species and functional impoverishment of tree assemblages reduce the phylogenetic diversity of the remaining tree assemblages. We detected a significant loss of tree phylogenetic diversity in forest edges, but not in core areas of small (<80 ha) forest fragments. This was attributed to a reduction of 11% in the average phylogenetic distance between any two randomly chosen individuals from forest edges; an increase of 17% in the average phylogenetic distance to closest non-conspecific relative for each individual in forest edges; and to the potential manifestation of late edge effects in the core areas of small forest remnants. We found no evidence supporting fragmentation-induced phylogenetic clustering or evenness. This could be explained by the low phylogenetic conservatism of key life-history traits corresponding to vulnerable species. Edge effects must be reduced to effectively protect tree phylogenetic diversity in the severely fragmented Brazilian Atlantic forest.	[Santos, Braulio A.; Arroyo-Rodriguez, Victor] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico; [Santos, Braulio A.; Tabarelli, Marcelo] Univ Fed Pernambuco, Dept Bot, Recife, PE, Brazil; [Moreno, Claudia E.] Univ Autonoma Estado Hidalgo, Ctr Invest Biol, Pachuca, Mexico	Universidad Nacional Autonoma de Mexico; Universidade Federal de Pernambuco; Universidad Autonoma del Estado de Hidalgo	Santos, BA (corresponding author), Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico.	bsantos@oikos.unam.mx	Moreno, Claudia/GRJ-1036-2022; Tabarelli, Marcelo/F-1088-2010; Arroyo-Rodríguez, Víctor/C-9255-2009; Virtual, Inct Herbario/J-8725-2013; Moreno, Claudia E./B-2733-2013; Santos, Bráulio A./M-2582-2013	Tabarelli, Marcelo/0000-0001-7573-7216; Arroyo-Rodríguez, Víctor/0000-0002-0858-0324; Moreno, Claudia E./0000-0002-9584-2619; Santos, Bráulio A./0000-0001-6046-4024	CNPq; Fundacao O Boticario de Protecao a Natureza; Conservation International-Brazil; Universidad Nacional Autonoma de Mexico	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao O Boticario de Protecao a Natureza; Conservation International-Brazil; Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	Financial support was provided by CNPq (www.cnpq.br) (graduate scholarship to B. Santos and research grant to M. Tabarelli), Fundacao O Boticario de Protecao a Natureza (www.fundacaoboticario.org.br), Conservation International-Brazil (www.conservation.org.br), and Universidad Nacional Autonoma de Mexico (postdoctoral fellowship to V. Arroyo-Rodriguez). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo-Rodriguez V, 2009, CONSERV BIOL, V23, P729, DOI 10.1111/j.1523-1739.2008.01120.x; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cadotte MW, 2010, ECOL LETT, V13, P96, DOI 10.1111/j.1461-0248.2009.01405.x; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; FAHRIG L, 1994, CONSERV BIOL, V8, P50, DOI 10.1046/j.1523-1739.1994.08010050.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Girao LC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000908; Gonzalez MA, 2010, J ECOL, V98, P137, DOI 10.1111/j.1365-2745.2009.01607.x; HARPER JL, 1994, PHILOS T R SOC B, V345, P5, DOI 10.1098/rstb.1994.0081; HUMPHRIES CJ, 1995, ANNU REV ECOL SYST, V26, P93, DOI 10.1146/annurev.es.26.110195.000521; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001017; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Lopes AV, 2009, BIOL CONSERV, V142, P1154, DOI 10.1016/j.biocon.2009.01.007; Martinez-Ramos M, 1998, TRENDS PLANT SCI, V3, P400, DOI 10.1016/S1360-1385(98)01313-2; MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; Oliveira MA, 2008, FOREST ECOL MANAG, V256, P1910, DOI 10.1016/j.foreco.2008.07.014; Pavoine S, 2005, ECOL LETT, V8, P579, DOI 10.1111/j.1461-0248.2005.00752.x; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Santos AMM, 2007, J BIOGEOGR, V34, P437, DOI 10.1111/j.1365-2699.2006.01604.x; Santos BA, 2008, BIOL CONSERV, V141, P249, DOI 10.1016/j.biocon.2007.09.018; SILVA JMC, 2000, NATURE, V404, P72, DOI DOI 10.1038/35003563; Silvertown J, 2006, ECOLOGY, V87, pS39, DOI 10.1890/0012-9658(2006)87[39:PATHOO]2.0.CO;2; Smith KG, 2009, ECOL LETT, V12, P1069, DOI 10.1111/j.1461-0248.2009.01363.x; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tabarelli M, 2008, BIOTROPICA, V40, P657, DOI 10.1111/j.1744-7429.2008.00454.x; Vamosi JC, 2008, ECOL LETT, V11, P1047, DOI 10.1111/j.1461-0248.2008.01215.x; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448	42	81	81	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12625	10.1371/journal.pone.0012625	http://dx.doi.org/10.1371/journal.pone.0012625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IV	20838613	Green Published, gold			2022-12-27	WOS:000281687100008
J	Atkins, N; Mitchell, JW; Romanova, EV; Morgan, DJ; Cominski, TP; Ecker, JL; Pintar, JE; Sweedler, JV; Gillette, MU				Atkins, Norman, Jr.; Mitchell, Jennifer W.; Romanova, Elena V.; Morgan, Daniel J.; Cominski, Tara P.; Ecker, Jennifer L.; Pintar, John E.; Sweedler, Jonathan V.; Gillette, Martha U.			Circadian Integration of Glutamatergic Signals by Little SAAS in Novel Suprachiasmatic Circuits	PLOS ONE			English	Article							GASTRIN-RELEASING-PEPTIDE; VASOACTIVE-INTESTINAL-PEPTIDE; PHASE-SHIFTS; NEURONAL RHYTHMS; GENE-EXPRESSION; RAT; NUCLEUS; CLOCK; VIP; MOUSE	Background: Neuropeptides are critical integrative elements within the central circadian clock in the suprachiasmatic nucleus (SCN), where they mediate both cell-to-cell synchronization and phase adjustments that cause light entrainment. Forward peptidomics identified little SAAS, derived from the proSAAS prohormone, among novel SCN peptides, but its role in the SCN is poorly understood. Methodology/Principal Findings: Little SAAS localization and co-expression with established SCN neuropeptides were evaluated by immunohistochemistry using highly specific antisera and stereological analysis. Functional context was assessed relative to c-FOS induction in light-stimulated animals and on neuronal circadian rhythms in glutamate-stimulated brain slices. We found that little SAAS-expressing neurons comprise the third most abundant neuropeptidergic class (16.4%) with unusual functional circuit contexts. Little SAAS is localized within the densely retinorecipient central SCN of both rat and mouse, but not the retinohypothalamic tract (RHT). Some little SAAS colocalizes with vasoactive intestinal polypeptide (VIP) or gastrin-releasing peptide (GRP), known mediators of light signals, but not arginine vasopressin (AVP). Nearly 50% of little SAAS neurons express c-FOS in response to light exposure in early night. Blockade of signals that relay light information, via NMDA receptors or VIP-and GRP-cognate receptors, has no effect on phase delays of circadian rhythms induced by little SAAS. Conclusions/Significance: Little SAAS relays signals downstream of light/glutamatergic signaling from eye to SCN, and independent of VIP and GRP action. These findings suggest that little SAAS forms a third SCN neuropeptidergic system, processing light information and activating phase-shifts within novel circuits of the central circadian clock.	[Atkins, Norman, Jr.; Sweedler, Jonathan V.; Gillette, Martha U.] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; [Mitchell, Jennifer W.; Gillette, Martha U.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Romanova, Elena V.; Sweedler, Jonathan V.; Gillette, Martha U.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Morgan, Daniel J.; Cominski, Tara P.; Pintar, John E.] Univ Med & Dent New Jersey, Dept Cell Biol & Neurosci, Newark, NJ 07103 USA; [Ecker, Jennifer L.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Rutgers State University New Brunswick; Rutgers State University Medical Center; Johns Hopkins University; University of Illinois System; University of Illinois Urbana-Champaign	Atkins, N (corresponding author), Univ Illinois, Neurosci Program, Urbana, IL 61801 USA.	mgillett@illinois.edu	Sweedler, Jonathan V/A-9405-2009	Sweedler, Jonathan V/0000-0003-3107-9922; Morgan, Daniel/0000-0002-9467-4019; Romanova, Elena/0000-0002-2040-3312; Atkins, Norman/0000-0002-0802-6032	National Institutes of Health [HL092571, P30 DA018310, DE018866, T32 MH/AG19957]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by grants from the National Institutes of Health (www.nih.gov): HL092571 (MUG), P30 DA018310 and DE018866 (JVS), and T32 MH/AG19957 (JP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Aida R, 2002, MOL PHARMACOL, V61, P26, DOI 10.1124/mol.61.1.26; ALBERS HE, 1991, J NEUROSCI, V11, P846; ALBERS HE, 1995, NEUROSCI LETT, V191, P63, DOI 10.1016/0304-3940(95)11559-1; Antle MC, 2005, TRENDS NEUROSCI, V28, P145, DOI 10.1016/j.tins.2005.01.003; Ashwood V, 1998, BIOORG MED CHEM LETT, V8, P2589, DOI 10.1016/S0960-894X(98)00462-4; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Beaule C, 2001, NEUROSCIENCE, V106, P249, DOI 10.1016/S0306-4522(01)00313-X; Beaule C, 2009, J BIOL RHYTHM, V24, P126, DOI 10.1177/0748730409332037; Bora A, 2008, J PROTEOME RES, V7, P4992, DOI 10.1021/pr800394e; Bradbury MJ, 1997, BRAIN RES, V768, P125, DOI 10.1016/S0006-8993(97)00629-X; CARD JP, 1984, NEUROSCIENCE, V13, P415, DOI 10.1016/0306-4522(84)90240-9; Cassone VM, 1988, J BIOL RHYTHM, V3, P71, DOI 10.1177/074873048800300106; Davidson Alec J, 2003, Novartis Found Symp, V253, P110; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Edelstein K, 2000, BRAIN RES, V870, P54, DOI 10.1016/S0006-8993(00)02401-X; EDGAR DM, 1993, J BIOL RHYTHM, V8, P17, DOI 10.1177/074873049300800102; Edgar DM, 1997, AM J PHYSIOL-REG I, V273, pR265, DOI 10.1152/ajpregu.1997.273.1.R265; Fricker LD, 2000, J NEUROSCI, V20, P639, DOI 10.1523/JNEUROSCI.20-02-00639.2000; GILLETTE MU, 1995, CIBA F SYMP, V183, P134; Gillette MU, 2005, SCIENCE, V309, P1196, DOI 10.1126/science.1111420; GILLETTE MU, 1986, BRAIN RES, V379, P176, DOI 10.1016/0006-8993(86)90273-8; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Gouraud SS, 2007, ENDOCRINOLOGY, V148, P3041, DOI 10.1210/en.2007-0181; Hannibal J, 2002, ANN MED, V34, P401, DOI 10.1080/078538902320772151; Hannibal J, 1997, J NEUROSCI, V17, P2637, DOI 10.1523/jneurosci.17-07-02637.1997; Harmar AJ, 2003, J NEUROENDOCRINOL, V15, P335, DOI 10.1046/j.1365-2826.2003.01005.x; Hatcher NG, 2008, P NATL ACAD SCI USA, V105, P12527, DOI 10.1073/pnas.0804340105; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Isobe Y, 1996, BRAIN RES BULL, V40, P287, DOI 10.1016/0361-9230(96)00023-8; Jobst EE, 2002, EUR J NEUROSCI, V16, P2469, DOI 10.1046/j.1460-9568.2002.02309.x; Kallingal GJ, 2006, EUR J NEUROSCI, V24, P2853, DOI 10.1111/j.1460-9568.2006.05165.x; Karatsoreos IN, 2007, ENDOCRINOLOGY, V148, P5487, DOI 10.1210/en.2007-0775; Karatsoreos IN, 2004, J NEUROSCI, V24, P68, DOI 10.1523/JNEUROSCI.1666-03.2004; Kawamoto K, 2003, J NEUROSCI RES, V74, P852, DOI 10.1002/jnr.10751; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; Lee JE, 2010, MOL CELL PROTEOMICS, V9, P285, DOI 10.1074/mcp.M900362-MCP200; McArthur AJ, 2000, J NEUROSCI, V20, P5496, DOI 10.1523/JNEUROSCI.20-14-05496.2000; MEDANIC M, 1992, J PHYSIOL-LONDON, V450, P629, DOI 10.1113/jphysiol.1992.sp019147; Mintz EM, 1999, J NEUROSCI, V19, P5124; Moody TW, 2006, J MOL NEUROSCI, V28, P231, DOI 10.1385/JMN:28:3:231; Morgan DJ, 2010, J NEUROCHEM; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; Morin LP, 2007, J BIOL RHYTHM, V22, P3, DOI 10.1177/0748730406296749; Morin LP, 2006, NEUROSCIENCE, V137, P1285, DOI 10.1016/j.neuroscience.2005.10.030; Mzhavia N, 2001, J BIOL CHEM, V276, P6207, DOI 10.1074/jbc.M009067200; Nielsen HS, 2002, EUR J NEUROSCI, V15, P570, DOI 10.1046/j.0953-816x.2001.01882.x; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; PANDOL SJ, 1986, AM J PHYSIOL, V250, pG553, DOI 10.1152/ajpgi.1986.250.4.G553; PROSSER RA, 1989, J NEUROSCI, V9, P1073; Reed HE, 2001, EUR J NEUROSCI, V13, P839, DOI 10.1046/j.0953-816x.2000.01437.x; Romanova EV, 2008, ANAL CHEM, V80, P3379, DOI 10.1021/ac7026047; Romijn HJ, 1997, EUR J NEUROSCI, V9, P2613, DOI 10.1111/j.1460-9568.1997.tb01691.x; Romijn HJ, 1998, J COMP NEUROL, V391, P397; Romijn HJ, 1996, J COMP NEUROL, V372, P1; Silver R, 1996, NEUROREPORT, V7, P1224, DOI 10.1097/00001756-199604260-00026; Stamp JA, 1997, BRAIN RES, V756, P215, DOI 10.1016/S0006-8993(97)00199-6; Tanaka M, 1997, J HISTOCHEM CYTOCHEM, V45, P1231, DOI 10.1177/002215549704500906; Tischkau SA, 2004, NEURON, V43, P539, DOI 10.1016/j.neuron.2004.07.027; VANDENPOL AN, 1980, J COMP NEUROL, V191, P661, DOI 10.1002/cne.901910410; WEICK RF, 1995, NEUROSCI BIOBEHAV R, V19, P251, DOI 10.1016/0149-7634(94)00057-8; WEICK RF, 1992, NEUROENDOCRINOLOGY, V56, P646, DOI 10.1159/000126288; Yan L, 2007, COLD SPRING HARB SYM, V72, P527, DOI 10.1101/sqb.2007.72.037	64	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12612	10.1371/journal.pone.0012612	http://dx.doi.org/10.1371/journal.pone.0012612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830308	gold, Green Published			2022-12-27	WOS:000281631300033
J	Das, J; Ghosh, J; Manna, P; Sil, PC				Das, Joydeep; Ghosh, Jyotirmoy; Manna, Prasenjit; Sil, Parames C.			Protective Role of Taurine against Arsenic-Induced Mitochondria-Dependent Hepatic Apoptosis via the Inhibition of PKC delta-JNK Pathway	PLOS ONE			English	Article							OXIDATIVE RENAL DYSFUNCTION; KINASE-C-DELTA; DRINKING-WATER; CELL-DEATH; PROTEIN; STRESS; TOXICITY; GLUTATHIONE; MICE; HEPATOTOXICITY	Background: Oxidative stress-mediated hepatotoxic effect of arsenic (As) is mainly due to the depletion of glutathione (GSH) in liver. Taurine, on the other hand, enhances intracellular production of GSH. Little is known about the mechanism of the beneficial role of taurine in As-induced hepatic pathophysiology. Therefore, in the present study we investigated its beneficial role in As-induced hepatic cell death via mitochondria-mediated pathway. Methodology/Principal Findings: Rats were exposed to NaAsO2 (2 mg/kg body weight for 6 months) and the hepatic tissue was used for oxidative stress measurements. In addition, the pathophysiologic effect of NaAsO2 (10 mu M) on hepatocytes was evaluated by determining cell viability, mitochondrial membrane potential and ROS generation. As caused mitochondrial injury by increased oxidative stress and reciprocal regulation of Bcl-2, Bcl-xL/Bad, Bax, Bim in association with increased level of Apaf-1, activation of caspase 9/3, cleavage of PARP protein and ultimately led to apoptotic cell death. In addition, As markedly increased JNK and p38 phosphorylation with minimal disturbance of ERK. Pre-exposure of hepatocytes to a JNK inhibitor SP600125 prevented As-induced caspase-3 activation, ROS production and loss in cell viability. Pre-exposure of hepatocytes to a p38 inhibitor SB2035, on the other hand, had practically no effect on these events. Besides, As activated PKC delta and pre-treatment of hepatocytes with its inhibitor, rottlerin, suppressed the activation of JNK indicating that PKC delta is involved in As-induced JNK activation and mitochondrial dependent apoptosis. Oral administration of taurine (50 mg/kg body weight for 2 weeks) both pre and post to NaAsO2 exposure or incubation of the hepatocytes with taurine (25 mM) were found to be effective in counteracting As-induced oxidative stress and apoptosis. Conclusions/Significance: Results indicate that taurine treatment improved As-induced hepatic damages by inhibiting PKC delta-JNK signalling pathways. Therefore taurine supplementation could provide a new approach for the reduction of hepatic complication due to arsenic poisoning.	[Das, Joydeep; Ghosh, Jyotirmoy; Manna, Prasenjit; Sil, Parames C.] Bose Inst, Div Mol Med, Kolkata, India	Department of Science & Technology (India); Bose Institute	Das, J (corresponding author), Bose Inst, Div Mol Med, Kolkata, India.	parames@bosemain.boseinst.ac.in	Das, Joydeep/AAE-3501-2021; Das, Joydeep/AAO-4770-2021	Manna, Prasenjit/0000-0003-1952-6531	Bose Institute	Bose Institute(Department of Science & Technology (India))	The work was supported by Bose Institute Internal Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aposhian HV, 1997, ANNU REV PHARMACOL, V37, P397, DOI 10.1146/annurev.pharmtox.37.1.397; BONAVENTURA J, 1972, ARCH BIOCHEM BIOPHYS, V150, P606, DOI 10.1016/0003-9861(72)90080-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carter DE, 2003, TOXICOL APPL PHARM, V193, P309, DOI 10.1016/j.taap.2003.07.009; Chang SI, 2007, TOXICOL APPL PHARM, V218, P196, DOI 10.1016/j.taap.2006.11.009; Chen C, 2008, J BIOL CHEM, V283, P4543, DOI 10.1074/jbc.M706299200; DAS D, 1995, ANALYST, V120, P917, DOI 10.1039/an9952000917; Das J, 2010, TOXICOLOGY, V269, P24, DOI 10.1016/j.tox.2010.01.003; Das J, 2010, FREE RADICAL RES, V44, P340, DOI 10.3109/10715760903513017; Das J, 2009, TOXICOL LETT, V187, P201, DOI 10.1016/j.toxlet.2009.03.001; Das Joydeep, 2008, Pathophysiology, V15, P181, DOI 10.1016/j.pathophys.2008.06.002; Das J, 2009, DRUG CHEM TOXICOL, V32, P93, DOI 10.1080/01480540802564171; Das S, 2005, TOXICOL APPL PHARM, V204, P18, DOI 10.1016/j.taap.2004.08.010; Dogru-Abbasoglu S, 2001, HUM EXP TOXICOL, V20, P23, DOI 10.1191/096032701673031525; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V70, P82; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Flora SJS, 2008, OXID MED CELL LONGEV, V1, P39, DOI 10.4161/oxim.1.1.6481; Flora SJS, 2009, CHEM-BIOL INTERACT, V177, P227, DOI 10.1016/j.cbi.2008.08.017; Ghosh J, 2008, TOXICOL IN VITRO, V22, P1918, DOI 10.1016/j.tiv.2008.09.010; Ghosh J, 2010, FOOD CHEM, V123, P1062, DOI 10.1016/j.foodchem.2010.05.062; Ghosh J, 2010, FREE RADICAL BIO MED, V48, P535, DOI 10.1016/j.freeradbiomed.2009.11.023; Ghosh J, 2009, TOXICOL APPL PHARM, V240, P73, DOI 10.1016/j.taap.2009.07.008; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hagar HH, 2004, TOXICOL LETT, V151, P335, DOI 10.1016/j.toxlet.2004.03.002; Hayes J, 2001, BRAIN RES BULL, V55, P239, DOI 10.1016/S0361-9230(01)00507-X; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; HODARNAU A, 1973, J CELL BIOL, V59, P222, DOI 10.1083/jcb.59.1.222; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; KALBHEN DA, 1967, Z KLIN CHEM KLIN BIO, V5, P299; KIND PRN, 1954, J CLIN PATHOL, V7, P322, DOI 10.1136/jcp.7.4.322; Kitchin KT, 2001, TOXICOL APPL PHARM, V172, P249, DOI 10.1006/taap.2001.9157; LEE CY, 1982, METHOD ENZYMOL, V89, P252; Madesh M, 1997, INDIAN J BIOCHEM BIO, V34, P535; Maioli E, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/742936; Majumder PK, 2001, CELL GROWTH DIFFER, V12, P465; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Manna P, 2009, AMINO ACIDS, V36, P417, DOI 10.1007/s00726-008-0094-x; Mingatto FE, 2002, J PHARMACOL EXP THER, V303, P601, DOI 10.1124/jpet.102.038620; Nardi N, 1997, J NEUROCHEM, V68, P750; NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3; Niwa K, 2002, FREE RADICAL RES, V36, P1147, DOI 10.1080/1071576021000016409; Okuno S, 2004, J NEUROSCI, V24, P7879, DOI 10.1523/JNEUROSCI.1745-04.2004; Pi JB, 2002, ENVIRON HEALTH PERSP, V110, P331, DOI 10.1289/ehp.02110331; Powell CT, 1996, CELL GROWTH DIFFER, V7, P419; Qu W, 2002, CARCINOGENESIS, V23, P151, DOI 10.1093/carcin/23.1.151; Ratnaike RN, 2003, POSTGRAD MED J, V79, P391, DOI 10.1136/pmj.79.933.391; REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Roy A, 2009, FREE RADICAL RES, V43, P995, DOI 10.1080/10715760903164998; Ruvolo PP, 1998, J BIOL CHEM, V273, P25436, DOI 10.1074/jbc.273.39.25436; Santra A, 2000, Indian J Gastroenterol, V19, P112; Sarkar K, 2006, TOXICOL IN VITRO, V20, P634, DOI 10.1016/j.tiv.2005.11.003; Schaffer S, 2003, ADV EXP MED BIOL, V526, P307; SELLINS KS, 1987, J IMMUNOL, V139, P3199; SMITH IK, 1988, ANAL BIOCHEM, V175, P408, DOI 10.1016/0003-2697(88)90564-7; States JC, 2002, TOXICOL APPL PHARM, V180, P83, DOI 10.1006/taap.2002.9376; Tabassum H, 2006, CLIN CHIM ACTA, V370, P129, DOI 10.1016/j.cca.2006.02.006; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamauchi H, 2004, TOXICOL APPL PHARM, V198, P291, DOI 10.1016/j.taap.2003.10.021; Zhao X, 1997, J BIOL CHEM, V272, P22751, DOI 10.1074/jbc.272.36.22751	64	74	83	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12602	10.1371/journal.pone.0012602	http://dx.doi.org/10.1371/journal.pone.0012602			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830294	Green Published, Green Submitted, gold			2022-12-27	WOS:000281631300026
J	Liao, CY; Gock, A; Michie, M; Morton, B; Anderson, A; Trowell, S				Liao, Chunyan; Gock, Andrew; Michie, Michelle; Morton, Bethany; Anderson, Alisha; Trowell, Stephen			Behavioural and Genetic Evidence for C. elegans' Ability to Detect Volatile Chemicals Associated with Explosives	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNEL; CAENORHABDITIS-ELEGANS; CHEMOSENSORY BEHAVIORS; OLFACTORY ADAPTATION; ALPHA-SUBUNITS; PROTEIN; RECEPTOR; ENCODES; NEURONS; PHOSPHORYLATION	Background: Automated standoff detection and classification of explosives based on their characteristic vapours would be highly desirable. Biologically derived odorant receptors have potential as the explosive recognition element in novel biosensors. Caenorhabditis elegans' genome contains over 1,000 uncharacterised candidate chemosensory receptors. It was not known whether any of these respond to volatile chemicals derived from or associated with explosives. Methodology/Principal Findings: We assayed C. elegans for chemotactic responses to chemical vapours of explosives and compounds associated with explosives. C. elegans failed to respond to many of the explosive materials themselves but showed strong chemotaxis with a number of compounds associated with commercial or homemade explosives. Genetic mutant strains were used to identify the likely neuronal location of a putative receptor responding to cyclohexanone, which is a contaminant of some compounded explosives, and to identify the specific transduction pathway involved. Upper limits on the sensitivity of the nematode were calculated. A sensory adaptation protocol was used to estimate the receptive range of the receptor. Conclusions/Significance:: The results suggest that C. elegans may be a convenient source of highly sensitive, narrowly tuned receptors to detect a range of explosive-associated volatiles.	[Liao, Chunyan] CSIRO Entomol, Canberra, ACT, Australia; CSIRO Food Futures Flagship, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Liao, CY (corresponding author), CSIRO Entomol, Canberra, ACT, Australia.	Stephen.Trowell@csiro.au	Trowell, Stephen/AAG-8943-2019; Trowell, Stephen C/B-8043-2008; Anderson, Alisha R/C-1499-2008; Anderson, Alisha/AAC-3505-2021	Trowell, Stephen C/0000-0002-0505-8741; Anderson, Alisha R/0000-0001-7013-116X; Anderson, Alisha/0000-0001-7013-116X	Australian Government's National Security Science and Technology Unit and Emergency Management Australia; CSIRO	Australian Government's National Security Science and Technology Unit and Emergency Management Australia(Australian Government); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This study was jointly funded by a competitive grant from the Australian Government's National Security Science and Technology Unit and Emergency Management Australia. It was co-funded by CSIRO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, except that the funding agencies reviewed the manuscript prior to publication solely to ensure that it did not disclose security-sensitive information.	Anderson AR, 2009, INSECT BIOCHEM MOLEC, V39, P189, DOI 10.1016/j.ibmb.2008.11.002; Bargmann C. I., 1997, C ELEGANS, P717; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Berna AZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006406; Bernhard N, 2000, LEARN MEMORY, V7, P199, DOI 10.1101/lm.7.4.199; Birnby DA, 2000, GENETICS, V155, P85; BRENNER S, 1974, GENETICS, V77, P71; BROWN NG, 1992, EUR J BIOCHEM, V208, P659, DOI 10.1111/j.1432-1033.1992.tb17232.x; Chou JH, 2001, GENETICS, V157, P211; Chou JH, 1996, COLD SPRING HARB SYM, V61, P157; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Colbert HA, 1997, J NEUROSCI, V17, P8259; DEAN KR, 1993, EUR J BIOCHEM, V213, P881, DOI 10.1111/j.1432-1033.1993.tb17832.x; Frokjaer-Jensen C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002467; Gardner JW, 2004, NATO SCI SER II MATH, V159, P1; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Harper RJ, 2005, TALANTA, V67, P313, DOI 10.1016/j.talanta.2005.05.019; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; Katz B, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.002.2009; Kiely A, 2007, J NEUROSCI METH, V159, P189, DOI 10.1016/j.jneumeth.2006.07.005; Koga M, 2004, J MOL BIOL, V336, P579, DOI 10.1016/j.jmb.2003.12.037; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; L'Etoile ND, 2002, NEURON, V36, P1079, DOI 10.1016/S0896-6273(02)01066-8; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lanjuin A, 2003, DEV CELL, V5, P621, DOI 10.1016/S1534-5807(03)00293-4; Lans H, 2004, GENETICS, V167, P1677, DOI 10.1534/genetics.103.024786; LOCHRIE MA, 1991, CELL REGUL, V2, P135, DOI 10.1091/mbc.2.2.135; Marshall B, 2010, CHEM SENSES, V35, P613, DOI 10.1093/chemse/bjq050; Melkman T, 2004, DEV BIOL, V265, P302, DOI 10.1016/j.ydbio.2003.07.005; Mukhopadhyay S, 2008, DEV CELL, V14, P762, DOI 10.1016/j.devcel.2008.03.002; *NAT RES COUNC, 2003, 1 NAT RES COUNC, pR21; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; PERETZ A, 1994, J GEN PHYSIOL, V104, P1057, DOI 10.1085/jgp.104.6.1057; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; Radhika V, 2007, NAT CHEM BIOL, V3, P325, DOI 10.1038/nchembio882; Rains GC, 2008, TRENDS BIOTECHNOL, V26, P288, DOI 10.1016/j.tibtech.2008.02.007; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Robertson HM, 1998, GENOME RES, V8, P449, DOI 10.1101/gr.8.5.449; Robertson HM, 2001, CHEM SENSES, V26, P151, DOI 10.1093/chemse/26.2.151; SENGUPTA P, 1993, CIBA F SYMP, V179, P235; SENGUPTA P, 1994, CELL, V79, P971, DOI 10.1016/0092-8674(94)90028-0; Sengupta P, 2007, PFLUG ARCH EUR J PHY, V454, P721, DOI 10.1007/s00424-006-0196-9; Smith RG, 2008, ANALYST, V133, P571, DOI 10.1039/b717933m; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Uchida O, 2003, DEVELOPMENT, V130, P1215, DOI 10.1242/dev.00341; Williams M, 2002, APPL ANIM BEHAV SCI, V78, P55, DOI 10.1016/S0168-1591(02)00081-3; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P12162, DOI 10.1073/pnas.94.22.12162; ZWAAL RR, 1993, P NATL ACAD SCI USA, V90, P7431, DOI 10.1073/pnas.90.16.7431	51	8	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12615	10.1371/journal.pone.0012615	http://dx.doi.org/10.1371/journal.pone.0012615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830309	Green Published, gold			2022-12-27	WOS:000281631300035
J	White, JF; Grisshammer, R				White, Jim F.; Grisshammer, Reinhard			Stability of the Neurotensin Receptor NTS1 Free in Detergent Solution and Immobilized to Affinity Resin	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; LARGE-SCALE PURIFICATION; HIGH-LEVEL EXPRESSION; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; BINDING-SITE; STRUCTURAL INSTABILITY; BOVINE RHODOPSIN; CRYSTALLIZATION; ACTIVATION	Background: Purification of recombinant membrane receptors is commonly achieved by use of an affinity tag followed by an additional chromatography step if required. This second step may exploit specific receptor properties such as ligand binding. However, the effects of multiple purification steps on protein yield and integrity are often poorly documented. We have previously reported a robust two-step purification procedure for the recombinant rat neurotensin receptor NTS1 to give milligram quantities of functional receptor protein. First, histidine-tagged receptors are enriched by immobilized metal affinity chromatography using Ni-NTA resin. Second, remaining contaminants in the Ni-NTA column eluate are removed by use of a subsequent neurotensin column yielding pure NTS1. Whilst the neurotensin column eluate contained functional receptor protein, we observed in the neurotensin column flow-through misfolded NTS1. Methods and Findings: To investigate the origin of the misfolded receptors, we estimated the amount of functional and misfolded NTS1 at each purification step by radio-ligand binding, densitometry of Coomassie stained SDS-gels, and protein content determination. First, we observed that correctly folded NTS1 suffers damage by exposure to detergent and various buffer compositions as seen by the loss of [3 H] neurotensin binding over time. Second, exposure to the neurotensin affinity resin generated additional misfolded receptor protein. Conclusion: Our data point towards two ways by which misfolded NTS1 may be generated: Damage by exposure to buffer components and by close contact of the receptor to the neurotensin affinity resin. Because NTS1 in detergent solution is stabilized by neurotensin, we speculate that the occurrence of aggregated receptor after contact with the neurotensin resin is the consequence of perturbations in the detergent belt surrounding the NTS1 transmembrane core. Both effects reduce the yield of functional receptor protein.	[White, Jim F.; Grisshammer, Reinhard] NINDS, NIH, US Dept HHS, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	White, JF (corresponding author), NINDS, NIH, US Dept HHS, Rockville, MD USA.	rkgriss@helix.nih.gov	Grisshammer, Reinhard/C-3089-2015		NIH, National Institute of Neurological Disorders and Stroke	NIH, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The research of JFW and RG was supported by the Intramural Research Program of the NIH, National Institute of Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alewijnse AE, 2000, MOL PHARMACOL, V57, P890; Barroso S, 2000, J BIOL CHEM, V275, P328, DOI 10.1074/jbc.275.1.328; Chelikani P, 2006, PROTEIN SCI, V15, P1433, DOI 10.1110/ps.062080006; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Grisshammer R, 1997, PROTEIN EXPRES PURIF, V11, P53, DOI 10.1006/prep.1997.0766; GRISSHAMMER R, 1993, BIOCHEM J, V295, P571, DOI 10.1042/bj2950571; GRISSHAMMER R, 1995, Q REV BIOPHYS, V28, P315, DOI 10.1017/S0033583500003504; Grisshammer R, 1999, BIOCHEM SOC T, V27, P899, DOI 10.1042/bst0270899; Grisshammer R, 2009, METHOD ENZYMOL, V463, P631, DOI 10.1016/S0076-6879(09)63036-6; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hulme Edward C., 1998, Biochemical Society Transactions, V26, pS361; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Kitabgi P, 2006, PEPTIDES, V27, P2461, DOI 10.1016/j.peptides.2006.02.013; Klaassen CHW, 1999, BIOCHEM J, V342, P293, DOI 10.1042/0264-6021:3420293; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Magnani F, 2008, P NATL ACAD SCI USA, V105, P10744, DOI 10.1073/pnas.0804396105; Martin S, 1999, MOL PHARMACOL, V55, P210, DOI 10.1124/mol.55.2.210; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Ohtaki T, 1998, J BIOL CHEM, V273, P15464, DOI 10.1074/jbc.273.25.15464; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Pang YP, 1996, J BIOL CHEM, V271, P15060, DOI 10.1074/jbc.271.25.15060; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; TANAKA K, 1990, NEURON, V4, P847, DOI 10.1016/0896-6273(90)90137-5; Tucker J, 1996, BIOCHEM J, V317, P891, DOI 10.1042/bj3170891; Warne T, 2003, BBA-BIOMEMBRANES, V1610, P133, DOI 10.1016/S0005-2736(02)00716-2; Warne T, 2009, PROTEIN EXPRES PURIF, V65, P204, DOI 10.1016/j.pep.2009.01.014; Weiss HM, 2002, EUR J BIOCHEM, V269, P82, DOI 10.1046/j.0014-2956.2002.02618.x; White JF, 2004, FEBS LETT, V564, P289, DOI 10.1016/S0014-5793(04)00195-4; WHITE JF, 2007, AUTOMATED LARGE SCAL; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Wilson MH, 2000, BIOCHEMISTRY-US, V39, P693, DOI 10.1021/bi9920275; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Yeliseev AA, 2005, PROTEIN SCI, V14, P2638, DOI 10.1110/ps.051550305	41	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12579	10.1371/journal.pone.0012579	http://dx.doi.org/10.1371/journal.pone.0012579			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830205	Green Submitted, gold, Green Published			2022-12-27	WOS:000281631300011
J	Wilkinson, A; Solan, M; Taylor, AFS; Alexander, IJ; Johnson, D				Wilkinson, Anna; Solan, Martin; Taylor, Andrew F. S.; Alexander, Ian J.; Johnson, David			Intraspecific Diversity Regulates Fungal Productivity and Respiration	PLOS ONE			English	Article							HEBELOMA-CYLINDROSPORUM; GENOTYPIC DIVERSITY; COMMUNITY STRUCTURE; GENETIC DIVERSITY; NITROGEN-SOURCES; ECTOMYCORRHIZAL; BIODIVERSITY; ECOSYSTEMS; ECOLOGY; SYMBIOSIS	Individuals and not just species are key components of biodiversity, yet the relationship between intraspecific diversity and ecosystem functioning in microbial systems remains largely untested. This limits our ability to understand and predict the effects of altered genetic diversity in regulating key ecosystem processes and functions. Here, we use a model fungal system to test the hypothesis that intraspecific genotypic richness of Paxillus obscurosporus stimulates biomass and CO(2) efflux, but that this is dependent on nitrogen supply. Using controlled experimental microcosms, we show that populations containing several genotypes (maximum 8) of the fungus had greater productivity and produced significantly more CO(2) than those with fewer genotypes. Moreover, intraspecific diversity had a much stronger effect than a four-fold manipulation of the carbon: nitrogen ratio of the growth medium. The effects of intraspecific diversity were underpinned by strong roles of individuals, but overall intraspecific diversity increased the propensity of populations to over-yield, indicating that both complementarity and selection effects can operate within species. Our data demonstrate the importance of intraspecific diversity over a range of nitrogen concentrations, and the need to consider fine scale phylogenetic information of microbial communities in understanding their contribution to ecosystem processes.	[Wilkinson, Anna; Alexander, Ian J.; Johnson, David] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Solan, Martin] Univ Aberdeen, Oceanlab, Newburgh, Scotland; [Taylor, Andrew F. S.] Macaulay Land Use Res Inst, Aberdeen AB9 2QJ, Scotland	University of Aberdeen; University of Aberdeen; James Hutton Institute	Wilkinson, A (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.	d.johnson@abdn.ac.uk	Johnson, David/N-3193-2013; Solan, Martin/E-9338-2012	Solan, Martin/0000-0001-9924-5574; Johnson, David/0000-0003-2299-2525	Natural Environment Research Council [NE/F006543/1]; Scottish Government Rural and Environment Research and Analysis Directorate (RERAD)	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Scottish Government Rural and Environment Research and Analysis Directorate (RERAD)	AW was supported by a studentship (NE/F006543/1) funded by the Natural Environment Research Council. AFST receives funding from the Scottish Government Rural and Environment Research and Analysis Directorate (RERAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Bailey JK, 2009, PHILOS T R SOC B, V364, P1607, DOI 10.1098/rstb.2008.0336; Bangert RK, 2005, CONSERV BIOL, V19, P379, DOI 10.1111/j.1523-1739.2005.00450.x; Baxter JW, 2001, NEW PHYTOL, V152, P139, DOI 10.1046/j.0028-646x.2001.00245.x; Bulling M, 2008, OECOLOGIA, V158, P511, DOI 10.1007/s00442-008-1160-5; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Crutsinger GM, 2008, ECOL LETT, V11, P16, DOI 10.1111/j.1461-0248.2007.01118.x; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Driebe EM, 2000, OECOLOGIA, V123, P99, DOI 10.1007/s004420050994; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; FINLAY RD, 1992, NEW PHYTOL, V120, P105, DOI 10.1111/j.1469-8137.1992.tb01063.x; Fitter AH, 2005, J ECOL, V93, P231, DOI 10.1111/j.0022-0477.2005.00990.x; Fransson PMA, 2007, FEMS MICROBIOL ECOL, V61, P246, DOI 10.1111/j.1574-6941.2007.00343.x; GAY G, 1993, NEW PHYTOL, V123, P335, DOI 10.1111/j.1469-8137.1993.tb03743.x; Godbold JA, 2009, OIKOS, V118, P77, DOI 10.1111/j.1600-0706.2008.17072.x; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; Gryta H, 1997, MOL ECOL, V6, P353, DOI 10.1046/j.1365-294X.1997.00200.x; Guidot A, 2005, MYCORRHIZA, V15, P167, DOI 10.1007/s00572-004-0318-1; Guidot A, 1999, APPL ENVIRON MICROB, V65, P903; Hedh J, 2009, MYCORRHIZA, V19, P549, DOI 10.1007/s00572-009-0252-3; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Ishida TA, 2007, NEW PHYTOL, V174, P430, DOI 10.1111/j.1469-8137.2007.02016.x; Jonsson LM, 2001, OIKOS, V93, P353, DOI 10.1034/j.1600-0706.2001.930301.x; Korkama T, 2006, NEW PHYTOL, V171, P815, DOI 10.1111/j.1469-8137.2006.01786.x; Langenheder S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010834; Lian CL, 2006, NEW PHYTOL, V171, P825, DOI 10.1111/j.1469-8137.2006.01801.x; Lilleskov EA, 2002, ECOLOGY, V83, P104, DOI 10.1890/0012-9658(2002)083[0104:BEFCCO]2.0.CO;2; Loreau M, 1998, OIKOS, V82, P600, DOI 10.2307/3546381; Malik M, 1999, STRUCTURE DYNAMICS F; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; MARX DH, 1969, PHYTOPATHOLOGY, V59, P153; Pickles BJ, 2010, NEW PHYTOL, V186, P755, DOI 10.1111/j.1469-8137.2010.03204.x; Piculell BJ, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-23; Pinheiro J., 2006, NLME R PACKAGE FITTI; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Sawyer NA, 2003, MYCORRHIZA, V13, P217, DOI 10.1007/s00572-003-0229-6; Tiunov AV, 2005, ECOL LETT, V8, P618, DOI 10.1111/j.1461-0248.2005.00757.x; Trenbath B. R., 1974, Advances in Agronomy, V26, P177, DOI 10.1016/S0065-2113(08)60871-8; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; West B. T., 2007, LINEAR MIXED MODELS	44	27	28	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12604	10.1371/journal.pone.0012604	http://dx.doi.org/10.1371/journal.pone.0012604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830299	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000281631300027
J	Yao, Z; Yoon, S; Kalie, E; Raviv, Z; Seger, R				Yao, Zhong; Yoon, Seunghee; Kalie, Eyal; Raviv, Ziv; Seger, Rony			Calcium Regulation of EGF-Induced ERK5 Activation: Role of Lad1-MEKK2 Interaction	PLOS ONE			English	Article							KINASE 1 BMK1; PROTEIN-KINASE; ADAPTER PROTEIN; TRANSCRIPTIONAL ACTIVATION; TYROSINE KINASES; GROWTH-FACTOR; C-FOS; MEK5; SURVIVAL; GENE	The ERK5 cascade is a MAPK pathway that transmits both mitogenic and stress signals, yet its mechanism of activation is not fully understood. Using intracellular calcium modifiers, we found that ERK5 activation by EGF is inhibited both by the depletion and elevation of intracellular calcium levels. This calcium effect was found to occur upstream of MEKK2, which is the MAP3K of the ERK5 cascade. Co-immunoprecipitation revealed that EGF increases MEKK2 binding to the adaptor protein Lad1, and this interaction was reduced by the intracellular calcium modifiers, indicating that a proper calcium concentration is required for the interactions and transmission of EGF signals to ERK5. In vitro binding assays revealed that the proper calcium concentration is required for a direct binding of MEKK2 to Lad1. The binding of these proteins is not affected by c-Src-mediated phosphorylation on Lad1, but slightly affects the Tyr phosphorylation of MEKK2, suggesting that the interaction with Lad1 is necessary for full Tyr phosphorylation of MEKK2. In addition, we found that changes in calcium levels affect the EGF-induced nuclear translocation of MEKK2 and thereby its effect on the nuclear ERK5 activity. Taken together, these findings suggest that calcium is required for EGF-induced ERK5 activation, and this effect is probably mediated by securing proper interaction of MEKK2 with the upstream adaptor protein Lad1.	[Yao, Zhong; Yoon, Seunghee; Kalie, Eyal; Raviv, Ziv; Seger, Rony] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Yao, Z (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	rony.seger@weizmann.ac.il			Israel Academy of Sciences; European Community [IST-2004-027265-SIMAP, LSHC-CT-2006-037731-GROWTHSTOP]	Israel Academy of Sciences; European Community(European Commission)	This work was supported by grants from the Israel Academy of Sciences and from the European Community's Sixth Framework Program projects IST-2004-027265-SIMAP and LSHC-CT-2006-037731-GROWTHSTOP. R.S. is an incumbent of the Yale Lewine and Ella Miller Lewine professorial chair for cancer research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 1997, J BIOL CHEM, V272, P20389, DOI 10.1074/jbc.272.33.20389; Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Akaike M, 2004, MOL CELL BIOL, V24, P8691, DOI 10.1128/MCB.24.19.8691-8704.2004; Arnoux V, 2008, MOL BIOL CELL, V19, P4738, DOI 10.1091/mbc.E07-10-1078; Barros JC, 2005, J CELL SCI, V118, P1663, DOI 10.1242/jcs.02308; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Montero JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005565; Carter EJ, 2009, J CELL SCI, V122, P3104, DOI 10.1242/jcs.045757; Chao TH, 1999, J BIOL CHEM, V274, P36035, DOI 10.1074/jbc.274.51.36035; Choi YB, 1999, J IMMUNOL, V163, P5242; Chuderland D, 2008, J BIOL CHEM, V283, P11176, DOI 10.1074/jbc.M709030200; Chuderland Dana, 2008, Commun Integr Biol, V1, P4; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cude K, 2007, J CELL BIOL, V177, P253, DOI 10.1083/jcb.200609166; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; Dinev D, 2001, EMBO REP, V2, P829, DOI 10.1093/embo-reports/kve177; English JM, 1998, J BIOL CHEM, V273, P3854, DOI 10.1074/jbc.273.7.3854; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Garcia-Hoz C, 2010, J BIOL CHEM, V285, P13480, DOI 10.1074/jbc.M109.098699; Garrington TP, 2000, EMBO J, V19, P5387, DOI 10.1093/emboj/19.20.5387; Ginnan R, 2002, AM J PHYSIOL-CELL PH, V282, pC754, DOI 10.1152/ajpcell.00335.2001; Girio A, 2007, CELL SIGNAL, V19, P1964, DOI 10.1016/j.cellsig.2007.05.005; Horbinski C, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-2; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kasler HG, 2000, MOL CELL BIOL, V20, P8382, DOI 10.1128/MCB.20.22.8382-8389.2000; Kato Y, 2000, J BIOL CHEM, V275, P18534, DOI 10.1074/jbc.M001573200; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Kondoh K, 2006, MOL CELL BIOL, V26, P1679, DOI 10.1128/MCB.26.5.1679-1690.2006; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; Liu LD, 2006, P NATL ACAD SCI USA, V103, P9697, DOI 10.1073/pnas.0603373103; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; Morimoto H, 2007, J BIOL CHEM, V282, P35449, DOI 10.1074/jbc.M704079200; Nakamura K, 2003, J BIOL CHEM, V278, P36989, DOI 10.1074/jbc.C300313200; Nicol RL, 2001, EMBO J, V20, P2757, DOI 10.1093/emboj/20.11.2757; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Park MK, 2000, EMBO J, V19, P5729, DOI 10.1093/emboj/19.21.5729; Pearson G, 2001, J BIOL CHEM, V276, P7927, DOI 10.1074/jbc.M009764200; Raviv Z, 2004, J CELL SCI, V117, P1773, DOI 10.1242/jcs.01040; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; Schramp M, 2008, J CELL BIOL, V181, P1195, DOI 10.1083/jcb.200801078; Sohn SJ, 2002, J BIOL CHEM, V277, P43344, DOI 10.1074/jbc.M207573200; Spiering D, 2009, J BIOL CHEM, V284, P24972, DOI 10.1074/jbc.M109.042911; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Sun WY, 2003, MOL CELL BIOL, V23, P2298, DOI 10.1128/MCB.23.7.2298-2308.2003; Sun WY, 2001, J BIOL CHEM, V276, P5093, DOI 10.1074/jbc.M003719200; Terasawa K, 2003, GENES CELLS, V8, P263, DOI 10.1046/j.1365-2443.2003.00631.x; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; TOROK K, 2007, SCI STKE; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Wang X, 2007, MOL CELL BIOL, V27, P7935, DOI 10.1128/MCB.00226-07; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Woo CH, 2006, J BIOL CHEM, V281, P32164, DOI 10.1074/jbc.M602369200; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Yan C, 1999, J BIOL CHEM, V274, P143, DOI 10.1074/jbc.274.1.143; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	59	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12627	10.1371/journal.pone.0012627	http://dx.doi.org/10.1371/journal.pone.0012627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830310	gold, Green Submitted, Green Published			2022-12-27	WOS:000281631300044
J	Davidson, MR; Larsen, JE; Yang, IA; Hayward, NK; Clarke, BE; Duhig, EE; Passmore, LH; Bowman, RV; Fong, KM				Davidson, Morgan R.; Larsen, Jill E.; Yang, Ian A.; Hayward, Nicholas K.; Clarke, Belinda E.; Duhig, Edwina E.; Passmore, Linda H.; Bowman, Rayleen V.; Fong, Kwun M.			MicroRNA-218 Is Deleted and Downregulated in Lung Squamous Cell Carcinoma	PLOS ONE			English	Article							SRC-FAMILY KINASES; CHROMOSOMAL-ABERRATIONS; EXPRESSION SIGNATURE; COLORECTAL-CANCER; GENOMIC MAPS; GENES; AMPLIFICATION; PROSTATE; TARGET; RNA	MicroRNAs (miRNAs) are a family of small, non-coding RNA species functioning as negative regulators of multiple target genes including tumour suppressor genes and oncogenes. Many miRNA gene loci are located within cancer-associated genomic regions. To identify potential new amplified oncogenic and/or deleted tumour suppressing miRNAs in lung cancer, we inferred miRNA gene dosage from high dimensional arrayCGH data. From miRBase v9.0 (http://microrna.sanger.ac.uk), 474 human miRNA genes were physically mapped to regions of chromosomal loss or gain identified from a high-resolution genome-wide arrayCGH study of 132 primary non-small cell lung cancers (NSCLCs) (a training set of 60 squamous cell carcinomas and 72 adenocarcinomas). MiRNAs were selected as candidates if their immediately flanking probes or host gene were deleted or amplified in at least 25% of primary tumours using both Analysis of Copy Errors algorithm and fold change (>=+/- 1.2) analyses. Using these criteria, 97 miRNAs mapped to regions of aberrant copy number. Analysis of three independent published lung cancer arrayCGH datasets confirmed that 22 of these miRNA loci showed directionally concordant copy number variation. MiR-218, encoded on 4p15.31 and 5q35.1 within two host genes (SLIT2 and SLIT3), in a region of copy number loss, was selected as a priority candidate for follow-up as it is reported as underexpressed in lung cancer. We confirmed decreased expression of mature miR-218 and its host genes by qRT-PCR in 39 NSCLCs relative to normal lung tissue. This downregulation of miR-218 was found to be associated with a history of cigarette smoking, but not human papilloma virus. Thus, we show for the first time that putative lung cancer-associated miRNAs can be identified from genome-wide arrayCGH datasets using a bioinformatics mapping approach, and report that miR-218 is a strong candidate tumour suppressing miRNA potentially involved in lung cancer.	[Davidson, Morgan R.; Larsen, Jill E.; Yang, Ian A.; Passmore, Linda H.; Bowman, Rayleen V.; Fong, Kwun M.] Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld 4032, Australia; [Davidson, Morgan R.; Larsen, Jill E.; Yang, Ian A.; Clarke, Belinda E.; Bowman, Rayleen V.; Fong, Kwun M.] Univ Queensland, Discipline Med, Brisbane, Qld, Australia; [Hayward, Nicholas K.] Queensland Inst Med Res, Oncogenom Lab, Brisbane, Qld 4006, Australia; [Clarke, Belinda E.; Duhig, Edwina E.] Prince Charles Hosp, Dept Anat Pathol, Brisbane, Qld 4032, Australia	Prince Charles Hospital; University of Queensland; QIMR Berghofer Medical Research Institute; Prince Charles Hospital	Davidson, MR (corresponding author), Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld 4032, Australia.	morgan.davidson@uqconnect.edu.au	hayward, nick/AAV-8802-2020; Fong, Kwun M/G-6369-2010; Larsen, Jill E/G-3787-2010; Bowman, Rayleen V/G-4144-2013; hayward, nicholas k/C-1367-2015; Yang, Ian A/B-9609-2008	Larsen, Jill E/0000-0001-7806-3931; hayward, nicholas k/0000-0003-4760-1033; Yang, Ian A/0000-0001-8338-1993; Davidson, Morgan/0000-0003-0881-1409; Fong, Kwun/0000-0002-6507-1403	National Health and Medical Research Council NHMRC; UQ Edwin Tooth PhD Scholarship; Cancer Council Queensland; Queensland Clinical Research Fellowship; Prince Charles Hospital Foundation; Smart State	National Health and Medical Research Council NHMRC(National Health and Medical Research Council (NHMRC) of Australia); UQ Edwin Tooth PhD Scholarship; Cancer Council Queensland(Cancer Council Queensland); Queensland Clinical Research Fellowship; Prince Charles Hospital Foundation; Smart State	This work was supported by NHMRC project grants; NHMRC Practitioner Fellowship (KF), NHMRC Research Fellowship (NH), NHMRC Career Development Award (IY), UQ Edwin Tooth PhD Scholarship (JL), Cancer Council Queensland PhD Scholarship (MD), Cancer Council Queensland Senior Research Fellowship (KF), Queensland Clinical Research Fellowship (KF, IY), The Prince Charles Hospital Foundation, Cancer Council Queensland, Smart State, and National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; BRENNAN J, 1991, CANCER RES, V51, P1708; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Dallol A, 2002, CANCER RES, V62, P5874; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dickinson RE, 2004, BRIT J CANCER, V91, P2071, DOI 10.1038/sj.bjc.6602222; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; FONG KM, 1995, CANCER RES, V55, P4268; GAO C, 2009, CANCER; Garnis C, 2005, GENOMICS, V85, P790, DOI 10.1016/j.ygeno.2005.02.015; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grutzmann R, 2004, NEOPLASIA, V6, P611, DOI 10.1593/neo.04295; Guida T, 2005, J CLIN ENDOCR METAB, V90, P4703, DOI 10.1210/jc.2004-2459; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; HOSACK DA, 2003, GENOME BIOL, V4, pP4, DOI DOI 10.1186/GB-2003-4-6-P4; Hsu PWC, 2006, NUCLEIC ACIDS RES, V34, pD135, DOI 10.1093/nar/gkj135; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Klein F, 2009, LUNG CANCER, V65, P13, DOI 10.1016/j.lungcan.2008.10.003; Kluiver J, 2006, GENE CHROMOSOME CANC, V45, P147, DOI 10.1002/gcc.20273; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Larsen JE, 2007, CLIN CANCER RES, V13, P2946, DOI 10.1158/1078-0432.CCR-06-2525; Larsen JE, 2007, CARCINOGENESIS, V28, P760, DOI 10.1093/carcin/bgl207; LEITE KR, 2009, UROL ONCOL; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lingjaerde OC, 2005, BIOINFORMATICS, V21, P821, DOI 10.1093/bioinformatics/bti113; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; Michael MZ, 2003, MOL CANCER RES, V1, P882; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Nishihara K, 2008, INT J ONCOL, V33, P245, DOI 10.3892/ijo_00000003; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ren B, 2006, ONCOGENE, V25, P1090, DOI 10.1038/sj.onc.1209134; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Salgia R, 1998, J CLIN ONCOL, V16, P1207, DOI 10.1200/JCO.1998.16.3.1207; Saramaki O, 2007, FRONT BIOSCI-LANDMRK, V12, P3287, DOI 10.2741/2312; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Tagawa H, 2005, LEUKEMIA, V19, P2013, DOI 10.1038/sj.leu.2403942; TAKAHASHI T, 1989, CANCER RES, V49, P2683; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang J, 2008, ONCOL REP, V19, P1155; Wright CM, 2008, J THORAC ONCOL, V3, P569, DOI 10.1097/JTO.0b013e318174e046; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang J, 2007, AM J PATHOL, V170, P366, DOI 10.2353/ajpath.2007.060706; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	65	96	103	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12560	10.1371/journal.pone.0012560	http://dx.doi.org/10.1371/journal.pone.0012560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838434	Green Published, Green Submitted, gold			2022-12-27	WOS:000281627700013
J	Cornman, RS				Cornman, R. Scott			The Distribution of GYR- and YLP-Like Motifs in Drosophila Suggests a General Role in Cuticle Assembly and Other Protein-Protein Interactions	PLOS ONE			English	Article							CUTICULAR PROTEINS; CONCERTED EVOLUTION; ANOPHELES-GAMBIAE; GENOME SEQUENCE; R CONSENSUS; ANNOTATION; SILKWORM; FAMILY; TOOL; PREDICTION	Background: Arthropod cuticle is composed predominantly of a self-assembling matrix of chitin and protein. Genes encoding structural cuticular proteins are remarkably abundant in arthropod genomes, yet there has been no systematic survey of conserved motifs across cuticular protein families. Methodology/Principal Findings: Two short sequence motifs with conserved tyrosines were identified in Drosophila cuticular proteins that were similar to the GYR and YLP Interpro domains. These motifs were found in members of the CPR, Tweedle, CPF/CPFL, and (in Anopheles gambiae) CPLCG cuticular protein families, and the Dusky/Miniature family of cuticleassociated proteins. Tweedle proteins have a characteristic motif architecture that is shared with the Drosophila protein GCR1 and its orthologs in other species, suggesting that GCR1 is also cuticular. A resilin repeat, which has been shown to confer elasticity, matched one of the motifs; a number of other Drosophila proteins of unknown function exhibit a motif architecture similar to that of resilin. The motifs were also present in some proteins of the peritrophic matrix and the eggshell, suggesting molecular convergence among distinct extracellular matrices. More surprisingly, gene regulation, development, and proteolysis were statistically over-represented ontology terms for all non-cuticular matches in Drosophila. Searches against other arthropod genomes indicate that the motifs are taxonomically widespread. Conclusions: This survey suggests a more general definition for GYR and YLP motifs and reveals their contribution to several types of extracellular matrix. They may define sites of protein interaction with DNA or other proteins, based on ontology analysis. These results can help guide experimental studies on the biochemistry of cuticle assembly.	[Cornman, R. Scott] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Cornman, RS (corresponding author), USDA, Bee Res Lab, Agr Res Serv, Beltsville, MD 20705 USA.	scott.cornman@gmail.com						Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; ANDERSEN SO, 1964, BIOCHIM BIOPHYS ACTA, V93, P213, DOI 10.1016/0304-4165(64)90289-2; ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P541, DOI 10.1016/j.ibmb.2010.05.002; Bailey TL, 1998, J COMPUT BIOL, V5, P211, DOI 10.1089/cmb.1998.5.211; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blake MB, 2002, INT J ELECTRON COMM, V7, P7, DOI 10.1080/10864415.2002.11044257; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cornman RS, 2009, INSECT MOL BIOL, V18, P607, DOI 10.1111/j.1365-2583.2009.00902.x; Cornman RS, 2008, INSECT BIOCHEM MOLEC, V38, P661, DOI 10.1016/j.ibmb.2008.04.001; Cornman RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-22; Cornman RS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008345; DAPHNIA P, DAPHNIA PULEX GENES; Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085; Engel J, 2005, TOP CURR CHEM, V247, P7, DOI 10.1007/b103818; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; FLAVELL AJ, 1987, NUCLEIC ACIDS RES, V15, P4035, DOI 10.1093/nar/15.10.4035; Guan X, 2006, P NATL ACAD SCI USA, V103, P16794, DOI 10.1073/pnas.0607616103; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HAMODRAKAS SJ, 1982, BIOCHIM BIOPHYS ACTA, V703, P216, DOI 10.1016/0167-4838(82)90051-6; Hamodrakas SJ, 2004, J STRUCT BIOL, V145, P226, DOI 10.1016/j.jsb.2003.10.004; Hamodrakas SJ, 2002, INSECT BIOCHEM MOLEC, V32, P1577, DOI 10.1016/S0965-1748(02)00079-6; Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477; He NJ, 2007, INSECT BIOCHEM MOLEC, V37, P135, DOI 10.1016/j.ibmb.2006.10.011; HENIKOFF S, 1995, GENE-COMBIS, V163, pGC17, DOI 10.1016/0378-1119(95)00486-P; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Horton P, 2006, SER ADV BIOINFORM, V3, P39, DOI 10.1142/9781860947292_0007; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Johannesson H, 2005, GENETICS, V171, P109, DOI 10.1534/genetics.105.040923; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Karouzou MV, 2007, INSECT BIOCHEM MOLEC, V37, P754, DOI 10.1016/j.ibmb.2007.03.007; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Neville A.C., 1975, BIOL ARTHROPOD CUTIC; Qin GK, 2009, BIOMACROMOLECULES, V10, P3227, DOI 10.1021/bm900735g; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Roch F, 2003, J CELL SCI, V116, P1199, DOI 10.1242/jcs.00298; SMITH DS, 1971, TISSUE CELL, V3, P477, DOI 10.1016/S0040-8166(71)80047-2; SMYTHE C, 1988, EMBO J, V7, P2681, DOI 10.1002/j.1460-2075.1988.tb03121.x; Syed ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003041; Togawa T, 2004, INSECT BIOCHEM MOLEC, V34, P1059, DOI 10.1016/j.ibmb.2004.06.008; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WEISFOGH T, 1960, J EXP BIOL, V37, P889; Williams CF, 2005, AGR HIST, V79, P109, DOI 10.1525/ah.2005.79.1.109; Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001; Wu TD, 2000, BIOINFORMATICS, V16, P233, DOI 10.1093/bioinformatics/16.3.233; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Zhang ZY, 2009, CURR BIOL, V19, P1200, DOI 10.1016/j.cub.2009.05.050	49	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12536	10.1371/journal.pone.0012536	http://dx.doi.org/10.1371/journal.pone.0012536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824096	Green Submitted, gold, Green Published			2022-12-27	WOS:000281480900019
J	Ren, JG; Seth, P; Everett, P; Clish, CB; Sukhatme, VP				Ren, Jian-Guo; Seth, Pankaj; Everett, Peter; Clish, Clary B.; Sukhatme, Vikas P.			Induction of Erythroid Differentiation in Human Erythroleukemia Cells by Depletion of Malic Enzyme 2	PLOS ONE			English	Article							MYELOGENOUS LEUKEMIA-CELLS; PENTOSE-PHOSPHATE PATHWAY; MALATE-ASPARTATE SHUTTLE; TRICARBOXYLIC-ACID CYCLE; ATP-CITRATE LYASE; MEGAKARYOCYTIC DIFFERENTIATION; K562 CELLS; BCR-ABL; OXIDATIVE STRESS; TYROSINE KINASE	Malic enzyme 2 (ME2) is a mitochondrial enzyme that catalyzes the conversion of malate to pyruvate and CO2 and uses NAD as a cofactor. Higher expression of this enzyme correlates with the degree of cell de-differentiation. We found that ME2 is expressed in K562 erythroleukemia cells, in which a number of agents have been found to induce differentiation either along the erythroid or the myeloid lineage. We found that knockdown of ME2 led to diminished proliferation of tumor cells and increased apoptosis in vitro. These findings were accompanied by differentiation of K562 cells along the erythroid lineage, as confirmed by staining for glycophorin A and hemoglobin production. ME2 knockdown also totally abolished growth of K562 cells in nude mice. Increased ROS levels, likely reflecting increased mitochondrial production, and a decreased NADPH/NADP+ ratio were noted but use of a free radical scavenger to decrease inhibition of ROS levels did not reverse the differentiation or apoptotic phenotype, suggesting that ROS production is not causally involved in the resultant phenotype. As might be expected, depletion of ME2 induced an increase in the NAD+/NADH ratio and ATP levels fell significantly. Inhibition of the malate-aspartate shuttle was insufficient to induce K562 differentiation. We also examined several intracellular signaling pathways and expression of transcription factors and intermediate filament proteins whose expression is known to be modulated during erythroid differentiation in K562 cells. We found that silencing of ME2 leads to phospho-ERK1/2 inhibition, phospho-AKT activation, increased GATA-1 expression and diminished vimentin expression. Metabolomic analysis, conducted to gain insight into intermediary metabolic pathways that ME2 knockdown might affect, showed that ME2 depletion resulted in high orotate levels, suggesting potential impairment of pyrimidine metabolism. Collectively our data point to ME2 as a potentially novel metabolic target for leukemia therapy.	[Ren, Jian-Guo; Seth, Pankaj; Everett, Peter; Sukhatme, Vikas P.] Beth Israel Deaconess Med Ctr, Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA; [Ren, Jian-Guo; Seth, Pankaj; Everett, Peter; Sukhatme, Vikas P.] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA; [Ren, Jian-Guo; Seth, Pankaj; Everett, Peter; Sukhatme, Vikas P.] Beth Israel Deaconess Med Ctr, Div Nephrol, Boston, MA 02215 USA; [Ren, Jian-Guo; Seth, Pankaj; Everett, Peter; Sukhatme, Vikas P.] Harvard Univ, Sch Med, Boston, MA USA; [Clish, Clary B.] Massachusetts Inst Technol & Harvard, Broad Inst, Metabolite Profiling Initiat, Cambridge, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Ren, JG (corresponding author), Beth Israel Deaconess Med Ctr, Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA.	vsukhatm@bidmc.harvard.edu	Clish, Clary B/ABB-9374-2021; Clish, Clary/AAB-7124-2019; Sukhatme, Vikas/W-2776-2019	Clish, Clary B/0000-0001-8259-9245; 	BIDMC [NCI K01- CA 104700]; NIDDK [T32 DK007199]; NATIONAL CANCER INSTITUTE [K01CA104700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007199] Funding Source: NIH RePORTER	BIDMC; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by seed funds from BIDMC to VPS, a K01 award to PS (NCI K01- CA 104700), and an NIDDK training grant to VPS (T32 DK007199) used to support JGR and PE. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED N, 1995, LEUKEMIA RES, V19, P263, DOI 10.1016/0145-2126(94)00158-7; BAGGETTO LG, 1992, BIOCHIMIE, V74, P959, DOI 10.1016/0300-9084(92)90016-8; BECKMAN BS, 1989, J CELL PHYSIOL, V139, P370, DOI 10.1002/jcp.1041390220; Benson JD, 2006, NATURE, V441, P451, DOI 10.1038/nature04873; BOARD M, 1990, BIOCHEM J, V265, P503, DOI 10.1042/bj2650503; Boren J, 2001, J BIOL CHEM, V276, P37747; COLEMAN PS, 1981, CRC CR REV BIOCH MOL, V11, P341, DOI 10.1080/10409238109104421; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Elorza A, 2008, J BIOL CHEM, V283, P30461, DOI 10.1074/jbc.M805400200; French D, 2009, BLOOD, V113, P4512, DOI 10.1182/blood-2008-07-172106; Greenberg DA, 2005, AM J HUM GENET, V76, P139, DOI 10.1086/426735; Griffin JL, 2004, PHYSIOL GENOMICS, V17, P140, DOI 10.1152/physiolgenomics.00158.2003; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Huang M, 2002, MOL PHARMACOL, V62, P463, DOI 10.1124/mol.62.3.463; Hung HC, 2005, BIOCHEMISTRY-US, V44, P12737, DOI 10.1021/bi050510b; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Jacquel A, 2006, ONCOGENE, V25, P781, DOI 10.1038/sj.onc.1209119; Jacquel A, 2003, FASEB J, V17, P2160, DOI 10.1096/fj.03-0322fje; JARVINEN M, 1990, J CELL PHYSIOL, V143, P310, DOI 10.1002/jcp.1041430215; Kang SK, 2004, FEBS LETT, V577, P361, DOI 10.1016/j.febslet.2004.10.031; Kawano T, 2004, LEUKEMIA RES, V28, P623, DOI 10.1016/j.leukres.2003.10.022; Kawano T, 2004, MOL CELL BIOCHEM, V258, P25, DOI 10.1023/B:MCBI.0000012830.96393.b9; Kim KW, 2001, J BIOL CHEM, V276, P13186, DOI 10.1074/jbc.M008092200; Kohmura K, 2004, J CELL PHYSIOL, V198, P370, DOI 10.1002/jcp.10426; Kubohara Y, 1999, BIOCHEM BIOPH RES CO, V263, P790, DOI 10.1006/bbrc.1999.1468; LANOUE KF, 1979, ANNU REV BIOCHEM, V48, P871, DOI 10.1146/annurev.bi.48.070179.004255; Lee BD, 2007, PSYCHIAT RES, V150, P1, DOI 10.1016/j.psychres.2006.06.001; LINDERHOROWITZ M, 1969, CANCER RES, V29, P1195; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; LOEBER G, 1991, J BIOL CHEM, V266, P3016; LOPEZALARCON L, 1986, CANCER RES, V46, P5589; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; MARESPERLMAN JA, 1988, CANCER RES, V48, P602; MATSUMOTO SS, 1990, BIOCHEM PHARMACOL, V39, P455, DOI 10.1016/0006-2952(90)90050-U; Matsumura I, 2000, BLOOD, V96, P2440; Meshkini A, 2008, TOXICOL IN VITRO, V22, P1503, DOI 10.1016/j.tiv.2008.05.005; Missiroli S, 2009, INT J BIOCHEM CELL B, V41, P570, DOI 10.1016/j.biocel.2008.07.002; Mitchell M, 2009, BIOL REPROD, V80, P295, DOI 10.1095/biolreprod.108.069864; MOREADITH RW, 1984, J BIOL CHEM, V259, P6215; NAGEL WO, 1980, J BIOL CHEM, V255, P3849; NAGY K, 1995, LEUKEMIA RES, V19, P203, DOI 10.1016/0145-2126(94)00138-Z; Oravecz K, 2002, TISSUE CELL, V34, P33, DOI 10.1054/tice.2001.0221; Park JI, 2001, CELL GROWTH DIFFER, V12, P481; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Racke FK, 2001, J BIOL CHEM, V276, P522, DOI 10.1074/jbc.M005236200; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Ren JG, 1998, CELL BIOL INT, V22, P41, DOI 10.1006/cbir.1998.0226; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; SABINE JR, 1976, EUR J CANCER, V12, P299, DOI 10.1016/0014-2964(76)90110-9; Sattler M, 2000, J BIOL CHEM, V275, P24273, DOI 10.1074/jbc.M002094200; SAUER LA, 1973, BIOCHEM BIOPH RES CO, V50, P524, DOI 10.1016/0006-291X(73)90871-1; SAUER LA, 1980, J BIOL CHEM, V255, P3844; Shiotsu Y, 2000, BLOOD, V96, P2284, DOI 10.1182/blood.V96.6.2284; Solomon KR, 2009, AM J PATHOL, V174, P1017, DOI 10.2353/ajpath.2009.080551; Suzuki M, 2009, MOL CELL BIOL, V29, P1163, DOI 10.1128/MCB.01572-08; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Verrax J, 2006, BIOCHEM PHARMACOL, V72, P671, DOI 10.1016/j.bcp.2006.05.025; WASILENKO WJ, 1985, CANCER LETT, V28, P35, DOI 10.1016/0304-3835(85)90089-8; Witt O, 2000, BLOOD, V95, P2391, DOI 10.1182/blood.V95.7.2391.007k21_2391_2396; Woessmann W, 2004, CELL BIOL INT, V28, P403, DOI 10.1016/j.cellbi.2004.03.009	65	44	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12520	10.1371/journal.pone.0012520	http://dx.doi.org/10.1371/journal.pone.0012520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824065	Green Published, gold, Green Submitted			2022-12-27	WOS:000281480900008
J	Buchanan, SS; Pyatt, DW; Carpenter, JF				Buchanan, Sandhya S.; Pyatt, David W.; Carpenter, John F.			Preservation of Differentiation and Clonogenic Potential of Human Hematopoietic Stem and Progenitor Cells during Lyophilization and Ambient Storage	PLOS ONE			English	Article							INTRACELLULAR TREHALOSE IMPROVES; EXTRACELLULAR ATP; P2X(7) RECEPTOR; BONE-MARROW; DESICCATION TOLERANCE; MAMMALIAN-CELLS; ENHANCED PROTECTION; GLASS TRANSITIONS; PHASE-TRANSITIONS; DIVALENT-CATIONS	Progenitor cell therapies show great promise, but their potential for clinical applications requires improved storage and transportation. Desiccated cells stored at ambient temperature would provide economic and practical advantages over approaches employing cell freezing and subzero temperature storage. The objectives of this study were to assess a method for loading the stabilizing sugar, trehalose, into hematopoietic stem and progenitor cells (HPC) and to evaluate the effects of subsequent freeze-drying and storage at ambient temperature on differentiation and clonogenic potential. HPC were isolated from human umbilical cord blood and loaded with trehalose using an endogenous cell surface receptor, termed P2Z. Solution containing trehalose-loaded HPC was placed into vials, which were transferred to a tray freeze-dryer and removed during each step of the freeze-drying process to assess differentiation and clonogenic potential. Control groups for these experiments were freshly isolated HPC. Control cells formed 1450 +/- 230 CFU-GM, 430 +/- 140 BFU-E, and 50 +/- 40 CFU-GEMM per 50 mu L. Compared to the values for the control cells, there was no statistical difference observed for cells removed at the end of the freezing step or at the end of primary drying. There was a gradual decrease in the number of CFU-GM and BFU-E for cells removed at different temperatures during secondary drying; however, there were no significant differences in the number of CFU-GEMM. To determine storage stability of lyophilized HPC, cells were stored for 4 weeks at 25 degrees C in the dark. Cells reconstituted immediately after lyophilization produced 580 +/- 90 CFU-GM (similar to 40%, relative to unprocessed controls p<0.0001), 170 +/- 70 BFU-E (similar to 40%, p<0.0001), and 41 +/- 22 CFU-GEMM (similar to 82%, p = 0.4171), and cells reconstituted after 28 days at room temperature produced 513 +/- 170 CFU-GM (similar to 35%, relative to unprocessed controls, p<0.0001), 112 +/- 68 BFU-E (similar to 26%, p<0.0001), and 36 +/- 17 CFU-GEMM (similar to 82%, p = 0.2164) These studies are the first to document high level retention of CFU-GEMM following lyophilization and storage for 4 weeks at 25 degrees C. This type of flexible storage stability would potentially permit the ability to ship and store HPC without the need for refrigeration.	[Buchanan, Sandhya S.; Carpenter, John F.] Univ Colorado, Ctr Pharmaceut Biotechnol, Aurora, CO USA; [Buchanan, Sandhya S.; Carpenter, John F.] Univ Colorado, Dept Pharmaceut Sci, Aurora, CO USA; [Pyatt, David W.] Summit Toxicol, Superior, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Buchanan, SS (corresponding author), Intervet Schering Plough, Discovery & Technol, Elkhorn, NE USA.	Sandhya.Buchanan@Merck.com			Defense Advanced Research Projects Agency/Naval Research Laboratories [N00173-01-1 G011]; NIH [5P30CA46934-15]	Defense Advanced Research Projects Agency/Naval Research Laboratories(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to acknowledge the Defense Advanced Research Projects Agency/Naval Research Laboratories Grant Number N00173-01-1 G011 for providing funding for these studies. Website: http://www.darpa.mil/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge Perkin-Elmer for supplying the Diamond DSC used in this study. We also would like to acknowledge the technical assistance of Karen Helm and Michael Ashton of the University of Colorado Cancer Center Flow Cytometry Core Facility who is supported by NIH grant 5P30CA46934-15.	Alessandrino E, 1999, BONE MARROW TRANSPL, V23, P533, DOI 10.1038/sj.bmt.1701609; Allison SD, 1999, ARCH BIOCHEM BIOPHYS, V365, P289, DOI 10.1006/abbi.1999.1175; Apasov SG, 1997, J IMMUNOL, V158, P5095; Ballerini P, 1996, NEUROREPORT, V7, P2533, DOI 10.1097/00001756-199611040-00026; Beattie GM, 1997, DIABETES, V46, P519, DOI 10.2337/diabetes.46.3.519; Beaujean F, 1998, BONE MARROW TRANSPL, V22, P1091, DOI 10.1038/sj.bmt.1701494; Bhatia R, 2005, J CLIN ONCOL, V23, P6699, DOI 10.1200/JCO.2005.10.330; BLOK MC, 1975, BIOCHIM BIOPHYS ACTA, V406, P187, DOI 10.1016/0005-2736(75)90003-6; BRUNI F, 1991, PLANT PHYSIOL, V96, P660, DOI 10.1104/pp.96.2.660; Buchanan S. S., 2005, CELL PRESERV TECHNOL, V3, P212, DOI DOI 10.1089/CPT.2005.3.212; Buchanan SS, 2004, STEM CELLS DEV, V13, P295, DOI 10.1089/154732804323099226; BUCHANAN SS, 2010, MECHANISTIC STUDY LO; BUCHANAN SS, 2006, PRESERVATION 2 THERA; Budagian V, 2003, J BIOL CHEM, V278, P1549, DOI 10.1074/jbc.M206383200; Cario-Toumaniantz C, 1998, CIRC RES, V83, P196, DOI 10.1161/01.RES.83.2.196; CARPENTER JF, 1986, ARCH BIOCHEM BIOPHYS, V250, P505, DOI 10.1016/0003-9861(86)90755-1; CARPENTER JF, 1993, ARCH BIOCHEM BIOPHYS, V303, P456, DOI 10.1006/abbi.1993.1309; CARPENTER JF, 1987, BIOCHIM BIOPHYS ACTA, V923, P109, DOI 10.1016/0304-4165(87)90133-4; CARPENTER JF, 1988, CRYOBIOLOGY, V25, P244, DOI 10.1016/0011-2240(88)90032-6; CARPENTER JF, 1987, CRYOBIOLOGY, V24, P455, DOI 10.1016/0011-2240(87)90049-6; CARPENTER JF, 1989, BIOCHEMISTRY-US, V28, P3916, DOI 10.1021/bi00435a044; Chen T, 2001, CRYOBIOLOGY, V43, P168, DOI 10.1006/cryo.2001.2360; Chretien S, 1996, EMBO J, V15, P4174, DOI 10.1002/j.1460-2075.1996.tb00792.x; Collo G, 1997, NEUROPHARMACOLOGY, V36, P1277, DOI 10.1016/S0028-3908(97)00140-8; CONGDON CC, 1957, J CELL COMPAR PHYSL, V50, P103, DOI 10.1002/jcp.1030500407; CoutinhoSilva R, 1996, BBA-BIOMEMBRANES, V1278, P125, DOI 10.1016/0005-2736(95)00200-6; CROWE JH, 1987, BIOCHEM J, V242, P1, DOI 10.1042/bj2420001; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; CROWE JH, 1988, BIOCHIM BIOPHYS ACTA, V947, P367, DOI 10.1016/0304-4157(88)90015-9; CROWE JH, 1989, P NATL ACAD SCI USA, V86, P520, DOI 10.1073/pnas.86.2.520; CROWE LM, 1985, ARCH BIOCHEM BIOPHYS, V242, P240, DOI 10.1016/0003-9861(85)90498-9; DAVIS JM, 1990, BLOOD, V75, P781; de Castro AG, 2000, FEBS LETT, V487, P199, DOI 10.1016/S0014-5793(00)02340-1; Deuchars SA, 2001, J NEUROSCI, V21, P7143, DOI 10.1523/JNEUROSCI.21-18-07143.2001; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; DIVIRGILIO F, 1995, IMMUNOL TODAY, V16, P524, DOI 10.1016/0167-5699(95)80045-X; ELMOATASSIM C, 1992, BIOCHIM BIOPHYS ACTA, V1134, P31, DOI 10.1016/0167-4889(92)90025-7; Eroglu A, 2003, CRYOBIOLOGY, V46, P121, DOI 10.1016/S0011-2240(03)00018-X; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Eroglu A, 2002, FERTIL STERIL, V77, P152, DOI 10.1016/S0015-0282(01)02959-4; Eschke D, 2002, N-S ARCH PHARMACOL, V365, P168, DOI 10.1007/s00210-001-0501-2; Gao D, 2000, ILAR J, V41, P187; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; Gordon SL, 2001, CRYOBIOLOGY, V43, P182, DOI 10.1006/cryo.2001.2361; GREEN JL, 1989, J PHYS CHEM-US, V93, P2880, DOI 10.1021/j100345a006; Greig AVH, 2003, J INVEST DERMATOL, V121, P1145, DOI 10.1046/j.1523-1747.2003.12567.x; Gudipaty L, 2001, AM J PHYSIOL-CELL PH, V280, pC943, DOI 10.1152/ajpcell.2001.280.4.C943; Guo N, 2000, NAT BIOTECHNOL, V18, P168, DOI 10.1038/72616; Hadzantonis M, 1999, CANCER BIOTHER RADIO, V14, P11, DOI 10.1089/cbr.1999.14.11; Halle P, 2001, TRANSFUSION, V41, P667, DOI 10.1046/j.1537-2995.2001.41050667.x; HER LM, 1994, PHARMACEUT RES, V11, P54, DOI 10.1023/A:1018989509893; HINO A, 1990, APPL ENVIRON MICROB, V56, P1386, DOI 10.1128/AEM.56.5.1386-1391.1990; HONADEL TE, 1988, CRYOBIOLOGY, V25, P331, DOI 10.1016/0011-2240(88)90041-7; JENNY FA, 2002, TRANSFUSION, V42, P1573; Kheirolomoom A, 2005, CRYOBIOLOGY, V51, P290, DOI 10.1016/j.cryobiol.2005.08.003; KITAMURA T, 1989, BLOOD, V73, P375; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lai JM, 2001, BIOCHEM J, V359, P227, DOI 10.1042/0264-6021:3590227; Li Q, 2003, J BIOL CHEM, V278, P47554, DOI 10.1074/jbc.M308306200; Lim M, 2006, INT J FOOD SCI TECH, V41, P507, DOI 10.1111/j.1365-2621.2005.01096.x; LORENZ E, 1951, J NATL CANCER I, V12, P197; MacKenzie AB, 1999, ANN NY ACAD SCI, V868, P716, DOI 10.1111/j.1749-6632.1999.tb11351.x; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; MCGANN LE, 1978, CRYOBIOLOGY, V15, P382, DOI 10.1016/0011-2240(78)90056-1; McGee HA, 1962, CRYOGENICS, V2, P257, DOI 10.1016/0011-2275(62)90001-2; Menze MA, 2005, AM J PHYSIOL-REG I, V288, pR501, DOI 10.1152/ajpregu.00490.2004; Michel AD, 1998, BRIT J PHARMACOL, V125, P1194, DOI 10.1038/sj.bjp.0702205; Motorin Dmitri, 2003, Hematology, V8, P313, DOI 10.1080/10245330310001612134; NADEMANEE A, 1994, J CLIN ONCOL, V12, P2176, DOI 10.1200/JCO.1994.12.10.2176; Natan D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005240; Nihei OK, 2000, MEM I OSWALDO CRUZ, V95, P415, DOI 10.1590/S0074-02762000000300019; Nihei OK, 2000, BLOOD, V96, P996, DOI 10.1182/blood.V96.3.996.015k02_996_1005; Podesta M, 2001, EXP HEMATOL, V29, P309, DOI 10.1016/S0301-472X(00)00678-0; Puhlev I, 2001, CRYOBIOLOGY, V42, P207, DOI 10.1006/cryo.2001.2324; REEB BA, 1992, BONE MARROW STEM CEL; Russo MJ, 1997, NAT BIOTECHNOL, V15, P278, DOI 10.1038/nbt0397-278; Sano F, 1999, CRYOBIOLOGY, V39, P80, DOI 10.1006/cryo.1999.2188; Schulze-Lohoff E, 1998, AM J PHYSIOL-RENAL, V275, pF962, DOI 10.1152/ajprenal.1998.275.6.F962; Searles JA, 2001, J PHARM SCI, V90, P860, DOI 10.1002/jps.1039; Shpall EJ, 1997, BLOOD, V90, P4313, DOI 10.1182/blood.V90.11.4313.4313_4313_4320; Slade L, 1995, Adv Food Nutr Res, V38, P103, DOI 10.1016/S1043-4526(08)60084-4; Sluyter R, 2004, J BIOL CHEM, V279, P44749, DOI 10.1074/jbc.M405631200; Smart ML, 2003, J BIOL CHEM, V278, P8853, DOI 10.1074/jbc.M211094200; Solini A, 1999, J CELL SCI, V112, P297; SPIELES G, 1995, CRYOBIOLOGY, V32, P366, DOI 10.1006/cryo.1995.1037; Steidl U, 2004, BLOOD, V104, P81, DOI 10.1182/blood-2004-01-0373; STEINBERG TH, 1989, METHOD CELL BIOL, V31, P45; STEINBERG TH, 1987, J BIOL CHEM, V262, P8884; STRONCEK DF, 1991, TRANSFUSION, V31, P521, DOI 10.1046/j.1537-2995.1991.31691306250.x; Suh BC, 2001, J IMMUNOL, V166, P6754, DOI 10.4049/jimmunol.166.11.6754; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; TAKAHASHI T, 1988, BIOPHYS J, V54, P509, DOI 10.1016/S0006-3495(88)82983-7; Testa U, 1998, LEUKEMIA, V12, P563, DOI 10.1038/sj.leu.2400967; THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102; Voermans C, 2001, J HEMATOTH STEM CELL, V10, P725, DOI 10.1089/152581601317210827; Wolfe J, 1999, CRYOBIOLOGY, V39, P103, DOI 10.1006/cryo.1999.2195; Wolkers WF, 2001, CRYOBIOLOGY, V42, P79, DOI 10.1006/cryo.2001.2306; Woods EJ, 2000, J HEMATOTH STEM CELL, V9, P161, DOI 10.1089/152581600319379	100	32	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12518	10.1371/journal.pone.0012518	http://dx.doi.org/10.1371/journal.pone.0012518			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824143	gold, Green Published, Green Submitted			2022-12-27	WOS:000281456100018
J	Bougatef, F; Menashi, S; Khayati, F; Naimi, B; Porcher, R; Podgorniak, MP; Millot, G; Janin, A; Calvo, F; Lebbe, C; Mourah, S				Bougatef, Faten; Menashi, Suzanne; Khayati, Farah; Naimi, Benyoussef; Porcher, Raphael; Podgorniak, Marie-Pierre; Millot, Guy; Janin, Anne; Calvo, Fabien; Lebbe, Celeste; Mourah, Samia			EMMPRIN Promotes Melanoma Cells Malignant Properties through a HIF-2alpha Mediated Up-Regulation of VEGF-Receptor-2	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BASIGIN CD147; EXPRESSION; RECEPTORS; CANCER; VEGF; INVASIVENESS; ANGIOGENESIS; INVASION; PROLIFERATION	EMMPRIN's expression in melanoma tissue was reported to be predictive of poor prognosis. Here we demonstrate that EMMPRIN up-regulated VEGF receptor-2 (VEGFR-2) in two different primary melanoma cell lines and consequently increased migration and proliferation of these cells while inhibiting their apoptosis. SiRNA inhibition of VEGFR-2 expression abrogated these EMMPRIN effects. EMMPRIN regulation of VEGFR-2 was mediated through the over-expression of HIF-2 alpha and its translocation to the nucleus where it forms heterodimers with HIF-1 beta. These results were supported by an in vivo correlation between the expression of EMMPRIN with that of VEGFR-2 in human melanoma tissues as well as with the extent of HIF-2 alpha localization in the nucleus. They demonstrate a novel mechanism by which EMMPRIN promotes tumor progression through HIF-2 alpha/VEGFR-2 mediated mechanism, with an autocrine role in melanoma cell malignancy. The inhibition of EMMPRIN in cancer may thus simultaneously target both the VEGFR-2/VEGF system and the matrix degrading proteases to block tumor cell growth and invasion.	[Bougatef, Faten; Khayati, Farah; Podgorniak, Marie-Pierre; Millot, Guy; Calvo, Fabien; Mourah, Samia] INSERM, Pharmacol Lab, UMR S 940, Paris, France; [Bougatef, Faten; Khayati, Farah; Porcher, Raphael; Podgorniak, Marie-Pierre; Millot, Guy; Janin, Anne; Calvo, Fabien; Lebbe, Celeste; Mourah, Samia] Univ Paris 07, Paris, France; [Bougatef, Faten; Khayati, Farah; Podgorniak, Marie-Pierre; Janin, Anne; Calvo, Fabien; Lebbe, Celeste; Mourah, Samia] Hop St Louis, AP HP, Paris, France; [Menashi, Suzanne] Hop Henri Mondor, CNRS, UMR 7149, Lab CRRET, F-94010 Creteil, France; [Menashi, Suzanne; Naimi, Benyoussef] Univ Paris 12, F-94000 Creteil, France; [Porcher, Raphael] INSERM, Dept Biostat & Med Data Proc, U717, Paris, France; [Janin, Anne] INSERM, U728, Paris, France; [Lebbe, Celeste] Hop St Louis, Dept Dermatol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Bougatef, F (corresponding author), INSERM, Pharmacol Lab, UMR S 940, Paris, France.	samia.mourah@sls.aphp.fr		Porcher, Raphael/0000-0002-5277-4679; calvo, fabien/0000-0002-0298-7633	Societe Francaise de Dermatologie (SFD); Fondation de l Avenir [ET8-489]	Societe Francaise de Dermatologie (SFD); Fondation de l Avenir	The authors acknowledge the support of the Societe Francaise de Dermatologie (SFD) and the Fondation de l Avenir (study ET8-489). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba M, 2008, BIOCHEM BIOPH RES CO, V374, P111, DOI 10.1016/j.bbrc.2008.06.122; BISWAS C, 1995, CANCER RES, V55, P434; Chen X, 2006, CANCER RES, V66, P11323, DOI 10.1158/0008-5472.CAN-06-1536; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Erhard H, 1997, MELANOMA RES, V7, pS19; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gabison EE, 2005, AM J PATHOL, V166, P209, DOI 10.1016/S0002-9440(10)62245-6; Gallagher SM, 2007, CANCER RES, V67, P4182, DOI 10.1158/0008-5472.CAN-06-3184; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Graells J, 2004, J INVEST DERMATOL, V123, P1151, DOI 10.1111/j.0022-202X.2004.23460.x; Hauschild A, 2009, J CLIN ONCOL, V27, P2823, DOI 10.1200/JCO.2007.15.7636; Huet E, 2008, CONNECT TISSUE RES, V49, P175, DOI 10.1080/03008200802151722; Jilaveanu L, 2009, CLIN CANCER RES, V15, P1076, DOI 10.1158/1078-0432.CCR-08-2280; Kanekura T, 2002, INT J CANCER, V99, P520, DOI 10.1002/ijc.10390; Lacal PM, 2005, INT J ONCOL, V27, P1625; Lee TH, 2007, PLOS MED, V4, P1101, DOI 10.1371/journal.pmed.0040186; Liu B, 1995, BIOCHEM BIOPH RES CO, V217, P721, DOI 10.1006/bbrc.1995.2832; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; McDermott R, 2004, J INVEST DERMATOL, V123, P72, DOI 10.1111/j.0022-202X.2004.22728.x; Muramatsu T, 2003, HISTOL HISTOPATHOL, V18, P981, DOI 10.14670/HH-18.981; Nabeshima K, 2006, PATHOL INT, V56, P359, DOI 10.1111/j.1440-1827.2006.01972.x; Park SK, 2003, MOL CELL BIOL, V23, P4959, DOI 10.1128/MCB.23.14.4959-4971.2003; Pisacane AM, 2005, MELANOMA RES, V15, P39, DOI 10.1097/00008390-200502000-00007; Quemener C, 2007, CANCER RES, V67, P9, DOI 10.1158/0008-5472.CAN-06-2448; Shields JD, 2007, ONCOGENE, V26, P2997, DOI 10.1038/sj.onc.1210114; Sini P, 2008, CANCER RES, V68, P1581, DOI 10.1158/0008-5472.CAN-06-4685; Straume O, 2001, AM J PATHOL, V159, P223, DOI 10.1016/S0002-9440(10)61688-4; Su J, 2009, CANCER LETT, V273, P140, DOI 10.1016/j.canlet.2008.07.034; Tang Y, 2005, CANCER RES, V65, P3193, DOI 10.1158/0008-5472.CAN-04-3605; Toole BP, 2003, CURR TOP DEV BIOL, V54, P371, DOI 10.1016/S0070-2153(03)54015-7; vandenOord JJ, 1997, AM J PATHOL, V151, P665; Voigt H, 2009, CANCER INVEST, V27, P329, DOI 10.1080/07357900802392675; Yan L, 2005, THROMB HAEMOSTASIS, V93, P199, DOI 10.1160/TH04-08-0536	33	25	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12265	10.1371/journal.pone.0012265	http://dx.doi.org/10.1371/journal.pone.0012265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824203	Green Published, gold, Green Submitted			2022-12-27	WOS:000281405300003
J	Herrmann, E; Hare, B; Call, J; Tomasello, M				Herrmann, Esther; Hare, Brian; Call, Josep; Tomasello, Michael			Differences in the Cognitive Skills of Bonobos and Chimpanzees	PLOS ONE			English	Article							APES PAN-PANISCUS; GREAT APES; PONGO-PYGMAEUS; GORILLA-GORILLA; SEX-DIFFERENCES; TROGLODYTES; BARRIERS; HORMONES; HUMANS	While bonobos and chimpanzees are both genetically and behaviorally very similar, they also differ in significant ways. Bonobos are more cautious and socially tolerant while chimpanzees are more dependent on extractive foraging, which requires tools. The similarities suggest the two species should be cognitively similar while the behavioral differences predict where the two species should differ cognitively. We compared both species on a wide range of cognitive problems testing their understanding of the physical and social world. Bonobos were more skilled at solving tasks related to theory of mind or an understanding of social causality, while chimpanzees were more skilled at tasks requiring the use of tools and an understanding of physical causality. These species differences support the role of ecological and socio-ecological pressures in shaping cognitive skills over relatively short periods of evolutionary time.	[Herrmann, Esther; Call, Josep; Tomasello, Michael] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Hare, Brian] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA; [Hare, Brian] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	Max Planck Society; Duke University; Duke University	Herrmann, E (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	eherrman@eva.mpg.de		Call Balaguer, Josep/0000-0002-8597-8336	European Research Commission [233297]; National Science Foundation [NSF-BCS-08-27552-02]	European Research Commission(European CommissionEuropean Commission Joint Research Centre); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by a grant to B.H. from the European Research Commission Advanced Grant Agreement 233297 and the National Science Foundation NSF-BCS-08-27552-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boesch C, 2000, CHIMPANZEES TAI FORE; Boesch Christophe, 2002, BEHAV DIVERSITY CHIM; Brauer J, 2005, J COMP PSYCHOL, V119, P145, DOI 10.1037/0735-7036.119.2.145; Call J., 2007, GESTURAL COMMUNICATI; Call J, 2006, ANIM COGN, V9, P393, DOI 10.1007/s10071-006-0037-4; de Waal Frans B. M., 1997, BONOBO FORGOTTEN APE; Deaner R. O., 2006, EVOL PSYCHOL, V4, DOI [10.1177/147470490600400114, DOI 10.1177/147470490600400114]; Driscoll I, 2005, HORM BEHAV, V47, P326, DOI 10.1016/j.yhbeh.2004.11.013; GRUBER T, ANIMAL BEHA IN PRESS; Hanus D, 2007, J COMP PSYCHOL, V121, P241, DOI 10.1037/0735-7036.121.3.241; Hare B, 2007, CURR BIOL, V17, P619, DOI 10.1016/j.cub.2007.02.040; Heilbronner SR, 2008, BIOL LETTERS, V4, P246, DOI 10.1098/rsbl.2008.0081; HERRMANN E, COMP GREAT APE UNPUB; Herrmann E, 2008, J COMP PSYCHOL, V122, P220, DOI 10.1037/0735-7036.122.2.220; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Hohmann G, 2003, CURR ANTHROPOL, V44, P563, DOI 10.1086/377649; Lonsdorf EV, 2004, NATURE, V428, P715, DOI 10.1038/428715a; Lonsdorf EV, 2005, ANIM BEHAV, V70, P673, DOI 10.1016/j.anbehav.2004.12.014; Martin-Ordas G, 2010, ANIM COGN, V13, P331, DOI 10.1007/s10071-009-0282-4; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; Pollick AS, 2007, P NATL ACAD SCI USA, V104, P8184, DOI 10.1073/pnas.0702624104; POVINELLI DJ, 1993, J COMP PSYCHOL, V107, P347, DOI 10.1037/0735-7036.107.4.347; Suda C, 2004, J COMP PSYCHOL, V118, P265, DOI 10.1037/0735-7036.118.3.265; Tomasello M, 1997, PRIMATE COGNITION; Vlamings PHJM, 2010, ANIM COGN, V13, P273, DOI 10.1007/s10071-009-0265-5; WELLMAN HM, 2010, DEV SCI; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wobber V, 2010, P NATL ACAD SCI USA, V107, P12457, DOI 10.1073/pnas.1007411107; Wobber V, 2010, CURR BIOL, V20, P226, DOI 10.1016/j.cub.2009.11.070; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017	30	118	118	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12438	10.1371/journal.pone.0012438	http://dx.doi.org/10.1371/journal.pone.0012438			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20806062	Green Submitted, Green Published, gold			2022-12-27	WOS:000281301500007
J	Kong, DJ; Banerjee, S; Ahmad, A; Li, YW; Wang, ZW; Sethi, S; Sarkar, FH				Kong, Dejuan; Banerjee, Sanjeev; Ahmad, Aamir; Li, Yiwei; Wang, Zhiwei; Sethi, Seema; Sarkar, Fazlul H.			Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in Prostate Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR-D; TUMOR-INITIATING CELLS; SELF-RENEWAL; DEVELOPMENTAL REGULATORS; DOWN-REGULATION; MIR-200 FAMILY; PDGF-D; INVASION; ANGIOGENESIS; TARGET	Background: Current management of patients diagnosed with prostate cancer (PCa) is very effective; however, tumor recurrence with Castrate Resistant Prostate Cancer (CRPC) and subsequent metastasis lead to poor survival outcome, suggesting that there is a dire need for novel mechanistic understanding of tumor recurrence, which would be critical for designing novel therapies. The recurrence and the metastasis of PCa are tightly linked with the biology of prostate cancer stem cells or cancer-initiating cells that is reminiscent of the acquisition of Epithelial to Mesenchymal Transition (EMT) phenotype. Increasing evidence suggests that EMT-type cells share many biological characteristics with cancer stem-like cells. Methodology/Principal Findings: In this study, we found that PCa cells with EMT phenotype displayed stem-like cell features characterized by increased expression of Sox2, Nanog, Oct4, Lin28B and/or Notch1, consistent with enhanced clonogenic and sphere (prostasphere)-forming ability and tumorigenecity in mice, which was associated with decreased expression of miR-200 and/or let-7 family. Reversal of EMT by re-expression of miR-200 inhibited prostasphere-forming ability of EMT-type cells and reduced the expression of Notch1 and Lin28B. Down-regulation of Lin28B increased let-7 expression, which was consistent with repressed self-renewal capability. Conclusions/Significance: These results suggest that miR-200 played a pivotal role in linking the characteristics of cancer stem-like cells with EMT-like cell signatures in PCa. Selective elimination of cancer stem-like cells by reversing the EMT phenotype to Mesenchymal-Epithelial Transition (MET) phenotype using novel agents would be useful for the prevention of tumor recurrence especially by eliminating those cells that are the "Root Cause" of tumor development and recurrence.	[Kong, Dejuan; Banerjee, Sanjeev; Ahmad, Aamir; Li, Yiwei; Wang, Zhiwei; Sethi, Seema; Sarkar, Fazlul H.] Wayne State Univ, Sch Med, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University	Kong, DJ (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48201 USA.	fsarkar@med.wayne.edu	Ahmad, Aamir/E-8747-2010; Wang, Zhiwei/A-6809-2011	Ahmad, Aamir/0000-0003-1784-5723; 	National Cancer Institute, National Institutes of Health (NIH) [5R01CA083695-08]; NATIONAL CANCER INSTITUTE [R01CA164318, R01CA083695] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by a grant from the National Cancer Institute, National Institutes of Health (NIH) (5R01CA083695-08 to FHS) (http://projectreporter.nih.gov/reporter_searchresults.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cano A, 2008, TRENDS CELL BIOL, V18, P357, DOI 10.1016/j.tcb.2008.05.005; Fischer ANM, 2007, ONCOGENE, V26, P3395, DOI 10.1038/sj.onc.1210121; Fox V, 2008, STEM CELLS, V26, P715, DOI 10.1634/stemcells.2007-0368; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Kasper S, 2008, J CELL PHYSIOL, V216, P332, DOI 10.1002/jcp.21489; Kasper S, 2009, UROL ONCOL-SEMIN ORI, V27, P301, DOI 10.1016/j.urolonc.2008.12.012; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Kong DJ, 2008, STEM CELLS, V26, P1425, DOI 10.1634/stemcells.2007-1076; Kong D, 2008, CANCER RES, V68, P1927, DOI 10.1158/0008-5472.CAN-07-3241; Kong DJ, 2007, CANCER RES, V67, P3310, DOI 10.1158/0008-5472.CAN-06-4277; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li H, 2003, ONCOGENE, V22, P1501, DOI 10.1038/sj.onc.1206223; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marian CO, 2009, BBA-MOL BASIS DIS, V1792, P289, DOI 10.1016/j.bbadis.2009.02.012; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Roudier MP, 2003, HUM PATHOL, V34, P646, DOI 10.1016/S0046-8177(03)00190-4; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Sotomayor P, 2009, PROSTATE, V69, P401, DOI 10.1002/pros.20895; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Ustach CV, 2005, MOL CELL BIOL, V25, P6279, DOI 10.1128/MCB.25.14.6279-6288.2005; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang ZW, 2007, CANCER RES, V67, P11377, DOI 10.1158/0008-5472.CAN-07-2803; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xu JC, 2006, PROSTATE, V66, P1664, DOI 10.1002/pros.20488; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	47	309	318	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12445	10.1371/journal.pone.0012445	http://dx.doi.org/10.1371/journal.pone.0012445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805998	gold, Green Published, Green Submitted			2022-12-27	WOS:000281301500012
J	Bao, W; Song, FF; Li, XY; Rong, SA; Yang, W; Zhang, MX; Yao, P; Hao, LP; Yang, NH; Hu, FB; Liu, LG				Bao, Wei; Song, Fangfang; Li, Xiangyang; Rong, Shuang; Yang, Wei; Zhang, Muxun; Yao, Ping; Hao, Liping; Yang, Nianhong; Hu, Frank B.; Liu, Liegang			Plasma Heme Oxygenase-1 Concentration Is Elevated in Individuals with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							ACTIVATED SIGNALING PATHWAYS; BETA-CELL DYSFUNCTION; OXIDATIVE STRESS; INSULIN-RESISTANCE; GENE-EXPRESSION; GLUCOSE; DEFENSE; DIAGNOSIS; P22(PHOX); DISEASE	Background: Circulating concentrations of heme oxygenase-1 (HO-1) have been recently reported to be elevated in several chronic disorders. However, no study has ever examined the association between circulating HO-1 concentrations and type 2 diabetes mellitus (T2DM). Methods and Findings: 581 cases with newly-diagnosed T2DM (New-T2DM) and 611 comparison controls were recruited in this two-phase case-control study, comprising 420 cases and 429 controls collected in the first phase study and 161 cases and 182 controls in the second phase replication study. Analyses, using both separated data and combined data from the two-phase studies, show that plasma HO-1 concentrations were significantly increased in New-T2DM cases compared to controls (P < 0.001). Plasma HO-1 concentrations were significantly correlated with plasma glucose concentrations, HOMA-beta and HOMA-IR (P < 0.001). After adjustment for age, sex, BMI and family history of diabetes, the ORs for New-T2DM in the highest quartile of plasma HO-1 concentrations, compared with the lowest, was 8.23 (95% CI 5.55-12.21; P for trend <0.001). The trend remained significant after additional adjustment for fasting plasma glucose/insulin, HOMA-beta/HOMAIR, TC/TG, smoking, drinking and history of hypertension, and even in further stratification analysis by age, sex, BMI, smoking, drinking and history of hypertension. Conclusions: Elevated plasma HO-1 concentrations are associated with higher ORs for New-T2DM, which add more knowledge regarding the important role of oxidative stress in T2DM. More consequent studies were warranted to confirm the clinical utility of plasma HO-1, especially in diagnosis and prognosis of T2DM and its complications.	[Bao, Wei; Song, Fangfang; Li, Xiangyang; Rong, Shuang; Yang, Wei; Yao, Ping; Hao, Liping; Yang, Nianhong; Liu, Liegang] Huazhong Univ Sci & Technol, Dept Food Hyg & Nutr, Tongji Med Coll, Sch Publ Hlth, Wuhan 430074, Peoples R China; [Bao, Wei; Song, Fangfang; Li, Xiangyang; Rong, Shuang; Yang, Wei; Yao, Ping; Hao, Liping; Yang, Nianhong; Liu, Liegang] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Song, Fangfang] Tianjin Med Univ, Canc Inst & Hosp, Dept Epidemiol & Biostat, Tianjin, Peoples R China; [Zhang, Muxun] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Internal Med,Inst Endocrinol, Wuhan 430074, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hu, Frank B.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Hu, Frank B.] Harvard Univ, Sch Med, Boston, MA USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Tianjin Medical University; Huazhong University of Science & Technology; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Bao, W (corresponding author), Huazhong Univ Sci & Technol, Dept Food Hyg & Nutr, Tongji Med Coll, Sch Publ Hlth, Wuhan 430074, Peoples R China.	fhu@hsph.harvard.edu; lgliu@mails.tjmu.edu.cn	Bao, Wei/AAG-2431-2019	Bao, Wei/0000-0002-7301-5786	National Natural Science Foundation [NSFC-30872116]; National Basic Research Program (973 Program) of China [2009CB118803-1]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 Program) of China(National Basic Research Program of China)	This study was supported by National Natural Science Foundation (NSFC-30872116) and partly by National Basic Research Program (973 Program, 2009CB118803-1) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Adaikalakoteswari A, 2006, DIABETIC MED, V23, P666, DOI 10.1111/j.1464-5491.2006.01879.x; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Avogaro A, 2003, J CLIN ENDOCR METAB, V88, P1753, DOI 10.1210/jc.2002-021025; Bruce CR, 2003, DIABETES, V52, P2338, DOI 10.2337/diabetes.52.9.2338; Calabrese V, 2007, CELL STRESS CHAPERON, V12, P299, DOI 10.1379/CSC-270.1; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Jonas JC, 2003, DIABETOLOGIA, V46, P1234, DOI 10.1007/s00125-003-1174-9; Kaneto H, 2007, ANTIOXID REDOX SIGN, V9, P355, DOI 10.1089/ars.2006.1465; Kirino M, 2008, J ALLERGY CLIN IMMUN, V122, P290, DOI 10.1016/j.jaci.2008.05.031; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; Mateo I, 2010, ACTA NEUROL SCAND, V121, P136, DOI 10.1111/j.1600-0404.2009.01261.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miyazaki T, 2010, INT J HEMATOL, V91, P229, DOI 10.1007/s12185-010-0495-y; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Morse D, 2002, AM J RESP CELL MOL, V27, P8, DOI 10.1165/ajrcmb.27.1.4862; Platt JL, 1998, NAT MED, V4, P1364, DOI 10.1038/3947; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sato T, 2006, AM J RESP CRIT CARE, V174, P906, DOI 10.1164/rccm.200508-1237OC; Schipper HM, 2004, FREE RADICAL BIO MED, V37, P1995, DOI 10.1016/j.freeradbiomed.2004.09.015; Schipper HM, 2000, NEUROLOGY, V54, P1297, DOI 10.1212/WNL.54.6.1297; Song FF, 2007, EUR J NUTR, V46, P61, DOI 10.1007/s00394-006-0632-9; Song FF, 2007, CLIN SCI, V112, P599, DOI 10.1042/CS20060323; Song FF, 2009, AM J EPIDEMIOL, V170, P747, DOI 10.1093/aje/kwp196; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Won KC, 2006, J KOREAN MED SCI, V21, P418, DOI 10.3346/jkms.2006.21.3.418; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	32	83	90	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12371	10.1371/journal.pone.0012371	http://dx.doi.org/10.1371/journal.pone.0012371			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811623	Green Published, gold, Green Submitted			2022-12-27	WOS:000281234700008
J	Veiga, MI; Ferreira, PE; Schmidt, BA; Ribacke, U; Bjorkman, A; Tichopad, A; Gil, JP				Veiga, Maria Isabel; Ferreira, Pedro Eduardo; Schmidt, Berit Aydin; Ribacke, Ulf; Bjorkman, Anders; Tichopad, Ales; Gil, Jose Pedro			Antimalarial Exposure Delays Plasmodium falciparum Intra-Erythrocytic Cycle and Drives Drug Transporter Genes Expression	PLOS ONE			English	Article							CHLOROQUINE RESISTANCE; MALARIA PARASITES; PFMDR1 GENE; SENSITIVITY; MEFLOQUINE; PFCRT; RECRUDESCENCE; LUMEFANTRINE; COMBINATION; QUININE	Background: Multi-drug resistant Plasmodium falciparum is a major obstacle to malaria control and is emerging as a complex phenomenon. Mechanisms of drug evasion based on the intracellular extrusion of the drug and/or modification of target proteins have been described. However, cellular mechanisms related with metabolic activity have also been seen in eukaryotic systems, e. g. cancer cells. Recent observations suggest that such mechanism may occur in P. falciparum. Methodology/Principal Findings: We therefore investigated the effect of mefloquine exposure on the cell cycle of three P. falciparum clones (3D7, FCB, W2) with different drug susceptibilities, while investigating in parallel the expression of four genes coding for confirmed and putative drug transporters (pfcrt, pfmdr1, pfmrp1 and pfmrp2). Mefloquine induced a previously not described dose and clone dependent delay in the intra-erythrocytic cycle of the parasite. Drug impact on cell cycle progression and gene expression was then merged using a non-linear regression model to determine specific drug driven expression. This revealed a mild, but significant, mefloquine driven gene induction up to 1.5 fold. Conclusions/Significance: Both cell cycle delay and induced gene expression represent potentially important mechanisms for parasites to escape the effect of the antimalarial drug.	[Veiga, Maria Isabel; Ferreira, Pedro Eduardo; Schmidt, Berit Aydin; Bjorkman, Anders; Gil, Jose Pedro] Karolinska Inst, Dept Med, Malaria Res Lab, Stockholm, Sweden; [Veiga, Maria Isabel; Ferreira, Pedro Eduardo; Gil, Jose Pedro] Univ Algarve, Ctr Mol & Struct Biomed, Inst Biotechnol & Bioengn, Drug Resistance & Pharmacogenet Grp, Faro, Portugal; [Ribacke, Ulf] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [Tichopad, Ales] Inst Biotechnol AS CR, Prague, Czech Republic; [Tichopad, Ales] Tech Univ Munich, D-8050 Freising Weihenstephan, Germany; [Gil, Jose Pedro] SUNY Binghamton, Dept Anthropol, Lab Mol Anthropol & Hlth, Binghamton, NY USA	Karolinska Institutet; Universidade do Algarve; Karolinska Institutet; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Technical University of Munich; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Veiga, MI (corresponding author), Karolinska Inst, Dept Med, Malaria Res Lab, Stockholm, Sweden.	isabel.veiga@ki.se	Ferreira, Pedro/AAD-4309-2020; Gil, José Pedro/AAB-6169-2020; Ferreira, Pedro/HDO-1346-2022; Veiga, Maria Isabel/H-9922-2018; Ferreira, Pedro/G-1717-2012; Ferreira, Pedro/Q-6748-2016	Ferreira, Pedro/0000-0002-2682-7722; Veiga, Maria Isabel/0000-0002-2205-8102; Ferreira, Pedro/0000-0002-2682-7722; Ferreira, Pedro/0000-0002-2682-7722; Gil, Jose Pedro/0000-0002-6107-9379	Swedish Development Cooperation Agency - Department for Research Cooperation [SWE 2005 - 0017, SWE 2005 - 4596, SWE-2007-174, SWE-2005-4027]; Fundacao para a Ciencia e Tecnologia (FCT)/Ministerio da Ciencia e Ensino Superior, Portugal - MCES [SFRH/BD/28393/2006, SFRH/BD/28368/2006]	Swedish Development Cooperation Agency - Department for Research Cooperation; Fundacao para a Ciencia e Tecnologia (FCT)/Ministerio da Ciencia e Ensino Superior, Portugal - MCES(Portuguese Foundation for Science and Technology)	This work was supported by project grants from the Swedish Development Cooperation Agency - Department for Research Cooperation (SWE 2005 0017, SWE 2005 - 4596, SWE-2007-174 and SWE-2005-4027). MIV and PEF are recipients of PhD grants from Fundacao para a Ciencia e Tecnologia (FCT)/Ministerio da Ciencia e Ensino Superior, Portugal - MCES (ref. SFRH/BD/28393/2006 and ref. SFRH/BD/28368/2006, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, WORLD MAL REP 2008; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; BARNES DA, 1992, EMBO J, V11, P3067, DOI 10.1002/j.1460-2075.1992.tb05378.x; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bozdech Z, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-17; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Cowman Alan F., 1993, Seminars in Cell Biology, V4, P29, DOI 10.1006/scel.1993.1004; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Ganesan K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000214; Gatton ML, 2006, AM J TROP MED HYG, V75, P212, DOI 10.4269/ajtmh.2006.75.212; Gunasekera AM, 2007, EXP PARASITOL, V117, P87, DOI 10.1016/j.exppara.2007.03.001; Johnson DJ, 2008, ANTIMICROB AGENTS CH, V52, P1438, DOI 10.1128/AAC.01392-07; Johnson DJ, 2004, MOL CELL, V15, P867, DOI 10.1016/j.molcel.2004.09.012; Klokouzas A, 2004, BIOCHEM BIOPH RES CO, V321, P197, DOI 10.1016/j.bbrc.2004.06.135; Lakshmanan V, 2005, EMBO J, V24, P2294, DOI 10.1038/sj.emboj.7600681; Lopes Dinora, 2002, Malar J, V1, P12, DOI 10.1186/1475-2875-1-12; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; Mu JB, 2003, MOL MICROBIOL, V49, P977, DOI 10.1046/j.1365-2958.2003.03627.x; Myrick A, 2003, MOL MICROBIOL, V49, P671, DOI 10.1046/j.1365-2958.2003.03597.x; Nakazawa S, 1995, EXP PARASITOL, V81, P556, DOI 10.1006/expr.1995.1149; Nakazawa S, 2002, ANTIMICROB AGENTS CH, V46, P958, DOI 10.1128/AAC.46.4.958-965.2002; Noedl H, 2005, ANTIMICROB AGENTS CH, V49, P3575, DOI 10.1128/AAC.49.8.3575-3577.2005; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Price RN, 2006, CLIN INFECT DIS, V42, P1570, DOI 10.1086/503423; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Rohrbach P, 2006, EMBO J, V25, P3000, DOI 10.1038/sj.emboj.7601203; Roninson IB, 2003, CANCER RES, V63, P2705; Sanchez CP, 2007, TRENDS PARASITOL, V23, P332, DOI 10.1016/j.pt.2007.04.013; Sauvage V, 2009, MOL BIOCHEM PARASIT, V167, P81, DOI 10.1016/j.molbiopara.2009.05.005; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Sidhu ABS, 2006, J INFECT DIS, V194, P528, DOI 10.1086/507115; Stahlberg A, 2003, CLIN CHEM, V49, P51, DOI 10.1373/49.1.51; Stepniewska K, 2010, J INFECT DIS, V201, P570, DOI 10.1086/650301; Thapar MM, 2005, T ROY SOC TROP MED H, V99, P62, DOI 10.1016/j.trstmh.2004.01.016; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Valderramos SG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000887; Varna M, 2009, INT J CANCER, V124, P991, DOI 10.1002/ijc.24049; WILSON CM, 1989, SCIENCE, V244, P1184, DOI 10.1126/science.2658061	41	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12408	10.1371/journal.pone.0012408	http://dx.doi.org/10.1371/journal.pone.0012408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811640	Green Submitted, Green Published, gold			2022-12-27	WOS:000281234700029
J	Aartsen, WM; van Cleef, KWR; Pellissier, LP; Hoek, RM; Vos, RM; Blits, B; Ehlert, EME; Balaggan, KS; Ali, RR; Verhaagen, J; Wijnholds, J				Aartsen, Wendy M.; van Cleef, Koen W. R.; Pellissier, Lucie P.; Hoek, Robert M.; Vos, Rogier M.; Blits, Bas; Ehlert, Erich M. E.; Balaggan, Kamaljit S.; Ali, Robin R.; Verhaagen, Joost; Wijnholds, Jan			GFAP-Driven GFP Expression in Activated Mouse Muller Glial Cells Aligning Retinal Blood Vessels Following Intravitreal Injection of AAV2/6 Vectors	PLOS ONE			English	Article							GENE-THERAPY; TRANSDUCTION; CRB1; MEMBRANE; PURIFICATION; DETACHMENT; PROMOTER; VISION; SIZE	Background: Muller cell gliosis occurs in various retinal pathologies regardless of the underlying cellular defect. Because activated Muller glial cells span the entire retina and align areas of injury, they are ideal targets for therapeutic strategies, including gene therapy. Methodology/Principal Findings: We used adeno-associated viral AAV2/6 vectors to transduce mouse retinas. The transduction pattern of AAV2/6 was investigated by studying expression of the green fluorescent protein (GFP) transgene using scanning-laser ophthalmoscopy and immuno-histochemistry. AAV2/6 vectors transduced mouse Muller glial cells aligning the retinal blood vessels. However, the transduction capacity was hindered by the inner limiting membrane (ILM) and besides Muller glial cells, several other inner retinal cell types were transduced. To obtain Muller glial cell-specific transgene expression, the cytomegalovirus (CMV) promoter was replaced by the glial fibrillary acidic protein (GFAP) promoter. Specificity and activation of the GFAP promoter was tested in a mouse model for retinal gliosis. Mice deficient for Crumbs homologue 1 (CRB1) develop gliosis after light exposure. Light exposure of Crb1(-/-) retinas transduced with AAV2/6-GFAP-GFP induced GFP expression restricted to activated Muller glial cells aligning retinal blood vessels. Conclusions/Significance: Our experiments indicate that AAV2 vectors carrying the GFAP promoter are a promising tool for specific expression of transgenes in activated glial cells.	[Aartsen, Wendy M.; van Cleef, Koen W. R.; Pellissier, Lucie P.; Hoek, Robert M.; Vos, Rogier M.; Wijnholds, Jan] Royal Netherlands Acad Arts & Sci, Dept Neuromed Genet, Netherlands Inst Neurosci, Amsterdam, Netherlands; [Blits, Bas; Ehlert, Erich M. E.; Verhaagen, Joost] Royal Netherlands Acad Arts & Sci, Dept Neuroregenerat, Netherlands Inst Neurosci, Amsterdam, Netherlands; [Blits, Bas] Amsterdam Mol Therapeut, Amsterdam, Netherlands; [Balaggan, Kamaljit S.; Ali, Robin R.] UCL, Div Mol Therapy, Inst Ophthalmol, London, England	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of London; University College London	Aartsen, WM (corresponding author), Royal Netherlands Acad Arts & Sci, Dept Neuromed Genet, Netherlands Inst Neurosci, Amsterdam, Netherlands.	j.wijnholds@nin.knaw.nl	Wijnholds, Jan/V-3896-2018; Pellissier, Lucie P/L-8239-2014; Ehlert, Erich M/A-4054-2012; Verhaagen, Joost/G-4773-2012	Wijnholds, Jan/0000-0003-0099-460X; Pellissier, Lucie P/0000-0001-7085-3242; Ali, Robin/0000-0003-3126-6517	ZonMw [43200004]; European Commission [HEALTH-F2-2008-200234]; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid	ZonMw(Netherlands Organization for Health Research and Development); European Commission(European CommissionEuropean Commission Joint Research Centre); Algemene Nederlandse Vereniging ter Voorkoming van Blindheid	This work was supported in part by Grants from ZonMw [http://www.zonmw.nl/en/organisation/; grant number 43200004 to J.W.], European Commission [HEALTH-F2-2008-200234 to J.W.], Rotterdamse Vereniging Blindenbelangen, Stichting Blindenpenning, Gelderse Blinden Stichting, Stichting Blindenhulp, Landelijke Stichting voor Blinden en Slechtzienden (LSBS) and Algemene Nederlandse Vereniging ter Voorkoming van Blindheid [to W.A. and J.W.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsen WM, 2006, HUM MOL GENET, V15, P1291, DOI 10.1093/hmg/ddl047; Allocca M, 2006, EXPERT OPIN BIOL TH, V6, P1279, DOI 10.1517/14712598.6.12.1279; Bainbridge J, 2008, EYE, V22, P1301, DOI 10.1038/eye.2008.23; Bainbridge JWB, 2006, GENE THER, V13, P1191, DOI 10.1038/sj.gt.3302812; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Blits B, 2010, J NEUROSCI METH, V185, P257, DOI 10.1016/j.jneumeth.2009.10.009; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Buch PK, 2008, GENE THER, V15, P849, DOI 10.1038/gt.2008.66; Cideciyan AV, 2009, NEW ENGL J MED, V361, P725, DOI 10.1056/NEJMc0903652; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Dalkara D, 2009, MOL THER, V17, P2096, DOI 10.1038/mt.2009.181; den Hollander AI, 2004, HUM MUTAT, V24, P355, DOI 10.1002/humu.20093; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Fisher SK, 2005, PROG RETIN EYE RES, V24, P395, DOI 10.1016/j.preteyeres.2004.10.004; Goldstein IM, 1996, VISION RES, V36, P2979, DOI 10.1016/0042-6989(96)00017-X; Greenberg KP, 2007, INVEST OPHTH VIS SCI, V48, P1844, DOI 10.1167/iovs.05-1570; Halfter W, 2006, INVEST OPHTH VIS SCI, V47, P3586, DOI 10.1167/iovs.05-1480; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Harvey AR, 2002, MOL CELL NEUROSCI, V21, P141, DOI 10.1006/mcne.2002.1168; HATA Y, 2005, GRAEFES ARCH CLIN EX, V245, P1019; Hellstrom M, 2009, GENE THER, V16, P521, DOI 10.1038/gt.2008.178; Hermens WTJMC, 1999, HUM GENE THER, V10, P1885, DOI 10.1089/10430349950017563; JOHNSON TV, 2008, EYE, P1980; Klein RL, 2008, MOL THER, V16, P89, DOI 10.1038/sj.mt.6300331; Klimczak RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007467; Koerber JT, 2009, MOL THER, V17, P2088, DOI 10.1038/mt.2009.184; Kuzmanovic M, 2003, INVEST OPHTH VIS SCI, V44, P3606, DOI 10.1167/iovs.02-1265; Luna G, 2009, INVEST OPHTH VIS SCI, V50, P3977, DOI 10.1167/iovs.08-2910; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Richard M, 2006, HUM MOL GENET, V15, pR235, DOI 10.1093/hmg/ddl195; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; van de Pavert SA, 2004, J CELL SCI, V117, P4169, DOI 10.1242/jcs.01301; van de Pavert SA, 2007, GLIA, V55, P1486, DOI 10.1002/glia.20561; van de Pavert SA, 2007, J NEUROSCI, V27, P564, DOI 10.1523/JNEUROSCI.3496-06.2007; van Rossum AGSH, 2006, HUM MOL GENET, V15, P2659, DOI 10.1093/hmg/ddl194; Verardo MR, 2008, INVEST OPHTH VIS SCI, V49, P3659, DOI 10.1167/iovs.07-1474; Wahlin KJ, 2000, INVEST OPHTH VIS SCI, V41, P927; Wang Y, 2002, CURR EYE RES, V24, P305, DOI 10.1076/ceyr.24.4.305.8408; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Wu KHC, 2003, BRIT J OPHTHALMOL, V87, P1159, DOI 10.1136/bjo.87.9.1159; Yanoff M, 1996, OCULAR PATHOLOGY; Zack DJ, 2000, NEURON, V26, P285, DOI 10.1016/S0896-6273(00)81160-5	44	32	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12387	10.1371/journal.pone.0012387	http://dx.doi.org/10.1371/journal.pone.0012387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808778	Green Published, gold, Green Submitted			2022-12-27	WOS:000281154300015
J	Woodward, OM; Li, Y; Yu, SQ; Greenwell, P; Wodarczyk, C; Boletta, A; Guggino, WB; Qian, F				Woodward, Owen M.; Li, Yun; Yu, Shengqiang; Greenwell, Patrick; Wodarczyk, Claas; Boletta, Alessandra; Guggino, William B.; Qian, Feng			Identification of a Polycystin-1 Cleavage Product, P100, That Regulates Store Operated Ca2+ Entry through Interactions with STIM1	PLOS ONE			English	Article							KIDNEY-DISEASE; CALCIUM-ENTRY; CHANNELS; CRAC; RECEPTOR; OLIGOMERIZATION; HOMEOSTASIS; EXPRESSION; APOPTOSIS; DEPLETION	Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a genetic disorder resulting in large kidney cysts and eventual kidney failure. Mutations in either the PKD1 or PKD2/TRPP2 genes and their respective protein products, polycystin-1 (PC1) and polycystin-2 (PC2) result in ADPKD. PC2 is known to function as a non-selective cation channel, but PC1's function and the function of PC1 cleavage products are not well understood. Here we identify an endogenous PC1 cleavage product, P100, a 100 kDa fragment found in both wild type and epitope tagged PKD1 knock-in mice. Expression of full length human PC1 (FL PC1) and the resulting P100 and C-Terminal Fragment (CTF) cleavage products in both MDCK and CHO cells significantly reduces the store operated Ca2+ entry (SOCE) resulting from thapsigargin induced store depletion. Exploration into the roles of P100 and CTF in SOCE inhibition reveal that P100, when expressed in Xenopus laevis oocytes, directly inhibits the SOCE currents but CTF does not, nor does P100 when containing the disease causing R4227X mutation. Interestingly, we also found that in PC1 expressing MDCK cells, translocation of the ER Ca2+ sensor protein STIM1 to the cell periphery was significantly altered. In addition, P100 Co-immunoprecipitates with STIM1 but CTF does not. The expression of P100 in CHO cells recapitulates the STIM1 translocation inhibition seen with FL PC1. These data describe a novel polycystin-1 cleavage product, P100, which functions to reduce SOCE via direct inhibition of STIM1 translocation; a function with consequences for ADPKD.	[Woodward, Owen M.; Li, Yun; Greenwell, Patrick; Guggino, William B.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Yu, Shengqiang; Qian, Feng] Johns Hopkins Sch Med, Div Nephrol, Dept Med, Baltimore, MD USA; [Wodarczyk, Claas; Boletta, Alessandra] Ist Sci San Raffaele, Div Genet & Cell Biol, Dulbecco Telethon Inst, I-20132 Milan, Italy	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Woodward, OM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	wguggino@jhmi.edu; fqjhupkd@jhmi.edu		Woodward, Owen M./0000-0001-9514-2180	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK032753-25A1, DK062199]; Fondazione Telethon Funding Source: Custom; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062199, R01DK032753, P30DK090868, R37DK032753] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Fondazione Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grants DK032753-25A1 (to W. B. G.) and DK062199 (to F. Q.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; Basavanna U, 2007, BIOCHEM BIOPH RES CO, V359, P367, DOI 10.1016/j.bbrc.2007.05.114; Bertuccio CA, 2009, J BIOL CHEM, V284, P21011, DOI 10.1074/jbc.M109.017756; Chauvet V, 2004, J CLIN INVEST, V114, P1433, DOI 10.1172/JCI200421753; Chiu WT, 2008, MOL BIOL CELL, V19, P2220, DOI 10.1091/mbc.E07-11-1170; Grimm DH, 2003, J BIOL CHEM, V278, P36786, DOI 10.1074/jbc.M306536200; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hartzell HC, 1996, J GEN PHYSIOL, V108, P157, DOI 10.1085/jgp.108.3.157; Hogan PG, 2007, TRENDS BIOCHEM SCI, V32, P235, DOI 10.1016/j.tibs.2007.03.009; Hooper KM, 2005, AM J PHYSIOL-RENAL, V289, pF521, DOI 10.1152/ajprenal.00355.2004; Kottgen M, 2007, BBA-MOL BASIS DIS, V1772, P836, DOI 10.1016/j.bbadis.2007.01.003; Lal M, 2008, HUM MOL GENET, V17, P3105, DOI 10.1093/hmg/ddn208; Li N, 2008, J CELL PHYSIOL, V216, P172, DOI 10.1002/jcp.21385; Li Y, 2005, J BIOL CHEM, V280, P41298, DOI 10.1074/jbc.M510082200; Li Y, 2009, J BIOL CHEM, V284, P36431, DOI 10.1074/jbc.M109.068916; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Manzati E, 2005, EXP CELL RES, V304, P391, DOI 10.1016/j.yexcr.2004.10.023; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Simons M, 2006, KIDNEY INT, V70, P854, DOI 10.1038/sj.ki.5001534; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Somlo S, 2001, CURR BIOL, V11, pR356, DOI 10.1016/S0960-9822(01)00193-2; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Sutters M, 2003, J LAB CLIN MED, V141, P91, DOI 10.1067/mlc.2003.13; Vanden Abeele F, 2002, CANCER CELL, V1, P169; Vanoverberghe K, 2004, CELL DEATH DIFFER, V11, P321, DOI 10.1038/sj.cdd.4401375; Wegierski T, 2009, EMBO J, V28, P490, DOI 10.1038/emboj.2008.307; Wei W, 2007, J BIOL CHEM, V282, P21729, DOI 10.1074/jbc.M703218200; Wildman SS, 2003, AM J PHYSIOL-RENAL, V285, pF1168, DOI 10.1152/ajprenal.00171.2003; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Wodarczyk C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007137; Yao Y, 1997, J GEN PHYSIOL, V109, P703, DOI 10.1085/jgp.109.6.703; Yu SQ, 2007, P NATL ACAD SCI USA, V104, P18688, DOI 10.1073/pnas.0708217104	40	50	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12305	10.1371/journal.pone.0012305	http://dx.doi.org/10.1371/journal.pone.0012305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808796	Green Published, gold			2022-12-27	WOS:000281153500003
J	Gomez, G; Pallas, V				Gomez, Gustavo; Pallas, Vicente			Noncoding RNA Mediated Traffic of Foreign mRNA into Chloroplasts Reveals a Novel Signaling Mechanism in Plants	PLOS ONE			English	Article							TRANSGENIC PLANTS; EXPRESSION; EVOLUTION; TRANSPORT; PROTEINS; NUCLEUS; PATHWAY; VIROIDS; IMPORT	Communication between chloroplasts and the nucleus is one of the milestones of the evolution of plants on earth. Proteins encoded by ancestral chloroplast-endogenous genes were transferred to the nucleus during the endosymbiotic evolution and originated this communication, which is mainly dependent on specific transit-peptides. However, the identification of nuclear-encoded proteins targeted to the chloroplast lacking these canonical signals suggests the existence of an alternative cellular pathway tuning this metabolic crosstalk. Non-coding RNAS (NcRNAs) are increasingly recognized as regulators of gene expression as they play roles previously believed to correspond to proteins. Avsunviroidae family viroids are the only noncoding functional RNAs that have been reported to traffic inside the chloroplasts. Elucidating mechanisms used by these pathogens to enter this organelle will unearth novel transport pathways in plant cells. Here we show that a viroid-derived NcRNA acting as a 5'UTR-end mediates the functional import of Green Fluorescent Protein (GFP) mRNA into chloroplast. This claim is supported by the observation at confocal microscopy of a selective accumulation of GFP in the chloroplast of the leaves expressing the chimeric vd-5'UTR/GFP and by the detection of the GFP mRNA in chloroplasts isolated from cells expressing this construct. These results support the existence of an alternative signaling mechanism in plants between the host cell and chloroplasts, where an ncRNA functions as a key regulatory molecule to control the accumulation of nuclear-encoded proteins in this organelle. In addition, our findings provide a conceptual framework to develop new biotechnological tools in systems using plant chloroplast as bioreactors. Finally, viroids of the family Avsunviroidae have probably evolved to subvert this signaling mechanism to regulate their differential traffic into the chloroplast of infected cells.	[Gomez, Gustavo; Pallas, Vicente] Univ Politecn Valencia, CSIC, IBMCP, E-46071 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Gomez, G (corresponding author), Univ Politecn Valencia, CSIC, IBMCP, E-46071 Valencia, Spain.	vpallas@ibmcp.upv.es	Gomez, Gustavo/E-3663-2012; Pallas, Vicente/N-1317-2014	Gomez, Gustavo/0000-0003-3715-7792; Pallas, Vicente/0000-0003-4954-989X	Spanish granting agency DGICYT [BIO2008-03528]; CSIC	Spanish granting agency DGICYT; CSIC	This work was supported by grant BIO2008-03528 from the Spanish granting agency DGICYT (www.micinn.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr M. Fares form critical reading of this manuscript. G. Gomez is the recipient of a contract from the CSIC.	Bruce BD, 2000, TRENDS CELL BIOL, V10, P440, DOI 10.1016/S0962-8924(00)01833-X; Bungard RA, 2004, BIOESSAYS, V26, P235, DOI 10.1002/bies.10405; Daniell H, 2009, TRENDS PLANT SCI, V14, P669, DOI 10.1016/j.tplants.2009.09.009; Daros JA, 2006, EMBO REP, V7, P593, DOI 10.1038/sj.embor.7400706; Ding B, 2009, ANNU REV PHYTOPATHOL, V47, P105, DOI 10.1146/annurev-phyto-080508-081927; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Fadda Z, 2003, J VIROL, V77, P6528, DOI 10.1128/JVI.77.11.6528-6532.2003; Fan PX, 2009, ELECTROPHORESIS, V30, P3024, DOI 10.1002/elps.200900172; Floss DM, 2007, TRANSGENIC RES, V16, P315, DOI 10.1007/s11248-007-9095-x; Gomez G, 2007, PLANT J, V51, P1041, DOI 10.1111/j.1365-313X.2007.03203.x; Gomez G, 2008, PLANT PHYSIOL, V148, P414, DOI 10.1104/pp.108.120808; Gomez G, 2009, TRENDS PLANT SCI, V14, P264, DOI 10.1016/j.tplants.2009.03.002; Hannapel DJ, 2010, J INTEGR PLANT BIOL, V52, P40, DOI 10.1111/j.1744-7909.2010.00911.x; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; Knoester M, 1998, P NATL ACAD SCI USA, V95, P1933, DOI 10.1073/pnas.95.4.1933; Koya V, 2005, INFECT IMMUN, V73, P8266, DOI 10.1128/IAI.73.12.8266-8274.2005; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; Lung B, 2006, NUCLEIC ACIDS RES, V34, P3842, DOI 10.1093/nar/gkl448; Nada A, 2004, J CELL SCI, V117, P3975, DOI 10.1242/jcs.01265; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Nicolai M, 2007, FEBS LETT, V581, P3921, DOI 10.1016/j.febslet.2007.07.017; Pogson BJ, 2008, TRENDS PLANT SCI, V13, P602, DOI 10.1016/j.tplants.2008.08.008; Roffey RA, 1996, PLANT PHYSIOL, V111, P1329, DOI 10.1104/pp.111.4.1329; Rymarquis LA, 2008, TRENDS PLANT SCI, V13, P329, DOI 10.1016/j.tplants.2008.02.009; Verma D, 2008, NAT PROTOC, V3, P739, DOI 10.1038/nprot.2007.522; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348	28	27	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12269	10.1371/journal.pone.0012269	http://dx.doi.org/10.1371/journal.pone.0012269			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808865	Green Published, gold			2022-12-27	WOS:000281075500008
J	Ding, SL; Chi, MM; Scull, BP; Rigby, R; Schwerbrock, NMJ; Magness, S; Jobin, C; Lund, PK				Ding, Shengli; Chi, Michael M.; Scull, Brooks P.; Rigby, Rachael; Schwerbrock, Nicole M. J.; Magness, Scott; Jobin, Christian; Lund, Pauline K.			High-Fat Diet: Bacteria Interactions Promote Intestinal Inflammation Which Precedes and Correlates with Obesity and Insulin Resistance in Mouse	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ADIPOSE-TISSUE; TNF-ALPHA; HEPATIC STEATOSIS; GUT MICROBIOTA; KAPPA-B; MECHANISMS; MICE; JNK	Background: Obesity induced by high fat (HF) diet is associated with inflammation which contributes to development of insulin resistance. Most prior studies have focused on adipose tissue as the source of obesity-associated inflammation. Increasing evidence links intestinal bacteria to development of diet-induced obesity (DIO). This study tested the hypothesis that HF western diet and gut bacteria interact to promote intestinal inflammation, which contributes to the progression of obesity and insulin resistance. Methodology/Principal Findings: Conventionally raised specific-pathogen free (CONV) and germ-free (GF) mice were given HF or low fat (LF) diet for 2-16 weeks. Body weight and adiposity were measured. Intestinal inflammation was assessed by evaluation of TNF-alpha mRNA and activation of a NF-kappa B-EGFP reporter gene. In CONV but not GF mice, HF diet induced increases in body weight and adiposity. HF diet induced ileal TNF-alpha mRNA in CONV but not GF mice and this increase preceded obesity and strongly and significantly correlated with diet induced weight gain, adiposity, plasma insulin and glucose. In CONV mice HF diet also resulted in activation of NF-kappa B-EGFP in epithelial cells, immune cells and endothelial cells of small intestine. Further experiments demonstrated that fecal slurries from CONV mice fed HF diet are sufficient to activate NF-kappa B-EGFP in GF NF-kappa B-EGFP mice. Conclusions/Significance: Bacteria and HF diet interact to promote proinflammatory changes in the small intestine, which precede weight gain and obesity and show strong and significant associations with progression of obesity and development of insulin resistance. To our knowledge, this is the first evidence that intestinal inflammation is an early consequence of HF diet which may contribute to obesity and associated insulin resistance. Interventions which limit intestinal inflammation induced by HF diet and bacteria may protect against obesity and insulin resistance.	[Ding, Shengli; Chi, Michael M.; Schwerbrock, Nicole M. J.; Jobin, Christian; Lund, Pauline K.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA; [Ding, Shengli; Chi, Michael M.; Schwerbrock, Nicole M. J.; Jobin, Christian; Lund, Pauline K.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Scull, Brooks P.] Vanderbilt Univ, Dept Gastroenterol, Med Ctr, Nashville, TN USA; [Rigby, Rachael] Univ Lancaster, Sch Hlth & Med, Div Biomed & Life Sci, Lancaster, England; [Magness, Scott] Univ N Carolina, Div Gastroenterol & Hepatol, Dept Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Vanderbilt University; Lancaster University; University of North Carolina; University of North Carolina Chapel Hill	Ding, SL (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA.	shengli_ding@med.unc.edu	Eckhardt, Erik/G-1567-2010; Rigby, Rachael/C-8206-2011; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Magness, Scott/0000-0002-2746-1224; Rigby, Rachael/0000-0002-6605-9609	National Institute of Environmental Health Sciences [P30ES10126];  [T32 MH075854-05]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH075854] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a postdoctoral fellowship award to M. Chi (T32 MH075854-05) and a pilot grant from the National Institute of Environmental Health Sciences (P30ES10126). IDOC: http://www.cpc.unc.edu/idoc. NIEHS: http://cehs.sph.unc.edu/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BGREENBERG AS, 2006, J CLIN NUTR S, V86, pS461; Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, pC1232, DOI 10.1152/ajpcell.00008.2006; Cani PD, 2008, PATHOL BIOL, V56, P305, DOI 10.1016/j.patbio.2007.09.008; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Dandona P, 1998, J CLIN ENDOCR METAB, V83, P2907, DOI 10.1210/jc.83.8.2907; De Taeye BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE713, DOI 10.1152/ajpendo.00194.2007; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Lee DE, 2009, AM J PHYSIOL-ENDOC M, V296, pE1210, DOI 10.1152/ajpendo.00015.2009; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Magness ST, 2004, J IMMUNOL, V173, P1561, DOI 10.4049/jimmunol.173.3.1561; Moller DE, 2000, TRENDS ENDOCRIN MET, V11, P212, DOI 10.1016/S1043-2760(00)00272-1; Pamir N, 2009, ENDOCRINOLOGY, V150, P4124, DOI 10.1210/en.2009-0137; Panagiotakos DB, 2005, ATHEROSCLEROSIS, V183, P308, DOI 10.1016/j.atherosclerosis.2005.03.010; Romanatto T, 2009, J BIOL CHEM, V284, P36213, DOI 10.1074/jbc.M109.030874; Serino M, 2007, DIABETES, V56, P2541, DOI 10.2337/db07-0360; Syrenicz A, 2006, NEUROENDOCRINOL LETT, V27, P453; Trayhurn P, 2006, J NUTR, V136, p1935S, DOI 10.1093/jn/136.7.1935S; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Visser M, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.1.e13; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	33	424	446	4	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12191	10.1371/journal.pone.0012191	http://dx.doi.org/10.1371/journal.pone.0012191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808947	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000280968000017
J	Ueshima, K; Fujiwara, T; Takao, S; Suzuki, E; Iwase, T; Doi, H; Subramanian, SV; Kawachi, I				Ueshima, Kazumune; Fujiwara, Takeo; Takao, Soshi; Suzuki, Etsuji; Iwase, Toshihide; Doi, Hiroyuki; Subramanian, S. V.; Kawachi, Ichiro			Does Social Capital Promote Physical Activity? A Population-Based Study in Japan	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; OF-SPORTS-MEDICINE; PUBLIC-HEALTH; MULTILEVEL ANALYSIS; POLITICAL-ECONOMY; UNITED-STATES; OLDER-ADULTS; LIFE-STYLE; PARTICIPATION; LEVEL	Background: To examine the association between individual-level social capital and physical activity. Methodology/Principal Findings: In February 2009, data were collected in a population-based cross-sectional survey in Okayama city, Japan. A cluster-sampling approach was used to randomly select 4,000 residents from 20 school districts. A total of 2260 questionnaires were returned (response rate: 57.4%). Individual-level social capital was assessed by an item inquiring about perceived trust of others in the community (cognitive dimension of social capital) categorized as low trust (43.0%), mid trust (38.6%), and high trust (17.3%), as well as participation in voluntary groups (structural dimension of social capital), which further distinguished between bonding (8.9%) and bridging (27.1%) social capital. Using logistic regression, we calculated the odds ratios (ORs) and 95% confidence intervals (CIs) for physical inactivity associated with each domain of social capital. Multiple imputation method was employed for missing data. Among total participants, 68.8% were physically active and 28.9% were inactive. Higher trust was associated with a significantly lower odds of physical inactivity (OR = 0.58, 95% CI = 0.42-0.79) compared with low trust. Both bridging and bonding social capital were marginally significantly associated with lower odds of physical inactivity (bridging, OR = 0.79, 95% CI = 0.62-1.00; bonding, OR = 0.71, 95% CI = 0.48-1.03) compared with lack of structural social capital. Conclusions/Significance: Low individual-level social capital, especially lower trust of others in the community, was associated with physical inactivity among Japanese adults.	[Ueshima, Kazumune; Takao, Soshi; Suzuki, Etsuji; Iwase, Toshihide; Doi, Hiroyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Epidemiol, Okayama, Japan; [Fujiwara, Takeo] Natl Inst Publ Hlth, Dept Hlth Promot, Sect Behav Sci, Saitama, Japan; [Subramanian, S. V.; Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	Okayama University; National Institute of Public Health - Japan; Harvard University; Harvard T.H. Chan School of Public Health	Ueshima, K (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Epidemiol, Okayama, Japan.	gmd19067@s.okayama-u.ac.jp	Suzuki, Etsuji/B-2342-2011	Suzuki, Etsuji/0000-0002-1290-5793	National Institutes of Health [NHLBI K25 HL081275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	No direct financial support or funding was available for conducting this study. S V Subramanian is partially supported by a National Institutes of Health Career Development Award (NHLBI K25 HL081275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SM, 2006, SCAND J PUBLIC HEALT, V34, P209, DOI 10.1080/14034940500307515; Dietz WH, 1996, P NUTR SOC, V55, P829, DOI 10.1079/PNS19960082; Duncan GE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002019; Fisher KJ, 2004, J AGING PHYS ACTIV, V12, P45, DOI 10.1123/japa.12.1.45; Fletcher GF, 1996, CIRCULATION, V94, P857, DOI 10.1161/01.CIR.94.4.857; Fujiwara T, 2008, J EPIDEMIOL COMMUN H, V62, P627, DOI 10.1136/jech.2007.064261; Fujiwara T, 2008, AM J PREV MED, V35, P139, DOI 10.1016/j.amepre.2008.04.015; Greiner KA, 2004, SOC SCI MED, V59, P2303, DOI 10.1016/j.socscimed.2004.03.023; HARPHAM T, 2006, SOCIAL CAPITAL MENTA, P11; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Humpel N, 2002, AM J PREV MED, V22, P188, DOI 10.1016/S0749-3797(01)00426-3; Inoue S, 2009, PREV MED, V48, P321, DOI 10.1016/j.ypmed.2009.01.014; Kawachi I, 2004, INT J EPIDEMIOL, V33, P682, DOI 10.1093/ije/dyh177; Kim D, 2006, SOC SCI MED, V63, P1045, DOI 10.1016/j.socscimed.2006.02.017; Lee HS, 2008, J GAMBL STUD, V24, P25, DOI 10.1007/s10899-007-9078-0; Leyden KM, 2003, AM J PUBLIC HEALTH, V93, P1546, DOI 10.2105/AJPH.93.9.1546; Lindstrom M, 2001, SOC SCI MED, V52, P441, DOI 10.1016/S0277-9536(00)00153-2; Lindstrom M, 2003, J EPIDEMIOL COMMUN H, V57, P23, DOI 10.1136/jech.57.1.23; LINDSTROM M, 2007, SOCIAL CAPITAL HLTH, P215; Mensink GBM, 1997, EUR J EPIDEMIOL, V13, P771, DOI 10.1023/A:1007474220830; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Szreter S, 2004, INT J EPIDEMIOL, V33, P650, DOI 10.1093/ije/dyh013; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Yusuf HR, 1996, ARCH INTERN MED, V156, P1321, DOI 10.1001/archinte.156.12.1321	26	71	74	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12135	10.1371/journal.pone.0012135	http://dx.doi.org/10.1371/journal.pone.0012135			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	637ZU	20808822	Green Published, gold, Green Submitted			2022-12-27	WOS:000280859700022
J	Moisenovich, MM; Ol'shevskaya, VA; Rokitskaya, TI; Ramonova, AA; Nikitina, RG; Savchenko, AN; Tatarskiy, VV; Kaplan, MA; Kalinin, VN; Kotova, EA; Uvarov, OV; Agapov, II; Antonenko, YN; Shtil, AA				Moisenovich, Mikhail M.; Ol'shevskaya, Valentina A.; Rokitskaya, Tatyana I.; Ramonova, Alla A.; Nikitina, Roza G.; Savchenko, Arina N.; Tatarskiy, Victor V., Jr.; Kaplan, Mikhail A.; Kalinin, Valery N.; Kotova, Elena A.; Uvarov, Oleg V.; Agapov, Igor I.; Antonenko, Yuri N.; Shtil, Alexander A.			Novel Photosensitizers Trigger Rapid Death of Malignant Human Cells and Rodent Tumor Transplants via Lipid Photodamage and Membrane Permeabilization	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; ROS RELEASE; DERIVATIVES; PORPHYRIN; OXIDATION; APOPTOSIS; PHTHALOCYANINES; MITOCHONDRIA; ANTIOXIDANTS; CHLORINS	Background: Apoptotic cascades may frequently be impaired in tumor cells; therefore, the approaches to circumvent these obstacles emerge as important therapeutic modalities. Methodology/Principal Findings: Our novel derivatives of chlorin e(6), that is, its amide (compound 2) and boronated amide (compound 5) evoked no dark toxicity and demonstrated a significantly higher photosensitizing efficacy than chlorin e(6) against transplanted aggressive tumors such as B16 melanoma and M-1 sarcoma. Compound 5 showed superior therapeutic potency. Illumination with red light of mammalian tumor cells loaded with 0.1 mu M of 5 caused rapid (within the initial minutes) necrosis as determined by propidium iodide staining. The laser confocal microscopy-assisted analysis of cell death revealed the following order of events: prior to illumination, 5 accumulated in Golgi cysternae, endoplasmic reticulum and in some (but not all) lysosomes. In response to light, the reactive oxygen species burst was concomitant with the drop of mitochondrial transmembrane electric potential, the dramatic changes of mitochondrial shape and the loss of integrity of mitochondria and lysosomes. Within 3-4 min post illumination, the plasma membrane became permeable for propidium iodide. Compounds 2 and 5 were one order of magnitude more potent than chlorin e(6) in photodamage of artificial liposomes monitored in a dye release assay. The latter effect depended on the content of non-saturated lipids; in liposomes consisting of saturated lipids no photodamage was detectable. The increased therapeutic efficacy of 5 compared with 2 was attributed to a striking difference in the ability of these photosensitizers to permeate through hydrophobic membrane interior as evidenced by measurements of voltage jump-induced relaxation of transmembrane current on planar lipid bilayers. Conclusions/Significance: The multimembrane photodestruction and cell necrosis induced by photoactivation of 2 and 5 are directly associated with membrane permeabilization caused by lipid photodamage.	[Moisenovich, Mikhail M.; Ramonova, Alla A.] Moscow MV Lomonosov State Univ, Dept Biol, Moscow, Russia; [Ol'shevskaya, Valentina A.; Savchenko, Arina N.; Kalinin, Valery N.] AN Nesmeyanov Organoelement Cpds Inst, Moscow, Russia; [Rokitskaya, Tatyana I.; Kotova, Elena A.; Antonenko, Yuri N.] Moscow MV Lomonosov State Univ, Belozersky Inst Physico Chem Biol, Moscow, Russia; [Nikitina, Roza G.; Kaplan, Mikhail A.] Med Radiol Res Ctr, Obninsk, Russia; [Tatarskiy, Victor V., Jr.; Shtil, Alexander A.] Blokhin Canc Ctr, Moscow, Russia; [Uvarov, Oleg V.] Prokhorov Inst Gen Phys, Moscow, Russia; [Agapov, Igor I.] Shumakov Res Ctr Transplantol & Artificial Organs, Moscow, Russia	Lomonosov Moscow State University; Russian Academy of Sciences; Nesmeyanov Institute of Organoelement Compounds; Lomonosov Moscow State University; N.N. Blokhin Russian Cancer Research Center; Russian Academy of Sciences; Prokhorov General Physics Institute of the Russian Academy of Sciences; V.I. Shumakov Federal Research Center of Transplantology & Artificial Organs	Moisenovich, MM (corresponding author), Moscow MV Lomonosov State Univ, Dept Biol, Moscow, Russia.	antonen@genebee.msu.su; shtilaa@yahoo.com	Rokitskaya, Tatyana/J-3541-2013; Ol'shevskaya, Valentina/ABA-9045-2020; Ramonova, Alena/U-2713-2017; Kotova, Elena/A-6214-2012; Tatarskiy, Victor V/K-1224-2017; Moisenovich, Michael/D-9428-2014; Shtil, Alexander A./K-1568-2017; Antonenko, Yuri N/K-1323-2013; Tatarskiy, Victor/T-1156-2019; Agapov, Igor/D-9450-2014; Uvarov, Oleg/I-1793-2018	Ramonova, Alena/0000-0003-0838-5454; Tatarskiy, Victor V/0000-0002-9080-5683; Shtil, Alexander A./0000-0001-6469-0221; Agapov, Igor/0000-0002-0273-4601; Uvarov, Oleg/0000-0001-9033-4802; Rokitskaya, Tatyana/0000-0002-7719-1875	Russian Foundation for Basic Research [09-04-97511-r-centre-a, 08-03-99084-r-ofi, 10-04-01518]; Ministry of Education and Science of Russian Federation [P2460, P2087]; Government of Sverdlovsk Region	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation); Government of Sverdlovsk Region	This work was supported by grants of Russian Foundation for Basic Research 09-04-97511-r-centre-a 08-03-99084-r-ofi, 10-04-01518, Federal Program 'Scientific and Scientific-Pedagogical Personnel of Innovative Russia for 2009-2013' of Ministry of Education and Science of Russian Federation (P2460 and P2087) and Government of Sverdlovsk Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARCLAY LRC, 1994, FREE RADICAL BIO MED, V16, P779, DOI 10.1016/0891-5849(94)90193-7; BENHUR E, 1995, TRANSFUSION, V35, P401, DOI 10.1046/j.1537-2995.1995.35595259150.x; Bourre L, 2003, J PHOTOCH PHOTOBIO B, V69, P179, DOI 10.1016/S1011-1344(03)00020-4; Brady NR, 2004, BIOPHYS J, V87, P2022, DOI 10.1529/biophysj.103.035097; Brandis A, 2005, PHOTOCHEM PHOTOBIOL, V81, P983, DOI 10.1562/2004-12-01-RA-389R1.1; Bronshtein I, 2004, BIOPHYS J, V87, P1155, DOI 10.1529/biophysj.104.041434; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Caruso JA, 2005, BIOCHEM J, V392, P325, DOI 10.1042/BJ20050313; DROR SB, 2009, PHOTOCHEM PHOTOBIOL, V8, P354, DOI DOI 10.1039/B814970D; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Floreani AA, 2007, CELL CYCLE, V6, P2835, DOI 10.4161/cc.6.22.4899; Girotti AW, 2001, J PHOTOCH PHOTOBIO B, V63, P103, DOI 10.1016/S1011-1344(01)00207-X; Hao E, 2008, ORG BIOMOL CHEM, V6, P3732, DOI 10.1039/b807836j; Hargus JA, 2007, PHOTOCHEM PHOTOBIOL, V83, P1006, DOI 10.1111/j.1751-1097.2007.00092.x; KETTERER B, 1971, J MEMBRANE BIOL, V5, P225, DOI 10.1007/BF01870551; Koudinova NV, 2003, INT J CANCER, V104, P782, DOI 10.1002/ijc.11002; Kuchin RAV, 2006, DOKL CHEM, V409, P135, DOI 10.1134/S0012500806080039; Kuznetsova NA, 2003, J PORPHYR PHTHALOCYA, V7, P147, DOI 10.1142/S1088424603000203; Lam M, 2001, J BIOL CHEM, V276, P47379, DOI 10.1074/jbc.M107678200; Lavi A, 2002, BIOPHYS J, V82, P2101, DOI 10.1016/S0006-3495(02)75557-4; Liu C, 2008, J AM CHEM SOC, V130, P14311, DOI 10.1021/ja8050298; Maisch T, 2009, MINI-REV MED CHEM, V9, P974, DOI 10.2174/138955709788681582; Melnikova VO, 2000, INT J CANCER, V88, P798, DOI 10.1002/1097-0215(20001201)88:5<798::AID-IJC18>3.0.CO;2-8; Mojzisova H, 2007, EUR BIOPHYS J BIOPHY, V36, P943, DOI 10.1007/s00249-007-0204-9; Mojzisova H, 2009, PHOTOCH PHOTOBIO SCI, V8, P778, DOI 10.1039/b822269j; MUELLER P, 1963, J PHYS CHEM-US, V67, P534, DOI 10.1021/j100796a529; Nieminen AL, 2003, INT REV CYTOL, V224, P29, DOI 10.1016/S0074-7696(05)24002-0; O'Connor AE, 2009, PHOTOCHEM PHOTOBIOL, V85, P1053, DOI 10.1111/j.1751-1097.2009.00585.x; Ohara K, 2009, J PHOTOCH PHOTOBIO B, V97, P132, DOI 10.1016/j.jphotobiol.2009.08.010; Ol'shevskaya VA, 2006, ORG BIOMOL CHEM, V4, P3815, DOI 10.1039/b607766h; Ol'shevskaya VA, 2007, B KOREAN CHEM SOC, V28, P1910; Ol'shevskaya VA, 2009, J ORGANOMET CHEM, V694, P1632, DOI 10.1016/j.jorganchem.2008.11.013; Ol'shevskaya VA, 2009, BIOORGAN MED CHEM, V17, P1297, DOI 10.1016/j.bmc.2008.12.016; Palma M, 2008, J PHYS CHEM A, V112, P13574, DOI 10.1021/jp804350n; Pandey RK, 1996, PHOTOCHEM PHOTOBIOL, V64, P194, DOI 10.1111/j.1751-1097.1996.tb02442.x; Pashkovskaya A, 2010, LANGMUIR, V26, P5726, DOI 10.1021/la903867a; Reiners JJ, 2002, CELL DEATH DIFFER, V9, P934, DOI 10.1038/sj.cdd.4401048; Renner M. W., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P145, DOI 10.2174/187152006776119135; Robertson CA, 2009, J PHOTOCH PHOTOBIO B, V96, P1, DOI 10.1016/j.jphotobiol.2009.04.001; Rokitskaya TI, 2008, J MEMBRANE BIOL, V224, P9, DOI 10.1007/s00232-008-9124-6; Sakharov DV, 2005, FEBS LETT, V579, P1255, DOI 10.1016/j.febslet.2005.01.024; Shchekotikhin AE, 2009, BIOORGAN MED CHEM, V17, P1861, DOI 10.1016/j.bmc.2009.01.047; Sholto A, 2008, PHOTOCH PHOTOBIO SCI, V7, P344, DOI 10.1039/b716377k; SMITH KM, 1985, J AM CHEM SOC, V107, P4946, DOI 10.1021/ja00303a021; Stein WD, 2004, CURR DRUG TARGETS, V5, P333, DOI 10.2174/1389450043345489; van den Heever SC, 2006, J ATMOS SCI, V63, P1752, DOI 10.1175/JAS3713.1; Wu YX, 2006, CELL CYCLE, V5, P729, DOI 10.4161/cc.5.7.2630; Ytzhak S, 2010, J PHYS CHEM B, V114, P10097, DOI 10.1021/jp103355m; Zhivotovsky B, 2004, CELL CYCLE, V3, P64; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	51	29	32	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12717	10.1371/journal.pone.0012717	http://dx.doi.org/10.1371/journal.pone.0012717			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856679	gold, Green Published, Green Submitted			2022-12-27	WOS:000281815800013
J	Wang, QH; Chen, K; Liu, R; Zhao, F; Gupta, S; Zhang, NN; Prud'homme, GJ				Wang, Qinghua; Chen, Kui; Liu, Rui; Zhao, Fang; Gupta, Sandeep; Zhang, Nina; Prud'homme, Gerald J.			Novel GLP-1 Fusion Chimera as Potent Long Acting GLP-1 Receptor Agonist	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; IN-VIVO; GLUCOSE-HOMEOSTASIS; INSULIN-SECRETION; DIABETES-MELLITUS; INCRETIN HORMONES; DB/DB MICE; CELL MASS; IGG-FC; GENE	GLP-1 has a variety of anti-diabetic effects. However, native GLP-1 is not suitable for therapy of diabetes due to its short half-life (t1/2<2 min). To circumvent this, we developed a long-lasting GLP-1 receptor agonist by the fusion of GLP-1 with human IgG2 Fc (GLP-1/hlgG2). ELISA-based receptor binding assay demonstrated that GLP-1/hlgG2 had high binding affinity to the GLP-1R in INS-1 cells (Kd = 13.90 +/- 1.52 nM). Upon binding, GLP-1/hlgG2 was rapidly internalized by INS-1 cells in a dynamin-dependent manner. Insulin RIA showed that GLP-1/IgG2 dose-dependently stimulated insulin secretion from INS-1 cells. Pharmacokinetic studies in CD1 mice showed that with intraperitoneal injection (i.p.), the GLP-1/hlgG2 peaked at 30 minutes in circulation and maintained a plateau for >168 h. Intraperitoneal glucose tolerance test (IPGTT) in mice showed that GLP-1/hlgG2 significantly decreased glucose excursion. Furthermore, IPGTT performed on mice one week after a single drug-injection also displayed significantly reduced glucose excursion, indicating that GLP-1/hlgG2 fusion protein has long-lasting effects on the modulation of glucose homeostasis. GLP-1/hlgG2 was found to be effective in reducing the incidence of diabetes in multiple-low-dose streptozotocin-induced type 1 diabetes in mice. Together, the long-lasting bioactive GLP-1/hlgG2 retains native GLP-1 activities and thus may serve as a potent GLP-1 receptor agonist.	[Wang, Qinghua; Chen, Kui; Liu, Rui; Zhao, Fang; Gupta, Sandeep; Zhang, Nina] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Div Endocrinol & Metab, Toronto, ON M5B 1W8, Canada; [Wang, Qinghua] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Wang, Qinghua] Univ Toronto, Dept Med, Toronto, ON, Canada; [Prud'homme, Gerald J.] St Michaels Hosp, Dept Lab Med, Toronto, ON M5B 1W8, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Wang, QH (corresponding author), St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Div Endocrinol & Metab, 30 Bond St, Toronto, ON M5B 1W8, Canada.	qinghua.wang@utoronto.ca	Wang, Qinghua/GVT-3252-2022; zhang, nina/GXH-0962-2022		Juvenile Diabetes Research Foundation; St Michael's Hospital; Canadian Institute for Health Research (CIHR); Canadian Diabetes association	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); St Michael's Hospital(University of Toronto); Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes association	This work was supported by grants from the Juvenile Diabetes Research Foundation (PI: Q Wang; Co-PI: G Prud'homme) and St Michael's Hospital. Research in the Wang lab was supported by Canadian Institute for Health Research (CIHR) and Canadian Diabetes association. Q Wang is supported by CIHR New Investigator Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahangari G, 2004, INT J IMMUNOPATH PH, V17, P33, DOI 10.1177/039463200401700105; Baggio LL, 2004, DIABETES, V53, P2492, DOI 10.2337/diabetes.53.9.2492; Baggio LL, 2004, DIABETES, V53, pS205, DOI 10.2337/diabetes.53.suppl_3.S205; BARAK LS, 1994, J BIOL CHEM, V269, P2790; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Dumont JA, 2006, BIODRUGS, V20, P151, DOI 10.2165/00063030-200620030-00002; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Holst JJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE199, DOI 10.1152/ajpendo.00545.2003; Huang CC, 2009, CURR OPIN BIOTECH, V20, P692, DOI 10.1016/j.copbio.2009.10.010; HUPESODMANN K, 1995, REGUL PEPTIDES, V58, P149, DOI 10.1016/0167-0115(95)00063-H; Irwin DM, 1997, P NATL ACAD SCI USA, V94, P7915, DOI 10.1073/pnas.94.15.7915; Jefferis R, 2002, IMMUNOL LETT, V82, P57, DOI 10.1016/S0165-2478(02)00019-6; Jorgensen R, 2005, MOL ENDOCRINOL, V19, P812, DOI 10.1210/me.2004-0312; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; King LB, 2000, IMMUNOL REV, V176, P86; Kumar M, 2007, GENE THER, V14, P162, DOI 10.1038/sj.gt.3302836; Kumpel BM, 2002, TRANSFUS CLIN BIOL, V9, P9, DOI 10.1016/S1246-7820(01)00209-9; Larrick J W, 1991, Hum Antibodies Hybridomas, V2, P172; Larsen J, 2001, DIABETES CARE, V24, P1416, DOI 10.2337/diacare.24.8.1416; Lee AY, 2002, ACTA DERM-VENEREOL, V82, P114, DOI 10.1080/00015550252948149; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Meier JJ, 2005, DIABETES-METAB RES, V21, P91, DOI 10.1002/dmrr.538; Melo MEF, 2002, J IMMUNOL, V168, P4788, DOI 10.4049/jimmunol.168.9.4788; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; MURPHY K, 2008, JANEWAYS IMMUNOBIOLO, P409; Patti ME, 2005, DIABETOLOGIA, V48, P2236, DOI 10.1007/s00125-005-1933-x; Perfetti R, 2000, ENDOCRINOLOGY, V141, P4600, DOI 10.1210/en.141.12.4600; Picha KM, 2008, DIABETES, V57, P1926, DOI 10.2337/db07-1775; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Prislovsky A, 2008, EXP HEMATOL, V36, P609, DOI 10.1016/j.exphem.2007.12.019; RUIZGRANDE C, 1990, CAN J PHYSIOL PHARM, V68, P1568, DOI 10.1139/y90-239; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Soltani N, 2007, GENE THER, V14, P981, DOI 10.1038/sj.gt.3302944; Syme CA, 2006, MOL ENDOCRINOL, V20, P3400, DOI 10.1210/me.2006-0178; Takai T, 2005, J CLIN IMMUNOL, V25, P1, DOI 10.1007/s10875-005-0353-8; THORENS B, 1993, DIABETES, V42, P1219, DOI 10.2337/diabetes.42.9.1219; Todd JF, 1997, EUR J CLIN INVEST, V27, P533, DOI 10.1046/j.1365-2362.1997.1490691.x; Uray K, 2004, J MOL RECOGNIT, V17, P95, DOI 10.1002/jmr.652; Wang Q, 2002, DIABETOLOGIA, V45, P1263, DOI 10.1007/s00125-002-0828-3; Wang YH, 1997, J CLIN INVEST, V99, P2883, DOI 10.1172/JCI119482; Weir ANC, 2002, BIOCHEM SOC T, V30, P512, DOI 10.1042/bst0300512; Widmann C, 1997, MOL ENDOCRINOL, V11, P1094, DOI 10.1210/me.11.8.1094; Woof JM, 2004, NAT REV IMMUNOL, V4, P89, DOI 10.1038/nri1266; YU SS, 1993, J BIOL CHEM, V268, P337; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7	46	32	40	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12734	10.1371/journal.pone.0012734	http://dx.doi.org/10.1371/journal.pone.0012734			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856794	gold, Green Submitted, Green Published			2022-12-27	WOS:000281815800015
J	Astarita, G; Jung, KM; Berchtold, NC; Nguyen, VQ; Gillen, DL; Head, E; Cotman, CW; Piomelli, D				Astarita, Giuseppe; Jung, Kwang-Mook; Berchtold, Nicole C.; Nguyen, Vinh Q.; Gillen, Daniel L.; Head, Elizabeth; Cotman, Carl W.; Piomelli, Daniele			Deficient Liver Biosynthesis of Docosahexaenoic Acid Correlates with Cognitive Impairment in Alzheimer's Disease	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; PLASMALOGEN DEFICIENCY; CELL-SURVIVAL; AMYLOID-BETA; RAT-LIVER; BRAIN; DIET; RETROCONVERSION; PHOSPHOLIPIDS; METABOLISM	Reduced brain levels of docosahexaenoic acid (C22: 6n-3), a neurotrophic and neuroprotective fatty acid, may contribute to cognitive decline in Alzheimer's disease. Here, we investigated whether the liver enzyme system that provides docosahexaenoic acid to the brain is dysfunctional in this disease. Docosahexaenoic acid levels were reduced in temporal cortex, mid-frontal cortex and cerebellum of subjects with Alzheimer's disease, compared to control subjects (P = 0.007). Mini Mental State Examination (MMSE) scores positively correlated with docosahexaenoic/alpha-linolenic ratios in temporal cortex (P = 0.005) and mid-frontal cortex (P = 0.018), but not cerebellum. Similarly, liver docosahexaenoic acid content was lower in Alzheimer's disease patients than control subjects (P = 0.011). Liver docosahexaenoic/alpha-linolenic ratios correlated positively with MMSE scores (r = 0.78; P<0.0001), and negatively with global deterioration scale grades (P = 0.013). Docosahexaenoic acid precursors, including tetracosahexaenoic acid (C24:6n-3), were elevated in liver of Alzheimer's disease patients (P = 0.041), whereas expression of peroxisomal D-bifunctional protein, which catalyzes the conversion of tetracosahexaenoic acid into docosahexaenoic acid, was reduced (P = 0.048). Other genes involved in docosahexaenoic acid metabolism were not affected. The results indicate that a deficit in D-bifunctional protein activity impairs docosahexaenoic acid biosynthesis in liver of Alzheimer's disease patients, lessening the flux of this neuroprotective fatty acid to the brain.	[Astarita, Giuseppe; Jung, Kwang-Mook; Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Astarita, Giuseppe] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, Rome, Italy; [Berchtold, Nicole C.; Cotman, Carl W.] Univ Calif Irvine, Inst Brain Aging & Dementia, Irvine, CA 92717 USA; [Nguyen, Vinh Q.; Gillen, Daniel L.] Univ Calif Irvine, Dept Stat, Irvine, CA 92717 USA; [Head, Elizabeth] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Piomelli, Daniele] Italian Inst Technol, Unit Drug Discovery & Dev, Genoa, Italy	University of California System; University of California Irvine; University of Rome Tor Vergata; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Kentucky; University of California System; University of California Irvine; Istituto Italiano di Tecnologia - IIT	Astarita, G (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA.	piomelli@uci.edu	Astarita, Giuseppe/AAD-1239-2019; Jung, Kwang-Mook/F-1035-2018; Astarita, Giuseppe/N-7346-2014	Jung, Kwang-Mook/0000-0003-4096-6953; Astarita, Giuseppe/0000-0001-6700-301X	National Institutes on Drug Abuse (ARRA); Agilent Foundation; National Institute on Aging [P50 AG016573, P01 AG00538, P30 AG19610]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901]; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE ON AGING [P30AG019610, P50AG016573, P01AG000538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012447] Funding Source: NIH RePORTER	National Institutes on Drug Abuse (ARRA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Agilent Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services; Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institutes on Drug Abuse (ARRA) and the Agilent Foundation (to D. Piomelli). The Alzheimer's Disease Research Center Neuropathology Core and the Institute for Brain Aging and Dementia of the University of California Irvine are supported by grants from the National Institute on Aging (P50 AG016573 and P01 AG00538). The Brain and Body Donation Program of Sun City, Arizona, is supported by a grant from the National Institute on Aging (P30 AG19610), the Arizona Department of Health Services (contract 211002), the Arizona Biomedical Research Commission (contracts 4001, 0011 and 05-901 to the Arizona Parkinson's Disease Consortium) and the Prescott Family Initiative of the Michael J. Fox Foundation for Parkinson's Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazan N. G., 1990, NUTR BRAIN, V8, P1; BAZAN NG, 1986, BIOCHEM BIOPH RES CO, V141, P600, DOI 10.1016/S0006-291X(86)80215-7; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; BROOKSBANK BWL, 1989, MOL CHEM NEUROPATHOL, V11, P157, DOI 10.1007/BF03160049; Burdge GC, 2005, REPROD NUTR DEV, V45, P581, DOI 10.1051/rnd:2005047; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Corrigan FM, 1998, INT J BIOCHEM CELL B, V30, P197, DOI 10.1016/S1357-2725(97)00125-8; Crawford MA, 2009, ANN NUTR METAB, V55, P202, DOI 10.1159/000229003; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Cunnane SC, 2009, PROG LIPID RES, V48, P239, DOI 10.1016/j.plipres.2009.04.001; Fraser T, 2010, NEUROCHEM RES, V35, P503, DOI 10.1007/s11064-009-0087-5; Goodenowe DB, 2007, J LIPID RES, V48, P2485, DOI 10.1194/jlr.P700023-JLR200; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Guan ZZ, 1999, J NEUROPATH EXP NEUR, V58, P740, DOI 10.1097/00005072-199907000-00008; HAINING JL, 1973, EXP GERONTOL, V8, P85, DOI 10.1016/0531-5565(73)90018-1; Han XL, 2001, J NEUROCHEM, V77, P1168, DOI 10.1046/j.1471-4159.2001.00332.x; Innis SM, 2008, BRAIN RES, V1237, P35, DOI 10.1016/j.brainres.2008.08.078; Jiang LL, 1997, J BIOCHEM-TOKYO, V121, P506; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Lukiw WJ, 2008, J NUTR, V138, P2510, DOI 10.3945/jn.108.096016; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Marszalek JR, 2005, ANNU REV CELL DEV BI, V21, P633, DOI 10.1146/annurev.cellbio.21.122303.120624; MARTINEZ M, 1992, BRAIN RES, V583, P171, DOI 10.1016/S0006-8993(10)80021-6; MARTINEZ M, 1990, NEUROLOGY, V40, P1292, DOI 10.1212/WNL.40.8.1292; MOORE SA, 1995, J LIPID RES, V36, P2433; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Prasad MR, 1998, NEUROCHEM RES, V23, P81, DOI 10.1023/A:1022457605436; Prince M, 2009, WORLD ALZHEIMER REPO; Rapoport SI, 2007, PROSTAG LEUKOTR ESS, V77, P251, DOI 10.1016/j.plefa.2007.10.023; Rapoport SI, 2010, PROSTAG LEUKOTR ESS, V82, P273, DOI 10.1016/j.plefa.2010.02.015; Rapoport SI, 2009, PROSTAG LEUKOTR ESS, V81, P119, DOI 10.1016/j.plefa.2009.05.021; SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903; SKINNER ER, 1993, BRAIN, V116, P717, DOI 10.1093/brain/116.3.717; SODERBERG M, 1991, LIPIDS, V26, P421, DOI 10.1007/BF02536067; Sprecher H, 1995, J LIPID RES, V36, P2471; Su HM, 2001, J BIOL CHEM, V276, P38115; VOSS A, 1991, J BIOL CHEM, V266, P19995; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Yilmaz Y, 2009, HEPATOLOGY, V49, P698, DOI 10.1002/hep.22752; Youssef J, 1999, ENVIRON HEALTH PERSP, V107, P791, DOI 10.2307/3454575	43	150	153	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12538	10.1371/journal.pone.0012538	http://dx.doi.org/10.1371/journal.pone.0012538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IV	20838618	Green Published, gold			2022-12-27	WOS:000281687100003
J	Frynta, D; Liskova, S; Bultmann, S; Burda, H				Frynta, Daniel; Liskova, Silvie; Bueltmann, Sebastian; Burda, Hynek			Being Attractive Brings Advantages: The Case of Parrot Species in Captivity	PLOS ONE			English	Article							ZOO VISITOR PREFERENCES; ARK; REINTRODUCTION; IMITATION; SURVIVAL; ANIMALS; AMAZON; TRADE; BIRDS; NEST	Background: Parrots are one of the most frequently kept and bred bird orders in captivity. This increases poaching and thus the potential importance of captive populations for rescue programmes managed by zoos and related institutions. Both captive breeding and poaching are selective and may be influenced by the attractiveness of particular species to humans. In this paper, we tested the hypothesis that the size of zoo populations is not only determined by conservation needs, but also by the perceived beauty of individual parrot species assessed by human observers. Methodology/Principal Findings: For the purpose of data collection, we defined four sets of species (40 parrots, 367 parrots, 34 amazons, 17 macaws). Then, we asked 776 human respondents to evaluate parrot pictures of the selected species according to perceived beauty and we analyzed its association with color and morphological characters. Irrespective of the species set, we found a good agreement among the respondents. The preferred species tended to be large, colorful, and long-tailed. Conclusions/Significance: We repeatedly confirmed significant, positive association between the perceived beauty and the size of worldwide zoo population. Moreover, the range size and body size appeared to be significant predictors of zoo population size. In contrast, the effects of other explanatory variables, including the IUCN (International Union for Conservation of Nature) listing, appeared insignificant. Our results may suggest that zoos preferentially keep beautiful parrots and pay less attention to conservation needs.	[Frynta, Daniel; Liskova, Silvie] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Bueltmann, Sebastian; Burda, Hynek] Univ Duisburg Essen, Dept Gen Zool, Fac Biosci, Essen, Germany	Charles University Prague; University of Duisburg Essen	Frynta, D (corresponding author), Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic.	frynta@centrum.cz	Rádlová, Silvie/D-5532-2017; Frynta, Daniel/L-7350-2016; Bultmann, Sebastian/AAC-7729-2020; Rádlová, Silvie/L-3388-2019	Rádlová, Silvie/0000-0003-3581-9780; Frynta, Daniel/0000-0002-1375-7972; Rádlová, Silvie/0000-0003-3581-9780	Grant Agency of the Academy of Sciences of the Czech Republic [IAA601410803]	Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic)	The project was supported by the The Grant Agency of the Academy of Sciences of the Czech Republic (project No. IAA601410803), http://www.isvav.cz/projectDetail.do?rowId = IAA601410803. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PK, 2003, SOC ANIM, V11, P393, DOI 10.1163/156853003322796109; [Anonymous], SPSS VERS 16 0; ARNDT T, 2004, LEXICON PARROTS 2 0; Balmford A, 2000, CONSERV BIOL, V14, P1193, DOI 10.1046/j.1523-1739.2000.99078.x; Balmford A, 1996, CONSERV BIOL, V10, P719, DOI 10.1046/j.1523-1739.1996.10030719.x; BEISSINGER SR, 1992, BIOSCIENCE, V42, P164, DOI 10.2307/1311821; *BIRDLIFE INT, BIRDLIFE CHECKL BIRD; Borsari A, 2005, ANIM COGN, V8, P48, DOI 10.1007/s10071-004-0221-3; Brightsmith D, 2005, BIOL CONSERV, V121, P465, DOI 10.1016/j.biocon.2004.05.016; BROCK MK, 1992, P NATL ACAD SCI USA, V89, P11121, DOI 10.1073/pnas.89.23.11121; Collar N.J., 1992, P1; Collazo JA, 2003, CONDOR, V105, P198, DOI 10.1650/0010-5422(2003)105[0198:SOCHPR]2.0.CO;2; Del Hoyo, 1997, HDB BIRDS WORLD SAND; Emery NJ, 2007, PHILOS T R SOC B, V362, P489, DOI 10.1098/rstb.2006.1991; Flesness NR, 1995, ZOO BIOL, V14, P509, DOI 10.1002/zoo.1430140603; Forshaw J.M., 2006, PARROTS WORLD IDENTI; Frynta D., 2009, P299; Funk MS, 2002, ANIM COGN, V5, P167, DOI 10.1007/s10071-002-0149-4; Gonzalez JA, 2003, BIOL CONSERV, V114, P437, DOI 10.1016/S0006-3207(03)00071-5; HAAHR M, TRUE RANDOM NUMBERS; Herrera M, 2007, BIRD CONSERV INT, V17, P295, DOI 10.1017/S0959270907000858; Huber L, 2006, ANIM COGN, V9, P295, DOI 10.1007/s10071-006-0033-8; Jeggo D. F., 2000, International Zoo Yearbook, V37, P214, DOI 10.1111/j.1748-1090.2000.tb00726.x; Juniper T, 2003, PARROTS GUIDE PARROT; Maresova J, 2008, ECOL ECON, V64, P554, DOI 10.1016/j.ecolecon.2007.03.012; Maresova J, 2009, THEOR BIOSCI, V128, P227, DOI 10.1007/s12064-009-0075-y; Maresova J, 2009, ETHOLOGY, V115, P297, DOI 10.1111/j.1439-0310.2009.01620.x; Meyers JM, 1996, WILDLIFE SOC B, V24, P15; Mui R, 2008, P R SOC B, V275, P2547, DOI 10.1098/rspb.2008.0566; Munn CA, 2006, MANUAL OF PARROT BEHAVIOR, P27, DOI 10.1002/9780470344651.ch3; Pain DJ, 2006, ANIM CONSERV, V9, P322, DOI 10.1111/j.1469-1795.2006.00040.x; PEPPERBERG IM, 1994, J COMP PSYCHOL, V108, P36, DOI 10.1037/0735-7036.108.1.36; Pepperberg IM., 1999, ALEX STUDIES COGNITI; Pepperberg IM, 2006, ANIM COGN, V9, P377, DOI 10.1007/s10071-006-0034-7; ROBILLER F, 1992, HDB VOGELPFLEGE PAPA, V1; Sanz V, 1998, CONSERV BIOL, V12, P430, DOI 10.1046/j.1523-1739.1998.96261.x; Schmitz C., LIMESURVEY OPEN SOUR; SHEPPARD C, 1995, ZOO BIOL, V14, P197, DOI 10.1002/zoo.1430140302; SNYDER NFR, 1994, CONDOR, V96, P845, DOI 10.2307/1369097; SOULE M, 1986, ZOO BIOL, V5, P101, DOI 10.1002/zoo.1430050205; *STATSOFT, STAT; Ward PI, 1998, CONSERV BIOL, V12, P1408, DOI 10.1046/j.1523-1739.1998.97402.x; Ward PI, 2000, CONSERV BIOL, V14, P1196, DOI 10.1046/j.1523-1739.2000.00026.x; WAZA, 2005, BUILD FUT WILDL WORL; White TH, 2005, CONDOR, V107, P424, DOI 10.1650/7672; Wilkinson R., 2000, International Zoo Yearbook, V37, P36, DOI 10.1111/j.1748-1090.2000.tb00705.x; Wright TF, 2001, CONSERV BIOL, V15, P710, DOI 10.1046/j.1523-1739.2001.015003710.x; Wright TF, 2008, MOL BIOL EVOL, V25, P2141, DOI 10.1093/molbev/msn160; Zentall TR, 2004, LEARN BEHAV, V32, P15, DOI 10.3758/BF03196003	49	61	62	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12568	10.1371/journal.pone.0012568	http://dx.doi.org/10.1371/journal.pone.0012568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830206	Green Published, gold, Green Submitted			2022-12-27	WOS:000281631300008
J	Read, JCA; Phillipson, GP; Serrano-Pedraza, I; Milner, AD; Parker, AJ				Read, Jenny C. A.; Phillipson, Graeme P.; Serrano-Pedraza, Ignacio; Milner, A. David; Parker, Andrew J.			Stereoscopic Vision in the Absence of the Lateral Occipital Cortex	PLOS ONE			English	Article							VERGENCE EYE-MOVEMENTS; CORTICAL AREA; RELATIVE DISPARITY; DEPTH-PERCEPTION; BINOCULAR DEPTH; PSYCHOMETRIC FUNCTION; VISUAL-CORTEX; REPRESENTATION; MOTION; NEURONS	Both dorsal and ventral cortical visual streams contain neurons sensitive to binocular disparities, but the two streams may underlie different aspects of stereoscopic vision. Here we investigate stereopsis in the neurological patient D. F., whose ventral stream, specifically lateral occipital cortex, has been damaged bilaterally, causing profound visual form agnosia. Despite her severe damage to cortical visual areas, we report that DF's stereo vision is strikingly unimpaired. She is better than many control observers at using binocular disparity to judge whether an isolated object appears near or far, and to resolve ambiguous structure-from-motion. DF is, however, poor at using relative disparity between features at different locations across the visual field. This may stem from a difficulty in identifying the surface boundaries where relative disparity is available. We suggest that the ventral processing stream may play a critical role in enabling healthy observers to extract fine depth information from relative disparities within one surface or between surfaces located in different parts of the visual field.	[Read, Jenny C. A.; Serrano-Pedraza, Ignacio] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Phillipson, Graeme P.] Univ Edinburgh, Inst Adapt & Neural Computat, Sch Informat, Edinburgh, Midlothian, Scotland; [Milner, A. David] Univ Durham, Dept Psychol, Durham DH1 3LE, England; [Parker, Andrew J.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	Newcastle University - UK; University of Edinburgh; Durham University; University of Oxford	Read, JCA (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.	j.c.a.read@ncl.ac.uk	Read, Jenny/A-7493-2013; Serrano-Pedraza, Ignacio/B-4862-2014; Parker, Andrew J/I-7867-2013	Read, Jenny/0000-0002-9029-5185; Serrano-Pedraza, Ignacio/0000-0002-4464-1905; Parker, Andrew J/0000-0001-5800-0407	Royal Society [UF041260]; MRC [G0601566, G0401090, G0700399]; Wellcome Trust [G0700399]; EPSRC; Medical Research Council [G0700399, G0601566, G0400132, G0401090] Funding Source: researchfish; MRC [G0400593, G0400132, G0802171, G9409531] Funding Source: UKRI	Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Royal Society (royalsociety.org): University Research Fellowship UF041260 to JCAR. MRC (www.mrc.ac.uk): New Investigator Award G0601566 to JCAR, grant G0401090 to ADM and grant G0700399 to AJP and others. Wellcome Trust (www.wellcome.ac.uk): grant G0700399 to AJP. EPSRC (www.epsrc.ac.uk): Neuroinformatics Doctoral Training Centre studentship to GPP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADLEY DC, 1995, NATURE, V373, P609, DOI 10.1038/373609a0; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bredfeldt CE, 2006, J NEUROSCI, V26, P7581, DOI 10.1523/JNEUROSCI.5308-05.2006; Bridge H, 2007, J VISION, V7, DOI 10.1167/7.14.15; Chowdhury SA, 2008, NEURON, V60, P367, DOI 10.1016/j.neuron.2008.08.023; COGAN AI, 1993, VISION RES, V33, P1959, DOI 10.1016/0042-6989(93)90021-N; Crawford JR, 2007, COGN NEUROPSYCHOL, V24, P343, DOI 10.1080/02643290701290146; Crawford JR, 2004, CORTEX, V40, P533, DOI 10.1016/S0010-9452(08)70145-X; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; Cumming BG, 1997, NATURE, V389, P280, DOI 10.1038/38487; Cumming BG, 1998, PERCEPTION, V27, P1367, DOI 10.1068/p271367; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; Dijkerman HC, 1996, EXP BRAIN RES, V112, P442; Dijkerman HC, 1999, NEUROPSYCHOLOGIA, V37, P1505, DOI 10.1016/S0028-3932(99)00063-9; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; ERKELENS CJ, 1985, VISION RES, V25, P583, DOI 10.1016/0042-6989(85)90164-6; Gilaie-Dotan S, 2002, HUM BRAIN MAPP, V15, P67, DOI 10.1002/hbm.10008; GILLAM B, 1984, PERCEPT PSYCHOPHYS, V36, P559, DOI 10.3758/BF03207516; Gillam B, 2007, PERCEPTION, V36, P596, DOI 10.1068/p5535; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Haefner RM, 2008, NEURON, V57, P147, DOI 10.1016/j.neuron.2007.10.042; HUMPHREY GK, 1991, PSYCHOL SCI, V2, P331, DOI 10.1111/j.1467-9280.1991.tb00161.x; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; Janssen P, 2000, NEURON, V27, P385, DOI 10.1016/S0896-6273(00)00045-3; Janssen P, 2003, NEURON, V37, P693, DOI 10.1016/S0896-6273(03)00023-0; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; Julesz B., 1971, FDN CYCLOPEAN PERCEP; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Krug K, 2004, J NEUROPHYSIOL, V92, P1586, DOI 10.1152/jn.00851.2003; Marotta JJ, 1997, EXP BRAIN RES, V116, P113, DOI 10.1007/PL00005731; Masson GS, 1997, NATURE, V389, P283, DOI 10.1038/38496; Mendola JD, 1999, J NEUROSCI, V19, P8560; MILNER AD, 1991, BRAIN, V114, P405, DOI 10.1093/brain/114.1.405; Mon-Williams M, 2001, EXP BRAIN RES, V139, P127, DOI 10.1007/s002210000657; Neri P, 1999, NATURE, V401, P695, DOI 10.1038/44409; Neri P, 2004, J NEUROPHYSIOL, V92, P1880, DOI 10.1152/jn.01042.2003; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Parker AJ, 2007, NAT REV NEUROSCI, V8, P379, DOI 10.1038/nrn2131; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Preston TJ, 2008, J NEUROSCI, V28, P11315, DOI 10.1523/JNEUROSCI.2728-08.2008; Read JCA, 2000, VISION RES, V40, P3345, DOI 10.1016/S0042-6989(00)00182-6; Rice NJ, 2006, EXP BRAIN RES, V174, P176, DOI 10.1007/s00221-006-0435-5; Roe AW, 2007, J NEUROSCI, V27, P11820, DOI 10.1523/JNEUROSCI.4164-07.2007; Spang K, 2008, J VISION, V8, DOI 10.1167/8.9.10; Takemura A, 2001, J NEUROPHYSIOL, V85, P2245, DOI 10.1152/jn.2001.85.5.2245; Tanabe S, 2004, J NEUROSCI, V24, P8170, DOI 10.1523/JNEUROSCI.5292-03.2004; Thomas OM, 2002, NAT NEUROSCI, V5, P472, DOI 10.1038/nn837; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Uka T, 2004, NEURON, V42, P297, DOI 10.1016/S0896-6273(04)00186-2; Uka T, 2006, J NEUROSCI, V26, P6791, DOI 10.1523/JNEUROSCI.5435-05.2006; Umeda K, 2007, J NEUROPHYSIOL, V98, P241, DOI 10.1152/jn.01336.2006; von der Heydt R, 2000, VISION RES, V40, P1955, DOI 10.1016/S0042-6989(00)00044-4; WESTHEIMER G, 1979, EXP BRAIN RES, V36, P585; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	59	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12608	10.1371/journal.pone.0012608	http://dx.doi.org/10.1371/journal.pone.0012608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830303	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000281631300030
J	Ribak, G; Swallow, JG; Jones, DR				Ribak, Gal; Swallow, John G.; Jones, David R.			Drag-Based 'Hovering' in Ducks: The Hydrodynamics and Energetic Cost of Bottom Feeding	PLOS ONE			English	Article							LABRIFORM LOCOMOTION; DIVING ENERGETICS; BEAT CYCLE; BODY-MASS; BIRDS; BUOYANCY; PROPULSION; MECHANICS; STROKE; LIFT	Diving ducks use their webbed feet to provide the propulsive force that moves them underwater. To hold position near the bottom while feeding, ducks paddle constantly to resist the buoyant force of the body. Using video sequences from two orthogonal cameras we reconstructed the 3-dimensional motion of the feet through water and estimated the forces involved with a quasi-steady blade-element model. We found that during station holding, near the bottom, ducks use drag based propulsion with the webbed area of the foot moving perpendicular to the trajectory of the foot. The body was pitched at 76 +/- 3.47 degrees below the horizon and the propulsive force was directed 26 +/- 1.9 degrees ventral to the body so that 98% of the propulsive force in the sagittal plane of the duck worked to oppose buoyancy. The mechanical work done by moving both feet through a paddling cycle was 1.1 +/- 0.2 J which was equivalent to an energy expenditure of 3.7 +/- 0.5 W to hold position while feeding at 1.5 m depth. We conclude that in shallow water the high energetic cost of feeding in ducks is due to the need to paddle constantly against buoyancy even after reaching the bottom. The mechanical energy spent on holding position near the bottom, while feeding, is approximately 2 fold higher than previous estimates that were made for similar bottom depths but based on the presumed motion of the body instead of motion of the feet.	[Ribak, Gal; Swallow, John G.] Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA; [Ribak, Gal; Jones, David R.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	University of South Dakota; University of British Columbia	Ribak, G (corresponding author), Technion Israel Inst Technol, Fac Aerosp Engn, Technion Autonomous Syst Program, IL-32000 Haifa, Israel.	gal.ribak@gmail.com		Ribak, Gal/0000-0002-6267-5471	Company of Biologists; Natural Sciences and Engineering Research Council of Canada; National Science Foundation [IOB-00448060]	Company of Biologists; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Science Foundation(National Science Foundation (NSF))	Funding for this work included a travel fellowship to GR from the Company of Biologists (www.biologists.com), a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) to DRJ and National Science Foundation (http://www.nsf.gov/) CAREER award grant no. IOB-00448060 to JGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigeldinger Terrye L., 1995, Journal of Experimental Biology, V198, P1567; BAUDINETTE RV, 1985, J COMP PHYSIOL B, V155, P373, DOI 10.1007/BF00687481; BLAKE RW, 1980, J EXP BIOL, V85, P337; BLAKE RW, 1979, J EXP BIOL, V82, P255; Butler PJ, 2004, RESP PHYSIOL NEUROBI, V141, P297, DOI 10.1016/j.resp.2004.01.010; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P41, DOI 10.1098/rstb.1984.0051; Fish FE, 1996, AM ZOOL, V36, P628, DOI 10.1093/icb/36.6.628; FISH FE, 1995, J EXP ZOOL, V273, P1, DOI 10.1002/jez.1402730102; GAL JM, 1988, J EXP BIOL, V138, P413; Heath JP, 2006, J EXP BIOL, V209, P3974, DOI 10.1242/jeb.02482; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; Johansson LC, 2003, NATURE, V424, P65, DOI 10.1038/nature01695; Johansson LC, 2001, J EXP BIOL, V204, P1687; KORTRIGHT FH, 1962, DUCKS GEESE SWANS N; Lovvorn JR, 2007, PHILOS T R SOC B, V362, P2079, DOI 10.1098/rstb.2007.2110; LOVVORN JR, 1991, CAN J ZOOL, V69, P2879, DOI 10.1139/z91-406; LOVVORN JR, 1994, ESTUARIES, V17, P62, DOI 10.2307/1352335; LOVVORN JR, 1991, CAN J ZOOL, V69, P2888, DOI 10.1139/z91-407; LOVVORN JR, 1991, J EXP BIOL, V159, P98; LOVVORN JR, 2009, BERING SEA ECOL APPL, V19, P1596; McPhail LT, 1998, COMP BIOCHEM PHYS A, V120, P219, DOI 10.1016/S1095-6433(98)00005-1; Miller MR, 2006, CONDOR, V108, P166, DOI 10.1650/0010-5422(2006)108[0166:TARBRM]2.0.CO;2; PRANGE HD, 1970, J EXP BIOL, V53, P763; Ribak G, 2004, J EXP BIOL, V207, P2101, DOI 10.1242/jeb.00997; Ribak G, 2008, J EXP BIOL, V211, P3009, DOI 10.1242/jeb.018895; Richman SE, 2008, J COMP PHYSIOL B, V178, P321, DOI 10.1007/s00360-007-0225-9; STEPHENSON R, 1994, J EXP BIOL, V190, P155; Vogel S, 1994, LIFE MOVING FLUIDS; Walker JA, 2000, P ROY SOC B-BIOL SCI, V267, P1875, DOI 10.1098/rspb.2000.1224; WILSON RP, 1992, AM NAT, V140, P179, DOI 10.1086/285409; WOAKES AJ, 1983, J EXP BIOL, V107, P311	31	4	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12565	10.1371/journal.pone.0012565	http://dx.doi.org/10.1371/journal.pone.0012565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830286	Green Submitted, Green Published, gold			2022-12-27	WOS:000281631300005
J	Fischer, Y; Ganic, E; Ameri, J; Xian, XJ; Johannesson, M; Semb, H				Fischer, Yvonne; Ganic, Elvira; Ameri, Jacqueline; Xian, Xiaojie; Johannesson, Martina; Semb, Henrik			NANOG Reporter Cell Lines Generated by Gene Targeting in Human Embryonic Stem Cells	PLOS ONE			English	Article							SELF-RENEWAL; HOMOLOGOUS RECOMBINATION; RNAI SCREEN; MOUSE; PLURIPOTENCY; DIFFERENTIATION; IDENTIFICATION; CLONING; SYSTEM; LOCUS	Background: Pluripotency and self-renewal of human embryonic stem cells (hESCs) is mediated by a complex interplay between extra-and intracellular signaling pathways, which regulate the expression of pluripotency-specific transcription factors. The homeodomain transcription factor NANOG plays a central role in maintaining hESC pluripotency, but the precise role and regulation of NANOG are not well defined. Methodology/Principal Findings: To facilitate the study of NANOG expression and regulation in viable hESC cultures, we generated fluorescent NANOG reporter cell lines by gene targeting in hESCs. In these reporter lines, the fluorescent reporter gene was co-expressed with endogenous NANOG and responded to experimental induction or repression of the NANOG promoter with appropriate changes in expression levels. Furthermore, NANOG reporter lines facilitated the separation of hESC populations based on NANOG expression levels and their subsequent characterization. Gene expression arrays on isolated hESC subpopulations revealed genes with differential expression in NANOG high and NANOG low hESCs, providing candidates for NANOG downstream targets hESCs. Conclusion/Significance: The newly derived NANOG reporter hESC lines present novel tools to visualize NANOG expression in viable hESCs. In future applications, these reporter lines can be used to elucidate the function and regulation of NANOG in pluripotent hESCs.	[Fischer, Yvonne; Ganic, Elvira; Ameri, Jacqueline; Semb, Henrik] Lund Univ, Stem Cell Ctr, Lund, Sweden; [Xian, Xiaojie] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Johannesson, Martina] Hagedorn Res Inst, Dept Stem Cell Biol, Gentofte, Denmark	Lund University; University of Copenhagen; Novo Nordisk; Hagedorn Research Institute	Fischer, Y (corresponding author), Lund Univ, Stem Cell Ctr, Lund, Sweden.	henrik.semb@med.lu.se		Ameri, Jacqueline/0000-0002-6146-3944; Semb, Henrik/0000-0002-6747-787X	Juvenile Diabetes Research Foundation [1-2007-1046, 35-2008-626]; Swedish Research Council [521-2006-4163, 521-2008-2446, 521-2009-20647]; JDRF-Center for Beta cell Therapy in Europe [512145]; Swedish Foundation for Strategic Research [A302:094]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); JDRF-Center for Beta cell Therapy in Europe; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by the Juvenile Diabetes Research Foundation [grant number 1-2007-1046, 35-2008-626]; the Swedish Research Council [grant number 521-2006-4163, 521-2008-2446, 521-2009-20647]; the JDRF-Center for Beta cell Therapy in Europe [grant number 512145] and the Swedish Foundation for Strategic Research [grant number A302:094]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; DENG CX, 1992, MOL CELL BIOL, V12, P3365, DOI 10.1128/MCB.12.8.3365; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Gadue P, 2009, STEM CELLS, V27, P2103, DOI 10.1002/stem.147; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Ohtsuka S, 2008, GENE THER, V15, P74, DOI 10.1038/sj.gt.3303065; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ruby KM, 2009, STEM CELLS, V27, P1496, DOI 10.1002/stem.73; Schaniel C, 2009, STEM CELLS, V27, P2979, DOI 10.1002/stem.223; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xue HP, 2009, STEM CELLS, V27, P1836, DOI 10.1002/stem.129; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	44	19	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12533	10.1371/journal.pone.0012533	http://dx.doi.org/10.1371/journal.pone.0012533			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824089	Green Published, Green Submitted, gold			2022-12-27	WOS:000281480900016
J	Adetifa, IMO; Ota, MOC; Walther, B; Hammond, AS; Lugos, MD; Jeffries, DJ; Donkor, SA; Adegbola, RA; Hill, PC				Adetifa, Ifedayo M. O.; Ota, Martin O. C.; Walther, Brigitte; Hammond, Abdulrahman S.; Lugos, Moses D.; Jeffries, David J.; Donkor, Simon A.; Adegbola, Richard A.; Hill, Philip C.			Decay Kinetics of an Interferon Gamma Release Assay with Anti-Tuberculosis Therapy in Newly Diagnosed Tuberculosis Cases	PLOS ONE			English	Article							T-CELL RESPONSES; LINKED IMMUNOSPOT ASSAY; MYCOBACTERIUM-TUBERCULOSIS; SKIN-TEST; PULMONARY TUBERCULOSIS; INFECTION; ELISPOT; CHILDREN; GAMBIA; CONTACTS	Background: Qualitative and quantitative changes in IGRA response offer promise as biomarkers to monitor Tuberculosis (TB) drug therapy, and for the comparison of new interventions. We studied the decay kinetics of TB-specific antigen T-cell responses measured with an in-house ELISPOT assay during the course of therapy. Methods: Newly diagnosed sputum smear positive TB cases with typical TB chest radiographs were recruited. All patients were given standard anti-TB treatment. Each subject was followed up for 6 months and treatment outcomes were documented. Blood samples were obtained for the ESAT-6 and CFP-10 (EC) ELISPOT at diagnosis, 1-, 2-, 4- and 6-months. Qualitative and quantitative reversion of the ELISPOT results were assessed with McNemar test, conditional logistic regression and mixed-effects hierarchical Poisson models. Results: A total of 116 cases were recruited and EC ELISPOT was positive for 87% (95 of 109) at recruitment. There was a significant decrease in the proportion of EC ELISPOT positive cases over the treatment period (p<0.001). Most of the reversion occurred between the start and first month of treatment and at completion at 6 months. ESAT-6 had higher median counts compared to CFP-10 at all time points. Counts for each antigen declined significantly with therapy (p<0.001). Reverters had lower median SFUs at the start of treatment compared to non-Reverters for both antigens. Apart from the higher median counts for non-Reverters, no other risk factors for non-reversion were found. Conclusions: TB treatment induces qualitative and quantitative reversion of a positive in-house IGRA in newly diagnosed cases of active TB disease. As this does not occur reliably in the majority of cured individuals, qualitative and quantitative reversion of an IGRA ELISPOT has limited clinical utility as a surrogate marker of treatment efficacy.	[Adetifa, Ifedayo M. O.; Ota, Martin O. C.; Hammond, Abdulrahman S.; Lugos, Moses D.; Donkor, Simon A.; Adegbola, Richard A.; Hill, Philip C.] Med Res Council United Kingdom Labs, Bacterial Dis Programme, Fajara, Gambia; [Walther, Brigitte; Jeffries, David J.] Med Res Council United Kingdom Labs, Stat & Data Support Unit, Fajara, Gambia	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Adetifa, IMO (corresponding author), Med Res Council United Kingdom Labs, Bacterial Dis Programme, Fajara, Gambia.	iadetifa@mrc.gm	Lugos, Moses D/AAZ-5179-2020; Hammond, Abdulrahman/F-1541-2011	Lugos, Moses D/0000-0002-4921-2691; 	Medical Research Council, The Gambia; European and Developing Countries [CG_ta_2005_40203_001]; MRC [MC_U190071468, MC_U190081968] Funding Source: UKRI; Medical Research Council [MC_U190081968, MC_U190071468] Funding Source: researchfish	Medical Research Council, The Gambia(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European and Developing Countries; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Medical Research Council, The Gambia. IMOA received funding from the European and Developing Countries Trials Partnership through a career development fellowship (grant CG_ta_2005_40203_001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RA, 2003, INT J TUBERC LUNG D, V7, P390; Adetifa IMO, 2007, INT J TUBERC LUNG D, V11, P350; Adetifa IMO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-122; Adetifa IMO, 2010, PEDIATR INFECT DIS J, V29, P439, DOI 10.1097/INF.0b013e3181cb45da; Aiken AM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-66; Bosshard V, 2009, RESP MED, V103, P30, DOI 10.1016/j.rmed.2008.09.012; Carrara S, 2004, CLIN INFECT DIS, V38, P754, DOI 10.1086/381754; CHEE CB, 2009, EUR RESP J; Chee CBE, 2007, AM J RESP CRIT CARE, V175, P282, DOI 10.1164/rccm.200608-1109OC; Connell TG, 2010, PEDIATR INFECT DIS J, V29, P285, DOI 10.1097/INF.0b013e3181c4822f; Connell TG, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-138; Crampin AC, 2010, AIDS, V24, P417, DOI 10.1097/QAD.0b013e32832f51cf; Dheda K, 2007, J INFECTION, V55, P169, DOI 10.1016/j.jinf.2007.02.005; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Dominguez J, 2009, DIAGN MICR INFEC DIS, V63, P43, DOI 10.1016/j.diagmicrobio.2008.09.010; Goletti D, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-11; Goletti D, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-5; Herrmann JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004130; Hill PC, 2006, PEDIATRICS, V117, P1542, DOI 10.1542/peds.2005-2095; Hill PC, 2005, CLIN INFECT DIS, V40, P273, DOI 10.1086/427030; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Hill PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001379; Houben RMGJ, 2010, INT J TUBERC LUNG D, V14, P909; Jeffries DJ, 2006, INT J TUBERC LUNG D, V10, P192; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Klenerman P, 2002, NAT REV IMMUNOL, V2, P263, DOI 10.1038/nri777; Kobashi Y, 2009, J INFECTION, V58, P197, DOI 10.1016/j.jinf.2008.08.009; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; Lugos MD, 2009, IMMUNOL INVEST, V38, P341, DOI 10.1080/08820130902748744; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Nicol MP, 2005, CLIN INFECT DIS, V40, P1301, DOI 10.1086/429245; Pai M, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-7; Ribeiro S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-23; Sauzullo I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005187; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; *WHO, 2007, 104 WHO; Wilkinson KA, 2006, J INFECT DIS, V193, P354, DOI 10.1086/499311; World Health Organization (WHO), 2009, WHOHTMTB2009420	40	24	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12502	10.1371/journal.pone.0012502	http://dx.doi.org/10.1371/journal.pone.0012502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824136	Green Published, gold, Green Submitted			2022-12-27	WOS:000281456100014
J	Akaneya, Y; Sohya, K; Kitamura, A; Kimura, F; Washburn, C; Zhou, RP; Ninan, I; Tsumoto, T; Ziff, EB				Akaneya, Yukio; Sohya, Kazuhiro; Kitamura, Akihiko; Kimura, Fumitaka; Washburn, Chris; Zhou, Renping; Ninan, Ipe; Tsumoto, Tadaharu; Ziff, Edward B.			Ephrin-A5 and EphA5 Interaction Induces Synaptogenesis during Early Hippocampal Development	PLOS ONE			English	Article							DENDRITIC SPINE MORPHOGENESIS; NEURONAL GENE-EXPRESSION; DEPENDENT PROTEIN-KINASE; FOCAL ADHESION KINASE; POSTNATAL-DEVELOPMENT; SYNAPSE FORMATION; NMDA RECEPTORS; AMPA RECEPTORS; EXCITATORY SYNAPSES; FILOPODIA FORMATION	Background: Synaptogenesis is a fundamental step in neuronal development. For spiny glutamatergic synapses in hippocampus and cortex, synaptogenesis involves adhesion of pre and postsynaptic membranes, delivery and anchorage of pre and postsynaptic structures including scaffolds such as PSD-95 and NMDA and AMPA receptors, which are glutamate-gated ion channels, as well as the morphological maturation of spines. Although electrical activity-dependent mechanisms are established regulators of these processes, the mechanisms that function during early development, prior to the onset of electrical activity, are unclear. The Eph receptors and ephrins provide cell contact-dependent pathways that regulate axonal and dendritic development. Members of the ephrin-A family are glycosyl-phosphatidylinositol-anchored to the cell surface and activate EphA receptors, which are receptor tyrosine kinases. Methodology/Principal Findings: Here we show that ephrin-A5 interaction with the EphA5 receptor following neuron-neuron contact during early development of hippocampus induces a complex program of synaptogenic events, including expression of functional synaptic NMDA receptor-PSD-95 complexes plus morphological spine maturation and the emergence of electrical activity. The program depends upon voltage-sensitive calcium channel Ca(2+) fluxes that activate PKA, CaMKII and PI3 kinase, leading to CREB phosphorylation and a synaptogenic program of gene expression. AMPA receptor subunits, their scaffolds and electrical activity are not induced. Strikingly, in contrast to wild type, stimulation of hippocampal slices from P6 EphA5 receptor functional knockout mice yielded no NMDA receptor currents. Conclusions/Significance: These studies suggest that ephrin-A5 and EphA5 signals play a necessary, activity-independent role in the initiation of the early phases of synaptogenesis. The coordinated expression of the NMDAR and PSD-95 induced by eprhin-A5 interaction with EphA5 receptors may be the developmental switch that induces expression of AMPAR and their interacting proteins and the transition to activity-dependent synaptic regulation.	[Akaneya, Yukio; Ziff, Edward B.] NYU, Dept Biochem, Sch Med, New York, NY 10016 USA; [Akaneya, Yukio; Sohya, Kazuhiro; Kitamura, Akihiko; Kimura, Fumitaka; Tsumoto, Tadaharu] Osaka Univ, Grad Sch Med, Div Neurophysiol, Suita, Osaka, Japan; [Sohya, Kazuhiro; Tsumoto, Tadaharu] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Washburn, Chris; Zhou, Renping] Rutgers State Univ, Coll Pharm, Canc Res Lab, Piscataway, NJ 08855 USA; [Ninan, Ipe] NYU, Sch Med, Dept Psychiat, New York, NY USA	New York University; Osaka University; RIKEN; Rutgers State University New Brunswick; New York University	Akaneya, Y (corresponding author), Fukui Social Insurance Hosp, Katsuyama City, Fukui, Japan.	edward.ziff@nyumc.org		Kitamura, Akihiko/0000-0002-8747-2902; Ninan, Ipe/0000-0001-9774-6455; Ziff, Edward/0000-0001-7389-8649	National Institutes of Health-National Institute on Aging (NIH-NIA) [AG13620]; National Science Foundation [NSF 10B 05-48561]; Japan Science and Technology Agency; NATIONAL INSTITUTE ON AGING [R01AG013620, R37AG013620] Funding Source: NIH RePORTER	National Institutes of Health-National Institute on Aging (NIH-NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Science Foundation(National Science Foundation (NSF)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a National Institutes of Health-National Institute on Aging (NIH-NIA) grant, AG13620 ( to E.Z.) (http://www.nia.nih.gov/), and a National Science Foundation grant, NSF 10B 05-48561 ( to R.Z.) ( http://www.nsf.gov/funding/), and a grant from the Japan Science and Technology Agency ( to T. T.) ( http://www.jst.go.jp/EN/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 2008, PROG BRAIN RES, V169, P97, DOI 10.1016/S0079-6123(07)00006-4; Allen KM, 1999, EPILEPSY RES, V36, P143, DOI 10.1016/S0920-1211(99)00048-0; Barbacid M, 1995, ANN NY ACAD SCI, V766, P442, DOI 10.1111/j.1749-6632.1995.tb26693.x; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; BENARI Y, 1991, NATURE, V353, P220, DOI 10.1038/353220a0; BESSHO Y, 1994, NEURON, V12, P87, DOI 10.1016/0896-6273(94)90154-6; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Corbo JC, 2002, J NEUROSCI, V22, P7548; Crump FT, 2001, J NEUROSCI, V21, P5079, DOI 10.1523/JNEUROSCI.21-14-05079.2001; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feoktistov I, 2000, MOL PHARMACOL, V58, P903, DOI 10.1124/mol.58.5.903; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Frank CA, 2009, NEURON, V61, P556, DOI 10.1016/j.neuron.2008.12.028; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Fukushima K, 2006, AM J PHYSIOL-GASTR L, V291, pG812, DOI 10.1152/ajpgi.00250.2005; Gerlai R, 1999, J NEUROSCI, V19, P9538; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Hu ZL, 2003, J NEUROSCI, V23, P10963; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Jourdi H, 2003, DEV BIOL, V263, P216, DOI 10.1016/j.ydbio.2003.07.008; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lau GC, 2004, J NEUROCHEM, V88, P564, DOI 10.1046/j.1471-4159.2003.02156.x; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; MAISONPIERRE PC, 1993, ONCOGENE, V8, P3277; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; Martinez A, 2005, NEUROSCIENCE, V135, P451, DOI 10.1016/j.neuroscience.2005.06.052; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; Moeller ML, 2006, J BIOL CHEM, V281, P1587, DOI 10.1074/jbc.M511756200; Moody WJ, 1998, J NEUROBIOL, V37, P97, DOI 10.1002/(SICI)1097-4695(199810)37:1<97::AID-NEU8>3.0.CO;2-3; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Murai KK, 2003, J CELL SCI, V116, P2823, DOI 10.1242/jcs.00625; Nishimura T, 2006, MOL BIOL CELL, V17, P1273, DOI 10.1091/mbc.E05-07-0700; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shi Y, 2009, J NEUROSCI, V29, P8129, DOI 10.1523/JNEUROSCI.4681-08.2009; SPIGELMAN I, 1992, J NEUROPHYSIOL, V68, P55, DOI 10.1152/jn.1992.68.1.55; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Subramaniam S, 2005, J NEUROSCI, V25, P2838, DOI 10.1523/JNEUROSCI.5060-04.2005; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; TANAKA O, 1995, BRAIN RES MOL BRAIN, V30, P1, DOI DOI 10.1016/0169-328X(94)00265-G; TAYLOR V, 1994, NEUROSCIENCE, V63, P163, DOI 10.1016/0306-4522(94)90014-0; Tolias KF, 2007, P NATL ACAD SCI USA, V104, P7265, DOI 10.1073/pnas.0702044104; Tremblay ME, 2007, J COMP NEUROL, V501, P691, DOI 10.1002/cne.21263; Tyzio R, 2003, J NEUROPHYSIOL, V90, P2964, DOI 10.1152/jn.00172.2003; Wang YF, 2001, J NEUROPHYSIOL, V86, P1252, DOI 10.1152/jn.2001.86.3.1252; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Yatani A, 2005, AM J PHYSIOL-HEART C, V288, pH650, DOI 10.1152/ajpheart.00268.2004; Zhang JH, 1997, MOL BRAIN RES, V47, P202, DOI 10.1016/S0169-328X(97)00051-X; ZHANG L, 1991, J PHYSIOL-LONDON, V444, P25, DOI 10.1113/jphysiol.1991.sp018864; Zhou RP, 1998, PHARMACOL THERAPEUT, V77, P151, DOI 10.1016/S0163-7258(97)00112-5	73	59	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12486	10.1371/journal.pone.0012486	http://dx.doi.org/10.1371/journal.pone.0012486			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824214	Green Published, Green Submitted, gold			2022-12-27	WOS:000281405300013
J	Gollner, S; Ivanenko, VN; Arbizu, PM; Bright, M				Gollner, Sabine; Ivanenko, Viatcheslav N.; Arbizu, Pedro Martinez; Bright, Monika			Advances in Taxonomy, Ecology, and Biogeography of Dirivultidae (Copepoda) Associated with Chemosynthetic Environments in the Deep Sea	PLOS ONE			English	Article							MID-ATLANTIC RIDGE; MOSBY-MUD-VOLCANO; HYDROTHERMAL-VENT; SIPHONOSTOMATOID COPEPODS; COLD SEEPS; PACIFIC; COMMUNITIES; WATER; APHOTOPONTIUS; SEDIMENTS	Background: Copepoda is one of the most prominent higher taxa with almost 80 described species at deep-sea hydrothermal vents. The unique copepod family Dirivultidae with currently 50 described species is the most species rich invertebrate family at hydrothermal vents. Methodology/Principal Findings: We reviewed the literature of Dirivultidae and provide a complete key to species, and map geographical and habitat specific distribution. In addition we discuss the ecology and origin of this family. Conclusions/Significance: Dirivultidae are only present at deep-sea hydrothermal vents and along the axial summit trough of midocean ridges, with the exception of Dirivultus dentaneus found associated with Lamellibrachia species at 1125 m depth off southern California. To our current knowledge Dirivultidae are unknown from shallow-water vents, seeps, whale falls, and wood falls. They are a prominent part of all communities at vents and in certain habitat types (like sulfide chimneys colonized by pompei worms) they are the most abundant animals. They are free-living on hard substrate, mostly found in aggregations of various foundation species (e. g. alvinellids, vestimentiferans, and bivalves). Most dirivultid species colonize more than one habitat type. Dirivultids have a world-wide distribution, but most genera and species are endemic to a single biogeographic region. Their origin is unclear yet, but immigration from other deep-sea chemosynthetic habitats (stepping stone hypothesis) or from the deep-sea sediments seems unlikely, since Dirivultidae are unknown from these environments. Dirivultidae is the most species rich family and thus can be considered the most successful taxon at deep-sea vents.	[Gollner, Sabine; Bright, Monika] Univ Vienna, Dept Marine Biol, Vienna, Austria; [Ivanenko, Viatcheslav N.] Moscow MV Lomonosov State Univ, Dept Invertebrate Zool, Moscow, Russia; [Gollner, Sabine; Arbizu, Pedro Martinez] Forschungsinst Senckenberg, Deutsch Zentrum Marine Biodiversitatsforsch, Wilhelmshaven, Germany	University of Vienna; Lomonosov Moscow State University; Senckenberg Gesellschaft fur Naturforschung (SGN)	Gollner, S (corresponding author), Univ Vienna, Dept Marine Biol, Vienna, Austria.	sabine.gollner@senckenberg.de	Bright, Monika/AAA-7015-2021; Ivanenko, Viatcheslav N/B-8198-2008; Bright, Monika/I-5542-2012	Bright, Monika/0000-0001-7066-1363; Ivanenko, Viatcheslav N/0000-0003-1255-0491; Martinez-Arbizu, Pedro/0000-0002-0891-1154	Austrian Science Foundation [P20190-B17]; ChEss; Census of Diversity of Abyssal Marine Life; Russian Foundation for Basic Research [09-04-01523-a]	Austrian Science Foundation(Austrian Science Fund (FWF)); ChEss; Census of Diversity of Abyssal Marine Life; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by the Austrian Science Foundation grant FWF (P20190-B17 to MB), by ChEss (mini-grant to SG), and Census of Diversity of Abyssal Marine Life grant and the Russian Foundation for Basic Research Grant (09-04-01523-a) to VNI. ChEss was covering the publishing costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, COPEPOD EVOLUTION; BOXSHALL GA, 1990, PHILOS T ROY SOC B, V328, P167, DOI 10.1098/rstb.1990.0113; Boxshall GA, 2004, INTRO COPEPOD DIVERS, P966; Bright M, 2010, DEEP-SEA RES PT II, V57, P1982, DOI 10.1016/j.dsr2.2010.05.003; Copley JTP, 2007, J MAR BIOL ASSOC UK, V87, P1141, DOI 10.1017/S0025315407055956; Desbruy`eres D., 2006, HDB HYDROTHERMAL VEN; Dinet A, 1988, OCEANOL ACTA, V85, P7; Etter RJ, 2001, MARINE COMMUNITY ECOLOGY, P367; Giere O, 2009, MEIOBENTHOLOGY MICRO, DOI 10.1007/978-3-540-68661-3; Gollner S, 2006, CAH BIOL MAR, V47, P397; Gollner S, 2007, MAR ECOL PROG SER, V337, P39, DOI 10.3354/meps337039; Gollner S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012321; Heptner M. V., 2002, Arthropoda Selecta, V11, P117; Hourdez S, 2000, BIOL BULL-US, V199, P95, DOI 10.2307/1542868; HUMES A G, 1989, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V11, P829; HUMES A G, 1980, Proceedings of the Biological Society of Washington, V93, P697; HUMES A G, 1990, Scientia Marina, V54, P145; HUMES A G, 1991, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V13, P121; HUMES A G, 1989, Pacific Science, V43, P27; HUMES AG, 1987, B MAR SCI, V41, P645; Humes AG, 1998, CAH BIOL MAR, V39, P51; HUMES AG, 1980, PAC SCI, V34, P143; HUMES AG, 1989, ZOOL SCR, V18, P103, DOI 10.1111/j.1463-6409.1989.tb00125.x; HUMES AG, 1984, CAN J ZOOL, V62, P2594, DOI 10.1139/z84-380; HUMES AG, 1994, J CRUSTACEAN BIOL, V14, P337, DOI 10.2307/1548913; Humes AG, 1996, B MAR SCI, V58, P609; HUMES AG, 1990, J NAT HIST, V24, P289, DOI 10.1080/00222939000770211; Humes AG, 1999, J MAR BIOL ASSOC UK, V79, P1053, DOI 10.1017/S0025315499001290; Huys R, 2007, MOL PHYLOGENET EVOL, V43, P368, DOI 10.1016/j.ympev.2007.02.004; Ivanenko V. N., 2002, Arthropoda Selecta, V11, P177; Ivanenko V.N., 1999, P207; Ivanenko VN, 2007, MAR ECOL-EVOL PERSP, V28, P49, DOI 10.1111/j.1439-0485.2006.00142.x; Ivanenko VN, 2006, ZOOTAXA, P1; Ivanenko VN, 1998, ZOOL ZH, V77, P1249; Ivanenko VN, 1998, J MARINE SYST, V15, P243, DOI 10.1016/S0924-7963(97)00067-5; IVANENKO VN, 2006, HDB DEEP SEA HYDROTH; JENSEN P, 1992, MAR ECOL PROG SER, V83, P103, DOI 10.3354/meps083103; KAMENEV GM, 1993, NEW ZEAL J MAR FRESH, V27, P407, DOI 10.1080/00288330.1993.9516582; Le Bris N, 2006, MAR CHEM, V98, P167, DOI 10.1016/j.marchem.2005.08.008; Le Bris N, 2005, DEEP-SEA RES PT I, V52, P1071, DOI 10.1016/j.dsr.2005.01.003; Le Bris N, 2007, REV ENVIRON SCI BIO, V6, P167; Limen H, 2008, MAR ECOL PROG SER, V359, P161, DOI 10.3354/meps07344; Martin Joel W., 2001, Natural History Museum of Los Angeles County Science Series, V39, pi; MONTAGNA PA, 1985, MAR ENVIRON RES, V16, P231, DOI 10.1016/0141-1136(85)90021-2; MONTAGNA PA, 1987, J MAR RES, V45, P761, DOI 10.1357/002224087788326894; MONTAGNA PA, 1989, J MAR RES, V47, P657, DOI 10.1357/002224089785076226; Olu K, 1997, DEEP-SEA RES PT I, V44, P811, DOI 10.1016/S0967-0637(96)00123-9; Palmer MA, 1988, OIL CHEM POLL, V4, P179; POWELL EN, 1983, MAR BIOL, V73, P269, DOI 10.1007/BF00392253; POWELL EN, 1981, INT REV GES HYDROBIO, V66, P675, DOI 10.1002/iroh.19810660504; Robinson CA, 2004, MAR ECOL-P S Z N I, V25, P313, DOI 10.1111/j.1439-0485.2004.00034.x; Sell AF, 2000, P ROY SOC B-BIOL SCI, V267, P2323, DOI 10.1098/rspb.2000.1286; Sergeeva NG, 2007, MAR ECOL-EVOL PERSP, V28, P152, DOI 10.1111/j.1439-0485.2006.00143.x; SHIRAYAMA Y, 1990, Journal of the Oceanographical Society of Japan, V46, P118, DOI 10.1007/BF02123438; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; Soltwedel T, 2005, J MARINE SYST, V55, P271, DOI 10.1016/j.jmarsys.2004.09.001; Sommer S, 2007, MAR ECOL PROG SER, V337, P27, DOI 10.3354/meps337027; Tarasov VG, 1999, CONT SHELF RES, V19, P79, DOI 10.1016/S0278-4343(98)00073-9; Thiermann F., 1994, Vie et Milieu, V44, P215; Tsurumi M, 2003, J MAR BIOL ASSOC UK, V83, P469, DOI 10.1017/S0025315403007367h; Tunnicliffe V, 1998, ADV MAR BIOL, V34, P353, DOI 10.1016/S0065-2881(08)60213-8; TUNNICLIFFE V, 1992, Palaios, V7, P338, DOI 10.2307/3514820; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; Van Dover CL, 2000, ECOLOGY HYDROTHERMAL; Van Gaever S, 2006, MAR ECOL PROG SER, V321, P143, DOI 10.3354/meps321143; Van Gaever S, 2009, DEEP-SEA RES PT I, V56, P772, DOI 10.1016/j.dsr.2008.12.015; Vanreusel A, 1997, MAR ECOL PROG SER, V157, P207, DOI 10.3354/meps157207; Zekely J, 2006, DEEP-SEA RES PT I, V53, P1363, DOI 10.1016/j.dsr.2006.05.010; Zeppilli D, 2009, AQUAT BIOL, V5, P75, DOI 10.3354/ab00140	69	32	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e9801	10.1371/journal.pone.0009801	http://dx.doi.org/10.1371/journal.pone.0009801			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20838422	gold, Green Published			2022-12-27	WOS:000281405300001
J	Boggy, GJ; Woolf, PJ				Boggy, Gregory J.; Woolf, Peter J.			A Mechanistic Model of PCR for Accurate Quantification of Quantitative PCR Data	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; SIGMOIDAL MODEL	Background: Quantitative PCR (qPCR) is a workhorse laboratory technique for measuring the concentration of a target DNA sequence with high accuracy over a wide dynamic range. The gold standard method for estimating DNA concentrations via qPCR is quantification cycle (C-q) standard curve quantification, which requires the time-and labor-intensive construction of a C-q standard curve. In theory, the shape of a qPCR data curve can be used to directly quantify DNA concentration by fitting a model to data; however, current empirical model-based quantification methods are not as reliable as C-q standard curve quantification. Principal Findings: We have developed a two-parameter mass action kinetic model of PCR (MAK2) that can be fitted to qPCR data in order to quantify target concentration from a single qPCR assay. To compare the accuracy of MAK2-fitting to other qPCR quantification methods, we have applied quantification methods to qPCR dilution series data generated in three independent laboratories using different target sequences. Quantification accuracy was assessed by analyzing the reliability of concentration predictions for targets at known concentrations. Our results indicate that quantification by MAK2-fitting is as reliable as C-q standard curve quantification for a variety of DNA targets and a wide range of concentrations. Significance: We anticipate that MAK2 quantification will have a profound effect on the way qPCR experiments are designed and analyzed. In particular, MAK2 enables accurate quantification of portable qPCR assays with limited sample throughput, where construction of a standard curve is impractical.	[Boggy, Gregory J.; Woolf, Peter J.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Boggy, GJ (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	gboggy@umich.edu		Boggy, Gregory/0000-0002-8283-5620	National Institutes of Health [U54-DA-021519]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor grant [GR687]; National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA021519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by National Institutes of Health grant U54-DA-021519, Michigan Economic Development Corporation and Michigan Technology Tri-Corridor grant GR687, and a graduate fellowship from the National Institutes of Health Cellular Biotechnology Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cikos S, 2009, ANAL BIOCHEM, V384, P1, DOI 10.1016/j.ab.2008.08.031; Gevertz JL, 2005, BIOTECHNOL BIOENG, V92, P346, DOI 10.1002/bit.20617; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Lagally ET, 2004, J PHYS D APPL PHYS, V37, pR245, DOI 10.1088/0022-3727/37/23/R01; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Mehra S, 2005, BIOTECHNOL BIOENG, V91, P848, DOI 10.1002/bit.20555; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Rutledge RG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh177; Rutledge RG, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-47; Smith MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-409; Spiess AN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-221; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103	15	68	70	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12355	10.1371/journal.pone.0012355	http://dx.doi.org/10.1371/journal.pone.0012355			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20814578	Green Published, gold, Green Submitted			2022-12-27	WOS:000281375500002
J	Goldwasser, J; Cohen, PY; Yang, E; Balaguer, P; Yarmush, ML; Nahmias, Y				Goldwasser, Jonathan; Cohen, Pazit Y.; Yang, Eric; Balaguer, Patrick; Yarmush, Martin L.; Nahmias, Yaakov			Transcriptional Regulation of Human and Rat Hepatic Lipid Metabolism by the Grapefruit Flavonoid Naringenin: Role of PPAR alpha, PPAR gamma and LXR alpha	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; FATTY-ACID OXIDATION; APOLIPOPROTEIN-B SECRETION; LIVER-X-RECEPTORS; HEPATOCYTE APO-B; NUCLEAR RECEPTORS; GENE-EXPRESSION; CROSS-TALK; CHOLESTEROL HOMEOSTASIS; NUTRITIONAL REGULATION	Disruption of lipid and carbohydrate homeostasis is an important factor in the development of prevalent metabolic diseases such as diabetes, obesity, and atherosclerosis. Therefore, small molecules that could reduce insulin dependence and regulate dyslipidemia could have a dramatic effect on public health. The grapefruit flavonoid naringenin has been shown to normalize lipids in diabetes and hypercholesterolemia, as well as inhibit the production of HCV. Here, we demonstrate that naringenin regulates the activity of nuclear receptors PPARa, PPARc, and LXRa. We show it activates the ligand-binding domain of both PPARa and PPARc, while inhibiting LXRa in GAL4-fusion reporters. Using TR-FRET, we show that naringenin is a partial agonist of LXRa, inhibiting its association with Trap220 co-activator in the presence of TO901317. In addition, naringenin induces the expression of PPARa co-activator, PGC1a. The flavonoid activates PPAR response element (PPRE) while suppressing LXRa response element (LXRE) in human hepatocytes, translating into the induction of PPAR-regulated fatty acid oxidation genes such as CYP4A11, ACOX, UCP1 and ApoAI, and inhibition of LXRa-regulated lipogenesis genes, such as FAS, ABCA1, ABCG1, and HMGR. This effect results in the induction of a fasted-like state in primary rat hepatocytes in which fatty acid oxidation increases, while cholesterol and bile acid production decreases. Our findings explain the myriad effects of naringenin and support its continued clinical development. Of note, this is the first description of a non-toxic, naturally occurring LXRa inhibitor.	[Goldwasser, Jonathan; Yang, Eric; Yarmush, Martin L.; Nahmias, Yaakov] Shriners Burns Hosp, Ctr Engn Med, Boston, MA USA; [Goldwasser, Jonathan] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Cohen, Pazit Y.; Nahmias, Yaakov] Hebrew Univ Jerusalem, Selim & Rachel Benin Sch Engn, Jerusalem, Israel; [Yang, Eric; Yarmush, Martin L.; Nahmias, Yaakov] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Balaguer, Patrick] Univ Montpellier I, INSERM, Montpellier, France	Harvard University; Massachusetts Institute of Technology (MIT); Hebrew University of Jerusalem; Harvard University; Harvard Medical School; Massachusetts General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Goldwasser, J (corresponding author), Shriners Burns Hosp, Ctr Engn Med, Boston, MA USA.	ynahmias@cs.huji.ac.il	Balaguer, Patrick/I-2973-2016; Nahmias, Yaakov/AAM-3872-2020; Nahmias, Yaakov/H-4725-2013	Nahmias, Yaakov/0000-0002-6051-616X; Nahmias, Yaakov/0000-0002-6051-616X; Yarmush, Martin/0000-0003-4986-8444	NIBIB NIH HHS [P41 EB-002503, P41 EB002503] Funding Source: Medline; NIDDK NIH HHS [K01 DK080241, P30-DK040561, P30 DK040561, P30 DK040561-15, K01DK080241] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK080241, P30DK040561] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allister EM, 2005, DIABETES, V54, P1676, DOI 10.2337/diabetes.54.6.1676; Borradaile NM, 2003, DIABETES, V52, P2554, DOI 10.2337/diabetes.52.10.2554; Borradaile NM, 2002, J LIPID RES, V43, P1544, DOI 10.1194/jlr.M200115-JLR200; BUCHMAN A, 2006, SCHIFFS DIS LIVER; Chang F, 2007, ANN PHARMACOTHER, V41, P973, DOI 10.1345/aph.1K013; Crestani M, 2004, EUR J LIPID SCI TECH, V106, P432, DOI 10.1002/ejlt.200300936; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Edwards PA, 2002, VASC PHARMACOL, V38, P249, DOI 10.1016/S1537-1891(02)00175-1; Forman BM, 1997, P NATL ACAD SCI USA, V94, P10588, DOI 10.1073/pnas.94.20.10588; Gastaldelli A, 2009, HEPATOLOGY, V49, P1537, DOI 10.1002/hep.22845; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gervois P, 2007, NAT CLIN PRACT ENDOC, V3, P145, DOI 10.1038/ncpendmet0397; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Gupta S, 2002, BIOCHEM BIOPH RES CO, V293, P338, DOI 10.1016/S0006-291X(02)00229-2; HOGAN P, 2002, DIABETES CARE, V26, P917; Hu X, 2003, MOL ENDOCRINOL, V17, P1019, DOI 10.1210/me.2002-0399; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Huong DTT, 2006, NUTRITION, V22, P546, DOI 10.1016/j.nut.2005.11.006; Ide T, 2003, MOL ENDOCRINOL, V17, P1255, DOI 10.1210/me.2002-0191; Jeon SM, 2007, TRANSL RES, V149, P15, DOI 10.1016/j.trsl.2006.08.001; Jung UJ, 2003, CLIN NUTR, V22, P561, DOI 10.1016/S0261-5614(03)00059-1; Kidambi S, 2009, P NATL ACAD SCI USA, V106, P15714, DOI 10.1073/pnas.0906820106; Kim K, 2008, BIOCHEM J, V416, P219, DOI 10.1042/BJ20081336; Kim SY, 2006, J MED FOOD, V9, P582, DOI 10.1089/jmf.2006.9.582; Kurowska EM, 2000, NUTR RES, V20, P121, DOI 10.1016/S0271-5317(99)00144-X; Kurowska EM, 2004, LIPIDS, V39, P143, DOI 10.1007/s11745-004-1212-8; Laffitte BA, 2001, MOL CELL BIOL, V21, P7558, DOI 10.1128/MCB.21.22.7558-7568.2001; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Lee CH, 2001, BIOCHEM BIOPH RES CO, V284, P681, DOI 10.1006/bbrc.2001.5001; Lee SH, 1999, ANN NUTR METAB, V43, P173, DOI 10.1159/000012783; Liu L, 2008, PHYTOTHER RES, V22, P1400, DOI 10.1002/ptr.2504; Mahmood S, 2008, CANCER INFORM, V6, P381; MARCUS SL, 1993, P NATL ACAD SCI USA, V90, P5723, DOI 10.1073/pnas.90.12.5723; Martin PGP, 2007, HEPATOLOGY, V45, P767, DOI 10.1002/hep.21510; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Millatt LJ, 2003, BBA-MOL CELL BIOL L, V1631, P107, DOI 10.1016/S1388-1981(02)00366-9; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; Mittra S, 2008, DRUG DISCOV TODAY, V13, P211, DOI 10.1016/j.drudis.2008.01.006; Miyata KS, 1996, J BIOL CHEM, V271, P9189, DOI 10.1074/jbc.271.16.9189; MULVIHILL EE, 2009, DIABETES; Na TY, 2009, HEPATOLOGY, V49, P1122, DOI 10.1002/hep.22740; Nahmias Y, 2008, HEPATOLOGY, V47, P1437, DOI 10.1002/hep.22197; Noguchi-Yachide T, 2007, CHEM PHARM BULL, V55, P1750, DOI 10.1248/cpb.55.1750; Ory DS, 2004, CIRC RES, V95, P660, DOI 10.1161/01.RES.0000143422.83209.be; PAWAR B, 2003, J BIOL CHEM; Rochette-Egly C, 2003, CELL SIGNAL, V15, P355, DOI 10.1016/S0898-6568(02)00115-8; Seimandi M, 2005, ANAL BIOCHEM, V344, P8, DOI 10.1016/j.ab.2005.06.010; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Son YL, 2009, BIOCHEM BIOPH RES CO, V384, P389, DOI 10.1016/j.bbrc.2009.04.131; Tobin KAR, 2000, MOL ENDOCRINOL, V14, P741, DOI 10.1210/me.14.5.741; van Raalte DH, 2004, PHARM RES-DORDR, V21, P1531, DOI 10.1023/B:PHAM.0000041444.06122.8d; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603; Wilcox LJ, 2001, J LIPID RES, V42, P725; Wilcox LJ, 1999, CARDIOVASC DRUG REV, V17, P160, DOI 10.1111/j.1527-3466.1999.tb00011.x; Yoshikawa T, 2003, MOL ENDOCRINOL, V17, P1240, DOI 10.1210/me.2002-0190; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001	59	164	170	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12399	10.1371/journal.pone.0012399	http://dx.doi.org/10.1371/journal.pone.0012399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811644	Green Submitted, Green Published, gold			2022-12-27	WOS:000281234700023
J	Sweiss, NJ; Bo, RH; Kapadia, R; Manst, D; Mahmood, F; Adhikari, T; Volkov, S; Badaracco, M; Smaron, M; Chang, A; Baron, J; Levine, JS				Sweiss, Nadera J.; Bo, Ronghai; Kapadia, Reena; Manst, Deborah; Mahmood, Farzan; Adhikari, Tara; Volkov, Suncica; Badaracco, Maria; Smaron, Mary; Chang, Anthony; Baron, Joseph; Levine, Jerrold S.			IgA Anti-beta 2-Glycoprotein I Autoantibodies Are Associated with an Increased Risk of Thromboembolic Events in Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							ANTI-BETA(2)-GLYCOPROTEIN I; ANTIPHOSPHOLIPID SYNDROME; ANTICARDIOLIPIN ANTIBODIES; CLINICAL-SIGNIFICANCE; THROMBOSIS; MANIFESTATIONS; CLASSIFICATION; CRITERIA	Background: The clinical utility of testing for antiphospholipid antibodies (aPL) of IgA isotype remains controversial. Methodology/Principal Findings: To address this issue, we reasoned that if IgA aPL contribute to the clinical manifestations of the antiphospholipid syndrome, then an association with thromboembolic events should manifest in patients whose only aPL is of IgA isotype. We performed a retrospective chart review of 56 patients (31 with systemic lupus erythematosus [SLE] and 25 without SLE) whose only positive aPL was IgA anti-beta 2-glycoprotein I (isolated IgA anti-beta 2GPI) and compared their clinical features with 56 individually matched control patients without any aPL. Patients with isolated IgA anti-beta 2GPI had a significantly increased number of thromboembolic events, as compared to controls. When patients were stratified into those with and without SLE, the association between isolated IgA anti-beta 2GPI and thromboembolic events persisted for patients with SLE, but was lost for those without SLE. Titers of IgA anti-beta 2GPI were significantly higher in SLE patients who suffered a thromboembolic event. Among patients with isolated IgA anti-beta 2GPI, there was an increased prevalence of diseases or morbidities involving organs of mucosal immunity (i.e., gastrointestinal system, pulmonary system, and skin). Conclusions/Significance: The presence of isolated IgA anti-beta 2GPI is associated with an increased risk of thromboembolic events, especially among patients with SLE. IgA anti-beta 2GPI is associated with an increased prevalence of morbidities involving organs of mucosal immunity.	[Sweiss, Nadera J.; Badaracco, Maria; Smaron, Mary] Univ Chicago, Dept Med, Rheumatol Sect, Chicago, IL 60637 USA; [Bo, Ronghai; Kapadia, Reena] Univ So Calif, Dept Med, Rheumatol Sect, Los Angeles, CA USA; [Manst, Deborah] Loyola Univ, Chicago Stritch Sch Med, Maywood, IL 60153 USA; [Mahmood, Farzan; Adhikari, Tara] Univ Cincinnati, Med Ctr, Div Pulm & Crit Care, Cincinnati, OH 45267 USA; [Volkov, Suncica] Univ Illinois, Dept Med, Rheumatol Sect, Chicago, IL USA; [Chang, Anthony] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Baron, Joseph] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Levine, Jerrold S.] Univ Illinois, Dept Med, Nephrol Sect, Chicago, IL USA; [Levine, Jerrold S.] Jesse Brown Vet Affairs Med Ctr, Dept Med, Nephrol Sect, Chicago, IL USA	University of Chicago; University of Southern California; Loyola University Chicago; University System of Ohio; University of Cincinnati; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Sweiss, NJ (corresponding author), Univ Chicago, Dept Med, Rheumatol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	nsweiss@medicine.bsd.uchicago.edu		Sweiss, Nadera/0000-0003-2215-0221; Chang, Anthony/0000-0002-6877-5510	Genzyme, Inc.	Genzyme, Inc.(Sanofi-AventisGenzyme Corporation)	This work was supported by a GRIP Renal Innovations Program Award from Genzyme, Inc. to JSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma Y, 2003, NEW ENGL J MED, V349, P2407, DOI 10.1056/NEJMoa035611; Bertolaccini ML, 2001, J RHEUMATOL, V28, P2637; Boin F, 2009, ARTHRITIS RHEUM-US, V60, P2480, DOI 10.1002/art.24684; Danowski A, 2006, J RHEUMATOL, V33, P1775; de Laat B, 2005, BLOOD, V105, P1540, DOI 10.1182/blood-2004-09-3387; Dieude M, 2004, ARTHRITIS RHEUM-US, V50, P3221, DOI 10.1002/art.20564; DIEUDE M, 2009, ARTHRITIS RHEUM, V60, pS766; ESCALANTE A, 1995, AM J MED, V98, P559, DOI 10.1016/S0002-9343(99)80014-X; Fanopoulos D, 1998, J RHEUMATOL, V25, P675; Greco TP, 2000, LUPUS, V9, P33, DOI 10.1177/096120330000900107; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hodak E, 2003, LUPUS, V12, P564, DOI 10.1191/0961203303lu403oa; Kawakami T, 2008, ARTHRIT RHEUM-ARTHR, V59, P561, DOI 10.1002/art.23528; Kumar S, 2009, LUPUS, V18, P1011, DOI 10.1177/0961203309103048; Lakos G, 1999, CLIN EXP IMMUNOL, V117, P574; Lee RM, 2001, AM J OBSTET GYNECOL, V185, P748, DOI 10.1067/mob.2001.117659; Lee SS, 2001, J RHEUMATOL, V28, P520; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Romero-Diaz J, 2009, J RHEUMATOL, V36, P68, DOI 10.3899/jrheum.071244; Samarkos M, 2006, CLIN RHEUMATOL, V25, P199, DOI 10.1007/s10067-005-1156-z; Selva-O'Callaghan A, 1998, THROMB HAEMOSTASIS, V79, P282; Shen YM, 2008, LUPUS, V17, P996, DOI 10.1177/0961203308093460; Tajima C, 1998, J RHEUMATOL, V25, P1730; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tsutsumi A, 1998, J RHEUMATOL, V25, P74	26	36	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12280	10.1371/journal.pone.0012280	http://dx.doi.org/10.1371/journal.pone.0012280			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808864	Green Published, gold, Green Submitted			2022-12-27	WOS:000281075500014
J	Minsaas, L; Planaguma, J; Madziva, M; Krakstad, BF; Masia-Balague, M; Katz, AA; Aragay, AM				Minsaas, Laura; Planaguma, Jesus; Madziva, Michael; Krakstad, Beate F.; Masia-Balague, Miriam; Katz, Arieh A.; Aragay, Anna M.			Filamin A Binds to CCR2B and Regulates Its Internalization	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; DOPAMINE D-3 RECEPTOR; INTRACELLULAR TRAFFICKING; KINASE ACTIVATION; PROTEIN FILAMIN; TERMINAL TAIL; ACTIN; CHEMOKINES; SIGNAL; CELLS	The chemokine (C-C motif) receptor 2B (CCR2B) is one of the two isoforms of the receptor for monocyte chemoattractant protein-1 (CCL2), the major chemoattractant for monocytes, involved in an array of chronic inflammatory diseases. Employing the yeast two-hybrid system, we identified the actin-binding protein filamin A (FLNa) as a protein that associates with the carboxyl-terminal tail of CCR2B. Co-immunoprecipitation experiments and in vitro pull down assays demonstrated that FLNa binds constitutively to CCR2B. The colocalization of endogenous CCR2B and filamin A was detected at the surface and in internalized vesicles of THP-1 cells. In addition, CCR2B and FLNa were colocalized in lamellipodia structures of CCR2B-expressing A7 cells. Expression of the receptor in filamin-deficient M2 cells together with siRNA experiments knocking down FLNa in HEK293 cells, demonstrated that lack of FLNa delays the internalization of the receptor. Furthermore, depletion of FLNa in THP-1 monocytes by RNA interference reduced the migration of cells in response to MCP-1. Therefore, FLNa emerges as an important protein for controlling the internalization and spatial localization of the CCR2B receptor in different dynamic membrane structures.	[Minsaas, Laura; Planaguma, Jesus; Krakstad, Beate F.; Aragay, Anna M.] Univ Bergen, Dept Biomed, Bergen, Norway; [Masia-Balague, Miriam; Aragay, Anna M.] CSIC, Inst Biol Mol Barcelona, Barcelona, Spain; [Madziva, Michael; Katz, Arieh A.] Univ Cape Town, Div Med Biochem, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Madziva, Michael; Katz, Arieh A.] Univ Cape Town, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa	University of Bergen; University of Cape Town; University of Cape Town	Minsaas, L (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	aarbmc@ibmb.csic.es	Aragay, Anna M/K-3813-2014; Katz, Arieh/F-5836-2012	Aragay, Anna M/0000-0002-8240-4126; 	Helse Vest and Ministerio de Ciencia e Innovacion [BFU2008-04262]	Helse Vest and Ministerio de Ciencia e Innovacion	The work was supported by the Helse Vest and Ministerio de Ciencia e Innovacion (BFU2008-04262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragay AM, 1998, P NATL ACAD SCI USA, V95, P2985, DOI 10.1073/pnas.95.6.2985; Awata H, 2001, J BIOL CHEM, V276, P34871, DOI 10.1074/jbc.M100775200; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cho EY, 2007, MOL ENDOCRINOL, V21, P2242, DOI 10.1210/me.2007-0202; Chuang JZ, 1998, J CELL BIOL, V142, P1245, DOI 10.1083/jcb.142.5.1245; Contento RL, 2008, P NATL ACAD SCI USA, V105, P10101, DOI 10.1073/pnas.0804286105; Enz R, 2002, FEBS LETT, V514, P184, DOI 10.1016/S0014-5793(02)02361-X; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Fletcher SJ, 2009, BIOCHEM SOC T, V37, P1072, DOI 10.1042/BST0371072; Franci C, 1996, J IMMUNOL, V157, P5606; Fromme BJ, 2008, AIDS RES HUM RETROV, V24, P1527, DOI 10.1089/aid.2008.0105; Hjalm G, 2001, J BIOL CHEM, V276, P34880, DOI 10.1074/jbc.M100784200; Huang CF, 2006, FEBS LETT, V580, P1795, DOI 10.1016/j.febslet.2006.02.035; Ithychanda SS, 2009, J BIOL CHEM, V284, P35113, DOI 10.1074/jbc.M109.060954; Jimenez-Baranda S, 2007, NAT CELL BIOL, V9, P838, DOI 10.1038/ncb1610; Jimenez-Sainz MC, 2003, MOL PHARMACOL, V64, P773, DOI 10.1124/mol.64.3.773; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kim KM, 2005, J BIOL CHEM, V280, P12774, DOI 10.1074/jbc.M408901200; KRUPNICK JG, 1998, ANN REV PHARM TOXICO, V289, P319; Li M, 2002, BIOCHEM PHARMACOL, V63, P859, DOI 10.1016/S0006-2952(01)00932-7; Lin RW, 2002, PHARMACOLOGY, V66, P173, DOI 10.1159/000065531; Lin RW, 2001, P NATL ACAD SCI USA, V98, P5258, DOI 10.1073/pnas.011538198; Liu GP, 1997, J CELL BIOL, V139, P1719, DOI 10.1083/jcb.139.7.1719; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; O'Hayre M, 2008, BIOCHEM J, V409, P635, DOI 10.1042/BJ20071493; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Onoprishvili I, 2003, MOL PHARMACOL, V64, P1092, DOI 10.1124/mol.64.5.1092; Petrecca K, 2000, J NEUROSCI, V20, P8736; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Scott MGH, 2006, MOL CELL BIOL, V26, P3432, DOI 10.1128/MCB.26.9.3432-3445.2006; Seck T, 2003, J BIOL CHEM, V278, P10408, DOI 10.1074/jbc.M209655200; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Terashima Y, 2005, NAT IMMUNOL, V6, P827, DOI 10.1038/ni1222; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Vroon A, 2004, J LEUKOCYTE BIOL, V75, P901, DOI 10.1189/jlb.0403136; Vroon A, 2006, J LEUKOCYTE BIOL, V80, P1214, DOI 10.1189/jlb.0606373; Zhang ML, 2005, J BIOL CHEM, V280, P11140, DOI 10.1074/jbc.M412242200	38	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12212	10.1371/journal.pone.0012212	http://dx.doi.org/10.1371/journal.pone.0012212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808917	Green Published, Green Submitted, gold			2022-12-27	WOS:000280968100016
J	Reifur, L; Yu, LE; Cruz-Reyes, J; vanHartesvelt, M; Koslowsky, DJ				Reifur, Larissa; Yu, Laura E.; Cruz-Reyes, Jorge; vanHartesvelt, Michelle; Koslowsky, Donna J.			The Impact of mRNA Structure on Guide RNA Targeting in Kinetoplastid RNA Editing	PLOS ONE			English	Article							BINDING PROTEINS; COMPLEX; GRNA; MITOCHONDRIA; TRANSCRIPTS; ANTISENSE; MECHANISM; INSERTION; GENE; SITE	Mitochondrial mRNA editing in Trypanosoma brucei requires the specific interaction of a guide RNA with its cognate mRNA. Hundreds of gRNAs are involved in the editing process, each needing to target their specific editing domain within the target message. We hypothesized that the structure surrounding the mRNA target may be a limiting factor and involved in the regulation process. In this study, we selected four mRNAs with distinct target structures and investigated how sequence and structure affected efficient gRNA targeting. Two of the mRNAs, including the ATPase subunit 6 and ND7-550 (5' end of NADH dehydrogenase subunit 7) that have open, accessible anchor binding sites show very efficient gRNA targeting. Electrophoretic mobility shift assays indicate that the cognate gRNA for ND7-550 had 10-fold higher affinity for its mRNA than the A6 pair. Surface plasmon resonance studies indicate that the difference in affinity was due to a four-fold faster association rate. As expected, mRNAs with considerable structure surrounding the anchor binding sites were less accessible and had very low affinity for their cognate gRNAs. In vitro editing assays indicate that efficient pairing is crucial for gRNA directed cleavage. However, only the A6 substrate showed gRNA-directed cleavage at the correct editing site. This suggests that different gRNA/mRNA pairs may require different "sets'' of accessory factors for efficient editing. By characterizing a number of different gRNA/mRNA interactions, we may be able to define a "bank'' of RNA editing substrates with different putative chaperone and other co-factor requirements. This will allow the more efficient identification and characterization of transcript specific RNA editing accessory proteins.	[Reifur, Larissa; Koslowsky, Donna J.] Michigan State Univ, Coll Vet Med, Comparat Med & Integrat Biol Program, E Lansing, MI 48824 USA; [Yu, Laura E.; Koslowsky, Donna J.] Michigan State Univ, Coll Nat Sci, Cell & Mol Biol Program, E Lansing, MI 48824 USA; [Cruz-Reyes, Jorge] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Koslowsky, Donna J.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Texas A&M University System; Texas A&M University College Station; Michigan State University	Reifur, L (corresponding author), Michigan State Univ, Coll Vet Med, Comparat Med & Integrat Biol Program, E Lansing, MI 48824 USA.	koslowsk@msu.edu	Cruz-Reyes, Jorge/GQP-1338-2022	Cruz-Reyes, Jorge/0000-0003-0545-1508	National Institutes of Health [AI45835]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health, Grant number AI45835 to Donna Koslowsky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler BK, 1997, MOL CELL BIOL, V17, P5377, DOI 10.1128/MCB.17.9.5377; Amarzguioui M, 2000, NUCLEIC ACIDS RES, V28, P4113, DOI 10.1093/nar/28.21.4113; Ammerman ML, 2008, RNA, V14, P1069, DOI 10.1261/rna.982908; Aphasizhev R, 2003, RNA, V9, P62, DOI 10.1261/rna.2134303; Birikh KR, 1997, RNA, V3, P429; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Carnes J, 2008, MOL CELL BIOL, V28, P122, DOI 10.1128/MCB.01374-07; Cifuentes-Rojas C, 2007, J BIOL CHEM, V282, P4265, DOI 10.1074/jbc.M605554200; Cruz-Reyes J, 1998, MOL CELL, V1, P401, DOI 10.1016/S1097-2765(00)80040-4; Cruz-Reyes J, 2002, MOL CELL BIOL, V22, P4652, DOI 10.1128/MCB.22.13.4652-4660.2002; DECKER CJ, 1990, CELL, V61, P1001, DOI 10.1016/0092-8674(90)90065-M; FEAGIN JE, 1987, CELL, V49, P337, DOI 10.1016/0092-8674(87)90286-8; FEAGIN JE, 1988, MOL CELL BIOL, V8, P1259, DOI 10.1128/MCB.8.3.1259; Golden DE, 2006, J MOL BIOL, V359, P585, DOI 10.1016/j.jmb.2006.03.041; Hernandez A, 2008, J MOL BIOL, V381, P35, DOI 10.1016/j.jmb.2008.05.003; Igo RP, 2002, MOL CELL BIOL, V22, P1567, DOI 10.1128/MCB.22.5.1567-1576.2002; Kabb AL, 2001, NUCLEIC ACIDS RES, V29, P2575, DOI 10.1093/nar/29.12.2575; Kable ML, 1996, SCIENCE, V273, P1189, DOI 10.1126/science.273.5279.1189; Katsamba PS, 2002, METHODS, V26, P95, DOI 10.1016/S1046-2023(02)00012-9; KAY E, 2006, MICROBE, V1, P63; KOSLOWSKY DJ, 1991, CELL, V67, P537, DOI 10.1016/0092-8674(91)90528-7; KOSLOWSKY DJ, 1992, MOL CELL BIOL, V12, P2043, DOI 10.1128/MCB.12.5.2043; KOSLOWSKY DJ, 1990, CELL, V62, P901, DOI 10.1016/0092-8674(90)90265-G; Koslowsky Donna J, 2004, RNA Biol, V1, P28; Leung SS, 1999, NUCLEIC ACIDS RES, V27, P778, DOI 10.1093/nar/27.3.778; Leung SS, 2001, RNA, V7, P1803; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; MATTHEWS J, 1993, FUNDAMENTALS RECEPTO, P7; Mlotshwa S, 2008, TRENDS PLANT SCI, V13, P375, DOI 10.1016/j.tplants.2008.04.009; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; Muller UF, 2002, NUCLEIC ACIDS RES, V30, P447, DOI 10.1093/nar/30.2.447; Muller UF, 2001, EMBO J, V20, P1394, DOI 10.1093/emboj/20.6.1394; Myszka DG, 1997, CURR OPIN BIOTECH, V8, P50, DOI 10.1016/S0958-1669(97)80157-7; Neilson JR, 2008, CELL, V134, P899, DOI 10.1016/j.cell.2008.09.006; Nordgren S, 2001, J MOL BIOL, V310, P1125, DOI 10.1006/jmbi.2001.4802; Ochsenreiter T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001566; Ochsenreiter T, 2006, EMBO REP, V7, P1128, DOI 10.1038/sj.embor.7400817; Pai RD, 2003, RNA, V9, P469, DOI 10.1261/rna.2175703; Patzel V, 1998, NAT BIOTECHNOL, V16, P64, DOI 10.1038/nbt0198-64; Pelletier M, 2003, RNA, V9, P457, DOI 10.1261/rna.2160803; POLLARD VW, 1992, EMBO J, V11, P4429, DOI 10.1002/j.1460-2075.1992.tb05543.x; Reifur L, 2008, RNA, V14, P2195, DOI 10.1261/rna.1144508; Rusche LN, 1997, EMBO J, V16, P4069, DOI 10.1093/emboj/16.13.4069; Schneider A, 2001, INT J PARASITOL, V31, P1403, DOI 10.1016/S0020-7519(01)00296-X; Schumacher MA, 2006, CELL, V126, P701, DOI 10.1016/j.cell.2006.06.047; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; von der Haar T, 2003, METHODS, V29, P167, DOI 10.1016/S1046-2023(02)00307-9; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200; WAGNER EGH, 1994, ANNU REV MICROBIOL, V48, P713, DOI 10.1146/annurev.mi.48.100194.003433; WALTER AE, 1994, P NATL ACAD SCI USA, V91, P9218, DOI 10.1073/pnas.91.20.9218	51	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12235	10.1371/journal.pone.0012235	http://dx.doi.org/10.1371/journal.pone.0012235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808932	Green Published, gold, Green Submitted			2022-12-27	WOS:000280968100027
J	Luo, Y; Good, CH; Diaz-Ruiz, O; Zhang, YJ; Hoffman, AF; Shan, LF; Kuang, SY; Malik, N; Chefer, VI; Tomac, AC; Lupica, CR; Backman, CM				Luo, Yu; Good, Cameron H.; Diaz-Ruiz, Oscar; Zhang, YaJun; Hoffman, Alexander F.; Shan, Lufei; Kuang, Serena Y.; Malik, Nasir; Chefer, Vladimir I.; Tomac, Andreas C.; Lupica, Carl R.; Backman, Cristina M.			NMDA Receptors on Non-Dopaminergic Neurons in the VTA Support Cocaine Sensitization	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; INDUCED NEUROBEHAVIORAL PLASTICITY; D-ASPARTATE RECEPTOR; DOPAMINE NEURONS; NUCLEUS-ACCUMBENS; SYNAPTIC PLASTICITY; ENVIRONMENTAL CONTEXT; PREFRONTAL CORTEX; GLUTAMATE; POTENTIATION	Background: The initiation of behavioral sensitization to cocaine and other psychomotor stimulants is thought to reflect N-methyl-D-aspartate receptor (NMDAR)-mediated synaptic plasticity in the mesolimbic dopamine (DA) circuitry. The importance of drug induced NMDAR mediated adaptations in ventral tegmental area (VTA) DA neurons, and its association with drug seeking behaviors, has recently been evaluated in Cre-loxp mice lacking functional NMDARs in DA neurons expressing Cre recombinase under the control of the endogenous dopamine transporter gene (NR1(DATCre) mice). Methodology and Principal Findings: Using an additional NR1(DATCre) mouse transgenic model, we demonstrate that while the selective inactivation of NMDARs in DA neurons eliminates the induction of molecular changes leading to synaptic strengthening, behavioral measures such as cocaine induced locomotor sensitization and conditioned place preference remain intact in NR1(DATCre) mice. Since VTA DA neurons projecting to the prefrontal cortex and amygdala express little or no detectable levels of the dopamine transporter, it has been speculated that NMDA receptors in DA neurons projecting to these brain areas may have been spared in NR1(DATCre) mice. Here we demonstrate that the NMDA receptor gene is ablated in the majority of VTA DA neurons, including those exhibiting undetectable DAT expression levels in our NR1(DATCre) transgenic model, and that application of an NMDAR antagonist within the VTA of NR1(DATCre) animals still blocks sensitization to cocaine. Conclusions/Significance: These results eliminate the possibility of NMDAR mediated neuroplasticity in the different DA neuronal subpopulations in our NR1(DATCre) mouse model and therefore suggest that NMDARs on non-DA neurons within the VTA must play a major role in cocaine-related addictive behavior.	[Luo, Yu; Good, Cameron H.; Diaz-Ruiz, Oscar; Zhang, YaJun; Hoffman, Alexander F.; Shan, Lufei; Kuang, Serena Y.; Malik, Nasir; Tomac, Andreas C.; Lupica, Carl R.; Backman, Cristina M.] Natl Inst Drug Abuse, Cellular Neurobiol Res Branch, NIH, Baltimore, MD USA; [Chefer, Vladimir I.] Natl Inst Drug Abuse, Behav Neurosci Branch, NIH, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Luo, Y (corresponding author), Natl Inst Drug Abuse, Cellular Neurobiol Res Branch, NIH, Baltimore, MD USA.	cbackman@mail.nih.gov	backman, cristina/C-1276-2013; Lupica, Carl/AAY-3193-2021; Diaz-Ruiz, Oscar/F-3162-2010; Hoffman, Alex/AIF-4544-2022; Hoffman, Alex/H-3035-2012	Lupica, Carl/0000-0002-5375-3263; Hoffman, Alex/0000-0002-2676-0628; Hoffman, Alex/0000-0002-2676-0628; Luo, Yu/0000-0002-7939-5505	National Institute on Drug Abuse, National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000457, ZIADA000561] Funding Source: NIH RePORTER	National Institute on Drug Abuse, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the Intramural Research Program of the National Institute on Drug Abuse, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badiani A, 2004, BEHAV PHARMACOL, V15, P327, DOI 10.1097/00008877-200409000-00004; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Bassareo V, 2002, J NEUROSCI, V22, P4709, DOI 10.1523/JNEUROSCI.22-11-04709.2002; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Carr DB, 2008, NEURON, V59, P353, DOI 10.1016/j.neuron.2008.07.025; Chen YH, 2008, FASEB J, V22, P261, DOI 10.1096/fj.07-8797com; Coulter CL, 1996, DEV BRAIN RES, V92, P172, DOI 10.1016/0165-3806(96)00004-1; Doetschman Thomas, 2009, V530, P423, DOI 10.1007/978-1-59745-471-1_23; Dunn JM, 2005, PSYCHOPHARMACOLOGY, V179, P172, DOI 10.1007/s00213-004-2054-9; Engblom D, 2008, NEURON, V59, P497, DOI 10.1016/j.neuron.2008.07.010; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gracy KN, 1996, BRAIN RES, V739, P169, DOI 10.1016/S0006-8993(96)00822-0; Harris GC, 2004, NEUROSCIENCE, V129, P841, DOI 10.1016/j.neuroscience.2004.09.018; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P73, DOI 10.1038/sj.npp.1300011; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; KALIVAS PW, 1993, J PHARMACOL EXP THER, V267, P486; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Li X, 2009, PSYCHOPHARMACOLOGY, V204, P1, DOI 10.1007/s00213-008-1432-0; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Parlato R, 2006, GENESIS, V44, P454, DOI 10.1002/dvg.20236; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Sombers LA, 2009, J NEUROSCI, V29, P1735, DOI 10.1523/JNEUROSCI.5562-08.2009; Stefani MR, 2006, J NEUROSCI, V26, P8810, DOI 10.1523/JNEUROSCI.1656-06.2006; Szumlinski KK, 2004, BEHAV PHARMACOL, V15, P373, DOI 10.1097/00008877-200409000-00010; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vezina P, 2000, PSYCHOPHARMACOLOGY, V151, P184, DOI 10.1007/s002130000463; Yamaguchi T, 2007, EUR J NEUROSCI, V25, P106, DOI 10.1111/j.1460-9568.2006.05263.x; Zweifel LS, 2008, NEURON, V59, P486, DOI 10.1016/j.neuron.2008.05.028; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106	36	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12141	10.1371/journal.pone.0012141	http://dx.doi.org/10.1371/journal.pone.0012141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808436	Green Published, gold, Green Submitted			2022-12-27	WOS:000280968000003
J	Nguyen, LT; Chau, JK; Perry, NA; de Boer, L; Zaat, SAJ; Vogel, HJ				Nguyen, Leonard T.; Chau, Johnny K.; Perry, Nicole A.; de Boer, Leonie; Zaat, Sebastian A. J.; Vogel, Hans J.			Serum Stabilities of Short Tryptophan-and Arginine-Rich Antimicrobial Peptide Analogs	PLOS ONE			English	Article							MODEL MEMBRANE INTERACTIONS; STRUCTURE-BASED DESIGN; ANTIBACTERIAL PEPTIDES; IN-VITRO; LACTOFERRICIN; CYCLIZATION; MICELLES; HEXAPEPTIDES; INFECTION; MECHANISM	Background: Several short antimicrobial peptides that are rich in tryptophan and arginine residues were designed with a series of simple modifications such as end capping and cyclization. The two sets of hexapeptides are based on the Trp- and Arg-rich primary sequences from the "antimicrobial centre" of bovine lactoferricin as well as an antimicrobial sequence obtained through the screening of a hexapeptide combinatorial library. Methodology/Principal Findings: HPLC, mass spectrometry and antimicrobial assays were carried out to explore the consequences of the modifications on the serum stability and microbicidal activity of the peptides. The results show that C-terminal amidation increases the antimicrobial activity but that it makes little difference to its proteolytic degradation in human serum. On the other hand, N-terminal acetylation decreases the peptide activities but significantly increases their protease resistance. Peptide cyclization of the hexameric peptides was found to be highly effective for both serum stability and antimicrobial activity. However the two cyclization strategies employed have different effects, with disulfide cyclization resulting in more active peptides while backbone cyclization results in more proteolytically stable peptides. However, the benefit of backbone cyclization did not extend to longer 11-mer peptides derived from the same region of lactoferricin. Mass spectrometry data support the serum stability assay results and allowed us to determine preferred proteolysis sites in the peptides. Furthermore, isothermal titration calorimetry experiments showed that the peptides all had weak interactions with albumin, the most abundant protein in human serum. Conclusions/Significance: Taken together, the results provide insight into the behavior of the peptides in human serum and will therefore aid in advancing antimicrobial peptide design towards systemic applications.	[Nguyen, Leonard T.; Chau, Johnny K.; Perry, Nicole A.; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Biochem Res Grp, Calgary, AB T2N 1N4, Canada; [de Boer, Leonie; Zaat, Sebastian A. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands	University of Calgary; University of Amsterdam; Academic Medical Center Amsterdam	Nguyen, LT (corresponding author), Univ Calgary, Dept Biol Sci, Biochem Res Grp, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca		Lieberman, Nicole/0000-0001-9334-8150	Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	Operating support was provided by a grant of the "Novel alternatives to antibiotics" program of the Canadian Institutes for Health Research. (http://www.cihr-irsc.gc.ca/e/193.html) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelt C, 2005, CHEMBIOCHEM, V6, P1654, DOI 10.1002/cbic.200500095; Blondelle SE, 1996, TRENDS BIOTECHNOL, V14, P60, DOI 10.1016/0167-7799(96)80922-X; Boulanger N, 2006, TRENDS PARASITOL, V22, P262, DOI 10.1016/j.pt.2006.04.003; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Brewer D, 2002, BIOCHEMISTRY-US, V41, P5526, DOI 10.1021/bi015926d; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Cudic M, 2002, PEPTIDES, V23, P2071, DOI 10.1016/S0196-9781(02)00244-9; Dathe M, 2004, BIOCHEMISTRY-US, V43, P9140, DOI 10.1021/bi035948v; Deslouches B, 2007, J ANTIMICROB CHEMOTH, V60, P669, DOI 10.1093/jac/dkm253; Cabrera MPDS, 2008, J PEPT SCI, V14, P661, DOI 10.1002/psc.960; Epand RM, 2008, DRUG NEWS PERSPECT, V21, P307, DOI 10.1358/dnp.2008.21.6.1246829; Friedrich C, 1999, ANTIMICROB AGENTS CH, V43, P1542, DOI 10.1128/AAC.43.7.1542; Gifford JL, 2005, CELL MOL LIFE SCI, V62, P2588, DOI 10.1007/s00018-005-5373-z; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Haug BE, 2008, J MED CHEM, V51, P4306, DOI 10.1021/jm701600a; Hilpert K, 2005, NAT BIOTECHNOL, V23, P1008, DOI 10.1038/nbt1113; Hoek KS, 1997, ANTIMICROB AGENTS CH, V41, P54, DOI 10.1128/AAC.41.1.54; Huther A, 2007, AIDS REV, V9, P208; Hunter HN, 2005, BBA-BIOMEMBRANES, V1668, P175, DOI 10.1016/j.bbamem.2004.12.004; Jang WS, 2007, ANTIMICROB AGENTS CH, V51, P4148, DOI 10.1128/AAC.00635-07; Jeu LA, 2004, CLIN THER, V26, P1728, DOI 10.1016/j.clinthera.2004.11.014; Jing W, 2003, J PEPT RES, V61, P219, DOI 10.1034/j.1399-3011.2003.00050.x; Junkes C, 2008, J PEPT SCI, V14, P535, DOI 10.1002/psc.940; Kovalchuk LV, 2007, ADV EXP MED BIOL, V601, P369; Krijgsveld J, 2000, J BIOL CHEM, V275, P20374, DOI 10.1074/jbc.275.27.20374; Kwakman PHS, 2006, ANTIMICROB AGENTS CH, V50, P3977, DOI 10.1128/AAC.00575-06; Lai JR, 2002, BIOCHEMISTRY-US, V41, P12835, DOI 10.1021/bi026127d; Lee IH, 1997, INFECT IMMUN, V65, P2898, DOI 10.1128/IAI.65.7.2898-2903.1997; Li Peng, 2002, Current Topics in Medicinal Chemistry, V2, P325, DOI 10.2174/1568026023394209; Maisetta G, 2008, PEPTIDES, V29, P1, DOI 10.1016/j.peptides.2007.10.013; Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8; Meyer JE, 2007, CURR PHARM DESIGN, V13, P3119, DOI 10.2174/138161207782110372; Nguyen LT, 2005, J PEPT SCI, V11, P379, DOI 10.1002/psc.629; Noto PB, 2008, PROTEIN SCI, V17, P1249, DOI 10.1110/ps.034330.108; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Park IY, 2004, J BIOL CHEM, V279, P13896, DOI 10.1074/jbc.M311418200; Park Y, 2005, J BIOCHEM MOL BIOL, V38, P507; POWELL MF, 1993, PHARMACEUT RES, V10, P1268, DOI 10.1023/A:1018953309913; Raguse TL, 2002, J AM CHEM SOC, V124, P12774, DOI 10.1021/ja0270423; Rezansoff AJ, 2005, J PEPT RES, V65, P491, DOI 10.1111/j.1399-3011.2005.00263.X; Richardson A, 2009, BIOCHEM BIOPH RES CO, V388, P736, DOI 10.1016/j.bbrc.2009.08.083; Rosengren KJ, 2004, BIOPOLYMERS, V76, P446, DOI 10.1002/bip.20159; Rosengren KJ, 2003, J AM CHEM SOC, V125, P12464, DOI 10.1021/JA0367703; Rozek A, 2003, BIOCHEMISTRY-US, V42, P14130, DOI 10.1021/bi035643g; Schibli DJ, 2006, BIOPHYS J, V91, P4413, DOI 10.1529/biophysj.106.085837; Schibli DJ, 1999, FEBS LETT, V446, P213, DOI 10.1016/S0014-5793(99)00214-8; Selsted ME, 2004, CURR PROTEIN PEPT SC, V5, P365, DOI 10.2174/1389203043379459; Shalev DE, 2002, BIOCHEMISTRY-US, V41, P7312, DOI 10.1021/bi016013m; Strom MB, 2002, J PEPT SCI, V8, P431, DOI 10.1002/psc.398; Svenson J, 2007, J MED CHEM, V50, P3334, DOI 10.1021/jm0703542; Tam JP, 2002, J BIOL CHEM, V277, P50450, DOI 10.1074/jbc.M208429200; Tomita Mamoru, 1994, Acta Paediatrica Japonica, V36, P585; Unger T, 2001, BIOCHEMISTRY-US, V40, P6388, DOI 10.1021/bi0026066; Williams JA, 2008, EXPERT OPIN PHARMACO, V9, P1575, DOI 10.1517/14656566.9.9.1575 ; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	57	214	227	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12684	10.1371/journal.pone.0012684	http://dx.doi.org/10.1371/journal.pone.0012684			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844765	gold, Green Published, Green Submitted			2022-12-27	WOS:000281687300019
J	Andrews, KS; Williams, GD; Levin, PS				Andrews, Kelly S.; Williams, Greg D.; Levin, Phillip S.			Seasonal and Ontogenetic Changes in Movement Patterns of Sixgill Sharks	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; JUVENILE LEMON SHARKS; HEXANCHUS-GRISEUS; PUGET-SOUND; CARCHARODON-CARCHARIAS; ALOPIAS-SUPERCILIOSUS; CALLINECTES-SAPIDUS; GALEOCERDO-CUVIER; ACOUSTIC TRACKING; LAMNA-DITROPIS	Background: Understanding movement patterns is fundamental to population and conservation biology. The way an animal moves through its environment influences the dynamics of local populations and will determine how susceptible it is to natural or anthropogenic perturbations. It is of particular interest to understand the patterns of movement for species which are susceptible to human activities (e.g. fishing), or that exert a large influence on community structure, such as sharks. Methodology/Principal Findings: We monitored the patterns of movement of 34 sixgill sharks Hexanchus griseus using two large-scale acoustic arrays inside and outside Puget Sound, Washington, USA. Sixgill sharks were residents in Puget Sound for up to at least four years before making large movements out of the estuary. Within Puget Sound, sixgills inhabited sites for several weeks at a time and returned to the same sites annually. Across four years, sixgills had consistent seasonal movements in which they moved to the north from winter to spring and moved to the south from summer to fall. Just prior to leaving Puget Sound, sixgills altered their behavior and moved twice as fast among sites. Nineteen of the thirty-four sixgills were detected leaving Puget Sound for the outer coast. Three of these sharks returned to Puget Sound. Conclusions/Significance: For most large marine predators, we have a limited understanding of how they move through their environment, and this clouds our ability to successfully manage their populations and their communities. With detailed movement information, such as that being uncovered with acoustic monitoring, we can begin to quantify the spatial and temporal impacts of large predators within the framework of their ecosystems.	[Andrews, Kelly S.; Williams, Greg D.; Levin, Phillip S.] NOAA, NW Fisheries Sci Ctr, Seattle, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA	Andrews, KS (corresponding author), NOAA, NW Fisheries Sci Ctr, Seattle, WA USA.	kelly.andrews@noaa.gov		Andrews, Kelly/0000-0001-7734-3800	United States Department of Commerce, Northwest Fisheries Science Center	United States Department of Commerce, Northwest Fisheries Science Center	This work was funded through United States Department of Commerce base funds for the Integrated Marine Ecology (IME) team at the Northwest Fisheries Science Center. Other than members of the IME team, funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2005, J EXP MAR BIOL ECOL, V319, P117, DOI 10.1016/j.jembe.2004.08.030; Andrews KS, 2007, CAN J ZOOL, V85, P1136, DOI 10.1139/Z07-088; Andrews KS, 2009, ANIM BEHAV, V78, P525, DOI 10.1016/j.anbehav.2009.05.027; [Anonymous], 2020, ECONOMIST 0326; [Anonymous], 1998, QUANTITATIVE ANAL MO; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Beckmann JP, 2003, J MAMMAL, V84, P594, DOI 10.1644/1545-1542(2003)084<0594:UBBTTI>2.0.CO;2; Begg CM, 2003, J ZOOL, V260, P301, DOI 10.1017/S0952836903003789; BEIER P, 1993, CONSERV BIOL, V7, P94, DOI 10.1046/j.1523-1739.1993.07010094.x; BEIER P, 1995, J MAMMAL, V76, P1056, DOI 10.2307/1382599; BELL RHV, 1971, SCI AM, V225, P86, DOI 10.1038/scientificamerican0771-86; Bolden SK, 2000, FISH B-NOAA, V98, P642; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Boustany AM, 2002, NATURE, V415, P35, DOI 10.1038/415035b; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; Camhi M, 1998, SHARKS THEIR RELATIV; CAREY FG, 1982, COPEIA, P254; CAREY FG, 1995, ENVIRON BIOL FISH, V42, P7, DOI 10.1007/BF00002345; Carr SD, 2004, ESTUAR COAST SHELF S, V60, P567, DOI 10.1016/j.ecss.2004.02.012; Carter SP, 2007, P ROY SOC B-BIOL SCI, V274, P2769, DOI 10.1098/rspb.2007.0998; Chatterjee S., 2015, REGRESSION ANAL EXAM; Chin A, 2010, GLOBAL CHANGE BIOL, V16, P1936, DOI 10.1111/j.1365-2486.2009.02128.x; Deutsch CJ, 2003, WILDLIFE MONOGR, P1; Dicken ML, 2007, MAR FRESHWATER RES, V58, P127, DOI 10.1071/MF06018; Dicken ML, 2006, AFR J MAR SCI, V28, P603, DOI 10.2989/18142320609504210; Domeier ML, 2008, MAR ECOL PROG SER, V370, P221, DOI 10.3354/meps07628; Dunbrack R, 2003, CAN J ZOOL, V81, P1107, DOI 10.1139/Z03-087; Ebert D. A., 2003, SHARKS RAYS CHIMAERA; EBERT DA, 1994, S AFR J MARINE SCI, V14, P213; Ebert DA, 2002, S AFR J MARINE SCI, V24, P359, DOI 10.2989/025776102784528439; EBERT DA, 1986, COPEIA, P131; Edwards HJ, 2010, BIOL CONSERV, V143, P457, DOI 10.1016/j.biocon.2009.11.013; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Fullard JH, 2001, ANIM BEHAV, V62, P349, DOI 10.1006/anbe.2001.1753; Hall-Aspland SA, 2005, MAR ECOL PROG SER, V305, P249, DOI 10.3354/meps305249; Heithaus MR, 2001, ENVIRON BIOL FISH, V61, P25, DOI 10.1023/A:1011021210685; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; HOLLAND KN, 1993, COPEIA, P495, DOI 10.2307/1447150; HOLTS DB, 1993, AUST J MAR FRESH RES, V44, P901; Hulbert LB, 2006, J FISH BIOL, V69, P406, DOI 10.1111/j.1095-8649.2006.01175.x; Hulbert LB, 2005, J FISH BIOL, V67, P490, DOI 10.1111/j.0022-1112.2005.00757.x; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; KETCHEN KS, 1972, J FISH RES BOARD CAN, V29, P1717, DOI 10.1139/f72-272; Madsen T, 1996, ECOLOGY, V77, P149, DOI 10.2307/2265663; Melnychuk MC, 2009, MAR FRESHWATER RES, V60, P1231, DOI 10.1071/MF08361; Moffitt EA, 2009, ECOL APPL, V19, P1835, DOI 10.1890/08-1101.1; MORRISSEY JF, 1993, COPEIA, P425; MORRISSEY JF, 1993, ENVIRON BIOL FISH, V38, P311, DOI 10.1007/BF00007524; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Nakano H, 2003, MAR ECOL PROG SER, V265, P255, DOI 10.3354/meps265255; Natanson LJ, 2002, FISH B-NOAA, V100, P266; Nelson DR, 1997, ENVIRON BIOL FISH, V49, P389, DOI 10.1023/A:1007369619576; OGDEN JC, 1973, ECOLOGY, V54, P589, DOI 10.2307/1935344; OHMAN MD, 1990, ECOL MONOGR, V60, P257, DOI 10.2307/1943058; Papastamatiou YP, 2009, ECOLOGY, V90, P996, DOI 10.1890/08-0491.1; Peterson CH, 2001, OECOLOGIA, V129, P349, DOI 10.1007/s004420100742; Reum JCP, 2008, ESTUAR COAST, V31, P790, DOI 10.1007/s12237-008-9064-5; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Ruckelshaus M.H., 2007, SOUND SCI SYNTHESIZI; *SAS I INC, 2004, SAS 9 1 3; Sims DW, 2006, J ANIM ECOL, V75, P176, DOI 10.1111/j.1365-2656.2005.01033.x; Sims DW, 2001, MAR BIOL, V139, P1165; Sinclair A.R.E., 1983, P240; Springer S., 1950, Texas Journal of Science, V2, P349; Stokesbury MJW, 2005, MAR BIOL, V148, P159, DOI 10.1007/s00227-005-0061-y; Strickland RM., 1983, FERTILE FJORD; UNDERWOOD AJ, 1997, ECOLOGICAL EXPT THEI; Weissinger MD, 2009, J WILDLIFE DIS, V45, P388, DOI 10.7589/0090-3558-45.2.388; Welbergen JA, 2008, ANIM BEHAV, V75, P1543, DOI 10.1016/j.anbehav.2007.10.007; Weng KC, 2004, FISH B-NOAA, V102, P221; Weng KC, 2008, MAR ECOL PROG SER, V372, P253, DOI 10.3354/meps07706; West GJ, 2001, ENVIRON BIOL FISH, V60, P283, DOI 10.1023/A:1007697816642; Williams GD, 2010, T AM FISH SOC, V139, P108, DOI 10.1577/T09-045.1; WINTER DF, 1975, MAR BIOL, V29, P139, DOI 10.1007/BF00388986; [No title captured]; [No title captured]; [No title captured]; [No title captured]	78	37	38	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12549	10.1371/journal.pone.0012549	http://dx.doi.org/10.1371/journal.pone.0012549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IV	20838617	Green Published, Green Submitted, gold			2022-12-27	WOS:000281687100004
J	Laxman, S; Sutter, BM; Tu, BP				Laxman, Sunil; Sutter, Benjamin M.; Tu, Benjamin P.			Behavior of a Metabolic Cycling Population at the Single Cell Level as Visualized by Fluorescent Gene Expression Reporters	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CONTINUOUS CULTURES; YEAST; OSCILLATIONS; PROTEIN; GLUCOSE; STATE; LIFE	Background: During continuous growth in specific chemostat cultures, budding yeast undergo robust oscillations in oxygen consumption that are accompanied by highly periodic changes in transcript abundance of a majority of genes, in a phenomenon called the Yeast Metabolic Cycle (YMC). This study uses fluorescent reporters of genes specific to different YMC phases in order to visualize this phenomenon and understand the temporal regulation of gene expression at the level of individual cells within the cycling population. Methodology: Fluorescent gene expression reporters for different phases of the YMC were constructed and stably integrated into the yeast genome. Subsequently, these reporter-expressing yeast were used to visualize YMC dynamics at the individual cell level in cultures grown in a chemostat or in a microfluidics platform under varying glucose concentrations, using fluorescence microscopy and quantitative Western blots. Conclusions: The behavior of single cells within a metabolic cycling population was visualized using phase-specific fluorescent reporters. The reporters largely recapitulated genome-specified mRNA expression profiles. A significant fraction of the cell population appeared to exhibit basal expression of the reporters, supporting the hypothesis that there are at least two distinct subpopulations of cells within the cycling population. Although approximately half of the cycling population initiated cell division in each permissive window of the YMC, metabolic synchrony of the population was maintained. Using a microfluidics platform we observed that low glucose concentrations appear to be necessary for metabolic cycling. Lastly, we propose that there is a temporal window in the oxidative growth phase of the YMC where the cycling population segregates into at least two subpopulations, one which will enter the cell cycle and one which does not.	[Laxman, Sunil; Sutter, Benjamin M.; Tu, Benjamin P.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Laxman, S (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	benjamin.tu@utsouthwestern.edu	Laxman, Sunil/F-9886-2018	Laxman, Sunil/0000-0002-0861-5080	Welch Foundation [I-1697]; American Cancer Society/Simmons Cancer Center [ACS-IRG-02-196]; UT Southwestern Medical Center; Burroughs Wellcome Fund	Welch Foundation(The Welch Foundation); American Cancer Society/Simmons Cancer Center(American Cancer Society); UT Southwestern Medical Center; Burroughs Wellcome Fund(Burroughs Wellcome Fund)	This work was supported by a Burroughs Wellcome Fund Career Award in Biomedical Sciences, a Welch Foundation Research Grant (I-1697), an American Cancer Society/Simmons Cancer Center Institutional Research Grant (ACS-IRG-02-196), and the UT Southwestern Medical Center Endowed Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Brauer MJ, 2005, MOL BIOL CELL, V16, P2503, DOI 10.1091/mbc.E04-11-0968; CHANCE B, 1964, P NATL ACAD SCI USA, V51, P1244, DOI 10.1073/pnas.51.6.1244; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Mateus C, 2000, YEAST, V16, P1313, DOI 10.1002/1097-0061(200010)16:14<1313::AID-YEA626>3.0.CO;2-O; Misteli T, 1997, NAT BIOTECHNOL, V15, P961, DOI 10.1038/nbt1097-961; Murray DB, 2003, EXP CELL RES, V287, P10, DOI 10.1016/S0014-4827(03)00068-5; PARULEKAR SJ, 1986, BIOTECHNOL BIOENG, V28, P700, DOI 10.1002/bit.260280509; PORRO D, 1988, BIOTECHNOL BIOENG, V32, P411, DOI 10.1002/bit.260320402; Richard P, 2003, FEMS MICROBIOL REV, V27, P547, DOI 10.1016/S0168-6445(03)00065-2; Robertson JB, 2008, P NATL ACAD SCI USA, V105, P17988, DOI 10.1073/pnas.0809482105; SATROUTDINOV AD, 1992, FEMS MICROBIOL LETT, V98, P261, DOI 10.1016/0378-1097(92)90167-M; Shi L, 2010, MOL BIOL CELL, V21, P1982, DOI 10.1091/mbc.E10-01-0056; Silverman SJ, 2010, P NATL ACAD SCI USA, V107, P6946, DOI 10.1073/pnas.1002422107; Sohn HY, 2000, YEAST, V16, P1185, DOI 10.1002/1097-0061(20000930)16:13<1185::AID-YEA619>3.0.CO;2-W; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tu BP, 2007, COLD SPRING HARB SYM, V72, P339, DOI 10.1101/sqb.2007.72.019; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; Tu BP, 2006, NAT REV MOL CELL BIO, V7, P696, DOI 10.1038/nrm1980; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; VONMEYEN HK, 1969, ARCH MIKROBIOL, V66, P289; Voth WP, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e59	27	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12595	10.1371/journal.pone.0012595	http://dx.doi.org/10.1371/journal.pone.0012595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830298	Green Published, gold, Green Submitted			2022-12-27	WOS:000281631300022
J	Zhang, C; Jackson, AP; Zhang, ZR; Han, Y; Yu, S; He, RQ; Perrett, S				Zhang, Chen; Jackson, Antony P.; Zhang, Zai-Rong; Han, Yan; Yu, Shun; He, Rong-Qiao; Perrett, Sarah			Amyloid-Like Aggregates of the Yeast Prion Protein Ure2 Enter Vertebrate Cells by Specific Endocytotic Pathways and Induce Apoptosis	PLOS ONE			English	Article							FORMATION IN-VITRO; SACCHAROMYCES-CEREVISIAE; NEURONAL CELLS; MAMMALIAN-CELLS; MEMBRANE DISRUPTION; MISFOLDING DISEASES; PARKINSONS-DISEASE; COMMON MECHANISM; ALPHA-SYNUCLEIN; LIPID RAFTS	Background: A number of amyloid diseases involve deposition of extracellular protein aggregates, which are implicated in mechanisms of cell damage and death. However, the mechanisms involved remain poorly understood. Methodology/Principal Findings: Here we use the yeast prion protein Ure2 as a generic model to investigate how amyloidlike protein aggregates can enter mammalian cells and convey cytotoxicity. The effect of three different states of Ure2 protein (native dimer, protofibrils and mature fibrils) was tested on four mammalian cell lines (SH-SY5Y, MES23.5, HEK-293 and HeLa) when added extracellularly to the medium. Immunofluorescence using a polyclonal antibody against Ure2 showed that all three protein states could enter the four cell lines. In each case, protofibrils significantly inhibited the growth of the cells in a dose-dependent manner, fibrils showed less toxicity than protofibrils, while the native state had no effect on cell growth. This suggests that the structural differences between the three protein states lead to their different effects upon cells. Protofibrils of Ure2 increased membrane conductivity, altered calcium homeostasis, and ultimately induced apoptosis. The use of standard inhibitors suggested uptake into mammalian cells might occur via receptormediated endocytosis. In order to investigate this further, we used the chicken DT40 B cell line DKOR, which allows conditional expression of clathrin. Uptake into the DKOR cell-line was reduced when clathrin expression was repressed suggesting similarities between the mechanism of PrP uptake and the mechanism observed here for Ure2. Conclusions/Significance: The results provide insight into the mechanisms by which amyloid aggregates may cause pathological effects in prion and amyloid diseases.	[Zhang, Chen; Zhang, Zai-Rong; Perrett, Sarah] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Jackson, Antony P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Han, Yan; Yu, Shun] Capital Univ Med Sci, Xuanwu Hosp, Beijing Inst Geriatr, Dept Neurobiol, Beijing, Peoples R China; [Han, Yan; Yu, Shun] Capital Univ Med Sci, Xuanwu Hosp, Beijing Inst Geriatr, Sino Japan Joint Lab Neurodegenerat Dis, Beijing, Peoples R China; [He, Rong-Qiao] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Zhang, Chen; Zhang, Zai-Rong] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Cambridge; Capital Medical University; Capital Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, C (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	sarah.perrett@cantab.net	Zhang, Zairong/G-1030-2013; Perrett, Sarah/AAS-9483-2020	Perrett, Sarah/0000-0003-0137-0997; Jackson, Antony Philip/0000-0002-2895-7387; ZHANG, ZAIRONG/0000-0001-9768-0548	National Natural Science Foundation of China [30620130109, 30670428, 30870482]; Chinese Ministry of Science and Technology [2006CB500703, 2006CB910903]; Chinese Academy of Sciences [KSCX2-YW-R-119, KSCX2-YW-R-256]; Royal Society International Joint	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); Royal Society International Joint	This work was supported by grants to S. P. from the National Natural Science Foundation of China (30620130109, 30670428, 30870482), the Chinese Ministry of Science and Technology (2006CB500703, 2006CB910903) and the Chinese Academy of Sciences (KSCX2-YW-R-119, KSCX2-YW-R-256), and was facilitated by a Royal Society International Joint-Project Grant (to Laura Itzhaki and S. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Bai M, 2004, J BIOL CHEM, V279, P50025, DOI 10.1074/jbc.M406612200; Bai Y, 2008, NEUROSCI RES, V62, P9, DOI 10.1016/j.neures.2008.05.004; Bousset L, 2001, BIOCHEMISTRY-US, V40, P13564, DOI 10.1021/bi011007b; Bousset L, 2001, STRUCTURE, V9, P39, DOI 10.1016/S0969-2126(00)00553-0; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Cecchi C, 2005, J CELL SCI, V118, P3459, DOI 10.1242/jcs.02473; Cecchi C, 2008, NEUROCHEM RES, V33, P2516, DOI 10.1007/s11064-008-9627-7; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chung HY, 1999, J BIOL CHEM, V274, P32301, DOI 10.1074/jbc.274.45.32301; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; COSCHIGANO PW, 1991, MOL CELL BIOL, V11, P822, DOI 10.1128/MCB.11.2.822; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Goedert M, 1998, CURR OPIN NEUROBIOL, V8, P619, DOI 10.1016/S0959-4388(98)80090-1; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hirakura Y, 2000, J NEUROSCI RES, V60, P490, DOI 10.1002/(SICI)1097-4547(20000515)60:4<490::AID-JNR7>3.0.CO;2-9; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jiang Y, 2004, J BIOL CHEM, V279, P3361, DOI 10.1074/jbc.M310494200; Kayed R, 1999, J MOL BIOL, V287, P781, DOI 10.1006/jmbi.1999.2646; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Krammer C, 2009, P NATL ACAD SCI USA, V106, P462, DOI 10.1073/pnas.0811571106; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lin MX, 1997, J BIOL CHEM, V272, P44; Magalhaes AC, 2005, J NEUROSCI, V25, P5207, DOI 10.1523/JNEUROSCI.0653-05.2005; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Oh JM, 2008, MOL CELL NEUROSCI, V39, P238, DOI 10.1016/j.mcn.2008.07.003; Perrett S, 1999, J MOL BIOL, V290, P331, DOI 10.1006/jmbi.1999.2872; Pieri L, 2006, J BIOL CHEM, V281, P15337, DOI 10.1074/jbc.M511647200; Pieri L, 2009, BIOPHYS J, V96, P3319, DOI 10.1016/j.bpj.2008.12.3958; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rappoport JZ, 2008, BIOCHEM J, V412, P415, DOI 10.1042/BJ20080474; Sarnataro D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005829; Schlumpberger M, 2000, PROTEIN SCI, V9, P440; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Sousa MM, 2001, AM J PATHOL, V159, P1993; Speare JO, 2010, EMBO J, V29, P782, DOI 10.1038/emboj.2009.392; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; Thual C, 1999, J BIOL CHEM, V274, P13666, DOI 10.1074/jbc.274.19.13666; Thual C, 2001, BIOCHEMISTRY-US, V40, P1764, DOI 10.1021/bi001916l; Umland TC, 2001, P NATL ACAD SCI USA, V98, P1459, DOI 10.1073/pnas.041607898; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Wadia JS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003314; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wettey FR, 2002, SCIENCE, V297, P1521, DOI 10.1126/science.1074222; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wu G, 2008, NEUROSCI LETT, V446, P11, DOI 10.1016/j.neulet.2008.09.020; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Zhang ZR, 2009, J BIOL CHEM, V284, P14058, DOI 10.1074/jbc.M901189200; Zhang ZR, 2008, J MOL BIOL, V384, P641, DOI 10.1016/j.jmb.2008.09.047; Zhu L, 2003, J MOL BIOL, V328, P235, DOI 10.1016/S0022-2836(03)00249-3	65	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12529	10.1371/journal.pone.0012529	http://dx.doi.org/10.1371/journal.pone.0012529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824085	Green Published, Green Submitted, gold			2022-12-27	WOS:000281480900014
J	Handel, AE; Williamson, AJ; Disanto, G; Handunnetthi, L; Giovannoni, G; Ramagopalan, SV				Handel, Adam E.; Williamson, Alexander J.; Disanto, Giulio; Handunnetthi, Lahiru; Giovannoni, Gavin; Ramagopalan, Sreeram V.			An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; CHLAMYDIA-PNEUMONIAE; ASSOCIATION; MS; ANTIBODIES; AGE	Background: Multiple sclerosis (MS) appears to develop in genetically susceptible individuals as a result of environmental exposures. Epstein-Barr virus (EBV) infection is an almost universal finding among individuals with MS. Symptomatic EBV infection as manifested by infectious mononucleosis (IM) has been shown in a previous meta-analysis to be associated with the risk of MS, however a number of much larger studies have since been published. Methods/Principal Findings: We performed a Medline search to identify articles published since the original meta-analysis investigating MS risk following IM. A total of 18 articles were included in this study, including 19390 MS patients and 16007 controls. We calculated the relative risk of MS following IM using a generic inverse variance with random effects model. This showed that the risk of MS was strongly associated with IM (relative risk (RR) 2.17; 95% confidence interval 1.97-2.39; p<10(-54)). Discussion: Our results establish firmly that a history of infectious mononucleosis significantly increases the risk of multiple sclerosis. Future work should focus on the mechanism of this association and interaction with other risk factors.	[Handel, Adam E.; Disanto, Giulio; Handunnetthi, Lahiru; Ramagopalan, Sreeram V.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Handel, Adam E.; Disanto, Giulio; Handunnetthi, Lahiru; Ramagopalan, Sreeram V.] Univ Oxford, Dept Clin Neurol, Oxford, England; [Williamson, Alexander J.] Univ Oxford, Dept Phys & Theoret Chem, Oxford, England; [Giovannoni, Gavin; Ramagopalan, Sreeram V.] Queen Mary Univ London, Blizard Inst Cell & Mol Sci, Barts & London Sch Med & Dent, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; University of London; Queen Mary University London	Handel, AE (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	g.giovannoni@qmul.ac.uk; sreeramr@well.ox.ac.uk	Handel, Adam/F-2489-2011	McKeating, Jane/0000-0002-7229-5886; Handunnetthi, Lahiru/0000-0002-8242-3722; Handel, Adam/0000-0001-8385-6346	Wellcome Trust [075491/Z/04]; Medical Research Council [G0801976]; Medical Research Council [G0801975] Funding Source: researchfish; MRC [G0801975, G0801976] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Wellcome Trust [GRANT NUMBER 075491/Z/04] and Medical Research Council [GRANT NUMBER G0801976]. SVR is a Goodger Scholar at the University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren C, 2009, EUR J EPIDEMIOL, V24, P541, DOI 10.1007/s10654-009-9367-2; Ascherio A, 2001, JAMA-J AM MED ASSOC, V286, P3083, DOI 10.1001/jama.286.24.3083; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; CASETTA I, 1994, NEUROEPIDEMIOLOGY, V13, P120, DOI 10.1159/000110369; Conn HO, 1997, J INTERN MED, V241, P177, DOI 10.1046/j.1365-2796.1997.118127000.x; Crawford DH, 2006, CLIN INFECT DIS, V43, P276, DOI 10.1086/505400; De Jager PL, 2009, LANCET NEUROL, V8, P1111, DOI 10.1016/S1474-4422(09)70275-3; Fainardi E, 2009, J NEUROVIROL, V15, P425, DOI 10.3109/13550280903475580; Farrell RA, 2009, NEUROLOGY, V73, P32, DOI 10.1212/WNL.0b013e3181aa29fe; GAUDET JPC, 1995, NEUROEPIDEMIOLOGY, V14, P188, DOI 10.1159/000109795; Goldacre MJ, 2004, J EPIDEMIOL COMMUN H, V58, P1032, DOI 10.1136/jech.2003.018366; Goodin DS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004565; Gusev E, 1996, ACTA NEUROL SCAND, V94, P386, DOI 10.1111/j.1600-0404.1996.tb00050.x; Haahr S, 1995, Mult Scler, V1, P73; Haahr S, 2004, ACTA NEUROL SCAND, V109, P270, DOI 10.1046/j.1600-0404.2003.00221.x; Hammond SR, 2000, BRAIN, V123, P968, DOI 10.1093/brain/123.5.968; Handel AE, 2010, NAT REV NEUROL, V6, P156, DOI 10.1038/nrneurol.2010.1; HANDEL AE, 2010, NAT REV NEUROL; HANDEL AE, 2010, EUR J NEUROL; Hernan MA, 2001, EPIDEMIOLOGY, V12, P301, DOI 10.1097/00001648-200105000-00009; HOPKINS RS, 1991, NEUROEPIDEMIOLOGY, V10, P192, DOI 10.1159/000110269; LINDBERG C, 1991, NEUROEPIDEMIOLOGY, V10, P62, DOI 10.1159/000110248; Lunemann JD, 2007, J VIROL, V81, P6777, DOI 10.1128/JVI.00153-07; Lunemann JD, 2010, ANN NEUROL, V67, P159, DOI 10.1002/ana.21886; Marrie RA, 2000, NEUROLOGY, V54, P2307, DOI 10.1212/WNL.54.12.2307; MARTYN CN, 1993, J NEUROL NEUROSUR PS, V56, P167, DOI 10.1136/jnnp.56.2.167; Nielsen TR, 2007, ARCH NEUROL-CHICAGO, V64, P72, DOI 10.1001/archneur.64.1.72; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; OPERSKALSKI EA, 1989, NEUROLOGY, V39, P825, DOI 10.1212/WNL.39.6.825; Ponsonby AL, 2005, JAMA-J AM MED ASSOC, V293, P463, DOI 10.1001/jama.293.4.463; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; Ramagopalan SV, 2009, NEUROEPIDEMIOLOGY, V32, P257, DOI 10.1159/000201564; Salvetti M, 2009, CURR OPIN NEUROL, V22, P201, DOI 10.1097/WCO.0b013e32832b4c8d; Simon KC, 2010, NEUROLOGY, V74, P1365, DOI 10.1212/WNL.0b013e3181dad57e; Sotgiu S, 2001, MULT SCLER, V7, P371, DOI 10.1177/135245850100700605; SOUBERBIELLE BE, 1990, ACTA NEUROL SCAND, V82, P303; Thacker EL, 2006, ANN NEUROL, V59, P499, DOI 10.1002/ana.20820; WARNER HB, 1981, LANCET, V2, P1290; Willis SN, 2009, BRAIN, V132, P3318, DOI 10.1093/brain/awp200; Zaadstra BM, 2008, MULT SCLER J, V14, P307, DOI 10.1177/1352458507084265; Zorzon M, 2003, NEUROL SCI, V24, P242, DOI 10.1007/s10072-003-0147-6	41	143	147	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12496	10.1371/journal.pone.0012496	http://dx.doi.org/10.1371/journal.pone.0012496			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824132	Green Submitted, Green Published, gold			2022-12-27	WOS:000281456100010
J	Konigsberger, S; Peckl-Schmid, D; Zaborsky, N; Patzak, I; Kiefer, F; Achatz, G				Koenigsberger, Sebastian; Peckl-Schmid, Doris; Zaborsky, Nadja; Patzak, Irene; Kiefer, Friedemann; Achatz, Gernot			HPK1 Associates with SKAP-HOM to Negatively Regulate Rap1-Mediated B-Lymphocyte Adhesion	PLOS ONE			English	Article							HEMATOPOIETIC PROGENITOR KINASE-1; MEDIATES RAP1-INDUCED ADHESION; T-CELL-ACTIVATION; INTEGRIN ACTIVATION; SYNAPSE FORMATION; IMMUNOLOGICAL-SYNAPSE; ACTIN POLYMERIZATION; RAP GTPASES; MOLECULE-1 ICAM-1; ADAPTER PROTEINS	Background: Hematopoietic progenitor kinase 1 (HPK1) is a Ste20-related serine/threonine kinase activated by a range of environmental stimuli including genotoxic stress, growth factors, inflammatory cytokines and antigen receptor triggering. Being inducibly recruited to membrane-proximal signalling scaffolds to regulate NFAT, AP-1 and NF kappa B-mediated gene transcription in T-cells, the function of HPK1 in B-cells to date remains rather ill-defined. Methodology/Principal Findings: By using two loss of function models, we show that HPK1 displays a novel function in regulating B-cell integrin activity. Wehi 231 lymphoma cells lacking HPK1 after shRNA mediated knockdown exhibit increased basic activation levels of Ras-related protein 1 (Rap1), accompanied by a severe lymphocyte function-associated antigen-1 (LFA-1) dependent homotypic aggregation and increased adhesion to intercellular adhesion molecule 1 (ICAM-1). The observed phenotype of enhanced integrin activity is caused downstream of Src, by a signalling module independent of PI3K and PLC, involving HPK1, SKAP55 homologue (SKAP-HOM) and Rap1-GTP-interacting adaptor molecule (RIAM). This alters actin dynamics and renders focal adhesion kinase (FAK) constitutively phosphorylated. Bone marrow and splenic B-cell development of HPK1(-/-) mice are largely unaffected, except age-related tendencies for increased splenic cellularity and BCR downregulation. In addition, naive splenic knockout B-cells appear hyperresponsive to a range of stimuli applied ex vivo as recently demonstrated by others for T-cells. Conclusions/Significance: We therefore conclude that HPK1 exhibits a dual function in B-cells by negatively regulating integrin activity and controlling cellular activation, which makes it an interesting candidate to study in pathological settings like autoimmunity and cancer.	[Koenigsberger, Sebastian; Peckl-Schmid, Doris; Zaborsky, Nadja; Achatz, Gernot] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Patzak, Irene] Canc Res UK London Res Inst, Lincolns Inn Fields Labs, London, England; [Kiefer, Friedemann] Max Planck Inst Mol Biomed, Dept Vasc Cell Biol, Munster, Germany	Salzburg University; Cancer Research UK; Max Planck Society	Konigsberger, S (corresponding author), Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria.	gernot.achatz@sbg.ac.at	Achatz, Gernot/E-5073-2011	Kiefer, Friedemann/0000-0002-3002-8237; Zaborsky, Nadja/0000-0002-9775-185X; Konigsberger, Sebastian/0000-0001-7514-2044	Forderung der Wissenschaftlichen Forschung (FWF) [P19017]; Oesterreichischen Nationalbank (OENB) [11710]	Forderung der Wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); Oesterreichischen Nationalbank (OENB)	The experimental work was funded by the Forderung der Wissenschaftlichen Forschung (FWF) project P19017 (http://www.fwf.ac.at) and the Oesterreichischen Nationalbank (OENB) grant 11710 (http://www.oenb.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arana E, 2008, IMMUNITY, V28, P88, DOI 10.1016/j.immuni.2007.12.003; Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Black DS, 2000, CELL MICROBIOL, V2, P401, DOI 10.1046/j.1462-5822.2000.00061.x; Buday L, 1999, BBA-REV BIOMEMBRANES, V1422, P187, DOI 10.1016/S0304-4157(99)00005-2; Carrasco YR, 2006, EMBO J, V25, P889, DOI 10.1038/sj.emboj.7600944; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Duchniewicz M, 2006, MOL CELL BIOL, V26, P643, DOI 10.1128/MCB.26.2.643-653.2006; DUSTIN ML, 1988, J CELL BIOL, V107, P321, DOI 10.1083/jcb.107.1.321; Geisberger R, 2006, IMMUNOL LETT, V102, P169, DOI 10.1016/j.imlet.2005.09.001; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Jo EK, 2005, J EXP MED, V201, P1733, DOI 10.1084/jem.20042577; Katagiri K, 2002, MOL CELL BIOL, V22, P1001, DOI 10.1128/MCB.22.4.1001-1015.2002; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Kliche S, 2006, MOL CELL BIOL, V26, P7130, DOI 10.1128/MCB.00331-06; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Le Bras S, 2004, J BIOL CHEM, V279, P15550, DOI 10.1074/jbc.M312659200; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Lin KBL, 2008, IMMUNITY, V28, P75, DOI 10.1016/j.immuni.2007.11.019; Ling P, 1999, MOL CELL BIOL, V19, P1359; Liou J, 2000, IMMUNITY, V12, P399, DOI 10.1016/S1074-7613(00)80192-2; Ma WB, 2001, ONCOGENE, V20, P1703, DOI 10.1038/sj.onc.1204224; Marie-Cardine A, 1998, FEBS LETT, V435, P55, DOI 10.1016/S0014-5793(98)01040-0; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; McLeod SJ, 2004, J BIOL CHEM, V279, P12009, DOI 10.1074/jbc.M313098200; Menasche G, 2007, MOL CELL BIOL, V27, P4070, DOI 10.1128/MCB.02011-06; Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017; MIYAKE K, 1991, J EXP MED, V173, P599, DOI 10.1084/jem.173.3.599; Nagata Y, 1999, BLOOD, V93, P3347, DOI 10.1182/blood.V93.10.3347.410k06_3347_3354; Niiro H, 2004, J IMMUNOL, V173, P5601, DOI 10.4049/jimmunol.173.9.5601; Nolz JC, 2008, J CELL BIOL, V182, P1231, DOI 10.1083/jcb.200801121; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Shui JW, 2007, NAT IMMUNOL, V8, P84, DOI 10.1038/ni1416; Spaargaren M, 2003, J EXP MED, V198, P1539, DOI 10.1084/jem.20011866; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Togni M, 2005, MOL CELL BIOL, V25, P8052, DOI 10.1128/MCB.25.18.8052-8063.2005; Tse KWK, 2009, J BIOL CHEM, V284, P22865, DOI 10.1074/jbc.M109.013169; Tsuji S, 2001, J EXP MED, V194, P529, DOI 10.1084/jem.194.4.529; Uruno T, 2003, BIOCHEM J, V371, P485, DOI 10.1042/BJ20021791; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weber M, 2008, J EXP MED, V205, P853, DOI 10.1084/jem.20072619	46	17	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12468	10.1371/journal.pone.0012468	http://dx.doi.org/10.1371/journal.pone.0012468			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824186	Green Published, gold, Green Submitted			2022-12-27	WOS:000281456100006
J	Archambault, P; Snelgrove, PVR; Fisher, JAD; Gagnon, JM; Garbary, DJ; Harvey, M; Kenchington, EL; Lesage, V; Levesque, M; Lovejoy, C; Mackas, DL; McKindsey, CW; Nelson, JR; Pepin, P; Piche, L; Poulin, M				Archambault, Philippe; Snelgrove, Paul V. R.; Fisher, Jonathan A. D.; Gagnon, Jean-Marc; Garbary, David J.; Harvey, Michel; Kenchington, Ellen L.; Lesage, Veronique; Levesque, Melanie; Lovejoy, Connie; Mackas, David L.; McKindsey, Christopher W.; Nelson, John R.; Pepin, Pierre; Piche, Laurence; Poulin, Michel			From Sea to Sea: Canada's Three Oceans of Biodiversity	PLOS ONE			English	Review							ST-LAWRENCE ESTUARY; SANDY BOTTOM ECOSYSTEM; MARINE BIODIVERSITY; DEEP-SEA; COMMUNITY STRUCTURE; BRITISH-COLUMBIA; ARCTIC-OCEAN; HUDSON-BAY; HETEROTROPHIC PRODUCTION; ZOOPLANKTON COMMUNITY		[Archambault, Philippe; Levesque, Melanie; Piche, Laurence] Univ Quebec, Inst Sci Mer Rimouski, Rimouski, PQ G5L 3A1, Canada; [Snelgrove, Paul V. R.] Mem Univ Newfoundland, Dept Biol, Ctr Ocean Sci, St John, NF, Canada; [Fisher, Jonathan A. D.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Gagnon, Jean-Marc; Poulin, Michel] Canadian Museum Nat, Div Res, Ottawa, ON K1P 6P4, Canada; [Garbary, David J.] St Francis Xavier Univ, Dept Biol, Antigonish, NS B2G 1C0, Canada; [Harvey, Michel; Lesage, Veronique; McKindsey, Christopher W.] Fisheries & Oceans Canada, Maurice Lamontagne Inst, Mont Joli, PQ G5H 3Z4, Canada; [Kenchington, Ellen L.] Fisheries & Oceans Canada, Bedford Inst Oceanog, Dartmouth, NS B2Y 4A2, Canada; [Lovejoy, Connie] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Lovejoy, Connie] Univ Laval, IBIS, Quebec City, PQ G1K 7P4, Canada; [Mackas, David L.; Nelson, John R.] Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC, Canada; [Pepin, Pierre] Fisheries & Oceans Canada, St John, NF, Canada	University of Quebec; Memorial University Newfoundland; Queens University - Canada; Saint Francis Xavier University - Canada; Fisheries & Oceans Canada; Bedford Institute of Oceanography; Fisheries & Oceans Canada; Laval University; Laval University; Fisheries & Oceans Canada; Fisheries & Oceans Canada	Archambault, P (corresponding author), Univ Quebec, Inst Sci Mer Rimouski, Rimouski, PQ G5L 3A1, Canada.	philippe_archambault@uqar.qc.ca	Lesage, Veronique/ABE-2682-2020; Lovejoy, Connie/A-3756-2008; McKindsey, Chris/AAH-6773-2020; Pepin, Pierre/I-4083-2013	Lovejoy, Connie/0000-0001-8027-2281; McKindsey, Chris/0000-0002-3026-6454; Garbary, David/0000-0001-5126-6608; Gagnon, Jean-Marc/0000-0003-2778-4215	Census of Marine Life, the Canadian Healthy Oceans Network (CHONe); Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Museum of Nature; Fisheries and Oceans Canada; ArcticNet; Canadian International Polar Year Program; U. S. National Science Foundation	Census of Marine Life, the Canadian Healthy Oceans Network (CHONe); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Museum of Nature; Fisheries and Oceans Canada; ArcticNet; Canadian International Polar Year Program; U. S. National Science Foundation(National Science Foundation (NSF))	This project was funded by the Census of Marine Life, the Canadian Healthy Oceans Network (CHONe), the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canadian Museum of Nature. The authors also acknowledge financial and ship time support from Fisheries and Oceans Canada and ArcticNet and the Canadian International Polar Year Program's Canada's Three Oceans project, the U. S. National Science Foundation's Beaufort Gyre Exploration Project and collaboration with the Japan Agency for Marine-Earth Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS W, 1975, 29 DEP ENV; Adey WH, 2008, J PHYCOL, V44, P1384, DOI 10.1111/j.1529-8817.2008.00605.x; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Tovar-Hernandez MA, 2007, J NAT HIST, V41, P511, DOI 10.1080/00222930701250912; ANDERSON JT, 1981, CAN J BOT, V59, P1793, DOI 10.1139/b81-240; ARSENEAU MJ, 2003, RAPP TECH CAN SCI HA, V2512; ATKINSON EG, 1989, CAN DATA REP FISH AQ, V744, P121; ATKINSON EG, 1989, CAN DATA REP FISH AQ, V745, P132; BAIN H, 1977, WELLINGTON CHA UNPUB; Baker KD, 2009, ENVIRON BIOL FISH, V85, P79, DOI 10.1007/s10641-009-9465-8; Bano N, 2002, APPL ENVIRON MICROB, V68, P505, DOI 10.1128/AEM.68.2.505-518.2002; Banse K, 1974, B FISH RES BOARD CAN, V185, P111; BARRIE JD, 1979, DIVERSITY MARINE BEN; Berard-Therriault L, 1999, PUBL SPEC CAN SCI HA, V128, P387, DOI DOI 10.1046/j.1469-1809.1999.6320101.x; Bernt KE, 1999, SCI TOTAL ENVIRON, V243, P243, DOI 10.1016/S0048-9697(99)00400-3; Boero Ferdinando, 2010, Diversity, V2, P115; BOSSE L, 1996, RAPP TECH CAN SCI HA, V2132, P1; BOUCHET P, 2006, EXPLORATION MARINE B, P33; BOURGET E, 1983, CAN J ZOOL, V61, P2509, DOI 10.1139/z83-333; BOURQUE M, INFLUENCE HYPOXIE MA; BOUSFIEL EL, 1960, CANADIAN ATLANTIC SE; BRIGGS JC, 1970, SYST ZOOL, V19, P19, DOI 10.2307/2412025; BRINKHURST RO, 1979, CAN J ZOOL, V57, P1553, DOI 10.1139/z79-203; BRINKHURST RO, 1987, CAN TECH REP HYDROGR, V85, P86; Brunel P., 1970, Trav. Pech. Queb., V32, P1; Brunel P., 1998, CATALOGUE MARINE INV; Buchanan GM, 2009, CONSERV BIOL, V23, P499, DOI 10.1111/j.1523-1739.2008.01083.x; BURD BJ, 1987, CAN TECH REP HYDROGR, V84, P28; BURD BJ, 1990, CANADIAN TECHNICAL R, V122, P49; BURD BJ, 1987, CAN TECH REP HYDROGR, V88, P71; BURSA A, 1961, J FISH RES BOARD CAN, V18, P51, DOI 10.1139/f61-004; BURSA AS, 1961, J FISH RES BOARD CAN, V18, P563, DOI 10.1139/f61-046; BURSA AS, 1969, J PROTOZOOL, V16, P411, DOI 10.1111/j.1550-7408.1969.tb02290.x; BURSA AS, 1969, ARCTIC ALPINE RES, V2, P152; BURSA AS, 1969, PHYCOLOGIA, V4, P8; BURSA AS, 1971, FISH RES BOARD CAN T, V267, P1; CADDY JF, 1977, FISH MAR SERV MANUS, V1431, P54; *CAN MUS NAT, 2004, CAN MAR TAX UNPUB; *CAN MUS NAT, 1996, DAT BANK CAN SYST TA; Carmack E. C., 1990, POLAR OCEANOGRAPHY A, P171, DOI DOI 10.1016/B978-0-12-653031-5.50009-6; Carmack EC, 2007, DEEP-SEA RES PT II, V54, P2578, DOI 10.1016/j.dsr2.2007.08.018; CITARELLA G, 1982, HYDROBIOLOGIA, V87, P113, DOI 10.1007/BF00015193; Coad B.W., 2004, CAN MS REP FISH AQUA, P2674; COAKLEY JP, 1993, ESTUARIES, V16, P873, DOI 10.2307/1352446; Colbourne E, 1997, CAN J FISH AQUAT SCI, V54, P68, DOI 10.1139/cjfas-54-S1-68; COLLIN AE, 1964, OCEANOGRAPHY MARINE, V2, P45; Conlan K, 2008, J MARINE SYST, V74, P864, DOI 10.1016/j.jmarsys.2007.10.002; COSEWIC, 2008, COSEWIC ASS UPD STAT; COSEWIC, 2003, COSEWIC ASS UPD STAT; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2013, COSEWIC ASS STAT REP; Costello MJ, 2006, MAR ECOL PROG SER, V316, P257, DOI 10.3354/meps316257; CRAWFORD WR, 1991, CONT SHELF RES, V11, P669, DOI 10.1016/0278-4343(91)90073-F; Crawford WR, 1999, ATMOS OCEAN, V37, P255, DOI 10.1080/07055900.1999.9649629; CROSS SF, 1991, CAN DATA REP HYDROGR, V92, P35; *CTR MAR BIOD, 2002, 3 OC BIOD CAN NAT PL, P14; Cusson M, 2007, MAR ECOL PROG SER, V331, P291, DOI 10.3354/meps331291; Daugbjerg N., 1994, RES ARCTIC BIOL IGLO, P1; Daugbjerg Niels, 1991, P39; DAVIDSON V. M., 1931, CONTR CANADIAN BIOL & FISH, V6, P497; DAYTON PK, 1995, AQUAT CONSERV, V5, P205, DOI 10.1002/aqc.3270050305; DeLong EF, 2009, NATURE, V459, P200, DOI 10.1038/nature08059; DENMAN K, 1985, CAN DATA REP HYDROGR, V36, P77; Desrosiers G, 2000, DEEP-SEA RES PT II, V47, P663, DOI 10.1016/S0967-0645(99)00122-8; Devine JA, 2006, NATURE, V439, P29, DOI 10.1038/439029a; DUNTON K, 1992, TRENDS ECOL EVOL, V7, P183, DOI 10.1016/0169-5347(92)90070-R; Eleftheriou A., 2005, METHODS STUDY MARINE, V3rd ed, DOI DOI 10.1111/maec.12189; *ENV CAN, 1995, CAN BIOD STRAT CAN R, P77; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; *FED BIOS GROUP, 1995, SYST IMP CRIS; FENNEL W, 2009, WATERSHEDS BAYS BOUN, P97; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Fisher JAD, 2002, MAR ECOL PROG SER, V240, P249, DOI 10.3354/meps240249; Fisher JAD, 2008, ECOL LETT, V11, P883, DOI 10.1111/j.1461-0248.2008.01216.x; FORBES JR, 1993, CAN DATA REP HYDROGR, V117, P247; FORBES JR, 1993, CAN DATA REP HYDROGR, V117, P212; FOY MG, 1976, FISH MAR SERV RES DE, V617, P44; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Fraser CM, 1937, HYDROIDS PACIFIC COA; GABRIELSON PW, 1990, PHYCOLOGICAL CONTRIB, V4; Galand PE, 2008, LIMNOL OCEANOGR, V53, P813, DOI 10.4319/lo.2008.53.2.0813; Galand PE, 2006, AQUAT MICROB ECOL, V44, P115, DOI 10.3354/ame044115; Galand PE, 2009, ENVIRON MICROBIOL, V11, P971, DOI 10.1111/j.1462-2920.2008.01822.x; Galand PE, 2008, J MARINE SYST, V74, P774, DOI 10.1016/j.jmarsys.2007.12.001; Galand PE, 2009, ISME J, V3, P860, DOI 10.1038/ismej.2009.23; Garbary DJ., 2001, ENCY LIFE SCI, DOI [10.1038/npg.els.0000312, DOI 10.1038/NPG.ELS.0000312]; GARBARY DJ, 1990, EVOLUTIONARY BIOGEOG; Garneau ME, 2006, AQUAT MICROB ECOL, V42, P27, DOI 10.3354/ame042027; Geraci Joseph R., 1999, P367; Gilbert D, 2005, LIMNOL OCEANOGR, V50, P1654, DOI 10.4319/lo.2005.50.5.1654; Gilbert Denis, 2007, Naturaliste Canadien (Quebec), V131, P67; GRADINGER R, 2010, LIFE WORLDS OCEANS D; Gray JS, 1997, MAR ECOL PROG SER, V159, P97, DOI 10.3354/meps159097; GRIFFITHS CL, 2010, PLOSONE; Grime JP, 1997, SCIENCE, V277, P1260, DOI 10.1126/science.277.5330.1260; GRONTVED JUL., 1938, MEDDELELSER OM GRONLAND, V82, P1; Hamilton AK, 2008, LIMNOL OCEANOGR, V53, P922, DOI 10.4319/lo.2008.53.3.0922; Hart J.L., 1973, B FISHERIES RES BOAR, V180, P740; HART JFL, 1982, BRIT COLUMBIA PROVIN, V40; Harvey M, 1997, CAN J FISH AQUAT SCI, V54, P1937, DOI 10.1139/f97-099; Harwood J, 2001, J MAMMAL, V82, P630, DOI 10.1644/1545-1542(2001)082<0630:MMATEI>2.0.CO;2; Henry LA, 2006, MAR ECOL PROG SER, V306, P63, DOI 10.3354/meps306063; HILL S, 1982, CAN DATA REP HYDROGR, V4, P103; HILL S, 1982, CAN DATA REP HYDROGR, V3, P118; HILL S, 1983, CAN DATA REP HYDROGR, V8, P93; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hsiao S.I., 1985, CANADIAN DATA REPORT, V539, P106; Hsiao S.I.C., 1980, CAN MANUSCR REP FISH, V1557, P17; HSIAO SIC, 1985, ARCTIC, V38, P31; HSIAO SIC, 1983, NOVA HEDWIGIA, V37, P225; HSIAO SIC, 1977, CAN J BOT, V55, P685, DOI 10.1139/b77-083; HSIAO SIC, 1980, CAN MANUSCR REP FISH, V1557, P139; HSIAO SIC, 1979, FISH MAR SERV DATA R, V155, P82; HSIAO SIC, 1976, BEAUFORT SEA PROJECT, P1; HUGHES RN, 1972, LIMNOL OCEANOGR, V17, P111, DOI 10.4319/lo.1972.17.1.0111; HUNTSMAN AG, 1919, CAN FISH EXPED, V1914, P421; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; Iselin C, 1930, P AM ACAD ARTS SCI, V66, P1, DOI 10.2307/20026316; JEAN Y, 1981, BRIT COLUMBIA PROVIN, V13, P1; JEFFERSON TA, FAO SPECIES IDENTIFI; Johnson WS, 2005, ZOOPLANKTON ATLANTIC; Jorgensen OA, 2005, CAN J FISH AQUAT SCI, V62, P1833, DOI 10.1139/F05-101; Kaiser MJ, 1998, ICES J MAR SCI, V55, P353, DOI 10.1006/jmsc.1997.0322; Kenchington ELR, 2006, J SEA RES, V56, P249, DOI 10.1016/j.seares.2006.03.010; Kenchington ELR, 2001, CAN J FISH AQUAT SCI, V58, P1043, DOI 10.1139/cjfas-58-6-1043; KNOX D, 1980, IDENTIFICATION ENUME; KONAR B, 2010, LIFE WORLDS OCEANS D; KOVACS KM, 2008, SCI PROG, V91; Lapoussiere A, 2009, CONT SHELF RES, V29, P1276, DOI 10.1016/j.csr.2009.02.004; Lavaniegos BE, 2003, DEEP-SEA RES PT II, V50, P2473, DOI 10.1016/S0967-0645(03)00132-2; Lavaniegos BE, 2007, PROG OCEANOGR, V75, P42, DOI 10.1016/j.pocean.2007.07.002; Lebeuf M, 2004, ENVIRON SCI TECHNOL, V38, P2971, DOI 10.1021/es035187j; Lee R.K.S., 1980, NAT MUS NAT SCI CANA, V9, P1; LESSARD S, 2009, LISTE ESPECES PHYTOP; Lindstrom SC, 2006, J APPL PHYCOL, V18, P637, DOI 10.1007/s10811-006-9076-0; Lindstrom SC, 2008, J APPL PHYCOL, V20, P951, DOI 10.1007/s10811-008-9313-9; Lindstrom SC, 2001, J BIOGEOGR, V28, P243, DOI 10.1046/j.1365-2699.2001.00529.x; Liu K.-K., 2009, WATERSHEDS BAYS BOUN, P141; Loder J., 1998, SEA VOLUME 11 GLOBAL, V5, P105; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Lovejoy C, 2006, APPL ENVIRON MICROB, V72, P3085, DOI 10.1128/AEM.72.5.3085-3095.2006; Lovejoy C, 2004, AQUAT MICROB ECOL, V34, P79, DOI 10.3354/ame034079; Lovejoy C, 2002, DEEP-SEA RES PT II, V49, P5027, DOI 10.1016/S0967-0645(02)00176-5; LUBINSK I, 1980, CAN B FISHS AAQUAT S; Luning K, 1990, SEAWEEDS THEIR ENV B; Mackas DL, 2002, PROG OCEANOGR, V54, P423, DOI 10.1016/S0079-6611(02)00062-9; Mackas DL, 2001, CAN J FISH AQUAT SCI, V58, P685, DOI 10.1139/cjfas-58-4-685; *MACLAREN ATL LTD, 1977, REP PRIM DAT COLL 19; *MACLAREN ATL LTD, 1978, APP REP BIOL STUD OF; *MACLAREN MAR INC, 1979, APP REP CRUIS 78 1 E; MANN A, 1925, REPORT CANADIAN ARCT, P3; MANTON I, 1975, PROC R SOC SER B-BIO, V189, P15, DOI 10.1098/rspb.1975.0037; MANTON I, 1976, CAN J BOT, V54, P1932, DOI 10.1139/b76-208; MANTON I, 1976, PROC R SOC SER B-BIO, V194, P179, DOI 10.1098/rspb.1976.0072; MARGOLIS L, 1989, SYNOPSIS PARASITES V, P1; MARTIN JL, 2001, CAN TECH REP FISH AQ, V2249, P85; MARTIN JL, 1999, CAN TECH REP FISH AQ, V2265, P132; MARTIN JL, 2006, CAN TECH REP FISH AQ, V2629, P88; Massana R, 2006, ENVIRON MICROBIOL, V8, P1515, DOI 10.1111/j.1462-2920.2006.01042.x; McAllister D.E., 1990, SYLLOGEUS, V64, P1; McDonald T., 1995, CAN SPEC PUBL FISH A, V122, P1; McLaughlin F, 2004, SEA, V14, P1211; Mooers AO, 2007, CONSERV BIOL, V21, P572, DOI 10.1111/j.1523-1739.2007.00689.x; Mora C, 2008, P ROY SOC B-BIOL SCI, V275, P149, DOI 10.1098/rspb.2007.1315; MOSQUIN T, 1995, CANADAS BIODIVERSITY, V24; Mueter FJ, 2008, ECOL APPL, V18, P309, DOI 10.1890/07-0564.1; Myers RA, 1997, ECOL APPL, V7, P91, DOI 10.1890/1051-0761(1997)007[0091:WDFSCT]2.0.CO;2; Norton TA, 1996, PHYCOLOGIA, V35, P308, DOI 10.2216/i0031-8884-35-4-308.1; *OC LAB ED, 1973, B MAR ECOL, V7, P1; OCONNELL B, 1978, AMAXAAP774; Ormond RFG, 1996, J MAR BIOL ASSOC UK, V76, P151, DOI 10.1017/S0025315400029076; PAYNE J, 2010, LIFE WORLDS OCEANS D; PEER DL, 1980, CAN TECH REP FISH AQ, V981, P74; Percy J.A., 1992, CAN DATA REP FISH AQ, V892, P136; Perry S.L., 1999, MAR FISH REV, V61, P1; Piepenburg D, 2005, POLAR BIOL, V28, P733, DOI 10.1007/s00300-005-0013-5; POLUNIN N, 1992, J BOT, V72, P197; POULIN M, 2009, LISTE ESPECES RECENS; Poulin M, 2010, EUR J PHYCOL, V45, P127, DOI 10.1080/09670260903509362; Power G., 1997, American Fisheries Society Symposium, V19, P13; PREFONTAINE G., 1962, NAT CANADIEN, V89, P237; Prena J, 1999, MAR ECOL PROG SER, V181, P107; PRENA J, 1996, GRAND BANKS OTTER TR; Quijon PA, 2005, OECOLOGIA, V144, P125, DOI 10.1007/s00442-005-0017-4; Quijon PA, 2005, POLAR BIOL, V28, P495, DOI 10.1007/s00300-005-0719-4; Radulovici Adriana E., 2010, Diversity, V2, P450; Ramey PA, 2003, MAR ECOL PROG SER, V262, P215, DOI 10.3354/meps262215; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; Reddy M.P.M., 2001, DESCRIPTIVE PHYS OCE; REID PC, 2003, GLOBAL CHANGE BIOL, V13, P1910; Reynolds JD, 2005, P ROY SOC B-BIOL SCI, V272, P2337, DOI 10.1098/rspb.2005.3281; RIEDEL A, 2003, CANADIAN DATA REPORT, V159, P54; Robba L, 2006, AM J BOT, V93, P1101, DOI 10.3732/ajb.93.8.1101; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Robertson DR, 2008, DIVERS DISTRIB, V14, P891, DOI 10.1111/j.1472-4642.2008.00519.x; Rombouts I, 2009, P ROY SOC B-BIOL SCI, V276, P3053, DOI 10.1098/rspb.2009.0742; Ross PS, 2004, ENVIRON TOXICOL CHEM, V23, P157, DOI 10.1897/03-85; Ross PS, 2000, MAR POLLUT BULL, V40, P504, DOI 10.1016/S0025-326X(99)00233-7; Rossong MA, 2006, J EXP MAR BIOL ECOL, V329, P281, DOI 10.1016/j.jembe.2005.09.007; Rozanska M, 2008, J MARINE SYST, V74, P887, DOI 10.1016/j.jmarsys.2007.11.009; Rutherford S, 1999, NATURE, V400, P749, DOI 10.1038/23449; SANDERSON BG, 1984, ATMOS OCEAN, V22, P484; Saucier FJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000686; Saunders GW, 2008, BOTANY, V86, P773, DOI 10.1139/B08-001; SCAGEL RF, 1993, SYNOPSIS BENTHIC MAR; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Scott W.B., 1988, CAN B FISH AQUAT SCI, V219, P1; SEARS JR, 1998, NEAS KEYS BENTHIC MA; SEIDENFADEN G, 1947, BOT CANADIAN E ARC 2, P138; SEKERAK AD, 1979, STUDIES PLANK UNPUB; SEKERAK AD, 1976, SUMMER SURVEYS MARIN; Shackell NL, 2003, AQUAT CONSERV, V13, P305, DOI 10.1002/aqc.554; Sheppard C, 2006, MAR POLLUT BULL, V52, P831, DOI 10.1016/j.marpolbul.2006.07.002; SHIH CT, 1971, FISH RES BOARD CAN B, V176, P264; SIEBURTH JM, 1978, LIMNOL OCEANOGR, V23, P1256, DOI 10.4319/lo.1978.23.6.1256; SIMARD N, 1996, RAPP STAT CAN SCI HA, V978, P199; Simon N, 2009, CR BIOL, V332, P159, DOI 10.1016/j.crvi.2008.09.009; Sloan NA, 2009, AQUAT CONSERV, V19, P827, DOI 10.1002/aqc.1019; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; Snelgrove PVR, 2004, SCOPE SER, V64, P161; Snelgrove PVR, 1999, BIOSCIENCE, V49, P129, DOI 10.2307/1313538; Snelgrove PVR, 1998, BIODIVERS CONSERV, V7, P1123, DOI 10.1023/A:1008867313340; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; SOURNIA A, 1991, J PLANKTON RES, V13, P1093, DOI 10.1093/plankt/13.5.1093; SOUTH GR, 1984, CAN J BOT, V62, P680, DOI 10.1139/b84-102; SOUTH GR, 1986, CATALOGUE DISTRIBUTI; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; SPRINGER AM, 1989, CONT SHELF RES, V9, P359, DOI 10.1016/0278-4343(89)90039-3; SQUIRES HJ, 1990, CAN B FISH AQUAT SCI, V221; STARR M, 2002, 20020623 DFO CAN SCI; Stewart P. L., 2002, CAN B FISH AQUAT SCI, V2425, pvii; STPIERRE JF, 1996, RAPP STAT CAN SCI HA, V986, P92; Straneo F., 2008, ARCTIC SUBARCTIC OCE, P249, DOI [10.1007/978-1-4020-6774-7_11., DOI 10.1007/978-1-4020-6774-7_11]; Stroeve JC, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021810; *TASK FORC CAN BIO, 1993, 1 TASK FORC CAN BIOS; Terrado R, 2009, AQUAT MICROB ECOL, V56, P25, DOI 10.3354/ame01327; Terrado R, 2008, J MARINE SYST, V74, P964, DOI 10.1016/j.jmarsys.2007.11.001; TETT P, 1995, J PLANKTON RES, V17, P1693, DOI 10.1093/plankt/17.8.1693; THOMSON D, 1975, MARINE ECOLOGY UNPUB; THOMSON DH, 1982, ARCTIC, V35, P61; Thomson R.E., 1989, CAN SPEC PUBL FISH A, V108, P265; Thomson R. E., 1981, CAN SPEC PUBL FISH A, V56, P291; Thurston H., 1990, TIDAL LIFE NATURAL H; Tovar-Hernandez MA, 2007, ZOOTAXA, P31; TUNNICLIFFE V, 1993, OUR LIVING LEGACY, P191; Tyack PL, 2008, J MAMMAL, V89, P549, DOI 10.1644/07-MAMM-S-307R.1; Vanden Berghe E., 2010, LIFE WORLDS OCEANS D; Vermeij GJ, 2008, SCIENCE, V321, P780, DOI 10.1126/science.1160852; VORS N, 1993, POLAR BIOL, V13, P113; WACASEY JW, 1980, CAN DATA REP FISH AQ, V205, P42; Wacasey JW, 1979, CAN DATA REP FISH AQ, V164, P99; WACASEY JW, 1977, FISH MAR SERV DATA R, V41, P187; WACASEY JW, 1976, FISH MAR SERV RES DE, V661, P62; WATERS RE, 1992, CAN TECH REP HYDROGR, V137, P59; Wells LE, 2003, AQUAT MICROB ECOL, V31, P19, DOI 10.3354/ame031019; WHITEAVES IF, 1901, GEOL SURV CAN PUBL, V722, P1; Whitehead H, 2008, ECOL LETT, V11, P1198, DOI 10.1111/j.1461-0248.2008.01234.x; WILCE RT, 1990, EVOLUTIONARY BIOGEOG, P322; WILDISH DJ, 1977, FISH MAR SERV MANUS, V1462, P14; WILDISH DJ, 1977, FISH MAR SERV MANUS, V1463, P13; Willey A., 1929, Contributions to Canadian Biology, V4, P527; Witman JD, 2008, ECOLOGY, V89, pS66, DOI 10.1890/07-1201.1; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2; WORM B, 2010, LIFE WORLDS OCEANS D; Zeller D, 2005, MAR POLICY, V29, P69, DOI 10.1016/j.marpol.2004.02.003; ZWANENBURG KCT, 2002, 3 OC BIOD DEV SCI PL; [No title captured]	268	73	78	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12182	10.1371/journal.pone.0012182	http://dx.doi.org/10.1371/journal.pone.0012182			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824204	Green Published, Green Accepted, gold			2022-12-27	WOS:000281405300002
J	Hannas, BR; Das, PC; Li, H; LeBlanc, GA				Hannas, Bethany R.; Das, Parikshit C.; Li, Hong; LeBlanc, Gerald A.			Intracellular Conversion of Environmental Nitrate and Nitrite to Nitric Oxide with Resulting Developmental Toxicity to the Crustacean Daphnia magna	PLOS ONE			English	Article							CYTOCHROME-OXIDASE; HYPOXIC CONDITIONS; IN-VIVO; REDUCTION; NITROGEN; GENERATION; EUTROPHICATION; NITRIFICATION; REPRODUCTION; DEGRADATION	Background: Nitrate and nitrite (jointly referred to herein as NO(x)) are ubiquitous environmental contaminants to which aquatic organisms are at particularly high risk of exposure. We tested the hypothesis that NO(x) undergo intracellular conversion to the potent signaling molecule nitric oxide resulting in the disruption of endocrine-regulated processes. Methodology/Principal Findings: These experiments were performed with insect cells (Drosophila S2) and whole organisms Daphnia magna. We first evaluated the ability of cells to convert nitrate (NO(3)(-)) and nitrite (NO(2)(-)) to nitric oxide using amperometric real-time nitric oxide detection. Both NO(3)(-) and NO(2)(-) were converted to nitric oxide in a substrate concentration-dependent manner. Further, nitric oxide trapping and fluorescent visualization studies revealed that perinatal daphnids readily convert NO(2)(-) to nitric oxide. Next, daphnids were continuously exposed to concentrations of the nitric oxide-donor sodium nitroprusside (positive control) and to concentrations of NO(3)(-) and NO(2)(-). All three compounds interfered with normal embryo development and reduced daphnid fecundity. Developmental abnormalities were characteristic of those elicited by compounds that interfere with ecdysteroid signaling. However, no compelling evidence was generated to indicate that nitric oxide reduced ecdysteroid titers. Conclusions/Significance: Results demonstrate that nitrite elicits developmental and reproductive toxicity at environmentally relevant concentrations due likely to its intracellular conversion to nitric oxide.	[Hannas, Bethany R.; Das, Parikshit C.; Li, Hong; LeBlanc, Gerald A.] N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Hannas, BR (corresponding author), US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA.	Gerald_leblanc@ncsu.edu			US Environmental Protection Agency [RD-83273901]; National Science Foundation [IOS-0744210]; EPA; National Institute of Environmental Health Sciences [T32 ES007046]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007046] Funding Source: NIH RePORTER	US Environmental Protection Agency(United States Environmental Protection Agency); National Science Foundation(National Science Foundation (NSF)); EPA(United States Environmental Protection Agency); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by US Environmental Protection Agency STAR grant RD-83273901 and National Science Foundation grant IOS-0744210 to GAL. BRH was supported by an EPA STAR Fellowship and National Institute of Environmental Health Sciences training grant #T32 ES007046. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer DL, 2002, J FOOD PROTECT, V65, P872, DOI 10.4315/0362-028X-65.5.872; BALTHIS WL, CCMADR0001 NOAA; BENJAMIN N, 1994, NATURE, V368, P502, DOI 10.1038/368502a0; Bjorne H, 2006, FREE RADICAL BIO MED, V41, P1404, DOI 10.1016/j.freeradbiomed.2006.07.020; BOCK E, 1995, ARCH MICROBIOL, V163, P16, DOI 10.1007/BF00262198; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Camargo JA, 2006, ENVIRON INT, V32, P831, DOI 10.1016/j.envint.2006.05.002; Castello PR, 2006, CELL METAB, V3, P277, DOI 10.1016/j.cmet.2006.02.011; Dave G, 2005, AQUAT TOXICOL, V73, P11, DOI 10.1016/j.aquatox.2005.02.006; DOWNES MT, 1988, APPL ENVIRON MICROB, V54, P172, DOI 10.1128/AEM.54.1.172-175.1988; FARRELL AJ, 1992, ANN RHEUM DIS, V51, P1219, DOI 10.1136/ard.51.11.1219; Galloway JN, 2002, AMBIO, V31, P64, DOI 10.1639/0044-7447(2002)031[0064:RNATWY]2.0.CO;2; Godber BLJ, 2000, J BIOL CHEM, V275, P7757, DOI 10.1074/jbc.275.11.7757; Guillette LJ, 2005, INTEGR COMP BIOL, V45, P19, DOI 10.1093/icb/45.1.19; Harris SH, 2009, CHEM GEOL, V267, P77, DOI 10.1016/j.chemgeo.2009.01.028; Howarth R. W., 2000, ISSUES ECOLOGY, V7, P1; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; Ignarro IG, 2000, NITRIC OXIDE BIOL PA; Jansson EA, 2008, NAT CHEM BIOL, V4, P411, DOI 10.1038/nchembio.92; Jensen FB, 2003, COMP BIOCHEM PHYS A, V135, P9, DOI 10.1016/S1095-6433(02)00323-9; Kelso BHL, 1997, APPL ENVIRON MICROB, V63, P4679, DOI 10.1128/AEM.63.12.4679-4685.1997; Larsen FJ, 2006, NEW ENGL J MED, V355, P2792, DOI 10.1056/NEJMc062800; Leavesley HB, 2008, TOXICOL SCI, V101, P101, DOI 10.1093/toxsci/kfm254; LeBlanc GA, 2000, ENVIRON HEALTH PERSP, V108, P1133, DOI 10.2307/3434824; Li HT, 2006, J BIOL CHEM, V281, P12546, DOI 10.1074/jbc.M511803200; Li HT, 2001, J BIOL CHEM, V276, P24482, DOI 10.1074/jbc.M011648200; Moreno-Vivian C, 1999, J BACTERIOL, V181, P6573; Mu XY, 2002, GEN COMP ENDOCR, V129, P127, DOI 10.1016/S0016-6480(02)00518-X; Mu XY, 2002, J EXP ZOOL, V292, P287, DOI 10.1002/jez.10020; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; Nordin R.N., 2001, WATER QUALITY CRITER; PAITIAN NA, 1985, BIOCHEM BIOPH RES CO, V133, P1104, DOI 10.1016/0006-291X(85)91250-1; Palma P, 2009, CHEMOSPHERE, V74, P676, DOI 10.1016/j.chemosphere.2008.10.021; Panesar NS, 2000, TOXICOL APPL PHARM, V169, P222, DOI 10.1006/taap.2000.9079; Philips Sarah, 2002, Re/Views in Environmental Science and Bio/Technology, V1, P115, DOI 10.1023/A:1020892826575; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Rosselli M, 1998, HUM REPROD UPDATE, V4, P3, DOI 10.1093/humupd/4.1.3; Scavia D, 2006, BIOGEOCHEMISTRY, V79, P187, DOI 10.1007/s10533-006-9011-0; SCHNEIDER F, 1994, HEPATOLOGY, V19, P38, DOI 10.1016/0270-9139(94)90050-7; SHARMA B, 1977, WATER RES, V11, P897, DOI 10.1016/0043-1354(77)90078-1; Smith VH, 1999, ENVIRON POLLUT, V100, P179, DOI 10.1016/S0269-7491(99)00091-3; SORENSEN J, 1978, APPL ENVIRON MICROB, V35, P301; Subramoniam T, 2000, COMP BIOCHEM PHYS C, V125, P135, DOI 10.1016/S0742-8413(99)00098-5; Turner RE, 2008, ENVIRON SCI TECHNOL, V42, P2323, DOI 10.1021/es071617k; United States Environmental Protection Agency, 2002, EPA822R02038; *US EPA, 1977, 570976003 USEPA; Virag L, 2003, TOXICOL LETT, V140, P113, DOI 10.1016/S0378-4274(02)00508-8; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VLADUTIU AO, 2002, CLIN IMMUNOL IMMUNOP, V76, P1; Webb A, 2004, P NATL ACAD SCI USA, V101, P13683, DOI 10.1073/pnas.0402927101; ZWEIER JL, 1995, NAT MED, V1, P804, DOI 10.1038/nm0895-804	52	39	40	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12453	10.1371/journal.pone.0012453	http://dx.doi.org/10.1371/journal.pone.0012453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805993	gold, Green Published, Green Submitted			2022-12-27	WOS:000281301500019
J	Wankhade, UD; Vella, KR; Fox, DL; Good, DJ				Wankhade, Umesh D.; Vella, Kristen R.; Fox, Dana L.; Good, Deborah J.			Deletion of Nhlh2 Results in a Defective Torpor Response and Reduced Beta Adrenergic Receptor Expression in Adipose Tissue	PLOS ONE			English	Article							COLD-EXPOSURE; BETA-3-ADRENERGIC RECEPTOR; MOLECULAR CHARACTERIZATION; GENE-EXPRESSION; OBESE GENE; BROWN; TRANSCRIPTION; CLONING; MICE; FAT	Background: Mice with a targeted deletion of the basic helix-loop-helix transcription factor, Nescient Helix-Loop-Helix 2 (Nhlh2), display adult-onset obesity with significant increases in their fat depots, abnormal responses to cold exposure, and reduced spontaneous physical activity levels. These phenotypes, accompanied by the hypothalamic expression of Nhlh2, make the Nhlh2 knockout (N2KO) mouse a useful model to study the role of central nervous system (CNS) control on peripheral tissue such as adipose tissue. Methodology: Differences in body temperature and serum analysis of leptin were performed in fasted and ad lib fed wildtype (WT) and N2KO mice. Histological analysis of white (WAT) and brown adipose tissue (BAT) was performed. Gene and protein level expression of inflammatory and metabolic markers were compared between the two genotypes. Principal Findings: We report significant differences in serum leptin levels and body temperature in N2KO mice compared with WT mice exposed to a 24-hour fast, suggestive of a defect in both white (WAT) and brown adipose tissue (BAT) function. As compared to WT mice, N2KO mice showed increased serum IL-6 protein and WAT IL-6 mRNA levels. This was accompanied by slight elevations of mRNA for several macrophage markers, including expression of macrophage specific protein F4/80 in adipose, suggestive of macrophage infiltration of WAT in the mutant animals. The mRNAs for beta 3-adrenergic receptors (beta 3-AR), beta 2-AR and uncoupling proteins were significantly reduced in WAT and BAT from N2KO mice compared with WT mice. Conclusions: These studies implicate Nhlh2 in the central control of WAT and BAT function, with lack of Nhlh2 leading to adipose inflammation and altered gene expression, impaired leptin response to fasting, all suggestive of a deficient torpor response in mutant animals.	[Wankhade, Umesh D.; Fox, Dana L.; Good, Deborah J.] Virginia Polytech Inst & State Univ, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA; [Vella, Kristen R.; Fox, Dana L.; Good, Deborah J.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Vella, Kristen R.; Fox, Dana L.; Good, Deborah J.] Univ Massachusetts, Mol & Cellular Biol Grad Program, Amherst, MA 01003 USA	Virginia Polytechnic Institute & State University; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Wankhade, UD (corresponding author), Virginia Polytech Inst & State Univ, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA.	goodd@vt.edu	Wankhade, Umesh/J-8739-2015	Wankhade, Umesh/0000-0003-4810-221X	National Institutes of Health (NIH) [R01 DK59903, T32 MH020051]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020051] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by funding from the National Institutes of Health (NIH): R01 DK59903 (to DJG) and T32 MH020051 (to KRV) and internal departmental and college funds (DJG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bamshad M, 1998, AM J PHYSIOL-REG I, V275, pR291, DOI 10.1152/ajpregu.1998.275.1.R291; Bamshad M, 1999, AM J PHYSIOL-REG I, V276, pR1569, DOI 10.1152/ajpregu.1999.276.6.R1569; Bartness TJ, 2007, PHYSIOL BEHAV, V91, P343, DOI 10.1016/j.physbeh.2007.04.002; Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399; BRAY GA, 1978, NATURE, V274, P900, DOI 10.1038/274900a0; Brito MN, 2007, ENDOCRINOLOGY, V148, P5339, DOI 10.1210/en.2007-0621; BRODIE BB, 1966, J PHARMACOL EXP THER, V154, P493; CANTU RC, 1967, AM J PHYSIOL, V212, P207, DOI 10.1152/ajplegacy.1967.212.1.207; Collins S, 2004, MOL ENDOCRINOL, V18, P2123, DOI 10.1210/me.2004-0193; Coyle CA, 2002, PHYSIOL BEHAV, V77, P387, DOI 10.1016/S0031-9384(02)00885-5; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dodt C, 2003, ACTA PHYSIOL SCAND, V177, P351, DOI 10.1046/j.1365-201X.2003.01077.x; EMORINE LJ, 1989, SCIENCE, V245, P1118, DOI 10.1126/science.2570461; Flier JS, 1998, J CLIN ENDOCR METAB, V83, P1407, DOI 10.1210/jc.83.5.1407; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; FOSTER MT, 2009, OBESITY SILVER SPRIN; Fox DL, 2008, MOL ENDOCRINOL, V22, P1438, DOI 10.1210/me.2008-0010; Garofalo MAR, 1996, J AUTONOM NERV SYST, V60, P206, DOI 10.1016/0165-1838(96)00037-9; Gettys TW, 1996, ENDOCRINOLOGY, V137, P4054, DOI 10.1210/en.137.9.4054; Gnacinska M, 2010, ENDOKRYNOL POL, V61, P160; Good DJ, 2008, EXERC SPORT SCI REV, V36, P187, DOI 10.1097/JES.0b013e31818782dd; Good DJ, 1997, NAT GENET, V15, P397, DOI 10.1038/ng0497-397; GOOD DJ, 2007, SOURCEBOOK MODELS BI, P683; GRANNEMAN JG, 1991, MOL PHARMACOL, V40, P895; GRANNEMAN JG, 1993, MOL PHARMACOL, V44, P264; Hardie LJ, 1996, BIOCHEM BIOPH RES CO, V223, P660, DOI 10.1006/bbrc.1996.0951; Jing EX, 2004, ENDOCRINOLOGY, V145, P1503, DOI 10.1210/en.2003-0834; LAZZARINI SJ, 1991, AM J PHYSIOL, V260, pR47, DOI 10.1152/ajpregu.1991.260.1.R47; Migliorini RH, 1997, AM J PHYSIOL-REG I, V272, pR656, DOI 10.1152/ajpregu.1997.272.2.R656; MOINAT M, 1995, FEBS LETT, V373, P131, DOI 10.1016/0014-5793(95)01030-I; MUZZIN P, 1991, J BIOL CHEM, V266, P24053; Nagase I, 1996, J CLIN INVEST, V97, P2898, DOI 10.1172/JCI118748; NAHMIAS C, 1991, EMBO J, V10, P3721, DOI 10.1002/j.1460-2075.1991.tb04940.x; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; Rikke BA, 2003, MECH AGEING DEV, V124, P663, DOI 10.1016/S0047-6374(03)00003-4; Ruschke K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005516; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Song CK, 2008, AM J PHYSIOL-REG I, V295, pR417, DOI 10.1152/ajpregu.00174.2008; SUSULIC VS, 1995, J BIOL CHEM, V270, P29483, DOI 10.1074/jbc.270.49.29483; Swoap SJ, 2006, J NEUROSCI, V26, P241, DOI 10.1523/JNEUROSCI.3721-05.2006; Swoap SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004038; TRAYHURN P, 1995, FEBS LETT, V368, P488, DOI 10.1016/0014-5793(95)00719-P; Vella KR, 2007, J NEUROENDOCRINOL, V19, P499, DOI 10.1111/j.1365-2826.2007.01556.x; VELLA KR, 2010, NEUROENDOCRINOLOGY J, V3, P38; Voss-Andreae A, 2007, ENDOCRINOLOGY, V148, P1550, DOI 10.1210/en.2006-1389; Youngstrom TG, 1998, AM J PHYSIOL-REG I, V275, pR1488, DOI 10.1152/ajpregu.1998.275.5.R1488; YOUNGSTROM TG, 1995, AM J PHYSIOL-REG I, V268, pR744, DOI 10.1152/ajpregu.1995.268.3.R744; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	51	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12324	10.1371/journal.pone.0012324	http://dx.doi.org/10.1371/journal.pone.0012324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808804	gold, Green Submitted, Green Published			2022-12-27	WOS:000281153500010
J	Tyagi, A; Bag, SK; Shukla, V; Roy, S; Tuli, R				Tyagi, Antariksh; Bag, Sumit K.; Shukla, Virendra; Roy, Sribash; Tuli, Rakesh			Oligonucleotide Frequencies of Barcoding Loci Can Discriminate Species across Kingdoms	PLOS ONE			English	Article							DNA BARCODES; TAXONOMY; IDENTIFY; IDENTIFICATION; LIFE	Background: DNA barcoding refers to the use of short DNA sequences for rapid identification of species. Genetic distance or character attributes of a particular barcode locus discriminate the species. We report an efficient approach to analyze short sequence data for discrimination between species. Methodology and Principal Findings: A new approach, Oligonucleotide Frequency Range (OFR) of barcode loci for species discrimination is proposed. OFR of the loci that discriminates between species was characteristic of a species, i.e., the maxima and minima within a species did not overlap with that of other species. We compared the species resolution ability of different barcode loci using p-distance, Euclidean distance of oligonucleotide frequencies, nucleotide-character based approach and OFR method. The species resolution by OFR was either higher or comparable to the other methods. A short fragment of 126 bp of internal transcribed spacer region in ribosomal RNA gene was sufficient to discriminate a majority of the species using OFR. Conclusions/Significance: Oligonucleotide frequency range of a barcode locus can discriminate between species. Ability to discriminate species using very short DNA fragments may have wider applications in forensic and conservation studies.	[Tyagi, Antariksh; Bag, Sumit K.; Shukla, Virendra; Roy, Sribash; Tuli, Rakesh] CSIR, Natl Bot Res Inst, Ctr Plant Mol Biol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI)	Tyagi, A (corresponding author), CSIR, Natl Bot Res Inst, Ctr Plant Mol Biol, Lucknow, Uttar Pradesh, India.	rakeshtuli@hotmail.com	Bag, Sumit/AAP-5728-2020; Bag, Sumit K/B-4010-2013; TULI, RAKESH/AAD-3047-2021; Tyagi, Antariksh/F-4367-2015	Bag, Sumit/0000-0001-8907-2841; Bag, Sumit K/0000-0001-8907-2841; Tyagi, Antariksh/0000-0002-4662-077X				Abe T, 2003, GENOME RES, V13, P693, DOI 10.1101/gr.634603; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Campbell A, 1999, P NATL ACAD SCI USA, V96, P9184, DOI 10.1073/pnas.96.16.9184; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-24; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hudson RR, 2003, EVOLUTION, V57, P182; Karlin S, 1998, ANNU REV GENET, V32, P185, DOI 10.1146/annurev.genet.32.1.185; KARLIN S, 1994, P NATL ACAD SCI USA, V91, P12832, DOI 10.1073/pnas.91.26.12832; KARLIN S, 1995, TRENDS GENET, V11, P283; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; Karlin S, 1998, CURR OPIN MICROBIOL, V1, P598, DOI 10.1016/S1369-5274(98)80095-7; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lipscomb D, 2003, TRENDS ECOL EVOL, V18, P65, DOI 10.1016/S0169-5347(02)00060-5; Machado CA, 2003, P ROY SOC B-BIOL SCI, V270, P1193, DOI 10.1098/rspb.2003.2333; Marshall E, 2005, SCIENCE, V307, P1037, DOI 10.1126/science.307.5712.1037; MAYR E, 1957, SPECIES PROBLEM, P371; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Nakashima H, 1998, DNA Res, V5, P251, DOI 10.1093/dnares/5.5.251; Nakashima H, 1997, DNA Res, V4, P185, DOI 10.1093/dnares/4.3.185; Newmaster SG, 2008, MOL ECOL RESOUR, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Rubinoff D, 2006, TRENDS ECOL EVOL, V21, P1, DOI 10.1016/j.tree.2005.10.019; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; Takahashi M, 2009, GENOMICS, V93, P525, DOI 10.1016/j.ygeno.2009.01.009; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tautz D, 2002, NATURE, V418, P479, DOI 10.1038/418479a; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x	45	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12330	10.1371/journal.pone.0012330	http://dx.doi.org/10.1371/journal.pone.0012330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808837	gold, Green Published, Green Submitted			2022-12-27	WOS:000281077000018
J	Lomholt, HB; Kilian, M				Lomholt, Hans B.; Kilian, Mogens			Population Genetic Analysis of Propionibacterium acnes Identifies a Subpopulation and Epidemic Clones Associated with Acne	PLOS ONE			English	Article							INFLAMMATORY ACNE; ESCHERICHIA-COLI; GENOME SEQUENCE; EXPRESSION; KERATINOCYTES; DIVERSITY; RESISTANT; VULGARIS; STRAINS; LIPOGENESIS	The involvement of Propionibacterium acnes in the pathogenesis of acne is controversial, mainly owing to its dominance as an inhabitant of healthy skin. This study tested the hypothesis that specific evolutionary lineages of the species are associated with acne while others are compatible with health. Phylogenetic reconstruction based on nine housekeeping genes was performed on 210 isolates of P. acnes from well-characterized patients with acne, various opportunistic infections, and from healthy carriers. Although evidence of recombination was observed, the results showed a basically clonal population structure correlated with allelic variation in the virulence genes tly and camp5, with pulsed field gel electrophoresis (PFGE)- and biotype, and with expressed putative virulence factors. An unexpected geographically and temporal widespread dissemination of some clones was demonstrated. The population comprised three major divisions, one of which, including an epidemic clone, was strongly associated with moderate to severe acne while others were associated with health and opportunistic infections. This dichotomy correlated with previously observed differences in in vitro inflammation-inducing properties. Comparison of five genomes representing acne-and health-associated clones revealed multiple both cluster-and strain-specific genes that suggest major differences in ecological preferences and redefines the spectrum of disease-associated virulence factors. The results of the study indicate that particular clones of P. acnes play an etiologic role in acne while others are associated with health.	[Lomholt, Hans B.; Kilian, Mogens] Aarhus Univ, Dept Med Microbiol & Immunol, Aarhus, Denmark	Aarhus University	Lomholt, HB (corresponding author), Aarhus Univ, Dept Med Microbiol & Immunol, Aarhus, Denmark.	kilian@microbiology.au.dk		Kilian, Mogens/0000-0002-5861-0472	LeoPharma Research Foundation	LeoPharma Research Foundation(LEO Pharma)	The project was supported by a non-conditional grant from the LeoPharma Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaza N, 2009, J DERMATOL, V36, P213, DOI 10.1111/j.1346-8138.2009.00626.x; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bek-Thomsen M, 2008, J CLIN MICROBIOL, V46, P3355, DOI 10.1128/JCM.00799-08; Brochet M, 2008, P NATL ACAD SCI USA, V105, P15961, DOI 10.1073/pnas.0803654105; BROOK I, 1991, REV INFECT DIS, V13, P819; Bruggemann H, 2004, SCIENCE, V305, P671, DOI 10.1126/science.1100330; BURKE BM, 1984, BRIT J DERMATOL, V111, P83, DOI 10.1111/j.1365-2133.1984.tb04020.x; CAUGANT DA, 1981, GENETICS, V98, P467; Coenye T, 2007, RES MICROBIOL, V158, P386, DOI 10.1016/j.resmic.2007.02.001; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Grange PA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000527; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; HOFFLER U, 1981, ZBL BAKT-INT J MED M, V250, P122; Hohwy J, 2001, INFECT IMMUN, V69, P6055, DOI 10.1128/IAI.69.10.6055-6063.2001; HOLLAND KT, 1974, J APPL BACTERIOL, V37, P289, DOI 10.1111/j.1365-2672.1974.tb00443.x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Iinuma K, 2009, J INVEST DERMATOL, V129, P2113, DOI 10.1038/jid.2009.46; Jakab E, 1996, YALE J BIOL MED, V69, P477; James WD, 2005, NEW ENGL J MED, V352, P1463, DOI 10.1056/NEJMcp033487; Jappe U, 2004, J EUR ACAD DERMATOL, V18, P450, DOI 10.1111/j.1468-3083.2004.00950.x; JOHNSON JL, 1972, J BACTERIOL, V109, P1047, DOI 10.1128/JB.109.3.1047-1066.1972; Kang S, 2005, AM J PATHOL, V166, P1691, DOI 10.1016/S0002-9440(10)62479-0; Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683; KISHISHITA M, 1979, APPL ENVIRON MICROB, V38, P585, DOI 10.1128/AEM.38.4.585-589.1979; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; McDowell A, 2005, J CLIN MICROBIOL, V43, P326, DOI 10.1128/JCM.43.1.326-334.2005; McDowell A, 2008, J MED MICROBIOL, V57, P218, DOI 10.1099/jmm.0.47489-0; MILLS OH, 1983, DERMATOLOGICA, V167, P57; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; Nagy I, 2005, J INVEST DERMATOL, V124, P931, DOI 10.1111/j.0022-202X.2005.23705.x; Nagy I, 2006, MICROBES INFECT, V8, P2195, DOI 10.1016/j.micinf.2006.04.001; Nakatsuji T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001551; Oprica C, 2004, ANAEROBE, V10, P155, DOI 10.1016/j.anaerobe.2004.02.002; Ross JI, 2003, BRIT J DERMATOL, V148, P467, DOI 10.1046/j.1365-2133.2003.05067.x; Sapadin AN, 2006, J AM ACAD DERMATOL, V54, P258, DOI 10.1016/j.jaad.2005.10.004; Schaller M, 2005, BRIT J DERMATOL, V153, P66, DOI 10.1111/j.1365-2133.2005.06530.x; SELANDER RK, 1990, BACTERIA TREATISE ST, V11, P11; SMITH RF, 1968, APPL MICROBIOL, V16, P1434, DOI 10.1128/AEM.16.9.1434-1436.1968; Sugisaki H, 2009, J DERMATOL SCI, V55, P47, DOI 10.1016/j.jdermsci.2009.02.015; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Trivedi NR, 2006, J INVEST DERMATOL, V126, P1071, DOI 10.1038/sj.jid.5700213; Valanne S, 2005, MICROBIOL-SGM, V151, P1369, DOI 10.1099/mic.0.27788-0; VOWELS BR, 1995, INFECT IMMUN, V63, P3158, DOI 10.1128/IAI.63.8.3158-3165.1995; WHITTAM TS, 1996, ESCHERICHIA COLI SAL, P2708; WILLIAMS.P, 1965, J INVEST DERMATOL, V45, P498, DOI 10.1038/jid.1965.164; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Zouboulis CC, 2009, J INVEST DERMATOL, V129, P2093, DOI 10.1038/jid.2009.190	50	174	188	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12277	10.1371/journal.pone.0012277	http://dx.doi.org/10.1371/journal.pone.0012277			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808860	Green Submitted, Green Published, gold			2022-12-27	WOS:000281075500012
J	Spitznagel, D; O'Rourke, JF; Leddy, N; Hanrahan, O; Nolan, DP				Spitznagel, Diana; O'Rourke, John F.; Leddy, Neal; Hanrahan, Orla; Nolan, Derek P.			Identification and Characterization of an Unusual Class I Myosin Involved in Vesicle Traffic in Trypanosoma brucei	PLOS ONE			English	Article							BLOOD-STREAM FORMS; HOST-CELL INVASION; ACANTHAMOEBA MYOSIN; UNCONVENTIONAL MYOSINS; GLIDING MOTILITY; PLASMA-MEMBRANE; EARLY ENDOSOMES; FYVE DOMAIN; ACTIN; ENDOCYTOSIS	Myosins are a multimember family of motor proteins with diverse functions in eukaryotic cells. African trypanosomes possess only two candidate myosins and thus represent a useful system for functional analysis of these motors. One of these candidates is an unusual class I myosin (TbMyo1) that is expressed at similar levels but organized differently during the life cycle of Trypanosoma brucei. This myosin localizes to the polarized endocytic pathway in bloodstream forms of the parasite. This organization is actin dependent. Knock down of TbMyo1 results in a significant reduction in endocytic activity, a cessation in cell division and eventually cell death. A striking morphological feature in these cells is an enlargement of the flagellar pocket, which is consistent with an imbalance in traffic to and from the surface. In contrast TbMyo1 is distributed throughout procyclic forms of the tsetse vector and a loss of similar to 90% of the protein has no obvious effects on growth or morphology. These results reveal a life cycle stage specific requirement for this myosin in essential endocytic traffic and represent the first description of the involvement of a motor protein in vesicle traffic in these parasites.	[Spitznagel, Diana; Hanrahan, Orla; Nolan, Derek P.] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Mol Parasitol Grp, Dublin 2, Ireland; [Leddy, Neal] Univ Dublin Trinity Coll, Ctr Microscopy & Anal, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin	Spitznagel, D (corresponding author), Univ Dublin Trinity Coll, Sch Biochem & Immunol, Mol Parasitol Grp, Dublin 2, Ireland.	denolan@tcd.ie		Nolan, Derek/0000-0002-3742-4304	Wellcome Trust; Science Foundation Ireland (SFI) [07/RFP/BICF358]	Wellcome Trust(Wellcome TrustEuropean Commission); Science Foundation Ireland (SFI)(Science Foundation Ireland)	This work has been supported by the Wellcome Trust senior fellowship award (DN) and Research Frontiers Programme Award (07/RFP/BICF358) from Science Foundation Ireland (SFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; BANNISTER LH, 1995, ANN TROP MED PARASIT, V89, P105, DOI 10.1080/00034983.1995.11812940; Barylko B, 2000, BBA-MOL CELL RES, V1496, P23, DOI 10.1016/S0167-4889(00)00006-9; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Brawley CM, 2009, P NATL ACAD SCI USA, V106, P9685, DOI 10.1073/pnas.0810451106; BRICKMAN MJ, 1993, EXP PARASITOL, V76, P329, DOI 10.1006/expr.1993.1041; BRUN R, 1979, ACTA TROP, V36, P289; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; DOBERSTEIN SK, 1992, J CELL BIOL, V117, P1241, DOI 10.1083/jcb.117.6.1241; Dobrowolski JM, 1997, MOL MICROBIOL, V26, P163, DOI 10.1046/j.1365-2958.1997.5671913.x; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engstler M, 2004, J CELL SCI, V117, P1105, DOI 10.1242/jcs.00938; ENGSTLER M, 2007, TRYPANSOMES GENOME; Field MC, 2007, TRAFFIC, V8, P629, DOI 10.1111/j.1600-0854.2007.00558.x; Field MC, 1999, PARASITOL TODAY, V15, P365, DOI 10.1016/S0169-4758(99)01499-4; Field MC, 2004, TRAFFIC, V5, P905, DOI 10.1111/j.1600-0854.2004.00234.x; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; GIRAO H, 2008, FEBS LETT, V21, P12; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall BS, 2006, J BIOL CHEM, V281, P27600, DOI 10.1074/jbc.M602183200; Hayakawa A, 2004, J BIOL CHEM, V279, P5958, DOI 10.1074/jbc.M310503200; Hayakawa A, 2006, P NATL ACAD SCI USA, V103, P11928, DOI 10.1073/pnas.0508832103; HAYDEN SM, 1990, J CELL BIOL, V111, P443, DOI 10.1083/jcb.111.2.443; HIRUMI H, 1994, PARASITOL TODAY, V10, P80, DOI 10.1016/0169-4758(94)90402-2; Idrissi FZ, 2008, J CELL BIOL, V180, P1219, DOI 10.1083/jcb.200708060; Jonsdottir GA, 2004, CURR BIOL, V14, P1604, DOI 10.1016/j.cub.2004.08.055; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kappe SHI, 2004, TRENDS PARASITOL, V20, P13, DOI 10.1016/j.pt.2003.10.011; Katta SS, 2009, MOL BIOCHEM PARASIT, V164, P105, DOI 10.1016/j.molbiopara.2008.12.002; Kessels MM, 2004, J CELL SCI, V117, P3077, DOI 10.1242/jcs.01290; Kumar S, 2007, EUKARYOT CELL, V6, P2029, DOI 10.1128/EC.00213-07; Kutateladze TG, 2006, BBA-MOL CELL BIOL L, V1761, P868, DOI 10.1016/j.bbalip.2006.03.011; Lee WL, 1999, J BIOL CHEM, V274, P35159, DOI 10.1074/jbc.274.49.35159; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; Morgan GW, 2004, J BIOL CHEM, V279, P10692, DOI 10.1074/jbc.M312178200; Morgan GW, 2002, TRENDS PARASITOL, V18, P540, DOI 10.1016/S1471-4922(02)02392-9; Nambiar R, 2009, P NATL ACAD SCI USA, V106, P11972, DOI 10.1073/pnas.0901641106; Neuhaus EM, 2000, J CELL BIOL, V150, P1013, DOI 10.1083/jcb.150.5.1013; Nolan DP, 2008, MOL BIOCHEM PARASIT, V157, P233, DOI 10.1016/j.molbiopara.2007.10.006; Nolan DP, 1999, CURR BIOL, V9, P1169, DOI 10.1016/S0960-9822(00)80018-4; O'Beirne C, 1998, MOL BIOCHEM PARASIT, V91, P165, DOI 10.1016/S0166-6851(97)00191-6; Oberholzer U, 2004, EUKARYOT CELL, V3, P1272, DOI 10.1128/EC.3.5.1272-1286.2004; Ostap EM, 2003, CELL MOTIL CYTOSKEL, V54, P29, DOI 10.1002/cm.10081; Overath P, 2004, MOL MICROBIOL, V53, P735, DOI 10.1111/j.1365-2958.2004.04224.x; Peck RF, 2008, MOL MICROBIOL, V68, P933, DOI 10.1111/j.1365-2958.2008.06195.x; POLLARD TD, 1973, J BIOL CHEM, V248, P4682; POLLARD TD, 1973, J BIOL CHEM, V248, P4691; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Raposo G, 1999, MOL BIOL CELL, V10, P1477, DOI 10.1091/mbc.10.5.1477; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; Salas-Cortes L, 2005, J CELL SCI, V118, P4823, DOI 10.1242/jcs.02607; Schmitz S, 2005, J MOL BIOL, V349, P113, DOI 10.1016/j.jmb.2005.03.056; Senda S, 2000, FEBS LETT, V484, P125, DOI 10.1016/S0014-5793(00)02137-2; Soldati T, 2003, TRAFFIC, V4, P358, DOI 10.1034/j.1600-0854.2003.t01-1-00095.x; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; SPITZNAGEL D, 2009, FEBS J; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Tang NY, 2002, J BIOL CHEM, V277, P42763, DOI 10.1074/jbc.M206388200; Taunton J, 2001, CURR OPIN CELL BIOL, V13, P85, DOI 10.1016/S0955-0674(00)00178-2; Tazeh NN, 2009, EUKARYOT CELL, V8, P1352, DOI 10.1128/EC.00156-09; Titus MA, 2000, J EUKARYOT MICROBIOL, V47, P191, DOI 10.1111/j.1550-7408.2000.tb00038.x; Tsiavaliaris G, 2008, J BIOL CHEM, V283, P4520, DOI 10.1074/jbc.M708113200; Tuxworth RI, 2000, TRAFFIC, V1, P11, DOI 10.1034/j.1600-0854.2000.010103.x; VOORHEIS HP, 1979, BIOCHEM J, V180, P11, DOI 10.1042/bj1800011; WEBSTER P, 1990, J CELL SCI, V96, P249; Wetzel DM, 2003, MOL BIOL CELL, V14, P396, DOI 10.1091/mbc.E02-08-0458; Yamashita RA, 1998, J BIOL CHEM, V273, P14644, DOI 10.1074/jbc.273.23.14644; Ye J, 2008, GENE DEV, V22, P322, DOI 10.1101/gad.455908	72	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12282	10.1371/journal.pone.0012282	http://dx.doi.org/10.1371/journal.pone.0012282			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808867	Green Published, gold, Green Submitted			2022-12-27	WOS:000281075500016
J	Wright, AP; Fox, AN; Johnson, KG; Zinn, K				Wright, Ashley P.; Fox, A. Nicole; Johnson, Karl G.; Zinn, Kai			Systematic Screening of Drosophila Deficiency Mutations for Embryonic Phenotypes and Orphan Receptor Ligands	PLOS ONE			English	Article							MOTOR AXON GUIDANCE; GROWTH CONE GUIDANCE; NERVOUS-SYSTEM; TYROSINE PHOSPHATASES; GENE ENCODES; MELANOGASTER; PROTEIN; MIDLINE; CELLS; GLIA	This paper defines a collection of Drosophila deletion mutations (deficiencies) that can be systematically screened for embryonic phenotypes, orphan receptor ligands, and genes affecting protein localization. It reports the results of deficiency screens we have conducted that have revealed new axon guidance phenotypes in the central nervous system and neuromuscular system and permitted a quantitative assessment of the number of potential genes involved in regulating guidance of specific motor axon branches. Deficiency "kits" that cover the genome with a minimum number of lines have been established to facilitate gene mapping. These kits cannot be systematically analyzed for phenotypes, however, since embryos homozygous for many deficiencies in these kits fail to develop due to the loss of key gene products encoded within the deficiency. To create new kits that can be screened for phenotype, we have examined the development of the nervous system in embryos homozygous for more than 700 distinct deficiency mutations. A kit of similar to 400 deficiency lines for which homozygotes have a recognizable nervous system and intact body walls encompasses >80% of the genome. Here we show examples of screens of this kit for orphan receptor ligands and neuronal antigen expression. It can also be used to find genes involved in expression, patterning, and subcellular localization of any protein that can be visualized by antibody staining. A subset kit of 233 deficiency lines, for which homozygotes develop relatively normally to late stage 16, covers similar to 50% of the genome. We have screened it for axon guidance phenotypes, and we present examples of new phenotypes we have identified. The subset kit can be used to screen for phenotypes affecting all embryonic organs. In the future, these deficiency kits will allow Drosophila researchers to rapidly and efficiently execute genome-wide anatomical screens that require examination of individual embryos at high magnification.	[Wright, Ashley P.; Fox, A. Nicole; Zinn, Kai] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Johnson, Karl G.] Pomona Coll, Dept Biol, Claremont, CA 91711 USA; [Johnson, Karl G.] Pomona Coll, Program Neurosci, Claremont, CA 91711 USA	California Institute of Technology; Claremont Colleges; Pomona College; Claremont Colleges; Pomona College	Wright, AP (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	zinnk@caltech.edu		Fox, Nicole/0000-0001-5012-9177; Johnson, Karl/0000-0003-3931-5985	NIH [NS028182, NS062821]; NSF [IOS-0841551]; NRSA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028182, R01NS062821] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH RO1 grants NS028182 and NS062821 to Kai Zinn, NSF grant IOS-0841551 to Karl Johnson and NRSA postdoctoral fellowship to A. Nicole Fox. The funders had no role in study design, collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso TB, 2002, DEV BIOL, V248, P369, DOI 10.1006/dbio.2002.0740; ARORA K, 1994, GENE DEV, V8, P2588, DOI 10.1101/gad.8.21.2588; CAMPBELL G, 1994, DEVELOPMENT, V120, P2957; CREWS ST, 1988, CELL, V52, P143, DOI 10.1016/0092-8674(88)90538-7; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Desai CJ, 1997, DEVELOPMENT, V124, P1941; Erhardt S, 2008, J CELL BIOL, V183, P805, DOI 10.1083/jcb.200806038; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; Giesen K, 2003, MECH DEVELOP, V120, P401, DOI 10.1016/S0925-4773(03)00009-1; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Gryzik T, 2004, CURR BIOL, V14, P659, DOI 10.1016/j.cub.2004.03.058; HALTER DA, 1995, DEVELOPMENT, V121, P317; Hidalgo A, 2000, DEVELOPMENT, V127, P393; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Kammerer M, 2001, EMBO J, V20, P4664, DOI 10.1093/emboj/20.17.4664; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Le Du MH, 2001, J BIOL CHEM, V276, P9158, DOI 10.1074/jbc.M009250200; Lee HY, 2009, J VIS EXP; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; Schindelholz B, 2001, DEVELOPMENT, V128, P4371; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Sink H, 2001, CELL, V105, P57, DOI 10.1016/S0092-8674(01)00296-3; Stathopoulos A, 2004, GENE DEV, V18, P687, DOI 10.1101/gad.1166404; THOMAS JB, 1988, CELL, V52, P133, DOI 10.1016/0092-8674(88)90537-5; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Vincent S, 1996, DEVELOPMENT, V122, P131; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981	36	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12288	10.1371/journal.pone.0012288	http://dx.doi.org/10.1371/journal.pone.0012288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808815	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000281075500020
J	Cong, YL; Wang, GM; Guan, ZH; Chang, SA; Zhang, QP; Yang, GL; Wang, WL; Meng, QF; Ren, WM; Wang, CF; Ding, ZA				Cong, Yanlong; Wang, Guangmei; Guan, Zhenhong; Chang, Shuang; Zhang, Quanpeng; Yang, Guilian; Wang, Weili; Meng, Qingfeng; Ren, Weiming; Wang, Chunfeng; Ding, Zhuang			Reassortant between Human-Like H3N2 and Avian H5 Subtype Influenza A Viruses in Pigs: A Potential Public Health Risk	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTIONS; GENETIC-CHARACTERIZATION; INTERSPECIES TRANSMISSION; HEMAGGLUTININ; SWINE; RECEPTOR; EVOLUTION; ORIGIN; CHINA; H9N2	Background: Human-like H3N2 influenza viruses have repeatedly been transmitted to domestic pigs in different regions of the world, but it is still uncertain whether any of these variants could become established in pig populations. The fact that different subtypes of influenza viruses have been detected in pigs makes them an ideal candidate for the genesis of a possible reassortant virus with both human and avian origins. However, the determination of whether pigs can act as a "mixing vessel'' for a possible future pandemic virus is still pending an answer. This prompted us to gather the epidemiological information and investigate the genetic evolution of swine influenza viruses in Jilin, China. Methods: Nasopharyngeal swabs were collected from pigs with respiratory illness in Jilin province, China from July 2007 to October 2008. All samples were screened for influenza A viruses. Three H3N2 swine influenza virus isolates were analyzed genetically and phylogenetically. Results: Influenza surveillance of pigs in Jilin province, China revealed that H3N2 influenza viruses were regularly detected from domestic pigs during 2007 to 2008. Phylogenetic analysis revealed that two distinguishable groups of H3N2 influenza viruses were present in pigs: the wholly contemporary human-like H3N2 viruses (represented by the Moscow/10/99-like sublineage) and double-reassortant viruses containing genes from contemporary human H3N2 viruses and avian H5 viruses, both co-circulating in pig populations. Conclusions: The present study reports for the first time the coexistence of wholly human-like H3N2 viruses and double-reassortant viruses that have emerged in pigs in Jilin, China. It provides updated information on the role of pigs in interspecies transmission and genetic reassortment of influenza viruses.	[Cong, Yanlong; Wang, Guangmei; Chang, Shuang; Zhang, Quanpeng; Ding, Zhuang] Jilin Univ, Coll Anim Sci & Vet Med, Changchun 130023, Jilin, Peoples R China; [Guan, Zhenhong] Jilin Univ, Inst Zoonoses, Changchun 130023, Jilin, Peoples R China; [Yang, Guilian; Ren, Weiming; Wang, Chunfeng] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin, Peoples R China; [Wang, Weili; Meng, Qingfeng] Jilin Entry Exit Inspect & Quarantine Bur, Changchun, Jilin, Peoples R China	Jilin University; Jilin University; Jilin Agricultural University	Cong, YL (corresponding author), Jilin Univ, Coll Anim Sci & Vet Med, Changchun 130023, Jilin, Peoples R China.	wangchunfeng@jlau.edu.cn; congyanlong@126.com		Yang, Gui-Lian/0000-0001-5224-1592	Jilin University [4305050102B6, 200903334]; National Natural Scientific Fund [30972192]	Jilin University(Jilin University); National Natural Scientific Fund	This study was supported by the Jilin University Scientific Research Startup Fund (4305050102B6), the Jilin University Basic Science Research Fund (200903334) and the National Natural Scientific Fund (30972192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi YH, 2010, EMERG INFECT DIS, V16, P1162, DOI 10.3201/eid1607.091881; Boni MF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010434; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Brown IH, 1998, J GEN VIROL, V79, P2947, DOI 10.1099/0022-1317-79-12-2947; Brown IH, 2001, INT CONGR SER, V1219, P173, DOI 10.1016/S0531-5131(01)00666-5; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Campitelli L, 1997, VIROLOGY, V232, P310, DOI 10.1006/viro.1997.8514; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; CLAAS ECJ, 1994, VIROLOGY, V204, P453, DOI 10.1006/viro.1994.1553; Cong YL, 2007, J GEN VIROL, V88, P2035, DOI 10.1099/vir.0.82783-0; DALY JM, 1998, TXB INFLUENZA, P168; GALLAGHER PJ, 1992, J VIROL, V66, P7136, DOI 10.1128/JVI.66.12.7136-7145.1992; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Ito T, 2000, MICROBIOL IMMUNOL, V44, P423, DOI 10.1111/j.1348-0421.2000.tb02516.x; Karasin AI, 2000, VIRUS RES, V68, P71, DOI 10.1016/S0168-1702(00)00154-4; KUNDIN WD, 1970, NATURE, V228, P857, DOI 10.1038/228857a0; LI MC, 2008, PLOS PHATHOGENS, V4, P1; Lindstrom S, 1996, ARCH VIROL, V141, P1349, DOI 10.1007/BF01718836; LUDWIG S, 1995, VIROLOGY, V212, P555, DOI 10.1006/viro.1995.1513; Marozin S, 2002, J GEN VIROL, V83, P735, DOI 10.1099/0022-1317-83-4-735; Nakajima K, 2003, J VIROL, V77, P10088, DOI 10.1128/JVI.77.18.10088-10098.2003; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Ohuchi M, 1997, J VIROL, V71, P8377, DOI 10.1128/JVI.71.11.8377-8384.1997; OLDEN K, 1982, BIOCHIM BIOPHYS ACTA, V650, P209, DOI 10.1016/0304-4157(82)90017-X; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; SEIDEL W, 1991, ARCH VIROL, V120, P289, DOI 10.1007/BF01310484; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; SHORTRIDGE KF, 1977, SCIENCE, V196, P1454, DOI 10.1126/science.867041; SHU LL, 1994, VIROLOGY, V202, P825, DOI 10.1006/viro.1994.1404; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Van Reeth K, 2004, VIRUS RES, V103, P115, DOI 10.1016/j.virusres.2004.02.023; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; Webby RJ, 2004, VIRUS RES, V103, P67, DOI 10.1016/j.virusres.2004.02.015; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Xu CT, 2004, MICROBES INFECT, V6, P919, DOI 10.1016/j.micinf.2004.04.015; Yassine HM, 2008, VACCINE, V26, P966, DOI 10.1016/j.vaccine.2007.11.094; Yu H, 2008, VET MICROBIOL, V131, P82, DOI 10.1016/j.vetmic.2008.02.024; Yu H, 2008, J CLIN MICROBIOL, V46, P1067, DOI 10.1128/JCM.01257-07; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999	46	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12591	10.1371/journal.pone.0012591	http://dx.doi.org/10.1371/journal.pone.0012591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830295	Green Submitted, Green Published, gold			2022-12-27	WOS:000281631300019
J	Ruhaak, LR; Uh, HW; Beekman, M; Koeleman, CAM; Hokke, CH; Westendorp, RGJ; Wuhrer, M; Houwing-Duistermaat, JJ; Slagboom, PE; Deelder, AM				Ruhaak, L. Renee; Uh, Hae-Won; Beekman, Marian; Koeleman, Carolien A. M.; Hokke, Cornelis H.; Westendorp, Rudi G. J.; Wuhrer, Manfred; Houwing-Duistermaat, Jeanine J.; Slagboom, P. Eline; Deelder, Andre M.			Decreased Levels of Bisecting GlcNAc Glycoforms of IgG Are Associated with Human Longevity	PLOS ONE			English	Article							STRUCTURAL-CHANGES; GLYCOSYLATION; SERUM; EXPRESSION; OLIGOSACCHARIDES; MECHANISMS; BIOMARKERS; PROTEINS; CDNA; AGE	Background: Markers for longevity that reflect the health condition and predict healthy aging are extremely scarce. Such markers are, however, valuable in aging research. It has been shown previously that the N-glycosylation pattern of human immunoglobulin G (IgG) is age-dependent. Here we investigate whether N-linked glycans reflect early features of human longevity. Methodology/Principal Findings: The Leiden Longevity Study (LLS) consists of nonagenarian sibling pairs, their offspring, and partners of the offspring serving as control. IgG subclass specific glycosylation patterns were obtained from 1967 participants in the LLS by MALDI-TOF-MS analysis of tryptic IgG Fc glycopeptides. Several regression strategies were applied to evaluate the association of IgG glycosylation with age, sex, and longevity. The degree of galactosylation of IgG decreased with increasing age. For the galactosylated glycoforms the incidence of bisecting GlcNAc increased as a function of age. Sex-related differences were observed at ages below 60 years. Compared to males, younger females had higher galactosylation, which decreased stronger with increasing age, resulting in similar galactosylation for both sexes from 60 onwards. In younger participants (<60 years of age), but not in the older age group (>60 years), decreased levels of non-galactosylated glycoforms containing a bisecting GlcNAc reflected early features of longevity. Conclusions/Significance: We here describe IgG glycoforms associated with calendar age at all ages and the propensity for longevity before middle age. As modulation of IgG effector functions has been described for various IgG glycosylation features, a modulatory effect may be expected for the longevity marker described in this study.	[Ruhaak, L. Renee; Koeleman, Carolien A. M.; Hokke, Cornelis H.; Wuhrer, Manfred; Deelder, Andre M.] Leiden Univ, Med Ctr, Dept Parasitol, Biomol Mass Spectrometry Unit, Leiden, Netherlands; [Uh, Hae-Won; Houwing-Duistermaat, Jeanine J.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Sect Med Stat, Leiden, Netherlands; [Beekman, Marian; Slagboom, P. Eline] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Sect Mol Epidemiol, Leiden, Netherlands; [Westendorp, Rudi G. J.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ruhaak, LR (corresponding author), Leiden Univ, Med Ctr, Dept Parasitol, Biomol Mass Spectrometry Unit, Leiden, Netherlands.	l.r.ruhaak@lumc.nl	Wuhrer, Manfred/ABE-9168-2020; Beekman, Marian/L-3004-2019; Houwing-Duistermaat, Jeanne/V-9048-2018; Hokke, Cornelis Hendrik/AAQ-4712-2021; Slagboom, P. Eline/R-4790-2016; Ruhaak, Renee/AAE-7668-2019	Wuhrer, Manfred/0000-0002-0814-4995; Beekman, Marian/0000-0003-0585-6206; Hokke, Cornelis Hendrik/0000-0003-3545-7804; Slagboom, P. Eline/0000-0002-2875-4723; Ruhaak, Renee/0000-0003-3737-3807; Houwing-Duistermaat, Jeanine/0000-0002-4505-7137; Uh, Hae-Won/0000-0003-4195-7872	IOP [IGE05007]	IOP	This work was supported by IOP Grant IGE05007. http://www.senternovem.nl/iopgenomics/index.asp. http://www.senternovem.nl/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HJ, 2006, J PROTEOME RES, V5, P1626, DOI 10.1021/pr060010k; Crimmins E, 2008, ADV CLIN CHEM, V46, P161, DOI 10.1016/S0065-2423(08)00405-8; Heijmans BT, 2006, PLOS MED, V3, P2317, DOI 10.1371/journal.pmed.0030495; Iida S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-58; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; NARASIMHAN S, 1982, J BIOL CHEM, V257, P235; NARIMATSU H, 1986, P NATL ACAD SCI USA, V83, P4720, DOI 10.1073/pnas.83.13.4720; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; PAREKH R, 1988, J EXP MED, V167, P1731, DOI 10.1084/jem.167.5.1731; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Peipp M, 2008, BLOOD, V112, P2390, DOI 10.1182/blood-2008-03-144600; Saldova R, 2007, GLYCOBIOLOGY, V17, P1344, DOI 10.1093/glycob/cwm100; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; SHAPER NL, 1986, P NATL ACAD SCI USA, V83, P1573, DOI 10.1073/pnas.83.6.1573; Shibata-Koyama M, 2009, EXP HEMATOL, V37, P309, DOI 10.1016/j.exphem.2008.11.006; Shikata K, 1998, GLYCOCONJUGATE J, V15, P683, DOI 10.1023/A:1006936431276; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Vanderschaeghe D, 2009, MOL CELL PROTEOMICS, V8, P986, DOI 10.1074/mcp.M800470-MCP200; Vanhooren V, 2007, REJUV RES, V10, P521, DOI 10.1089/rej.2007.0556; Westendorp RGJ, 2009, J AM GERIATR SOC, V57, P1634, DOI 10.1111/j.1532-5415.2009.02381.x; Wuhrer M, 2007, PROTEOMICS, V7, P4070, DOI 10.1002/pmic.200700289; Yamada E, 1997, GLYCOCONJUGATE J, V14, P401, DOI 10.1023/A:1018582930906	22	87	90	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12566	10.1371/journal.pone.0012566	http://dx.doi.org/10.1371/journal.pone.0012566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830288	gold, Green Submitted, Green Published			2022-12-27	WOS:000281631300006
J	Schulz, P; Werner, J; Stauber, T; Henriksen, K; Fendler, K				Schulz, Patrick; Werner, Johannes; Stauber, Tobias; Henriksen, Kim; Fendler, Klaus			The G215R Mutation in the Cl-/H+-Antiporter ClC-7 Found in ADO II Osteopetrosis Does Not Abolish Function but Causes a Severe Trafficking Defect	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT OSTEOPETROSIS; LYSOSOMAL STORAGE DISEASE; CLCN7 GENE-MUTATIONS; CHLORIDE CHANNELS; PROKARYOTIC HOMOLOG; BONE-RESORPTION; BETA-SUBUNIT; OSTEOCLASTS; ACIDIFICATION; TRANSPORTERS	Background: ClC-7 is a ubiquitous transporter which is broadly expressed in mammalian tissues. It is implied in the pathogenesis of lysosomal storage disease and osteopetrosis. Because of its endosomal/lysosomal localization it is still poorly characterized. Methodology/Principal Findings: An electrophysiological characterization of rat ClC-7 using solid-supported membrane-based electrophysiology is presented. The measured currents show the characteristics of ClC-7 and confirm its function as a Cl-/H+-antiporter. We have used rat ClC-7 in CHO cells as a model system to investigate the functionality and cellular localization of the wt transporter and its variant G213R ClC-7 which is the analogue of human G215R ClC-7 responsible for autosomal dominant osteopetrosis type II. Our study shows that rat G213R ClC-7 is functional but has a localization defect in CHO cells which prevents it from being correctly targeted to the lysosomal membrane. The electrophysiological assay is tested as a tool for drug discovery. The assay is validated with a number of drug candidates. It is shown that ClC-7 is inhibited by DIDS, NPPB and NS5818 at micromolar concentrations. Conclusions/Significance: It is suggested that the scenario found in the CHO model system also applies to the human transporter and that mislocalization rather than impaired functionality of G215R ClC-7 is the primary cause of the related autosomal dominant osteopetrosis type II. Furthermore, the robust solid-supported membrane-based electrophysiological assay is proposed for rapid screening for potential ClC-7 inhibitors which are discussed for treatment of osteoporosis.	[Schulz, Patrick; Werner, Johannes; Fendler, Klaus] Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany; [Stauber, Tobias] Leibniz Inst Mol Pharmakol FMP, Berlin, Germany; [Stauber, Tobias] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Henriksen, Kim] Nord Biosci, Herlev, Denmark	Max Planck Society; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Nordic Bioscience	Schulz, P (corresponding author), Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany.	klaus.fendler@biophys.mpg.de	Stauber, Tobias/E-4005-2010; Werner, Johannes/U-4724-2019	Stauber, Tobias/0000-0003-0727-6109; Fendler, Klaus/0000-0002-5699-7060; Werner, Johannes/0000-0001-7322-4433	Max Planck Gesellschaft zur Foerderung der Wissenschaften e.V., 80084 Munchen, Germany; Deutsche Forschungsgemeinschaft, 53170 Bonn, Germany [SFB 807, SFB 740]; Nordic Biosciences, 2730 Herlev, Denmark; Nordic Biosciences	Max Planck Gesellschaft zur Foerderung der Wissenschaften e.V., 80084 Munchen, Germany; Deutsche Forschungsgemeinschaft, 53170 Bonn, Germany(German Research Foundation (DFG)); Nordic Biosciences, 2730 Herlev, Denmark; Nordic Biosciences	This work was funded by the Max Planck Gesellschaft zur Foerderung der Wissenschaften e.V., 80084 Munchen, Germany (P.S., J.W., K.F.), the Deutsche Forschungsgemeinschaft, SFB 807 to K.F. (P.S.) and SFB 740 to Thomas J. Jentsch (T. S.), 53170 Bonn, Germany, and Nordic Biosciences, 2730 Herlev, Denmark (K.H.). As Nordic Biosciences have employed K.H. they did have a role in reading the manuscript and decision to publish. Apart from that Nordic Biosciences had no role in study design, data collection and analysis and have no financial interest in the manuscript.; Kim Hendriksen is an employee of Nordic Biosciences. Nordic Biosciences supported the study through salaries and materials but had no role in the study design or performance and have no financial interest of the results. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Accardi A, 2004, J GEN PHYSIOL, V123, P109, DOI 10.1085/jgp.200308935; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; AUTUORI F, 1982, J CELL SCI, V57, P1; Brandt S, 1995, FEBS LETT, V377, P15, DOI 10.1016/0014-5793(95)01298-2; Campos-Xavier AB, 2003, HUM GENET, V112, P186, DOI 10.1007/s00439-002-0861-9; Cleiren E, 2001, HUM MOL GENET, V10, P2861, DOI 10.1093/hmg/10.25.2861; Diewald L, 2002, BIOCHEM BIOPH RES CO, V291, P421, DOI 10.1006/bbrc.2002.6462; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Frattini A, 2003, J BONE MINER RES, V18, P1740, DOI 10.1359/jbmr.2003.18.10.1740; Freundt EC, 2007, CELL RES, V17, P956, DOI 10.1038/cr.2007.80; Garcia-Celma JJ, 2007, LANGMUIR, V23, P10074, DOI 10.1021/la701188f; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Henriksen K, 2004, AM J PATHOL, V164, P1537, DOI 10.1016/S0002-9440(10)63712-1; Henriksen K, 2008, CALCIFIED TISSUE INT, V83, P230, DOI 10.1007/s00223-008-9168-8; Henriksen K, 2009, BIOCHEM BIOPH RES CO, V378, P804, DOI 10.1016/j.bbrc.2008.11.145; HUNTER MJ, 1961, BIOCHIM BIOPHYS ACTA, V47, P580, DOI 10.1016/0006-3002(61)90553-4; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Kajiya H, 2009, PFLUG ARCH EUR J PHY, V458, P1049, DOI 10.1007/s00424-009-0689-4; Karsdal MA, 2005, AM J PATHOL, V166, P467, DOI 10.1016/S0002-9440(10)62269-9; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Maritzen T, 2008, J NEUROSCI, V28, P10587, DOI 10.1523/JNEUROSCI.3750-08.2008; Matsuda JJ, 2008, AM J PHYSIOL-CELL PH, V294, pC251, DOI 10.1152/ajpcell.00338.2007; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Neagoe I, 2010, J BIOL CHEM, V285, P21689, DOI 10.1074/jbc.M110.125971; Nilius B, 2003, ACTA PHYSIOL SCAND, V177, P119, DOI 10.1046/j.1365-201X.2003.01060.x; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Plans V, 2009, PFLUG ARCH EUR J PHY, V458, P23, DOI 10.1007/s00424-008-0597-z; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Schaller S, 2005, DRUG NEWS PERSPECT, V18, P489, DOI 10.1358/dnp.2005.18.8.944546; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Schulz P, 2008, METHODS, V46, P97, DOI 10.1016/j.ymeth.2008.07.002; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Suzuki T, 2006, J CELL PHYSIOL, V206, P792, DOI 10.1002/jcp.20516; VENTURI M, 2003, MEMBRANE PROTEIN PUR; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Waguespack SG, 2003, J BONE MINER RES, V18, P1513, DOI 10.1359/jbmr.2003.18.8.1513; Waguespack SG, 2007, J CLIN ENDOCR METAB, V92, P771, DOI 10.1210/jc.2006-1986; Wartosch L, 2009, FASEB J, V23, P4056, DOI 10.1096/fj.09-130880; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao QX, 2009, BIOCHEM BIOPH RES CO, V384, P277, DOI 10.1016/j.bbrc.2009.04.088; Zifarelli G, 2007, REV PHYSIOL BIOCH P, V158, P23, DOI 10.1007/112_2006_0605	45	35	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12585	10.1371/journal.pone.0012585	http://dx.doi.org/10.1371/journal.pone.0012585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830208	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000281631300014
J	van Hensbroek, MB; Calis, JCJ; Phiri, KS; Vet, R; Munthali, F; Kraaijenhagen, R; van den Berg, H; Faragher, B; Bates, I; Molyneux, ME				van Hensbroek, Michael Boele; Calis, Job C. J.; Phiri, Kamija S.; Vet, Raymond; Munthali, Francis; Kraaijenhagen, Rob; van den Berg, Henk; Faragher, Brian; Bates, Imelda; Molyneux, Malcolm E.			Pathophysiological Mechanisms of Severe Anaemia in Malawian Children	PLOS ONE			English	Article							BLOOD-TRANSFUSION; NORTHERN GHANA; BONE-MARROW; IRON STORES; MALARIA; AREA	Background: Severe anaemia is a major cause of morbidity and mortality in African children. The aetiology is multi-factorial, but interventions have often targeted only one or a few causal factors, with limited success. Methods and Findings: We assessed the contribution of different pathophysiological mechanisms (red cell production failure [RCPF], haemolysis and blood loss) to severe anaemia in Malawian children in whom etiological factors have been described previously. More complex associations between etiological factors and the mechanisms were explored using structural equation modelling. In 235 children with severe anaemia (haemoglobin <3.2 mMol/L [5.0 g/dl]) studied, RCPF, haemolysis and blood loss were found in 48.1%, 21.7% and 6.9%, respectively. The RCPF figure increased to 86% when a less stringent definition of RCPF was applied. RCPF was the most common mechanism in each of the major etiological subgroups (39.7-59.7%). Multiple aetiologies were common in children with severe anaemia. In the final model, nutritional and infectious factors, including malaria, were directly or indirectly associated with RCPF, but not with haemolysis. Conclusion: RCPF was the most common pathway leading to severe anaemia, from a variety of etiological factors, often found in combination. Unlike haemolysis or blood loss, RCPF is a defect that is likely to persist to a significant degree unless all of its contributing aetiologies are corrected. This provides a further explanation for the limited success of the single factor interventions that have commonly been applied to the prevention or treatment of severe anaemia. Our findings underline the need for a package of measures directed against all of the local aetiologies of this often fatal paediatric syndrome.	[van Hensbroek, Michael Boele; Calis, Job C. J.; Phiri, Kamija S.; Munthali, Francis; Molyneux, Malcolm E.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [van Hensbroek, Michael Boele; Calis, Job C. J.; van den Berg, Henk] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; [van Hensbroek, Michael Boele; Faragher, Brian; Bates, Imelda; Molyneux, Malcolm E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Vet, Raymond] Univ Amsterdam, Acad Med Ctr, Dept Specialized Hematol, NL-1105 AZ Amsterdam, Netherlands; [Kraaijenhagen, Rob] Meander Med Ctr, Dept Clin Chem, Amersfoort, Netherlands	University of Malawi; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Liverpool School of Tropical Medicine; University of Liverpool; University of Amsterdam; Academic Medical Center Amsterdam; Meander Medisch Centrum	van Hensbroek, MB (corresponding author), Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	MBVH04@Gmail.com		Phiri, Kamija/0000-0003-1753-2727; Boele van Hensbroek, Michael/0000-0003-1907-5427; bates, imelda/0000-0002-0862-8199	Wellcome Trust [064722]; Royal Netherlands Academy of Arts and Sciences; Nutricia Research Foundation; Ter Meulen Fund	Wellcome Trust(Wellcome TrustEuropean Commission); Royal Netherlands Academy of Arts and Sciences; Nutricia Research Foundation(Danone Nutricia); Ter Meulen Fund	The study was supported by a grant (064722) from the Wellcome Trust and by independent grants from the Royal Netherlands Academy of Arts and Sciences, Nutricia Research Foundation, and the Ter Meulen Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscipt.	Arbuckle J., 2007, AMOS 7 0 USERS GUIDE; Behrman RE, 2004, NELSON TXB PEDIAT, V17th; BIERI JG, 1979, AM J CLIN NUTR, V32, P2143, DOI 10.1093/ajcn/32.10.2143; Bojang KA, 1997, ANN TROP PAEDIATR, V17, P355, DOI 10.1080/02724936.1997.11747910; CALIS JCJ, 2008, NEW ENGL J MED, V258, P12; Crawley J, 2004, AM J TROP MED HYG, V71, P25, DOI 10.4269/ajtmh.2004.71.25; de Gruijter JM, 2005, TROP MED INT HEALTH, V10, P574, DOI 10.1111/j.1365-3156.2005.01440.x; Dicko A, 2004, BLOOD, V104, P1198, DOI 10.1182/blood-2003-11-3884; EKVALL HP, 2000, THESIS U STOCKHOLM S; English M, 2002, LANCET, V359, P494, DOI 10.1016/S0140-6736(02)07666-3; GALE E, 1963, J CLIN INVEST, V42, P1076, DOI 10.1172/JCI104793; Graham SM, 2000, T ROY SOC TROP MED H, V94, P310, DOI 10.1016/S0035-9203(00)90337-7; KATZ N, 1970, J PARASITOL, V56, P1032, DOI 10.2307/3277532; Koram KA, 2000, AM J TROP MED HYG, V62, P670, DOI 10.4269/ajtmh.2000.62.670; LACKRITZ EM, 1992, LANCET, V340, P524, DOI 10.1016/0140-6736(92)91719-O; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3; Newton CRJC, 1997, TROP MED INT HEALTH, V2, P165, DOI 10.1046/j.1365-3156.1997.d01-238.x; Phiri KS, 2009, J CLIN PATHOL, V62, P685, DOI 10.1136/jcp.2009.064451; Shaker Z A, 1994, J Egypt Soc Parasitol, V24, P656; Tomarken AJ, 2005, ANNU REV CLIN PSYCHO, V1, P31, DOI 10.1146/annurev.clinpsy.1.102803.144239	22	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12589	10.1371/journal.pone.0012589	http://dx.doi.org/10.1371/journal.pone.0012589			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830291	gold, Green Accepted, Green Published			2022-12-27	WOS:000281631300017
J	Denzler, KL; Waters, R; Jacobs, BL; Rochon, Y; Langland, JO				Denzler, Karen L.; Waters, Robert; Jacobs, Bertram L.; Rochon, Yvan; Langland, Jeffrey O.			Regulation of Inflammatory Gene Expression in PBMCs by Immunostimulatory Botanicals	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; NF-KAPPA-B; ASTRAGALUS-MEMBRANACEUS; ALTERNATIVE MEDICINE; GLYCYRRHIZA-GLABRA; IN-VITRO; COMPLEMENTARY MEDICINE; BACTERIAL ENDOPHYTES; ECHINACEA-PURPUREA; RADIX-ASTRAGALI	Many hundreds of botanicals are used in complementary and alternative medicine for therapeutic use as antimicrobials and immune stimulators. While there exists many centuries of anecdotal evidence and few clinical studies on the activity and efficacy of these botanicals, limited scientific evidence exists on the ability of these botanicals to modulate the immune and inflammatory responses. Using botanogenomics (or herbogenomics), this study provides novel insight into inflammatory genes which are induced in peripheral blood mononuclear cells following treatment with immunomodulatory botanical extracts. These results may suggest putative genes involved in the physiological responses thought to occur following administration of these botanical extracts. Using extracts from immunostimulatory herbs (Astragalus membranaceus, Sambucus cerulea, Andrographis paniculata) and an immunosuppressive herb (Urtica dioica), the data presented supports previous cytokine studies on these herbs as well as identifying additional genes which may be involved in immune cell activation and migration and various inflammatory responses, including wound healing, angiogenesis, and blood pressure modulation. Additionally, we report the presence of lipopolysaccharide in medicinally prepared extracts of these herbs which is theorized to be a natural and active component of the immunostimulatory herbal extracts. The data presented provides a more extensive picture on how these herbs may be mediating their biological effects on the immune and inflammatory responses.	[Denzler, Karen L.; Waters, Robert; Jacobs, Bertram L.; Langland, Jeffrey O.] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; [Waters, Robert; Rochon, Yvan; Langland, Jeffrey O.] SW Coll Naturopath Med, Dept Naturopath Res, Tempe, AZ USA; [Rochon, Yvan] Herbal Vital Inc, Sedona, AZ USA	Arizona State University; Arizona State University-Tempe	Denzler, KL (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA.	Jeffrey.Langland@asu.edu			Arizona State University Biodesign Institute; Southwest College of Naturopathic Medicine	Arizona State University Biodesign Institute; Southwest College of Naturopathic Medicine	Funding was provided by the Arizona State University Biodesign Institute and the Southwest College of Naturopathic Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Barak V, 2001, EUR CYTOKINE NETW, V12, P290; BARAK V, 2004, ISR MED ASSOC J, V4, P919; Barnes Patricia M, 2004, Adv Data, P1; Barrios-Rodiles M, 1998, J IMMUNOL, V161, P2441; Bergner P., 2005, MED HERBALISM, V14, P1; Bezugla Y, 2006, PROSTAG OTH LIPID M, V79, P93, DOI 10.1016/j.prostaglandins.2005.11.001; Block Keith I, 2003, Integr Cancer Ther, V2, P247, DOI 10.1177/1534735403256419; Brush J, 2006, PHYTOTHER RES, V20, P687, DOI 10.1002/ptr.1938; Caroff M, 2002, MICROBES INFECT, V4, P915, DOI 10.1016/S1286-4579(02)01612-X; Chen W, 2008, EXP CLIN ENDOCR DIAB, V116, P468, DOI 10.1055/s-2008-1058081; Cho WCS, 2007, CANCER LETT, V252, P43, DOI 10.1016/j.canlet.2006.12.001; Cho WCS, 2007, J ETHNOPHARMACOL, V113, P132, DOI 10.1016/j.jep.2007.05.020; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Dong Jing, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P872; Dong TTX, 2006, J AGR FOOD CHEM, V54, P2767, DOI 10.1021/jf053163l; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; FISHER P, 1994, BRIT MED J, V309, P107, DOI 10.1136/bmj.309.6947.107; Fleming LW, 1999, SCOT MED J, V44, P176, DOI 10.1177/003693309904400609; Fontanarosa PB, 1998, JAMA-J AM MED ASSOC, V280, P1618, DOI 10.1001/jama.280.18.1618; Freudenberg MA, 2008, IMMUNOBIOLOGY, V213, P193, DOI 10.1016/j.imbio.2007.11.008; Fu PP, 2009, J ENVIRON SCI HEAL C, V27, P91, DOI 10.1080/10590500902885676; Ganguly T, 2001, PHYTOMEDICINE, V8, P348, DOI 10.1078/0944-7113-00055; GESSANI S, 1993, J IMMUNOL, V151, P3758; Girard R, 2003, J CELL SCI, V116, P293, DOI 10.1242/jcs.00212; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hallemeesch MM, 2003, AM J PHYSIOL-ENDOC M, V285, pE871, DOI 10.1152/ajpendo.00004.2002; Han DO, 2009, METHOD FIND EXP CLIN, V31, P95, DOI 10.1358/mf.2009.31.2.1353846; Han SJ, 2002, J BIOL CHEM, V277, P44715, DOI 10.1074/jbc.M202524200; HIKINO H, 1976, PLANTA MED, V30, P297, DOI 10.1055/s-0028-1097733; Hmama Z, 1999, J BIOL CHEM, V274, P1050, DOI 10.1074/jbc.274.2.1050; HONG H, 1986, ORIENTAL MATERIA MED; Kang YJ, 2008, EXP BIOL MED, V233, P1059, DOI 10.3181/0802-MR-47; KAWAGUCHI H, 1995, RES COMMUN MOL PATH, V89, P317; Kumar RA, 2004, J ETHNOPHARMACOL, V92, P291, DOI 10.1016/j.jep.2004.03.004; Kusum Mayura, 2004, Journal of the Medical Association of Thailand, V87, P1065; Langland JO, 2006, J VIROL, V80, P10083, DOI 10.1128/JVI.00607-06; Lee KY, 2005, INT IMMUNOPHARMACOL, V5, P1225, DOI 10.1016/j.intimp.2005.02.020; Lei Yan, 2003, Zhongguo Zhongyao Zazhi, V28, P876; Liu J.P., 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003711.PUB2; Mao Su-ping, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P121; Martin KW, 2003, ANTIVIR THER, V8, P77; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Matkovic Z, 2010, PHYTOTHER RES, V24, P175, DOI [10.1002/ptr.2877, 10.1002/ptr.3062]; Mechtcheriakova D, 2007, CELL SIGNAL, V19, P748, DOI 10.1016/j.cellsig.2006.09.004; Mietus-Snyder M, 1998, ARTERIOSCL THROM VAS, V18, P1440, DOI 10.1161/01.ATV.18.9.1440; Moeenrezakhanlou A, 2008, J LEUKOCYTE BIOL, V84, P519, DOI 10.1189/jlb.1207833; Nose M, 1998, BIOL PHARM BULL, V21, P1110, DOI 10.1248/bpb.21.1110; Peng Tianqing, 1995, Chinese Medical Sciences Journal, V10, P146; Pernerstorfer T, 1999, CIRCULATION, V100, P2485, DOI 10.1161/01.CIR.100.25.2485; Pollet I, 2003, BLOOD, V102, P1740, DOI 10.1182/blood-2003-01-0288; PURI A, 1993, J NAT PROD, V56, P995, DOI 10.1021/np50097a002; Qi ZH, 2006, HYPERTENSION, V48, P323, DOI 10.1161/01.HYP.0000231934.67549.b7; Ragupathi G, 2008, VACCINE, V26, P4860, DOI 10.1016/j.vaccine.2008.06.098; Ramanathan M, 2007, MOL BIOL CELL, V18, P14, DOI 10.1091/mbc.E06-07-0596; Riehemann K, 1999, FEBS LETT, V442, P89, DOI 10.1016/S0014-5793(98)01622-6; Rios JL, 1997, PHYTOTHER RES, V11, P411, DOI 10.1002/(SICI)1099-1573(199709)11:6<411::AID-PTR132>3.0.CO;2-6; Ritchie MR, 2007, P NUTR SOC, V66, P479, DOI 10.1017/S0029665107005794; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; Setty AR, 2005, SEMIN ARTHRITIS RHEU, V34, P773, DOI 10.1016/j.semarthrit.2005.01.011; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Shi CS, 2008, BLOOD, V112, P3661, DOI 10.1182/blood-2008-03-142760; Shon YH, 2002, BIOL PHARM BULL, V25, P77, DOI 10.1248/bpb.25.77; Sinclair S, 1998, Altern Med Rev, V3, P338; Spelman K, 2006, ALTERN MED REV, V11, P128; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003; SUN Y, 2004, YI JUN YI XUE XUE BA, V24, P57; Tan BKH, 2004, CURR MED CHEM, V11, P1423, DOI 10.2174/0929867043365161; Teucher T, 1996, ARZNEIMITTEL-FORSCH, V46, P906; Thomas KJ, 2001, COMPLEMENT THER MED, V9, P2, DOI 10.1054/ctim.2000.0407; THORNE, 2005, ALTERN MED REV, V10, P51; WANG F, 2008, ZHONGGUO ZHONG XI YI, V28; Wei GH, 2003, INT J SYST EVOL MICR, V53, P1575, DOI 10.1099/ijs.0.02031-0; Wei HM, 2003, ONCOL REP, V10, P1507; Yang XY, 2010, VACCINE, V28, P737, DOI 10.1016/j.vaccine.2009.10.065; Yesilada E, 2005, J ETHNOPHARMACOL, V96, P71, DOI 10.1016/j.jep.2004.08.036; YIN X, 2010, BIOCH BIOPHYS RES CO; Yu SY, 2007, J ETHNOPHARMACOL, V110, P352, DOI 10.1016/j.jep.2006.09.024; Zaks-Zilberman M, 1998, INFECT IMMUN, V66, P4669, DOI 10.1128/IAI.66.10.4669-4675.1998; ZHAO HY, 1991, CHINESE MED J-PEKING, V104, P770; Zhu XL, 2007, PHYTOTHER RES, V21, P663, DOI 10.1002/ptr.2144; Zwickey H, 2007, PHYTOTHER RES, V21, P1109, DOI 10.1002/ptr.2207	84	23	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12561	10.1371/journal.pone.0012561	http://dx.doi.org/10.1371/journal.pone.0012561			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838436	Green Submitted, gold, Green Published			2022-12-27	WOS:000281627700014
J	Patel, VN; Bebek, G; Mariadason, JM; Wang, DH; Augenlicht, LH; Chance, MR				Patel, Vishal N.; Bebek, Gurkan; Mariadason, John M.; Wang, Donghai; Augenlicht, Leonard H.; Chance, Mark R.			Prediction and Testing of Biological Networks Underlying Intestinal Cancer	PLOS ONE			English	Article							CELL MATURATION; PROSTATE-CANCER; EXPRESSION DATA; TUMOR-FORMATION; BREAST-CANCER; PROTEIN; DIFFERENTIATION; DATABASE; GROWTH; PROLIFERATION	Colorectal cancer progresses through an accumulation of somatic mutations, some of which reside in so-called "driver'' genes that provide a growth advantage to the tumor. To identify points of intersection between driver gene pathways, we implemented a network analysis framework using protein interactions to predict likely connections - both precedented and novel - between key driver genes in cancer. We applied the framework to find significant connections between two genes, Apc and Cdkn1a (p21), known to be synergistic in tumorigenesis in mouse models. We then assessed the functional coherence of the resulting Apc-Cdkn1a network by engineering in vivo single node perturbations of the network: mouse models mutated individually at Apc (Apc(1638N+/-)) or Cdkn1a (Cdkn1a(-/-)), followed by measurements of protein and gene expression changes in intestinal epithelial tissue. We hypothesized that if the predicted network is biologically coherent (functional), then the predicted nodes should associate more specifically with dysregulated genes and proteins than stochastically selected genes and proteins. The predicted Apc-Cdkn1a network was significantly perturbed at the mRNA-level by both single gene knockouts, and the predictions were also strongly supported based on physical proximity and mRNA coexpression of proteomic targets. These results support the functional coherence of the proposed Apc-Cdkn1a network and also demonstrate how network-based predictions can be statistically tested using high-throughput biological data.	[Patel, Vishal N.; Bebek, Gurkan; Chance, Mark R.] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Patel, Vishal N.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Bebek, Gurkan; Chance, Mark R.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Mariadason, John M.; Wang, Donghai; Augenlicht, Leonard H.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Oncol, Bronx, NY 10467 USA; [Chance, Mark R.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Case Western Reserve University	Patel, VN (corresponding author), Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA.	mark.chance@case.edu	Mariadason, John/N-2003-2013	Mariadason, John/0000-0001-9123-7684	National Center for Research Resources [UL1-RR024989]; Case Western Reserve University Comprehensive Cancer Center [P30-CA043703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Case Western Reserve University Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by the National Institutes of Health Grants UL1-RR024989 from the National Center for Research Resources (Clinical and Translational Science Awards) and P30-CA043703 from the Case Western Reserve University Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1932, STAT METHODS RES WOR; Arora S, 2003, CANCER RES, V63, P6894; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bebek G, 2006, THEOR COMPUT SCI, V369, P239, DOI 10.1016/j.tcs.2006.08.045; Bebek G, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-335; Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Chang J, 2008, J PROTEOMICS, V71, P530, DOI 10.1016/j.jprot.2008.08.003; Chang YM, 2008, ONCOGENE, V27, P6365, DOI 10.1038/onc.2008.250; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Constancio-Lund SS, 2009, MOL CARCINOGEN, V48, P156, DOI 10.1002/mc.20466; Ekins S, 2006, DRUG METAB DISPOS, V34, P495, DOI 10.1124/dmd.105.008458; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Guzman-Aranguez A, 2005, J CELL BIOCHEM, V94, P178, DOI 10.1002/jcb.20293; Halberg RB, 2008, GENETICS, V180, P601, DOI 10.1534/genetics.108.091967; Han LY, 2006, CANCER RES, V66, P8633, DOI 10.1158/0008-5472.CAN-06-1410; Hayashi M, 2008, CLIN CANCER RES, V14, P7843, DOI 10.1158/1078-0432.CCR-08-1064; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Inokuchi J, 2009, INT J CANCER, V124, P68, DOI 10.1002/ijc.23928; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kong SW, 2006, BIOINFORMATICS, V22, P2373, DOI 10.1093/bioinformatics/btl401; Kuiper N. H., 1962, P K NED AKAD WETENSC, P38; Laiho P, 2007, ONCOGENE, V26, P312, DOI 10.1038/sj.onc.1209778; Larrea MD, 2008, MOL CELL BIOL, V28, P6462, DOI 10.1128/MCB.02300-07; Marsh V, 2008, NAT GENET, V40, P1436, DOI 10.1038/ng.256; Martin NG, 2008, FEBS J, V275, P3099, DOI 10.1111/j.1742-4658.2008.06463.x; Mewes HW, 1999, NUCLEIC ACIDS RES, V27, P44, DOI 10.1093/nar/27.1.44; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Nakamura J, 2009, INT J ONCOL, V34, P1181, DOI 10.3892/ijo_00000246; NIBBE RK, PLOS COMPUT IN PRESS; Nibbe RK, 2009, MOL CELL PROTEOMICS, V8, P827, DOI 10.1074/mcp.M800428-MCP200; Paoni NF, 2003, PHYSIOL GENOMICS, V15, P228, DOI 10.1152/physiolgenomics.00078.2003; Park JH, 2009, AM J PHYSIOL-CELL PH, V297, pC935, DOI 10.1152/ajpcell.00121.2009; Parmer TG, 1999, BRIT J CANCER, V79, P59, DOI 10.1038/sj.bjc.6690012; Scholl FA, 2004, CANCER RES, V64, P6035, DOI 10.1158/0008-5472.CAN-04-0017; Sithanandam G, 2005, ONCOGENE, V24, P1847, DOI 10.1038/sj.onc.1208381; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trobridge P, 2009, GASTROENTEROLOGY, V136, P1680, DOI 10.1053/j.gastro.2009.01.066; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; Veeramani S, 2005, ONCOGENE, V24, P7203, DOI 10.1038/sj.onc.1208852; Vizcaino JA, 2009, PROTEOMICS, V9, P4276, DOI 10.1002/pmic.200900402; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; WEISER MM, 1973, J BIOL CHEM, V248, P2536; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xing JP, 2008, AM J PHYSIOL-RENAL, V295, pF145, DOI 10.1152/ajprenal.00092.2008; Yamaguchi T, 2008, J CELL PHYSIOL, V217, P423, DOI 10.1002/jcp.21517; Yang WC, 2001, CANCER RES, V61, P565; Yao DG, 2008, J CELL SCI, V121, P1758, DOI 10.1242/jcs.021147; Zirbes TK, 2000, INT J CANCER, V89, P14, DOI 10.1002/(SICI)1097-0215(20000120)89:1<14::AID-IJC3>3.0.CO;2-L	57	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12497	10.1371/journal.pone.0012497	http://dx.doi.org/10.1371/journal.pone.0012497			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824133	Green Published, gold			2022-12-27	WOS:000281456100011
J	Bereczky-Veress, B; Abdelmagid, N; Piehl, F; Bergstrom, T; Olsson, T; Skoldenberg, B; Diez, M				Bereczky-Veress, Biborka; Abdelmagid, Nada; Piehl, Fredrik; Bergstrom, Tomas; Olsson, Tomas; Skoldenberg, Birgit; Diez, Margarita			Influence of Perineurial Cells and Toll-Like Receptors 2 and 9 on Herpes simplex Type 1 Entry to the Central Nervous System in Rat Encephalitis	PLOS ONE			English	Article							SCHWANN-CELLS; VIRUS; TLR9; PROLIFERATION; RECOGNITION; ACTIVATION; EXPRESSION; MODEL	Herpes simplex encephalitis (HSE) is a rare disease with high mortality and significant morbidity among survivors. We have previously shown that susceptibility to HSE was host-strain dependent, as severe, lethal HSE developed after injection of human Herpes simplex type 1 virus (HSV-1) into the whiskers area of DA rats, whereas PVG rats remained completely asymptomatic. In the present study we investigated the early immunokinetics in these strains to address the underlying molecular mechanisms for the observed difference. The virus distribution and the immunological responses were compared in the whiskers area, trigeminal ganglia and brain stem after 12 hours and the first four days following infection using immunohistochemistry and qRT-PCR. A conspicuous immunopathological finding was a strain-dependent difference in the spread of the HSV-1 virus to the trigeminal ganglia, only seen in DA rats already from 12 hpi. In the whiskers area infected perineurial cells were abundant in the susceptible DA strain after 2 dpi, whereas in the resistant PVG rats HSV-1 spread was confined only to the epineurium. In both strains activation of Iba1(+)/ED1(+) phagocytic cells followed the distribution pattern of HSV-1 staining, which was visible already at 12 hours after infection. Notably, in PVG rats higher mRNA expression of Toll-like receptors (Tlr) -2 and -9, together with increased staining for Iba1/ED1 was detected in the whiskers area. In contrast, all other Tlr-pathway markers were expressed at higher levels in the susceptible DA rats. Our data demonstrate the novel observation that genetically encoded properties of the host nerve and perineurial cells, recruitment of phagocyting cells together with the low expression of Tlr2 and -9 in the periphery define the susceptibility to HSV-1 entry into the nervous system.	[Bereczky-Veress, Biborka; Skoldenberg, Birgit] Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Med Solna,Unit Infect Dis, Stockholm, Sweden; [Abdelmagid, Nada; Piehl, Fredrik; Olsson, Tomas; Diez, Margarita] Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Clin Neurosci,Neuroimmunol Unit, Stockholm, Sweden; [Bergstrom, Tomas] Univ Gothenburg, Dept Clin Virol, Gothenburg, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Gothenburg	Bereczky-Veress, B (corresponding author), Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Med Solna,Unit Infect Dis, Stockholm, Sweden.	margarita.diez@ki.se	Piehl, Fredrik/E-3451-2013	Bergstrom, Tomas/0000-0002-9257-6757; Abdelmagid, Nada/0000-0002-8200-347X; Olsson, Tomas/0000-0002-2938-1877	European Union [LSHM-CT-2005-018637, LSHG-CT-2005-019015]; Swedish Brain Foundation; Swedish Society of Medicine; Magnus Bergvalls Foundation; Wadsworth Foundation; Torsten and Ragnar Soderbergs Foundation; Foundation for the Memory of Sigurd and Elsa Golje; Borklunds Foundation; Nils and Bibbi Jenssens Foundation; Montel Williams Foundation; Swedish Society for Medical Research; Swedish Research Council; Swedish Association of Persons with Neurological Disabilities	European Union(European Commission); Swedish Brain Foundation; Swedish Society of Medicine; Magnus Bergvalls Foundation; Wadsworth Foundation; Torsten and Ragnar Soderbergs Foundation; Foundation for the Memory of Sigurd and Elsa Golje; Borklunds Foundation; Nils and Bibbi Jenssens Foundation; Montel Williams Foundation; Swedish Society for Medical Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Association of Persons with Neurological Disabilities	This work is supported by 6th Framework Program of the European Union, NeuroproMiSe, LSHM-CT-2005-018637 and the EURATools, LSHG-CT-2005-019015, as well as by grants from the Swedish Brain Foundation, Swedish Society of Medicine, Magnus Bergvalls Foundation, Wadsworth Foundation, Torsten and Ragnar Soderbergs Foundation, Foundation for the Memory of Sigurd and Elsa Golje, Borklunds Foundation, Nils and Bibbi Jenssens Foundation, Montel Williams Foundation, Swedish Society for Medical Research, Swedish Research Council and The Swedish Association of Persons with Neurological Disabilities. The funders had no role in study design, data collection and analysis, preparation of the manuscript or decision to publish.	Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; AURELIUS E, 1993, J INFECT DIS, V168, P1248, DOI 10.1093/infdis/168.5.1248; Bereczky-Veress B, 2008, J NEUROVIROL, V14, P102, DOI 10.1080/13550280701883832; BERGSTROM T, 1990, J GEN VIROL, V71, P405, DOI 10.1099/0022-1317-71-2-405; Boehme KW, 2006, J IMMUNOL, V177, P7094, DOI 10.4049/jimmunol.177.10.7094; Bove GM, 2009, J NEUROIMMUNOL, V213, P26, DOI 10.1016/j.jneuroim.2009.06.005; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Cheng C, 2002, NEUROSCIENCE, V115, P321, DOI 10.1016/S0306-4522(02)00291-9; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Danielii J.F., 1958, GENERAL CYTOCHEMICAL, P399; GOETHALS S, 2010, GLIA; Hjalmarsson A, 2009, J NEUROL, V256, P1243, DOI 10.1007/s00415-009-5106-6; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; JESSEN KR, 1984, J NEUROCYTOL, V13, P923, DOI 10.1007/BF01148594; Kastrukoff LF, 2010, VIROLOGY, V400, P248, DOI 10.1016/j.virol.2010.02.013; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Mansur DS, 2005, AM J PATHOL, V166, P1419, DOI 10.1016/S0002-9440(10)62359-0; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PEASE DC, 1962, ANAT REC, V142, P342; Peltier DC, 2010, J IMMUNOL, V184, P7010, DOI 10.4049/jimmunol.0904133; Sarangi PP, 2007, J VIROL, V81, P11128, DOI 10.1128/JVI.01008-07; Sato A, 2006, P NATL ACAD SCI USA, V103, P17343, DOI 10.1073/pnas.0605102103; Skoldenberg B, 2006, J NEUROL, V253, P163, DOI 10.1007/s00415-005-0941-6; SKOLDENBERG B, 1984, LANCET, V2, P707; Smirkin A, 2010, J CEREBR BLOOD F MET, V30, P603, DOI 10.1038/jcbfm.2009.233; Sorensen LN, 2008, J IMMUNOL, V181, P8604, DOI 10.4049/jimmunol.181.12.8604; Sorkin LS, 1997, NEUROSCIENCE, V81, P255, DOI 10.1016/S0306-4522(97)00147-4; Triolo D, 2006, J CELL SCI, V119, P3981, DOI 10.1242/jcs.03168; Wuest TR, 2008, FRONT BIOSCI-LANDMRK, V13, P4862, DOI 10.2741/3045; YAMAZAKI T, 1993, AM J PATHOL, V143, P410; ZAMBONI L, 1967, J CELL BIOL, V35, pA148; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	34	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12350	10.1371/journal.pone.0012350	http://dx.doi.org/10.1371/journal.pone.0012350			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20806060	Green Submitted, Green Published, gold			2022-12-27	WOS:000281301500003
J	Melnikova, VO; Dobroff, AS; Zigler, M; Villares, GJ; Braeuer, RR; Wang, H; Huang, L; Bar-Eli, M				Melnikova, Vladislava O.; Dobroff, Andrey S.; Zigler, Maya; Villares, Gabriel J.; Braeuer, Russell R.; Wang, Hua; Huang, Li; Bar-Eli, Menashe			CREB Inhibits AP-2 alpha Expression to Regulate the Malignant Phenotype of Melanoma	PLOS ONE			English	Article							TRANSCRIPTION FACTOR AP-2; PROTEASE-ACTIVATED RECEPTOR-1; ELEMENT-BINDING PROTEIN; CANCER-CELL GROWTH; TUMOR-GROWTH; IN-VIVO; QUANTITATIVE-ANALYSIS; PROMOTER REGION; GENE-EXPRESSION; METASTASIS	Background: The loss of AP-2 alpha and increased activity of cAMP-responsive element binding (CREB) protein are two hallmarks of malignant progression of cutaneous melanoma. However, the molecular mechanism responsible for the loss of AP-2 alpha during melanoma progression remains unknown. Methodology/Principal Findings: Herein, we demonstrate that both inhibition of PKA-dependent CREB phosphorylation, as well as silencing of CREB expression by shRNA, restored AP-2 alpha protein expression in two metastatic melanoma cell lines. Moreover, rescue of CREB expression in CREB-silenced cell lines downregulates expression of AP-2 alpha. Loss of AP-2 alpha expression in metastatic melanoma occurs via a dual mechanism involving binding of CREB to the AP-2 alpha promoter and CREB-induced overexpression of another oncogenic transcription factor, E2F-1. Upregulation of AP-2 alpha expression following CREB silencing increases endogenous p21(Waf1) and decreases MCAM/MUC18, both known to be downstream target genes of AP-2 alpha involved in melanoma progression. Conclusions/Significance: Since AP-2 alpha regulates several genes associated with the metastatic potential of melanoma including cKIT, VEGF, PAR-1, MCAM/MUC18, and p21(Waf1), our data identified CREB as a major regulator of the malignant melanoma phenotype.	[Melnikova, Vladislava O.; Dobroff, Andrey S.; Zigler, Maya; Villares, Gabriel J.; Braeuer, Russell R.; Wang, Hua; Huang, Li; Bar-Eli, Menashe] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Melnikova, VO (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	mbareli@mdanderson.org	Dobroff, Andrey/A-9814-2016	Dobroff, Andrey/0000-0003-2162-9951	National Institutes of Health [CA76098]; NATIONAL CANCER INSTITUTE [R01CA076098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research was supported by National Institutes of Health R01 Grant CA76098 (to M.B-E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINO AP, 1981, J EXP MED, V154, P1764, DOI 10.1084/jem.154.6.1764; Bar-Eli M, 2001, PIGM CELL RES, V14, P78, DOI 10.1034/j.1600-0749.2001.140202.x; Bar-Eli M, 1999, CANCER METAST REV, V18, P377, DOI 10.1023/A:1006377309524; BAUER R, 1994, NUCLEIC ACIDS RES, V22, P1413, DOI 10.1093/nar/22.8.1413; Bell LA, 2004, CELL DEATH DIFFER, V11, P137, DOI 10.1038/sj.cdd.4401324; Berger AJ, 2005, CANCER RES, V65, P11185, DOI 10.1158/0008-5472.CAN-05-2300; Berger AJ, 2003, CANCER RES, V63, P8103; Bhoumik A, 2008, CELL CYCLE, V7, P2341, DOI 10.4161/cc.6388; COPEMAN MC, 1992, PATHOLOGY, V24, P307, DOI 10.3109/00313029209068886; Cowley GP, 1996, J PATHOL, V179, P183, DOI 10.1002/(SICI)1096-9896(199606)179:2<183::AID-PATH554>3.0.CO;2-W; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DESCHEEMAEKER KA, 1992, J BIOL CHEM, V267, P15086; Dobroff AS, 2009, J BIOL CHEM, V284, P26194, DOI 10.1074/jbc.M109.019836; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Gee JMW, 1999, J PATHOL, V189, P514, DOI 10.1002/(SICI)1096-9896(199912)189:4<514::AID-PATH463>3.0.CO;2-9; Gershenwald JE, 2001, ONCOGENE, V20, P3363, DOI 10.1038/sj.onc.1204450; Gille J, 1997, EMBO J, V16, P750, DOI 10.1093/emboj/16.4.750; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Heimberger AB, 2005, CLIN CANCER RES, V11, P267; Huang S, 1998, EMBO J, V17, P4358, DOI 10.1093/emboj/17.15.4358; Jean D, 2000, MOL CELL BIOCHEM, V212, P19, DOI 10.1023/A:1007128101751; Jean D, 1998, J BIOL CHEM, V273, P16501, DOI 10.1074/jbc.273.26.16501; Jean D, 2001, CRIT REV IMMUNOL, V21, P275; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P9160, DOI 10.1073/pnas.93.17.9160; Jonckheere N, 2009, BRIT J CANCER, V101, P637, DOI 10.1038/sj.bjc.6605190; Leslie MC, 2005, J CELL BIOCHEM, V94, P25, DOI 10.1002/jcb.20296; LI LM, 1989, JNCI-J NATL CANCER I, V81, P1406, DOI 10.1093/jnci/81.18.1406; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McGary EC, 2002, CANCER BIOL THER, V1, P459, DOI 10.4161/cbt.1.5.158; McPherson LA, 2002, J BIOL CHEM, V277, P45028, DOI 10.1074/jbc.M208924200; Melnikova VO, 2008, CANCER BIOL THER, V7, P997, DOI 10.4161/cbt.7.7.6535; Melnikova VO, 2006, PIGM CELL RES, V19, P395, DOI 10.1111/j.1600-0749.2006.00331.x; Melnikova VO, 2009, J BIOL CHEM, V284, P28845, DOI 10.1074/jbc.M109.042150; Melnikova VO, 2006, J BIOL CHEM, V281, P2911, DOI 10.1074/jbc.M508683200; Miele ME, 1996, MOL CARCINOGEN, V15, P284, DOI 10.1002/(SICI)1098-2744(199604)15:4<284::AID-MC6>3.0.CO;2-G; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; NATALI PG, 1994, INT J CANCER, V56, P341, DOI 10.1002/ijc.2910560308; Nyormoi O, 2003, CLIN EXP METASTAS, V20, P251, DOI 10.1023/A:1022991302172; PATHAK S, 1983, CYTOGENET CELL GENET, V36, P573, DOI 10.1159/000131975; Poser I, 2004, HISTOL HISTOPATHOL, V19, P173, DOI 10.14670/HH-19.173; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Ropponen KM, 1999, BRIT J CANCER, V81, P133, DOI 10.1038/sj.bjc.6690662; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Schwartz B, 2007, ONCOGENE, V26, P4049, DOI 10.1038/sj.onc.1210193; Sharpless NE, 2003, ONCOGENE, V22, P5055, DOI 10.1038/sj.onc.1206809; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Silins G, 1997, BIOCHEM BIOPH RES CO, V230, P413, DOI 10.1006/bbrc.1996.5979; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Stevens C, 2003, ARCH BIOCHEM BIOPHYS, V412, P157, DOI 10.1016/S0003-9861(03)00054-7; Tellez C, 2003, J BIOL CHEM, V278, P46632, DOI 10.1074/jbc.M309159200; Tellez CS, 2007, J INVEST DERMATOL, V127, P387, DOI 10.1038/sj.jid.5700539; TRENT JM, 1990, SCIENCE, V247, P568, DOI 10.1126/science.2300817; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; VANDENOORD JJ, 1994, AM J PATHOL, V145, P294; VERSCHRAEGEN CF, 1991, ANTICANCER RES, V11, P529; Villares GJ, 2009, CANCER RES, V69, P6730, DOI 10.1158/0008-5472.CAN-09-0300; Wajapeyee N, 2003, J BIOL CHEM, V278, P52093, DOI 10.1074/jbc.M305624200; WALKER GJ, 1995, GENE CHROMOSOME CANC, V12, P134, DOI 10.1002/gcc.2870120208; Walker GJ, 1998, GENE CHROMOSOME CANC, V22, P157, DOI 10.1002/(SICI)1098-2264(199806)22:2<157::AID-GCC11>3.0.CO;2-N; WELCH DR, 1991, INT J CANCER, V47, P227, DOI 10.1002/ijc.2910470211; WELCH DR, 1994, ONCOGENE, V9, P255; WERNER H, 1990, BIOCHEM BIOPH RES CO, V169, P1021, DOI 10.1016/0006-291X(90)91996-6; White PC, 2006, ONCOGENE, V25, P2170, DOI 10.1038/sj.onc.1209255; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Xie SH, 1997, ONCOGENE, V15, P2069, DOI 10.1038/sj.onc.1201358; Xie YB, 2009, ONCOL REP, V21, P1345, DOI 10.3892/or_00000360; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78; ZHANG J, 1995, CANCER RES, V55, P4640; Zhang J, 2003, DEV DYNAM, V228, P194, DOI 10.1002/dvdy.10365; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	70	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12452	10.1371/journal.pone.0012452	http://dx.doi.org/10.1371/journal.pone.0012452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805990	gold, Green Published, Green Submitted			2022-12-27	WOS:000281301500018
J	Bohn, M; Heermann, DW				Bohn, Manfred; Heermann, Dieter W.			Diffusion-Driven Looping Provides a Consistent Framework for Chromatin Organization	PLOS ONE			English	Article							HUMAN INTERPHASE CHROMOSOMES; 3-DIMENSIONAL STRUCTURE; GENE-EXPRESSION; RING POLYMERS; MONTE-CARLO; IN-SITU; ARCHITECTURE; TERRITORIES; MODEL; DNA	Chromatin folding inside the interphase nucleus of eukaryotic cells is done on multiple scales of length and time. Despite recent progress in understanding the folding motifs of chromatin, the higher-order structure still remains elusive. Various experimental studies reveal a tight connection between genome folding and function. Chromosomes fold into a confined subspace of the nucleus and form distinct territories. Chromatin looping seems to play a dominant role both in transcriptional regulation as well as in chromatin organization and has been assumed to be mediated by long-range interactions in many polymer models. However, it remains a crucial question which mechanisms are necessary to make two chromatin regions become co-located, i.e. have them in spatial proximity. We demonstrate that the formation of loops can be accomplished solely on the basis of diffusional motion. The probabilistic nature of temporary contacts mimics the effects of proteins, e. g. transcription factors, in the solvent. We establish testable quantitative predictions by deriving scale-independent measures for comparison to experimental data. In this Dynamic Loop (DL) model, the co-localization probability of distant elements is strongly increased compared to linear non-looping chains. The model correctly describes folding into a confined space as well as the experimentally observed cell-to-cell variation. Most importantly, at biological densities, model chromosomes occupy distinct territories showing less inter-chromosomal contacts than linear chains. Thus, dynamic diffusion-based looping, i.e. gene co-localization, provides a consistent framework for chromatin organization in eukaryotic interphase nuclei.	[Bohn, Manfred; Heermann, Dieter W.] Heidelberg Univ, Inst Theoret Phys, Heidelberg, Germany; [Heermann, Dieter W.] Inst Mol Biophys, Jackson Lab, Bar Harbor, ME USA	Ruprecht Karls University Heidelberg; Jackson Laboratory	Bohn, M (corresponding author), Heidelberg Univ, Inst Theoret Phys, Heidelberg, Germany.	bohn@tphys.uni-heidelberg.de			Landesgraduiertenforderung Baden-Wurttemberg	Landesgraduiertenforderung Baden-Wurttemberg	M. B. has received funding from the Landesgraduiertenforderung Baden-Wurttemberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; Belmont AS, 2001, TRENDS CELL BIOL, V11, P250, DOI 10.1016/S0962-8924(01)02000-1; Binder K, 2002, MONTE CARLO SIMULATI; Binder K., 1995, MONTE CARLO MOL DYNA; Bode J, 2003, CHROMOSOME RES, V11, P435, DOI 10.1023/A:1024918525818; BOHN M, 2010, J CHEM PHYS IN PRESS; Bohn M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051805; Bohn M, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3126651; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; BRANCO M, 2006, PLOS BIOL, V4, P97; BRUNS W, 1992, MAKROMOL CHEM-THEOR, V1, P287; Bystricky K, 2004, P NATL ACAD SCI USA, V101, P16495, DOI 10.1073/pnas.0402766101; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; CARMESIN I, 1988, MACROMOLECULES, V21, P2819, DOI 10.1021/ma00187a030; Cook PR, 2009, J CELL BIOL, V186, P825, DOI 10.1083/jcb.200903083; Cook PR, 2002, NAT GENET, V32, P347, DOI 10.1038/ng1102-347; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; De Gennes P.-G., 1979, SCALING CONCEPTS POL; de Nooijer S, 2009, NUCLEIC ACIDS RES, V37, P3558, DOI 10.1093/nar/gkp219; Dekker J, 2003, TRENDS BIOCHEM SCI, V28, P277, DOI 10.1016/S0968-0004(03)00089-6; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DEUTSCH HP, 1991, J CHEM PHYS, V94, P2294, DOI 10.1063/1.459901; Diesinger PM, 2009, BIOPHYS J, V97, P2146, DOI 10.1016/j.bpj.2009.06.057; Dietzel S, 2004, J CELL SCI, V117, P4603, DOI 10.1242/jcs.01330; Dundr M, 2001, BIOCHEM J, V356, P297, DOI 10.1042/0264-6021:3560297; DUPLANTIER B, 1989, J STAT PHYS, V54, P581, DOI 10.1007/BF01019770; Eils R, 1996, J CELL BIOL, V135, P1427, DOI 10.1083/jcb.135.6.1427; Emanuel M, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025008; Fraser P, 2006, CURR OPIN GENET DEV, V16, P490, DOI 10.1016/j.gde.2006.08.002; Galande S, 2007, CURR OPIN GENET DEV, V17, P408, DOI 10.1016/j.gde.2007.08.003; Gilbert N, 2005, INT REV CYTOL, V242, P283; Goetze S, 2007, MOL CELL BIOL, V27, P4475, DOI 10.1128/MCB.00208-07; GROSBERG A, 1993, EUROPHYS LETT, V23, P373, DOI 10.1209/0295-5075/23/5/012; Grosberg A.Y., 1994, STAT PHYS MACROMOLEC; HAHNFELDT P, 1993, P NATL ACAD SCI USA, V90, P7854, DOI 10.1073/pnas.90.16.7854; HOROWITZ RA, 1994, J CELL BIOL, V125, P1, DOI 10.1083/jcb.125.1.1; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Khalil A, 2007, CHROMOSOME RES, V15, P899, DOI 10.1007/s10577-007-1172-8; Langowski J, 2006, EUR PHYS J E, V19, P241, DOI 10.1140/epje/i2005-10067-9; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lowenstein MG, 2004, MOL BIOL CELL, V15, P5678, DOI 10.1091/mbc.E04-04-0289; Lua R, 2004, POLYMER, V45, P717, DOI 10.1016/j.polymer.2003.10.073; Marenduzzo D, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/09/L09002; Marenduzzo D, 2007, TRENDS GENET, V23, P126, DOI 10.1016/j.tig.2007.01.007; Mateos-Langerak J, 2009, P NATL ACAD SCI USA, V106, P3812, DOI 10.1073/pnas.0809501106; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Muller M, 1996, PHYS REV E, V53, P5063, DOI 10.1103/PhysRevE.53.5063; Muller M, 2000, PHYS REV E, V61, P4078, DOI 10.1103/PhysRevE.61.4078; Munkel C, 1998, PHYS REV E, V57, P5888, DOI 10.1103/PhysRevE.57.5888; Munkel C, 1999, J MOL BIOL, V285, P1053, DOI 10.1006/jmbi.1998.2361; PAUL W, 1991, J PHYS II, V1, P37, DOI 10.1051/jp2:1991138; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Rosa A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000153; SACHS RK, 1995, P NATL ACAD SCI USA, V92, P2710, DOI 10.1073/pnas.92.7.2710; Scheuermann MO, 2004, EXP CELL RES, V301, P266, DOI 10.1016/j.yexcr.2004.08.031; Schiessel H, 2001, BIOPHYS J, V80, P1940, DOI 10.1016/S0006-3495(01)76164-4; SIKORAV JL, 1994, BIOPHYS J, V66, P827, DOI 10.1016/S0006-3495(94)80859-8; SIKORSKI A, 1994, POLYMER, V35, P3792, DOI 10.1016/0032-3861(94)90565-7; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; SOKAL AD, 1996, FUNCTIONAL INTEGRATI; St-Jean P, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061923; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; vanHolde K, 1996, P NATL ACAD SCI USA, V93, P10548, DOI 10.1073/pnas.93.20.10548; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; WOODCOCK CLF, 1984, J CELL BIOL, V99, P42, DOI 10.1083/jcb.99.1.42; YOKOTA H, 1995, J CELL BIOL, V130, P1239, DOI 10.1083/jcb.130.6.1239; Zink D, 2004, J CELL BIOL, V166, P815, DOI 10.1083/jcb.200404107	68	119	122	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12218	10.1371/journal.pone.0012218	http://dx.doi.org/10.1371/journal.pone.0012218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811620	Green Submitted, Green Published, gold			2022-12-27	WOS:000281234700002
J	Hildebrandt, MAT; Komaki, R; Liao, Z; Gu, JA; Chang, JY; Ye, YQ; Lu, C; Stewart, DJ; Minna, JD; Roth, JA; Lippman, SM; Cox, JD; Hong, WK; Spitz, MR; Wu, XF				Hildebrandt, Michelle A. T.; Komaki, Ritsuko; Liao, Zhongxing; Gu, Jian; Chang, Joe Y.; Ye, Yuanqing; Lu, Charles; Stewart, David J.; Minna, John D.; Roth, Jack A.; Lippman, Scott M.; Cox, James D.; Hong, Waun Ki; Spitz, Margaret R.; Wu, Xifeng			Genetic Variants in Inflammation-Related Genes Are Associated with Radiation-Induced Toxicity Following Treatment for Non-Small Cell Lung Cancer	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; NORMAL TISSUE-REACTIONS; TNF POLYMORPHISM; TRANSCRIPTION; EXPRESSION; RADIOTHERAPY; REGION; RISK; PNEUMONITIS; STATISTICS	Treatment of non-small cell lung cancer (NSCLC) with radiotherapy or chemoradiotherapy is often accompanied by the development of esophagitis and pneumonitis. Identifying patients who might be at increased risk for normal tissue toxicity would help in determination of the optimal radiation dose to avoid these events. We profiled 59 single nucleotide polymorphisms (SNPs) from 37 inflammation-related genes in 173 NSCLC patients with stage IIIA/IIIB (dry) disease who were treated with definitive radiation or chemoradiation. For esophagitis risk, nine SNPs were associated with a 1.5-to 4-fold increase in risk, including three PTGS2 (COX2) variants: rs20417 (HR: 1.93, 95% CI: 1.10-3.39), rs5275 (HR: 1.58, 95% CI: 1.09-2.27), and rs689470 (HR: 3.38, 95% CI: 1.09-10.49). Significantly increased risk of pneumonitis was observed for patients with genetic variation in the proinflammatory genes IL1A, IL8, TNF, TNFRSF1B, and MIF. In contrast, NOS3: rs1799983 displayed a protective effect with a 45% reduction in pneumonitis risk (HR: 0.55, 95% CI: 0.31-0.96). Pneumonitis risk was also modulated by polymorphisms in anti-inflammatory genes, including genetic variation in IL13. rs20541 and rs180925 each resulted in increased risk (HR: 2.95, 95% CI: 1.14-7.63 and HR: 3.23, 95% CI: 1.03-10.18, respectively). The cumulative effect of these SNPs on risk was dose-dependent, as evidenced by a significantly increased risk of either toxicity with an increasing number of risk genotypes (P, 0.001). These results suggest that genetic variations among inflammation pathway genes may modulate the development of radiation-induced toxicity and, ultimately, help in identifying patients who are at an increased likelihood for such events.	[Hildebrandt, Michelle A. T.; Gu, Jian; Ye, Yuanqing; Spitz, Margaret R.; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Komaki, Ritsuko; Liao, Zhongxing; Chang, Joe Y.; Cox, James D.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Lu, Charles; Stewart, David J.; Lippman, Scott M.; Hong, Waun Ki] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Roth, Jack A.] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center	Hildebrandt, MAT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	xwu@mdanderson.org	Gu, Jian/Q-4780-2018; Wang, Weili/D-1546-2011	Gu, Jian/0000-0003-3499-0973; 	NATIONAL CANCER INSTITUTE [R01CA111646, P50CA070907, R01CA127219, R01CA055769] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA055769, P50 CA070907, R01 CA111646, R01 CA127219, R01 CA127219-04, R01 CA55769] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andreassen CN, 2003, RADIOTHER ONCOL, V69, P127, DOI 10.1016/j.radonc.2003.09.010; Andreassen CN, 2002, RADIOTHER ONCOL, V64, P131, DOI 10.1016/S0167-8140(02)00154-8; Andreassen CN, 2005, RADIOTHER ONCOL, V75, P18, DOI 10.1016/j.radonc.2004.12.012; Barnett GC, 2009, NAT REV CANCER, V9, P134, DOI 10.1038/nrc2587; Cameron L, 2006, J IMMUNOL, V177, P8633, DOI 10.4049/jimmunol.177.12.8633; Crawley E, 1999, ARTHRITIS RHEUM-US, V42, P1101, DOI 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dixon DA, 2004, CURR PHARM DESIGN, V10, P635, DOI 10.2174/1381612043453171; Dominici R, 2002, IMMUNOGENETICS, V54, P82, DOI 10.1007/s00251-002-0445-9; Engels EA, 2007, CANCER RES, V67, P6520, DOI 10.1158/0008-5472.CAN-07-0370; FINKELSTEIN JN, 1994, INT J RADIAT ONCOL, V28, P621, DOI 10.1016/0360-3016(94)90187-2; Gao LB, 2009, CARCINOGENESIS, V30, P295, DOI 10.1093/carcin/bgn281; Gasche C, 2003, J IMMUNOL, V170, P5578, DOI 10.4049/jimmunol.170.11.5578; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Hershey GKK, 1997, NEW ENGL J MED, V337, P1720, DOI 10.1056/NEJM199712113372403; Higuchi T, 1998, TISSUE ANTIGENS, V51, P605, DOI 10.1111/j.1399-0039.1998.tb03002.x; Hill MR, 2006, AM J RESP CRIT CARE, V174, P915, DOI 10.1164/rccm.200512-1839OC; Hohjoh H, 2001, GENES IMMUN, V2, P105, DOI 10.1038/sj.gene.6363721; Hull J, 2000, THORAX, V55, P1023, DOI 10.1136/thorax.55.12.1023; HUTH C, 2008, ANN MED, P1; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kabesch M, 2003, J ALLERGY CLIN IMMUN, V112, P893, DOI 10.1016/j.jaci.2003.08.033; Kawaguchi Y, 2007, IMMUNOGENETICS, V59, P441, DOI 10.1007/s00251-007-0213-y; Kiszel P, 2007, CYTOKINE, V40, P17, DOI 10.1016/j.cyto.2007.08.001; Lv K, 2006, SCAND J IMMUNOL, V64, P164, DOI 10.1111/j.1365-3083.2006.01786.x; Morita C, 2001, ARTHRITIS RHEUM-US, V44, P2819, DOI 10.1002/1529-0131(200112)44:12<2819::AID-ART469>3.0.CO;2-2; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Papafili A, 2002, ARTERIOSCL THROM VAS, V22, P1631, DOI 10.1161/01.ATV.0000030340.80207.C5; PUTHOTHU B, 2008, PEDIAT ALLERGY IMMUN; Quarmby S, 2003, INT J RADIAT BIOL, V79, P137, DOI 10.1080/0955300021000045673; Robnett TJ, 2000, INT J RADIAT ONCOL, V48, P89, DOI 10.1016/S0360-3016(00)00648-9; ROSE J, 2008, RADIOTHER ONCOL; RUBIN P, 1995, INT J RADIAT ONCOL, V33, P99, DOI 10.1016/0360-3016(95)00095-G; Sato H, 2007, J ALLERGY CLIN IMMUN, V119, P687, DOI 10.1016/j.jaci.2006.10.028; Singh AK, 2003, INT J RADIAT ONCOL, V55, P337, DOI 10.1016/S0360-3016(02)03937-8; Soga Y, 2003, J CLIN PERIODONTOL, V30, P524, DOI 10.1034/j.1600-051X.2003.00287.x; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Terry CF, 2000, J BIOL CHEM, V275, P18138, DOI 10.1074/jbc.M000379200; Till A, 2005, J BIOL CHEM, V280, P5994, DOI 10.1074/jbc.M411541200; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; Tucker SL, 2008, INT J RADIAT ONCOL, V72, P568, DOI 10.1016/j.ijrobp.2008.04.053; van Heel DA, 2002, HUM MOL GENET, V11, P1281, DOI 10.1093/hmg/11.11.1281; Veldman BA, 2002, J HYPERTENS, V20, P2023, DOI 10.1097/00004872-200210000-00022; Vladich FD, 2005, J CLIN INVEST, V115, P747, DOI 10.1172/JCI200522818; Wang SL, 2006, INT J RADIAT ONCOL, V66, P1399, DOI 10.1016/j.ijrobp.2006.07.1337; Wang XL, 2000, FEBS LETT, V471, P45, DOI 10.1016/S0014-5793(00)01356-9	47	79	84	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12402	10.1371/journal.pone.0012402	http://dx.doi.org/10.1371/journal.pone.0012402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811626	gold, Green Published, Green Submitted			2022-12-27	WOS:000281234700025
J	Hov, JR; Keitel, V; Laerdahl, JK; Spomer, L; Ellinghaus, E; ElSharawy, A; Melum, E; Boberg, KM; Manke, T; Balschun, T; Schramm, C; Bergquist, A; Weismuller, T; Gotthardt, D; Rust, C; Henckaerts, L; Onnie, CM; Weersma, RK; Sterneck, M; Teufel, A; Runz, H; Stiehl, A; Ponsioen, CY; Wijmenga, C; Vatn, MH; Stokkers, PCF; Vermeire, S; Mathew, CG; Lie, BA; Beuers, U; Manns, MP; Schreiber, S; Schrumpf, E; Haussinger, D; Franke, A; Karlsen, TH				Hov, Johannes R.; Keitel, Verena; Laerdahl, Jon K.; Spomer, Lina; Ellinghaus, Eva; ElSharawy, Abdou; Melum, Espen; Boberg, Kirsten M.; Manke, Thomas; Balschun, Tobias; Schramm, Christoph; Bergquist, Annika; Weismueller, Tobias; Gotthardt, Daniel; Rust, Christian; Henckaerts, Liesbet; Onnie, Clive M.; Weersma, Rinse K.; Sterneck, Martina; Teufel, Andreas; Runz, Heiko; Stiehl, Adolf; Ponsioen, Cyriel Y.; Wijmenga, Cisca; Vatn, Morten H.; Stokkers, Pieter C. F.; Vermeire, Severine; Mathew, Christopher G.; Lie, Benedicte A.; Beuers, Ulrich; Manns, Michael P.; Schreiber, Stefan; Schrumpf, Erik; Haeussinger, Dieter; Franke, Andre; Karlsen, Tom H.		IBSEN Study Grp	Mutational Characterization of the Bile Acid Receptor TGR5 in Primary Sclerosing Cholangitis	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENTS; PROTEIN-COUPLED RECEPTORS; ULCERATIVE-COLITIS; GENE-EXPRESSION; CYSTIC-FIBROSIS; CROHN-DISEASE; BOWEL-DISEASE; LIVER-DISEASE; WEB SERVER; SUSCEPTIBILITY	Background: TGR5, the G protein-coupled bile acid receptor 1 (GPBAR1), has been linked to inflammatory pathways as well as bile homeostasis, and could therefore be involved in primary sclerosing cholangitis (PSC) a chronic inflammatory bile duct disease. We aimed to extensively investigate TGR5 sequence variation in PSC, as well as functionally characterize detected variants. Methodology/Principal Findings: Complete resequencing of TGR5 was performed in 267 PSC patients and 274 healthy controls. Six nonsynonymous mutations were identified in addition to 16 other novel single-nucleotide polymorphisms. To investigate the impact from the nonsynonymous variants on TGR5, we created a receptor model, and introduced mutated TGR5 constructs into human epithelial cell lines. By using confocal microscopy, flow cytometry and a cAMP-sensitive luciferase assay, five of the nonsynonymous mutations (W83R, V178M, A217P, S272G and Q296X) were found to reduce or abolish TGR5 function. Fine-mapping of the previously reported PSC and UC associated locus at chromosome 2q35 in large patient panels revealed an overall association between the TGR5 single-nucleotide polymorphism rs11554825 and PSC (odds ratio = 1.14, 95% confidence interval: 1.03-1.26, p = 0.010) and UC (odds ratio = 1.19, 95% confidence interval 1.11-1.27, p = 8.5x10(-7)), but strong linkage disequilibrium precluded demarcation of TGR5 from neighboring genes. Conclusions/Significance: Resequencing of TGR5 along with functional investigations of novel variants provided unique insight into an important candidate gene for several inflammatory and metabolic conditions. While significant TGR5 associations were detected in both UC and PSC, further studies are needed to conclusively define the role of TGR5 variation in these diseases.	[Hov, Johannes R.; Melum, Espen; Boberg, Kirsten M.; Schrumpf, Erik; Karlsen, Tom H.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Norwegian PSC Res Ctr,Clin Specialized Med & Surg, N-0027 Oslo, Norway; [Hov, Johannes R.; Melum, Espen] Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway; [Hov, Johannes R.; Melum, Espen; Vatn, Morten H.; Schrumpf, Erik] Univ Oslo, Inst Clin Med, Oslo, Norway; [Keitel, Verena; Spomer, Lina; Haeussinger, Dieter] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infectiol, Dusseldorf, Germany; [Laerdahl, Jon K.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Ctr Mol Biol & Neurosci, N-0027 Oslo, Norway; [Laerdahl, Jon K.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Inst Med Microbiol, N-0027 Oslo, Norway; [Ellinghaus, Eva; ElSharawy, Abdou; Balschun, Tobias; Schreiber, Stefan; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [ElSharawy, Abdou; Schreiber, Stefan] Univ Hosp Schleswig Holstein, Dept Med 1, Kiel, Germany; [Manke, Thomas] Max Planck Inst Mol Genet, Berlin, Germany; [Schramm, Christoph; Sterneck, Martina] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany; [Bergquist, Annika] Karolinska Univ Hosp Huddinge, Dept Gastroenterol & Hepatol, Stockholm, Sweden; [Balschun, Tobias; Manns, Michael P.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany; [Weismueller, Tobias; Manns, Michael P.] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, D-3000 Hannover, Germany; [Gotthardt, Daniel; Stiehl, Adolf] Univ Heidelberg Hosp, Dept Med, Heidelberg, Germany; [Rust, Christian] Univ Munich, Dept Med 2, Munich, Germany; [Henckaerts, Liesbet; Vermeire, Severine] Univ Hosp Gasthuisberg, Dept Gastroenterol, B-3000 Louvain, Belgium; [Onnie, Clive M.; Mathew, Christopher G.] Kings Coll London, Dept Med & Mol Genet, Sch Med, London WC2R 2LS, England; [Weersma, Rinse K.] Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, NL-9713 AV Groningen, Netherlands; [Weersma, Rinse K.; Wijmenga, Cisca] Univ Groningen, Groningen, Netherlands; [Teufel, Andreas] Johannes Gutenberg Univ Mainz, Dept Med 1, D-6500 Mainz, Germany; [Runz, Heiko] Univ Heidelberg Hosp, Dept Human Genet, Heidelberg, Germany; [Ponsioen, Cyriel Y.; Stokkers, Pieter C. F.; Beuers, Ulrich] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands; [Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Vatn, Morten H.] Akershus Univ Hosp, Inst Clin Epidemiol & Mol Biol Epigen, Lorenskog, Norway; [Vatn, Morten H.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Clin Specialized Med & Surg, N-0027 Oslo, Norway; [Lie, Benedicte A.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Inst Immunol, N-0027 Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; Heinrich Heine University Dusseldorf; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf; Karolinska Institutet; Karolinska University Hospital; Hannover Medical School; Hannover Medical School; Ruprecht Karls University Heidelberg; University of Munich; KU Leuven; University Hospital Leuven; University of London; King's College London; University of Groningen; University of Groningen; Johannes Gutenberg University of Mainz; Ruprecht Karls University Heidelberg; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway	Hov, JR (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Norwegian PSC Res Ctr,Clin Specialized Med & Surg, N-0027 Oslo, Norway.	j.e.r.hov@medisin.uio.no	Ellinghaus, Eva/E-6490-2012; Teufel, Andreas/ABD-8000-2021; Hov, Johannes R/J-1480-2019; Keitel, Verena/AAF-3471-2019; Wijmenga, Cisca/D-2173-2009; Franke, Andre/B-2151-2010; Weismüller, Tobias J./I-1879-2019; Keitel, Verena/AAH-9016-2021; Weersma, Rinse/ABE-3807-2021; Henckaerts, Liesbet/AAB-5706-2021; Wijmenga, Cisca/AAE-7719-2019; Mathew, Christopher G/G-3434-2015; Manke, Thomas/L-9075-2019	Ellinghaus, Eva/0000-0003-2914-3382; Hov, Johannes R/0000-0002-5900-8096; Franke, Andre/0000-0003-1530-5811; Weismüller, Tobias J./0000-0001-9736-1483; Keitel, Verena/0000-0003-1383-7662; Wijmenga, Cisca/0000-0002-5635-1614; Mathew, Christopher G/0000-0003-4178-1838; Henckaerts, Liesbet/0000-0003-2880-1400; Bergquist, Annika/0000-0002-3858-6241; Vermeire, Severine/0000-0001-9942-3019; Laerdahl, Jon Kristen/0000-0002-0826-9464; Schramm, Christoph/0000-0002-4264-1928	Norwegian PSC research center; Research Council of Norway; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 575, Klinische Forschergruppe-217]; German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN); Popgen biobank; DFG; Integrated Research and Treatment Center - Transplantation [01EO0802]; United Kingdom Medical Research Council (MRC) [G0000934]; Wellcome Trust [068545/Z/02]; Medical Research Council [G0000934] Funding Source: researchfish; MRC [G0000934] Funding Source: UKRI	Norwegian PSC research center; Research Council of Norway(Research Council of Norway); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); Popgen biobank; DFG(German Research Foundation (DFG)); Integrated Research and Treatment Center - Transplantation; United Kingdom Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Norwegian PSC research center, Research Council of Norway, the Deutsche Forschungsgemeinschaft through Sonderforschungsbereich 575 Dusseldorf "Experimental Hepatology'' and Klinische Forschergruppe-217 Dusseldorf "Hepatobiliary transport and liver disease'' and the German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN), the Popgen biobank, the DFG excellence cluster "Inflammation at Interfaces'' and the Integrated Research and Treatment Center - Transplantation (reference number: 01EO0802). The 1958 British Birth Cohort collection is funded by the United Kingdom Medical Research Council (MRC, grant G0000934) and The Wellcome Trust (grant 068545/Z/02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bergquist A, 2008, CLIN GASTROENTEROL H, V6, P939, DOI 10.1016/j.cgh.2008.03.016; Blanco PG, 2004, AM J PHYSIOL-GASTR L, V287, pG491, DOI 10.1152/ajpgi.00452.2003; Boberg KM, 1998, SCAND J GASTROENTERO, V33, P99; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Broome U, 2006, SEMIN LIVER DIS, V26, P31, DOI 10.1055/s-2006-933561; CHAPMAN RWG, 1980, GUT, V21, P870, DOI 10.1136/gut.21.10.870; Colombo C, 2007, CURR OPIN PULM MED, V13, P529, DOI 10.1097/MCP.0b013e3282f10a16; COTECCHIA S, 1992, J BIOL CHEM, V267, P1633; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; De La Vega FA, 2005, MUTAT RES-FUND MOL M, V573, P111, DOI 10.1016/j.mrfmmm.2005.01.008; de Ligt RAF, 2005, EUR J PHARMACOL, V510, P1, DOI 10.1016/j.ejphar.2005.01.007; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Gaborik Z, 1998, FEBS LETT, V428, P147, DOI 10.1016/S0014-5793(98)00511-0; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; HUNYADY L, 1995, J BIOL CHEM, V270, P9702, DOI 10.1074/jbc.270.17.9702; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Karlsen TH, 2010, DIGEST LIVER DIS, V42, P390, DOI 10.1016/j.dld.2010.01.011; Karlsen TH, 2010, CURR OPIN GASTROEN, V26, P251, DOI 10.1097/MOG.0b013e328336807d; Karlsen TH, 2010, GASTROENTEROLOGY, V138, P1102, DOI 10.1053/j.gastro.2009.11.046; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2008, BIOCHEM BIOPH RES CO, V372, P78, DOI 10.1016/j.bbrc.2008.04.171; Keitel V, 2007, HEPATOLOGY, V45, P695, DOI 10.1002/hep.21458; Keitel V, 2009, HEPATOLOGY, V50, P861, DOI 10.1002/hep.23032; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Maruyama T, 2006, J ENDOCRINOL, V191, P197, DOI 10.1677/joe.1.06546; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; O'Mahony CA, 2006, SEMIN LIVER DIS, V26, P3, DOI 10.1055/s-2006-933559; Pall H, 2007, J PEDIATR-US, V151, P255, DOI 10.1016/j.jpeds.2007.03.062; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sato H, 2008, J MED CHEM, V51, P1831, DOI 10.1021/jm7015864; Sheth S, 2003, HUM GENET, V113, P286, DOI 10.1007/s00439-003-0963-z; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Tobler Andreas R, 2005, J Biomol Tech, V16, P398; Vassileva G, 2006, BIOCHEM J, V398, P423, DOI 10.1042/BJ20060537; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005; WIESNER RH, 1980, GASTROENTEROLOGY, V79, P200	51	91	92	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12403	10.1371/journal.pone.0012403	http://dx.doi.org/10.1371/journal.pone.0012403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811628	Green Submitted, Green Published, gold			2022-12-27	WOS:000281234700026
J	Katanayeva, N; Kopein, D; Portmann, R; Hess, D; Katanaev, VL				Katanayeva, Natalya; Kopein, Damir; Portmann, Reto; Hess, Daniel; Katanaev, Vladimir L.			Competing Activities of Heterotrimeric G Proteins in Drosophila Wing Maturation	PLOS ONE			English	Article							TRIMERIC G-PROTEIN; ASYMMETRIC CELL-DIVISION; SIGNALING PATHWAY; ALPHA; MELANOGASTER; ACTIVATION; EXPRESSION; SUBUNIT; DEATH; GENE	Drosophila genome encodes six alpha-subunits of heterotrimeric G proteins. The G alpha s alpha-subunit is involved in the post-eclosion wing maturation, which consists of the epithelial-mesenchymal transition and cell death, accompanied by unfolding of the pupal wing into the firm adult flight organ. Here we show that another alpha-subunit G alpha o can specifically antagonize the G alpha s activities by competing for the G beta 13F/G gamma 1 subunits of the heterotrimeric Gs protein complex. Loss of G beta 13F, G gamma 1, or G alpha s, but not any other G protein subunit, results in prevention of post-eclosion cell death and failure of the wing expansion. However, cell death prevention alone is not sufficient to induce the expansion defect, suggesting that the failure of epithelial-mesenchymal transition is key to the folded wing phenotypes. Overactivation of G alpha s with cholera toxin mimics expression of constitutively activated G alpha s and promotes wing blistering due to precocious cell death. In contrast, co-overexpression of G beta 13F and G gamma 1 does not produce wing blistering, revealing the passive role of the G beta gamma in the G alpha s mediated activation of apoptosis, but hinting at the possible function of G beta gamma in the epithelial-mesenchymal transition. Our results provide a comprehensive functional analysis of the heterotrimeric G protein proteome in the late stages of Drosophila wing development.	[Katanayeva, Natalya; Kopein, Damir; Katanaev, Vladimir L.] Univ Konstanz, Dept Biol, Constance, Germany; [Portmann, Reto; Hess, Daniel] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Katanaev, Vladimir L.] Russian Acad Sci, Inst Prot Res, Pushchino 142292, Russia	University of Konstanz; Friedrich Miescher Institute for Biomedical Research; Russian Academy of Sciences	Katanayeva, N (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.	vladimir.katanaev@uni-konstanz.de	Katanaev, Vladimir/F-9480-2014; Portmann, Reto/K-9122-2017	Katanaev, Vladimir/0000-0002-7909-5617; Portmann, Reto/0000-0001-8979-7439; Kopein, Damir/0000-0003-1176-5829	Deutsche Forschungsgemeinschaft [TR-SFB11, KA2721/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was funded by TR-SFB11 and KA2721/1-1(Deutsche Forschungsgemeinschaft) to V. L. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brody T, 2000, J CELL BIOL, V150, pF83, DOI 10.1083/jcb.150.2.F83; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Chen CM, 1999, DEVELOPMENT, V126, P5441; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Dave RH, 2009, NEUROSIGNALS, V17, P100, DOI 10.1159/000186693; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DOLPH PJ, 1994, NATURE, V370, P59, DOI 10.1038/370059a0; Egger-Adam D, 2010, DEV DYNAM, V239, P168, DOI 10.1002/dvdy.22060; Ferris J, 2006, NAT NEUROSCI, V9, P1036, DOI 10.1038/nn1738; FITCH CL, 1993, CELL SIGNAL, V5, P187, DOI 10.1016/0898-6568(93)90070-3; Fremion E, 1999, J CELL BIOL, V145, P1063, DOI 10.1083/jcb.145.5.1063; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; HAY BA, 1994, DEVELOPMENT, V120, P2121; Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; JOHNSON SA, 1987, TISSUE CELL, V19, P505, DOI 10.1016/0040-8166(87)90044-9; Kalidas S, 2002, NEURON, V33, P177, DOI 10.1016/S0896-6273(02)00560-3; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Katanaev VL, 2006, P NATL ACAD SCI USA, V103, P6524, DOI 10.1073/pnas.0601853103; Katanaev VL, 2006, CELL CYCLE, V5, P2464, DOI 10.4161/cc.5.21.3410; Katanaev VL, 2007, BIOCHEM J, V401, P485, DOI 10.1042/BJ20060517; Kiger JA, 2007, DEV BIOL, V301, P178, DOI 10.1016/j.ydbio.2006.08.011; Kimura KI, 2004, DEVELOPMENT, V131, P1597, DOI 10.1242/dev.01049; Kopein D, 2009, MOL BIOL CELL, V20, P3865, DOI 10.1091/mbc.E09-01-0021; Lunde K, 1998, DEVELOPMENT, V125, P4145; Malbon CC, 2005, NAT REV MOL CELL BIO, V6, P689, DOI 10.1038/nrm1716; McIntire WE, 2009, NEUROSIGNALS, V17, P82, DOI 10.1159/000186692; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; MOSS J, 1988, ADV ENZYMOL RAMB, V61, P303; Natzle JE, 2008, GENETICS, V180, P885, DOI 10.1534/genetics.108.092908; Neumann CJ, 1996, DEVELOPMENT, V122, P1781; OGDEN SK, 2008, NATURE; PARKS S, 1991, CELL, V64, P447, DOI 10.1016/0092-8674(91)90652-F; QUAN F, 1993, P NATL ACAD SCI USA, V90, P4236, DOI 10.1073/pnas.90.9.4236; Ratnaparkhi A, 2002, J NEUROSCI, V22, P4499, DOI 10.1523/JNEUROSCI.22-11-04499.2002; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Schulz S, 1999, J BIOL CHEM, V274, P37605, DOI 10.1074/jbc.274.53.37605; Schwabe T, 2005, CELL, V123, P133, DOI 10.1016/j.cell.2005.08.037; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WOLFGANG WJ, 1990, J NEUROSCI, V10, P1014; Wolfgang WJ, 1996, P NATL ACAD SCI USA, V93, P14542, DOI 10.1073/pnas.93.25.14542; Wolfgang WJ, 2004, DEV BIOL, V268, P295, DOI 10.1016/j.ydbio.2004.01.007; Wolfgang WJ, 2001, GENETICS, V158, P1189; Yi P, 2008, DEV CELL, V15, P704, DOI 10.1016/j.devcel.2008.10.001; Yi P, 2006, SCIENCE, V313, P1301, DOI 10.1126/science.1127704	49	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12331	10.1371/journal.pone.0012331	http://dx.doi.org/10.1371/journal.pone.0012331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808795	Green Published, gold, Green Submitted			2022-12-27	WOS:000281153500013
J	Nantajit, D; Fan, M; Duru, N; Wen, YF; Reed, JC; Li, JJ				Nantajit, Danupon; Fan, Ming; Duru, Nadire; Wen, Yunfei; Reed, John C.; Li, Jian Jian			Cyclin B1/Cdk1 Phosphorylation of Mitochondrial p53 Induces Anti-Apoptotic Response (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							BREAST-CANCER CELLS; PROTEIN-KINASE; IONIZING-RADIATION; DNA-BINDING; TRANSLOCATION; ARREST; B1; LOCALIZATION; ACTIVATION; EXPRESSION	The pro-apoptotic function of p53 has been well defined in preventing genomic instability and cell transformation. However, the intriguing fact that p53 contributes to a pro-survival advantage of tumor cells under DNA damage conditions raises a critical question in radiation therapy for the 50% human cancers with intact p53 function. Herein, we reveal an antiapoptotic role of mitochondrial p53 regulated by the cell cycle complex cyclin B1/Cdk1 in irradiated human colon cancer HCT116 cells with p53(+/+) status. Steady-state levels of p53 and cyclin B1/Cdk1 were identified in the mitochondria of many human and mouse cells, and their mitochondrial influx was significantly enhanced by radiation. The mitochondrial kinase activity of cyclin B1/Cdk1 was found to specifically phosphorylate p53 at Ser-315 residue, leading to enhanced mitochondrial ATP production and reduced mitochondrial apoptosis. The improved mitochondrial function can be blocked by transfection of mutant p53 Ser-315-Ala, or by siRNA knockdown of cyclin B1 and Cdk1 genes. Enforced translocation of cyclin B1 and Cdk1 into mitochondria with a mitochondrial-targeting-peptide increased levels of Ser-315 phosphorylation on mitochondrial p53, improved ATP production and decreased apoptosis by sequestering p53 from binding to Bcl-2 and Bcl-xL. Furthermore, reconstitution of wild-type p53 in p53-deficient HCT116 p53(-/-) cells resulted in an increased mitochondrial ATP production and suppression of apoptosis. Such phenomena were absent in the p53-deficient HCT116 p53(-/-) cells reconstituted with the mutant p53. These results demonstrate a unique anti-apoptotic function of mitochondrial p53 regulated by cyclin B1/Cdk1-mediated Ser-315 phosphorylation in p53-wild-type tumor cells, which may provide insights for improving the efficacy of anti-cancer therapy, especially for tumors that retain p53.	[Nantajit, Danupon; Fan, Ming; Duru, Nadire; Li, Jian Jian] Univ Calif Davis, Dept Radiat Oncol, Sacramento, CA 95817 USA; [Wen, Yunfei; Reed, John C.] Sanford Burnham Med Res Inst, Program Cell Death & Apoptosis, La Jolla, CA USA; [Li, Jian Jian] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA	University of California System; University of California Davis; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Davis	Nantajit, D (corresponding author), Univ Calif Davis, Dept Radiat Oncol, Sacramento, CA 95817 USA.	jijli@ucdavis.edu	Nantajit, Danupon/CAF-7353-2022	Li, Jian Jian/0000-0003-3694-9675	National Institutes of Health [CA133402]; US Department of Energy Office of Science [DE-SC0001271]; NATIONAL CANCER INSTITUTE [R01CA152313, R01CA133402] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy Office of Science(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA133402 and the US Department of Energy Office of Science DE-SC0001271. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KM, 2008, ONCOGENE, V27, P6738, DOI 10.1038/onc.2008.265; Allan LA, 2007, MOL CELL, V26, P301, DOI 10.1016/j.molcel.2007.03.019; Bache M, 2001, INT J CANCER, V96, P110, DOI 10.1002/ijc.1002; Bakhanashvili M, 2008, CELL DEATH DIFFER, V15, P1865, DOI 10.1038/cdd.2008.122; BERNHARD EJ, 1994, RADIAT RES, V138, pS64, DOI 10.2307/3578764; BIARD DSF, 1994, CANCER RES, V54, P3361; BISCHOFF JR, 1990, P NATL ACAD SCI USA, V87, P4766, DOI 10.1073/pnas.87.12.4766; Blaydes JP, 2001, J BIOL CHEM, V276, P4699, DOI 10.1074/jbc.M003485200; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen DX, 2006, CANCER RES, V66, P3485, DOI 10.1158/0008-5472.CAN-05-4103; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Deveraux Quinn L., 2001, Cardiology Clinics, V19, P57; Essmann F, 2005, J BIOL CHEM, V280, P37169, DOI 10.1074/jbc.M502052200; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Ferecatu I, 2009, BIOCHEM BIOPH RES CO, V387, P772, DOI 10.1016/j.bbrc.2009.07.111; Finley NL, 2004, J BIOL CHEM, V279, P54833, DOI 10.1074/jbc.M408304200; Fuster JJ, 2007, TRENDS MOL MED, V13, P192, DOI 10.1016/j.molmed.2007.03.002; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HARLEY ME, 2010, EMBO J; Hassan KA, 2002, CANCER RES, V62, P6414; Helton ES, 2007, J CELL BIOCHEM, V100, P883, DOI 10.1002/jcb.21091; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Kirsch DG, 2010, SCIENCE, V327, P593, DOI 10.1126/science.1166202; Kojima K, 2009, CANCER SCI, V100, P1128, DOI 10.1111/j.1349-7006.2009.01150.x; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Li ZK, 2001, RADIAT RES, V155, P543, DOI 10.1667/0033-7587(2001)155[0543:EGAIMH]2.0.CO;2; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Maity A, 1996, ONCOGENE, V13, P1647; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; MARCOTE MJ, 1993, MOL CELL BIOL, V13, P5122, DOI 10.1128/MCB.13.8.5122; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Murphy ME, 2004, CELL CYCLE, V3, P836; MUSCHEL RJ, 1991, CANCER RES, V51, P5113; Nemajerova A, 2005, FEBS LETT, V579, P6079, DOI 10.1016/j.febslet.2005.09.074; Nemajerova A, 2005, CELL DEATH DIFFER, V12, P197, DOI 10.1038/sj.cdd.4401526; O'Connor DS, 2000, P NATL ACAD SCI USA, V97, P13103, DOI 10.1073/pnas.240390697; Ozeki M, 2004, ANTICANCER RES, V24, P2657; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Park JY, 2009, CIRC RES, V105, P705, DOI 10.1161/CIRCRESAHA.109.205310; RIZZUTO R, 1995, CURR BIOL, V5, P635, DOI 10.1016/S0960-9822(95)00128-X; RIZZUTO R, 1989, J BIOL CHEM, V264, P10595; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; Saleem A, 2009, PHYSIOL GENOMICS, V37, P58, DOI 10.1152/physiolgenomics.90346.2008; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Sansome C, 2001, FEBS LETT, V488, P110, DOI 10.1016/S0014-5793(00)02368-1; Song YM, 2008, CARCINOGENESIS, V29, P307, DOI 10.1093/carcin/bgm269; Su ZZ, 2006, ONCOGENE, V25, P2339, DOI 10.1038/sj.onc.1209271; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Tedeschi A, 2009, EMBO REP, V10, P576, DOI 10.1038/embor.2009.89; Terrano DT, 2010, MOL CELL BIOL, V30, P640, DOI 10.1128/MCB.00882-09; TISHLER RB, 1993, CANCER RES, V53, P2212; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Vousden KH, 2010, P NATL ACAD SCI USA, V107, P7117, DOI 10.1073/pnas.1002656107; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; Xia LQ, 2004, CANCER RES, V64, P221, DOI 10.1158/0008-5472.CAN-03-0969; Yoshida Y, 2003, CANCER RES, V63, P3729; Yuan JP, 2004, ONCOGENE, V23, P5843, DOI 10.1038/sj.onc.1207757; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zhao YF, 2005, CANCER RES, V65, P3745, DOI 10.1158/0008-5472.CAN-04-3835; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	66	42	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12341	10.1371/journal.pone.0012341	http://dx.doi.org/10.1371/journal.pone.0012341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808790	Green Submitted, gold, Green Published			2022-12-27	WOS:000281153500021
J	Kemper, K; Tol, MJPM; Medema, JP				Kemper, Kristel; Tol, Marc J. P. M.; Medema, Jan Paul			Mouse Tissues Express Multiple Splice Variants of Prominin-1	PLOS ONE			English	Article							HUMAN HEMATOPOIETIC STEM; CD133 EXPRESSION; CELL ANTIGEN; AC133; PROTEIN; MARKER; PROMOTER; MUTATION; GROWTH; GENE	Prominin-1, a heavily glycosylated pentaspan membrane protein, is mainly known for its function as a marker for (cancer) stem cells, although it can also be detected on differentiated cells. Mouse prominin-1 expression is heavily regulated by splicing in eight different variants. The function or the expression pattern of prominin-1 and its splice variants (SVs) is thus far unknown. In this study, we analyzed the expression of the prominin-1 splice variants on mRNA level in several mouse tissues and found a broad tissue expression of the majority of SVs, but a specific set of SVs had a much more restricted expression profile. For instance, the testis expressed only SV3 and SV7. Moreover, SV8 was solely detected in the eye. Intriguingly, prominin-1 knockout mice do not suffer from gross abnormalities, but do show signs of blindness, which suggest that SV8 has a specific function in this tissue. In addition, databases searches for putative promoter regions in the mouse prominin-1 gene revealed three potential promoter regions that could be linked to specific SVs. Interestingly, for both SV7 and SV8, a specific potential promoter region could be identified. To conclude, the majority of mouse prominin-1 splice variants are widely expressed in mouse tissues. However, specific expression of a few variants, likely driven by specific promoters, suggests distinct regulation and a potential important function for these variants in certain tissues.	[Kemper, Kristel; Tol, Marc J. P. M.; Medema, Jan Paul] Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol Med, LEXOR Lab Expt Oncol & Radiobiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Kemper, K (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol Med, LEXOR Lab Expt Oncol & Radiobiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	k.kemper@amc.uva.nl		Medema, Jan Paul/0000-0003-3045-2924; Tol, Marcus/0000-0002-8312-699X	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO); Academic Medical Center Graduate School	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); Academic Medical Center Graduate School	This work was supported by a Vici grant of the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) (Jan Paul Medema) and a scholarship of the Academic Medical Center Graduate School (Kristel Kemper). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boivin D, 2009, BIOCHEMISTRY-US, V48, P3998, DOI 10.1021/bi900159d; Bots M, 2005, BLOOD, V105, P1153, DOI 10.1182/blood-2004-03-0791; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; CORBEIL D, 2009, EXPRESSION DISTINCT; Fargeas CA, 2007, TISSUE ANTIGENS, V69, P602, DOI 10.1111/j.1399-0039.2007.00825.x; Fargeas CA, 2004, J CELL SCI, V117, P4301, DOI 10.1242/jcs.01315; Florek M, 2005, CELL TISSUE RES, V319, P15, DOI 10.1007/s00441-004-1018-z; Immervoll H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-48; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Maw MA, 2000, HUM MOL GENET, V9, P27, DOI 10.1093/hmg/9.1.27; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; OH H, 2005, INVESTIGATIVE OPHTHA, V46; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; SARGE KD, 1994, BIOL REPROD, V50, P1334, DOI 10.1095/biolreprod50.6.1334; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Shmelkov SV, 2004, BLOOD, V103, P2055, DOI 10.1182/blood-2003-06-1881; Singh SK, 2004, NEURO-ONCOLOGY, V6, P348; SNIPPERT H, 2009, GASTROENTEROLOGY; Tabu K, 2008, CELL RES, V18, P1037, DOI 10.1038/cr.2008.270; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Wilkerson DC, 2008, BIOL REPROD, V79, P283, DOI 10.1095/biolreprod.107.066241; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Yi JM, 2008, CANCER RES, V68, P8094, DOI 10.1158/0008-5472.CAN-07-6208; Yin A, 1997, EXP HEMATOL, V25, P523; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zhang QJ, 2007, HUM GENET, V122, P293, DOI 10.1007/s00439-007-0395-2; ZHU L, 2008, NATURE	30	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12325	10.1371/journal.pone.0012325	http://dx.doi.org/10.1371/journal.pone.0012325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808829	Green Submitted, Green Published, gold			2022-12-27	WOS:000281077000015
J	Conde, E; Angulo, B; Redondo, P; Toldos, O; Garcia-Garcia, E; Suarez-Gauthier, A; Rubio-Viqueira, B; Marron, C; Garcia-Lujan, R; Sanchez-Cespedes, M; Lopez-Encuentra, A; Paz-Ares, L; Lopez-Rios, F				Conde, Esther; Angulo, Barbara; Redondo, Pilar; Toldos, Oscar; Garcia-Garcia, Elena; Suarez-Gauthier, Ana; Rubio-Viqueira, Belen; Marron, Carmen; Garcia-Lujan, Ricardo; Sanchez-Cespedes, Montse; Lopez-Encuentra, Angel; Paz-Ares, Luis; Lopez-Rios, Fernando			The Use of P63 Immunohistochemistry for the Identification of Squamous Cell Carcinoma of the Lung	PLOS ONE			English	Article							TISSUE MICROARRAY; GENE-EXPRESSION; PHASE-III; CANCER; ADENOCARCINOMA; CLASSIFICATION; OVEREXPRESSION; CARBOPLATIN; PACLITAXEL; SIGNATURES	Introduction: While some targeted agents should not be used in squamous cell carcinomas (SCCs), other agents might preferably target SCCs. In a previous microarray study, one of the top differentially expressed genes between adenocarcinomas (ACs) and SCCs is P63. It is a well-known marker of squamous differentiation, but surprisingly, its expression is not widely used for this purpose. Our goals in this study were (1) to further confirm our microarray data, (2) to analize the value of P63 immunohistochemistry (IHC) in reducing the number of large cell carcinoma (LCC) diagnoses in surgical specimens, and (3) to investigate the potential of P63 IHC to minimize the proportion of "carcinoma NOS (not otherwise specified)'' in a prospective series of small tumor samples. Methods: With these goals in mind, we studied (1) a tissue-microarray comprising 33 ACs and 99 SCCs on which we performed P63 IHC, (2) a series of 20 surgically resected LCCs studied for P63 and TTF-1 IHC, and (3) a prospective cohort of 66 small thoracic samples, including 32 carcinoma NOS, that were further classified by the result of P63 and TTF-1 IHC. Results: The results in the three independent cohorts were as follows: (1) P63 IHC was differentially expressed in SCCs when compared to ACs (p<0.0001); (2) half of the 20 (50%) LCCs were positive for P63 and were reclassified as SCCs; and (3) all P63 positive cases (34%) were diagnosed as SCCs. Conclusions: P63 IHC is useful for the identification of lung SCCs.	[Conde, Esther; Angulo, Barbara; Redondo, Pilar; Garcia-Garcia, Elena; Suarez-Gauthier, Ana; Lopez-Rios, Fernando] Univ San Pablo, CEU, Lab Dianas Terapeut, Ctr Integral Oncol Clara Campal,Hosp Univ Madrid, Madrid, Spain; [Toldos, Oscar] Pathol Thorac Surg & Hosp Univ 12 Octubre, Madrid, Spain; [Rubio-Viqueira, Belen] Univ San Pablo, CEU, Dept Oncol, Hosp Univ Madrid Sanchinarro, Madrid, Spain; [Garcia-Lujan, Ricardo; Lopez-Encuentra, Angel] Hosp Univ 12 Octubre, Dept Pulm, Madrid, Spain; [Sanchez-Cespedes, Montse] Hop Llobregat, Genes & Canc Grp, PEBC, IDIBELL, Barcelona, Spain; [Paz-Ares, Luis] Inst Biomed Sevilla, Dept Oncol, Seville, Spain; [Paz-Ares, Luis] Hosp Univ Virgen Rocio, Seville, Spain	San Pablo CEU University; Hospital Universitario 12 de Octubre; San Pablo CEU University; Hospital Universitario 12 de Octubre; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Conde, E (corresponding author), Univ San Pablo, CEU, Lab Dianas Terapeut, Ctr Integral Oncol Clara Campal,Hosp Univ Madrid, Madrid, Spain.	flopezrios@hospitaldemadrid.com	Diez Redondo, Pilar/GQZ-7708-2022; Paz-Ares, Luis/AAH-2750-2019; Sanchez-Cespedes, Montse/H-8485-2012	Sanchez-Cespedes, Montse/0000-0002-6045-5627; Lopez-Encuentra, Angel/0000-0003-1285-0777	Fundacion Mutua Madrilena; CIBER Respiratory Disease [ISCIII-CB06/06]; Red Tematica de Investigacion Cooperativa en Cancer (RTICC) [RD06/0020/0062]	Fundacion Mutua Madrilena(Instituto de Salud Carlos III); CIBER Respiratory Disease; Red Tematica de Investigacion Cooperativa en Cancer (RTICC)	This work was partially funded by grants from Fundacion Mutua Madrilena to EC, FLR, and LPA; CIBER Respiratory Disease to ALE (ISCIII-CB06/06); and Red Tematica de Investigacion Cooperativa en Cancer (RTICC) to MSC (RD06/0020/0062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatschek S, 2004, CANCER RES, V64, P844, DOI 10.1158/0008-5472.CAN-03-2361; ANG DC, 2010, EXPRESSION SQUAMOUS; Angulo B, 2008, J PATHOL, V214, P347, DOI 10.1002/path.2267; Au NHC, 2004, APPL IMMUNOHISTO M M, V12, P240, DOI 10.1097/00129039-200409000-00010; Au NHC, 2004, J PATHOL, V204, P101, DOI 10.1002/path.1612; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Borczuk AC, 2003, AM J PATHOL, V163, P1949, DOI 10.1016/S0002-9440(10)63553-5; BRAMBILLA E, 2004, WHO CLASSIFICATION T, P45; Camilo R, 2006, HUM PATHOL, V37, P542, DOI 10.1016/j.humpath.2005.12.019; de Marinis F, 2008, J THORAC ONCOL, V3, P30, DOI 10.1097/JTO.0b013e31815e8b48; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Hayes DN, 2006, J CLIN ONCOL, V24, P5079, DOI 10.1200/JCO.2005.05.1748; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Johansson Leif, 2004, Ann Diagn Pathol, V8, P259, DOI 10.1016/j.anndiagpath.2004.07.001; Kargi A, 2007, APPL IMMUNOHISTO M M, V15, P415, DOI 10.1097/PAI.0b013e31802fab75; Karp DD, 2009, J CLIN ONCOL, V27, P2516, DOI 10.1200/JCO.2008.19.9331; Kaufmann O, 2001, AM J CLIN PATHOL, V116, P823; Kim DH, 2010, ACTA CYTOL, V54, P55, DOI 10.1159/000324967; Lebanony D, 2009, J CLIN ONCOL, V27, P2030, DOI 10.1200/JCO.2008.19.4134; Massion PP, 2003, CANCER RES, V63, P7113; Monica V, 2009, MODERN PATHOL, V22, P709, DOI 10.1038/modpathol.2009.30; Nylander K, 2002, J PATHOL, V198, P417, DOI 10.1002/path.1231; Pelosi G, 2002, J PATHOL, V198, P100, DOI 10.1002/path.1166; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ring BZ, 2009, MODERN PATHOL, V22, P1032, DOI 10.1038/modpathol.2009.60; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Rossi G, 2009, J CLIN ONCOL, V27, pE141, DOI 10.1200/JCO.2009.24.0515; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Shah RB, 2004, AM J CLIN PATHOL, V122, P517, DOI 10.1309/WRM51C70P1NBFE4K; Sheikh HA, 2004, MODERN PATHOL, V17, P1134, DOI 10.1038/modpathol.3800163; Shimada Y, 2009, CANCER SCI, V100, P2054, DOI 10.1111/j.1349-7006.2009.01295.x; Tan DF, 2003, HUM PATHOL, V34, P597, DOI 10.1016/S0046-8177(03)00180-1; Ullmann R, 2004, J PATHOL, V203, P798, DOI 10.1002/path.1584; Wang BY, 2002, HUM PATHOL, V33, P921, DOI 10.1053/hupa.2002.126878; Werling RW, 2003, AM J SURG PATHOL, V27, P82, DOI 10.1097/00000478-200301000-00009; Wu MX, 2003, AM J CLIN PATHOL, V119, P696, DOI 10.1309/XCP6EWPB3BMRKA; Yamagata N, 2003, CLIN CANCER RES, V9, P4695	38	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12209	10.1371/journal.pone.0012209	http://dx.doi.org/10.1371/journal.pone.0012209			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808915	gold, Green Submitted, Green Published			2022-12-27	WOS:000280968100013
J	Gerber, LR; Gonzalez-Suarez, M; Hernandez-Camacho, CJ; Young, JK; Sabo, JL				Gerber, Leah R.; Gonzalez-Suarez, Manuela; Hernandez-Camacho, Claudia J.; Young, Julie K.; Sabo, John L.			The Cost of Male Aggression and Polygyny in California Sea Lions (Zalophus californianus)	PLOS ONE			English	Article							ANTARCTIC FUR SEALS; GULF-OF-CALIFORNIA; FELIS-CATUS L; REPRODUCTIVE SUCCESS; SEXUAL SELECTION; AGONISTIC INTERACTIONS; ARCTOCEPHALUS-GAZELLA; MALE HARASSMENT; MATING SUCCESS; BEHAVIOR	In polygynous mating systems, males often increase their fecundity via aggressive defense of mates and/or resources necessary for successful mating. Here we show that both male and female reproductive behavior during the breeding season (June-August) affect female fecundity, a vital rate that is an important determinant of population growth rate and viability. By using 4 years of data on behavior and demography of California sea lions (Zalophus californianus), we found that male behavior and spatial dynamics-aggression and territory size-are significantly related to female fecundity. Higher rates of male aggression and larger territory sizes were associated with lower estimates of female fecundity within the same year. Female aggression was significantly and positively related to fecundity both within the same year as the behavior was measured and in the following year. These results indicate that while male aggression and defense of territories may increase male fecundity, such interactions may cause a reduction in the overall population growth rate by lowering female fecundity. Females may attempt to offset male-related reductions in female fecundity by increasing their own aggression-perhaps to defend pups from incidental injury or mortality. Thus in polygynous mating systems, male aggression may increase male fitness at the cost of female fitness and overall population viability.	[Gerber, Leah R.; Gonzalez-Suarez, Manuela; Hernandez-Camacho, Claudia J.; Young, Julie K.; Sabo, John L.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Gonzalez-Suarez, Manuela] Univ Paris 06, CNRS, UMR 7625, Lab Ecol & Evolut, Paris, France	Arizona State University; Arizona State University-Tempe; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Gerber, LR (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	leah.gerber@asu.edu	Camacho, Claudia J. Hernández/Q-8914-2018; González-Suárez, Manuela/B-9740-2008	Camacho, Claudia J. Hernández/0000-0002-6309-9728; González-Suárez, Manuela/0000-0001-5069-8900; Gerber, Leah/0000-0002-6763-6842; Young, Julie/0000-0003-4522-0157	National Science Foundation (NSF) [0347960]; National Center for Ecological Analysis and Synthesis (NCEAS); European Community [FP7/2007-2013, 235897]; Spanish Ministry of Science and Innovation [CGL2009-07301/BOS]	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); National Center for Ecological Analysis and Synthesis (NCEAS); European Community(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the National Science Foundation (NSF), Grant No. 0347960. LRG was supported as a National Center for Ecological Analysis and Synthesis (NCEAS) sabbatical fellow while writing this paper. MGS was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 235897, and the Spanish Ministry of Science and Innovation (Project: CGL2009-07301/BOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1973, 2 S INF THEOR BUD AK; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; ALVAREZ F, 1993, CAN J ZOOL, V71, P376, DOI 10.1139/z93-052; ARNOLD SJ, 1994, AM NAT, V143, P317, DOI 10.1086/285606; BALDI RC, 1996, ANIMAL BEHAV, V51; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BESTER MN, 1994, S AFR J ZOOL, V29, P168; BONESS DJ, 1995, BEHAV ECOL SOCIOBIOL, V36, P1; BONNELL ML, 1987, J WILDLIFE MANAGE, V51, P13, DOI 10.2307/3801621; BOWEN WD, 1991, BEHAV ECOLOGY PINNIP; Bradshaw CJA, 2002, ICES J MAR SCI, V59, P770, DOI 10.1006/jmsc.2002.1246; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cassini MH, 2003, CAN J ZOOL, V81, P1154, DOI 10.1139/Z03-098; Cassini MH, 2001, MAMMAL REV, V31, P169, DOI 10.1046/j.1365-2907.2001.00084.x; Cassini MH, 1999, BEHAV ECOL, V10, P612, DOI 10.1093/beheco/10.5.612; Caswell, 2000, MATRIX POPULATION MO; Chilvers BL, 2005, CAN J ZOOL, V83, P642, DOI 10.1139/Z05-048; Clutton-Brock T.H., 1982, BEHAV ECOLOGY 2 SEXE; CLUTTONBROCK TH, 1989, P ROY SOC LOND B BIO, V236, P158; DOIDGE DW, 1984, J ZOOL, V202, P449, DOI 10.1111/j.1469-7998.1984.tb05095.x; Duckworth RA, 2006, BEHAV ECOL, V17, P1011, DOI 10.1093/beheco/arl035; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; FERNANDEZ G, 2007, GLOBAL SAS FORUM, V191; FRANCIS JM, 1987, INTERFEMALE AGGRESSI; Garcia-Aguilar Maria Concepcion, 2003, Aquatic Mammals, V29, P67, DOI 10.1578/016754203101024086; Gemmell NJ, 2001, MOL ECOL, V10, P451, DOI 10.1046/j.1365-294x.2001.01186.x; Gerber LR, 2006, FRONT ECOL ENVIRON, V4, P419, DOI 10.1890/1540-9295(2006)4[419:IBDIDM]2.0.CO;2; HARCOURT R, 1992, CAN J ZOOL, V70, P320, DOI 10.1139/z92-048; Heath C, 1989, THESIS U CALIFORNIA; Hernandez-Camacho CJ, 2008, MAR MAMMAL SCI, V24, P664, DOI 10.1111/j.1748-7692.2008.00199.x; HIRUKI LM, 1993, CAN J ZOOL, V71, P469, DOI 10.1139/z93-067; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Jacobs DF, 2008, J MAMMAL, V89, P1212, DOI 10.1644/07-MAMM-A-171.1; le Boeuf B.J., 1983, Proceedings of the California Academy of Sciences, V43, P77; Le Galliard JF, 2005, P NATL ACAD SCI USA, V102, P18231, DOI 10.1073/pnas.0505172102; LEBOEUF BJ, 1977, MAMMALIA, V41, P167, DOI 10.1515/mamm.1977.41.2.167; Lewis S, 2006, OECOLOGIA, V147, P606, DOI 10.1007/s00442-005-0321-z; MACKENZIE A, 1995, AM NAT, V145, P633, DOI 10.1086/285759; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; MCCANN TS, 1980, J ZOOL, V192, P295; MELIN SR, 2002, THESIS U MINNESOTA; Milner-Gulland EJ, 2003, NATURE, V422, P135, DOI 10.1038/422135a; Mysterud A, 2002, J ANIM ECOL, V71, P907, DOI 10.1046/j.1365-2656.2002.00655.x; NATOLI E, 1990, ANIM BEHAV, V40, P183, DOI 10.1016/S0003-3472(05)80679-7; NATOLI E, 1991, ANIM BEHAV, V42, P227, DOI 10.1016/S0003-3472(05)80554-8; Ono KA, 1996, BEHAV ECOL SOCIOBIOL, V38, P31, DOI 10.1007/s002650050214; PACKER C, 1983, INFANTICIDE ANIMALS; Peterson RS, 1967, NATURAL HIST BEHAV C, V1; Porschmann U, 2010, MOL ECOL, V19, P2574, DOI 10.1111/j.1365-294X.2010.04665.x; PONTIER D, 1995, OIKOS, V73, P299, DOI 10.2307/3545954; Rankin DJ, 2007, OIKOS, V116, P335, DOI [10.1111/j.2006.0030-1299.15451.x, 10.1111/j.0030-1299.2007.15451.x]; Renison D, 2003, WILSON BULL, V115, P58, DOI 10.1676/02-040; RIEDMAN M, 1990, PINNIPEDS SEALS SEA; Robertson KL, 2008, CAN J ZOOL, V86, P237, DOI 10.1139/Z07-136; *SAS I, 2008, SAS SYST WIND VERS 9; SINGER F, 1995, BEHAV ECOL SOCIOBIOL, V36, P313, DOI 10.1007/BF00167792; SMITH JNM, 1982, AUK, V99, P555; Trillmich F., 1991, PINNIPEDS EL NINO RE, P293; Trivers R, 1972, PARENTAL INVESTMENT; Tuljapurkar SD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000785; WADE MJ, 1979, AM NAT, V114, P742, DOI 10.1086/283520; WADE MJ, 1980, ANIM BEHAV, V28, P446, DOI 10.1016/S0003-3472(80)80052-2; Wilkinson IS, 2000, MAR MAMMAL SCI, V16, P494, DOI 10.1111/j.1748-7692.2000.tb00942.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Yoccoz NG, 2002, P ROY SOC B-BIOL SCI, V269, P1523, DOI 10.1098/rspb.2002.2047; Young JK, 2008, BEHAVIOUR, V145, P1797, DOI 10.1163/156853908786279646; Young Julie K., 2008, Aquatic Mammals, V34, P102, DOI 10.1578/AM.34.1.2008.102	67	13	14	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12230	10.1371/journal.pone.0012230	http://dx.doi.org/10.1371/journal.pone.0012230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808931	Green Submitted, gold, Green Published			2022-12-27	WOS:000280968100026
J	Vanaerschot, M; Maes, I; Ouakad, M; Adaui, V; Maes, L; De Doncker, S; Rijal, S; Chappuis, F; Dujardin, JC; Decuypere, S				Vanaerschot, Manu; Maes, Ilse; Ouakad, Meriem; Adaui, Vanessa; Maes, Louis; De Doncker, Simonne; Rijal, Suman; Chappuis, Francois; Dujardin, Jean-Claude; Decuypere, Saskia			Linking In Vitro and In Vivo Survival of Clinical Leishmania donovani Strains	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; SODIUM STIBOGLUCONATE; ANTIMONY; RESISTANCE; SUSCEPTIBILITY; MECHANISMS; METACYCLOGENESIS; SIGNALS; PCR	Background: Leishmania donovani is an intracellular protozoan parasite that causes a lethal systemic disease, visceral leishmaniasis (VL), and is transmitted between mammalian hosts by phlebotomine sandflies. Leishmania expertly survives in these 'hostile' environments with a unique redox system protecting against oxidative damage, and host manipulation skills suppressing oxidative outbursts of the mammalian host. Treating patients imposes an additional stress on the parasite and sodium stibogluconate (SSG) was used for over 70 years in the Indian subcontinent. Methodology/Principal Findings: We evaluated whether the survival capacity of clinical L. donovani isolates varies significantly at different stages of their life cycle by comparing proliferation, oxidative stress tolerance and infection capacity of 3 Nepalese L. donovani strains in several in vitro and in vivo models. In general, the two strains that were resistant to SSG, a stress encountered in patients, attained stationary phase at a higher parasite density, contained a higher amount of metacyclic parasites and had a greater capacity to cause in vivo infection in mice compared to the SSG-sensitive strain. Conclusions/Significance: The 2 SSG-resistant strains had superior survival skills as promastigotes and as amastigotes compared to the SSG-sensitive strain. These results could indicate that Leishmania parasites adapting successfully to antimonial drug pressure acquire an overall increased fitness, which stands in contrast to what is found for other organisms, where drug resistance is usually linked to a fitness cost. Further validation experiments are under way to verify this hypothesis.	[Vanaerschot, Manu; Maes, Ilse; Ouakad, Meriem; Adaui, Vanessa; De Doncker, Simonne; Dujardin, Jean-Claude; Decuypere, Saskia] Inst Trop Med, Unit Mol Parasitol, Dept Parasitol, B-2000 Antwerp, Belgium; [Vanaerschot, Manu; Maes, Louis; Dujardin, Jean-Claude] Univ Antwerp, Lab Microbiol Parasitol & Hyg, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Adaui, Vanessa] Univ Peruana Cayetano Heredia, Inst Trop Med Alexander von Humboldt, Lima, Peru; [Rijal, Suman] BP Koirala Inst Hlth Sci, Dept Internal Med, Dharan, Nepal; [Chappuis, Francois] Univ Hosp Geneva, Div Int & Humanitarian Med, Geneva, Switzerland; [Chappuis, Francois] Univ Geneva, Geneva, Switzerland	Institute of Tropical Medicine (ITM); University of Antwerp; Universidad Peruana Cayetano Heredia; B.P. Koirala Institute of Health Sciences; University of Geneva; University of Geneva	Vanaerschot, M (corresponding author), Inst Trop Med, Unit Mol Parasitol, Dept Parasitol, B-2000 Antwerp, Belgium.	jcdujardin@itg.be	Vanaerschot, Manu/B-6812-2013; Dujardin, Jean-Claude/AAO-1783-2021; Maes, Louis JRM/A-2384-2017; Adaui, Vanessa/AAU-7219-2020	Vanaerschot, Manu/0000-0002-9141-2347; Maes, Louis JRM/0000-0002-2324-9509; Decuypere, Saskia/0000-0001-5036-4601; Chappuis, Francois/0000-0003-0442-7610	EC [ICA4-CT-2001-10076, 222895]; FWO Flanders [G.0103.06, 1.5.147.09]; Agency for Innovation; Baillet-Latour Foundation	EC(European CommissionEuropean Commission Joint Research Centre); FWO Flanders(FWO); Agency for Innovation; Baillet-Latour Foundation	This research was funded by the EC-INCO-Dev project LeishNatDrug-R (contract ICA4-CT-2001-10076), the FWO Flanders (contract G.0103.06 and 1.5.147.09) and the EC-FP7 project Kaladrug-R (contract 222895). Manu Vanaerschot has a fellowship from the Agency for Innovation by Science and Technology in Flanders (IWT) and Saskia Decuypere has a grant from the Baillet-Latour Foundation. (EC:http://cordis.europa.eu/home_en.html, FWO Flanders: http://www.fwo.be/, IWT: http://www.iwt.be/, Baillet-Latour Foundation: http://www.inbevbailletlatour.com/.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; BANDYOPADHYAY P, 1991, J PARASITOL, V77, P411, DOI 10.2307/3283129; Basu JM, 2006, ANTIMICROB AGENTS CH, V50, P1788, DOI [10.1128/AAC.50.5.1788-1797.2006, 10.1128/AAC.50.5.1768-1797.2006]; Bates PA, 2004, CURR MOL MED, V4, P601, DOI 10.2174/1566524043360285; BERENS RL, 1976, J PARASITOL, V62, P360, DOI 10.2307/3279142; Bhardwaj S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/109189; Carter KC, 2005, PARASITOLOGY, V131, P747, DOI 10.1017/S0031182005008486; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; CUNNINGHAM ML, 1995, EUR J BIOCHEM, V230, P460, DOI 10.1111/j.1432-1033.1995.tb20583.x; DASILVA R, 1987, INFECT IMMUN, V55, P2802, DOI 10.1128/IAI.55.11.2802-2806.1987; Dominguez M, 2003, MICROBES INFECT, V5, P507, DOI 10.1016/S1286-4579(03)00071-6; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; Gomez MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000213; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Holzmuller P, 2005, ANTIMICROB AGENTS CH, V49, P4406, DOI 10.1128/AAC.49.10.4406-4409.2005; Kamhawi S, 2006, TRENDS PARASITOL, V22, P439, DOI 10.1016/j.pt.2006.06.012; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Kumar D, 2009, ANTIMICROB AGENTS CH, V53, P835, DOI 10.1128/AAC.01233-08; Laurent T, 2007, INFECT GENET EVOL, V7, P206, DOI 10.1016/j.meegid.2006.08.005; Lazazzera BA, 2000, CURR OPIN MICROBIOL, V3, P177, DOI 10.1016/S1369-5274(00)00072-2; Mandal G, 2007, PARASITOLOGY, V134, P1679, DOI 10.1017/S0031182007003150; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741; Nandan D, 2005, CLIN IMMUNOL, V114, P266, DOI 10.1016/j.clim.2004.07.017; Nandan D, 2007, BIOCHEM BIOPH RES CO, V364, P601, DOI 10.1016/j.bbrc.2007.10.065; Nicolas L, 2002, J CLIN MICROBIOL, V40, P1666, DOI 10.1128/JCM.40.5.1666-1669.2002; OUAKAD M, 2009, P 4 WORLD C LEISHM 2; Poljsak B, 2005, J APPL TOXICOL, V25, P535, DOI 10.1002/jat.1093; Rijal S, 2003, T ROY SOC TROP MED H, V97, P350, DOI 10.1016/S0035-9203(03)90167-2; Rijal S, 2007, MICROBES INFECT, V9, P529, DOI 10.1016/j.micinf.2007.01.009; Rolao N, 2004, ACTA TROP, V90, P123, DOI 10.1016/j.actatropica.2003.09.010; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Thakur CP, 2003, T ROY SOC TROP MED H, V97, P409, DOI 10.1016/S0035-9203(03)90071-X; Tintaya KWQ, 2004, J INFECT DIS, V189, P1035, DOI 10.1086/382049; van Meirvenne N., 1975, Annales Soc belge Med trop, V55, P1; Vassella E, 1997, J CELL SCI, V110, P2661; VINCENT SH, 1989, SEMIN HEMATOL, V26, P105; WHO, 2002, WORLD HLTH REP, P192; Wyllie S, 2004, J BIOL CHEM, V279, P39925, DOI 10.1074/jbc.M405635200; ZILBERSTEIN D, 1994, ANNU REV MICROBIOL, V48, P449, DOI 10.1146/annurev.mi.48.100194.002313	40	51	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12211	10.1371/journal.pone.0012211	http://dx.doi.org/10.1371/journal.pone.0012211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808916	gold, Green Published, Green Submitted			2022-12-27	WOS:000280968100015
J	Griffin, JT; Cairns, M; Ghani, AC; Roper, C; Schellenberg, D; Carneiro, I; Newman, RD; Grobusch, MP; Greenwood, B; Chandramohan, D; Gosling, RD				Griffin, Jamie T.; Cairns, Matthew; Ghani, Azra C.; Roper, Cally; Schellenberg, David; Carneiro, Ilona; Newman, Robert D.; Grobusch, Martin P.; Greenwood, Brian; Chandramohan, Daniel; Gosling, Roly D.			Protective Efficacy of Intermittent Preventive Treatment of Malaria in Infants (IPTi) Using Sulfadoxine-Pyrimethamine and Parasite Resistance	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; ANTIMALARIAL-DRUG RESISTANCE; PLASMODIUM-FALCIPARUM MALARIA; DIHYDROPTEROATE SYNTHASE GENE; MOLECULAR MARKERS; DOUBLE-BLIND; UNCOMPLICATED MALARIA; ROUTINE VACCINATIONS; COMBINATION THERAPY; MOZAMBICAN INFANTS	Background: Intermittent Preventive Treatment of malaria in infants using sulfadoxine-pyrimethamine (SP-IPTi) is recommended by WHO for implementation in settings where resistance to SP is not high. Here we examine the relationship between the protective efficacy of SP-IPTi and measures of SP resistance. Methods and Results: We analysed the relationship between protective efficacy reported in the 7 SP-IPTi trials and contemporaneous data from 6 in vivo efficacy studies using SP and 7 molecular studies reporting frequency of dhfr triple and dhps double mutations within 50km of the trial sites. We found a borderline significant association between frequency of the dhfr triple mutation and protective efficacy to 12 months of age of SP-IPTi. This association is significantly biased due to differences between studies, namely number of doses of SP given and follow up times. However, fitting a simple probabilistic model to determine the relationship between the frequency of the dhfr triple, dhps double and dhfr/dhps quintuple mutations associated with resistance to SP and protective efficacy, we found a significant inverse relationship between the dhfr triple mutation frequency alone and the dhfr/dhps quintuple mutations and efficacy at 35 days post the 9 month dose and up to 12 months of age respectively. Conclusions: A significant relationship was found between the frequency of the dhfr triple mutation and SP-IPTi protective efficacy at 35 days post the 9 month dose. An association between the protective efficacy to 12 months of age and dhfr triple and dhfr/dhps quintuple mutations was found but should be viewed with caution due to bias. It was not possible to define a more definite relationship based on the data available from these trials.	[Griffin, Jamie T.; Ghani, Azra C.] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London, England; [Cairns, Matthew; Roper, Cally; Schellenberg, David; Carneiro, Ilona; Greenwood, Brian; Chandramohan, Daniel; Gosling, Roly D.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Newman, Robert D.] Ctr Dis Control & Prevent, Malaria Branch, Atlanta, GA USA; [Grobusch, Martin P.] Univ Amsterdam, Dept Internal Med, Div Infect Dis Trop Med & AIDS, Amsterdam Med Ctr, Amsterdam, Netherlands; [Grobusch, Martin P.] Hosp Albert Schweitzer, Med Res Unit, Lambarene, Gabon	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Centers for Disease Control & Prevention - USA; University of Amsterdam; Academic Medical Center Amsterdam	Griffin, JT (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London, England.	Roly.Gosling@Gmail.com	Roper, Cally/K-2989-2013; Ghani, Azra/B-8560-2009	Roper, Cally/0000-0002-6545-309X; Ghani, Azra/0000-0002-0007-4910; Schellenberg, David/0000-0001-8222-0186	IPTi Consortium, Bill and Melinda Gates Foundation [38773]; Medical Research Council [G0600719B] Funding Source: researchfish	IPTi Consortium, Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the IPTi Consortium through a grant from the Bill and Melinda Gates Foundation grant number 38773. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abacassamo F, 2004, TROP MED INT HEALTH, V9, P200, DOI 10.1046/j.1365-3156.2003.01182.x; Alifrangis M, 2009, AM J TROP MED HYG, V80, P523, DOI 10.4269/ajtmh.2009.80.523; Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; BROOKS DR, 1994, EUR J BIOCHEM, V224, P397, DOI 10.1111/j.1432-1033.1994.00397.x; CAIRNS M, PLOS ONE, V5, pE9467; Cairns M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002227; Chandramohan D, 2005, BMJ-BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; COWMAN AF, 1988, P NATL ACAD SCI USA, V85, P9109, DOI 10.1073/pnas.85.23.9109; Gesase S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004569; Gosling RD, 2009, LANCET, V374, P1521, DOI 10.1016/S0140-6736(09)60997-1; Gosling RD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-54; Grobusch MP, 2007, CURR OPIN INFECT DIS, V20, P613, DOI 10.1097/QCO.0b013e3282f1ae3b; Grobusch MP, 2007, J INFECT DIS, V196, P1595, DOI 10.1086/522160; Karema C, 2010, ANTIMICROB AGENTS CH, V54, P477, DOI 10.1128/AAC.00498-09; Kobbe R, 2007, CLIN INFECT DIS, V45, pS16, DOI 10.1086/518575; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Laufer MK, 2007, AM J TROP MED HYG, V77, P160, DOI 10.4269/ajtmh.2007.77.160; Lynch C, 2008, J INFECT DIS, V197, P1598, DOI 10.1086/587845; Macete E, 2006, J INFECT DIS, V194, P276, DOI 10.1086/505431; Marks F, 2005, ANTIMICROB AGENTS CH, V49, P1101, DOI 10.1128/AAC.49.3.1101-1105.2005; May J, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-198; Mayor A, 2008, J INFECT DIS, V197, P1737, DOI 10.1086/588144; Mockenhaupt FP, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-42; Mockenhaupt FP, 2005, TROP MED INT HEALTH, V10, P512, DOI 10.1111/j.1365-3156.2005.01427.x; Mockenhaupt FP, 2007, ANTIMICROB AGENTS CH, V51, P3273, DOI 10.1128/AAC.00513-07; Oduro AR, 2005, TROP MED INT HEALTH, V10, P279, DOI 10.1111/j.1365-3156.2004.01382.x; Omar SA, 2001, T ROY SOC TROP MED H, V95, P315, DOI 10.1016/S0035-9203(01)90250-0; Pearce RJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000055; PETERSON DS, 1988, P NATL ACAD SCI USA, V85, P9114, DOI 10.1073/pnas.85.23.9114; Picot S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-89; Ross A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002661; Schellenberg D, 2002, AM J TROP MED HYG, V67, P17, DOI 10.4269/ajtmh.2002.67.17; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Staedke SG, 2004, TROP MED INT HEALTH, V9, P624, DOI 10.1111/j.1365-3156.2004.01239.x; TRIGLIA T, 1994, P NATL ACAD SCI USA, V91, P7149, DOI 10.1073/pnas.91.15.7149; Vestergaard LS, 2007, AM J TROP MED HYG, V77, P153, DOI 10.4269/ajtmh.2007.77.153; White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-9; *WHO, 2009, TECHN CONS INT PREV; World Health Organization (WHO), 2010, WHO POL REC INT PREV	39	26	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12618	10.1371/journal.pone.0012618	http://dx.doi.org/10.1371/journal.pone.0012618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20838642	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000281631300038
J	Martinez-Castilla, LP; Rodriguez-Sotres, R				Martinez-Castilla, Leon P.; Rodriguez-Sotres, Rogelio			A Score of the Ability of a Three-Dimensional Protein Model to Retrieve Its Own Sequence as a Quantitative Measure of Its Quality and Appropriateness	PLOS ONE			English	Article							HIDDEN MARKOV-MODELS; STRUCTURE PREDICTION; TOPOFIT METHOD; DESIGN; DATABASE; RECOGNITION; ALIGNMENTS; SELECTION; ENERGY; FOLD	Background: Despite the remarkable progress of bioinformatics, how the primary structure of a protein leads to a three-dimensional fold, and in turn determines its function remains an elusive question. Alignments of sequences with known function can be used to identify proteins with the same or similar function with high success. However, identification of function-related and structure-related amino acid positions is only possible after a detailed study of every protein. Folding pattern diversity seems to be much narrower than sequence diversity, and the amino acid sequences of natural proteins have evolved under a selective pressure comprising structural and functional requirements acting in parallel. Principal Findings: The approach described in this work begins by generating a large number of amino acid sequences using ROSETTA [Dantas G et al. (2003) J Mol Biol 332: 449-460], a program with notable robustness in the assignment of amino acids to a known three-dimensional structure. The resulting sequence-sets showed no conservation of amino acids at active sites, or protein-protein interfaces. Hidden Markov models built from the resulting sequence sets were used to search sequence databases. Surprisingly, the models retrieved from the database sequences belonged to proteins with the same or a very similar function. Given an appropriate cutoff, the rate of false positives was zero. According to our results, this protocol, here referred to as Rd.HMM, detects fine structural details on the folding patterns, that seem to be tightly linked to the fitness of a structural framework for a specific biological function. Conclusion: Because the sequence of the native protein used to create the Rd.HMM model was always amongst the top hits, the procedure is a reliable tool to score, very accurately, the quality and appropriateness of computer-modeled 3D-structures, without the need for spectroscopy data. However, Rd.HMM is very sensitive to the conformational features of the models' backbone.	[Martinez-Castilla, Leon P.; Rodriguez-Sotres, Rogelio] Univ Nacl Autonoma Mexico, Fac Quim, Dept Bioquim, Mexico City 04510, DF, Mexico; [Martinez-Castilla, Leon P.] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Martinez-Castilla, LP (corresponding author), Univ Nacl Autonoma Mexico, Fac Quim, Dept Bioquim, Mexico City 04510, DF, Mexico.	sotres@servidor.unam.mx	Rodriguez-Sotres, Rogelio/A-3381-2008	Rodriguez-Sotres, Rogelio/0000-0002-9443-3207	Universidad Nacional Autonoma de Mexico [PAPIIT-DGAPA-IN210909, PAPIIT-DGAPA-IN211609, FQ-PAIP-6290-09, FQ-PAIP 6290-07, DGSCA-IXTLI-IN501506]; Consejo Nacional de Ciencia y Tecnologia [CB-2008-01/101186]	Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was funded by the Universidad Nacional Autonoma de Mexico, grants PAPIIT-DGAPA-IN210909, PAPIIT-DGAPA-IN211609, FQ-PAIP-6290-09, FQ-PAIP 6290-07, DGSCA-IXTLI-IN501506 and DGSCA-Supercomputing, and by Consejo Nacional de Ciencia y Tecnologia grant CB-2008-01/101186. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abyzov A, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-78; Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Chivian D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl480; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; Gomez-Garcia MR, 2006, BIOCHEM J, V395, P211, DOI 10.1042/BJ20051657; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Ilyin VA, 2004, PROTEIN SCI, V13, P1865, DOI 10.1110/ps.04672604; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Karplus K, 2005, PROTEINS, V61, P135, DOI 10.1002/prot.20730; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; Karplus K, 2001, PROTEINS, P86, DOI 10.1002/prot.10021; Karplus K, 2003, PROTEINS, V53, P491, DOI 10.1002/prot.10540; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Leslin CM, 2007, NUCLEIC ACIDS RES, V35, pD317, DOI 10.1093/nar/gkl809; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Pei JM, 2003, P NATL ACAD SCI USA, V100, P11361, DOI 10.1073/pnas.2034878100; POCHAPSKY TC, 1994, BIOCHEMISTRY-US, V33, P6424, DOI 10.1021/bi00187a006; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Raha K, 2000, PROTEIN SCI, V9, P1106, DOI 10.1110/ps.9.6.1106; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Saunders CT, 2005, J MOL BIOL, V346, P631, DOI 10.1016/j.jmb.2004.11.062; Schuster-Bockler B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-7; Sheffler W, 2009, PROTEIN SCI, V18, P229, DOI 10.1002/pro.8; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tronrud DE, 2009, PROTEIN SCI, V18, P2, DOI 10.1002/pro.13; Wallner B, 2007, PROTEINS, V69, P184, DOI 10.1002/prot.21774; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290	35	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12483	10.1371/journal.pone.0012483	http://dx.doi.org/10.1371/journal.pone.0012483			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830209	gold, Green Published, Green Submitted			2022-12-27	WOS:000281631300002
J	Yu, YL; Zhang, HL; Zhu, G				Yu, Yonglan; Zhang, Haili; Zhu, Guan			Plant-Type Trehalose Synthetic Pathway in Cryptosporidium and Some Other Apicomplexans	PLOS ONE			English	Article							N-ACETYLGLUCOSAMINE PYROPHOSPHORYLASE; UDP-GLUCOSE PYROPHOSPHORYLASE; FATTY-ACID SYNTHESIS; GENOME SEQUENCE; ARABIDOPSIS-THALIANA; PHOSPHATE SYNTHASE; EIMERIA-TENELLA; THEILERIA-PARVA; MANNITOL CYCLE; METABOLISM	Background: The trehalose synthetic pathway is present in bacteria, fungi, plants and invertebrate animals, but is absent in vertebrates. This disaccharide mainly functions as a stress protectant against desiccation, heat, cold and oxidation. Genes involved in trehalose synthesis have been observed in apicomplexan parasites, but little was known about these enzymes. Study on trehalose synthesis in apicomplexans would not only shed new light into the evolution of this pathway, but also provide data for exploring this pathway as novel drug target. Methodology/Principal Findings: We have observed the presence of the trehalose synthetic pathway in Cryptosporidium and other apicomplexans and alveolates. Two key enzymes (trehalose 6-phosphate synthase [T6PS; EC 2.4.1.15] and trehalose phosphatase [TPase; EC 3.1.3.12] are present as Class II bifunctional proteins (T6PS-TPase) in the majority of apicomplexans with the exception of Plasmodium species. The enzyme for synthesizing the precursor (UDP-glucose) is homologous to dual-substrate UDP-galactose/glucose pyrophosphorylases (UGGPases), rather than the "classic'' UDPglucose pyrophosphorylase (UGPase). Phylogenetic recontructions indicate that both T6PS-TPases and UGGPases in apicomplexans and other alveolates are evolutionarily affiliated with stramenopiles and plants. The expression level of T6PS-TPase in C. parvum is highly elevated in the late intracellular developmental stage prior to or during the production of oocysts, implying that trehalose may be important in oocysts as a protectant against environmental stresses. Finally, trehalose has been detected in C. parvum oocysts, thus confirming the trehalose synthetic activity in this parasite. Conclusions/Significance: A trehalose synthetic pathway is described in the majority of apicomplexan parasites including Cryptosporidium and the presence of trehalose was confirmed in the C. parvum oocyst. Key enzymes in the pathway (i.e., T6PS-TPase and UGGPase) are plant-type and absent in humans and animals, and may potentially serve as novel drug targets in the apicomplexans.	[Yu, Yonglan] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Yu, Yonglan; Zhang, Haili; Zhu, Guan] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX USA; [Zhu, Guan] Texas A&M Univ, Fac Genet Program, College Stn, TX USA	China Agricultural University; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Yu, YL (corresponding author), China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China.	GZHU@CVM.TAMU.EDU	Zhu, Guan/AFJ-2945-2022; ZHU, GUAN/D-8147-2011; ZHU, GUAN/GQB-0299-2022	Zhu, Guan/0000-0003-3888-0659; ZHU, GUAN/0000-0003-3888-0659	National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) [R01 AI44594, R21 AI055278]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044594, R21AI055278] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work reported here is in part supported by grants from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) (R01 AI44594 and R21 AI055278 to GZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Abrahamsen MS, 1999, MOL BIOCHEM PARASIT, V104, P141, DOI 10.1016/S0166-6851(99)00081-X; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Allocco JJ, 2001, J PARASITOL, V87, P1441, DOI 10.1645/0022-3395(2001)087[1441:NMBETD]2.0.CO;2; Allocco JJ, 1999, J PARASITOL, V85, P167, DOI 10.2307/3285614; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aurrecoechea C, 2010, NUCLEIC ACIDS RES, V38, pD415, DOI 10.1093/nar/gkp941; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Brinkman FSL, 2002, GENOME RES, V12, P1159, DOI 10.1101/gr.341802; Bulik DA, 2000, J BIOL CHEM, V275, P14722, DOI 10.1074/jbc.275.19.14722; Cai XM, 2005, ANTIMICROB AGENTS CH, V49, P4437, DOI 10.1128/AAC.49.11.4437-4442.2005; Carroll JD, 2007, FEBS J, V274, P1701, DOI 10.1111/j.1742-4658.2007.05715.x; CAVALIERSMITH T, 1991, SYST ASSOC SPEC VOL, V45, P113; Chary SN, 2008, PLANT PHYSIOL, V146, P97, DOI 10.1104/pp.107.107441; Chen QF, 2004, J EXP BIOL, V207, P3125, DOI 10.1242/jeb.01133; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dai N, 2006, PLANT PHYSIOL, V142, P294, DOI 10.1104/pp.106.083634; De Silva-Udawatta MN, 2001, MOL MICROBIOL, V40, P1345, DOI 10.1046/j.1365-2958.2001.02477.x; Dmitryjuk M, 2003, COMP BIOCHEM PHYS B, V136, P61, DOI 10.1016/S1096-4959(03)00170-2; Eastmond PJ, 2003, J EXP BOT, V54, P533, DOI 10.1093/jxb/erg039; Eastmond PJ, 2003, CURR OPIN PLANT BIOL, V6, P231, DOI 10.1016/S1369-5266(03)00037-2; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Finlay BJ, 2004, PHILOS T R SOC B, V359, P599, DOI 10.1098/rstb.2003.1450; Frison M, 2007, FEBS LETT, V581, P4010, DOI 10.1016/j.febslet.2007.07.036; Gancedo C, 2004, FEMS YEAST RES, V4, P351, DOI 10.1016/S1567-1356(03)00222-8; Gardner MJ, 2005, SCIENCE, V309, P134, DOI 10.1126/science.1110439; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Halford NG, 2003, PLANT BIOTECHNOL J, V1, P381, DOI 10.1046/j.1467-7652.2003.00046.x; Hanson J, 2009, CURR OPIN PLANT BIOL, V12, P562, DOI 10.1016/j.pbi.2009.07.014; Harthill JE, 2006, PLANT J, V47, P211, DOI 10.1111/j.1365-313X.2006.02780.x; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kleczkowski LA, 2004, PLANT PHYSIOL, V134, P912, DOI 10.1104/pp.103.036053; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Lariviere L, 2005, J MOL BIOL, V352, P139, DOI 10.1016/j.jmb.2005.07.007; Lee SH, 2007, NAT REV MICROBIOL, V5, P287, DOI 10.1038/nrmicro1617; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Leyman B, 2001, TRENDS PLANT SCI, V6, P510, DOI 10.1016/S1360-1385(01)02125-2; Li P, 2008, PHYSIOL PLANTARUM, V133, P544, DOI 10.1111/j.1399-3054.2008.01101.x; Lu ZB, 2005, BIOCHEMISTRY-US, V44, P8684, DOI 10.1021/bi050009j; Maruyama S, 2008, PLANT SIGNAL BEHAV, V3, P140, DOI 10.4161/psb.3.2.5066; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Meng M, 2009, PLANT CELL PHYSIOL, V50, P998, DOI 10.1093/pcp/pcp052; Mio T, 1998, J BIOL CHEM, V273, P14392, DOI 10.1074/jbc.273.23.14392; Mok MTS, 2005, J BIOL CHEM, V280, P39363, DOI 10.1074/jbc.M509209200; Morrison DA, 2009, TRENDS PARASITOL, V25, P375, DOI 10.1016/j.pt.2009.05.010; Moustafa A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002205; Muller J, 2001, PLANT PHYSIOL, V125, P1086, DOI 10.1104/pp.125.2.1086; Oesterreicher TJ, 2001, GENE, V270, P211, DOI 10.1016/S0378-1119(01)00474-7; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; Parrou JL, 2005, FEMS YEAST RES, V5, P503, DOI 10.1016/j.femsyr.2005.01.002; Paul M, 2007, CURR OPIN PLANT BIOL, V10, P303, DOI 10.1016/j.pbi.2007.04.001; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Paul Matthew J, 2008, Biochem J, V412, pe1, DOI 10.1042/BJ20080598; Peneff C, 2001, EMBO J, V20, P6191, DOI 10.1093/emboj/20.22.6191; Ramon M, 2009, PLANT CELL ENVIRON, V32, P1015, DOI 10.1111/j.1365-3040.2009.01985.x; Rider SD, 2008, J CELL BIOCHEM, V104, P2207, DOI 10.1002/jcb.21784; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmatz DM, 1997, PARASITOLOGY, V114, pS81; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Templeton TJ, 2004, INFECT IMMUN, V72, P980, DOI 10.1128/IAI.72.2.980-987.2004; Uhland K, 2000, J BIOL CHEM, V275, P23439, DOI 10.1074/jbc.M002793200; Whitaker JW, 2009, NUCLEIC ACIDS RES, V37, pD531, DOI 10.1093/nar/gkn826; Whitaker JW, 2009, BIOCHEM SOC T, V37, P792, DOI 10.1042/BST0370792; Wingler A, 2002, PHYTOCHEMISTRY, V60, P437, DOI 10.1016/S0031-9422(02)00137-1; Wu WS, 2006, J BIOCHEM MOL BIOL, V39, P158; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; Zeng B, 2006, MICROBIOL-SGM, V152, P2355, DOI 10.1099/mic.0.28944-0	70	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12593	10.1371/journal.pone.0012593	http://dx.doi.org/10.1371/journal.pone.0012593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830297	Green Published, gold, Green Submitted			2022-12-27	WOS:000281631300021
J	Byrne, JV; Beltechi, R; Yarnold, JA; Birks, J; Kamran, M				Byrne, James V.; Beltechi, Radu; Yarnold, Julia A.; Birks, Jacqueline; Kamran, Mudassar			Early Experience in the Treatment of Intra-Cranial Aneurysms by Endovascular Flow Diversion: A Multicentre Prospective Study	PLOS ONE			English	Article							PIPELINE EMBOLIZATION DEVICE; CEREBRAL ANEURYSMS; PARENT VESSEL; FOLLOW-UP; RECONSTRUCTION; PLACEMENT; STENT; THERAPY	Introduction: Flow diversion is a new approach to the endovascular treatment of intracranial aneurysms which uses a high density mesh stent to induce sac thrombosis. These devices have been designed for the treatment of complex shaped and large size aneurysms. So far published safety and efficacy data on this approach is sparse. Material and Methods: Over 8 months, standardized clinical and angiographic data were collected on 70 patients treated with a flow diverter device (SILK flow diverter (SFD)) in 18 centres worldwide. Treatment and early follow up details were audited centrally. SFDs were deployed alone in 57 (81%) or with endosaccular coils in 10 (14%) aneurysms, which included: 44 (63%) saccular, 26 (37%) fusiform shapes and 18 (26%) small, 37 (53%) large, 15 (21%) giant sizes. Treatment outcome data up to 30 days were reported for all patients, with clinical (50 patients) and imaging (49 patients) follow up (median 119 days) data available. Results: Difficulties in SFD deployment were reported in 15 (21%) and parent artery thrombosis in 8 (11%) procedures. Procedural complications caused stroke in 1 and serious extracranial bleeding in 3 patients; 2 of whom developed fatal pneumonias. Delayed worsening of symptoms occurred in 5 patients (3 transient, 1 permanent neurological deficit, and 1 death) and fatal aneurysm bleeding in 1 patient. Overall permanent morbidity rates were 2 (4%) and mortality 4 (8%). Statistical analysis revealed no significant association between complications and variables related to treated aneurysm morphology or rupture status. Conclusion: This series is the largest reporting outcome of the new treatment approach and provides data for future study design. Procedural difficulties in SFD deployment were frequent and anti-thrombosis prophylaxis appears to reduce the resulting clinical sequelae, but at the cost of morbidity due to extracranial bleeding. Delayed morbidity appears to be a consequence of the new approach and warrants care in selecting patients for treatment and future larger studies.	[Byrne, James V.; Beltechi, Radu; Yarnold, Julia A.; Kamran, Mudassar] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Birks, Jacqueline] Univ Oxford, Ctr Stat Med, Oxford, England	University of Oxford; University of Oxford	Byrne, JV (corresponding author), Univ Oxford, Nuffield Dept Surg Sci, Oxford, England.	james.byrne@nds.ox.ac.uk			Balt Extrusion	Balt Extrusion	This study was supported by a grant made to the Nuffield Department of Surgery, University of Oxford by Balt Extrusion. The funders were consulted in the study design but had no executive role in the final protocol. They had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Campi A, 2007, STROKE, V38, P1538, DOI 10.1161/STROKEAHA.106.466987; Doerfler A, 2004, J NEUROSURG, V100, P150, DOI 10.3171/jns.2004.100.1.0150; Fiorella D, 2009, J NEUROINTERV SURG, V1, P56, DOI 10.1136/jnis.2009.000083; Higashida RT, 1997, J NEUROSURG, V87, P944, DOI 10.3171/jns.1997.87.6.0944; Li MH, 2009, RADIOLOGY, V253, P470, DOI 10.1148/radiol.2532090037; Liou TM, 2007, J BIOMECH, V40, P1268, DOI 10.1016/j.jbiomech.2006.05.024; Lylyk P, 2002, J NEUROSURG, V97, P1306, DOI 10.3171/jns.2002.97.6.1306; Lylyk P, 2009, NEUROSURGERY, V64, P632, DOI 10.1227/01.NEU.0000339109.98070.65; Ries T, 2007, AM J NEURORADIOL, V28, P1755, DOI 10.3174/ajnr.A0649; Sadasivan C, 2009, STROKE, V40, P952, DOI 10.1161/STROKEAHA.108.533760; Szikora I, 2006, ACTA NEUROCHIR, V148, P711, DOI 10.1007/s00701-006-0785-6; SZIKORA I, 2010, AJNR AM J NEURO 0211; Thornton J, 2002, NEUROSURGERY, V50, P239, DOI 10.1097/00006123-200202000-00003; Zenteno MA, 2008, J NEUROSURG, V108, P1104, DOI 10.3171/JNS/2008/108/6/1104	14	219	230	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12492	10.1371/journal.pone.0012492	http://dx.doi.org/10.1371/journal.pone.0012492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824070	Green Published, Green Submitted, gold			2022-12-27	WOS:000281480900001
J	Kothapalli, R; Khan, AM; Basappa; Gopalsamy, A; Chong, YS; Annamalai, L				Kothapalli, Roopa; Khan, Asif M.; Basappa; Gopalsamy, Anupriya; Chong, Yap Seng; Annamalai, Loganath			Cheminformatics-Based Drug Design Approach for Identification of Inhibitors Targeting the Characteristic Residues of MMP-13 Hemopexin Domain	PLOS ONE			English	Article							X-RAY-STRUCTURE; COLLAGEN; POTENT; OSTEOARTHRITIS; DISCOVERY; CARTILAGE; FIELD	Background: MMP-13, a zinc dependent protease which catalyses the cleavage of type II collagen, is expressed in osteoarthritis (OA) and rheumatoid arthritis (RA) patients, but not in normal adult tissues. Therefore, the protease has been intensively studied as a target for the inhibition of progression of OA and RA. Recent reports suggest that selective inhibition of MMP-13 may be achieved by targeting the hemopexin (Hpx) domain of the protease, which is critical for substrate specificity. In this study, we applied a cheminformatics-based drug design approach for the identification and characterization of inhibitors targeting the amino acid residues characteristic to Hpx domain of MMP-13; these inhibitors may potentially be employed in the treatment of OA and RA. Methodology/Principal Findings: Sequence-based mutual information analysis revealed five characteristic (completely conserved and unique), putative functional residues of the Hpx domain of MMP-13 (these residues hereafter are referred to as HCR-13(of)). Binding of a ligand to as many of the HCR-13(pf) is postulated to result in an increased selective inhibition of the Hpx domain of MMP-13. Through the in silico structure-based high-throughput virtual screening (HTVS) method of Glide, against a large public library of 16908 molecules from Maybridge, PubChem and Binding, we identified 25 ligands that interact with at least one of the HCR-13pf. Assessment of cross-reactivity of the 25 ligands with MMP-1 and MMP-8, members of the collagenase family as MMP-13, returned seven lead molecules that did not bind to any one of the putative functional residues of Hpx domain of MMP-1 and any of the catalytic active site residues of MMP-1 and -8, suggesting that the ligands are not likely to interact with the functional or catalytic residues of other MMPs. Further, in silico analysis of physicochemical and pharmacokinetic parameters based on Lipinski's rule of five and ADMET (absorption, distribution, metabolism, excretion and toxicity) respectively, suggested potential utility of the compounds as drug leads. Conclusions/Significance: We have identified seven distinct drug-like molecules binding to the HCR-13pf of MMP-13 with no observable cross-reactivity to MMP-1 and MMP-8. These molecules are potential selective inhibitors of MMP-13 that can be experimentally validated and their backbone structural scaffold could serve as building blocks in designing drug-like molecules for OA, RA and other inflammatory disorders. The systematic cheminformatics-based drug design approach applied herein can be used for rational search of other public/commercial combinatorial libraries for more potent molecules, capable of selectively inhibiting the collagenolytic activity of MMP-13.	[Kothapalli, Roopa; Gopalsamy, Anupriya; Chong, Yap Seng; Annamalai, Loganath] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 117595, Singapore; [Khan, Asif M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Basappa] Singapore MIT Alliance Res & Technol, Ctr Life Sci, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; Singapore-MIT Alliance for Research & Technology Centre (SMART)	Kothapalli, R (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 117595, Singapore.	obgannam@nus.edu.sg	Khan, Mohammad Asif/F-4663-2010; Khan, M. Asif/ABE-7839-2021	Khan, Mohammad Asif/0000-0001-9202-279X; Khan, M. Asif/0000-0001-9202-279X; Basappa, Basappa/0000-0002-8844-468X; Chong, Yap Seng/0000-0002-7232-8473; Gopalsamy, Anupriya/0000-0002-2774-5454	Lee Foundation, Singapore	Lee Foundation, Singapore	The authors gratefully acknowledge a generous grant from the Lee Foundation, Singapore for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baragi VM, 2009, ARTHRITIS RHEUM-US, V60, P2008, DOI 10.1002/art.24629; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ezhilarasan R, 2009, INT J CANCER, V124, P306, DOI 10.1002/ijc.23951; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GomisRuth FX, 1996, J MOL BIOL, V264, P556, DOI 10.1006/jmbi.1996.0661; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Johnson AR, 2007, J BIOL CHEM, V282, P27781, DOI 10.1074/jbc.M703286200; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 2006, QIKPROP VERSION 3 0; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Kim SH, 2005, BIOORG MED CHEM LETT, V15, P1101, DOI 10.1016/j.bmcl.2004.12.016; Lauer-Fields JL, 2009, J BIOL CHEM, V284, P24017, DOI 10.1074/jbc.M109.016873; LI J, 1995, STRUCTURE, V3, P541, DOI 10.1016/S0969-2126(01)00188-5; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; Matter H, 1999, J MED CHEM, V42, P1908, DOI 10.1021/jm980631s; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S18; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Neuhold LA, 2001, J CLIN INVEST, V107, P35, DOI 10.1172/JCI10564; PIECHA D, 2009, INFLAMM RES; SCHNUTE ME, 2009, BIOORG MED CHEM LETT; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wu JJ, 2005, BIOORG MED CHEM LETT, V15, P4105, DOI 10.1016/j.bmcl.2005.06.019	29	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12494	10.1371/journal.pone.0012494	http://dx.doi.org/10.1371/journal.pone.0012494			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824169	Green Published, gold, Green Submitted			2022-12-27	WOS:000281405300019
J	Baker, NM; Zeitlin, SG; Shi, LZ; Shah, J; Berns, MW				Baker, Norman M.; Zeitlin, Samantha G.; Shi, Linda Z.; Shah, Jagesh; Berns, Michael W.			Chromosome Tips Damaged in Anaphase Inhibit Cytokinesis	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; DNA-DAMAGE; CELLULAR-RESPONSES; CELLS; LASER; MITOSIS; KINETOCHORE; INSTABILITY; TELOMERES; TENSION	Genome maintenance is ensured by a variety of biochemical sensors and pathways that repair accumulated damage. During mitosis, the mechanisms that sense and resolve DNA damage remain elusive. Studies have demonstrated that damage accumulated on lagging chromosomes can activate the spindle assembly checkpoint. However, there is little known regarding damage to DNA after anaphase onset. In this study, we demonstrate that laser-induced damage to chromosome tips (presumptive telomeres) in anaphase of Potorous tridactylis cells (PtK2) inhibits cytokinesis. In contrast, equivalent irradiation of non-telomeric chromosome regions or control irradiations in either the adjacent cytoplasm or adjacent to chromosome tips near the spindle midzone during anaphase caused no change in the eventual completion of cytokinesis. Damage to only one chromosome tip caused either complete absence of furrow formation, a prolonged delay in furrow formation, or furrow regression. When multiple chromosome tips were irradiated in the same cell, the cytokinesis defects increased, suggesting a potential dose-dependent mechanism. These results suggest a mechanism in which dysfunctional telomeres inhibit mitotic exit.	[Baker, Norman M.] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [Zeitlin, Samantha G.] Univ Calif San Diego, Ludwig Inst Canc Res, Cell Biol Lab, La Jolla, CA 92093 USA; [Shi, Linda Z.; Berns, Michael W.] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Bioengn, La Jolla, CA 92093 USA; [Shah, Jagesh] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Shah, Jagesh] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Berns, Michael W.] Univ Calif Irvine, Beckman Laser Inst, Irvine, CA USA	University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of California System; University of California Irvine	Baker, NM (corresponding author), Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA.	jagesh@hms.harvard.edu; mwberns@uci.edu		Berns, Michael/0000-0002-9640-2885	NCI NIH HHS [BC085852] Funding Source: Medline; NIGMS NIH HHS [R01 GM077238] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077238] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anantha RW, 2008, P NATL ACAD SCI USA, V105, P12903, DOI 10.1073/pnas.0803001105; Berns MW, 2007, METHOD CELL BIOL, V82, P1; Botvinick EL, 2004, BIOPHYS J, V87, P4203, DOI 10.1529/biophysj.104.049528; Botvinick EL, 2005, MICROSC RES TECHNIQ, V68, P65, DOI 10.1002/jemt.20216; Ciapponi L, 2008, CYTOGENET GENOME RES, V122, P365, DOI 10.1159/000167824; Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dynek JN, 2004, SCIENCE, V304, P97, DOI 10.1126/science.1094754; Gomez-Godinez V, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717684; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Khodjakov A, 1997, J CELL BIOL, V136, P229, DOI 10.1083/jcb.136.2.229; Kong X, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp221; Mikhailov A, 2002, CURR BIOL, V12, P1797, DOI 10.1016/S0960-9822(02)01226-5; Musaro M, 2008, NAT GENET, V40, P362, DOI 10.1038/ng.2007.64; O'Connell CB, 2008, J CELL BIOL, V183, P29, DOI 10.1083/jcb.200801038; Pobiega S, 2010, GENE DEV, V24, P720, DOI 10.1101/gad.571510; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; SASAKI K, 1991, OPT LETT, V16, P1463, DOI 10.1364/OL.16.001463; Shrivastav N, 2010, CARCINOGENESIS, V31, P59, DOI 10.1093/carcin/bgp262; SKIBBENS RV, 1995, J CELL SCI, V108, P2537; Skoufias DA, 2004, MOL CELL, V15, P977, DOI 10.1016/j.molcel.2004.08.018; SPURCK TP, 1990, J CELL BIOL, V111, P1505, DOI 10.1083/jcb.111.4.1505; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Thanasoula M, 2010, CURR BIOL, V20, P521, DOI 10.1016/j.cub.2010.01.046; Wheatley SP, 1996, J CELL BIOL, V135, P981, DOI 10.1083/jcb.135.4.981	28	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12398	10.1371/journal.pone.0012398	http://dx.doi.org/10.1371/journal.pone.0012398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811641	Green Published, gold			2022-12-27	WOS:000281234700022
J	York, TP; Strauss, JF; Neale, MC; Eaves, LJ				York, Timothy P.; Strauss, Jerome F., III; Neale, Michael C.; Eaves, Lindon J.			Racial Differences in Genetic and Environmental Risk to Preterm Birth	PLOS ONE			English	Article							GESTATIONAL-AGE; DISPARITIES; WEIGHT; HEALTH; TNF	Preterm birth is more prevalent in African Americans than European Americans and contributes to 3.4 times more African American infant deaths. Models of social inequity do not appreciably account for this marked disparity and molecular genetic studies have yet to characterize whether allelic differences that exist between races contribute to this gap. In this study, biometrical genetic models are applied to a large mixed-race sample consisting of 733,339 births to measure the extent that heritable factors and environmental exposures predict the timing of birth and explain differences between racial groups. Although we expected significant differences in mean gestational age between racial groups, we did not anticipate the variance of gestational age in African Americans (sigma(2) = 7.097) to be nearly twice that of European Americans (sigma(2) = 3.764). Our results show that this difference in the variance of gestational age can largely be attributed to environmental sources; which were 3.1 times greater in African Americans. Specifically, environmental factors that change between pregnancies, versus exposures that influence all pregnancies within a family, are largely responsible for the increased reproductive heterogeneity observed in African American mothers. Although the contribution of both fetal and maternal genetic factors differed between race categories, genetic studies may best be directed to understanding the differences in the sociocultural sources of this heterogeneity, and their possible interaction with genetic differences within and between races. This study provides a comprehensive description of the relative genetic and environmental contributions to racial differences in gestational age.	[York, Timothy P.; Neale, Michael C.; Eaves, Lindon J.] Virginia Commonwealth Univ, Sch Med, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23284 USA; [York, Timothy P.; Strauss, Jerome F., III; Neale, Michael C.; Eaves, Lindon J.] Virginia Commonwealth Univ, Sch Med, Dept Human & Mol Genet, Richmond, VA USA; [Strauss, Jerome F., III] Virginia Commonwealth Univ, Sch Med, Dept Obstet & Gynecol, Richmond, VA USA; [Neale, Michael C.; Eaves, Lindon J.] Virginia Commonwealth Univ, Sch Med, Dept Psychiat, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	York, TP (corresponding author), Virginia Commonwealth Univ, Sch Med, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23284 USA.	tpyork@vcu.edu	Neale, Michael/AAD-5056-2020		National Institutes of Health [R01 HD034612, P60 MD002256, DA-18673]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA018673, R01DA018673] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P60MD002256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research was supported by National Institutes of Health grants R01 HD034612, P60 MD002256 and DA-18673. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LS, 2002, TWIN RES, V5, P449, DOI 10.1375/twin.5.5.449; Anum EA, 2009, PEDIATR RES, V65, P1, DOI 10.1203/PDR.0b013e31818912e7; Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; Behrman RE, 2007, PRETERM BIRTH CAUSES; EAVES LJ, 1978, HEREDITY, V41, P249, DOI 10.1038/hdy.1978.101; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fiscella Kevin, 2005, J Natl Med Assoc, V97, P1516; Goldenberg RL, 1996, AM J OBSTET GYNECOL, V175, P1317, DOI 10.1016/S0002-9378(96)70048-0; Joreskog K.G., 1996, LISREL 8 USERS REFER; Kaufman JS, 1997, EPIDEMIOLOGY, V8, P621, DOI 10.1097/00001648-199710000-00002; Lang JM, 1996, EPIDEMIOLOGY, V7, P369, DOI 10.1097/00001648-199607000-00006; Lu MC, 2004, AM J OBSTET GYNECOL, V191, P691, DOI 10.1016/j.ajog.2004.04.018; Lu Michael C, 2003, Matern Child Health J, V7, P13, DOI 10.1023/A:1022537516969; Lunde A, 2007, AM J EPIDEMIOL, V165, P734, DOI 10.1093/aje/kwk107; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Macones GA, 2004, AM J OBSTET GYNECOL, V190, P1504, DOI 10.1016/j.ajog.2004.01.001; Martin JA., 2009, NATL VITAL STAT REP, V57, P1; MARTIN NG, 1977, HEREDITY, V38, P79, DOI 10.1038/hdy.1977.9; Mathews T J, 2008, Natl Vital Stat Rep, V57, P1; Menon R, 2006, HUM HERED, V62, P107, DOI 10.1159/000096301; Mountain JL, 2004, NAT GENET, V36, pS48, DOI 10.1038/ng1456; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Neale MC, 1992, METHODOLOGY GENETIC; NEALE MC, 1999, MX STAT MODELING RIC; Posthuma D, 2003, TWIN RES, V6, P361, DOI 10.1375/twin.6.5.361; Risch N., 2002, GENOME BIOL, V3, pcomm, DOI [10.1186/gb-2002-3-7-comment2007, 10.1186/GB-2002-3-7-COMMENT2007]; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Treloar S A, 2000, Twin Res, V3, P80, DOI 10.1375/twin.3.2.80; Van den Oord EJCG, 2000, DEMOGRAPHY, V37, P285, DOI 10.2307/2648042; York TP, 2009, TWIN RES HUM GENET, V12, P333, DOI 10.1375/twin.12.4.333	31	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12391	10.1371/journal.pone.0012391	http://dx.doi.org/10.1371/journal.pone.0012391			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811627	Green Submitted, gold, Green Published			2022-12-27	WOS:000281234700016
J	Stroeymeyt, N; Guerrieri, FJ; van Zweden, JS; d'Ettorre, P				Stroeymeyt, Nathalie; Guerrieri, Fernando J.; van Zweden, Jelle S.; d'Ettorre, Patrizia			Rapid Decision-Making with Side-Specific Perceptual Discrimination in Ants	PLOS ONE			English	Article							NESTMATE-RECOGNITION CUES; OLFACTORY DISCRIMINATION; CUTICULAR HYDROCARBONS; KIN RECOGNITION; SOCIAL INSECTS; SPEED; ACCURACY; HONEYBEE; TIME; HABITUATION	Background: Timely decision making is crucial for survival and reproduction. Organisms often face a speed-accuracy trade-off, as fully informed, accurate decisions require time-consuming gathering and treatment of information. Optimal strategies for decision-making should therefore vary depending on the context. In mammals, there is mounting evidence that multiple systems of perceptual discrimination based on different neural circuits emphasize either fast responses or accurate treatment of stimuli depending on the context. Methodology/Principal Findings: We used the ant Camponotus aethiops to test the prediction that fast information processing achieved through direct neural pathways should be favored in situations where quick reactions are adaptive. Social insects discriminate readily between harmless group-members and dangerous strangers using easily accessible cuticular hydrocarbons as nestmate recognition cues. We show that i) tethered ants display rapid aggressive reactions upon presentation of non-nestmate odor (120 to 160 ms); ii) ants' aggressiveness towards non-nestmates can be specifically reduced by exposure to non-nestmate odor only, showing that social interactions are not required to alter responses towards non-nestmates; iii) decision-making by ants does not require information transfer between brain hemispheres, but relies on side-specific decision rules. Conclusions/Significance: Our results strongly suggest that first-order olfactory processing centers (up to the antennal lobes) are likely to play a key role in ant nestmate recognition. We hypothesize that the coarse level of discrimination achieved in the antennal lobes early in odor processing provides enough information to determine appropriate behavioral responses towards non-nestmates. This asks for a reappraisal of the mechanisms underlying social recognition in insects.	[Stroeymeyt, Nathalie; Guerrieri, Fernando J.; van Zweden, Jelle S.; d'Ettorre, Patrizia] Univ Copenhagen, Dept Biol, Ctr Social Evolut, Copenhagen, Denmark	University of Copenhagen	Stroeymeyt, N (corresponding author), Univ Bristol, Ant Lab, Sch Biol Sci, Bristol, Avon, England.	Nathalie.Stroeymeyt@bristol.ac.uk	Guerrieri, Fernando/AAE-1745-2019; van Zweden, Jelle S./AAD-7858-2020; Guerrieri, Fernando J/B-5229-2016; Stroeymeyt, Nathalie/H-2371-2013	Guerrieri, Fernando/0000-0001-9872-9067; van Zweden, Jelle S./0000-0001-5283-5470; Guerrieri, Fernando J/0000-0001-9872-9067; Stroeymeyt, Nathalie/0000-0001-8047-449X	EU-Marie Curie Excellence	EU-Marie Curie Excellence(European Commission)	This study was supported by the EU-Marie Curie Excellence Grant "CODICES" assigned to PdE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; BRAUN G, 1992, J NEUROPHYSIOL, V67, P588, DOI 10.1152/jn.1992.67.3.588; BREED MD, 1992, ANIM BEHAV, V44, P519, DOI 10.1016/0003-3472(92)90060-M; Chaline N, 2005, CHEM SENSES, V30, P327, DOI 10.1093/chemse/bji027; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; D'Ettorre P, 2005, CURR BIOL, V15, P2170, DOI 10.1016/j.cub.2005.10.067; D'Ettorre P, 2004, P ROY SOC B-BIOL SCI, V271, P1427, DOI 10.1098/rspb.2004.2742; d'Ettorre P, 2010, ANT ECOLOGY, P194; Dani FR, 2005, CHEM SENSES, V30, P477, DOI 10.1093/chemse/bji040; Dani FR, 2001, ANIM BEHAV, V62, P165, DOI 10.1006/anbe.2001.1714; Devaud JM, 2001, J NEUROSCI, V21, P6274, DOI 10.1523/JNEUROSCI.21-16-06274.2001; Ditzen M, 2003, CHEM SENSES, V28, P781, DOI 10.1093/chemse/bjg070; Errard C, 1997, INSECT SOC, V44, P189, DOI 10.1007/s000400050040; FONTA C, 1993, CHEM SENSES, V18, P101, DOI 10.1093/chemse/18.2.101; GADAGKAR R, 1985, P INDIAN AS-ANIM SCI, V94, P587, DOI 10.1007/BF03191863; Giurfa M, 2003, CURR OPIN NEUROBIOL, V13, P726, DOI 10.1016/j.conb.2003.10.015; Greene MJ, 2003, NATURE, V423, P32, DOI 10.1038/423032a; Grossberg S, 2008, VISION RES, V48, P1345, DOI 10.1016/j.visres.2008.02.019; Guerrieri FJ, 2008, J EXP BIOL, V211, P1109, DOI 10.1242/jeb.008508; Guerrieri FJ, 2009, P ROY SOC B-BIOL SCI, V276, P2461, DOI 10.1098/rspb.2008.1860; Hefetz Abraham, 2007, Myrmecological News, V10, P59; HOMBERG U, 1989, ANNU REV ENTOMOL, V34, P477, DOI 10.1146/annurev.en.34.010189.002401; HOMBERG U, 1988, CELL TISSUE RES, V254, P255; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Komischke B, 2003, BEHAV BRAIN RES, V145, P135, DOI 10.1016/S0166-4328(03)00105-0; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Krofczik S, 2009, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.009.2008; LACY RC, 1983, AM NAT, V121, P489, DOI 10.1086/284078; LAING DG, 1994, BRAIN RES, V651, P317, DOI 10.1016/0006-8993(94)90712-9; Langen TA, 2000, BEHAV ECOL SOCIOBIOL, V48, P285, DOI 10.1007/s002650000223; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; LeDoux J. E., 1996, EMOTIONAL BRAIN; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Lenoir A, 2009, J CHEM ECOL, V35, P913, DOI 10.1007/s10886-009-9669-6; Leon M, 2009, CELL MOL LIFE SCI, V66, P2135, DOI 10.1007/s00018-009-0011-9; Leonhardt SD, 2007, J COMP PHYSIOL A, V193, P993, DOI 10.1007/s00359-007-0252-8; Luce R. D., 1986, RESPONSE TIMES; Marshall JAR, 2006, J R SOC INTERFACE, V3, P243, DOI 10.1098/rsif.2005.0075; Marshall JAR, 2009, J R SOC INTERFACE, V6, P1065, DOI 10.1098/rsif.2008.0511; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Orivel J, 1997, BEHAV ECOL SOCIOBIOL, V40, P87, DOI 10.1007/s002650050319; Ottoni EB, 2000, BEHAV RES METH INS C, V32, P446, DOI 10.3758/BF03200814; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Sandoz JC, 2002, LEARN MEMORY, V9, P337, DOI 10.1101/lm.50502; Sandoz JC, 2001, LEARN MEMORY, V8, P286, DOI 10.1101/lm.41401; Skorupski P, 2010, J NEUROSCI, V30, P3896, DOI 10.1523/JNEUROSCI.5700-09.2010; SLOTNICK BM, 1990, COMP PERCEPTION, P155; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; Stroeymeyt N, 2007, BEHAV ECOL SOCIOBIOL, V61, P1449, DOI 10.1007/s00265-007-0377-3; Sumana A, 2008, J ETHOL, V26, P207, DOI 10.1007/s10164-007-0049-9; Trimmer PC, 2008, P ROY SOC B-BIOL SCI, V275, P2353, DOI 10.1098/rspb.2008.0417; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Uchida N, 2006, NAT REV NEUROSCI, V7, P485, DOI 10.1038/nrn1933; van Zweden JS, 2007, P ROY SOC B-BIOL SCI, V274, P1421, DOI 10.1098/rspb.2007.0113; van Zweden JS, 2009, J INSECT PHYSIOL, V55, P158, DOI 10.1016/j.jinsphys.2008.11.001; Vander Meer Robert K., 1998, P79; Vasquez GM, 2008, BEHAV ECOL SOCIOBIOL, V62, P537, DOI 10.1007/s00265-007-0478-z; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Wright GA, 2009, BEHAV NEUROSCI, V123, P36, DOI 10.1037/a0014040; Wyatt TD, 2009, NATURE, V457, P262, DOI 10.1038/457262a	63	27	27	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12377	10.1371/journal.pone.0012377	http://dx.doi.org/10.1371/journal.pone.0012377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808782	Green Submitted, Green Published, gold			2022-12-27	WOS:000281154300012
J	Maydan, M; McDonald, PC; Sanghera, J; Yan, J; Rallis, C; Pinchin, S; Hannigan, GE; Foster, LJ; Ish-Horowicz, D; Walsh, MP; Dedhar, S				Maydan, Mykola; McDonald, Paul C.; Sanghera, Jasbinder; Yan, Jun; Rallis, Charalampos; Pinchin, Sheena; Hannigan, Gregory E.; Foster, Leonard J.; Ish-Horowicz, David; Walsh, Michael P.; Dedhar, Shoukat			Integrin-Linked Kinase Is a Functional Mn2+-Dependent Protein Kinase that Regulates Glycogen Synthase Kinase-3 beta (GSK-3 beta) Phosphorylation	PLOS ONE			English	Article							PHOSPHATASE TARGET SUBUNIT; TUMOR-SUPPRESSOR PTEN; BINDING-PROTEIN; BETA-CATENIN; DEPENDENT PATHWAYS; ENDOTHELIAL-CELLS; B/AKT ACTIVATION; FOCAL ADHESIONS; ILK; SURVIVAL	Background: Integrin-linked kinase (ILK) is a highly evolutionarily conserved, multi-domain signaling protein that localizes to focal adhesions, myofilaments and centrosomes where it forms distinct multi-protein complexes to regulate cell adhesion, cell contraction, actin cytoskeletal organization and mitotic spindle assembly. Numerous studies have demonstrated that ILK can regulate the phosphorylation of various protein and peptide substrates in vitro, as well as the phosphorylation of potential substrates and various signaling pathways in cultured cell systems. Nevertheless, the ability of ILK to function as a protein kinase has been questioned because of its atypical kinase domain. Methodology/Principal Findings: Here, we have expressed full-length recombinant ILK, purified it to >94% homogeneity, and characterized its kinase activity. Recombinant ILK readily phosphorylates glycogen synthase kinase-3 (GSK-3) peptide and the 20-kDa regulatory light chains of myosin (LC20). Phosphorylation kinetics are similar to those of other active kinases, and mutation of the ATP-binding lysine (K220 within subdomain 2) causes marked reduction in enzymatic activity. We show that ILK is a Mn-dependent kinase (the K-m for MnATP is similar to 150-fold less than that for MgATP). Conclusions/Significance: Taken together, our data demonstrate that ILK is a bona fide protein kinase with enzyme kinetic properties similar to other active protein kinases.	[Maydan, Mykola; McDonald, Paul C.; Dedhar, Shoukat] BC Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC, Canada; [Sanghera, Jasbinder; Yan, Jun] SignalChem Inc, Richmond, BC, Canada; [Rallis, Charalampos; Pinchin, Sheena; Ish-Horowicz, David] London Res Inst, Lab Dev Genet, London, England; [Rallis, Charalampos; Pinchin, Sheena] UCL, Dept Genet Evolut & Environm, London, England; [Rallis, Charalampos; Pinchin, Sheena] UCL, Inst Canc, London, England; [Hannigan, Gregory E.] Monash Inst Med Res, Ctr Canc Res, Melbourne, Vic, Australia; [Foster, Leonard J.; Dedhar, Shoukat] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Walsh, Michael P.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada	British Columbia Cancer Agency; University of London; University College London; University of London; University College London; Monash University; University of British Columbia; University of Calgary	Maydan, M (corresponding author), BC Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC, Canada.	sdedhar@bccrc.ca		Ish-Horowicz, David/0000-0001-5684-7129; Dedhar, Shoukat/0000-0003-4355-1657; Rallis, Charalampos/0000-0002-4390-0266	Canadian Cancer Society Research Institute; Cancer Research UK; Canadian Institutes of Health Research	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Cancer Research UK(Cancer Research UK); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Cancer Society Research Institute (SD), Cancer Research UK (DIH) and the Canadian Institutes of Health Research (MPW). SignalChem Inc (JS and JY) produced and provided the recombinant proteins used in the study. As such, they were involved in data collection and preparation of the manuscript as it relates to the production of these recombinant proteins. The remaining funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Attwell S, 2003, MOL BIOL CELL, V14, P4813, DOI 10.1091/mbc.E03-05-0308; Bendig G, 2006, GENE DEV, V20, P2361, DOI 10.1101/gad.1448306; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; D'Amico M, 2000, J BIOL CHEM, V275, P32649, DOI 10.1074/jbc.M000643200; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Deng JT, 2002, BIOCHEM J, V367, P517, DOI 10.1042/BJ20020522; Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200; Edwards LA, 2005, ONCOGENE, V24, P3596, DOI 10.1038/sj.onc.1208427; Erdodi F, 2003, BIOCHEM BIOPH RES CO, V306, P382, DOI 10.1016/S0006-291X(03)00976-8; Esfandiarei M, 2006, CIRC RES, V99, P354, DOI 10.1161/01.RES.0000237022.72726.01; Eswaran J, 2009, P NATL ACAD SCI USA, V106, P20198, DOI 10.1073/pnas.0901989106; Eto M, 2009, J BIOL CHEM, V284, P35273, DOI 10.1074/jbc.R109.059972; Fielding AB, 2008, J CELL BIOL, V180, P681, DOI 10.1083/jcb.200710074; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Guo W, 2007, DEV BIOL, V306, P457, DOI 10.1016/j.ydbio.2007.03.019; HANKS SK, 1995, FASEB J, V9, P579; HANLEY RM, 1988, BIOCHEM BIOPH RES CO, V152, P122, DOI 10.1016/S0006-291X(88)80688-0; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Huang JA, 2006, BIOCHEM J, V396, P193, DOI 10.1042/BJ20051772; Imanishi Y, 2007, CANCER RES, V67, P4254, DOI 10.1158/0008-5472.CAN-06-4100; Joshi MB, 2007, FASEB J, V21, P3083, DOI 10.1096/fj.06-7723com; Kannan N, 2008, CELL, V133, P204, DOI 10.1016/j.cell.2008.04.005; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; Kiss E, 2002, BIOCHEM J, V365, P79, DOI 10.1042/BJ20011295; Knoll R, 2007, CIRCULATION, V116, P515, DOI 10.1161/CIRCULATIONAHA.107.689984; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Leung-Hagesteijn C, 2005, MOL CELL BIOL, V25, P3648, DOI 10.1128/MCB.25.9.3648-3657.2005; Liu E, 2005, MOL CELL BIOL, V25, P11145, DOI 10.1128/MCB.25.24.11145-11155.2005; Lovitt B, 2010, BIOCHEMISTRY-US, V49, P3092, DOI 10.1021/bi901726c; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; Muranyi A, 2002, BIOCHEM J, V366, P211, DOI 10.1042/BJ20020401; Naska S, 2006, J NEUROSCI, V26, P13344, DOI 10.1523/JNEUROSCI.4462-06.2006; Nho RS, 2005, J BIOL CHEM, V280, P26630, DOI 10.1074/jbc.M411798200; Novak A, 1998, P NATL ACAD SCI USA, V95, P4374, DOI 10.1073/pnas.95.8.4374; Oinuma I, 2007, J BIOL CHEM, V282, P303, DOI 10.1074/jbc.M607979200; Oloumi A, 2006, ONCOGENE, V25, P7747, DOI 10.1038/sj.onc.1209752; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Pinkse GGM, 2005, J HEPATOL, V42, P87, DOI 10.1016/j.jhep.2004.09.010; Quelo I, 2004, J BIOL CHEM, V279, P43893, DOI 10.1074/jbc.M406310200; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; Troussard AA, 2006, CANCER RES, V66, P393, DOI 10.1158/0008-5472.CAN-05-2304; Troussard AA, 1999, MOL CELL BIOL, V19, P7420; VANHOOK AM, 2010, SCI SIGNAL, V3, pEC133; Wang HV, 2008, J CELL BIOL, V180, P1037, DOI 10.1083/jcb.200707175; White DE, 2001, ONCOGENE, V20, P7064, DOI 10.1038/sj.onc.1204910; White DE, 2006, GENE DEV, V20, P2355, DOI 10.1101/gad.1458906; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Yamaji S, 2001, J CELL BIOL, V153, P1251, DOI 10.1083/jcb.153.6.1251; Yau CYF, 2005, CANCER RES, V65, P1497, DOI 10.1158/0008-5472.CAN-04-2940; Younes MN, 2007, ARCH OTOLARYNGOL, V133, P15, DOI 10.1001/archotol.133.1.15; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	61	67	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12356	10.1371/journal.pone.0012356	http://dx.doi.org/10.1371/journal.pone.0012356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20827300	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000281153500029
J	Han, JN; Sachdev, PS; Sidhu, KS				Han, Jinnuo; Sachdev, Perminder S.; Sidhu, Kuldip S.			A Combined Epigenetic and Non-Genetic Approach for Reprogramming Human Somatic Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; NUCLEAR TRANSFER; GENE-EXPRESSION; DEFINED FACTORS; ES CELLS; FIBROBLASTS; MOUSE; INDUCTION; EXTRACTS; GENERATION	Reprogramming of somatic cells to different extents has been reported using different methods. However, this is normally accompanied by the use of exogenous materials, and the overall reprogramming efficiency has been low. Chemicals and small molecules have been used to improve the reprogramming process during somatic cell nuclear transfer (SCNT) and induced pluripotent stem (iPS) cell generation. We report here the first application of a combined epigenetic and non-genetic approach for reprogramming somatic cells, i.e., DNA methyltransferase (DNMT) and histone deacetylase (HDAC) inhibitors, and human embryonic stem cell (hESC) extracts. When somatic cells were pretreated with these inhibitors before exposure to hESC (MEL1) extracts, morphological analysis revealed a higher rate of hESC-like colony formation than without pretreatment. Quantitative PCR (qPCR) demonstrated that pluripotency genes were upregulated when compared to those of somatic cells or treated with hESC extracts alone. Overall changes in methylation and acetylation levels of pretreated somatic cells suggests that epigenetic states of the cells have an effect on reprogramming efficiency induced by hESC extracts. KnockOutserum replacement (KOSR (TM)) medium (KO-SR) played a positive role in inducing expression of the pluripotency genes. hESC extracts could be an alternative approach to reprogram somatic cells without introducing exogenous materials. The epigenetic pre-treatment of somatic cells could be used to improve the efficiency of reprogramming process. Under differentiation conditions, the reprogrammed cells exhibited differentiation ability into neurons suggesting that, although fully reprogramming was not achieved, the cells could be transdifferentiated after reprogramming.	[Han, Jinnuo; Sachdev, Perminder S.; Sidhu, Kuldip S.] Univ New S Wales, Fac Med, Sydney, NSW, Australia	University of New South Wales Sydney	Han, JN (corresponding author), Univ New S Wales, Fac Med, Sydney, NSW, Australia.	k.sidhu@unsw.edu.au	SIDHU, kuldip/AAI-8361-2020; Sachdev, Perminder/ABC-1137-2020	Sachdev, Perminder/0000-0002-9595-3220	Australia National Health and Medical Research Council (NHRMC) [ID 568969]	Australia National Health and Medical Research Council (NHRMC)(National Health and Medical Research Council (NHMRC) of Australia)	The project was funded by Australia National Health and Medical Research Council (NHRMC) Program, grant ID 568969 (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberio R, 2005, EXP CELL RES, V307, P131, DOI 10.1016/j.yexcr.2005.02.028; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Balasubramanian S, 2009, STEM CELLS, V27, P3053, DOI 10.1002/stem.242; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bian YH, 2009, EPIGENETICS-US, V4, P194, DOI 10.4161/epi.4.3.8787; BRU T, 2008, EXPT CELL RES   0815, P2634; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Cheng J, 2004, GENESIS, V39, P100, DOI 10.1002/gene.20031; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Dashwood RH, 2006, CARCINOGENESIS, V27, P344, DOI 10.1093/carcin/bgi253; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Eilertsen KJ, 2007, ANIM REPROD SCI, V98, P129, DOI 10.1016/j.anireprosci.2006.10.019; El Kharroubi A, 2001, J BIOL CHEM, V276, P8674, DOI 10.1074/jbc.M009392200; Enright BP, 2003, BIOL REPROD, V69, P896, DOI 10.1095/biolreprod.103.017954; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Han J, 2008, CURR STEM CELL RES T, V3, P66; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hattori N, 2007, GENES CELLS, V12, P387, DOI 10.1111/j.1365-2443.2007.01058.x; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Hutchison CJ, 2004, NAT CELL BIOL, V6, P1062, DOI 10.1038/ncb1104-1062; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kimura H, 2004, MOL CELL BIOL, V24, P5710, DOI 10.1128/MCB.24.13.5710-5720.2004; Lagarkova MA, 2006, CELL CYCLE, V5, P416, DOI 10.4161/cc.5.4.2440; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li XY, 2008, STEM CELLS DEV, V17, P1079, DOI 10.1089/scd.2007.0247; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Miyamoto K, 2009, BIOL REPROD, V80, P935, DOI 10.1095/biolreprod.108.073676; Neri T, 2007, CLONING STEM CELLS, V9, P394, DOI 10.1089/clo.2006.0011; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Page RL, 2009, CLONING STEM CELLS, V11, P417, DOI 10.1089/clo.2009.0015; Pomp O, 2008, BRAIN RES, V1230, P50, DOI 10.1016/j.brainres.2008.07.029; Rajasingh J, 2008, CIRC RES, V102, pE107, DOI 10.1161/CIRCRESAHA.108.176115; Ruau D, 2008, STEM CELLS, V26, P920, DOI 10.1634/stemcells.2007-0649; Rybouchkin A, 2006, BIOL REPROD, V74, P1083, DOI 10.1095/biolreprod.105.047456; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taranger CK, 2005, MOL BIOL CELL, V16, P5719, DOI 10.1091/mbc.e05-06-0572; Turek-Plewa J, 2005, CELL MOL BIOL LETT, V10, P631; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wu Dongmei, 2009, J Vis Exp, DOI 10.3791/1553; Xu YN, 2009, ANAT REC, V292, P1229, DOI 10.1002/ar.20919; Zhao XY, 2010, NAT PROTOC, V5, P963, DOI 10.1038/nprot.2010.61; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	49	44	48	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12297	10.1371/journal.pone.0012297	http://dx.doi.org/10.1371/journal.pone.0012297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808872	Green Published, Green Submitted, gold			2022-12-27	WOS:000281075500024
J	Koch, M; Denzler, J; Redies, C				Koch, Michael; Denzler, Joachim; Redies, Christoph			1/f(2) Characteristics and Isotropy in the Fourier Power Spectra of Visual Art, Cartoons, Comics, Mangas, and Different Categories of Photographs	PLOS ONE			English	Article							NATURAL IMAGES; DRIP PAINTINGS; STATISTICS; SCENES; RECOGNITION; PERCEPTION; CORTEX; FACES; CELLS	Art images and natural scenes have in common that their radially averaged (1D) Fourier spectral power falls according to a power-law with increasing spatial frequency (1/f(2) characteristics), which implies that the power spectra have scale-invariant properties. In the present study, we show that other categories of man-made images, cartoons and graphic novels (comics and mangas), have similar properties. Further on, we extend our investigations to 2D power spectra. In order to determine whether the Fourier power spectra of man-made images differed from those of other categories of images (photographs of natural scenes, objects, faces and plants and scientific illustrations), we analyzed their 2D power spectra by principal component analysis. Results indicated that the first fifteen principal components allowed a partial separation of the different image categories. The differences between the image categories were studied in more detail by analyzing whether the mean power and the slope of the power gradients from low to high spatial frequencies varied across orientations in the power spectra. Mean power was generally higher in cardinal orientations both in real-world photographs and artworks, with no systematic difference between the two types of images. However, the slope of the power gradients showed a lower degree of mean variability across spectral orientations (i.e., more isotropy) in art images, cartoons and graphic novels than in photographs of comparable subject matters. Taken together, these results indicate that art images, cartoons and graphic novels possess relatively uniform 1/f(2) characteristics across all orientations. In conclusion, the man-made stimuli studied, which were presumably produced to evoke pleasant and/or enjoyable visual perception in human observers, form a subset of all images and share statistical properties in their Fourier power spectra. Whether these properties are necessary or sufficient to induce aesthetic perception remains to be investigated.	[Koch, Michael; Denzler, Joachim] Univ Jena, Dept Comp Sci, Jena, Germany; [Koch, Michael; Redies, Christoph] Univ Jena, Inst Anat 1, Sch Med, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Koch, M (corresponding author), Univ Jena, Dept Comp Sci, Jena, Germany.	redies@mti.uni-jena.de			German Research Council [RE 616/5-1]	German Research Council(German Research Foundation (DFG))	This work was supported by a grant from the German Research Council (grant number RE 616/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Ramirez J, 2008, PHYSICA A, V387, P281, DOI 10.1016/j.physa.2007.08.047; [Anonymous], 1973, LANGUAGES ART APPROA; Beauvois MW, 2007, MUSIC PERCEPT, V24, P247, DOI 10.1525/MP.2007.24.3.247; Bosworth RG, 2006, J OPT SOC AM A, V23, P2085, DOI 10.1364/JOSAA.23.002085; Burke E., 1757, PHILOS ENQUIRY ORIGI; BURTON GJ, 1987, APPL OPTICS, V26, P157, DOI 10.1364/AO.26.000157; Danto Arthur, 1981, TRANSFIGURATION COMM; Fechner G.T., 1876, VORSCHULE STHETIK; Fernandez D, 2008, PERCEPTION, V37, P1098, DOI 10.1068/p5814; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Geisler WS, 2008, ANNU REV PSYCHOL, V59, P167, DOI 10.1146/annurev.psych.58.110405.085632; Georghiades AS, 2001, IEEE T PATTERN ANAL, V23, P643, DOI 10.1109/34.927464; Graham DJ, 2008, PERCEPTION, V37, P1341, DOI 10.1068/p5971; Graham DJ, 2010, VISION RES, V50, P1503, DOI 10.1016/j.visres.2010.05.002; Graham DJ, 2008, SPATIAL VISION, V21, P149, DOI 10.1163/156856808782713771; Hansen BC, 2004, J VISION, V4, P1044, DOI 10.1167/4.12.5; Hoyer PO, 2002, NEUROCOMPUTING, V44, P459, DOI 10.1016/S0925-2312(02)00400-9; Hyvarinen A, 2009, COMPUT IMAGING VIS, V39, P1; Joye Y, 2007, REV GEN PSYCHOL, V11, P305, DOI 10.1037/1089-2680.11.4.305; Kandinsky Wassily, 1914, ART SPIRITUAL HARMON; Kant I., 1790, WERKAUSGABE ZWOLF BA; Lee A. B., 1999, P IEEE WORKSH STAT C, P1; Mahalanobis P.C., 1936, P NAT I SCI INDIA, V2, P49; Martinez A., 1998, AR FACE DATABASE CVC; MUREIKA JR, 2005, CHAOS, P15; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Olshausen BA, 1996, NETWORK-COMP NEURAL, V7, P333, DOI 10.1088/0954-898X/7/2/014; PAUL G, 1988, BEAUTY BRAIN BIOL AS, P15; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Redies C, 2007, NETWORK-COMP NEURAL, V18, P235, DOI 10.1080/09548980701574496; Redies C, 2008, SPATIAL VISION, V21, P97, DOI 10.1163/156856808782713780; Spehar B, 2003, COMPUT GRAPH-UK, V27, P813, DOI 10.1016/S0097-8493(03)00154-7; Taylor RP, 1999, NATURE, V399, P422, DOI 10.1038/20833; TOLHURST DJ, 1992, OPHTHAL PHYSL OPT, V12, P229, DOI 10.1111/j.1475-1313.1992.tb00296.x; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; Yu YG, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108103; Zeki S., 1999, J CONSCIOUSNESS STUD, V6, P76	45	43	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12268	10.1371/journal.pone.0012268	http://dx.doi.org/10.1371/journal.pone.0012268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808863	gold, Green Submitted, Green Published			2022-12-27	WOS:000281075500007
J	Seimon, TA; Kim, MJ; Blumenthal, A; Koo, J; Ehrt, S; Wainwright, H; Bekker, LG; Kaplan, G; Nathan, C; Tabas, I; Russell, DG				Seimon, Tracie A.; Kim, Mi-Jeong; Blumenthal, Antje; Koo, Jovanka; Ehrt, Sabine; Wainwright, Helen; Bekker, Linda-Gail; Kaplan, Gilla; Nathan, Carl; Tabas, Ira; Russell, David G.			Induction of ER Stress in Macrophages of Tuberculosis Granulomas	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; ADVANCED ATHEROSCLEROTIC LESIONS; OXIDATIVE STRESS; INNATE IMMUNITY; CELL-DEATH; APOPTOSIS; HOST; CHOLESTEROL; RECEPTORS	Background: The endoplasmic reticulum (ER) stress pathway known as the Unfolded Protein Response (UPR) is an adaptive survival pathway that protects cells from the buildup of misfolded proteins, but under certain circumstances it can lead to apoptosis. ER stress has been causally associated with macrophage apoptosis in advanced atherosclerosis of mice and humans. Because atherosclerosis shares certain features with tuberculosis (TB) with regard to lesional macrophage accumulation, foam cell formation, and apoptosis, we investigated if the ER stress pathway is activated during TB infection. Principal Findings: Here we show that ER stress markers such as C/EBP homologous protein (CHOP; also known as GADD153), phosphorylated inositol-requiring enzyme 1 alpha (Ire1 alpha) and eukaryotic initiation factor 2 alpha (eIF2 alpha), and activating transcription factor 3 (ATF3) are expressed in macrophage-rich areas of granulomas in lungs of mice infected with virulent Mycobacterium tuberculosis (Mtb). These areas were also positive for numerous apoptotic cells as assayed by TUNEL. Microarray analysis of human caseous TB granulomas isolated by laser capture microdissection reveal that 73% of genes involved in the UPR are upregulated at the mRNA transcript level. The expression of two ER stress markers, ATF3 and CHOP, were also increased in macrophages of human TB granulomas when assayed by immunohistochemistry. CHOP has been causally associated with ER stress-induced macrophage apoptosis. We found that apoptosis was more abundant in granulomas as compared to non-granulomatous tissue isolated from patients with pulmonary TB, and apoptosis correlated with CHOP expression in areas surrounding the centralized areas of caseation. Conclusions: In summary, ER stress is induced in macrophages of TB granulomas in areas where apoptotic cells accumulate in mice and humans. Although macrophage apoptosis is generally thought to be beneficial in initially protecting the host from Mtb infection, death of infected macrophages in advanced granulomas might favor dissemination of the bacteria. Therefore future work is needed to determine if ER-stress is causative for apoptosis and plays a role in the host response to infection.	[Seimon, Tracie A.] Columbia Univ, Dept Med, Div Mol Med, New York, NY 10027 USA; [Kim, Mi-Jeong; Russell, David G.] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA; [Blumenthal, Antje; Koo, Jovanka; Ehrt, Sabine; Nathan, Carl] Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med Coll, New York, NY 10021 USA; [Wainwright, Helen] UCT Fac Hlth Sci, Div Anat Pathol, Cape Town, South Africa; [Bekker, Linda-Gail] Univ Cape Town, Dept Med, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Kaplan, Gilla] Univ Med & Dent New Jersey, PHRI Ctr, Lab Mycobacterial Immun & Pathogenesis, Newark, NJ 07103 USA; [Tabas, Ira] Columbia Univ, Dept Med, Dept Pathol & Cell Biol, New York, NY USA	Columbia University; Cornell University; Cornell University; University of Cape Town; University of Cape Town; Rutgers State University New Brunswick; Rutgers State University Medical Center; Columbia University	Seimon, TA (corresponding author), Columbia Univ, Dept Med, Div Mol Med, New York, NY 10027 USA.	tseimon@wcs.org	Bekker, Linda-Gail/AAZ-8929-2020; Russell, David G/D-4533-2009; Blumenthal, Antje/A-3608-2011; Ehrt, Sabine/AAU-6449-2020; Russell, David G/N-5280-2019	Russell, David G/0000-0002-9748-750X; Blumenthal, Antje/0000-0003-3673-7015; Russell, David G/0000-0002-9748-750X; BEKKER, LINDA-GAIL/0000-0002-0755-4386	National Institutes of Health [NHLBI 055936, NIAID 057086, RO1AI05338, NHLBI 075662]; American Heart Association [0735594T]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from the National Institutes of Health NHLBI 055936 and NIAID 057086 to DGR, RO1AI05338 to GK, and NHLBI 075662 to IT, and an American Heart Association Scientist Development Grant 0735594T (TAS). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055; Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Choi HH, 2010, FEBS LETT, V584, P2445, DOI 10.1016/j.febslet.2010.04.050; Cruz D, 2008, J CLIN INVEST, V118, P2917, DOI 10.1172/JCI34189; D'Avila H, 2006, J IMMUNOL, V176, P3087, DOI 10.4049/jimmunol.176.5.3087; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Dickhout JG, 2005, ARTERIOSCL THROM VAS, V25, P2623, DOI 10.1161/01.ATV.0000189159.96900.d9; Ernst JD, 1998, INFECT IMMUN, V66, P1277, DOI 10.1128/IAI.66.4.1277-1281.1998; Fayyazi A, 2000, J PATHOL, V191, P417, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH664&gt;3.0.CO;2-R; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fratazzi C, 1999, J LEUKOCYTE BIOL, V66, P763, DOI 10.1002/jlb.66.5.763; Gartner T, 2008, VACCINE, V26, P1458, DOI 10.1016/j.vaccine.2007.12.056; Haworth R, 1997, J EXP MED, V186, P1431, DOI 10.1084/jem.186.9.1431; Heldwein KA, 2003, J LEUKOCYTE BIOL, V74, P277, DOI 10.1189/jlb.0103026; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Hunter RL, 2007, TUBERCULOSIS, V87, P267, DOI 10.1016/j.tube.2006.11.003; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; KONDO E, 1971, JPN J MED SCI BIOL, V24, P345, DOI 10.7883/yoken1952.24.345; KONDO E, 1976, JPN J MED SCI BIOL, V29, P123, DOI 10.7883/yoken1952.29.123; Kornfeld H, 1999, CELL DEATH DIFFER, V6, P71, DOI 10.1038/sj.cdd.4400454; Kusner DJ, 2005, CLIN IMMUNOL, V114, P239, DOI 10.1016/j.clim.2004.07.016; Lee SH, 2009, INT ECON REV, V50, P1, DOI 10.1111/j.1468-2354.2008.00522.x; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Lim WS, 2008, CIRCULATION, V117, P940, DOI 10.1161/CIRCULATIONAHA.107.711275; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Malik ZA, 2001, J IMMUNOL, V166, P3392, DOI 10.4049/jimmunol.166.5.3392; Manning-Tobin JJ, 2009, ARTERIOSCL THROM VAS, V29, P19, DOI 10.1161/ATVBAHA.108.176644; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Placido R, 2006, CELL IMMUNOL, V244, P10, DOI 10.1016/j.cellimm.2007.02.001; Pluddemann Annette, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000159; Riendeau CJ, 2003, INFECT IMMUN, V71, P254, DOI 10.1128/IAI.71.1.254-259.2003; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; SEIMON T, 2010, CELL METABO IN PRESS; SEIMON T, 2009, J CLIN INVEST, V119; Seimon T, 2009, J LIPID RES, V50, pS382, DOI 10.1194/jlr.R800032-JLR200; Seimon TA, 2006, P NATL ACAD SCI USA, V103, P19794, DOI 10.1073/pnas.0609671104; Shi SP, 2005, J IMMUNOL, V175, P3318, DOI 10.4049/jimmunol.175.5.3318; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; TABAS I, 2002, BIOCH LIPIDS LIPOPRO, P573; Tamaki N, 2008, AM J PHYSIOL-GASTR L, V294, pG498, DOI 10.1152/ajpgi.00482.2007; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Thuerauf DJ, 2006, CIRC RES, V99, P275, DOI 10.1161/01.RES.0000233317.70421.03; Williams BL, 2006, J VIROL, V80, P8613, DOI 10.1128/JVI.00836-06; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1	56	93	94	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12772	10.1371/journal.pone.0012772	http://dx.doi.org/10.1371/journal.pone.0012772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856677	Green Published, gold, Green Submitted			2022-12-27	WOS:000281815800030
J	Ahmed, SM; Zerihun, A				Ahmed, Syed Masud; Zerihun, Abebual			Possession and Usage of Insecticidal Bed Nets among the People of Uganda: Is BRAC Uganda Health Programme Pursuing a Pro-Poor Path?	PLOS ONE			English	Article							TREATED NETS; MALARIA CONTROL; PREGNANT-WOMEN; COVERAGE; BEDNETS; AFRICA; ACCEPTABILITY; ELIMINATION; PREFERENCE; CAMPAIGN	Background: The use of insecticidal bed nets is found to be an effective public health tool for control of malaria, especially for under-five children and pregnant women. BRAC, an indigenous Bangladeshi non-governmental development organization, started working in the East African state of Uganda in June 2006. As part of its efforts to improve the health and well-being of its participants, BRAC Uganda has been distributing long lasting insecticide-treated bed nets (LLIN) at a subsidized price through health volunteers since February 2008. This study was conducted in March-April 2009 to examine how equitable the programme had been in consistence with BRAC Uganda's pro-poor policy. Methodology/Principal Findings: Information on possession of LLINs and relevant knowledge on its proper use and maintenance was collected from households either with an under-five child and/or a pregnant woman. The sample included three villages from each of the 10 branch offices where BRAC Uganda's community-based health programme was operating. Data were collected by trained enumerators through face-to-face interviews using a hand-held personal digital assistant (PDA). Findings reveal that the study population had superficial knowledge on malaria and its transmission, including the use and maintenance of LLINs. The households' rate of possession of bed nets (41-59%), and the proportion of under-five children (17-19%) and pregnant women (25-27%) who reported sleeping under an LLIN were not encouraging. Inequity was observed in the number of LLINs possessed by the households, in the knowledge on its use and maintenance, and between the two programme areas. Conclusions/Significance: The BRAC Uganda's LLINs distribution at a subsidized price appeared to be inadequate and inequitable, and BRAC's knowledge dissemination is insufficient for initiating preventive actions such as proper use of LLINs to interrupt malaria transmission. Findings contribute to the on-going debate on LLINs distribution in Africa and make a strong case for its free distribution.	[Ahmed, Syed Masud] BRAC, Res & Evaluat Div, Dhaka, Bangladesh; [Zerihun, Abebual] BRAC, Evaluat & Res Unit, E Africa Programmes, Kampala, Uganda	Bangladesh Rural Advancement Committee BRAC	Ahmed, SM (corresponding author), BRAC, Res & Evaluat Div, Dhaka, Bangladesh.	ahmed.sm@brac.net	Ahmed, Syed Masud/AGQ-4786-2022; Ahmed, Syed/GSN-7305-2022	Ahmed, Syed Masud/0000-0001-5032-7181; 	MasterCard Foundation	MasterCard Foundation	The MasterCard Foundation provided funding for this research including the use of PDAs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla S, 2001, BMJ-BRIT MED J, V322, P270, DOI 10.1136/bmj.322.7281.270; [Anonymous], 2007, INS TREAT NETS POS S, P12; [Anonymous], 1998, COCHRANE DB SYST REV; Atkinson JA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-298; Atkinson JA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-119; Bates N, 2007, AM J TROP MED HYG, V77, P314, DOI 10.4269/ajtmh.2007.77.314; BEER N, 2010, TANZANIA MALARIA J, V9, P173, DOI DOI 10.1186/1475-2875-9-173; *BRAC, 2007, ANN REP 2006; De La Cruz N, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-61; Gamble C, 2007, PLOS MED, V4, P506, DOI 10.1371/journal.pmed.0040107; GARBOWSKY M, 2005, B WORLD HEALTH ORGAN, V83, P195; Grabowsky M, 2007, TROP MED INT HEALTH, V12, P815, DOI 10.1111/j.1365-3156.2007.01862.x; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Guyatt HL, 2002, TROP MED INT HEALTH, V7, P409, DOI 10.1046/j.1365-3156.2002.00879.x; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Howard N, 2003, TROP MED INT HEALTH, V8, P1043, DOI 10.1046/j.1365-3156.2003.01163.x; *MIN HLTH MAL CONT, 2005, UG MAL CONTR STRAT P; Nabarro DN, 1998, SCIENCE, V280, P2067, DOI 10.1126/science.280.5372.2067; Nganda RY, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-42; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; *ROLL BACK MAL WHO, 2003, AB DECL AFR SUMM ROL; Snow RW, 2008, PLOS MED, V5, P1068, DOI 10.1371/journal.pmed.0050142; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Teklehaimanot A, 2007, AM J TROP MED HYG, V77, P138, DOI 10.4269/ajtmh.2007.77.138; Teklehaimanot A, 2007, LANCET, V369, P2143, DOI 10.1016/S0140-6736(07)60951-9; Thwing J, 2008, TROP MED INT HEALTH, V13, P827, DOI 10.1111/j.1365-3156.2008.02070.x; Webster J, 2005, LANCET INFECT DIS, V5, P709, DOI 10.1016/S1473-3099(05)70269-3; *WHO, 2007, INS TREAT MOSQ NTS W	29	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12660	10.1371/journal.pone.0012660	http://dx.doi.org/10.1371/journal.pone.0012660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844749	Green Published, gold			2022-12-27	WOS:000281687300007
J	Law, JH; Li, Y; To, K; Wang, M; Astanehe, A; Lambie, K; Dhillon, J; Jones, SJM; Gleave, ME; Eaves, CJ; Dunn, SE				Law, Jennifer H.; Li, Yvonne; To, Karen; Wang, Michelle; Astanehe, Arezoo; Lambie, Karen; Dhillon, Jaspreet; Jones, Steven J. M.; Gleave, Martin E.; Eaves, Connie J.; Dunn, Sandra E.			Molecular Decoy to the Y-Box Binding Protein-1 Suppresses the Growth of Breast and Prostate Cancer Cells whilst Sparing Normal Cell Viability	PLOS ONE			English	Article							RIBOSOMAL S6 KINASE; FACTOR RECEPTOR; NUCLEAR EXPRESSION; ANDROGEN RECEPTOR; YB-1; PROGRESSION; DIFFERENTIATION; GLIOBLASTOMA; RESISTANCE; INHIBITION	The Y-box binding protein-1 (YB-1) is an oncogenic transcription/translation factor that is activated by phosphorylation at S102 whereby it induces the expression of growth promoting genes such as EGFR and HER-2. We recently illustrated by an in vitro kinase assay that a novel peptide to YB-1 was highly phosphorylated by the serine/threonine p90 S6 kinases RSK-1 and RSK-2, and to a lesser degree PKC alpha and AKT. Herein, we sought to develop this decoy cell permeable peptide (CPP) as a cancer therapeutic. This 9-mer was designed as an interference peptide that would prevent endogenous YB-1 S-102 phosphorylation based on molecular docking. In cancer cells, the CPP blocked P-YB-1(S102) and down-regulated both HER-2 and EGFR transcript level and protein expression. Further, the CPP prevented YB-1 from binding to the EGFR promoter in a gel shift assay. Notably, the growth of breast (SUM149, MDA-MB-453, AU565) and prostate (PC3, LNCap) cancer cells was inhibited by similar to 90% with the CPP. Further, treatment with this peptide enhanced sensitivity and overcame resistance to trastuzumab in cells expressing amplified HER-2. By contrast, the CPP had no inhibitory effect on the growth of normal immortalized breast epithelial (184htert) cells, primary breast epithelial cells, nor did it inhibit differentiation of hematopoietic progenitors. These data collectively suggest that the CPP is a novel approach to suppressing the growth of cancer cells while sparing normal cells and thereby establishes a proof-of-concept that blocking YB-1 activation is a new course of cancer therapeutics.	[Law, Jennifer H.; To, Karen; Wang, Michelle; Astanehe, Arezoo; Dhillon, Jaspreet; Dunn, Sandra E.] Univ British Columbia, Lab Oncogenom Res, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada; [Li, Yvonne; Jones, Steven J. M.] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC, Canada; [Gleave, Martin E.] Univ British Columbia, Vancouver Gen Hosp, Prostate Ctr, Vancouver, BC V5Z 1M9, Canada; [Lambie, Karen; Eaves, Connie J.] Univ British Columbia, Terry Fox Labs, BC Canc Agcy, Vancouver, BC V5Z 1M9, Canada	Child & Family Research Institute; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Law, JH (corresponding author), Univ British Columbia, Lab Oncogenom Res, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada.	sedunn@interchange.ubc.ca	Li, Yvonne/M-2459-2019; Wang, Michelle/GYA-3899-2022; Jones, Steven J/C-3621-2009	Jones, Steven J/0000-0003-3394-2208; Eaves, Connie/0000-0002-3452-1926	Canadian Institute for Health Research [CIHR PPP-82580]; National Cancer Institute of Canada [NCIC 016512, NCIC 017192]; Canadian Breast Cancer Research Alliance	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Breast Cancer Research Alliance	This work was funded through grants provided by the Canadian Institute for Health Research Proof-of-Principle Grant (CIHR PPP-82580; www.cihr-irsc.gc.ca), the National Cancer Institute of Canada (NCIC 016512 and NCIC 017192; http://www.cancer.ca/Research.aspx?sc_lang=en), and the Canadian Breast Cancer Research Alliance (www.breast.cancer.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Altieri DC, 2006, MOL CANCER THER, V5, P478, DOI 10.1158/1535-7163.MCT-05-0436; Bargou RC, 1997, NAT MED, V3, P447, DOI 10.1038/nm0497-447; Bidwell GL, 2009, J CONTROL RELEASE, V135, P2, DOI 10.1016/j.jconrel.2008.11.015; Browne BC, 2009, CURR CANCER DRUG TAR, V9, P419, DOI 10.2174/156800909788166484; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Chatterjee M, 2008, BLOOD, V111, P3714, DOI 10.1182/blood-2007-05-089151; Clark DE, 2005, CANCER RES, V65, P3108; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Faury D, 2007, J CLIN ONCOL, V25, P1196, DOI 10.1200/JCO.2006.07.8626; Gao YY, 2009, MOL CANCER THER, V8, P3276, DOI 10.1158/1535-7163.MCT-09-0478; Gimenez-Bonafe P, 2004, PROSTATE, V59, P337, DOI 10.1002/pros.20023; Gu CD, 2001, ANTICANCER RES, V21, P2357; Habibi G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2156; Hadaschik BA, 2007, CURR OPIN UROL, V17, P182, DOI 10.1097/MOU.0b013e3280dd8a4f; Hogge DE, 1996, BLOOD, V88, P3765, DOI 10.1182/blood.V88.10.3765.bloodjournal88103765; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kabouridis PS, 2003, TRENDS BIOTECHNOL, V21, P498, DOI 10.1016/j.tibtech.2003.09.008; Kashihara M, 2009, J THORAC ONCOL, V4, P1066, DOI 10.1097/JTO.0b013e3181ae2828; Law JH, 2008, CANCER RES, V68, P10238, DOI 10.1158/0008-5472.CAN-08-2755; Lee C, 2008, CANCER RES, V68, P8661, DOI 10.1158/0008-5472.CAN-08-1082; Marrett LD, 2008, CAN MED ASSOC J, V179, P1163, DOI 10.1503/cmaj.080760; Mellado B, 2009, CLIN TRANSL ONCOL, V11, P5, DOI 10.1007/s12094-009-0304-3; Oda Y, 1998, CLIN CANCER RES, V4, P2273; Orange JS, 2008, CELL MOL LIFE SCI, V65, P3564, DOI 10.1007/s00018-008-8222-z; Plescia J, 2005, CANCER CELL, V7, P457, DOI 10.1016/j.ccr.2005.03.035; Prive GG, 2006, CURR OPIN GENET DEV, V16, P71, DOI 10.1016/j.gde.2005.12.010; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Shibahara K, 2001, CLIN CANCER RES, V7, P3151; Shibao K, 1999, INT J CANCER, V83, P732; Smith JA, 2005, CANCER RES, V65, P1027; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stingl J, 1998, DIFFERENTIATION, V63, P201, DOI 10.1111/j.1432-0436.1998.00201.x; Stingl J, 2005, J MAMMARY GLAND BIOL, V10, P49, DOI 10.1007/s10911-005-2540-7; Stratford AL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1767; Stratford AL, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2202; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; To K, 2007, MOL PHARMACOL, V72, P641, DOI 10.1124/mol.107.036111; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; WU J, 2007, TRANSL ONCOGENOMICS, V2, P1; Wu J, 2006, CANCER RES, V66, P4872, DOI 10.1158/0008-5472.CAN-05-3561; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yoshikawa T, 2009, BIOMATERIALS, V30, P3318, DOI 10.1016/j.biomaterials.2009.02.031	46	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12661	10.1371/journal.pone.0012661	http://dx.doi.org/10.1371/journal.pone.0012661			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844753	Green Published, gold, Green Submitted			2022-12-27	WOS:000281687300008
J	Pham, N; Fazio, V; Cucullo, L; Teng, QS; Biberthaler, P; Bazarian, JJ; Janigro, D				Pham, Nancy; Fazio, Vincent; Cucullo, Luca; Teng, Qingshan; Biberthaler, Peter; Bazarian, Jeffrey J.; Janigro, Damir			Extracranial Sources of S100B Do Not Affect Serum Levels	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; NEURON-SPECIFIC ENOLASE; MINOR HEAD TRAUMA; ACUTE ISCHEMIC-STROKE; S-100B PROTEIN; BARRIER DISRUPTION; CARDIAC-SURGERY; PERIPHERAL MARKERS; BLOOD; DAMAGE	S100B, established as prevalent protein of the central nervous system, is a peripheral biomarker for blood-brain barrier disruption and often also a marker of brain injury. However, reports of extracranial sources of S100B, especially from adipose tissue, may confound its interpretation in the clinical setting. The objective of this study was to characterize the tissue specificity of S100B and assess how extracranial sources of S100B affect serum levels. The extracranial sources of S100B were determined by analyzing nine different types of human tissues by ELISA and Western blot. In addition, brain and adipose tissue were further analyzed by mass spectrometry. A study of 200 subjects was undertaken to determine the relationship between body mass index (BMI) and S100B serum levels. We also measured the levels of S100B homo- and heterodimers in serum quantitatively after blood-brain barrier disruption. Analysis of human tissues by ELISA and Western blot revealed variable levels of S100B expression. By ELISA, brain tissue expressed the highest S100B levels. Similarly, Western blot measurements revealed that brain tissue expressed high levels of S100B but comparable levels were found in skeletal muscle. Mass spectrometry of brain and adipose tissue confirmed the presence of S100B but also revealed the presence of S100A1. The analysis of 200 subjects revealed no statistically significant relationship between BMI and S100B levels. The main species of S100B released from the brain was the B-B homodimer. Our results show that extracranial sources of S100B do not affect serum levels. Thus, the diagnostic value of S100B and its negative predictive value in neurological diseases in intact subjects (without traumatic brain or bodily injury from accident or surgery) are not compromised in the clinical setting.	[Pham, Nancy; Janigro, Damir] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland Clin Fdn, Cleveland, OH 44106 USA; [Fazio, Vincent; Cucullo, Luca] Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA; [Biberthaler, Peter] Univ Munich, Surg Dept Munich Cent, Munich, Germany; [Bazarian, Jeffrey J.] Univ Rochester, Sch Med, Dept Emergency Med, Rochester, NY USA	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Munich; University of Rochester	Pham, N (corresponding author), Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland Clin Fdn, Cleveland, OH 44106 USA.	janigrd@ccf.org	Cucullo, Luca/X-2765-2019	Cucullo, Luca/0000-0002-2827-7162; Janigro, Damir/0000-0003-2165-5826	Roche Diagnostics [RO1 NS43284, RO1 NS38195, R21 HD057256]; Cleveland Clinic- Swedish Satellite Laboratory Feasibility Project, Federal Appropriation Washington State; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD057256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043284, R01NS038195] Funding Source: NIH RePORTER	Roche Diagnostics; Cleveland Clinic- Swedish Satellite Laboratory Feasibility Project, Federal Appropriation Washington State; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by RO1 NS43284, RO1 NS38195, R21 HD057256 to Damir Janigro. It was also supported by "A Prospective Pilot Study on S100B in TBI" funded by Roche Diagnostics and by the Cleveland Clinic- Swedish Satellite Laboratory Feasibility Project, Federal Appropriation Washington State. None of the funding agencies had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Khaliq H, 2000, CLIN CHEM LAB MED, V38, P1173, DOI 10.1515/CCLM.2000.181; Abdul-Khaliq H, 2000, CLIN CHEM LAB MED, V38, P1169, DOI 10.1515/CCLM.2000.180; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; AURELL A, 1991, STROKE, V22, P1254, DOI 10.1161/01.STR.22.10.1254; BAUDIER J, 1986, J BIOL CHEM, V261, P8204; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Biberthaler P, 2002, EUR J MED RES, V7, P164; Biberthaler P, 2000, ACT NEUR S, V76, P177; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Biberthaler P, 2001, SHOCK, V16, P97, DOI 10.1097/00024382-200116020-00002; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Dassan P, 2009, CEREBROVASC DIS, V27, P295, DOI 10.1159/000199468; DONATO R, 2001, INT J BIOCHEM CELL B, V637, P668; Fazio V, 2004, ANN THORAC SURG, V78, P46, DOI 10.1016/j.athoracsur.2003.11.042; Foerch C, 2007, STROKE, V38, P2491, DOI 10.1161/STROKEAHA.106.480111; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Goncalves CA, 2008, CLIN BIOCHEM, V41, P755, DOI 10.1016/j.clinbiochem.2008.04.003; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Herrmann M, 1999, RESTOR NEUROL NEUROS, V14, P109; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Korfias S, 2006, CURR MED CHEM, V13, P3719, DOI 10.2174/092986706779026129; Mann M, 2008, J PROTEOME RES, V7, P3065, DOI 10.1021/pr800463v; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Marchi N, 2003, J NEUROSCI, V23, P1949; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Mazzone PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007242; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; Mussack T, 2000, ACT NEUR S, V76, P393; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Pelinka LE, 2004, SHOCK, V21, P72, DOI 10.1097/01.shk.0000101672.49265.14; Pineau JC, 2007, ANN NUTR METAB, V51, P421, DOI 10.1159/000111161; Portela LVC, 2002, CLIN CHEM, V48, P950; Raabe A, 1998, J NEUROL NEUROSUR PS, V65, P930, DOI 10.1136/jnnp.65.6.930; Raabe A, 2003, RESTOR NEUROL NEUROS, V21, P159; Rothermundt M, 2004, INT REV NEUROBIOL, V59, P445; Ruan S, 2009, J NEUROTRAUM, V26, P1655, DOI [10.1089/neu.2009.0928, 10.1089/neu.2009-0928]; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; Steiner J, 2010, PSYCHONEUROENDOCRINO, V35, P321, DOI 10.1016/j.psyneuen.2009.07.012; Vogelbaum MA, 2005, CANCER-AM CANCER SOC, V104, P817, DOI 10.1002/cncr.21220; Watson P, 2005, AM J PHYSIOL-REG I, V288, pR1689, DOI 10.1152/ajpregu.00676.2004	48	94	98	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12691	10.1371/journal.pone.0012691	http://dx.doi.org/10.1371/journal.pone.0012691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844757	Green Submitted, gold, Green Published			2022-12-27	WOS:000281687300022
J	Ali, M; Al-Olayan, EM; Lewis, S; Matthews, H; Hurd, H				Ali, Medhat; Al-Olayan, Ebtesam M.; Lewis, Steven; Matthews, Holly; Hurd, Hilary			Naturally Occurring Triggers that Induce Apoptosis-Like Programmed Cell Death in Plasmodium berghei Ookinetes	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ANOPHELES-STEPHENSI; PUTATIVE ROLE; MIDGUT CELLS; MALARIA INFECTION; TRYPANOSOMA-CRUZI; ENDONUCLEASE-G; IN-VITRO; FALCIPARUM; MECHANISM	Several protozoan parasites have been shown to undergo a form of programmed cell death that exhibits morphological features associated with metazoan apoptosis. These include the rodent malaria parasite, Plasmodium berghei. Malaria zygotes develop in the mosquito midgut lumen, forming motile ookinetes. Up to 50% of these exhibit phenotypic markers of apoptosis; as do those grown in culture. We hypothesised that naturally occurring signals induce many ookinetes to undergo apoptosis before midgut traversal. To determine whether nitric oxide and reactive oxygen species act as such triggers, ookinetes were cultured with donors of these molecules. Exposure to the nitric oxide donor SNP induced a significant increase in ookinetes with condensed nuclear chromatin, activated caspase-like molecules and translocation of phosphatidylserine that was dose and time related. Results from an assay that detects the potential-dependent accumulation of aggregates of JC-1 in mitochondria suggested that nitric oxide does not operate via loss of mitochondrial membrane potential. L-DOPA (reactive oxygen species donor) also caused apoptosis in a dose and time dependent manner. Removal of white blood cells significantly decreased ookinetes exhibiting a marker of apoptosis in vitro. Inhibition of the activity of nitric oxide synthase in the mosquito midgut epithelium using L-NAME significantly decreased the proportion of apoptotic ookinetes and increased the number of oocysts that developed. Introduction of a nitric oxide donor into the blood meal had no effect on mosquito longevity but did reduce prevalence and intensity of infection. Thus, nitric oxide and reactive oxygen species are triggers of apoptosis in Plasmodium ookinetes. They occur naturally in the mosquito midgut lumen, sourced from infected blood and mosquito tissue. Up regulation of mosquito nitric oxide synthase activity has potential as a transmission blocking strategy.	[Ali, Medhat; Al-Olayan, Ebtesam M.; Lewis, Steven; Matthews, Holly; Hurd, Hilary] Univ Keele, Sch Life Sci, Keele ST5 5BG, Staffs, England; [Ali, Medhat] Ain Shams Univ, Dept Zool, Cairo, Egypt; [Al-Olayan, Ebtesam M.] King Saud Univ, Dept Zool, Riyadh, Saudi Arabia	Keele University; Egyptian Knowledge Bank (EKB); Ain Shams University; King Saud University	Ali, M (corresponding author), Univ Keele, Sch Life Sci, Keele ST5 5BG, Staffs, England.	h.hurd@keele.ac.uk	Ali, Medhat M/L-9546-2013	Ali, Medhat M/0000-0002-1695-9772	Wellcome Trust [069162/Z/02/Z]; Saudi Arabian Government; Egyptian Government	Wellcome Trust(Wellcome TrustEuropean Commission); Saudi Arabian Government; Egyptian Government	Funding for insectary facilities was provided by The Wellcome Trust, (069162/Z/02/Z), www.wellcome.ac.uk. EMA and MA received scholarships from the Saudi Arabian Government and the Egyptian Government, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahmed AM, 2006, MICROBES INFECT, V8, P308, DOI 10.1016/j.micinf.2005.06.026; Akman-Anderson L, 2007, INFECT IMMUN, V75, P4012, DOI 10.1128/IAI.00645-07; Al-Olayan EM, 2002, INT J PARASITOL, V32, P1133, DOI 10.1016/S0020-7519(02)00087-5; Algeciras-Schimnich A, 2002, CURR OPIN CELL BIOL, V14, P721, DOI 10.1016/S0955-0674(02)00384-8; Ambit A, 2008, CELL DEATH DIFFER, V15, P113, DOI 10.1038/sj.cdd.4402232; Ameisen JC, 2004, CELL DEATH DIFFER, V11, P4, DOI 10.1038/sj.cdd.4401356; Ameisen JC, 2002, CELL DEATH DIFFER, V9, P367, DOI 10.1038/sj.cdd.4400950; Arambage SC, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-32; Aravind L, 2001, SCIENCE, V291, P1279, DOI 10.1126/science.291.5507.1279; Bai P, 2001, FREE RADICAL BIO MED, V31, P1616, DOI 10.1016/S0891-5849(01)00756-0; Balmer P, 2000, PARASITE IMMUNOL, V22, P97, DOI 10.1046/j.1365-3024.2000.00281.x; Baton Luke A., 2008, P74, DOI 10.1007/978-0-387-76717-8_7; Borner C, 1999, CELL DEATH DIFFER, V6, P497, DOI 10.1038/sj.cdd.4400525; Bras M, 2005, BIOCHEMISTRY-MOSCOW+, V70, P231, DOI 10.1007/s10541-005-0105-4; Bruchhaus I, 2007, TRENDS PARASITOL, V23, P376, DOI 10.1016/j.pt.2007.06.004; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Cao Ya-Ming, 1998, Parasitology International, V47, P225, DOI 10.1016/S1383-5769(98)00026-9; Carter V, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-35; Carter V, 2007, INT J PARASITOL, V37, P1221, DOI 10.1016/j.ijpara.2007.03.005; Ch'ng JH, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.2; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Colasanti M, 2001, TRENDS PARASITOL, V17, P575, DOI 10.1016/S1471-4922(01)02191-2; Crampton A, 2001, INFECT GENET EVOL, V1, P131, DOI 10.1016/S1567-1348(01)00017-X; Das R, 2008, APOPTOSIS, V13, P867, DOI 10.1007/s10495-008-0224-7; Debrabant A, 2003, INT J PARASITOL, V33, P257, DOI 10.1016/S0020-7519(03)00008-0; Debrabant Alain, 2003, Kinetoplastid Biology and Disease, V2, pUnpaginated, DOI 10.1186/1475-9292-2-7; Deponte M, 2008, BBA-MOL CELL RES, V1783, P1396, DOI 10.1016/j.bbamcr.2008.01.018; Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115; DING AH, 1988, J IMMUNOL, V141, P2407; Duszenko M, 2006, TRENDS PARASITOL, V22, P536, DOI 10.1016/j.pt.2006.08.010; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; Figarella K, 2006, CELL DEATH DIFFER, V13, P1802, DOI 10.1038/sj.cdd.4401862; Fuertes Miguel A., 2008, P1; Galluzzi L, 2008, CELL DEATH DIFFER, V15, P1113, DOI 10.1038/cdd.2008.28; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Gannavaram S, 2008, J CELL SCI, V121, P99, DOI 10.1242/jcs.014050; Getti GT, 2008, PARASITOLOGY, V135, P1391, DOI 10.1017/S0031182008004915; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Harada M, 2001, PARASITOL RES, V87, P605, DOI 10.1007/s004360100432; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Herrera-Ortiz A, 2004, INSECT BIOCHEM MOLEC, V34, P893, DOI 10.1016/j.ibmb.2004.05.007; Holzmuller P, 2006, PARASITOLOGY, V132, pS19, DOI 10.1017/S0031182006000837; Jaramillo M, 2003, J IMMUNOL, V171, P4243, DOI 10.4049/jimmunol.171.8.4243; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim KM, 2002, J BIOCHEM MOL BIOL, V35, P127; Kobayashi T, 2003, CELL DEATH DIFFER, V10, P634, DOI 10.1038/sj.cdd.4401216; Koonin EV, 2002, CELL DEATH DIFFER, V9, P394, DOI 10.1038/sj.cdd.4400991; Kosec G, 2006, MOL BIOCHEM PARASIT, V145, P18, DOI 10.1016/j.molbiopara.2005.09.001; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200; Lanz-Mendoza H, 2002, J PARASITOL, V88, P702, DOI 10.1645/0022-3395(2002)088[0702:SAIAAH]2.0.CO;2; Le Chat L, 2007, MOL BIOCHEM PARASIT, V153, P41, DOI 10.1016/j.molbiopara.2007.01.016; Lee N, 2007, EUKARYOT CELL, V6, P1745, DOI 10.1128/EC.00123-07; Lensen AHW, 1997, INFECT IMMUN, V65, P3834, DOI 10.1128/IAI.65.9.3834-3837.1997; Lim JH, 2005, INFECT IMMUN, V73, P2778, DOI 10.1128/IAI.73.5.2778-2789.2005; Luckhart S, 2003, INFECT IMMUN, V71, P3000, DOI 10.1128/IAI.71.6.3000-3009.2003; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; Luckhart S, 2003, MOL BIOCHEM PARASIT, V128, P83, DOI 10.1016/S0166-6851(03)00016-1; Madeo F, 2009, BIOCHEM BIOPH RES CO, V382, P227, DOI 10.1016/j.bbrc.2009.02.117; Mariante RM, 2003, HISTOCHEM CELL BIOL, V120, P129, DOI 10.1007/s00418-003-0548-x; Marrelli MT, 2007, P NATL ACAD SCI USA, V104, P5580, DOI 10.1073/pnas.0609809104; MELLOUK S, 1994, INFECT IMMUN, V62, P4043, DOI 10.1128/IAI.62.9.4043-4046.1994; Meslin B, 2007, J INFECT DIS, V195, P1852, DOI 10.1086/518253; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; NAOTUNNE TD, 1993, IMMUNOLOGY, V78, P555; NATHAN C, 1995, CELL, V82, P873, DOI 10.1016/0092-8674(95)90019-5; Nguewa PA, 2004, TRENDS PARASITOL, V20, P375, DOI 10.1016/j.pt.2004.05.006; Ojcius DM, 1999, MICROBES INFECT, V1, P1163, DOI 10.1016/S1286-4579(99)00246-4; Peng BW, 2003, PARASITOLOGY, V126, P541, DOI 10.1017/S0031182003003226; Peterson TML, 2007, FREE RADICAL BIO MED, V42, P132, DOI 10.1016/j.freeradbiomed.2006.10.037; Piacenza L, 2007, BIOCHEM J, V403, P323, DOI 10.1042/BJ20061281; Picot S, 1997, T ROY SOC TROP MED H, V91, P590, DOI 10.1016/S0035-9203(97)90039-0; Rico E, 2009, MOL BIOCHEM PARASIT, V163, P28, DOI 10.1016/j.molbiopara.2008.09.007; Rivero A, 2006, TRENDS PARASITOL, V22, P219, DOI 10.1016/j.pt.2006.02.014; ROCKETT KA, 1991, INFECT IMMUN, V59, P3280, DOI 10.1128/IAI.59.9.3280-3283.1991; Skorokhod OA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-73; Sobolewski P, 2005, TRENDS PARASITOL, V21, P415, DOI 10.1016/j.pt.2005.07.002; Tahar R, 2002, EMBO J, V21, P6673, DOI 10.1093/emboj/cdf664; Taylor-Robinson AW, 1998, LANCET, V351, P1630, DOI 10.1016/S0140-6736(05)77685-6; Tsikas D, 2007, J CHROMATOGR B, V851, P51, DOI 10.1016/j.jchromb.2006.07.054; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vaughan JA, 2007, TRENDS PARASITOL, V23, P63, DOI 10.1016/j.pt.2006.12.009; Vaux DL, 1996, P NATL ACAD SCI USA, V93, P2239, DOI 10.1073/pnas.93.6.2239; Vercammen D, 2007, J CELL BIOL, V179, P375, DOI 10.1083/jcb.200705193; Welburn SC, 1997, PARASITOL TODAY, V13, P22, DOI 10.1016/S0169-4758(96)10076-4; Zieler H, 2000, P NATL ACAD SCI USA, V97, P11516, DOI 10.1073/pnas.97.21.11516	87	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12634	10.1371/journal.pone.0012634	http://dx.doi.org/10.1371/journal.pone.0012634			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844583	Green Published, gold, Green Submitted			2022-12-27	WOS:000281687200004
J	Arnott, A; Jardine, D; Wilson, K; Gorry, PR; Merlin, K; Grey, P; Law, MG; Dax, EM; Kelleher, AD; Smith, DE; McPhee, DA				Arnott, Alicia; Jardine, Darren; Wilson, Kim; Gorry, Paul R.; Merlin, Kate; Grey, Patricia; Law, Matthew G.; Dax, Elizabeth M.; Kelleher, Anthony D.; Smith, Don E.; McPhee, Dale A.		Pulse Study Team	High Viral Fitness during Acute HIV-1 Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; STRUCTURED TREATMENT INTERRUPTION; TYPE-1 FITNESS; IN-VIVO; MOLECULAR EVOLUTION; RECOMBINANT VIRUSES; REPLICATIVE FITNESS; DISEASE PROGRESSION; DRUG-RESISTANCE; ENVELOPE GENE	Several clinical studies have shown that, relative to disease progression, HIV-1 isolates that are less fit are also less pathogenic. The aim of the present study was to investigate the relationship between viral fitness and control of viral load (VL) in acute and early HIV-1 infection. Samples were obtained from subjects participating in two clinical studies. In the PULSE study, antiretroviral therapy (ART) was initiated before, or no later than six months following seroconversion. Subjects then underwent multiple structured treatment interruptions (STIs). The PHAEDRA study enrolled and monitored a cohort of individuals with documented evidence of primary infection. The subset chosen were individuals identified no later than 12 months following seroconversion to HIV-1, who were not receiving ART. The relative fitness of primary isolates obtained from study participants was investigated ex vivo. Viral DNA production was quantified using a novel real time PCR assay. Following intermittent ART, the fitness of isolates obtained from 5 of 6 PULSE subjects decreased over time. In contrast, in the absence of ART the fitness of paired isolates obtained from 7 of 9 PHAEDRA subjects increased over time. However, viral fitness did not correlate with plasma VL. Most unexpected was the high relative fitness of isolates obtained at Baseline from PULSE subjects, before initiating ART. It is widely thought that the fitness of strains present during the acute phase is low relative to strains present during chronic HIV-1 infection, due to the bottleneck imposed upon transmission. The results of this study provide evidence that the relative fitness of strains present during acute HIV-1 infection may be higher than previously thought. Furthermore, that viral fitness may represent an important clinical parameter to be considered when deciding whether to initiate ART during early HIV-1 infection.	[Arnott, Alicia; Jardine, Darren; Wilson, Kim; Dax, Elizabeth M.; McPhee, Dale A.] St Vincents Inst, Natl Serol Reference Lab, Melbourne, Vic, Australia; [Arnott, Alicia; McPhee, Dale A.] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia; [Gorry, Paul R.; Dax, Elizabeth M.; McPhee, Dale A.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Gorry, Paul R.] Burnet Inst, Melbourne, Vic, Australia; [Gorry, Paul R.] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Merlin, Kate; Grey, Patricia; Law, Matthew G.; Kelleher, Anthony D.; Smith, Don E.] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; [Kelleher, Anthony D.] St Vincents Ctr Appl Med Res, Sydney, NSW, Australia	St. Vincent's Institute of Medical Research; Monash University; University of Melbourne; Burnet Institute; Monash University; University of New South Wales Sydney; Kirby Institute	Arnott, A (corresponding author), Inst Pasteur, Phnom Penh, Cambodia.	dale@nrl.gov.au	McPhee, Dale A/D-1825-2011	Law, Matthew/0000-0002-3540-8837; Arnott, Alicia/0000-0003-2637-8936	Monash University; Australian Centre for HIV and Hepatitis; Foundation for AIDS Research (amfAR) [106669]; Australian National Health and Medical Research Council [502617]	Monash University(Monash University); Australian Centre for HIV and Hepatitis; Foundation for AIDS Research (amfAR); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Alicia Arnott, Monash University Post-graduate Scholarship; Australian Centre for HIV and Hepatitis Research Grant; the Foundation for AIDS Research (amfAR) Grant (106669) and the Australian National Health and Medical Research Council Project Grant (502617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyakov IM, 2004, IMMUNITY, V20, P247, DOI 10.1016/S1074-7613(04)00053-6; Bernardin F, 2005, J VIROL, V79, P11523, DOI 10.1128/JVI.79.17.11523-11528.2005; Bloch MT, 2006, JAIDS-J ACQ IMM DEF, V42, P192, DOI 10.1097/01.qai.0000219779.50668.e6; Borderia AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010319; Borroto R J, 1997, Rev Panam Salud Publica, V1, P3; Campbell TB, 2003, J VIROL, V77, P12105, DOI 10.1128/JVI.77.22.12105-12112.2003; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; CLARKE DK, 1994, P NATL ACAD SCI USA, V91, P4821, DOI 10.1073/pnas.91.11.4821; Derdeyn CA, 2008, CURR OPIN HIV AIDS, V3, P16, DOI 10.1097/COH.0b013e3282f2982c; Desire N, 2001, J CLIN MICROBIOL, V39, P1303, DOI 10.1128/JCM.39.4.1303-1310.2001; Dykes C, 2007, CLIN MICROBIOL REV, V20, P550, DOI 10.1128/CMR.00017-07; Falster K, 2008, SEX HEALTH, V5, P141, DOI 10.1071/SH07082; Ferbas J, 1996, J VIROL, V70, P7285, DOI 10.1128/JVI.70.10.7285-7289.1996; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Frater AJ, 2006, J VIROL, V80, P7226, DOI 10.1128/JVI.02014-05; Gali Y, 2007, VIROLOGY, V364, P140, DOI 10.1016/j.virol.2007.02.021; Garcia-Perez J, 2008, HIV MED, V9, P160, DOI 10.1111/j.1468-1293.2007.00540.x; Geffin R, 2000, AIDS RES HUM RETROV, V16, P1855, DOI 10.1089/08892220050195810; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Gorry PR, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-66; Gottlieb GS, 2008, J INFECT DIS, V197, P1011, DOI 10.1086/529206; Gray L, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-75; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KIERNAN R, 1990, AIDS RES HUM RETROV, V6, P743, DOI 10.1089/aid.1990.6.743; KIM SY, 1989, J VIROL, V63, P3708, DOI 10.1128/JVI.63.9.3708-3713.1989; Koch M, 2003, VIROLOGY, V313, P387, DOI 10.1016/S0042-6822(03)00294-0; Kondo M, 2005, J INFECT DIS, V192, P56, DOI 10.1086/430739; Kong XH, 2008, J VIROL, V82, P11609, DOI 10.1128/JVI.00952-08; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Loh L, 2008, AIDS RES HUM RETROV, V24, P1067, DOI 10.1089/aid.2007.0309; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Mariani R, 1996, J VIROL, V70, P7752, DOI 10.1128/JVI.70.11.7752-7764.1996; Miura T, 2010, J VIROL, V84, P7581, DOI 10.1128/JVI.00286-10; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Navis M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002422; Oelrichs RB, 2000, J BIOMED SCI, V7, P128, DOI 10.1007/BF02256619; Parisi SG, 2007, J CLIN MICROBIOL, V45, P1783, DOI 10.1128/JCM.00056-07; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Peut V, 2006, CURR HIV RES, V4, P191, DOI 10.2174/157016206776055110; Quinones-Mateu ME, 2000, J VIROL, V74, P9222, DOI 10.1128/JVI.74.19.9222-9233.2000; Rangel HR, 2003, J VIROL, V77, P9069, DOI 10.1128/JVI.77.16.9069-9073.2003; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Salvi R, 1998, J VIROL, V72, P3646, DOI 10.1128/JVI.72.5.3646-3657.1998; Sewell AK, 2000, STEM CELLS, V18, P230, DOI 10.1634/stemcells.18-4-230; SIMMONDS P, 1991, J VIROL, V65, P6266, DOI 10.1128/JVI.65.11.6266-6276.1991; Soto-Ramirez LE, 2008, AIDS RES HUM RETROV, V24, P797, DOI 10.1089/aid.2007.0246; SPIRA AI, 1995, J VIROL, V69, P422, DOI 10.1128/JVI.69.1.422-429.1995; Tebit DM, 2007, AIDS REV, V9, P75; Trkola A, 2003, J VIROL, V77, P13146, DOI 10.1128/JVI.77.24.13146-13155.2003; Troyer RM, 2005, J VIROL, V79, P9006, DOI 10.1128/JVI.79.14.9006-9018.2005; Vandegraaff N, 2001, J VIROL, V75, P11253, DOI 10.1128/JVI.75.22.11253-11260.2001; VANVALEN L, 1974, J MOL EVOL, V3, P89, DOI 10.1007/BF01796554; Verity EE, 2006, AIDS, V20, P505, DOI 10.1097/01.aids.0000210604.78385.95; Verity EE, 2007, J VIROL, V81, P9268, DOI 10.1128/JVI.00650-07; von Briesen H, 1999, AIDS, V13, P307, DOI 10.1097/00002030-199902250-00002; Wang YM, 2007, CURR HIV RES, V5, P235; Weber J, 2003, J GEN VIROL, V84, P2217, DOI 10.1099/vir.0.19123-0; Weber J, 2006, J VIROL METHODS, V136, P102, DOI 10.1016/j.jviromet.2006.04.004; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wood N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000414; Yun ZB, 2002, J CLIN MICROBIOL, V40, P3883, DOI 10.1128/JCM.40.10.3883-3884.2002	63	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12631	10.1371/journal.pone.0012631	http://dx.doi.org/10.1371/journal.pone.0012631			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844589	gold, Green Published			2022-12-27	WOS:000281687200002
J	Li, L; Cheng, C; Xia, CH; White, TW; Fletcher, DA; Gong, XH				Li, Lin; Cheng, Catherine; Xia, Chun-hong; White, Thomas W.; Fletcher, Daniel A.; Gong, Xiaohua			Connexin Mediated Cataract Prevention in Mice	PLOS ONE			English	Article							FIBER CELL-DIFFERENTIATION; AGE-RELATED CATARACT; LENS DEVELOPMENT; POINT MUTATION; MOUSE LENS; CRYSTALLIN; GROWTH; EYE; MICROPHTHALMIA; PROTEOLYSIS	Cataracts, named for any opacity in the ocular lens, remain the leading cause of vision loss in the world. Non-surgical methods for cataract prevention are still elusive. We have genetically tested whether enhanced lens gap junction communication, provided by increased alpha 3 connexin (Cx46) proteins expressed from alpha 8(Ki alpha 3) knock-in alleles in Gja8(tm1(Gj alpha 3)Tww) mice, could prevent nuclear cataracts caused by the gamma B-crystallin S11R mutation in Crygb(S11R/S11R) mice. Remarkably, homozygous knock-in alpha 8(Ki alpha 3/Ki alpha 3) mice fully prevented nuclear cataracts, while single knock-in alpha 8(Ki alpha 3/-) allele mice showed variable suppression of nuclear opacities in Crygb(S11R/S11R) mutant mice. Cataract prevention was correlated with the suppression of many pathological processes, including crystallin degradation and fiber cell degeneration, as well as preservation of normal calcium levels and stable actin filaments in the lens. This work demonstrates that enhanced intercellular gap junction communication can effectively prevent or delay nuclear cataract formation and suggests that small metabolites transported through gap junction channels protect the stability of crystallin proteins and the cytoskeletal structures in the lens core. Thus, the use of an array of small molecules to promote lens homeostasis may become a feasible non-surgical approach for nuclear cataract prevention in the future.	[Li, Lin; Cheng, Catherine; Xia, Chun-hong; Gong, Xiaohua] Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA; [Li, Lin; Cheng, Catherine; Xia, Chun-hong; Gong, Xiaohua] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [White, Thomas W.] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Fletcher, Daniel A.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California Berkeley	Li, L (corresponding author), Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA.	xgong@berkeley.edu	White, Thomas W./R-3605-2019; White, Thomas/GPG-4026-2022	White, Thomas/0000-0002-3285-7434	National Eye Institute [EY013849, EY013163]; NATIONAL EYE INSTITUTE [R01EY013849, R01EY013163] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Eye Institute (http://www.nei.nih.gov/) grants EY013849 (to XG) and EY013163 (to TW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asbell PA, 2005, LANCET, V365, P599; Baruch A, 2001, J BIOL CHEM, V276, P28999, DOI 10.1074/jbc.M103628200; BASSNETT S, 1992, DEV DYNAM, V194, P85, DOI 10.1002/aja.1001940202; Biswas S, 2004, TRENDS MOL MED, V10, P78, DOI 10.1016/j.molmed.2003.12.007; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Chong EW, 2008, OPHTHALMOLOGY, V115, P597, DOI 10.1016/j.ophtha.2008.01.033; De Maria A, 2009, J BIOL CHEM, V284, P13542, DOI 10.1074/jbc.M900561200; Fernandez MM, 2008, CURR OPIN OPHTHALMOL, V19, P66, DOI 10.1097/ICU.0b013e3282f2d7b6; Gao JY, 2004, J GEN PHYSIOL, V124, P289, DOI 10.1085/jgp.200409121; Gerido DA, 2003, INVEST OPHTH VIS SCI, V44, P2669, DOI 10.1167/iovs.02-1311; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Gong XH, 1999, DEV GENET, V24, P27, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<27::AID-DVG4>3.0.CO;2-7; Gong X, 2007, J MEMBRANE BIOL, V218, P9, DOI 10.1007/s00232-007-9033-0; Goodenough D.A., 1992, Seminars in Cell Biology, V3, P49; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Jaenicke R, 2001, CRIT REV BIOCHEM MOL, V36, P435, DOI 10.1080/20014091074237; Kuszak JR, 2004, EXP EYE RES, V78, P673, DOI 10.1016/j.exer.2003.09.016; Li L, 2008, INVEST OPHTH VIS SCI, V49, P304, DOI 10.1167/iovs.07-0942; Liu HQ, 2005, J BIOL CHEM, V280, P25071, DOI 10.1074/jbc.M502490200; Maraini G, 2009, ANN I SUPER SANITA, V45, P119; Martinez-Wittinghan FJ, 2004, INVEST OPHTH VIS SCI, V45, P3629, DOI 10.1167/iovs.04-0445; Mathias RT, 2010, PHYSIOL REV, V90, P179, DOI 10.1152/physrev.00034.2009; Miller JW, 2009, ARCH OPHTHALMOL-CHIC, V127, P1680, DOI 10.1001/archophthalmol.2009.321; Nowak RB, 2009, J CELL BIOL, V186, P915, DOI 10.1083/jcb.200905065; Puk O, 2008, INVEST OPHTH VIS SCI, V49, P1525, DOI 10.1167/iovs.07-1033; Rong P, 2002, DEVELOPMENT, V129, P167; Sonntag S, 2009, EUR J CELL BIOL, V88, P65, DOI 10.1016/j.ejcb.2008.08.004; Tan AG, 2008, AM J CLIN NUTR, V87, P1899, DOI 10.1093/ajcn/87.6.1899; Tang YJ, 2007, INVEST OPHTH VIS SCI, V48, P2685, DOI 10.1167/iovs.06-0926; Toh T, 2007, CLIN EXP OPHTHALMOL, V35, P664, DOI 10.1111/j.1442-9071.2007.01559.x; Ueda Y, 2002, INVEST OPHTH VIS SCI, V43, P205; White TW, 1998, J CELL BIOL, V143, P815, DOI 10.1083/jcb.143.3.815; White TW, 2002, SCIENCE, V295, P319, DOI 10.1126/science.1067582; Williams PT, 2009, INVEST OPHTH VIS SCI, V50, P95, DOI 10.1167/iovs.08-1797; Xia CH, 2006, J CELL SCI, V119, P2138, DOI 10.1242/jcs.02940	35	17	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12624	10.1371/journal.pone.0012624	http://dx.doi.org/10.1371/journal.pone.0012624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844585	Green Published, gold, Green Submitted			2022-12-27	WOS:000281687200001
J	van Soolingen, D; Hernandez-Pando, R; Orozco, H; Aguilar, D; Magis-Escurra, C; Amaral, L; van Ingen, J; Boeree, MJ				van Soolingen, Dick; Hernandez-Pando, Rogelio; Orozco, Hector; Aguilar, Diana; Magis-Escurra, Cecile; Amaral, Leonard; van Ingen, Jakko; Boeree, Martin J.			The Antipsychotic Thioridazine Shows Promising Therapeutic Activity in a Mouse Model of Multidrug-Resistant Tuberculosis	PLOS ONE			English	Article							EXPERIMENTAL PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; DE-POINTES; PHENOTHIAZINES; CHEMOTHERAPY; CELLS; MICE	Multidrug- and extensively drug-resistant tuberculosis have emerged as grave threats to public health worldwide. Very few active drugs are available or likely to become available soon. To address these problems we revisited a classical observation, the applicability of phenothiazines as antimicrobial drugs. Within this pharmacological class we selected thioridazine, which is most efficacious and least toxic, when used as an antipsychotic drug. We tested thioridazine monotherapy in the Balb/c mouse model for its activity to treat both susceptible and multidrug-resistant tuberculosis by a two months daily oral administration of 32 and 70 mg/kg. In addition, we tested its additive value when combined with a standard first-line regimen for susceptible tuberculosis. Thioridazine treatment resulted in a significant reduction of colony-forming-units of the susceptible (-4.4 log CFU, p<0.05) and multidrug-resistant tuberculosis bacilli (-2.4 log CFU, p<0.009) in the lung both at one and two months after infection, compared to controls. Moreover, when thioridazine was added to a regimen containing rifampicin, isoniazid and pyrazinamide for susceptible tuberculosis, a significant synergistic effect was achieved (-6.2 vs -5.9 log CFU, p<0.01). Thioridazine may represent an effective compound for treatment of susceptible and multidrug-resistant tuberculosis. The phenothiazines and their targets represent interesting novel opportunities in the search for antituberculosis drugs.	[van Soolingen, Dick; van Ingen, Jakko] Natl Inst Publ Hlth & Environm, Natl Mycobacteria Reference Lab, Labs Infect Dis & Perinatal Screening, NL-3720 BA Bilthoven, Netherlands; [van Soolingen, Dick] Radboud Univ Nijmegen, Med Ctr, Dept Clin Microbiol, NL-6525 ED Nijmegen, Netherlands; [van Soolingen, Dick] Radboud Univ Nijmegen, Med Ctr, Dept Resp Dis, NL-6525 ED Nijmegen, Netherlands; [Hernandez-Pando, Rogelio; Orozco, Hector; Aguilar, Diana] Natl Inst Med Sci & Nutr Salvador Zubiran, Dept Pathol, Expt Pathol Sect, Mexico City, DF, Mexico; [Magis-Escurra, Cecile; van Ingen, Jakko; Boeree, Martin J.] Radboud Univ Nijmegen, Med Ctr, Univ Ctr Chron Dis Dekkerswald, NL-6525 ED Nijmegen, Netherlands; [Amaral, Leonard] Univ Nova Lisboa, Inst Hyg & Trop Med, Mycobacteriol Unit, P-1200 Lisbon, Portugal	Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	van Soolingen, D (corresponding author), Natl Inst Publ Hlth & Environm, Natl Mycobacteria Reference Lab, Labs Infect Dis & Perinatal Screening, NL-3720 BA Bilthoven, Netherlands.	dick.van.soolingen@rivm.nl	Boeree, Martin J./G-6132-2010; van Ingen, Jakko/D-5526-2014; Ibanez, C. Magis-Escurra/L-4500-2015; Amaral, Leonard/I-2112-2012	van Ingen, Jakko/0000-0002-0581-2003; Amaral, Leonard/0000-0003-3127-1295; Hernandez-Pando, Rogelio/0000-0003-1292-3833				Amaral L, 2001, J ANTIMICROB CHEMOTH, V47, P505, DOI 10.1093/jac/47.5.505; Amaral L, 2010, INT J ANTIMICROB AG, V35, P524, DOI 10.1016/j.ijantimicag.2009.12.019; Bettencourt MV, 2000, INT J ANTIMICROB AG, V16, P69, DOI 10.1016/S0924-8579(00)00199-0; De Steenwinkel JEM, 2009, INT J IMMUNOPATH PH, V22, P723, DOI 10.1177/039463200902200318; DHAUNSI GS, 1993, NEUROPHARMACOLOGY, V32, P439; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Dutta NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010069; Fabre RA, 2004, CLIN EXP IMMUNOL, V136, P215, DOI 10.1111/j.1365-2249.2004.02454.x; FORREST FM, 1963, REV AGRESSOLOGIE, V4, P259; Glassman AH, 2001, AM J PSYCHIAT, V158, P1774, DOI 10.1176/appi.ajp.158.11.1774; Hadjimitova V, 2003, CELL BIOL TOXICOL, V19, P3, DOI 10.1023/A:1022061513581; Hernandez-Pando R, 2006, CLIN EXP IMMUNOL, V144, P264, DOI 10.1111/j.1365-2249.2006.03049.x; Hernandez-Pando R, 2005, J INFECT DIS, V191, P299, DOI 10.1086/426453; HernandezPando R, 1996, IMMUNOLOGY, V89, P26; Iannini Paul B, 2002, Expert Opin Drug Saf, V1, P121, DOI 10.1517/14740338.1.2.121; JARNAGIN JL, 1980, STAIN TECHNOL, V55, P253, DOI 10.3109/10520298009067249; KRISTIANSEN JEH, 1979, ACTA PATH MICRO IM B, V87, P317; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Martins M, 2007, IN VIVO, V21, P771; Ordway D, 2003, ANTIMICROB AGENTS CH, V47, P917, DOI 10.1128/AAC.47.3.917-922.2003; Ordway DJ, 2004, J INFECT DIS, V190, P756, DOI 10.1086/422532; Poluzzi E, 2010, DRUG SAFETY, V33, P303, DOI 10.2165/11531850-000000000-00000; Sohaskey CD, 2008, J BACTERIOL, V190, P2981, DOI 10.1128/JB.01857-07; Spigelman MK, 2007, J INFECT DIS, V196, pS28, DOI 10.1086/518663; van Ingen J, 2009, INT J ANTIMICROB AG, V34, P190, DOI 10.1016/j.ijantimicag.2009.02.015; Viveiros M, 2001, INT J ANTIMICROB AG, V17, P225, DOI 10.1016/S0924-8579(00)00343-5; *WHO, 2008, ANT DRUG RES WORLD	27	70	72	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12640	10.1371/journal.pone.0012640	http://dx.doi.org/10.1371/journal.pone.0012640			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20844587	Green Published, gold, Green Submitted			2022-12-27	WOS:000281687200009
J	Jagannathan, R; Kaveti, S; Desnoyer, RW; Willard, B; Kinter, M; Karnik, SS				Jagannathan, Rajaganapathi; Kaveti, Suma; Desnoyer, Russell W.; Willard, Belinda; Kinter, Michael; Karnik, Sadashiva S.			AT(1) Receptor Induced Alterations in Histone H2A Reveal Novel Insights into GPCR Control of Chromatin Remodeling	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ANGIOTENSIN-II; POSTTRANSLATIONAL MODIFICATIONS; GENE-TRANSCRIPTION; MASS-SPECTROMETRY; H3 VARIANTS; IN-VIVO; ANG-II; PHOSPHORYLATION; ACTIVATION	Chronic activation of angiotensin II (AngII) type 1 receptor (AT(1)R), a prototypical G protein-coupled receptor (GPCR) induces gene regulatory stress which is responsible for phenotypic modulation of target cells. The AT(1)R-selective drugs reverse the gene regulatory stress in various cardiovascular diseases. However, the molecular mechanisms are not clear. We speculate that activation states of AT(1)R modify the composition of histone isoforms and post-translational modifications (PTM), thereby alter the structure-function dynamics of chromatin. We combined total histone isolation, FPLC separation, and mass spectrometry techniques to analyze histone H2A in HEK293 cells with and without AT(1)R activation. We have identified eight isoforms: H2AA, H2AG, H2AM, H2AO, H2AQ, Q96QV6, H2AC and H2AL. The isoforms, H2AA, H2AC and H2AQ were methylated and H2AC was phosphorylated. The relative abundance of specific H2A isoforms and PTMs were further analyzed in relationship to the activation states of AT(1)R by immunochemical studies. Within 2 hr, the isoforms, H2AA/O exchanged with H2AM. The monomethylated H2AC increased rapidly and the phosphorylated H2AC decreased, thus suggesting that enhanced H2AC methylation is coupled to Ser1p dephosphorylation. We show that H2A125Kme1 promotes interaction with the heterochromatin associated protein, HP1 alpha. These specific changes in H2A are reversed by treatment with the AT(1)R specific inhibitor losartan. Our analysis provides a first step towards an awareness of histone code regulation by GPCRs.	[Jagannathan, Rajaganapathi; Desnoyer, Russell W.; Karnik, Sadashiva S.] Cleveland Clin Fdn, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Kaveti, Suma; Willard, Belinda; Kinter, Michael] Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Jagannathan, R (corresponding author), Cleveland Clin Fdn, Dept Mol Cardiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	karniks@ccf.org	Karnik, Sadashiva/Y-2477-2019	Karnik, Sadashiva/0000-0003-0746-2753; Kinter, Michael/0000-0001-7409-8918	National Institutes of Health [HL083243, HL57470]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057470, R01HL083243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by RO1 Grants HL083243 and HL57470 to S.S. Karnik from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvelo-Ceron D, 2000, MOL BIOL REP, V27, P61, DOI 10.1023/A:1007156629024; Ausio J, 2001, BIOCHEM CELL BIOL, V79, P693, DOI 10.1139/bcb-79-6-693; Balbi APC, 2009, BRAZ J MED BIOL RES, V42, P38, DOI 10.1590/S0100-879X2009000100007; Bao YH, 2004, EMBO J, V23, P3314, DOI 10.1038/sj.emboj.7600316; Barber CM, 2004, CHROMOSOMA, V112, P360, DOI 10.1007/s00412-004-0281-9; Beck HC, 2006, MOL CELL PROTEOMICS, V5, P1314, DOI 10.1074/mcp.M600007-MCP200; Bock C, 2007, PLOS COMPUT BIOL, V3, P1055, DOI 10.1371/journal.pcbi.0030110; Bonenfant D, 2006, MOL CELL PROTEOMICS, V5, P541, DOI 10.1074/mcp.M500288-MCP200; Bonenfant D, 2007, MOL CELL PROTEOMICS, V6, P1917, DOI 10.1074/mcp.M700070-MCP200; Brasier AR, 2000, MOL CELL BIOCHEM, V212, P155, DOI 10.1023/A:1007133710837; Chen IY, 2006, J BIOL CHEM, V281, P19369, DOI 10.1074/jbc.M601443200; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Davis FJ, 2005, AM J PHYSIOL-HEART C, V288, pH1477, DOI 10.1152/ajpheart.00789.2004; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Dzau VJ, 2005, J CLIN INVEST, V115, P2319, DOI 10.1172/JCI26384; Eskeland R, 2004, BIOCHEMISTRY-US, V43, P3740, DOI 10.1021/bi035964s; Espino PS, 2005, J CELL BIOCHEM, V94, P1088, DOI 10.1002/jcb.20387; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Garcia BA, 2005, BIOCHEMISTRY-US, V44, P13202, DOI 10.1021/bi050906n; Goll MG, 2002, GENE DEV, V16, P1739, DOI 10.1101/gad.1013902; Griendling KK, 1996, ANNU REV PHARMACOL, V36, P281, DOI 10.1146/annurev.pharmtox.36.1.281; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Henikoff S, 2005, P NATL ACAD SCI USA, V102, P5308, DOI 10.1073/pnas.0501853102; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Karnik SS, 2003, TRENDS ENDOCRIN MET, V14, P431, DOI 10.1016/j.tem.2003.09.007; Lee C, 2007, FEBS LETT, V581, P2517, DOI 10.1016/j.febslet.2007.04.069; LEE JH, 2009, HUM MOL GENET; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; MacLellan WR, 1998, CIRCULATION, V97, P1433; Majors AK, 2002, ARTERIOSCL THROM VAS, V22, P1354, DOI 10.1161/01.ATV.0000023899.93940.7C; Mariani MR, 2003, J STEROID BIOCHEM, V86, P167, DOI 10.1016/S0960-0760(03)00267-X; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; McKinsey TA, 1999, CURR OPIN GENET DEV, V9, P267, DOI 10.1016/S0959-437X(99)80040-9; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Miura S, 2002, J BIOL CHEM, V277, P24299, DOI 10.1074/jbc.M202743200; MORISHITA R, 1994, J CLIN INVEST, V94, P978, DOI 10.1172/JCI117464; Nakatani Y, 2006, E SCHERING RES FDN W, V57, P89; OKA SI, 2009, J MOL MED; Perez DM, 2005, PHARMACOL REV, V57, P147, DOI 10.1124/pr.57.2.2; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strange PG, 2008, CURR OPIN DRUG DISC, V11, P196; Su XD, 2009, PROTEOMICS, V9, P1197, DOI 10.1002/pmic.200800333; Thiriet C, 2005, GENE DEV, V19, P677, DOI 10.1101/gad.1265205; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; VAQUERO A, 2003, SCI AGING KNOWLEDGE, pRE4, DOI DOI 10.1126/SAGEKE.2003.14.RE4; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Ye SX, 2009, NAT CHEM BIOL, V5, P397, DOI 10.1038/nchembio.167; Yoshida T, 2004, CIRC RES, V94, P1075, DOI 10.1161/01.RES.0000125622.46280.95; Yue H, 2010, CARDIOVASC RES, V85, P90, DOI 10.1093/cvr/cvp285; Zhan YM, 2005, J CLIN INVEST, V115, P2508, DOI 10.1172/JCI24403; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6; Zhang Y, 2004, J BIOL CHEM, V279, P21866, DOI 10.1074/jbc.M400099200	59	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2010	5	9							e12552	10.1371/journal.pone.0012552	http://dx.doi.org/10.1371/journal.pone.0012552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647OL	20838438	gold, Green Published, Green Submitted			2022-12-27	WOS:000281627700005
J	Inaba, M; Yuan, HB; Salzmann, V; Fuller, MT; Yamashita, YM				Inaba, Mayu; Yuan, Hebao; Salzmann, Viktoria; Fuller, Margaret T.; Yamashita, Yukiko M.			E-Cadherin Is Required for Centrosome and Spindle Orientation in Drosophila Male Germline Stem Cells	PLOS ONE			English	Article							ADHERENS JUNCTIONS; OVERLAPPING ROLES; MITOTIC SPINDLES; DIVISION; APC2; ADHESION; NICHE; DIFFERENTIATION; POLARITY; PROTEIN	Many adult stem cells reside in a special microenvironment known as the niche, where they receive essential signals that specify stem cell identity. Cell-cell adhesion mediated by cadherin and integrin plays a crucial role in maintaining stem cells within the niche. In Drosophila melanogaster, male germline stem cells (GSCs) are attached to niche component cells (i.e., the hub) via adherens junctions. The GSC centrosomes and spindle are oriented toward the hub-GSC junction, where E-cadherin-based adherens junctions are highly concentrated. For this reason, adherens junctions are thought to provide a polarity cue for GSCs to enable proper orientation of centrosomes and spindles, a critical step toward asymmetric stem cell division. However, understanding the role of E-cadherin in GSC polarity has been challenging, since GSCs carrying E-cadherin mutations are not maintained in the niche. Here, we tested whether E-cadherin is required for GSC polarity by expressing a dominant-negative form of E-cadherin. We found that E-cadherin is indeed required for polarizing GSCs toward the hub cells, an effect that may be mediated by Apc2. We also demonstrated that E-cadherin is required for the GSC centrosome orientation checkpoint, which prevents mitosis when centrosomes are not correctly oriented. We propose that E-cadherin orchestrates multiple aspects of stem cell behavior, including polarization of stem cells toward the stem cell-niche interface and adhesion of stem cells to the niche supporting cells.	[Inaba, Mayu; Yuan, Hebao; Salzmann, Viktoria; Yamashita, Yukiko M.] Univ Michigan, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Inaba, Mayu; Yuan, Hebao; Salzmann, Viktoria; Yamashita, Yukiko M.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA; [Yamashita, Yukiko M.] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; [Fuller, Margaret T.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Fuller, Margaret T.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University; Stanford University	Inaba, M (corresponding author), Univ Michigan, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA.	yukikomy@umich.edu	Yuan, Hebao/E-2032-2011	Yuan, Hebao/0000-0003-4425-3678; Fuller, Margaret T/0000-0002-3804-4987; Yamashita, Yukiko/0000-0001-5541-0216	National Institutes of Health [R01GM086481-01, P01 DK53074]; Searle Scholar Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health (R01GM086481-01), Searle Scholar Program, March of Dimes Basil O'Connor Starter Scholar Award ( to YMY); NIH P01 DK53074 ( to MTF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Y, 2002, DEVELOPMENT, V129, P1751; Akong K, 2002, DEV BIOL, V250, P71, DOI 10.1006/dbio.2002.0777; Akong K, 2002, DEV BIOL, V250, P91, DOI 10.1006/dbio.2002.0776; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; den Elzen N, 2009, MOL BIOL CELL, V20, P3740, DOI 10.1091/mbc.E09-01-0023; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; Desai RA, 2009, J CELL SCI, V122, P905, DOI 10.1242/jcs.028183; Dupin I, 2009, J CELL BIOL, V185, P779, DOI 10.1083/jcb.200812034; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Jin ZG, 2008, CELL STEM CELL, V2, P39, DOI 10.1016/j.stem.2007.10.021; Le Borgne R, 2002, CURR BIOL, V12, P95, DOI 10.1016/S0960-9822(01)00648-0; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Loulier K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000176; Lu BW, 2001, NATURE, V409, P522, DOI 10.1038/35054077; Marthiens V, 2010, J CELL SCI, V123, P1613, DOI 10.1242/jcs.054312; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; McCartney BM, 2001, NAT CELL BIOL, V3, P933, DOI 10.1038/ncb1001-933; Megraw TL, 1999, DEVELOPMENT, V126, P2829; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; Mirkovic I, 2006, DEVELOPMENT, V133, P3283, DOI 10.1242/dev.02468; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nezi LG, 2009, CURR OPIN CELL BIOL, V21, P785, DOI 10.1016/j.ceb.2009.09.007; Oda H, 1999, DEV BIOL, V216, P406, DOI 10.1006/dbio.1999.9494; Raymond K, 2009, CURR OPIN CELL BIOL, V21, P623, DOI 10.1016/j.ceb.2009.05.004; Siegrist SE, 2006, DEVELOPMENT, V133, P529, DOI 10.1242/dev.02211; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Vaizel-Ohayon D, 1999, CURR BIOL, V9, P889, DOI 10.1016/S0960-9822(99)80393-5; Van Doren M, 1998, CURR BIOL, V8, P243; Voog J, 2008, NATURE, V454, P1132, DOI 10.1038/nature07173; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795	30	100	100	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12473	10.1371/journal.pone.0012473	http://dx.doi.org/10.1371/journal.pone.0012473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824213	Green Published, Green Submitted, gold			2022-12-27	WOS:000281405300011
J	Pani, AM; Hobart, HH; Morris, CA; Mervis, CB; Bray-Ward, P; Kimberley, KW; Rios, CM; Clark, RC; Gulbronson, MD; Gowans, GC; Gregg, RG				Pani, Ariel M.; Hobart, Holly H.; Morris, Colleen A.; Mervis, Carolyn B.; Bray-Ward, Patricia; Kimberley, Kendra W.; Rios, Cecilia M.; Clark, Robin C.; Gulbronson, Maricela D.; Gowans, Gordon C.; Gregg, Ronald G.			Genome Rearrangements Detected by SNP Microarrays in Individuals with Intellectual Disability Referred with Possible Williams Syndrome	PLOS ONE			English	Article							MULTIPLE CONGENITAL-ANOMALIES; CONTIGUOUS GENE DELETION; COPY-NUMBER VARIATION; STRUCTURAL VARIATION; MENTAL-RETARDATION; SEGMENTAL DUPLICATIONS; OLIGONUCLEOTIDE ARRAYS; RECOMBINATION; DISORDERS; HYBRIDIZATION	Background: Intellectual disability ( ID) affects 2-3% of the population and may occur with or without multiple congenital anomalies (MCA) or other medical conditions. Established genetic syndromes and visible chromosome abnormalities account for a substantial percentage of ID diagnoses, although for similar to 50% the molecular etiology is unknown. Individuals with features suggestive of various syndromes but lacking their associated genetic anomalies pose a formidable clinical challenge. With the advent of microarray techniques, submicroscopic genome alterations not associated with known syndromes are emerging as a significant cause of ID and MCA. Methodology/Principal Findings: High-density SNP microarrays were used to determine genome wide copy number in 42 individuals: 7 with confirmed alterations in the WS region but atypical clinical phenotypes, 31 with ID and/or MCA, and 4 controls. One individual from the first group had the most telomeric gene in the WS critical region deleted along with 2 Mb of flanking sequence. A second person had the classic WS deletion and a rearrangement on chromosome 5p within the Cri du Chat syndrome ( OMIM: 123450) region. Six individuals from the ID/MCA group had large rearrangements ( 3 deletions, 3 duplications), one of whom had a large inversion associated with a deletion that was not detected by the SNP arrays. Conclusions/Significance: Combining SNP microarray analyses and qPCR allowed us to clone and sequence 21 deletion breakpoints in individuals with atypical deletions in the WS region and/or ID or MCA. Comparison of these breakpoints to databases of genomic variation revealed that 52% occurred in regions harboring structural variants in the general population. For two probands the genomic alterations were flanked by segmental duplications, which frequently mediate recurrent genome rearrangements; these may represent new genomic disorders. While SNP arrays and related technologies can identify potentially pathogenic deletions and duplications, obtaining sequence information from the breakpoints frequently provides additional information.	[Pani, Ariel M.; Gregg, Ronald G.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [Hobart, Holly H.; Bray-Ward, Patricia; Kimberley, Kendra W.; Rios, Cecilia M.] Univ Nevada, Sch Med, Pediat Genet Lab, Las Vegas, NV 89154 USA; [Morris, Colleen A.] Univ Nevada, Sch Med, Dept Pediat, Las Vegas, NV 89154 USA; [Mervis, Carolyn B.] Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40292 USA; [Clark, Robin C.] Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA USA; [Gulbronson, Maricela D.; Gowans, Gordon C.] Univ Louisville, Sch Med, Dept Pediat, Louisville, KY 40292 USA	University of Louisville; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Louisville; Loma Linda University; University of Louisville	Pani, AM (corresponding author), Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA.	rggreg02@gwise.louisville.edu		Gregg, Ronald/0000-0001-5805-224X	National Institutes of Health, National Institute of Neurological Disorders and Stroke [R01 NS35102]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035102] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by R01 NS35102 from the National Institutes of Health, National Institute of Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos-Landgraf JM, 1999, AM J HUM GENET, V65, P370, DOI 10.1086/302510; [Anonymous], ONLINE MENDELIAN INH; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Ballif BC, 2007, NAT GENET, V39, P1071, DOI 10.1038/ng2107; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Carvalho CMB, 2010, P NATL ACAD SCI USA, V107, P1765, DOI 10.1073/pnas.0906222107; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Christiansen J, 2004, CIRC RES, V94, P1429, DOI 10.1161/01.RES.0000130528.72330.5c; Curry CJ, 1997, AM J MED GENET, V72, P468, DOI 10.1002/(SICI)1096-8628(19971112)72:4<468::AID-AJMG18>3.0.CO;2-P; Cusco I, 2008, GENOME RES, V18, P683, DOI 10.1101/gr.073197.107; Dai L, 2009, AM J MED GENET A, V149A, P302, DOI 10.1002/ajmg.a.32652; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Edelmann L, 2007, J MED GENET, V44, P136, DOI 10.1136/jmg.2006.044537; Engelen JJM, 2002, AM J MED GENET, V109, P149, DOI 10.1002/ajmg.10287; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Friedman JM, 2006, AM J HUM GENET, V79, P500, DOI 10.1086/507471; Hobart HH, 2010, AM J MED GENET C, V154C, P220, DOI 10.1002/ajmg.c.30258; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lupski JR, 2006, NAT GENET, V38, P974, DOI 10.1038/ng0906-974; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Menten B, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039453; Ming JRE, 2006, HUM MUTAT, V27, P467, DOI 10.1002/humu.20322; Morris CA, 2003, AM J MED GENET A, V123A, P45, DOI 10.1002/ajmg.a.20496; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Osborne Lucy R., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S146239940700035X; Padegimas LS, 1998, ANAL BIOCHEM, V260, P149, DOI 10.1006/abio.1998.2719; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Rauch A, 2006, AM J MED GENET A, V140A, P2063, DOI 10.1002/ajmg.a.31416; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rojahn J.A.M., 2007, HDB INTELLECTUAL DEV, P1, DOI DOI 10.1007/0-387-32931-5_1; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Sharp AJ, 2009, HUM MUTAT, V30, P135, DOI 10.1002/humu.20843; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Slater HR, 2005, AM J HUM GENET, V77, P709, DOI 10.1086/497343; Slavotinek AM, 2008, HUM GENET, V124, P1, DOI 10.1007/s00439-008-0513-9; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Tassabehji M, 2005, SCIENCE, V310, P1184, DOI 10.1126/science.1116142; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Winnepenninckx B, 2003, BRIT J DEV DISABIL, V49, P29, DOI 10.1179/096979503799104138	50	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12349	10.1371/journal.pone.0012349	http://dx.doi.org/10.1371/journal.pone.0012349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824207	gold, Green Published, Green Submitted			2022-12-27	WOS:000281405300005
J	Wang, F; Huang, S; Ma, L				Wang, Fei; Huang, Shi; Ma, Long			Caenorhabditis elegans Operons Contain a Higher Proportion of Genes with Multiple Transcripts and Use 3 ' Splice Sites Differentially	PLOS ONE			English	Article							CONSERVATION; INTRONS	RNA splicing generates multiple transcript isoforms from a single gene and enhances the complexity of eukaryotic gene expression. In some eukaryotes, operon exists as an ancient regulatory mechanism of gene expression that requires strict positional and regulatory relationships among its genes. It remains unknown whether operonic genes generate transcript isoforms in a similar manner as non-operonic genes do, the expression of which is less likely limited by their positions and relationships with surrounding genes. We analyzed the number of transcript isoforms of Caenorhabditis elegans operonic genes and found that C. elegans operons contain a much higher proportion of genes with multiple transcript isoforms than non-operonic genes do. For genes that express multiple transcript isoforms, there is no apparent difference between the number of isoforms in operonic and non-operonic genes. C. elegans operonic genes also have a different preference of the 2' most common 3' splice sites compared to non-operonic genes. Our analyses suggest that C. elegans operons enhance expression complexity by increasing the proportion of genes that express multiple transcript isoforms and maintain splicing efficiency by differential use of common 3' splice sites.	[Wang, Fei; Huang, Shi; Ma, Long] Cent South Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China	Central South University	Wang, F (corresponding author), Cent South Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China.	longmace@gmail.com	Ma, Longtao/N-8458-2019		National Science Foundation of China [30971639]; Central South University of China	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central South University of China	This study was funded by the National Science Foundation of China grant 30971639 and a research grant provided by the Central South University of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumenthal T, 1998, BIOESSAYS, V20, P480, DOI 10.1002/(SICI)1521-1878(199806)20:6&lt;480::AID-BIES6&gt;3.0.CO;2-Q; Blumenthal T, 2003, NAT REV GENET, V4, P110, DOI 10.1038/nrg995; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; Blumenthal Thomas, 2004, Briefings in Functional Genomics & Proteomics, V3, P199, DOI 10.1093/bfgp/3.3.199; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Hollins C, 2005, RNA, V11, P248, DOI 10.1261/rna.7221605; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kent WJ, 2000, NUCLEIC ACIDS RES, V28, P91, DOI 10.1093/nar/28.1.91; Kent WJ, 2000, GENOME RES, V10, P1115, DOI 10.1101/gr.10.8.1115; Ma L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000708; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; ZAHLER AM, 2005, ALTERNATIVE SPLICING; Zhang HB, 1996, RNA, V2, P380	15	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12456	10.1371/journal.pone.0012456	http://dx.doi.org/10.1371/journal.pone.0012456			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805997	gold, Green Submitted, Green Published			2022-12-27	WOS:000281301500022
J	Rosen, DB; Putta, S; Covey, T; Huang, YW; Nolan, GP; Cesano, A; Minden, MD; Fantl, WJ				Rosen, David B.; Putta, Santosh; Covey, Todd; Huang, Ying-Wen; Nolan, Garry P.; Cesano, Alessandra; Minden, Mark D.; Fantl, Wendy J.			Distinct Patterns of DNA Damage Response and Apoptosis Correlate with Jak/Stat and PI3Kinase Response Profiles in Human Acute Myelogenous Leukemia	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; RIBOSOMAL-PROTEIN S6; SIGNAL-TRANSDUCTION; CANCER; EXPRESSION; KINASE; MUTATIONS; NETWORK; IMPACT	Background: Single cell network profiling (SCNP) utilizing flow cytometry measures alterations in intracellular signaling responses. Here SCNP was used to characterize Acute Myeloid Leukemia (AML) disease subtypes based on survival, DNA damage response and apoptosis pathways. Methodology and Principal Findings: Thirty four diagnostic non-M3 AML samples from patients with known clinical outcome were treated with a panel of myeloid growth factors and cytokines, as well as with apoptosis-inducing agents. Analysis of induced Jak/Stat and PI3K pathway responses in blasts from individual patient samples identified subgroups with distinct signaling profiles that were not seen in the absence of a modulator. In vitro exposure of patient samples to etoposide, a DNA damaging agent, revealed three distinct "DNA damage response (DDR)/apoptosis'' profiles: 1) AML blasts with a defective DDR and failure to undergo apoptosis; 2) AML blasts with proficient DDR and failure to undergo apoptosis; 3) AML blasts with proficiency in both DDR and apoptosis pathways. Notably, AML samples from clinical responders fell within the "DDR/apoptosis'' proficient profile and, as well, had low PI3K and Jak/Stat signaling responses. In contrast, samples from clinical non responders had variable signaling profiles often with in vitro apoptotic failure and elevated PI3K pathway activity. Individual patient samples often harbored multiple, distinct, leukemia-associated cell populations identifiable by their surface marker expression, functional performance of signaling pathway in the face of cytokine or growth factor stimulation, as well as their response to apoptosis-inducing agents. Conclusions and Significance: Characterizing and tracking changes in intracellular pathway profiles in cell subpopulations both at baseline and under therapeutic pressure will likely have important clinical applications, potentially informing the selection of beneficial targeted agents, used either alone or in combination with chemotherapy.	[Rosen, David B.; Putta, Santosh; Covey, Todd; Huang, Ying-Wen; Cesano, Alessandra; Fantl, Wendy J.] Nodality Inc, San Francisco, CA USA; [Minden, Mark D.] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; [Nolan, Garry P.; Fantl, Wendy J.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Stanford University	Rosen, DB (corresponding author), Nodality Inc, San Francisco, CA USA.	wjfantl@stanford.edu	Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043; Huang, Ying-Wen/0000-0003-3727-7903	Nodality Inc.	Nodality Inc.	Nodality Inc. funded this research. Nodality had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Baldus CD, 2007, BRIT J HAEMATOL, V137, P387, DOI 10.1111/j.1365-2141.2007.06566.x; Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; Becker H, 2010, J CLIN ONCOL, V28, P596, DOI 10.1200/JCO.2009.25.1496; Benekli M, 2002, BLOOD, V99, P252, DOI 10.1182/blood.V99.1.252; Benekli M, 2003, BLOOD, V101, P2940, DOI 10.1182/blood-2002-04-1204; Brierley MM, 2005, J INTERF CYTOK RES, V25, P733, DOI 10.1089/jir.2005.25.733; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bunting KD, 2007, FRONT BIOSCI-LANDMRK, V12, P2807, DOI 10.2741/2274; Cheong JW, 2003, BRIT J HAEMATOL, V122, P454, DOI 10.1046/j.1365-2141.2003.04452.x; Choudhary C, 2005, INT J HEMATOL, V82, P93, DOI 10.1532/IJH97.05090; Coffer PJ, 2000, ONCOGENE, V19, P2511, DOI 10.1038/sj.onc.1203479; COULDWELL WT, 1994, FEBS LETT, V345, P43, DOI 10.1016/0014-5793(94)00415-3; Cox J, 2007, CELL, V130, P395, DOI 10.1016/j.cell.2007.07.032; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; Danna EA, 2006, CURR OPIN CHEM BIOL, V10, P20, DOI 10.1016/j.cbpa.2005.12.021; de Jonge-Peeters SDPWM, 2007, CRIT REV ONCOL HEMAT, V62, P214, DOI 10.1016/j.critrevonc.2007.02.003; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Doepfner KT, 2007, CRIT REV ONCOL HEMAT, V63, P215, DOI 10.1016/j.critrevonc.2007.05.005; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Fathi AT, 2010, CANCER TREAT REV, V36, P142, DOI 10.1016/j.ctrv.2009.12.004; Fraser IDC, 2009, NAT IMMUNOL, V10, P327, DOI 10.1038/ni.1711; Han L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007989; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Ho MM, 2008, EXP HEMATOL, V36, P433, DOI 10.1016/j.exphem.2007.11.014; Irish JM, 2006, NAT REV CANCER, V6, P146, DOI 10.1038/nrc1804; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Irish JM, 2006, BLOOD, V108, P3135, DOI 10.1182/blood-2006-02-003921; Irish JM, 2006, J IMMUNOL, V177, P1581, DOI 10.4049/jimmunol.177.3.1581; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kim HS, 2007, CELL SIGNAL, V19, P454, DOI 10.1016/j.cellsig.2006.09.003; Kishimoto T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1916; Kok K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005145; Kok K, 2009, TRENDS BIOCHEM SCI, V34, P115, DOI 10.1016/j.tibs.2009.01.003; KORNBLAU SM, 2010, CLIN CANC R IN PRESS; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Lowenberg Bob, 2008, Hematology Am Soc Hematol Educ Program, P1, DOI 10.1182/asheducation-2008.1.1; Marcucci Guido, 2009, Clin Adv Hematol Oncol, V7, P448; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Martelli AM, 2009, EXPERT OPIN INV DRUG, V18, P1333, DOI 10.1517/14728220903136775; Masson K, 2009, CELL SIGNAL, V21, P1717, DOI 10.1016/j.cellsig.2009.06.002; Meshinchi S, 2009, CLIN CANCER RES, V15, P4263, DOI 10.1158/1078-0432.CCR-08-1123; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; Mrozek K, 2009, CURR OPIN HEMATOL, V16, P64, DOI 10.1097/MOH.0b013e3283257b42; Muslimovic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005859; Pawson T, 2008, FEBS LETT, V582, P1266, DOI 10.1016/j.febslet.2008.02.011; Ravandi F, 2007, CANCER-AM CANCER SOC, V110, P1900, DOI 10.1002/cncr.23000; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schlenk RF, 2009, CURR OPIN HEMATOL, V16, P98, DOI 10.1097/MOH.0b013e3283257adb; Seita J, 2008, BLOOD, V111, P1903, DOI 10.1182/blood-2007-06-093328; Shipley JL, 2009, EXP HEMATOL, V37, P649, DOI 10.1016/j.exphem.2009.04.002; STELZER GT, 1993, ANN NY ACAD SCI, V677, P265, DOI 10.1111/j.1749-6632.1993.tb38783.x; Sujobert P, 2005, BLOOD, V106, P1063, DOI 10.1182/blood-2004-08-3225; Svirnovski AI, 2009, HEMATOLOGY, V14, P204, DOI 10.1179/102453309X426218; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Valentino L, 2006, BIOCHEM PHARMACOL, V71, P713, DOI 10.1016/j.bcp.2005.12.017; Vogt PK, 2009, CURR OPIN GENET DEV, V19, P12, DOI 10.1016/j.gde.2008.11.011; Wierenga ATJ, 2008, MOL CELL BIOL, V28, P6668, DOI 10.1128/MCB.01025-08; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yoshida H, 2009, J LEUKOCYTE BIOL, V86, P1295, DOI 10.1189/jlb.0609445; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	68	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12405	10.1371/journal.pone.0012405	http://dx.doi.org/10.1371/journal.pone.0012405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811632	Green Submitted, gold, Green Published			2022-12-27	WOS:000281234700027
J	Carmon, A; Guertin, MJ; Grushko, O; Marshall, B; MacIntyre, R				Carmon, Amber; Guertin, Michael J.; Grushko, Olga; Marshall, Brad; MacIntyre, Ross			A Molecular Analysis of Mutations at the Complex dumpy Locus in Drosophila melanogaster	PLOS ONE			English	Article							GENETIC-ANALYSIS; SELECTION PRESSURE; RNA-SEQ; EVOLUTION; COMPLEMENTATION; MUTAGENESIS; EXPRESSION; CHARACTER; NONSENSE; ADHESION	The Drosophila dumpy gene consists of seventy eight coding exons and encodes a huge extracellular matrix protein containing large numbers of epidermal growth factor-like (EGF) modules and a novel module called dumpy (DPY). A molecular analysis of forty five mutations in the dumpy gene of Drosophila melanogaster was carried out. Mutations in this gene affect three phenotypes: wing shape, thoracic cuticular defects, and lethality. Most of the mutations were chemically induced in a single dumpy allele and were analyzed using a nuclease that cleaves single base pair mismatches in reannealed duplexes followed by dHPLC. Additionally, several spontaneous mutations were analyzed. Virtually all of the chemically induced mutations, except for several in a single exon, either generate nonsense codons or lesions that result in downstream stop codons in the reading frame. The remaining chemically induced mutations remove splice sites in the nascent dumpy message. We propose that the vast majority of nonsense mutations that affect all three basic dumpy phenotypes are in constitutive exons, whereas nonsense mutants that remove only one or two of the basic functions are in alternatively spliced exons. Evolutionary comparisons of the dumpy gene from seven Drosophila species show strong conservation of the 5' ends of exons where mutants with partial dumpy function are found. In addition, reverse transcription PCR analyses reveal transcripts in which exons marked by nonsense mutations with partial dumpy function are absent.	[Carmon, Amber; Guertin, Michael J.; Marshall, Brad; MacIntyre, Ross] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA; [Grushko, Olga] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	Cornell University; University of Michigan System; University of Michigan	Carmon, A (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	rjm18@cornell.edu			United States Department of Agriculture [NYC-165426]; National Institutes of Health [1R21HD059073-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD059073] Funding Source: NIH RePORTER	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by the United States Department of Agriculture Hatch Project award NYC-165426 (http://www.usda.gov/) and National Institutes of Health grant 1R21HD059073-01A1 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenburg E, 1920, GENETICS, V5, P1; Behm-Ansmant I, 2006, GENE DEV, V20, P391, DOI 10.1101/gad.1407606; Bokel C, 2005, J CELL SCI, V118, P633, DOI 10.1242/jcs.01619; Bridges CB, 1919, GENETICS, V4, P283; CARLSON EA, 1962, GENETICS, V47, P321; CARLSON EA, 1959, GENETICS, V44, P347; CARLSON EA, 1959, Q REV BIOL, V34, P33, DOI 10.1086/402574; Carmon A, 2007, GENETICS, V176, P309, DOI 10.1534/genetics.106.060897; Carmon A, 2010, FLY, V4, P117, DOI 10.4161/fly.4.2.11953; Carmon A, 2010, J MOL EVOL, V70, P260, DOI 10.1007/s00239-010-9327-1; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; DAVIS MB, 1988, GENETICS, V120, P755; FINCHAM JRS, 1966, COMPLEMENTATION MAPS, P90; GRACE D, 1980, GENETICS, V94, P647; GRACE D, 1970, MUTAT RES, V10, P489, DOI 10.1016/0027-5107(70)90008-4; Graveley BR, 2005, CELL, V123, P65, DOI 10.1016/j.cell.2005.07.028; Horiuchi T, 2006, BIOL CELL, V98, P135, DOI 10.1042/BC20050002; Horiuchi T, 2003, GENE DEV, V17, P2496, DOI 10.1101/gad.1137303; JACK J, 1995, GENETICS, V139, P1689; Jazwinska A, 2003, NAT CELL BIOL, V5, P895, DOI 10.1038/ncb1049; JENKINS JB, 1967, GENETICS, V57, P783; Krauss V, 2004, GENE, V331, P165, DOI 10.1016/j.gene.2004.02.019; LEWIS EB, 1968, DROSOPHILA INFORM SE, V43, P193; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; Lu HC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000608; Mahoney MB, 2006, GENETICS, V172, P2309, DOI 10.1534/genetics.104.035170; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mohr OL, 1923, STUD MENDELIANA AD C, P266; MOHR OTTO L., 1929, ZEITSCHR INDUKT ABSTAMMUNGS U VERERBUNGSLEHRE, V50, P113, DOI 10.1007/BF01742053; MONTGOMERIE DW, 1974, RECOMBINATION MUTATI; Morgan T. H, 1915, MECH MENDELIAN HERED; Morgan TH, 1911, SCIENCE, V33, P496, DOI 10.1126/science.33.848.496; MORGAN TH, 1929, CONTRIBUTIONS GENETI, P171; Muller HJ, 1922, AM NAT, V56, P32, DOI 10.1086/279846; Olson S, 2007, NAT STRUCT MOL BIOL, V14, P1134, DOI 10.1038/nsmb1339; Prout M, 1997, GENETICS, V146, P275; Rowley JD, 2008, SCIENCE, V321, P1302, DOI 10.1126/science.1163791; Rozen S, 2000, Methods Mol Biol, V132, P365; SEDEROFF R, 1967, NATURE, V216, P1348, DOI 10.1038/2161348b0; SEGRAVES WA, 1984, J MOL BIOL, V175, P1, DOI 10.1016/0022-2836(84)90441-8; SOUTHIN JL, 1966, MUTAT RES, V3, P54, DOI 10.1016/0027-5107(66)90007-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilkin MB, 2000, CURR BIOL, V10, P559, DOI 10.1016/S0960-9822(00)00482-6; Xing Y, 2005, P NATL ACAD SCI USA, V102, P13526, DOI 10.1073/pnas.0501213102; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896	46	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12319	10.1371/journal.pone.0012319	http://dx.doi.org/10.1371/journal.pone.0012319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20811586	Green Published, gold, Green Submitted			2022-12-27	WOS:000281153500007
J	Durrmeyer, X; Hovhannisyan, S; Medard, Y; Jacqz-Aigrain, E; Decobert, F; Barre, J; Alberti, C; Aujard, Y; Danan, C; Baud, O				Durrmeyer, Xavier; Hovhannisyan, Shushanik; Medard, Yves; Jacqz-Aigrain, Evelyne; Decobert, Fabrice; Barre, Jerome; Alberti, Corinne; Aujard, Yannick; Danan, Claude; Baud, Olivier			Are Cytochrome P450 CYP2C8 and CYP2C9 Polymorphisms Associated with Ibuprofen Response in Very Preterm Infants?	PLOS ONE			English	Article							PATENT DUCTUS-ARTERIOSUS; HYALINE-MEMBRANE DISEASE; NEONATAL-MORTALITY; DEVELOPMENTAL EXPRESSION; GENETIC POLYMORPHISMS; RACIAL-DIFFERENCES; HUMAN LIVER; RISK; METABOLISM; PHARMACOKINETICS	Background: Patent ductus arteriosus (PDA) in extremely preterm infants remains a challenging condition with conflicting treatment strategies. Ibuprofen is currently used to treat PDA with ductal closure failure rate up to 40%. We test the hypothesis that cytochrome P450 CYP2C8/2C9 polymorphisms may predict ibuprofen response. Methodology/Principal Findings: We studied extremely preterm neonates with haemodynamically significant PDA and treated with ibuprofen. One or two variant CYP2C8 and/or 2C9 alleles were found in 17% of the population, most of them were from Caucasian ethnicity (67-74%). Response to ibuprofen and clinical course of infants carrying variants CYP2C8 and CYP2C9 were similar. Comparing infants with wild type or variant CYP2C8 and CYP2C9 genotypes, response rate to ibuprofen was significantly higher in wild type than in mutated carriers in univariate analysis (73% versus 52%, p = 0.04). Comparing responders (ductus closure; n = 75) and non-responders (surgical ligation; n = 36), the only two factors significantly associated with the response to ibuprofen using multivariate analysis were higher gestational age and non Caucasian ethnicity but not CYP2C polymorphism. Conclusions: CYP2C polymorphism was not associated with PDA response to ibuprofen and this factor appears not appropriate to optimize the ductal closure rate by modulating ibuprofen dosing strategy. This study points out the role for ethnicity in the interindividual variability of response to ibuprofen in extremely preterm infants.	[Durrmeyer, Xavier; Decobert, Fabrice; Danan, Claude] CHI Creteil, Neonatal Intens Care Unit, Creteil, France; [Hovhannisyan, Shushanik; Aujard, Yannick; Baud, Olivier] Robert Debre Childrens Hosp, Neonatal Intens Care Unit, Paris, France; [Medard, Yves; Jacqz-Aigrain, Evelyne] Robert Debre Childrens Hosp, CIC INSERM 9202, Dept Pediat Pharmacol & Pharmacogenet, Paris, France; [Barre, Jerome] CHI Creteil, Clin Res Funct Unit, Creteil, France; [Alberti, Corinne] Robert Debre Childrens Hosp, CIC EC, Clin Epidemiol Unit, Paris, France; [Durrmeyer, Xavier; Hovhannisyan, Shushanik; Medard, Yves; Jacqz-Aigrain, Evelyne; Decobert, Fabrice; Barre, Jerome; Alberti, Corinne; Aujard, Yannick; Danan, Claude; Baud, Olivier] Fdn PremUP, Paris, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Durrmeyer, X (corresponding author), CHI Creteil, Neonatal Intens Care Unit, Creteil, France.	olivier.baud@rdb.aphp.fr	Jacqz-Aigrain, Evelyne/AAW-7089-2021; Durrmeyer, Xavier/AAB-7519-2020	Jacqz-Aigrain, Evelyne/0000-0002-4285-7067; Durrmeyer, Xavier/0000-0002-6303-7252	Institut National Scientifique Et de la Recherche Medicale (INSERM); Mairie de Paris	Institut National Scientifique Et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Mairie de Paris(Region Ile-de-France)	Institut National Scientifique Et de la Recherche Medicale (INSERM) and Mairie de Paris funded this study. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agundez JAG, 2009, EXPERT OPIN DRUG MET, V5, P607, DOI [10.1517/17425250902970998, 10.1517/17425250902970998 ]; Alexander GR, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e61; Aranda JV, 1997, ACTA PAEDIATR, V86, P289, DOI 10.1111/j.1651-2227.1997.tb08892.x; Bhandari V, 2009, PEDIATRICS, V123, P669, DOI 10.1542/peds.2008-1117; Clyman RI, 2007, J PEDIATR-US, V150, P216, DOI 10.1016/j.jpeds.2006.12.048; Cogolludo AL, 2009, AM J PHYSIOL-LUNG C, V297, pL619, DOI 10.1152/ajplung.00092.2009; Dagle JM, 2009, PEDIATRICS, V123, P1116, DOI 10.1542/peds.2008-0313; Dai D, 2001, PHARMACOGENETICS, V11, P597, DOI 10.1097/00008571-200110000-00006; Desfrere L, 2005, J CLIN PHARM THER, V30, P121, DOI 10.1111/j.1365-2710.2005.00630.x; El Hajjar M, 2005, ARCH DIS CHILD-FETAL, V90, pF419, DOI 10.1136/adc.2003.027698; Engel SAM, 2005, EPIDEMIOLOGY, V16, P478, DOI 10.1097/01.ede.0000164535.36412.6b; Engel SAM, 2005, EPIDEMIOLOGY, V16, P469, DOI 10.1097/01.ede.0000164539.09250.31; FARRELL PM, 1976, PEDIATRICS, V58, P167; Fleming I, 2001, CIRC RES, V88, P44, DOI 10.1161/01.RES.88.1.44; Fontaine RH, 2008, P NATL ACAD SCI USA, V105, P16779, DOI 10.1073/pnas.0803004105; FUJIKURA T, 1966, AM J OBSTET GYNECOL, V95, P572; Garcia-Martin E, 2004, CLIN PHARMACOL THER, V76, P119, DOI 10.1016/j.clpt.2004.04.006; Garcia-Martin E, 2006, MOL DIAGN THER, V10, P29, DOI 10.1007/BF03256440; Gibson CS, 2007, OBSTET GYNECOL, V109, P384, DOI 10.1097/01.AOG.0000252712.62241.1a; Hamman MA, 1997, BIOCHEM PHARMACOL, V54, P33, DOI 10.1016/S0006-2952(97)00143-3; Hammerman C, 2001, DRUG SAFETY, V24, P537, DOI 10.2165/00002018-200124070-00005; Hamvas A, 1996, NEW ENGL J MED, V334, P1635, DOI 10.1056/NEJM199606203342504; Hessol NA, 2005, PEDIATRICS, V115, pE44, DOI 10.1542/peds.2004-0478; HULSEY TC, 1993, AM J OBSTET GYNECOL, V168, P572, DOI 10.1016/0002-9378(93)90496-6; Imig JD, 2000, AM J PHYSIOL-RENAL, V279, pF965, DOI 10.1152/ajprenal.2000.279.6.F965; Ivey KN, 2006, J CLIN INVEST, V116, P2863, DOI 10.1172/JCI30349; Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092; Koukouritaki SB, 2004, J PHARMACOL EXP THER, V308, P965, DOI 10.1124/jpet.103.060137; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; LEEMANN TD, 1993, DRUG EXP CLIN RES, V19, P189; Lopez-Rodriguez R, 2008, PHARMACOL RES, V58, P77, DOI 10.1016/j.phrs.2008.07.004; Martinez C, 2005, BRIT J CLIN PHARMACO, V59, P62, DOI 10.1111/j.1365-2125.2004.02183.x; Mata-Greenwood E, 2008, REPROD SCI, V15, P9, DOI 10.1177/1933719107312160; McCurnin D, 2008, PEDIATRICS, V121, P945, DOI 10.1542/peds.2007-2051; Moin F, 2003, AM J PERINAT, V20, P313; Narayanan M, 2000, J PEDIATR-US, V136, P330, DOI 10.1067/mpd.2000.103414; Nelson KB, 2005, PEDIATR RES, V57, P494, DOI 10.1203/01.PDR.0000156477.00386.E7; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; PALDER SB, 1987, J PEDIATR SURG, V22, P1171, DOI 10.1016/S0022-3468(87)80730-3; Ranganathan D, 2000, J PEDIATR-US, V136, P454, DOI 10.1016/S0022-3476(00)90007-6; RIFKIND AB, 1995, ARCH BIOCHEM BIOPHYS, V320, P380, DOI 10.1016/0003-9861(95)90023-3; ROSS S, 1981, PEDIATRICS, V68, P790; Totah RA, 2005, CLIN PHARMACOL THER, V77, P341, DOI 10.1016/j.clpt.2004.12.267; Treluyer JM, 1997, PHARMACOGENETICS, V7, P441, DOI 10.1097/00008571-199712000-00002; TRUS T, 1993, J PEDIATR SURG, V28, P1137, DOI 10.1016/0022-3468(93)90148-E; Van Overmeire B, 2001, CLIN PHARMACOL THER, V70, P336, DOI 10.1067/mcp.2001.118453; Yasar U, 2002, BIOCHEM BIOPH RES CO, V299, P25, DOI 10.1016/S0006-291X(02)02592-5	47	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12329	10.1371/journal.pone.0012329	http://dx.doi.org/10.1371/journal.pone.0012329			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808793	Green Published, Green Submitted, gold			2022-12-27	WOS:000281153500012
J	Chen, J; Gomes, AR; Monteiro, LJ; Wong, SY; Wu, LH; Ng, TT; Karadedou, CT; Millour, J; Ip, YC; Cheung, YN; Sunters, A; Chan, KYK; Lam, EWF; Khoo, US				Chen, Jie; Gomes, Ana R.; Monteiro, Lara J.; Wong, San Yu; Wu, Lai Han; Ng, Ting-Ting; Karadedou, Christina T.; Millour, Julie; Ip, Ying-Chi; Cheung, Yuen Nei; Sunters, Andrew; Chan, Kelvin Y. K.; Lam, Eric W. -F.; Khoo, Ui-Soon			Constitutively Nuclear FOXO3a Localization Predicts Poor Survival and Promotes Akt Phosphorylation in Breast Cancer	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; ENDOCRINE THERAPY; LEUKEMIC-CELLS; ANTIESTROGEN RESISTANCE; GEFITINIB IRESSA; EXPRESSION; APOPTOSIS; KINASE; INHIBITOR; TAMOXIFEN	Background: The PI3K-Akt signal pathway plays a key role in tumorigenesis and the development of drug-resistance. Cytotoxic chemotherapy resistance is linked to limited therapeutic options and poor prognosis. Methodology/Principal Findings: Examination of FOXO3a and phosphorylated-Akt (P-Akt) expression in breast cancer tissue microarrays showed nuclear FOXO3a was associated with lymph node positivity (p = 0.052), poor prognosis (p = 0.014), and P-Akt expression in invasive ductal carcinoma. Using tamoxifen and doxorubicin-sensitive and -resistant breast cancer cell lines as models, we found that doxorubicin-but not tamoxifen-resistance is associated with nuclear accumulation of FOXO3a, consistent with the finding that sustained nuclear FOXO3a is associated with poor prognosis. We also established that doxorubicin treatment induces proliferation arrest and FOXO3a nuclear relocation in sensitive breast cancer cells. Induction of FOXO3a activity in doxorubicin-sensitive MCF-7 cells was sufficient to promote Akt phosphorylation and arrest cell proliferation. Conversely, knockdown of endogenous FOXO3a expression reduced PI3K/Akt activity. Using MDA-MB-231 cells, in which FOXO3a activity can be induced by 4-hydroxytamoxifen, we showed that FOXO3a induction up-regulates PI3K-Akt activity and enhanced doxorubicin resistance. However FOXO3a induction has little effect on cell proliferation, indicating that FOXO3a or its downstream activity is deregulated in the cytotoxic drug resistant breast cancer cells. Thus, our results suggest that sustained FOXO3a activation can enhance hyperactivation of the PI3K/Akt pathway. Conclusions/Significance: Together these data suggest that lymph node metastasis and poor survival in invasive ductal breast carcinoma are linked to an uncoupling of the Akt-FOXO3a signaling axis. In these breast cancers activated Akt fails to inactivate and re-localize FOXO3a to the cytoplasm, and nuclear-targeted FOXO3a does not induce cell death or cell cycle arrest. As such, sustained nuclear FOXO3a expression in breast cancer may culminate in cancer progression and the development of an aggressive phenotype similar to that observed in cytotoxic chemotherapy resistant breast cancer cell models.	[Chen, Jie; Wong, San Yu; Wu, Lai Han; Ip, Ying-Chi; Cheung, Yuen Nei; Chan, Kelvin Y. K.; Khoo, Ui-Soon] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Chen, Jie; Gomes, Ana R.; Monteiro, Lara J.; Ng, Ting-Ting; Karadedou, Christina T.; Millour, Julie; Sunters, Andrew; Lam, Eric W. -F.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Canc Res UK Labs, London, England; [Sunters, Andrew] Univ London Royal Vet Coll, Dept Vet Basic Sci, London, England	University of Hong Kong; Cancer Research UK; Imperial College London; University of London; University of London Royal Veterinary College	Chen, J (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.	eric.lam@imperial.ac.uk; uskhoo@pathology.hku.hk	Khoo, Ui Soon/C-4293-2009; Khoo, Ui Soon/C-1345-2014; Chan, Kelvin/HGA-3097-2022; Monteiro, Lara J/AAU-8518-2020; Lam, Eric W-F/AAW-8566-2020; Khoo, Ui Soon/K-2041-2019	Khoo, Ui Soon/0000-0003-2200-7505; Khoo, Ui Soon/0000-0003-2200-7505; Lam, Eric W-F/0000-0003-1274-3576; 	University of Hong Kong [200807176071]; Research Grants Council of Hong Kong [HKU 767307M]; Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/47191/2008, SFRH/BD/44818/2008]; Breast Cancer Campaign [2007NovPhD16 Lam]; Cancer Research UK [C37/A5606]; Cancer Research UK [12011] Funding Source: researchfish	University of Hong Kong(University of Hong Kong); Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Breast Cancer Campaign; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was partly funded by grants from the Committee on Research and Conference Grants from the University of Hong Kong (CRCG)(200807176071); the Research Grants Council of Hong Kong General Research Fund (GRF) (HKU 767307M); Fundacao para a Ciencia e a Tecnologia (FCT) (SFRH/BD/47191/2008) (SFRH/BD/44818/2008) (http://alfa.fct.mctes.pt); Breast Cancer Campaign (2007NovPhD16 Lam) (http://www.breastcancercampaign.org); and Cancer Research UK (C37/A5606) (http://www.cancerresearchuk.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BRUNNER N, 1989, CANCER CELL-MON REV, V1, P81; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Clark AS, 2002, MOL CANCER THER, V1, P707; Clarke R, 2001, J STEROID BIOCHEM, V76, P71, DOI 10.1016/S0960-0760(00)00193-X; Clarke R, 2001, PHARMACOL REV, V53, P25; deGraffenried LA, 2003, ANN ONCOL, V14, P1051, DOI 10.1093/annonc/mdg291; Duffy MJ, 2005, CLIN CHEM, V51, P494, DOI 10.1373/clinchem.2004.046227; Elkak AE, 2001, CURR MED RES OPIN, V17, P282, DOI 10.1185/030079901753403180; Faridi J, 2003, CLIN CANCER RES, V9, P2933; de Mattos SF, 2008, MOL CANCER THER, V7, P3237, DOI 10.1158/1535-7163.MCT-08-0398; Freedman O. C., 2005, Cancer Treatment Reviews, V31, P1, DOI 10.1016/j.ctrv.2004.09.008; Frogne T, 2005, ENDOCR-RELAT CANCER, V12, P599, DOI 10.1677/erc.1.00946; Goss PE, 2008, CLIN BREAST CANCER, V8, P411, DOI 10.3816/CBC.2008.n.049; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Hui RCY, 2008, MOL CELL BIOL, V28, P5886, DOI 10.1128/MCB.01265-07; Hui RCY, 2008, MOL CANCER THER, V7, P670, DOI 10.1158/1535-7163.MCT-07-0397; Jin GS, 2004, ACTA MED OKAYAMA, V58, P197; Johnston SRD, 1997, ANTI-CANCER DRUG, V8, P911, DOI 10.1097/00001813-199711000-00002; Krol J, 2007, MOL CANCER THER, V6, P3169, DOI 10.1158/1535-7163.MCT-07-0507; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; McGovern UB, 2009, MOL CANCER THER, V8, P582, DOI 10.1158/1535-7163.MCT-08-0805; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nordigarden A, 2009, BLOOD, V113, P2302, DOI 10.1182/blood-2008-07-167023; Riggins RB, 2005, VITAM HORM, V71, P201, DOI 10.1016/S0083-6729(05)71007-4; Riggins RB, 2005, MOL CANCER THER, V4, P33; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; Storz P, 2009, MOL CELL BIOL, V29, P4906, DOI 10.1128/MCB.00077-09; Sunters A, 2006, CANCER RES, V66, P212, DOI 10.1158/0008-5472.CAN-05-1997; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Yamashita H, 2008, INT J CLIN ONCOL, V13, P380, DOI 10.1007/s10147-008-0818-7; Yang JY, 2009, CLIN CANCER RES, V15, P752, DOI 10.1158/1078-0432.CCR-08-0124	33	66	68	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12293	10.1371/journal.pone.0012293	http://dx.doi.org/10.1371/journal.pone.0012293			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808831	Green Published, gold, Green Submitted			2022-12-27	WOS:000281077000007
J	Mathews, WC; Cachay, ER; Caperna, J; Sitapati, A; Cosman, B; Abramson, I				Mathews, William C.; Cachay, Edward R.; Caperna, Joseph; Sitapati, Amy; Cosman, Bard; Abramson, Ian			Estimating the Accuracy of Anal Cytology in the Presence of an Imperfect Reference Standard	PLOS ONE			English	Article							SQUAMOUS INTRAEPITHELIAL LESIONS; HUMAN-PAPILLOMAVIRUS; MEN; HISTOPATHOLOGY; PERFORMANCE; INFECTION; NEOPLASIA; DISEASE; CANCER; TESTS	Background: The study aim is to estimate sensitivity and specificity of anal cytology for histologic HSIL in analyses adjusted for the imperfect biopsy reference standard. Methods and Principal Findings: Retrospective cohort study of an anal dysplasia screening program for HIV infected adults. We estimated the prevalence of histologic HSIL by concurrent cytology category and the associated cytology ROC area. Cytology operating characteristics for HSIL were estimated and adjusted for the imperfect reference standard by 3 methodologies. The study cohort included 261 patients with 3 available measures: (1) referral cytology; (2) HRA cytology; and (3) HRA directed biopsy. The prevalence of biopsy HSIL varied according to the concurrent HRA cytology result: 64.5% for HSIL or ASC-H, 12.6% for LSIL, 10.9% for ASCUS, and 6.3% for no abnormality. The cytology ROC area was 0.78. The observed prevalence of HSIL was 37% (referral cytology), 24% (HRA cytology), and 24% (HRA biopsy). Unadjusted estimates of sensitivity and specificity of cytology were 0.66 and 0.90, respectively. Adjusted estimates varied from 0.47-0.89 (sensitivity) and 0.89-1.0 (specificity). Conclusions: Analysis of a single dataset yields widely different estimates of anal cytology operating characteristics that depend on difficult to verify assumptions regarding the accuracy of the imperfect reference standard.	[Mathews, William C.; Cachay, Edward R.; Caperna, Joseph; Sitapati, Amy] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Cosman, Bard] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Abramson, Ian] Univ Calif San Diego, Dept Math, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Mathews, WC (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.	cmathews@ucsd.edu	Mathews, William C/E-4451-2010	Mathews, William C/0000-0002-2352-0725	Center for AIDS Research (CFAR)-Network of Integrated Clinical Systems [AI067039]; Pacific AIDS Education and Training Center [H4A HA 00058]; University of California at San Diego, CFAR [AI 36214]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI067039, P30AI036214] Funding Source: NIH RePORTER	Center for AIDS Research (CFAR)-Network of Integrated Clinical Systems; Pacific AIDS Education and Training Center; University of California at San Diego, CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the following grants: Center for AIDS Research (CFAR)-Network of Integrated Clinical Systems (AI067039), Pacific AIDS Education and Training Center (H4A HA 00058) and University of California at San Diego, CFAR (AI 36214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J, 2008, SEX TRANSM INFECT, V84, P94, DOI 10.1136/sti.2007.027250; Bjorge T, 2002, BRIT J CANCER, V87, P61, DOI 10.1038/sj.bjc.6600350; Byrom J, 2006, INT J GYNECOL CANCER, V16, P253, DOI 10.1111/j.1525-1438.2006.00344.x; Carns B, 2008, INT J CLIN EXP PATHO, V1, P285; Chiao EY, 2006, CLIN INFECT DIS, V43, P223, DOI 10.1086/505219; Chin-Hong PV, 2002, CLIN INFECT DIS, V35, P1127, DOI 10.1086/344057; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; DIBONITO L, 1993, CANCER-AM CANCER SOC, V72, P3002, DOI 10.1002/1097-0142(19931115)72:10<3002::AID-CNCR2820721023>3.0.CO;2-4; Fox PA, 2006, CURR OPIN INFECT DIS, V19, P62, DOI 10.1097/01.qco.0000199019.50451.a8; Fremont-Smith M, 2004, CANCER CYTOPATHOL, V102, P269, DOI 10.1002/cncr.20599; Hadgu A, 2005, EPIDEMIOLOGY, V16, P604, DOI 10.1097/01.ede.0000173042.07579.17; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Ho KS, 2010, CURR OPIN INFECT DIS, V23, P21, DOI 10.1097/QCO.0b013e328334fe5a; Jay N, 1997, DIS COLON RECTUM, V40, P919, DOI 10.1007/BF02051199; Lytwyn A, 2005, CANCER-AM CANCER SOC, V103, P1447, DOI 10.1002/cncr.20927; Mathews Christopher, 2007, Open AIDS J, V1, P11, DOI 10.2174/1874613600701010011; Mathews WC, 2004, JAIDS-J ACQ IMM DEF, V37, P1610, DOI 10.1097/00126334-200412150-00014; Mathews Wm Christopher, 2003, Top HIV Med, V11, P45; McCutcheon AL, 1987, LATENT CLASS ANAL; Nathan M, 2010, AIDS, V24, P373, DOI 10.1097/QAD.0b013e328333ab8e; Palefsky JM, 1998, AIDS, V12, P495, DOI 10.1097/00002030-199805000-00011; Pepe MS, 2007, BIOSTATISTICS, V8, P474, DOI 10.1093/biostatistics/kxl038; Reitsma JB, 2009, J CLIN EPIDEMIOL, V62, P797, DOI 10.1016/j.jclinepi.2009.02.005; Solomon D., 2004, BETHESDA SYSTEM REPO; STAQUET M, 1981, J CHRON DIS, V34, P599, DOI 10.1016/0021-9681(81)90059-X; *TRIPATH IM, BD SUREPATH PAP TEST	26	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12284	10.1371/journal.pone.0012284	http://dx.doi.org/10.1371/journal.pone.0012284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808869	Green Submitted, Green Published, gold			2022-12-27	WOS:000281075500017
J	Dehlink, E; Baker, AH; Yen, E; Nurko, S; Fiebiger, E				Dehlink, Eleonora; Baker, Alexandra H.; Yen, Elizabeth; Nurko, Samuel; Fiebiger, Edda			Relationships between Levels of Serum IgE, Cell-Bound IgE, and IgE-Receptors on Peripheral Blood Cells in a Pediatric Population	PLOS ONE			English	Article							FC-EPSILON-RI; IMMUNOGLOBULIN-E LEVELS; MEDIATOR RELEASE; LANGERHANS CELLS; HUMAN BASOPHILS; MAST-CELLS; EXPRESSION; MONOCYTES; CHILDREN; SURFACE	Background: Elevated serum immunoglobulin (Ig) E is a diagnostic marker of immediate-type allergic reactions. We hypothesize that serum IgE does not necessarily reflect total body IgE because in vivo IgE can be bound to cell surface receptors such as Fc epsilon RI and Fc epsilon RII (CD23). The aim of this study was to analyze the relationships between levels of serum IgE, cell-bound IgE, and IgE-receptors on peripheral blood cells in a pediatric population. Methodology: Whole blood samples from 48 children (26 boys, 22 girls, mean age 10,3 +/- 5,4 years) were analyzed by flow cytometry for Fc epsilon RI, CD23, and cell-bound IgE on dendritic cells (CD11c+MHC class II+), monocytes (CD14+), basophils (CD123+MHC class II-) and neutrophils (myeloperoxidase+). Total serum IgE was measured by ELISA and converted into z-units to account for age-dependent normal ranges. Correlations were calculated using Spearman rank correlation test. Principal Findings: Dendritic cells, monocytes, basophils, and neutrophils expressed the high affinity IgE-receptor Fc epsilon RI. Dendritic cells and monocytes also expressed the low affinity receptor CD23. The majority of IgE-receptor positive cells carried IgE on their surface. Expression of both IgE receptors was tightly correlated with cell-bound IgE. In general, cell-bound IgE on Fc epsilon RI+ cells correlated well with serum IgE. However, some patients carried high amounts of cell-bound IgE despite low total serum IgE levels. Conclusion/Significance: In pediatric patients, levels of age-adjusted serum IgE, cell-bound IgE, and Fc epsilon RI correlate. Even in the absence of elevated levels of serum IgE, cell-bound IgE can be detected on peripheral blood cells in a subgroup of patients.	[Dehlink, Eleonora; Baker, Alexandra H.; Yen, Elizabeth; Nurko, Samuel; Fiebiger, Edda] Harvard Univ, Sch Med, Div Gastroenterol & Nutr, Childrens Hosp Boston, Boston, MA 02115 USA; [Dehlink, Eleonora; Baker, Alexandra H.; Yen, Elizabeth; Nurko, Samuel; Fiebiger, Edda] Harvard Univ, Sch Med, EGID Ctr, Childrens Hosp Boston, Boston, MA USA; [Dehlink, Eleonora] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Medical University of Vienna	Dehlink, E (corresponding author), Harvard Univ, Sch Med, Div Gastroenterol & Nutr, Childrens Hosp Boston, Boston, MA 02115 USA.	edda.fiebiger@childrens.harvard.edu	Baker, Alexandra/ABF-1321-2021	Yen, Elizabeth/0000-0002-7172-8723; Nurko, Samuel/0000-0003-0936-4807	Gerber Foundation; Thrasher Research Fund; AGA; NIH [K24DK82792-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082792] Funding Source: NIH RePORTER	Gerber Foundation; Thrasher Research Fund; AGA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Gerber Foundation (Drs. Nurko and Fiebiger) and the Thrasher Research Fund (Dr. Dehlink). Further support came from a Research Scholar Award from the AGA (to E.F.) and NIH K24DK82792-1 (to S.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam JP, 2003, J ALLERGY CLIN IMMUN, V112, P141, DOI 10.1067/mai.2003.1607; Alphonse MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001921; Beck LA, 2004, J ALLERGY CLIN IMMUN, V114, P527, DOI 10.1016/j.jaci.2004.06.032; Benhamou AH, 2008, PEDIATR ALLERGY IMMU, V19, P173, DOI 10.1111/j.1399-3038.2007.00602.x; BIEBER T, 1992, RES IMMUNOL, V143, P445, DOI 10.1016/S0923-2494(05)80082-3; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Celik-Bilgili S, 2005, CLIN EXP ALLERGY, V35, P268, DOI 10.1111/j.1365-2222.2005.02150.x; Chehade M, 2007, CURR OPIN ALLERGY CL, V7, P264, DOI 10.1097/ACI.0b013e32814a5607; CONROY MC, 1977, J IMMUNOL, V118, P1317; Gomez G, 2007, J IMMUNOL, V179, P1353, DOI 10.4049/jimmunol.179.2.1353; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; KJELLMAN NIM, 1976, CLIN ALLERGY, V6, P51, DOI 10.1111/j.1365-2222.1976.tb01411.x; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Kubota T, 2006, J IMMUNOL, V176, P7008, DOI 10.4049/jimmunol.176.11.7008; Lemieux GA, 2007, J BIOL CHEM, V282, P14836, DOI 10.1074/jbc.M608414200; LIANG Y, 2009, J IMMUNOL METHODS; MacGlashan D, 2005, ANN NY ACAD SCI, V1050, P73, DOI 10.1196/annals.1313.009; MALVEAUX FJ, 1978, J CLIN INVEST, V62, P176, DOI 10.1172/JCI109103; MAURER D, 1994, J EXP MED, V179, P745, DOI 10.1084/jem.179.2.745; Mora J, 2009, CLIN IMMUNOL, V132, P132, DOI 10.1016/j.clim.2009.03.513; Nopp A, 2006, ALLERGY, V61, P298, DOI 10.1111/j.1398-9995.2006.00987.x; Novak N, 2003, J ALLERGY CLIN IMMUN, V112, P252, DOI 10.1067/mai.2003.1595; Prussin C, 2003, J ALLERGY CLIN IMMUN, V112, P1147, DOI 10.1016/j.jaci.2003.10.003; Rolinck-Werninghaus C, 2008, ALLERGY, V63, P1339, DOI 10.1111/j.1398-9995.2008.01692.x; Saini SS, 2000, J ALLERGY CLIN IMMUN, V106, P514, DOI 10.1067/mai.2000.108431; Saini SS, 1999, J IMMUNOL, V162, P5624; Sihra BS, 1997, J ALLERGY CLIN IMMUN, V99, P699, DOI 10.1016/S0091-6749(97)70033-2; Wada T, 1999, PEDIATR RES, V46, P603, DOI 10.1203/00006450-199911000-00018; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Wollenberg A, 1998, ARCH DERMATOL RES, V290, P517, DOI 10.1007/s004030050345; Yamaguchi M, 1999, J IMMUNOL, V162, P5455	31	49	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12204	10.1371/journal.pone.0012204	http://dx.doi.org/10.1371/journal.pone.0012204			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808937	gold, Green Submitted, Green Published			2022-12-27	WOS:000280968000027
J	Elrod, HA; Fan, SQ; Muller, S; Chen, GZ; Pan, L; Tighiouart, M; Shin, DM; Khuri, FR; Sun, SY				Elrod, Heath A.; Fan, Songqing; Muller, Susan; Chen, Georgia Z.; Pan, Lin; Tighiouart, Mourad; Shin, Dong M.; Khuri, Fadlo R.; Sun, Shi-Yong			Analysis of Death Receptor 5 and Caspase-8 Expression in Primary and Metastatic Head and Neck Squamous Cell Carcinoma and Their Prognostic Impact	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; LYMPH-NODE METASTASIS; CANCER-THERAPY; TUMOR SURVEILLANCE; LUNG-CANCER; MU-CALPAIN; TRAIL; MIGRATION; NEUROBLASTOMA; ADHESION	Death receptor 5 (DR5) and caspase-8 are major components in the extrinsic apoptotic pathway. The alterations of the expression of these proteins during the metastasis of head and neck squamous cell carcinoma (HNSCC) and their prognostic impact have not been reported. The present study analyzes the expression of DR5 and caspase-8 by immunohistochemistry (IHC) in primary and metastatic HNSCCs and their impact on patient survival. Tumor samples in this study included 100 primary HNSCC with no evidence of metastasis, 100 primary HNSCC with lymph node metastasis (LNM) and 100 matching LNM. IHC analysis revealed a significant loss or downregulation of DR5 expression in primary tumors with metastasis and their matching LNM compared to primary tumors with no evidence of metastasis. A similar trend was observed in caspase-8 expression although it was not statistically significant. Downregulation of caspase-8 and DR5 expression was significantly correlated with poorly differentiated tumors compared to moderately and well differentiated tumors. Univariate analysis indicates that, in HNSCC with no metastasis, higher expression of caspase-8 significantly correlated with better disease-free survival and overall survival. However, in HNSCC with LNM, higher caspase-8 expression significantly correlated with poorer disease-free survival and overall survival. Similar results were also generated when we combined both DR5 and caspase-8. Taken together, we suggest that both DR5 and caspase-8 are involved in regulation of HNSCC metastasis. Our findings warrant further investigation on the dual role of caspase-8 in cancer development.	[Elrod, Heath A.; Fan, Songqing; Chen, Georgia Z.; Shin, Dong M.; Khuri, Fadlo R.; Sun, Shi-Yong] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Elrod, Heath A.; Fan, Songqing; Muller, Susan; Chen, Georgia Z.; Pan, Lin; Tighiouart, Mourad; Shin, Dong M.; Khuri, Fadlo R.; Sun, Shi-Yong] Winship Canc Inst, Atlanta, GA USA; [Muller, Susan] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Pan, Lin; Tighiouart, Mourad] Emory Univ, Sch Med, Dept Biostat & Bioinformat, Atlanta, GA USA	Emory University; Emory University; Emory University	Elrod, HA (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA.	ssun@emory.edu	Shin, Dong Moon/G-9649-2013; Khuri, Fadlo R./AAU-4942-2020; Ray, Dana M/C-3470-2013	Shin, Dong Moon/0000-0002-8245-4174; Khuri, Fadlo R./0000-0002-8638-7618; 	Georgia Cancer Coalition Distinguished Cancer Scholar award; National Institutes of Health [CA128613]; NATIONAL CANCER INSTITUTE [P50CA128613] Funding Source: NIH RePORTER	Georgia Cancer Coalition Distinguished Cancer Scholar award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Georgia Cancer Coalition Distinguished Cancer Scholar award (SYS) and National Institutes of Health SPORE P50 grant CA128613 (SYS and FRK for Project 2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasan A, 2003, CYTOKINE GROWTH F R, V14, P337, DOI 10.1016/S1359-6101(03)00029-7; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Barbero S, 2008, J BIOL CHEM, V283, P13031, DOI 10.1074/jbc.M800549200; Barbero S, 2009, CANCER RES, V69, P3755, DOI 10.1158/0008-5472.CAN-08-3937; Bellail AC, 2009, REV RECENT CLIN TRIA, V4, P34, DOI 10.2174/157488709787047530; Cooper WA, 2008, CANCER, V113, P135, DOI 10.1002/cncr.23528; Duiker EW, 2010, GYNECOL ONCOL, V116, P549, DOI 10.1016/j.ygyno.2009.09.014; Finlay D, 2007, CANCER RES, V67, P11704, DOI 10.1158/0008-5472.CAN-07-1906; Frisch SM, 2008, CANCER RES, V68, P4491, DOI 10.1158/0008-5472.CAN-08-0952; Fulda S, 2006, CANCER RES, V66, P10016, DOI 10.1158/0008-5472.CAN-05-4079; Ganten TM, 2009, J MOL MED, V87, P995, DOI 10.1007/s00109-009-0510-z; Grosse-Wilde A, 2008, J CLIN INVEST, V118, P100, DOI 10.1172/JCI33061; Harada K, 2002, CANCER RES, V62, P5897; Heijink DM, 2007, CELL ONCOL, V29, P409; Helfer B, 2006, CANCER RES, V66, P4273, DOI 10.1158/0008-5472.CAN-05-4183; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hopkins-Donaldson S, 2003, CELL DEATH DIFFER, V10, P356, DOI 10.1038/sj.cdd.4401157; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Koornstra JJ, 2005, EUR J CANCER, V41, P1195, DOI 10.1016/j.ejca.2005.02.018; Laguinge LM, 2008, CANCER RES, V68, P909, DOI 10.1158/0008-5472.CAN-06-1806; Lu LM, 2007, J IMMUNOL, V178, P936, DOI 10.4049/jimmunol.178.2.936; Maduro JH, 2009, INT J RADIAT ONCOL, V75, P203, DOI 10.1016/j.ijrobp.2009.03.071; Muller S, 2008, CANCER-AM CANCER SOC, V113, P97, DOI 10.1002/cncr.23557; Murin S, 2004, CHEST, V125, P1467, DOI 10.1378/chest.125.4.1467; Nagaraj NS, 2007, TOXICOL LETT, V170, P134, DOI 10.1016/j.toxlet.2007.02.014; Nam NJ, 2002, APMIS, V110, P825, DOI 10.1034/j.1600-0463.2002.1101109.x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pingoud-Meier C, 2003, CLIN CANCER RES, V9, P6401; Reesink-Peters N, 2005, GYNECOL ONCOL, V96, P705, DOI 10.1016/j.ygyno.2004.10.046; Samara RN, 2007, CANCER RES, V67, P4774, DOI 10.1158/0008-5472.CAN-06-4315; Seiwert TY, 2005, BRIT J CANCER, V92, P1341, DOI 10.1038/sj.bjc.6602510; Senft J, 2007, CANCER RES, V67, P11505, DOI 10.1158/0008-5472.CAN-07-5755; Shivapurkar N, 2002, CANCER BIOL THER, V1, P65, DOI 10.4161/cbt.1.1.45; Soung YH, 2005, CANCER RES, V65, P815; Soung YH, 2005, ONCOGENE, V24, P141, DOI 10.1038/sj.onc.1208244; Spierings DCJ, 2003, CLIN CANCER RES, V9, P3397; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Trauzold A, 2006, ONCOGENE, V25, P7434, DOI 10.1038/sj.onc.1209719; Vakkala M, 1999, BRIT J CANCER, V81, P592, DOI 10.1038/sj.bjc.6690735; van Geelen CM, 2006, J CLIN ONCOL, V24, P4998, DOI 10.1200/JCO.2006.06.8809; Virkajarvi N, 1998, HISTOPATHOLOGY, V33, P432, DOI 10.1046/j.1365-2559.1998.00553.x; Wajant H, 2002, APOPTOSIS, V7, P449, DOI 10.1023/A:1020039225764; Wajant H, 2006, CANC TREAT, V130, P141; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Xu B, 2008, ONCOLOGY-BASEL, V74, P229, DOI 10.1159/000151392; Xu LJ, 2006, J BIOL CHEM, V281, P4457, DOI 10.1074/jbc.M510721200; Xu LJ, 2004, J BIOL CHEM, V279, P53683, DOI 10.1074/jbc.M409889200; Zhang X, 2004, CLIN CANCER RES, V10, P8451, DOI 10.1158/1078-0432.CCR-04-0546; Zhuang LQ, 2006, HUM PATHOL, V37, P1286, DOI 10.1016/j.humpath.2006.04.026; Zuzak TJ, 2002, EUR J CANCER, V38, P83, DOI 10.1016/S0959-8049(01)00355-0	52	32	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12178	10.1371/journal.pone.0012178	http://dx.doi.org/10.1371/journal.pone.0012178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808443	Green Submitted, Green Published, gold			2022-12-27	WOS:000280968000009
J	Hessel, A; Schwendinger, M; Fritz, D; Coulibaly, S; Holzer, GW; Sabarth, N; Kistner, O; Wodal, W; Kerschbaum, A; Savidis-Dacho, H; Crowe, BA; Kreil, TR; Barrett, PN; Falkner, FG				Hessel, Annett; Schwendinger, Michael; Fritz, Daniela; Coulibaly, Sogue; Holzer, Georg W.; Sabarth, Nicolas; Kistner, Otfried; Wodal, Walter; Kerschbaum, Astrid; Savidis-Dacho, Helga; Crowe, Brian A.; Kreil, Thomas R.; Barrett, P. Noel; Falkner, Falko G.			A Pandemic Influenza H1N1 Live Vaccine Based on Modified Vaccinia Ankara Is Highly Immunogenic and Protects Mice in Active and Passive Immunizations	PLOS ONE			English	Article							CROSS-CLADE PROTECTION; CD8(+) T-CELLS; VIRUS-INFECTION; A/H5N1 VIRUSES; IMMUNITY; H5N1; RECOMBINANTS; ANTIBODIES; SEQUENCE; ANTIGEN	Background: The development of novel influenza vaccines inducing a broad immune response is an important objective. The aim of this study was to evaluate live vaccines which induce both strong humoral and cell-mediated immune responses against the novel human pandemic H1N1 influenza virus, and to show protection in a lethal animal challenge model. Methodology/Principal Findings: For this purpose, the hemagglutinin (HA) and neuraminidase (NA) genes of the influenza A/California/07/2009 (H1N1) strain (CA/07) were inserted into the replication-deficient modified vaccinia Ankara (MVA) virus - a safe poxviral live vector - resulting in MVA-H1-Ca and MVA-N1-Ca vectors. These live vaccines, together with an inactivated whole virus vaccine, were assessed in a lung infection model using immune competent Balb/c mice, and in a lethal challenge model using severe combined immunodeficient (SCID) mice after passive serum transfer from immunized mice. Balb/c mice vaccinated with the MVA-H1-Ca virus or the inactivated vaccine were fully protected from lung infection after challenge with the influenza H1N1 wild-type strain, while the neuraminidase virus MVA-N1-Ca induced only partial protection. The live vaccines were already protective after a single dose and induced substantial amounts of neutralizing antibodies and of interferon-gamma-secreting (IFN-gamma) CD4- and CD8 T-cells in lungs and spleens. In the lungs, a rapid increase of HA-specific CD4- and CD8 T cells was observed in vaccinated mice shortly after challenge with influenza swine flu virus, which probably contributes to the strong inhibition of pulmonary viral replication observed. In addition, passive transfer of antisera raised in MVA-H1-Ca vaccinated immune-competent mice protected SCID mice from lethal challenge with the CA/07 wild-type virus. Conclusions/Significance: The non-replicating MVA-based H1N1 live vaccines induce a broad protective immune response and are promising vaccine candidates for pandemic influenza.	[Hessel, Annett; Schwendinger, Michael; Fritz, Daniela; Coulibaly, Sogue; Holzer, Georg W.; Sabarth, Nicolas; Kistner, Otfried; Wodal, Walter; Kerschbaum, Astrid; Savidis-Dacho, Helga; Crowe, Brian A.; Kreil, Thomas R.; Barrett, P. Noel; Falkner, Falko G.] Baxter BioSci, Biomed Res Ctr, R&D Vaccines, Orth, Austria		Hessel, A (corresponding author), Baxter BioSci, Biomed Res Ctr, R&D Vaccines, Orth, Austria.	falknef@baxter.com	Sabarth, Nicolas/GQQ-0093-2022; Sabarth, Nicolas/GQP-7376-2022	Sabarth, Nicolas/0000-0003-3844-6297; 	Baxter BioScience	Baxter BioScience	This study was funded by Baxter BioScience. The funders were involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	ALEXANDROVA GI, 1984, INFECT IMMUN, V44, P734, DOI 10.1128/IAI.44.3.734-739.1984; Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Cerwenka A, 1999, J IMMUNOL, V163, P5535; Epstein SL, 1998, J IMMUNOL, V160, P322; GUBAREVA LV, 1994, VIROLOGY, V199, P89, DOI 10.1006/viro.1994.1100; Himly M, 1998, VIROLOGY, V248, P295, DOI 10.1006/viro.1998.9290; Holzer GW, 1998, VIROLOGY, V249, P160, DOI 10.1006/viro.1998.9307; Karron RA, 2009, VACCINE, V27, P4953, DOI 10.1016/j.vaccine.2009.05.099; KILBOURNE ED, 1968, J VIROL, V2, P281, DOI 10.1128/JVI.2.4.281-288.1968; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Kistner O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009349; Kreijtz JHCM, 2009, VACCINE, V27, P6296, DOI 10.1016/j.vaccine.2009.03.020; Kreijtz JHCM, 2009, J INFECT DIS, V199, P405, DOI 10.1086/595984; Kreijtz JHCM, 2007, J INFECT DIS, V195, P1598, DOI 10.1086/517614; Kreijtz JHCM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007790; Lawrence CW, 2005, J IMMUNOL, V174, P5332, DOI 10.4049/jimmunol.174.9.5332; Maassab HF, 1999, REV MED VIROL, V9, P237, DOI 10.1002/(SICI)1099-1654(199910/12)9:4&lt;237::AID-RMV252&gt;3.0.CO;2-G; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mayrhofer J, 2009, J VIROL, V83, P5192, DOI 10.1128/JVI.02081-08; McGill J, 2009, J IMMUNOL, V183, P4177, DOI 10.4049/jimmunol.0901109; MEYER H, 1991, J GEN VIROL, V72, P1031, DOI 10.1099/0022-1317-72-5-1031; Ober BT, 2002, J VIROL, V76, P7713, DOI 10.1128/JVI.76.15.7713-7723.2002; Palese P, 1999, ARCH VIROL, P131; Poon LLM, 2009, J IMMUNOL, V182, P3063, DOI 10.4049/jimmunol.0803467; Ramirez JC, 2000, J VIROL, V74, P7651, DOI 10.1128/JVI.74.16.7651-7655.2000; Sandbulte MR, 2009, INFLUENZA OTHER RESP, V3, P233, DOI 10.1111/j.1750-2659.2009.00094.x; Scheiflinger F, 1998, ARCH VIROL, V143, P467, DOI 10.1007/s007050050303; SCHERLE PA, 1992, J IMMUNOL, V148, P212; Seo SH, 2002, J VIROL, V76, P4886, DOI 10.1128/JVI.76.10.4886-4890.2002; Suguitan AL, 2009, VIROLOGY, V395, P280, DOI 10.1016/j.virol.2009.09.017; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Talon J, 2000, P NATL ACAD SCI USA, V97, P4309, DOI 10.1073/pnas.070525997; WILLIAMS SP, 1993, VIROLOGY, V196, P660, DOI 10.1006/viro.1993.1522; Wood JM, 2004, NAT REV MICROBIOL, V2, P842, DOI 10.1038/nrmicro979; World Health Organization, 2002, WHO MAN AN INFL DIAG; WRIGHT PF, 2005, ORTHOMYXOVIRUSES FIE, P1692; Wyatt LS, 1996, VACCINE, V14, P1451, DOI 10.1016/S0264-410X(96)00072-2; YAP KL, 1978, SCAND J IMMUNOL, V8, P413, DOI 10.1111/j.1365-3083.1978.tb00536.x; Yen HL, 2009, CURR TOP MICROBIOL, V333, P3, DOI 10.1007/978-3-540-92165-3_1; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417	40	28	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12217	10.1371/journal.pone.0012217	http://dx.doi.org/10.1371/journal.pone.0012217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808939	Green Submitted, Green Published, gold			2022-12-27	WOS:000280968000030
J	Patil, R; Das, S; Stanley, A; Yadav, L; Sudhakar, A; Varma, AK				Patil, Rohan; Das, Suranjana; Stanley, Ashley; Yadav, Lumbani; Sudhakar, Akulapalli; Varma, Ashok K.			Optimized Hydrophobic Interactions and Hydrogen Bonding at the Target-Ligand Interface Leads the Pathways of Drug-Designing	PLOS ONE			English	Article							BIOLOGICAL EVALUATION; RATIONAL DESIGN; PROTEIN; INHIBITORS; BINDING; COMPLEXES; SIALIDASE; DOCKING; KINASES	Background: Weak intermolecular interactions such as hydrogen bonding and hydrophobic interactions are key players in stabilizing energetically-favored ligands, in an open conformational environment of protein structures. However, it is still poorly understood how the binding parameters associated with these interactions facilitate a drug-lead to recognize a specific target and improve drugs efficacy. To understand this, comprehensive analysis of hydrophobic interactions, hydrogen bonding and binding affinity have been analyzed at the interface of c-Src and c-Abl kinases and 4-amino substituted 1H-pyrazolo [3, 4-d] pyrimidine compounds. Methodology: In-silico docking studies were performed, using Discovery Studio software modules LigandFit, CDOCKER and ZDOCK, to investigate the role of ligand binding affinity at the hydrophobic pocket of c-Src and c-Abl kinase. Hydrophobic and hydrogen bonding interactions of docked molecules were compared using LigPlot program. Furthermore, 3D-QSAR and MFA calculations were scrutinized to quantify the role of weak interactions in binding affinity and drug efficacy. Conclusions: The in-silico method has enabled us to reveal that a multi-targeted small molecule binds with low affinity to its respective targets. But its binding affinity can be altered by integrating the conformationally favored functional groups at the active site of the ligand-target interface. Docking studies of 4-amino-substituted molecules at the bioactive cascade of the c-Src and c-Abl have concluded that 3D structural folding at the protein-ligand groove is also a hallmark for molecular recognition of multi-targeted compounds and for predicting their biological activity. The results presented here demonstrate that hydrogen bonding and optimized hydrophobic interactions both stabilize the ligands at the target site, and help alter binding affinity and drug efficacy.	[Patil, Rohan; Das, Suranjana; Stanley, Ashley; Yadav, Lumbani; Varma, Ashok K.] Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, Maharashtra, India; [Sudhakar, Akulapalli] Boys Town Natl Res Hosp, Cell Signaling & Tumor Angiogenesis Lab, Omaha, NE 68131 USA; [Sudhakar, Akulapalli] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Sudhakar, Akulapalli] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Boys Town National Research Hospital; Creighton University; University of Nebraska System; University of Nebraska Medical Center	Patil, R (corresponding author), Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA.	avarma@actrec.gov.in			Department of Science and Technology-Science And Engineering Research Council [SR/FT/LS-074/2007]; Advanced Centre for Treatment, Research and Education in Cancer, Kharghar; Flight Attendant Medical Research Institute [062558, RO1CA143128]; NATIONAL CANCER INSTITUTE [R01CA143128] Funding Source: NIH RePORTER	Department of Science and Technology-Science And Engineering Research Council; Advanced Centre for Treatment, Research and Education in Cancer, Kharghar; Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this study was fully supported by Department of Science and Technology-Science And Engineering Research Council fast track award grant (SR/FT/LS-074/2007), institutional funds from Advanced Centre for Treatment, Research and Education in Cancer, Kharghar to AKV. This work was partly supported by Flight Attendant Medical Research Institute Young Clinical Scientist Award Grant FAMRI#062558 and RO1CA143128 to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhinge A, 2004, STRUCTURE, V12, P1989, DOI 10.1016/j.str.2004.09.005; Bhise SB, 2004, INDIAN J BIOCHEM BIO, V41, P273; BLUNDELL T, 1983, NATURE, V304, P273, DOI 10.1038/304273a0; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Choulier L, 2002, PROTEIN ENG, V15, P373, DOI 10.1093/protein/15.5.373; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; Davis AM, 1999, ANGEW CHEM INT EDIT, V38, P737, DOI 10.1002/(SICI)1521-3773(19990315)38:6<736::AID-ANIE736>3.0.CO;2-R; Desiraju GR, 2005, CHEM COMMUN, P2995, DOI 10.1039/b504372g; Desiraju GR, 1996, ACCOUNTS CHEM RES, V29, P441, DOI 10.1021/ar950135n; DESJARLAIS RL, 1990, P NATL ACAD SCI USA, V87, P6644, DOI 10.1073/pnas.87.17.6644; DiMagno SG, 2006, CURR TOP MED CHEM, V6, P1473, DOI 10.2174/156802606777951127; Fernandez A, 2007, CANCER RES, V67, P4028, DOI 10.1158/0008-5472.CAN-07-0345; Fontana P, 2005, BIOINFORMATICS, V21, P393, DOI 10.1093/bioinformatics/bti013; Gangjee A, 2008, ANTI-CANCER AGENT ME, V8, P205, DOI 10.2174/187152008783497064; Ghosh AK, 2008, ORG BIOMOL CHEM, V6, P3703, DOI 10.1039/b809178a; HANSCH C, 1991, METHOD ENZYMOL, V202, P512; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Kondru RK, 2000, SCIENCE, V288, P1981; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lipton SA, 2004, NATURE, V428, P473, DOI 10.1038/428473a; Lu YX, 2009, J PHYS CHEM B, V113, P12615, DOI 10.1021/jp906352e; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Mobley DL, 2009, STRUCTURE, V17, P489, DOI 10.1016/j.str.2009.02.010; Moza B, 2006, P NATL ACAD SCI USA, V103, P9867, DOI 10.1073/pnas.0600220103; Ohlson S, 2008, DRUG DISCOV TODAY, V13, P433, DOI 10.1016/j.drudis.2008.02.001; Panigrahi SK, 2008, AMINO ACIDS, V34, P617, DOI 10.1007/s00726-007-0015-4; Panigrahi SK, 2007, PROTEINS, V67, P128, DOI 10.1002/prot.21253; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Petsalaki E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000335; Qian SB, 2009, J BIOL CHEM, V284, P26797, DOI 10.1074/jbc.M109.032334; ROBERTS NA, 1990, SCIENCE, V248, P358, DOI 10.1126/science.2183354; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Schenone S, 2008, EUR J MED CHEM, V43, P2665, DOI 10.1016/j.ejmech.2008.01.034; Simeonov A, 2008, ANAL BIOCHEM, V375, P60, DOI 10.1016/j.ab.2007.11.039; Sun H, 2010, CHEM BIOL DRUG DES, V75, P3, DOI 10.1111/j.1747-0285.2009.00899.x; Szuromi P, 2004, SCIENCE, V303, P1795, DOI 10.1126/science.303.5665.1795; Taylor NR, 1998, J MED CHEM, V41, P798, DOI 10.1021/jm9703754; Valdar WSJ, 2001, PROTEINS, V42, P108; Varghese JN, 1999, DRUG DEVELOP RES, V46, P176, DOI 10.1002/(SICI)1098-2299(199903/04)46:3/4<176::AID-DDR4>3.0.CO;2-6; Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X; Verma S, 2007, MED CHEM, V3, P605, DOI 10.2174/157340607782360371; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; White Alex W., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000641	47	229	244	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12029	10.1371/journal.pone.0012029	http://dx.doi.org/10.1371/journal.pone.0012029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808434	Green Submitted, Green Published, gold			2022-12-27	WOS:000280968000002
J	Reimann, M; Friedrich, C; Gasch, J; Reichmann, H; Rudiger, H; Ziemssen, T				Reimann, Manja; Friedrich, Constanze; Gasch, Julia; Reichmann, Heinz; Ruediger, Heinz; Ziemssen, Tjalf			Trigonometric Regressive Spectral Analysis Reliably Maps Dynamic Changes in Baroreflex Sensitivity and Autonomic Tone: The Effect of Gender and Age	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; DIFFERENT EXTRAPYRAMIDAL SYNDROMES; BLOOD-PRESSURE; ARTERIAL BAROREFLEX; ESSENTIAL-HYPERTENSION; SYMPATHETIC ACTIVITY; HEALTHY-SUBJECTS; POSTURAL STRESS; YOUNG-WOMEN; MORTALITY	Background: The assessment of baroreflex sensitivity (BRS) has emerged as prognostic tool in cardiology. Although available computer-assisted methods, measuring spontaneous fluctuations of heart rate and blood pressure in the time and frequency domain are easily applicable, they do not allow for quantification of BRS during cardiovascular adaption processes. This, however, seems an essential criterion for clinical application. We evaluated a novel algorithm based on trigonometric regression regarding its ability to map dynamic changes in BRS and autonomic tone during cardiovascular provocation in relation to gender and age. Methodology/Principal Findings: We continuously recorded systemic arterial pressure, electrocardiogram and respiration in 23 young subjects (25+/-2 years) and 22 middle-aged subjects (56+/-4 years) during cardiovascular autonomic testing (metronomic breathing, Valsalva manoeuvre, head-up tilt). Baroreflex- and spectral analysis was performed using the algorithm of trigonometric regressive spectral analysis. There was an age-related decline in spontaneous BRS and high frequency oscillations of RR intervals. Changes in autonomic tone evoked by cardiovascular provocation were observed as shifts in the ratio of low to high frequency oscillations of RR intervals and blood pressure. Respiration at 0.1 Hz elicited an increase in BRS while head-up tilt and Valsalva manoeuvre resulted in a downregulation of BRS. The extent of autonomic adaption was in general more pronounced in young individuals and declined stronger with age in women than in men. Conclusions/Significance: The trigonometric regressive spectral analysis reliably maps age- and gender-related differences in baroreflex- and autonomic function and is able to describe adaption processes of baroreceptor circuit during cardiovascular stimulation. Hence, this novel algorithm may be a useful screening tool to detect abnormalities in cardiovascular adaption processes even when resting values appear to be normal.	[Reimann, Manja; Friedrich, Constanze; Gasch, Julia; Reichmann, Heinz; Ruediger, Heinz; Ziemssen, Tjalf] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Neurol, Auton & Neuroendocrinol Lab, D-8027 Dresden, Germany; [Reimann, Manja; Ruediger, Heinz; Ziemssen, Tjalf] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Neurol & Internal Med 3, Res Grp Neurometab, D-8027 Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Reimann, M (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Neurol, Auton & Neuroendocrinol Lab, D-8027 Dresden, Germany.	manjareimann@uniklinikum-dresden.de	Ziemssen, Tjalf/J-2017-2019	Ziemssen, Tjalf/0000-0001-8799-8202	University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany; Cephalon; Novartis; TEVA; Lundbeck; GlaxoSmithKline; Boehringer Ingelheim; Schering/Bayer HealthCare; UCB/Schwarz Pharma; Desitin; Pfizer; Solvay; Roland Ernst Foundation	University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany; Cephalon; Novartis(Novartis); TEVA(Teva Pharmaceutical Industries); Lundbeck(Lundbeck Corporation); GlaxoSmithKline(GlaxoSmithKline); Boehringer Ingelheim(Boehringer Ingelheim); Schering/Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); UCB/Schwarz Pharma(UCB Pharma SA); Desitin; Pfizer(Pfizer); Solvay(Solvay SA); Roland Ernst Foundation	The study was supported by the University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; M. Reimann, C. Friedrich, J. Gasch and H. Rudiger report no disclosures. H. Reichmann serves on scientific advisory boards, receives speaker honoraria, and/or receives funding for travel from Cephalon, Novartis, TEVA, Lundbeck, GlaxoSmithKline, Boehringer Ingelheim, Schering/Bayer HealthCare, UCB/Schwarz Pharma, Desitin, Pfizer, and Solvay. T. Ziemssen has received speaker honoraria from Biogen Idec, Sanofi-Aventis, MerckSerono, Novartis, Teva, and Bayer Healthcare. He serves as a consultant for Teva, Novartis, and Bayer HealthCare, and receives research support from the Roland Ernst Foundation.	Barnett SR, 1999, HYPERTENSION, V33, P1195, DOI 10.1161/01.HYP.33.5.1195; Bernardi L, 1992, G Ital Cardiol, V22, P517; Bernardi L, 2001, J HYPERTENS, V19, P2221, DOI 10.1097/00004872-200112000-00016; Brown CM, 2003, EUR J CLIN INVEST, V33, P10, DOI 10.1046/j.1365-2362.2003.01093.x; ECKBERG DL, 1977, J PHYSIOL-LONDON, V269, P579, DOI 10.1113/jphysiol.1977.sp011916; Evans JM, 2001, J APPL PHYSIOL, V91, P2611, DOI 10.1152/jappl.2001.91.6.2611; Fauvel JP, 2007, HYPERTENSION, V50, P543, DOI 10.1161/HYPERTENSIONAHA.107.090811; Friedrich C, 2008, J NEURAL TRANSM, V115, P1527, DOI 10.1007/s00702-008-0127-3; Friedrich C, 2010, MOVEMENT DISORD, V25, P315, DOI 10.1002/mds.22844; GOLDSTEIN DS, 1983, CIRCULATION, V68, P234, DOI 10.1161/01.CIR.68.2.234; Hilz MJ, 2000, FORTSCHR NEUROL PSYC, V68, P37, DOI 10.1055/s-2000-11641; Johansson M, 2007, J HYPERTENS, V25, P163, DOI 10.1097/01.hjh.0000254377.18983.eb; Joseph CN, 2005, HYPERTENSION, V46, P714, DOI 10.1161/01.HYP.0000179581.68566.7d; KORNER PI, 1989, CLIN EXP PHARMACOL P, P45; Kornet L, 2005, J HYPERTENS, V23, P815, DOI 10.1097/01.hjh.0000163151.50825.e2; La Rovere MT, 2001, CIRCULATION, V103, P2072; La Rovere MT, 1998, LANCET, V351, P478; Lahiri MK, 2008, J AM COLL CARDIOL, V51, P1725, DOI 10.1016/j.jacc.2008.01.038; Laitinen T, 2004, J APPL PHYSIOL, V96, P2333, DOI 10.1152/japplphysiol.00444.2003; Laitinen T, 1998, J APPL PHYSIOL, V84, P576, DOI 10.1152/jappl.1998.84.2.576; LaRovere MT, 1997, PACE, V20, P2602; Laude D, 2004, AM J PHYSIOL-REG I, V286, pR226, DOI 10.1152/ajpregu.00709.2002; Lavi S, 2007, AM J PHYSIOL-REG I, V292, pR788, DOI 10.1152/ajpregu.00352.2006; LIPSITZ LA, 1990, CIRCULATION, V81, P1803, DOI 10.1161/01.CIR.81.6.1803; MALLIANI A, 1994, AM J CARDIOL, V73, pC3, DOI 10.1016/0002-9149(94)90617-3; Mattace-Raso FUS, 2007, J HYPERTENS, V25, P1421, DOI 10.1097/HJH.0b013e32811d6a07; MENSE L, CIRC J IN PRESS; Minson CT, 2000, CIRCULATION, V102, P1473, DOI 10.1161/01.CIR.102.13.1473; Minson CT, 2000, CIRCULATION, V101, P862, DOI 10.1161/01.CIR.101.8.862; Monahan KD, 2001, AM J PHYSIOL-HEART C, V281, pH284, DOI 10.1152/ajpheart.2001.281.1.H284; Mukai S, 2003, J GERONTOL A-BIOL, V58, P626; Oka H, 2003, EUR NEUROL, V50, P230, DOI 10.1159/000073865; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Parati G, 2000, J HYPERTENS, V18, P7, DOI 10.1097/00004872-200018010-00003; PARATI G, 1988, HYPERTENSION, V12, P214, DOI 10.1161/01.HYP.12.2.214; Radaelli A, 2004, J HYPERTENS, V22, P1361, DOI 10.1097/01.hjh.0000125446.28861.51; Rudiger H, 1999, COMPUT METH PROG BIO, V58, P1, DOI 10.1016/S0169-2607(98)00070-4; Saeed NP, 2009, J VASC RES, V46, P469, DOI 10.1159/000200962; Schmidt C, 2009, J NEURAL TRANSM, V116, P875, DOI 10.1007/s00702-009-0239-4; Skrapari I, 2007, OBESITY, V15, P1685, DOI 10.1038/oby.2007.201; Skrapari I, 2006, CURR DIABETES REV, V2, P329, DOI 10.2174/157339906777950589; Tank J, 2005, HYPERTENSION, V45, P1159, DOI 10.1161/01.HYP.0000165695.98915.9a; Tzeng YC, 2009, J APPL PHYSIOL, V107, P718, DOI 10.1152/japplphysiol.00548.2009; Westerhof BE, 2006, AM J PHYSIOL-HEART C, V291, pH2864, DOI 10.1152/ajpheart.01024.2005; Zhang R, 2002, J PHYSIOL-LONDON, V543, P337, DOI 10.1113/jphysiol.2001.013398; Ziemssen Tjalf, 2008, J Clin Monit Comput, V22, P159, DOI 10.1007/s10877-008-9117-0	46	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12187	10.1371/journal.pone.0012187	http://dx.doi.org/10.1371/journal.pone.0012187			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808439	Green Submitted, Green Published, gold			2022-12-27	WOS:000280968000014
J	Shen, AL; O'Leary, KA; Dubielzig, RR; Drinkwater, N; Murphy, CJ; Kasper, CB; Bradfield, CA				Shen, Anna L.; O'Leary, Kathleen A.; Dubielzig, Richard R.; Drinkwater, Norman; Murphy, Christopher J.; Kasper, Charles B.; Bradfield, Christopher A.			The PPCD1 Mouse: Characterization of a Mouse Model for Posterior Polymorphous Corneal Dystrophy and Identification of a Candidate Gene	PLOS ONE			English	Article							IRIDOCORNEAL ENDOTHELIAL SYNDROME; MUTATIONS; COL8A2; CHROMOSOME-20; LINKAGE; MICE; METAPLASIA; EXCLUSION; INTERACTS; DISEASE	The PPCD1 mouse, a spontaneous mutant that arose in our mouse colony, is characterized by an enlarged anterior chamber resulting from metaplasia of the corneal endothelium and blockage of the iridocorneal angle by epithelialized corneal endothelial cells. The presence of stratified multilayered corneal endothelial cells with abnormal patterns of cytokeratin expression are remarkably similar to those observed in human posterior polymorphous corneal dystrophy (PPCD) and the sporadic condition, iridocorneal endothelial syndrome. Affected eyes exhibit epithelialized corneal endothelial cells, with inappropriate cytokeratin expression and proliferation over the iridocorneal angle and posterior cornea. We have termed this the "mouse PPCD1'' phenotype and mapped the mouse locus for this phenotype, designated "Ppcd1'', to a 6.1 Mbp interval on Chromosome 2, which is syntenic to the human Chromosome 20 PPCD1 interval. Inheritance of the mouse PPCD1 phenotype is autosomal dominant, with complete penetrance on the sensitive DBA/2J background and decreased penetrance on the C57BL/6J background. Comparative genome hybridization has identified a hemizygous 78 Kbp duplication in the mapped interval. The endpoints of the duplication are located in positions that disrupt the genes Csrp2bp and 6330439K17Rik and lead to duplication of the pseudogene LOC100043552. Quantitative reverse transcriptase-PCR indicates that expression levels of Csrp2bp and 6330439K17Rik are decreased in eyes of PPCD1 mice. Based on the observations of decreased gene expression levels, association with ZEB1-related pathways, and the report of corneal opacities in Csrp2bp(tm1a(KOMP)Wtsi) heterozygotes and embryonic lethality in nulls, we postulate that duplication of the 78 Kbp segment leading to haploinsufficiency of Csrp2bp is responsible for the mouse PPCD1 phenotype. Similarly, CSRP2BP haploinsufficiency may lead to human PPCD.	[Shen, Anna L.; O'Leary, Kathleen A.; Drinkwater, Norman; Kasper, Charles B.; Bradfield, Christopher A.] Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Dubielzig, Richard R.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Shen, Anna L.; Dubielzig, Richard R.; Murphy, Christopher J.; Bradfield, Christopher A.] Univ Wisconsin, Eye Res Inst, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Murphy, Christopher J.] Univ Wisconsin, Sch Vet Med, Dept Surg Sci, Madison, WI 53706 USA; [Dubielzig, Richard R.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shen, AL (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, 1400 Univ Ave, Madison, WI 53706 USA.	alshen@wisc.edu			National Institutes of Health [R03-EY015565, P01-CA022484, P30-CA014520, ES013566]; Eye Research Institute, University of Wisconsin-Madison; NATIONAL CANCER INSTITUTE [P01CA022484, P30CA014520] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R03EY015565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013566] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eye Research Institute, University of Wisconsin-Madison; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research has been supported by Grants R03-EY015565, P01-CA022484, P30-CA014520, and ES013566 from the National Institutes of Health and a Rapid Response Initiative Grant from the Eye Research Institute, University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldave AJ, 2007, AM J MED GENET A, V143A, P2549, DOI 10.1002/ajmg.a.31978; Aldave AJ, 2009, CORNEA, V28, P801, DOI 10.1097/ICO.0b013e31819672fb; Anderson NJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P624; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; Chow RL, 2004, P NATL ACAD SCI USA, V101, P1754, DOI 10.1073/pnas.0306520101; CIBIS GW, 1977, ARCH OPHTHALMOL-CHIC, V95, P1529; Ciralsky Jessica, 2007, Semin Ophthalmol, V22, P241, DOI 10.1080/08820530701745157; Cockerham GC, 2002, CORNEA, V21, P787, DOI 10.1097/00003226-200211000-00012; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46, P1934, DOI 10.1167/iovs.04-0937; Guelman S, 2009, MOL CELL BIOL, V29, P1176, DOI 10.1128/MCB.01599-08; Gwilliam R, 2005, INVEST OPHTH VIS SCI, V46, P4480, DOI 10.1167/iovs.05-0269; Haider NB, 2002, HUM MOL GENET, V11, P1195, DOI 10.1093/hmg/11.10.1195; HEON E, 1995, HUM MOL GENET, V4, P485, DOI 10.1093/hmg/4.3.485; Hidayat AA, 2006, CORNEA, V25, P956, DOI 10.1097/01.ico.0000228786.84581.ee; HIRST LW, 1995, INVEST OPHTH VIS SCI, V36, P820; Hopfer U, 2005, FASEB J, V19, P1232, DOI 10.1096/fj.04-3019com; Hosseini SM, 2008, MOL VIS, V14, P71; Howell DN, 1997, INVEST OPHTH VIS SCI, V38, P1896; Jirsova K, 2007, EXP EYE RES, V84, P680, DOI 10.1016/j.exer.2006.12.006; Klintworth GK, 2003, FRONT BIOSCI-LANDMRK, V8, pD687, DOI 10.2741/1018; Krafchak CM, 2005, AM J HUM GENET, V77, P694, DOI 10.1086/497348; Lee SJ, 2007, EXP MOL MED, V39, P450, DOI 10.1038/emm.2007.49; Lefebvre V, 2009, OPTOMETRY, V80, P431, DOI 10.1016/j.optm.2009.02.009; Liu YQ, 2008, INVEST OPHTH VIS SCI, V49, P1843, DOI 10.1167/iovs.07-0789; Moroi SE, 2003, AM J OPHTHALMOL, V135, P461, DOI 10.1016/S0002-9394(02)02032-9; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Ramalho JS, 2004, BRIT J OPHTHALMOL, V88, P428, DOI 10.1136/bjo.2003.028787; RIAZUDDIN SA, 1945, AM J HUM GENET, V53, P4; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; Shimizu S, 2004, AM J MED GENET A, V130A, P372, DOI 10.1002/ajmg.a.30267; TOMA NMG, 1995, HUM MOL GENET, V4, P2395, DOI 10.1093/hmg/4.12.2395; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Vincent AL, 2009, MOL VIS, V15, P2544; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; Yellore VS, 2007, GENET MED, V9, P228, DOI 10.1097/GIM.0b013e31803c4dc2; Yellore VS, 2005, INVEST OPHTH VIS SCI, V46, P1599, DOI 10.1167/iovs.04-1321	36	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12213	10.1371/journal.pone.0012213	http://dx.doi.org/10.1371/journal.pone.0012213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808945	Green Submitted, Green Published, gold			2022-12-27	WOS:000280968000028
J	Tsvetanova, NG; Klass, DM; Salzman, J; Brown, PO				Tsvetanova, Nikoleta G.; Klass, Daniel M.; Salzman, Julia; Brown, Patrick O.			Proteome-Wide Search Reveals Unexpected RNA-Binding Proteins in Saccharomyces cerevisiae	PLOS ONE			English	Article							ASH1 MESSENGER-RNA; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ENDOPLASMIC-RETICULUM; GLOBAL ANALYSIS; YEAST; ACONITASE; LOCALIZATION; STABILITY; COMPLEXES; DEPENDS	The vast landscape of RNA-protein interactions at the heart of post-transcriptional regulation remains largely unexplored. Indeed it is likely that, even in yeast, a substantial fraction of the regulatory RNA-binding proteins (RBPs) remain to be discovered. Systematic experimental methods can play a key role in discovering these RBPs - most of the known yeast RBPs lack RNA-binding domains that might enable this activity to be predicted. We describe here a proteome-wide approach to identify RNA-protein interactions based on in vitro binding of RNA samples to yeast protein microarrays that represent over 80% of the yeast proteome. We used this procedure to screen for novel RBPs and RNA-protein interactions. A complementary mass spectrometry technique also identified proteins that associate with yeast mRNAs. Both the protein microarray and mass spectrometry methods successfully identify previously annotated RBPs, suggesting that other proteins identified in these assays might be novel RBPs. Of 35 putative novel RBPs identified by either or both of these methods, 12, including 75% of the eight most highly-ranked candidates, reproducibly associated with specific cellular RNAs. Surprisingly, most of the 12 newly discovered RBPs were enzymes. Functional characteristics of the RNA targets of some of the novel RBPs suggest coordinated post-transcriptional regulation of subunits of protein complexes and a possible link between mRNA trafficking and vesicle transport. Our results suggest that many more RBPs still remain to be identified and provide a set of candidates for further investigation.	[Tsvetanova, Nikoleta G.; Klass, Daniel M.; Salzman, Julia; Brown, Patrick O.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Tsvetanova, Nikoleta G.; Klass, Daniel M.; Salzman, Julia; Brown, Patrick O.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Salzman, Julia] Stanford Univ, Dept Stat, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Tsvetanova, NG (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	pbrown@pmgm2.stanford.edu			National Institutes of Health [NIH RO1 CA77097]; Stanford Graduate Fellowship; National Science Foundation; National Science Foundation Mathematical Sciences [NSF-DMS 0940077]; NATIONAL CANCER INSTITUTE [R01CA077097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Graduate Fellowship(Stanford University); National Science Foundation(National Science Foundation (NSF)); National Science Foundation Mathematical Sciences(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported mainly by the Howard Hughes Medical Institute and by a grant from the National Institutes of Health to POB (NIH RO1 CA77097). POB is an investigator for the Howard Hughes Medical Institute. NGT was also partially supported by a Stanford Graduate Fellowship. DMK was also partially supported by a National Science Foundation pre-doctoral fellowship. JS was supported by National Science Foundation Mathematical Sciences Grant (NSF-DMS 0940077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronov S, 2007, MOL CELL BIOL, V27, P3441, DOI 10.1128/MCB.01643-06; BASILION JP, 1994, P NATL ACAD SCI USA, V91, P574, DOI 10.1073/pnas.91.2.574; BEINERT H, 1993, FASEB J, V7, P1442, DOI 10.1096/fasebj.7.15.8262329; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; Bohl F, 2000, EMBO J, V19, P5514, DOI 10.1093/emboj/19.20.5514; Butt J, 1996, P NATL ACAD SCI USA, V93, P4345, DOI 10.1073/pnas.93.9.4345; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; CHU E, 1993, BIOCHEMISTRY-US, V32, P4756, DOI 10.1021/bi00069a009; CLERCH LB, 1993, FASEB J, V7, pA1233; Cohen M, 2003, J BIOL CHEM, V278, P51989, DOI 10.1074/jbc.C300451200; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Galani K, 2001, EMBO J, V20, P6889, DOI 10.1093/emboj/20.23.6889; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Halbach A, 2009, EMBO J, V28, P2959, DOI 10.1038/emboj.2009.240; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; HENTZE MW, 2010, TRENDS BIOCH SCI; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Hubble J, 2009, NUCLEIC ACIDS RES, V37, pD898, DOI 10.1093/nar/gkn786; Irie K, 2002, EMBO J, V21, P1158, DOI 10.1093/emboj/21.5.1158; Keene JD, 2007, COLD SPRING HARB SYM, V72, P157, DOI 10.1101/sqb.2007.72.013; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kolesnikova O, 2010, RNA, V16, P926, DOI 10.1261/rna.1914110; Li KQ, 2007, J MOL BIOL, V372, P194, DOI 10.1016/j.jmb.2007.06.052; Long RM, 2000, EMBO J, V19, P6592, DOI 10.1093/emboj/19.23.6592; Maxon ME, 2001, P NATL ACAD SCI USA, V98, P1495, DOI 10.1073/pnas.98.4.1495; Muller O, 2003, J CELL SCI, V116, P1107, DOI 10.1242/jcs.00328; NAGY E, 1995, J BIOL CHEM, V270, P2755, DOI 10.1074/jbc.270.6.2755; Negm RS, 2006, GENET ENG NEWS, V26, P26; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Paquin N, 2007, MOL CELL, V26, P795, DOI 10.1016/j.molcel.2007.05.016; Sil A, 1996, CELL, V84, P711, DOI 10.1016/S0092-8674(00)81049-1; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; SMITH SS, 1992, P NATL ACAD SCI USA, V89, P4744, DOI 10.1073/pnas.89.10.4744; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Walsh C., 2006, POSTTRANSLATIONAL MO; Zhou Y, 2008, MOL CANCER RES, V6, P1375, DOI 10.1158/1541-7786.MCR-07-2170; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; Zhu J, 2007, P NATL ACAD SCI USA, V104, P3129, DOI 10.1073/pnas.0611617104	44	120	125	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12671	10.1371/journal.pone.0012671	http://dx.doi.org/10.1371/journal.pone.0012671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844764	Green Submitted, gold, Green Published			2022-12-27	WOS:000281687300015
J	Punnoose, EA; Atwal, SK; Spoerke, JM; Savage, H; Pandita, A; Yeh, RF; Pirzkall, A; Fine, BM; Amler, LC; Chen, DS; Lackner, MR				Punnoose, Elizabeth A.; Atwal, Siminder K.; Spoerke, Jill M.; Savage, Heidi; Pandita, Ajay; Yeh, Ru-Fang; Pirzkall, Andrea; Fine, Bernard M.; Amler, Lukas C.; Chen, Daniel S.; Lackner, Mark R.			Molecular Biomarker Analyses Using Circulating Tumor Cells	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; IN-SITU HYBRIDIZATION; GENE AMPLIFICATION; PERIPHERAL-BLOOD; STEM-CELL; EXPRESSION; HER2; SURVIVAL; OVEREXPRESSION; HETEROGENEITY	Background: Evaluation of cancer biomarkers from blood could significantly enable biomarker assessment by providing a relatively non-invasive source of representative tumor material. Circulating Tumor Cells (CTCs) isolated from blood of metastatic cancer patients hold significant promise in this regard. Methodology/Principal Findings: Using spiked tumor-cells we evaluated CTC capture on different CTC technology platforms, including CellSearch (R) and two biochip platforms, and used the isolated CTCs to develop and optimize assays for molecular characterization of CTCs. We report similar performance for the various platforms tested in capturing CTCs, and find that capture efficiency is dependent on the level of EpCAM expression. We demonstrate that captured CTCs are amenable to biomarker analyses such as HER2 status, qRT-PCR for breast cancer subtype markers, KRAS mutation detection, and EGFR staining by immunofluorescence (IF). We quantify cell surface expression of EGFR in metastatic lung cancer patient samples. In addition, we determined HER2 status by IF and FISH in CTCs from metastatic breast cancer patients. In the majority of patients (89%) we found concordance with HER2 status from patient tumor tissue, though in a subset of patients (11%), HER2 status in CTCs differed from that observed in the primary tumor. Surprisingly, we found CTC counts to be higher in ER+ patients in comparison to HER2+ and triple negative patients, which could be explained by low EpCAM expression and a more mesenchymal phenotype of tumors belonging to the basal-like molecular subtype of breast cancer. Conclusions/Significance: Our data suggests that molecular characterization from captured CTCs is possible and can potentially provide real-time information on biomarker status. In this regard, CTCs hold significant promise as a source of tumor material to facilitate clinical biomarker evaluation. However, limitations exist from a purely EpCAM based capture system and addition of antibodies to mesenchymal markers could further improve CTC capture efficiency to enable routine biomarker analysis from CTCs.	[Punnoose, Elizabeth A.; Atwal, Siminder K.; Spoerke, Jill M.; Savage, Heidi; Amler, Lukas C.; Lackner, Mark R.] Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA; [Pandita, Ajay] Genentech Inc, Dept Mol Diagnost & Canc Cell Biol, San Francisco, CA 94080 USA; [Yeh, Ru-Fang] Genentech Inc, Dept Biostat, San Francisco, CA 94080 USA; [Pirzkall, Andrea; Fine, Bernard M.; Chen, Daniel S.] Genentech Inc, Dept Oncol Exploratory Clin Dev, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Punnoose, EA (corresponding author), Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA.	punnoose.elizabeth@gene.com	Lackner, Mark/G-4597-2012; Chen, Daniel Shin-Yu/AGD-8923-2022	Lackner, Mark/0000-0002-6375-2037; Chen, Daniel Shin-Yu/0000-0001-5085-3579; Fine, Bernard/0000-0002-5483-476X	Genentech	Genentech(Roche HoldingGenentech)	This study was funded by Genentech (www.gene.com). All authors are employees of Genentech and Genentech played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. This affiliation, however, does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aktas B, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2333; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Ashworth T. R, 1869, AUST MED J, V14, P146, DOI DOI 10.1038/SJ.BJC.6604218; Attard G, 2009, CANCER RES, V69, P2912, DOI 10.1158/0008-5472.CAN-08-3667; BARDELLI A, 2010, J CLIN ONCOLOGY; Bozzetti C, 2003, CANCER CYTOPATHOL, V99, P310, DOI 10.1002/cncr.11731; CARDEN CP, 2009, DRUG DISCOV TODAY; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; de Bono JS, 2007, CLIN CANCER RES, V13, P3611, DOI 10.1158/1078-0432.CCR-07-0268; FLORES LM, BR J CANC, V102, P1495; Gancberg D, 2002, ANN ONCOL, V13, P1036, DOI 10.1093/annonc/mdf252; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; He H, 2010, PROSTATE, V70, P518, DOI 10.1002/pros.21086; Hicks DG, 2005, HUM PATHOL, V36, P250, DOI 10.1016/j.humpath.2004.11.010; Hu XL, 2009, MOL CANCER RES, V7, P511, DOI 10.1158/1541-7786.MCR-08-0107; HUTCHINS LF, 1990, DM-DIS MON, V36, P63; Jarry A, 2004, MOL CELL PROBE, V18, P349, DOI 10.1016/j.mcp.2004.05.004; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; Lackner MR, 2010, EXPERT REV MOL DIAGN, V10, P75, DOI [10.1586/erm.09.78, 10.1586/ERM.09.78]; Lange PH, 1998, CANCER METAST REV, V17, P331, DOI 10.1023/A:1006106209527; MAHESWARAN S, CURR OPIN GENET DEV; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; MCCARTY KS, 1986, CANCER RES, V46, P4244; Meng SD, 2004, P NATL ACAD SCI USA, V101, P9393, DOI 10.1073/pnas.0402993101; Miller MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/617421; MOMBURG F, 1987, CANCER RES, V47, P2883; Mostert B, 2009, CANCER TREAT REV, V35, P463, DOI 10.1016/j.ctrv.2009.03.004; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Brien C, 2008, CANCER RES, V68, P5380, DOI 10.1158/0008-5472.CAN-08-0234; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Payne RE, 2009, PHARMACOGENOMICS, V10, P51, DOI 10.2217/14622416.10.1.51; Pestrin M, 2009, BREAST CANCER RES TR, V118, P523, DOI 10.1007/s10549-009-0461-7; ROSS AA, 1993, BLOOD, V82, P2605; Sekido Y, 2003, INT J ONCOL, V22, P1225; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Sequist LV, 2009, J THORAC ONCOL, V4, P281, DOI 10.1097/JTO.0b013e3181989565; Shimizu C, 2000, J SURG ONCOL, V73, P17, DOI 10.1002/(SICI)1096-9098(200001)73:1<17::AID-JSO5>3.3.CO;2-U; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smith GD, 2008, J CLIN PATHOL, V61, P487, DOI 10.1136/jcp.2007.051425; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stott SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000403; Suzuki H, 1998, CANCER RES, V58, P204; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; Tan DSW, 2009, CANCER J, V15, P406, DOI 10.1097/PPO.0b013e3181bd0445; Tanaka F, 2009, CLIN CANCER RES, V15, P6980, DOI 10.1158/1078-0432.CCR-09-1095; Vance GH, 2009, ARCH PATHOL LAB MED, V133, P611, DOI 10.1043/1543-2165-133.4.611; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; WANG LH, CLIN CANC RES, V16, P1073; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Wolff AC, 2007, J CLIN ONCOL, V25, P4021, DOI 10.1200/JCO.2007.11.4363; Zidan J, 2005, BRIT J CANCER, V93, P552, DOI 10.1038/sj.bjc.6602738	55	198	215	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12517	10.1371/journal.pone.0012517	http://dx.doi.org/10.1371/journal.pone.0012517			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IV	20838621	Green Published, gold, Green Submitted			2022-12-27	WOS:000281687100002
J	Raz, L; Zhang, QG; Zhou, CF; Han, D; Gulati, P; Yang, LC; Yang, F; Wang, RM; Brann, DW				Raz, Limor; Zhang, Quan-Guang; Zhou, Cai-feng; Han, Dong; Gulati, Priya; Yang, Li-cai; Yang, Fang; Wang, Rui-min; Brann, Darrell W.			Role of Rac1 GTPase in NADPH Oxidase Activation and Cognitive Impairment Following Cerebral Ischemia in the Rat	PLOS ONE			English	Article							SUPEROXIDE-PRODUCTION; KINASE ACTIVATION; CELL-DEATH; DAMAGE; ESTROGEN; NEUROPROTECTION; ATTENUATION; INHIBITION; PROTECTS; NEURONS	Background: Recent work by our laboratory and others has implicated NADPH oxidase as having an important role in reactive oxygen species (ROS) generation and neuronal damage following cerebral ischemia, although the mechanisms controlling NADPH oxidase in the brain remain poorly understood. The purpose of the current study was to examine the regulatory and functional role of the Rho GTPase, Rac1 in NADPH oxidase activation, ROS generation and neuronal cell death/cognitive dysfunction following global cerebral ischemia in the male rat. Methodology/Principal Findings: Our studies revealed that NADPH oxidase activity and superoxide (O-2(-)) production in the hippocampal CA1 region increased rapidly after cerebral ischemia to reach a peak at 3 h post-reperfusion, followed by a fall in levels by 24 h post-reperfusion. Administration of a Rac GTPase inhibitor (NSC23766) 15 min before cerebral ischemia significantly attenuated NADPH oxidase activation and O-2(-) production at 3 h after stroke as compared to vehicle-treated controls. NSC23766 also attenuated "in situ'' O-2(-) production in the hippocampus after ischemia/reperfusion, as determined by fluorescent oxidized hydroethidine staining. Oxidative stress damage in the hippocampal CA1 after ischemia/reperfusion was also significantly attenuated by NSC23766 treatment, as evidenced by a marked attenuation of immunostaining for the oxidative stress damage markers, 4-HNE, 8-OHdG and H2AX at 24 h in the hippocampal CA1 region following cerebral ischemia. In addition, Morris Water maze testing revealed that Rac GTPase inhibition after ischemic injury significantly improved hippocampal-dependent memory and cognitive spatial abilities at 7-9 d post reperfusion as compared to vehicle-treated animals. Conclusions/Significance: The results of the study suggest that Rac1 GTPase has a critical role in mediating ischemia/reperfusion injury-induced NADPH oxidase activation, ROS generation and oxidative stress in the hippocampal CA1 region of the rat, and thus contributes significantly to neuronal degeneration and cognitive dysfunction following cerebral ischemia.	[Raz, Limor; Zhang, Quan-Guang; Han, Dong; Gulati, Priya; Brann, Darrell W.] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Zhou, Cai-feng; Yang, Li-cai; Yang, Fang; Wang, Rui-min] N China Coal Med Univ, Expt & Res Ctr, Tangshan, Hebei, Peoples R China	University System of Georgia; Augusta University; North China University of Science & Technology	Raz, L (corresponding author), Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA.	rmwang1213@yahoo.com.cn; dbrann@mcg.edu			National Institute of Neurological Diseases and Stroke (NINDS) National Institutes of Health [NS050730]; National Natural Science Foundation in China [30970664]; National Science Foundation of Hebei Province in China [C2008000997]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050730] Funding Source: NIH RePORTER	National Institute of Neurological Diseases and Stroke (NINDS) National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Hebei Province in China; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by a Research Grant (NS050730) from the National Institute of Neurological Diseases and Stroke (NINDS), National Institutes of Health. Additional funding for parts of the study came from the National Natural Science Foundation in China (30970664) and the National Science Foundation of Hebei Province in China (C2008000997). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; Chen H, 2009, J CEREB BLOOD FLOW M; Chtistophe M, 2006, CURR PHARM DESIGN, V12, P739, DOI 10.2174/138161206775474242; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; GOODRICHHUNSAKE.NJ, 2009, HIPPOCAMPUS; Gu ZL, 2001, NEUROREPORT, V12, P897, DOI 10.1097/00001756-200104170-00006; Haruta M, 2009, P NATL ACAD SCI USA, V106, P9397, DOI 10.1073/pnas.0808940106; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Koga H, 1999, J BIOL CHEM, V274, P25051, DOI 10.1074/jbc.274.35.25051; Kuroda S, 1997, CLIN NEUROSCI, V4, P199; Maneen MJ, 2007, AM J PHYSIOL-HEART C, V292, pH1042, DOI 10.1152/ajpheart.00800.2006; Miyano K, 2007, BIOCHIMIE, V89, P1133, DOI 10.1016/j.biochi.2007.05.003; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nanetti L, 2007, MOL CELL BIOCHEM, V303, P19, DOI 10.1007/s11010-007-9451-4; Ozaki M, 2001, TRANSPLANT P, V33, P863, DOI 10.1016/S0041-1345(00)02352-6; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Sawada N, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000162; Serrano F, 2003, BRAIN RES, V988, P193, DOI 10.1016/S0006-8993(03)03364-X; Suh SW, 2008, ANN NEUROL, V64, P654, DOI 10.1002/ana.21511; Tang XN, 2008, NEUROSCIENCE, V154, P556, DOI 10.1016/j.neuroscience.2008.03.090; Vallet P, 2005, NEUROSCIENCE, V132, P233, DOI 10.1016/j.neuroscience.2004.12.038; Wakade C, 2008, ENDOCRINOLOGY, V149, P367, DOI 10.1210/en.2007-0899; Yang LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009851; Zhang QG, 2008, J NEUROSCI, V28, P8430, DOI 10.1523/JNEUROSCI.2752-08.2008; Zhang QG, 2006, J NEUROCHEM, V98, P1886, DOI 10.1111/j.1471-4159.2006.04020.x; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zhang QG, 2009, BRAIN RES, V1265, P138, DOI 10.1016/j.brainres.2009.01.033	32	97	100	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12606	10.1371/journal.pone.0012606	http://dx.doi.org/10.1371/journal.pone.0012606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830300	gold, Green Published, Green Submitted			2022-12-27	WOS:000281631300029
J	Al Gadban, MM; Smith, KJ; Soodavar, F; Piansay, C; Chassereau, C; Twal, WO; Klein, RL; Virella, G; Lopes-Virella, MF; Hammad, SM				Al Gadban, Mohammed M.; Smith, Kent J.; Soodavar, Farzan; Piansay, Christabelle; Chassereau, Charlyne; Twal, Waleed O.; Klein, Richard L.; Virella, Gabriel; Lopes-Virella, Maria F.; Hammad, Samar M.			Differential Trafficking of Oxidized LDL and Oxidized LDL Immune Complexes in Macrophages: Impact on Oxidative Stress	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; MONOCYTE-DERIVED MACROPHAGES; SCAVENGER RECEPTORS; HEAT-SHOCK; OXLDL; CHOLESTEROL; METABOLISM; BETA(2)-GLYCOPROTEIN-I; ATHEROSCLEROSIS; CELLS	Background: Oxidized low-density lipoproteins (oxLDL) and oxLDL-containing immune complexes (oxLDL-IC) contribute to formation of lipid-laden macrophages (foam cells). It has been shown that oxLDL-IC are considerably more efficient than oxLDL in induction of foam cell formation, inflammatory cytokines secretion, and cell survival promotion. Whereas oxLDL is taken up by several scavenger receptors, oxLDL-IC are predominantly internalized through the FCc receptor I (FCc RI). This study examined differences in intracellular trafficking of lipid and apolipoprotein moieties of oxLDL and oxLDL-IC and the impact on oxidative stress. Methodology/Findings: Fluorescently labeled lipid and protein moieties of oxLDL co-localized within endosomal and lysosomal compartments in U937 human monocytic cells. In contrast, the lipid moiety of oxLDL-IC was detected in the endosomal compartment, whereas its apolipoprotein moiety advanced to the lysosomal compartment. Cells treated with oxLDL-IC prior to oxLDL demonstrated co-localization of internalized lipid moieties from both oxLDL and oxLDL-IC in the endosomal compartment. This sequential treatment likely inhibited oxLDL lipid moieties from trafficking to the lysosomal compartment. In RAW 264.7 macrophages, oxLDL-IC but not oxLDL induced GFP-tagged heat shock protein 70 (HSP70) and HSP70B', which co-localized with the lipid moiety of oxLDL-IC in the endosomal compartment. This suggests that HSP70 family members might prevent the degradation of the internalized lipid moiety of oxLDL-IC by delaying its advancement to the lysosome. The data also showed that mitochondrial membrane potential was decreased and generation of reactive oxygen and nitrogen species was increased in U937 cell treated with oxLDL compared to oxLDL-IC. Conclusions/Significance: Findings suggest that lipid and apolipoprotein moieties of oxLDL-IC traffic to separate cellular compartments, and that HSP70/70B' might sequester the lipid moiety of oxLDL-IC in the endosomal compartment. This mechanism could ultimately influence macrophage function and survival. Furthermore, oxLDL-IC might regulate the intracellular trafficking of free oxLDL possibly through the induction of HSP70/70B'.	[Al Gadban, Mohammed M.; Smith, Kent J.; Soodavar, Farzan; Twal, Waleed O.; Hammad, Samar M.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Piansay, Christabelle] Med Univ S Carolina, Summer Undergrad Res Program, Coll Grad Studies, Charleston, SC 29425 USA; [Chassereau, Charlyne; Klein, Richard L.; Lopes-Virella, Maria F.] Med Univ S Carolina, Dept Med, Div Endocrinol, Charleston, SC 29425 USA; [Klein, Richard L.; Lopes-Virella, Maria F.] Ralph H Johnson Vet Affairs Med Ctr, Res Serv, Charleston, SC USA; [Virella, Gabriel] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina	Al Gadban, MM (corresponding author), Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA.	hammadsm@musc.edu		Hammad, Samar/0000-0002-1313-2542	National Institutes of Health (NIH) [HL079274]; NIH (ARRA) [R01 HL079274-04S1]; NCRR [P20 RR17677]; NIH [P01 HL55782, R01 DK081352, R01 DK081352-02S1]; Department of Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677, P20RR016461] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079274, P01HL055782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081352] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (ARRA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (NIH) grant HL079274, NIH (ARRA) grant R01 HL079274-04S1, and the South Carolina COBRE in Lipidomics and Pathobiology (P20 RR17677 from NCRR) to SMH, and NIH grants P01 HL55782, R01 DK081352 and R01 DK081352-02S1 (ARRA) to MLV, and funding from the Department of Veterans Affairs to MLV and RLK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmis R, 2003, CIRC RES, V92, pE20, DOI 10.1161/01.RES.0000051886.43510.90; Ballinger SW, 2002, CIRCULATION, V106, P544, DOI 10.1161/01.CIR.0000023921.93743.89; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6; Boullier A, 2006, ARTERIOSCL THROM VAS, V26, P1169, DOI 10.1161/01.ATV.0000210279.97308.9a; Brown AJ, 2000, J LIPID RES, V41, P226; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; Cataldi A, 2010, CURR PHARM DESIGN, V16, P1387, DOI 10.2174/138161210791033969; Deigner HP, 2001, FASEB J, V15, P807, DOI 10.1096/fj.15.3.807; Deng TL, 2008, CELL BIOL INT, V32, P1425, DOI 10.1016/j.cellbi.2008.08.013; Flaberg E, 2006, ACTA HISTOCHEM CYTOC, V39, P103, DOI 10.1267/ahc.05056; Freeman B A, 1995, Adv Pharmacol, V34, P45; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GRIFFITH RL, 1988, J EXP MED, V168, P1041, DOI 10.1084/jem.168.3.1041; Hammad SM, 2009, ATHEROSCLEROSIS, V202, P394, DOI 10.1016/j.atherosclerosis.2008.05.032; Hammad SM, 2006, PROSTAG OTH LIPID M, V79, P126, DOI 10.1016/j.prostaglandins.2005.12.004; Hoekstra KA, 2004, BIOCHEM CELL BIOL, V82, P351, DOI 10.1139/O04-006; Huang Y, 1999, ARTERIOSCL THROM VAS, V19, P1600, DOI 10.1161/01.ATV.19.7.1600; Iles KE, 2002, IMMUNOL RES, V26, P95, DOI 10.1385/IR:26:1-3:095; Jerome WG, 1998, J LIPID RES, V39, P1362; Kajiwara T, 2007, J AUTOIMMUN, V29, P164, DOI 10.1016/j.jaut.2007.07.003; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Kuwana M, 2005, BLOOD, V105, P1552, DOI 10.1182/blood-2004-08-3145; Lopes-Virella MF, 2000, ATHEROSCLEROSIS, V152, P107, DOI 10.1016/S0021-9150(99)00456-6; LOPESVIRELLA MF, 1994, CLIN IMMUNOL IMMUNOP, V73, P155, DOI 10.1006/clin.1994.1184; LopesVirella MF, 1997, ATHEROSCLEROSIS, V135, P161, DOI 10.1016/S0021-9150(97)00157-3; LOPESVIRELLA MF, 1991, ARTERIOSCLER THROMB, V11, P1356, DOI 10.1161/01.ATV.11.5.1356; Lougheed M, 1999, ARTERIOSCL THROM VAS, V19, P1881, DOI 10.1161/01.ATV.19.8.1881; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; Oksjoki R, 2006, ARTERIOSCL THROM VAS, V26, P576, DOI 10.1161/01.ATV.0000201041.14438.8d; Patel RP, 2000, FREE RADICAL BIO MED, V28, P1780, DOI 10.1016/S0891-5849(00)00235-5; PITAS RE, 1981, ARTERIOSCLEROSIS, V1, P177, DOI 10.1161/01.ATV.1.3.177; Puddu P, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-112; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Saad AF, 2006, J LIPID RES, V47, P1975, DOI 10.1194/jlr.M600064-JLR200; SIOW RCM, 1995, FEBS LETT, V368, P239, DOI 10.1016/0014-5793(95)00650-X; Smith KJ, 2010, J BIOL CHEM, V285, P15985, DOI 10.1074/jbc.M110.113605; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; Su CY, 1998, J MOL CELL CARDIOL, V30, P587, DOI 10.1006/jmcc.1997.0622; Sun B, 2007, J LIPID RES, V48, P2560, DOI 10.1194/jlr.M700163-JLR200; SUNDSTROM C, 1976, INT J CANC, V17; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Victor VM, 2009, CURR PHARM DESIGN, V15, P2988, DOI 10.2174/138161209789058093; Virella G, 2000, CLIN IMMUNOL, V95, P135, DOI 10.1006/clim.2000.4857; Virella G, 2004, J LIPID RES, V45, P1859, DOI 10.1194/jlr.M400095-JLR200; Virella G, 2002, CLIN IMMUNOL, V105, P81, DOI 10.1006/clim.2002.5269; VIRELLA G, 1995, CLIN IMMUNOL IMMUNOP, V75, P179, DOI 10.1006/clin.1995.1069; Yamaguchi Y, 2007, BLOOD, V110, P4312, DOI 10.1182/blood-2007-07-100008; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271; Yuan XM, 2000, FREE RADICAL BIO MED, V28, P208, DOI 10.1016/S0891-5849(99)00220-8	53	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12534	10.1371/journal.pone.0012534	http://dx.doi.org/10.1371/journal.pone.0012534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824093	Green Published, gold, Green Submitted			2022-12-27	WOS:000281480900017
J	Fradin, D; Cheslack-Postava, K; Ladd-Acosta, C; Newschaffer, C; Chakravarti, A; Arking, DE; Feinberg, A; Fallin, MD				Fradin, Delphine; Cheslack-Postava, Keely; Ladd-Acosta, Christine; Newschaffer, Craig; Chakravarti, Aravinda; Arking, Dan E.; Feinberg, Andrew; Fallin, M. Daniele			Parent-Of-Origin Effects in Autism Identified through Genome-Wide Linkage Analysis of 16,000 SNPs	PLOS ONE			English	Article							PRADER-WILLI; ANGELMAN SYNDROME; GENE-EXPRESSION; MELATONIN; DISORDER; LOCI; ASSOCIATION; REVEALS; COMMON; RISK	Background: Autism is a common heritable neurodevelopmental disorder with complex etiology. Several genome-wide linkage and association scans have been carried out to identify regions harboring genes related to autism or autism spectrum disorders, with mixed results. Given the overlap in autism features with genetic abnormalities known to be associated with imprinting, one possible reason for lack of consistency would be the influence of parent-of-origin effects that may mask the ability to detect linkage and association. Methods and Findings: We have performed a genome-wide linkage scan that accounts for potential parent-of-origin effects using 16,311 SNPs among families from the Autism Genetic Resource Exchange (AGRE) and the National Institute of Mental Health (NIMH) autism repository. We report parametric (GH, Genehunter) and allele-sharing linkage (Aspex) results using a broad spectrum disorder case definition. Paternal-origin genome-wide statistically significant linkage was observed on chromosomes 4 (LODGH = 3.79, empirical p, 0.005 and LODAspex = 2.96, p = 0.008), 15 (LODGH = 3.09, empirical p, 0.005 and LODAspex = 3.62, empirical p = 0.003) and 20 (LODGH = 3.36, empirical p, 0.005 and LODAspex = 3.38, empirical p = 0.006). Conclusions: These regions may harbor imprinted sites associated with the development of autism and offer fruitful domains for molecular investigation into the role of epigenetic mechanisms in autism.	[Fradin, Delphine; Fallin, M. Daniele] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Fradin, Delphine; Ladd-Acosta, Christine; Feinberg, Andrew] Johns Hopkins Univ, Sch Med, Dept Med, Ctr Epigenet,Inst Basic Biomed Sci, Baltimore, MD 21205 USA; [Cheslack-Postava, Keely] Columbia Univ, Robert Wood Johnson Fdn Hlth & Soc Scholars, New York, NY USA; [Newschaffer, Craig] Drexel Univ, Dept Epidemiol, Philadelphia, PA 19104 USA; [Chakravarti, Aravinda; Arking, Dan E.] Johns Hopkins Univ, Ctr Complex Dis Gen, McKusick Nathans Inst Genet Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Columbia University; Robert Wood Johnson Foundation (RWJF); Drexel University; Johns Hopkins University	Fradin, D (corresponding author), Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	dfallin@jhsph.edu	Feinberg, Andrew/AAY-7666-2020; Fradin, Delphine/K-7181-2015	Fradin, Delphine/0000-0001-6231-2649; Feinberg, Andrew/0000-0002-8364-1991	CENTERS FOR DISEASE CONTROL AND PREVENTION [U10DD000183] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064547, R01MH052708, P01MH039437] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50 HG003233, 2P50HG003233] Funding Source: Medline; NIMH NIH HHS [MH00219, MH52708, MH00980, R01 MH064547, MH64547, MH39437] Funding Source: Medline; NCBDD CDC HHS [5U01DD000183, U10 DD000183] Funding Source: Medline	CENTERS FOR DISEASE CONTROL AND PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCBDD CDC HHS		Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Arndt TL, 2005, INT J DEV NEUROSCI, V23, P189, DOI 10.1016/j.ijdevneu.2004.11.001; Ashley-Koch A, 1999, GENOMICS, V61, P227, DOI 10.1006/geno.1999.5968; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Bakker SC, 2003, AM J HUM GENET, V72, P1251, DOI 10.1086/375143; Bartlett CW, 2004, HUM HERED, V57, P10, DOI 10.1159/000077385; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Bolton C, 1994, Healthc Manage Forum, V7, P51; Cohen D, 2005, J AUTISM DEV DISORD, V35, P103, DOI 10.1007/s10803-004-1038-2; Cook EH, 1997, AM J HUM GENET, V60, P928; Davies W, 2005, NEUROSCI BIOBEHAV R, V29, P421, DOI 10.1016/j.neubiorev.2004.11.007; Descheemaeker MJ, 2002, J INTELL DISABIL RES, V46, P41, DOI 10.1046/j.1365-2788.2002.00354.x; Evans DM, 2004, AM J HUM GENET, V75, P687, DOI 10.1086/424696; Feinberg AP, 2002, CANCER RES, V62, P6784; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Jin XW, 2003, MOL CELL BIOL, V23, P1054, DOI 10.1128/MCB.23.3.1054-1060.2003; JORDE LB, 1991, AM J HUM GENET, V49, P932; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kulman G, 2000, NEUROENDOCRINOL LETT, V21, P31; Lamb JA, 2005, J MED GENET, V42, P132, DOI 10.1136/jmg.2004.025668; Lippiello PM, 2006, MED HYPOTHESES, V66, P985, DOI 10.1016/j.mehy.2005.11.015; Liu C, 1997, NEURON, V19, P91, DOI 10.1016/S0896-6273(00)80350-5; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Ma DQ, 2009, ANN HUM GENET, V73, P263, DOI 10.1111/j.1469-1809.2009.00523.x; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCauley JL, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-1; McInnes LA, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-21; Melke J, 2008, MOL PSYCHIATR, V13, P90, DOI 10.1038/sj.mp.4002016; Michaelis RC, 1997, AM J MED GENET, V71, P298, DOI 10.1002/(SICI)1096-8628(19970822)71:3<298::AID-AJMG10>3.0.CO;2-F; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Nir I, 1995, J AUTISM DEV DISORD, V25, P641, DOI 10.1007/BF02178193; RITVO ER, 1985, AM J PSYCHIAT, V142, P187; RITVO ER, 1989, AM J PSYCHIAT, V146, P1032; Sauter S, 2003, AM J MED GENET A, V120A, P533, DOI 10.1002/ajmg.a.20089; Schanen NC, 2006, HUM MOL GENET, V15, pR138, DOI 10.1093/hmg/ddl213; Schroer RJ, 1998, AM J MED GENET, V76, P327, DOI 10.1002/(SICI)1096-8628(19980401)76:4<327::AID-AJMG8>3.0.CO;2-M; Steffenburg S, 1996, PEDIATR NEUROL, V14, P131, DOI 10.1016/0887-8994(96)00011-2; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Sukumar S, 1999, AM J MED GENET, V87, P17, DOI 10.1002/(SICI)1096-8628(19991105)87:1<17::AID-AJMG4>3.0.CO;2-G; Tordjman S, 2005, BIOL PSYCHIAT, V57, P134, DOI 10.1016/j.biopsych.2004.11.003; Trillingsgaard A, 2004, AUTISM, V8, P163, DOI 10.1177/1362361304042720; Veltman MWM, 2005, PSYCHIAT GENET, V15, P243, DOI 10.1097/00041444-200512000-00006; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wassink TH, 2005, HUM GENET, V117, P200, DOI 10.1007/s00439-005-1257-4; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Wimpory D, 2002, J INTELL DISABIL RES, V46, P352, DOI 10.1046/j.1365-2788.2002.00423.x; Yonan AL, 2003, AM J HUM GENET, V73, P886, DOI 10.1086/378778	55	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12513	10.1371/journal.pone.0012513	http://dx.doi.org/10.1371/journal.pone.0012513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824079	gold, Green Published, Green Submitted			2022-12-27	WOS:000281480900006
J	Osada, T; Ogino, H; Hino, T; Ichinose, S; Nakamura, K; Omori, A; Noce, T; Masutani, M				Osada, Tomoharu; Ogino, Hideki; Hino, Toshiaki; Ichinose, Sachiyo; Nakamura, Kenji; Omori, Akira; Noce, Toshiaki; Masutani, Mitsuko			PolyADP-Ribosylation Is Required for Pronuclear Fusion during Postfertilization in Mice	PLOS ONE			English	Article							ADP-RIBOSE POLYMERASE; POLY(ADP-RIBOSE) POLYMERASE; IN-VITRO; POTENT INHIBITOR; NUCLEAR; MOUSE; KINASE; PARP-1; FERTILIZATION; EXPRESSION	Background: During fertilization, pronuclear envelope breakdown (PNEB) is followed by the mingling of male and female genomes. Dynamic chromatin and protein rearrangements require posttranslational modification (PTM) for the postfertilization development. Methodology/Principal Findings: Inhibition of poly(ADP-ribose) polymerase activity (PARylation) by either PJ-34 or 5-AIQ resulted in developmental arrest of fertilized embryos at the PNEB. PARylation inhibition affects spindle bundle formation and phosphorylation of Erk molecules of metaphase II (MII) unfertilized oocytes. We found a frequent appearance of multiple pronuclei (PN) in the PARylation-inhibited embryos, suggesting defective polymerization of tubulins. Attenuated phosphorylation of lamin A/C by PARylation was detected in the PARylation-inhibited embryos at PNEB. This was associated with sustained localization of heterodomain protein 1 (HP1) at the PN of the one-cell embryos arrested by PARylation inhibition. Conclusions/Significance: Our findings indicate that PARylation is required for pronuclear fusion during postfertilization processes. These data further suggest that PARylation regulates protein dynamics essential for the beginning of mouse zygotic development. PARylation and its involving signal-pathways may represent potential targets as contraceptives.	[Osada, Tomoharu] Mitsubishi Chem Medience Corp, Adv Med Sci Res Ctr, Minato Ku, Tokyo, Japan; [Osada, Tomoharu; Noce, Toshiaki] Mitsubishi Kagaku Inst Life Sci MITILS, Dept Regenerat & Dev Biol, Tokyo, Japan; [Ogino, Hideki; Masutani, Mitsuko] Natl Inst Canc Res, Div Biochem, Chuo Ku, Tokyo, Japan; [Ogino, Hideki; Masutani, Mitsuko] Natl Inst Canc Res, ADP Ribosylat Oncol Project, Chuo Ku, Tokyo, Japan; [Hino, Toshiaki; Nakamura, Kenji] Mitsubishi Kagaku Inst Life Sci MITILS, Mouse Genome Technol Lab, Tokyo, Japan; [Ichinose, Sachiyo; Omori, Akira] Mitsubishi Kagaku Inst Life Sci MITILS, Biomol Struct Anal Lab, Tokyo, Japan	Mitsubishi Kagaku Institute of Life Sciences (MITILS); National Cancer Center - Japan; National Cancer Center - Japan; Mitsubishi Kagaku Institute of Life Sciences (MITILS); Mitsubishi Kagaku Institute of Life Sciences (MITILS)	Osada, T (corresponding author), Mitsubishi Chem Medience Corp, Adv Med Sci Res Ctr, Minato Ku, Tokyo, Japan.	osada.tomoharu@mg.medience.co.jp; mmasutan@ncc.go.jp	noce, toshiaki/L-1739-2013		Ministry of Education, Science, Sports, and Culture of Japan [18870035]; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work is supported in part by Grant-in-Aid from the Ministry of Education, Science, Sports, and Culture of Japan (T. O., 18870035) (http://www.mext.go.jp), Grant-in-Aid for the Third Term Comprehensive 10-year Strategy for Cancer Control (M. M., H19-Sanjigan-Ippan-003) and Grant-in-Aid from the Ministry of Health, Labour and Welfare of Japan (M. M.) (http://www.mhlw.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkarim GE, 2001, INT J MOL MED, V7, P255; Arney KL, 2002, INT J DEV BIOL, V46, P317; Bakondi E, 2002, J HISTOCHEM CYTOCHEM, V50, P91, DOI 10.1177/002215540205000110; Chang P, 2004, NATURE, V432, P645, DOI 10.1038/nature03061; Chang P, 2009, MOL BIOL CELL, V20, P4575, DOI 10.1091/mbc.E09-06-0477; CLARKE HJ, 1992, BIOCHEM CELL BIOL, V70, P856, DOI 10.1139/o92-134; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; EPEL D, 1981, CELL, V23, P543, DOI 10.1016/0092-8674(81)90150-1; Erdelyi K, 2005, MOL PHARMACOL, V68, P895, DOI 10.1124/mol.105.012518; Fan HY, 2004, BIOL REPROD, V70, P535, DOI 10.1095/biolreprod.103.022830; Florman HM, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P55; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fossati S, 2007, NEUROCHEM INT, V50, P203, DOI 10.1016/j.neuint.2006.08.009; GERACE L, 1980, CELL, V19, P277, DOI 10.1016/0092-8674(80)90409-2; Hakelien AM, 2008, EXP CELL RES, V314, P1869, DOI 10.1016/j.yexcr.2008.02.018; Huang D, 2009, CARDIOVASC RES, V81, P98, DOI 10.1093/cvr/cvn264; Imamura T, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-4; Inbar-Rozensal D, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2445; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; Masutani M, 1999, P NATL ACAD SCI USA, V96, P2301, DOI 10.1073/pnas.96.5.2301; McDonald MC, 2000, BRIT J PHARMACOL, V130, P843, DOI 10.1038/sj.bjp.0703391; Midorikawa R, 2006, CELL, V125, P371, DOI 10.1016/j.cell.2006.02.039; Monaco L, 2005, P NATL ACAD SCI USA, V102, P14244, DOI 10.1073/pnas.0506252102; Osada T, 2005, MOL REPROD DEV, V72, P329, DOI 10.1002/mrd.20319; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; Quenet D, 2008, FASEB J, V22, P3853, DOI 10.1096/fj.08-113464; Rawe VY, 2003, HUM REPROD, V18, P576, DOI 10.1093/humrep/deg114; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Satchell MA, 2003, J NEUROCHEM, V85, P697, DOI 10.1046/j.1471-4159.2003.01707.x; SCHATTEN G, 1985, P NATL ACAD SCI USA, V82, P4727, DOI 10.1073/pnas.82.14.4727; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Shimokawa T, 1999, J BIOCHEM-TOKYO, V126, P748, DOI 10.1093/oxfordjournals.jbchem.a022512; SIMERLY C, 1993, METHOD ENZYMOL, V225, P516; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; SUGIMURA T, 1994, MOL CELL BIOCHEM, V138, P5, DOI 10.1007/BF00928437; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; Terret ME, 2003, DEVELOPMENT, V130, P5169, DOI 10.1242/dev.00731; Tong C, 2003, CELL RES, V13, P375, DOI 10.1038/sj.cr.7290183; Valdor R, 2008, MOL IMMUNOL, V45, P1863, DOI 10.1016/j.molimm.2007.10.044; Vignon Xavier, 2002, Cloning and Stem Cells, V4, P363, DOI 10.1089/153623002321025041; WHITTEN WK, 1968, J REPROD FERTIL, V17, P399, DOI 10.1530/jrf.0.0170399; Yanagimachi R., 1994, P189; Yoda Y., 1971, JAPANESE J ANIM REPR, V16, P147, DOI [DOI 10.1262/JRD1955.16.147, 10.1262/jrd1955.16.147]	48	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12526	10.1371/journal.pone.0012526	http://dx.doi.org/10.1371/journal.pone.0012526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824066	Green Published, gold, Green Submitted			2022-12-27	WOS:000281480900012
J	Hodsoll, J; Quinn, KA; Hodsoll, S				Hodsoll, John; Quinn, Kimberly A.; Hodsoll, Sara			Attentional Prioritization of Infant Faces Is Limited to Own-Race Infants	PLOS ONE			English	Article							PERSON PERCEPTION; BABY SCHEMA; RECOGNITION; BIAS; COMPONENTS; CONTACT; FEAR	Background: Recent evidence indicates that infant faces capture attention automatically, presumably to elicit caregiving behavior from adults and leading to greater probability of progeny survival. Elsewhere, evidence demonstrates that people show deficiencies in the processing of other-race relative to own-race faces. We ask whether this other-race effect impacts on attentional attraction to infant faces. Using a dot-probe task to reveal the spatial allocation of attention, we investigate whether other-race infants capture attention. Principal Findings: South Asian and White participants (young adults aged 18-23 years) responded to a probe shape appearing in a location previously occupied by either an infant face or an adult face; across trials, the race (South Asian/White) of the faces was manipulated. Results indicated that participants were faster to respond to probes that appeared in the same location as infant faces than adult faces, but only on own-race trials. Conclusions/Significance: Own-race infant faces attract attention, but other-race infant faces do not. Sensitivity to face-specific care-seeking cues in other-race kindenschema may be constrained by interracial contact and experience.	[Hodsoll, John] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Hodsoll, John; Quinn, Kimberly A.] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Hodsoll, Sara] UCL, Dept Psychol, London, England	University of London; Queen Mary University London; University of Birmingham; University of London; University College London	Hodsoll, J (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	John.Hodsoll@gmail.com	Hodsoll, John/I-3928-2012	Hodsoll, John/0000-0001-7546-9901; Lauwereyns, Jan/0000-0003-0551-2550	Biotechnology and Biological Sciences Research Council	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council Fellowship to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bentin S, 2006, J COGNITIVE NEUROSCI, V18, P1406, DOI 10.1162/jocn.2006.18.8.1406; Bernstein MJ, 2007, PSYCHOL SCI, V18, P706, DOI 10.1111/j.1467-9280.2007.01964.x; BERRY DS, 1985, J PERS SOC PSYCHOL, V48, P312, DOI 10.1037/0022-3514.48.2.312; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Brosch T, 2008, PSYCHOL SCI, V19, P362, DOI 10.1111/j.1467-9280.2008.02094.x; Brosch T, 2007, EMOTION, V7, P685, DOI 10.1037/1528-3542.7.3.685; BROWN E, 1993, PERCEPTION, V22, P829, DOI 10.1068/p220829; BURTON AM, 1993, PERCEPTION, V22, P153, DOI 10.1068/p220153; Cloutier J, 2005, J PERS SOC PSYCHOL, V88, P885, DOI 10.1037/0022-3514.88.6.885; Glocker ML, 2009, P NATL ACAD SCI USA, V106, P9115, DOI 10.1073/pnas.0811620106; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; Hayward WG, 2008, COGNITION, V106, P1017, DOI 10.1016/j.cognition.2007.04.002; HRDY SB, 2008, FAM RELAT, P39; Hugenberg K, 2008, SOC PERSONAL PSYCHOL, V2, P1052, DOI 10.1111/j.1751-9004.2008.00090.x; Humphreys GW, 2005, VIS COGN, V12, P249, DOI 10.1080/13506280444000148; Ito TA, 2004, PERS SOC PSYCHOL B, V30, P1267, DOI 10.1177/0146167204264335; Kringelbach ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001664; Lebrecht S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004215; Levin DT, 2000, J EXP PSYCHOL GEN, V129, P559, DOI 10.1037//0096-3445.129.4.559; Lipp OV, 2005, EMOTION, V5, P365, DOI 10.1037/1528-3542.5.3.365; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; LORENZ K, 1985, Z TIERPSYCHOL, V5, P233; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; McKone E, 2007, PERCEPTION, V36, P224, DOI 10.1068/p5499; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Michel C, 2006, VIS COGN, V14, P55, DOI 10.1080/13506280500158761; NG WJ, 1994, J CROSS CULT PSYCHOL, V25, P217, DOI 10.1177/0022022194252004; Papesh MH, 2010, COGNITION, V116, P283, DOI 10.1016/j.cognition.2010.05.001; Sangrigoli S, 2005, PSYCHOL SCI, V16, P440; TRONICK E, 1978, J AM ACAD CHILD PSY, V17, P1, DOI 10.1016/S0002-7138(09)62273-1; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; VANSELST M, 1994, Q J EXP PSYCHOL-A, V47, P631, DOI 10.1080/14640749408401131; Wright DB, 2003, APPL COGNITIVE PSYCH, V17, P365, DOI 10.1002/acp.898	34	31	34	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12509	10.1371/journal.pone.0012509	http://dx.doi.org/10.1371/journal.pone.0012509			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	645KT	20824137	Green Submitted, Green Published, gold			2022-12-27	WOS:000281456100015
J	Lee, S; Ramenzoni, NC; Holme, P				Lee, Sungmin; Ramenzoni, Nica C.; Holme, Petter			Emergence of Collective Memories	PLOS ONE			English	Article							HOLOCAUST	Background: We understand the dynamics of the world around us as by associating pairs of events, where one event has some influence on the other. These pairs of events can be aggregated into a web of memories representing our understanding of an episode of history. The events and the associations between them need not be directly experienced-they can also be acquired by communication. In this paper we take a network approach to study the dynamics of memories of history. Methodology/Principal Findings: First we investigate the network structure of a data set consisting of reported events by several individuals and how associations connect them. We focus our measurement on degree distributions, degree correlations, cycles (which represent inconsistencies as they would break the time ordering) and community structure. We proceed to model effects of communication using an agent-based model. We investigate the conditions for the memory webs of different individuals to converge to collective memories, how groups where the individuals have similar memories (but different from other groups) can form. Conclusions/Significance: Our work outlines how the cognitive representation of memories and social structure can co-evolve as a contagious process. We generate some testable hypotheses including that the number of groups is limited as a function of the total population size.	[Lee, Sungmin; Holme, Petter] Umea Univ, Dept Phys, Umea, Sweden; [Ramenzoni, Nica C.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA; [Holme, Petter] Sungkyunkwan Univ, Dept Energy Sci, Suwon, South Korea	Umea University; University of Virginia; Sungkyunkwan University (SKKU)	Lee, S (corresponding author), Umea Univ, Dept Phys, Umea, Sweden.	petter.holme@physics.umu.se	Lee, Sungmin/F-2317-2010; Holme, Petter/A-7646-2008; Ramenzoni, Verónica C./J-8632-2012	Lee, Sungmin/0000-0001-7902-3229; Holme, Petter/0000-0003-2156-1096; Ramenzoni, Verónica C./0000-0003-3003-5012	Wenner-Gren Foundations; Swedish Foundation for Strategic Research; Swedish Research Council; MEST [R31-2008-000-10029-0]	Wenner-Gren Foundations; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Wenner-Gren Foundations (SM), the Swedish Foundation for Strategic Research (PH), the Swedish Research Council (PH), and the WCU program through NRF Korea funded by MEST (R31-2008-000-10029-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1968, INT AFF, V44, P152; Baldassarri D, 2007, AM SOCIOL REV, V72, P784, DOI 10.1177/000312240707200507; Bartlett FC., 1995, REMEMBERING STUDY EX, V2nd edn; Bearman P, 1999, SOC SCI HIST, V23, P501; Brower B., 1999, HIST MEM, V11, P77; Caldarelli G., 2007, SCALE FREE NETWORKS; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Curty P, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/03/P03013; Gale, 1957, PAC J MATH, V7, P1073, DOI DOI 10.2140/PJM.1957.7.1073; Holme P, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046111; Holme P, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056108; Jaccard P, 1901, B SOC VAUD SCI NAT, V37, P547, DOI [10.5169/seals.266450, DOI 10.5169/SEALS.266450, DOI 10.5169/SEALS-266450]; Klein KL, 2000, REPRESENTATIONS, P127, DOI 10.1525/rep.2000.69.1.01p0064y; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Miller P.J., 2007, HDB CULTURAL PSYCHOL, P595; NELSON K, 1993, PSYCHOL SCI, V4, P7, DOI 10.1111/j.1467-9280.1993.tb00548.x; Nelson KD, 2004, PSYCHOL REV, V111, P486, DOI 10.1037/0033-295X.111.2.486; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Olick JK, 1997, AM SOCIOL REV, V62, P921, DOI 10.2307/2657347; Park J, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026112; Podeh Elie, 2000, HIST MEM, V12, P65, DOI DOI 10.2979/HIS.2000.12.1.65; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Yerushalmi Yosef H., 1982, ZAKHOR JEWISH HIST J	27	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12522	10.1371/journal.pone.0012522	http://dx.doi.org/10.1371/journal.pone.0012522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	645KT	20824141	Green Submitted, Green Published, gold			2022-12-27	WOS:000281456100020
J	Sarac, OS; Atalay, V; Cetin-Atalay, R				Sarac, Oemer Sinan; Atalay, Volkan; Cetin-Atalay, Rengul			GOPred: GO Molecular Function Prediction by Combined Classifiers	PLOS ONE			English	Article							PROTEIN FUNCTION; CLASSIFICATION; SEQUENCE; ANNOTATION; SUPPORT; DISCOVERY; SOFTWARE; GENOMES	Functional protein annotation is an important matter for in vivo and in silico biology. Several computational methods have been proposed that make use of a wide range of features such as motifs, domains, homology, structure and physicochemical properties. There is no single method that performs best in all functional classification problems because information obtained using any of these features depends on the function to be assigned to the protein. In this study, we portray a novel approach that combines different methods to better represent protein function. First, we formulated the function annotation problem as a classification problem defined on 300 different Gene Ontology (GO) terms from molecular function aspect. We presented a method to form positive and negative training examples while taking into account the directed acyclic graph (DAG) structure and evidence codes of GO. We applied three different methods and their combinations. Results show that combining different methods improves prediction accuracy in most cases. The proposed method, GOPred, is available as an online computational annotation tool (http://kinaz.fen.bilkent.edu.tr/gopred).	[Sarac, Oemer Sinan; Atalay, Volkan] Middle E Tech Univ, Dept Comp Engn, TR-06531 Ankara, Turkey; [Cetin-Atalay, Rengul] Bilkent Univ, Dept Mol Biol & Genet, Fac Sci, Ankara, Turkey	Middle East Technical University; Ihsan Dogramaci Bilkent University	Sarac, OS (corresponding author), Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany.	rengul@bilkent.edu.tr	Atalay, Volkan/M-2256-2016; Cetin-Atalay, Rengul/O-9826-2014; Cetin-Atalay, Rengul/F-5780-2013	Atalay, Volkan/0000-0001-7850-0601; Cetin-Atalay, Rengul/0000-0003-2408-6606; Cetin-Atalay, Rengul/0000-0003-2408-6606	Scientific and Technological Research Council of Turkey (TUBITAK-EEAG) [105E035]	Scientific and Technological Research Council of Turkey (TUBITAK-EEAG)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This study was supported by The Scientific and Technological Research Council of Turkey (TUBITAK-EEAG) (105E035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTAY C, 1970, BLOOD-J HEMATOL, V36, P219, DOI 10.1182/blood.V36.2.219.219; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARAMPATZIS A, 2001, P 10 TEXT RETRIEVAL, P596; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; BENHUR A, 2003, ISMB S, V26, P33; Blekas K, 2005, J COMPUT BIOL, V12, P64, DOI 10.1089/cmb.2005.12.64; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Cheng BYM, 2005, PROTEINS, V58, P955, DOI 10.1002/prot.20373; Cho YJ, 2008, P NATL ACAD SCI USA, V105, P5396, DOI 10.1073/pnas.0705410105; COLBY WW, 1986, MOL CELL BIOL, V6, P730, DOI 10.1128/MCB.6.2.730; Costa V, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-250; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; DEMOS D, 2000, PROTEINS, V41, P98; Duda R.O., 2000, PATTERN CLASSIFICATI; Eisner R.P.B., 2005, P IEEE S COMP INT BI; Engelhardt BE, 2005, PLOS COMPUT BIOL, V1, P432, DOI 10.1371/journal.pcbi.0010045; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Friedberg I, 2006, BRIEF BIOINFORM, V7, P225, DOI 10.1093/bib/bbl004; Gilks WR, 2005, MATH BIOSCI, V193, P223, DOI 10.1016/j.mbs.2004.08.001; Guermeur Y, 2004, NEUROCOMPUTING, V56, P305, DOI 10.1016/j.neucom.2003.10.004; Hannenhalli SS, 2000, J MOL BIOL, V303, P61, DOI 10.1006/jmbi.2000.4036; Hasumi H, 2008, GENE, V415, P60, DOI 10.1016/j.gene.2008.02.022; Hawkins T, 2006, PROTEIN SCI, V15, P1550, DOI 10.1110/ps.062153506; Holloway DT, 2006, IBM J RES DEV, V50, P631, DOI 10.1147/rd.506.0631; Jensen LJ, 2002, J MOL BIOL, V319, P1257, DOI 10.1016/S0022-2836(02)00379-0; Karchin R, 2002, BIOINFORMATICS, V18, P147, DOI 10.1093/bioinformatics/18.1.147; King RD, 2000, YEAST, V17, P283, DOI 10.1002/1097-0061(200012)17:4<283::AID-YEA52>3.0.CO;2-F; Kittler J, 1998, IEEE T PATTERN ANAL, V20, P226, DOI 10.1109/34.667881; Kunik V, 2005, 2005 IEEE Computational Systems Bioinformatics Conference, Proceedings, P80, DOI 10.1109/CSB.2005.39; Leslie CS, 2004, BIOINFORMATICS, V20, P467, DOI 10.1093/bioinformatics/btg431; Liu AH, 2001, IBM SYST J, V40, P379, DOI 10.1147/sj.402.0379; Martin DMA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-178; McChesney PA, 2006, CANCER RES, V66, P1346, DOI 10.1158/0008-5472.CAN-05-3593; Melvin I, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-389; Pasquier C, 2001, PROTEINS, V44, P361, DOI 10.1002/prot.1101; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sarac OS, 2008, COMPUT BIOL CHEM, V32, P122, DOI 10.1016/j.compbiolchem.2007.11.004; Sasson O, 2006, PROTEIN SCI, V15, P1557, DOI 10.1110/ps.062185706; Schwanbeck R, 2008, CELLS TISSUES ORGANS, V188, P91, DOI 10.1159/000113531; Shanahan James G., 2003, CIKM ACM, P247; Sohn SY, 2007, PATTERN RECOGN, V40, P33, DOI 10.1016/j.patcog.2006.06.027; SOKOLOV A, 2008, P 2 INT WORKSH MACH, P49; Tanaka S, 2004, J BIOL CHEM, V279, P14256, DOI 10.1074/jbc.M313755200; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; Wang JTL, 2001, IBM SYST J, V40, P426, DOI 10.1147/sj.402.0426; Wang XY, 2003, INFORM SCIENCES, V155, P1, DOI 10.1016/S0020-0255(03)00067-7; Wass MN, 2008, BIOINFORMATICS, V24, P798, DOI 10.1093/bioinformatics/btn037; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yildiz A, 2005, TRENDS CELL BIOL, V15, P112, DOI 10.1016/j.tcb.2004.12.007; ZHAI C, 1998, P TREC 7, P96	52	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12382	10.1371/journal.pone.0012382	http://dx.doi.org/10.1371/journal.pone.0012382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824206	Green Submitted, gold, Green Published			2022-12-27	WOS:000281405300006
J	Cellurale, C; Weston, CR; Reilly, J; Garlick, DS; Jerry, DJ; Sluss, HK; Davis, RJ				Cellurale, Cristina; Weston, Claire R.; Reilly, Judith; Garlick, David S.; Jerry, D. Joseph; Sluss, Hayla K.; Davis, Roger J.			Role of JNK in a Trp53-Dependent Mouse Model of Breast Cancer	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAY; JUN NH2-TERMINAL KINASE; GLIOBLASTOMA CELLS; TUMOR-SUPPRESSOR; MICE; GROWTH; DIFFERENTIATION; PROLIFERATION; ACTIVATION; CARCINOMA	The cJun NH(2)-terminal kinase (JNK) signal transduction pathway has been implicated in mammary carcinogenesis. To test the role of JNK, we examined the effect of ablation of the Jnk1 and Jnk2 genes in a Trp53-dependent model of breast cancer using BALB/c mice. We detected no defects in mammary gland development in virgin mice or during lactation and involution in control studies of Jnk1(-/-) and Jnk2(-/-) mice. In a Trp53(-/+) genetic background, mammary carcinomas were detected in 43% of control mice, 70% of Jnk1(-/-) mice, and 53% of Jnk2(-/-) mice. These data indicate that JNK1 and JNK2 are not essential for mammary carcinoma development in the Trp53(-/+) BALB/c model of breast cancer. In contrast, this analysis suggests that JNK may partially contribute to tumor suppression. This conclusion is consistent with the finding that tumor-free survival of JNK-deficient Trp53(-/+) mice was significantly reduced compared with control Trp53(-/+) mice. We conclude that JNK1 and JNK2 can act as suppressors of mammary tumor development.	[Cellurale, Cristina; Weston, Claire R.; Reilly, Judith; Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA; [Garlick, David S.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Jerry, D. Joseph] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Sluss, Hayla K.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Worcester	Cellurale, C (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA.	Roger.Davis@Umassmed.Edu		Davis, Roger/0000-0002-0130-1652	National Institutes of Health, National Cancer Institute (NCI) [R01CA65861]; National Institutes of Health, National Institute of Diabetes Digestive disorders and Kidney (NIDDK) [P30DK52530]; NATIONAL CANCER INSTITUTE [R01CA065861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052530] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, National Institute of Diabetes Digestive disorders and Kidney (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health, National Cancer Institute (NCI) (www.nci.nih.gov) grant number R01CA65861 to RJD. RJD is an Investigator of the Howard Hughes Medical Institute. RJD and HKS are members of the Diabetes and Endocrinology Research Center of the University of Massachusetts Medical School that is funded by the National Institutes of Health, National Institute of Diabetes Digestive disorders and Kidney (NIDDK) (www.niddk.nih.gov) grant number P30DK52530. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch JM, 2001, ONCOGENE, V20, P4621, DOI 10.1038/sj.onc.1204621; Blackburn AC, 2004, CANCER RES, V64, P5140, DOI 10.1158/0008-5472.CAN-03-3435; Bost F, 1999, MOL CELL BIOL, V19, P1938; Chen NY, 2001, CANCER RES, V61, P3908; Chen PL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010443; Cui J, 2006, CANCER RES, V66, P10024, DOI 10.1158/0008-5472.CAN-06-0136; Das M, 2009, CELL, V136, P249, DOI 10.1016/j.cell.2008.11.017; Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Debies MT, 2001, J MAMMARY GLAND BIOL, V6, P441, DOI 10.1023/A:1014739131690; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Hayakawa J, 2004, MOL CELL, V16, P521, DOI 10.1016/j.molcel.2004.10.024; Hess P, 2002, NAT GENET, V32, P201, DOI 10.1038/ng946; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Jerry DJ, 1998, ONCOGENE, V17, P2305, DOI 10.1038/sj.onc.1202157; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kuperwasser C, 2000, AM J PATHOL, V157, P2151, DOI 10.1016/S0002-9440(10)64853-5; Potapova O, 2000, J BIOL CHEM, V275, P24767, DOI 10.1074/jbc.M904591199; Su Gloria H, 2002, Hum Mutat, V19, P81, DOI 10.1002/humu.9002; Teng DHF, 1997, CANCER RES, V57, P4177; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Whitmarsh AJ, 2007, ONCOGENE, V26, P3172, DOI 10.1038/sj.onc.1210410; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Yang YM, 2003, CLIN CANCER RES, V9, P391	30	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12469	10.1371/journal.pone.0012469	http://dx.doi.org/10.1371/journal.pone.0012469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644KL	20814571	gold, Green Published, Green Submitted			2022-12-27	WOS:000281375500004
J	Antczak, P; Ortega, F; Chipman, JK; Falciani, F				Antczak, Philipp; Ortega, Fernando; Chipman, J. Kevin; Falciani, Francesco			Mapping Drug Physico-Chemical Features to Pathway Activity Reveals Molecular Networks Linked to Toxicity Outcome	PLOS ONE			English	Article							EXPRESSION; SELECTION	The identification of predictive biomarkers is at the core of modern toxicology. So far, a number of approaches have been proposed. These rely on statistical inference of toxicity response from either compound features (i.e., QSAR), in vitro cell based assays or molecular profiling of target tissues (i.e., expression profiling). Although these approaches have already shown the potential of predictive toxicology, we still do not have a systematic approach to model the interaction between chemical features, molecular networks and toxicity outcome. Here, we describe a computational strategy designed to address this important need. Its application to a model of renal tubular degeneration has revealed a link between physicochemical features and signalling components controlling cell communication pathways, which in turn are differentially modulated in response to toxic chemicals. Overall, our findings are consistent with the existence of a general toxicity mechanism operating in synergy with more specific single-target based mode of actions (MOAs) and provide a general framework for the development of an integrative approach to predictive toxicology.	[Antczak, Philipp; Ortega, Fernando; Chipman, J. Kevin; Falciani, Francesco] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Birmingham	Falciani, F (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	f.falciani@bham.ac.uk	Ortega, Fernando/G-2129-2015; Falciani, Francesco/F-3490-2010; Antczak, Philipp/L-5879-2019	Ortega, Fernando/0000-0002-3172-2095; Antczak, Philipp/0000-0001-9600-7757	Biotechnology and Biological Sciences Research Council (BBSRC); United Kingdom Natural Environment Research Council (NERC) [NE/C507661/1]; NERC [NE/D000793/1] Funding Source: UKRI; Natural Environment Research Council [NE/D000793/1, NE/C507661/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United Kingdom Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work has been partially supported by a Biotechnology and Biological Sciences Research Council (BBSRC) PhD studentship to PA and by the United Kingdom Natural Environment Research Council (NERC) Post-Genomic and Proteomic Programme grant NE/C507661/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin RP, 2002, TOXICOLOGY, V181, P555, DOI 10.1016/S0300-483X(02)00481-X; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bushel PR, 2002, J BIOMED INFORM, V35, P160, DOI 10.1016/S1532-0464(02)00525-7; Cariello NF, 2002, MUTAGENESIS, V17, P321, DOI 10.1093/mutage/17.4.321; Chipman JK, 2003, TOXICOL SCI, V71, P146, DOI 10.1093/toxsci/71.2.146; Conesa A, 2008, GENOMICS, V92, P373, DOI 10.1016/j.ygeno.2008.05.015; Dieterle F, 2008, CURR OPIN DRUG DISC, V11, P60; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; Doi AM, 2007, TOXICOL PATHOL, V35, P533, DOI 10.1080/01926230701338941; Fielden MR, 2005, TOXICOL PATHOL, V33, P675, DOI 10.1080/01926230500321213; Freeman JW, 2004, FRONT BIOSCI-LANDMRK, V9, P1889, DOI 10.2741/1388; Geng H, 2009, AM J PATHOL, V174, P1291, DOI 10.2353/ajpath.2009.080295; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Judson R, 2009, ENVIRON HEALTH PERSP, V117, P685, DOI 10.1289/ehp.0800168; KLAASSEN C, 1993, J OCCUPATIONAL ENV M, V35, P76; Kong SW, 2006, BIOINFORMATICS, V22, P2373, DOI 10.1093/bioinformatics/btl401; Lobenhofer EK, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r100; Mayr LM, 2009, CURR OPIN PHARMACOL, V9, P580, DOI 10.1016/j.coph.2009.08.004; Merlot C, 2010, DRUG DISCOV TODAY, V15, P16, DOI 10.1016/j.drudis.2009.09.010; Pereira CV, 2009, CURR DRUG SAF, V4, P34, DOI 10.2174/157488609787354440; RAYCHAUDHURI S, 2000, PAC S BIOC PAC S BIO; Sameith K, 2008, BIOINFORMATICS, V24, P2602, DOI 10.1093/bioinformatics/btn489; SCHOEPPE W, 1977, P ROY SOC MED, V70, P36, DOI 10.1177/00359157770700S207; SONG S, 2006, PRINCIPAL COORDINATE; Song S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-502; Steiner G, 2004, ENVIRON HEALTH PERSP, V112, P1236, DOI 10.1289/txg.7036; TEAM RDC, 2005, R LANGUAGE ENV STAT; Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y; Thomas RS, 2001, MOL PHARMACOL, V60, P1189, DOI 10.1124/mol.60.6.1189; Trevino V, 2006, BIOINFORMATICS, V22, P1154, DOI 10.1093/bioinformatics/btl074; Vayer P, 2009, M S-MED SCI, V25, P871, DOI 10.1051/medsci/20092510871; Vedani A, 2006, BASIC CLIN PHARMACOL, V99, P195, DOI 10.1111/j.1742-7843.2006.pto_471.x; Waring JF, 2002, TOXICOLOGY, V181, P537, DOI 10.1016/S0300-483X(02)00477-8	33	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12385	10.1371/journal.pone.0012385	http://dx.doi.org/10.1371/journal.pone.0012385			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20811577	Green Submitted, Green Published, gold			2022-12-27	WOS:000281301500004
J	Murray, SA; Morgan, JL; Kane, C; Sharma, Y; Heffner, CS; Lake, J; Donahue, LR				Murray, Stephen A.; Morgan, Judith L.; Kane, Coleen; Sharma, Yashoda; Heffner, Caleb S.; Lake, Jeffrey; Donahue, Leah Rae			Mouse Gestation Length Is Genetically Determined	PLOS ONE			English	Article							PRETERM BIRTH; MICE; PARTURITION; INSIGHTS; BIOLOGY	Background: Preterm birth is an enormous public health problem, affecting over 12% of live births and costing over $26 billion in the United States alone. The causes are complex, but twin studies support the role of genetics in determining gestation length. Despite widespread use of the mouse in studies of the genetics of preterm birth, there have been few studies that actually address the precise natural gestation length of the mouse, and to what degree the timing of labor and birth is genetically determined. Methodology/Principal Findings: To further develop the mouse as a genetic model of preterm birth, we developed a high-throughput monitoring system and measured the gestation length in 15 inbred strains. Our results show an unexpectedly wide variation in overall gestation length between strains that approaches two full days, while intra-strain variation is quite low. Although litter size shows a strong inverse correlation with gestation length, genetic difference alone accounts for a significant portion of the variation. In addition, ovarian transplant experiments support a primary role of maternal genetics in the determination of gestation length. Preliminary analysis of gestation length in the C57BL/6J-Chr#(A/J)/NaJ chromosome substitution strain (B.A CSS) panel suggests complex genetic control of gestation length. Conclusions/Significance: Together, these data support the role of genetics in regulating gestation length and present the mouse as an important tool for the discovery of genes governing preterm birth.	[Murray, Stephen A.; Morgan, Judith L.; Kane, Coleen; Sharma, Yashoda; Heffner, Caleb S.; Lake, Jeffrey; Donahue, Leah Rae] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Murray, SA (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	leahrae.donahue@jax.org		Heffner, Caleb/0000-0002-2631-6201	March of Dimes [MOD154LRD]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD011102] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by the March of Dimes (www.marchofdimes.com) Grant #MOD154LRD. The funders, as part of a panel of independent scientists who have an interest in this work, helped conceive and design the study, and have served as advisers during the work. The data collection, analysis, decision to publish and preparation of the manuscript was entirely the work of the authors.	BEHRMAN RE, 2007, PRETERM BIRTH CAUSES, pR16; Chaudhari BP, 2008, CLIN GENET, V74, P493, DOI 10.1111/j.1399-0004.2008.01124.x; DeFranco E, 2007, SEMIN REPROD MED, V25, P40, DOI 10.1055/s-2006-956774; Delahunty KM, 2009, J CLIN DENSITOM, V12, P89, DOI 10.1016/j.jocd.2008.10.008; Elovitz MA, 2004, TRENDS ENDOCRIN MET, V15, P479, DOI 10.1016/j.tem.2004.10.009; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Kimura T, 1999, REV REPROD, V4, P73, DOI 10.1530/ror.0.0040073; KISTKA ZA, 2008, AM J OBSTET GYNECOL, V43, pE41; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Ratajczak CK, 2008, PEDIATR RES, V64, P581, DOI 10.1203/PDR.0b013e31818718d2; Romero R, 2010, AM J OBSTET GYNECOL, V202; Sztein J, 1998, BIOL REPROD, V58, P1071, DOI 10.1095/biolreprod58.4.1071; Wilcox AJ, 2008, AM J EPIDEMIOL, V167, P474, DOI 10.1093/aje/kwm319	13	82	82	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12418	10.1371/journal.pone.0012418	http://dx.doi.org/10.1371/journal.pone.0012418			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811634	Green Published, Green Submitted, gold			2022-12-27	WOS:000281234700032
J	Allan, GM; Korownyk, C; LaSalle, K; Vandermeer, B; Ma, V; Klein, D; Manca, D				Allan, G. Michael; Korownyk, Christina; LaSalle, Kate; Vandermeer, Ben; Ma, Victoria; Klein, Douglas; Manca, Donna			Do Randomized Controlled Trials Discuss Healthcare Costs?	PLOS ONE			English	Article							DRUG COSTS; ASSOCIATION; CONCLUSIONS; INTERESTS; QUALITY	Background: Healthcare costs, particularly pharmaceutical costs, are a dominant issue for most healthcare organizations, but it is unclear if randomized controlled trials (RCTs) routinely discuss costs. Our objective was to assess the frequency and factors associated with the inclusion of costs in RCTs. Methods and Findings: We randomly sampled 188 RCTs spanning three years (2003-2005) from six high impact journals. The sample size for RCTs was based on a calculation to estimate the inclusion of actual drug costs with a precision of +/-3%. Two reviewers independently extracted cost data and study characteristics. Frequencies were calculated and potential characteristics associated with the inclusion of costs were explored. Actual drug costs were included in 4.7% (9/188) of RCTs; any actual costs were included in 7.4% (14/188) of RCTs; and any mention of costs was included in 27.7% (52/188) of RCTs. As the amount of industry funding increased across RCTs, from non-profit to mixed to fully industry funded RCTs, there was a statistically significant reduction in the number of RCTs with any actual costs (Cochran-Armitage test, p = 0.005) and any mention of costs (Cochran-Armitage test, p = 0.02). Logistic regression analysis also indicated funding was associated with the inclusion of any actual cost (OR = 0.34, p = 0.009) or any mention of costs (OR = 0.63, p = 0.02). Journal, study conclusions, study location, primary author's country and product age were not associated with inclusion of cost information. Conclusion: While physicians are encouraged to consider costs when prescribing drugs for their patients, actual drug costs were provided in only 5% of RCTs and were not mentioned at all in 72% of RCTs. Industry funded trials were less likely to include cost information. No other factors were associated with the inclusion of cost information.	[Allan, G. Michael; Korownyk, Christina; LaSalle, Kate; Ma, Victoria; Klein, Douglas; Manca, Donna] Univ Alberta, Dept Family Med, Edmonton, AB, Canada; [Allan, G. Michael] Inst Hlth Econ, Edmonton, AB, Canada; [Vandermeer, Ben] Univ Alberta, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada	University of Alberta; University of Alberta	Allan, GM (corresponding author), Univ Alberta, Dept Family Med, Edmonton, AB, Canada.	michael.allan@ualberta.ca	Manca, Donna P/K-4737-2016; manca, donna p/F-9623-2010	Manca, Donna P/0000-0001-6073-7715; manca, donna p/0000-0001-6073-7715; Korownyk, Christina/0000-0003-4953-9392	Institute of Health Economics	Institute of Health Economics	The project was funded by a $10,000 grant from the Institute of Health Economics. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan GM, 2008, INT J TECHNOL ASSESS, V24, P158, DOI 10.1017/S0266462308080227; Allan GM, 2007, PLOS MED, V4, P1486, DOI 10.1371/journal.pmed.0040283; Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Anis AH, 2005, CAN MED ASSOC J, V173, P1335, DOI 10.1503/cmaj.045146; Beilby JJ, 1997, MED J AUSTRALIA, V167, P89, DOI 10.5694/j.1326-5377.1997.tb138787.x; Bhandari M, 2004, CAN MED ASSOC J, V170, P477; BOVIER PA, 2009, BMC HEALTH SERV RES, V5, P72; Garrison LP, 2003, VALUE HEALTH, V6, P6, DOI 10.1046/j.1524-4733.2003.00003.x; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; Guterman JJ, 2002, J GEN INTERN MED, V17, P792, DOI 10.1046/j.1525-1497.2002.20144.x; Guyatt G, 2008, USERS GUIDES MED LIT; Hart J, 1997, J INTERN MED, V241, P415, DOI 10.1046/j.1365-2796.1997.137143000.x; Hsu J, 2006, NEW ENGL J MED, V354, P2349, DOI 10.1056/NEJMsa054436; HUX JE, 1994, PHARMACOECONOMICS, V5, P343, DOI 10.2165/00019053-199405040-00008; Innes G, 2000, CJEM, V2, P95; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Lexchin J, 2004, INT J HEALTH SERV, V34, P101, DOI 10.2190/4M3E-L0YF-W1TD-EKG0; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; *OECD HLTH DIV, 2006, OECD HLTH DAT 2006; Pitkin RM, 1999, JAMA-J AM MED ASSOC, V281, P1110, DOI 10.1001/jama.281.12.1110; Prosser H, 2005, SOC SCI MED, V60, P1335, DOI 10.1016/j.socscimed.2004.07.013; RINGENBERG R, 1998, INDIANA MED, V81, P136; Roth EJ, 2001, ARCH PHYS MED REHAB, V82, P633, DOI 10.1053/apmr.2001.22624; Salman H, 1999, PUBLIC HEALTH, V113, P243, DOI 10.1038/sj.ph.1900579; SEAY M, 2005, ISSUE BRIEF HLTH POL, V31, P1; Shrank WH, 2006, AM J MANAG CARE, V12, P545; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Yaphe J, 2001, FAM PRACT, V18, P565, DOI 10.1093/fampra/18.6.565	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12318	10.1371/journal.pone.0012318	http://dx.doi.org/10.1371/journal.pone.0012318			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	641TV	20808794	Green Published, gold, Green Submitted			2022-12-27	WOS:000281153500006
J	Mat, WK; Xue, H; Wong, JTF				Mat, Wai-Kin; Xue, Hong; Wong, J. Tze-Fei			Genetic Code Mutations: The Breaking of a Three Billion Year Invariance	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; UNNATURAL AMINO-ACID; ESCHERICHIA-COLI; COEVOLUTION THEORY; MAMMALIAN-CELLS; PROTEINS; TRYPTOPHAN; SUPPRESSION; EVOLUTION; GROWTH	The genetic code has been unchanging for some three billion years in its canonical ensemble of encoded amino acids, as indicated by the universal adoption of this ensemble by all known organisms. Code mutations beginning with the encoding of 4-fluoro-Trp by Bacillus subtilis, initially replacing and eventually displacing Trp from the ensemble, first revealed the intrinsic mutability of the code. This has since been confirmed by a spectrum of other experimental code alterations in both prokaryotes and eukaryotes. To shed light on the experimental conversion of a rigidly invariant code to a mutating code, the present study examined code mutations determining the propagation of Bacillus subtilis on Trp and 4-, 5- and 6-fluorotryptophans. The results obtained with the mutants with respect to cross-inhibitions between the different indole amino acids, and the growth effects of individual nutrient withdrawals rendering essential their biosynthetic pathways, suggested that oligogenic barriers comprising sensitive proteins which malfunction with amino acid analogues provide effective mechanisms for preserving the invariance of the code through immemorial time, and mutations of these barriers open up the code to continuous change.	[Mat, Wai-Kin] Hong Kong Univ Sci & Technol, Fok Ying Tung Grad Sch, Appl Genom Ctr, Hong Kong, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Mat, WK (corresponding author), Hong Kong Univ Sci & Technol, Fok Ying Tung Grad Sch, Appl Genom Ctr, Hong Kong, Hong Kong, Peoples R China.	bcjtw@ust.hk		Xue, Hong/0000-0002-8133-9828; Wong, J. Tze-Fei/0000-0001-8539-8537	Research Grants Council of Hong Kong [HKUST6437/06M]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by The Research Grants Council of Hong Kong (Grant No. HKUST6437/06M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacher JM, 2007, METH MOL B, V352, P23; Bacher JM, 2004, TRENDS ECOL EVOL, V19, P69, DOI 10.1016/j.tree.2003.11.007; Bacher JM, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-24; Bacher JM, 2001, J BACTERIOL, V183, P5414, DOI 10.1128/JB.183.18.5414-5425.2001; Bock A, 2001, SCIENCE, V292, P453, DOI 10.1126/science.1060637; BRONSKILL PM, 1988, BIOCHEM J, V249, P305, DOI 10.1042/bj2490305; Budisa N., 2006, ENG GENETIC CODE, P90; COHEN P, 2000, NEW SCI, V167, P32; Cropp TA, 2007, NAT PROTOC, V2, P2590, DOI 10.1038/nprot.2007.378; Doring V, 2001, SCIENCE, V292, P501, DOI 10.1126/science.1057718; Gibson DG, 2010, CREATION BACTERIAL C; HESMAN T, 2000, SCI NEWS, V157, P360, DOI DOI 10.2307/4012452; Kohrer C, 2004, NUCLEIC ACIDS RES, V32, P6200, DOI 10.1093/nar/gkh959; KWOK Y, 1980, CAN J BIOCHEM CELL B, V58, P213, DOI 10.1139/o80-029; Lee HS, 2009, J AM CHEM SOC, V131, P12921, DOI 10.1021/ja904896s; LEMEIGNAN B, 1993, J MOL BIOL, V231, P161, DOI 10.1006/jmbi.1993.1269; MAT WK, 2004, AM SOC MICR 104 M; Mehl RA, 2003, J AM CHEM SOC, V125, P935, DOI 10.1021/ja0284153; PENKE B, 1974, ANAL BIOCHEM, V60, P45, DOI 10.1016/0003-2697(74)90129-8; Pezo V, 2004, P NATL ACAD SCI USA, V101, P8593, DOI 10.1073/pnas.0402893101; Sakamoto K, 2002, NUCLEIC ACIDS RES, V30, P4692, DOI 10.1093/nar/gkf589; Santoro SW, 2003, NUCLEIC ACIDS RES, V31, P6700, DOI 10.1093/nar/gkg903; Tang Y, 2002, BIOCHEMISTRY-US, V41, P10635, DOI 10.1021/bi026130x; Tze-Fei J Wong, 2009, PREBIOTIC EVOLUTION, P110; Wong JTF, 2007, ORIGINS LIFE EVOL B, V37, P403, DOI 10.1007/s11084-007-9094-1; WONG JT, 1984, DYNAMICS BIOCH SYSTE, P247; WONG JT, 2002, FUNDAMENTALS LIFE, P473; WONG JT, 2010, CHEM SYNTHE IN PRESS; WONG JTF, 1976, P NATL ACAD SCI USA, V73, P2336, DOI 10.1073/pnas.73.7.2336; Wong JTF, 2005, BIOESSAYS, V27, P416, DOI 10.1002/bies.20208; WONG JTF, 1975, P NATL ACAD SCI USA, V72, P1909, DOI 10.1073/pnas.72.5.1909; WONG JTF, 1983, P NATL ACAD SCI-BIOL, V80, P6303, DOI 10.1073/pnas.80.20.6303	32	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12206	10.1371/journal.pone.0012206	http://dx.doi.org/10.1371/journal.pone.0012206			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808824	Green Published, gold, Green Submitted			2022-12-27	WOS:000281077000002
J	Jacox, E; Gotea, V; Ovcharenko, I; Elnitski, L				Jacox, Edwin; Gotea, Valer; Ovcharenko, Ivan; Elnitski, Laura			Tissue-Specific and Ubiquitous Expression Patterns from Alternative Promoters of Human Genes	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; MAMMALIAN GENOMES; P1 PROMOTER; DNA; IDENTIFICATION; LIVER; RNA; CONSERVATION; EVOLUTION; SELECTION	Background: Transcriptome diversity provides the key to cellular identity. One important contribution to expression diversity is the use of alternative promoters, which creates mRNA isoforms by expanding the choice of transcription initiation sites of a gene. The proximity of the basal promoter to the transcription initiation site enables prediction of a promoter's location based on the gene annotations. We show that annotation of alternative promoters regulating expression of transcripts with distinct first exons enables a novel methodology to quantify expression levels and tissue specificity of mRNA isoforms. Principal Findings: The use of distinct alternative first exons in 3,296 genes was examined using exon-microarray data from 11 human tissues. Comparing two transcripts from each gene we found that the activity of alternative promoters (i.e., P1 and P2) was not correlated through tissue specificity or level of expression. Furthermore neither P1 nor P2 conferred any bias for tissue-specific or ubiquitous expression. Genes associated with specific diseases produced transcripts whose limited expression patterns were consistent with the tissue affected in disease. Notably, genes that were historically designated as tissue-specific or housekeeping had alternative isoforms that showed differential expression. Furthermore, only a small number of alternative promoters showed expression exclusive to a single tissue indicating that "tissue preference" provides a better description of promoter activity than tissue specificity. When compared to gene expression data in public databases, as few as 22% of the genes had detailed information for more than one isoform, whereas the remainder collapsed the expression patterns from individual transcripts into one profile. Conclusions: We describe a computational pipeline that uses microarray data to assess the level of expression and breadth of tissue profiles for transcripts with distinct first exons regulated by alternative promoters. We conclude that alternative promoters provide individualized regulation that is confirmed through expression levels, tissue preference and chromatin modifications. Although the selective use of alternative promoters often goes uncharacterized in gene expression analyses, transcripts produced in this manner make unique contributions to the cell that requires further exploration.	[Jacox, Edwin; Gotea, Valer; Elnitski, Laura] NHGRI, NIH, Rockville, MD USA; [Gotea, Valer; Ovcharenko, Ivan] NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA	Jacox, E (corresponding author), NHGRI, NIH, Rockville, MD USA.	Elnitski@mail.nih.gov	Elnitski, Laura/AAD-3595-2021	Elnitski, Laura/0000-0003-1065-019X; Gotea, Valer/0000-0001-7857-3309	National Human Genome Research Institute, National Institutes of Health; National Center for Biotechnology Information, National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200323] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM200881] Funding Source: NIH RePORTER	National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Center for Biotechnology Information, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	LE is supported by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health. IO is supported by the Intramural Research Program of the National Center for Biotechnology Information, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6; Baek D, 2007, GENOME RES, V17, P145, DOI 10.1101/gr.5872707; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Briancon N, 2006, EMBO J, V25, P1253, DOI 10.1038/sj.emboj.7601021; Briancon N, 2004, J BIOL CHEM, V279, P33398, DOI 10.1074/jbc.M405312200; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Eeckhoute J, 2003, ENDOCRINOLOGY, V144, P1686, DOI 10.1210/en.2002-0024; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Faulkner GJ, 2009, CELL CYCLE, V8, P2895, DOI 10.4161/cc.8.18.9536; Garaud S, 2008, J IMMUNOL, V181, P2010, DOI 10.4049/jimmunol.181.3.2010; Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607; Gopal E, 2007, BBA-BIOMEMBRANES, V1768, P2690, DOI 10.1016/j.bbamem.2007.06.031; Harries LW, 2008, DIABETES, V57, P1745, DOI 10.2337/db07-1742; HOBART MJ, 1977, J EXP MED, V146, P629, DOI 10.1084/jem.146.2.629; Huh JW, 2009, MOL CELLS, V28, P111, DOI 10.1007/s10059-009-0106-z; Jiang JT, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-25; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li X, 2007, DRUG METAB PHARMACOK, V22, P152, DOI 10.2133/dmpk.22.152; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Luzzi V, 2003, J MOL DIAGN, V5, P9, DOI 10.1016/S1525-1578(10)60445-X; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Murphy R, 2008, DIABETES RES CLIN PR, V79, pS30, DOI 10.1016/S0168-8227(08)70721-6; Nagayama S, 2004, ONCOGENE, V23, P5551, DOI 10.1038/sj.onc.1207710; Nemeth E, 2009, SEMIN IMMUNOPATHOL, V31, P333, DOI 10.1007/s00281-009-0173-4; Niu NF, 2007, DIABETES-METAB RES, V23, P21, DOI 10.1002/dmrr.641; Okamoto R, 2006, CELL SIGNAL, V18, P1408, DOI 10.1016/j.cellsig.2005.11.001; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; REID RA, 1994, MOL BRAIN RES, V21, P1, DOI 10.1016/0169-328X(94)90372-7; Riggins GJ, 2001, HUM MOL GENET, V10, P663, DOI 10.1093/hmg/10.7.663; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Severin J, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r39; Shields DJ, 2001, BBA-MOL CELL BIOL L, V1532, P105, DOI 10.1016/S1388-1981(01)00122-6; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tsuritani K, 2007, GENOME RES, V17, P1005, DOI 10.1101/gr.6030107; WAYE MMY, 1995, MIAM WINT BIOT S P, V6; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yasojima K, 1998, CIRC RES, V83, P860, DOI 10.1161/01.RES.83.8.860; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	48	25	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12274	10.1371/journal.pone.0012274	http://dx.doi.org/10.1371/journal.pone.0012274			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20806066	Green Submitted, Green Published, gold			2022-12-27	WOS:000281011600032
J	Gangaiah, D; Liu, Z; Arcos, J; Kassem, II; Sanad, Y; Torrelles, JB; Rajashekara, G				Gangaiah, Dharanesh; Liu, Zhe; Arcos, Jesus; Kassem, Issmat I.; Sanad, Yasser; Torrelles, Jordi B.; Rajashekara, Gireesh			Polyphosphate Kinase 2: A Novel Determinant of Stress Responses and Pathogenesis in Campylobacter jejuni	PLOS ONE			English	Article							INORGANIC POLYPHOSPHATE; BIOFILM FORMATION; PSEUDOMONAS-AERUGINOSA; VIBRIO-CHOLERAE; SURVIVAL; VIRULENCE; IDENTIFICATION; ADAPTATION; ENTERITIS; ALGINATE	Background: Inorganic polyphosphate (poly P) plays an important role in stress tolerance and virulence in many bacteria. PPK1 is the principal enzyme involved in poly P synthesis, while PPK2 uses poly P to generate GTP, a signaling molecule that serves as an alternative energy source and a precursor for various physiological processes. Campylobacter jejuni, an important cause of foodborne gastroenteritis in humans, possesses homologs of both ppk1 and ppk2. ppk1 has been previously shown to impact the pathobiology of C. jejuni. Methodology/Principal Findings: Here, we demonstrate for the first time that the deletion of ppk2 in C. jejuni resulted in a significant decrease in poly P-dependent GTP synthesis, while displaying an increased intracellular ATP: GTP ratio. The Delta ppk2 mutant exhibited a significant survival defect under osmotic, nutrient, aerobic, and antimicrobial stresses and displayed an enhanced ability to form static biofilms. However, the Delta ppk2 mutant was not defective in poly P and ppGpp synthesis suggesting that PPK2-mediated stress tolerance is not ppGpp-mediated. Importantly, the Delta ppk2 mutant was significantly attenuated in invasion and intracellular survival within human intestinal epithelial cells as well as in chicken colonization. Conclusions/Significance: Taken together, we have highlighted the role of PPK2 as a novel pathogenicity determinant that is critical for C. jejuni survival, adaptation, and persistence in the host environments. PPK2 is absent in humans and animals; therefore, can serve as a novel target for therapeutic intervention of C. jejuni infections.	[Gangaiah, Dharanesh; Liu, Zhe; Kassem, Issmat I.; Sanad, Yasser; Rajashekara, Gireesh] Ohio State Univ, Food Anim Hlth Res Program, Ohio Agr Res Dev Ctr, Dept Vet Prevent Med, Wooster, OH USA; [Arcos, Jesus; Torrelles, Jordi B.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Gangaiah, D (corresponding author), Ohio State Univ, Food Anim Hlth Res Program, Ohio Agr Res Dev Ctr, Dept Vet Prevent Med, Wooster, OH USA.	rajashekara.2@osu.edu	Rajashekara, Gireesh/E-3913-2011; Torrelles, Jordi/E-4204-2011	Sanad, Yasser/0000-0001-6008-5630; KASSEM, ISSMAT/0000-0002-2978-9573	USDA [2007-35201-18414]; Ohio Agricultural Research and Development Center; Ohio State University	USDA(United States Department of Agriculture (USDA)); Ohio Agricultural Research and Development Center; Ohio State University(Ohio State University)	Research in Dr. Rajashekara's lab is supported by the USDA grant 2007-35201-18414 and by the Ohio Agricultural Research and Development Center, The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Altekruse SF, 1999, EMERG INFECT DIS, V5, P28, DOI 10.3201/eid0501.990104; Bacon DJ, 2000, INFECT IMMUN, V68, P4384, DOI 10.1128/IAI.68.8.4384-4390.2000; BEERY JT, 1988, APPL ENVIRON MICROB, V54, P2365, DOI 10.1128/AEM.54.10.2365-2370.1988; Candon HL, 2007, J BACTERIOL, V189, P8099, DOI 10.1128/JB.01037-07; Chakrabarty AM, 1998, MOL MICROBIOL, V28, P875, DOI 10.1046/j.1365-2958.1998.00846.x; Chaveerach P, 2003, APPL ENVIRON MICROB, V69, P711, DOI 10.1128/AEM.69.1.711-714.2003; Day WA, 2000, INFECT IMMUN, V68, P6337, DOI 10.1128/IAI.68.11.6337-6345.2000; DEMELO MA, 1989, INFECT IMMUN, V57, P2214, DOI 10.1128/IAI.57.7.2214-2222.1989; Fields JA, 2008, J BACTERIOL, V190, P3411, DOI 10.1128/JB.01928-07; Gangaiah D, 2009, APPL ENVIRON MICROB, V75, P7838, DOI 10.1128/AEM.01603-09; Gaynor EC, 2005, MOL MICROBIOL, V56, P8, DOI 10.1111/j.1365-2958.2005.04525.x; Hughes R, 2004, LANCET NEUROL, V3, P644, DOI 10.1016/S1474-4422(04)00902-0; Ishige K, 2002, P NATL ACAD SCI USA, V99, P16684, DOI 10.1073/pnas.262655299; Jahid IK, 2006, APPL ENVIRON MICROB, V72, P7043, DOI 10.1128/AEM.00924-06; Joshua GWP, 2006, MICROBIOL-SGM, V152, P387, DOI 10.1099/mic.0.28358-0; Kalischuk LD, 2010, AM J PHYSIOL-GASTR L, V298, pG1, DOI 10.1152/ajpgi.00193.2009; Kim HY, 1998, MOL MICROBIOL, V27, P717, DOI 10.1046/j.1365-2958.1998.00702.x; Kim KS, 2002, P NATL ACAD SCI USA, V99, P7675, DOI 10.1073/pnas.112210499; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; KORNBERG A, 1995, J BACTERIOL, V177, P491, DOI 10.1128/jb.177.3.491-496.1995; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Lecuit M, 2004, NEW ENGL J MED, V350, P239, DOI 10.1056/NEJMoa031887; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Lindner SN, 2007, APPL ENVIRON MICROB, V73, P5026, DOI 10.1128/AEM.00600-07; Malik-Kale P, 2008, J BACTERIOL, V190, P2286, DOI 10.1128/JB.01736-07; McLennan MK, 2008, J BACTERIOL, V190, P1097, DOI 10.1128/JB.00516-07; Mendrygal KE, 2000, J BACTERIOL, V182, P599, DOI 10.1128/JB.182.3.599-606.2000; Miller WG, 2000, APPL ENVIRON MICROB, V66, P5426, DOI 10.1128/AEM.66.12.5426-5436.2000; Nocek B, 2008, P NATL ACAD SCI USA, V105, P17730, DOI 10.1073/pnas.0807563105; Ogawa N, 2000, J BACTERIOL, V182, P6687, DOI 10.1128/JB.182.23.6687-6693.2000; Pandit SB, 2003, PROTEINS, V52, P585, DOI 10.1002/prot.10420; Pogacar MS, 2009, INT J FOOD MICROBIOL, V129, P68, DOI 10.1016/j.ijfoodmicro.2008.11.010; PONKA A, 1981, ANN RHEUM DIS, V40, P414, DOI 10.1136/ard.40.4.414; Price-Carter M, 2005, J BACTERIOL, V187, P3088, DOI 10.1128/JB.187.9.3088-3099.2005; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Raskin DM, 2007, P NATL ACAD SCI USA, V104, P4636, DOI 10.1073/pnas.0611650104; Reid AN, 2008, APPL ENVIRON MICROB, V74, P1583, DOI 10.1128/AEM.01507-07; Reid AN, 2008, APPL ENVIRON MICROB, V74, P1598, DOI 10.1128/AEM.01508-07; Ritz M, 2009, J MICROBIOL METH, V76, P196, DOI 10.1016/j.mimet.2008.10.014; ROLLINS DM, 1986, APPL ENVIRON MICROB, V52, P531, DOI 10.1128/AEM.52.3.531-538.1986; RUSSELL RG, 1993, J INFECT DIS, V168, P210, DOI 10.1093/infdis/168.1.210; Sambrook J., 2001, MOL CLONING LAB MANU; Seufferheld MJ, 2008, APPL ENVIRON MICROB, V74, P5867, DOI 10.1128/AEM.00501-08; Sundin GW, 1996, J BACTERIOL, V178, P7120, DOI 10.1128/jb.178.24.7120-7128.1996; Sureka K, 2009, MOL MICROBIOL, V74, P1187, DOI 10.1111/j.1365-2958.2009.06925.x; Svensson SL, 2009, MOL MICROBIOL, V71, P253, DOI 10.1111/j.1365-2958.2008.06534.x; Tan SM, 2005, J BACTERIOL, V187, P7687, DOI 10.1128/JB.187.22.7687-7695.2005; Tholozan JL, 1999, APPL ENVIRON MICROB, V65, P1110; Wilson DL, 2003, MICROBIOL-SGM, V149, P3603, DOI 10.1099/mic.0.26531-0; Wosten MMSM, 2006, MOL MICROBIOL, V62, P278, DOI 10.1111/j.1365-2958.2006.05372.x; YAO RJ, 1993, GENE, V130, P127, DOI 10.1016/0378-1119(93)90355-7; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718	57	48	53	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12142	10.1371/journal.pone.0012142	http://dx.doi.org/10.1371/journal.pone.0012142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808906	Green Published, gold, Green Submitted			2022-12-27	WOS:000280968100004
J	Heron, SF; Willis, BL; Skirving, WJ; Eakin, CM; Page, CA; Miller, IR				Heron, Scott F.; Willis, Bette L.; Skirving, William J.; Eakin, C. Mark; Page, Cathie A.; Miller, Ian R.			Summer Hot Snaps and Winter Conditions: Modelling White Syndrome Outbreaks on Great Barrier Reef Corals	PLOS ONE			English	Article							DYNAMICS; DISEASE; TEMPERATURE; PATTERNS; ECOLOGY; SHIFTS	Coral reefs are under increasing pressure in a changing climate, one such threat being more frequent and destructive outbreaks of coral diseases. Thermal stress from rising temperatures has been implicated as a causal factor in disease outbreaks observed on the Great Barrier Reef, Australia, and elsewhere in the world. Here, we examine seasonal effects of satellite-derived temperature on the abundance of coral diseases known as white syndromes on the Great Barrier Reef, considering both warm stress during summer and deviations from mean temperatures during the preceding winter. We found a high correlation (r(2) = 0.953) between summer warm thermal anomalies (Hot Snap) and disease abundance during outbreak events. Inclusion of thermal conditions during the preceding winter revealed that a significant reduction in disease outbreaks occurred following especially cold winters (Cold Snap), potentially related to a reduction in pathogen loading. Furthermore, mild winters (i.e., neither excessively cool nor warm) frequently preceded disease outbreaks. In contrast, disease outbreaks did not typically occur following warm winters, potentially because of increased disease resistance of the coral host. Understanding the balance between the effects of warm and cold winters on disease outbreak will be important in a warming climate. Combining the influence of winter and summer thermal effects resulted in an algorithm that yields both a Seasonal Outlook of disease risk at the conclusion of winter and near real-time monitoring of Outbreak Risk during summer. This satellite-derived system can provide coral reef managers with an assessment of risk three-to-six months in advance of the summer season that can then be refined using near-real-time summer observations. This system can enhance the capacity of managers to prepare for and respond to possible disease outbreaks and focus research efforts to increase understanding of environmental impacts on coral disease in this era of rapidly changing climate.	[Heron, Scott F.] Natl Ocean & Atmospher Adm, Townsville, Qld, Australia; [Heron, Scott F.; Skirving, William J.] James Cook Univ, Dept Phys, Sch Engn & Phys Sci, Townsville, Qld 4811, Australia; [Heron, Scott F.; Skirving, William J.] James Cook Univ, Marine Geophys Lab, Sch Engn & Phys Sci, Townsville, Qld 4811, Australia; [Willis, Bette L.; Page, Cathie A.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Willis, Bette L.; Page, Cathie A.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Eakin, C. Mark] Natl Ocean & Atmospher Adm, Silver Spring, MD USA; [Miller, Ian R.] Australian Inst Marine Sci, Long Term Monitoring Program, Townsville, Qld 4810, Australia	National Oceanic Atmospheric Admin (NOAA) - USA; James Cook University; James Cook University; James Cook University; James Cook University; National Oceanic Atmospheric Admin (NOAA) - USA; Australian Institute of Marine Science	Heron, SF (corresponding author), Natl Ocean & Atmospher Adm, Townsville, Qld, Australia.	scott.heron@noaa.gov	Heron, Scott F/E-7928-2011; Eakin, C. Mark/F-5585-2010; Skirving, William/E-7927-2011	Eakin, C. Mark/0000-0002-5987-0858; Heron, Scott/0000-0001-5262-6978; Skirving, William/0000-0003-0167-6427	NOAA; World Bank/Global Environment Facility Coral Reef Targeted Research Remote Sensing and Coral Disease Working Groups; Marine and Tropical Sciences	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); World Bank/Global Environment Facility Coral Reef Targeted Research Remote Sensing and Coral Disease Working Groups; Marine and Tropical Sciences	This work was supported by the NOAA Coral Reef Conservation Program; the World Bank/Global Environment Facility Coral Reef Targeted Research Remote Sensing and Coral Disease Working Groups; and the Marine and Tropical Sciences Research Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandt ME, 2009, DIS AQUAT ORGAN, V87, P117, DOI 10.3354/dao02137; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Eakin C. M., 2009, V205, P41; Harvell C. D., 2007, OCEANOGRAPHY, V20, P58; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hoegh-Guldberg O, 2005, LIMNOL OCEANOGR, V50, P265, DOI 10.4319/lo.2005.50.1.0265; Hoegh-Guldberg O, 2004, CORAL REEFS, V23, P444, DOI 10.1007/s00338-004-0401-2; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jones RJ, 2004, MAR ECOL PROG SER, V281, P63, DOI 10.3354/meps281063; Kilpatrick KA, 2001, J GEOPHYS RES-OCEANS, V106, P9179, DOI 10.1029/1999JC000065; KIRKWOOD CW, DECISION TREE PRIMER; Lafferty KD, 2004, ANNU REV ECOL EVOL S, V35, P31, DOI 10.1146/annurev.ecolsys.35.021103.105704; Liu G., 2003, EOS, V84, P137, DOI [10.1029/2003EO150001, DOI 10.1029/2003E0150001]; Mao-Jones J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000345; Maynard JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032175; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Ninio R, 2002, CORAL REEFS, V21, P95, DOI 10.1007/s00338-001-0202-9; Ninio R, 2000, MAR ECOL PROG SER, V194, P65, DOI 10.3354/meps194065; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Sato Y, 2009, P R SOC B, V276, P2795, DOI 10.1098/rspb.2009.0481; Skirving W, 2006, RE S D I PR, V9, P11, DOI 10.1007/1-4020-3968-9_2; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sweatman H.H., 2008, 8 AUSTR I MAR SCI; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Wobeser G.A, 2006, ESSENTIALS DIS WILD	28	81	81	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12210	10.1371/journal.pone.0012210	http://dx.doi.org/10.1371/journal.pone.0012210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808912	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000280968100014
J	Kanazawa, S; Fujiwara, T; Matsuzaki, S; Shingaki, K; Taniguchi, M; Miyata, S; Tohyama, M; Sakai, Y; Yano, K; Hosokawa, K; Kubo, T				Kanazawa, Shigeyuki; Fujiwara, Toshihiro; Matsuzaki, Shinsuke; Shingaki, Kenta; Taniguchi, Manabu; Miyata, Shingo; Tohyama, Masaya; Sakai, Yasuo; Yano, Kenji; Hosokawa, Ko; Kubo, Tateki			bFGF Regulates PI3-Kinase-Rac1-JNK Pathway and Promotes Fibroblast Migration in Wound Healing	PLOS ONE			English	Article							ENDOTHELIAL-CELL-MIGRATION; RHO-ASSOCIATED KINASE; GROWTH-FACTOR; ALPHA(V)BETA(3) INTEGRIN; SIGNALING PATHWAYS; ACTIVATION; GTPASES; RECEPTOR; MOTILITY; POLARITY	Fibroblast proliferation and migration play important roles in wound healing. bFGF is known to promote both fibroblast proliferation and migration during the process of wound healing. However, the signal transduction of bFGF-induced fibroblast migration is still unclear, because bFGF can affect both proliferation and migration. Herein, we investigated the effect of bFGF on fibroblast migration regardless of its effect on fibroblast proliferation. We noticed involvement of the small GTPases of the Rho family, PI3-kinase, and JNK. bFGF activated RhoA, Rac1, PI3-kinase, and JNK in cultured fibroblasts. Inhibition of RhoA did not block bFGF-induced fibroblast migration, whereas inhibition of Rac1, PI3-kinase, or JNK blocked the fibroblastmigration significantly. PI3-kinase- inhibited cells down-regulated the activities of Rac1 and JNK, and Rac1-inhibited cells down-regulated JNK activity, suggesting that PI3-kinase is upstream of Rac1 and that JNK is downstream of Rac1. Thus, we concluded that PI3-kinase, Rac1, and JNK were essential for bFGF-induced fibroblast migration, which is a novel pathway of bFGF-induced cell migration.	[Kanazawa, Shigeyuki; Fujiwara, Toshihiro; Sakai, Yasuo; Yano, Kenji; Hosokawa, Ko; Kubo, Tateki] Osaka Univ, Grad Sch Med, Dept Plast Surg, Osaka, Japan; [Matsuzaki, Shinsuke; Shingaki, Kenta; Taniguchi, Manabu; Miyata, Shingo; Tohyama, Masaya] Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Osaka, Japan	Osaka University; Osaka University	Kanazawa, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Plast Surg, Osaka, Japan.	tateki@psurg.med.osaka-u.ac.jp			Osaka University	Osaka University	This work was supported in part by Osaka University operating budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alblas J, 2001, MOL BIOL CELL, V12, P2137, DOI 10.1091/mbc.12.7.2137; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; BILATO C, 1995, J CLIN INVEST, V96, P1905, DOI 10.1172/JCI118236; Chang YZ, 2002, CIRC RES, V91, P390, DOI 10.1161/01.RES.0000033524.92083.64; Chen BH, 2002, J BIOL CHEM, V277, P33857, DOI 10.1074/jbc.M204429200; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jones PL, 1997, J CELL BIOL, V139, P279, DOI 10.1083/jcb.139.1.279; Kavurma MM, 2003, J CELL BIOCHEM, V89, P289, DOI 10.1002/jcb.10497; Kim S, 2000, J BIOL CHEM, V275, P33920, DOI 10.1074/jbc.M003668200; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kondo H, 2000, BIOCHEM BIOPH RES CO, V272, P648, DOI 10.1006/bbrc.2000.2790; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Kurokawa K, 2005, BIOCHEM SOC T, V33, P631, DOI 10.1042/BST0330631; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Liu GZ, 2001, J CELL BIOCHEM, V83, P129, DOI 10.1002/jcb.1208; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Ohgoda O, 1998, J DERMATOL SCI, V17, P123, DOI 10.1016/S0923-1811(98)00003-6; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Ridley A, 2000, J CELL BIOL, V150, pF107, DOI 10.1083/jcb.150.4.F107; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Royal I, 2000, MOL BIOL CELL, V11, P1709, DOI 10.1091/mbc.11.5.1709; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; SATO Y, 1988, J CELL BIOL, V107, P1199, DOI 10.1083/jcb.107.3.1199; SCHLEEF RR, 1982, TISSUE CELL, V14, P629, DOI 10.1016/0040-8166(82)90053-2; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; SCHREIER T, 1993, RES EXP MED, V193, P195, DOI 10.1007/BF02576227; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Smith LG, 2004, CURR BIOL, V14, pR109, DOI 10.1016/j.cub.2004.01.016; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; TSUBOI R, 1990, J CELL BIOL, V110, P511, DOI 10.1083/jcb.110.2.511; Tsuboi Ryoji, 1992, Journal of Dermatology (Tokyo), V19, P652; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; van Horssen R, 2006, J CELL BIOCHEM, V99, P1536, DOI 10.1002/jcb.20994; Verma S, 2004, J BIOL CHEM, V279, P34062, DOI 10.1074/jbc.M404814200; Wagner W, 2007, J CELL MOL MED, V11, P1342, DOI 10.1111/j.1582-4934.2007.00037.x; Wang DI, 1999, EXP MOL PATHOL, V66, P179, DOI 10.1006/exmp.1999.2265; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Woodard AS, 1998, J CELL SCI, V111, P469; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895; Zhang L, 2003, EMBO J, V22, P4443, DOI 10.1093/emboj/cdg440	69	110	114	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12228	10.1371/journal.pone.0012228	http://dx.doi.org/10.1371/journal.pone.0012228			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808927	Green Published, gold, Green Submitted			2022-12-27	WOS:000280968100025
J	Sangeetha, VM; Kale, VP; Limaye, LS				Sangeetha, V. M.; Kale, Vaijayanti P.; Limaye, Lalita S.			Expansion of Cord Blood CD34(+) Cells in Presence of zVADfmk and zLLYfmk Improved Their In Vitro Functionality and In Vivo Engraftment in NOD/SCID Mouse	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; SELF-RENEWAL; LONG-TERM; BCL-2 EXPRESSION; PROGENITOR CELLS; TRANSPLANTATION; APOPTOSIS; SERUM; DIFFERENTIATION; THROMBOPOIETIN	Background: Cord blood (CB) is a promising source for hematopoietic stem cell transplantations. The limitation of cell dose associated with this source has prompted the ex vivo expansion of hematopoietic stem and progenitor cells (HSPCs). However, the expansion procedure is known to exhaust the stem cell pool causing cellular defects that promote apoptosis and disrupt homing to the bone marrow. The role of apoptotic machinery in the regulation of stem cell compartment has been speculated in mouse hematopoietic and embryonic systems. We have consistently observed an increase in apoptosis in the cord blood derived CD34(+) cells cultured with cytokines compared to their freshly isolated counterpart. The present study was undertaken to assess whether pharmacological inhibition of apoptosis could improve the outcome of expansion. Methodology/Principal Findings: CB CD34(+) cells were expanded with cytokines in the presence or absence of cell permeable inhibitors of caspases and calpains; zVADfmk and zLLYfmk respectively. A novel role of apoptotic protease inhibitors was observed in increasing the CD34(+) cell content of the graft during ex vivo expansion. This was further reflected in improved in vitro functional aspects of the HSPCs; a higher clonogenicity and long term culture initiating potential. These cells sustained superior long term engraftment and an efficient regeneration of major lympho-myeloid lineages in the bone marrow of NOD/SCID mouse compared to the cells expanded with growth factors alone. Conclusion/Significance: Our data show that, use of either zVADfmk or zLLYfmk in the culture medium improves expansion of CD34(+) cells. The strategy protects stem cell pool and committed progenitors, and improves their in vitro functionality and in vivo engraftment. This observation may complement the existing protocols used in the manipulation of hematopoietic cells for therapeutic purposes. These findings may have an impact in the CB transplant procedures involving a combined infusion of unmanipulated and expanded grafts.	[Sangeetha, V. M.; Kale, Vaijayanti P.; Limaye, Lalita S.] Natl Ctr Cell Sci, Stem Cell Biol Lab, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Sangeetha, VM (corresponding author), Natl Ctr Cell Sci, Stem Cell Biol Lab, Pune, Maharashtra, India.	lslimaye@nccs.res.in	Vadakke-Madathil, Sangeetha/B-5340-2011; Kale, Vaijayanti/R-9342-2019	Vadakke-Madathil, Sangeetha/0000-0002-4948-9412; Kale, Vaijayanti/0000-0001-7498-7563	Defence research development organization (DRDO) (Life Science Research Board), Government of India, New Delhi; Lady Tata Trust, Mumbai, India	Defence research development organization (DRDO) (Life Science Research Board), Government of India, New Delhi(Defence Research & Development Organisation (DRDO)); Lady Tata Trust, Mumbai, India	The present work received financial support from DRDO (LSRB) Defence research development organization (Life Science Research Board), Government of India, New Delhi. SVM is a recipient of the Lady Tata Trust's Senior research scholarship, Mumbai, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenzi Faris Q., 2009, Yale Journal of Biology and Medicine, V82, P7; Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059; Ballen KK, 2005, BLOOD, V105, P3786, DOI 10.1182/blood-2004-10-4125; Barker JN, 2003, NAT REV CANCER, V3, P526, DOI 10.1038/nrc1125; BROXMEYER HE, 2009, BONE MARROW TRANSPL, P1; Bryder D, 2001, J EXP MED, V194, P941, DOI 10.1084/jem.194.7.941; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; DALEY JP, FOCUS; Danet GH, 2001, EXP HEMATOL, V29, P1465, DOI 10.1016/S0301-472X(01)00750-0; de Lima M, 2008, BONE MARROW TRANSPL, V41, P771, DOI 10.1038/sj.bmt.1705979; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Gluckman E, 2001, TRANSFUS CLIN BIOL, V8, P146, DOI 10.1016/S1246-7820(01)00132-X; Hatzold J, 2008, PLOS BIOL, V6, P771, DOI 10.1371/journal.pbio.0060084; Hofmeister CC, 2007, BONE MARROW TRANSPL, V39, P11, DOI 10.1038/sj.bmt.1705538; Hogan CJ, 2002, P NATL ACAD SCI USA, V99, P413, DOI 10.1073/pnas.012336799; IMAI Y, 2009, STEM CELLS DEV; Janzen V, 2008, CELL STEM CELL, V2, P584, DOI 10.1016/j.stem.2008.03.012; Jaroscak J, 2003, BLOOD, V101, P5061, DOI 10.1182/blood-2001-12-0290; KANG HJ, 2009, BONE MARROW TRANSPLA; Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365; KELLY SS, 2009, BONE MARROW TRANSPL, P1; Kogler G, 1999, BONE MARROW TRANSPL, V24, P397, DOI 10.1038/sj.bmt.1701916; Limaye LS, 2001, J HEMATOTH STEM CELL, V10, P709, DOI 10.1089/152581601753193931; Liu BL, 2003, EXP HEMATOL, V31, P824, DOI 10.1016/S0301-472X(03)00161-9; MacMillan ML, 2009, BONE MARROW TRANSPL, V43, P447, DOI 10.1038/bmt.2008.348; Majhail NS, 2006, CURR OPIN IMMUNOL, V18, P571, DOI 10.1016/j.coi.2006.07.015; Mattia G, 2008, EXP HEMATOL, V36, P244, DOI 10.1016/j.exphem.2007.09.006; Moore MAS, 2007, EXP HEMATOL, V35, P105, DOI 10.1016/j.exphem.2007.01.018; Neumar RW, 2003, J BIOL CHEM, V278, P14162, DOI 10.1074/jbc.M212255200; Nishino T, 2009, EXP HEMATOL, V37, P1364, DOI 10.1016/j.exphem.2009.09.001; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Piacibello W, 1999, BLOOD, V93, P3736, DOI 10.1182/blood.V93.11.3736.411k01_3736_3749; Piacibello W, 1997, BLOOD, V89, P2644, DOI 10.1182/blood.V89.8.2644; Sasnoor LM, 2005, TRANSPLANTATION, V80, P1251, DOI 10.1097/01.tp.0000169028.01327.90; Sasnoor LM, 2003, J HEMATOTH STEM CELL, V12, P553, DOI 10.1089/152581603322448268; Seet LF, 2009, EUR J HAEMATOL, V82, P124, DOI 10.1111/j.1600-0609.2008.01169.x; Stroh C, 2002, FASEB J, V16, P1651, DOI 10.1096/fj.02-0034fje; Tanaka H, 2006, STEM CELLS, V24, P2592, DOI 10.1634/stemcells.2005-0434; Ueda T, 2000, J CLIN INVEST, V105, P1013, DOI 10.1172/JCI8583; Yamane T, 2005, P NATL ACAD SCI USA, V102, P3312, DOI 10.1073/pnas.0500167102	42	24	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12221	10.1371/journal.pone.0012221	http://dx.doi.org/10.1371/journal.pone.0012221			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808921	Green Submitted, gold, Green Published			2022-12-27	WOS:000280968100020
J	Dong, HY; Paquette, M; Williams, A; Zoeller, RT; Wade, M; Yauk, C				Dong, Hongyan; Paquette, Martin; Williams, Andrew; Zoeller, R. Thomas; Wade, Mike; Yauk, Carole			Thyroid Hormone May Regulate mRNA Abundance in Liver by Acting on MicroRNAs	PLOS ONE			English	Article							MUSCLE-SPECIFIC MICRORNAS; GENES; TARGETS; SPECIFICITY; EXPRESSION; MIR-133; MIRNAS; FAMILY; MICE	MicroRNAs (miRNAs) are extensively involved in diverse biological processes. However, very little is known about the role of miRNAs in mediating the action of thyroid hormones (TH). Appropriate TH levels are known to be critically important for development, differentiation and maintenance of metabolic balance in mammals. We induced transient hypothyroidism in juvenile mice by short-term exposure to methimazole and perchlorate from post natal day (PND) 12 to 15. The expression of miRNAs in the liver was analyzed using Taqman Low Density Arrays (containing up to 600 rodent miRNAs). We found the expression of 40 miRNAs was significantly altered in the livers of hypothyroid mice compared to euthyroid controls. Among the miRNAs, miRs-1, 206, 133a and 133b exhibited a massive increase in expression (50- to 500-fold). The regulation of TH on the expression of miRs-1, 206, 133a and 133b was confirmed in various mouse models including: chronic hypothyroid, short-term hyperthyroid and short-term hypothyroid followed by TH supplementation. TH regulation of these miRNAs was also confirmed in mouse hepatocyte AML 12 cells. The expression of precursors of miRs-1, 206, 133a and 133b were examined in AML 12 cells and shown to decrease after TH treatment, only pre-mir-206 and pre-mir-133b reached statistical significance. To identify the targets of these miRNAs, DNA microarrays were used to examine hepatic mRNA levels in the short-term hypothyroid mouse model relative to controls. We found transcripts from 92 known genes were significantly altered in these hypothyroid mice. Web-based target predication software (TargetScan and Microcosm) identified 14 of these transcripts as targets of miRs-1, 206, 133a and 133b. The vast majority of these mRNA targets were significantly down-regulated in hypothyroid mice, corresponding with the up-regulation of miRs-1, 206, 133a and 133b in hypothyroid mouse liver. To further investigate target genes, miR-206 was over-expressed in AML 12 cells. TH treatment of cells over-expressing miR-206 resulted in decreased miR-206 expression, and a significant increase in two predicted target genes, Mup1 and Gpd2. The results suggest that TH regulation of these genes may occur secondarily via miR-206. These studies provide new insight into the role of miRNAs in mediating TH regulation of gene expression.	[Dong, Hongyan; Paquette, Martin; Williams, Andrew; Wade, Mike; Yauk, Carole] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada; [Zoeller, R. Thomas] Univ Massachusetts, Mol & Cellular Biol Program, Amherst, MA 01003 USA	Health Canada; University of Massachusetts System; University of Massachusetts Amherst	Dong, HY (corresponding author), Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada.	hongyan_dong@hc-sc.gc.ca		Wade, Michael/0000-0002-7331-3839; Yauk, Carole/0000-0002-6725-3454; Williams, Andrew/0000-0002-7637-7686; Yauk, Carole/0000-0003-4919-876X	Canada Genomics Research and Development Initiative; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010026] Funding Source: NIH RePORTER	Canada Genomics Research and Development Initiative; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was founded by the Health Canada Genomics Research and Development Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boelaert K, 2005, J ENDOCRINOL, V187, P1, DOI 10.1677/joe.1.06131; Bryzgalova G, 2008, J STEROID BIOCHEM, V111, P262, DOI 10.1016/j.jsbmb.2008.06.010; Chen XM, 2009, WORLD J GASTROENTERO, V15, P1665, DOI 10.3748/wjg.15.1665; Dong H, 2007, ENDOCRINOLOGY, V148, P3932, DOI 10.1210/en.2007-0452; Dong HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004610; Dossantos RA, 2003, ENDOCRINOLOGY, V144, P5469, DOI 10.1210/en.2003-0687; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; Higgins JJ., 2003, INTRO MODERN NONPARA; Kato Y, 2009, INT J BIOCHEM CELL B, V41, P2225, DOI 10.1016/j.biocel.2009.04.018; Kerr MK, 2001, P NATL ACAD SCI USA, V98, P8961, DOI 10.1073/pnas.161273698; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; Lynn FC, 2009, TRENDS ENDOCRIN MET, V20, P452, DOI 10.1016/j.tem.2009.05.007; MEES ST, 2009, J SURG RES; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Nitto T, 2008, GENE, V426, P57, DOI 10.1016/j.gene.2008.08.019; Stahlberg Nina, 2005, BMC Physiol, V5, P8, DOI 10.1186/1472-6793-5-8; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Visser WE, 2009, J CLIN ENDOCR METAB, V94, P3487, DOI 10.1210/jc.2009-0782; Wu H., 2003, MAANOVA SOFTWARE PAC; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200; [No title captured]; [No title captured]; [No title captured]; [No title captured]	32	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12136	10.1371/journal.pone.0012136	http://dx.doi.org/10.1371/journal.pone.0012136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20808432	Green Published, gold			2022-12-27	WOS:000280862200005
J	Jarvikivi, J; Vainio, M; Aalto, D				Jarvikivi, Juhani; Vainio, Martti; Aalto, Daniel			Real-Time Correlates of Phonological Quantity Reveal Unity of Tonal and Non-Tonal Languages	PLOS ONE			English	Article							SPEECH-PERCEPTION; GENES; FREQUENCY; MOVEMENT	Discrete phonological phenomena form our conscious experience of language: continuous changes in pitch appear as distinct tones to the speakers of tone languages, whereas the speakers of quantity languages experience duration categorically. The categorical nature of our linguistic experience is directly reflected in the traditionally clear-cut linguistic classification of languages into tonal or non-tonal. However, some evidence suggests that duration and pitch are fundamentally interconnected and co-vary in signaling word meaning in non-tonal languages as well. We show that pitch information affects real-time language processing in a (non-tonal) quantity language. The results suggest that there is no unidirectional causal link from a genetically-based perceptual sensitivity towards pitch information to the appearance of a tone language. They further suggest that the contrastive categories tone and quantity may be based on simultaneously co-varying properties of the speech signal and the processing system, even though the conscious experience of the speakers may highlight only one discrete variable at a time.	[Jarvikivi, Juhani] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Vainio, Martti] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Aalto, Daniel] Aalto Univ, Inst Math, Espoo, Finland	Max Planck Society; University of Helsinki; Aalto University	Jarvikivi, J (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.	juhani.jarvikivi@helsinki.fi	Aalto, Daniel/AAF-7056-2019	Vainio, Martti/0000-0003-2570-0196; Aalto, Daniel/0000-0002-8611-6404	Academy of Finland [107606]	Academy of Finland(Academy of Finland)	The study was supported by Academy of Finland grant no. 107606 to MV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen R. H., 2008, ANAL LINGUISTIC DATA; Bishop D, 2009, ANN NY ACAD SCI, V1156, P1, DOI 10.1111/j.1749-6632.2009.04419.x; Boersma Paul, 2002, GLOT INT, V5, P341; BROWN SW, 1995, PERCEPT PSYCHOPHYS, V57, P105, DOI 10.3758/BF03211853; Catford J.C., 1977, FUNDAMENTAL PROBLEMS; Coleman J., 2002, PHONETICS PHONOLOGY, P96; Cutler A, 1997, LANG SPEECH, V40, P141, DOI 10.1177/002383099704000203; Dediu D, 2007, P NATL ACAD SCI USA, V104, P10944, DOI 10.1073/pnas.0610848104; Duanmu S., 2000, PHONOLOGY STANDARD C; Dupoux E., 2002, PHONETICS PHONOLOGY, P168; DURAND J., 2002, PHONOLOGY PHONETICS, P10; Eimas P. D., 1987, CATEGORICAL PERCEPTI, P161; Gordon M., 2002, STUD LANG, V25, P423, DOI DOI 10.1075/SL.25.3.03G0R; Gussenhoven C., 2002, PHONOLOGY TONE INTON, P47; HARRIKARI H, 2000, PUBLICATIONS DEP GEN, V33; Hawkins S, 2003, J PHONETICS, V31, P373, DOI 10.1016/j.wocn.2003.09.006; Hawkins S, 2010, J PHONETICS, V38, P60, DOI 10.1016/j.wocn.2009.02.001; Hirst D. J., 1998, INTONATION SYSTEMS S, P1; JACKENDOFF R, 2007, LANGUAGE CONSCIOUSNE, P79; Jun S.-A, 2005, PROSODIC TYPOLOGY PH, P430, DOI DOI 10.1093/ACPROF:OSO/9780199249633.003.0016; Karlsson F., 1969, VIRITTAJA, V73, P351; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; LADEFOGED P, 2004, UCLA WORKING PAPERS, V103, P1; Leboe LC, 2008, PSYCHON B REV, V15, P1122, DOI 10.3758/PBR.15.6.1122; LEHISTE I, 1965, LANGUAGE, V41, P447, DOI 10.2307/411787; Lehiste I., 1970, SUPRASEGMENTALS; Lehiste Ilse, 2004, P TAL 2004, P111; Lehiste L., 1976, J PHONETICS, V4, P113, DOI DOI 10.1016/S0095-4470(19)31231-8; LEHNERTLEHOUILL.H, 2006, P ICPHS, V19, P757; Lehtonen Jaakko, 1970, ASPECTS QUANTITY STA; Lippus P, 2009, J PHONETICS, V37, P388, DOI 10.1016/j.wocn.2009.07.002; Maddieson I, 1999, HDB PHONETIC SCI, P619; Maddieson I., 2005, WORLD ATLAS LANGUAGE, P58; MALMBERG B, 1952, STUDIA LINGUISTICA, V6; MARSLENWILSON W, 1994, PSYCHOL REV, V101, P3, DOI 10.1037/0033-295X.101.1.3; Myers Scott, 2000, PHONOLOGICAL KNOWLED, P245; Nettle D, 2007, P NATL ACAD SCI USA, V104, P10755, DOI 10.1073/pnas.0704517104; Norris D, 2006, COGNITIVE PSYCHOL, V53, P146, DOI 10.1016/j.cogpsych.2006.03.001; ODELL M, 2003, ACTA U TAMPERENSIS, V979; PIERREHUMBERT J, 1990, J PHONETICS, V18, P375, DOI 10.1016/S0095-4470(19)30380-8; PISONI DB, 1976, J ACOUST SOC AM, V59, pS39, DOI 10.1121/1.2002669; Sohn H.-M., 2001, KOREAN LANGUAGE; Suomi K, 2005, J PHONETICS, V33, P291, DOI 10.1016/j.wocn.2005.01.002; VAINIO M, 2006, P 2 INT S TON ASP LA, P111; van Dommelen WA, 1999, J PHONETICS, V27, P107, DOI 10.1006/jpho.1999.0087; Werker JF, 2005, TRENDS COGN SCI, V9, P519, DOI 10.1016/j.tics.2005.09.003; Werker JF, 2002, INFANT BEHAV DEV, V25, P121, DOI 10.1016/S0163-6383(02)00093-0; Ylinen S, 2005, LANG SPEECH, V48, P313, DOI 10.1177/00238309050480030401; YU ACL, 2010, LAB PHONOLO IN PRESS, V10; Zhang J., 2001, THESIS U CALIFORNIA	50	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12603	10.1371/journal.pone.0012603	http://dx.doi.org/10.1371/journal.pone.0012603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	648IV	20838615	Green Published, Green Submitted, gold			2022-12-27	WOS:000281687100006
J	Aaron, E; Kempf, MC; Criniti, S; Tedaldi, E; Gracely, E; Warriner, A; Kumar, R; Bachmann, LH				Aaron, Erika; Kempf, Mirjam-Colette; Criniti, Shannon; Tedaldi, Ellen; Gracely, Ed; Warriner, Amy; Kumar, Ritu; Bachmann, Laura H.			Adverse Events in a Cohort of HIV Infected Pregnant and Non-Pregnant Women Treated with Nevirapine versus Non-Nevirapine Antiretroviral Medication	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C; HEPATOTOXICITY; THERAPY; TOXICITY; SAFETY; RISK; EFFICACY; GENDER; COUNT	Background: Predictors of adverse events (AE) associated with nevirapine use are needed to better understand reports of severe rash or liver enzyme elevation (LEE) in HIV+ women. Methodology: AE rates following ART initiation were retrospectively assessed in a multi-site cohort of 612 women. Predictors of onset of rash or LEE were determined using univariate and multivariate analyses. Principal Findings: Of 612 subjects, 152 (24.8%) initiated NVP-based regimens with 86 (56.6%) pregnant; 460 (75.2%) initiated non-NVP regimens with 67 (14.6%) pregnant. LEE: No significant difference was found between regimens in the development of new grade >= 2 LEE (p = 0.885). Multivariate logistic regression demonstrated an increased likelihood of LEE with HCV co-infection (OR 2.502, 95% CI: 1.04 to 6, p = 0.040); pregnancy, NVP-based regimen, and baseline CD4 >250 cells/mm(3) were not associated with this toxicity. Rash: NVP initiation was associated with rash after controlling for CD4 and pregnancy (OR 2.78; 95% CI: 1.14-6.76), as was baseline CD4 >250 cells/mm(3) when controlling for pregnancy and type of regimen (OR 2.68; 95% CI: 1.19-6.02 p = 0.017). Conclusions: CD4 at initiation of therapy was a predictor of rash but not LEE with NVP use in HIV+ women. Pregnancy was not an independent risk factor for the development of AEs assessed. The findings from this study have significant implications for women of child-bearing age initiating NVP-based ART particularly in resource limited settings. This study sheds more confidence on the lack of LEE risk and the need to monitor rash with the use of this medication.	[Aaron, Erika; Criniti, Shannon] Drexel Univ, Div Infect Dis & HIV Med, Dept Med, Coll Med, Philadelphia, PA 19104 USA; [Kempf, Mirjam-Colette] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Tedaldi, Ellen] Temple Univ, Sch Med, Philadelphia, PA 19122 USA; [Gracely, Ed] Drexel Univ, Dept Family Community & Prevent Med, Coll Med, Philadelphia, PA 19104 USA; [Warriner, Amy] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Kumar, Ritu] Mercer Univ, Dept Internal Med, Macon, GA 31207 USA; [Bachmann, Laura H.] WG Hefner Med Ctr, Salisbury, NC USA; [Bachmann, Laura H.] Wake Forest Univ Hlth Sci, Winston Salem, NC USA	Drexel University; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Drexel University; University of Alabama System; University of Alabama Birmingham; Mercer University; Wake Forest University; Wake Forest University School of Medicine	Aaron, E (corresponding author), Drexel Univ, Div Infect Dis & HIV Med, Dept Med, Coll Med, Philadelphia, PA 19104 USA.	eaaron@drexelmed.edu	Gracely, Ed/B-7188-2014	Gracely, Ed/0000-0002-8344-3223	Boehringer Ingelheim Pharmaceuticals, Inc.	Boehringer Ingelheim Pharmaceuticals, Inc.(Boehringer Ingelheim)	This investigator-initiated research project was funded by Boehringer Ingelheim Pharmaceuticals, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylor MS, 2004, JAIDS-J ACQ IMM DEF, V35, P538, DOI 10.1097/00126334-200404150-00014; Bersoff-Matcha SJ, 2001, CLIN INFECT DIS, V32, P124, DOI 10.1086/317536; Bonnet F, 2002, CLIN INFECT DIS, V35, P1231, DOI 10.1086/343046; De Lazzari E, 2008, HIV MED, V9, P221, DOI 10.1111/j.1468-1293.2008.00552.x; den Brinker M, 2000, AIDS, V14, P2895, DOI 10.1097/00002030-200012220-00011; Diethrich Edward B, 2004, Am Heart Hosp J, V2, P89, DOI 10.1111/j.1541-9215.2004.03364.x; Ekouevi DK, 2007, AIDS RES HUM RETROV, V23, P1469, DOI 10.1089/aid.2007.0059; Harris M, 2003, JAIDS-J ACQ IMM DEF, V34, pS53, DOI 10.1097/00126334-200309011-00008; Hitti J, 2004, JAIDS-J ACQ IMM DEF, V36, P772, DOI 10.1097/00126334-200407010-00002; Jamisse L, 2007, JAIDS-J ACQ IMM DEF, V44, P371, DOI 10.1097/QAI.0b013e318032bbee; Joao EC, 2006, AM J OBSTET GYNECOL, V194, P199, DOI 10.1016/j.ajog.2005.05.015; Kappelhoff BS, 2005, ANTIVIR THER, V10, P489; Lyons F, 2006, HIV MED, V7, P255, DOI 10.1111/j.1468-1293.2006.00369.x; Martinez E, 2001, AIDS, V15, P1261, DOI 10.1097/00002030-200107060-00007; Medrano J, 2008, AIDS REV, V10, P110; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; MURPHY RL, 1996, EXPERT OPIN INV DRUG, V5, P1183; *NIH D, 2004, TABL GRAD SEV AD PED; Nunez M, 2006, J HEPATOL, V44, pS132, DOI 10.1016/j.jhep.2005.11.027; Ouyang DW, 2010, AIDS, V24, P109, DOI 10.1097/QAD.0b013e3283323941; Ouyang DW, 2009, AIDS, V23, P2425, DOI 10.1097/QAD.0b013e32832e34b1; Pollard RB, 1998, CLIN THER, V20, P1071, DOI 10.1016/S0149-2918(98)80105-7; Reisler RB, 2003, JAIDS-J ACQ IMM DEF, V34, P379, DOI 10.1097/00126334-200312010-00004; Rivero A, 2007, J ANTIMICROB CHEMOTH, V59, P342, DOI 10.1093/jac/dkl524; Stern JO, 2003, JAIDS-J ACQ IMM DEF, V34, pS21, DOI 10.1097/00126334-200309011-00005; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Sundaram M, 2009, J INFECTION, V58, P255, DOI 10.1016/j.jinf.2009.01.003; van Leth F, 2005, AIDS, V19, P463, DOI 10.1097/01.aids.0000162334.12815.5b; Vogel M, 2009, J ANTIMICROB CHEMOTH, V63, P988, DOI 10.1093/jac/dkp044; *WHO, 2009, RAP ADV US ANT DRUGS	30	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12617	10.1371/journal.pone.0012617	http://dx.doi.org/10.1371/journal.pone.0012617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20838641	Green Published, gold, Green Submitted			2022-12-27	WOS:000281631300037
J	Bitto, A; Lerner, C; Torres, C; Roell, M; Malaguti, M; Perez, V; Lorenzini, A; Hrelia, S; Ikeno, Y; Matzko, ME; McCarter, R; Sell, C				Bitto, Alessandro; Lerner, Chad; Torres, Claudio; Roell, Michaela; Malaguti, Marco; Perez, Viviana; Lorenzini, Antonello; Hrelia, Silvana; Ikeno, Yuji; Matzko, Michelle Elizabeth; McCarter, Roger; Sell, Christian			Long-Term IGF-I Exposure Decreases Autophagy and Cell Viability	PLOS ONE			English	Article							GROWTH-FACTOR-I; CHAPERONE-MEDIATED AUTOPHAGY; LIFE-SPAN EXTENSION; AGE-RELATED DECLINE; C-ELEGANS; INSULIN; RECEPTOR; MICE; DIFFERENTIATION; HORMONE	A reduction in IGF-I signaling has been found to increase lifespan in multiple organisms despite the fact that IGF-I is a trophic factor for many cell types and has been found to have protective effects against multiple forms of damage in acute settings. The increase in longevity seen in response to reduced IGF-I signaling suggests that there may be differences between the acute and chronic impact of IGF-I signaling. We have examined the possibility that long-term stimulation with IGF-I may have a negative impact at the cellular level using quiescent human fibroblasts. We find that fibroblast cells exposed to IGF-I for 14 days have reduced long-term viability as judged by colony forming assays, which is accompanied by an accumulation of senescent cells. In addition we observe an accumulation of cells with depolarized mitochondria and a reduction in autophagy in the long-term IGF-I treated cultures. An examination of mice with reduced IGF-I levels reveals evidence of enhanced autophagy and fibroblast cells derived from these mice have a larger mitochondrial mass relative to controls indicating that changes in mitochondrial turnover occurs in animals with reduced IGF-I. The results indicate that chronic IGF-I stimulation leads to mitochondrial dysfunction and reduced cell viability.	[Bitto, Alessandro; Lerner, Chad; Torres, Claudio; Lorenzini, Antonello; Sell, Christian] Drexel Univ, Dept Pathol, Coll Med, Philadelphia, PA 19104 USA; [Roell, Michaela; Malaguti, Marco; Lorenzini, Antonello] G Moruzzi Univ Bologna, Dept Biochem, Bologna, Italy; [Perez, Viviana; Hrelia, Silvana] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Ikeno, Yuji; McCarter, Roger] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, Res Serv, Audie Murphy VA Hosp STVHCS, San Antonio, TX 78229 USA; [Ikeno, Yuji; McCarter, Roger] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, Res Serv, Audie Murphy VA Hosp STVHCS, San Antonio, TX 78229 USA; [Matzko, Michelle Elizabeth] Penn State Univ, Dept Biobehav Hlth, State Coll, PA USA	Drexel University; University of Bologna; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Bitto, A (corresponding author), Drexel Univ, Dept Pathol, Coll Med, Philadelphia, PA 19104 USA.	christian.sell@drexelmed.edu	Hrelia, Silvana/P-2864-2015; Malaguti, Marco/K-5994-2015; Lorenzini, Antonello/G-4463-2012; LORENZINI, ANTONELLO/E-6582-2016	Hrelia, Silvana/0000-0001-7857-4512; Malaguti, Marco/0000-0003-0349-7772; LORENZINI, ANTONELLO/0000-0001-9615-9697	National Institutes of Health, Institute on Aging [AG022443]; NATIONAL INSTITUTE ON AGING [R01AG022443] Funding Source: NIH RePORTER	National Institutes of Health, Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant AG022443 from the National Institutes of Health, Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Bluher S, 2005, BEST PRACT RES CL EN, V19, P577, DOI 10.1016/j.beem.2005.07.011; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Cavallini G, 2001, EXP GERONTOL, V36, P497, DOI 10.1016/S0531-5565(00)00224-2; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Cristofalo VJ, 1980, J TISSUE CULTURE MET, V6, P117; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002; Dell'Orco R T, 1975, Adv Exp Med Biol, V53, P41; Farre JC, 2009, CURR OPIN CELL BIOL, V21, P522, DOI 10.1016/j.ceb.2009.04.015; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Galvin CD, 2003, MOL CELL ENDOCRINOL, V200, P19, DOI 10.1016/S0303-7207(02)00420-3; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Gu YP, 2004, FEBS LETT, V577, P357, DOI 10.1016/j.febslet.2004.10.040; Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003; Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; HASHIMOTO Y, 2009, GENES CELLS; Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lembo G, 1996, J CLIN INVEST, V98, P2648, DOI 10.1172/JCI119086; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Martin MJ, 2006, MOL CELL BIOL, V26, P1754, DOI 10.1128/MCB.26.5.1754-1769.2006; McKeehan W L, 1976, Dev Biol Stand, V37, P97; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; MIZUSHIMA N, CURR OPIN CELL BIOL, V22, P132; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; O'Kusky JR, 2000, J NEUROSCI, V20, P8435, DOI 10.1523/JNEUROSCI.20-22-08435.2000; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SELL C, 1995, CANCER RES, V55, P303; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; TOLLEFSEN SE, 1989, J BIOL CHEM, V264, P13810; TORRESALEMAN I, 1989, INT J DEV NEUROSCI, V7, P195, DOI 10.1016/0736-5748(89)90069-5; Trinei M, 2006, BBA-BIOENERGETICS, V1757, P624, DOI 10.1016/j.bbabio.2006.05.029; Valentinis B, 1999, ONCOGENE, V18, P1827, DOI 10.1038/sj.onc.1202471; Valentinis B, 1998, J CELL PHYSIOL, V176, P648, DOI 10.1002/(SICI)1097-4652(199809)176:3<648::AID-JCP22>3.3.CO;2-6; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851	46	44	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12592	10.1371/journal.pone.0012592	http://dx.doi.org/10.1371/journal.pone.0012592			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647PO	20830296	gold, Green Published, Green Submitted			2022-12-27	WOS:000281631300020
J	Loh, DH; Navarro, J; Hagopian, A; Wang, LM; Deboer, T; Colwell, CS				Loh, Dawn H.; Navarro, Juliana; Hagopian, Arkady; Wang, Louisa M.; Deboer, Tom; Colwell, Christopher S.			Rapid Changes in the Light/Dark Cycle Disrupt Memory of Conditioned Fear in Mice	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; LONG-TERM POTENTIATION; CLOCK GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; PASSIVE-AVOIDANCE; CIRCADIAN-CLOCK; JET-LAG; CORTICOSTERONE RHYTHM; PERIODIC INTERVALS; RETENTION DEFICITS	Background: Circadian rhythms govern many aspects of physiology and behavior including cognitive processes. Components of neural circuits involved in learning and memory, e. g., the amygdala and the hippocampus, exhibit circadian rhythms in gene expression and signaling pathways. The functional significance of these rhythms is still not understood. In the present study, we sought to determine the impact of transiently disrupting the circadian system by shifting the light/dark (LD) cycle. Such "jet lag" treatments alter daily rhythms of gene expression that underlie circadian oscillations as well as disrupt the synchrony between the multiple oscillators found within the body. Methodology/Principal Findings: We subjected adult male C57Bl/6 mice to a contextual fear conditioning protocol either before or after acute phase shifts of the LD cycle. As part of this study, we examined the impact of phase advances and phase delays, and the effects of different magnitudes of phase shifts. Under all conditions tested, we found that recall of fear conditioned behavior was specifically affected by the jet lag. We found that phase shifts potentiated the stress-evoked corticosterone response without altering baseline levels of this hormone. The jet lag treatment did not result in overall sleep deprivation, but altered the temporal distribution of sleep. Finally, we found that prior experience of jet lag helps to compensate for the reduced recall due to acute phase shifts. Conclusions/Significance: Acute changes to the LD cycle affect the recall of fear-conditioned behavior. This suggests that a synchronized circadian system may be broadly important for normal cognition and that the consolidation of memories may be particularly sensitive to disruptions of circadian timing.	[Loh, Dawn H.; Navarro, Juliana; Hagopian, Arkady; Wang, Louisa M.; Colwell, Christopher S.] Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA; [Deboer, Tom] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands	University of California System; University of California Los Angeles; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Loh, DH (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA.	ccolwell@mednet.ucla.edu	Colwell, Chris/AAM-6111-2020	Loh, Dawn/0000-0001-7876-5757; Colwell, Christopher/0000-0002-1059-184X	National Institutes of Health [HL84240]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL084240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Part of this work was supported by a National Institutes of Health grant to CSC [HL84240]. http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; Abrari K, 2008, NEUROBIOL LEARN MEM, V89, P178, DOI 10.1016/j.nlm.2007.07.005; Abrari K, 2009, NEUROBIOL LEARN MEM, V91, P260, DOI 10.1016/j.nlm.2008.10.008; Albus H, 2005, CURR BIOL, V15, P886, DOI 10.1016/j.cub.2005.03.051; Amir S, 2004, J NEUROSCI, V24, P781, DOI 10.1523/JNEUROSCI.4488-03.2004; Bozon B, 2003, PHILOS T R SOC B, V358, P805, DOI 10.1098/rstb.2002.1224; BUIJS RM, 1993, AM J PHYSIOL, V264, pR1186, DOI 10.1152/ajpregu.1993.264.6.R1186; Cai DJ, 2009, BEHAV NEUROSCI, V123, P713, DOI 10.1037/a0016415; Cain SW, 2004, BEHAV BRAIN RES, V150, P201, DOI 10.1016/j.bbr.2003.07.001; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; Chaudhury D, 2005, J BIOL RHYTHM, V20, P225, DOI 10.1177/0748730405276352; Chaudhury D, 2002, BEHAV BRAIN RES, V133, P95, DOI 10.1016/S0166-4328(01)00471-5; Chaudhury D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-63; Cho K, 2000, J NEUROSCI, V20, part. no.; Cho KW, 2001, NAT NEUROSCI, V4, P567, DOI 10.1038/88384; Cordero MI, 2003, HORM BEHAV, V44, P338, DOI 10.1016/S0018-506X(03)00160-0; Craig LA, 2008, BRAIN RES BULL, V76, P141, DOI 10.1016/j.brainresbull.2008.02.013; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; Davidson AJ, 2009, EUR J NEUROSCI, V29, P171, DOI 10.1111/j.1460-9568.2008.06534.x; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; Deboer T, 1996, J COMP PHYSIOL A, V179, P483; Deboer T, 2007, EUR J NEUROSCI, V26, P3518, DOI 10.1111/j.1460-9568.2007.05964.x; Devan BD, 2001, NEUROBIOL LEARN MEM, V75, P51, DOI 10.1006/nlme.1999.3957; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Neto SPD, 2008, PHYSIOL BEHAV, V94, P523, DOI 10.1016/j.physbeh.2008.03.013; Eastman CI, 2009, SLEEP MED CLIN, V4, P241, DOI 10.1016/j.jsmc.2009.02.006; Eckel-Mahan KL, 2008, NAT NEUROSCI, V11, P1074, DOI 10.1038/nn.2174; Evans JA, 2009, CURR BIOL, V19, pR156, DOI 10.1016/j.cub.2009.01.023; FEKETE M, 1985, PHYSIOL BEHAV, V34, P883, DOI 10.1016/0031-9384(85)90008-3; Fernandez RI, 2003, P NATL ACAD SCI USA, V100, P14415, DOI 10.1073/pnas.2336172100; FRANKEN P, 1995, AM J PHYSIOL-REG I, V269, pR691, DOI 10.1152/ajpregu.1995.269.3.R691; Fukuhara C, 2004, J NEUROSCI, V24, P1803, DOI 10.1523/JNEUROSCI.4988-03.2004; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; HALBERG F, 1959, AM J PHYSIOL, V197, P1083, DOI 10.1152/ajplegacy.1959.197.5.1083; Hampp G, 2008, CURR BIOL, V18, P678, DOI 10.1016/j.cub.2008.04.012; HARRIS KM, 1983, BRAIN RES, V261, P69, DOI 10.1016/0006-8993(83)91284-2; HOLLOWAY FA, 1973, BEHAV BIOL, V9, P1, DOI 10.1016/S0091-6773(73)80164-6; HOLLOWAY FA, 1973, SCIENCE, V180, P208, DOI 10.1126/science.180.4082.208; Hui GK, 2004, NEUROBIOL LEARN MEM, V81, P67, DOI 10.1016/j.nlm.2003.09.002; Jilg A, 2010, HIPPOCAMPUS, V20, P377, DOI 10.1002/hipo.20637; Kandel ER, 2001, BIOSCIENCE REP, V21, P565, DOI 10.1023/A:1014775008533; Korz V, 2007, LEARN MEMORY, V14, P160, DOI 10.1101/lm.459807; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Loh DH, 2008, NEUROENDOCRINOLOGY, V88, P246, DOI 10.1159/000140676; Lyons LC, 2006, J NEUROSCI, V26, P8662, DOI 10.1523/JNEUROSCI.2307-06.2006; Ma WP, 2007, NEUROSCI RES, V59, P224, DOI 10.1016/j.neures.2007.06.1474; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Mueller AD, 2008, AM J PHYSIOL-REG I, V294, pR1693, DOI 10.1152/ajpregu.00858.2007; Nagano M, 2003, J NEUROSCI, V23, P6141; Nakamura W, 2005, J NEUROSCI, V25, P5481, DOI 10.1523/JNEUROSCI.0889-05.2005; PITTENDRIGH C, 1958, P NATL ACAD SCI USA, V44, P965, DOI 10.1073/pnas.44.9.965; Raghavan AV, 1999, BRAIN RES, V833, P311, DOI 10.1016/S0006-8993(99)01523-1; Reddy AB, 2002, J NEUROSCI, V22, P7326; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Rodrigues SM, 2009, ANNU REV NEUROSCI, V32, P289, DOI 10.1146/annurev.neuro.051508.135620; Rollag MD, 2003, J BIOL RHYTHM, V18, P227, DOI [10.1177/0748730403018003005, 10.1177/0748730403253382]; Ruby NF, 2008, P NATL ACAD SCI USA, V105, P15593, DOI 10.1073/pnas.0808259105; Sage D, 2001, AM J PHYSIOL-ENDOC M, V280, pE260, DOI 10.1152/ajpendo.2001.280.2.E260; Sakai T, 2004, P NATL ACAD SCI USA, V101, P16058, DOI 10.1073/pnas.0401472101; Schwartz MD, 2005, J BIOL RHYTHM, V20, P526, DOI 10.1177/0748730405280924; SEI H, 1992, NEUROSCI LETT, V137, P161, DOI 10.1016/0304-3940(92)90394-M; STEPHAN FK, 1978, BEHAV BIOL, V22, P456, DOI 10.1016/S0091-6773(78)92565-8; SWANSON LW, 1983, NEUROENDOCRINOLOGY, V36, P165, DOI 10.1159/000123454; TAPP WN, 1981, SCIENCE, V211, P1056, DOI 10.1126/science.7193351; Valentinuzzi VS, 2004, J BIOL RHYTHM, V19, P312, DOI 10.1177/0748730404265688; Valentinuzzi VS, 2001, ANIM LEARN BEHAV, V29, P133, DOI 10.3758/BF03192822; Vansteensel MJ, 2003, CURR BIOL, V13, P1538, DOI 10.1016/S0960-9822(03)00560-8; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Wang LMC, 2009, ASN NEURO, V1, DOI 10.1042/AN20090020; Waterhouse J, 2007, LANCET, V369, P1117, DOI 10.1016/S0140-6736(07)60529-7; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Wright KP, 2006, J COGNITIVE NEUROSCI, V18, P508, DOI 10.1162/jocn.2006.18.4.508; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yan LL, 2004, EUR J NEUROSCI, V19, P1105, DOI 10.1111/j.1460-9568.2004.03189.x; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	78	73	77	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12546	10.1371/journal.pone.0012546	http://dx.doi.org/10.1371/journal.pone.0012546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	645RB	20824058	Green Published, gold, Green Submitted			2022-12-27	WOS:000281480900027
J	Bianchi-Frias, D; Vakar-Lopez, F; Coleman, IM; Plymate, SR; Reed, MJ; Nelson, PS				Bianchi-Frias, Daniella; Vakar-Lopez, Funda; Coleman, Ilsa M.; Plymate, Stephen R.; Reed, May J.; Nelson, Peter S.			The Effects of Aging on the Molecular and Cellular Composition of the Prostate Microenvironment	PLOS ONE			English	Article							SCANNING-ELECTRON-MICROSCOPY; GENE-EXPRESSION; VENTRAL PROSTATE; EXTRACELLULAR-MATRIX; CANCER INCIDENCE; MOUSE PROSTATE; INDUCED GROWTH; CROSS-LINKING; COLLAGEN; FIBROBLASTS	Background: Advancing age is associated with substantial increases in the incidence rates of common diseases affecting the prostate gland including benign prostatic hyperplasia (BPH) and prostate carcinoma. The prostate is comprised of a functional secretory epithelium, a basal epithelium, and a supporting stroma comprised of structural elements, and a spectrum of cell types that includes smooth muscle cells, fibroblasts, and inflammatory cells. As reciprocal interactions between epithelium and stromal constituents are essential for normal organogenesis and serve to maintain normal functions, discordance within the stroma could permit or promote disease processes. In this study we sought to identify aging-associated alterations in the mouse prostate microenvironment that could influence pathology. Methodology/Principal Findings: We quantitated transcript levels in microdissected glandular-adjacent stroma from young (age 4 months) and old (age 20-24 months) C57BL/6 mice, and identified a significant change in the expression of 1259 genes (p<0.05). These included increases in transcripts encoding proteins associated with inflammation (e. g., Ccl8, Ccl12), genotoxic/oxidative stress (e. g., Apod, Serpinb5) and other paracrine-acting effects (e. g., Cyr61). The expression of several collagen genes (e. g., Col1a1 and Col3a1) exhibited age-associated declines. By histology, immunofluorescence, and electron microscopy we determined that the collagen matrix is abundant and disorganized, smooth muscle cell orientation is disordered, and inflammatory infiltrates are significantly increased, and are comprised of macrophages, T cells and, to a lesser extent, B cells. Conclusion/Significance: These findings demonstrate that during normal aging the prostate stroma exhibits phenotypic and molecular characteristics plausibly contributing to the striking age associated pathologies affecting the prostate.	[Bianchi-Frias, Daniella; Coleman, Ilsa M.; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Bianchi-Frias, Daniella; Coleman, Ilsa M.; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Vakar-Lopez, Funda; Nelson, Peter S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Plymate, Stephen R.; Reed, May J.; Nelson, Peter S.] Univ Washington, Dept Med, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bianchi-Frias, D (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA.	pnelson@fhcrc.org			Department of Defense - Congressionally Directed Medical Research Programs [NCI P50 CA103728, R01 DK069690]; Tumor Microenvironment Network [U54 CA126540]; NATIONAL CANCER INSTITUTE [U54CA126540, P20CA103728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069690] Funding Source: NIH RePORTER	Department of Defense - Congressionally Directed Medical Research Programs(United States Department of Defense); Tumor Microenvironment Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a predoctoral fellowship from the Department of Defense - Congressionally Directed Medical Research Programs, a Seattle Cancer and Aging Program pilot award NCI P50 CA103728, R01 DK069690, and the Tumor Microenvironment Network U54 CA126540. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2003, CANCER RES, V63, P3886; Abbott DE, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r79; Antonioli E, 2004, J ANDROL, V25, P50; Antonioli E, 2007, J ANDROL, V28, P777, DOI 10.2164/jandrol.107.002873; BARCELLOSHOFF MH, 1989, DEVELOPMENT, V105, P223; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Baylin SB, 1998, ADV CANCER RES, V72, P141; Begley L, 2005, AGING CELL, V4, P291, DOI 10.1111/j.1474-9726.2005.00173.x; Berquin IM, 2005, J BIOL CHEM, V280, P36442, DOI 10.1074/jbc.M504945200; BERRY SJ, 1986, PROSTATE, V9, P363, DOI 10.1002/pros.2990090406; BERRY SJ, 1984, J UROLOGY, V132, P474, DOI 10.1016/S0022-5347(17)49698-4; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bianchi-Frias D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r117; Blando J, 2009, AM J PATHOL, V174, P1869, DOI 10.2353/ajpath.2009.080055; BORNSTEI.P, 1970, AM J MED, V49, P429, DOI 10.1016/S0002-9343(70)80036-5; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, AGING CELL, V6, P261, DOI 10.1111/j.1474-9726.2007.00292.x; Campos SGP, 2008, INT J EXP PATHOL, V89, P13, DOI 10.1111/j.1365-2613.2007.00550.x; Cloos PAC, 2000, BIOCHEM J, V345, P473, DOI 10.1042/0264-6021:3450473; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Davidovic M, 1999, MED HYPOTHESES, V53, P329, DOI 10.1054/mehy.1998.0767; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Dilley TK, 2003, EXP CELL RES, V290, P38, DOI 10.1016/S0014-4827(03)00308-2; Eckes B, 2006, J INVEST DERM SYMP P, V11, P66, DOI 10.1038/sj.jidsymp.5650003; Fata JE, 2004, BREAST CANCER RES, V6, P1, DOI 10.1186/bcr634; Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hsing AW, 2000, INT J CANCER, V85, P60, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;60::AID-IJC11&gt;3.0.CO;2-B; Ilio KY, 2000, PROSTATE, V43, P3, DOI 10.1002/(SICI)1097-0045(20000401)43:1<3::AID-PROS2>3.0.CO;2-J; Izumiya K, 1997, ARCH ANDROLOGY, V38, P231, DOI 10.3109/01485019708994882; Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930; Kassen A, 1996, PROSTATE, V28, P89, DOI 10.1002/(SICI)1097-0045(199602)28:2<89::AID-PROS3>3.0.CO;2-I; Kiefer JA, 2001, MATRIX BIOL, V20, P429, DOI 10.1016/S0945-053X(01)00159-7; Kim SK, 2007, J EXP BIOL, V210, P1607, DOI 10.1242/jeb.004887; Koreckij T, 2009, BRIT J CANCER, V101, P263, DOI 10.1038/sj.bjc.6605178; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Lau KM, 2003, LAB INVEST, V83, P743, DOI 10.1097/01.LAB.0000069519.06988.24; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P533, DOI 10.1196/annals.1333.061; Morrison C, 2000, UROL RES, V28, P304, DOI 10.1007/s002400000123; MUNTZING J, 1980, Prostate, V1, P71, DOI 10.1002/pros.2990010110; Nelson WB, 2004, J UROLOGY, V172, P6; Nickoloff BJ, 2004, CANCER RES, V64, P2956, DOI 10.1158/0008-5472.CAN-03-2388; ODONNELL MD, 1991, J ELECTRON MICR TECH, V19, P486, DOI 10.1002/jemt.1060190411; Palapattu GS, 2005, CARCINOGENESIS, V26, P1170, DOI 10.1093/carcin/bgh317; Patil CK, 2005, MECH AGEING DEV, V126, P1040, DOI 10.1016/j.mad.2005.08.001; Peyton SR, 2007, CELL BIOCHEM BIOPHYS, V47, P300, DOI 10.1007/s12013-007-0004-y; POLLARD M, 1987, PROSTATE, V11, P219, DOI 10.1002/pros.2990110303; POLLARD M, 1992, CANCER LETT, V67, P113, DOI 10.1016/0304-3835(92)90133-G; Pritchard CC, 2001, P NATL ACAD SCI USA, V98, P13266, DOI 10.1073/pnas.221465998; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Ratnacaram CK, 2008, P NATL ACAD SCI USA, V105, P2521, DOI 10.1073/pnas.0712021105; Reyes I, 2005, PROSTATE, V63, P169, DOI 10.1002/pros.20164; Risques RA, 2008, GASTROENTEROLOGY, V135, P410, DOI 10.1053/j.gastro.2008.04.008; Ruangpanit N, 2001, MATRIX BIOL, V20, P193, DOI 10.1016/S0945-053X(01)00135-4; Rullis I, 1975, Urology, V6, P295, DOI 10.1016/0090-4295(75)90749-9; SAKR WA, 1994, IN VIVO, V8, P439; Salm SN, 2002, PROSTATE, V51, P175, DOI 10.1002/pros.10075; Salminen A, 2008, AGEING RES REV, V7, P83, DOI 10.1016/j.arr.2007.09.002; SHAIN SA, 1978, J CLIN INVEST, V61, P654, DOI 10.1172/JCI108977; SHAIN SA, 1977, ONCOLOGY, V34, P114, DOI 10.1159/000225203; SHAPIRO E, 1992, PROSTATE, V20, P259, DOI 10.1002/pros.2990200402; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki H, 1996, ARCH ANDROLOGY, V36, P205, DOI 10.3109/01485019608987097; Varani J, 2006, AM J PATHOL, V168, P1861, DOI 10.2353/ajpath.2006.051302; Vercelli M, 2000, CRIT REV ONCOL HEMAT, V35, P133, DOI 10.1016/S1040-8428(99)00067-0; Vilamaior PSL, 2000, PROSTATE, V45, P253; WARD JM, 1980, LAB INVEST, V43, P517; Zhan M, 2007, GENOME RES, V17, P1236, DOI 10.1101/gr.6216607	74	82	85	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2010	5	9							e12501	10.1371/journal.pone.0012501	http://dx.doi.org/10.1371/journal.pone.0012501			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645KT	20824135	Green Submitted, Green Published, gold			2022-12-27	WOS:000281456100013
J	Piechota, M; Korostynski, M; Przewlocki, R				Piechota, Marcin; Korostynski, Michal; Przewlocki, Ryszard			Identification of cis-Regulatory Elements in the Mammalian Genome: The cREMaG Database	PLOS ONE			English	Article							FACTOR-BINDING SITES; OVER-REPRESENTATION; PROMOTER PROPERTIES; SEQUENCE-ANALYSIS; 2008 UPDATE; TRANSCRIPTION; GENES; EXPRESSION; MOUSE; CONSERVATION	Background: A growing number of gene expression-profiling datasets provides a reliable source of information about gene co-expression. In silico analyses of the properties shared among the promoters of co-expressed genes facilitates the identification of transcription factors (TFs) involved in the co-regulation of those genes. Our previous experience with microarray data led to the development of a database suitable for the examination of regulatory motifs in the promoters of co-expressed genes. Methodology: We introduce the cREMaG (cis-Regulatory Elements in the Mammalian Genome) system designed for in silico studies of the promoter properties of co-regulated mammalian genes. The cREMaG system offers an analysis of data obtained from human, mouse, rat, bovine and canine gene expression-profiling studies. More than eight analysis parameters can be utilized in user-defined combinations. The selection of alternative transcription start sites and information about CpG islands are also available. Conclusions: Using the cREMaG system, we successfully identified TFs mediating transcriptional responses in reference gene sets. The cREMaG system facilitates in silico studies of mammalian transcriptional gene regulation. The resource is freely available at http://www.cremag.org.	[Piechota, Marcin; Korostynski, Michal; Przewlocki, Ryszard] Polish Acad Sci, Inst Pharmacol, Dept Mol Neuropharmacol, Krakow, Poland	Polish Academy of Sciences	Piechota, M (corresponding author), Polish Acad Sci, Inst Pharmacol, Dept Mol Neuropharmacol, Krakow, Poland.	marpiech@if-pan.krakow.pl	Piechota, Marcin/G-9464-2011; Korostynski, Michal/AAS-2626-2021	Korostynski, Michal/0000-0002-4273-7401; Piechota, Marcin/0000-0003-2468-151X	European Union [LSHM-CT-2004-005166, PBZ-MNiI-2/1/2005, NN405 274137]	European Union(European Commission)	This work was supported by European Union grants LSHM-CT-2004-005166, PBZ-MNiI-2/1/2005 and NN405 274137. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2005, NUCLEIC ACIDS RES, V33, pW393, DOI 10.1093/nar/gki354; Bajic VB, 2006, PLOS GENET, V2, P614, DOI 10.1371/journal.pgen.0020054; Berezikov E, 2005, NUCLEIC ACIDS RES, V33, pW447, DOI 10.1093/nar/gki378; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chang LW, 2007, NUCLEIC ACIDS RES, V35, pW238, DOI 10.1093/nar/gkm308; Chauvin TR, 2004, BIOL REPROD, V71, P560, DOI 10.1095/biolreprod.103.026302; Chiba H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-152; de Bartolomeis Andrea, 2003, Psychopharmacol Bull, V37, P51; Defrance M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-396; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Hackenberg M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-7; Hannenhalli S, 2008, BIOINFORMATICS, V24, P1325, DOI 10.1093/bioinformatics/btn198; Hestand MS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-495; Hinata K, 2003, ONCOGENE, V22, P1955, DOI 10.1038/sj.onc.1206198; Jura J, 2008, BBA-GENE REGUL MECH, V1779, P383, DOI 10.1016/j.bbagrm.2008.04.006; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kawaji H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r40; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Korostynski M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r128; Korostynski M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-146; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lemberger T, 2008, FASEB J, V22, P2872, DOI 10.1096/fj.08-107888; Lenhard B, 2002, BIOINFORMATICS, V18, P1135, DOI 10.1093/bioinformatics/18.8.1135; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; Parkitna JR, 2010, FASEB J, V24, P2427, DOI 10.1096/fj.09-151423; Pheasant M, 2007, GENOME RES, V17, P1245, DOI 10.1101/gr.6406307; Piechota M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r48; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Sauer T, 2006, BIOINFORMATICS, V22, P430, DOI 10.1093/bioinformatics/bti819; Schmid CD, 2006, NUCLEIC ACIDS RES, V34, pD82, DOI 10.1093/nar/gkj146; Sharov AA, 2006, DNA RES, V13, P123, DOI 10.1093/dnares/dsl005; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2997, DOI 10.1093/nar/10.9.2997; Sui SJH, 2007, NUCLEIC ACIDS RES, V35, pW245, DOI 10.1093/nar/gkm427; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Xuan ZY, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r72; Yeung KY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r48; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zhang GC, 2007, MOL PHARMACOL, V71, P1148, DOI 10.1124/mol.106.028399	44	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2010	5	8							e12465	10.1371/journal.pone.0012465	http://dx.doi.org/10.1371/journal.pone.0012465			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644TX	20824209	Green Published, gold, Green Submitted			2022-12-27	WOS:000281405300010
J	Wallach, I; Jaitly, N; Lilien, R				Wallach, Izhar; Jaitly, Navdeep; Lilien, Ryan			A Structure-Based Approach for Mapping Adverse Drug Reactions to the Perturbation of Underlying Biological Pathways	PLOS ONE			English	Article							GENE-EXPRESSION; PARKINSONS-DISEASE; HEPARAN-SULFATE; INGUINAL-HERNIA; CANCER RISK; PROTEIN; GLYCOSAMINOGLYCANS; PHARMACOLOGY; METABOLISM; MECHANISMS	Adverse drug reactions (ADR), also known as side-effects, are complex undesired physiologic phenomena observed secondary to the administration of pharmaceuticals. Several phenomena underlie the emergence of each ADR; however, a dominant factor is the drug's ability to modulate one or more biological pathways. Understanding the biological processes behind the occurrence of ADRs would lead to the development of safer and more effective drugs. At present, no method exists to discover these ADR-pathway associations. In this paper we introduce a computational framework for identifying a subset of these associations based on the assumption that drugs capable of modulating the same pathway may induce similar ADRs. Our model exploits multiple information resources. First, we utilize a publicly available dataset pairing drugs with their observed ADRs. Second, we identify putative protein targets for each drug using the protein structure database and in-silico virtual docking. Third, we label each protein target with its known involvement in one or more biological pathways. Finally, the relationships among these information sources are mined using multiple stages of logistic-regression while controlling for over-fitting and multiple-hypothesis testing. As proof-of-concept, we examined a dataset of 506 ADRs, 730 drugs, and 830 human protein targets. Our method yielded 185 ADR-pathway associations of which 45 were selected to undergo a manual literature review. We found 32 associations to be supported by the scientific literature.	[Wallach, Izhar; Jaitly, Navdeep; Lilien, Ryan] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Lilien, Ryan] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada; [Wallach, Izhar; Lilien, Ryan] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto	Wallach, I (corresponding author), Univ Toronto, Dept Comp Sci, Toronto, ON, Canada.	izharw@cs.toronto.edu; lilien@cs.toronto.edu			Bill and Melinda Gates Foundation; Natural Sciences and Engineering Research Council of Canada	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work is supported by grants to R. H. L. from the Bill and Melinda Gates Foundation (Grand Challenges Explorations) and the Natural Sciences and Engineering Research Council of Canada (Discovery). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SSSJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-63; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; An Jianghong, 2004, Genome Inform, V15, P31; Aoki K, 2004, J BIOL CHEM, V279, P39798, DOI 10.1074/jbc.M402677200; Banks PA, 2006, AM J GASTROENTEROL, V101, P2379, DOI 10.1111/j.1572-0241.2006.00856.x; Basaria S, 2000, DIABETES CARE, V23, P564, DOI 10.2337/diacare.23.4.564; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bau DT, 2006, CANCER LETT, V240, P1, DOI 10.1016/j.canlet.2005.08.003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Das S, 2009, J BIOL CHEM, V284, P22888, DOI 10.1074/jbc.M109.021949; DiGiovanni CW, 2007, J AM ACAD ORTHOP SUR, V15, P208, DOI 10.5435/00124635-200704000-00004; Durrant JD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000648; Ericson E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000151; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Finnen RL, 2006, J VIROL, V80, P10325, DOI 10.1128/JVI.00939-06; FLINT MH, 1982, CONNECT TISSUE RES, V9, P173, DOI 10.3109/03008208209160258; Fliri AF, 2005, NAT CHEM BIOL, V1, P389, DOI 10.1038/nchembio747; Fliri AF, 2007, CHEMMEDCHEM, V2, P1774, DOI 10.1002/cmdc.200700153; FRIEDLAND IM, 1962, J BIOL CHEM, V237, P3829; Fu YP, 2003, CANCER RES, V63, P2440; Guha R, 2006, J CHEM INF MODEL, V46, P991, DOI 10.1021/ci050400b; Gurujeyalakshmi G, 1996, J PHARMACOL EXP THER, V277, P1152; Huang BD, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-19; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; IMURA H, 2000, NEW ENGL J MED, V342, P1533; International Union of Biochemistry and Molecular Biology. Nomenclature Committee. Webb EC, 1992, ENZ NOM 1992 REC NOM; Irwin JJ, 2009, J MED CHEM, V52, P5712, DOI 10.1021/jm9006966; Isaia GC, 1999, ACTA DIABETOL, V36, P35, DOI 10.1007/s005920050142; James M C, 2000, Prog Cell Cycle Res, V4, P71; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Joyce JG, 1999, J BIOL CHEM, V274, P5810, DOI 10.1074/jbc.274.9.5810; KANEHISA M, 2009, NUCLEIC ACIDS RES; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; KEISER MJ, 2009, NATURE; Kim SJ, 2007, IEEE J-STSP, V1, P606, DOI 10.1109/JSTSP.2007.910971; Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Kuschel B, 2002, HUM MOL GENET, V11, P1399, DOI 10.1093/hmg/11.12.1399; Levenshtein V. I., 1966, BINARY CODES CAPABLE; Liebler DC, 2005, NAT REV DRUG DISCOV, V4, P410, DOI 10.1038/nrd1720; Liu HX, 2009, SCAND J GASTROENTERO, V44, P626, DOI 10.1080/00365520902745047; Menozzi FD, 2002, MOL MICROBIOL, V43, P1379, DOI 10.1046/j.1365-2958.2002.02841.x; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Sakai Y, 2009, INT J UROL, V16, P848, DOI 10.1111/j.1442-2042.2009.02370.x; Sambrook P, 2001, BEST PRACT RES CL RH, V15, P401, DOI 10.1053/berh.2001.0157; Scheiber J, 2009, J MED CHEM, V52, P3103, DOI 10.1021/jm801546k; Srinivasan P, 2004, J AM SOC INF SCI TEC, V55, P396, DOI 10.1002/asi.10389; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Thomas AA, 2009, J AM COLL SURGEONS, V209, P371, DOI 10.1016/j.jamcollsurg.2009.05.015; Wadstrom T, 1999, J MED MICROBIOL, V48, P223, DOI 10.1099/00222615-48-3-223; Warner TF, 2002, PATHOL RES PRACT, V198, P701, DOI 10.1078/0344-0338-00324; Whitebread S, 2005, DRUG DISCOV TODAY, V10, P1421, DOI 10.1016/S1359-6446(05)03632-9; *WHO COLL CTR DRUG, 2009, WHO COLL CTR DRUG ST; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wong F, 1997, J GASTROEN HEPATOL, V12, P437, DOI 10.1111/j.1440-1746.1997.tb00463.x; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Xie L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000387; Yang L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000441; Zsoldos Z, 2007, J MOL GRAPH MODEL, V26, P198, DOI 10.1016/j.jmgm.2006.06.002	67	45	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12063	10.1371/journal.pone.0012063	http://dx.doi.org/10.1371/journal.pone.0012063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808786	Green Published, Green Submitted, gold			2022-12-27	WOS:000281153500001
J	Pulimeno, P; Bauer, C; Stutz, J; Citi, S				Pulimeno, Pamela; Bauer, Christoph; Stutz, Jeffrey; Citi, Sandra			PLEKHA7 Is an Adherens Junction Protein with a Tissue Distribution and Subcellular Localization Distinct from ZO-1 and E-Cadherin	PLOS ONE			English	Article							CELL-CELL-ADHESION; MICROTUBULE ORGANIZATION; MONOCLONAL-ANTIBODIES; ZONULA OCCLUDENS; EPITHELIAL-CELLS; GENE-EXPRESSION; TIGHT JUNCTIONS; BETA-CATENIN; ACTIN; RAT	The pleckstrin-homology-domain-containing protein PLEKHA7 was recently identified as a protein linking the E-cadherinp-120 ctn complex to the microtubule cytoskeleton. Here we characterize the expression, tissue distribution and subcellular localization of PLEKHA7 by immunoblotting, immunofluorescence microscopy, immunoelectron microscopy, and northern blotting in mammalian tissues. Anti-PLEKHA7 antibodies label the junctional regions of cultured kidney epithelial cells by immunofluorescence microscopy, and major polypeptides of M-r similar to 135 kDa and similar to 145 kDa by immunoblotting of lysates of cells and tissues. Two PLEKHA7 transcripts (similar to 5.5 kb and similar to 6.5 kb) are detected in epithelial tissues. PLEKHA7 is detected at epithelial junctions in sections of kidney, liver, pancreas, intestine, retina, and cornea, and its tissue distribution and subcellular localization are distinct from ZO-1. For example, PLEKHA7 is not detected within kidney glomeruli. Similarly to E-cadherin, p120 ctn, beta-catenin and alpha-catenin, PLEKHA7 is concentrated in the apical junctional belt, but unlike these adherens junction markers, and similarly to afadin, PLEKHA7 is not localized along the lateral region of polarized epithelial cells. Immunoelectron microscopy definitively establishes that PLEKHA7 is localized at the adherens junctions in colonic epithelial cells, at a mean distance of 28 nm from the plasma membrane. In summary, we show that PLEKHA7 is a cytoplasmic component of the epithelial adherens junction belt, with a subcellular localization and tissue distribution that is distinct from that of ZO-1 and most AJ proteins, and we provide the first description of its distribution and localization in several tissues.	[Pulimeno, Pamela; Stutz, Jeffrey; Citi, Sandra] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Bauer, Christoph] Univ Geneva, Natl Ctr Competence Res Frontiers Genet, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Pulimeno, P (corresponding author), Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland.	sandra.citi@unige.ch	Citi, Sandra/E-4514-2014	Citi, Sandra/0000-0002-6537-4818	Swiss National Science Foundation [3100A0-116763/1]; Swiss Cancer League [OCS-01916-08-2006]; State of Geneva	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; State of Geneva	This research was supported by individual research grants to SC from the Swiss National Science Foundation (grant no. 3100A0-116763/1) and the Swiss Cancer League (OCS-01916-08-2006), and by the State of Geneva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Dejana E, 2009, CELL TISSUE RES, V335, P17, DOI 10.1007/s00441-008-0694-5; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Franke WW, 2009, CELL TISSUE RES, V338, P1, DOI 10.1007/s00441-009-0849-z; FRANKE WW, 1987, CIBA F SYMP, V125, P26; Guillemot L, 2004, J CELL SCI, V117, P5245, DOI 10.1242/jcs.01399; Guillemot L, 2008, BBA-BIOMEMBRANES, V1778, P601, DOI 10.1016/j.bbamem.2007.09.032; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HOWARTH AG, 1992, AM J PHYSIOL, V262, pC461, DOI 10.1152/ajpcell.1992.262.2.C461; Hunziker W, 2009, ANN NY ACAD SCI, V1165, P28, DOI 10.1111/j.1749-6632.2009.04033.x; ITOH M, 1991, J CELL BIOL, V115, P1449, DOI 10.1083/jcb.115.5.1449; Ivanov AI, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-12; Kilpatrick KE, 1997, HYBRIDOMA, V16, P381, DOI 10.1089/hyb.1997.16.381; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Mareel M, 1997, J CELL PHYSIOL, V173, P271, DOI 10.1002/(SICI)1097-4652(199711)173:2<271::AID-JCP34>3.0.CO;2-G; Markov AG, 2010, J COMP PHYSIOL B, V180, P591, DOI 10.1007/s00360-009-0440-7; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Moll R, 2009, CELL TISSUE RES, V335, P109, DOI 10.1007/s00441-008-0700-y; Musch A, 2004, TRAFFIC, V5, P1, DOI 10.1046/j.1600-0854.2003.00149.x; Omri S, 2010, CLIN OPHTHALMOL, V4, P183; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Rahner C, 2001, GASTROENTEROLOGY, V120, P411, DOI 10.1053/gast.2001.21736; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Saaf AM, 2007, MOL BIOL CELL, V18, P4245, DOI 10.1091/mbc.E07-04-0309; SCHNABEL E, 1990, J CELL BIOL, V111, P1255, DOI 10.1083/jcb.111.3.1255; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wu J, 1998, HYBRIDOMA, V17, P175, DOI 10.1089/hyb.1998.17.175; YAP AS, 1995, EXP CELL RES, V218, P540, DOI 10.1006/excr.1995.1189	41	62	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12207	10.1371/journal.pone.0012207	http://dx.doi.org/10.1371/journal.pone.0012207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808826	Green Published, Green Submitted, gold			2022-12-27	WOS:000281077000003
J	Villa, CE; Caccia, M; Sironi, L; D'Alfonso, L; Collini, M; Rivolta, I; Miserocchi, G; Gorletta, T; Zanoni, I; Granucci, F; Chirico, G				Villa, Carlo E.; Caccia, Michele; Sironi, Laura; D'Alfonso, Laura; Collini, Maddalena; Rivolta, Ilaria; Miserocchi, Giuseppe; Gorletta, Tatiana; Zanoni, Ivan; Granucci, Francesca; Chirico, Giuseppe			Accumulative Difference Image Protocol for Particle Tracking in Fluorescence Microscopy Tested in Mouse Lymphonodes	PLOS ONE			English	Article							IN-VIVO; DYNAMICS; SPECTROSCOPY; EXCITATION; CELLS	The basic research in cell biology and in medical sciences makes large use of imaging tools mainly based on confocal fluorescence and, more recently, on non-linear excitation microscopy. Substantially the aim is the recognition of selected targets in the image and their tracking in time. We have developed a particle tracking algorithm optimized for low signal/noise images with a minimum set of requirements on the target size and with no a priori knowledge of the type of motion. The image segmentation, based on a combination of size sensitive filters, does not rely on edge detection and is tailored for targets acquired at low resolution as in most of the in-vivo studies. The particle tracking is performed by building, from a stack of Accumulative Difference Images, a single 2D image in which the motion of the whole set of the particles is coded in time by a color level. This algorithm, tested here on solid-lipid nanoparticles diffusing within cells and on lymphocytes diffusing in lymphonodes, appears to be particularly useful for the cellular and the in-vivo microscopy image processing in which few a priori assumption on the type, the extent and the variability of particle motions, can be done.	[Villa, Carlo E.; Caccia, Michele; Sironi, Laura; D'Alfonso, Laura; Collini, Maddalena; Chirico, Giuseppe] Univ Milano Bicocca, Dipartimento Fis, Milan, Italy; [Rivolta, Ilaria; Miserocchi, Giuseppe] Univ Milano Bicocca, Dipartimento Med Sperimentale, Monza, Italy; [Gorletta, Tatiana; Zanoni, Ivan; Granucci, Francesca] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy	University of Milano-Bicocca; University of Milano-Bicocca; University of Milano-Bicocca	Villa, CE (corresponding author), Univ Milano Bicocca, Dipartimento Fis, Milan, Italy.	giuseppe.chirico@mib.infn.it	Caccia, Michele/AAW-2808-2021; Caccia, Michele/Q-5623-2018; Villa, Carlo Emanuele/AAT-6978-2020; GRANUCCI, Francesca/K-6150-2019; D'Alfonso, Laura/J-4193-2012; Sironi, Laura/AAA-5384-2022	Caccia, Michele/0000-0002-2968-5635; D'Alfonso, Laura/0000-0002-7378-4462; CHIRICO, Giuseppe/0000-0001-6578-6460; Villa, Carlo Emanuele/0000-0002-1208-3160; Zanoni, Ivan/0000-0002-3423-7474; SIRONI, LAURA/0000-0002-6638-7709; granucci, francesca/0000-0002-7046-4914	EU [201842]; European Commission	EU(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	We acknowledge the EU contract ENCITE (n. 201842) funding to G.C and F.G. ENCITE is co-funded by the European Commission under the 7th Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Shalom Y., 2004, ESTIMATION APPL TRAC; Caccia M, 2008, EUR BIOPHYS J BIOPHY, V37, P979, DOI 10.1007/s00249-008-0323-y; Cavanagh LL, 2008, IMMUNOL CELL BIOL, V86, P428, DOI 10.1038/icb.2008.25; Celli S, 2008, IMMUNOL REV, V221, P182, DOI 10.1111/j.1600-065X.2008.00588.x; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Cheezum MK, 2001, BIOPHYS J, V81, P2378, DOI 10.1016/S0006-3495(01)75884-5; Degerman J, 2009, J MICROSC-OXFORD, V233, P178, DOI 10.1111/j.1365-2818.2008.03108.x; DIASPRO A, 2005, Q REV BIOPHYS, V97, P166; DOI M, 1999, THEORY POLYM DYNAMIC, pCH1; Gonzalez R. C., 2002, DIGITAL IMAGE PROCES; Hand AJ, 2009, J MICROSC-OXFORD, V234, P62, DOI 10.1111/j.1365-2818.2009.03144.x; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; *IMPR, VOL; Kalaidzidis Y, 2009, J MATH BIOL, V58, P57, DOI 10.1007/s00285-008-0180-4; Khandoga AG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004693; Li D, 2009, OPT LETT, V34, P202, DOI 10.1364/OL.34.000202; Moerner WE, 2003, REV SCI INSTRUM, V74, P3597, DOI 10.1063/1.1589587; PAL NR, 1993, PATTERN RECOGN, V26, P1277, DOI 10.1016/0031-3203(93)90135-J; Parikesit GOF, 2009, BIOMICROFLUIDICS, V3, DOI 10.1063/1.3270523; Rabut G, 2004, J MICROSC-OXFORD, V216, P131, DOI 10.1111/j.0022-2720.2004.01404.x; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Verestoy J., 1999, Machine Graphics & Vision, V8, P553; Wang F, 2006, NANOTECHNOLOGY, V17, pR1, DOI 10.1088/0957-4484/17/1/R01	24	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12216	10.1371/journal.pone.0012216	http://dx.doi.org/10.1371/journal.pone.0012216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808918	Green Submitted, gold, Green Published			2022-12-27	WOS:000280968100017
J	Gorringe, KL; George, J; Anglesio, MS; Ramakrishna, M; Etemadmoghadam, D; Cowin, P; Sridhar, A; Williams, LH; Boyle, SE; Yanaihara, N; Okamoto, A; Urashima, M; Smyth, GK; Campbell, IG; Bowtell, DDL				Gorringe, Kylie L.; George, Joshy; Anglesio, Michael S.; Ramakrishna, Manasa; Etemadmoghadam, Dariush; Cowin, Prue; Sridhar, Anita; Williams, Louise H.; Boyle, Samantha E.; Yanaihara, Nozomu; Okamoto, Aikou; Urashima, Mitsuyoshi; Smyth, Gordon K.; Campbell, Ian G.; Bowtell, David D. L.		Australian Ovarian Canc Study	Copy Number Analysis Identifies Novel Interactions Between Genomic Loci in Ovarian Cancer	PLOS ONE			English	Article							CIRCULAR BINARY SEGMENTATION; HIGH-RESOLUTION ANALYSIS; BREAST-CANCER; EXPRESSION ANALYSIS; COLORECTAL CANCERS; SEROUS CARCINOMAS; SPORADIC BREAST; GENE; HYBRIDIZATION; AMPLIFICATIONS	Ovarian cancer is a heterogeneous disease displaying complex genomic alterations, and consequently, it has been difficult to determine the most relevant copy number alterations with the scale of studies to date. We obtained genome-wide copy number alteration (CNA) data from four different SNP array platforms, with a final data set of 398 ovarian tumours, mostly of the serous histological subtype. Frequent CNA aberrations targeted many thousands of genes. However, high-level amplicons and homozygous deletions enabled filtering of this list to the most relevant. The large data set enabled refinement of minimal regions and identification of rare amplicons such as at 1p34 and 20q11. We performed a novel co-occurrence analysis to assess cooperation and exclusivity of CNAs and analysed their relationship to patient outcome. Positive associations were identified between gains on 19 and 20q, gain of 20q and loss of X, and between several regions of loss, particularly 17q. We found weak correlations of CNA at genomic loci such as 19q12 with clinical outcome. We also assessed genomic instability measures and found a correlation of the number of higher amplitude gains with poorer overall survival. By assembling the largest collection of ovarian copy number data to date, we have been able to identify the most frequent aberrations and their interactions.	[Gorringe, Kylie L.; Ramakrishna, Manasa; Sridhar, Anita; Boyle, Samantha E.; Campbell, Ian G.] Peter MacCallum Canc Ctr, Victorian Breast Canc Res Consortium, Canc Genet Lab, Melbourne, Australia; [Gorringe, Kylie L.; Ramakrishna, Manasa; Campbell, Ian G.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [George, Joshy; Anglesio, Michael S.; Etemadmoghadam, Dariush; Cowin, Prue; Bowtell, David D. L.] Peter MacCallum Canc Ctr, Canc Genet & Genom Lab, Melbourne, Australia; [George, Joshy] Univ Melbourne, Dept Biochem, Parkville, Vic 3052, Australia; [Williams, Louise H.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Yanaihara, Nozomu; Okamoto, Aikou; Urashima, Mitsuyoshi] Jikei Univ, Sch Med, Tokyo, Japan; [Smyth, Gordon K.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia	Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Jikei University; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Gorringe, KL (corresponding author), Peter MacCallum Canc Ctr, Victorian Breast Canc Res Consortium, Canc Genet Lab, Melbourne, Australia.	ian.campbell@petermac.org; david.bowtell@petermac.org	Bowtell, David/H-1007-2016; George, Joshy/K-4841-2019; Smyth, Gordon/B-5276-2008; Gorringe, Kylie L/H-3264-2019; campbell, Ian G/F-6006-2011	Bowtell, David/0000-0001-9089-7525; Smyth, Gordon/0000-0001-9221-2892; Gorringe, Kylie L/0000-0001-5681-2022; George, Joshy/0000-0001-8510-8229; Anglesio, Michael/0000-0003-1639-5003; Campbell, Ian/0000-0002-7773-4155	National Health and Medical Research Council of Australia; Victorian Breast Cancer Research Consortium (VBCRC), Australia; Department of Defense (DOD), United States of America; Victorian Life Sciences Computation Initiative (VLSCI); United States Army Medical Research and Materiel Command [DAMD17- 01- 1- 0729]; Cancer Council Victoria; Queensland Cancer Fund; Cancer Council New South Wales; Cancer Council South Australia; Cancer Foundation of Western Australia; Cancer Council Tasmania; National Health and Medical Research Council of Australia (NHMRC)	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Breast Cancer Research Consortium (VBCRC), Australia; Department of Defense (DOD), United States of America(United States Department of Defense); Victorian Life Sciences Computation Initiative (VLSCI); United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Queensland Cancer Fund; Cancer Council New South Wales(Cancer Council New South Wales); Cancer Council South Australia(Cancer Council South Australia); Cancer Foundation of Western Australia(Cancer Council Western Australia); Cancer Council Tasmania(Cancer Council Tasmania); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia; the Victorian Breast Cancer Research Consortium (VBCRC), Australia; and the Department of Defense (DOD), United States of America. JG is supported by an Australian Postgraduate Award. MR is supported by a Cancer Council of Victoria Postgraduate Scholarship. This research was also supported by a Victorian Life Sciences Computation Initiative (VLSCI) grant on its Peak Computing Facility at the University of Melbourne and at Victorian Partnership for Advanced Computing (VPAC). Australian Ovarian Cancer Study (AOCS) was supported by the United States Army Medical Research and Materiel Command under DAMD17- 01- 1- 0729, The Cancer Council Victoria, Queensland Cancer Fund, The Cancer Council New South Wales, The Cancer Council South Australia, The Cancer Foundation of Western Australia, The Cancer Council Tasmania, and the National Health and Medical Research Council of Australia (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudis M, 2001, BIOINFORMATICS, V17, P1228, DOI 10.1093/bioinformatics/17.12.1228; Bayani J, 2002, CANCER RES, V62, P3466; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Birrer MJ, 2007, J CLIN ONCOL, V25, P2281, DOI 10.1200/JCO.2006.09.0795; Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Brown LA, 2006, GYNECOL ONCOL, V100, P264, DOI 10.1016/j.ygyno.2005.08.026; CAMPBELL IG, 1992, CANCER RES, V52, P5416; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Courjal F, 1997, CANCER RES, V57, P4360; Dimova I, 2009, ONKOLOGIE, V32, P405, DOI 10.1159/000219368; Etemadmoghadam D, 2009, CLIN CANCER RES, V15, P1417, DOI 10.1158/1078-0432.CCR-08-1564; Fischer A, 2007, CIRC RES, V100, P856, DOI 10.1161/01.RES.0000260913.95642.3b; French CA, 2001, AM J PATHOL, V159, P1987, DOI 10.1016/S0002-9440(10)63049-0; Gilks CB, 2008, HUM PATHOL, V39, P1239, DOI 10.1016/j.humpath.2008.01.003; Gorello P, 2008, LEUKEMIA, V22, P216, DOI 10.1038/sj.leu.2404894; Gorringe KL, 2008, GENE CHROMOSOME CANC, V47, P933, DOI 10.1002/gcc.20595; Gorringe KL, 2007, CLIN CANCER RES, V13, P4731, DOI 10.1158/1078-0432.CCR-07-0502; Gorringe KL, 2009, GENE CHROMOSOME CANC, V48, P931, DOI 10.1002/gcc.20694; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haverty PM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-21; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; Henderson LJ, 2005, BRIT J CANCER, V92, P1553, DOI 10.1038/sj.bjc.6602452; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Hoglund M, 2003, CANCER RES, V63, P3378; Hughes-Davies L, 2003, CELL, V115, P523, DOI 10.1016/S0092-8674(03)00930-9; Kadota M, 2009, CANCER RES, V69, P7357, DOI 10.1158/0008-5472.CAN-09-0064; Kiechle M, 2001, CANCER, V91, P534, DOI 10.1002/1097-0142(20010201)91:3<534::AID-CNCR1031>3.3.CO;2-K; Lambros MBK, 2005, J PATHOL, V205, P29, DOI 10.1002/path.1681; Mani M, 2009, CANCER RES, V69, P7577, DOI 10.1158/0008-5472.CAN-09-0773; Nakayama K, 2007, INT J CANCER, V120, P2613, DOI 10.1002/ijc.22609; Nanjundan M, 2007, CANCER RES, V67, P3074, DOI 10.1158/0008-5472.CAN-06-2366; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; Naylor TL, 2005, BREAST CANCER RES, V7, pR1186, DOI 10.1186/bcr1356; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Partheen K, 2004, GENE CHROMOSOME CANC, V40, P342, DOI 10.1002/gcc.20053; Piriyapongsa J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000203; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Ramakrishna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009983; Sangha N, 2008, NEOPLASIA, V10, P1362, DOI 10.1593/neo.08784; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smyth GK, 2003, INST MATH S, V40, P115; Sparks AB, 1998, CANCER RES, V58, P1130; Stallings RL, 2006, CANCER RES, V66, P3673, DOI 10.1158/0008-5472.CAN-05-4154; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Watanabe T, 2002, JPN J CANCER RES, V93, P1114, DOI 10.1111/j.1349-7006.2002.tb01213.x; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zhao GQ, 1996, GENE DEV, V10, P1657, DOI 10.1101/gad.10.13.1657	54	67	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e11408	10.1371/journal.pone.0011408	http://dx.doi.org/10.1371/journal.pone.0011408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20844748	Green Published, Green Submitted, gold			2022-12-27	WOS:000281687300001
J	Sheng, T; Gheytanchi, A; Aziz-Zadeh, L				Sheng, Tong; Gheytanchi, Anahita; Aziz-Zadeh, Lisa			Default Network Deactivations Are Correlated with Psychopathic Personality Traits	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; CORTICAL MIDLINE STRUCTURES; RESTING BRAIN; INDIVIDUAL-DIFFERENCES; RETROSPLENIAL CORTEX; CONSTRUCT-VALIDITY; SOCIAL COGNITION; DECISION-MAKING; SELF; MODE	Background: The posteromedial cortex (PMC) and medial prefrontal cortex (mPFC) are part of a network of brain regions that has been found to exhibit decreased activity during goal-oriented tasks. This network is thought to support a baseline of brain activity, and is commonly referred to as the "default network''. Although recent reports suggest that the PMC and mPFC are associated with affective, social, and self-referential processes, the relationship between these default network components and personality traits, especially those pertaining to social context, is poorly understood. Methodology/Principal Findings: In the current investigation, we assessed the relationship between PMC and mPFC deactivations and psychopathic personality traits using fMRI and a self-report measure. We found that PMC deactivations predicted traits related to egocentricity and mPFC deactivations predicted traits related to decision-making. Conclusions/Significance: These results suggest that the PMC and mPFC are associated with processes involving self-relevancy and affective decision-making, consistent with previous reports. More generally, these findings suggest a link between default network activity and personality traits.	[Sheng, Tong; Aziz-Zadeh, Lisa] Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA; [Sheng, Tong] Univ So Calif, Grad Program Neurosci, Los Angeles, CA USA; [Aziz-Zadeh, Lisa] Univ So Calif, Div Occupat Sci & Occupat Therapy, Los Angeles, CA USA; [Gheytanchi, Anahita] Pacific Grad Sch Psychol, Palo Alto, CA USA	University of Southern California; University of Southern California; University of Southern California	Sheng, T (corresponding author), Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA.	tsheng@usc.edu	Sheng, Tong/C-6306-2019	Sheng, Tong/0000-0003-1067-7608	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R03HD057594]; James H. Zumberge Individual Award; USC Brain and Creativity Institute; USC Dornsife Cognitive Neuroimaging Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD057594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC009975] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); James H. Zumberge Individual Award; USC Brain and Creativity Institute; USC Dornsife Cognitive Neuroimaging Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by Award Number R03HD057594 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The content is solely the responsibility of the authors and does not represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health. This project was also generously funded by a James H. Zumberge Individual Award and the USC Brain and Creativity Institute, and the USC Dornsife Cognitive Neuroimaging Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Aziz-Zadeh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008759; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BENOIT R, 2009, NEUROIMAGE, V47, pS184; Blonigen DM, 2003, PERS INDIV DIFFER, V35, P179, DOI 10.1016/S0191-8869(02)00184-8; Brett M., 2002, 8 INT C FUNCT MAPP H; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Canli T, 2001, BEHAV NEUROSCI, V115, P33, DOI 10.1037//0735-7044.115.1.33; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; Cooper BG, 2001, J NEUROSCI, V21, P3986, DOI 10.1523/JNEUROSCI.21-11-03986.2001; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; D'Argembeau A, 2007, J COGNITIVE NEUROSCI, V19, P935, DOI 10.1162/jocn.2007.19.6.935; Damasio A, 1995, DESCARTES ERROR EMOT; Dolan MC, 2002, PSYCHIAT RES-NEUROIM, V116, P133, DOI 10.1016/S0925-4927(02)00085-9; DREWE E A, 1975, Cortex, V11, P8; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fellows LK, 2007, NEUROLOGY, V68, P991, DOI 10.1212/01.wnl.0000257835.46290.57; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; GHATAN PH, 1995, NEUROIMAGE, V2, P112, DOI 10.1006/nimg.1995.1014; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Harrison BJ, 2008, P NATL ACAD SCI USA, V105, P9781, DOI 10.1073/pnas.0711791105; Hart SD., 1992, ADV PSYCHOL ASSESS, P103, DOI 10.1007/978-1-4757-9101-3_4; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Heatherton TF, 2006, SOC COGN AFFECT NEUR, V1, P18, DOI 10.1093/scan/nsl001; Johnson MK, 2006, SOC COGN AFFECT NEUR, V1, P56, DOI 10.1093/scan/nsl004; Kim SH, 2008, NEUROREPORT, V19, P883, DOI 10.1097/WNR.0b013e328300080f; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Lilienfeld S.O., 2005, PROFESSIONAL MANUAL; Lilienfeld SO, 1996, J PERS ASSESS, V66, P488, DOI 10.1207/s15327752jpa6603_3; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Parvizi J, 2006, P NATL ACAD SCI USA, V103, P1563, DOI 10.1073/pnas.0507729103; Patrick CJ, 2006, PSYCHOL ASSESSMENT, V18, P204, DOI 10.1037/1040-3590.18.2.204; Paulhus DL, 2002, J RES PERS, V36, P556, DOI 10.1016/S0092-6566(02)00505-6; Pujol J, 2002, NEUROIMAGE, V15, P847, DOI 10.1006/nimg.2001.1004; Raichle ME, 2005, J COMP NEUROL, V493, P167, DOI 10.1002/cne.20752; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RAINE A, 1992, SCHIZOPHR RES, V7, P237, DOI 10.1016/0920-9964(92)90018-Z; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Schneider F, 2008, NEUROSCIENCE, V157, P120, DOI 10.1016/j.neuroscience.2008.08.014; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Sutin AR, 2009, CEREB CORTEX, V19, P2797, DOI 10.1093/cercor/bhp066; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Uzieblo K, 2007, PERS INDIV DIFFER, V43, P657, DOI 10.1016/j.paid.2007.01.008; van den Bos W, 2009, J NEUROSCI, V29, P7631, DOI 10.1523/JNEUROSCI.1821-09.2009; Wicker B, 2003, BRAIN RES REV, V43, P224, DOI 10.1016/j.brainresrev.2003.08.003; Wolbers T, 2005, J NEUROSCI, V25, P3333, DOI 10.1523/JNEUROSCI.4705-04.2005; Zald DH, 2002, P NATL ACAD SCI USA, V99, P2450, DOI 10.1073/pnas.042457199	60	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2010	5	9							e12611	10.1371/journal.pone.0012611	http://dx.doi.org/10.1371/journal.pone.0012611			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	647PO	20830290	Green Published, gold, Green Submitted			2022-12-27	WOS:000281631300032
J	Kovacs, IA; Palotai, R; Szalay, MS; Csermely, P				Kovacs, Istvan A.; Palotai, Robin; Szalay, Mate S.; Csermely, Peter			Community Landscapes: An Integrative Approach to Determine Overlapping Network Module Hierarchy, Identify Key Nodes and Predict Network Dynamics	PLOS ONE			English	Article							COMPLEX NETWORKS; RESOLUTION; PROTEINS; MODEL	Background: Network communities help the functional organization and evolution of complex networks. However, the development of a method, which is both fast and accurate, provides modular overlaps and partitions of a heterogeneous network, has proven to be rather difficult. Methodology/Principal Findings: Here we introduce the novel concept of ModuLand, an integrative method family determining overlapping network modules as hills of an influence function- based, centrality- type community landscape, and including several widely used modularization methods as special cases. As various adaptations of the method family, we developed several algorithms, which provide an efficient analysis of weighted and directed networks, and (1) determine pervasively overlapping modules with high resolution; (2) uncover a detailed hierarchical network structure allowing an efficient, zoom- in analysis of large networks; (3) allow the determination of key network nodes and (4) help to predict network dynamics. Conclusions/Significance: The concept opens a wide range of possibilities to develop new approaches and applications including network routing, classification, comparison and prediction.	[Kovacs, Istvan A.; Palotai, Robin; Szalay, Mate S.; Csermely, Peter] Semmelweis Univ, Dept Med Chem, Budapest, Hungary; [Kovacs, Istvan A.] Eotvos Lorand Univ, Dept Phys, Budapest, Hungary	Semmelweis University; Eotvos Lorand University	Kovacs, IA (corresponding author), Semmelweis Univ, Dept Med Chem, Budapest, Hungary.	csermely@eok.sote.hu	Csermely, Peter/J-2067-2017; Kovacs, Istvan/A-8447-2013	Csermely, Peter/0000-0001-9234-0659; Kovacs, Istvan/0000-0002-6890-6277	EU [FP6-518230]; Hungarian Science Foundation [OTKA K-69105]; Unilever Hungary to the Hungarian Student Research Foundation	EU(European Commission); Hungarian Science Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Unilever Hungary to the Hungarian Student Research Foundation(Unilever)	This research was supported by research grants from the EU (FP6-518230), Hungarian Science Foundation (OTKA K-69105) and by an unrestricted grant from Unilever Hungary to the Hungarian Student Research Foundation, which helped the research of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Arenas A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.114102; Axelsen JB, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036119; Baerveldt C, 2004, SOC NETWORKS, V26, P55, DOI 10.1016/j.socnet.2004.01.003; Bagrow JP, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046108; BERRY JW, 2009, TOLERATING COMMUNITY; Bertin N, 2007, PLOS BIOL, V5, P1206, DOI 10.1371/journal.pbio.0050153; Blatt M, 1996, PHYS REV LETT, V76, P3251, DOI 10.1103/PhysRevLett.76.3251; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Capocci A, 2005, PHYSICA A, V352, P669, DOI 10.1016/j.physa.2004.12.050; CLARK ML, 1992, J PSYCHOL, V126, P393, DOI 10.1080/00223980.1992.10543372; Csermely P, 2008, TRENDS BIOCHEM SCI, V33, P569, DOI 10.1016/j.tibs.2008.09.006; Eckmann JP, 2002, P NATL ACAD SCI USA, V99, P5825, DOI 10.1073/pnas.032093399; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; FIEDLER M, 1975, CZECH MATH J, V25, P607; FORTUNATO S, 2007, P SPIE, V6601; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gansner ER, 2000, SOFTWARE PRACT EXPER, V30, P1203, DOI 10.1002/1097-024X(200009)30:11<1203::AID-SPE338>3.0.CO;2-N; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Grendar M, 2006, ENTROPY-SWITZ, V8, P169, DOI DOI 10.3390/E8030169; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hinneburg A., 1998, Proceedings Fourth International Conference on Knowledge Discovery and Data Mining, P58; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Komurov K, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100149; KOVACS I, 2007, Patent No. 2007093960; KRIOUKOV D, 2008, ACM SIGMETRICS PERFO, V37, P15; Kumpula JM, 2007, EUR PHYS J B, V56, P41, DOI 10.1140/epjb/e2007-00088-4; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Moody J, 2001, AM J SOCIOL, V107, P679, DOI 10.1086/338954; NELSON DL, 1980, BEHAV RES METH INSTR, V12, P16, DOI 10.3758/BF03208320; Nepusz T, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016107; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Ramani AK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-R40; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; TIBELY G, 2010, COMMUNITIES MESOSCOP; Vragovic I, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036122; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752	48	137	140	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12528	10.1371/journal.pone.0012528	http://dx.doi.org/10.1371/journal.pone.0012528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	645RB	20824084	Green Submitted, Green Published, gold			2022-12-27	WOS:000281480900013
J	Serb, JM; Orr, MC; Greenlee, MHW				Serb, Jeanne M.; Orr, Megan C.; Greenlee, M. Heather West			Using Evolutionary Conserved Modules in Gene Networks as a Strategy to Leverage High Throughput Gene Expression Queries	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; RETINAL GANGLION-CELL; MOUSE RETINA; BILIVERDIN REDUCTASE; FATE DETERMINATION; AMACRINE CELLS; GROWTH CONE; LOCALIZATION; DROSOPHILA; CALPAIN	Background: Large-scale gene expression studies have not yielded the expected insight into genetic networks that control complex processes. These anticipated discoveries have been limited not by technology, but by a lack of effective strategies to investigate the data in a manageable and meaningful way. Previous work suggests that using a pre-determined seednetwork of gene relationships to query large-scale expression datasets is an effective way to generate candidate genes for further study and network expansion or enrichment. Based on the evolutionary conservation of gene relationships, we test the hypothesis that a seed network derived from studies of retinal cell determination in the fly, Drosophila melanogaster, will be an effective way to identify novel candidate genes for their role in mouse retinal development. Methodology/Principal Findings: Our results demonstrate that a number of gene relationships regulating retinal cell differentiation in the fly are identifiable as pairwise correlations between genes from developing mouse retina. In addition, we demonstrate that our extracted seed-network of correlated mouse genes is an effective tool for querying datasets and provides a context to generate hypotheses. Our query identified 46 genes correlated with our extracted seed-network members. Approximately 54% of these candidates had been previously linked to the developing brain and 33% had been previously linked to the developing retina. Five of six candidate genes investigated further were validated by experiments examining spatial and temporal protein expression in the developing retina. Conclusions/Significance: We present an effective strategy for pursuing a systems biology approach that utilizes an evolutionary comparative framework between two model organisms, fly and mouse. Future implementation of this strategy will be useful to determine the extent of network conservation, not just gene conservation, between species and will facilitate the use of prior biological knowledge to develop rational systems-based hypotheses.	[Serb, Jeanne M.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Orr, Megan C.] Iowa State Univ, Dept Stat, Ames, IA USA; [Greenlee, M. Heather West] Iowa State Univ, Dept Biomed Sci, Bioinformat & Computat Biol Program, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University	Serb, JM (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	serb@iastate.edu		Serb, Jeanne/0000-0003-2112-470X	Center for Integrative Animal Genomics (CIAG) at Iowa State University	Center for Integrative Animal Genomics (CIAG) at Iowa State University	This work was supported by the Center for Integrative Animal Genomics (CIAG) at Iowa State University (http://www.ciag.iastate.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD H, 1988, ARCH BIOCHEM BIOPHYS, V266, P416, DOI 10.1016/0003-9861(88)90273-1; Ahuja P, 2005, NEUROSCIENCE, V131, P935, DOI 10.1016/j.neuroscience.2004.11.012; Allen GW, 2001, J NEUROSCI RES, V66, P396, DOI 10.1002/jnr.1232; Amrein L, 2005, CELL TISSUE RES, V322, P365, DOI 10.1007/s00441-005-0036-9; [Anonymous], HOMOLOGENE; [Anonymous], PUBMED; Asano T, 2001, J NEUROCHEM, V79, P1129, DOI 10.1046/j.1471-4159.2001.00662.x; Azuma M, 2008, SURV OPHTHALMOL, V53, P150, DOI 10.1016/j.survophthal.2007.12.006; Bell R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000414; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; BORDER BG, 1993, J NEUROCHEM, V61, P2104, DOI 10.1111/j.1471-4159.1993.tb07448.x; Brown NL, 1998, DEVELOPMENT, V125, P4821; Brown NL, 2001, DEVELOPMENT, V128, P2497; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; BUTTE A, 2003, ANAL GENE EXPRESSION; Carpintero P, 1999, MOL BRAIN RES, V70, P141, DOI 10.1016/S0169-328X(99)00115-1; Charrier E, 2006, GENES CELLS, V11, P1337, DOI 10.1111/j.1365-2443.2006.01024.x; Chen R, 1999, DEVELOPMENT, V126, P935; Chen YN, 2006, BIOCHEM BIOPH RES CO, V341, P1, DOI 10.1016/j.bbrc.2005.12.150; Corbetta S, 2009, FASEB J, V23, P1347, DOI 10.1096/fj.08-121574; Davis JA, 1996, J NEUROSCI, V16, P5082; de Brouwer APM, 2007, AM J HUM GENET, V81, P507, DOI 10.1086/520706; Donner AL, 2004, INT J DEV BIOL, V48, P743, DOI 10.1387/ijdb.041877ad; Dorrell MI, 2004, INVEST OPHTH VIS SCI, V45, P1009, DOI 10.1167/iovs.03-0806; Dyer MA, 2001, J COMP NEUROL, V429, P601; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; El-Khodor BF, 2001, DEV BRAIN RES, V129, P47, DOI 10.1016/S0165-3806(01)00181-X; EWING JF, 1995, BRAIN RES, V672, P29, DOI 10.1016/0006-8993(94)01290-X; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Fullerton MD, 2007, MOL CELL BIOL, V27, P3327, DOI 10.1128/MCB.01527-06; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Griffith OL, 2005, GENOMICS, V86, P476, DOI 10.1016/j.ygeno.2005.06.009; Gu C, 2006, NEURON, V52, P803, DOI 10.1016/j.neuron.2006.10.022; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hartemink Alexander J, 2002, Pac Symp Biocomput, P437; HECKER LA, 2008, BIOINFORMATICS BIOL, P91; Hou ST, 2006, J NEUROSCI, V26, P2241, DOI 10.1523/JNEUROSCI.4485-05.2006; Hwang IK, 2008, J NEUROSCI RES, V86, P1823, DOI 10.1002/jnr.21621; Ivanov D, 2008, J NEUROSCI METH, V174, P10, DOI 10.1016/j.jneumeth.2008.06.016; Jones Stephen E., 2000, Molecular Cell Biology Research Communications, V4, P20, DOI 10.1006/mcbr.2000.0250; Kanan Y, 2007, INVEST OPHTH VIS SCI, V48, P40, DOI 10.1167/iovs.06-0592; Kasai T, 2004, PROTEIN SCI, V13, P545, DOI 10.1110/ps.03401004; Kielbasa SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003210; Kim HJ, 2007, AM J HUM GENET, V81, P552, DOI 10.1086/519529; Koyabu Y, 2001, J BIOL CHEM, V276, P6889, DOI 10.1074/jbc.C000773200; Lai MZ, 2005, NAT NEUROSCI, V8, P435, DOI 10.1038/nn1418; LAND M. F., 2006, ANIMAL EYES; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee R, 2008, J NEUROSCI, V28, P5910, DOI 10.1523/JNEUROSCI.0632-08.2008; Lee SS, 2003, YONSEI MED J, V44, P1059, DOI 10.3349/ymj.2003.44.6.1059; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Lim YS, 2008, NEURON, V59, P746, DOI 10.1016/j.neuron.2008.07.032; Liu JW, 2006, BRAIN RES, V1098, P113, DOI 10.1016/j.brainres.2006.04.086; Liu JW, 2008, J NEUROCHEM, V106, P2015, DOI 10.1111/j.1471-4159.2008.05507.x; Liu YH, 2009, DEV CELL, V16, P280, DOI 10.1016/j.devcel.2009.01.006; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Lobo MK, 2008, J NEUROSCI RES, V86, P2134, DOI 10.1002/jnr.21666; Magwene PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r100; Manfroid I, 2004, DEVELOPMENT, V131, P1065, DOI 10.1242/dev.00977; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; McKee AE, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-14; Miller NLG, 2009, HUM MOL GENET, V18, P248, DOI 10.1093/hmg/ddn344; Mitchell DC, 2007, MOL VIS, V13, P1144; Monaghan MM, 2001, J NEUROSCI, V21, P5973, DOI 10.1523/JNEUROSCI.21-16-05973.2001; Munemasa Y, 2008, INVEST OPHTH VIS SCI, V49, P3535, DOI 10.1167/iovs.08-1716; Nagahama H, 2001, ANAT EMBRYOL, V203, P77, DOI 10.1007/s004290000146; Nakajima E, 2006, INVEST OPHTH VIS SCI, V47, P5469, DOI 10.1167/iovs.06-0567; Nakazawa T, 2000, BRAIN RES, V861, P399, DOI 10.1016/S0006-8993(00)02056-4; Niiya A, 1998, EXP EYE RES, V67, P699, DOI 10.1006/exer.1998.0562; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Panahian N, 1999, BRAIN RES, V850, P1, DOI 10.1016/S0006-8993(99)01726-6; Pappu KS, 2004, INT J DEV BIOL, V48, P913, DOI 10.1387/ijdb.041875kp; Quach TT, 2008, FASEB J, V22, P401, DOI 10.1096/fj.07-9012com; Quach TT, 2000, GENE, V242, P175, DOI 10.1016/S0378-1119(99)00528-4; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; RICHARD A. J., 2002, APPL MULTIVARIATE ST; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Sanchez-Camacho C, 2008, DEVELOPMENT, V135, P3531, DOI 10.1242/dev.023663; Seimiya M, 2000, DEVELOPMENT, V127, P1879; Sharma AK, 2007, CURR EYE RES, V32, P259, DOI 10.1080/02713680601161238; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Shichiri M, 2003, NAT MED, V9, P1166, DOI 10.1038/nm913; Shkumatava A, 2005, EMBO REP, V6, P563, DOI 10.1038/sj.embor.7400416; Sinclair A, 2002, NOVART FDN SYMP, V244, P102; Suh LH, 2004, J NEUROSCI, V24, P1976, DOI 10.1523/JNEUROSCI.1670-03.2004; Sweeney KJ, 2000, MECH DEVELOP, V92, P263, DOI 10.1016/S0925-4773(00)00242-2; Tang YP, 2006, BRAIN RES, V1126, P102, DOI 10.1016/j.brainres.2006.08.002; Thies E, 2003, J NEUROBIOL, V54, P358, DOI 10.1002/neu.10135; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Tsim TY, 2004, NEUROSCIENCE, V123, P951, DOI 10.1016/j.neuroscience.2003.10.024; van Heyningen V, 2002, HUM MOL GENET, V11, P1161, DOI 10.1093/hmg/11.10.1161; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Walls G., 1967, VERTEBRATE EYE ITS A; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wawersik S, 2000, HUM MOL GENET, V9, P917, DOI 10.1093/hmg/9.6.917; Wilson MJ, 2001, CELL MOTIL CYTOSKEL, V49, P229, DOI 10.1002/cm.1036; Xu PX, 1997, DEVELOPMENT, V124, P219; Yona G, 2006, BIOINFORMATICS, V22, P1616, DOI 10.1093/bioinformatics/btl127; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Zhang SSM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-48	105	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2010	5	9							e12525	10.1371/journal.pone.0012525	http://dx.doi.org/10.1371/journal.pone.0012525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645RB	20824082	Green Submitted, gold, Green Published			2022-12-27	WOS:000281480900011
J	Hamilton, MJ; Buchanan, B				Hamilton, Marcus J.; Buchanan, Briggs			Archaeological Support for the Three-Stage Expansion of Modern Humans across Northeastern Eurasia and into the Americas	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; RADIOCARBON-DATES; LATE PLEISTOCENE; COLONIZATION; AGE; CALIBRATION; SIBERIA; POPULATIONS; ENVIRONMENT; TIMESCALE	Background: Understanding the dynamics of the human range expansion across northeastern Eurasia during the late Pleistocene is central to establishing empirical temporal constraints on the colonization of the Americas [1]. Opinions vary widely on how and when the Americas were colonized, with advocates supporting either a pre-[2] or post-[1,3,4,5,6] last glacial maximum (LGM) colonization, via either a land bridge across Beringia [3,4,5], a sea-faring Pacific Rim coastal route [1,3], a trans-Arctic route [4], or a trans-Atlantic oceanic route [5]. Here we analyze a large sample of radiocarbon dates from the northeast Eurasian Upper Paleolithic to identify the origin of this expansion, and estimate the velocity of colonization wave as it moved across northern Eurasia and into the Americas. Methodology/Principal Findings: We use diffusion models [6,7] to quantify these dynamics. Our results show the expansion originated in the Altai region of southern Siberia similar to 46kBP, and from there expanded across northern Eurasia at an average velocity of 0.16 km per year. However, the movement of the colonizing wave was not continuous but underwent three distinct phases: 1) an initial expansion from 47-32k calBP; 2) a hiatus from similar to 32-16k calBP, and 3) a second expansion after the LGM similar to 16k calBP. These results provide archaeological support for the recently proposed three-stage model of the colonization of the Americas [8,9]. Our results falsify the hypothesis of a pre-LGM terrestrial colonization of the Americas and we discuss the importance of these empirical results in the light of alternative models. Conclusions/Significance: Our results demonstrate that the radiocarbon record of Upper Paleolithic northeastern Eurasia supports a post-LGM terrestrial colonization of the Americas falsifying the proposed pre-LGM terrestrial colonization of the Americas. We show that this expansion was not a simple process, but proceeded in three phases, consistent with genetic data, largely in response to the variable climatic conditions of late Pleistocene northeast Eurasia. Further, the constraints imposed by the spatiotemporal gradient in the empirical radiocarbon record across this entire region suggests that North America cannot have been colonized much before the existing Clovis radiocarbon record suggests.	[Hamilton, Marcus J.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Hamilton, Marcus J.] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Hamilton, Marcus J.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Buchanan, Briggs] Simon Fraser Univ, Dept Archaeol, Burnaby, BC V5A 1S6, Canada; [Buchanan, Briggs] Univ Missouri, Dept Anthropol, Columbia, MO 65211 USA	University of New Mexico; University of New Mexico; The Santa Fe Institute; Simon Fraser University; University of Missouri System; University of Missouri Columbia	Hamilton, MJ (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	marcusj@unm.edu		Buchanan, Briggs/0000-0002-5684-9615	National Science Foundation [DEB 0541625]; Rockefeller Foundation; Social Sciences and Humanities Research Council of Canada; University of Missouri	National Science Foundation(National Science Foundation (NSF)); Rockefeller Foundation; Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); University of Missouri	MJH was supported by National Science Foundation grant DEB 0541625 and the Rockefeller Foundation. BB was funded by a Social Sciences and Humanities Research Council of Canada Fellowship and the University of Missouri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PH, 2001, QUATERNARY SCI REV, V20, P93, DOI 10.1016/S0277-3791(00)00129-3; [Anonymous], 2002, DESOLATE LANDSCAPES; Bae K, 2002, RADIOCARBON, V44, P473, DOI 10.1017/S0033822200031842; Bannai M, 1996, AM J PHYS ANTHROPOL, V101, P1, DOI 10.1002/(SICI)1096-8644(199609)101:1<1::AID-AJPA1>3.0.CO;2-Z; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Bradley B, 2004, WORLD ARCHAEOL, V36, P459, DOI 10.1080/0043824042000303656; Brantingham G., 2004, ENTERING AM NE ASIA, P255; Brigham-Grette J, 2001, QUATERNARY SCI REV, V20, P15, DOI 10.1016/S0277-3791(00)00134-7; Chlachula J, 2003, QUATERNARY SCI REV, V22, P1879, DOI 10.1016/S0277-3791(03)00182-3; Dillehay T. D, 1989, PALEOENVIRONMENT SIT, VI; Dixon EJ, 1999, BONES BOATS BISON AR; Dyke AS, 2004, DEV QUA SCI, V2, P373, DOI 10.1016/S1571-0866(04)80209-4; Endicott P, 2009, TRENDS ECOL EVOL, V24, P515, DOI 10.1016/j.tree.2009.04.006; Fagundes NJR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003157; Fort J, 2004, CAMB ARCHAEOL J, V14, P53, DOI 10.1017/S0959774304000046; Fort J, 2003, ANTIQUITY, V77, P520, DOI 10.1017/S0003598X00092577; Fort J., 2009, BRIT ARCHAEOLOGICAL, V1964, P211; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Graf KE, 2009, J ARCHAEOL SCI, V36, P694, DOI 10.1016/j.jas.2008.10.014; Guthrie RD, 2006, NATURE, V441, P207, DOI 10.1038/nature04604; Guthrie RD, 2001, QUATERNARY SCI REV, V20, P549; Hamilton MJ, 2007, P NATL ACAD SCI USA, V104, P15625, DOI 10.1073/pnas.0704215104; Haynes G., 2002, EARLY SETTLEMENT N A; Haynes Jr C.V., 2005, PALEOAMERICAN ORIGIN, P113; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Ho SYW, 2008, AM J HUM GENET, V83, P142, DOI 10.1016/j.ajhg.2008.06.014; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Hoffecker J. F., 2007, HUMAN ECOLOGY BERING; Hoffecker JF, 2005, EVOL ANTHROPOL, V14, P186, DOI 10.1002/evan.20066; Hubberten HW, 2004, QUATERNARY SCI REV, V23, P1333, DOI 10.1016/j.quascirev.2003.12.012; Ikawa-Smith F., 2004, ENTERING AM NE ASIA, P285; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jin HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004210; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Klein R.G., 2009, HUMAN CAREER HUMAN B, V3rd; Kuzmin YV, 2008, J ARCHAEOL RES, V16, P163, DOI 10.1007/s10814-007-9019-6; Kuzmin YV, 1996, J ARCHAEOL SCI, V23, P577, DOI 10.1006/jasc.1996.0054; KUZMIN YV, J HUMAN EVO IN PRESS; Madsen D. B., 2004, ENTERING AM NE ASIA; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Meltzer D. J., 2009, 1 PEOPLES NEW WORLD; Mulligan CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003199; Norton CJ, 2010, QUATERN INT, V211, P113, DOI 10.1016/j.quaint.2009.05.002; Norton CJ, 2009, EVOL ANTHROPOL, V18, P247, DOI 10.1002/evan.20235; Norton CJ, 2000, J HUM EVOL, V38, P803, DOI 10.1006/jhev.1999.0390; O'Connell JF, 2004, J ARCHAEOL SCI, V31, P835, DOI 10.1016/j.jas.2003.11.005; O'Rourke DH, 2010, CURR BIOL, V20, pR202, DOI 10.1016/j.cub.2009.11.051; Ono A, 2002, RADIOCARBON, V44, P477, DOI 10.1017/S0033822200031854; Pavlov P, 2004, J HUM EVOL, V47, P3, DOI 10.1016/j.jhevol.2004.05.002; Pavlov P, 2001, NATURE, V413, P64, DOI 10.1038/35092552; Petraglia M, 2009, P NATL ACAD SCI USA, V106, P12261, DOI 10.1073/pnas.0810842106; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; Pitulko VV, 2004, SCIENCE, V303, P52, DOI 10.1126/science.1085219; Pulquerio MJF, 2007, TRENDS ECOL EVOL, V22, P180, DOI 10.1016/j.tree.2006.11.013; Seong C, 2009, J ANTHROPOL RES, V65, P417, DOI 10.3998/jar.0521004.0065.303; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Steele J, 2009, HUM BIOL, V81, P121, DOI 10.3378/027.081.0302; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166; Weninger B, 2007, CALPAL 2007 COLOGNE; Weninger B, 2004, RADIOCARBON ARCHAEOL, V62, P9; Weninger B, 2008, J HUM EVOL, V55, P772, DOI 10.1016/j.jhevol.2008.08.017	65	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2010	5	8							e12472	10.1371/journal.pone.0012472	http://dx.doi.org/10.1371/journal.pone.0012472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	644KL	20814574	gold, Green Published			2022-12-27	WOS:000281375500007
J	Pugach, P; Krarup, A; Gettie, A; Kuroda, M; Blanchard, J; Piatak, M; Lifson, JD; Trkola, A; Robbiani, M				Pugach, Pavel; Krarup, Anders; Gettie, Agegnehu; Kuroda, Marcelo; Blanchard, James; Piatak, Michael, Jr.; Lifson, Jeffrey D.; Trkola, Alexandra; Robbiani, Melissa			In Vivo Binding and Retention of CD4-Specific DARPin 57.2 in Macaques	PLOS ONE			English	Article							ANKYRIN REPEAT PROTEINS; ANTI-CD4 MONOCLONAL-ANTIBODY; ANTIRETROVIRAL ACTIVITY; VIRUS; LYMPHOCYTES; SELECTION; EFFICACY; TNX-355; TYPE-1	Background: The recently described Designed Ankyrin Repeat Protein (DARPin) technology can produce highly selective ligands to a variety of biological targets at a low production cost. Methodology/Principal Findings: To investigate the in vivo use of DARPins for future application to novel anti-HIV strategies, we identified potent CD4-specific DARPins that recognize rhesus CD4 and followed the fate of intravenously injected CD4-specific DARPin 57.2 in rhesus macaques. The human CD4-specific DARPin 57.2 bound macaque CD4(+) cells and exhibited potent inhibitory activity against SIV infection in vitro. DARPin 57.2 or the control E3_5 DARPin was injected into rhesus macaques and the fate of cell-free and cell-bound CD4-specific DARPin was evaluated. DARPin-bound CD4(+) cells were detected in the peripheral blood as early as 30 minutes after the injection, decreasing within 6 hours and being almost undetectable within 24 hours. The amount of DARPin bound was dependent on the amount of DARPin injected. CD4-specific DARPin was also detected on CD4(+) cells in the lymph nodes within 30 minutes, which persisted with similar kinetics to blood. More extensive analysis using blood revealed that DARPin 57.2 bound to all CD4(+) cell types (T cells, monocytes, dendritic cells) in vivo and in vitro with the amount of binding directly proportional to the amount of CD4 on the cell surface. Cell-free DARPins were also detected in the plasma, but were rapidly cleared from circulation. Conclusions/Significance: We demonstrated that the CD4-specific DARPin can rapidly and selectively bind its target cells in vivo, warranting further studies on possible clinical use of the DARPin technology.	[Pugach, Pavel; Robbiani, Melissa] Populat Council, Ctr Biomed Res, New York, NY 10021 USA; [Gettie, Agegnehu] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Krarup, Anders; Trkola, Alexandra] Univ Zurich Hosp, Div Infect Dis, CH-8091 Zurich, Switzerland; [Kuroda, Marcelo; Blanchard, James] Tulane Univ, Hlth Sci Ctr, Tulane Natl Primate Res Ctr, Covington, LA USA; [Piatak, Michael, Jr.; Lifson, Jeffrey D.] SAIC Frederick Inc, AIDS & Canc Virus Program, Natl Canc Inst, Frederick, MD USA	Population Council; Rockefeller University; University of Zurich; University Zurich Hospital; Tulane University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Pugach, P (corresponding author), Populat Council, Ctr Biomed Res, 1230 York Ave, New York, NY 10021 USA.	mrobbiani@popcouncil.org	Trkola, Alexandra/K-2115-2012	Trkola, Alexandra/0000-0003-1013-876X	Campbell Foundation; National Institutes of Health (NIH) [AI040877, AI084133]; National Cancer Institute, NIH [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084133, R37AI040877, R01AI040877] Funding Source: NIH RePORTER	Campbell Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Campbell Foundation, by National Institutes of Health (NIH) grants AI040877 and AI084133 and in part with federal funds from the National Cancer Institute, NIH, under contract HHSN261200800001E. PP is an F.M. Kirby Foundation fellow. MR is a 2002 and AT is a 2006 Elizabeth Glaser Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Cline AN, 2005, J MED PRIMATOL, V34, P303; Crostarosa F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008060; Jacobson JM, 2009, ANTIMICROB AGENTS CH, V53, P450, DOI 10.1128/AAC.00942-08; Krzywda S, 2004, J BIOL CHEM, V279, P1541, DOI 10.1074/jbc.M310265200; Kuritzkes DR, 2004, J INFECT DIS, V189, P286, DOI 10.1086/380802; Milovnik P, 2009, PROTEIN ENG DES SEL, V22, P357, DOI 10.1093/protein/gzp011; MOREL P, 1993, MOL IMMUNOL, V30, P649, DOI 10.1016/0161-5890(93)90076-N; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Patterson S, 2001, J VIROL, V75, P6710, DOI 10.1128/JVI.75.14.6710-6713.2001; Pugach P, 2004, VIROLOGY, V321, P8, DOI 10.1016/j.virol.2003.12.012; Reimann KA, 1997, AIDS RES HUM RETROV, V13, P933, DOI 10.1089/aid.1997.13.933; Schweizer A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000109; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Stumpp MT, 2007, CURR OPIN DRUG DISC, V10, P153; Teleshova N, 2006, J IMMUNOL, V177, P8531, DOI 10.4049/jimmunol.177.12.8531; Turville SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003162; *UDOHAHS, 1985, GUID CAR US LAB AN, P1; Veazey RS, 2005, NATURE, V438, P99, DOI 10.1038/nature04055; Veesler D, 2009, J BIOL CHEM, V284, P30718, DOI 10.1074/jbc.M109.037812; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Zahnd C, 2006, J BIOL CHEM, V281, P35167, DOI 10.1074/jbc.M602547200; Zahnd C, 2010, CANCER RES, V70, P1595, DOI 10.1158/0008-5472.CAN-09-2724	25	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12455	10.1371/journal.pone.0012455	http://dx.doi.org/10.1371/journal.pone.0012455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805996	Green Published, gold, Green Submitted			2022-12-27	WOS:000281301500021
J	Shaffer, MH; Huang, YP; Corbo, E; Wu, GF; Velez, M; Choi, JK; Saotome, I; Cannon, JL; McClatchey, AI; Sperling, AI; Maltzman, JS; Oliver, PM; Bhandoola, A; Laufer, TM; Burkhardt, JK				Shaffer, Meredith H.; Huang, Yanping; Corbo, Evann; Wu, Gregory F.; Velez, Marielena; Choi, John K.; Saotome, Ichiko; Cannon, Judy L.; McClatchey, Andrea I.; Sperling, Anne I.; Maltzman, Jonathan S.; Oliver, Paula M.; Bhandoola, Avinash; Laufer, Terri M.; Burkhardt, Janis K.			Ezrin Is Highly Expressed in Early Thymocytes, but Dispensable for T Cell Development in Mice	PLOS ONE			English	Article							IMMUNOLOGICAL SYNAPSE; ERM PROTEINS; MOESIN; RADIXIN; CYTOSKELETON; LYMPHOCYTES; DEFECTS; CD43; MICROVILLI; KNOCKOUT	Background: Ezrin/radixin/moesin (ERM) proteins are highly homologous proteins that function to link cargo molecules to the actin cytoskeleton. Ezrin and moesin are both expressed in mature lymphocytes, where they play overlapping roles in cell signaling and polarity, but their role in lymphoid development has not been explored. Methodology/Principal Findings: We characterized ERM protein expression in lymphoid tissues and analyzed the requirement for ezrin expression in lymphoid development. In wildtype mice, we found that most cells in the spleen and thymus express both ezrin and moesin, but little radixin. ERM protein expression in the thymus was differentially regulated, such that ezrin expression was highest in immature thymocytes and diminished during T cell development. In contrast, moesin expression was low in early thymocytes and upregulated during T cell development. Mice bearing a germline deletion of ezrin exhibited profound defects in the size and cellularity of the spleen and thymus, abnormal thymic architecture, diminished hematopoiesis, and increased proportions of granulocytic precursors. Further analysis using fetal liver chimeras and thymic transplants showed that ezrin expression is dispensable in hematopoietic and stromal lineages, and that most of the defects in lymphoid development in ezrin(-/-) mice likely arise as a consequence of nutritional stress. Conclusions/Significance: We conclude that despite high expression in lymphoid precursor cells, ezrin is dispensable for lymphoid development, most likely due to redundancy with moesin.	[Shaffer, Meredith H.; Huang, Yanping; Choi, John K.; Oliver, Paula M.; Burkhardt, Janis K.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Shaffer, Meredith H.; Huang, Yanping; Choi, John K.; Oliver, Paula M.; Burkhardt, Janis K.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Shaffer, Meredith H.; Huang, Yanping; Velez, Marielena; Choi, John K.; Oliver, Paula M.; Bhandoola, Avinash; Burkhardt, Janis K.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Corbo, Evann; Maltzman, Jonathan S.; Laufer, Terri M.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Wu, Gregory F.] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Saotome, Ichiko; McClatchey, Andrea I.] Massachusetts Gen Hosp, Ctr Canc, Dept Pathol, Charlestown, MA USA; [Saotome, Ichiko; McClatchey, Andrea I.] Harvard Univ, Sch Med, Charlestown, MA USA; [Cannon, Judy L.; Sperling, Anne I.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Harvard University; Massachusetts General Hospital; Harvard University; University of Chicago	Shaffer, MH (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	jburkhar@mail.med.upenn.edu	Sperling, Anne/ACZ-2351-2022; Shaffer, Meredith/N-5984-2017; Choi, John Kim/N-7558-2018	Choi, John Kim/0000-0002-2861-0180; Burkhardt, Janis/0000-0002-8176-1375; Sperling, Anne I./0000-0002-4265-9212; Cannon, Judy/0000-0003-0069-8106; Shaffer, Meredith/0000-0002-6982-7968	National Institutes of Health (NIH) [R01 AI50098, P01 CA093615, T32-HD07516-09, T32-GM7229-29]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA093615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093566, R01AI050098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (http://www.nih.gov) grants R01 AI50098 and P01 CA093615 (to J.K.B.) and by NIH training grants T32-HD07516-09 and T32-GM7229-29 (to M. H. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allenspach EJ, 2001, IMMUNITY, V15, P739, DOI 10.1016/S1074-7613(01)00224-2; Bonilha VL, 2006, EXP EYE RES, V82, P720, DOI 10.1016/j.exer.2005.09.013; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Brown MJ, 2003, BLOOD, V102, P3890, DOI 10.1182/blood-2002-12-3807; Cullinan P, 2002, IMMUNOL REV, V189, P111, DOI 10.1034/j.1600-065X.2002.18910.x; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; Doi Y, 1999, J BIOL CHEM, V274, P2315, DOI 10.1074/jbc.274.4.2315; Elmore SA, 2006, TOXICOL PATHOL, V34, P656, DOI 10.1080/01926230600865556; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Garcia GG, 2007, J IMMUNOL, V179, P6403, DOI 10.4049/jimmunol.179.10.6403; Ilani T, 2007, J CELL BIOL, V179, P733, DOI 10.1083/jcb.200707199; Ivetic A, 2002, J BIOL CHEM, V277, P2321, DOI 10.1074/jbc.M109460200; Kikuchi S, 2002, NAT GENET, V31, P320, DOI 10.1038/ng905; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Langbein L, 2003, EUR J CELL BIOL, V82, P385, DOI 10.1078/0171-9335-00330; Lozupone F, 2004, J BIOL CHEM, V279, P9199, DOI 10.1074/jbc.M305561200; LUNDBERG K, 1991, BIOCHEM BIOPH RES CO, V178, P16, DOI 10.1016/0006-291X(91)91773-6; MCPHEE SJ, 2006, PATHOPHYSIOLOGY DIS, pR9; MILLER JFA, 1959, NATURE, V184, P1809, DOI 10.1038/1841809a0; OKAYAMA T, 2008, BIOCH BIOPHYS ACTA; Parlato S, 2000, EMBO J, V19, P5123, DOI 10.1093/emboj/19.19.5123; Potter DA, 1998, J CELL BIOL, V141, P647, DOI 10.1083/jcb.141.3.647; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; SATO N, 1992, J CELL SCI, V103, P131; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Shaffer MH, 2009, J IMMUNOL, V182, P1021, DOI 10.4049/jimmunol.182.2.1021; Shcherbina A, 1999, FEBS LETT, V443, P31, DOI 10.1016/S0014-5793(98)01674-3; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295	30	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12404	10.1371/journal.pone.0012404	http://dx.doi.org/10.1371/journal.pone.0012404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20806059	Green Published, Green Submitted, gold			2022-12-27	WOS:000281301500005
J	Gao, X; Wang, ZY; Martin, J; Abubucker, S; Zhang, X; Mitreva, M; Hawdon, JM				Gao, Xin; Wang, Zhengyuan; Martin, John; Abubucker, Sahar; Zhang, Xu; Mitreva, Makedonka; Hawdon, John M.			Identification of Hookworm DAF-16/FOXO Response Elements and Direct Gene Targets	PLOS ONE			English	Article							DNA-BINDING-SITES; AGE-1 PI3 KINASE; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTOR; ANCYLOSTOMA-CANINUM; CRYSTAL-STRUCTURE; LIFE-SPAN; PROTEIN; LONGEVITY; DIAPAUSE	Background: The infective stage of the parasitic nematode hookworm is developmentally arrested in the environment and needs to infect a specific host to complete its life cycle. The canine hookworm (Ancylostoma caninum) is an excellent model for investigating human hookworm infections. The transcription factor of A. caninum, Ac-DAF-16, which has a characteristic fork head or "winged helix" DNA binding domain (DBD), has been implicated in the resumption of hookworm development in the host. However, the precise roles of Ac-DAF-16 in hookworm parasitism and its downstream targets are unknown. In the present study, we combined molecular techniques and bioinformatics to identify a group of Ac-DAF-16 binding sites and target genes. Methodology/Principal Findings: The DNA binding domain of Ac-DAF-16 was used to select genomic fragments by in vitro genomic selection. Twenty four bound genomic fragments were analyzed for the presence of the DAF-16 family binding element (DBE) and possible alternative Ac-DAF-16 bind motifs. The 22 genes linked to these genomic fragments were identified using bioinformatics tools and defined as candidate direct gene targets of Ac-DAF-16. Their developmental stage-specific expression patterns were examined. Also, a new putative DAF-16 binding element was identified. Conclusions/Significance: Our results show that Ac-DAF-16 is involved in diverse biological processes throughout hookworm development. Further investigation of these target genes will provide insights into the molecular basis by which Ac-DAF-16 regulates its downstream gene network in hookworm infection.	[Gao, Xin; Hawdon, John M.] George Washington Univ, Med Ctr, Dept Microbiol & Trop Med, Washington, DC 20037 USA; [Wang, Zhengyuan; Martin, John; Abubucker, Sahar; Zhang, Xu; Mitreva, Makedonka] Washington Univ, Sch Med, Dept Genet, Genome Ctr, St Louis, MO 63110 USA	George Washington University; Washington University (WUSTL)	Gao, X (corresponding author), George Washington Univ, Med Ctr, Dept Microbiol & Trop Med, Washington, DC 20037 USA.	mtmjmh@gwumc.edu	Wang, Zhengyuan/GWV-6069-2022; Gao, Cyan/O-9316-2014; Hawdon, John/I-1201-2019; wang, zhengyuan/HGA-0435-2022	Hawdon, John/0000-0002-6164-1413; wang, zhengyuan/0000-0002-8447-9674; Mitreva, Makedonka/0000-0001-9572-3436	National Institute of Allergy and Infectious Diseases [1R01AI069293, R01AI081803]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069293, R01AI081803] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants 1R01AI069293 and R01AI081803 from the National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubucker S, 2008, MOL BIOCHEM PARASIT, V157, P187, DOI 10.1016/j.molbiopara.2007.11.001; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brand A, 2004, INT J PARASITOL, V34, P909, DOI 10.1016/j.ijpara.2004.04.003; Brent MM, 2008, STRUCTURE, V16, P1407, DOI 10.1016/j.str.2008.06.013; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gao X, 2009, INT J PARASITOL, V39, P407, DOI 10.1016/j.ijpara.2008.09.005; GOTTLIEB S, 1994, GENETICS, V137, P107; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; HACKER U, 1992, P NATL ACAD SCI USA, V89, P8754, DOI 10.1073/pnas.89.18.8754; Hawdon J.M., 1991, P274; HAWDON JM, 1991, J HELMINTHOL SOC W, V58, P140; Hawdon JM, 2003, INT J PARASITOL, V33, P787, DOI 10.1016/S0020-7519(03)00088-2; HOTEZ P, 1993, PARASITOL TODAY, V9, P23, DOI 10.1016/0169-4758(93)90159-D; Hu M, 2010, INT J PARASITOL, V40, P405, DOI 10.1016/j.ijpara.2009.09.005; Jakobsen MR, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh064; KELLER EB, 1984, P NATL ACAD SCI-BIOL, V81, P7417, DOI 10.1073/pnas.81.23.7417; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kiss JE, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-21; Kojima T, 2006, J BIOSCI BIOENG, V101, P440, DOI 10.1263/jbb.101.440; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Liu JS, 1995, J AM STAT ASSOC, V90, P1156, DOI 10.2307/2291508; Liu Tao, 2004, BMC Developmental Biology, V4; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Martin J, 2009, NUCLEIC ACIDS RES, V37, pD571, DOI 10.1093/nar/gkn744; Massey HC, 2006, INT J PARASITOL, V36, P347, DOI 10.1016/j.ijpara.2005.11.007; Massey HC, 2003, INT J PARASITOL, V33, P1537, DOI 10.1016/S0020-7519(03)00205-4; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Mitreva M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-58; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; NEUWALD AF, 1995, PROTEIN SCI, V4, P1618, DOI 10.1002/pro.5560040820; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; ROGERS WP, 1963, ADV PARASIT, V1, P109, DOI 10.1016/S0065-308X(08)60503-5; Sapio MR, 2005, DEV BIOL, V282, P231, DOI 10.1016/j.ydbio.2005.03.011; Schad G.A., 1982, P361; Shostak Y, 2004, GENE DEV, V18, P2529, DOI 10.1101/gad.1218504; Sleumer MC, 2009, NUCLEIC ACIDS RES, V37, P1323, DOI 10.1093/nar/gkn1041; Staley JP, 2009, CURR OPIN CELL BIOL, V21, P109, DOI 10.1016/j.ceb.2009.01.003; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Tissenbaum HA, 2000, P NATL ACAD SCI USA, V97, P460, DOI 10.1073/pnas.97.1.460; Tissenbaum HA, 1998, GENETICS, V148, P703; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-307; WEBB DC, 1994, PHOSPHATE IN MICROORGANISMS, P37; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5; Whittle CM, 2009, P NATL ACAD SCI USA, V106, P12049, DOI 10.1073/pnas.0812894106; Zhao ZY, 2007, GENETICS, V175, P1407, DOI 10.1534/genetics.106.066720	60	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12289	10.1371/journal.pone.0012289	http://dx.doi.org/10.1371/journal.pone.0012289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808816	Green Published, Green Submitted, gold			2022-12-27	WOS:000281075500021
J	Herrera, GM; Meredith, AL				Herrera, Gerald M.; Meredith, Andrea L.			Diurnal Variation in Urodynamics of Rat	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; NOCTURNAL POLYURIA; CIRCADIAN-RHYTHMS; RENAL-FUNCTION; OVERACTIVE BLADDER; FEMALE RATS; HEART-RATE; ANESTHETICS; KIDNEY; TEMPERATURE	In humans, the storage and voiding functions of the urinary bladder have a characteristic diurnal variation, with increased voiding during the day and urine storage during the night. However, in animal models, the daily functional differences in urodynamics have not been well-studied. The goal of this study was to identify key urodynamic parameters that vary between day and night. Rats were chronically instrumented with an intravesical catheter, and bladder pressure, voided volumes, and micturition frequency were measured by continuous filling cystometry during the light (inactive) or dark (active) phases of the circadian cycle. Cage activity was recorded by video during the experiment. We hypothesized that nocturnal rats entrained to a standard 12: 12 light: dark cycle would show greater ambulatory activity and more frequent, smaller volume micturitions in the dark compared to the light. Rats studied during the light phase had a bladder capacity of 1.44+/-0.21 mL and voided every 8.2+/-1.2 min. Ambulatory activity was lower in the light phase, and rats slept during the recording period, awakening only to urinate. In contrast, rats studied during the dark were more active, had a lower bladder capacities (0.65+/-0.18 mL), and urinated more often (every 3.7+/-0.9 min). Average bladder pressures were not significantly different between the light and dark (13.40+/-2.49 and 12.19+/-2.85 mmHg, respectively). These results identify a day-night difference in bladder capacity and micturition frequency in chronically-instrumented nocturnal rodents that is phase-locked to the normal circadian locomotor activity rhythm of the animal. Furthermore, since it has generally been assumed that the daily hormonal regulation of renal function is a major driver of the circadian rhythm in urination, and few studies have addressed the involvement of the lower urinary tract, these results establish the bladder itself as a target for circadian regulation.	[Herrera, Gerald M.] Catamount Res & Dev Co, St Albans, VT USA; [Herrera, Gerald M.] Med Associates Inc, St Albans, VT USA; [Meredith, Andrea L.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Herrera, GM (corresponding author), Catamount Res & Dev Co, St Albans, VT USA.	ameredith@som.umaryland.edu		Meredith, Andrea/0000-0003-1061-2302	University of Maryland Medical School; NIDDK [R21DK089337]; Catamount Research & Development, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK089337] Funding Source: NIH RePORTER	University of Maryland Medical School; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Catamount Research & Development, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	ALM was supported by University of Maryland Medical School startup funds and NIDDK (R21DK089337). This study was funded by Catamount Research & Development, Inc. GMH is a full-time employee and co-owner of Catamount Research & Development, Inc. and was involved in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartness TJ, 2001, J BIOL RHYTHM, V16, P196, DOI 10.1177/074873001129001908; BUIJSEN JGM, 1994, NEPHROL DIAL TRANSPL, V9, P1330; CHAMBERLAIN PF, 1984, OBSTET GYNECOL, V64, P657; COLWELL CS, 1993, J BIOL RHYTHM, V8, P179, DOI 10.1177/074873049300800301; De Guchtenaere A, 2007, J UROLOGY, V178, P2626, DOI 10.1016/j.juro.2007.08.028; Dispersyn G, 2009, ANESTHESIOLOGY, V110, P1305, DOI 10.1097/ALN.0b013e3181a10225; DORR W, 1992, J UROLOGY, V148, P183, DOI 10.1016/S0022-5347(17)36549-7; Dorr W, 1997, UROL INT, V58, P153; Drake NL, 2005, AM J OBSTET GYNECOL, V192, P1682, DOI 10.1016/j.ajog.2004.11.033; Ghoniem GM, 1996, J UROLOGY, V156, P233, DOI 10.1016/S0022-5347(01)66007-5; GOLDMAN R, 1951, J CLIN INVEST, V30, P1191, DOI 10.1172/JCI102538; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Kalsbeek A, 2006, CHRONOBIOL INT, V23, P201, DOI 10.1080/07420520500464528; Kalsbeek A, 2004, J NEUROSCI, V24, P7604, DOI 10.1523/JNEUROSCI.5328-03.2004; Kelada Ehab, 2007, Archives of Gynecology and Obstetrics, V275, P223, DOI 10.1007/s00404-006-0247-7; Kiddoo DA, 2006, AM J PHYSIOL-REG I, V290, pR1697, DOI 10.1152/ajpregu.00742.2005; KOOPMAN MG, 1985, NETH J MED, V28, P416; Ku JH, 2004, BJU INT, V93, P1005, DOI 10.1111/j.1464-410X.2004.04770.x; LONGHURST PA, 1992, J UROLOGY, V148, P1615, DOI 10.1016/S0022-5347(17)36981-1; Matsuura S, 2000, NEUROUROL URODYNAM, V19, P87, DOI 10.1002/(SICI)1520-6777(2000)19:1<87::AID-NAU9>3.0.CO;2-O; MILLS JN, 1951, J PHYSIOL-LONDON, V113, P528, DOI 10.1113/jphysiol.1951.sp004593; OLIVER JE, 1973, AM J VET RES, V34, P665; Oosting J, 1997, J HYPERTENS, V15, P401, DOI 10.1097/00004872-199715040-00011; Prudian F, 1997, N-S ARCH PHARMACOL, V355, P774, DOI 10.1007/PL00005012; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schmidt F, 2001, NEUROUROL URODYNAM, V20, P287, DOI 10.1002/nau.1006; SHIRLEY DG, 1989, J PHYSIOL-LONDON, V408, P67, DOI 10.1113/jphysiol.1989.sp017447; Sly DJ, 1999, J AUTONOM NERV SYST, V77, P73, DOI 10.1016/S0165-1838(99)00031-4; Smith PP, 2008, NEUROUROL URODYNAM, V27, P324, DOI 10.1002/nau.20512; STEWART FA, 1978, RADIAT RES, V75, P649, DOI 10.2307/3574851; Van Hoeck K, 2007, EUR J PEDIATR, V166, P579, DOI 10.1007/s00431-006-0286-x; VANACKER BAC, 1992, J LAB CLIN MED, V120, P400; Weiss JP, 2002, UROLOGY, V60, P28, DOI 10.1016/S0090-4295(02)01789-2; Weiss JP, 2003, CURR UROL REP, V4, P362, DOI DOI 10.1007/S11934-003-0007-1; WESSON LG, 1964, MEDICINE, V43, P547, DOI 10.1097/00005792-196409000-00002; Zuber AM, 2009, P NATL ACAD SCI USA, V106, P16523, DOI 10.1073/pnas.0904890106	36	38	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12298	10.1371/journal.pone.0012298	http://dx.doi.org/10.1371/journal.pone.0012298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808873	Green Submitted, gold, Green Published			2022-12-27	WOS:000281075500025
J	Barton, MD; Delneri, D; Oliver, SG; Rattray, M; Bergman, CM				Barton, Michael D.; Delneri, Daniela; Oliver, Stephen G.; Rattray, Magnus; Bergman, Casey M.			Evolutionary Systems Biology of Amino Acid Biosynthetic Cost in Yeast	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROTEIN EVOLUTION; GENE-EXPRESSION; SELECTION; RECONSTRUCTION; MINIMIZATION; MODEL; RATES; USAGE	Every protein has a biosynthetic cost to the cell based on the synthesis of its constituent amino acids. In order to optimise growth and reproduction, natural selection is expected, where possible, to favour the use of proteins whose constituents are cheaper to produce, as reduced biosynthetic cost may confer a fitness advantage to the organism. Quantifying the cost of amino acid biosynthesis presents challenges, since energetic requirements may change across different cellular and environmental conditions. We developed a systems biology approach to estimate the cost of amino acid synthesis based on genome-scale metabolic models and investigated the effects of the cost of amino acid synthesis on Saccharomyces cerevisiae gene expression and protein evolution. First, we used our two new and six previously reported measures of amino acid cost in conjunction with codon usage bias, tRNA gene number and atomic composition to identify which of these factors best predict transcript and protein levels. Second, we compared amino acid cost with rates of amino acid substitution across four species in the genus Saccharomyces. Regardless of which cost measure is used, amino acid biosynthetic cost is weakly associated with transcript and protein levels. In contrast, we find that biosynthetic cost and amino acid substitution rates show a strong negative correlation, but for only a subset of cost measures. In the economy of the yeast cell, we find that the cost of amino acid synthesis plays a limited role in shaping transcript and protein expression levels compared to that of translational optimisation. Biosynthetic cost does, however, appear to affect rates of amino acid evolution in Saccharomyces, suggesting that expensive amino acids may only be used when they have specific structural or functional roles in protein sequences. However, as there appears to be no single currency to compute the cost of amino acid synthesis across all cellular and environmental conditions, we conclude that a systems approach is necessary to unravel the full effects of amino acid biosynthetic cost in complex biological systems.	[Barton, Michael D.; Delneri, Daniela; Oliver, Stephen G.; Bergman, Casey M.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Barton, Michael D.] No Kentucky Univ, Dept Biol Sci, Highland Hts, KY 41076 USA; [Oliver, Stephen G.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Rattray, Magnus] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England	University of Manchester; Northern Kentucky University; University of Cambridge; University of Manchester	Barton, MD (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	mail@michaelbarton.me.uk	Bergman, Casey/F-7854-2010; Zeef, Leo/D-6922-2011; Rattray, Magnus/B-4393-2009; Rattray, Magnus/AAE-3297-2021; Oliver, Stephen/AAQ-5992-2021	Bergman, Casey/0000-0002-5462-9854; Rattray, Magnus/0000-0001-8196-5565; Rattray, Magnus/0000-0001-8196-5565; Oliver, Stephen/0000-0003-3410-6439; Barton, Michael/0000-0002-0064-2279; Delneri, Daniela/0000-0001-8070-411X	Natural Environment Research Council [NER/S/R/2005/13609, NE/B500190/1, NER/T/S/2001/00343]; Biotechnology and Biological Sciences Research Council [BB/C008219/1]; Biotechnology and Biological Sciences Research Council [BB/C505140/2, BB/C505140/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Natural Environment Research Council Ph. D. studentship NER/S/R/2005/13609 to MDB, Natural Environment Research Council advanced fellowship NE/B500190/1 to DD, NER/T/S/2001/00343 to SGO, and Biotechnology and Biological Sciences Research Council grant BB/C008219/1 to SGO, MR, and CMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 2003, AUTOMATIC CONTROL IE, V19, P716; Akashi H, 2003, GENETICS, V164, P1291; Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Berkelaar M., IP SOLVE OPEN SOURCE; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; Brauer MJ, 2005, MOL BIOL CELL, V16, P2503, DOI 10.1091/mbc.E04-11-0968; Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057; Carlson RP, 2007, BIOINFORMATICS, V23, P1258, DOI 10.1093/bioinformatics/btm082; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Craig CL, 1998, MOL BIOL EVOL, V15, P774, DOI 10.1093/oxfordjournals.molbev.a025981; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Heizer EM, 2006, MOL BIOL EVOL, V23, P1670, DOI 10.1093/molbev/msl029; Hong EL, 2008, NUCLEIC ACIDS RES, V36, pD577, DOI 10.1093/nar/gkm909; Hurst LD, 2006, NATURE, V442, pE11, DOI 10.1038/nature05137; IKEMURA T, 1982, J MOL BIOL, V158, P573, DOI 10.1016/0022-2836(82)90250-9; Jansen R, 2003, NUCLEIC ACIDS RES, V31, P2242, DOI 10.1093/nar/gkg306; Lee JM, 2006, BRIEF BIOINFORM, V7, P140, DOI 10.1093/bib/bbl007; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; R Core Team, 2018, R LANG ENV STAT COMP; Raiford DW, 2008, J MOL EVOL, V67, P621, DOI 10.1007/s00239-008-9162-9; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Rocha EPC, 2004, MOL BIOL EVOL, V21, P108, DOI 10.1093/molbev/msh004; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Seligmann H, 2003, J MOL EVOL, V56, P151, DOI 10.1007/s00239-002-2388-z; Shlomi T, 2005, P NATL ACAD SCI USA, V102, P7695, DOI 10.1073/pnas.0406346102; Swire J, 2007, J MOL EVOL, V64, P558, DOI 10.1007/s00239-006-0206-8; VARMA A, 1993, APPL ENVIRON MICROB, V59, P2465, DOI 10.1128/AEM.59.8.2465-2473.1993; Wagner A, 2005, MOL BIOL EVOL, V22, P1365, DOI 10.1093/molbev/msi126; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	39	45	47	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e11935	10.1371/journal.pone.0011935	http://dx.doi.org/10.1371/journal.pone.0011935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808905	Green Published, gold			2022-12-27	WOS:000280968100002
J	Zhang, Q; Yang, RY; Tang, JJ; Yang, HS; Hu, SJ; Chen, X				Zhang, Qian; Yang, Ruyi; Tang, Jianjun; Yang, Haishui; Hu, Shuijin; Chen, Xin			Positive Feedback between Mycorrhizal Fungi and Plants Influences Plant Invasion Success and Resistance to Invasion	PLOS ONE			English	Article							SOLIDAGO-CANADENSIS L.; SOIL BIOTA; COMMUNITY STRUCTURE; GROWTH; GRASS; NITROGEN; COLONIZATION; COEXISTENCE; SERPENTINE; DIVERSITY	Negative or positive feedback between arbuscular mycorrhizal fungi (AMF) and host plants can contribute to plant species interactions, but how this feedback affects plant invasion or resistance to invasion is not well known. Here we tested how alterations in AMF community induced by an invasive plant species generate feedback to the invasive plant itself and affect subsequent interactions between the invasive species and its native neighbors. We first examined the effects of the invasive forb Solidago canadensis L. on AMF communities comprising five different AMF species. We then examined the effects of the altered AMF community on mutualisms formed with the native legume forb species Kummerowia striata (Thunb.) Schindl. and on the interaction between the invasive and native plants. The host preferences of the five AMF were also assessed to test whether the AMF form preferred mutualistic relations with the invasive and/or the native species. We found that S. canadensis altered AMF spore composition by increasing one AMF species (Glomus geosporum) while reducing Glomus mosseae, which is the dominant species in the field. The host preference test showed that S. canadensis had promoted the abundance of AMF species (G. geosporum) that most promoted its own growth. As a consequence, the altered AMF community enhanced the competitiveness of invasive S. canadensis at the expense of K. striata. Our results demonstrate that the invasive S. canadensis alters soil AMF community composition because of fungal-host preference. This change in the composition of the AMF community generates positive feedback to the invasive S. canadensis itself and decreases AM associations with native K. striata, thereby making the native K. striata less dominant.	[Zhang, Qian; Yang, Ruyi; Tang, Jianjun; Yang, Haishui; Chen, Xin] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Ruyi] Anhui Normal Univ, Coll Environm Sci, Wuhu, Peoples R China; [Hu, Shuijin] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA	Zhejiang University; Anhui Normal University; University of North Carolina; North Carolina State University	Chen, X (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	chen-tang@zju.edu.cn	Schlyter, Fredrik/F-8567-2015	Schlyter, Fredrik/0000-0002-1244-0308; Hu, Shuijin/0000-0002-3225-5126; Yang, Haishui/0000-0001-7255-9653	Zhejiang Provincial Natural Science Foundation of China [Z5090089]; Research Fund for the Doctoral Program of Higher Education of China (RFDP) [20070335079]; Natural Science Foundation of China (NSFC) [3073020, 30870405]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Research Fund for the Doctoral Program of Higher Education of China (RFDP)(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the Zhejiang Provincial Natural Science Foundation of China (No. Z5090089), the Research Fund for the Doctoral Program of Higher Education of China (RFDP, No. 20070335079), and the Natural Science Foundation of China (NSFC, No. 3073020 and 30870405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batten KM, 2006, BIOL INVASIONS, V8, P217, DOI 10.1007/s10530-004-3856-8; Bever JD, 2009, ECOL LETT, V12, P13, DOI 10.1111/j.1461-0248.2008.01254.x; Bever JD, 2002, PLANT SOIL, V244, P281, DOI 10.1023/A:1020221609080; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Bever JD, 1996, J ECOL, V84, P71, DOI 10.2307/2261701; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Bever JD, 2002, P ROY SOC B-BIOL SCI, V269, P2595, DOI 10.1098/rspb.2002.2162; Bray SR, 2003, ECOL APPL, V13, P565, DOI 10.1890/1051-0761(2003)013[0565:MDAGPA]2.0.CO;2; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P1007, DOI 10.2136/sssaj1993.03615995005700040021x; Callaway RM, 2008, ECOLOGY, V89, P1043, DOI 10.1890/07-0370.1; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Carey EV, 2004, PLANT ECOL, V172, P133, DOI 10.1023/B:VEGE.0000026031.14086.f1; Chen X, 2005, APPL SOIL ECOL, V28, P259, DOI 10.1016/j.apsoil.2004.07.009; Chen X, 2004, AGR ECOSYST ENVIRON, V102, P377, DOI 10.1016/j.agee.2003.08.006; Cornejo P, 2004, FEMS MICROBIOL LETT, V241, P265, DOI 10.1016/j.femsle.2004.10.030; Eom AH, 2000, OECOLOGIA, V122, P435, DOI 10.1007/s004420050050; Fransen B, 2001, ECOLOGY, V82, P2534, DOI 10.1890/0012-9658(2001)082[2534:SNHACB]2.0.CO;2; GERDEMANN J. W., 1963, TRANS BRIT MYCOL SOC, V46, P235; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hausmann NT, 2009, NEW PHYTOL, V183, P1188, DOI 10.1111/j.1469-8137.2009.02882.x; Hawkes CV, 2006, PLANT SOIL, V281, P369, DOI 10.1007/s11104-005-4826-3; Hu S, 2001, NATURE, V409, P188, DOI 10.1038/35051576; Jansa J, 2008, NEW PHYTOL, V177, P779, DOI 10.1111/j.1469-8137.2007.02294.x; Kiers ET, 2006, ECOLOGY, V87, P1627, DOI 10.1890/0012-9658(2006)87[1627:MSITAM]2.0.CO;2; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Kowalchuk GA, 2002, MOL ECOL, V11, P571, DOI 10.1046/j.0962-1083.2001.01457.x; Liang ZB, 2008, SOIL BIOL BIOCHEM, V40, P956, DOI 10.1016/j.soilbio.2007.11.016; Lu JZ, 2007, ACTA PHYTOTAXON SIN, V45, P670, DOI 10.1360/aps06200; Marler MJ, 1999, ECOLOGY, V80, P1180, DOI 10.1890/0012-9658(1999)080[1180:MIECEO]2.0.CO;2; Moora M, 2004, FUNCT ECOL, V18, P554, DOI 10.1111/j.0269-8463.2004.00876.x; Mummey DL, 2006, PLANT SOIL, V288, P81, DOI 10.1007/s11104-006-9091-6; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Olsen S. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P403; PLENCHETTE C, 1983, PLANT SOIL, V70, P199, DOI 10.1007/BF02374780; Reinhart KO, 2006, NEW PHYTOL, V170, P445, DOI 10.1111/j.1469-8137.2006.01715.x; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Schechter SP, 2008, MOL ECOL, V17, P3198, DOI 10.1111/j.1365-294X.2008.03828.x; SCHEUBLIN TR, 2007, J ECOL, V85, P2682; Seifert EK, 2009, ECOLOGY, V90, P1055, DOI 10.1890/08-0419.1; SEMPLE JC, 2006, FLORA N AM MAGNOLI 2; SEMPLE JC, 2006, FLORA N AM MAGNOLI 7; SIMON L, 1992, APPL ENVIRON MICROB, V58, P291, DOI 10.1128/AEM.58.1.291-295.1992; Stampe ED, 2003, OIKOS, V100, P362, DOI 10.1034/j.1600-0706.2003.12006.x; Stinson KA, 2006, PLOS BIOL, V4, P727, DOI 10.1371/journal.pbio.0040140; Sykorova Z, 2007, APPL ENVIRON MICROB, V73, P5426, DOI 10.1128/AEM.00987-07; Tanaka Y, 2005, PLANT CELL ENVIRON, V28, P1247, DOI 10.1111/j.1365-3040.2005.01360.x; Tang J.J., 2009, B SCI TECHNOLOGY, V25, P233; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van der Heijden MGA, 2003, NEW PHYTOL, V157, P569, DOI 10.1046/j.1469-8137.2003.00688.x; van der Putten WH, 2007, ECOLOGY, V88, P978, DOI 10.1890/06-1051; Vandenkoornhuyse P, 2003, MOL ECOL, V12, P3085, DOI 10.1046/j.1365-294X.2003.01967.x; Vogelsang KM, 2009, ECOLOGY, V90, P399, DOI 10.1890/07-2144.1; Weber E, 2001, CONSERV BIOL, V15, P122, DOI 10.1046/j.1523-1739.2001.99424.x; Yang RY, 2007, ALLELOPATHY J, V19, P241; ZANBINKI CA, 2002, FUNCT ECOL, V16, P758; Zhang Q, 2007, ALLELOPATHY J, V20, P71; Zhang SS, 2009, APPL SOIL ECOL, V41, P215, DOI 10.1016/j.apsoil.2008.11.002	60	126	144	8	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12380	10.1371/journal.pone.0012380	http://dx.doi.org/10.1371/journal.pone.0012380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20548795	Green Submitted, gold, Green Published			2022-12-27	WOS:000281154300014
J	Burl, S; Adetifa, UJ; Cox, M; Touray, E; Whittle, H; McShane, H; Rowland-Jones, SL; Flanagan, KL				Burl, Sarah; Adetifa, Uche J.; Cox, Momodou; Touray, Ebrima; Whittle, Hilton; McShane, Helen; Rowland-Jones, Sarah L.; Flanagan, Katie L.			The Tuberculin Skin Test (TST) Is Affected by Recent BCG Vaccination but Not by Exposure to Non-Tuberculosis Mycobacteria (NTM) during Early Life	PLOS ONE			English	Article							CALMETTE-GUERIN VACCINATION; IMMUNE-RESPONSES; T-CELLS; REACTIVITY; HYPERSENSITIVITY; INTERLEUKIN-10; DEPRESSION; ANERGY	The tuberculin skin test (TST) is widely used in TB clinics to aid Mycobacterium tuberculosis (M.tb) diagnosis, but the definition and the significance of a positive test in very young children is still unclear. This study compared the TST in Gambian children at 41/2 months of age who either received BCG vaccination at birth (Group 1) or were BCG naive (Group 2) in order to examine the role of BCG vaccination and/or exposure to environmental mycobacteria in TST reactivity at this age. Nearly half of the BCG vaccinated children had a positive TST (>= 5 mm) whereas all the BCG naive children were non-reactive, confirming that recent BCG vaccination affects TST reactivity. The BCG naive children demonstrated in vitro PPD responses in peripheral blood in the absence of TST reactivity, supporting exposure to and priming by environmental mycobacterial antigens. Group 2 were then vaccinated at 41/2 months of age and a repeat TST was performed at 20-28 months of age. Positive reactivity (>= 5 mm) was evident in 11.1% and 12.5% infants from Group 1 and Group 2 respectively suggesting that the timing of BCG vaccination had little effect by this age. We further assessed for immune correlates in peripheral blood at 41/2 months of age. Mycobacterial specific IFN gamma responses were greater in TST responders than in non-responders, although the size of induration did not correlate with IFN gamma. However the IFN gamma: IL-10 ratio positively correlated with TST induration suggesting that the relationship between PPD induced IFN gamma and IL-10 in the peripheral blood may be important in controlling TST reactivity. Collectively these data provide further insights into how the TST is regulated in early life, and how a positive response might be interpreted.	[Burl, Sarah; Adetifa, Uche J.; Cox, Momodou; Touray, Ebrima; Whittle, Hilton; Flanagan, Katie L.] Med Res Council UK Gambia, Fajara, Gambia; [McShane, Helen] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [McShane, Helen] Univ Oxford, Jenner Inst, Oxford, England; [Rowland-Jones, Sarah L.] Univ Oxford, WIMM, Oxford, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of Oxford; Jenner Institute; University of Oxford	Burl, S (corresponding author), Med Res Council UK Gambia, Fajara, Gambia.	sburl0712@gmail.com		Levy, Ofer/0000-0002-5859-1945; Flanagan, Katie/0000-0002-1575-1953; McShane, Helen/0000-0002-2126-5142	Medical Research Council (MRC), The Gambia; MRC [MC_UP_A900_1115, MC_UP_A900_1122, MC_U190081990] Funding Source: UKRI; Medical Research Council [MC_U190081990, MC_U190085854] Funding Source: researchfish	Medical Research Council (MRC), The Gambia(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by The Medical Research Council (MRC), The Gambia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRODY JA, 1964, NEW ENGL J MED, V271, P1294, DOI 10.1056/NEJM196412172712505; BURL S, 2010, J IMMUNOLOG IN PRESS; Cavani A, 2003, J IMMUNOL, V171, P5760, DOI 10.4049/jimmunol.171.11.5760; Chan PC, 2008, INT J TUBERC LUNG D, V12, P1401; CORRAH PT, 1994, THESIS OPEN U FAJARA; Davids V, 2006, J INFECT DIS, V193, P531, DOI 10.1086/499825; Delgado JC, 2002, P NATL ACAD SCI USA, V99, P7576, DOI 10.1073/pnas.062056099; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; FINNEY O, 2009, THESIS U LONDON LOND; Floyd S, 2000, INT J TUBERC LUNG D, V4, P1133; Ildirim I, 1995, PEDIATR INFECT DIS J, V14, P1060, DOI 10.1097/00006454-199512000-00006; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Martins MVBS, 2007, TUBERCULOSIS, V87, P202, DOI 10.1016/j.tube.2006.07.006; Menzies D, 2000, CLIN INFECT DIS, V31, pS71, DOI 10.1086/314075; MENZIES R, 1992, AM REV RESPIR DIS, V145, P621, DOI 10.1164/ajrccm/145.3.621; Miles DJC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002905; MiretCuadras P, 1996, TUBERCLE LUNG DIS, V77, P52, DOI 10.1016/S0962-8479(96)90076-3; Mitchell AG, 1935, AM J DIS CHILD, V49, P695, DOI 10.1001/archpedi.1935.01970030141012; Nadler R, 2003, CLIN EXP IMMUNOL, V131, P206, DOI 10.1046/j.1365-2249.2003.02071.x; Newport MJ, 2004, GENES IMMUN, V5, P122, DOI 10.1038/sj.gene.6364051; Okan F, 2006, INT J TUBERC LUNG D, V10, P1337; Ota MOC, 2006, J TROP PEDIATRICS, V52, P136, DOI 10.1093/tropej/fmi087; PESANTI EL, 1994, AM J RESP CRIT CARE, V149, P1699, DOI 10.1164/ajrccm.149.6.7710481; RODYSILL KJ, 1989, J AM GERIATR SOC, V37, P435, DOI 10.1111/j.1532-5415.1989.tb02640.x; Santiago EM, 2003, PEDIATRICS, V112, pE298, DOI 10.1542/peds.112.4.e298; SEPULVEDA RL, 1994, TUBERCLE LUNG DIS, V75, P138, DOI 10.1016/0962-8479(94)90043-4; Shingadia D, 2003, LANCET INFECT DIS, V3, P624, DOI 10.1016/S1473-3099(03)00771-0; Sigmundsdottir H, 2004, CLIN IMMUNOL, V111, P119, DOI 10.1016/j.clim.2004.01.003; STARR S, 1964, PEDIATRICS, V33, P769; STARR S, 1964, NEW ENGL J MED, V270, P386, DOI 10.1056/NEJM196402202700802; Sterne JAC, 1996, TUBERCLE LUNG DIS, V77, P117, DOI 10.1016/S0962-8479(96)90025-8; *UNICEF, 2005, GLANC GAMB STAT; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; WEIR RE, 1994, J IMMUNOL METHODS, V176, P93, DOI 10.1016/0022-1759(94)90353-0	34	109	112	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12287	10.1371/journal.pone.0012287	http://dx.doi.org/10.1371/journal.pone.0012287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	21533209	Green Published, gold, Green Submitted			2022-12-27	WOS:000281075500019
J	Truman, JP; Garcia-Barros, M; Kaag, M; Hambardzumyan, D; Stancevic, B; Chan, M; Fuks, Z; Kolesnick, R; Haimovitz-Friedman, A				Truman, Jean-Philip; Garcia-Barros, Monica; Kaag, Matthew; Hambardzumyan, Dolores; Stancevic, Branka; Chan, Michael; Fuks, Zvi; Kolesnick, Richard; Haimovitz-Friedman, Adriana			Endothelial Membrane Remodeling Is Obligate for Anti-Angiogenic Radiosensitization during Tumor Radiosurgery	PLOS ONE			English	Article							RADIATION-INDUCED APOPTOSIS; FIBROBLAST-GROWTH-FACTOR; ACID SPHINGOMYELINASE; CERAMIDE SYNTHASE; LNCAP CELLS; MICE; RADIOTHERAPY; RAFTS; NORMALIZATION; INHIBITION	Background: While there is significant interest in combining anti-angiogenesis therapy with conventional anti-cancer treatment, clinical trials have as of yet yielded limited therapeutic gain, mainly because mechanisms of anti-angiogenic therapy remain to a large extent unknown. Currently, anti-angiogenic tumor therapy is conceptualized to either "normalize" dysfunctional tumor vasculature, or to prevent recruitment of circulating endothelial precursors into the tumor. An alternative biology, restricted to delivery of anti-angiogenics immediately prior to single dose radiotherapy (radiosurgery), is provided in the present study. Methodology/Principal Findings: Genetic data indicate an acute wave of ceramide-mediated endothelial apoptosis, initiated by acid sphingomyelinase (ASMase), regulates tumor stem cell response to single dose radiotherapy, obligatory for tumor cure. Here we show VEGF prevented radiation-induced ASMase activation in cultured endothelium, occurring within minutes after radiation exposure, consequently repressing apoptosis, an event reversible with exogenous C(16)-ceramide. Anti-VEGFR2 acts conversely, enhancing ceramide generation and apoptosis. In vivo, MCA/129 fibrosarcoma tumors were implanted in asmase(+/+) mice or asmase(-/-) littermates and irradiated in the presence or absence of anti-VEGFR2 DC101 or anti-VEGF G6-31 antibodies. These anti-angiogenic agents, only if delivered immediately prior to single dose radiotherapy, de-repressed radiation-induced ASMase activation, synergistically increasing the endothelial apoptotic component of tumor response and tumor cure. Anti-angiogenic radiosensitization was abrogated in tumors implanted in asmase(-/-) mice that provide apoptosis-resistant vasculature, or in wild-type littermates pre-treated with anti-ceramide antibody, indicating that ceramide is necessary for this effect. Conclusions/Significance: These studies show that angiogenic factors fail to suppress apoptosis if ceramide remains elevated while anti-angiogenic therapies fail without ceramide elevation, defining a ceramide rheostat that determines outcome of single dose radiotherapy. Understanding the temporal sequencing of anti-angiogenic drugs and radiation enables optimized radiosensitization and design of innovative radiosurgery clinical trials.	[Truman, Jean-Philip; Fuks, Zvi; Haimovitz-Friedman, Adriana] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; [Garcia-Barros, Monica; Stancevic, Branka; Kolesnick, Richard] Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, New York, NY 10021 USA; [Kaag, Matthew] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Hambardzumyan, Dolores] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Chan, Michael] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Wake Forest University	Truman, JP (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA.	a-haimovitz-friedman@ski.mskcc.org			National Institutes of Health [R01 CA105125, R01 CA085704]; D.K. Ludwig Fund for Cancer Research	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); D.K. Ludwig Fund for Cancer Research	This work was supported by National Institutes of Health R01 CA105125 to Adriana Haimovitz-Friedman, NIH R01 CA085704 to Richard Kolesnick, and a gift from the Virginia and D.K. Ludwig Fund for Cancer Research to Zvi Fuks. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bocci G, 2001, MOL HUM REPROD, V7, P771, DOI 10.1093/molehr/7.8.771; Cremesti A, 2001, J BIOL CHEM, V276, P23954, DOI 10.1074/jbc.M101866200; Ferrara N, 1999, CURR TOP MICROBIOL, V237, P1; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fuks Z, 2005, CANCER CELL, V8, P89, DOI 10.1016/j.ccr.2005.07.014; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Garzotto M, 1999, CANCER RES, V59, P5194; Garzotto M, 1998, CANCER RES, V58, P2260; Geng L, 2001, CANCER RES, V61, P2413; Goggel R, 2004, NAT MED, V10, P155, DOI 10.1038/nm977; Grassme H, 2003, ONCOGENE, V22, P5457, DOI 10.1038/sj.onc.1206540; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Gulbins E, 2004, J MOL MED, V82, P357, DOI 10.1007/s00109-004-0539-y; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; HAIMOVITZFRIEDMAN A, 1991, CANCER RES, V51, P2552; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; KIM JH, 1986, CANCER RES, V46, P1120; Kolesnick R, 2003, ONCOGENE, V22, P5897, DOI 10.1038/sj.onc.1206702; Korsisaari N, 2007, P NATL ACAD SCI USA, V104, P10625, DOI 10.1073/pnas.0704213104; Lacour S, 2004, CANCER RES, V64, P3593, DOI 10.1158/0008-5472.CAN-03-2787; MCCAMMON R, 2008, INT J RAD ONCOL BIOL; Nix M, 2000, CELL DEATH DIFFER, V7, P413, DOI 10.1038/sj.cdd.4400666; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pena LA, 2000, CANCER RES, V60, P321; Rotolo JA, 2005, J BIOL CHEM, V280, P26425, DOI 10.1074/jbc.M414569200; Rotolo JA, 2008, INT J RADIAT ONCOL, V70, P804, DOI 10.1016/j.ijrobp.2007.11.043; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Sessa C, 2008, NAT CLIN PRACT ONCOL, V5, P378, DOI 10.1038/ncponc1150; Siejka A, 2003, LIFE SCI, V72, P2473, DOI 10.1016/S0024-3205(03)00164-4; Tabas I, 1999, CHEM PHYS LIPIDS, V102, P123, DOI 10.1016/S0009-3084(99)00080-8; UCHIDA K, 1994, AM J PHYSIOL, V266, P81; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Witte L, 1998, CANCER METAST REV, V17, P155, DOI 10.1023/A:1006094117427; Yamada Y, 2008, INT J RADIAT ONCOL, V71, P484, DOI 10.1016/j.ijrobp.2007.11.046; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200	39	94	97	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12310	10.1371/journal.pone.0012310	http://dx.doi.org/10.1371/journal.pone.0012310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20941382	Green Published, gold, Green Submitted			2022-12-27	WOS:000281075500027
J	Tang, YQ; Jaganath, IB; Sekaran, SD				Tang, Yin-Quan; Jaganath, Indu Bala; Sekaran, Shamala Devi			Phyllanthus spp. Induces Selective Growth Inhibition of PC-3 and MeWo Human Cancer Cells through Modulation of Cell Cycle and Induction of Apoptosis	PLOS ONE			English	Article							PROSTATE-CANCER; AMARUS; EXPRESSION; ACID; EXTRACT; PLANTS	Background: Phyllanthus is a traditional medicinal plant that has been used in the treatment of many diseases including hepatitis and diabetes. The main aim of the present work was to investigate the potential cytotoxic effects of aqueous and methanolic extracts of four Phyllanthus species (P. amarus, P. niruri, P. urinaria and P. watsonii) against skin melanoma and prostate cancer cells. Methodology/Principal Findings: Phyllanthus plant appears to possess cytotoxic properties with half-maximal inhibitory concentration (IC50) values of 150-300 mu g/ml for aqueous extract and 50-150 mu g/ml for methanolic extract that were determined using the MTS reduction assay. In comparison, the plant extracts did not show any significant cytotoxicity on normal human skin (CCD-1127Sk) and prostate (RWPE-1) cells. The extracts appeared to act by causing the formation of a clear "ladder'' fragmentation of apoptotic DNA on agarose gel, displayed TUNEL-positive cells with an elevation of caspase-3 and -7 activities. The Lactate Dehydrogenase (LDH) level was lower than 15% in Phyllanthus treated-cancer cells. These indicate that Phyllanthus extracts have the ability to induce apoptosis with minimal necrotic effects. Furthermore, cell cycle analysis revealed that Phyllanthus induced a Go/G1-phase arrest on PC-3 cells and a S-phase arrest on MeWo cells and these were accompanied by accumulation of cells in the Sub-G1 (apoptosis) phase. The cytotoxic properties may be due to the presence of polyphenol compounds such as ellagitannins, gallotannins, flavonoids and phenolic acids found both in the water and methanol extract of the plants. Conclusions/Significance: Phyllanthus plant exerts its growth inhibition effect in a selective manner towards cancer cells through the modulation of cell cycle and induction of apoptosis via caspases activation in melanoma and prostate cancer cells. Hence, Phyllanthus may be sourced for the development of a potent apoptosis-inducing anticancer agent.	[Tang, Yin-Quan; Sekaran, Shamala Devi] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Jaganath, Indu Bala] MARDI, Ctr Biotechnol, Serdang, Malaysia	Universiti Malaya; Institute Penyelidikan Dan Kemajuan Pertanian	Tang, YQ (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	shamalamy@yahoo.com	tang, yin/GXZ-6989-2022; Devi, Shamala Devi/B-9735-2010; Tang, Yin-Quan/J-5859-2013; Sekaran, Shamala Devi/B-8482-2008; Tang, Yin-Quan/K-5725-2017	Devi, Shamala Devi/0000-0002-0478-0425; Sekaran, Shamala Devi/0000-0002-0478-0425; Tang, Yin-Quan/0000-0001-7327-2830; Jaganath, Indu/0000-0002-3272-9598	University Malaya [UM PS183/2009B]; Malaysian Agricultural and Research Development Institute (MARDI) [53-02-03-1002]	University Malaya(Universiti Malaya); Malaysian Agricultural and Research Development Institute (MARDI)	This study was funded by the Postgraduate Research Grant, University Malaya (UM PS183/2009B)(www.um.edu.my) and Malaysian Agricultural and Research Development Institute (MARDI) (53-02-03-1002)(www.mardi.gov.my). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM CANC SOC, 2009, CANC FACTS FIG 2009, P19; Asha VV, 2007, FITOTERAPIA, V78, P134, DOI 10.1016/j.fitote.2006.10.009; Baek SJ, 2004, CARCINOGENESIS, V25, P2425, DOI 10.1093/carcin/bgh255; BLUMBERG BS, 1990, VACCINE, V8, pS86, DOI 10.1016/0264-410X(90)90225-B; *CANC RES UK, 2010, SKIN CANC UK INC STA; Che XH, 2010, BASIC CLIN PHARMACOL, V106, P30, DOI 10.1111/j.1742-7843.2009.00465.x; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; CRAGG GM, 2007, BIOACTIVE NATURAL PR; Deichmann M, 1999, J CLIN ONCOL, V17, P1891, DOI 10.1200/JCO.1999.17.6.1891; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Faried A, 2007, INT J ONCOL, V30, P605; Guchelaar H J, 1992, Clin Oncol (R Coll Radiol), V4, P388, DOI 10.1016/S0936-6555(05)81134-3; Hastak K, 2005, FASEB J, V19, P789, DOI 10.1096/fj.04-2226fje; Huang ST, 2004, LIFE SCI, V75, P339, DOI 10.1016/j.lfs.2003.12.013; Jeena KJ, 1999, CANCER LETT, V136, P11, DOI 10.1016/S0304-3835(98)00294-8; Ji BC, 2009, J AGR FOOD CHEM, V57, P7596, DOI 10.1021/jf901308p; Jin UH, 2005, LIFE SCI, V77, P2760, DOI 10.1016/j.lfs.2005.02.028; Kasibhatla S, 2003, MOL CANCER THER, V2, P573; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim SJ, 2006, BIOCHEM BIOPH RES CO, V339, P463, DOI 10.1016/j.bbrc.2005.11.040; Kloucek P, 2005, J ETHNOPHARMACOL, V99, P309, DOI 10.1016/j.jep.2005.01.062; Lansky EP, 2005, INVEST NEW DRUG, V23, P11, DOI 10.1023/B:DRUG.0000047101.02178.07; Lee CD, 1996, EUR J CLIN INVEST, V26, P1069, DOI 10.1046/j.1365-2362.1996.410595.x; Madson JG, 2009, AM J PATHOL, V174, P2357, DOI 10.2353/ajpath.2009.080638; Maecker HL, 2000, CANCER RES, V60, P4638; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mailloux A, 2001, EUR J CELL BIOL, V80, P442, DOI 10.1078/0171-9335-00171; Mazumder A, 2006, NAT PROD RES, V20, P323, DOI 10.1080/14786410600650404; Mazunder UK, 2005, EURO B DRUG RES, V13, P15; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; Ott M, 1997, EUR J CLIN INVEST, V27, P908, DOI 10.1046/j.1365-2362.1997.2020749.x; Prakash A, 1995, PHYTOTHER RES, V9, P594, DOI 10.1002/ptr.2650090813; Puri N, 2004, FASEB J, V18, P1373, DOI 10.1096/fj.04-1774com; Rajeshkumar NV, 2000, J ETHNOPHARMACOL, V73, P215, DOI 10.1016/S0378-8741(00)00311-1; Rajeshkumar NV, 2002, J ETHNOPHARMACOL, V81, P17, DOI 10.1016/S0378-8741(01)00419-6; RAPHAEL KR, 2002, J EXP BIOL, V40, P905; Ren WY, 2003, MED RES REV, V23, P519, DOI 10.1002/med.10033; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Shoeb M., 2006, BANGL J PHARMACOL, V1, P35, DOI [10.3329/bjp.v1i2.486, DOI 10.3329/BJP.V1I2.486]; Soini Y, 1998, AM J PATHOL, V153, P1041, DOI 10.1016/S0002-9440(10)65649-0; Sun J, 2006, CANCER LETT, V241, P124, DOI 10.1016/j.canlet.2005.10.027; VARMA A, 2009, ECAM IN PRESS; VENKATESWARAN PS, 1997, P NATL ACAD SCI USA, V84, P274; WINGO PA, 1995, CA-CANCER J CLIN, V45, P8, DOI 10.3322/canjclin.45.1.8; Zhang Z, 2003, P NATL ACAD SCI USA, V100, P11636, DOI 10.1073/pnas.1934692100; Zhou MX, 2002, J PHARMACOL EXP THER, V303, P124, DOI 10.1124/jpet.102.037192; Zhou S, 1997, Zhongguo Zhong Yao Za Zhi, V22, P109	47	105	108	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12644	10.1371/journal.pone.0012644	http://dx.doi.org/10.1371/journal.pone.0012644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IV	20838625	Green Published, gold, Green Submitted			2022-12-27	WOS:000281687100013
J	Li, K; Wang, R; Lozada, E; Fan, W; Orren, DK; Luo, JY				Li, Kai; Wang, Rui; Lozada, Enerlyn; Fan, Wei; Orren, David K.; Luo, Jianyuan			Acetylation of WRN Protein Regulates Its Stability by Inhibiting Ubiquitination	PLOS ONE			English	Article							WERNER-SYNDROME PROTEIN; DNA-REPAIR; RECQ HELICASES; SYNDROME GENE; TRANSCRIPTION; DAMAGE; DEACETYLATION; LOCALIZATION; COACTIVATOR; MUTATIONS	Background: WRN is a multi-functional protein involving DNA replication, recombination and repair. WRN acetylation has been demonstrated playing an important role in response to DNA damage. We previously found that WRN acetylation can regulate its enzymatic activities and nuclear distribution. Methodology/Principal Finding: Here, we investigated the factors involved in WRN acetylation and found that CBP and p300 are the only major acetyltransferases for WRN acetylation. We further identified 6 lysine residues in WRN that are subject to acetylation. Interestingly, WRN acetylation can increase its protein stability. SIRT1-mediated deacetylation of WRN reverses this effect. CBP dramatically increases the half-life of wild type WRN, while mutation of these 6 lysine residues (WRN-6KR) abrogates this increase. We further found that WRN stability is regulated by the ubiquitination pathway and WRN acetylation by CBP significantly reduces its ubiquitination. Importantly, we found that WRN is strongly acetylated and stabilized in response to mitomycin C (MMC) treatment. H1299 cells stably expressing WRN-6KR, which mimics unacetylated WRN, display significantly higher MMC sensitivity compared with the cells expressing wild-type WRN. Conclusion/Significance: Taken together, these data demonstrate that WRN acetylation regulates its stability and has significant implications regarding the role of acetylation on WRN function in response to DNA damage.	[Li, Kai; Wang, Rui; Fan, Wei; Luo, Jianyuan] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Li, Kai; Wang, Rui; Fan, Wei; Luo, Jianyuan] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA USA; [Lozada, Enerlyn; Orren, David K.] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Kentucky	Li, K (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA.	Jianyuan.luo@umassmed.edu	Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914	National Institutes of Health National Institute on Aging (NIH/NIA) [R01AG026534, R01AG027258]; NATIONAL CANCER INSTITUTE [R01CA113371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026534, R01AG027258] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Aging (NIH/NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institutes of Health National Institute on Aging (NIH/NIA) grant R01AG026534 to J. Luo and R01AG027258 to D. Orren. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blander G, 2002, J BIOL CHEM, V277, P50934, DOI 10.1074/jbc.M210479200; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; Ge XJ, 2009, MOL BIOL CELL, V20, P419, DOI 10.1091/mbc.E08-08-0792; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Inari A, 2004, J BIOL CHEM, V279, P30830, DOI 10.1074/jbc.M402403200; Kahyo T, 2008, FEBS LETT, V582, P2479, DOI 10.1016/j.febslet.2008.06.031; Karmakar P, 2005, MECH AGEING DEV, V126, P1146, DOI 10.1016/j.mad.2005.06.004; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kusumoto R, 2007, MECH AGEING DEV, V128, P50, DOI 10.1016/j.mad.2006.11.010; Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097; Lee JW, 2005, MECH AGEING DEV, V126, P79, DOI 10.1016/j.mad.2004.09.011; Li K, 2008, J BIOL CHEM, V283, P7590, DOI 10.1074/jbc.M709707200; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25; MARTIN GM, 1970, LAB INVEST, V23, P86; Muftuoglu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001918; Mushegian AR, 1997, P NATL ACAD SCI USA, V94, P5831, DOI 10.1073/pnas.94.11.5831; Ogburn CE, 1997, HUM GENET, V101, P121, DOI 10.1007/s004390050599; Poot M, 2001, FASEB J, V15, P1224, DOI 10.1096/fj.00-0611fje; Rausa FM, 2004, J BIOL CHEM, V279, P43070, DOI 10.1074/jbc.M407472200; Singh DK, 2009, BIOGERONTOLOGY, V10, P235, DOI 10.1007/s10522-008-9205-z; STEFANINI M, 1989, MUTAT RES, V219, P179, DOI 10.1016/0921-8734(89)90013-1; Vaitiekunaite R, 2007, MECH AGEING DEV, V128, P650, DOI 10.1016/j.mad.2007.09.004; Wang R, 2005, J BIOL CHEM, V280, P11528, DOI 10.1074/jbc.M413930200; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	27	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10341	10.1371/journal.pone.0010341	http://dx.doi.org/10.1371/journal.pone.0010341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20808827	Green Published, Green Submitted, gold			2022-12-27	WOS:000277079300021
J	Zhang, Y; Zhu, SL; Yan, DM; Liu, GY; Bai, RY; Wang, DY; Chen, L; Zhu, H; An, HQ; Kew, O; Xu, WB				Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Kew, Olen; Xu, Wenbo			Natural Type 3/Type 2 Intertypic Vaccine-Related Poliovirus Recombinants with the First Crossover Sites within the VP1 Capsid Coding Region	PLOS ONE			English	Article							POLIOMYELITIS; GENOMES; VIRUS; CHILD; CIRCULATION; SEROTYPE-2; SEQUENCES; OUTBREAK; MUTATION; STRAINS	Background: Ten uncommon natural type 3/type 2 intertypic poliovirus recombinants were isolated from stool specimens from nine acute flaccid paralysis case patients and one healthy vaccinee in China from 2001 to 2008. Principal Findings: Complete genomic sequences revealed their vaccine-related genomic features and showed that their first crossover sites were randomly distributed in the 39 end of the VP1 coding region. The length of donor Sabin 2 sequences ranged from 55 to 136 nucleotides, which is the longest donor sequence reported in the literature for this type of poliovirus recombination. The recombination resulted in the introduction of Sabin 2 neutralizing antigenic site 3a (NAg3a) into a Sabin 3 genomic background in the VP1 coding region, which may have been altered by some of the type 3-specific antigenic properties, but had not acquired any type 2-specific characterizations. NAg3a of the Sabin 3 strain seems atypical; other wild-type poliovirus isolates that have circulated in recent years have sequences of NAg3a more like the Sabin 2 strain. Conclusions: 10 natural type 3/type 2 intertypic VP1 capsid-recombinant polioviruses, in which the first crossover sites were found to be in the VP1 coding region, were isolated and characterized. In spite of the complete replacement of NAg3a by type 2-specific amino acids, the serotypes of the recombinants were not altered, and they were totally neutralized by polyclonal type 3 antisera but not at all by type 2 antisera. It is possible that recent type 3 wild poliovirus isolates may be a recombinant having NAg3a sequences derived from another strain during between 1967 and 1980, and the type 3/type 2 recombination events in the 39 end of the VP1 coding region may result in a higher fitness.	[Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China; [Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China; [Bai, Ruyin] Taishan Med Univ, Taishan City, Peoples R China; [Kew, Olen] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Shandong First Medical University & Shandong Academy of Medical Sciences; Centers for Disease Control & Prevention - USA	Zhang, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China.	wenbo_xu1@yahoo.com.cn	zijlstra, andries/G-4564-2013; Zhang, Yiqiang/D-9613-2012; zhang, yong jie/B-9054-2009	zijlstra, andries/0000-0001-8460-8803; Li, Tao-Sheng/0000-0002-7653-8873; Zhang, Yiqiang/0000-0003-0691-6645; zhang, yong jie/0000-0002-6331-2189; Waisman, David/0000-0002-5097-9662; Zhang, Yong/0000-0002-2692-5437	National Key Technology R&D Program of China [2008BAI56B00]; National Key Science and Technology Projects of China [2008ZX10004-008]; World Health Organization [I8/181/978]; NATIONAL CANCER INSTITUTE [K01CA120711] Funding Source: NIH RePORTER	National Key Technology R&D Program of China(National Key Technology R&D Program); National Key Science and Technology Projects of China; World Health Organization(World Health Organization); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Key Technology R&D Program of China (Project No. 2008BAI56B00), National Key Science and Technology Projects of China (Project No. 2008ZX10004-008), and a grant I8/181/978 from the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JP, 1997, J INFECT DIS, V175, pS176, DOI 10.1093/infdis/175.Supplement_1.S176; BALANANT J, 1991, VIROLOGY, V184, P645, DOI 10.1016/0042-6822(91)90434-D; Belnap DM, 2000, P NATL ACAD SCI USA, V97, P73, DOI 10.1073/pnas.97.1.73; Blomqvist S, 2004, J VIROL, V78, P4876, DOI 10.1128/JVI.78.9.4876-4883.2004; Blomqvist S, 2003, J GEN VIROL, V84, P573, DOI 10.1099/vir.0.18708-0; Cuervo NS, 2001, J VIROL, V75, P5740, DOI 10.1128/JVI.75.13.5740-5751.2001; Dedepsidis E, 2008, FEMS IMMUNOL MED MIC, V52, P343, DOI 10.1111/j.1574-695X.2008.00381.x; Freistadt MS, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-28; Friedrich F, 1996, ACTA VIROL, V40, P27; FURIONE M, 1993, VIROLOGY, V196, P199; HIRST GK, 1962, COLD SPRING HARB SYM, V27, P303, DOI 10.1101/SQB.1962.027.001.028; JARVIS TC, 1992, EMBO J, V11, P3135, DOI 10.1002/j.1460-2075.1992.tb05386.x; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Karakasiliotis L, 2004, MOL CELL PROBE, V18, P103, DOI 10.1016/j.mcp.2003.09.009; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2004, B WORLD HEALTH ORGAN, V82, P16; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; KOHARA M, 1988, J VIROL, V62, P2828, DOI 10.1128/JVI.62.8.2828-2835.1988; KOHARA M, 1985, J VIROL, V53, P786, DOI 10.1128/JVI.53.3.786-792.1985; Liang XF, 2006, J INFECT DIS, V194, P545, DOI 10.1086/506359; LIPSKAYA GY, 1991, J MED VIROL, V35, P290, DOI 10.1002/jmv.1890350415; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Martin J, 2002, J VIROL, V76, P10921, DOI 10.1128/JVI.76.21.10921-10928.2002; Martinez CV, 2004, J INFECT DIS, V190, P409, DOI 10.1086/421703; MINOR PD, 1986, J GEN VIROL, V67, P1283, DOI 10.1099/0022-1317-67-7-1283; MINOR PD, 1989, J GEN VIROL, V70, P1117, DOI 10.1099/0022-1317-70-5-1117; MINOR PD, 1992, J GEN VIROL, V73, P3065, DOI 10.1099/0022-1317-73-12-3065; MINOR PD, 1993, DEV BIOL STAND, V78, P17; Minor P, 2009, VACCINE, V27, P2649, DOI 10.1016/j.vaccine.2009.02.071; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; Rousset D, 2003, EMERG INFECT DIS, V9, P885; Shahmahmoodi S, 2008, VIRUS RES, V137, P168, DOI 10.1016/j.virusres.2008.07.006; Shimizu H, 2004, J VIROL, V78, P13512, DOI 10.1128/JVI.78.24.13512-13521.2004; Stanway G, 2005, VIRUS TAXONOMY, P757; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao ZX, 2010, VIRUS RES, V150, P56, DOI 10.1016/j.virusres.2010.02.014; TOYODA H, 1984, J MOL BIOL, V174, P561, DOI 10.1016/0022-2836(84)90084-6; VANDERAVOORT HGAM, 1995, J CLIN MICROBIOL, V33, P2562, DOI 10.1128/JCM.33.10.2562-2566.1995; World Health Organization, 2004, POL LAB MAN, V4th; YANG CF, 1992, VIRUS RES, V24, P277, DOI 10.1016/0168-1702(92)90124-R; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; Zhang Y, 2010, J GEN VIROL, V91, P421, DOI 10.1099/vir.0.014258-0; Zhang Y, 2010, ARCH VIROL, V155, P197, DOI 10.1007/s00705-009-0564-9	43	190	199	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15300	10.1371/journal.pone.0015300	http://dx.doi.org/10.1371/journal.pone.0015300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	20463924	Green Published, gold, Green Submitted			2022-12-27	WOS:000285576900026
J	Zhang, Y; Schulte, W; Pink, D; Phipps, K; Zijlstra, A; Lewis, JD; Waisman, DM				Zhang, Yi; Schulte, Wendy; Pink, Desmond; Phipps, Kyle; Zijlstra, Andries; Lewis, John D.; Waisman, David Morton			Sensitivity of Cancer Cells to Truncated Diphtheria Toxin	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; ACUTE MYELOID-LEUKEMIA; FACTOR FUSION PROTEIN; GROWTH-FACTOR; DENILEUKIN DIFTITOX; CYNOMOLGUS MONKEYS; MOUSE MODEL; IN-VIVO; EXPRESSION; CYTOTOXICITY	Background: Diphtheria toxin (DT) has been utilized as a prospective anti-cancer agent for the targeted delivery of cytotoxic therapy to otherwise untreatable neoplasia. DT is an extremely potent toxin for which the entry of a single molecule into a cell can be lethal. DT has been targeted to cancer cells by deleting the cell receptor-binding domain and combining the remaining catalytic portion with targeting proteins that selectively bind to the surface of cancer cells. It has been assumed that "receptorless'' DT cannot bind to and kill cells. In the present study, we report that "receptorless'' recombinant DT385 is in fact cytotoxic to a variety of cancer cell lines. Methods: In vitro cytotoxicity of DT385 was measured by cell proliferation, cell staining and apoptosis assays. For in vivo studies, the chick chorioallantoic membrane (CAM) system was used to evaluate the effect of DT385 on angiogenesis. The CAM and mouse model system was used to evaluate the effect of DT385 on HEp3 and Lewis lung carcinoma (LLC) tumor growth, respectively. Results: Of 18 human cancer cell lines tested, 15 were affected by DT385 with IC(50) ranging from 0.12-2.8 mu M. Furthermore, high concentrations of DT385 failed to affect growth arrested cells. The cellular toxicity of DT385 was due to the inhibition of protein synthesis and induction of apoptosis. In vivo, DT385 diminished angiogenesis and decreased tumor growth in the CAM system, and inhibited the subcutaneous growth of LLC tumors in mice. Conclusion: DT385 possesses anti-angiogenic and anti-tumor activity and may have potential as a therapeutic agent.	[Zhang, Yi; Phipps, Kyle; Waisman, David Morton] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Zhang, Yi; Phipps, Kyle; Waisman, David Morton] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Schulte, Wendy; Pink, Desmond; Zijlstra, Andries; Lewis, John D.] Innovascreen Inc, Halifax, NS, Canada; [Zijlstra, Andries] Vanderbilt Univ, Dept Pathol, Nashville, TN USA; [Lewis, John D.] Univ Western Ontario, Dept Oncol, London, ON, Canada	Dalhousie University; Dalhousie University; Vanderbilt University; Western University (University of Western Ontario)	Zhang, Y (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	david.waisman@dal.ca	zijlstra, andries/G-4564-2013; Zhang, Yiqiang/D-9613-2012; zhang, yong jie/B-9054-2009	zijlstra, andries/0000-0001-8460-8803; Li, Tao-Sheng/0000-0002-7653-8873; Zhang, Yiqiang/0000-0003-0691-6645; zhang, yong jie/0000-0002-6331-2189; Waisman, David/0000-0002-5097-9662; Zhang, Yong/0000-0002-2692-5437	Nova Scotia Health Research Foundation (NSHRF); Dalhousie University; NCIC/Terry Fox Foundation [018176]; NATIONAL CANCER INSTITUTE [K01CA120711] Funding Source: NIH RePORTER	Nova Scotia Health Research Foundation (NSHRF); Dalhousie University; NCIC/Terry Fox Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the Nova Scotia Health Research Foundation (NSHRF). YZ is supported by a studentship from the Cancer Research Training Program, Dalhousie University. JDL is supported by grant #018176 from the NCIC/Terry Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley RG, 2003, CANCER RES, V63, P5866; BENITEZKING G, 1989, J CELL SCI, V93, P53; Black JH, 2003, LEUKEMIA, V17, P155, DOI 10.1038/sj.leu.2402744; CHADWICK DE, 1993, LEUKEMIA LYMPHOMA, V11, P249, DOI 10.3109/10428199309087002; Chan CH, 1996, BLOOD, V88, P1445, DOI 10.1182/blood.V88.4.1445.bloodjournal8841445; Cherepanov P, 2000, FASEB J, V14, P1389, DOI 10.1096/fj.14.10.1389; Cohen KA, 2004, LEUKEMIA LYMPHOMA, V45, P1647, DOI 10.1080/10428190410001663572; COLLIER RJ, 1975, BACTERIOL REV, V39, P54, DOI 10.1128/MMBR.39.1.54-85.1975; Duvic M, 2008, FUTURE ONCOL, V4, P457, DOI 10.2217/14796694.4.4.457; Falnes PO, 1998, EMBO J, V17, P615, DOI 10.1093/emboj/17.2.615; Feuring-Buske M, 2000, EXP HEMATOL, V28, P1390, DOI 10.1016/S0301-472X(00)00542-7; FITZGERALD D, 1989, J NATL CANCER I, V81, P1455, DOI 10.1093/jnci/81.19.1455; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; GILL DM, 1973, J BIOL CHEM, V248, P654; Gonzalez-Moreno O, 2005, INT J CANCER, V114, P870, DOI 10.1002/ijc.20789; Hall PD, 1999, LEUKEMIA, V13, P629, DOI 10.1038/sj.leu.2401357; Hogge DE, 2006, CLIN CANCER RES, V12, P1284, DOI 10.1158/1078-0432.CCR-05-2070; HONJO T, 1971, J BIOL CHEM, V246, P4251; Hotchkiss CE, 1999, TOXICOL APPL PHARM, V158, P152, DOI 10.1006/taap.1999.8691; IWAMOTO R, 1994, EMBO J, V13, P2322, DOI 10.1002/j.1460-2075.1994.tb06516.x; KIND C, 1975, ANAT EMBRYOL, V147, P127, DOI 10.1007/BF00306727; Kreitman RJ, 2006, AAPS J, V8, pE532, DOI 10.1208/aapsj080363; Kwon M, 2001, BIOCHEMISTRY-US, V40, P13246, DOI 10.1021/bi0113420; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; Li G, 2002, P NATL ACAD SCI USA, V99, P832, DOI 10.1073/pnas.022649699; MADSHUS IH, 1992, CURR TOP MICROBIOL, V175, P1; Mercapide J, 2002, CLIN CANCER RES, V8, P1740; MOYNIHAN MR, 1981, INFECT IMMUN, V32, P575, DOI 10.1128/IAI.32.2.575-582.1981; MURPHY JR, 1986, P NATL ACAD SCI USA, V83, P8258, DOI 10.1073/pnas.83.21.8258; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; PAPPENHEIMER AM, 1993, PROTEIN SCI, V2, P292; Ramage JG, 2003, LEUKEMIA RES, V27, P79, DOI 10.1016/S0145-2126(02)00077-2; Ramakrishnan S, 1996, CANCER RES, V56, P1324; Turturro F, 2007, EXPERT REV ANTICANC, V7, P11, DOI 10.1586/14737140.7.1.11; Urieto JO, 2004, PROTEIN EXPRES PURIF, V33, P123, DOI 10.1016/j.pep.2003.09.003; Wild R, 2004, BREAST CANCER RES TR, V85, P161, DOI 10.1023/B:BREA.0000025407.02896.ec; WILLIAMS DP, 1990, J BIOL CHEM, V265, P20673; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; Zijlstra A, 2004, J BIOL CHEM, V279, P27633, DOI 10.1074/jbc.M313617200; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	40	190	199	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10498	10.1371/journal.pone.0010498	http://dx.doi.org/10.1371/journal.pone.0010498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463924	Green Submitted, Green Published, gold			2022-12-27	WOS:000277379400031
